data_2k3f_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k3f _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.798 ' HD2' ' HG3' ' A' ' 62' ' ' GLU . 17.1 mmtt . . . . . 0 N--CA 1.438 -1.027 0 N-CA-C 108.695 -0.854 . . . . 10.0 108.695 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.0 t -72.97 122.99 26.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 110.251 -0.277 . . . . 10.0 110.251 -174.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.57 -32.82 11.24 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.961 -0.755 . . . . 10.0 108.961 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -168.02 -168.28 0.95 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.33 -0.85 . . . . 10.0 113.214 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.533 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 78.5 mt-30 -143.84 135.54 26.2 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 114.015 -1.448 . . . . 10.0 108.689 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.904 HG23 ' HG ' ' A' ' 28' ' ' LEU . 1.3 mm -122.89 83.52 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 119.03 -0.509 . . . . 10.0 109.767 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -78.0 138.72 38.97 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 120.513 1.506 . . . . 10.0 109.231 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.646 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -154.15 132.0 11.59 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.333 -0.618 . . . . 10.0 109.333 -171.725 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.495 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 19.8 pt20 -94.04 109.87 21.6 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.525 -0.917 . . . . 10.0 108.525 171.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.646 ' HG ' ' HB3' ' A' ' 11' ' ' LEU . 94.7 mt -130.1 135.95 28.26 Favored Pre-proline 0 CA--C 1.496 -1.097 0 CA-C-O 121.553 0.692 . . . . 10.0 112.51 -165.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.659 ' HB2' ' CB ' ' A' ' 17' ' ' LYS . 28.0 Cg_exo -58.56 120.67 8.7 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 123.054 2.503 . . . . 10.0 111.914 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' A' ' 50' ' ' ALA . . . -62.77 127.66 32.3 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 114.696 -1.138 . . . . 10.0 108.139 171.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.71 4.4 65.96 Favored Glycine 0 CA--C 1.525 0.704 0 O-C-N 126.003 2.064 . . . . 10.0 113.123 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.659 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . 2.6 mmmm -147.32 29.52 0.96 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.393 1.257 . . . . 10.0 114.393 -172.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.47 150.41 36.67 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.472 1.033 . . . . 10.0 110.155 175.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.51 ' C ' ' H ' ' A' ' 21' ' ' ALA . 15.3 t -177.69 140.3 0.43 Allowed Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 121.422 0.629 . . . . 10.0 110.861 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.49 ' HD2' ' HA ' ' A' ' 19' ' ' THR . 2.8 Cg_endo -42.17 23.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.478 0.581 1 C-N-CA 129.474 6.783 . . . . 10.0 117.463 176.18 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.619 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . . . -57.88 174.22 0.34 Allowed Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 107.997 -1.112 . . . . 10.0 107.997 163.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.619 ' HD2' ' HB2' ' A' ' 21' ' ' ALA . 57.5 Cg_exo -37.3 -42.69 1.04 Allowed 'Trans proline' 0 CA--C 1.548 1.184 0 C-N-CA 122.407 2.071 . . . . 10.0 114.043 177.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.59 ' HB2' HG22 ' A' ' 24' ' ' VAL . 27.2 Cg_exo -38.11 -71.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 123.744 2.962 . . . . 10.0 115.572 167.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 1.042 HG13 HD11 ' A' ' 35' ' ' ILE . 62.0 t -89.05 -54.68 7.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 114.013 -1.448 . . . . 10.0 114.043 -159.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.17 -65.41 2.94 Favored Glycine 0 C--O 1.228 -0.222 0 CA-C-N 114.616 -1.174 . . . . 10.0 112.992 -175.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -55.84 -43.75 54.13 Favored 'Trans proline' 0 C--O 1.222 -0.312 0 C-N-CA 123.092 2.528 . . . . 10.0 112.429 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.448 ' HB1' ' CG2' ' A' ' 9' ' ' ILE . . . -53.28 -78.09 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.401 0.619 . . . . 10.0 111.414 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.904 ' HG ' HG23 ' A' ' 9' ' ' ILE . 2.1 mt -66.94 -45.89 76.4 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.172 0.804 . . . . 10.0 113.172 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.26 -39.98 96.76 Favored Glycine 0 N--CA 1.459 0.18 0 CA-C-N 116.103 -0.499 . . . . 10.0 112.899 -174.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -60.84 -26.69 67.53 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.233 -0.284 . . . . 10.0 110.233 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -99.25 16.58 22.42 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.47 0.652 . . . . 10.0 109.895 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.26 4.57 86.23 Favored Glycine 0 CA--C 1.499 -0.957 0 CA-C-N 114.748 -1.115 . . . . 10.0 113.216 167.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.695 HG12 ' CD2' ' A' ' 66' ' ' PHE . 3.4 t -81.33 146.36 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 113.301 0.852 . . . . 10.0 113.301 -172.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.401 ' HB2' ' HB2' ' A' ' 37' ' ' GLU . 90.8 m-20 -70.31 96.7 1.15 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.256 0.622 . . . . 10.0 110.5 172.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 1.042 HD11 HG13 ' A' ' 24' ' ' VAL . 13.7 mm -55.54 -38.67 50.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-O 122.078 0.942 . . . . 10.0 112.188 177.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.457 ' SD ' ' N ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -70.01 -43.25 71.73 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 113.476 -1.693 . . . . 10.0 112.432 177.191 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.621 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 14.2 mt-10 -54.81 -50.0 69.62 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 118.988 -1.085 . . . . 10.0 109.437 170.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.6 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 77.8 t80 -53.87 -56.5 17.12 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 114.031 1.123 . . . . 10.0 114.031 175.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.3 t -58.71 -48.31 81.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.719 -1.128 . . . . 10.0 111.193 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.411 ' HE3' ' HB2' ' A' ' 40' ' ' LYS . 49.3 mtmt -66.86 -23.34 66.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 118.602 -1.239 . . . . 10.0 108.971 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.799 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 55.2 mtt180 -74.54 -64.68 0.98 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.093 -0.958 . . . . 10.0 111.776 173.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.731 ' HZ ' ' HB2' ' A' ' 54' ' ' LEU . 67.2 t80 -55.05 -45.6 75.27 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-O 121.165 0.507 . . . . 10.0 110.554 -174.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.628 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.8 OUTLIER -59.69 -52.49 65.26 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.209 -0.905 . . . . 10.0 110.23 -177.319 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.82 -39.75 95.25 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 119.56 -0.856 . . . . 10.0 112.014 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.799 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 11.2 mt-10 -69.02 -36.72 78.09 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.635 0.731 . . . . 10.0 111.407 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.52 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 72.7 p -91.34 4.33 52.66 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.856 -1.066 . . . . 10.0 112.036 -173.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.53 -36.48 15.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.764 -1.107 . . . . 10.0 112.543 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.2 p-10 -81.99 -37.36 26.72 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 115.224 -0.898 . . . . 10.0 111.434 -175.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.51 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 36.8 mttp -95.41 22.17 7.26 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.039 -0.726 . . . . 10.0 109.039 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -56.51 154.81 8.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.662 -1.154 . . . . 10.0 113.581 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.47 17.2 53.5 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 110.035 -1.226 . . . . 10.0 110.035 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.508 ' HB2' HD23 ' A' ' 54' ' ' LEU . 22.0 mmt -136.11 126.66 26.98 Favored 'General case' 0 C--O 1.207 -1.164 0 C-N-CA 116.11 -2.236 . . . . 10.0 114.032 -165.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.471 HG23 ' HB2' ' A' ' 12' ' ' GLN . 46.2 mm -67.09 91.0 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 121.763 -0.586 . . . . 10.0 109.549 170.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.731 ' HB2' ' HZ ' ' A' ' 42' ' ' PHE . 3.7 mt -76.96 130.7 74.91 Favored Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 122.183 0.193 . . . . 10.0 110.593 -176.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -74.94 95.34 0.97 Allowed 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.384 2.056 . . . . 10.0 111.553 173.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.409 HG23 HG12 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -99.52 158.2 3.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 119.016 0.826 . . . . 10.0 111.972 -172.41 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.421 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 96.3 t -135.42 120.17 27.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.312 -0.403 . . . . 10.0 110.207 171.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.7 HD12 HD23 ' A' ' 28' ' ' LEU . 14.8 mt -106.15 141.68 20.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 119.595 -0.842 . . . . 10.0 108.897 -175.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 68.1 m -125.39 99.98 6.29 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.043 -0.981 . . . . 10.0 109.024 175.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.48 ' HA ' ' CB ' ' A' ' 66' ' ' PHE . 2.8 p -89.18 137.94 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.003 0 C-N-CA 123.653 0.781 . . . . 10.0 111.095 -178.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 84.8 m-85 -98.94 171.05 8.3 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 122.17 0.986 . . . . 10.0 112.753 -176.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.798 ' HG3' ' HD2' ' A' ' 4' ' ' LYS . 3.0 mm-40 -53.15 -26.24 16.27 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.389 -1.732 . . . . 10.0 113.2 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.441 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 28.7 m-20 -78.09 -12.38 59.99 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.485 -0.486 . . . . 10.0 111.14 -176.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER 84.1 4.94 0.72 Allowed 'General case' 0 CA--C 1.508 -0.672 0 O-C-N 124.558 1.161 . . . . 10.0 108.917 -163.237 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.425 ' O ' HG21 ' A' ' 60' ' ' VAL . 6.2 p -71.02 172.5 8.98 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 113.504 -1.68 . . . . 10.0 107.916 171.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.695 ' CD2' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -169.86 -176.31 2.31 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 120.147 1.339 . . . . 10.0 109.825 174.277 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.6 p -160.11 168.61 25.12 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 102.944 -2.984 . . . . 10.0 102.944 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.414 ' CB ' HG12 ' A' ' 58' ' ' ILE . 45.6 p90 -161.43 158.79 27.27 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 109.125 -0.694 . . . . 10.0 109.125 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.421 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 22.2 pt -128.04 162.06 34.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 106.923 -1.51 . . . . 10.0 106.923 -176.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.53 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 2.6 mt -135.8 117.39 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 107.379 -1.341 . . . . 10.0 107.379 -175.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.609 ' HA ' ' OD1' ' A' ' 115' ' ' ASP . 0.3 OUTLIER -79.27 84.77 5.17 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 123.408 0.442 . . . . 10.0 110.516 -171.069 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.733 ' HB ' ' HG2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -49.17 99.04 0.2 Allowed Pre-proline 0 C--N 1.313 -0.981 0 CA-C-N 114.413 -1.267 . . . . 10.0 108.989 167.202 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.498 ' HG2' ' HB2' ' A' ' 77' ' ' PHE . 38.3 Cg_endo -74.74 174.22 13.06 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.136 2.558 . . . . 10.0 113.932 -158.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.459 ' HD2' ' CB ' ' A' ' 73' ' ' PRO . 86.8 Cg_exo -26.21 -60.69 0.07 OUTLIER 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 125.129 3.886 . . . . 10.0 114.466 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 128' ' ' ILE . . . -171.43 -23.95 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.519 0.933 . . . . 10.0 113.519 175.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.723 ' HA ' ' HE3' ' A' ' 135' ' ' MET . 35.3 p -47.03 -43.35 19.63 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.177 0.513 . . . . 10.0 111.914 -173.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.56 ' HB3' HD22 ' A' ' 78' ' ' LEU . 13.0 t80 -47.79 -68.02 0.22 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.631 -1.168 . . . . 10.0 112.574 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.937 ' HB3' HD12 ' A' ' 108' ' ' ILE . 2.3 mm? -85.02 -11.31 55.7 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.567 -171.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.402 HD11 ' HE2' ' A' ' 135' ' ' MET . 39.6 mt -72.33 -25.42 61.55 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.344 -0.543 . . . . 10.0 109.549 172.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 76' ' ' SER . 34.7 mmtp -59.32 -50.88 72.29 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.788 -1.19 . . . . 10.0 107.788 166.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -67.76 33.05 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 114.057 -1.428 . . . . 10.0 113.578 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.458 ' CB ' HG12 ' A' ' 100' ' ' VAL . . . -170.48 -60.35 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.668 0.747 . . . . 10.0 112.732 -172.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.289 -2.027 0 CA-C-N 113.464 -1.698 . . . . 10.0 108.942 179.663 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 CA--C 1.538 0.489 0 CA-C-O 121.278 0.561 . . . . 10.0 112.094 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -160.13 174.07 36.85 Favored Glycine 0 CA--C 1.5 -0.894 0 N-CA-C 107.929 -2.069 . . . . 10.0 107.929 178.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.876 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -149.37 173.02 13.98 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-O 122.629 1.204 . . . . 10.0 111.429 -164.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.458 HG12 ' CB ' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -150.73 -143.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 CA-C-N 111.982 -2.372 . . . . 10.0 105.986 -173.378 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.517 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 0.1 OUTLIER -164.93 144.66 7.05 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 107.48 -1.304 . . . . 10.0 107.48 -160.188 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.584 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 9.0 mmm180 -44.27 -43.5 7.39 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 124.241 0.963 . . . . 10.0 111.741 -177.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -57.89 -44.72 86.88 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.329 0.585 . . . . 10.0 111.539 176.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.717 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.1 OUTLIER -60.04 -47.25 86.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.219 -0.901 . . . . 10.0 108.702 178.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.892 HG22 ' HB ' ' A' ' 128' ' ' ILE . 26.2 mm -43.31 -55.34 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 CA-C-N 115.093 -0.958 . . . . 10.0 110.939 171.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.801 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 8.4 tt0 -49.2 -57.36 6.85 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 114.494 -1.23 . . . . 10.0 112.946 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -53.4 -59.63 4.33 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 124.057 0.848 . . . . 10.0 110.878 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.937 HD12 ' HB3' ' A' ' 78' ' ' LEU . 10.0 mm -46.88 -51.88 4.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.992 -1.004 . . . . 10.0 110.646 172.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.468 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -53.31 -40.29 64.67 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.655 -0.702 . . . . 10.0 112.554 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.801 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 50.3 mttm -70.87 -53.42 15.22 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.172 -0.467 . . . . 10.0 110.561 -174.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.641 HG23 ' HG3' ' A' ' 112' ' ' LYS . 7.7 t -55.99 -35.32 66.65 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.727 -0.67 . . . . 10.0 112.567 -176.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.749 ' HD3' HD21 ' A' ' 78' ' ' LEU . 8.7 mtmp? -103.08 17.36 24.24 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.057 0.456 . . . . 10.0 110.762 -176.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.732 ' HG3' ' HB1' ' A' ' 118' ' ' ALA . 50.4 ttm -49.65 -45.33 78.73 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.374 -0.83 . . . . 10.0 112.372 176.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 113' ' ' MET . 42.2 Cg_endo -64.62 -25.67 61.86 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 121.65 1.567 . . . . 10.0 112.569 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.609 ' OD1' ' HA ' ' A' ' 71' ' ' LYS . 12.8 m-20 -89.46 -50.9 5.83 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 114.936 -1.029 . . . . 10.0 111.16 -175.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 9.1 mp -64.06 -3.55 2.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.441 -1.254 . . . . 10.0 111.754 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 115' ' ' ASP . 64.4 t30 59.6 51.42 6.42 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.262 -1.335 . . . . 10.0 109.851 177.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.732 ' HB1' ' HG3' ' A' ' 113' ' ' MET . . . -80.78 116.64 20.88 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 113.873 -1.512 . . . . 10.0 112.651 -172.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -65.91 -41.88 90.89 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.314 -0.995 . . . . 10.0 108.314 168.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.0 p -149.76 143.54 25.47 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 106.922 -1.511 . . . . 10.0 106.922 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.587 HD13 ' HB2' ' A' ' 124' ' ' ALA . 66.9 tp -52.16 -33.02 38.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.225 1.195 . . . . 10.0 114.225 -176.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -50.15 -37.76 36.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.329 0.585 . . . . 10.0 110.885 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.14 -50.17 56.33 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 119.047 -1.061 . . . . 10.0 110.916 175.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.587 ' HB2' HD13 ' A' ' 121' ' ' LEU . . . -57.49 -38.7 75.01 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 120.762 -0.375 . . . . 10.0 110.736 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.548 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 89.1 mtp -56.0 -37.22 68.84 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.674 0.39 . . . . 10.0 111.425 177.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -63.08 -48.34 79.02 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.04 -0.527 . . . . 10.0 109.729 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.5 mt -51.17 -62.67 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 CA-C-O 121.464 0.65 . . . . 10.0 111.245 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.892 ' HB ' HG22 ' A' ' 105' ' ' ILE . 15.9 mm -49.84 -57.02 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 CA-C-N 114.189 -1.368 . . . . 10.0 111.152 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.604 ' HG3' HG13 ' A' ' 105' ' ' ILE . 3.9 mt-10 -54.04 -47.28 71.74 Favored 'General case' 0 N--CA 1.436 -1.149 0 O-C-N 124.097 0.873 . . . . 10.0 110.069 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.5 -46.64 61.65 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.463 -0.875 . . . . 10.0 111.51 -173.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.475 HG22 ' HB1' ' A' ' 75' ' ' ALA . 90.2 m -47.6 -60.29 2.65 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.188 -1.006 . . . . 10.0 108.601 170.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -48.0 -53.07 17.37 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.954 0.502 . . . . 10.0 111.852 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 129' ' ' GLU . 43.4 mtpt -50.23 -50.28 50.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.002 178.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.8 m -66.31 -31.39 72.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.945 0.403 . . . . 10.0 111.031 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.723 ' HE3' ' HA ' ' A' ' 76' ' ' SER . 48.8 mtm -81.4 4.08 22.14 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.795 1.035 . . . . 10.0 113.795 -178.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 81.0 18.83 68.75 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 119.657 1.117 . . . . 10.0 111.586 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.497 ' CD1' ' HE1' ' A' ' 135' ' ' MET . 23.3 mt -105.21 127.69 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 CA-C-O 121.146 0.498 . . . . 10.0 111.513 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.876 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -89.14 157.13 18.4 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.475 -0.784 . . . . 10.0 109.585 179.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.7 m -116.35 132.1 66.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.5 -0.926 . . . . 10.0 108.5 170.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.608 ' O ' ' HB2' ' A' ' 141' ' ' ASP . 26.9 m -133.94 69.65 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 116.057 1.873 . . . . 10.0 116.057 -175.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.608 ' HB2' ' O ' ' A' ' 140' ' ' VAL . 3.6 t0 . . . . . 0 C--N 1.296 -1.745 0 CA-C-O 117.864 -1.065 . . . . 10.0 109.012 141.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.514 ' HD3' ' H ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.464 0 CA-C-O 121.501 0.667 . . . . 10.0 110.699 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.2 t -73.79 141.3 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.581 -0.736 . . . . 10.0 110.649 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.31 -45.51 4.08 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.307 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.54 152.17 25.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.51 1.3 . . . . 10.0 114.51 -174.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.768 HE21 ' HA ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -92.55 133.14 36.24 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.514 -1.221 . . . . 10.0 107.852 170.184 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.607 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -123.09 83.16 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.348 -0.612 . . . . 10.0 109.348 174.365 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.439 ' HG2' HG23 ' A' ' 57' ' ' VAL . 52.8 mttp -77.27 132.24 38.57 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 120.807 1.639 . . . . 10.0 108.921 172.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.783 HD13 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -158.58 125.6 4.86 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 122.336 1.065 . . . . 10.0 111.689 -179.236 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.454 ' HG2' ' HA ' ' A' ' 55' ' ' PRO . 28.8 mt-30 -83.5 121.56 27.36 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.132 -1.395 . . . . 10.0 110.59 -172.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.783 HD21 HD13 ' A' ' 11' ' ' LEU . 88.2 mt -138.64 144.36 41.78 Favored Pre-proline 0 CA--C 1.507 -0.687 0 CA-C-O 121.484 0.659 . . . . 10.0 111.96 -170.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.77 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 4.3 Cg_exo -65.98 126.97 16.77 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 123.467 2.778 . . . . 10.0 111.655 176.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.715 ' HB3' HD12 ' A' ' 54' ' ' LEU . . . -62.12 128.46 36.22 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 108.062 -1.088 . . . . 10.0 108.062 171.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.95 -1.04 87.72 Favored Glycine 0 N--CA 1.443 -0.882 0 O-C-N 125.612 1.82 . . . . 10.0 112.74 -174.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.77 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 15.1 tppt? -140.46 102.59 4.37 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 122.359 1.076 . . . . 10.0 111.835 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -170.33 129.66 0.88 Allowed 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 113.405 -1.725 . . . . 10.0 110.856 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.671 ' HA ' ' HB2' ' A' ' 39' ' ' CYS . 2.1 t -176.87 -44.87 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 115.046 -0.979 . . . . 10.0 113.112 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.719 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 72.6 Cg_endo -103.93 124.4 0.07 OUTLIER 'Trans proline' 0 N--CA 1.413 -3.244 0 N-CA-C 115.557 1.329 . . . . 10.0 115.557 -162.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 1.042 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 9.63 -87.15 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.392 0 CA-C-N 109.664 -3.425 . . . . 10.0 114.824 166.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.64 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 11.4 Cg_exo -26.07 -55.99 0.09 OUTLIER 'Trans proline' 0 CA--C 1.559 1.734 0 C-N-CA 123.74 2.96 . . . . 10.0 115.722 -162.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.719 ' HD2' ' O ' ' A' ' 20' ' ' PRO . 37.4 Cg_endo -80.48 -73.96 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.277 0 C-N-CA 122.419 2.079 . . . . 10.0 112.083 168.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 1.042 HG11 HD12 ' A' ' 35' ' ' ILE . 53.5 t -57.37 -54.73 27.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 127.564 2.346 . . . . 10.0 114.672 -173.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 1.042 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -48.41 -72.55 0.43 Allowed Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.107 -0.952 . . . . 10.0 113.173 -175.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.7 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 16.5 Cg_exo -44.98 -47.98 11.42 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.523 2.816 . . . . 10.0 112.272 171.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.473 ' HB1' ' O ' ' A' ' 24' ' ' VAL . . . -46.37 -98.51 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 123.624 0.578 . . . . 10.0 112.376 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.892 HD23 HD11 ' A' ' 35' ' ' ILE 0.351 0.0 OUTLIER -73.87 -38.84 64.3 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 117.176 -1.81 . . . . 10.0 113.363 -174.684 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.756 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -66.15 -39.34 94.54 Favored Glycine 0 N--CA 1.462 0.407 0 C-N-CA 121.43 -0.414 . . . . 10.0 113.859 -173.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.473 ' HB3' ' O ' ' A' ' 26' ' ' PRO . 9.0 tt0 -67.82 -7.19 25.76 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.541 -0.864 . . . . 10.0 111.172 176.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -99.94 22.92 10.49 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.624 -0.716 . . . . 10.0 109.284 168.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.19 -6.89 63.99 Favored Glycine 0 CA--C 1.503 -0.712 0 CA-C-N 115.341 -0.845 . . . . 10.0 113.112 167.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.846 HG12 ' CD2' ' A' ' 66' ' ' PHE . 3.4 t -83.29 148.75 4.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 114.619 1.34 . . . . 10.0 114.619 -169.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.537 ' HB3' ' HB2' ' A' ' 37' ' ' GLU . 44.7 t-20 -70.75 98.68 1.58 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.468 0.707 . . . . 10.0 110.639 172.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 1.042 HD12 HG11 ' A' ' 24' ' ' VAL . 19.4 mm -53.78 -36.28 29.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.155 -0.929 . . . . 10.0 112.164 175.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 66.8 mtm -65.19 -52.78 52.76 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.62 -1.627 . . . . 10.0 111.699 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.537 ' HB2' ' HB3' ' A' ' 34' ' ' ASN . 12.7 mm-40 -56.88 -38.8 73.27 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.615 -0.834 . . . . 10.0 110.927 175.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . 91.3 t80 -57.85 -58.7 7.21 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 113.506 0.928 . . . . 10.0 113.506 170.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.671 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -57.7 -52.26 66.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 113.988 -1.46 . . . . 10.0 112.039 -177.535 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.502 ' HB3' ' HE3' ' A' ' 40' ' ' LYS . 0.7 OUTLIER -66.47 -21.71 66.19 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.554 -0.858 . . . . 10.0 108.691 -176.082 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.672 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 12.9 mtp180 -74.09 -63.9 1.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.662 -0.699 . . . . 10.0 112.074 168.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.505 ' CZ ' HG22 ' A' ' 46' ' ' THR . 71.1 t80 -54.33 -45.52 72.69 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-O 121.082 0.468 . . . . 10.0 110.682 -172.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.623 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.8 OUTLIER -58.97 -51.62 69.27 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.074 -0.966 . . . . 10.0 109.771 -178.402 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.96 98.97 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 119.034 -1.066 . . . . 10.0 112.186 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.672 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 7.3 mt-10 -66.9 -39.31 87.41 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.823 0.821 . . . . 10.0 110.834 -178.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.626 HG22 HD11 ' A' ' 54' ' ' LEU . 72.1 p -92.13 -0.4 57.44 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.735 -1.121 . . . . 10.0 112.748 -172.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.96 -39.62 12.76 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.915 0.886 . . . . 10.0 112.777 -174.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -75.78 -34.13 60.2 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.506 -0.77 . . . . 10.0 110.958 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.422 ' HB3' ' CE ' ' A' ' 52' ' ' MET . 36.7 mttp -97.15 17.88 16.19 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.828 0.851 . . . . 10.0 109.998 -175.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -52.07 145.47 10.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.205 -0.907 . . . . 10.0 113.232 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.68 15.85 35.79 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 110.604 -0.998 . . . . 10.0 110.604 -177.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.703 ' SD ' ' HB2' ' A' ' 77' ' ' PHE . 51.3 mtm -138.12 125.81 22.29 Favored 'General case' 0 C--O 1.211 -0.94 0 C-N-CA 116.274 -2.171 . . . . 10.0 115.193 -166.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.3 mm -66.55 91.78 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 118.313 0.506 . . . . 10.0 109.639 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.715 HD12 ' HB3' ' A' ' 15' ' ' ALA . 8.0 mt -83.2 135.85 44.07 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.852 -0.796 . . . . 10.0 108.852 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.543 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 8.0 Cg_exo -75.86 108.94 2.79 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.237 1.958 . . . . 10.0 111.016 174.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -100.58 155.08 4.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 119.833 1.197 . . . . 10.0 111.573 -174.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.439 HG23 ' HG2' ' A' ' 10' ' ' LYS . 93.6 t -134.81 115.58 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 CA-C-N 116.662 -0.244 . . . . 10.0 110.447 175.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.607 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 16.0 mt -107.07 141.93 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.554 0 CA-C-O 121.669 0.747 . . . . 10.0 109.157 -174.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.7 m -124.8 99.15 6.02 Favored 'General case' 0 C--N 1.28 -2.453 0 CA-C-N 114.665 -1.152 . . . . 10.0 108.869 174.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 65' ' ' SER . 2.4 p -89.61 140.17 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 CA-C-N 119.43 1.014 . . . . 10.0 110.19 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -98.51 160.67 14.13 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.548 -0.751 . . . . 10.0 111.55 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.411 ' OE1' ' HB2' ' A' ' 4' ' ' LYS . 16.6 mt-10 -54.22 -19.13 4.68 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 124.37 1.068 . . . . 10.0 113.142 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 26.5 t70 -75.46 -13.71 60.39 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.572 -0.74 . . . . 10.0 110.472 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.706 ' HE3' ' HA ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 83.33 1.2 1.07 Allowed 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 114.448 -1.251 . . . . 10.0 110.379 -167.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.469 ' O ' HG22 ' A' ' 60' ' ' VAL . 57.9 m -71.68 174.86 6.21 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 114.753 -1.112 . . . . 10.0 108.846 169.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.846 ' CD2' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -171.09 -176.79 2.02 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 119.394 0.997 . . . . 10.0 109.307 174.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 p -162.58 162.54 27.25 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 103.434 -2.802 . . . . 10.0 103.434 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.444 ' CB ' HG12 ' A' ' 58' ' ' ILE . 47.6 p90 -162.11 158.09 24.24 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.522 0.677 . . . . 10.0 109.233 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.9 pt -128.45 158.78 40.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.543 0 CA-C-N 114.612 -1.176 . . . . 10.0 108.503 -175.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.469 HD13 ' CE1' ' A' ' 42' ' ' PHE . 2.8 mm -112.75 127.27 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 108.016 -1.105 . . . . 10.0 108.016 -178.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.641 ' C ' ' HD2' ' A' ' 73' ' ' PRO . 4.2 mptp? -80.16 93.3 5.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.024 0.916 . . . . 10.0 112.211 -172.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.73 HG23 ' HA ' ' A' ' 112' ' ' LYS . 9.2 t -59.55 -34.6 23.2 Favored Pre-proline 0 CA--C 1.569 1.693 0 CA-C-N 113.569 -1.651 . . . . 10.0 113.332 169.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.712 ' HD2' ' N ' ' A' ' 72' ' ' THR . 2.7 Cg_endo -41.9 -49.26 5.69 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 124.519 3.479 . . . . 10.0 117.331 -171.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.541 ' HD3' ' HG2' ' A' ' 73' ' ' PRO . 73.7 Cg_exo -42.33 -35.06 3.35 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.858 2.372 . . . . 10.0 113.47 -174.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 72.51 -25.59 0.18 Allowed 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 113.723 1.009 . . . . 10.0 113.723 168.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.5 m -50.63 -46.91 58.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.167 0.508 . . . . 10.0 110.92 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.703 ' HB2' ' SD ' ' A' ' 52' ' ' MET . 8.6 p90 -72.23 -29.46 63.96 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.765 -0.652 . . . . 10.0 111.428 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.751 ' O ' ' HB3' ' A' ' 81' ' ' LYS . 1.8 tp -86.0 -28.18 24.36 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.233 0.54 . . . . 10.0 111.255 -175.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 79' ' ' LEU . 3.7 mm? -59.39 -35.1 73.3 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 107.993 -1.114 . . . . 10.0 107.993 168.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.584 ' HZ2' ' HB3' ' A' ' 80' ' ' LYS . 7.3 ttpm? -70.31 -12.26 61.47 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.756 -0.656 . . . . 10.0 111.921 172.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.751 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 17.0 tptm -56.72 -50.75 71.28 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.25 -0.907 . . . . 10.0 109.103 165.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.517 ' C ' HG12 ' A' ' 100' ' ' VAL . . . -72.56 -49.58 31.52 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.964 1.706 . . . . 10.0 112.755 170.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . . . . . . . . 0 C--N 1.293 -1.887 0 CA-C-N 112.688 -2.051 . . . . 10.0 109.326 -169.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.465 HG11 ' O ' ' A' ' 136' ' ' GLY . 7.1 p . . . . . 0 CA--C 1.536 0.435 0 CA-C-O 121.393 0.616 . . . . 10.0 111.512 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -166.88 161.37 35.18 Favored Glycine 0 CA--C 1.497 -1.078 0 N-CA-C 108.725 -1.75 . . . . 10.0 108.725 -174.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -143.73 177.72 8.31 Favored 'General case' 0 CA--C 1.473 -2.004 0 CA-C-O 122.359 1.075 . . . . 10.0 110.767 -169.522 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.517 HG12 ' C ' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -163.76 -165.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.404 -2.73 0 CA-C-N 111.793 -2.458 . . . . 10.0 106.184 -170.55 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.612 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 19.0 p -109.83 150.39 28.46 Favored 'General case' 0 C--N 1.268 -2.968 0 CA-C-N 114.753 -1.112 . . . . 10.0 111.833 -170.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.668 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 22.4 tpp180 -43.62 -43.73 5.9 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 113.588 -1.642 . . . . 10.0 109.688 168.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 18.4 tppt? -58.35 -43.15 88.19 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.153 0.501 . . . . 10.0 112.168 176.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.649 ' O ' HG12 ' A' ' 108' ' ' ILE . 57.6 mt-30 -67.22 -38.72 85.74 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.407 -0.59 . . . . 10.0 109.407 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.668 ' HB ' ' O ' ' A' ' 102' ' ' ARG . 34.9 mm -46.83 -51.15 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.589 -0.732 . . . . 10.0 111.012 166.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.707 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 31.8 tt0 -48.28 -54.26 14.31 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.283 -1.326 . . . . 10.0 112.836 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -52.48 -57.88 8.51 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 123.925 0.766 . . . . 10.0 110.151 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.649 HG12 ' O ' ' A' ' 104' ' ' GLN . 5.5 mm -46.19 -59.97 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 114.328 -1.305 . . . . 10.0 109.923 173.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.511 ' HB1' HG13 ' A' ' 128' ' ' ILE . . . -50.62 -37.28 39.47 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 123.686 0.616 . . . . 10.0 112.44 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.707 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 39.4 mttt -71.09 -58.67 3.33 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.004 -0.544 . . . . 10.0 111.478 -175.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.49 HG22 HD21 ' A' ' 78' ' ' LEU . 4.7 t -55.4 -34.83 64.73 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 113.011 0.745 . . . . 10.0 113.011 -175.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.977 ' HD3' HD12 ' A' ' 128' ' ' ILE . 0.1 OUTLIER -99.03 7.38 46.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 120.931 0.396 . . . . 10.0 110.828 -173.36 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.838 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 40.1 ttm -48.11 -41.32 41.55 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.231 -0.895 . . . . 10.0 112.424 175.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 113' ' ' MET . 26.7 Cg_endo -59.61 -32.48 96.05 Favored 'Trans proline' 0 C--N 1.366 1.471 0 C-N-CA 121.787 1.658 . . . . 10.0 112.128 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.556 ' CB ' ' HD3' ' A' ' 73' ' ' PRO . 0.8 OUTLIER -91.44 -47.89 7.19 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 114.788 -1.096 . . . . 10.0 112.34 -173.39 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.963 HD22 HD11 ' A' ' 127' ' ' ILE . 7.0 mp -64.18 2.05 0.63 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.527 -1.215 . . . . 10.0 111.871 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.488 ' H ' ' C ' ' A' ' 115' ' ' ASP . 8.7 p30 54.75 45.67 26.22 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.164 -1.38 . . . . 10.0 109.662 177.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.838 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -80.8 118.17 22.09 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 112.805 -1.998 . . . . 10.0 112.103 -172.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.22 -37.61 83.88 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.75 -0.659 . . . . 10.0 109.874 170.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.2 p -155.41 144.66 20.95 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.442 -0.947 . . . . 10.0 108.442 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.524 ' O ' ' HG2' ' A' ' 125' ' ' MET . 62.6 tp -52.08 -40.39 61.14 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 115.077 1.51 . . . . 10.0 115.077 -173.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -51.63 -33.08 31.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.148 0.499 . . . . 10.0 111.045 176.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.18 -49.26 65.31 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 118.797 -1.161 . . . . 10.0 110.865 172.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.605 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -57.78 -33.68 68.79 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.91 0.386 . . . . 10.0 110.652 178.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.631 ' O ' ' HB3' ' A' ' 129' ' ' GLU . 80.1 mmm -56.36 -39.02 72.2 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.73 0.3 . . . . 10.0 111.425 176.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -61.21 -56.68 17.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.832 -0.622 . . . . 10.0 111.432 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.963 HD11 HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -50.98 -57.9 2.4 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 C-N-CA 119.994 -0.683 . . . . 10.0 111.146 -178.465 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.977 HD12 ' HD3' ' A' ' 112' ' ' LYS . 25.4 mm -50.56 -57.23 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 CA-C-N 114.649 -1.16 . . . . 10.0 111.801 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.631 ' HB3' ' O ' ' A' ' 125' ' ' MET . 0.0 OUTLIER -53.33 -41.38 65.67 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.748 -0.66 . . . . 10.0 109.272 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.649 ' HA2' ' HE2' ' A' ' 133' ' ' LYS . . . -71.36 -46.47 41.29 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.739 -0.744 . . . . 10.0 111.862 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 62.7 m -44.37 -65.6 0.49 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 114.561 -0.82 . . . . 10.0 109.011 169.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.472 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -48.77 -50.71 32.75 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.026 -0.534 . . . . 10.0 111.312 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.649 ' HE2' ' HA2' ' A' ' 130' ' ' GLY . 17.0 ttpt -47.98 -53.95 14.48 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.75 -1.114 . . . . 10.0 111.499 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.1 m -66.13 -30.91 71.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.341 0.591 . . . . 10.0 110.69 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.52 ' HE1' ' CD1' ' A' ' 137' ' ' ILE . 46.8 mtp -80.31 5.64 14.2 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.701 1.0 . . . . 10.0 113.701 -177.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.465 ' O ' HG11 ' A' ' 97' ' ' VAL . . . 85.46 6.15 84.0 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 119.351 0.978 . . . . 10.0 111.548 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 37.4 mt -97.21 127.27 49.61 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.834 0 CA-C-O 121.672 0.749 . . . . 10.0 111.777 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 99' ' ' LYS . 0.7 OUTLIER -88.56 158.87 18.15 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.514 -1.221 . . . . 10.0 108.868 178.134 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.3 m -117.44 127.01 74.97 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.518 0 CA-C-O 122.213 1.006 . . . . 10.0 108.348 171.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 101' ' ' THR . 19.3 m -112.54 154.62 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.231 0 CA-C-N 113.676 -1.602 . . . . 10.0 107.676 176.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 31.9 t70 . . . . . 0 C--N 1.276 -2.608 0 CA-C-N 114.534 -1.212 . . . . 10.0 110.872 -177.065 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.659 0.266 . . . . 10.0 110.895 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.0 t -63.11 139.19 21.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.576 -0.738 . . . . 10.0 110.992 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.86 -32.0 5.93 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.288 -0.414 . . . . 10.0 110.521 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.496 ' HB1' ' CG1' ' A' ' 60' ' ' VAL . . . -158.97 152.98 23.47 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.161 1.171 . . . . 10.0 114.161 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.798 HE21 ' HA ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -99.51 133.17 44.22 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.885 -1.052 . . . . 10.0 108.36 173.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.599 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -124.6 82.21 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 120.063 -0.655 . . . . 10.0 110.099 174.395 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 46.1 tttm -78.25 128.9 34.4 Favored 'General case' 0 C--N 1.314 -0.944 0 O-C-N 120.368 -1.458 . . . . 10.0 109.754 175.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.727 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -158.76 131.11 6.82 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 122.139 0.971 . . . . 10.0 112.262 -176.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -88.63 126.23 35.19 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.746 -1.116 . . . . 10.0 111.423 -174.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.727 HD21 HD11 ' A' ' 11' ' ' LEU . 63.7 mt -143.88 145.07 29.1 Favored Pre-proline 0 CA--C 1.511 -0.538 0 CA-C-O 121.098 0.475 . . . . 10.0 112.09 -174.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.639 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 24.8 Cg_exo -61.17 129.68 29.46 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.408 2.739 . . . . 10.0 112.405 175.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.704 ' HB3' HD13 ' A' ' 54' ' ' LEU . . . -62.23 129.09 39.17 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.343 -1.354 . . . . 10.0 107.343 168.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.88 0.75 86.05 Favored Glycine 0 N--CA 1.441 -1.004 0 O-C-N 125.498 1.749 . . . . 10.0 113.088 -175.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.639 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 3.9 tmtp? -144.46 99.86 3.44 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.147 0.974 . . . . 10.0 112.047 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 39' ' ' CYS . . . -171.2 139.39 1.34 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.407 -1.27 . . . . 10.0 112.972 175.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.639 ' HA ' ' HB3' ' A' ' 39' ' ' CYS . 17.0 m -170.74 -66.88 0.0 OUTLIER Pre-proline 0 N--CA 1.437 -1.094 0 O-C-N 124.322 1.014 . . . . 10.0 110.813 178.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.72 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 86.3 Cg_endo -105.84 129.48 0.06 OUTLIER 'Trans proline' 0 N--CA 1.425 -2.511 0 N-CA-C 117.621 2.123 . . . . 10.0 117.621 -148.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 1.112 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 20.44 -83.87 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.412 0 CA-C-N 109.474 -3.512 . . . . 10.0 115.152 166.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.801 ' HD3' ' HB2' ' A' ' 21' ' ' ALA . 93.1 Cg_exo -39.39 -55.85 1.44 Allowed 'Trans proline' 0 C--N 1.382 2.308 0 CA-C-N 122.561 1.95 . . . . 10.0 112.489 -174.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.856 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 40.3 Cg_endo -91.02 116.1 0.47 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.822 1.681 . . . . 10.0 111.026 154.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.856 ' HB ' ' O ' ' A' ' 23' ' ' PRO . 4.0 t 111.1 -42.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 C-N-CA 119.013 -1.075 . . . . 10.0 109.152 156.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 1.112 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -49.82 -75.11 0.22 Allowed Glycine 0 CA--C 1.523 0.583 0 CA-C-N 113.369 -1.741 . . . . 10.0 113.77 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.68 ' HA ' ' HG3' ' A' ' 30' ' ' GLN . 31.4 Cg_exo -54.79 -33.94 82.92 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.638 2.225 . . . . 10.0 111.39 175.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 24' ' ' VAL . . . -51.72 -98.08 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.113 0.412 . . . . 10.0 112.113 175.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.905 HD22 HD12 ' A' ' 35' ' ' ILE 0.319 0.0 OUTLIER -72.88 -28.09 62.29 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 117.596 -1.642 . . . . 10.0 112.943 -174.412 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.746 ' N ' HD21 ' A' ' 28' ' ' LEU . . . -68.58 -39.36 86.69 Favored Glycine 0 N--CA 1.464 0.501 0 C-N-CA 120.736 -0.745 . . . . 10.0 112.967 -176.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.68 ' HG3' ' HA ' ' A' ' 26' ' ' PRO . 23.5 mt-30 -65.38 -12.6 53.73 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.166 -1.014 . . . . 10.0 110.736 174.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.408 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 96.0 m-70 -100.46 18.28 19.45 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.944 -0.702 . . . . 10.0 109.809 173.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.57 1.94 70.7 Favored Glycine 0 CA--C 1.5 -0.887 0 CA-C-N 114.824 -1.08 . . . . 10.0 113.695 169.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.875 HG11 ' CD2' ' A' ' 66' ' ' PHE . 3.4 t -85.41 146.65 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 113.623 0.971 . . . . 10.0 113.623 -170.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -68.67 100.96 1.21 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.226 0.536 . . . . 10.0 110.95 171.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.905 HD12 HD22 ' A' ' 28' ' ' LEU . 8.7 mm -53.15 -39.94 36.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.943 -1.026 . . . . 10.0 111.217 174.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.89 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 3.7 mpp? -64.02 -47.35 80.6 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 113.357 -1.747 . . . . 10.0 111.076 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.588 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 18.5 tp10 -56.75 -45.01 82.29 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.873 -0.731 . . . . 10.0 110.234 173.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.569 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . 85.0 t80 -55.81 -60.07 3.98 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.661 1.356 . . . . 10.0 114.661 173.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.89 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 24.8 p -61.57 -49.19 77.65 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 114.838 -1.074 . . . . 10.0 112.02 -175.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.471 ' HD3' ' HA ' ' A' ' 40' ' ' LYS . 28.1 mmtp -65.66 -21.26 66.54 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.543 -0.863 . . . . 10.0 109.762 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.795 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 5.7 mtp180 -71.6 -65.35 0.77 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 119.357 -0.937 . . . . 10.0 111.436 167.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.52 ' HE2' ' O ' ' A' ' 14' ' ' PRO . 66.8 t80 -52.8 -47.01 67.9 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.602 -171.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.621 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.8 OUTLIER -60.01 -52.78 63.92 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.944 -1.026 . . . . 10.0 110.254 -176.361 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.9 96.09 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 118.884 -1.127 . . . . 10.0 112.187 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.795 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 9.6 mt-10 -68.74 -37.2 79.24 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 121.583 0.706 . . . . 10.0 111.172 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.611 HG22 HD12 ' A' ' 54' ' ' LEU . 73.0 p -89.14 0.22 56.91 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.125 -0.943 . . . . 10.0 112.567 -173.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.95 -38.34 7.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.007 -0.997 . . . . 10.0 113.008 -175.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -76.05 -36.57 58.98 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.718 -0.673 . . . . 10.0 111.138 -174.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -100.88 23.1 11.09 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 123.013 0.525 . . . . 10.0 109.903 -176.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -52.31 143.83 14.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.158 -0.928 . . . . 10.0 112.789 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.87 20.08 24.95 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 114.948 -1.024 . . . . 10.0 110.57 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.484 ' HB2' HD22 ' A' ' 54' ' ' LEU . 67.4 mtt -138.41 123.41 19.0 Favored 'General case' 0 C--O 1.208 -1.084 0 C-N-CA 117.243 -1.783 . . . . 10.0 114.262 -168.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.0 mm -65.68 91.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 118.626 0.648 . . . . 10.0 109.674 172.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.704 HD13 ' HB3' ' A' ' 15' ' ' ALA . 8.6 mt -81.06 131.49 59.41 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.178 -0.675 . . . . 10.0 109.178 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -71.83 106.54 2.01 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 C-N-CA 122.306 2.004 . . . . 10.0 110.962 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.37 151.63 5.86 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-N 119.449 1.022 . . . . 10.0 111.221 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 95.2 t -134.32 116.79 23.02 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 N-CA-C 110.288 -0.264 . . . . 10.0 110.288 175.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.599 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 14.9 mt -104.19 142.6 17.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.723 0.773 . . . . 10.0 109.623 -172.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 84.5 m -126.6 95.57 4.39 Favored 'General case' 0 N--CA 1.411 -2.383 0 CA-C-N 114.659 -1.155 . . . . 10.0 108.998 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 65' ' ' SER . 1.5 p -89.95 137.49 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.122 0 CA-C-N 119.386 0.994 . . . . 10.0 110.581 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -95.59 179.54 5.1 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.621 -0.718 . . . . 10.0 112.486 -176.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -53.12 -33.16 51.07 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 124.87 1.268 . . . . 10.0 112.444 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.555 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 35.5 t70 -80.85 -9.58 59.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.698 -1.137 . . . . 10.0 111.568 -168.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 0.2 OUTLIER 81.3 6.6 1.24 Allowed 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 122.632 1.206 . . . . 10.0 110.823 -166.135 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.567 ' O ' HG22 ' A' ' 60' ' ' VAL . 58.6 m -71.4 172.01 10.21 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 112.796 -2.002 . . . . 10.0 107.693 168.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.875 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -168.68 -176.25 2.69 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 119.948 1.249 . . . . 10.0 109.525 175.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.4 p -158.65 166.67 31.5 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 102.79 -3.041 . . . . 10.0 102.79 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 49.4 p90 -161.06 156.88 25.24 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 176.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.0 mt -116.47 167.23 9.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.058 -1.46 . . . . 10.0 107.058 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.3 mt -142.22 114.21 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 107.691 -1.226 . . . . 10.0 107.691 -175.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.547 ' HB3' ' HG2' ' A' ' 73' ' ' PRO . 12.9 mmtp -72.41 99.18 2.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.414 1.102 . . . . 10.0 112.493 -166.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.771 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 14.6 t -62.6 -33.98 13.24 Favored Pre-proline 0 CA--C 1.569 1.693 0 CA-C-N 113.197 -1.82 . . . . 10.0 112.178 169.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.771 ' HD2' ' N ' ' A' ' 72' ' ' THR . 1.0 OUTLIER -40.18 -43.82 3.85 Favored 'Trans proline' 0 C--N 1.386 2.5 0 C-N-CA 124.867 3.711 . . . . 10.0 117.976 -175.245 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 71' ' ' LYS . 40.8 Cg_exo -37.44 -29.7 0.11 Allowed 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 123.52 2.813 . . . . 10.0 114.47 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 1.076 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . . . 75.59 -45.73 0.55 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.997 0.74 . . . . 10.0 112.997 169.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 43.7 t -47.1 -37.11 9.17 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 123.841 0.713 . . . . 10.0 111.728 -175.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -47.24 -56.52 6.57 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.814 0.816 . . . . 10.0 111.534 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.538 HD21 HG23 ' A' ' 111' ' ' THR . 10.8 mp -98.54 -18.72 18.01 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.678 0.752 . . . . 10.0 109.689 -171.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.537 HD23 ' HB1' ' A' ' 132' ' ' ALA . 2.5 tp -64.85 -36.58 84.8 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 114.827 -1.078 . . . . 10.0 108.444 174.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.564 ' C ' ' H ' ' A' ' 82' ' ' ALA . 47.4 mtmt -64.1 -40.27 95.87 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.617 168.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.802 ' HA ' ' HE2' ' A' ' 81' ' ' LYS . 7.0 mmpt? -61.98 33.58 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.982 0.913 . . . . 10.0 113.15 171.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.606 ' HB1' HG13 ' A' ' 100' ' ' VAL . . . -171.42 -48.76 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 122.328 1.061 . . . . 10.0 109.394 -172.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.29 -2.01 0 CA-C-N 112.846 -1.979 . . . . 10.0 109.326 171.715 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 136' ' ' GLY . 7.8 p . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 120.929 0.395 . . . . 10.0 111.305 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.615 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -159.29 172.1 35.9 Favored Glycine 0 CA--C 1.493 -1.293 0 N-CA-C 108.08 -2.008 . . . . 10.0 108.08 170.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.912 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -143.13 167.51 21.93 Favored 'General case' 0 CA--C 1.479 -1.759 0 CA-C-O 122.664 1.221 . . . . 10.0 111.119 -169.152 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.749 HG11 ' HB2' ' A' ' 104' ' ' GLN . 2.1 t -131.53 -150.53 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.409 -2.478 0 CA-C-N 111.834 -2.439 . . . . 10.0 107.054 -173.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 0.3 OUTLIER -167.42 133.98 2.21 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 105.894 -1.891 . . . . 10.0 105.894 -164.486 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.481 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 13.1 tpp180 -40.67 -44.91 2.26 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 125.055 1.472 . . . . 10.0 110.939 -171.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.52 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 16.9 tppt? -58.06 -42.94 86.56 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.398 0.888 . . . . 10.0 113.398 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.749 ' HB2' HG11 ' A' ' 100' ' ' VAL . 20.1 mm-40 -66.9 -52.02 48.36 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.089 -0.708 . . . . 10.0 109.089 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.837 HG23 ' HG3' ' A' ' 129' ' ' GLU . 28.7 mm -35.2 -55.29 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 O-C-N 124.074 0.859 . . . . 10.0 110.592 165.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.683 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 23.2 tt0 -50.36 -56.48 11.18 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.815 1.246 . . . . 10.0 113.12 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.531 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 12.5 mm-40 -54.58 -57.64 10.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.826 -1.079 . . . . 10.0 110.703 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.584 ' O ' HG22 ' A' ' 111' ' ' THR . 45.2 mt -50.19 -51.43 17.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.596 -1.183 . . . . 10.0 110.528 173.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.5 ' HB1' HG13 ' A' ' 128' ' ' ILE . . . -53.23 -34.26 56.39 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 112.582 0.586 . . . . 10.0 112.582 174.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.683 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 96.8 mttt -69.7 -52.29 26.89 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 120.853 0.359 . . . . 10.0 111.081 -177.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 108' ' ' ILE . 4.2 t -56.11 -29.12 60.19 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.944 -0.571 . . . . 10.0 111.606 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 1.076 ' HE3' ' HA ' ' A' ' 75' ' ' ALA . 49.7 mttm -103.89 -5.15 22.6 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 112.253 0.464 . . . . 10.0 112.253 -175.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.616 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 14.5 ptp -53.66 -32.87 11.94 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 112.985 0.735 . . . . 10.0 112.985 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 113' ' ' MET . 32.4 Cg_endo -62.83 -31.05 78.12 Favored 'Trans proline' 0 C--N 1.371 1.762 0 CA-C-N 120.651 1.268 . . . . 10.0 111.518 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.62 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 1.0 OUTLIER -102.78 -40.25 6.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.589 -1.187 . . . . 10.0 114.04 -169.357 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.571 ' HG ' HD11 ' A' ' 127' ' ' ILE . 0.9 OUTLIER -63.77 38.66 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 114.258 -1.337 . . . . 10.0 113.264 -174.315 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 43.4 t30 23.0 44.9 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 O-C-N 124.141 0.901 . . . . 10.0 111.024 -168.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.66 ' O ' ' HB2' ' A' ' 119' ' ' ASN . . . -73.88 -82.15 0.06 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.817 -1.083 . . . . 10.0 113.358 -169.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.66 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 5.7 m-20 101.26 -29.92 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 O-C-N 125.203 1.565 . . . . 10.0 110.412 -173.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 41.7 p -155.26 141.01 18.08 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.814 -1.18 . . . . 10.0 107.814 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.55 ' O ' ' HG3' ' A' ' 125' ' ' MET . 3.4 tm? -53.61 -44.05 69.15 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.832 1.049 . . . . 10.0 113.832 -175.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -53.64 -37.09 62.76 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.165 0.507 . . . . 10.0 111.507 174.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.575 ' O ' ' HG3' ' A' ' 126' ' ' LYS . . . -67.07 -47.24 71.87 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 118.241 -1.384 . . . . 10.0 110.276 174.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.538 ' HA ' HD12 ' A' ' 127' ' ' ILE . . . -55.99 -34.38 65.72 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.012 -0.675 . . . . 10.0 110.839 175.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.55 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 80.0 mtp -55.9 -45.38 78.66 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.175 0.805 . . . . 10.0 113.175 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.628 ' HD2' HG13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -63.6 -37.3 86.81 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.709 -0.478 . . . . 10.0 109.709 -178.338 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.628 HG13 ' HD2' ' A' ' 126' ' ' LYS . 83.6 mt -55.72 -64.04 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 CA-C-O 121.85 0.833 . . . . 10.0 111.569 175.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.5 HG13 ' HB1' ' A' ' 109' ' ' ALA . 25.0 mm -50.22 -59.67 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 CA-C-N 113.437 -1.71 . . . . 10.0 111.691 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.837 ' HG3' HG23 ' A' ' 105' ' ' ILE . 6.3 mt-10 -53.2 -40.39 64.4 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.454 -0.793 . . . . 10.0 110.091 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -71.36 -45.17 49.29 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.356 -0.926 . . . . 10.0 111.715 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.439 HG23 ' HB2' ' A' ' 75' ' ' ALA . 97.8 m -46.5 -61.17 1.93 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.185 -1.008 . . . . 10.0 108.906 169.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.537 ' HB1' HD23 ' A' ' 79' ' ' LEU . . . -50.74 -47.99 59.21 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.761 -0.654 . . . . 10.0 111.826 177.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 18.2 ttpt -44.44 -56.41 4.28 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 124.025 0.828 . . . . 10.0 110.448 176.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.5 m -64.54 -30.0 71.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.717 -0.674 . . . . 10.0 111.666 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.475 ' HE1' HD21 ' A' ' 79' ' ' LEU . 29.9 mtm -81.38 3.46 24.33 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 114.077 1.139 . . . . 10.0 114.077 -176.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.518 ' O ' HG12 ' A' ' 97' ' ' VAL . . . 84.07 20.04 59.93 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 120.066 1.303 . . . . 10.0 111.748 -177.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.685 ' CG2' HG23 ' A' ' 100' ' ' VAL . 1.8 mp -107.17 126.23 63.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.683 0.754 . . . . 10.0 112.079 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.912 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -90.31 158.87 16.94 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.522 -1.217 . . . . 10.0 108.997 175.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.472 HG12 HG13 ' A' ' 105' ' ' ILE . 19.1 m -114.71 124.3 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.216 0 N-CA-C 108.002 -1.111 . . . . 10.0 108.002 170.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 100' ' ' VAL . 5.0 m -108.52 157.24 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 CA-C-N 114.194 -1.366 . . . . 10.0 109.723 178.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.3 t70 . . . . . 0 C--N 1.287 -2.15 0 CA-C-N 113.057 -1.883 . . . . 10.0 110.28 174.073 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.773 ' HD3' ' H ' ' A' ' 4' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.442 -0.867 0 N-CA-C 109.618 -0.512 . . . . 10.0 109.618 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 93.1 t -79.41 133.33 30.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.64 -0.504 . . . . 10.0 109.64 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.454 ' HB1' ' HA ' ' A' ' 62' ' ' GLU . . . -98.5 -37.54 9.53 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.115 -0.698 . . . . 10.0 109.115 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -164.67 -171.28 2.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 122.026 0.917 . . . . 10.0 113.423 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 54.6 mt-30 -137.83 132.95 33.37 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.737 -1.574 . . . . 10.0 108.316 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.571 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -119.9 80.91 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.88 -0.785 . . . . 10.0 108.88 179.199 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -81.83 122.41 27.68 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 120.063 1.301 . . . . 10.0 107.847 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.617 HD12 HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -156.84 130.3 8.08 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.163 0.982 . . . . 10.0 111.812 -171.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -81.99 120.93 25.88 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.297 -1.32 . . . . 10.0 110.225 -172.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.617 HD22 HD12 ' A' ' 11' ' ' LEU . 73.8 mt -138.57 135.32 17.92 Favored Pre-proline 0 CA--C 1.505 -0.752 0 CA-C-O 121.65 0.738 . . . . 10.0 112.051 -173.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.54 ' HB2' ' CB ' ' A' ' 17' ' ' LYS . 34.3 Cg_exo -54.94 123.6 14.19 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.641 2.894 . . . . 10.0 112.189 174.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.544 ' HB3' HD11 ' A' ' 54' ' ' LEU . . . -62.4 126.56 27.74 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.536 -1.283 . . . . 10.0 107.536 170.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.96 -1.06 85.93 Favored Glycine 0 CA--C 1.529 0.906 0 O-C-N 125.755 1.909 . . . . 10.0 113.238 -173.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.54 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . 6.0 tmtt? -142.81 95.85 2.84 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.185 0.993 . . . . 10.0 112.284 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 39' ' ' CYS . . . -169.61 137.49 1.77 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.41 -1.268 . . . . 10.0 112.644 175.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.532 ' HA ' ' CB ' ' A' ' 39' ' ' CYS . 1.8 t -178.05 -48.93 0.0 OUTLIER Pre-proline 0 N--CA 1.435 -1.182 0 CA-C-N 114.81 -1.086 . . . . 10.0 112.275 174.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.729 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 83.5 Cg_endo -101.53 134.64 0.15 Allowed 'Trans proline' 0 N--CA 1.407 -3.596 0 N-CA-C 116.231 1.589 . . . . 10.0 116.231 -150.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 1.008 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . 16.53 -64.94 0.0 OUTLIER Pre-proline 0 C--N 1.286 -2.184 0 CA-C-N 109.005 -3.725 . . . . 10.0 117.639 154.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.758 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 47.0 Cg_exo -53.87 -63.64 0.21 Allowed 'Trans proline' 0 CA--C 1.565 2.061 0 CA-C-N 123.606 2.324 . . . . 10.0 115.398 -176.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.758 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 58.3 Cg_endo -77.33 -52.24 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.607 2.204 . . . . 10.0 112.553 175.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.936 HG13 HD12 ' A' ' 35' ' ' ILE . 67.4 t -83.48 -44.95 18.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 111.896 -2.411 . . . . 10.0 111.957 -165.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.706 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -45.28 -53.36 7.94 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 114.259 -1.337 . . . . 10.0 114.234 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 1.008 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 50.5 Cg_exo -66.58 -49.29 1.75 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.228 2.619 . . . . 10.0 111.82 177.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.495 ' HB1' ' CG2' ' A' ' 9' ' ' ILE . . . -49.01 -74.85 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.323 0.583 . . . . 10.0 110.911 -177.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.791 HD21 ' HE2' ' A' ' 66' ' ' PHE . 3.5 mt -71.29 -44.99 64.12 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.649 0.981 . . . . 10.0 113.649 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.64 -41.45 98.91 Favored Glycine 0 N--CA 1.459 0.203 0 CA-C-N 116.237 -0.438 . . . . 10.0 113.359 -172.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -61.57 -26.52 68.01 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.94 -0.304 . . . . 10.0 110.491 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -99.06 17.37 19.94 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.847 -0.741 . . . . 10.0 109.982 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.417 ' HA3' ' HZ2' ' A' ' 64' ' ' LYS . . . 77.01 11.91 85.14 Favored Glycine 0 CA--C 1.499 -0.944 0 CA-C-N 114.708 -1.133 . . . . 10.0 112.894 168.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.858 HG11 ' CD2' ' A' ' 66' ' ' PHE . 1.8 t -83.7 148.02 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 113.738 1.014 . . . . 10.0 113.738 -174.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -69.93 95.51 0.94 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.739 0.816 . . . . 10.0 110.606 174.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.936 HD12 HG13 ' A' ' 24' ' ' VAL . 22.0 mm -49.74 -43.27 18.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 114.722 -1.127 . . . . 10.0 111.783 177.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.857 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 10.7 ptm -66.05 -49.53 67.34 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 112.766 -2.016 . . . . 10.0 113.03 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.511 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 36.2 mt-10 -59.41 -32.99 70.69 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.114 -1.035 . . . . 10.0 110.912 176.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.727 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 72.1 t80 -63.49 -59.65 4.38 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 114.485 1.291 . . . . 10.0 114.485 169.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.857 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 23.7 p -60.07 -48.85 79.99 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 114.37 -1.287 . . . . 10.0 111.917 -175.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -65.32 -20.79 66.56 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.198 -0.667 . . . . 10.0 109.198 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.651 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 10.0 mtp180 -77.63 -64.25 1.19 Allowed 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 119.379 -0.928 . . . . 10.0 113.338 169.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.585 ' HZ ' ' HB2' ' A' ' 54' ' ' LEU . 45.3 t80 -55.9 -45.47 78.64 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 120.912 0.387 . . . . 10.0 110.113 -173.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.453 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.9 OUTLIER -59.01 -50.35 74.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.547 -0.751 . . . . 10.0 110.09 -179.587 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.69 96.26 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 118.816 -1.154 . . . . 10.0 112.649 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 5.1 pt-20 -73.78 -32.02 63.58 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 119.622 -0.831 . . . . 10.0 112.545 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.756 HG23 HD13 ' A' ' 54' ' ' LEU . 68.6 p -88.16 1.66 53.9 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 115.674 -0.694 . . . . 10.0 111.213 -177.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -47.56 -37.22 11.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.957 -1.02 . . . . 10.0 111.961 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.44 -45.39 39.0 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 114.194 -1.366 . . . . 10.0 110.538 -174.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.833 ' HD2' ' HZ ' ' A' ' 77' ' ' PHE . 30.2 mtmm -101.14 29.08 4.88 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 121.808 0.813 . . . . 10.0 109.472 -175.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.526 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -56.72 157.58 5.31 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 113.615 -1.63 . . . . 10.0 113.482 177.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.0 20.92 44.3 Favored Glycine 0 CA--C 1.505 -0.538 0 N-CA-C 109.883 -1.287 . . . . 10.0 109.883 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.616 ' HB2' HD22 ' A' ' 54' ' ' LEU . 14.6 mmt -137.28 123.14 20.08 Favored 'General case' 0 C--O 1.21 -1.018 0 C-N-CA 117.31 -1.756 . . . . 10.0 113.401 -167.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.7 mm -64.15 91.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.926 -0.768 . . . . 10.0 108.926 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.756 HD13 HG23 ' A' ' 46' ' ' THR . 6.7 mt -79.19 127.11 80.24 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.552 -0.536 . . . . 10.0 109.552 -176.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.679 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 15.3 Cg_exo -70.85 99.63 0.88 Allowed 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 121.895 1.73 . . . . 10.0 110.397 172.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.12 148.82 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 119.57 1.077 . . . . 10.0 111.315 -172.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.421 ' HB ' ' CD1' ' A' ' 69' ' ' ILE . 71.5 t -126.53 115.01 40.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 120.866 -0.334 . . . . 10.0 110.521 171.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.748 HD13 HD22 ' A' ' 28' ' ' LEU . 17.7 mt -106.47 140.25 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 108.052 -1.092 . . . . 10.0 108.052 -175.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 94.0 m -123.81 99.32 6.22 Favored 'General case' 0 C--N 1.276 -2.607 0 CA-C-N 115.163 -0.926 . . . . 10.0 108.717 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 65' ' ' SER . 2.4 p -86.24 136.76 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.002 0 CA-C-N 118.897 0.771 . . . . 10.0 110.118 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 93.2 m-85 -93.96 170.5 9.49 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.076 -0.966 . . . . 10.0 112.507 -177.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.504 ' HG3' ' C ' ' A' ' 4' ' ' LYS . 16.3 mt-10 -63.28 -20.24 65.29 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.203 -1.362 . . . . 10.0 111.654 -177.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -78.97 -8.87 59.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.404 -0.816 . . . . 10.0 110.51 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.417 ' HZ2' ' HA3' ' A' ' 32' ' ' GLY . 13.1 mmmm 83.15 0.75 1.13 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.442 1.097 . . . . 10.0 110.423 -171.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.517 ' O ' HG22 ' A' ' 60' ' ' VAL . 18.5 m -70.01 -178.77 1.68 Allowed 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 114.915 -1.038 . . . . 10.0 109.117 171.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.858 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -170.32 -175.89 2.05 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 119.679 1.127 . . . . 10.0 110.242 174.622 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.1 p -161.21 166.44 27.78 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 103.302 -2.851 . . . . 10.0 103.302 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.437 ' CB ' HG12 ' A' ' 58' ' ' ILE . 49.1 p90 -161.6 157.08 24.14 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 109.137 -0.69 . . . . 10.0 109.137 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.421 ' CD1' ' HB ' ' A' ' 57' ' ' VAL . 2.0 pp -136.55 152.59 29.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.327 -0.99 . . . . 10.0 108.327 -177.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.728 HG21 HD12 ' A' ' 54' ' ' LEU . 1.8 mm -100.9 132.07 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 108.089 -1.078 . . . . 10.0 108.089 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.679 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 32.4 mmmt -80.42 99.07 7.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.981 0.896 . . . . 10.0 112.194 -171.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.866 ' HB ' ' HB3' ' A' ' 112' ' ' LYS . 78.6 p -64.32 -29.35 3.74 Favored Pre-proline 0 CA--C 1.569 1.681 0 CA-C-N 113.778 -1.556 . . . . 10.0 114.852 172.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.64 ' HG3' ' HB3' ' A' ' 115' ' ' ASP . 72.9 Cg_exo -40.8 -48.36 4.57 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 123.909 3.073 . . . . 10.0 116.925 -172.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.523 ' HD3' ' HB2' ' A' ' 73' ' ' PRO . 88.7 Cg_exo -48.11 -30.29 14.06 Favored 'Trans proline' 0 C--N 1.363 1.323 0 C-N-CA 122.159 1.906 . . . . 10.0 112.733 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 68.44 -44.35 0.51 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.933 0.893 . . . . 10.0 112.865 176.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.534 ' HA ' ' HB2' ' A' ' 79' ' ' LEU . 7.4 m -49.6 -33.47 15.32 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 122.852 0.461 . . . . 10.0 110.468 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.833 ' HZ ' ' HD2' ' A' ' 49' ' ' LYS . 20.9 t80 -43.93 -58.82 2.57 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.92 -1.036 . . . . 10.0 111.822 172.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.833 ' HB3' HG21 ' A' ' 108' ' ' ILE . 6.3 tp -95.98 -14.33 23.11 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.46 -0.496 . . . . 10.0 110.333 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.75 HD23 HG22 ' A' ' 128' ' ' ILE . 2.3 mm? -64.62 -44.31 90.95 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 109.243 -0.651 . . . . 10.0 109.243 171.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.557 ' HD2' ' O ' ' A' ' 80' ' ' LYS . 1.7 tmmm? -63.52 -30.58 71.68 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 115.51 -0.768 . . . . 10.0 109.434 174.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.484 ' HB2' ' HA ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -60.28 -40.17 89.46 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.991 0.737 . . . . 10.0 112.991 173.44 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.64 ' HB3' HG13 ' A' ' 100' ' ' VAL . . . -66.66 -43.14 85.35 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 123.294 1.521 . . . . 10.0 110.636 171.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.281 -2.39 0 CA-C-N 111.125 -2.762 . . . . 10.0 108.563 -175.335 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.42 HG13 ' N ' ' A' ' 98' ' ' GLY . 8.3 p . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 112.384 0.513 . . . . 10.0 112.384 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -166.93 161.27 35.1 Favored Glycine 0 CA--C 1.5 -0.885 0 N-CA-C 109.452 -1.459 . . . . 10.0 109.452 173.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.743 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -145.32 177.85 8.52 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 122.676 1.227 . . . . 10.0 111.649 -165.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.742 ' O ' HG21 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -157.68 -143.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 CA-C-N 111.813 -2.449 . . . . 10.0 105.465 -177.388 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -163.32 143.37 8.84 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 108.117 -1.068 . . . . 10.0 108.117 -157.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.611 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 6.7 tpp180 -42.21 -38.86 1.87 Allowed 'General case' 0 CA--C 1.548 0.876 0 O-C-N 124.727 1.267 . . . . 10.0 110.921 -174.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -57.86 -44.94 86.9 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.178 0.807 . . . . 10.0 113.178 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.526 ' O ' HG13 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -61.39 -47.39 86.02 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.529 -0.915 . . . . 10.0 108.529 177.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.834 HG22 ' HB ' ' A' ' 128' ' ' ILE . 1.9 mp -40.44 -56.51 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 CA-C-N 115.044 -0.98 . . . . 10.0 112.274 168.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.812 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 16.9 tt0 -47.15 -57.86 4.66 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 124.74 1.216 . . . . 10.0 111.835 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.626 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 68.5 mm-40 -52.91 -55.38 23.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.969 -1.014 . . . . 10.0 110.986 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.833 HG21 ' HB3' ' A' ' 78' ' ' LEU . 32.4 mt -51.57 -54.84 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.902 -0.59 . . . . 10.0 109.925 174.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.484 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -50.6 -42.42 55.86 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 124.047 0.842 . . . . 10.0 112.63 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.812 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 70.1 mttt -67.43 -49.68 62.66 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 122.187 0.994 . . . . 10.0 108.876 -176.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 98.5 m -53.02 -22.29 5.59 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 113.302 -1.772 . . . . 10.0 112.77 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.866 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 1.2 ptpp? -131.11 11.2 5.02 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 113.886 1.069 . . . . 10.0 113.886 -178.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.714 ' HG3' ' HD3' ' A' ' 114' ' ' PRO . 8.7 ptp -48.95 -38.35 25.5 Favored Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 118.714 0.688 . . . . 10.0 112.6 167.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.714 ' HD3' ' HG3' ' A' ' 113' ' ' MET . 34.3 Cg_endo -63.06 -27.83 74.0 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 121.42 1.413 . . . . 10.0 112.316 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.64 ' HB3' ' HG3' ' A' ' 73' ' ' PRO . 4.7 m-20 -95.99 -47.48 6.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.041 -0.981 . . . . 10.0 111.838 -175.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.601 HD23 ' HG3' ' A' ' 112' ' ' LYS . 7.5 mp -64.12 -1.92 1.79 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.002 -1.454 . . . . 10.0 111.053 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.44 ' H ' ' C ' ' A' ' 115' ' ' ASP . 0.2 OUTLIER 63.79 45.53 4.4 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.773 -1.558 . . . . 10.0 109.733 176.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.602 ' HB2' ' HB2' ' A' ' 113' ' ' MET . . . -82.5 114.7 21.1 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 113.703 -1.589 . . . . 10.0 112.198 -175.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -66.7 -33.48 75.73 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.246 -0.65 . . . . 10.0 109.246 169.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 45.7 t -150.83 144.46 25.06 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.007 -1.479 . . . . 10.0 107.007 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.592 ' O ' HD13 ' A' ' 121' ' ' LEU . 2.5 tm? -51.61 -34.51 37.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.824 -1.08 . . . . 10.0 112.433 -176.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.546 ' HA ' ' HG3' ' A' ' 125' ' ' MET . 14.4 mm-40 -48.23 -42.7 31.06 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.425 0.631 . . . . 10.0 111.152 174.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.09 -46.45 77.62 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 118.708 -1.197 . . . . 10.0 110.34 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.495 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -57.33 -37.42 72.5 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.149 176.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.546 ' HG3' ' HA ' ' A' ' 122' ' ' GLU . 19.9 mtp -54.74 -38.83 67.64 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.61 0.243 . . . . 10.0 111.505 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.481 ' HE2' ' O ' ' A' ' 122' ' ' GLU . 61.7 mmtt -63.66 -47.97 79.12 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.831 -0.803 . . . . 10.0 108.831 -178.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 124' ' ' ALA . 78.9 mt -51.1 -62.86 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-O 121.659 0.742 . . . . 10.0 110.614 176.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.834 ' HB ' HG22 ' A' ' 105' ' ' ILE . 32.9 mm -53.4 -56.66 7.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 113.949 -1.478 . . . . 10.0 112.636 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.405 ' HG3' ' N ' ' A' ' 130' ' ' GLY . 0.0 OUTLIER -54.98 -39.36 68.92 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.546 -0.909 . . . . 10.0 108.546 -179.198 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.452 ' HA2' ' HE2' ' A' ' 133' ' ' LYS . . . -70.73 -46.78 44.28 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.531 -0.758 . . . . 10.0 111.657 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 84.3 m -46.2 -63.49 0.98 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.334 -0.933 . . . . 10.0 109.28 170.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.08 -49.81 39.9 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.873 -0.603 . . . . 10.0 111.358 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.452 ' HE2' ' HA2' ' A' ' 130' ' ' GLY . 26.8 ttpt -48.61 -53.22 19.33 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.711 -1.131 . . . . 10.0 111.55 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 43.5 m -67.63 -28.12 67.46 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 111.792 0.293 . . . . 10.0 111.792 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.512 ' HE3' ' CD1' ' A' ' 137' ' ' ILE . 7.4 mtm -80.05 6.41 11.55 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.614 0.968 . . . . 10.0 113.614 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 81.09 10.81 84.42 Favored Glycine 0 N--CA 1.452 -0.261 0 CA-C-N 119.504 1.047 . . . . 10.0 111.55 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 32.1 mt -100.57 126.54 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-O 121.165 0.507 . . . . 10.0 111.005 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.743 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -85.25 154.01 22.23 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.205 -0.998 . . . . 10.0 109.15 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.7 m -111.21 120.63 62.25 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.488 0 N-CA-C 107.314 -1.365 . . . . 10.0 107.314 169.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.742 HG21 ' O ' ' A' ' 100' ' ' VAL . 29.9 m -101.39 152.11 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 CA-C-N 114.123 -1.399 . . . . 10.0 108.76 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 26.3 t0 . . . . . 0 C--N 1.294 -1.823 0 CA-C-N 112.874 -1.966 . . . . 10.0 112.876 -173.646 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.434 ' HB3' ' OE2' ' A' ' 62' ' ' GLU . 47.9 tttp . . . . . 0 N--CA 1.442 -0.857 0 N-CA-C 107.929 -1.138 . . . . 10.0 107.929 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.2 t -62.12 124.94 17.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 120.721 0.296 . . . . 10.0 110.498 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -99.68 -28.73 13.04 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.454 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -165.93 -167.6 1.11 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.166 -0.924 . . . . 10.0 112.811 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 9.7 pt20 -148.19 135.77 20.69 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.134 -1.394 . . . . 10.0 109.462 178.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.567 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -120.88 80.56 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 109.022 -0.733 . . . . 10.0 109.022 -178.301 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 30.8 tttt -79.61 125.19 29.3 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 120.101 1.318 . . . . 10.0 108.154 177.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.555 HD11 HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.8 130.48 7.35 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 122.024 0.916 . . . . 10.0 111.978 -172.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -82.91 120.8 26.15 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.24 -1.345 . . . . 10.0 110.105 -173.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.555 HD22 HD11 ' A' ' 11' ' ' LEU . 47.4 mt -136.56 137.69 24.6 Favored Pre-proline 0 N--CA 1.443 -0.82 0 CA-C-O 121.696 0.76 . . . . 10.0 112.213 -171.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.596 ' HB2' ' CB ' ' A' ' 17' ' ' LYS . 22.9 Cg_exo -58.91 122.83 12.27 Favored 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 123.603 2.869 . . . . 10.0 111.663 173.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.639 ' HB2' HD13 ' A' ' 54' ' ' LEU . . . -62.08 128.95 38.55 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.176 -1.046 . . . . 10.0 108.176 171.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.71 0.78 81.78 Favored Glycine 0 N--CA 1.442 -0.944 0 O-C-N 126.122 2.139 . . . . 10.0 112.786 -174.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.596 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . 5.9 tmtt? -142.05 91.58 2.36 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.86 0.838 . . . . 10.0 112.024 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.36 135.58 5.18 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.449 -1.25 . . . . 10.0 112.588 175.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.5 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 1.4 t -178.29 -50.52 0.0 OUTLIER Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.191 -0.913 . . . . 10.0 112.37 173.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.655 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 84.9 Cg_endo -101.42 125.59 0.11 Allowed 'Trans proline' 0 N--CA 1.414 -3.197 0 N-CA-C 115.726 1.395 . . . . 10.0 115.726 -154.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 1.11 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 12.04 -89.99 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.534 0 CA-C-N 109.347 -3.569 . . . . 10.0 114.713 168.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.772 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 47.7 Cg_exo -26.72 -56.51 0.1 OUTLIER 'Trans proline' 0 CA--C 1.559 1.742 0 C-N-CA 123.041 2.494 . . . . 10.0 115.824 -161.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.772 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 37.4 Cg_endo -77.75 -72.7 0.01 OUTLIER 'Trans proline' 0 CA--C 1.551 1.327 0 C-N-CA 122.267 1.978 . . . . 10.0 112.327 168.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.946 HG11 HD12 ' A' ' 35' ' ' ILE . 74.9 t -59.55 -54.85 28.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 112.218 -2.264 . . . . 10.0 114.734 -173.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 1.11 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -46.44 -70.27 0.7 Allowed Glycine 0 C--O 1.22 -0.763 0 CA-C-N 114.808 -1.087 . . . . 10.0 113.787 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.588 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 23.5 Cg_exo -47.76 -46.7 20.53 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.489 2.793 . . . . 10.0 112.701 173.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.13 -77.34 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.319 0.581 . . . . 10.0 111.361 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.809 HD21 HD12 ' A' ' 58' ' ' ILE . 3.3 mt -69.39 -52.05 30.68 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 114.088 1.144 . . . . 10.0 114.088 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.2 -40.13 83.24 Favored Glycine 0 N--CA 1.462 0.367 0 CA-C-N 115.562 -0.744 . . . . 10.0 113.374 -172.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -60.11 -26.3 66.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.851 0.358 . . . . 10.0 110.408 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -99.97 17.02 22.01 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 120.008 -0.677 . . . . 10.0 109.771 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.492 ' HA3' ' HD3' ' A' ' 64' ' ' LYS . . . 82.99 7.57 86.98 Favored Glycine 0 CA--C 1.499 -0.941 0 CA-C-N 114.639 -1.164 . . . . 10.0 113.292 167.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.852 HG11 ' CD2' ' A' ' 66' ' ' PHE . 1.6 t -83.1 145.78 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 113.763 1.023 . . . . 10.0 113.763 -173.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.559 ' HB3' ' HG2' ' A' ' 37' ' ' GLU . 55.0 t-20 -70.58 100.28 1.8 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.452 0.644 . . . . 10.0 110.384 173.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.946 HD12 HG11 ' A' ' 24' ' ' VAL . 23.2 mm -53.54 -40.35 41.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 114.753 -1.112 . . . . 10.0 112.036 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 77.0 mtp -65.5 -53.01 48.55 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.189 -1.823 . . . . 10.0 112.434 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.559 ' HG2' ' HB3' ' A' ' 34' ' ' ASN . 7.0 pt-20 -61.52 -31.17 71.17 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 118.168 -1.413 . . . . 10.0 109.99 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.655 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 68.7 t80 -59.52 -58.97 6.26 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 119.502 -0.879 . . . . 10.0 112.849 168.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.448 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -56.22 -50.02 72.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 113.896 -1.502 . . . . 10.0 111.792 -178.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -64.85 -22.42 66.99 Favored 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 118.945 -1.102 . . . . 10.0 108.529 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.794 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 62.9 mtt180 -76.97 -64.3 1.16 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.032 -1.067 . . . . 10.0 111.863 169.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.556 ' CZ ' HG21 ' A' ' 46' ' ' THR . 76.8 t80 -54.18 -48.64 70.71 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-N 119.052 0.842 . . . . 10.0 110.784 -171.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -60.27 -51.75 68.22 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.768 -1.105 . . . . 10.0 110.328 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.07 -37.51 87.5 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.172 -1.011 . . . . 10.0 111.53 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.794 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 15.5 mm-40 -63.44 -45.34 91.33 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 122.02 0.914 . . . . 10.0 110.399 177.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.581 ' CG2' HD12 ' A' ' 54' ' ' LEU . 73.0 p -90.12 3.89 52.0 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.279 -1.328 . . . . 10.0 112.43 -167.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -47.1 -39.04 12.41 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.912 -1.04 . . . . 10.0 111.497 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.95 -48.09 77.89 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 114.125 -1.398 . . . . 10.0 111.532 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -98.84 21.96 10.78 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 123.217 0.607 . . . . 10.0 110.291 -172.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -51.99 133.05 32.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.066 -0.97 . . . . 10.0 112.634 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.37 19.27 10.08 Favored Glycine 0 CA--C 1.504 -0.599 0 N-CA-C 110.707 -0.957 . . . . 10.0 110.707 -176.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.569 ' HB2' HD22 ' A' ' 54' ' ' LEU . 66.9 mtt -138.74 125.5 20.91 Favored 'General case' 0 C--O 1.212 -0.885 0 C-N-CA 117.272 -1.771 . . . . 10.0 114.102 -168.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.6 mm -66.17 89.63 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 109.259 -0.645 . . . . 10.0 109.259 171.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.639 HD13 ' HB2' ' A' ' 15' ' ' ALA . 8.2 mt -79.22 137.44 56.44 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.285 -0.635 . . . . 10.0 109.285 -177.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 54' ' ' LEU . 6.5 Cg_exo -76.28 106.12 2.2 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.13 1.887 . . . . 10.0 110.592 172.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.429 HG23 HG12 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -105.74 153.61 7.18 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-N 119.775 1.17 . . . . 10.0 110.731 -175.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 60.1 t -134.79 119.11 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 C-N-CA 120.789 -0.365 . . . . 10.0 110.244 173.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.809 HD12 HD21 ' A' ' 28' ' ' LEU . 15.7 mt -108.0 140.95 24.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 C-N-CA 119.861 -0.735 . . . . 10.0 109.132 -174.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.8 m -124.91 101.05 6.88 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 114.776 -1.102 . . . . 10.0 108.947 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.533 HG21 ' O ' ' A' ' 65' ' ' SER . 2.6 p -90.0 135.77 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.673 0 C-N-CA 124.016 0.927 . . . . 10.0 111.102 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -96.69 -177.05 3.78 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.746 -0.661 . . . . 10.0 112.572 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.434 ' OE2' ' HB3' ' A' ' 4' ' ' LYS . 29.3 mt-10 -55.07 -32.36 61.88 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.411 -1.268 . . . . 10.0 113.182 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.85 -11.25 59.87 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.611 -0.722 . . . . 10.0 111.334 -170.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.492 ' HD3' ' HA3' ' A' ' 32' ' ' GLY . 11.9 mmpt? 84.21 3.78 0.77 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.184 -1.043 . . . . 10.0 108.184 -164.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.533 ' O ' HG21 ' A' ' 60' ' ' VAL . 73.3 m -71.82 174.46 6.86 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.997 -1.456 . . . . 10.0 108.651 172.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.852 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -168.91 -175.45 2.36 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 119.655 1.116 . . . . 10.0 110.259 175.336 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 p -159.74 166.47 30.39 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 102.821 -3.029 . . . . 10.0 102.821 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.457 ' CB ' HG12 ' A' ' 58' ' ' ILE . 48.2 p90 -163.27 155.1 17.61 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.464 0.649 . . . . 10.0 109.492 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.4 pt -120.39 165.94 15.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 114.697 -1.138 . . . . 10.0 108.353 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.429 HG12 HG23 ' A' ' 56' ' ' VAL . 19.8 mt -138.46 113.13 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 107.152 -1.425 . . . . 10.0 107.152 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.577 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 11.6 mmmm -75.78 104.38 6.29 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 122.079 0.942 . . . . 10.0 112.676 -160.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.525 ' O ' ' HD2' ' A' ' 112' ' ' LYS . 65.6 p -64.5 -24.97 1.35 Allowed Pre-proline 0 CA--C 1.566 1.56 0 CA-C-N 113.52 -1.673 . . . . 10.0 114.48 171.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.587 ' HD3' ' CG ' ' A' ' 115' ' ' ASP . 74.9 Cg_exo -38.83 -53.3 1.94 Allowed 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 122.993 2.462 . . . . 10.0 115.005 -173.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.459 ' CD ' ' HB2' ' A' ' 73' ' ' PRO . 19.5 Cg_endo -59.13 99.33 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 121.502 1.468 . . . . 10.0 110.618 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.689 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . . . -72.44 -8.48 55.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.113 -0.494 . . . . 10.0 111.115 -174.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.63 -38.58 46.9 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.916 0.76 . . . . 10.0 112.094 -175.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.532 ' HB3' ' SD ' ' A' ' 52' ' ' MET . 36.2 m-85 -70.7 -54.89 10.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.548 0.69 . . . . 10.0 111.223 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.715 ' HB3' HD11 ' A' ' 108' ' ' ILE . 3.7 mm? -74.86 -30.51 61.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.598 0.713 . . . . 10.0 110.109 -173.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.56 ' HB3' ' HE3' ' A' ' 135' ' ' MET . 0.8 OUTLIER -62.07 -39.08 91.2 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.933 -0.766 . . . . 10.0 108.933 175.311 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -62.27 -20.39 64.22 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.042 -0.526 . . . . 10.0 111.775 172.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.491 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 13.5 tptp -62.88 -44.31 96.46 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.553 -0.859 . . . . 10.0 110.848 173.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.506 ' CB ' HG12 ' A' ' 100' ' ' VAL . . . -76.87 -53.09 8.35 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.273 1.429 . . . . 10.0 112.024 171.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.805 0 CA-C-N 111.655 -2.52 . . . . 10.0 107.752 -177.689 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.419 HG11 ' O ' ' A' ' 136' ' ' GLY . 11.5 p . . . . . 0 CA--C 1.55 0.957 0 N-CA-C 112.583 0.586 . . . . 10.0 112.583 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -96.07 149.82 19.44 Favored Glycine 0 CA--C 1.503 -0.695 0 N-CA-C 109.818 -1.313 . . . . 10.0 109.818 171.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.977 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -143.63 141.49 30.61 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 122.668 1.223 . . . . 10.0 110.841 168.554 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.844 ' HB ' ' HG2' ' A' ' 104' ' ' GLN . 1.7 m -163.34 -145.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 111.436 -2.62 . . . . 10.0 106.858 -165.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.455 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 1.3 t -163.84 141.81 7.38 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 120.478 -0.489 . . . . 10.0 110.363 -160.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.603 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 0.0 OUTLIER -44.07 -29.82 0.66 Allowed 'General case' 0 CA--C 1.555 1.137 0 O-C-N 124.606 1.192 . . . . 10.0 112.51 -172.626 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.573 ' N ' ' HD3' ' A' ' 102' ' ' ARG . 17.6 tppt? -60.14 -45.15 93.98 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.688 0.625 . . . . 10.0 112.688 175.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.844 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 0.7 OUTLIER -56.6 -47.14 80.25 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.725 -1.213 . . . . 10.0 107.725 178.26 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.931 HG21 ' HB ' ' A' ' 128' ' ' ILE . 2.0 mp -43.69 -51.16 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.654 0 CA-C-N 114.29 -1.323 . . . . 10.0 112.174 172.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.813 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 23.0 tt0 -52.48 -55.6 20.83 Favored 'General case' 0 CA--C 1.506 -0.724 0 O-C-N 124.287 0.992 . . . . 10.0 111.718 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.73 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 66.1 mm-40 -52.58 -57.21 10.71 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 114.408 -1.269 . . . . 10.0 109.993 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.715 HD11 ' HB3' ' A' ' 78' ' ' LEU . 16.4 mm -52.0 -50.4 34.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.496 -0.774 . . . . 10.0 110.534 175.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.463 ' HB3' HD11 ' A' ' 121' ' ' LEU . . . -53.33 -39.06 63.8 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.711 -0.677 . . . . 10.0 112.736 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.813 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 64.5 mttt -72.42 -50.38 26.75 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 122.045 0.926 . . . . 10.0 109.226 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.9 m -51.32 -34.03 31.71 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 113.522 -1.672 . . . . 10.0 113.325 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.689 ' HE2' ' HA ' ' A' ' 75' ' ' ALA . 5.6 mtmp? -119.16 17.2 13.21 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.506 0.67 . . . . 10.0 109.229 -172.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.813 ' HG3' ' HB2' ' A' ' 118' ' ' ALA . 43.5 ttm -50.66 -47.0 86.01 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 114.708 -1.133 . . . . 10.0 113.048 177.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 113' ' ' MET . 20.3 Cg_endo -57.9 -24.44 64.64 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.168 1.912 . . . . 10.0 112.384 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.587 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 4.3 m-20 -94.26 -49.81 5.55 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.206 -0.906 . . . . 10.0 112.317 -177.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.516 ' CD1' ' HA ' ' A' ' 73' ' ' PRO . 10.1 mp -65.6 38.28 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 114.396 -1.274 . . . . 10.0 113.014 -177.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.422 ' H ' ' C ' ' A' ' 115' ' ' ASP . 9.4 t30 19.59 51.12 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 O-C-N 124.843 1.34 . . . . 10.0 112.025 -171.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.813 ' HB2' ' HG3' ' A' ' 113' ' ' MET . . . -80.93 107.56 13.85 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.131 0.789 . . . . 10.0 113.131 -173.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.45 -37.6 85.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.624 0.726 . . . . 10.0 109.282 169.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.8 p -151.87 144.25 24.08 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.203 -1.406 . . . . 10.0 107.203 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.631 ' O ' ' HG2' ' A' ' 125' ' ' MET . 62.3 tp -51.93 -31.75 30.0 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 114.311 1.226 . . . . 10.0 114.311 -175.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -49.87 -39.76 40.43 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.681 0.753 . . . . 10.0 110.074 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.616 ' O ' ' HG3' ' A' ' 126' ' ' LYS . . . -66.93 -49.46 65.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.771 -1.104 . . . . 10.0 111.186 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.584 ' HB2' HD13 ' A' ' 121' ' ' LEU . . . -56.19 -34.96 66.71 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.92 -0.712 . . . . 10.0 110.719 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.729 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 50.6 mmm -56.64 -45.25 81.7 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.058 0.762 . . . . 10.0 113.058 178.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.746 ' HD3' ' N ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -65.14 -36.36 84.01 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.776 -0.453 . . . . 10.0 109.776 -177.853 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.746 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 73.4 mt -54.37 -65.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-O 121.571 0.7 . . . . 10.0 110.707 174.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.931 ' HB ' HG21 ' A' ' 105' ' ' ILE . 20.5 mm -51.05 -54.26 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 CA-C-N 113.853 -1.521 . . . . 10.0 112.365 -177.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.565 ' HG2' ' HA ' ' A' ' 126' ' ' LYS . 6.6 pt-20 -56.45 -44.58 80.63 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.382 -0.599 . . . . 10.0 109.382 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.519 ' HA2' ' HD2' ' A' ' 133' ' ' LYS . . . -69.33 -46.9 54.92 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.869 -0.605 . . . . 10.0 111.81 -175.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.564 HG21 ' HB2' ' A' ' 75' ' ' ALA . 64.8 m -44.99 -61.29 1.68 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.648 -0.871 . . . . 10.0 108.648 168.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.56 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -49.06 -46.23 44.13 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.895 -0.593 . . . . 10.0 112.353 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.519 ' HD2' ' HA2' ' A' ' 130' ' ' GLY . 65.2 mttm -49.88 -53.64 24.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.815 176.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 9.4 m -67.23 -31.79 72.38 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.482 0.658 . . . . 10.0 110.476 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.56 ' HE3' ' HB3' ' A' ' 79' ' ' LEU . 26.0 mtp -77.67 -1.15 29.59 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 114.071 1.137 . . . . 10.0 114.071 -177.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.419 ' O ' HG11 ' A' ' 97' ' ' VAL . . . 77.66 28.8 56.55 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 119.403 1.001 . . . . 10.0 111.949 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.56 ' HB ' ' HB1' ' A' ' 132' ' ' ALA . 1.7 mp -107.11 124.75 63.1 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.076 0 CA-C-O 121.612 0.72 . . . . 10.0 109.993 176.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.977 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 1.3 pt-20 -87.42 149.89 24.15 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.268 -1.382 . . . . 10.0 107.268 176.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 23.7 m -118.88 136.92 54.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.03 -1.1 . . . . 10.0 108.03 174.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 100' ' ' VAL . 8.2 m -135.65 71.48 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 113.801 1.037 . . . . 10.0 113.801 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.833 -1.08 . . . . 10.0 112.564 141.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? . . . . . 0 C--O 1.226 -0.184 0 CA-C-O 120.369 0.128 . . . . 10.0 110.742 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 50.1 t -66.84 138.15 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 122.812 0.445 . . . . 10.0 111.356 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -108.92 -40.91 4.88 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.727 -0.471 . . . . 10.0 109.727 173.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.455 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -156.73 151.03 25.26 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 113.656 0.984 . . . . 10.0 113.656 -176.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -95.27 134.63 37.83 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.842 -1.072 . . . . 10.0 108.26 171.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.6 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.5 OUTLIER -119.95 81.77 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 108.662 -0.866 . . . . 10.0 108.662 171.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -79.05 126.63 30.95 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 120.69 1.587 . . . . 10.0 108.098 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.516 HD21 HD12 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.42 128.56 6.72 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 122.331 1.062 . . . . 10.0 111.603 -176.09 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -83.06 119.07 24.01 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 113.816 -1.538 . . . . 10.0 110.086 -171.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.516 HD12 HD21 ' A' ' 11' ' ' LEU . 58.2 mt -137.73 137.84 22.67 Favored Pre-proline 0 CA--C 1.507 -0.688 0 CA-C-O 121.697 0.76 . . . . 10.0 112.427 -170.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.755 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 33.8 Cg_exo -56.05 123.8 14.72 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.752 2.968 . . . . 10.0 112.131 173.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.691 ' HB1' HD11 ' A' ' 54' ' ' LEU . . . -61.82 127.01 29.37 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 107.538 -1.282 . . . . 10.0 107.538 170.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.18 -5.78 81.84 Favored Glycine 0 N--CA 1.441 -1.014 0 O-C-N 125.765 1.916 . . . . 10.0 113.242 -175.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.755 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 2.2 mmmp? -138.47 104.65 5.21 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.562 1.181 . . . . 10.0 112.247 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -167.76 133.29 1.95 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.049 -1.432 . . . . 10.0 111.712 173.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.652 ' HA ' ' HB2' ' A' ' 39' ' ' CYS . 1.8 t -179.01 -40.66 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.102 -0.954 . . . . 10.0 113.075 177.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.667 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 85.0 Cg_endo -105.75 124.43 0.05 OUTLIER 'Trans proline' 0 N--CA 1.415 -3.146 0 N-CA-C 115.821 1.431 . . . . 10.0 115.821 -161.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 1.099 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 9.75 -84.56 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.545 0 CA-C-N 109.745 -3.389 . . . . 10.0 115.084 165.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.976 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 39.4 Cg_exo -28.74 -57.27 0.13 Allowed 'Trans proline' 0 CA--C 1.562 1.88 0 C-N-CA 122.912 2.408 . . . . 10.0 115.898 -164.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.976 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 6.0 Cg_exo -81.38 -55.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 123.102 2.534 . . . . 10.0 111.919 171.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.97 HG13 HD11 ' A' ' 35' ' ' ILE . 49.6 t -81.01 -52.49 14.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 112.209 -2.269 . . . . 10.0 113.659 -166.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 1.099 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -48.0 -74.07 0.28 Allowed Glycine 0 C--O 1.214 -1.122 0 CA-C-N 114.702 -1.135 . . . . 10.0 113.681 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.635 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 34.7 Cg_exo -46.9 -42.86 24.91 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.514 2.809 . . . . 10.0 112.833 175.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.04 -79.95 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.248 0.547 . . . . 10.0 111.011 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.777 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . 2.2 mt -67.65 -47.1 70.53 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 114.178 1.177 . . . . 10.0 114.178 -177.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.78 -37.24 92.16 Favored Glycine 0 C--N 1.32 -0.351 0 CA-C-N 115.606 -0.724 . . . . 10.0 113.432 -173.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.54 -26.73 67.11 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.848 -0.427 . . . . 10.0 109.848 175.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -99.86 16.66 23.03 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 120.055 -0.658 . . . . 10.0 110.09 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.9 9.21 85.7 Favored Glycine 0 CA--C 1.503 -0.658 0 CA-C-N 114.809 -1.087 . . . . 10.0 113.532 168.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.725 HG13 ' CD2' ' A' ' 66' ' ' PHE . 11.4 t -81.77 147.14 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 114.078 1.14 . . . . 10.0 114.078 -172.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -69.03 96.93 0.82 Allowed 'General case' 0 C--N 1.347 0.457 0 C-N-CA 123.38 0.672 . . . . 10.0 110.765 171.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.97 HD11 HG13 ' A' ' 24' ' ' VAL . 20.0 mm -55.52 -38.41 49.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 121.983 0.897 . . . . 10.0 112.163 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -46.94 74.31 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.611 -1.631 . . . . 10.0 112.076 175.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.648 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 17.7 mt-10 -58.83 -43.74 90.73 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 118.66 -1.216 . . . . 10.0 110.479 174.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.573 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 79.3 t80 -54.71 -56.82 15.15 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 113.599 0.963 . . . . 10.0 113.599 173.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.652 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -55.92 -52.36 64.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.001 -1.454 . . . . 10.0 111.666 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -65.79 -21.61 66.51 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 119.097 -1.041 . . . . 10.0 109.02 -176.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.76 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 85.9 mtt180 -78.13 -63.53 1.37 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 115.311 -0.859 . . . . 10.0 112.144 171.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.559 ' CZ ' HG22 ' A' ' 46' ' ' THR . 75.3 t80 -55.15 -44.38 75.06 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 121.251 0.548 . . . . 10.0 110.367 -172.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.626 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.8 OUTLIER -60.48 -49.25 78.32 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.056 -0.974 . . . . 10.0 109.911 -178.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.17 96.76 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.035 -1.066 . . . . 10.0 112.349 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.76 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 4.6 mm-40 -65.43 -43.37 90.71 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.951 0.882 . . . . 10.0 110.756 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.657 HG22 HD13 ' A' ' 54' ' ' LEU . 71.6 p -92.52 4.66 53.12 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 114.223 -1.353 . . . . 10.0 112.136 -171.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -47.22 -36.89 9.44 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.809 -1.087 . . . . 10.0 112.548 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -81.33 -40.69 23.2 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.678 -0.692 . . . . 10.0 111.823 -176.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.0 mttp -92.01 18.54 7.81 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 108.822 -0.807 . . . . 10.0 108.822 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.42 147.64 7.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.803 -1.089 . . . . 10.0 113.393 -177.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.49 18.96 31.32 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 114.813 -1.085 . . . . 10.0 110.513 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.564 ' HB2' HD22 ' A' ' 54' ' ' LEU . 61.6 mtt -138.34 127.65 24.49 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 116.693 -2.003 . . . . 10.0 114.866 -167.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.4 mm -65.23 91.71 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 O-C-N 121.787 -0.57 . . . . 10.0 109.58 170.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.691 HD11 ' HB1' ' A' ' 15' ' ' ALA . 8.3 mt -84.63 130.65 52.42 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.928 -0.768 . . . . 10.0 108.928 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.507 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 14.3 Cg_exo -71.79 105.91 1.89 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.557 1.505 . . . . 10.0 110.635 173.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.22 142.81 13.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 119.9 1.227 . . . . 10.0 110.597 -174.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 89.4 t -119.71 111.83 34.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 120.332 -0.547 . . . . 10.0 110.431 171.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.771 ' CD1' HD21 ' A' ' 28' ' ' LEU . 15.5 mt -105.8 139.22 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.932 0 N-CA-C 107.972 -1.122 . . . . 10.0 107.972 -174.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.8 m -123.24 97.31 5.36 Favored 'General case' 0 N--CA 1.402 -2.836 0 CA-C-N 114.793 -1.094 . . . . 10.0 108.787 178.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 65' ' ' SER . 4.4 p -86.66 137.37 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.956 0 CA-C-N 119.402 1.001 . . . . 10.0 110.089 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -95.8 172.11 8.23 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.777 0.799 . . . . 10.0 112.857 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -60.38 -22.96 63.93 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.249 -1.341 . . . . 10.0 111.841 -177.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 10.7 m-20 -77.68 -10.47 59.54 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.353 -0.839 . . . . 10.0 111.527 -176.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 55.1 mtpt 83.85 2.5 0.91 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 124.35 1.031 . . . . 10.0 109.459 -166.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.466 ' O ' HG22 ' A' ' 60' ' ' VAL . 14.6 t -73.74 172.13 12.03 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 113.924 -1.489 . . . . 10.0 107.369 174.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.725 ' CD2' HG13 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -169.75 -178.82 3.1 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 120.45 1.477 . . . . 10.0 109.692 175.582 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.3 p -161.83 169.41 21.37 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 103.542 -2.762 . . . . 10.0 103.542 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.435 ' CB ' HG12 ' A' ' 58' ' ' ILE . 49.8 p90 -162.5 159.3 24.75 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.545 -0.539 . . . . 10.0 109.545 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.9 mt -119.62 166.66 13.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 107.256 -1.387 . . . . 10.0 107.256 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.471 HD12 ' CE1' ' A' ' 42' ' ' PHE . 6.4 mm -126.42 122.18 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 107.004 -1.48 . . . . 10.0 107.004 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.594 ' C ' ' HD2' ' A' ' 73' ' ' PRO . 10.5 mmtp -76.64 96.82 4.25 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 122.188 0.994 . . . . 10.0 112.288 -169.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.721 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 3.4 t -59.46 -35.08 26.67 Favored Pre-proline 0 CA--C 1.56 1.362 0 CA-C-N 113.189 -1.823 . . . . 10.0 112.891 166.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.721 ' HD2' ' N ' ' A' ' 72' ' ' THR . 1.2 Cg_endo -39.69 -47.1 3.61 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 124.33 3.354 . . . . 10.0 116.114 -173.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.573 ' HD3' ' HG2' ' A' ' 73' ' ' PRO . 27.9 Cg_exo -61.62 88.57 0.1 OUTLIER 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 121.267 1.311 . . . . 10.0 111.061 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.562 ' HB1' HG22 ' A' ' 131' ' ' THR . . . -62.54 -17.54 60.07 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.404 -0.816 . . . . 10.0 110.923 -177.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.747 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 17.1 m -54.06 -37.93 64.71 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.868 -0.605 . . . . 10.0 111.331 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -75.08 -50.27 16.98 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.22 0.533 . . . . 10.0 111.27 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.758 ' HB3' HD13 ' A' ' 108' ' ' ILE . 3.5 mm? -70.93 -27.53 63.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.186 0.517 . . . . 10.0 110.377 -176.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 62.1 mt -75.16 -21.66 58.63 Favored 'General case' 0 C--O 1.209 -1.039 0 CA-C-N 115.954 -0.566 . . . . 10.0 110.619 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.747 ' HG2' ' O ' ' A' ' 76' ' ' SER . 75.2 mmtt -61.84 -36.82 82.32 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.349 0.595 . . . . 10.0 109.676 171.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -60.8 -51.13 70.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.581 -0.736 . . . . 10.0 112.43 176.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.733 ' CB ' HG12 ' A' ' 100' ' ' VAL . . . -75.08 -64.99 0.93 Allowed 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 123.149 1.452 . . . . 10.0 110.715 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.775 0 CA-C-N 111.514 -2.584 . . . . 10.0 108.427 176.632 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.404 HG11 ' N ' ' A' ' 98' ' ' GLY . 4.2 p . . . . . 0 CA--C 1.533 0.292 0 CA-C-O 121.225 0.536 . . . . 10.0 112.167 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.444 ' C ' ' HG3' ' A' ' 99' ' ' LYS . . . -168.95 173.59 43.48 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 108.852 -1.699 . . . . 10.0 108.852 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.665 ' O ' HG13 ' A' ' 100' ' ' VAL . 16.9 mtmt -149.15 177.85 9.26 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-N 117.37 0.585 . . . . 10.0 109.981 -159.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.733 HG12 ' CB ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -166.5 111.55 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.496 -1.108 0 CA-C-O 122.643 1.211 . . . . 10.0 111.816 167.241 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.718 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 1.1 t -41.58 147.27 0.19 Allowed 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 112.071 -2.331 . . . . 10.0 113.954 173.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.56 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 11.5 mmm180 -39.21 -37.78 0.44 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 111.725 -2.489 . . . . 10.0 112.911 -170.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -57.46 -48.39 79.29 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.651 0.611 . . . . 10.0 112.651 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.649 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.5 OUTLIER -59.28 -46.01 89.7 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.115 -0.698 . . . . 10.0 109.115 -178.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.682 HG22 ' HB ' ' A' ' 128' ' ' ILE . 30.6 mm -40.49 -56.89 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 114.883 -1.053 . . . . 10.0 112.448 168.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.83 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 26.6 tt0 -44.51 -60.15 2.1 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.165 0.802 . . . . 10.0 113.165 -178.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 110' ' ' LYS . 25.9 mt-10 -56.11 -49.66 73.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.619 -0.719 . . . . 10.0 110.653 -175.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.758 HD13 ' HB3' ' A' ' 78' ' ' LEU . 21.2 mm -50.62 -55.71 5.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.366 -0.834 . . . . 10.0 110.206 172.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.475 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -49.9 -47.19 52.26 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.298 0.851 . . . . 10.0 113.298 177.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.83 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 12.5 mtpp -67.16 -49.33 65.14 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.664 0.745 . . . . 10.0 109.923 -173.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.582 HG23 ' HG1' ' A' ' 72' ' ' THR . 1.3 m -58.31 -29.92 66.26 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 114.557 -1.201 . . . . 10.0 112.003 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.73 ' HB3' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -93.24 -16.27 24.97 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.589 0.755 . . . . 10.0 110.759 -176.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.971 ' HG3' ' HB1' ' A' ' 118' ' ' ALA . 5.1 ttp -48.75 -44.46 68.71 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 113.448 0.907 . . . . 10.0 113.448 -175.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 113' ' ' MET . 12.6 Cg_endo -56.06 -30.28 77.97 Favored 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 121.836 1.691 . . . . 10.0 111.615 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.435 ' CB ' ' HD3' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -93.34 -45.86 7.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.525 -1.216 . . . . 10.0 111.875 -176.417 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.73 HD22 ' HB3' ' A' ' 112' ' ' LYS . 3.6 mp -63.49 -2.95 1.78 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.127 -1.397 . . . . 10.0 112.218 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 61.0 t30 61.69 45.43 7.96 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.297 -1.32 . . . . 10.0 109.548 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.971 ' HB1' ' HG3' ' A' ' 113' ' ' MET . . . -86.35 121.0 28.31 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.691 -1.595 . . . . 10.0 112.289 -176.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -67.6 -33.22 74.56 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.225 -0.657 . . . . 10.0 109.225 171.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.0 t -154.96 143.87 20.85 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.965 -1.494 . . . . 10.0 106.965 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.575 ' HB2' ' HE3' ' A' ' 113' ' ' MET . 29.7 tp -53.45 -31.11 44.06 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.19 1.552 . . . . 10.0 115.19 -172.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -48.89 -40.16 28.72 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.722 0.692 . . . . 10.0 110.083 175.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.4 -47.82 66.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.622 -1.172 . . . . 10.0 111.04 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.552 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -57.93 -36.61 72.75 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.624 -0.43 . . . . 10.0 110.429 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.53 ' HG3' ' HG ' ' A' ' 121' ' ' LEU . 64.7 mtp -61.82 -34.75 76.5 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.361 0.6 . . . . 10.0 110.169 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -64.12 -51.23 64.92 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.682 -1.144 . . . . 10.0 109.465 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.525 HG21 ' HG ' ' A' ' 116' ' ' LEU . 76.1 mt -50.98 -62.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 CA-C-N 115.266 -0.879 . . . . 10.0 110.727 177.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.682 ' HB ' HG22 ' A' ' 105' ' ' ILE . 26.5 mm -50.36 -54.51 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.078 0 CA-C-N 114.779 -1.1 . . . . 10.0 111.153 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 133' ' ' LYS . 42.5 tt0 -53.56 -44.83 69.6 Favored 'General case' 0 N--CA 1.435 -1.214 0 O-C-N 124.119 0.887 . . . . 10.0 109.227 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.543 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -72.45 -45.93 35.22 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.618 -0.801 . . . . 10.0 111.698 -175.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.562 HG22 ' HB1' ' A' ' 75' ' ' ALA . 85.8 m -46.48 -60.1 2.56 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.359 -0.92 . . . . 10.0 109.575 171.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -48.24 -48.14 35.49 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.396 -0.82 . . . . 10.0 111.926 175.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 130' ' ' GLY . 47.9 mtpt -47.62 -54.25 12.43 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.755 0.659 . . . . 10.0 111.52 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 44.9 m -64.58 -30.82 71.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.879 0.371 . . . . 10.0 111.019 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.42 ' HE2' HD13 ' A' ' 137' ' ' ILE . 43.5 mtm -79.65 7.94 7.47 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.502 0.927 . . . . 10.0 113.502 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.7 3.74 80.3 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 119.436 1.016 . . . . 10.0 111.564 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.475 HG21 ' HA ' ' A' ' 99' ' ' LYS . 39.9 mt -99.29 134.93 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-O 121.712 0.767 . . . . 10.0 112.58 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.521 ' HG2' ' HG2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -96.89 160.03 14.59 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.704 -1.135 . . . . 10.0 109.571 177.279 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.3 m -107.66 131.63 57.39 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.647 0 N-CA-C 106.68 -1.6 . . . . 10.0 106.68 170.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.718 ' O ' ' HA ' ' A' ' 101' ' ' THR . 3.4 m -117.22 -178.9 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-N 114.809 -1.087 . . . . 10.0 109.661 -174.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 38.9 t70 . . . . . 0 C--N 1.281 -2.407 0 CA-C-N 112.635 -2.075 . . . . 10.0 109.026 163.961 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.594 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.525 0 N-CA-C 109.225 -0.657 . . . . 10.0 109.225 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.02 139.96 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 122.671 0.388 . . . . 10.0 111.874 -173.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.511 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . . . -112.07 -36.58 5.32 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.134 -0.485 . . . . 10.0 109.708 172.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.467 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -155.4 143.03 19.69 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.25 0.833 . . . . 10.0 113.25 -177.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -93.16 130.1 38.94 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.648 -1.241 . . . . 10.0 107.648 170.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.615 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -119.95 81.66 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.051 -0.722 . . . . 10.0 109.051 176.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.579 ' HZ3' ' HB2' ' A' ' 10' ' ' LYS . 9.6 mtmp? -79.13 127.39 31.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 120.137 1.335 . . . . 10.0 108.413 175.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.68 HD13 HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.3 127.62 6.4 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.295 1.045 . . . . 10.0 111.731 -175.025 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -83.13 121.62 27.29 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.172 -1.377 . . . . 10.0 110.117 -172.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.68 HD22 HD13 ' A' ' 11' ' ' LEU . 69.3 mt -139.16 139.88 24.57 Favored Pre-proline 0 CA--C 1.506 -0.728 0 CA-C-O 121.737 0.78 . . . . 10.0 111.963 -170.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.783 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 11.9 Cg_exo -59.61 124.65 15.9 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 123.426 2.751 . . . . 10.0 111.506 173.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.663 ' HB1' HD11 ' A' ' 54' ' ' LEU . . . -61.87 126.98 29.24 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 107.956 -1.127 . . . . 10.0 107.956 170.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.85 -2.23 88.34 Favored Glycine 0 N--CA 1.44 -1.093 0 O-C-N 125.66 1.85 . . . . 10.0 112.933 -175.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.783 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 74.9 mmtt -140.27 107.74 5.57 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 118.007 0.904 . . . . 10.0 112.422 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -169.77 134.41 1.35 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.92 -1.491 . . . . 10.0 112.052 171.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.532 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 1.6 t 178.92 -39.61 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.542 0 O-C-N 124.157 0.911 . . . . 10.0 113.169 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.726 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 71.8 Cg_endo -103.71 122.44 0.07 OUTLIER 'Trans proline' 0 N--CA 1.417 -2.983 0 N-CA-C 115.935 1.475 . . . . 10.0 115.935 -161.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.948 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 9.12 -82.91 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.451 0 CA-C-N 110.283 -3.144 . . . . 10.0 115.06 162.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.753 ' HD3' ' HB1' ' A' ' 21' ' ' ALA . 70.1 Cg_exo -33.16 -56.97 0.34 Allowed 'Trans proline' 0 CA--C 1.564 2.019 0 C-N-CA 122.182 1.921 . . . . 10.0 115.676 -164.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.726 ' HD2' ' O ' ' A' ' 20' ' ' PRO . 58.2 Cg_endo -78.62 -59.24 0.04 OUTLIER 'Trans proline' 0 CA--C 1.553 1.457 0 C-N-CA 122.734 2.29 . . . . 10.0 113.158 170.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.468 HG11 HG23 ' A' ' 35' ' ' ILE . 3.9 t -80.89 -36.81 15.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 112.441 -2.163 . . . . 10.0 113.388 -165.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.948 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -53.92 -69.03 1.35 Allowed Glycine 0 C--N 1.305 -1.142 0 CA-C-N 113.514 -1.676 . . . . 10.0 112.471 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.467 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 70.2 Cg_exo -50.87 -43.41 47.21 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.845 2.363 . . . . 10.0 112.117 172.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.451 ' O ' ' HD2' ' A' ' 31' ' ' HIS . . . -50.81 -96.54 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 112.372 0.508 . . . . 10.0 112.372 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.698 HD23 ' N ' ' A' ' 29' ' ' GLY 0.307 0.0 OUTLIER -75.11 -26.36 59.19 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 118.152 -1.419 . . . . 10.0 113.573 -176.233 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.698 ' N ' HD23 ' A' ' 28' ' ' LEU . . . -68.53 -40.99 85.99 Favored Glycine 0 N--CA 1.465 0.589 0 C-N-CA 120.926 -0.654 . . . . 10.0 112.68 -175.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -60.96 -21.41 63.45 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.112 -0.635 . . . . 10.0 110.099 175.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.451 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 97.8 m-70 -99.09 19.81 14.53 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.629 -0.828 . . . . 10.0 110.215 178.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.555 ' HA3' ' HD2' ' A' ' 64' ' ' LYS . . . 86.59 4.61 82.82 Favored Glycine 0 CA--C 1.501 -0.785 0 CA-C-N 115.201 -0.909 . . . . 10.0 113.363 167.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.659 HG12 ' CD2' ' A' ' 66' ' ' PHE . 4.6 t -83.01 146.2 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 113.414 0.894 . . . . 10.0 113.414 -172.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.434 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 0.6 OUTLIER -69.07 99.96 1.18 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.818 0.447 . . . . 10.0 110.321 171.731 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.533 ' CD1' ' HA2' ' A' ' 25' ' ' GLY . 83.2 mt -53.0 -40.14 35.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.807 0.813 . . . . 10.0 111.594 175.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 72.2 mtm -68.04 -46.66 70.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.67 -1.605 . . . . 10.0 111.783 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.555 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 10.4 tp10 -56.13 -45.25 79.64 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.298 -0.561 . . . . 10.0 109.758 174.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.573 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 48.0 t80 -57.04 -55.34 35.92 Favored 'General case' 0 C--O 1.212 -0.877 0 N-CA-C 113.97 1.1 . . . . 10.0 113.97 171.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -50.35 71.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.663 -1.153 . . . . 10.0 111.886 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.72 -22.76 66.63 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 119.368 -0.933 . . . . 10.0 108.753 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.737 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 87.2 mtt180 -76.95 -64.18 1.19 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.264 -0.88 . . . . 10.0 112.168 171.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.557 ' CZ ' HG23 ' A' ' 46' ' ' THR . 80.2 t80 -55.27 -47.38 75.58 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.419 0.628 . . . . 10.0 110.094 -171.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.625 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.8 OUTLIER -61.02 -48.24 82.72 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.489 -1.232 . . . . 10.0 110.317 -177.46 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.48 91.25 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.076 -1.05 . . . . 10.0 112.119 177.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.737 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 7.7 mm-40 -65.62 -40.35 92.48 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.823 0.821 . . . . 10.0 110.751 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.616 ' HB ' ' CB ' ' A' ' 15' ' ' ALA . 73.0 p -93.11 2.87 56.52 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 114.436 -1.256 . . . . 10.0 112.835 -170.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.11 -35.4 11.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.993 -1.003 . . . . 10.0 112.281 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -81.43 -43.1 19.4 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 115.314 -0.857 . . . . 10.0 111.561 -176.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -92.17 20.65 5.75 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.799 -0.815 . . . . 10.0 108.799 -176.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.3 149.21 7.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.952 -1.022 . . . . 10.0 113.09 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.41 18.95 36.91 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.937 -1.029 . . . . 10.0 110.671 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.718 ' SD ' ' HB2' ' A' ' 77' ' ' PHE . 59.8 mtt -140.38 125.55 18.64 Favored 'General case' 0 C--O 1.212 -0.902 0 C-N-CA 117.419 -1.712 . . . . 10.0 113.941 -165.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 50.1 mm -66.82 90.73 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 118.657 0.662 . . . . 10.0 109.665 172.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.663 HD11 ' HB1' ' A' ' 15' ' ' ALA . 10.0 mt -81.7 140.12 47.39 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.426 -0.583 . . . . 10.0 109.426 -177.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.701 ' HG2' ' HG2' ' A' ' 74' ' ' PRO . 3.6 Cg_exo -79.35 103.85 1.67 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.228 1.952 . . . . 10.0 110.896 172.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.99 155.64 3.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 119.885 1.22 . . . . 10.0 111.178 -175.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.448 HG12 ' HG2' ' A' ' 10' ' ' LYS . 96.7 t -134.79 112.51 15.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.015 174.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.615 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 24.4 mt -102.63 142.27 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.716 0 N-CA-C 108.133 -1.062 . . . . 10.0 108.133 -174.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.7 m -124.77 96.63 4.95 Favored 'General case' 0 N--CA 1.406 -2.648 0 CA-C-N 115.011 -0.995 . . . . 10.0 108.861 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.499 ' HA ' ' CB ' ' A' ' 66' ' ' PHE . 2.0 p -90.5 135.85 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 CA-C-N 119.479 1.036 . . . . 10.0 110.268 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -91.86 170.6 9.75 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.99 -1.004 . . . . 10.0 112.635 -176.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.594 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 14.2 mt-10 -60.4 -20.78 60.9 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.684 -1.598 . . . . 10.0 112.03 -176.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.441 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 2.9 m-20 -85.53 -4.72 59.24 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.329 -0.85 . . . . 10.0 112.09 -176.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.555 ' HD2' ' HA3' ' A' ' 32' ' ' GLY . 40.2 mmtt 81.99 0.65 1.45 Allowed 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 122.188 0.994 . . . . 10.0 110.334 -169.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.449 ' O ' HG23 ' A' ' 60' ' ' VAL . 17.4 m -70.83 168.43 16.8 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.736 -1.574 . . . . 10.0 107.289 173.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.659 ' CD2' HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -168.94 -177.12 2.87 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 120.687 1.585 . . . . 10.0 109.818 176.115 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.2 p -162.6 169.35 20.34 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 103.077 -2.935 . . . . 10.0 103.077 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.435 ' CB ' HG12 ' A' ' 58' ' ' ILE . 42.4 p90 -163.39 159.91 22.92 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.756 -0.831 . . . . 10.0 108.756 177.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 23.7 pt -129.19 161.57 38.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.468 -1.308 . . . . 10.0 107.468 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.414 HD11 ' CG2' ' A' ' 46' ' ' THR . 7.6 mt -126.95 120.15 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 106.568 -1.641 . . . . 10.0 106.568 -176.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.785 ' HE2' ' HA ' ' A' ' 71' ' ' LYS . 5.7 mmmm -76.4 98.2 4.49 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 122.325 1.06 . . . . 10.0 113.042 -160.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.615 ' O ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -44.6 -44.45 20.68 Favored Pre-proline 0 CA--C 1.56 1.337 0 CA-C-N 112.682 -2.054 . . . . 10.0 114.997 164.607 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.632 ' HD3' ' CG ' ' A' ' 115' ' ' ASP . 2.4 Cg_endo -39.43 -56.01 1.41 Allowed 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 124.268 3.312 . . . . 10.0 116.205 -171.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.701 ' HG2' ' HG2' ' A' ' 55' ' ' PRO . 88.9 Cg_exo -43.5 -34.74 5.35 Favored 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 123.207 2.604 . . . . 10.0 113.729 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.614 ' HB2' HD21 ' A' ' 79' ' ' LEU . . . 73.98 -31.77 0.22 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.679 0.992 . . . . 10.0 113.679 170.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.678 ' O ' ' HD3' ' A' ' 80' ' ' LYS . 47.9 t -42.24 -56.96 2.72 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 123.753 0.658 . . . . 10.0 111.958 -175.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.718 ' HB2' ' SD ' ' A' ' 52' ' ' MET . 32.7 p90 -55.9 -37.02 68.33 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.574 0.583 . . . . 10.0 112.574 -175.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 78' ' ' LEU . 1.3 tp -88.55 -32.2 18.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.871 0.367 . . . . 10.0 110.595 -174.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.614 HD21 ' HB2' ' A' ' 75' ' ' ALA . 4.3 mm? -63.8 -33.15 75.03 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.47 -0.567 . . . . 10.0 109.47 172.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.678 ' HD3' ' O ' ' A' ' 76' ' ' SER . 3.9 mptp? -56.04 -46.47 78.87 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.816 -0.629 . . . . 10.0 110.12 172.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 81' ' ' LYS . 2.8 mmtm -57.23 -43.42 82.86 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.509 0.929 . . . . 10.0 113.509 -176.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.491 ' HB3' HG13 ' A' ' 100' ' ' VAL . . . -65.94 -49.0 69.47 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 123.044 1.402 . . . . 10.0 110.086 175.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.489 ' HB2' ' HA3' ' A' ' 98' ' ' GLY . . . . . . . . 0 C--N 1.291 -1.942 0 CA-C-N 111.306 -2.679 . . . . 10.0 110.358 -171.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.463 ' CG1' ' H ' ' A' ' 98' ' ' GLY . 7.3 p . . . . . 0 CA--C 1.537 0.463 0 N-CA-C 112.358 0.503 . . . . 10.0 112.358 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.767 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -111.17 154.72 16.52 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 109.16 -1.576 . . . . 10.0 109.16 169.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.752 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 21.1 pttp -153.8 153.43 32.14 Favored 'General case' 0 CA--C 1.474 -1.958 0 CA-C-O 122.358 1.075 . . . . 10.0 109.865 164.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.61 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.7 OUTLIER -164.62 -162.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.414 -2.251 0 CA-C-N 111.976 -2.374 . . . . 10.0 105.958 -167.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.54 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 9.6 p -119.49 159.37 24.42 Favored 'General case' 0 C--N 1.275 -2.639 0 C-N-CA 119.494 -0.882 . . . . 10.0 111.838 -170.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.665 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 29.0 mmt180 -44.0 -41.92 5.69 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.193 -1.367 . . . . 10.0 110.334 170.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 3.1 tppp? -59.03 -44.8 91.8 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.672 0.619 . . . . 10.0 112.672 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.62 ' O ' HG12 ' A' ' 108' ' ' ILE . 58.9 mm-40 -58.33 -52.85 63.87 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.763 -0.829 . . . . 10.0 108.763 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.665 ' HB ' ' O ' ' A' ' 102' ' ' ARG . 31.4 mm -38.04 -51.68 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.704 0 CA-C-N 114.318 -1.31 . . . . 10.0 111.899 167.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.749 ' HA ' ' SD ' ' A' ' 125' ' ' MET . 34.2 tt0 -52.95 -58.7 6.07 Favored 'General case' 0 C--O 1.215 -0.746 0 C-N-CA 124.627 1.171 . . . . 10.0 113.55 -177.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -58.36 -47.08 84.95 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 119.913 -0.715 . . . . 10.0 110.554 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.62 HG12 ' O ' ' A' ' 104' ' ' GLN . 19.8 mm -48.46 -60.75 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.558 166.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.545 ' HB1' HG13 ' A' ' 128' ' ' ILE . . . -51.33 -38.01 50.81 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.138 0.422 . . . . 10.0 112.138 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.679 ' O ' ' HG2' ' A' ' 113' ' ' MET . 83.4 mttt -70.36 -54.44 12.49 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.854 -174.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.718 HG22 ' HG3' ' A' ' 112' ' ' LYS . 5.8 t -57.05 -24.65 55.36 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.804 -0.635 . . . . 10.0 111.208 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.88 ' HZ1' HD13 ' A' ' 116' ' ' LEU . 5.8 mtpm? -105.98 -11.0 16.32 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.69 0.626 . . . . 10.0 112.69 -175.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.679 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 22.7 ptm -51.82 -31.5 6.36 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 113.845 1.054 . . . . 10.0 113.845 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 113' ' ' MET . 31.6 Cg_endo -63.02 -28.02 74.45 Favored 'Trans proline' 0 C--N 1.368 1.558 0 CA-C-N 121.063 1.415 . . . . 10.0 111.31 174.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.632 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -100.19 -38.51 8.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.406 -1.27 . . . . 10.0 113.431 -172.115 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.88 HD13 ' HZ1' ' A' ' 112' ' ' LYS . 3.0 mp -62.93 -1.37 0.88 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.928 -1.033 . . . . 10.0 112.021 -175.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.439 ' H ' ' C ' ' A' ' 115' ' ' ASP . 56.7 t30 58.38 65.56 1.24 Allowed 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.084 -1.417 . . . . 10.0 109.596 175.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.537 ' HB2' ' HB1' ' A' ' 123' ' ' ALA . . . -142.86 143.07 31.93 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.88 -1.054 . . . . 10.0 112.142 -171.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.444 ' C ' HD21 ' A' ' 119' ' ' ASN . 0.2 OUTLIER -65.72 -74.93 0.1 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.444 -1.253 . . . . 10.0 109.553 176.139 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.7 m -82.52 147.79 28.46 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.371 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.656 HD11 ' C ' ' A' ' 121' ' ' LEU . 1.5 tm? -55.11 -34.36 63.62 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.462 -0.57 . . . . 10.0 109.462 163.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -50.78 -38.51 48.58 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.307 0.575 . . . . 10.0 111.102 173.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -67.61 -45.57 75.04 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 118.635 -1.226 . . . . 10.0 110.466 175.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.56 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -56.29 -32.78 64.9 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.487 -0.324 . . . . 10.0 110.848 175.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.749 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 84.0 mmm -58.17 -37.09 74.06 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.017 0.437 . . . . 10.0 110.89 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.521 ' HA ' ' HG2' ' A' ' 129' ' ' GLU . 3.5 mptp? -62.56 -54.28 42.13 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.233 -0.894 . . . . 10.0 111.933 177.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.626 HD11 HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -51.55 -57.93 2.75 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 C-N-CA 119.178 -1.009 . . . . 10.0 110.595 178.375 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.593 ' HB ' HG23 ' A' ' 105' ' ' ILE . 24.1 mm -50.73 -58.41 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 114.578 -1.192 . . . . 10.0 112.448 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.521 ' HG2' ' HA ' ' A' ' 126' ' ' LYS . 11.6 pt-20 -53.42 -44.32 68.68 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.862 -0.792 . . . . 10.0 108.862 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.4 -47.77 55.66 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.779 -0.725 . . . . 10.0 111.329 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.529 HG23 ' HE3' ' A' ' 135' ' ' MET . 69.6 m -43.07 -67.18 0.3 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.105 -1.048 . . . . 10.0 108.727 170.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.528 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . . . -51.18 -48.63 61.9 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.851 -0.613 . . . . 10.0 112.331 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -47.81 -52.81 17.53 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.95 -0.568 . . . . 10.0 111.919 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 28.9 t -64.72 -29.36 70.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.752 0.31 . . . . 10.0 110.98 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.529 ' HE3' HG23 ' A' ' 131' ' ' THR . 56.9 mtm -82.45 2.25 33.61 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 114.29 1.218 . . . . 10.0 114.29 -175.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.78 10.9 69.02 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 120.148 1.34 . . . . 10.0 111.777 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.767 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 2.7 mp -99.09 125.26 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 CA-C-O 121.64 0.733 . . . . 10.0 110.593 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.752 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -91.26 157.12 17.33 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.618 -1.174 . . . . 10.0 108.915 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.43 ' C ' HG11 ' A' ' 140' ' ' VAL . 17.6 m -117.47 127.84 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.726 -0.472 . . . . 10.0 109.726 174.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 100' ' ' VAL . 18.5 m -147.28 74.49 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 N-CA-C 116.151 1.908 . . . . 10.0 116.151 -170.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.501 ' OD1' ' HB2' ' A' ' 102' ' ' ARG . 1.3 m-20 . . . . . 0 C--N 1.289 -2.043 0 C-N-CA 119.823 -0.751 . . . . 10.0 110.844 145.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.652 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . 61.4 tttp . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 109.274 -0.639 . . . . 10.0 109.274 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.4 t -61.21 124.7 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 120.813 0.34 . . . . 10.0 110.528 -174.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.97 -27.0 8.6 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 120.54 -0.464 . . . . 10.0 110.344 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.588 ' HB2' ' CG1' ' A' ' 60' ' ' VAL . . . -160.45 174.64 13.8 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.222 0.823 . . . . 10.0 113.222 177.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.509 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 23.2 mm-40 -129.86 127.32 39.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.399 -1.273 . . . . 10.0 108.244 177.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.779 HG23 ' HG ' ' A' ' 28' ' ' LEU . 1.4 mm -116.2 87.01 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.121 -0.696 . . . . 10.0 109.121 -178.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.41 ' HG2' HG22 ' A' ' 57' ' ' VAL . 15.4 mtpp -78.28 142.68 37.63 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 121.097 1.771 . . . . 10.0 110.255 175.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 24' ' ' VAL . 1.0 OUTLIER -156.81 135.48 11.6 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.649 -0.705 . . . . 10.0 109.115 -176.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -96.3 113.22 24.79 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.635 -0.876 . . . . 10.0 108.635 172.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.469 HD11 HD21 ' A' ' 11' ' ' LEU . 31.5 mt -132.51 145.87 59.08 Favored Pre-proline 0 CA--C 1.501 -0.913 0 CA-C-O 121.147 0.499 . . . . 10.0 111.269 -169.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.738 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 5.8 Cg_exo -71.66 123.15 9.19 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 123.102 2.534 . . . . 10.0 111.31 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.637 ' HB1' HD13 ' A' ' 54' ' ' LEU . . . -60.32 127.41 31.65 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 107.936 -1.135 . . . . 10.0 107.936 172.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.22 -1.05 89.34 Favored Glycine 0 N--CA 1.438 -1.19 0 O-C-N 125.671 1.857 . . . . 10.0 112.354 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.738 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 45.2 tptt -139.52 110.76 6.97 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 122.943 1.354 . . . . 10.0 112.588 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.415 ' CB ' HD22 ' A' ' 43' ' ' ASN . . . -161.4 128.95 4.13 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.669 -2.06 . . . . 10.0 108.753 168.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.49 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 25.3 p -158.7 66.8 3.21 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 105.897 -1.89 . . . . 10.0 105.897 -174.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.685 ' HG3' HG23 ' A' ' 35' ' ' ILE . 5.7 Cg_exo 12.37 49.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.659 1 C-N-CA 130.673 7.582 . . . . 10.0 116.814 -175.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.586 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -57.6 167.75 1.26 Allowed Pre-proline 0 N--CA 1.441 -0.916 0 CA-C-N 112.545 -2.116 . . . . 10.0 109.601 164.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.586 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 72.9 Cg_exo -36.97 -44.35 1.12 Allowed 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 123.648 2.899 . . . . 10.0 114.967 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 22' ' ' PRO . 18.7 Cg_exo -36.29 -66.14 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.808 3.005 . . . . 10.0 114.508 168.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.967 HG13 HD13 ' A' ' 35' ' ' ILE . 58.9 t -85.61 -56.27 5.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 114.433 -1.258 . . . . 10.0 114.02 -164.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.22 -67.67 1.28 Allowed Glycine 0 CA--C 1.521 0.455 0 O-C-N 124.37 1.044 . . . . 10.0 113.276 -174.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.431 ' HD2' ' O ' ' A' ' 22' ' ' PRO . 90.5 Cg_exo -52.03 -46.23 33.8 Favored 'Trans proline' 0 C--O 1.222 -0.289 0 C-N-CA 123.876 3.051 . . . . 10.0 112.8 174.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.5 -79.28 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.296 0.569 . . . . 10.0 111.799 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.889 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . 1.5 mt -67.73 -45.03 76.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.793 -0.64 . . . . 10.0 112.694 -176.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.49 -38.16 90.28 Favored Glycine 0 C--N 1.324 -0.126 0 CA-C-N 115.912 -0.585 . . . . 10.0 112.674 -173.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -65.07 -21.89 66.89 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.915 0.388 . . . . 10.0 110.752 177.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -98.86 16.62 21.75 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.345 0.593 . . . . 10.0 109.958 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.0 2.9 89.42 Favored Glycine 0 CA--C 1.503 -0.68 0 CA-C-N 115.092 -0.958 . . . . 10.0 113.657 168.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.654 HG11 ' CD2' ' A' ' 66' ' ' PHE . 2.0 t -78.96 148.06 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 113.009 0.744 . . . . 10.0 113.009 -173.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.512 ' OD1' ' HB3' ' A' ' 37' ' ' GLU . 0.3 OUTLIER -71.06 90.71 0.86 Allowed 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.919 0.866 . . . . 10.0 109.997 172.532 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.967 HD13 HG13 ' A' ' 24' ' ' VAL . 11.5 mm -53.54 -40.87 43.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 113.818 -1.537 . . . . 10.0 112.081 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 50.6 mtm -66.0 -47.15 75.43 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.594 -1.639 . . . . 10.0 111.967 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.606 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 32.3 tt0 -58.71 -37.68 76.66 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 118.661 -1.216 . . . . 10.0 109.612 173.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.579 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 81.6 t80 -54.61 -58.95 5.5 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 119.554 -0.859 . . . . 10.0 112.767 170.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -54.51 -53.34 55.72 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 114.069 -1.423 . . . . 10.0 111.324 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -67.05 -21.9 65.89 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 119.694 -0.803 . . . . 10.0 109.749 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.8 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 13.7 mtm180 -76.56 -62.48 1.61 Allowed 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 119.543 -0.863 . . . . 10.0 112.286 169.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.524 ' CZ ' HG21 ' A' ' 46' ' ' THR . 63.9 t80 -52.41 -42.06 63.74 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 118.006 0.366 . . . . 10.0 110.536 -172.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.536 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.9 OUTLIER -60.86 -50.08 74.87 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.817 179.512 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.72 -41.58 99.23 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.742 -0.783 . . . . 10.0 112.341 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.8 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 4.4 mm-40 -65.82 -44.23 86.21 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.751 0.786 . . . . 10.0 110.81 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.652 HG21 HD12 ' A' ' 54' ' ' LEU . 76.8 p -89.79 5.09 47.62 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.534 -1.212 . . . . 10.0 111.85 -170.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.88 -40.22 9.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.955 -1.02 . . . . 10.0 112.224 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.88 -32.7 65.58 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.692 -0.685 . . . . 10.0 111.166 -176.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.419 ' HB3' ' HE3' ' A' ' 52' ' ' MET . 59.1 mttp -99.42 17.64 19.74 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.791 0.837 . . . . 10.0 110.105 -175.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -50.26 142.3 10.24 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.172 -0.922 . . . . 10.0 112.873 -176.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.31 18.92 31.86 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.541 -0.754 . . . . 10.0 111.456 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.603 ' SD ' ' HB2' ' A' ' 77' ' ' PHE . 45.7 mtm -141.15 129.72 22.68 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 116.853 -1.939 . . . . 10.0 114.386 -167.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.3 mm -67.52 92.06 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.567 -0.531 . . . . 10.0 109.567 172.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.652 HD12 HG21 ' A' ' 46' ' ' THR . 6.5 mt -81.2 130.02 64.43 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 109.697 -0.483 . . . . 10.0 109.697 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.822 ' HG2' ' HG3' ' A' ' 74' ' ' PRO . 18.0 Cg_exo -71.31 103.02 1.34 Allowed 'Trans proline' 0 C--N 1.331 -0.347 0 C-N-CA 122.571 2.181 . . . . 10.0 111.233 172.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.09 156.48 3.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 119.505 1.048 . . . . 10.0 111.706 -175.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.41 HG22 ' HG2' ' A' ' 10' ' ' LYS . 96.0 t -135.98 117.75 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.209 170.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.778 HG21 HD23 ' A' ' 28' ' ' LEU . 12.6 mt -109.93 135.04 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.705 0 N-CA-C 108.595 -0.891 . . . . 10.0 108.595 -175.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.0 m -117.7 95.47 4.95 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 114.954 -1.021 . . . . 10.0 108.308 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.588 ' CG1' ' HB2' ' A' ' 7' ' ' ALA . 2.7 p -86.73 138.11 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.012 0 CA-C-N 119.61 1.095 . . . . 10.0 110.784 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -92.87 163.85 13.55 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.514 -0.766 . . . . 10.0 111.745 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.652 ' HG2' ' HB3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -60.7 -19.9 59.79 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.605 -1.18 . . . . 10.0 112.093 -179.132 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.33 -4.69 52.04 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.317 -0.856 . . . . 10.0 111.861 -177.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 83.24 -1.74 1.2 Allowed 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 124.318 1.011 . . . . 10.0 109.443 -170.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.6 m -72.6 168.71 18.08 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.572 -1.194 . . . . 10.0 108.327 174.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.654 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -169.47 -179.99 3.63 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 120.477 1.49 . . . . 10.0 109.471 176.088 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 p -160.54 168.67 24.55 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 103.241 -2.874 . . . . 10.0 103.241 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.536 ' HE1' ' HE ' ' A' ' 41' ' ' ARG . 51.4 p90 -163.56 155.94 17.85 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.759 -0.83 . . . . 10.0 108.759 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mt -124.19 167.58 17.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 106.922 -1.51 . . . . 10.0 106.922 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.624 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 2.6 mm -121.84 124.69 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 N-CA-C 106.485 -1.672 . . . . 10.0 106.485 177.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.685 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 32.0 mmmt -78.73 101.51 7.59 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.943 0.878 . . . . 10.0 111.897 -165.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.753 ' HB ' ' HG2' ' A' ' 112' ' ' LYS . 8.3 p -56.6 -34.73 28.24 Favored Pre-proline 0 CA--C 1.562 1.423 0 CA-C-N 113.449 -1.705 . . . . 10.0 113.974 169.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.731 ' HD2' ' N ' ' A' ' 72' ' ' THR . 4.8 Cg_exo -35.68 -52.15 0.93 Allowed 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 124.838 3.692 . . . . 10.0 115.907 -176.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.822 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 16.7 Cg_endo -58.76 103.45 0.16 Allowed 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.401 1.401 . . . . 10.0 110.495 173.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.613 ' O ' ' HB2' ' A' ' 79' ' ' LEU . . . -81.13 0.39 36.45 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.245 -0.434 . . . . 10.0 111.364 -171.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.7 t -61.7 -55.29 31.99 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.141 -0.481 . . . . 10.0 111.451 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.667 ' HE1' ' HG2' ' A' ' 74' ' ' PRO . 37.7 p90 -77.77 -27.51 50.31 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.609 0.596 . . . . 10.0 112.609 -171.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.497 ' HB3' HD11 ' A' ' 108' ' ' ILE . 1.1 mm? -75.14 -46.54 33.62 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.416 0.626 . . . . 10.0 110.721 174.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.613 ' HB2' ' O ' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -64.16 -35.6 81.31 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.808 -0.442 . . . . 10.0 109.808 -179.27 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.594 ' HA ' ' HB1' ' A' ' 83' ' ' ALA . 20.2 ttpt -60.61 -31.86 71.02 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.819 -0.628 . . . . 10.0 110.262 173.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 21.9 ttpp -52.56 -44.84 66.11 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 110.439 -0.208 . . . . 10.0 110.439 177.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.657 ' HB1' ' HG2' ' A' ' 104' ' ' GLN . . . -73.52 -46.81 45.52 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.81 1.644 . . . . 10.0 111.657 172.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.594 ' HB1' ' HA ' ' A' ' 80' ' ' LYS . . . . . . . . 0 C--N 1.288 -2.071 0 CA-C-N 111.532 -2.576 . . . . 10.0 111.718 -168.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 136' ' ' GLY . 12.4 p . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 112.286 0.476 . . . . 10.0 112.286 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.56 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -165.2 155.12 26.3 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 109.439 -1.464 . . . . 10.0 109.439 175.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.676 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 9.2 ptpt -137.87 169.75 17.24 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-O 122.734 1.254 . . . . 10.0 111.71 -161.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.695 ' O ' HG22 ' A' ' 140' ' ' VAL . 0.8 OUTLIER -159.5 -144.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 111.456 -2.611 . . . . 10.0 106.132 -174.087 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.475 HG22 ' CG2' ' A' ' 140' ' ' VAL . 28.5 p -154.64 148.21 25.26 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.127 -1.805 . . . . 10.0 106.127 -157.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.656 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 38.3 mmt180 -43.7 -42.47 5.37 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 123.895 0.747 . . . . 10.0 109.894 174.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -57.46 -44.04 84.49 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.69 0.626 . . . . 10.0 112.69 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.657 ' HG2' ' HB1' ' A' ' 82' ' ' ALA . 1.1 mp0 -60.35 -50.04 75.21 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 109.157 -0.683 . . . . 10.0 109.157 177.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.949 HG21 ' HB ' ' A' ' 128' ' ' ILE . 33.0 mm -40.59 -54.1 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.446 -1.252 . . . . 10.0 111.398 169.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.715 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 23.7 tt0 -49.17 -51.37 33.0 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.837 -1.074 . . . . 10.0 112.382 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -51.27 -60.76 2.76 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.131 -0.941 . . . . 10.0 110.016 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.584 HG12 ' O ' ' A' ' 104' ' ' GLN . 13.4 mm -47.53 -53.0 4.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 113.811 -1.54 . . . . 10.0 110.552 174.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.84 -34.4 53.97 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.663 0.616 . . . . 10.0 112.663 175.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.715 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 64.3 mttm -73.54 -53.86 9.57 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 116.468 -0.333 . . . . 10.0 110.976 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.754 HG23 ' HG3' ' A' ' 112' ' ' LYS . 11.4 t -56.74 -33.68 66.79 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.293 -0.412 . . . . 10.0 111.704 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.754 ' HG3' HG23 ' A' ' 111' ' ' THR . 17.7 mtpp -96.87 -1.31 46.23 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 122.736 0.414 . . . . 10.0 111.321 -177.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.682 ' HE3' ' HB2' ' A' ' 121' ' ' LEU . 52.6 ttm -49.33 -47.34 76.95 Favored Pre-proline 0 N--CA 1.468 0.446 0 N-CA-C 112.836 0.68 . . . . 10.0 112.836 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 113' ' ' MET . 32.8 Cg_endo -63.26 -26.55 71.96 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 121.443 1.429 . . . . 10.0 111.979 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.506 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -97.97 -44.45 6.66 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.952 -1.022 . . . . 10.0 113.576 -171.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.644 ' HG ' HD13 ' A' ' 127' ' ' ILE . 2.2 mp -66.22 42.22 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.708 -1.133 . . . . 10.0 113.232 -177.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 65.9 t30 14.64 53.0 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 O-C-N 124.776 1.298 . . . . 10.0 112.28 -167.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.407 ' O ' ' CB ' ' A' ' 119' ' ' ASN . . . -65.8 -78.8 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.612 0.967 . . . . 10.0 113.612 -165.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 118' ' ' ALA . 38.5 t-20 99.72 -41.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.883 1.273 . . . . 10.0 108.323 -175.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 47.6 t -148.81 139.54 22.77 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 106.758 -1.571 . . . . 10.0 106.758 173.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.682 ' HB2' ' HE3' ' A' ' 113' ' ' MET . 3.2 tm? -53.19 -33.76 54.06 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.157 -0.928 . . . . 10.0 113.324 -177.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -50.02 -42.62 49.73 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.749 0.785 . . . . 10.0 110.697 173.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.49 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . . . -65.7 -49.09 69.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.487 -1.233 . . . . 10.0 110.719 -178.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.573 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -54.93 -37.9 66.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.527 178.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.638 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 78.4 mmm -52.96 -40.34 63.62 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.138 0.792 . . . . 10.0 113.138 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.49 ' HD2' ' HA ' ' A' ' 123' ' ' ALA . 10.3 mttt -63.25 -46.8 85.19 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.291 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.644 HD13 ' HG ' ' A' ' 116' ' ' LEU . 73.2 mt -50.19 -62.58 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-N 115.6 -0.727 . . . . 10.0 110.012 175.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.949 ' HB ' HG21 ' A' ' 105' ' ' ILE . 10.5 mm -53.18 -58.03 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-N 114.058 -1.428 . . . . 10.0 111.441 -176.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.56 -44.01 62.58 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 123.849 0.718 . . . . 10.0 109.584 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -69.9 -45.84 55.49 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.415 -0.897 . . . . 10.0 111.881 -177.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 75' ' ' ALA . 22.4 m -48.2 -58.12 4.96 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.486 -0.857 . . . . 10.0 109.762 171.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.543 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -53.38 -44.57 68.74 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 111.812 0.301 . . . . 10.0 111.812 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 34.7 tttp -45.33 -55.15 6.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.491 -0.777 . . . . 10.0 110.956 174.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.0 m -64.58 -31.56 72.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.984 0.421 . . . . 10.0 111.529 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 10.7 mtm -78.61 -8.84 59.05 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.272 0.841 . . . . 10.0 113.272 -174.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.571 ' O ' HG13 ' A' ' 97' ' ' VAL . . . 88.72 14.36 61.38 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 119.587 1.085 . . . . 10.0 111.74 -178.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 2.0 mp -96.95 124.84 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.95 0 CA-C-O 121.624 0.726 . . . . 10.0 111.062 -177.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.676 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.3 OUTLIER -84.03 146.68 27.83 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.611 -1.177 . . . . 10.0 109.323 177.544 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.7 m -116.64 124.02 72.29 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.782 0 N-CA-C 106.458 -1.682 . . . . 10.0 106.458 174.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.695 HG22 ' O ' ' A' ' 100' ' ' VAL . 33.1 m -106.88 170.01 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.149 0 CA-C-N 113.753 -1.567 . . . . 10.0 110.063 -175.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 . . . . . 0 C--N 1.288 -2.078 0 CA-C-N 113.148 -1.842 . . . . 10.0 108.482 -177.451 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.431 ' HB3' ' HG3' ' A' ' 62' ' ' GLU . 21.2 ttpt . . . . . 0 N--CA 1.448 -0.544 0 N-CA-C 107.371 -1.344 . . . . 10.0 107.371 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.5 t -62.6 127.29 22.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 O-C-N 123.376 0.422 . . . . 10.0 111.148 -174.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -102.51 -28.55 12.11 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.091 -0.707 . . . . 10.0 109.091 176.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.515 ' HB1' ' CG1' ' A' ' 60' ' ' VAL . . . -162.52 177.85 9.1 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.295 0.85 . . . . 10.0 113.295 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 78.3 mt-30 -134.65 129.63 35.14 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 114.493 -1.23 . . . . 10.0 107.963 175.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.631 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 5.4 mt -124.1 87.24 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 109.038 -0.727 . . . . 10.0 109.038 -175.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.497 ' HG3' HG22 ' A' ' 57' ' ' VAL . 3.2 mppt? -78.37 146.39 34.66 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 120.991 -1.068 . . . . 10.0 110.178 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.426 ' CD2' HG22 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -156.77 137.16 12.97 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.088 -0.505 . . . . 10.0 109.902 -175.573 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.411 ' HB3' ' CG2' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -93.84 113.28 25.28 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.312 -0.996 . . . . 10.0 108.312 169.528 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.461 HD12 HG22 ' A' ' 24' ' ' VAL . 15.5 mt -132.1 152.88 80.97 Favored Pre-proline 0 C--O 1.212 -0.909 0 CA-C-O 121.31 0.576 . . . . 10.0 111.652 -171.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.608 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 5.5 Cg_exo -78.63 123.59 5.96 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 123.244 2.629 . . . . 10.0 111.784 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.547 ' HB2' HD12 ' A' ' 54' ' ' LEU . . . -61.75 126.67 28.15 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.987 -1.116 . . . . 10.0 107.987 172.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.03 1.79 90.4 Favored Glycine 0 N--CA 1.438 -1.192 0 O-C-N 126.043 2.089 . . . . 10.0 112.108 -177.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.608 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 9.6 tptp -141.56 113.45 7.88 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 122.999 1.381 . . . . 10.0 112.102 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.434 ' CB ' HD22 ' A' ' 43' ' ' ASN . . . -159.04 140.56 13.26 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 112.869 -1.969 . . . . 10.0 108.561 164.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.407 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 48.0 p -157.64 61.02 2.12 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 105.837 -1.912 . . . . 10.0 105.837 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.68 ' HG3' ' CG2' ' A' ' 35' ' ' ILE . 0.1 OUTLIER 15.41 49.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.692 1 C-N-CA 129.687 6.925 . . . . 10.0 116.11 -178.011 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.63 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . . . -56.08 170.58 0.44 Allowed Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 111.553 -2.567 . . . . 10.0 109.736 165.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.63 ' HD2' ' HB2' ' A' ' 21' ' ' ALA . 79.6 Cg_exo -37.39 -44.76 1.46 Allowed 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 123.291 2.661 . . . . 10.0 114.814 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 22' ' ' PRO . 6.4 Cg_exo -38.18 -62.56 0.3 Allowed 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 123.346 2.697 . . . . 10.0 114.374 170.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.953 HG13 HD11 ' A' ' 35' ' ' ILE . 61.6 t -87.44 -56.58 5.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 114.207 1.188 . . . . 10.0 114.207 -163.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.48 -66.52 2.2 Favored Glycine 0 C--O 1.226 -0.348 0 O-C-N 124.02 0.825 . . . . 10.0 113.366 -174.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.441 ' HD2' ' O ' ' A' ' 22' ' ' PRO . 86.4 Cg_exo -53.01 -42.41 64.77 Favored 'Trans proline' 0 C--O 1.225 -0.141 0 C-N-CA 123.262 2.641 . . . . 10.0 112.577 174.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.478 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . . . -53.17 -79.76 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.401 0.619 . . . . 10.0 111.433 177.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.871 HD23 HG21 ' A' ' 58' ' ' ILE . 2.5 mt -67.17 -46.77 72.97 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.521 -0.763 . . . . 10.0 113.016 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.9 -35.6 87.39 Favored Glycine 0 C--O 1.228 -0.232 0 CA-C-N 116.428 -0.351 . . . . 10.0 112.931 -173.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -64.2 -22.72 67.05 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.72 0.295 . . . . 10.0 110.222 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -99.87 15.53 26.73 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.408 0.623 . . . . 10.0 109.603 175.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.457 ' HA3' ' CE ' ' A' ' 64' ' ' LYS . . . 74.28 14.47 80.68 Favored Glycine 0 CA--C 1.501 -0.799 0 CA-C-N 114.687 -1.142 . . . . 10.0 113.692 170.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.585 HG12 ' CD2' ' A' ' 66' ' ' PHE . 0.9 OUTLIER -82.74 148.88 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 C-N-CA 120.252 -0.579 . . . . 10.0 112.474 -177.074 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -71.11 92.78 0.99 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.701 0.762 . . . . 10.0 110.296 174.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.953 HD11 HG13 ' A' ' 24' ' ' VAL . 14.6 mm -53.94 -40.02 43.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 114.422 -1.263 . . . . 10.0 112.35 178.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.417 ' SD ' ' N ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -68.95 -41.88 77.42 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 113.909 -1.496 . . . . 10.0 111.613 177.267 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.571 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 22.2 mt-10 -55.77 -44.71 77.94 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 118.932 -1.107 . . . . 10.0 109.611 169.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.571 ' HB2' ' HE2' ' A' ' 66' ' ' PHE . 84.6 t80 -52.74 -58.62 6.26 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.076 1.139 . . . . 10.0 114.076 172.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 39.9 t -56.9 -51.6 68.47 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 114.75 -1.114 . . . . 10.0 110.924 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.478 ' HA ' ' HD3' ' A' ' 40' ' ' LYS . 28.7 mmtp -67.47 -20.88 65.53 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 119.269 -0.972 . . . . 10.0 110.297 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.604 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 92.7 mtt180 -73.85 -62.85 1.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.912 -0.715 . . . . 10.0 112.103 170.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.487 ' HE2' ' O ' ' A' ' 14' ' ' PRO . 73.3 t80 -56.42 -48.55 76.72 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-N 115.572 -0.74 . . . . 10.0 110.415 -173.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.452 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.9 OUTLIER -59.7 -49.44 77.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.308 -0.86 . . . . 10.0 110.286 -176.739 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.81 -46.08 91.06 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.169 -1.013 . . . . 10.0 112.71 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 9.5 pt-20 -71.32 -31.25 67.17 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 120.16 -0.616 . . . . 10.0 112.355 -176.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.539 HG21 HD11 ' A' ' 54' ' ' LEU . 63.3 p -91.06 2.88 55.99 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.45 -0.795 . . . . 10.0 111.591 -175.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.74 -38.71 7.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.001 -0.999 . . . . 10.0 112.934 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.521 ' OD1' ' HG3' ' A' ' 49' ' ' LYS . 0.5 OUTLIER -81.94 -26.49 33.98 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.729 -0.669 . . . . 10.0 112.199 -174.44 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.521 ' HG3' ' OD1' ' A' ' 48' ' ' ASP . 36.4 mttp -101.72 18.55 20.13 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.473 0.654 . . . . 10.0 109.437 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -50.32 140.95 12.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.704 -1.134 . . . . 10.0 112.928 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.59 18.08 26.7 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 114.984 -1.007 . . . . 10.0 110.774 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.45 ' HB2' HD22 ' A' ' 54' ' ' LEU . 65.6 mtt -137.12 127.23 26.09 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 117.137 -1.825 . . . . 10.0 113.92 -167.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.411 ' CG2' ' HB3' ' A' ' 12' ' ' GLN . 50.9 mm -68.97 90.61 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.268 -0.641 . . . . 10.0 109.268 171.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.547 HD12 ' HB2' ' A' ' 15' ' ' ALA . 6.6 mt -77.74 140.03 62.99 Favored Pre-proline 0 N--CA 1.449 -0.482 0 N-CA-C 108.665 -0.865 . . . . 10.0 108.665 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 54' ' ' LEU . 5.3 Cg_exo -77.92 104.78 1.91 Allowed 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.59 2.193 . . . . 10.0 110.889 172.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.54 151.26 4.9 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 CA-C-N 118.893 0.769 . . . . 10.0 111.324 -174.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.497 HG22 ' HG3' ' A' ' 10' ' ' LYS . 99.3 t -135.58 119.81 26.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.981 -0.377 . . . . 10.0 109.981 172.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.871 HG21 HD23 ' A' ' 28' ' ' LEU . 13.0 mt -108.81 137.55 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 N-CA-C 108.36 -0.978 . . . . 10.0 108.36 -174.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.0 m -123.07 96.57 5.06 Favored 'General case' 0 N--CA 1.407 -2.601 0 CA-C-N 114.688 -1.142 . . . . 10.0 108.818 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 65' ' ' SER . 4.3 p -85.73 137.28 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 CA-C-N 119.298 0.953 . . . . 10.0 110.436 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -100.71 178.17 4.78 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.797 0.808 . . . . 10.0 113.056 -176.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.431 ' HG3' ' HB3' ' A' ' 4' ' ' LYS . 28.0 mt-10 -50.57 -33.59 22.43 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.796 -1.547 . . . . 10.0 113.718 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.7 -6.51 57.34 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.517 0.562 . . . . 10.0 112.517 -172.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.457 ' CE ' ' HA3' ' A' ' 32' ' ' GLY . 26.9 mmmt 83.51 5.51 0.79 Allowed 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 124.643 1.214 . . . . 10.0 108.569 -168.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.55 ' O ' HG23 ' A' ' 60' ' ' VAL . 22.0 t -73.74 175.79 6.88 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 113.355 -1.748 . . . . 10.0 107.67 173.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.585 ' CD2' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -170.0 -178.93 3.03 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 120.523 1.51 . . . . 10.0 109.866 176.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.9 p -157.64 170.31 22.68 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 103.233 -2.876 . . . . 10.0 103.233 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.437 ' HB3' HG12 ' A' ' 58' ' ' ILE . 48.7 p90 -163.4 157.58 20.11 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.802 -0.814 . . . . 10.0 108.802 174.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.47 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 29.2 pt -122.77 167.77 16.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.014 -1.106 . . . . 10.0 108.014 -176.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.451 HD13 ' CE1' ' A' ' 42' ' ' PHE . 1.9 mm -135.39 117.61 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 107.093 -1.447 . . . . 10.0 107.093 -176.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.619 ' HE2' ' HA ' ' A' ' 71' ' ' LYS . 9.4 mmmm -75.41 97.92 3.76 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.228 -0.589 . . . . 10.0 110.761 -172.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.26 98.0 0.16 Allowed Pre-proline 0 C--N 1.317 -0.809 0 O-C-N 124.639 1.212 . . . . 10.0 109.342 169.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.607 ' HG3' ' CD2' ' A' ' 77' ' ' PHE . 54.3 Cg_endo -67.54 137.29 42.22 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.409 2.073 . . . . 10.0 112.681 -162.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.84 ' HA ' HD11 ' A' ' 116' ' ' LEU . 85.1 Cg_exo -47.29 88.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.746 2.964 . . . . 10.0 113.689 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.627 ' H ' ' HD3' ' A' ' 112' ' ' LYS . . . 70.59 -41.82 0.51 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.073 -0.967 . . . . 10.0 113.569 174.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.9 p -40.83 -73.73 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.3 1.222 . . . . 10.0 114.3 -167.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.607 ' CD2' ' HG3' ' A' ' 73' ' ' PRO . 8.5 m-30 -61.97 -21.81 65.13 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.349 0.87 . . . . 10.0 113.349 -172.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 1.034 ' HB3' HD12 ' A' ' 108' ' ' ILE . 6.3 mp -101.02 -12.77 18.6 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 119.499 -0.88 . . . . 10.0 111.288 -178.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.413 ' CD1' ' HB3' ' A' ' 75' ' ' ALA . 50.6 mt -76.99 -26.48 53.92 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.07 -1.085 . . . . 10.0 108.07 165.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 61.5 mmtt -59.79 -38.72 82.68 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.207 -0.906 . . . . 10.0 109.5 167.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.538 ' HD3' ' HA ' ' A' ' 81' ' ' LYS . 53.5 mmtt -64.25 -44.64 91.17 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.528 0.936 . . . . 10.0 113.528 175.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.624 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -71.61 -56.31 6.1 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.562 1.945 . . . . 10.0 112.966 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.285 -2.224 0 CA-C-N 111.069 -2.787 . . . . 10.0 105.872 -179.565 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.552 HG11 ' C ' ' A' ' 136' ' ' GLY . 8.2 p . . . . . 0 CA--C 1.553 1.061 0 CA-C-O 122.635 1.207 . . . . 10.0 111.308 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 33.07 -168.76 0.01 OUTLIER Glycine 0 CA--C 1.533 1.204 0 CA-C-N 113.942 -1.481 . . . . 10.0 115.171 -165.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.682 ' CB ' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -160.85 178.26 9.59 Favored 'General case' 0 CA--C 1.488 -1.413 0 CA-C-O 121.791 0.805 . . . . 10.0 112.044 -172.122 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.624 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -159.8 -166.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 113.502 -1.681 . . . . 10.0 111.938 -179.451 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 39.0 p -97.56 143.29 28.4 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 112.734 -2.03 . . . . 10.0 111.473 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.639 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 0.4 OUTLIER -47.87 -41.18 23.58 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.599 -0.728 . . . . 10.0 109.925 166.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.06 -43.3 77.8 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.655 0.382 . . . . 10.0 111.758 175.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.592 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -57.52 -50.74 72.09 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.411 -0.959 . . . . 10.0 108.411 174.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.759 HG23 ' HB ' ' A' ' 128' ' ' ILE . 27.9 mm -44.2 -49.82 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 114.522 -1.217 . . . . 10.0 111.53 174.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.715 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 27.6 tt0 -50.88 -57.16 9.18 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.766 1.227 . . . . 10.0 112.356 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.691 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 70.0 mm-40 -51.66 -58.59 5.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.347 -1.297 . . . . 10.0 110.17 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 1.034 HD12 ' HB3' ' A' ' 78' ' ' LEU . 22.8 mm -48.33 -51.6 9.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.318 -0.855 . . . . 10.0 110.742 173.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.509 ' HB1' HG13 ' A' ' 128' ' ' ILE . . . -51.89 -42.66 62.89 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.499 0.555 . . . . 10.0 112.499 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.715 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 73.6 mttt -68.21 -52.58 32.67 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 122.045 0.926 . . . . 10.0 109.261 -177.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 85.5 m -51.46 -23.8 4.35 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 113.506 -1.679 . . . . 10.0 112.514 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.772 ' HZ1' HD11 ' A' ' 78' ' ' LEU . 29.5 mttp -122.63 1.19 9.44 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 113.171 0.804 . . . . 10.0 113.171 -175.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.553 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 23.3 ptm -50.18 -36.81 22.62 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 113.149 0.796 . . . . 10.0 113.149 176.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 113' ' ' MET . 58.7 Cg_endo -69.55 -29.76 24.33 Favored 'Trans proline' 0 C--N 1.367 1.515 0 CA-C-N 120.989 1.389 . . . . 10.0 111.912 178.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.616 ' OD2' ' HE2' ' A' ' 71' ' ' LYS . 2.7 t70 -87.24 -46.02 10.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.132 0.968 . . . . 10.0 110.454 -173.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.84 HD11 ' HA ' ' A' ' 74' ' ' PRO . 4.9 mp -65.1 -1.1 1.94 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 113.68 -1.6 . . . . 10.0 112.191 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 115' ' ' ASP . 26.0 m-80 58.98 50.39 8.39 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.853 -1.067 . . . . 10.0 109.247 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.413 ' O ' ' CB ' ' A' ' 119' ' ' ASN . . . -65.98 -74.78 0.1 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.28 -1.327 . . . . 10.0 113.099 -166.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 118' ' ' ALA . 27.3 t-20 102.43 -40.52 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.545 0 O-C-N 124.929 1.393 . . . . 10.0 109.354 -176.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.5 t -151.41 133.96 15.5 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 103.584 -2.747 . . . . 10.0 103.584 174.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.499 ' O ' ' HG3' ' A' ' 125' ' ' MET . 2.8 tm? -52.97 -35.05 58.59 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.386 0.884 . . . . 10.0 113.386 -173.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.581 ' HA ' ' HG3' ' A' ' 125' ' ' MET . 2.2 mp0 -51.46 -33.78 32.54 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 118.691 0.678 . . . . 10.0 110.734 175.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.42 -47.4 60.93 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 118.581 -1.247 . . . . 10.0 110.575 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.499 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -54.95 -39.01 68.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.835 -0.62 . . . . 10.0 110.305 175.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.581 ' HG3' ' HA ' ' A' ' 122' ' ' GLU . 17.2 mtp -54.96 -38.43 67.75 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 112.124 0.416 . . . . 10.0 112.124 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -62.19 -47.51 84.15 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 108.929 -0.767 . . . . 10.0 108.929 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.459 HD11 ' HA ' ' A' ' 124' ' ' ALA . 67.3 mt -50.92 -64.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 114.996 -1.002 . . . . 10.0 110.284 175.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.759 ' HB ' HG23 ' A' ' 105' ' ' ILE . 16.0 mm -52.81 -60.54 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 CA-C-N 114.496 -1.229 . . . . 10.0 111.394 -176.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.581 ' HB3' ' O ' ' A' ' 125' ' ' MET . 0.0 OUTLIER -51.75 -43.47 62.94 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.264 -0.88 . . . . 10.0 109.732 179.299 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.63 -45.25 29.35 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.717 -0.754 . . . . 10.0 111.909 -175.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.523 HG23 ' HB1' ' A' ' 75' ' ' ALA . 51.9 m -50.5 -56.97 9.23 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.513 -0.844 . . . . 10.0 109.765 173.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.99 -57.28 7.88 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 120.969 0.414 . . . . 10.0 111.031 175.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -46.45 -59.01 3.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.954 -1.021 . . . . 10.0 112.253 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.8 p -66.59 -24.5 66.34 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.057 0.391 . . . . 10.0 112.057 -174.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.534 ' O ' ' HG3' ' A' ' 135' ' ' MET . 0.0 OUTLIER -84.43 -3.41 58.33 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 112.936 0.717 . . . . 10.0 112.936 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.552 ' C ' HG11 ' A' ' 97' ' ' VAL . . . 105.05 -5.85 42.63 Favored Glycine 0 N--CA 1.441 -1.007 0 O-C-N 121.001 -1.062 . . . . 10.0 112.688 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.464 HD12 ' HE2' ' A' ' 135' ' ' MET . 70.6 mt -87.43 129.87 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 CA-C-N 117.516 0.658 . . . . 10.0 111.093 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.682 ' HG2' ' CB ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -85.58 156.98 20.5 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.029 -0.987 . . . . 10.0 109.282 177.345 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 22.2 m -119.43 136.34 56.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.078 -1.082 . . . . 10.0 108.078 168.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.3 m -136.26 69.99 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 115.573 1.694 . . . . 10.0 115.573 -176.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.3 t70 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.113 -0.946 . . . . 10.0 109.296 138.928 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 4' ' ' LYS . 29.5 mtpt . . . . . 0 C--O 1.221 -0.44 0 N-CA-C 110.071 -0.344 . . . . 10.0 110.071 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 38.0 t -67.15 145.0 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.895 0.378 . . . . 10.0 111.389 -177.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.79 -36.41 4.51 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.27 173.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.45 ' HB1' ' CG1' ' A' ' 60' ' ' VAL . . . -159.61 151.17 20.1 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.272 1.212 . . . . 10.0 114.272 -177.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -93.71 129.19 40.12 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.303 -1.369 . . . . 10.0 107.303 168.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.62 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.8 OUTLIER -120.94 82.36 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.786 -0.82 . . . . 10.0 108.786 175.119 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -78.9 146.13 33.73 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 120.895 1.679 . . . . 10.0 109.42 177.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -156.11 134.63 11.64 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.313 -0.625 . . . . 10.0 109.313 -174.308 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.546 ' OE1' ' HA ' ' A' ' 55' ' ' PRO . 10.9 mm100 -91.82 112.26 24.11 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.018 -1.105 . . . . 10.0 108.018 171.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.447 HD12 HD21 ' A' ' 11' ' ' LEU . 28.8 mt -131.54 133.97 24.99 Favored Pre-proline 0 CA--C 1.504 -0.803 0 CA-C-O 121.644 0.735 . . . . 10.0 112.463 -170.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.634 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 18.5 Cg_exo -56.75 122.18 11.37 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 123.292 2.661 . . . . 10.0 111.846 174.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.633 ' HB1' HD11 ' A' ' 54' ' ' LEU . . . -61.62 126.78 28.57 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 107.514 -1.291 . . . . 10.0 107.514 169.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.39 0.21 89.64 Favored Glycine 0 N--CA 1.44 -1.1 0 O-C-N 125.883 1.989 . . . . 10.0 112.998 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.634 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 18.6 tptp -142.8 98.88 3.37 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 118.331 1.066 . . . . 10.0 111.979 175.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.18 136.87 9.03 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.433 -1.258 . . . . 10.0 112.121 176.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.548 ' HA ' ' HB2' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -179.98 -54.96 0.0 OUTLIER Pre-proline 0 N--CA 1.443 -0.81 0 CA-C-N 115.318 -0.856 . . . . 10.0 111.836 174.677 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.638 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 73.5 Cg_endo -99.16 129.66 0.19 Allowed 'Trans proline' 0 N--CA 1.411 -3.372 0 N-CA-C 115.67 1.373 . . . . 10.0 115.67 -153.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 1.071 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 12.13 -83.54 0.0 OUTLIER Pre-proline 0 C--N 1.294 -1.842 0 CA-C-N 108.604 -3.907 . . . . 10.0 115.489 166.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.97 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 65.5 Cg_exo -30.53 -55.16 0.21 Allowed 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 122.963 2.442 . . . . 10.0 115.709 -164.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.97 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 5.2 Cg_exo -84.09 -56.55 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.438 2.759 . . . . 10.0 112.094 170.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.909 HG13 HD11 ' A' ' 35' ' ' ILE . 89.3 t -80.37 -53.76 12.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 112.719 -2.037 . . . . 10.0 114.922 -167.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 1.071 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -50.65 -74.48 0.28 Allowed Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.203 -0.908 . . . . 10.0 113.452 -173.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.818 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 17.0 Cg_exo -42.79 -43.99 8.95 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.77 2.98 . . . . 10.0 112.441 171.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.567 ' HB1' ' O ' ' A' ' 24' ' ' VAL . . . -50.06 -98.94 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 123.793 0.683 . . . . 10.0 112.43 177.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.886 HD23 HD13 ' A' ' 35' ' ' ILE 0.341 0.0 OUTLIER -73.18 -34.33 65.94 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 117.555 -1.658 . . . . 10.0 113.138 -173.472 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.72 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -67.5 -39.53 91.11 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 121.164 -0.541 . . . . 10.0 113.505 -175.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.727 ' HG3' ' HA ' ' A' ' 26' ' ' PRO . 26.9 mt-30 -68.43 -6.46 24.85 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 118.635 -1.226 . . . . 10.0 111.212 175.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.559 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 72.6 m-70 -102.04 22.98 12.21 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.381 0.61 . . . . 10.0 109.584 168.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.28 -3.69 76.35 Favored Glycine 0 CA--C 1.503 -0.699 0 CA-C-N 115.306 -0.861 . . . . 10.0 113.567 168.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.842 HG13 ' CD2' ' A' ' 66' ' ' PHE . 5.0 t -82.99 149.79 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 113.785 1.031 . . . . 10.0 113.785 -170.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.462 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -71.39 99.3 1.95 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.001 0.429 . . . . 10.0 110.687 170.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.909 HD11 HG13 ' A' ' 24' ' ' VAL . 16.4 mm -51.49 -37.15 18.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 122.21 1.005 . . . . 10.0 111.643 172.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.588 ' HE2' ' HA ' ' A' ' 36' ' ' MET . 5.9 mmt -65.7 -50.31 65.35 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.312 -1.767 . . . . 10.0 111.957 174.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 34' ' ' ASN . 5.6 tp10 -56.09 -41.09 74.64 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.079 -0.648 . . . . 10.0 110.211 174.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.556 ' CA ' ' HZ ' ' A' ' 66' ' ' PHE . 89.9 t80 -56.24 -58.79 6.48 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 113.899 1.074 . . . . 10.0 113.899 171.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.548 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -62.72 -50.3 71.64 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 114.368 -1.287 . . . . 10.0 111.87 -175.415 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -62.88 -23.06 67.15 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 119.223 -0.991 . . . . 10.0 108.911 -177.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.833 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 63.0 mtt180 -75.5 -64.82 0.99 Allowed 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 119.252 -0.979 . . . . 10.0 111.798 166.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.515 ' CZ ' HG21 ' A' ' 46' ' ' THR . 60.3 t80 -50.99 -49.72 59.75 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.09 0.859 . . . . 10.0 111.571 -170.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -60.09 -49.88 75.92 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.514 -0.766 . . . . 10.0 110.425 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.05 -39.81 95.84 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.069 -1.052 . . . . 10.0 112.081 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.833 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 5.9 mm-40 -66.89 -41.76 86.65 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.841 0.829 . . . . 10.0 111.047 -178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.515 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 81.7 p -90.91 1.5 56.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.414 -1.266 . . . . 10.0 112.056 -170.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.46 -37.23 5.01 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.995 -1.002 . . . . 10.0 112.921 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -82.19 -24.96 34.65 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.807 -0.633 . . . . 10.0 112.491 -174.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.4 mttp -104.5 19.06 21.01 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.487 0.66 . . . . 10.0 109.305 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -48.73 143.5 5.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.404 -1.271 . . . . 10.0 112.565 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.99 20.89 27.01 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 114.846 -1.07 . . . . 10.0 110.917 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.499 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 64.2 mtt -138.53 128.87 25.9 Favored 'General case' 0 C--O 1.206 -1.189 0 C-N-CA 117.083 -1.847 . . . . 10.0 114.154 -169.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.8 mm -70.01 93.2 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 121.586 -0.696 . . . . 10.0 109.754 172.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.766 HD22 ' HE2' ' A' ' 77' ' ' PHE . 3.3 mt -80.45 130.04 66.68 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.15 -0.315 . . . . 10.0 110.15 -176.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.546 ' HA ' ' OE1' ' A' ' 12' ' ' GLN . 21.1 Cg_exo -69.68 103.48 1.16 Allowed 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 122.683 2.256 . . . . 10.0 111.44 171.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 69' ' ' ILE . 0.5 OUTLIER -101.9 160.32 4.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 119.402 1.001 . . . . 10.0 112.217 -174.539 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.4 t -137.09 119.98 20.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.034 -0.53 . . . . 10.0 110.561 173.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.62 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 14.8 mt -110.65 138.2 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.596 0 N-CA-C 108.012 -1.107 . . . . 10.0 108.012 -178.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.4 m -123.48 96.57 5.03 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 114.837 -1.074 . . . . 10.0 108.801 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.493 HG21 ' O ' ' A' ' 65' ' ' SER . 2.3 p -89.04 139.03 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 CA-C-N 119.481 1.037 . . . . 10.0 110.568 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 70.2 m-85 -96.06 167.86 10.96 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 112.747 0.647 . . . . 10.0 112.747 -177.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -56.66 -23.55 42.48 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 124.271 1.029 . . . . 10.0 112.808 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 6.7 m-20 -80.12 -7.43 58.9 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.683 -1.144 . . . . 10.0 111.287 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 3.2 mptt 79.99 3.4 2.01 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 114.645 -1.161 . . . . 10.0 111.974 -171.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.493 ' O ' HG21 ' A' ' 60' ' ' VAL . 15.6 m -73.11 173.89 8.73 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 107.498 -1.297 . . . . 10.0 107.498 170.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.842 ' CD2' HG13 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -168.81 -176.73 2.79 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 120.293 1.406 . . . . 10.0 108.778 174.505 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 p -159.77 168.85 24.93 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 102.759 -3.052 . . . . 10.0 102.759 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.434 ' CB ' HG12 ' A' ' 58' ' ' ILE . 53.3 p90 -163.24 152.89 15.25 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.933 -1.136 . . . . 10.0 107.933 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' ' 56' ' ' VAL . 1.9 mt -116.47 168.84 7.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 106.232 -1.766 . . . . 10.0 106.232 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.8 mt -137.75 113.76 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 N-CA-C 106.306 -1.738 . . . . 10.0 106.306 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 71' ' ' LYS . 3.6 mptp? -77.3 102.12 6.59 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.604 -166.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 111' ' ' THR . 0.2 OUTLIER -58.28 91.24 0.03 OUTLIER Pre-proline 0 C--N 1.315 -0.906 0 O-C-N 124.733 1.271 . . . . 10.0 108.786 165.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.77 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 49.3 Cg_endo -93.7 -166.63 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 123.541 2.828 . . . . 10.0 112.742 -156.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.77 ' HD2' ' HB2' ' A' ' 73' ' ' PRO . 67.5 Cg_exo -30.05 133.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 123.316 2.677 . . . . 10.0 111.785 168.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.522 ' HB2' HG23 ' A' ' 131' ' ' THR . . . -60.52 -8.97 3.14 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.289 0.848 . . . . 10.0 113.289 -166.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.648 ' HA ' ' HE2' ' A' ' 135' ' ' MET . 1.2 m -50.31 -29.23 9.32 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.604 0.716 . . . . 10.0 110.253 174.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.766 ' HE2' HD22 ' A' ' 54' ' ' LEU . 36.4 t80 -56.01 -66.03 0.5 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.532 -1.213 . . . . 10.0 111.441 176.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.639 HD23 ' HE2' ' A' ' 112' ' ' LYS . 2.7 mm? -82.19 -13.67 56.78 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.903 -0.498 . . . . 10.0 110.233 -175.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.621 HD12 HD13 ' A' ' 137' ' ' ILE . 3.0 mm? -72.9 -23.71 60.75 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 109.341 -0.614 . . . . 10.0 109.341 171.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 21.4 mmtp -61.89 -40.73 96.43 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.423 -0.584 . . . . 10.0 109.423 167.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.489 ' HD3' ' HA ' ' A' ' 81' ' ' LYS . 24.9 mmtp -62.96 -48.25 79.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.581 -0.736 . . . . 10.0 112.839 174.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.57 ' HB2' ' OE1' ' A' ' 104' ' ' GLN . . . -72.23 -62.68 1.35 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 127.328 2.251 . . . . 10.0 113.564 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.284 -2.259 0 CA-C-N 110.864 -2.88 . . . . 10.0 106.941 -175.787 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 98' ' ' GLY . 0.9 OUTLIER . . . . . 0 N--CA 1.404 -2.739 0 CA-C-O 121.799 0.809 . . . . 10.0 111.177 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.406 ' N ' HG13 ' A' ' 97' ' ' VAL . . . -57.92 179.51 1.06 Allowed Glycine 0 C--N 1.308 -0.981 0 CA-C-N 113.819 -1.537 . . . . 10.0 113.088 176.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.454 ' HE2' ' HB3' ' A' ' 99' ' ' LYS . 9.8 ptpt -154.26 172.37 17.74 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 122.693 1.235 . . . . 10.0 111.883 -159.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.609 ' O ' HG22 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -160.6 -146.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 111.889 -2.414 . . . . 10.0 105.965 -171.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.582 ' O ' ' HG3' ' A' ' 104' ' ' GLN . 1.7 t -162.06 139.73 8.67 Favored 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 119.834 -0.747 . . . . 10.0 109.511 -152.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.648 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 0.0 OUTLIER -43.14 -48.61 6.4 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 114.36 -1.291 . . . . 10.0 111.535 -173.509 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -56.63 -46.09 81.18 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.127 0.788 . . . . 10.0 113.127 178.201 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.615 ' O ' HG13 ' A' ' 108' ' ' ILE . 3.7 pp0? -67.74 -37.26 81.91 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.454 -0.943 . . . . 10.0 108.454 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.888 HG23 ' HB ' ' A' ' 128' ' ' ILE . 23.3 mm -47.26 -51.01 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 115.503 -0.771 . . . . 10.0 110.862 168.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.655 ' HG2' ' HE3' ' A' ' 110' ' ' LYS . 23.8 tt0 -50.36 -57.34 8.15 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.296 1.438 . . . . 10.0 113.191 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.487 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 4.3 pt-20 -59.09 -43.55 91.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.355 -0.839 . . . . 10.0 111.199 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.615 HG13 ' O ' ' A' ' 104' ' ' GLN . 56.9 mt -51.71 -58.57 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 120.7 0.286 . . . . 10.0 110.919 166.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.528 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . . . -44.69 -35.11 2.49 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 123.556 0.742 . . . . 10.0 112.334 177.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.655 ' HE3' ' HG2' ' A' ' 106' ' ' GLU . 96.6 mttt -74.45 -53.65 9.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.548 -0.751 . . . . 10.0 111.557 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.544 HG21 ' O ' ' A' ' 108' ' ' ILE . 2.1 t -59.41 -8.74 1.91 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.298 0.851 . . . . 10.0 113.298 -177.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.639 ' HE2' HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -129.94 13.73 5.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.247 0.546 . . . . 10.0 110.379 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.499 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 1.8 ttt -50.65 -46.91 85.95 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 114.844 -1.071 . . . . 10.0 112.389 178.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 113' ' ' MET . 60.6 Cg_endo -69.2 -22.27 34.91 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 121.726 1.617 . . . . 10.0 113.299 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -87.94 -55.15 3.88 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 122.344 1.068 . . . . 10.0 110.537 -175.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.619 HD23 ' HD3' ' A' ' 112' ' ' LYS . 7.1 mp -67.87 178.61 1.69 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 113.267 -1.788 . . . . 10.0 113.746 -168.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -96.72 41.88 1.1 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 112.002 -2.363 . . . . 10.0 112.645 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 119' ' ' ASN . . . -63.38 -99.68 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 113.756 1.021 . . . . 10.0 113.756 174.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.597 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 5.0 m120 105.16 -78.01 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.8 1.64 . . . . 10.0 107.768 -168.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.439 ' HB3' ' OE1' ' A' ' 122' ' ' GLU . 47.2 m -81.54 146.65 30.05 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.735 -0.839 . . . . 10.0 108.735 163.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.754 ' O ' ' HG3' ' A' ' 125' ' ' MET . 61.1 tp -59.66 -37.68 79.42 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.15 -1.02 . . . . 10.0 110.548 167.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 126' ' ' LYS . 3.4 mp0 -51.21 -36.68 42.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.674 0.749 . . . . 10.0 109.617 171.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.555 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . . . -69.38 -46.96 65.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.577 -1.192 . . . . 10.0 110.735 177.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.574 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -55.7 -41.29 73.56 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 110.179 -0.304 . . . . 10.0 110.179 176.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.754 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 75.2 mtp -55.75 -33.42 64.27 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.762 0.425 . . . . 10.0 111.827 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' A' ' 123' ' ' ALA . 42.6 mtmt -63.86 -50.77 67.51 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.629 -0.508 . . . . 10.0 109.629 178.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.455 ' CD1' HD22 ' A' ' 116' ' ' LEU . 47.5 mt -49.32 -63.86 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 121.49 0.662 . . . . 10.0 110.379 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.888 ' HB ' HG23 ' A' ' 105' ' ' ILE . 4.9 mm -52.13 -55.07 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 CA-C-N 113.843 -1.526 . . . . 10.0 111.306 -177.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.583 ' CD ' ' HE ' ' A' ' 102' ' ' ARG . 49.2 mt-10 -54.49 -44.51 72.72 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 109.923 -0.399 . . . . 10.0 109.923 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -69.62 -46.01 56.51 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.708 -0.758 . . . . 10.0 111.748 -174.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.522 HG23 ' HB2' ' A' ' 75' ' ' ALA . 51.6 m -50.09 -58.62 5.13 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.536 -0.832 . . . . 10.0 109.379 171.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.402 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -50.71 -53.4 31.69 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.008 0.433 . . . . 10.0 111.22 176.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -47.84 -48.43 30.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.198 -0.91 . . . . 10.0 111.32 176.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 27.2 t -63.61 -35.85 81.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.0 0.428 . . . . 10.0 110.732 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.648 ' HE2' ' HA ' ' A' ' 76' ' ' SER . 53.4 mtm -84.66 10.68 10.58 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.579 0.955 . . . . 10.0 113.579 -174.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 81.55 8.19 87.28 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 119.341 0.973 . . . . 10.0 112.127 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.621 HD13 HD12 ' A' ' 79' ' ' LEU . 47.4 mt -94.73 124.93 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 CA-C-O 121.39 0.614 . . . . 10.0 112.017 -176.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.416 ' HG2' ' HD3' ' A' ' 99' ' ' LYS . 2.0 tt0 -84.38 151.79 24.47 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.125 -1.03 . . . . 10.0 110.943 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.403 HG13 HG13 ' A' ' 105' ' ' ILE . 16.6 m -113.45 126.44 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.045 0 N-CA-C 107.8 -1.185 . . . . 10.0 107.8 168.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.609 HG22 ' O ' ' A' ' 100' ' ' VAL . 2.9 m -104.83 138.54 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-N 114.44 -1.255 . . . . 10.0 109.302 176.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 C--N 1.29 -2.003 0 CA-C-N 114.678 -1.146 . . . . 10.0 109.821 -177.09 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 10.3 mmtp . . . . . 0 C--O 1.196 -1.749 0 CA-C-O 119.484 -0.293 . . . . 10.0 110.25 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.1 t -74.58 119.42 22.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 119.153 0.888 . . . . 10.0 109.863 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.415 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . . . -98.13 -35.18 10.48 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.83 -0.804 . . . . 10.0 108.83 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -161.29 -174.06 4.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.037 -0.983 . . . . 10.0 112.801 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 26.8 mt-30 -141.56 131.3 24.21 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.123 -1.399 . . . . 10.0 108.649 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.582 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.9 OUTLIER -120.89 80.98 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 108.945 -0.761 . . . . 10.0 108.945 -176.391 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 56' ' ' VAL . 57.4 tttp -79.43 128.5 33.43 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 119.82 1.191 . . . . 10.0 108.339 176.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.644 HD11 HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.85 127.98 6.18 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 122.116 0.96 . . . . 10.0 111.471 -174.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.56 119.32 22.37 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.226 -1.352 . . . . 10.0 109.749 -172.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.644 HD22 HD11 ' A' ' 11' ' ' LEU . 46.8 mt -135.52 140.31 33.7 Favored Pre-proline 0 CA--C 1.502 -0.896 0 N-CA-C 113.138 0.792 . . . . 10.0 113.138 -170.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.612 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 14.7 Cg_exo -61.87 122.44 10.98 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 123.325 2.683 . . . . 10.0 111.241 174.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.513 ' HB1' HD12 ' A' ' 54' ' ' LEU . . . -60.84 125.11 22.49 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.637 -1.246 . . . . 10.0 107.637 169.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.83 1.83 89.82 Favored Glycine 0 N--CA 1.442 -0.905 0 O-C-N 126.015 2.072 . . . . 10.0 113.115 -173.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.612 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 7.6 tppt? -144.07 105.27 4.24 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.334 1.067 . . . . 10.0 113.14 177.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 39' ' ' CYS . . . -172.47 128.89 0.55 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.776 -1.556 . . . . 10.0 111.202 170.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.48 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 15.6 m -174.06 -43.46 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.132 0.895 . . . . 10.0 112.166 -174.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.811 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 44.2 Cg_endo -98.68 122.3 0.14 Allowed 'Trans proline' 0 N--CA 1.434 -2.008 0 C-N-CA 121.104 1.203 . . . . 10.0 114.892 -166.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 1.096 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . -3.51 -80.05 0.0 OUTLIER Pre-proline 0 C--O 1.212 -0.919 0 CA-C-N 111.658 -2.519 . . . . 10.0 114.542 166.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.867 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 52.4 Cg_exo -22.33 -55.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.978 3.119 . . . . 10.0 115.995 -165.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.867 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 10.0 Cg_endo -81.81 -75.97 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 122.347 2.031 . . . . 10.0 112.151 168.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.421 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 92.7 t -60.95 -46.73 96.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 112.542 -2.117 . . . . 10.0 114.919 -171.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 1.096 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -49.55 -73.41 0.36 Allowed Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 114.472 -1.24 . . . . 10.0 113.225 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.655 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 11.2 Cg_exo -45.89 -43.17 19.86 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.885 3.057 . . . . 10.0 112.737 171.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.46 ' O ' ' HD2' ' A' ' 31' ' ' HIS . . . -49.22 -98.23 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.567 0.58 . . . . 10.0 112.567 175.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.554 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.297 0.0 OUTLIER -70.41 -25.38 63.19 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 118.278 -1.369 . . . . 10.0 113.529 -174.872 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.27 -35.54 90.47 Favored Glycine 0 N--CA 1.464 0.521 0 C-N-CA 121.285 -0.483 . . . . 10.0 112.513 -177.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -58.83 -25.93 63.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.136 0.493 . . . . 10.0 109.72 173.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.46 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 71.7 m-70 -99.55 17.89 19.3 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.584 0.707 . . . . 10.0 109.488 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.471 ' HA3' ' HE2' ' A' ' 64' ' ' LYS . . . 85.62 6.39 83.26 Favored Glycine 0 CA--C 1.5 -0.88 0 CA-C-N 114.492 -1.231 . . . . 10.0 113.411 168.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.779 HG11 ' CD2' ' A' ' 66' ' ' PHE . 1.9 t -86.66 147.74 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 114.044 1.127 . . . . 10.0 114.044 -172.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -68.08 102.97 1.41 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.546 0.738 . . . . 10.0 111.348 174.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.577 ' O ' ' HB3' ' A' ' 39' ' ' CYS . 90.2 mt -50.72 -45.84 27.76 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 CA-C-O 122.526 1.155 . . . . 10.0 110.6 172.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -67.2 -52.21 43.97 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 111.833 -2.44 . . . . 10.0 112.898 -177.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -56.12 -38.51 70.87 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 120.035 -0.666 . . . . 10.0 110.05 177.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.766 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 20.9 t80 -59.8 -59.29 5.66 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 114.045 1.128 . . . . 10.0 114.045 168.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.577 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -54.86 -53.36 56.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.498 -1.683 . . . . 10.0 112.11 -176.222 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.436 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 12.3 tppt? -68.63 -19.25 64.41 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.611 -0.836 . . . . 10.0 109.101 -176.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.78 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 64.9 mtt180 -79.91 -62.53 1.65 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.115 -1.034 . . . . 10.0 112.907 168.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CZ ' HG22 ' A' ' 46' ' ' THR . 66.3 t80 -53.99 -45.69 71.5 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 119.213 0.915 . . . . 10.0 110.11 -174.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.606 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.9 OUTLIER -61.45 -51.36 69.01 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.536 -1.211 . . . . 10.0 110.874 -178.04 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.96 -37.38 86.85 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 118.815 -1.154 . . . . 10.0 111.811 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.78 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 7.6 mm-40 -67.48 -45.31 76.28 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.896 0.855 . . . . 10.0 110.882 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.683 HG22 HD11 ' A' ' 54' ' ' LEU . 82.7 p -85.67 2.77 43.93 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-N 114.567 -1.197 . . . . 10.0 112.111 -171.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.3 -36.59 14.49 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.812 -1.085 . . . . 10.0 112.318 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -83.4 -34.74 25.46 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.008 -0.996 . . . . 10.0 110.888 -174.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mtpp -97.6 20.84 11.17 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.804 -0.813 . . . . 10.0 108.804 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.485 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -55.1 152.21 8.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.524 -1.216 . . . . 10.0 113.582 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.16 16.26 44.77 Favored Glycine 0 CA--C 1.507 -0.462 0 N-CA-C 109.879 -1.288 . . . . 10.0 109.879 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.455 ' HB2' HD22 ' A' ' 54' ' ' LEU . 45.7 mtm -137.97 125.8 22.5 Favored 'General case' 0 C--O 1.213 -0.859 0 C-N-CA 116.385 -2.126 . . . . 10.0 114.562 -166.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.0 mm -66.1 90.22 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.514 -0.55 . . . . 10.0 109.514 172.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.683 HD11 HG22 ' A' ' 46' ' ' THR . 7.9 mt -79.4 128.69 74.49 Favored Pre-proline 0 N--CA 1.447 -0.61 0 N-CA-C 108.972 -0.751 . . . . 10.0 108.972 -177.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.648 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 11.0 Cg_exo -72.33 95.02 0.76 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.002 1.802 . . . . 10.0 110.756 174.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.486 ' O ' ' HG3' ' A' ' 10' ' ' LYS . 0.4 OUTLIER -92.38 157.74 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 119.125 0.875 . . . . 10.0 111.417 -171.06 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.417 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 89.4 t -135.04 117.53 22.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 110.278 -0.268 . . . . 10.0 110.278 172.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.582 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 24.0 mt -106.59 139.5 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 108.027 -1.101 . . . . 10.0 108.027 -175.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.7 m -123.44 98.36 5.82 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 108.481 -0.933 . . . . 10.0 108.481 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 65' ' ' SER . 1.5 p -87.03 136.0 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.07 0 CA-C-N 118.979 0.809 . . . . 10.0 111.286 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.582 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 89.5 m-85 -94.12 170.19 9.71 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 114.989 -1.005 . . . . 10.0 113.011 -175.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.445 ' HG3' ' HB3' ' A' ' 4' ' ' LYS . 28.9 mt-10 -63.17 -17.61 62.57 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.535 -1.211 . . . . 10.0 111.824 -176.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.429 ' HB2' ' HG ' ' A' ' 65' ' ' SER . 5.8 m-20 -78.0 -10.78 59.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.136 175.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.471 ' HE2' ' HA3' ' A' ' 32' ' ' GLY . 1.6 mtpt 80.69 2.28 1.79 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.416 1.086 . . . . 10.0 109.527 -169.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.548 ' O ' HG23 ' A' ' 60' ' ' VAL . 21.2 p -69.26 -179.24 1.54 Allowed 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.776 -1.556 . . . . 10.0 108.616 170.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.779 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -171.02 -175.1 1.65 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 120.032 1.287 . . . . 10.0 110.538 174.096 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 p -157.9 170.45 22.3 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 102.875 -3.009 . . . . 10.0 102.875 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -158.69 156.5 30.05 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.423 -0.954 . . . . 10.0 108.423 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.417 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 24.8 pt -128.71 153.26 37.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.272 -1.381 . . . . 10.0 107.272 -177.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.58 HG22 HD13 ' A' ' 54' ' ' LEU . 3.6 mm -107.87 132.0 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 N-CA-C 107.626 -1.25 . . . . 10.0 107.626 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.648 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 5.1 mmtp -77.32 85.54 3.74 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 118.942 -1.103 . . . . 10.0 109.337 176.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.818 HG22 ' HB3' ' A' ' 112' ' ' LYS . 15.3 t -63.99 -21.62 0.76 Allowed Pre-proline 0 CA--C 1.558 1.26 0 CA-C-N 112.745 -2.025 . . . . 10.0 113.151 174.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.872 ' HB3' ' HB2' ' A' ' 112' ' ' LYS . 56.8 Cg_endo -101.91 55.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.22 1.947 . . . . 10.0 117.144 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.562 ' HD3' ' O ' ' A' ' 71' ' ' LYS . 17.0 Cg_exo -71.86 -17.52 28.89 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 N-CA-C 107.9 -1.616 . . . . 10.0 107.9 154.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 69.19 -55.34 0.56 Allowed 'General case' 0 C--N 1.343 0.307 0 CA-C-N 113.335 -1.757 . . . . 10.0 111.481 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.589 ' HA ' ' HE1' ' A' ' 135' ' ' MET . 13.5 p -56.87 -40.17 75.69 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.055 -0.52 . . . . 10.0 111.923 -176.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.62 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -74.75 -33.74 62.37 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.106 0.479 . . . . 10.0 111.697 -173.086 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.744 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 3.7 tp -89.57 -17.8 27.83 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.533 -0.867 . . . . 10.0 108.905 177.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.532 HD23 ' HB2' ' A' ' 132' ' ' ALA . 8.7 tp -72.05 -23.26 61.34 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.316 -0.994 . . . . 10.0 108.316 168.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.62 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 24.0 mmtm -64.04 -27.5 69.15 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-O 121.195 0.521 . . . . 10.0 109.769 167.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.744 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -60.33 -45.18 94.34 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.484 -0.486 . . . . 10.0 111.508 171.665 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.649 ' HB3' HG13 ' A' ' 100' ' ' VAL . . . -71.07 -55.85 7.38 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.642 1.577 . . . . 10.0 112.075 173.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.289 -2.023 0 CA-C-N 111.907 -2.406 . . . . 10.0 107.63 -176.85 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 113.648 0.981 . . . . 10.0 113.648 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.637 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -156.56 165.93 33.13 Favored Glycine 0 N--CA 1.44 -1.084 0 N-CA-C 109.461 -1.456 . . . . 10.0 109.461 176.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.647 ' HB3' ' HZ1' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -154.1 170.86 20.15 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-O 122.197 0.999 . . . . 10.0 110.57 -163.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.649 HG13 ' HB3' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -159.37 -143.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-N 112.834 -1.985 . . . . 10.0 106.584 -172.56 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.584 ' OG1' ' HG2' ' A' ' 104' ' ' GLN . 17.2 p -153.9 143.98 22.05 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 107.618 -1.253 . . . . 10.0 107.618 -153.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.621 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 12.9 tpt180 -42.62 -41.24 3.0 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 114.854 -1.066 . . . . 10.0 110.034 177.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.542 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 3.5 tmtm? -60.15 -46.26 90.28 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.403 0.52 . . . . 10.0 112.403 177.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.584 ' HG2' ' OG1' ' A' ' 101' ' ' THR . 14.0 mm100 -66.02 -42.82 89.16 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.982 -0.747 . . . . 10.0 108.982 -177.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.856 HG22 ' HB ' ' A' ' 128' ' ' ILE . 30.8 mm -40.53 -58.11 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 114.604 -1.18 . . . . 10.0 110.832 164.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.621 ' HG2' ' HE3' ' A' ' 110' ' ' LYS . 31.7 tt0 -47.79 -50.35 26.07 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 114.633 -1.167 . . . . 10.0 112.917 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.418 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 35.2 mm-40 -54.45 -58.1 8.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.303 -0.862 . . . . 10.0 111.143 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.677 ' O ' HG21 ' A' ' 111' ' ' THR . 11.8 mm -48.97 -53.58 7.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-O 121.932 0.873 . . . . 10.0 109.95 172.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.548 ' HB2' ' HB1' ' A' ' 124' ' ' ALA . . . -48.67 -36.68 16.57 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.02 -0.991 . . . . 10.0 112.354 176.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.621 ' HE3' ' HG2' ' A' ' 106' ' ' GLU . 84.1 mttt -74.95 -54.02 7.95 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.409 -0.36 . . . . 10.0 111.44 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.677 HG21 ' O ' ' A' ' 108' ' ' ILE . 7.1 t -51.52 -22.93 3.53 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.242 1.201 . . . . 10.0 114.242 -171.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.872 ' HB2' ' HB3' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -130.01 19.4 5.48 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.576 0.703 . . . . 10.0 109.404 -174.593 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.653 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 54.8 ttm -52.21 -43.17 89.87 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 114.712 -1.131 . . . . 10.0 111.855 169.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.653 ' HD2' ' N ' ' A' ' 113' ' ' MET . 10.9 Cg_endo -52.64 -29.77 42.73 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.706 2.27 . . . . 10.0 112.259 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.5 ' CB ' ' HG3' ' A' ' 73' ' ' PRO . 21.1 t70 -91.19 -43.8 9.63 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.926 -1.034 . . . . 10.0 111.454 -176.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.648 HD21 ' NZ ' ' A' ' 112' ' ' LYS . 3.2 mp -69.02 178.26 2.31 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.723 -1.581 . . . . 10.0 114.509 -167.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -94.29 29.55 2.17 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 111.303 -2.68 . . . . 10.0 112.209 171.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.533 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . . . -73.97 92.03 2.08 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.346 0.499 . . . . 10.0 112.346 175.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -66.28 -28.71 68.91 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.609 -0.885 . . . . 10.0 108.609 172.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.7 t -152.96 140.92 20.24 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 105.441 -2.059 . . . . 10.0 105.441 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.775 ' O ' ' HG3' ' A' ' 125' ' ' MET . 45.0 tp -53.07 -32.56 47.72 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.117 1.154 . . . . 10.0 114.117 -172.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -50.17 -35.92 28.2 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.591 0.71 . . . . 10.0 110.243 173.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.75 -50.56 56.6 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.236 -0.986 . . . . 10.0 110.969 176.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.697 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -60.23 -31.99 70.7 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 119.734 -0.786 . . . . 10.0 110.738 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.775 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 75.5 mtp -58.0 -36.42 72.63 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.701 0.286 . . . . 10.0 110.746 176.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -64.24 -54.06 39.43 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.101 0.56 . . . . 10.0 111.726 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.757 HD11 HD13 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -51.48 -57.72 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 121.33 0.586 . . . . 10.0 110.739 179.005 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.856 ' HB ' HG22 ' A' ' 105' ' ' ILE . 21.5 mm -51.2 -54.06 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 CA-C-N 114.745 -1.116 . . . . 10.0 111.879 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.623 ' HG3' HG21 ' A' ' 105' ' ' ILE . 80.8 mt-10 -54.8 -40.97 70.04 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 123.325 0.391 . . . . 10.0 110.031 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -69.8 -46.8 51.56 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.194 -1.003 . . . . 10.0 111.015 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.53 HG23 ' HE3' ' A' ' 135' ' ' MET . 86.3 m -44.59 -64.12 0.76 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 113.98 -1.11 . . . . 10.0 109.308 169.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.532 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -48.13 -50.3 29.14 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.008 -0.542 . . . . 10.0 111.775 177.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -49.05 -52.82 23.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.972 -1.013 . . . . 10.0 111.324 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 22.8 t -64.04 -33.02 74.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.868 0.366 . . . . 10.0 111.262 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.589 ' HE1' ' HA ' ' A' ' 76' ' ' SER . 67.9 mtm -84.46 8.07 17.63 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 114.316 1.228 . . . . 10.0 114.316 -174.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 78.9 15.34 80.83 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 119.815 1.188 . . . . 10.0 111.603 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.637 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 19.4 mt -100.43 122.74 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 CA-C-O 121.5 0.667 . . . . 10.0 111.228 178.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.61 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -88.51 156.2 19.22 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 115.0 -1.0 . . . . 10.0 109.569 -179.217 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 17.1 m -115.47 121.22 66.78 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 CA-C-O 122.141 0.972 . . . . 10.0 108.517 172.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.645 HG21 ' O ' ' A' ' 100' ' ' VAL . 4.9 m -105.21 148.91 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 CA-C-N 113.752 -1.567 . . . . 10.0 108.544 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 34.2 t70 . . . . . 0 C--N 1.286 -2.168 0 CA-C-N 113.718 -1.583 . . . . 10.0 110.571 179.684 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.8 tptt . . . . . 0 C--O 1.223 -0.333 0 N-CA-C 109.81 -0.441 . . . . 10.0 109.81 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.32 130.13 25.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.771 0.32 . . . . 10.0 111.272 -176.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.63 -40.58 5.72 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.576 -0.527 . . . . 10.0 109.576 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.469 ' HB1' ' CG1' ' A' ' 60' ' ' VAL . . . -155.37 155.52 33.78 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 113.861 1.06 . . . . 10.0 113.861 -176.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -92.64 136.25 33.39 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.424 -1.262 . . . . 10.0 109.145 170.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.629 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -123.62 79.56 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.299 -1.0 . . . . 10.0 108.299 165.317 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.448 ' HG2' HG12 ' A' ' 57' ' ' VAL . 52.9 mttm -81.33 125.58 30.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 120.531 1.514 . . . . 10.0 107.751 175.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.588 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -158.15 131.35 7.49 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 122.485 1.136 . . . . 10.0 112.562 -172.155 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.506 ' HB3' HG22 ' A' ' 53' ' ' ILE . 23.2 mt-30 -84.04 116.51 22.88 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 113.79 -1.55 . . . . 10.0 111.489 -173.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.588 HD21 HD11 ' A' ' 11' ' ' LEU . 80.0 mt -136.65 140.73 32.96 Favored Pre-proline 0 C--O 1.219 -0.542 0 N-CA-C 113.262 0.838 . . . . 10.0 113.262 -172.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.768 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 36.0 Cg_exo -63.28 131.95 34.23 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 C-N-CA 124.443 3.429 . . . . 10.0 113.445 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.515 ' O ' ' HA2' ' A' ' 51' ' ' GLY . . . -56.73 124.41 18.32 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 108.447 -0.945 . . . . 10.0 108.447 167.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.33 7.16 82.13 Favored Glycine 0 N--CA 1.444 -0.818 0 O-C-N 125.356 1.66 . . . . 10.0 113.507 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.768 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 24.5 mmtp -142.49 97.95 3.21 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.236 1.018 . . . . 10.0 112.798 178.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.617 ' O ' ' HB2' ' A' ' 39' ' ' CYS . . . -171.35 135.84 0.98 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.321 -1.309 . . . . 10.0 112.967 172.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.625 HG21 ' HD3' ' A' ' 20' ' ' PRO . 1.1 t -179.04 -45.3 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 114.894 -1.048 . . . . 10.0 113.354 175.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.794 ' HD2' ' H ' ' A' ' 21' ' ' ALA . 69.6 Cg_endo -118.34 -46.54 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.257 0 N-CA-C 117.002 1.885 . . . . 10.0 117.002 -171.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.794 ' H ' ' HD2' ' A' ' 20' ' ' PRO . . . -47.48 154.74 0.82 Allowed Pre-proline 0 N--CA 1.467 0.392 0 N-CA-C 113.688 0.995 . . . . 10.0 113.688 -165.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.534 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 53.5 Cg_exo -38.94 -41.18 1.71 Allowed 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 124.583 3.522 . . . . 10.0 115.075 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.51 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 3.1 Cg_exo -41.26 -54.69 2.49 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.542 2.161 . . . . 10.0 112.448 167.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.408 HG11 HD13 ' A' ' 28' ' ' LEU . 89.2 t -89.68 -55.54 6.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.59 -1.186 . . . . 10.0 113.887 -170.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.501 ' HA2' ' CD1' ' A' ' 35' ' ' ILE . . . -45.61 -73.2 0.3 Allowed Glycine 0 C--N 1.337 0.59 0 CA-C-N 114.247 -1.342 . . . . 10.0 113.668 -175.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.534 ' HD2' ' O ' ' A' ' 22' ' ' PRO . 88.9 Cg_exo -51.27 -44.44 43.03 Favored 'Trans proline' 0 C--O 1.225 -0.133 0 C-N-CA 123.561 2.84 . . . . 10.0 112.667 173.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 23' ' ' PRO . . . -50.71 -76.19 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.496 0.665 . . . . 10.0 111.38 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.69 HD21 ' CD1' ' A' ' 58' ' ' ILE . 3.8 mt -69.34 -44.33 71.85 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.331 -0.849 . . . . 10.0 113.098 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.44 -44.35 97.75 Favored Glycine 0 C--O 1.229 -0.159 0 CA-C-N 116.253 -0.431 . . . . 10.0 112.949 -173.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -62.06 -25.43 67.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.647 0.261 . . . . 10.0 110.565 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -101.34 13.64 34.43 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 120.113 -0.635 . . . . 10.0 110.787 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.34 12.94 83.83 Favored Glycine 0 CA--C 1.503 -0.707 0 CA-C-N 114.947 -1.024 . . . . 10.0 113.036 169.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.56 ' HB ' ' HB3' ' A' ' 28' ' ' LEU . 48.3 t -81.78 142.39 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 115.194 -0.503 . . . . 10.0 111.992 -173.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.407 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 81.6 m-20 -67.29 90.27 0.22 Allowed 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.025 0.441 . . . . 10.0 110.022 175.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.688 HG12 ' HB2' ' A' ' 28' ' ' LEU . 33.7 mt -55.24 -39.65 52.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.767 0.794 . . . . 10.0 111.463 177.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.676 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 62.9 mtm -64.55 -50.61 66.6 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.903 -1.498 . . . . 10.0 111.113 176.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.597 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 20.2 tt0 -55.66 -50.05 71.27 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.05 -0.66 . . . . 10.0 110.313 174.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.631 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . 61.9 t80 -55.65 -54.97 37.67 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 113.732 1.012 . . . . 10.0 113.732 176.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.676 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 8.8 p -56.19 -48.11 77.02 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.346 -0.843 . . . . 10.0 110.662 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.419 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 46.5 mmtm -67.69 -22.32 65.28 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.712 -0.795 . . . . 10.0 109.925 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.808 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 29.9 mtp180 -75.77 -63.75 1.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.651 -0.704 . . . . 10.0 111.559 171.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.602 ' CZ ' HG23 ' A' ' 46' ' ' THR . 79.3 t80 -55.33 -47.16 76.1 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.481 0.658 . . . . 10.0 110.619 -173.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.595 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.9 OUTLIER -61.06 -48.3 82.38 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.674 -1.148 . . . . 10.0 110.539 -176.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.94 93.68 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 118.901 -1.12 . . . . 10.0 111.737 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.808 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 11.4 mm-40 -66.53 -39.21 88.49 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.711 0.767 . . . . 10.0 111.786 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.624 ' CG2' HD12 ' A' ' 54' ' ' LEU . 64.6 p -92.6 -10.96 35.58 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 114.096 1.146 . . . . 10.0 114.096 -166.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.52 -37.19 37.8 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 113.575 0.954 . . . . 10.0 113.575 -171.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -75.35 -35.99 61.08 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.576 -0.738 . . . . 10.0 109.268 -175.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.453 ' O ' ' HE2' ' A' ' 52' ' ' MET . 4.3 mppt? -93.87 49.33 1.33 Allowed 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 122.926 0.49 . . . . 10.0 110.848 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.914 ' HB3' ' HG3' ' A' ' 52' ' ' MET . . . 100.0 -152.84 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 114.885 1.439 . . . . 10.0 114.885 146.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 15' ' ' ALA . . . -123.99 83.6 0.36 Allowed Glycine 0 N--CA 1.419 -2.466 0 N-CA-C 105.491 -3.043 . . . . 10.0 105.491 164.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.914 ' HG3' ' HB3' ' A' ' 50' ' ' ALA . 29.3 mtm -139.1 131.15 27.93 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 116.214 1.931 . . . . 10.0 116.214 -160.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.506 HG22 ' HB3' ' A' ' 12' ' ' GLN . 0.4 OUTLIER -67.94 94.29 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 119.38 -0.928 . . . . 10.0 110.225 171.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.624 HD12 ' CG2' ' A' ' 46' ' ' THR . 11.4 mt -83.36 128.53 64.08 Favored Pre-proline 0 N--CA 1.437 -1.108 0 CA-C-N 115.139 -0.937 . . . . 10.0 108.788 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.408 ' O ' ' HD3' ' A' ' 71' ' ' LYS . 26.9 Cg_exo -64.88 98.05 0.29 Allowed 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.216 1.944 . . . . 10.0 110.946 175.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.47 153.74 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 119.011 0.823 . . . . 10.0 110.946 -173.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.448 HG12 ' HG2' ' A' ' 10' ' ' LYS . 92.4 t -134.27 114.23 18.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 C-N-CA 121.015 -0.274 . . . . 10.0 110.359 173.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.69 ' CD1' HD21 ' A' ' 28' ' ' LEU . 22.8 mt -106.66 137.49 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.795 0 N-CA-C 108.003 -1.11 . . . . 10.0 108.003 -173.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 31.6 m -121.76 95.53 4.71 Favored 'General case' 0 N--CA 1.405 -2.675 0 CA-C-N 114.707 -1.133 . . . . 10.0 108.642 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.484 HG21 HG23 ' A' ' 33' ' ' VAL . 3.1 p -86.64 137.14 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-N 119.28 0.945 . . . . 10.0 110.599 -178.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.496 ' HH ' ' HG1' ' A' ' 67' ' ' THR . 66.0 m-85 -96.28 172.49 7.92 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 113.001 0.741 . . . . 10.0 113.001 -176.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -53.86 -27.25 28.82 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.03 -1.441 . . . . 10.0 112.602 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.579 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 4.0 m-20 -77.61 -10.76 59.69 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.371 -0.832 . . . . 10.0 111.591 -173.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.579 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 51.5 mtpt 83.3 -0.16 1.13 Allowed 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.276 1.036 . . . . 10.0 109.537 -164.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.6 m -70.89 170.77 11.95 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 113.626 -1.624 . . . . 10.0 108.234 173.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.631 ' CZ ' ' HB2' ' A' ' 38' ' ' PHE . 6.0 p90 -168.44 -176.12 2.74 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 120.372 1.442 . . . . 10.0 110.373 175.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.496 ' HG1' ' HH ' ' A' ' 61' ' ' TYR . 32.6 p -157.72 171.74 19.77 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 103.1 -2.926 . . . . 10.0 103.1 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.431 ' CB ' HG12 ' A' ' 58' ' ' ILE . 38.1 p90 -161.41 155.62 22.56 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.404 -0.962 . . . . 10.0 108.404 177.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 29.9 pt -128.53 166.97 24.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.289 -1.375 . . . . 10.0 107.289 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.464 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 2.5 mt -138.1 119.02 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 107.544 -1.28 . . . . 10.0 107.544 -177.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.408 ' HD3' ' O ' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -83.44 67.55 9.38 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.597 -0.89 . . . . 10.0 108.597 -176.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.473 ' HB ' ' HB3' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -20.59 96.37 0.05 OUTLIER Pre-proline 0 C--O 1.224 -0.24 0 O-C-N 125.879 1.987 . . . . 10.0 112.244 176.005 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.403 ' CB ' ' HD2' ' A' ' 77' ' ' PHE . 3.8 Cg_exo -36.65 124.3 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 124.406 3.404 . . . . 10.0 113.65 -167.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.535 ' HA ' ' HZ1' ' A' ' 112' ' ' LYS . 86.1 Cg_exo -48.09 86.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.17 3.247 . . . . 10.0 114.085 -176.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 1.061 ' H ' ' HE2' ' A' ' 112' ' ' LYS . . . 72.49 -49.75 0.7 Allowed 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 124.708 1.203 . . . . 10.0 112.509 173.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.554 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 8.0 p -37.39 -65.29 0.32 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 114.116 1.154 . . . . 10.0 114.116 -171.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.713 ' HB3' ' SD ' ' A' ' 52' ' ' MET . 41.6 m-85 -72.32 -40.75 67.22 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.26 0.837 . . . . 10.0 113.26 -171.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.788 ' HB3' HD13 ' A' ' 108' ' ' ILE . 2.7 mm? -68.32 -30.62 69.64 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.547 -0.721 . . . . 10.0 109.863 177.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.416 ' CD1' ' HB1' ' A' ' 75' ' ' ALA . 28.0 mt -70.94 -25.41 62.73 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.967 -0.56 . . . . 10.0 110.914 175.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.554 ' HG2' ' O ' ' A' ' 76' ' ' SER . 25.1 mmmt -54.15 -49.28 69.62 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 108.638 -0.875 . . . . 10.0 108.638 174.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -58.33 -44.99 88.92 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.881 0.697 . . . . 10.0 112.881 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.693 ' HB3' ' HG2' ' A' ' 104' ' ' GLN . . . -65.86 -55.57 16.35 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 123.031 1.396 . . . . 10.0 110.165 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.542 ' HB3' ' HA3' ' A' ' 98' ' ' GLY . . . . . . . . 0 C--N 1.286 -2.164 0 CA-C-N 111.119 -2.764 . . . . 10.0 110.597 -172.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 136' ' ' GLY . 3.3 p . . . . . 0 N--CA 1.434 -1.262 0 N-CA-C 108.41 -0.959 . . . . 10.0 108.41 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -133.92 147.99 19.26 Favored Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 109.325 -1.51 . . . . 10.0 109.325 164.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.706 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 64.4 pttt -148.11 160.95 42.36 Favored 'General case' 0 CA--C 1.472 -2.022 0 CA-C-O 122.144 0.973 . . . . 10.0 108.803 172.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.511 HG13 ' HB3' ' A' ' 82' ' ' ALA . 1.2 m -161.18 -162.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.411 -2.399 0 CA-C-N 112.486 -2.143 . . . . 10.0 106.772 -166.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.564 HG22 HG23 ' A' ' 140' ' ' VAL . 15.9 p -121.7 159.06 27.36 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 114.543 -1.208 . . . . 10.0 111.106 -173.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.66 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 16.2 tpt180 -43.12 -44.84 5.16 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.919 -1.492 . . . . 10.0 110.165 171.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -58.01 -44.29 87.17 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.801 0.667 . . . . 10.0 112.801 177.429 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.693 ' HG2' ' HB3' ' A' ' 82' ' ' ALA . 1.4 tp60 -55.63 -54.86 38.92 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.895 -0.78 . . . . 10.0 108.895 177.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.743 HG23 ' HB ' ' A' ' 128' ' ' ILE . 45.5 mm -35.96 -52.93 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-N 113.985 -1.461 . . . . 10.0 112.604 167.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.689 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 25.5 tt0 -47.57 -59.63 3.12 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.529 1.132 . . . . 10.0 113.183 -175.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -55.94 -49.82 72.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.129 -0.941 . . . . 10.0 110.519 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.788 HD13 ' HB3' ' A' ' 78' ' ' LEU . 13.8 mm -49.86 -57.42 2.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.652 -0.704 . . . . 10.0 110.641 171.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.512 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -52.23 -35.65 50.19 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.923 -0.581 . . . . 10.0 112.371 177.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.689 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 46.9 mttt -74.97 -56.09 5.1 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.707 -0.679 . . . . 10.0 111.42 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.464 HG23 ' CG ' ' A' ' 112' ' ' LYS . 13.2 t -54.47 -30.41 53.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.931 -0.577 . . . . 10.0 112.375 -176.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 1.061 ' HE2' ' H ' ' A' ' 75' ' ' ALA . 0.8 OUTLIER -113.48 23.71 12.92 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 121.062 -0.255 . . . . 10.0 110.888 -178.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.762 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 46.5 ttm -48.48 -44.3 64.85 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.359 -0.382 . . . . 10.0 111.696 175.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 113' ' ' MET . 56.7 Cg_endo -68.04 -20.64 44.11 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.587 1.525 . . . . 10.0 113.172 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 117' ' ' ASN . 12.4 t70 -83.55 -54.95 4.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.604 -0.726 . . . . 10.0 110.441 -176.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.646 HD21 HD12 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -65.43 -0.32 1.86 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.686 -1.143 . . . . 10.0 112.618 -177.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' ' 115' ' ' ASP . 15.5 m120 60.25 46.93 9.72 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.717 -1.128 . . . . 10.0 109.309 -177.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.762 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -79.84 113.63 18.14 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.358 -1.292 . . . . 10.0 112.625 -173.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -67.39 -36.04 80.52 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.148 -0.686 . . . . 10.0 109.148 169.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.5 p -150.59 146.4 26.52 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.955 -1.128 . . . . 10.0 107.955 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.591 ' O ' ' HG2' ' A' ' 125' ' ' MET . 39.6 tp -53.06 -40.47 64.03 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 114.446 1.276 . . . . 10.0 114.446 -177.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -51.13 -35.19 34.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.309 0.576 . . . . 10.0 111.026 176.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.587 ' O ' ' HG3' ' A' ' 126' ' ' LYS . . . -67.64 -49.08 64.69 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 118.816 -1.153 . . . . 10.0 110.607 173.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.645 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -56.86 -29.05 62.53 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.684 -0.806 . . . . 10.0 110.328 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.657 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 82.8 mmm -61.55 -41.55 97.52 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 113.06 0.763 . . . . 10.0 113.06 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.74 ' HD3' ' N ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -66.7 -45.27 79.31 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 122.161 -0.337 . . . . 10.0 111.816 178.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.74 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -55.12 -60.59 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 C-N-CA 120.164 -0.614 . . . . 10.0 110.662 178.443 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.743 ' HB ' HG23 ' A' ' 105' ' ' ILE . 19.8 mm -50.36 -55.02 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.219 0 CA-C-N 115.614 -0.721 . . . . 10.0 110.774 -177.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.465 ' HG2' ' HZ2' ' A' ' 133' ' ' LYS . 36.6 tt0 -54.46 -44.3 72.44 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 114.753 -1.112 . . . . 10.0 108.898 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.59 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -72.07 -46.2 37.08 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 121.154 -0.546 . . . . 10.0 112.166 -174.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.557 HG23 ' HB2' ' A' ' 75' ' ' ALA . 68.1 m -46.96 -57.69 4.73 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.483 0.658 . . . . 10.0 109.431 171.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.6 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -49.08 -43.26 40.96 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 114.94 -1.027 . . . . 10.0 111.876 175.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 130' ' ' GLY . 58.6 mttp -48.74 -53.02 20.64 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.439 0.462 . . . . 10.0 110.876 176.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.9 m -66.96 -32.87 74.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.024 0.44 . . . . 10.0 111.446 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.461 ' HE2' ' HA ' ' A' ' 76' ' ' SER . 38.3 mtm -79.85 -1.05 37.31 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.934 1.087 . . . . 10.0 113.934 -175.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.468 ' O ' HG13 ' A' ' 97' ' ' VAL . . . 83.49 23.78 52.76 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 119.619 1.1 . . . . 10.0 112.142 -177.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.6 ' HB ' ' HB1' ' A' ' 132' ' ' ALA . 3.0 mp -109.26 126.63 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 CA-C-O 121.525 0.679 . . . . 10.0 111.043 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.706 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -91.9 157.86 16.6 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.553 -1.203 . . . . 10.0 108.906 179.31 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 19.5 m -119.02 134.52 62.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.177 -0.675 . . . . 10.0 109.177 171.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.564 HG23 HG22 ' A' ' 101' ' ' THR . 28.7 m -133.85 71.07 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 116.052 1.871 . . . . 10.0 116.052 -173.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 20.5 t0 . . . . . 0 C--N 1.3 -1.571 0 CA-C-N 114.321 -1.309 . . . . 10.0 109.041 138.791 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.475 ' HB2' ' HZ3' ' A' ' 4' ' ' LYS . 10.3 mtmp? . . . . . 0 CA--C 1.52 -0.188 0 N-CA-C 109.776 -0.453 . . . . 10.0 109.776 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.462 HG11 HG23 ' A' ' 59' ' ' THR . 45.2 t -62.13 131.53 27.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 116.222 -0.444 . . . . 10.0 111.155 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.93 -35.39 7.31 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.687 -0.486 . . . . 10.0 109.687 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.495 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -154.11 141.27 19.45 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.327 0.862 . . . . 10.0 113.327 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -94.2 126.96 39.76 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 106.654 -1.61 . . . . 10.0 106.654 171.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.604 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 1.9 mt -125.67 85.59 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 120.241 -0.584 . . . . 10.0 109.864 -177.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.553 ' HG2' HG23 ' A' ' 57' ' ' VAL . 58.1 mttp -75.92 132.86 40.53 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 120.338 -0.545 . . . . 10.0 109.85 176.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.771 HD13 HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -158.34 127.21 5.55 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.154 0.978 . . . . 10.0 111.607 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -85.92 122.87 30.59 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.502 -1.226 . . . . 10.0 110.724 -172.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.771 HD22 HD13 ' A' ' 11' ' ' LEU . 94.0 mt -141.56 135.66 14.96 Favored Pre-proline 0 CA--C 1.51 -0.584 0 CA-C-O 121.659 0.742 . . . . 10.0 112.044 -172.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.604 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 53.1 Cg_exo -49.94 124.34 12.4 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.818 3.012 . . . . 10.0 112.943 170.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.651 ' HB3' HD12 ' A' ' 54' ' ' LEU . . . -62.73 128.76 37.44 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.599 -1.259 . . . . 10.0 107.599 170.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.35 0.48 78.35 Favored Glycine 0 N--CA 1.446 -0.693 0 O-C-N 125.513 1.758 . . . . 10.0 112.992 -174.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.604 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -143.84 96.08 2.84 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.941 0.877 . . . . 10.0 112.038 -178.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.524 ' O ' ' HB2' ' A' ' 39' ' ' CYS . . . -170.62 135.85 1.19 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.073 -1.422 . . . . 10.0 112.733 177.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.643 ' H ' ' HD3' ' A' ' 20' ' ' PRO . 5.9 t -179.61 -36.26 0.0 OUTLIER Pre-proline 0 N--CA 1.443 -0.777 0 CA-C-N 115.236 -0.893 . . . . 10.0 113.357 176.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.726 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 89.3 Cg_endo -104.04 129.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.409 -3.476 0 N-CA-C 116.492 1.689 . . . . 10.0 116.492 -157.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.954 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . 13.09 -58.24 0.0 OUTLIER Pre-proline 0 C--N 1.288 -2.078 0 CA-C-N 109.228 -3.624 . . . . 10.0 118.546 152.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.754 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 45.3 Cg_exo -57.69 -63.9 0.14 Allowed 'Trans proline' 0 CA--C 1.566 2.115 0 CA-C-N 123.576 2.313 . . . . 10.0 115.409 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.754 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 58.6 Cg_endo -77.42 -52.04 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.681 2.254 . . . . 10.0 112.74 176.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.981 HG12 HD11 ' A' ' 35' ' ' ILE . 77.5 t -81.89 -49.46 17.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 111.702 -2.499 . . . . 10.0 111.894 -166.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.697 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -44.15 -52.97 6.83 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 113.968 -1.469 . . . . 10.0 113.39 178.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.954 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 23.9 Cg_exo -71.96 -43.82 1.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.179 2.586 . . . . 10.0 111.236 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.514 ' O ' ' HD2' ' A' ' 31' ' ' HIS . . . -50.58 -93.81 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.434 0.459 . . . . 10.0 111.897 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.765 HD23 HD13 ' A' ' 35' ' ' ILE 0.356 0.0 OUTLIER -77.15 -19.24 57.12 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 117.306 -1.758 . . . . 10.0 113.797 -174.535 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.55 -39.48 60.84 Favored Glycine 0 N--CA 1.467 0.714 0 C-N-CA 120.666 -0.778 . . . . 10.0 113.092 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.592 ' HB3' ' O ' ' A' ' 26' ' ' PRO . 13.0 tt0 -56.61 -26.14 54.83 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.746 0.308 . . . . 10.0 110.628 175.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.514 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 70.0 m-70 -96.47 23.63 6.62 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.739 -0.784 . . . . 10.0 109.86 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.44 ' HA3' ' CE ' ' A' ' 64' ' ' LYS . . . 81.66 6.92 88.72 Favored Glycine 0 CA--C 1.494 -1.232 0 CA-C-N 115.27 -0.877 . . . . 10.0 112.813 167.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.881 HG11 ' CD2' ' A' ' 66' ' ' PHE . 2.4 t -85.26 146.97 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 113.628 0.973 . . . . 10.0 113.628 -175.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.6 ' ND2' ' HB3' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -69.97 101.71 1.84 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.649 0.737 . . . . 10.0 111.477 174.321 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.981 HD11 HG12 ' A' ' 24' ' ' VAL . 21.2 mm -53.49 -39.25 35.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 114.152 -1.385 . . . . 10.0 112.175 176.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.797 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 3.2 mpp? -66.13 -51.38 58.5 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.335 -1.757 . . . . 10.0 111.907 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.6 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 44.0 tt0 -57.83 -40.13 79.28 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.109 -1.036 . . . . 10.0 110.23 176.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.642 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 89.0 t80 -57.47 -58.97 5.95 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 113.877 1.066 . . . . 10.0 113.877 171.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.797 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 19.8 p -60.08 -47.43 85.91 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 114.563 -1.199 . . . . 10.0 111.36 -175.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -65.26 -24.29 67.28 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.988 -0.745 . . . . 10.0 108.988 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.776 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 19.2 mtp180 -74.2 -64.48 1.01 Allowed 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.598 -0.841 . . . . 10.0 112.35 170.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.55 ' CZ ' HG23 ' A' ' 46' ' ' THR . 76.5 t80 -53.37 -45.18 69.11 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 121.157 0.503 . . . . 10.0 110.376 -172.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.63 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.8 OUTLIER -59.18 -51.01 71.85 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.026 -0.988 . . . . 10.0 110.235 -177.685 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.27 -41.67 99.04 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.209 -0.996 . . . . 10.0 112.232 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.776 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 10.6 mt-10 -68.6 -40.33 80.47 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.795 0.807 . . . . 10.0 111.166 -176.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.685 HG23 HD11 ' A' ' 54' ' ' LEU . 75.4 p -87.81 0.54 55.64 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 114.778 -1.101 . . . . 10.0 112.28 -173.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.04 -35.27 2.9 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.231 1.013 . . . . 10.0 113.233 -175.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -86.91 -33.54 19.69 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.806 -0.634 . . . . 10.0 112.391 -173.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.569 ' HB3' ' HZ ' ' A' ' 77' ' ' PHE . 39.3 mttm -96.94 20.45 11.12 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.181 -0.674 . . . . 10.0 109.181 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.569 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -54.36 157.74 2.65 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 125.223 1.409 . . . . 10.0 114.128 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.05 22.07 43.39 Favored Glycine 0 CA--C 1.501 -0.812 0 N-CA-C 109.121 -1.592 . . . . 10.0 109.121 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.587 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 40.4 tpp -140.99 120.21 12.94 Favored 'General case' 0 C--O 1.205 -1.242 0 C-N-CA 117.42 -1.712 . . . . 10.0 114.737 -159.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.6 mm -63.11 92.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 121.688 -0.632 . . . . 10.0 109.999 172.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.685 HD11 HG23 ' A' ' 46' ' ' THR . 7.2 mt -82.65 129.37 62.73 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.71 -0.478 . . . . 10.0 109.71 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.407 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 14.9 Cg_exo -71.51 103.37 1.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 121.918 1.746 . . . . 10.0 110.262 171.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.02 153.79 3.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 119.726 1.148 . . . . 10.0 110.903 -173.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.553 HG23 ' HG2' ' A' ' 10' ' ' LYS . 61.5 t -133.09 111.66 16.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 176.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.604 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 17.2 mt -102.9 140.66 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.789 0 N-CA-C 108.534 -0.913 . . . . 10.0 108.534 -172.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.462 HG23 HG11 ' A' ' 5' ' ' VAL . 57.2 m -125.19 94.45 4.17 Favored 'General case' 0 N--CA 1.402 -2.863 0 CA-C-N 114.774 -1.103 . . . . 10.0 108.873 177.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 65' ' ' SER . 2.2 p -89.82 134.67 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 O-C-N 121.264 -0.898 . . . . 10.0 110.16 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -91.84 172.34 8.53 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.69 -0.686 . . . . 10.0 112.658 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -63.75 -19.25 64.82 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.298 -0.865 . . . . 10.0 111.393 -178.799 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.48 ' HB3' ' HG ' ' A' ' 65' ' ' SER . 27.3 t70 -77.55 -10.45 59.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.811 -1.086 . . . . 10.0 111.237 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.44 ' CE ' ' HA3' ' A' ' 32' ' ' GLY . 28.1 mmmt 82.55 -3.76 1.38 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.328 1.051 . . . . 10.0 110.961 -172.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.596 ' O ' HG23 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -68.93 179.45 1.83 Allowed 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.661 -0.866 . . . . 10.0 108.661 170.843 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.881 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -166.06 -176.51 3.78 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 119.851 1.205 . . . . 10.0 109.828 175.128 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.3 p -158.12 166.84 31.45 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 102.275 -3.231 . . . . 10.0 102.275 178.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.416 ' CB ' HG12 ' A' ' 58' ' ' ILE . 45.1 p90 -163.66 154.64 16.23 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.207 -1.035 . . . . 10.0 108.207 175.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.507 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 29.2 pt -117.01 164.14 13.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.613 -1.254 . . . . 10.0 107.613 -177.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.466 HG23 HD13 ' A' ' 54' ' ' LEU . 10.5 mm -117.22 126.27 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 106.561 -1.644 . . . . 10.0 106.561 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 71' ' ' LYS . 50.3 mmtt -72.47 104.29 3.76 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 119.576 -0.85 . . . . 10.0 109.988 -177.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.676 ' O ' ' HE2' ' A' ' 112' ' ' LYS . 8.2 p -41.57 139.06 1.55 Allowed Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 112.973 -1.921 . . . . 10.0 109.27 174.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.455 ' HB3' ' HB3' ' A' ' 77' ' ' PHE . 8.7 Cg_exo -32.59 104.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 124.192 3.262 . . . . 10.0 113.256 -174.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.445 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 74.6 Cg_exo -38.85 -47.66 2.76 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.064 2.509 . . . . 10.0 110.565 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.524 ' CB ' HG21 ' A' ' 131' ' ' THR . . . 174.91 -47.58 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 113.824 -1.534 . . . . 10.0 109.364 159.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.65 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 83.9 p -64.68 -30.46 71.48 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 109.817 -0.438 . . . . 10.0 109.817 -178.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.676 ' HE2' HD21 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -41.89 -70.27 0.11 Allowed 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.87 0.868 . . . . 10.0 111.122 175.478 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.78 ' HB3' HD11 ' A' ' 108' ' ' ILE . 12.5 tp -90.25 -17.48 27.39 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.078 -0.51 . . . . 10.0 109.849 -170.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.7 mt -69.2 -33.16 72.92 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.259 172.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.65 ' HG3' ' O ' ' A' ' 76' ' ' SER . 48.5 mttp -60.81 -41.52 95.85 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.35 -0.611 . . . . 10.0 109.35 171.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -58.4 -39.91 80.98 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.851 -0.613 . . . . 10.0 112.422 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.578 ' CB ' HG11 ' A' ' 100' ' ' VAL . . . -69.96 -53.03 19.6 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.975 1.369 . . . . 10.0 110.875 174.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.292 -1.922 0 CA-C-N 111.473 -2.603 . . . . 10.0 111.437 -171.243 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 97' ' ' VAL . 7.1 p . . . . . 0 CA--C 1.54 0.593 0 CA-C-O 121.98 0.895 . . . . 10.0 111.694 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 38.92 -161.83 0.01 OUTLIER Glycine 0 C--N 1.323 -0.181 0 CA-C-N 114.21 -1.359 . . . . 10.0 112.656 -170.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.549 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 8.4 ptpp? -158.85 177.58 11.01 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 122.273 1.035 . . . . 10.0 111.022 177.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.735 ' O ' HG23 ' A' ' 140' ' ' VAL . 1.0 OUTLIER -155.54 -145.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-N 112.285 -2.234 . . . . 10.0 105.981 -176.147 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.565 HG22 HE21 ' A' ' 104' ' ' GLN . 0.1 OUTLIER -162.77 142.72 9.32 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 109.048 -0.723 . . . . 10.0 109.048 -157.44 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.725 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 1.5 tpt180 -43.31 -39.97 3.33 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 124.934 1.396 . . . . 10.0 110.795 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.544 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 17.8 tppt? -60.13 -44.42 94.93 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.521 0.563 . . . . 10.0 112.521 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.65 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -63.81 -47.96 78.76 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.758 -0.83 . . . . 10.0 108.758 178.509 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.725 ' HB ' ' O ' ' A' ' 102' ' ' ARG . 43.2 mm -35.53 -58.15 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 114.949 -1.023 . . . . 10.0 111.544 163.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.664 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 33.1 tt0 -47.33 -54.65 10.54 Favored 'General case' 0 C--O 1.209 -1.07 0 C-N-CA 124.636 1.174 . . . . 10.0 113.146 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -53.2 -58.15 8.03 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 123.743 0.652 . . . . 10.0 110.971 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.78 HD11 ' HB3' ' A' ' 78' ' ' LEU . 7.7 mm -46.79 -55.86 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.243 -0.889 . . . . 10.0 109.963 172.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.565 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -53.27 -38.08 62.74 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.684 -0.689 . . . . 10.0 112.833 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.664 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 76.4 mttt -72.2 -56.92 4.73 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 116.109 -0.496 . . . . 10.0 111.052 -173.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 72' ' ' THR . 1.8 t -54.61 -33.3 60.22 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.171 -0.922 . . . . 10.0 110.168 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 1.108 ' HD2' HD12 ' A' ' 116' ' ' LEU . 4.5 mmtt -91.74 -12.22 34.57 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 112.64 0.607 . . . . 10.0 112.64 -177.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 45.7 ttm -37.27 -52.7 2.27 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 113.25 0.833 . . . . 10.0 113.25 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -64.49 -22.74 65.19 Favored 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 121.456 1.437 . . . . 10.0 112.988 -178.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.712 ' HB3' ' HD3' ' A' ' 112' ' ' LYS . 3.6 t70 -99.25 -42.19 7.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.819 0.818 . . . . 10.0 112.152 -175.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 1.108 HD12 ' HD2' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -63.82 -0.22 1.0 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.105 -1.407 . . . . 10.0 111.815 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.444 ' H ' ' C ' ' A' ' 115' ' ' ASP . 2.6 p-10 56.85 43.88 24.21 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 113.971 -1.468 . . . . 10.0 108.886 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 119' ' ' ASN . . . -65.39 -74.62 0.1 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 112.7 -2.045 . . . . 10.0 113.272 -166.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 118' ' ' ALA . 28.7 t-20 103.57 -42.87 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 O-C-N 125.08 1.488 . . . . 10.0 109.096 -173.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.5 t -153.79 139.75 18.23 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.391 -1.707 . . . . 10.0 106.391 173.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.616 HD11 ' O ' ' A' ' 121' ' ' LEU . 1.5 tm? -50.47 -35.26 28.18 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.34 0.867 . . . . 10.0 113.34 -174.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.518 ' HA ' ' HG3' ' A' ' 125' ' ' MET . 1.6 mp0 -51.15 -41.31 60.03 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.584 0.707 . . . . 10.0 111.013 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.93 -47.37 74.94 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 118.787 -1.165 . . . . 10.0 110.488 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.469 ' HA ' HG22 ' A' ' 127' ' ' ILE . . . -58.6 -29.86 66.78 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.837 -0.345 . . . . 10.0 111.0 176.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.526 ' O ' ' HB2' ' A' ' 129' ' ' GLU . 5.0 mtp -54.92 -41.02 70.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.903 0.382 . . . . 10.0 111.087 175.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -63.37 -54.68 33.03 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.632 -0.713 . . . . 10.0 112.173 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.947 HD13 HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -52.29 -59.35 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 120.212 -0.595 . . . . 10.0 111.144 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.634 ' HB ' HG22 ' A' ' 105' ' ' ILE . 27.4 mm -51.7 -56.65 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 CA-C-N 114.841 -1.072 . . . . 10.0 111.676 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.542 ' HG3' HG21 ' A' ' 105' ' ' ILE . 5.3 mt-10 -51.95 -44.15 63.8 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 123.824 0.702 . . . . 10.0 109.143 177.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.73 -45.97 63.18 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.393 -0.908 . . . . 10.0 111.08 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.524 HG21 ' CB ' ' A' ' 75' ' ' ALA . 49.9 m -46.75 -64.77 0.68 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.144 -1.028 . . . . 10.0 109.148 169.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -47.49 -52.62 16.67 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.147 0.499 . . . . 10.0 111.561 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -52.19 -53.5 42.47 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.943 -1.026 . . . . 10.0 112.163 178.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 22.9 p -68.34 -25.5 65.14 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.044 0.45 . . . . 10.0 110.599 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.495 ' HE3' HD13 ' A' ' 137' ' ' ILE . 45.1 mtm -75.42 -8.41 56.63 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 112.731 0.641 . . . . 10.0 112.731 178.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 96.48 2.65 60.11 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 118.995 0.816 . . . . 10.0 111.765 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.495 HD13 ' HE3' ' A' ' 135' ' ' MET . 51.7 mt -95.02 136.38 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 CA-C-N 117.54 0.67 . . . . 10.0 112.029 -178.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.574 ' HG3' ' N ' ' A' ' 139' ' ' VAL . 0.0 OUTLIER -84.7 156.28 21.54 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 119.097 -1.041 . . . . 10.0 110.544 177.22 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.574 ' N ' ' HG3' ' A' ' 138' ' ' GLU . 17.3 m -120.03 126.21 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.55 0 N-CA-C 107.561 -1.274 . . . . 10.0 107.561 170.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 100' ' ' VAL . 26.2 m -107.2 167.95 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 CA-C-N 113.555 -1.657 . . . . 10.0 108.415 176.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 . . . . . 0 C--N 1.285 -2.198 0 CA-C-N 113.921 -1.49 . . . . 10.0 110.814 178.563 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.0 mttt . . . . . 0 C--O 1.218 -0.584 0 N-CA-C 110.003 -0.369 . . . . 10.0 110.003 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.7 t -65.61 141.3 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 122.737 0.415 . . . . 10.0 111.097 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -109.48 -46.77 3.48 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.198 175.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -156.39 156.98 34.8 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 114.034 1.124 . . . . 10.0 114.034 -173.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -92.05 136.31 33.27 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.244 -1.344 . . . . 10.0 108.357 169.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.6 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -122.73 82.0 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 108.799 -0.815 . . . . 10.0 108.799 169.478 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.466 ' HG2' HG23 ' A' ' 57' ' ' VAL . 48.1 mtpt -78.9 130.97 36.21 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 120.444 1.474 . . . . 10.0 108.396 172.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.543 HD12 HD23 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -159.21 129.59 5.82 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.95 0.881 . . . . 10.0 111.255 -178.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -83.23 119.71 24.9 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.346 -1.297 . . . . 10.0 109.941 -172.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.543 HD23 HD12 ' A' ' 11' ' ' LEU . 55.2 mt -137.07 135.54 19.89 Favored Pre-proline 0 CA--C 1.5 -0.97 0 CA-C-O 121.878 0.847 . . . . 10.0 112.659 -171.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.721 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 25.2 Cg_exo -54.35 123.12 12.81 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 123.622 2.882 . . . . 10.0 111.486 172.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.586 ' CB ' ' HB ' ' A' ' 46' ' ' THR . . . -61.35 125.45 23.81 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.158 -1.423 . . . . 10.0 107.158 168.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.0 -0.97 89.3 Favored Glycine 0 N--CA 1.44 -1.039 0 O-C-N 125.774 1.921 . . . . 10.0 113.233 -175.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.721 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 19.4 tptm -143.47 109.34 5.22 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.296 1.048 . . . . 10.0 112.705 176.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -171.69 142.21 1.54 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.256 -1.338 . . . . 10.0 112.747 172.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.526 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 2.7 t 179.44 -43.02 0.0 OUTLIER Pre-proline 0 C--O 1.207 -1.165 0 O-C-N 124.059 0.85 . . . . 10.0 113.129 175.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.669 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 85.6 Cg_endo -103.25 131.19 0.1 OUTLIER 'Trans proline' 0 N--CA 1.413 -3.259 0 N-CA-C 117.175 1.952 . . . . 10.0 117.175 -153.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.942 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . 13.96 -57.37 0.0 OUTLIER Pre-proline 0 C--N 1.289 -2.041 0 CA-C-N 108.615 -3.902 . . . . 10.0 119.275 153.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.691 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 32.5 Cg_exo -60.46 -63.33 0.12 Allowed 'Trans proline' 0 CA--C 1.562 1.888 0 CA-C-N 123.415 2.255 . . . . 10.0 115.252 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.691 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 55.7 Cg_endo -75.16 -52.86 0.1 Allowed 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.412 2.075 . . . . 10.0 112.239 174.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.735 HG11 HD13 ' A' ' 35' ' ' ILE . 83.1 t -83.26 -47.27 18.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 111.622 -2.535 . . . . 10.0 112.155 -166.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.838 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -42.67 -53.23 5.27 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 114.241 -1.345 . . . . 10.0 114.232 176.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.942 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 32.5 Cg_exo -70.01 -45.73 1.36 Allowed 'Trans proline' 0 CA--C 1.51 -0.719 0 C-N-CA 123.249 2.633 . . . . 10.0 111.324 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.514 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . . . -51.33 -68.42 0.17 Allowed 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.376 0.608 . . . . 10.0 111.061 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.601 HD23 ' CD1' ' A' ' 58' ' ' ILE . 5.9 mt -78.0 -51.62 10.07 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.84 1.052 . . . . 10.0 113.84 -176.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.19 -42.01 96.97 Favored Glycine 0 N--CA 1.461 0.304 0 CA-C-N 116.117 -0.492 . . . . 10.0 113.314 -171.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -60.27 -25.93 66.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.716 0.294 . . . . 10.0 110.646 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -102.3 16.75 25.29 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.641 -0.824 . . . . 10.0 110.623 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.48 9.25 87.1 Favored Glycine 0 CA--C 1.501 -0.797 0 CA-C-N 114.904 -1.043 . . . . 10.0 113.2 168.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.719 HG11 ' CD2' ' A' ' 66' ' ' PHE . 1.9 t -83.06 147.83 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 113.357 0.873 . . . . 10.0 113.357 -174.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -68.64 100.41 1.13 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.224 0.535 . . . . 10.0 111.132 172.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.735 HD13 HG11 ' A' ' 24' ' ' VAL . 1.4 mm -52.12 -42.03 34.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.684 -1.144 . . . . 10.0 111.132 173.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 82.9 mtp -64.75 -53.18 51.24 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 112.973 -1.921 . . . . 10.0 111.749 177.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.523 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 40.9 mt-10 -57.09 -41.21 78.45 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 118.945 -1.102 . . . . 10.0 110.93 177.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.662 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 75.5 t80 -57.83 -57.87 10.88 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 113.701 1.0 . . . . 10.0 113.701 172.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -56.15 -49.57 73.57 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.339 -1.301 . . . . 10.0 111.366 -178.561 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.458 ' HD3' ' O ' ' A' ' 40' ' ' LYS . 12.7 tmtt? -66.96 -22.83 65.91 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.665 -0.865 . . . . 10.0 108.665 -178.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.764 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 26.8 mtt180 -75.93 -64.45 1.08 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.062 -1.055 . . . . 10.0 112.253 170.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.56 ' CZ ' HG21 ' A' ' 46' ' ' THR . 70.1 t80 -55.98 -45.72 78.89 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.032 0.444 . . . . 10.0 110.883 -172.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.588 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.9 OUTLIER -61.09 -48.99 79.12 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.246 -0.888 . . . . 10.0 110.191 -178.106 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.43 -36.96 85.46 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 118.971 -1.092 . . . . 10.0 112.084 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.764 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 42.4 mm-40 -64.01 -47.84 78.72 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.933 0.873 . . . . 10.0 110.687 178.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.65 HG21 HD11 ' A' ' 54' ' ' LEU . 73.3 p -89.44 5.88 43.31 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.017 -1.447 . . . . 10.0 112.209 -168.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -47.9 -35.86 11.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.488 -1.233 . . . . 10.0 112.616 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -86.39 -36.39 19.2 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 115.491 -0.777 . . . . 10.0 111.487 -174.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -95.91 20.11 10.48 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.673 -0.862 . . . . 10.0 108.673 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.436 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -53.75 150.1 7.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.06 -1.427 . . . . 10.0 112.73 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.92 20.32 28.76 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 114.759 -1.11 . . . . 10.0 110.36 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.5 ' HB2' HD22 ' A' ' 54' ' ' LEU . 63.3 mtt -138.88 127.32 23.0 Favored 'General case' 0 C--O 1.208 -1.094 0 C-N-CA 117.527 -1.669 . . . . 10.0 114.595 -168.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.3 mm -67.15 91.93 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 118.773 0.715 . . . . 10.0 109.213 169.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.65 HD11 HG21 ' A' ' 46' ' ' THR . 9.4 mt -80.67 136.8 51.37 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.059 -0.719 . . . . 10.0 109.059 -176.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.488 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 7.4 Cg_exo -75.7 104.25 1.87 Allowed 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.202 1.935 . . . . 10.0 110.682 172.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.86 152.99 4.53 Favored 'Isoleucine or valine' 0 C--N 1.344 0.363 0 CA-C-N 119.706 1.139 . . . . 10.0 111.112 -174.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.466 HG23 ' HG2' ' A' ' 10' ' ' LYS . 97.1 t -134.15 113.57 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 110.106 -0.331 . . . . 10.0 110.106 174.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.601 ' CD1' HD23 ' A' ' 28' ' ' LEU . 20.6 mt -108.14 139.96 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 108.099 -1.074 . . . . 10.0 108.099 -174.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 60.5 m -122.31 97.08 5.3 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 114.833 -1.076 . . . . 10.0 108.88 176.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.496 HG21 ' O ' ' A' ' 65' ' ' SER . 2.6 p -87.86 138.12 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.186 0 O-C-N 121.017 -1.052 . . . . 10.0 110.461 -178.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -93.78 172.12 8.45 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.179 -0.919 . . . . 10.0 112.961 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -62.96 -21.31 66.01 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 113.813 -1.539 . . . . 10.0 111.43 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -76.89 -12.9 60.02 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 113.905 -1.498 . . . . 10.0 110.997 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.578 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 8.5 mmpt? 83.77 -3.26 1.13 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.244 1.018 . . . . 10.0 110.11 -170.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.496 ' O ' HG21 ' A' ' 60' ' ' VAL . 31.6 m -69.57 179.2 2.19 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.349 -0.841 . . . . 10.0 109.349 171.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.719 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -170.25 -176.25 2.17 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 119.639 1.109 . . . . 10.0 110.174 175.379 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.5 p -158.36 164.26 36.5 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 102.987 -2.968 . . . . 10.0 102.987 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.431 ' CB ' HG12 ' A' ' 58' ' ' ILE . 50.7 p90 -161.31 157.29 25.24 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.403 0.62 . . . . 10.0 109.539 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.414 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 23.1 pt -127.99 165.86 26.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 114.846 -1.07 . . . . 10.0 108.31 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.441 HD12 ' CE1' ' A' ' 42' ' ' PHE . 1.7 mm -127.86 130.46 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 108.396 -0.965 . . . . 10.0 108.396 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 65.1 mmtt -77.88 83.26 4.22 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.025 -0.731 . . . . 10.0 109.025 176.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.4 ' OG1' ' HA ' ' A' ' 112' ' ' LYS . 18.8 p -30.01 101.17 0.15 Allowed Pre-proline 0 C--N 1.326 -0.437 0 O-C-N 125.845 1.965 . . . . 10.0 110.934 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.59 ' HB2' HD13 ' A' ' 78' ' ' LEU . 50.9 Cg_exo -20.52 106.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.13 1 C-N-CA 125.432 4.088 . . . . 10.0 114.326 -164.032 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.565 ' O ' ' HD3' ' A' ' 112' ' ' LYS . 24.8 Cg_exo -23.64 -54.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.361 1.189 1 C-N-CA 126.143 4.562 . . . . 10.0 115.229 -169.781 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.462 ' HB1' HG23 ' A' ' 131' ' ' THR . . . -176.6 -43.68 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 120.46 0.171 . . . . 10.0 111.313 171.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.639 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 23.1 t -57.34 -35.53 70.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.05 -0.523 . . . . 10.0 112.152 -171.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -70.32 -40.27 74.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.922 0.392 . . . . 10.0 111.552 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.833 HD23 ' HZ1' ' A' ' 112' ' ' LYS . 8.5 mp -82.53 -26.62 32.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.252 0.549 . . . . 10.0 110.071 -178.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.4 mt -60.56 -40.42 91.55 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.91 -0.774 . . . . 10.0 108.91 170.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.639 ' HG3' ' O ' ' A' ' 76' ' ' SER . 59.0 mttp -63.46 -23.35 67.36 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.481 -0.327 . . . . 10.0 111.189 175.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.561 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -58.02 -52.43 65.55 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 121.005 -0.278 . . . . 10.0 110.594 174.024 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.757 ' HB1' ' HG3' ' A' ' 104' ' ' GLN . . . -84.52 -62.48 1.54 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.466 1.506 . . . . 10.0 112.113 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.718 0 CA-C-N 111.329 -2.668 . . . . 10.0 107.929 -178.814 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 136' ' ' GLY . 7.7 p . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 112.954 0.724 . . . . 10.0 112.954 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -169.57 152.28 19.24 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.263 -1.135 . . . . 10.0 110.263 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.671 ' CB ' ' HB3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -148.21 177.42 9.41 Favored 'General case' 0 CA--C 1.48 -1.739 0 CA-C-O 122.625 1.202 . . . . 10.0 110.491 -166.17 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.58 HG12 ' CB ' ' A' ' 82' ' ' ALA . 0.7 OUTLIER -164.89 -163.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 CA-C-N 111.308 -2.678 . . . . 10.0 105.639 -166.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.443 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 0.5 OUTLIER -127.98 156.26 42.97 Favored 'General case' 0 C--N 1.269 -2.901 0 C-N-CA 118.41 -1.316 . . . . 10.0 112.816 -169.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.667 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 8.4 tpp180 -40.37 -41.54 1.4 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 113.635 -1.621 . . . . 10.0 110.958 177.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -57.45 -44.15 84.53 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.922 0.712 . . . . 10.0 112.922 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.757 ' HG3' ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -61.75 -50.2 73.33 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.601 -0.84 . . . . 10.0 108.804 176.057 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.95 HG21 ' HG3' ' A' ' 129' ' ' GLU . 27.3 mm -38.32 -56.56 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.703 -1.135 . . . . 10.0 110.897 170.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 28.9 tt0 -50.68 -60.89 2.57 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.744 1.218 . . . . 10.0 113.222 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 31.4 mt-10 -57.97 -55.86 29.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.366 -1.288 . . . . 10.0 111.338 -176.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.58 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 46.8 mt -47.71 -50.05 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 116.651 -0.25 . . . . 10.0 110.568 171.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.52 ' HB2' HD13 ' A' ' 121' ' ' LEU . . . -49.46 -51.03 38.51 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.109 0.781 . . . . 10.0 113.109 176.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.552 ' HB3' HD11 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -76.07 -30.1 58.21 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.057 0.391 . . . . 10.0 112.057 -174.011 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.4 m -54.39 -46.38 73.09 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.033 0.444 . . . . 10.0 111.153 173.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.833 ' HZ1' HD23 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -100.4 17.69 20.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.867 -0.606 . . . . 10.0 111.026 -176.192 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.954 ' HG3' ' HB1' ' A' ' 118' ' ' ALA . 45.2 ttm -47.64 -46.71 61.0 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.017 -0.538 . . . . 10.0 112.229 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 113' ' ' MET . 33.2 Cg_endo -64.79 -21.7 64.37 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.521 1.481 . . . . 10.0 113.493 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.479 ' OD1' ' HD2' ' A' ' 71' ' ' LYS . 24.6 t70 -90.12 -53.2 4.58 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.812 0.815 . . . . 10.0 110.872 -178.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.506 HD12 ' HB2' ' A' ' 112' ' ' LYS . 10.3 mp -63.61 -2.96 1.88 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 113.72 -1.582 . . . . 10.0 111.49 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 115' ' ' ASP . 2.9 t-20 60.92 48.19 6.92 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.852 -1.522 . . . . 10.0 109.644 176.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.954 ' HB1' ' HG3' ' A' ' 113' ' ' MET . . . -80.47 114.36 19.31 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.134 -1.394 . . . . 10.0 112.522 -173.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -67.59 -36.22 80.48 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.455 0.645 . . . . 10.0 110.028 171.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.7 p -151.22 143.5 24.11 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 106.841 -1.54 . . . . 10.0 106.841 176.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.67 ' O ' ' HG3' ' A' ' 125' ' ' MET . 58.6 tp -54.27 -34.84 61.72 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 113.794 1.035 . . . . 10.0 113.794 -175.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -48.73 -39.78 26.06 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.59 0.709 . . . . 10.0 110.326 173.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.575 ' HA ' ' HD3' ' A' ' 126' ' ' LYS . . . -66.64 -49.61 65.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.927 -1.033 . . . . 10.0 110.836 176.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.573 ' HB1' HD12 ' A' ' 121' ' ' LEU . . . -57.16 -36.47 70.79 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.632 0.253 . . . . 10.0 110.381 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.67 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 83.1 mtp -55.48 -35.65 65.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.183 -0.462 . . . . 10.0 111.981 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.575 ' HD3' ' HA ' ' A' ' 123' ' ' ALA . 0.1 OUTLIER -64.52 -49.3 71.85 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 110.026 -0.361 . . . . 10.0 110.026 177.397 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 124' ' ' ALA . 55.8 mt -50.68 -63.64 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-O 121.336 0.589 . . . . 10.0 110.846 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.825 ' HB ' HG22 ' A' ' 105' ' ' ILE . 27.5 mm -50.76 -55.53 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 CA-C-N 114.45 -1.25 . . . . 10.0 111.687 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.95 ' HG3' HG21 ' A' ' 105' ' ' ILE . 7.1 mt-10 -52.83 -45.36 67.28 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 123.811 0.695 . . . . 10.0 109.72 178.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -71.6 -44.78 48.55 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.468 -0.872 . . . . 10.0 111.71 -174.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.462 HG23 ' HB1' ' A' ' 75' ' ' ALA . 90.9 m -45.75 -61.49 1.69 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.253 -0.973 . . . . 10.0 109.943 170.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.64 -49.39 47.34 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.565 -1.198 . . . . 10.0 111.876 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -48.37 -54.57 13.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.555 -0.748 . . . . 10.0 111.55 178.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.4 t -63.23 -31.47 72.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.572 0.701 . . . . 10.0 110.382 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.459 ' HE2' ' CD1' ' A' ' 137' ' ' ILE . 35.8 mtp -80.06 7.72 8.57 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.897 1.073 . . . . 10.0 113.897 -176.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.518 ' O ' HG13 ' A' ' 97' ' ' VAL . . . 84.64 3.8 88.0 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 119.478 1.035 . . . . 10.0 111.789 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.504 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 33.3 mt -96.78 127.79 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 CA-C-O 121.959 0.885 . . . . 10.0 111.83 -176.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.671 ' HB3' ' CB ' ' A' ' 99' ' ' LYS . 39.1 tt0 -88.21 159.43 18.15 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.156 -1.384 . . . . 10.0 108.768 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.47 HG12 HG13 ' A' ' 105' ' ' ILE . 17.9 m -117.92 134.1 62.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 108.341 -0.985 . . . . 10.0 108.341 167.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 100' ' ' VAL . 26.9 m -138.62 69.37 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 114.784 1.401 . . . . 10.0 114.784 -174.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.9 t70 . . . . . 0 C--N 1.298 -1.673 0 CA-C-O 117.771 -1.109 . . . . 10.0 110.257 145.455 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 2.3 mtpp . . . . . 0 C--O 1.222 -0.358 0 N-CA-C 109.723 -0.473 . . . . 10.0 109.723 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.5 t -62.93 138.61 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 122.833 0.453 . . . . 10.0 111.719 -176.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.61 -38.47 5.17 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 173.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.508 ' HB2' ' CG1' ' A' ' 60' ' ' VAL . . . -154.28 141.34 19.35 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.857 0.688 . . . . 10.0 112.857 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -98.67 115.65 29.15 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.053 -1.462 . . . . 10.0 107.053 173.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.578 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 3.7 mt -113.9 85.45 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.051 0 N-CA-C 108.803 -0.814 . . . . 10.0 108.803 -174.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.772 ' HZ3' ' HB2' ' A' ' 10' ' ' LYS . 10.1 mtmp? -77.85 148.26 34.75 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 119.136 0.88 . . . . 10.0 110.304 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.403 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 0.8 OUTLIER -156.38 135.3 11.88 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.003 -0.74 . . . . 10.0 109.003 -178.226 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -93.79 111.46 23.16 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.199 -1.038 . . . . 10.0 108.199 169.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 15.0 mt -127.94 135.21 27.16 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 121.594 0.711 . . . . 10.0 112.324 -166.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.529 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 22.1 Cg_exo -57.88 121.2 9.61 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.532 2.821 . . . . 10.0 111.861 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.594 ' HB2' HD12 ' A' ' 54' ' ' LEU . . . -61.72 127.48 31.66 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 107.768 -1.197 . . . . 10.0 107.768 170.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.9 0.36 89.38 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 125.695 1.872 . . . . 10.0 112.625 -174.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.529 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 4.6 tmtp? -141.09 100.95 3.93 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.992 0.901 . . . . 10.0 111.911 177.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.84 132.24 3.67 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.421 -1.263 . . . . 10.0 112.395 176.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.462 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -177.03 -53.68 0.0 OUTLIER Pre-proline 0 N--CA 1.448 -0.537 0 N-CA-C 112.697 0.629 . . . . 10.0 112.697 178.5 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.586 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 80.6 Cg_endo -104.53 128.09 0.07 OUTLIER 'Trans proline' 0 N--CA 1.416 -3.044 0 N-CA-C 116.211 1.581 . . . . 10.0 116.211 -154.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 1.092 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 16.04 -84.11 0.0 OUTLIER Pre-proline 0 C--N 1.294 -1.806 0 CA-C-N 108.58 -3.918 . . . . 10.0 116.251 165.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 3.2 Cg_exo -31.31 -56.79 0.23 Allowed 'Trans proline' 0 CA--C 1.558 1.679 0 C-N-CA 122.906 2.404 . . . . 10.0 115.419 -165.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 5.4 Cg_exo -83.95 -49.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 123.346 2.697 . . . . 10.0 112.237 171.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.849 HG11 HD11 ' A' ' 35' ' ' ILE . 57.9 t -88.87 -45.68 15.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 112.449 -2.16 . . . . 10.0 113.484 -163.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 1.092 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -47.56 -80.6 0.05 OUTLIER Glycine 0 C--O 1.221 -0.692 0 CA-C-N 114.609 -1.178 . . . . 10.0 114.304 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.592 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 13.0 Cg_exo -43.28 -41.2 9.97 Favored 'Trans proline' 0 CA--C 1.52 -0.223 0 C-N-CA 123.544 2.83 . . . . 10.0 112.316 174.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.489 ' HB1' ' CG2' ' A' ' 9' ' ' ILE . . . -52.47 -77.94 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.644 0.735 . . . . 10.0 111.255 176.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.668 HD22 ' CD1' ' A' ' 58' ' ' ILE . 6.9 mt -75.55 -42.74 51.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.961 -1.018 . . . . 10.0 113.725 -173.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.9 -38.22 95.77 Favored Glycine 0 N--CA 1.463 0.489 0 CA-C-N 116.526 -0.306 . . . . 10.0 113.214 -176.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -63.87 -21.18 66.33 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 119.506 -0.877 . . . . 10.0 109.699 175.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -103.91 7.17 36.78 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.888 -0.725 . . . . 10.0 111.861 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.81 ' HA3' ' HZ2' ' A' ' 64' ' ' LYS . . . 56.79 37.44 77.48 Favored Glycine 0 CA--C 1.509 -0.31 0 CA-C-N 115.309 -0.86 . . . . 10.0 112.899 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.648 HG12 ' CD1' ' A' ' 66' ' ' PHE . 55.8 t -74.72 -32.15 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 115.734 1.753 . . . . 10.0 115.734 -169.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 90.06 78.17 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 125.3 1.44 . . . . 10.0 109.581 -169.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.849 HD11 HG11 ' A' ' 24' ' ' VAL . 1.4 mt -51.92 -40.63 28.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 113.046 -1.888 . . . . 10.0 113.336 176.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 87.5 mtp -63.04 -47.18 84.11 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 117.523 -1.671 . . . . 10.0 111.495 173.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.598 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 21.7 tp10 -60.0 -43.47 95.16 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 118.979 -1.088 . . . . 10.0 110.252 176.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.584 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 71.7 t80 -56.5 -57.04 14.05 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 113.928 1.084 . . . . 10.0 113.928 172.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.43 -50.14 73.98 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.882 0.873 . . . . 10.0 111.729 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -63.29 -22.88 67.15 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.244 -0.982 . . . . 10.0 108.756 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.826 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 33.1 mtm-85 -78.53 -64.31 1.2 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 118.228 -0.892 . . . . 10.0 112.192 168.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.525 ' CZ ' HG21 ' A' ' 46' ' ' THR . 69.8 t80 -53.11 -48.0 68.18 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 119.477 1.035 . . . . 10.0 110.224 -169.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -60.02 -50.24 74.52 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.037 -0.983 . . . . 10.0 110.326 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.72 93.71 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 119.157 -1.017 . . . . 10.0 111.943 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.826 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 7.0 mm-40 -66.26 -44.72 82.86 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 122.203 1.002 . . . . 10.0 110.713 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.612 ' CG2' HD11 ' A' ' 54' ' ' LEU . 81.6 p -89.76 0.5 56.96 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 113.963 -1.472 . . . . 10.0 111.986 -171.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.08 -38.81 8.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.307 -0.86 . . . . 10.0 112.44 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -79.44 -25.63 41.96 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.551 -0.75 . . . . 10.0 111.206 -173.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -108.41 21.66 17.0 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.555 0.742 . . . . 10.0 109.955 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -52.64 148.19 7.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.991 -1.004 . . . . 10.0 112.868 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.9 19.27 31.8 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 110.816 -0.914 . . . . 10.0 110.816 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.681 ' SD ' ' HB3' ' A' ' 77' ' ' PHE . 67.4 mtt -139.28 126.21 20.97 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 117.211 -1.796 . . . . 10.0 114.555 -166.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.3 mm -68.13 91.51 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.255 -0.646 . . . . 10.0 109.255 172.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.612 HD11 ' CG2' ' A' ' 46' ' ' THR . 7.7 mt -82.45 131.68 54.77 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.619 -0.511 . . . . 10.0 109.619 -177.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.573 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 17.1 Cg_exo -69.62 102.82 1.05 Allowed 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.394 2.063 . . . . 10.0 111.196 172.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.486 HG21 HG12 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -101.03 156.84 4.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 119.501 1.046 . . . . 10.0 111.016 -175.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.474 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 86.9 t -136.23 116.1 17.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.085 -0.507 . . . . 10.0 110.508 172.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.668 ' CD1' HD22 ' A' ' 28' ' ' LEU . 18.1 mt -105.57 140.39 23.78 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.925 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 -175.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.3 m -126.96 95.88 4.45 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 114.962 -1.017 . . . . 10.0 109.14 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.508 ' CG1' ' HB2' ' A' ' 7' ' ' ALA . 3.3 p -85.99 136.0 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 119.124 0.875 . . . . 10.0 109.827 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -94.51 173.33 7.68 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.496 0.665 . . . . 10.0 112.55 -176.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 24.8 mt-10 -62.14 -19.33 62.92 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.638 -1.164 . . . . 10.0 112.285 -177.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 4.6 m-20 -78.35 -11.55 59.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.588 -0.733 . . . . 10.0 111.041 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.81 ' HZ2' ' HA3' ' A' ' 32' ' ' GLY . 18.6 mtpp 82.04 1.19 1.42 Allowed 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 114.654 -1.157 . . . . 10.0 110.329 -167.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.434 ' O ' HG21 ' A' ' 60' ' ' VAL . 51.0 m -70.53 174.7 5.5 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.369 -1.287 . . . . 10.0 108.184 172.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.648 ' CD1' HG12 ' A' ' 33' ' ' VAL . 8.8 p90 -167.99 -179.02 3.97 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 121.394 1.906 . . . . 10.0 110.326 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.5 p -161.51 171.88 17.37 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 103.791 -2.67 . . . . 10.0 103.791 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 50.7 p90 -163.52 157.76 20.02 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.757 -0.831 . . . . 10.0 108.757 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.474 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 31.3 pt -127.77 164.9 28.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 107.767 -1.197 . . . . 10.0 107.767 -178.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.486 HG12 HG21 ' A' ' 56' ' ' VAL . 8.2 mt -138.84 123.17 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 108.034 -1.099 . . . . 10.0 108.034 -174.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.646 ' C ' ' HD2' ' A' ' 73' ' ' PRO . 41.5 mmtt -75.93 95.07 3.47 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.896 1.331 . . . . 10.0 113.531 -168.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.647 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -59.83 -33.46 16.03 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-N 112.554 -2.112 . . . . 10.0 114.743 167.605 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.768 ' HD3' ' HB3' ' A' ' 115' ' ' ASP . 9.2 Cg_endo -50.11 -42.19 46.96 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.683 2.922 . . . . 10.0 117.282 -171.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.582 ' HD3' ' HG2' ' A' ' 73' ' ' PRO . 82.9 Cg_exo -44.98 -31.33 5.33 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 122.366 2.044 . . . . 10.0 113.141 -178.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.761 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . . . 70.32 -38.47 0.41 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.72 1.007 . . . . 10.0 113.72 170.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -50.04 -31.21 12.44 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 122.982 0.513 . . . . 10.0 111.85 -175.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.681 ' HB3' ' SD ' ' A' ' 52' ' ' MET . 73.6 m-85 -61.19 -55.58 30.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.165 0.507 . . . . 10.0 111.257 178.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.8 HD23 ' HZ3' ' A' ' 112' ' ' LYS . 3.3 mm? -78.72 -27.03 44.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.912 -175.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.85 HD21 HG22 ' A' ' 108' ' ' ILE . 3.5 mm? -59.56 -50.24 74.65 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.716 -0.475 . . . . 10.0 109.716 174.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.526 ' HA ' ' HB1' ' A' ' 83' ' ' ALA . 63.3 mttp -66.47 -15.39 63.32 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.557 177.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 3.1 tppp? -61.69 -38.77 89.07 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 120.778 -0.369 . . . . 10.0 110.294 171.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.51 ' CB ' HG13 ' A' ' 100' ' ' VAL . . . -85.44 -57.31 3.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.428 1.891 . . . . 10.0 112.394 172.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.526 ' HB1' ' HA ' ' A' ' 80' ' ' LYS . . . . . . . . 0 C--N 1.3 -1.572 0 CA-C-N 110.76 -2.927 . . . . 10.0 107.268 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 136' ' ' GLY . 14.5 p . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 112.311 0.486 . . . . 10.0 112.311 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.734 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -159.18 165.49 34.3 Favored Glycine 0 CA--C 1.497 -1.059 0 N-CA-C 109.034 -1.627 . . . . 10.0 109.034 174.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.735 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 13.4 pttm -152.01 169.75 21.58 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 122.394 1.092 . . . . 10.0 110.771 -166.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -161.9 -145.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-N 112.119 -2.31 . . . . 10.0 105.807 -169.331 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 0.1 OUTLIER -162.49 144.99 10.99 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.372 -0.931 . . . . 10.0 108.937 -155.876 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.644 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 16.0 mmm180 -41.68 -50.14 4.21 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 124.57 1.169 . . . . 10.0 111.562 -177.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 24.8 tptp -56.31 -43.7 79.2 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.223 0.453 . . . . 10.0 112.223 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.56 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -61.39 -49.05 78.45 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.149 -0.686 . . . . 10.0 109.149 177.378 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.807 HG22 ' HG3' ' A' ' 129' ' ' GLU . 25.8 mm -40.26 -53.6 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 114.948 -1.024 . . . . 10.0 111.017 170.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.73 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 21.7 tt0 -51.02 -56.54 12.0 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 114.935 -1.029 . . . . 10.0 112.872 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.518 ' OE2' ' HE3' ' A' ' 110' ' ' LYS . 19.2 mm-40 -51.82 -58.49 6.28 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.119 -0.946 . . . . 10.0 110.551 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.85 HG22 HD21 ' A' ' 79' ' ' LEU . 26.3 mm -50.2 -50.37 20.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.851 -1.068 . . . . 10.0 110.679 173.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.512 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -51.19 -36.24 40.34 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 112.578 0.584 . . . . 10.0 112.578 175.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.73 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 39.7 mttm -71.74 -54.0 11.66 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.256 -177.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.569 HG21 ' O ' ' A' ' 108' ' ' ILE . 6.1 t -53.5 -28.51 31.43 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.666 0.617 . . . . 10.0 112.666 -175.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.832 ' HB3' ' HZ1' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -118.07 17.59 14.03 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.904 -0.497 . . . . 10.0 111.55 -177.727 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.667 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 48.6 ttm -49.17 -47.26 76.15 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.706 -0.679 . . . . 10.0 112.342 175.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 113' ' ' MET . 33.6 Cg_endo -61.53 -25.58 79.7 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 122.099 1.866 . . . . 10.0 112.418 -177.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.768 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 2.0 m-20 -93.96 -45.76 7.46 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.074 -0.966 . . . . 10.0 112.143 -173.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.784 HD22 HD11 ' A' ' 127' ' ' ILE . 5.3 mp -62.12 -4.35 1.66 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 114.661 -1.154 . . . . 10.0 111.268 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 115' ' ' ASP . 14.2 m120 64.23 43.86 4.67 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.87 -1.514 . . . . 10.0 109.066 177.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.667 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -80.64 109.13 14.88 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.942 -1.481 . . . . 10.0 112.331 -174.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -68.48 -36.43 78.94 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.902 -0.777 . . . . 10.0 108.902 173.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 87.3 p -145.88 143.42 29.57 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.089 -1.448 . . . . 10.0 107.089 172.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.602 ' O ' ' HG3' ' A' ' 125' ' ' MET . 41.1 tp -53.45 -29.46 35.73 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.944 1.461 . . . . 10.0 114.944 -174.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -50.67 -33.9 24.39 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 122.016 0.913 . . . . 10.0 110.067 174.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.9 -49.81 41.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.133 -1.394 . . . . 10.0 110.264 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.606 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -57.35 -35.29 69.73 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.991 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.602 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 79.8 mtp -55.61 -39.47 70.82 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 122.249 -0.282 . . . . 10.0 111.639 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -64.13 -52.34 59.58 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.447 0.536 . . . . 10.0 112.447 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.784 HD11 HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -52.24 -58.87 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 C-N-CA 119.879 -0.728 . . . . 10.0 110.412 177.649 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.712 ' HB ' HG23 ' A' ' 105' ' ' ILE . 22.9 mm -49.81 -55.92 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 CA-C-N 115.184 -0.916 . . . . 10.0 111.473 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.807 ' HG3' HG22 ' A' ' 105' ' ' ILE . 8.0 mt-10 -52.69 -42.64 64.96 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 123.718 0.636 . . . . 10.0 109.828 177.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -75.02 -46.02 18.12 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 121.215 -0.517 . . . . 10.0 112.643 -174.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.531 HG21 ' HE3' ' A' ' 135' ' ' MET . 53.7 m -46.31 -59.74 2.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.942 -0.762 . . . . 10.0 108.942 170.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.473 ' HB2' ' CG2' ' A' ' 137' ' ' ILE . . . -52.17 -50.02 62.66 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.232 -0.44 . . . . 10.0 111.959 174.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 50.4 tttm -46.11 -50.8 14.96 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 123.656 0.598 . . . . 10.0 111.45 176.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.8 m -60.97 -38.3 85.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.39 -0.368 . . . . 10.0 111.845 -175.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.795 ' HG3' HD12 ' A' ' 137' ' ' ILE . 14.9 ptt? -91.4 17.7 8.16 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.274 1.213 . . . . 10.0 114.274 -174.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.47 ' O ' HG13 ' A' ' 97' ' ' VAL . . . 89.22 13.04 62.48 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 120.043 1.292 . . . . 10.0 112.99 175.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.795 HD12 ' HG3' ' A' ' 135' ' ' MET . 2.4 mp -98.99 126.72 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-O 121.683 0.754 . . . . 10.0 111.375 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.735 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -87.81 156.22 19.51 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.574 -1.194 . . . . 10.0 109.476 177.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.473 HG13 HG13 ' A' ' 105' ' ' ILE . 17.0 m -115.87 125.48 73.02 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.536 0 N-CA-C 108.14 -1.059 . . . . 10.0 108.14 169.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 100' ' ' VAL . 28.3 m -105.24 152.82 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 CA-C-N 113.753 -1.567 . . . . 10.0 107.693 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 . . . . . 0 C--N 1.275 -2.639 0 CA-C-N 114.048 -1.433 . . . . 10.0 111.101 -175.468 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.535 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 2.9 tppp? . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 106.453 -1.684 . . . . 10.0 106.453 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.5 t -61.47 126.82 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.521 0.6 . . . . 10.0 111.579 -171.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.27 -39.28 5.73 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.852 -0.613 . . . . 10.0 109.518 176.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.505 ' HB1' ' CG1' ' A' ' 60' ' ' VAL . . . -154.88 144.68 21.57 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.463 0.912 . . . . 10.0 113.463 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -92.37 133.65 35.67 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 107.436 -1.32 . . . . 10.0 107.436 169.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.619 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -121.53 82.72 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.717 -0.846 . . . . 10.0 108.717 175.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -77.67 126.54 31.04 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 120.199 1.363 . . . . 10.0 107.826 175.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.731 HD11 HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -156.96 123.56 5.03 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 122.868 1.318 . . . . 10.0 111.92 -175.387 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -85.22 122.36 29.3 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.257 -1.792 . . . . 10.0 110.387 -171.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.731 HD22 HD11 ' A' ' 11' ' ' LEU . 85.6 mt -140.46 145.32 40.37 Favored Pre-proline 0 C--O 1.214 -0.764 0 CA-C-O 121.197 0.523 . . . . 10.0 111.903 -170.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.744 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 2.8 Cg_exo -67.75 127.27 15.96 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 123.815 3.01 . . . . 10.0 111.816 177.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.671 ' HB2' HD13 ' A' ' 54' ' ' LEU . . . -62.1 129.77 42.36 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 172.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.02 -2.38 84.07 Favored Glycine 0 N--CA 1.441 -0.974 0 O-C-N 125.619 1.824 . . . . 10.0 112.574 -175.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.744 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 28.8 mmtp -138.79 102.78 4.65 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.743 0.782 . . . . 10.0 111.639 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.669 ' O ' ' HB2' ' A' ' 39' ' ' CYS . . . -170.27 133.97 1.15 Allowed 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.174 -1.375 . . . . 10.0 111.951 172.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.613 ' HA ' ' CB ' ' A' ' 39' ' ' CYS . 3.4 t 179.69 -39.79 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 114.694 -1.139 . . . . 10.0 112.939 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.783 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 97.4 Cg_endo -104.31 124.44 0.07 OUTLIER 'Trans proline' 0 N--CA 1.411 -3.352 0 N-CA-C 115.659 1.369 . . . . 10.0 115.659 -161.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 1.013 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 6.18 -82.08 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.552 0 CA-C-N 109.799 -3.364 . . . . 10.0 114.606 161.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.843 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 68.3 Cg_exo -30.01 -56.62 0.18 Allowed 'Trans proline' 0 CA--C 1.56 1.804 0 C-N-CA 122.791 2.327 . . . . 10.0 115.521 -164.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.843 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 38.2 Cg_endo -82.19 -71.98 0.01 OUTLIER 'Trans proline' 0 CA--C 1.552 1.417 0 C-N-CA 122.817 2.345 . . . . 10.0 112.321 168.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.909 HG11 HD12 ' A' ' 35' ' ' ILE . 96.0 t -53.93 -52.84 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 127.869 2.467 . . . . 10.0 114.756 -175.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 1.013 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -45.44 -69.69 0.74 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 114.493 -1.231 . . . . 10.0 112.939 -178.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.62 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 24.0 Cg_exo -47.75 -49.63 13.21 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.206 2.604 . . . . 10.0 112.99 172.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.466 ' O ' ' HD2' ' A' ' 31' ' ' HIS . . . -43.61 -100.2 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 O-C-N 124.285 0.99 . . . . 10.0 112.789 176.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.884 HD21 HD11 ' A' ' 35' ' ' ILE 0.342 0.0 OUTLIER -76.43 -27.28 56.17 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 117.759 -1.577 . . . . 10.0 113.838 -175.067 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.527 ' N ' HD23 ' A' ' 28' ' ' LEU . . . -69.69 -40.4 76.64 Favored Glycine 0 CA--C 1.527 0.787 0 O-C-N 121.781 -0.575 . . . . 10.0 113.279 -174.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.456 ' HB3' ' O ' ' A' ' 26' ' ' PRO . 29.1 tt0 -59.87 -19.5 51.63 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 120.471 -0.492 . . . . 10.0 109.902 175.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.466 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 83.7 m-70 -98.92 24.53 7.6 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.201 -0.599 . . . . 10.0 110.334 176.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.826 ' HA3' ' HD2' ' A' ' 64' ' ' LYS . . . 89.17 -1.44 82.7 Favored Glycine 0 CA--C 1.495 -1.164 0 CA-C-N 115.48 -0.782 . . . . 10.0 112.608 166.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.874 HG11 ' CD2' ' A' ' 66' ' ' PHE . 3.1 t -83.44 148.64 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 114.107 1.151 . . . . 10.0 114.107 -170.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.438 ' N ' HG13 ' A' ' 33' ' ' VAL . 4.9 m-20 -67.67 96.57 0.56 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.361 0.664 . . . . 10.0 110.56 172.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.909 HD12 HG11 ' A' ' 24' ' ' VAL . 17.2 mm -52.43 -39.24 28.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 122.005 0.907 . . . . 10.0 111.444 173.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.822 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 71.0 mtm -66.22 -50.4 63.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.447 -1.706 . . . . 10.0 112.087 175.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.537 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 1.6 tt0 -58.34 -40.16 81.43 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.138 -1.025 . . . . 10.0 110.128 176.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.59 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 90.8 t80 -56.15 -57.89 10.28 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 114.009 1.114 . . . . 10.0 114.009 170.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.822 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 14.2 p -59.63 -50.42 73.92 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 114.093 -1.412 . . . . 10.0 111.759 -176.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.409 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 58.5 tttm -66.42 -21.18 66.21 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 119.914 -0.714 . . . . 10.0 109.367 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.794 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 3.8 mtp180 -73.59 -65.65 0.8 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.352 -0.939 . . . . 10.0 112.146 169.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.515 ' CZ ' HG22 ' A' ' 46' ' ' THR . 72.9 t80 -53.58 -45.04 69.81 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.806 -171.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.593 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.9 OUTLIER -59.62 -52.34 65.95 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.113 -0.949 . . . . 10.0 110.724 -178.301 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.03 96.28 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 118.817 -1.153 . . . . 10.0 112.385 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.794 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 13.1 mt-10 -67.55 -41.81 83.65 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.868 0.842 . . . . 10.0 111.142 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.572 ' CG2' HD12 ' A' ' 54' ' ' LEU . 80.1 p -88.84 4.56 47.3 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.782 -1.099 . . . . 10.0 112.155 -172.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.95 -42.65 18.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.106 -0.952 . . . . 10.0 112.168 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.68 -47.7 84.59 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 114.517 -1.22 . . . . 10.0 111.574 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.676 ' HZ3' HD12 ' A' ' 78' ' ' LEU . 39.6 mttm -101.36 24.1 10.07 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.268 0.556 . . . . 10.0 110.265 -171.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -53.23 145.09 14.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.695 -1.138 . . . . 10.0 112.622 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.34 16.75 36.4 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.844 -0.902 . . . . 10.0 110.844 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.523 ' SD ' ' HD1' ' A' ' 77' ' ' PHE . 41.0 mtm -141.88 127.37 18.91 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 117.675 -1.61 . . . . 10.0 115.144 -165.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.0 mm -65.9 92.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 O-C-N 121.759 -0.588 . . . . 10.0 109.947 174.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.671 HD13 ' HB2' ' A' ' 15' ' ' ALA . 6.9 mt -83.51 129.83 58.53 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 108.2 -1.037 . . . . 10.0 108.2 178.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -71.5 111.41 3.11 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 C-N-CA 121.8 1.666 . . . . 10.0 110.619 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -100.11 153.56 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 119.997 1.272 . . . . 10.0 111.133 -176.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.406 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 77.1 t -134.1 116.8 23.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 109.786 -0.45 . . . . 10.0 109.786 174.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.619 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 17.5 mt -107.6 140.86 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 N-CA-C 108.704 -0.85 . . . . 10.0 108.704 -173.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.5 m -123.48 100.68 6.93 Favored 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 114.942 -1.026 . . . . 10.0 108.621 173.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 65' ' ' SER . 1.6 p -91.89 136.56 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.815 0 CA-C-N 119.227 0.921 . . . . 10.0 110.35 -177.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -95.7 172.52 7.99 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.041 0.448 . . . . 10.0 112.055 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 58.7 mt-10 -57.22 -20.59 28.14 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 113.996 -1.457 . . . . 10.0 111.959 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -73.69 -18.02 61.06 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.618 -1.173 . . . . 10.0 110.919 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.826 ' HD2' ' HA3' ' A' ' 32' ' ' GLY . 23.8 mtmt 82.27 -3.98 1.44 Allowed 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 124.205 1.002 . . . . 10.0 110.173 -164.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.589 ' O ' HG22 ' A' ' 60' ' ' VAL . 28.6 t -68.25 176.5 2.73 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.506 -0.924 . . . . 10.0 108.506 171.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.874 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -166.98 -176.84 3.54 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 120.124 1.329 . . . . 10.0 110.11 176.502 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.4 p -162.08 161.0 28.1 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 103.018 -2.956 . . . . 10.0 103.018 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.443 ' CB ' HG12 ' A' ' 58' ' ' ILE . 47.0 p90 -160.96 158.17 27.61 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 109.045 -0.724 . . . . 10.0 109.045 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.406 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 30.4 pt -119.95 165.98 14.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 114.443 -1.253 . . . . 10.0 108.059 -175.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.439 HD13 ' CE1' ' A' ' 42' ' ' PHE . 4.4 mm -125.09 119.93 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 106.704 -1.591 . . . . 10.0 106.704 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.7 ' C ' ' HD2' ' A' ' 73' ' ' PRO . 29.5 mmmt -77.28 86.87 3.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.671 0.748 . . . . 10.0 110.731 -169.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.739 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 12.7 t -67.71 -13.9 0.25 Allowed Pre-proline 0 CA--C 1.57 1.748 0 CA-C-N 114.04 -1.437 . . . . 10.0 114.597 174.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.992 ' HD3' ' HB3' ' A' ' 115' ' ' ASP . 3.9 Cg_exo -34.76 -51.89 0.68 Allowed 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 124.057 3.171 . . . . 10.0 115.298 174.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.44 ' HD2' ' O ' ' A' ' 71' ' ' LYS . 27.2 Cg_exo -62.49 112.03 1.48 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 CA-C-N 120.633 1.262 . . . . 10.0 110.987 173.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.491 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -80.35 3.69 20.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.844 0.355 . . . . 10.0 110.582 -178.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.668 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 1.4 m -56.16 -36.61 68.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.561 -0.745 . . . . 10.0 111.306 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.589 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 24.7 m-85 -65.54 -57.22 8.74 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 122.194 0.997 . . . . 10.0 111.433 -176.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.676 HD12 ' HZ3' ' A' ' 49' ' ' LYS . 0.8 OUTLIER -73.82 -23.72 59.7 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.123 -0.944 . . . . 10.0 109.894 -173.434 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.2 mt -83.01 -13.71 55.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.698 -0.683 . . . . 10.0 110.9 174.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' A' ' 76' ' ' SER . 28.4 mmtp -56.15 -60.87 2.87 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.833 -0.803 . . . . 10.0 108.833 170.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -63.71 -45.11 91.48 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.86 -0.609 . . . . 10.0 112.064 178.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.616 ' HB3' HG12 ' A' ' 100' ' ' VAL . . . -61.77 -57.95 9.89 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 123.137 1.446 . . . . 10.0 110.115 -171.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.291 -1.962 0 CA-C-N 111.472 -2.604 . . . . 10.0 110.067 178.449 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.446 HG12 ' N ' ' A' ' 98' ' ' GLY . 3.4 p . . . . . 0 CA--C 1.537 0.45 0 N-CA-C 113.692 0.997 . . . . 10.0 113.692 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.446 ' N ' HG12 ' A' ' 97' ' ' VAL . . . -171.26 173.64 44.82 Favored Glycine 0 CA--C 1.49 -1.509 0 N-CA-C 108.621 -1.792 . . . . 10.0 108.621 -171.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.661 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -150.56 -179.8 7.53 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 122.853 1.311 . . . . 10.0 112.223 -160.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.761 ' O ' HG22 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -155.33 -144.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-N 111.527 -2.579 . . . . 10.0 105.182 -176.429 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 1.4 t -166.02 142.84 5.23 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 107.087 -1.449 . . . . 10.0 107.087 -155.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.675 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 23.1 tpp180 -41.62 -42.03 2.36 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 124.732 1.27 . . . . 10.0 111.204 -171.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.482 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 25.3 tptp -59.91 -46.44 89.33 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.737 1.014 . . . . 10.0 113.737 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.597 ' O ' HG13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -60.09 -45.66 92.18 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.189 -1.041 . . . . 10.0 108.189 178.691 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 1.006 HG21 ' HB ' ' A' ' 128' ' ' ILE . 39.4 mm -43.13 -52.77 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 CA-C-N 114.393 -1.276 . . . . 10.0 111.25 170.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.801 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 16.9 tt0 -48.52 -61.84 1.81 Allowed 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.967 -1.015 . . . . 10.0 112.967 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.541 ' HA ' ' HD3' ' A' ' 110' ' ' LYS . 37.7 mt-10 -56.62 -46.67 80.79 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.695 -1.139 . . . . 10.0 110.844 -175.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.685 HG21 ' HD3' ' A' ' 112' ' ' LYS . 34.2 mt -52.8 -58.43 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 115.759 -0.655 . . . . 10.0 110.085 169.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.468 ' HB1' HD12 ' A' ' 121' ' ' LEU . . . -45.48 -40.6 8.59 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.473 0.709 . . . . 10.0 112.695 177.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.801 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 38.9 mtpt -73.22 -48.76 32.29 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.737 -0.665 . . . . 10.0 111.368 -175.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.51 HG21 ' O ' ' A' ' 108' ' ' ILE . 1.1 t -57.2 -38.41 73.63 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 112.573 0.583 . . . . 10.0 112.573 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.685 ' HD3' HG21 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -98.21 6.46 47.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 122.602 0.361 . . . . 10.0 111.172 -174.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.686 ' HA ' HD13 ' A' ' 116' ' ' LEU . 54.1 ttm -50.25 -38.86 42.29 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.491 -0.777 . . . . 10.0 112.669 176.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' A' ' 113' ' ' MET . 35.1 Cg_endo -61.28 -31.74 89.51 Favored 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 121.726 1.617 . . . . 10.0 111.782 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.992 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 0.4 OUTLIER -93.71 -52.99 4.21 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.891 -1.504 . . . . 10.0 112.719 -170.263 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.686 HD13 ' HA ' ' A' ' 113' ' ' MET . 0.3 OUTLIER -72.99 -177.46 2.43 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 123.034 1.397 . . . . 10.0 113.871 -173.18 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -96.46 49.03 1.1 Allowed 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 112.443 -2.162 . . . . 10.0 113.088 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.566 ' HB1' ' HB2' ' A' ' 124' ' ' ALA . . . -64.66 -102.64 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.811 1.041 . . . . 10.0 113.811 173.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 118' ' ' ALA . 24.5 t-20 107.12 -78.42 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.829 1.652 . . . . 10.0 107.789 -167.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.2 t -87.15 147.86 25.44 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.622 -1.251 . . . . 10.0 107.622 162.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.654 ' O ' ' HG2' ' A' ' 125' ' ' MET . 61.8 tp -56.25 -34.7 66.64 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.673 -0.811 . . . . 10.0 110.938 166.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 32.2 mt-10 -48.35 -40.46 25.51 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.564 0.697 . . . . 10.0 110.38 173.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.25 -47.73 63.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.545 -1.207 . . . . 10.0 110.959 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.631 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -56.83 -40.35 75.87 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.405 -0.518 . . . . 10.0 110.122 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.792 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 74.7 mmm -53.35 -40.24 64.75 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.387 0.675 . . . . 10.0 110.727 176.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.64 ' HA ' ' HG2' ' A' ' 129' ' ' GLU . 13.6 mmmm -68.32 -45.07 73.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.06 -0.973 . . . . 10.0 110.234 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.453 ' CD1' HD22 ' A' ' 116' ' ' LEU . 92.8 mt -49.73 -65.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-O 121.178 0.514 . . . . 10.0 110.175 173.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 1.006 ' HB ' HG21 ' A' ' 105' ' ' ILE . 12.5 mm -50.79 -56.19 5.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.711 -1.131 . . . . 10.0 112.399 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.657 ' HG3' ' N ' ' A' ' 130' ' ' GLY . 0.3 OUTLIER -56.51 -41.86 77.39 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 109.14 -0.689 . . . . 10.0 109.14 -177.793 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.657 ' N ' ' HG3' ' A' ' 129' ' ' GLU . . . -72.83 -47.62 24.96 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.58 -0.736 . . . . 10.0 111.563 -175.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.491 HG21 ' HB3' ' A' ' 75' ' ' ALA . 35.3 m -46.25 -61.8 1.62 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.099 -1.051 . . . . 10.0 109.691 170.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.412 ' HB3' ' HB ' ' A' ' 137' ' ' ILE . . . -48.17 -47.84 34.83 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.0 -0.545 . . . . 10.0 111.97 174.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.58 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 79.1 tttt -48.53 -54.22 15.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.938 -1.028 . . . . 10.0 111.593 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.5 m -66.85 -29.28 69.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.044 0.45 . . . . 10.0 111.197 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.466 ' HE2' HD13 ' A' ' 137' ' ' ILE . 49.8 mtm -80.44 4.49 17.97 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.52 0.933 . . . . 10.0 113.52 -177.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.97 11.43 79.01 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 119.364 0.984 . . . . 10.0 111.784 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.466 HD13 ' HE2' ' A' ' 135' ' ' MET . 27.4 mt -101.66 131.33 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 CA-C-O 121.509 0.671 . . . . 10.0 112.411 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.661 ' HB3' ' HB2' ' A' ' 99' ' ' LYS . 7.8 tp10 -84.79 156.61 21.29 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 115.188 -0.915 . . . . 10.0 110.279 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.7 m -117.98 121.88 68.37 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.218 0 N-CA-C 107.889 -1.152 . . . . 10.0 107.889 165.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.761 HG22 ' O ' ' A' ' 100' ' ' VAL . 25.1 m -101.52 143.17 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 CA-C-N 113.961 -1.472 . . . . 10.0 108.265 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.7 t70 . . . . . 0 C--N 1.286 -2.163 0 CA-C-N 113.48 -1.691 . . . . 10.0 109.98 -173.378 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.478 ' HB3' ' HG3' ' A' ' 62' ' ' GLU . 30.5 mmtm . . . . . 0 CA--C 1.533 0.298 0 N-CA-C 111.26 0.096 . . . . 10.0 111.26 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.1 t -63.24 140.36 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.027 0.531 . . . . 10.0 111.329 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.46 -37.67 4.26 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 120.84 -0.344 . . . . 10.0 110.306 174.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.462 ' HB3' HG12 ' A' ' 60' ' ' VAL . . . -153.67 153.0 31.47 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.19 0.811 . . . . 10.0 113.19 -176.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -95.6 134.07 38.91 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.023 -1.103 . . . . 10.0 108.023 170.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.651 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.7 OUTLIER -120.65 80.19 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 168.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -82.52 127.61 33.49 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 120.265 1.393 . . . . 10.0 108.482 176.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.709 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.27 128.75 6.91 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.959 0.885 . . . . 10.0 111.412 -174.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -78.52 122.67 26.17 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.311 -1.313 . . . . 10.0 110.141 -172.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.709 HD21 HD11 ' A' ' 11' ' ' LEU . 89.2 mt -140.43 133.66 14.93 Favored Pre-proline 0 N--CA 1.443 -0.817 0 CA-C-O 121.805 0.812 . . . . 10.0 112.072 -173.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.697 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 50.1 Cg_exo -52.0 125.08 16.19 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 124.072 3.181 . . . . 10.0 112.62 171.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.619 ' HB3' HD13 ' A' ' 54' ' ' LEU . . . -62.13 127.29 30.69 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 107.696 -1.224 . . . . 10.0 107.696 169.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.85 -2.72 82.6 Favored Glycine 0 N--CA 1.443 -0.888 0 O-C-N 125.987 2.055 . . . . 10.0 112.744 -174.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.697 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 15.9 mmtp -140.16 99.62 3.71 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.083 0.944 . . . . 10.0 112.553 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -168.29 134.72 1.96 Allowed 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 114.073 -1.421 . . . . 10.0 111.767 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.658 ' HA ' ' HB2' ' A' ' 39' ' ' CYS . 1.6 t -178.11 -48.46 0.0 OUTLIER Pre-proline 0 N--CA 1.438 -1.06 0 CA-C-N 115.154 -0.93 . . . . 10.0 112.674 176.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.718 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 83.0 Cg_endo -104.62 133.25 0.09 OUTLIER 'Trans proline' 0 N--CA 1.409 -3.468 0 N-CA-C 117.049 1.903 . . . . 10.0 117.049 -152.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.895 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . 12.67 -63.3 0.0 OUTLIER Pre-proline 0 C--N 1.284 -2.243 0 CA-C-N 108.473 -3.967 . . . . 10.0 117.52 154.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.786 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 52.8 Cg_exo -52.63 -63.88 0.22 Allowed 'Trans proline' 0 CA--C 1.566 2.096 0 CA-C-N 123.964 2.451 . . . . 10.0 114.513 -177.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.786 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 60.4 Cg_endo -78.05 -52.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 122.624 2.216 . . . . 10.0 113.109 174.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.811 HG13 HD11 ' A' ' 35' ' ' ILE . 79.8 t -80.99 -45.27 21.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-N 111.995 -2.366 . . . . 10.0 112.689 -166.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.74 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -40.57 -64.75 1.13 Allowed Glycine 0 CA--C 1.521 0.448 0 O-C-N 124.808 1.318 . . . . 10.0 113.32 178.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.895 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 80.1 Cg_exo -58.77 -48.4 14.91 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.798 2.999 . . . . 10.0 111.39 177.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.634 ' O ' ' HD2' ' A' ' 31' ' ' HIS . . . -48.4 -94.22 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 124.344 1.028 . . . . 10.0 111.764 -176.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.634 HD21 ' HA ' ' A' ' 35' ' ' ILE 0.314 0.0 OUTLIER -81.02 -28.55 35.4 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 118.119 -1.432 . . . . 10.0 114.198 -174.946 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.556 ' N ' HD23 ' A' ' 28' ' ' LEU . . . -68.75 -40.84 85.01 Favored Glycine 0 N--CA 1.468 0.769 0 O-C-N 121.17 -0.956 . . . . 10.0 113.248 -176.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.573 ' HG3' ' HA ' ' A' ' 26' ' ' PRO . 27.5 mt-30 -66.26 -6.8 15.07 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 118.639 -1.225 . . . . 10.0 110.603 175.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.634 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 88.2 m-70 -105.82 16.26 25.48 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 120.496 -0.482 . . . . 10.0 111.49 171.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.726 ' HA3' ' HD2' ' A' ' 64' ' ' LYS . . . 69.65 22.74 76.81 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.763 -0.653 . . . . 10.0 113.862 172.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.593 HG12 ' CD1' ' A' ' 66' ' ' PHE . 73.9 t -75.22 -30.02 22.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -167.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 91.18 79.27 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 122.868 1.318 . . . . 10.0 109.982 -172.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.811 HD11 HG13 ' A' ' 24' ' ' VAL . 1.1 mm -47.36 -49.19 9.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 112.055 -2.339 . . . . 10.0 113.579 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 79.4 mtp -64.33 -46.63 82.68 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.587 -1.642 . . . . 10.0 111.31 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.721 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 21.3 tt0 -62.52 -42.21 99.37 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 117.955 -1.498 . . . . 10.0 110.589 178.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.673 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . 38.6 t80 -56.87 -53.38 58.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.457 0.91 . . . . 10.0 113.457 172.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.658 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -57.48 -47.1 82.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.286 -0.87 . . . . 10.0 111.16 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -65.57 -22.11 66.66 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.138 -1.025 . . . . 10.0 109.357 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.747 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 94.2 mtt180 -76.91 -65.55 0.93 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.444 -0.798 . . . . 10.0 112.3 173.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.536 ' HE1' ' O ' ' A' ' 14' ' ' PRO . 67.4 t80 -57.28 -42.43 81.63 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.108 0.48 . . . . 10.0 110.305 -171.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.576 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.8 OUTLIER -58.87 -52.17 66.9 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.316 -0.856 . . . . 10.0 109.916 179.491 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.87 92.73 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 119.476 -0.89 . . . . 10.0 112.229 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.747 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 27.9 mm-40 -64.21 -47.66 78.87 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 122.034 0.921 . . . . 10.0 110.887 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.768 HG23 HD12 ' A' ' 54' ' ' LEU . 63.1 p -89.13 3.3 52.31 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.104 -1.407 . . . . 10.0 112.026 -169.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.21 -41.12 12.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.139 -0.937 . . . . 10.0 113.043 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.96 -19.86 29.8 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.794 -0.639 . . . . 10.0 111.573 -171.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.755 ' HB3' ' HZ3' ' A' ' 49' ' ' LYS . 6.1 mtpm? -109.18 21.57 16.97 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 123.605 0.762 . . . . 10.0 109.194 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.03 150.91 3.99 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.936 -1.029 . . . . 10.0 113.09 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.6 20.36 32.09 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 110.564 -1.014 . . . . 10.0 110.564 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.618 ' HB2' HD23 ' A' ' 54' ' ' LEU . 66.9 mtt -137.75 124.45 21.05 Favored 'General case' 0 C--O 1.211 -0.924 0 C-N-CA 117.203 -1.799 . . . . 10.0 113.829 -168.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 50.3 mm -65.77 91.7 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.928 -0.767 . . . . 10.0 108.928 171.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.768 HD12 HG23 ' A' ' 46' ' ' THR . 8.9 mt -84.69 126.42 68.66 Favored Pre-proline 0 N--CA 1.448 -0.534 0 N-CA-C 108.79 -0.819 . . . . 10.0 108.79 -178.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.752 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 20.6 Cg_exo -68.52 106.77 1.49 Allowed 'Trans proline' 0 C--N 1.329 -0.458 0 C-N-CA 121.654 1.569 . . . . 10.0 110.619 172.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -96.67 142.98 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 120.254 1.388 . . . . 10.0 110.891 -174.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 58.3 t -116.67 111.23 34.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 120.594 -0.442 . . . . 10.0 110.654 171.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.651 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 28.6 mt -105.11 138.38 30.27 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.829 0 N-CA-C 107.139 -1.43 . . . . 10.0 107.139 -176.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.7 m -122.95 95.08 4.48 Favored 'General case' 0 N--CA 1.408 -2.559 0 CA-C-N 115.009 -0.996 . . . . 10.0 108.849 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.494 HG22 HG22 ' A' ' 33' ' ' VAL . 1.5 p -87.8 135.21 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.819 0 CA-C-N 119.425 1.011 . . . . 10.0 110.804 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -93.47 177.58 5.98 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.576 -0.738 . . . . 10.0 112.689 -173.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.478 ' HG3' ' HB3' ' A' ' 4' ' ' LYS . 5.9 mm-40 -55.63 -24.75 35.29 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 113.896 -1.502 . . . . 10.0 112.652 -178.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.511 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 20.0 t70 -79.37 -15.81 57.28 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.988 -1.005 . . . . 10.0 111.163 -177.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.726 ' HD2' ' HA3' ' A' ' 32' ' ' GLY . 28.6 mtmm 82.3 5.35 1.08 Allowed 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 114.764 -1.107 . . . . 10.0 110.339 -160.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 60' ' ' VAL . 21.5 t -71.26 173.08 8.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.002 -1.851 . . . . 10.0 106.002 175.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.673 ' CZ ' ' HB2' ' A' ' 38' ' ' PHE . 29.9 p90 -169.86 -177.18 2.56 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 121.994 2.179 . . . . 10.0 111.391 177.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.9 p -157.39 175.08 14.46 Favored 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 103.156 -2.905 . . . . 10.0 103.156 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.499 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 21.6 p90 -163.84 159.42 21.13 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.549 -0.908 . . . . 10.0 108.549 177.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.3 161.64 41.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.299 -1.371 . . . . 10.0 107.299 177.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.695 HG22 HD11 ' A' ' 54' ' ' LEU . 4.9 mm -109.52 134.06 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 108.228 -1.027 . . . . 10.0 108.228 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 1.122 ' HZ2' ' HA ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -81.88 91.05 6.48 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.179 0.514 . . . . 10.0 109.964 178.083 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.921 ' HB ' ' HG3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -50.16 104.17 0.41 Allowed Pre-proline 0 C--N 1.312 -1.037 0 CA-C-N 113.846 -1.524 . . . . 10.0 110.144 173.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.519 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 39.1 Cg_endo -66.5 149.35 84.46 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.608 2.206 . . . . 10.0 112.683 -169.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.784 ' HA ' HD12 ' A' ' 116' ' ' LEU . 47.5 Cg_exo -33.45 -61.24 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 124.098 3.199 . . . . 10.0 113.507 -178.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.509 ' HB1' HG23 ' A' ' 131' ' ' THR . . . -174.28 10.8 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 112.853 0.686 . . . . 10.0 112.853 176.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.5 t -60.06 -64.24 1.02 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.068 0.461 . . . . 10.0 111.383 -174.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.456 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 80.7 m-85 -71.66 -28.61 63.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.179 -0.464 . . . . 10.0 111.231 -176.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.658 ' O ' ' HB3' ' A' ' 81' ' ' LYS . 3.0 mm? -84.21 -28.4 27.33 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.094 0.474 . . . . 10.0 111.098 -173.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 75' ' ' ALA . 11.3 mt -72.68 -36.33 67.86 Favored 'General case' 0 C--O 1.211 -0.952 0 C-N-CA 120.048 -0.661 . . . . 10.0 109.685 175.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -65.98 -21.34 66.4 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.02 0.438 . . . . 10.0 110.557 174.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.658 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 1.8 tmtp? -57.6 -50.25 73.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.391 -0.368 . . . . 10.0 110.536 171.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.675 ' HB3' ' HG3' ' A' ' 104' ' ' GLN . . . -79.12 -55.2 5.29 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.288 1.835 . . . . 10.0 113.208 176.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.29 -2.005 0 CA-C-N 111.152 -2.749 . . . . 10.0 107.453 -177.806 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.44 HG11 ' N ' ' A' ' 98' ' ' GLY . 7.2 p . . . . . 0 N--CA 1.447 -0.602 0 N-CA-C 113.001 0.741 . . . . 10.0 113.001 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -169.75 168.34 41.26 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 110.517 -1.033 . . . . 10.0 110.517 177.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.62 ' O ' HG12 ' A' ' 100' ' ' VAL . 0.7 OUTLIER -158.19 173.97 15.89 Favored 'General case' 0 CA--C 1.481 -1.705 0 CA-C-O 121.23 0.538 . . . . 10.0 110.847 -160.737 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.647 HG11 ' CB ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -164.36 -169.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 113.769 -1.559 . . . . 10.0 110.631 -171.513 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.8 p -104.86 141.48 36.45 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 114.252 -1.34 . . . . 10.0 112.3 -169.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.684 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 5.0 ttp180 -46.53 -38.69 9.71 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.717 -0.674 . . . . 10.0 110.207 171.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 20.1 tptm -58.17 -45.42 87.53 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.211 -0.45 . . . . 10.0 111.658 174.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.675 ' HG3' ' HB3' ' A' ' 82' ' ' ALA . 2.2 tm0? -60.13 -56.73 18.02 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.339 -0.615 . . . . 10.0 109.339 175.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.785 HG22 ' HB ' ' A' ' 128' ' ' ILE . 24.3 mm -26.72 -57.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 123.812 0.695 . . . . 10.0 112.317 162.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.738 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 30.1 tt0 -50.35 -58.07 6.5 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.008 0.923 . . . . 10.0 112.904 178.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.972 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 8.5 mt-10 -55.61 -46.43 77.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.488 -0.778 . . . . 10.0 110.767 -178.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.561 HD12 ' HB3' ' A' ' 78' ' ' LEU . 31.4 mm -58.88 -50.38 79.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.455 -0.793 . . . . 10.0 109.407 175.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.448 ' HB1' ' CB ' ' A' ' 124' ' ' ALA . . . -53.81 -40.53 66.44 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.158 -0.928 . . . . 10.0 113.248 176.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.972 ' HD2' ' HA ' ' A' ' 107' ' ' GLU . 36.4 mttm -63.87 -50.04 70.38 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 121.693 0.758 . . . . 10.0 109.125 -177.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 89.4 m -49.12 -59.46 3.63 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 113.786 -1.552 . . . . 10.0 111.926 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.921 ' HG3' ' HB ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -93.51 16.57 13.3 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.691 0.997 . . . . 10.0 113.691 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.617 ' HG3' ' HB1' ' A' ' 118' ' ' ALA . 47.6 ttm -41.94 -50.9 10.37 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 118.593 0.633 . . . . 10.0 111.902 168.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 113' ' ' MET . 42.5 Cg_endo -66.69 -20.9 52.44 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 121.583 1.522 . . . . 10.0 113.321 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.418 ' C ' ' H ' ' A' ' 117' ' ' ASN . 0.7 OUTLIER -91.94 -49.73 6.08 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.647 0.737 . . . . 10.0 111.26 -177.368 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.784 HD12 ' HA ' ' A' ' 74' ' ' PRO . 7.2 mp -62.58 -3.23 1.37 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.235 -1.348 . . . . 10.0 111.494 178.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.418 ' H ' ' C ' ' A' ' 115' ' ' ASP . 58.5 t30 64.03 45.34 4.21 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.108 -1.406 . . . . 10.0 109.268 177.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.617 ' HB1' ' HG3' ' A' ' 113' ' ' MET . . . -85.13 119.76 25.88 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 113.448 -1.705 . . . . 10.0 113.041 -174.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -65.36 -42.92 92.26 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.782 -0.822 . . . . 10.0 108.782 167.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.2 p -143.88 149.26 36.65 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.957 -1.127 . . . . 10.0 107.957 -177.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -50.42 -39.8 48.42 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 114.753 -1.112 . . . . 10.0 112.041 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.547 ' HA ' ' HG3' ' A' ' 125' ' ' MET . 1.8 mp0 -47.88 -42.11 26.01 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.786 0.803 . . . . 10.0 111.135 177.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.89 -48.0 70.07 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 118.428 -1.309 . . . . 10.0 110.831 177.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -55.59 -38.26 69.17 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.007 177.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.679 ' O ' ' HB2' ' A' ' 129' ' ' GLU . 20.6 mtp -55.06 -39.4 69.19 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.59 0.709 . . . . 10.0 110.076 -176.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.69 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 0.3 OUTLIER -65.34 -46.66 79.36 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.153 -1.385 . . . . 10.0 110.441 -178.281 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 124' ' ' ALA . 63.6 mt -52.37 -62.81 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-N 116.165 -0.471 . . . . 10.0 111.112 175.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.785 ' HB ' HG22 ' A' ' 105' ' ' ILE . 11.8 mm -53.67 -54.44 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.121 0 CA-C-N 115.08 -0.964 . . . . 10.0 110.349 -177.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.679 ' HB2' ' O ' ' A' ' 125' ' ' MET . 0.8 OUTLIER -53.24 -41.68 65.68 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.076 -0.965 . . . . 10.0 110.097 178.342 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.547 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -75.21 -44.41 22.9 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.843 -0.694 . . . . 10.0 111.86 -176.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.509 HG23 ' HB1' ' A' ' 75' ' ' ALA . 93.0 m -47.5 -59.8 2.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.099 -1.051 . . . . 10.0 109.28 170.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.486 ' HB3' ' HB ' ' A' ' 137' ' ' ILE . . . -50.51 -51.33 48.51 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.739 -0.664 . . . . 10.0 111.274 174.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 77.3 tttt -44.75 -56.04 4.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.854 -1.066 . . . . 10.0 111.792 175.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.3 t -64.11 -31.22 72.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.108 0.48 . . . . 10.0 111.176 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.471 ' HE1' ' CD1' ' A' ' 137' ' ' ILE . 50.3 mtm -83.12 4.52 26.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.837 1.051 . . . . 10.0 113.837 -176.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.75 12.68 77.04 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 120.161 1.346 . . . . 10.0 111.929 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 25.6 mt -101.79 124.14 55.41 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 CA-C-O 121.579 0.705 . . . . 10.0 111.29 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.413 ' HG3' ' N ' ' A' ' 139' ' ' VAL . 0.0 OUTLIER -88.58 158.44 18.27 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 114.549 -1.205 . . . . 10.0 109.317 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.413 ' N ' ' HG3' ' A' ' 138' ' ' GLU . 17.6 m -115.08 135.16 55.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 108.093 -1.077 . . . . 10.0 108.093 169.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.4 m -133.17 69.43 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 114.869 1.433 . . . . 10.0 114.869 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.5 t70 . . . . . 0 C--N 1.31 -1.117 0 CA-C-O 118.666 -0.683 . . . . 10.0 110.657 140.788 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.402 ' HB2' ' OE2' ' A' ' 62' ' ' GLU . 60.2 mttm . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 121.002 0.43 . . . . 10.0 111.136 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.8 132.75 28.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.297 -0.865 . . . . 10.0 111.552 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' A' ' 62' ' ' GLU . . . -102.98 -37.2 7.9 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.089 -0.708 . . . . 10.0 109.089 173.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.444 ' HB1' ' CG1' ' A' ' 60' ' ' VAL . . . -154.89 -175.2 5.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.899 0.857 . . . . 10.0 112.66 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 4.1 pt20 -142.0 130.48 22.51 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.087 -1.415 . . . . 10.0 108.241 178.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.568 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -119.77 84.13 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 109.406 -0.591 . . . . 10.0 109.406 -176.579 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.761 ' HB2' ' HZ2' ' A' ' 10' ' ' LYS . 8.0 mtmp? -77.56 130.27 36.71 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 120.664 1.574 . . . . 10.0 107.72 176.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.768 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.87 124.84 4.99 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 122.379 1.085 . . . . 10.0 111.594 -176.607 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -82.85 120.18 25.33 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.878 -1.51 . . . . 10.0 109.716 -172.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.768 HD21 HD11 ' A' ' 11' ' ' LEU . 92.1 mt -137.34 138.73 25.76 Favored Pre-proline 0 CA--C 1.5 -0.953 0 CA-C-O 121.512 0.672 . . . . 10.0 112.036 -172.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.802 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 40.1 Cg_exo -55.71 124.88 17.37 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 123.204 2.603 . . . . 10.0 111.646 171.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.683 ' HB1' HD11 ' A' ' 54' ' ' LEU . . . -62.02 126.39 27.17 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 106.996 -1.483 . . . . 10.0 106.996 168.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.29 -5.04 79.08 Favored Glycine 0 CA--C 1.529 0.909 0 O-C-N 125.515 1.759 . . . . 10.0 113.599 -175.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.802 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 31.9 mmtp -139.89 102.59 4.45 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.519 1.159 . . . . 10.0 111.674 178.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 39' ' ' CYS . . . -170.17 130.7 0.96 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.17 -1.377 . . . . 10.0 111.927 175.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 65.0 m -166.7 -59.38 0.01 OUTLIER Pre-proline 0 N--CA 1.437 -1.122 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.907 -177.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.798 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 84.1 Cg_endo -108.05 136.22 0.05 OUTLIER 'Trans proline' 0 N--CA 1.421 -2.778 0 N-CA-C 117.05 1.904 . . . . 10.0 117.05 -157.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 1.045 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 11.69 -85.63 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.585 1 CA-C-N 108.393 -4.003 . . . . 10.0 115.335 167.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.862 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 56.9 Cg_exo -32.08 -54.43 0.32 Allowed 'Trans proline' 0 CA--C 1.558 1.711 0 C-N-CA 122.662 2.242 . . . . 10.0 115.579 -163.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.862 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 32.0 Cg_endo -84.54 -53.63 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 122.516 2.144 . . . . 10.0 112.651 168.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.783 HG11 ' CD1' ' A' ' 35' ' ' ILE . 75.9 t -81.53 -55.98 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 113.331 -1.759 . . . . 10.0 113.991 -167.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 1.045 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -43.1 -77.46 0.09 OUTLIER Glycine 0 CA--C 1.519 0.335 0 CA-C-N 114.736 -1.12 . . . . 10.0 114.1 -177.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.779 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 22.8 Cg_exo -45.09 -41.82 16.18 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.817 3.011 . . . . 10.0 112.681 173.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.565 ' HB1' ' O ' ' A' ' 24' ' ' VAL . . . -51.08 -101.52 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 123.475 0.484 . . . . 10.0 111.858 176.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.674 HD22 ' C ' ' A' ' 28' ' ' LEU 0.308 0.0 OUTLIER -73.33 -25.8 60.77 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 117.511 -1.676 . . . . 10.0 112.951 -172.422 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.594 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -71.83 -40.78 57.34 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.098 -0.572 . . . . 10.0 113.024 -176.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -63.09 -16.71 60.86 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 119.178 -1.009 . . . . 10.0 109.712 175.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.529 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 95.7 m-70 -98.88 20.1 13.78 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 120.12 -0.632 . . . . 10.0 110.102 176.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.47 -1.64 76.39 Favored Glycine 0 CA--C 1.5 -0.872 0 CA-C-N 115.201 -0.909 . . . . 10.0 113.126 167.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.732 HG12 ' CD2' ' A' ' 66' ' ' PHE . 11.3 t -82.48 147.1 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 113.305 0.854 . . . . 10.0 113.305 -172.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.408 ' N ' HG11 ' A' ' 33' ' ' VAL . 95.7 m-20 -69.69 98.91 1.25 Allowed 'General case' 0 C--N 1.341 0.219 0 CA-C-O 121.291 0.567 . . . . 10.0 110.868 172.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.783 ' CD1' HG11 ' A' ' 24' ' ' VAL . 2.5 mm -52.31 -39.25 27.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.867 -1.061 . . . . 10.0 111.464 174.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.741 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 85.3 mtp -64.61 -52.1 59.24 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 113.244 -1.798 . . . . 10.0 111.618 176.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.636 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 31.1 mt-10 -58.49 -40.12 81.92 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.11 -1.036 . . . . 10.0 111.024 176.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.552 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 90.3 t80 -58.33 -59.74 4.87 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.929 1.085 . . . . 10.0 113.929 172.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.741 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 18.3 p -58.82 -48.05 82.64 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 114.832 -1.077 . . . . 10.0 111.761 -177.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -65.22 -22.74 66.92 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.824 -0.806 . . . . 10.0 108.824 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.737 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 10.7 mtm180 -78.45 -63.26 1.44 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 119.321 -0.952 . . . . 10.0 112.899 170.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.511 ' CZ ' HG21 ' A' ' 46' ' ' THR . 67.4 t80 -55.2 -43.61 74.59 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 118.717 0.689 . . . . 10.0 110.403 -172.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.621 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.8 OUTLIER -59.8 -51.38 69.97 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.311 -0.858 . . . . 10.0 109.851 -179.625 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.98 -40.25 97.18 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 119.239 -0.985 . . . . 10.0 112.182 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.737 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 23.5 mt-10 -67.92 -45.24 74.93 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.578 0.704 . . . . 10.0 111.079 -178.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.694 HG21 HD13 ' A' ' 54' ' ' LEU . 72.3 p -86.93 6.2 33.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.998 -1.001 . . . . 10.0 112.209 -172.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.7 -34.61 5.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.632 -1.167 . . . . 10.0 112.561 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -79.63 -38.54 33.6 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.585 -0.734 . . . . 10.0 112.053 -176.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -94.14 18.66 10.42 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 109.127 -0.694 . . . . 10.0 109.127 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -50.46 133.88 24.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.08 -0.963 . . . . 10.0 112.661 -178.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.05 19.48 10.1 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 114.786 -1.097 . . . . 10.0 110.799 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.608 ' HB2' HD23 ' A' ' 54' ' ' LEU . 67.3 mtt -137.5 127.48 25.81 Favored 'General case' 0 C--O 1.208 -1.108 0 C-N-CA 117.457 -1.697 . . . . 10.0 114.295 -169.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.2 mm -65.94 91.74 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 118.688 0.676 . . . . 10.0 109.372 169.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.694 HD13 HG21 ' A' ' 46' ' ' THR . 6.9 mt -81.08 138.06 49.41 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 -177.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 54' ' ' LEU . 3.7 Cg_exo -78.67 104.84 1.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.95 1.766 . . . . 10.0 110.472 172.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -101.01 144.14 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 119.716 1.144 . . . . 10.0 110.995 -175.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 85.0 t -119.4 118.51 57.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 116.224 -0.444 . . . . 10.0 110.475 171.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.568 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 16.4 mt -104.94 141.29 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.722 0 N-CA-C 108.515 -0.921 . . . . 10.0 108.515 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.8 m -127.68 97.89 5.0 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 114.714 -1.13 . . . . 10.0 109.134 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 65' ' ' SER . 2.1 p -91.3 136.03 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 O-C-N 121.276 -0.89 . . . . 10.0 110.618 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -92.48 171.14 9.23 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.586 -0.734 . . . . 10.0 112.292 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.408 ' HA ' ' HB3' ' A' ' 6' ' ' ALA . 39.7 mt-10 -58.38 -23.51 57.22 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.594 -1.184 . . . . 10.0 112.77 -177.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.53 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 2.8 m-20 -81.27 -6.41 58.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.872 -0.604 . . . . 10.0 112.568 -176.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 53.5 mtpt 83.97 1.31 0.95 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.967 0.889 . . . . 10.0 110.011 -167.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.453 ' O ' HG22 ' A' ' 60' ' ' VAL . 8.5 t -72.01 172.23 10.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.313 -1.312 . . . . 10.0 108.016 172.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.732 ' CD2' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -167.6 -177.48 3.55 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 120.241 1.382 . . . . 10.0 109.501 176.207 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.482 ' HA ' HH22 ' A' ' 41' ' ' ARG . 22.2 p -157.82 169.95 23.46 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 103.217 -2.883 . . . . 10.0 103.217 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.426 ' HB3' HG12 ' A' ' 58' ' ' ILE . 56.2 p90 -164.18 153.86 14.24 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.622 -0.881 . . . . 10.0 108.622 176.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.5 pt -131.89 153.24 38.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 108.178 -1.045 . . . . 10.0 108.178 -176.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.537 HG23 HD12 ' A' ' 54' ' ' LEU . 1.6 mm -107.39 131.76 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.389 -1.338 . . . . 10.0 107.389 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.655 ' C ' ' HD2' ' A' ' 73' ' ' PRO . 13.9 mmmm -77.71 90.2 4.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.033 0.92 . . . . 10.0 110.999 -177.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.586 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -60.63 -32.93 12.52 Favored Pre-proline 0 CA--C 1.562 1.434 0 CA-C-N 113.758 -1.564 . . . . 10.0 115.134 172.49 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.661 ' HG2' ' HD3' ' A' ' 74' ' ' PRO . 14.0 Cg_endo -54.8 -36.69 91.61 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.377 2.718 . . . . 10.0 117.281 -170.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.661 ' HD3' ' HG2' ' A' ' 73' ' ' PRO . 79.8 Cg_exo -47.14 -29.25 8.72 Favored 'Trans proline' 0 C--N 1.366 1.481 0 C-N-CA 121.963 1.776 . . . . 10.0 112.504 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.46 ' HB2' HG21 ' A' ' 131' ' ' THR . . . 73.04 -42.33 0.53 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.474 0.916 . . . . 10.0 113.474 169.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.2 p -45.43 -35.65 3.84 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.575 0.75 . . . . 10.0 112.69 -175.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.553 ' HB3' ' SD ' ' A' ' 52' ' ' MET . 75.3 m-85 -55.14 -50.31 69.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.545 0.688 . . . . 10.0 111.34 178.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.75 ' HB3' HD12 ' A' ' 108' ' ' ILE . 4.8 mp -93.25 -12.58 29.83 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.081 -0.648 . . . . 10.0 111.591 -174.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.43 ' HA ' HD13 ' A' ' 79' ' ' LEU . 3.3 mm? -62.12 -37.28 84.52 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.17 -1.048 . . . . 10.0 108.17 166.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -56.74 -43.17 80.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.104 -0.953 . . . . 10.0 110.185 172.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? -54.94 -46.71 75.0 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.517 -0.765 . . . . 10.0 112.33 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.505 ' CB ' HG13 ' A' ' 100' ' ' VAL . . . -70.44 -49.17 51.48 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.087 1.355 . . . . 10.0 111.678 174.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.288 -2.08 0 CA-C-N 111.413 -2.63 . . . . 10.0 111.298 -167.82 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.5 p . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 116.118 1.895 . . . . 10.0 116.118 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -152.39 162.04 29.7 Favored Glycine 0 N--CA 1.431 -1.661 0 N-CA-C 109.793 -1.323 . . . . 10.0 109.793 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.762 ' CB ' ' HG2' ' A' ' 138' ' ' GLU . 0.1 OUTLIER -139.93 168.53 19.6 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 122.851 1.31 . . . . 10.0 111.187 -170.478 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.628 ' O ' HG21 ' A' ' 140' ' ' VAL . 2.6 m -156.37 -146.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 CA-C-N 111.516 -2.583 . . . . 10.0 104.732 -171.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.417 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 6.6 t -164.5 156.84 16.55 Favored 'General case' 0 C--N 1.282 -2.344 0 C-N-CA 117.693 -1.603 . . . . 10.0 110.71 -163.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.601 ' NH1' ' HE3' ' A' ' 125' ' ' MET . 1.3 tmt_? -41.79 -42.94 2.79 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 112.718 -2.037 . . . . 10.0 110.628 -175.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -59.27 -44.22 92.46 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.032 0.753 . . . . 10.0 113.032 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.653 ' O ' HG12 ' A' ' 108' ' ' ILE . 3.1 mp0 -60.7 -51.76 67.99 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.392 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.684 HG22 ' HB ' ' A' ' 128' ' ' ILE . 39.3 mm -36.95 -53.32 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 CA-C-N 114.806 -1.088 . . . . 10.0 111.309 167.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.796 ' HA ' ' SD ' ' A' ' 125' ' ' MET . 4.9 tt0 -50.81 -60.25 3.25 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.833 -1.076 . . . . 10.0 113.168 -177.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -55.97 -48.97 74.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.157 -0.928 . . . . 10.0 110.502 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.75 HD12 ' HB3' ' A' ' 78' ' ' LEU . 18.4 mm -51.77 -56.58 5.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.593 171.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.507 ' HB3' HG13 ' A' ' 128' ' ' ILE . . . -50.83 -35.19 31.13 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.371 0.508 . . . . 10.0 112.371 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.768 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 92.7 mttt -76.91 -51.59 10.94 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 116.004 -0.544 . . . . 10.0 111.113 -178.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.632 HG21 ' O ' ' A' ' 108' ' ' ILE . 10.3 t -57.26 -17.73 13.13 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.145 0.794 . . . . 10.0 113.145 -176.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.748 ' HZ2' ' HB3' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -132.21 18.84 4.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.374 0.607 . . . . 10.0 110.011 -179.248 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.632 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 46.5 ttm -48.52 -45.63 69.14 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 114.798 -1.092 . . . . 10.0 112.307 175.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 113' ' ' MET . 19.0 Cg_endo -55.8 -23.62 42.7 Favored 'Trans proline' 0 C--N 1.363 1.291 0 C-N-CA 122.364 2.043 . . . . 10.0 112.338 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.608 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 5.0 m-20 -96.8 -46.44 6.26 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.883 -1.053 . . . . 10.0 112.85 -173.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.589 ' CD2' HD13 ' A' ' 127' ' ' ILE . 6.6 mp -63.92 36.92 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 114.525 -1.216 . . . . 10.0 112.986 -176.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.465 ' H ' ' C ' ' A' ' 115' ' ' ASP . 0.2 OUTLIER 17.96 54.34 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.181 1.392 . . . . 10.0 112.279 -172.099 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -103.23 123.27 46.43 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.464 0.913 . . . . 10.0 113.464 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -67.64 -33.55 75.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.34 0.59 . . . . 10.0 109.854 169.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.1 p -148.43 145.41 27.99 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.569 -0.9 . . . . 10.0 108.569 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.666 ' O ' ' HG2' ' A' ' 125' ' ' MET . 56.7 tp -51.85 -38.44 55.97 Favored 'General case' 0 C--O 1.219 -0.542 0 N-CA-C 114.52 1.304 . . . . 10.0 114.52 -176.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.535 ' O ' ' HD3' ' A' ' 126' ' ' LYS . 19.8 mm-40 -49.66 -37.14 27.31 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.24 0.543 . . . . 10.0 110.931 176.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.04 -47.8 70.28 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 118.651 -1.22 . . . . 10.0 110.574 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.544 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -59.06 -30.98 68.45 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.212 0.53 . . . . 10.0 110.658 177.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.796 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 86.8 mmm -58.21 -38.71 77.31 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.495 0.664 . . . . 10.0 110.771 178.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.535 ' HD3' ' O ' ' A' ' 122' ' ' GLU . 4.0 mptp? -65.14 -52.04 57.59 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.954 -1.021 . . . . 10.0 111.846 177.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.589 HD13 ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -52.36 -58.83 2.0 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.688 0 C-N-CA 119.803 -0.759 . . . . 10.0 110.806 178.504 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.684 ' HB ' HG22 ' A' ' 105' ' ' ILE . 27.4 mm -50.75 -58.96 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.88 0 C-N-CA 123.801 0.84 . . . . 10.0 111.746 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.601 ' HG3' HG21 ' A' ' 105' ' ' ILE . 4.3 mt-10 -52.76 -43.68 65.97 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.548 -0.751 . . . . 10.0 109.453 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.489 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -71.5 -46.66 39.08 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.461 -0.876 . . . . 10.0 111.481 -176.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.46 HG21 ' HB2' ' A' ' 75' ' ' ALA . 51.7 m -46.63 -62.41 1.39 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.972 -1.114 . . . . 10.0 110.047 173.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.587 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . . . -50.91 -48.64 60.55 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.845 -0.616 . . . . 10.0 111.699 174.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 58.7 tttm -47.31 -54.99 9.62 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.366 -0.834 . . . . 10.0 111.037 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.7 m -65.91 -28.56 69.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.061 0.457 . . . . 10.0 110.637 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 43.6 mtm -81.29 -2.26 48.33 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.507 0.928 . . . . 10.0 113.507 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 80.88 44.58 8.2 Favored Glycine 0 C--O 1.216 -1.01 0 CA-C-N 119.696 1.135 . . . . 10.0 112.219 -177.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.587 ' HB ' ' HB2' ' A' ' 132' ' ' ALA . 1.9 mm -119.86 127.12 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.67 0 CA-C-O 121.389 0.614 . . . . 10.0 110.475 175.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.762 ' HG2' ' CB ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -87.49 145.76 26.11 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 114.948 -1.024 . . . . 10.0 109.326 176.104 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 18.9 m -113.46 134.62 55.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 107.634 -1.247 . . . . 10.0 107.634 171.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.628 HG21 ' O ' ' A' ' 100' ' ' VAL . 12.9 m -129.65 72.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 114.674 1.361 . . . . 10.0 114.674 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.024 0 N-CA-C 114.216 1.191 . . . . 10.0 114.216 140.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.514 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 27.4 mtpp . . . . . 0 C--O 1.221 -0.447 0 N-CA-C 109.051 -0.722 . . . . 10.0 109.051 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.4 t -62.97 133.97 28.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 122.392 0.277 . . . . 10.0 110.679 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.53 -38.61 6.39 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.394 -0.595 . . . . 10.0 109.394 174.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.516 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -157.44 159.02 36.9 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 113.58 0.955 . . . . 10.0 113.58 -175.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.749 HE21 ' HA ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -100.88 135.45 42.3 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.53 -1.214 . . . . 10.0 108.416 170.208 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.579 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -120.16 80.15 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 108.317 -0.994 . . . . 10.0 108.317 167.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.439 ' HG2' HG12 ' A' ' 57' ' ' VAL . 36.2 mttm -80.79 129.69 34.66 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 121.08 1.764 . . . . 10.0 107.484 176.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.51 HD22 HD12 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -158.09 130.28 7.01 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 122.209 1.004 . . . . 10.0 111.601 -176.603 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -81.75 119.13 23.47 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.026 -1.443 . . . . 10.0 109.664 -172.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.51 HD12 HD22 ' A' ' 11' ' ' LEU . 33.2 mt -136.06 133.97 20.02 Favored Pre-proline 0 CA--C 1.504 -0.822 0 CA-C-O 121.495 0.664 . . . . 10.0 112.578 -169.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.573 ' HB2' ' CB ' ' A' ' 17' ' ' LYS . 39.8 Cg_exo -56.05 122.97 12.71 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 123.534 2.823 . . . . 10.0 111.866 172.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.607 ' CB ' ' HB ' ' A' ' 46' ' ' THR . . . -60.38 128.53 37.17 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 107.814 -1.18 . . . . 10.0 107.814 170.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.6 1.29 82.53 Favored Glycine 0 CA--C 1.527 0.832 0 O-C-N 125.808 1.942 . . . . 10.0 112.972 -175.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.573 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . 0.7 OUTLIER -142.01 88.66 2.12 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.022 0.911 . . . . 10.0 112.089 -177.773 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.75 133.02 3.95 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.898 -1.046 . . . . 10.0 112.514 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.556 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 4.5 t 175.07 -42.86 0.0 OUTLIER Pre-proline 0 C--O 1.22 -0.487 0 O-C-N 124.349 1.031 . . . . 10.0 112.615 177.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.676 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 56.5 Cg_endo -99.07 121.45 0.12 Allowed 'Trans proline' 0 N--CA 1.42 -2.845 0 CA-C-N 120.612 1.254 . . . . 10.0 115.24 -159.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 1.086 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 10.65 -85.19 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 109.907 -3.315 . . . . 10.0 115.26 167.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.84 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 26.2 Cg_exo -25.11 -57.52 0.07 OUTLIER 'Trans proline' 0 CA--C 1.561 1.83 0 C-N-CA 123.543 2.829 . . . . 10.0 115.913 -165.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.84 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 1.0 OUTLIER -86.16 -59.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.363 1.309 0 C-N-CA 123.365 2.71 . . . . 10.0 112.474 171.401 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.417 HG12 HG23 ' A' ' 35' ' ' ILE . 36.7 t -73.95 -43.07 52.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 112.159 -2.292 . . . . 10.0 113.759 -168.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 1.086 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -54.74 -71.8 0.66 Allowed Glycine 0 C--O 1.218 -0.857 0 CA-C-N 114.588 -1.187 . . . . 10.0 113.221 -177.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.583 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 17.1 Cg_exo -46.15 -46.27 16.7 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.52 2.813 . . . . 10.0 112.653 173.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.7 -75.25 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.437 0.637 . . . . 10.0 111.375 177.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.699 HD22 ' CD1' ' A' ' 58' ' ' ILE . 5.0 mt -69.65 -46.96 64.94 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.512 0.93 . . . . 10.0 113.512 -177.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.43 -40.33 97.49 Favored Glycine 0 C--N 1.32 -0.35 0 CA-C-N 115.462 -0.79 . . . . 10.0 113.481 -172.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -63.44 -27.14 69.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.057 0.456 . . . . 10.0 110.327 178.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -99.11 13.18 33.79 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.379 0.609 . . . . 10.0 110.353 177.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.492 ' O ' ' HE3' ' A' ' 64' ' ' LYS . . . 76.45 11.41 85.15 Favored Glycine 0 CA--C 1.501 -0.799 0 CA-C-N 114.883 -1.053 . . . . 10.0 113.319 171.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.781 HG12 ' CD1' ' A' ' 66' ' ' PHE . 59.6 t -80.92 139.58 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 112.117 0.414 . . . . 10.0 112.117 -172.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.5 100.52 1.81 Allowed 'General case' 0 C--N 1.343 0.284 0 CA-C-O 121.586 0.708 . . . . 10.0 110.875 178.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.484 ' CD1' ' HA2' ' A' ' 25' ' ' GLY . 92.9 mt -51.0 -45.9 29.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 114.604 -1.18 . . . . 10.0 111.931 175.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.8 mtm -64.73 -54.68 27.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 112.997 -1.91 . . . . 10.0 111.246 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -53.37 -44.02 68.25 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 121.172 -0.211 . . . . 10.0 110.432 177.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.592 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 56.7 t80 -59.79 -56.24 24.26 Favored 'General case' 0 C--O 1.213 -0.834 0 N-CA-C 114.052 1.131 . . . . 10.0 114.052 171.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.455 ' SG ' ' HB ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -57.59 -49.79 75.24 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.968 0.907 . . . . 10.0 111.968 -177.739 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -65.46 -21.18 66.61 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 119.471 -0.892 . . . . 10.0 108.853 -176.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.652 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 46.9 mtt180 -78.9 -62.04 1.82 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.221 -0.9 . . . . 10.0 112.652 168.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.561 ' CZ ' HG21 ' A' ' 46' ' ' THR . 79.4 t80 -53.27 -48.4 68.34 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.535 0.683 . . . . 10.0 110.065 -173.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.632 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.8 OUTLIER -61.16 -47.78 84.61 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.674 -1.148 . . . . 10.0 110.27 -176.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.79 -38.91 92.51 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 119.163 -1.015 . . . . 10.0 112.077 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.652 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 37.1 mm-40 -63.24 -45.84 89.71 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.147 0.975 . . . . 10.0 110.303 178.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.607 ' HB ' ' CB ' ' A' ' 15' ' ' ALA . 70.0 p -90.87 -0.48 57.74 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.15 -1.386 . . . . 10.0 112.477 -167.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.35 -37.09 7.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.15 -0.932 . . . . 10.0 112.577 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -83.64 -24.76 31.26 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.337 -0.847 . . . . 10.0 111.429 -172.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.7 mtmm -113.23 25.84 10.99 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.54 0.686 . . . . 10.0 109.959 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.414 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -54.13 154.92 3.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.39 -1.277 . . . . 10.0 113.257 177.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.95 21.06 40.57 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.574 -1.01 . . . . 10.0 110.574 -177.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.535 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 67.3 mtt -139.47 125.23 19.52 Favored 'General case' 0 C--O 1.209 -1.065 0 C-N-CA 116.866 -1.934 . . . . 10.0 114.653 -166.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.6 mm -66.88 91.39 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 109.409 -0.589 . . . . 10.0 109.409 172.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.59 HD12 ' HB3' ' A' ' 15' ' ' ALA . 7.2 mt -82.2 131.49 56.07 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.62 -0.511 . . . . 10.0 109.62 -177.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.508 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 13.5 Cg_exo -72.06 96.04 0.77 Allowed 'Trans proline' 0 C--N 1.331 -0.377 0 C-N-CA 122.5 2.133 . . . . 10.0 111.265 173.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.45 HG22 HG12 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -92.96 157.65 2.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 119.586 1.084 . . . . 10.0 111.579 -174.668 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.487 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 95.2 t -135.39 115.94 18.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.4 173.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.699 ' CD1' HD22 ' A' ' 28' ' ' LEU . 25.5 mt -108.81 138.0 37.98 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.742 0 N-CA-C 107.953 -1.129 . . . . 10.0 107.953 -174.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.3 m -123.13 92.83 3.78 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 114.845 -1.07 . . . . 10.0 109.102 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.516 ' CG1' ' HB3' ' A' ' 7' ' ' ALA . 2.6 p -86.0 134.8 26.43 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 O-C-N 121.258 -0.901 . . . . 10.0 110.817 -177.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -91.98 173.58 7.77 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.748 0.785 . . . . 10.0 112.939 -176.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.514 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 59.7 mt-10 -61.71 -15.98 45.19 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.122 -1.399 . . . . 10.0 112.506 -178.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.611 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 7.1 m-20 -75.52 -17.41 60.1 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.51 -0.476 . . . . 10.0 110.692 177.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.611 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 42.1 mtpt 82.41 1.62 1.28 Allowed 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 124.492 1.12 . . . . 10.0 109.993 -160.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.7 t -73.43 174.32 8.34 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 113.313 -1.767 . . . . 10.0 106.846 173.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.781 ' CD1' HG12 ' A' ' 33' ' ' VAL . 55.7 p90 -169.35 -176.1 2.42 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 122.077 2.217 . . . . 10.0 110.764 177.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 58' ' ' ILE . 25.4 p -157.32 174.91 14.71 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 103.022 -2.955 . . . . 10.0 103.022 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.43 ' CB ' HG12 ' A' ' 58' ' ' ILE . 35.8 p90 -163.72 157.92 19.69 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.472 -0.936 . . . . 10.0 108.472 177.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.487 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 38.8 pt -127.74 166.99 23.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 106.702 -1.592 . . . . 10.0 106.702 177.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.454 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 8.9 mt -134.17 124.8 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 107.514 -1.291 . . . . 10.0 107.514 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 30.4 mmmt -76.93 81.78 3.48 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.721 -0.844 . . . . 10.0 108.721 -176.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.723 HG22 ' HA ' ' A' ' 112' ' ' LYS . 1.7 t -50.66 116.5 7.03 Favored Pre-proline 0 C--N 1.312 -1.035 0 N-CA-C 107.057 -1.46 . . . . 10.0 107.057 174.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.706 ' HG3' ' CE1' ' A' ' 77' ' ' PHE . 61.3 Cg_endo -65.87 166.46 20.39 Favored 'Trans proline' 0 CA--C 1.517 -0.331 0 C-N-CA 123.451 2.767 . . . . 10.0 114.939 -153.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.794 ' HA ' HD23 ' A' ' 116' ' ' LEU . 19.7 Cg_exo -67.63 55.67 0.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.141 2.56 . . . . 10.0 111.14 170.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.447 ' HB3' HD12 ' A' ' 128' ' ' ILE . . . 75.46 -22.33 0.27 Allowed 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 113.572 0.952 . . . . 10.0 113.572 173.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.2 p -38.06 -78.89 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.571 1.322 . . . . 10.0 114.571 -167.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.706 ' CE1' ' HG3' ' A' ' 73' ' ' PRO . 3.2 p90 -82.51 -18.84 40.13 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.009 0.744 . . . . 10.0 113.009 -173.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.613 ' HB3' HD12 ' A' ' 108' ' ' ILE . 2.7 mm? -67.99 -36.19 79.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.399 0.618 . . . . 10.0 109.765 172.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.448 HD23 HG22 ' A' ' 128' ' ' ILE . 27.0 mt -62.56 -39.48 93.78 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.683 -0.69 . . . . 10.0 110.837 176.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.434 ' HA ' ' HB2' ' A' ' 83' ' ' ALA . 37.0 ttpt -66.04 -17.4 64.66 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.37 -0.532 . . . . 10.0 111.01 176.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.541 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 11.3 mmmm -64.56 -39.47 93.81 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 121.572 -0.705 . . . . 10.0 111.117 169.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.697 ' HB3' ' HG3' ' A' ' 104' ' ' GLN . . . -78.5 -56.33 4.52 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.492 1.917 . . . . 10.0 112.277 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.434 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . . . . . . . . 0 C--N 1.294 -1.808 0 CA-C-N 110.825 -2.898 . . . . 10.0 105.844 177.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.616 HG13 ' N ' ' A' ' 98' ' ' GLY . 3.9 p . . . . . 0 CA--C 1.544 0.733 0 N-CA-C 117.027 2.232 . . . . 10.0 117.027 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.616 ' N ' HG13 ' A' ' 97' ' ' VAL . . . -58.32 160.13 13.89 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 114.593 0.597 . . . . 10.0 114.593 -158.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.829 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -154.79 172.34 18.13 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 115.593 -0.303 . . . . 10.0 111.201 -157.901 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.682 HG11 ' O ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -168.29 114.16 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-O 122.887 1.327 . . . . 10.0 111.869 179.511 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 1.2 t -39.78 143.62 0.23 Allowed 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 111.458 -2.61 . . . . 10.0 114.149 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.753 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 26.6 mtt180 -46.34 -32.63 3.28 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 112.243 -2.253 . . . . 10.0 113.732 -170.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.5 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 17.5 tppt? -57.67 -44.22 85.58 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.859 -0.526 . . . . 10.0 111.742 178.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.697 ' HG3' ' HB3' ' A' ' 82' ' ' ALA . 0.6 OUTLIER -56.95 -47.99 79.38 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.603 -0.888 . . . . 10.0 108.603 176.21 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.982 HG21 ' HB ' ' A' ' 128' ' ' ILE . 32.7 mm -43.09 -49.41 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.141 -1.391 . . . . 10.0 111.852 173.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.808 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 28.8 tt0 -46.86 -62.17 1.52 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.093 0.957 . . . . 10.0 113.262 175.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.618 ' HA ' ' HD3' ' A' ' 110' ' ' LYS . 47.7 mt-10 -52.73 -54.8 28.69 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.232 -0.895 . . . . 10.0 110.803 -176.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.627 ' O ' HG21 ' A' ' 111' ' ' THR . 24.5 mm -47.42 -55.43 2.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.124 -0.944 . . . . 10.0 110.126 170.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.616 ' O ' ' HE2' ' A' ' 112' ' ' LYS . . . -49.19 -36.95 21.1 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.888 0.699 . . . . 10.0 112.888 176.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.808 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 51.4 mtpt -72.58 -49.24 33.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.832 -0.622 . . . . 10.0 111.299 -174.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.627 HG21 ' O ' ' A' ' 108' ' ' ILE . 6.1 t -53.67 -36.57 62.28 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.091 0.404 . . . . 10.0 112.091 -177.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.86 ' HD2' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -106.71 13.5 27.97 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 113.336 0.865 . . . . 10.0 113.336 -174.792 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.698 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 14.6 ptp -55.2 -39.37 76.69 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 113.056 0.762 . . . . 10.0 113.056 176.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.596 ' HD3' ' HG3' ' A' ' 113' ' ' MET . 73.2 Cg_endo -71.13 -28.94 18.25 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 121.326 1.35 . . . . 10.0 112.112 -179.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -95.88 -42.48 8.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.825 -1.079 . . . . 10.0 113.673 -170.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.86 HD22 ' HD2' ' A' ' 112' ' ' LYS . 1.1 mp -71.16 9.64 0.71 Allowed 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.118 -0.946 . . . . 10.0 113.272 -177.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 63.77 36.44 10.54 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 122.21 1.005 . . . . 10.0 108.529 174.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 119' ' ' ASN . . . -69.56 -69.85 0.32 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 113.9 -1.5 . . . . 10.0 113.076 -167.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' A' ' 118' ' ' ALA . 27.3 t-20 100.87 -38.88 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.659 1.224 . . . . 10.0 110.412 -178.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 89.2 p -145.92 144.76 30.37 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.023 -1.473 . . . . 10.0 107.023 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.567 ' O ' ' HG3' ' A' ' 125' ' ' MET . 50.8 tp -58.59 -41.98 87.02 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.915 0.709 . . . . 10.0 112.915 178.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -48.23 -43.64 32.45 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.394 0.616 . . . . 10.0 109.687 174.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.592 ' O ' ' HG3' ' A' ' 126' ' ' LYS . . . -62.88 -51.93 65.09 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.624 -1.171 . . . . 10.0 111.292 173.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.706 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -55.34 -30.49 60.38 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.252 -0.905 . . . . 10.0 111.652 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.567 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 83.4 mtp -61.55 -46.33 90.35 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.791 1.034 . . . . 10.0 113.791 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.739 ' HD3' ' N ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -62.83 -40.02 96.12 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.094 0.405 . . . . 10.0 112.094 -178.04 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.739 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -55.11 -59.33 2.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 C-N-CA 118.785 -1.166 . . . . 10.0 109.779 174.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.982 ' HB ' HG21 ' A' ' 105' ' ' ILE . 12.9 mm -49.47 -57.85 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 CA-C-N 114.82 -1.082 . . . . 10.0 111.856 -175.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' A' ' 125' ' ' MET . 6.8 pt-20 -55.77 -44.71 77.97 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.118 -0.633 . . . . 10.0 109.948 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -69.15 -49.2 41.81 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.601 -0.727 . . . . 10.0 112.396 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 74' ' ' PRO . 44.9 m -45.72 -62.04 1.46 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.853 -0.673 . . . . 10.0 109.904 171.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.592 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . . . -49.37 -51.09 36.99 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.222 -0.444 . . . . 10.0 111.235 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -48.29 -48.61 35.74 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 123.911 0.757 . . . . 10.0 111.759 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.1 m -62.53 -39.69 94.38 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.636 0.255 . . . . 10.0 111.254 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.729 ' HG3' HD12 ' A' ' 137' ' ' ILE . 23.6 ptt? -90.63 15.69 10.5 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.477 0.917 . . . . 10.0 113.477 -173.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 103.5 -21.78 38.01 Favored Glycine 0 C--N 1.331 0.273 0 CA-C-N 119.627 1.103 . . . . 10.0 112.759 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.729 HD12 ' HG3' ' A' ' 135' ' ' MET . 2.0 mp -83.15 128.33 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 CA-C-O 122.94 1.353 . . . . 10.0 111.33 -169.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.829 ' HB3' ' HB3' ' A' ' 99' ' ' LYS . 3.3 tp10 -85.64 157.93 20.22 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 112.288 -2.233 . . . . 10.0 109.196 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.462 ' N ' ' HG3' ' A' ' 138' ' ' GLU . 17.1 m -116.49 124.73 72.99 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.371 0 N-CA-C 107.59 -1.263 . . . . 10.0 107.59 168.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 101' ' ' THR . 1.8 m -98.28 160.12 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 C-N-CA 119.143 -1.023 . . . . 10.0 109.409 -175.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 C--N 1.297 -1.694 0 CA-C-N 115.059 -0.973 . . . . 10.0 110.085 179.735 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt . . . . . 0 C--O 1.223 -0.3 0 N-CA-C 108.279 -1.008 . . . . 10.0 108.279 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.22 129.52 25.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.689 0.28 . . . . 10.0 110.851 -174.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.56 -36.3 7.16 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 175.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.531 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -158.91 178.26 10.28 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.177 0.806 . . . . 10.0 113.177 -177.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 93.9 mt-30 -129.32 132.73 47.17 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.182 -1.372 . . . . 10.0 109.184 174.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.576 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.4 OUTLIER -116.47 81.14 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 N-CA-C 108.452 -0.944 . . . . 10.0 108.452 176.303 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -81.63 123.58 28.81 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 120.256 -1.527 . . . . 10.0 108.412 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.626 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.7 132.93 8.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.986 0.898 . . . . 10.0 111.881 -173.061 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -87.13 123.57 32.32 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.726 -1.125 . . . . 10.0 110.815 -172.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.626 HD21 HD11 ' A' ' 11' ' ' LEU . 82.7 mt -138.82 137.94 20.69 Favored Pre-proline 0 C--O 1.218 -0.564 0 CA-C-O 121.51 0.671 . . . . 10.0 112.648 -174.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.74 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 23.6 Cg_exo -58.45 134.18 59.52 Favored 'Trans proline' 0 C--N 1.327 -0.583 0 C-N-CA 124.238 3.292 . . . . 10.0 112.518 174.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 46' ' ' THR . . . -56.1 133.93 52.37 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.131 -1.433 . . . . 10.0 107.131 166.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.33 0.06 50.99 Favored Glycine 0 N--CA 1.443 -0.897 0 O-C-N 125.448 1.717 . . . . 10.0 113.449 174.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.74 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 14.0 mmmm -138.41 77.45 1.63 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.481 1.141 . . . . 10.0 111.017 -178.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 39' ' ' CYS . . . -156.96 130.73 8.21 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.907 -0.717 . . . . 10.0 112.027 176.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.553 ' HA ' ' HB3' ' A' ' 39' ' ' CYS . 1.5 t -179.27 -41.66 0.0 OUTLIER Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 114.092 -1.413 . . . . 10.0 112.328 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.703 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 98.7 Cg_endo -103.08 127.31 0.09 OUTLIER 'Trans proline' 0 N--CA 1.408 -3.51 0 N-CA-C 115.503 1.309 . . . . 10.0 115.503 -161.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 1.057 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 11.09 -86.54 0.0 OUTLIER Pre-proline 0 C--N 1.295 -1.764 0 CA-C-N 109.12 -3.673 . . . . 10.0 115.605 166.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.916 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 51.3 Cg_exo -30.88 -55.09 0.23 Allowed 'Trans proline' 0 CA--C 1.559 1.773 0 C-N-CA 122.863 2.376 . . . . 10.0 115.74 -162.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.916 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 5.0 Cg_exo -81.53 -57.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.791 2.327 . . . . 10.0 112.246 171.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 1.071 HG12 HD12 ' A' ' 35' ' ' ILE . 57.5 t -79.83 -52.01 15.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 112.556 -2.111 . . . . 10.0 114.187 -167.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 1.057 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -50.73 -74.51 0.28 Allowed Glycine 0 C--O 1.216 -0.982 0 CA-C-N 114.831 -1.077 . . . . 10.0 113.537 -176.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.714 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 19.9 Cg_exo -45.01 -43.88 15.29 Favored 'Trans proline' 0 CA--C 1.517 -0.344 0 C-N-CA 123.777 2.985 . . . . 10.0 112.993 174.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.413 ' HB1' ' O ' ' A' ' 24' ' ' VAL . . . -50.24 -77.23 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.498 0.666 . . . . 10.0 111.271 175.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.764 HD23 ' CD1' ' A' ' 58' ' ' ILE . 3.3 mt -69.65 -48.49 59.64 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.872 1.064 . . . . 10.0 113.872 -176.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.62 -37.21 88.72 Favored Glycine 0 C--N 1.32 -0.353 0 CA-C-N 115.416 -0.811 . . . . 10.0 113.261 -174.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -63.75 -24.92 67.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.706 0.289 . . . . 10.0 110.559 176.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -100.47 16.52 24.32 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.652 0.739 . . . . 10.0 109.899 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.14 3.39 88.96 Favored Glycine 0 CA--C 1.5 -0.858 0 CA-C-N 114.549 -1.205 . . . . 10.0 113.59 168.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.843 HG11 ' CD2' ' A' ' 66' ' ' PHE . 2.9 t -80.56 146.45 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 113.664 0.987 . . . . 10.0 113.664 -171.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.856 HD21 ' HG2' ' A' ' 37' ' ' GLU . 54.5 t30 -74.27 104.17 4.94 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.643 0.735 . . . . 10.0 110.973 174.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 1.071 HD12 HG12 ' A' ' 24' ' ' VAL . 22.3 mm -53.91 -38.14 35.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 114.092 -1.413 . . . . 10.0 112.413 177.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.858 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -61.8 -56.83 15.37 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 113.503 -1.68 . . . . 10.0 112.038 176.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.856 ' HG2' HD21 ' A' ' 34' ' ' ASN . 21.1 mm-40 -56.64 -35.28 68.17 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.737 -1.185 . . . . 10.0 110.46 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.611 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 87.3 t80 -60.11 -60.53 3.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.187 1.18 . . . . 10.0 114.187 171.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.858 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 20.9 p -60.84 -47.01 88.3 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.005 -0.998 . . . . 10.0 111.706 -176.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.57 ' HE2' ' HB3' ' A' ' 36' ' ' MET . 52.5 mtmt -63.83 -23.69 67.46 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.416 -0.914 . . . . 10.0 109.59 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.749 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 20.3 mtp180 -73.98 -65.09 0.88 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 119.658 -0.817 . . . . 10.0 111.504 168.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.644 ' HZ ' ' HB2' ' A' ' 54' ' ' LEU . 71.4 t80 -54.34 -48.58 71.26 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.17 0.51 . . . . 10.0 110.559 -170.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.653 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.8 OUTLIER -61.2 -50.89 71.29 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.265 -0.879 . . . . 10.0 110.32 -176.712 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.0 -38.83 87.44 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 118.88 -1.128 . . . . 10.0 111.77 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.749 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 13.3 mt-10 -67.48 -42.52 82.82 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.769 0.795 . . . . 10.0 111.296 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.61 HG23 HD13 ' A' ' 54' ' ' LEU . 68.0 p -89.62 -2.17 58.23 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 114.877 -1.056 . . . . 10.0 112.342 -169.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -44.51 -37.54 3.57 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 124.098 0.874 . . . . 10.0 112.696 -174.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -80.8 -21.06 41.23 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.298 -0.864 . . . . 10.0 111.357 -172.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.907 ' HB3' ' HZ ' ' A' ' 77' ' ' PHE . 51.8 mttp -100.97 23.52 10.58 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 123.399 1.571 . . . . 10.0 109.238 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . 0.382 . . 49.03 -90.24 0.02 OUTLIER 'General case' 0 CA--C 1.47 -2.122 0 N-CA-C 119.641 3.2 . . . . 10.0 119.641 165.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -137.99 76.6 0.35 Allowed Glycine 0 N--CA 1.429 -1.822 0 N-CA-C 109.9 -1.28 . . . . 10.0 109.9 -171.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.653 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 24.9 mmt -138.61 126.38 22.24 Favored 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 116.907 -1.917 . . . . 10.0 114.177 -164.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.2 mm -64.7 85.53 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 109.432 -0.581 . . . . 10.0 109.432 175.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.644 ' HB2' ' HZ ' ' A' ' 42' ' ' PHE . 9.8 mt -80.88 132.3 57.68 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.434 -0.58 . . . . 10.0 109.434 -175.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 54' ' ' LEU . 16.1 Cg_exo -71.33 93.91 0.66 Allowed 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.753 2.302 . . . . 10.0 111.888 176.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.461 HG22 HG12 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -92.69 154.66 3.18 Favored 'Isoleucine or valine' 0 C--N 1.345 0.383 0 CA-C-N 119.081 0.855 . . . . 10.0 111.236 -174.591 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.423 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 90.3 t -134.68 116.22 20.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.332 -0.395 . . . . 10.0 110.181 172.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.764 ' CD1' HD23 ' A' ' 28' ' ' LEU . 16.1 mt -105.62 140.24 24.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.16 -1.052 . . . . 10.0 108.16 -173.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.8 m -124.52 95.38 4.51 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 114.927 -1.033 . . . . 10.0 108.611 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.572 HG21 ' O ' ' A' ' 65' ' ' SER . 3.5 p -85.28 137.52 20.69 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 CA-C-N 119.167 0.894 . . . . 10.0 110.827 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -95.91 170.87 9.0 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 112.855 0.687 . . . . 10.0 112.855 -177.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -60.89 -20.98 62.86 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.688 -1.142 . . . . 10.0 112.259 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.701 ' HB3' ' HG ' ' A' ' 65' ' ' SER . 7.2 t70 -73.96 -15.35 61.11 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.137 -0.938 . . . . 10.0 110.934 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 44.5 mtpt 84.54 0.77 0.87 Allowed 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 114.722 -1.127 . . . . 10.0 110.782 -169.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.701 ' HG ' ' HB3' ' A' ' 63' ' ' ASP . 8.8 p -73.85 -177.08 2.67 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 114.87 -1.059 . . . . 10.0 108.777 170.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.843 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -170.22 -176.92 2.35 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 120.38 1.446 . . . . 10.0 109.483 176.171 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.1 p -159.44 173.04 16.82 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 103.127 -2.916 . . . . 10.0 103.127 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.434 ' CB ' HG12 ' A' ' 58' ' ' ILE . 47.8 p90 -164.48 162.74 22.08 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.361 -0.607 . . . . 10.0 109.361 175.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.423 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 24.9 pt -130.71 167.73 25.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 107.206 -1.405 . . . . 10.0 107.206 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.518 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 4.3 mt -137.24 121.98 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 108.058 -1.09 . . . . 10.0 108.058 -178.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -84.46 72.63 10.6 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.073 -0.714 . . . . 10.0 109.073 -176.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.407 ' OG1' ' HE2' ' A' ' 112' ' ' LYS . 6.7 t -30.98 99.09 0.12 Allowed Pre-proline 0 C--N 1.318 -0.796 0 O-C-N 126.078 2.111 . . . . 10.0 110.762 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.656 ' HG2' ' HD2' ' A' ' 77' ' ' PHE . 3.3 Cg_endo -47.1 139.26 15.49 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 124.237 3.291 . . . . 10.0 114.214 -163.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.573 ' HA ' HD11 ' A' ' 116' ' ' LEU . 94.9 Cg_exo -20.8 -79.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.844 1 C-N-CA 126.245 4.63 . . . . 10.0 115.387 -168.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.57 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -143.48 -39.01 0.32 Allowed 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.033 -0.667 . . . . 10.0 111.501 -178.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.67 ' HA ' ' HE1' ' A' ' 135' ' ' MET . 1.7 p -41.96 -56.15 2.88 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 124.221 0.951 . . . . 10.0 112.697 -174.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.907 ' HZ ' ' HB3' ' A' ' 49' ' ' LYS . 0.7 OUTLIER -53.87 -65.93 0.48 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.012 -0.54 . . . . 10.0 112.242 -179.378 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.676 HD22 ' HE2' ' A' ' 112' ' ' LYS . 1.3 mm? -76.88 -12.62 59.98 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.25 -0.98 . . . . 10.0 111.789 -172.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.441 HD21 ' HA ' ' A' ' 79' ' ' LEU . 13.5 mt -67.15 -30.55 70.56 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.106 -0.702 . . . . 10.0 109.106 168.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.541 ' HG3' ' O ' ' A' ' 76' ' ' SER . 98.1 mttt -64.37 -23.65 67.37 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.481 171.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 6.7 mmmt -63.48 -48.01 79.39 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.432 0.53 . . . . 10.0 112.432 170.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.64 ' CB ' HG11 ' A' ' 100' ' ' VAL . . . -68.59 -41.0 80.25 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.373 1.869 . . . . 10.0 111.665 174.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.288 -2.099 0 CA-C-N 111.644 -2.525 . . . . 10.0 108.081 -177.549 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.515 ' CG1' ' H ' ' A' ' 98' ' ' GLY . 4.8 p . . . . . 0 N--CA 1.443 -0.807 0 N-CA-C 111.772 0.286 . . . . 10.0 111.772 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -113.31 162.43 12.37 Favored Glycine 0 CA--C 1.495 -1.157 0 N-CA-C 108.714 -1.754 . . . . 10.0 108.714 166.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.791 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 11.3 ptpt -151.58 156.17 39.92 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-O 122.41 1.1 . . . . 10.0 109.574 168.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.64 HG11 ' CB ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -160.0 -144.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-N 112.278 -2.237 . . . . 10.0 106.538 -168.158 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.513 ' HB ' HG21 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -165.19 146.91 7.68 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 108.359 -0.978 . . . . 10.0 108.359 -155.294 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.716 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 1.6 mmt85 -43.97 -40.94 5.0 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 124.219 0.95 . . . . 10.0 111.638 -175.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.419 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 2.1 tmtt? -55.54 -50.59 69.61 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.133 0.492 . . . . 10.0 111.621 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.633 ' O ' HG12 ' A' ' 108' ' ' ILE . 18.5 mm-40 -62.28 -44.94 95.37 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 108.665 -0.865 . . . . 10.0 108.665 -178.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.716 ' HB ' ' O ' ' A' ' 102' ' ' ARG . 38.9 mm -41.07 -54.64 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 114.297 -1.32 . . . . 10.0 111.596 166.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.709 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 45.5 tt0 -49.79 -53.16 26.92 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.803 0.841 . . . . 10.0 112.359 177.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.706 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 47.3 mm-40 -51.74 -55.56 18.94 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 114.958 -1.019 . . . . 10.0 109.996 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.633 HG12 ' O ' ' A' ' 104' ' ' GLN . 10.5 mm -49.61 -58.51 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.285 -0.87 . . . . 10.0 110.098 172.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.48 ' HB1' ' HB2' ' A' ' 124' ' ' ALA . . . -50.8 -33.56 23.98 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.032 0.753 . . . . 10.0 113.032 -178.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.709 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 53.7 mttm -67.52 -57.24 6.85 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.915 0.864 . . . . 10.0 109.165 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 90.5 m -53.42 -36.07 61.11 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 113.716 -1.584 . . . . 10.0 111.995 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.676 ' HE2' HD22 ' A' ' 78' ' ' LEU . 32.3 mmtp -96.45 -7.88 33.71 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.741 0.645 . . . . 10.0 112.741 -173.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.403 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 43.4 ttm -39.18 -49.28 4.45 Favored Pre-proline 0 CA--C 1.532 0.282 0 O-C-N 123.565 0.54 . . . . 10.0 112.386 175.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 113' ' ' MET . 61.6 Cg_endo -70.61 -23.45 26.89 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 120.991 1.128 . . . . 10.0 113.625 -177.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -88.21 -53.34 4.75 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.108 0.48 . . . . 10.0 110.991 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.673 ' CD2' HD11 ' A' ' 127' ' ' ILE . 1.6 mp -65.02 34.3 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.153 -1.385 . . . . 10.0 113.018 -175.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 19.78 51.86 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 O-C-N 124.51 1.131 . . . . 10.0 111.816 -167.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.433 ' O ' ' CB ' ' A' ' 119' ' ' ASN . . . -66.3 -79.13 0.05 OUTLIER 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 113.62 0.97 . . . . 10.0 113.62 -165.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 118' ' ' ALA . 3.1 t-20 101.94 -42.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 O-C-N 125.527 1.767 . . . . 10.0 108.947 -172.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.3 t -146.72 145.29 29.92 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.004 -1.11 . . . . 10.0 108.004 176.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.433 ' O ' ' HG3' ' A' ' 125' ' ' MET . 0.6 OUTLIER -51.68 -46.04 63.68 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.514 -0.766 . . . . 10.0 112.729 -179.132 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.432 ' H ' ' CD ' ' A' ' 122' ' ' GLU . 2.4 mp0 -50.22 -37.39 35.17 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.597 0.713 . . . . 10.0 110.781 178.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.38 -47.05 65.41 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 118.429 -1.308 . . . . 10.0 111.143 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.723 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -57.71 -34.88 69.94 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.66 -0.7 . . . . 10.0 110.769 175.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.433 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 7.7 mtt -53.74 -40.77 66.43 Favored 'General case' 0 N--CA 1.463 0.186 0 O-C-N 121.985 -0.447 . . . . 10.0 112.01 176.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -62.06 -51.83 66.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.017 -0.538 . . . . 10.0 111.761 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.673 HD11 ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -53.47 -56.67 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 119.81 -0.756 . . . . 10.0 110.475 177.459 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.723 HG12 ' O ' ' A' ' 124' ' ' ALA . 11.8 mm -50.74 -51.49 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 CA-C-N 115.138 -0.937 . . . . 10.0 110.949 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 125' ' ' MET . 49.4 mt-10 -51.97 -42.72 63.14 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 120.44 -0.504 . . . . 10.0 110.087 177.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -69.79 -49.65 34.65 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.612 -0.804 . . . . 10.0 111.358 -175.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.57 HG21 ' HB3' ' A' ' 75' ' ' ALA . 99.2 m -49.26 -60.5 2.76 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.267 -0.966 . . . . 10.0 109.827 173.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.21 -50.04 40.08 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.433 -0.349 . . . . 10.0 111.358 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 88.1 tttt -45.7 -59.27 2.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.553 -0.748 . . . . 10.0 111.951 174.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.1 t -65.04 -28.07 69.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.801 0.334 . . . . 10.0 111.305 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.67 ' HE1' ' HA ' ' A' ' 76' ' ' SER . 54.0 mtm -80.43 -6.14 57.62 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.936 0.717 . . . . 10.0 112.936 -177.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.449 ' O ' HG11 ' A' ' 97' ' ' VAL . . . 82.83 29.15 35.78 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 118.966 0.803 . . . . 10.0 111.852 -177.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.56 ' CD1' ' HE2' ' A' ' 135' ' ' MET . 8.4 mt -112.69 123.75 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.256 0 CA-C-O 121.608 0.718 . . . . 10.0 110.764 177.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.791 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -84.84 150.61 24.89 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.552 -1.204 . . . . 10.0 109.633 -179.13 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.435 HG12 HG13 ' A' ' 105' ' ' ILE . 18.2 m -115.43 131.26 68.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.052 -1.092 . . . . 10.0 108.052 170.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.513 HG21 ' HB ' ' A' ' 101' ' ' THR . 30.6 m -123.63 62.84 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 114.657 1.354 . . . . 10.0 114.657 -177.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.45 ' OXT' ' HB2' ' A' ' 102' ' ' ARG . 9.6 t70 . . . . . 0 C--N 1.291 -1.943 0 CA-C-N 114.303 -1.317 . . . . 10.0 109.627 143.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.9 ttm . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -51.21 111.4 0.56 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.296 0.85 . . . . 10.0 113.296 -174.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -127.52 126.01 41.44 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 115.648 -0.706 . . . . 10.0 109.729 168.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.798 ' HD2' ' HG3' ' A' ' 62' ' ' GLU . 17.1 mmtt -134.48 71.3 1.45 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.695 -0.854 . . . . 10.0 108.695 169.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.0 t -72.97 122.99 26.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 110.251 -0.277 . . . . 10.0 110.251 -174.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.57 -32.82 11.24 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.961 -0.755 . . . . 10.0 108.961 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -168.02 -168.28 0.95 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.33 -0.85 . . . . 10.0 113.214 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.533 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 78.5 mt-30 -143.84 135.54 26.2 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 114.015 -1.448 . . . . 10.0 108.689 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.904 HG23 ' HG ' ' A' ' 28' ' ' LEU . 1.3 mm -122.89 83.52 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 119.03 -0.509 . . . . 10.0 109.767 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -78.0 138.72 38.97 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 120.513 1.506 . . . . 10.0 109.231 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.646 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 1.0 OUTLIER -154.15 132.0 11.59 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.333 -0.618 . . . . 10.0 109.333 -171.725 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.495 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 19.8 pt20 -94.04 109.87 21.6 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.525 -0.917 . . . . 10.0 108.525 171.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.646 ' HG ' ' HB3' ' A' ' 11' ' ' LEU . 94.7 mt -130.1 135.95 28.26 Favored Pre-proline 0 CA--C 1.496 -1.097 0 CA-C-O 121.553 0.692 . . . . 10.0 112.51 -165.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.659 ' HB2' ' CB ' ' A' ' 17' ' ' LYS . 28.0 Cg_exo -58.56 120.67 8.7 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 123.054 2.503 . . . . 10.0 111.914 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' A' ' 50' ' ' ALA . . . -62.77 127.66 32.3 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 114.696 -1.138 . . . . 10.0 108.139 171.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.71 4.4 65.96 Favored Glycine 0 CA--C 1.525 0.704 0 O-C-N 126.003 2.064 . . . . 10.0 113.123 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.659 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . 2.6 mmmm -147.32 29.52 0.96 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.393 1.257 . . . . 10.0 114.393 -172.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.47 150.41 36.67 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.472 1.033 . . . . 10.0 110.155 175.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.51 ' C ' ' H ' ' A' ' 21' ' ' ALA . 15.3 t -177.69 140.3 0.43 Allowed Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 121.422 0.629 . . . . 10.0 110.861 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.49 ' HD2' ' HA ' ' A' ' 19' ' ' THR . 2.8 Cg_endo -42.17 23.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.478 0.581 1 C-N-CA 129.474 6.783 . . . . 10.0 117.463 176.18 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.619 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . . . -57.88 174.22 0.34 Allowed Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 107.997 -1.112 . . . . 10.0 107.997 163.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.619 ' HD2' ' HB2' ' A' ' 21' ' ' ALA . 57.5 Cg_exo -37.3 -42.69 1.04 Allowed 'Trans proline' 0 CA--C 1.548 1.184 0 C-N-CA 122.407 2.071 . . . . 10.0 114.043 177.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.59 ' HB2' HG22 ' A' ' 24' ' ' VAL . 27.2 Cg_exo -38.11 -71.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 123.744 2.962 . . . . 10.0 115.572 167.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 1.042 HG13 HD11 ' A' ' 35' ' ' ILE . 62.0 t -89.05 -54.68 7.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 114.013 -1.448 . . . . 10.0 114.043 -159.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.17 -65.41 2.94 Favored Glycine 0 C--O 1.228 -0.222 0 CA-C-N 114.616 -1.174 . . . . 10.0 112.992 -175.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -55.84 -43.75 54.13 Favored 'Trans proline' 0 C--O 1.222 -0.312 0 C-N-CA 123.092 2.528 . . . . 10.0 112.429 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.448 ' HB1' ' CG2' ' A' ' 9' ' ' ILE . . . -53.28 -78.09 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.401 0.619 . . . . 10.0 111.414 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.904 ' HG ' HG23 ' A' ' 9' ' ' ILE . 2.1 mt -66.94 -45.89 76.4 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.172 0.804 . . . . 10.0 113.172 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.26 -39.98 96.76 Favored Glycine 0 N--CA 1.459 0.18 0 CA-C-N 116.103 -0.499 . . . . 10.0 112.899 -174.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -60.84 -26.69 67.53 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.233 -0.284 . . . . 10.0 110.233 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -99.25 16.58 22.42 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.47 0.652 . . . . 10.0 109.895 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.26 4.57 86.23 Favored Glycine 0 CA--C 1.499 -0.957 0 CA-C-N 114.748 -1.115 . . . . 10.0 113.216 167.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.695 HG12 ' CD2' ' A' ' 66' ' ' PHE . 3.4 t -81.33 146.36 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 113.301 0.852 . . . . 10.0 113.301 -172.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.401 ' HB2' ' HB2' ' A' ' 37' ' ' GLU . 90.8 m-20 -70.31 96.7 1.15 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.256 0.622 . . . . 10.0 110.5 172.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 1.042 HD11 HG13 ' A' ' 24' ' ' VAL . 13.7 mm -55.54 -38.67 50.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-O 122.078 0.942 . . . . 10.0 112.188 177.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.457 ' SD ' ' N ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -70.01 -43.25 71.73 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 113.476 -1.693 . . . . 10.0 112.432 177.191 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.621 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 14.2 mt-10 -54.81 -50.0 69.62 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 118.988 -1.085 . . . . 10.0 109.437 170.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.6 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 77.8 t80 -53.87 -56.5 17.12 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 114.031 1.123 . . . . 10.0 114.031 175.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.3 t -58.71 -48.31 81.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.719 -1.128 . . . . 10.0 111.193 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.411 ' HE3' ' HB2' ' A' ' 40' ' ' LYS . 49.3 mtmt -66.86 -23.34 66.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 118.602 -1.239 . . . . 10.0 108.971 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.799 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 55.2 mtt180 -74.54 -64.68 0.98 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.093 -0.958 . . . . 10.0 111.776 173.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.731 ' HZ ' ' HB2' ' A' ' 54' ' ' LEU . 67.2 t80 -55.05 -45.6 75.27 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-O 121.165 0.507 . . . . 10.0 110.554 -174.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.628 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.8 OUTLIER -59.69 -52.49 65.26 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.209 -0.905 . . . . 10.0 110.23 -177.319 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.82 -39.75 95.25 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 119.56 -0.856 . . . . 10.0 112.014 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.799 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 11.2 mt-10 -69.02 -36.72 78.09 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.635 0.731 . . . . 10.0 111.407 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.52 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 72.7 p -91.34 4.33 52.66 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.856 -1.066 . . . . 10.0 112.036 -173.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.53 -36.48 15.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.764 -1.107 . . . . 10.0 112.543 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.2 p-10 -81.99 -37.36 26.72 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 115.224 -0.898 . . . . 10.0 111.434 -175.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.51 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 36.8 mttp -95.41 22.17 7.26 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.039 -0.726 . . . . 10.0 109.039 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -56.51 154.81 8.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.662 -1.154 . . . . 10.0 113.581 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.47 17.2 53.5 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 110.035 -1.226 . . . . 10.0 110.035 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.508 ' HB2' HD23 ' A' ' 54' ' ' LEU . 22.0 mmt -136.11 126.66 26.98 Favored 'General case' 0 C--O 1.207 -1.164 0 C-N-CA 116.11 -2.236 . . . . 10.0 114.032 -165.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.471 HG23 ' HB2' ' A' ' 12' ' ' GLN . 46.2 mm -67.09 91.0 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 121.763 -0.586 . . . . 10.0 109.549 170.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.731 ' HB2' ' HZ ' ' A' ' 42' ' ' PHE . 3.7 mt -76.96 130.7 74.91 Favored Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 122.183 0.193 . . . . 10.0 110.593 -176.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -74.94 95.34 0.97 Allowed 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.384 2.056 . . . . 10.0 111.553 173.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.409 HG23 HG12 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -99.52 158.2 3.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 119.016 0.826 . . . . 10.0 111.972 -172.41 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.421 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 96.3 t -135.42 120.17 27.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.312 -0.403 . . . . 10.0 110.207 171.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.7 HD12 HD23 ' A' ' 28' ' ' LEU . 14.8 mt -106.15 141.68 20.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 119.595 -0.842 . . . . 10.0 108.897 -175.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 68.1 m -125.39 99.98 6.29 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.043 -0.981 . . . . 10.0 109.024 175.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.48 ' HA ' ' CB ' ' A' ' 66' ' ' PHE . 2.8 p -89.18 137.94 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.003 0 C-N-CA 123.653 0.781 . . . . 10.0 111.095 -178.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 84.8 m-85 -98.94 171.05 8.3 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 122.17 0.986 . . . . 10.0 112.753 -176.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.798 ' HG3' ' HD2' ' A' ' 4' ' ' LYS . 3.0 mm-40 -53.15 -26.24 16.27 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.389 -1.732 . . . . 10.0 113.2 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.441 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 28.7 m-20 -78.09 -12.38 59.99 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.485 -0.486 . . . . 10.0 111.14 -176.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER 84.1 4.94 0.72 Allowed 'General case' 0 CA--C 1.508 -0.672 0 O-C-N 124.558 1.161 . . . . 10.0 108.917 -163.237 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.425 ' O ' HG21 ' A' ' 60' ' ' VAL . 6.2 p -71.02 172.5 8.98 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 113.504 -1.68 . . . . 10.0 107.916 171.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.695 ' CD2' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -169.86 -176.31 2.31 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 120.147 1.339 . . . . 10.0 109.825 174.277 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.6 p -160.11 168.61 25.12 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 102.944 -2.984 . . . . 10.0 102.944 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.414 ' CB ' HG12 ' A' ' 58' ' ' ILE . 45.6 p90 -161.43 158.79 27.27 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 109.125 -0.694 . . . . 10.0 109.125 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.421 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 22.2 pt -128.04 162.06 34.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 106.923 -1.51 . . . . 10.0 106.923 -176.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.53 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 2.6 mt -135.8 117.39 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 107.379 -1.341 . . . . 10.0 107.379 -175.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.609 ' HA ' ' OD1' ' A' ' 115' ' ' ASP . 0.3 OUTLIER -79.27 84.77 5.17 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 123.408 0.442 . . . . 10.0 110.516 -171.069 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.733 ' HB ' ' HG2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -49.17 99.04 0.2 Allowed Pre-proline 0 C--N 1.313 -0.981 0 CA-C-N 114.413 -1.267 . . . . 10.0 108.989 167.202 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.498 ' HG2' ' HB2' ' A' ' 77' ' ' PHE . 38.3 Cg_endo -74.74 174.22 13.06 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.136 2.558 . . . . 10.0 113.932 -158.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.459 ' HD2' ' CB ' ' A' ' 73' ' ' PRO . 86.8 Cg_exo -26.21 -60.69 0.07 OUTLIER 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 125.129 3.886 . . . . 10.0 114.466 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 128' ' ' ILE . . . -171.43 -23.95 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.519 0.933 . . . . 10.0 113.519 175.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.723 ' HA ' ' HE3' ' A' ' 135' ' ' MET . 35.3 p -47.03 -43.35 19.63 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.177 0.513 . . . . 10.0 111.914 -173.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.56 ' HB3' HD22 ' A' ' 78' ' ' LEU . 13.0 t80 -47.79 -68.02 0.22 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.631 -1.168 . . . . 10.0 112.574 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.937 ' HB3' HD12 ' A' ' 108' ' ' ILE . 2.3 mm? -85.02 -11.31 55.7 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.567 -171.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.402 HD11 ' HE2' ' A' ' 135' ' ' MET . 39.6 mt -72.33 -25.42 61.55 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.344 -0.543 . . . . 10.0 109.549 172.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 76' ' ' SER . 34.7 mmtp -59.32 -50.88 72.29 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.788 -1.19 . . . . 10.0 107.788 166.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -67.76 33.05 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 114.057 -1.428 . . . . 10.0 113.578 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.458 ' CB ' HG12 ' A' ' 100' ' ' VAL . . . -170.48 -60.35 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.668 0.747 . . . . 10.0 112.732 -172.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.55 -27.47 66.25 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 113.464 -1.698 . . . . 10.0 108.942 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.82 59.44 1.79 Allowed Glycine 0 CA--C 1.498 -1.031 0 C-N-CA 119.871 -1.157 . . . . 10.0 110.241 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.58 ' C ' ' H ' ' A' ' 87' ' ' LYS . 29.4 pt -153.18 32.66 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.011 -1.107 . . . . 10.0 108.011 -169.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -69.8 7.0 0.98 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 113.663 -1.608 . . . . 10.0 109.881 174.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.58 ' H ' ' C ' ' A' ' 85' ' ' ILE . 6.3 tmtm? -169.22 -46.42 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.66 -1.609 . . . . 10.0 106.71 -178.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 146.98 166.08 12.13 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.055 -0.975 . . . . 10.0 111.389 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.3 p -75.86 164.47 26.18 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.219 -0.66 . . . . 10.0 109.219 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.6 p -68.75 -35.58 77.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.681 0.277 . . . . 10.0 111.002 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.587 ' N ' ' HD2' ' A' ' 92' ' ' PRO . 14.2 tp10 -175.5 -46.35 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.318 -178.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 91' ' ' GLU . 5.8 Cg_exo -39.67 109.79 0.1 OUTLIER 'Trans proline' 0 C--N 1.364 1.356 0 C-N-CA 123.183 2.589 . . . . 10.0 113.129 173.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.516 ' HZ2' HG23 ' A' ' 97' ' ' VAL . 25.9 mtpp -155.48 74.95 0.91 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.416 -0.811 . . . . 10.0 108.945 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.557 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 52.2 ttm-85 -78.94 41.09 0.42 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.56 -0.533 . . . . 10.0 109.56 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 1.2 mppt? 84.31 -37.81 0.06 Allowed 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 107.9 -1.148 . . . . 10.0 107.9 -172.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.726 HG22 ' HB3' ' A' ' 138' ' ' GLU . 58.1 mt -88.1 94.43 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 114.929 -1.032 . . . . 10.0 109.608 171.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.516 HG23 ' HZ2' ' A' ' 93' ' ' LYS . 2.7 p -50.81 -54.78 8.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.773 -0.649 . . . . 10.0 112.094 -175.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -160.13 174.07 36.85 Favored Glycine 0 CA--C 1.5 -0.894 0 N-CA-C 107.929 -2.069 . . . . 10.0 107.929 178.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.876 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -149.37 173.02 13.98 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-O 122.629 1.204 . . . . 10.0 111.429 -164.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.458 HG12 ' CB ' ' A' ' 82' ' ' ALA . 0.2 OUTLIER -150.73 -143.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 CA-C-N 111.982 -2.372 . . . . 10.0 105.986 -173.378 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.517 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 0.1 OUTLIER -164.93 144.66 7.05 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 107.48 -1.304 . . . . 10.0 107.48 -160.188 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.584 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 9.0 mmm180 -44.27 -43.5 7.39 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 124.241 0.963 . . . . 10.0 111.741 -177.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -57.89 -44.72 86.88 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.329 0.585 . . . . 10.0 111.539 176.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.717 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.1 OUTLIER -60.04 -47.25 86.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.219 -0.901 . . . . 10.0 108.702 178.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.892 HG22 ' HB ' ' A' ' 128' ' ' ILE . 26.2 mm -43.31 -55.34 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 CA-C-N 115.093 -0.958 . . . . 10.0 110.939 171.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.801 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 8.4 tt0 -49.2 -57.36 6.85 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 114.494 -1.23 . . . . 10.0 112.946 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -53.4 -59.63 4.33 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 124.057 0.848 . . . . 10.0 110.878 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.937 HD12 ' HB3' ' A' ' 78' ' ' LEU . 10.0 mm -46.88 -51.88 4.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.992 -1.004 . . . . 10.0 110.646 172.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.468 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -53.31 -40.29 64.67 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.655 -0.702 . . . . 10.0 112.554 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.801 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 50.3 mttm -70.87 -53.42 15.22 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.172 -0.467 . . . . 10.0 110.561 -174.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.641 HG23 ' HG3' ' A' ' 112' ' ' LYS . 7.7 t -55.99 -35.32 66.65 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.727 -0.67 . . . . 10.0 112.567 -176.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.749 ' HD3' HD21 ' A' ' 78' ' ' LEU . 8.7 mtmp? -103.08 17.36 24.24 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.057 0.456 . . . . 10.0 110.762 -176.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.732 ' HG3' ' HB1' ' A' ' 118' ' ' ALA . 50.4 ttm -49.65 -45.33 78.73 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.374 -0.83 . . . . 10.0 112.372 176.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 113' ' ' MET . 42.2 Cg_endo -64.62 -25.67 61.86 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 121.65 1.567 . . . . 10.0 112.569 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.609 ' OD1' ' HA ' ' A' ' 71' ' ' LYS . 12.8 m-20 -89.46 -50.9 5.83 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 114.936 -1.029 . . . . 10.0 111.16 -175.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 9.1 mp -64.06 -3.55 2.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.441 -1.254 . . . . 10.0 111.754 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 115' ' ' ASP . 64.4 t30 59.6 51.42 6.42 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.262 -1.335 . . . . 10.0 109.851 177.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.732 ' HB1' ' HG3' ' A' ' 113' ' ' MET . . . -80.78 116.64 20.88 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 113.873 -1.512 . . . . 10.0 112.651 -172.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -65.91 -41.88 90.89 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.314 -0.995 . . . . 10.0 108.314 168.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.0 p -149.76 143.54 25.47 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 106.922 -1.511 . . . . 10.0 106.922 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.587 HD13 ' HB2' ' A' ' 124' ' ' ALA . 66.9 tp -52.16 -33.02 38.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.225 1.195 . . . . 10.0 114.225 -176.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -50.15 -37.76 36.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.329 0.585 . . . . 10.0 110.885 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.14 -50.17 56.33 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 119.047 -1.061 . . . . 10.0 110.916 175.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.587 ' HB2' HD13 ' A' ' 121' ' ' LEU . . . -57.49 -38.7 75.01 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 120.762 -0.375 . . . . 10.0 110.736 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.548 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 89.1 mtp -56.0 -37.22 68.84 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.674 0.39 . . . . 10.0 111.425 177.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -63.08 -48.34 79.02 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.04 -0.527 . . . . 10.0 109.729 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.5 mt -51.17 -62.67 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 CA-C-O 121.464 0.65 . . . . 10.0 111.245 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.892 ' HB ' HG22 ' A' ' 105' ' ' ILE . 15.9 mm -49.84 -57.02 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 CA-C-N 114.189 -1.368 . . . . 10.0 111.152 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.604 ' HG3' HG13 ' A' ' 105' ' ' ILE . 3.9 mt-10 -54.04 -47.28 71.74 Favored 'General case' 0 N--CA 1.436 -1.149 0 O-C-N 124.097 0.873 . . . . 10.0 110.069 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.5 -46.64 61.65 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.463 -0.875 . . . . 10.0 111.51 -173.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.475 HG22 ' HB1' ' A' ' 75' ' ' ALA . 90.2 m -47.6 -60.29 2.65 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.188 -1.006 . . . . 10.0 108.601 170.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -48.0 -53.07 17.37 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.954 0.502 . . . . 10.0 111.852 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 129' ' ' GLU . 43.4 mtpt -50.23 -50.28 50.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.002 178.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.8 m -66.31 -31.39 72.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.945 0.403 . . . . 10.0 111.031 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.723 ' HE3' ' HA ' ' A' ' 76' ' ' SER . 48.8 mtm -81.4 4.08 22.14 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.795 1.035 . . . . 10.0 113.795 -178.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 96' ' ' ILE . . . 81.0 18.83 68.75 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 119.657 1.117 . . . . 10.0 111.586 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.497 ' CD1' ' HE1' ' A' ' 135' ' ' MET . 23.3 mt -105.21 127.69 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 CA-C-O 121.146 0.498 . . . . 10.0 111.513 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.876 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -89.14 157.13 18.4 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.475 -0.784 . . . . 10.0 109.585 179.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.7 m -116.35 132.1 66.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.5 -0.926 . . . . 10.0 108.5 170.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.608 ' O ' ' HB2' ' A' ' 141' ' ' ASP . 26.9 m -133.94 69.65 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 116.057 1.873 . . . . 10.0 116.057 -175.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.608 ' HB2' ' O ' ' A' ' 140' ' ' VAL . 3.6 t0 . . . . . 0 C--N 1.296 -1.745 0 CA-C-O 117.864 -1.065 . . . . 10.0 109.012 141.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 mmt . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 120.643 0.259 . . . . 10.0 110.404 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.08 -12.75 34.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.245 0.545 . . . . 10.0 110.552 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.871 ' NZ ' ' HH ' ' A' ' 61' ' ' TYR . 46.7 mtmt -78.33 155.77 29.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.646 -0.706 . . . . 10.0 109.841 176.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.514 ' HD3' ' H ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -75.48 94.32 3.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.501 0.667 . . . . 10.0 110.699 -179.55 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.2 t -73.79 141.3 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.581 -0.736 . . . . 10.0 110.649 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.31 -45.51 4.08 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.307 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.54 152.17 25.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.51 1.3 . . . . 10.0 114.51 -174.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.768 HE21 ' HA ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -92.55 133.14 36.24 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.514 -1.221 . . . . 10.0 107.852 170.184 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.607 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -123.09 83.16 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.348 -0.612 . . . . 10.0 109.348 174.365 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.439 ' HG2' HG23 ' A' ' 57' ' ' VAL . 52.8 mttp -77.27 132.24 38.57 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 120.807 1.639 . . . . 10.0 108.921 172.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.783 HD13 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -158.58 125.6 4.86 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 122.336 1.065 . . . . 10.0 111.689 -179.236 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.454 ' HG2' ' HA ' ' A' ' 55' ' ' PRO . 28.8 mt-30 -83.5 121.56 27.36 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.132 -1.395 . . . . 10.0 110.59 -172.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.783 HD21 HD13 ' A' ' 11' ' ' LEU . 88.2 mt -138.64 144.36 41.78 Favored Pre-proline 0 CA--C 1.507 -0.687 0 CA-C-O 121.484 0.659 . . . . 10.0 111.96 -170.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.77 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 4.3 Cg_exo -65.98 126.97 16.77 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 123.467 2.778 . . . . 10.0 111.655 176.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.715 ' HB3' HD12 ' A' ' 54' ' ' LEU . . . -62.12 128.46 36.22 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 108.062 -1.088 . . . . 10.0 108.062 171.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.95 -1.04 87.72 Favored Glycine 0 N--CA 1.443 -0.882 0 O-C-N 125.612 1.82 . . . . 10.0 112.74 -174.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.77 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 15.1 tppt? -140.46 102.59 4.37 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 122.359 1.076 . . . . 10.0 111.835 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -170.33 129.66 0.88 Allowed 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 113.405 -1.725 . . . . 10.0 110.856 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.671 ' HA ' ' HB2' ' A' ' 39' ' ' CYS . 2.1 t -176.87 -44.87 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 115.046 -0.979 . . . . 10.0 113.112 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.719 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 72.6 Cg_endo -103.93 124.4 0.07 OUTLIER 'Trans proline' 0 N--CA 1.413 -3.244 0 N-CA-C 115.557 1.329 . . . . 10.0 115.557 -162.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 1.042 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 9.63 -87.15 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.392 0 CA-C-N 109.664 -3.425 . . . . 10.0 114.824 166.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.64 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 11.4 Cg_exo -26.07 -55.99 0.09 OUTLIER 'Trans proline' 0 CA--C 1.559 1.734 0 C-N-CA 123.74 2.96 . . . . 10.0 115.722 -162.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.719 ' HD2' ' O ' ' A' ' 20' ' ' PRO . 37.4 Cg_endo -80.48 -73.96 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.277 0 C-N-CA 122.419 2.079 . . . . 10.0 112.083 168.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 1.042 HG11 HD12 ' A' ' 35' ' ' ILE . 53.5 t -57.37 -54.73 27.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 127.564 2.346 . . . . 10.0 114.672 -173.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 1.042 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -48.41 -72.55 0.43 Allowed Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.107 -0.952 . . . . 10.0 113.173 -175.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.7 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 16.5 Cg_exo -44.98 -47.98 11.42 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.523 2.816 . . . . 10.0 112.272 171.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.473 ' HB1' ' O ' ' A' ' 24' ' ' VAL . . . -46.37 -98.51 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 123.624 0.578 . . . . 10.0 112.376 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.892 HD23 HD11 ' A' ' 35' ' ' ILE 0.351 0.0 OUTLIER -73.87 -38.84 64.3 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 117.176 -1.81 . . . . 10.0 113.363 -174.684 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.756 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -66.15 -39.34 94.54 Favored Glycine 0 N--CA 1.462 0.407 0 C-N-CA 121.43 -0.414 . . . . 10.0 113.859 -173.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.473 ' HB3' ' O ' ' A' ' 26' ' ' PRO . 9.0 tt0 -67.82 -7.19 25.76 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.541 -0.864 . . . . 10.0 111.172 176.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -99.94 22.92 10.49 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.624 -0.716 . . . . 10.0 109.284 168.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.19 -6.89 63.99 Favored Glycine 0 CA--C 1.503 -0.712 0 CA-C-N 115.341 -0.845 . . . . 10.0 113.112 167.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.846 HG12 ' CD2' ' A' ' 66' ' ' PHE . 3.4 t -83.29 148.75 4.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 114.619 1.34 . . . . 10.0 114.619 -169.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.537 ' HB3' ' HB2' ' A' ' 37' ' ' GLU . 44.7 t-20 -70.75 98.68 1.58 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.468 0.707 . . . . 10.0 110.639 172.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 1.042 HD12 HG11 ' A' ' 24' ' ' VAL . 19.4 mm -53.78 -36.28 29.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.155 -0.929 . . . . 10.0 112.164 175.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 66.8 mtm -65.19 -52.78 52.76 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.62 -1.627 . . . . 10.0 111.699 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.537 ' HB2' ' HB3' ' A' ' 34' ' ' ASN . 12.7 mm-40 -56.88 -38.8 73.27 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.615 -0.834 . . . . 10.0 110.927 175.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . 91.3 t80 -57.85 -58.7 7.21 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 113.506 0.928 . . . . 10.0 113.506 170.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.671 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -57.7 -52.26 66.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 113.988 -1.46 . . . . 10.0 112.039 -177.535 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.502 ' HB3' ' HE3' ' A' ' 40' ' ' LYS . 0.7 OUTLIER -66.47 -21.71 66.19 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.554 -0.858 . . . . 10.0 108.691 -176.082 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.672 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 12.9 mtp180 -74.09 -63.9 1.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.662 -0.699 . . . . 10.0 112.074 168.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.505 ' CZ ' HG22 ' A' ' 46' ' ' THR . 71.1 t80 -54.33 -45.52 72.69 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-O 121.082 0.468 . . . . 10.0 110.682 -172.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.623 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.8 OUTLIER -58.97 -51.62 69.27 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.074 -0.966 . . . . 10.0 109.771 -178.402 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.96 98.97 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 119.034 -1.066 . . . . 10.0 112.186 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.672 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 7.3 mt-10 -66.9 -39.31 87.41 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.823 0.821 . . . . 10.0 110.834 -178.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.626 HG22 HD11 ' A' ' 54' ' ' LEU . 72.1 p -92.13 -0.4 57.44 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.735 -1.121 . . . . 10.0 112.748 -172.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.96 -39.62 12.76 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.915 0.886 . . . . 10.0 112.777 -174.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -75.78 -34.13 60.2 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.506 -0.77 . . . . 10.0 110.958 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.422 ' HB3' ' CE ' ' A' ' 52' ' ' MET . 36.7 mttp -97.15 17.88 16.19 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.828 0.851 . . . . 10.0 109.998 -175.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -52.07 145.47 10.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.205 -0.907 . . . . 10.0 113.232 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.68 15.85 35.79 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 110.604 -0.998 . . . . 10.0 110.604 -177.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.703 ' SD ' ' HB2' ' A' ' 77' ' ' PHE . 51.3 mtm -138.12 125.81 22.29 Favored 'General case' 0 C--O 1.211 -0.94 0 C-N-CA 116.274 -2.171 . . . . 10.0 115.193 -166.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.3 mm -66.55 91.78 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 118.313 0.506 . . . . 10.0 109.639 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.715 HD12 ' HB3' ' A' ' 15' ' ' ALA . 8.0 mt -83.2 135.85 44.07 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.852 -0.796 . . . . 10.0 108.852 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.543 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 8.0 Cg_exo -75.86 108.94 2.79 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.237 1.958 . . . . 10.0 111.016 174.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -100.58 155.08 4.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 119.833 1.197 . . . . 10.0 111.573 -174.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.439 HG23 ' HG2' ' A' ' 10' ' ' LYS . 93.6 t -134.81 115.58 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 CA-C-N 116.662 -0.244 . . . . 10.0 110.447 175.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.607 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 16.0 mt -107.07 141.93 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.554 0 CA-C-O 121.669 0.747 . . . . 10.0 109.157 -174.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.7 m -124.8 99.15 6.02 Favored 'General case' 0 C--N 1.28 -2.453 0 CA-C-N 114.665 -1.152 . . . . 10.0 108.869 174.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 65' ' ' SER . 2.4 p -89.61 140.17 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 CA-C-N 119.43 1.014 . . . . 10.0 110.19 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.871 ' HH ' ' NZ ' ' A' ' 3' ' ' LYS . 73.4 m-85 -98.51 160.67 14.13 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.548 -0.751 . . . . 10.0 111.55 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.411 ' OE1' ' HB2' ' A' ' 4' ' ' LYS . 16.6 mt-10 -54.22 -19.13 4.68 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 124.37 1.068 . . . . 10.0 113.142 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 26.5 t70 -75.46 -13.71 60.39 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.572 -0.74 . . . . 10.0 110.472 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.706 ' HE3' ' HA ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 83.33 1.2 1.07 Allowed 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 114.448 -1.251 . . . . 10.0 110.379 -167.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.469 ' O ' HG22 ' A' ' 60' ' ' VAL . 57.9 m -71.68 174.86 6.21 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 114.753 -1.112 . . . . 10.0 108.846 169.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.846 ' CD2' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -171.09 -176.79 2.02 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 119.394 0.997 . . . . 10.0 109.307 174.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 p -162.58 162.54 27.25 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 103.434 -2.802 . . . . 10.0 103.434 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.444 ' CB ' HG12 ' A' ' 58' ' ' ILE . 47.6 p90 -162.11 158.09 24.24 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.522 0.677 . . . . 10.0 109.233 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.9 pt -128.45 158.78 40.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.543 0 CA-C-N 114.612 -1.176 . . . . 10.0 108.503 -175.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.469 HD13 ' CE1' ' A' ' 42' ' ' PHE . 2.8 mm -112.75 127.27 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 108.016 -1.105 . . . . 10.0 108.016 -178.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.641 ' C ' ' HD2' ' A' ' 73' ' ' PRO . 4.2 mptp? -80.16 93.3 5.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.024 0.916 . . . . 10.0 112.211 -172.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.73 HG23 ' HA ' ' A' ' 112' ' ' LYS . 9.2 t -59.55 -34.6 23.2 Favored Pre-proline 0 CA--C 1.569 1.693 0 CA-C-N 113.569 -1.651 . . . . 10.0 113.332 169.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.712 ' HD2' ' N ' ' A' ' 72' ' ' THR . 2.7 Cg_endo -41.9 -49.26 5.69 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 124.519 3.479 . . . . 10.0 117.331 -171.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.541 ' HD3' ' HG2' ' A' ' 73' ' ' PRO . 73.7 Cg_exo -42.33 -35.06 3.35 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.858 2.372 . . . . 10.0 113.47 -174.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 72.51 -25.59 0.18 Allowed 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 113.723 1.009 . . . . 10.0 113.723 168.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.5 m -50.63 -46.91 58.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.167 0.508 . . . . 10.0 110.92 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.703 ' HB2' ' SD ' ' A' ' 52' ' ' MET . 8.6 p90 -72.23 -29.46 63.96 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.765 -0.652 . . . . 10.0 111.428 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.751 ' O ' ' HB3' ' A' ' 81' ' ' LYS . 1.8 tp -86.0 -28.18 24.36 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.233 0.54 . . . . 10.0 111.255 -175.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 79' ' ' LEU . 3.7 mm? -59.39 -35.1 73.3 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 107.993 -1.114 . . . . 10.0 107.993 168.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.755 ' HD3' ' HB2' ' A' ' 86' ' ' GLU . 7.3 ttpm? -70.31 -12.26 61.47 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.756 -0.656 . . . . 10.0 111.921 172.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.751 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 17.0 tptm -56.72 -50.75 71.28 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.25 -0.907 . . . . 10.0 109.103 165.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.517 ' C ' HG12 ' A' ' 100' ' ' VAL . . . -72.56 -49.58 31.52 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.964 1.706 . . . . 10.0 112.755 170.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . . . -80.12 159.24 26.14 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 112.688 -2.051 . . . . 10.0 109.326 -169.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.81 -21.52 12.16 Favored Glycine 0 C--N 1.31 -0.876 0 C-N-CA 118.318 -1.896 . . . . 10.0 110.746 165.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.604 HG22 HG23 ' A' ' 97' ' ' VAL . 2.1 pp -64.25 145.17 14.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 113.741 1.015 . . . . 10.0 113.741 -177.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.755 ' HB2' ' HD3' ' A' ' 80' ' ' LYS . 31.0 tt0 -171.41 40.27 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.099 -0.955 . . . . 10.0 108.882 164.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -162.77 16.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.114 -0.948 . . . . 10.0 110.355 177.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -124.89 5.94 8.37 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.655 -0.783 . . . . 10.0 112.134 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.1 m -76.17 -33.62 59.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.079 0.466 . . . . 10.0 110.812 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.9 p -78.69 1.18 23.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.988 -0.551 . . . . 10.0 111.436 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -174.82 96.35 0.29 Allowed Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 108.683 -0.858 . . . . 10.0 108.683 176.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.29 -174.68 2.35 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 123.006 2.47 . . . . 10.0 113.038 -173.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -72.33 -36.07 68.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.009 -0.542 . . . . 10.0 110.691 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -166.36 -37.12 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.362 0.601 . . . . 10.0 109.634 175.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -160.34 8.98 0.1 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.092 -0.958 . . . . 10.0 110.256 176.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.47 HG21 ' O ' ' A' ' 136' ' ' GLY . 1.3 mt -156.16 167.66 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 109.034 -0.728 . . . . 10.0 109.034 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.604 HG23 HG22 ' A' ' 85' ' ' ILE . 7.1 p -112.22 -61.3 2.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.393 0.616 . . . . 10.0 111.512 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.576 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -166.88 161.37 35.18 Favored Glycine 0 CA--C 1.497 -1.078 0 N-CA-C 108.725 -1.75 . . . . 10.0 108.725 -174.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -143.73 177.72 8.31 Favored 'General case' 0 CA--C 1.473 -2.004 0 CA-C-O 122.359 1.075 . . . . 10.0 110.767 -169.522 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.517 HG12 ' C ' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -163.76 -165.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.404 -2.73 0 CA-C-N 111.793 -2.458 . . . . 10.0 106.184 -170.55 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.612 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 19.0 p -109.83 150.39 28.46 Favored 'General case' 0 C--N 1.268 -2.968 0 CA-C-N 114.753 -1.112 . . . . 10.0 111.833 -170.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.668 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 22.4 tpp180 -43.62 -43.73 5.9 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 113.588 -1.642 . . . . 10.0 109.688 168.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 18.4 tppt? -58.35 -43.15 88.19 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.153 0.501 . . . . 10.0 112.168 176.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.649 ' O ' HG12 ' A' ' 108' ' ' ILE . 57.6 mt-30 -67.22 -38.72 85.74 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.407 -0.59 . . . . 10.0 109.407 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.668 ' HB ' ' O ' ' A' ' 102' ' ' ARG . 34.9 mm -46.83 -51.15 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.589 -0.732 . . . . 10.0 111.012 166.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.707 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 31.8 tt0 -48.28 -54.26 14.31 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.283 -1.326 . . . . 10.0 112.836 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -52.48 -57.88 8.51 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 123.925 0.766 . . . . 10.0 110.151 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.649 HG12 ' O ' ' A' ' 104' ' ' GLN . 5.5 mm -46.19 -59.97 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 114.328 -1.305 . . . . 10.0 109.923 173.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.511 ' HB1' HG13 ' A' ' 128' ' ' ILE . . . -50.62 -37.28 39.47 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 123.686 0.616 . . . . 10.0 112.44 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.707 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 39.4 mttt -71.09 -58.67 3.33 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.004 -0.544 . . . . 10.0 111.478 -175.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.49 HG22 HD21 ' A' ' 78' ' ' LEU . 4.7 t -55.4 -34.83 64.73 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 113.011 0.745 . . . . 10.0 113.011 -175.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.977 ' HD3' HD12 ' A' ' 128' ' ' ILE . 0.1 OUTLIER -99.03 7.38 46.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 120.931 0.396 . . . . 10.0 110.828 -173.36 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.838 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 40.1 ttm -48.11 -41.32 41.55 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.231 -0.895 . . . . 10.0 112.424 175.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' A' ' 113' ' ' MET . 26.7 Cg_endo -59.61 -32.48 96.05 Favored 'Trans proline' 0 C--N 1.366 1.471 0 C-N-CA 121.787 1.658 . . . . 10.0 112.128 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.556 ' CB ' ' HD3' ' A' ' 73' ' ' PRO . 0.8 OUTLIER -91.44 -47.89 7.19 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 114.788 -1.096 . . . . 10.0 112.34 -173.39 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.963 HD22 HD11 ' A' ' 127' ' ' ILE . 7.0 mp -64.18 2.05 0.63 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.527 -1.215 . . . . 10.0 111.871 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.488 ' H ' ' C ' ' A' ' 115' ' ' ASP . 8.7 p30 54.75 45.67 26.22 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.164 -1.38 . . . . 10.0 109.662 177.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.838 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -80.8 118.17 22.09 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 112.805 -1.998 . . . . 10.0 112.103 -172.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.22 -37.61 83.88 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.75 -0.659 . . . . 10.0 109.874 170.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.2 p -155.41 144.66 20.95 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.442 -0.947 . . . . 10.0 108.442 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.524 ' O ' ' HG2' ' A' ' 125' ' ' MET . 62.6 tp -52.08 -40.39 61.14 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 115.077 1.51 . . . . 10.0 115.077 -173.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -51.63 -33.08 31.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.148 0.499 . . . . 10.0 111.045 176.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.18 -49.26 65.31 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 118.797 -1.161 . . . . 10.0 110.865 172.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.605 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -57.78 -33.68 68.79 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.91 0.386 . . . . 10.0 110.652 178.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.631 ' O ' ' HB3' ' A' ' 129' ' ' GLU . 80.1 mmm -56.36 -39.02 72.2 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.73 0.3 . . . . 10.0 111.425 176.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -61.21 -56.68 17.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.832 -0.622 . . . . 10.0 111.432 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.963 HD11 HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -50.98 -57.9 2.4 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 C-N-CA 119.994 -0.683 . . . . 10.0 111.146 -178.465 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.977 HD12 ' HD3' ' A' ' 112' ' ' LYS . 25.4 mm -50.56 -57.23 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 CA-C-N 114.649 -1.16 . . . . 10.0 111.801 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.631 ' HB3' ' O ' ' A' ' 125' ' ' MET . 0.0 OUTLIER -53.33 -41.38 65.67 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.748 -0.66 . . . . 10.0 109.272 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.649 ' HA2' ' HE2' ' A' ' 133' ' ' LYS . . . -71.36 -46.47 41.29 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.739 -0.744 . . . . 10.0 111.862 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 62.7 m -44.37 -65.6 0.49 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 114.561 -0.82 . . . . 10.0 109.011 169.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.472 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -48.77 -50.71 32.75 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.026 -0.534 . . . . 10.0 111.312 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.649 ' HE2' ' HA2' ' A' ' 130' ' ' GLY . 17.0 ttpt -47.98 -53.95 14.48 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.75 -1.114 . . . . 10.0 111.499 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.1 m -66.13 -30.91 71.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.341 0.591 . . . . 10.0 110.69 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.52 ' HE1' ' CD1' ' A' ' 137' ' ' ILE . 46.8 mtp -80.31 5.64 14.2 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.701 1.0 . . . . 10.0 113.701 -177.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.47 ' O ' HG21 ' A' ' 96' ' ' ILE . . . 85.46 6.15 84.0 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 119.351 0.978 . . . . 10.0 111.548 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 37.4 mt -97.21 127.27 49.61 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.834 0 CA-C-O 121.672 0.749 . . . . 10.0 111.777 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.61 ' O ' ' HB2' ' A' ' 99' ' ' LYS . 0.7 OUTLIER -88.56 158.87 18.15 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.514 -1.221 . . . . 10.0 108.868 178.134 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.3 m -117.44 127.01 74.97 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.518 0 CA-C-O 122.213 1.006 . . . . 10.0 108.348 171.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 101' ' ' THR . 19.3 m -112.54 154.62 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.231 0 CA-C-N 113.676 -1.602 . . . . 10.0 107.676 176.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 31.9 t70 . . . . . 0 C--N 1.276 -2.608 0 CA-C-N 114.534 -1.212 . . . . 10.0 110.872 -177.065 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtt . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 110.185 -0.302 . . . . 10.0 110.185 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.12 175.04 9.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.707 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -93.29 103.75 15.97 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.802 0.334 . . . . 10.0 110.121 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -83.18 127.13 33.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.345 -0.389 . . . . 10.0 110.895 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.0 t -63.11 139.19 21.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.576 -0.738 . . . . 10.0 110.992 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.86 -32.0 5.93 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.288 -0.414 . . . . 10.0 110.521 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.496 ' HB1' ' CG1' ' A' ' 60' ' ' VAL . . . -158.97 152.98 23.47 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.161 1.171 . . . . 10.0 114.161 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.798 HE21 ' HA ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -99.51 133.17 44.22 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.885 -1.052 . . . . 10.0 108.36 173.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.599 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -124.6 82.21 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 120.063 -0.655 . . . . 10.0 110.099 174.395 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 46.1 tttm -78.25 128.9 34.4 Favored 'General case' 0 C--N 1.314 -0.944 0 O-C-N 120.368 -1.458 . . . . 10.0 109.754 175.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.727 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -158.76 131.11 6.82 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 122.139 0.971 . . . . 10.0 112.262 -176.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -88.63 126.23 35.19 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.746 -1.116 . . . . 10.0 111.423 -174.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.727 HD21 HD11 ' A' ' 11' ' ' LEU . 63.7 mt -143.88 145.07 29.1 Favored Pre-proline 0 CA--C 1.511 -0.538 0 CA-C-O 121.098 0.475 . . . . 10.0 112.09 -174.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.639 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 24.8 Cg_exo -61.17 129.68 29.46 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.408 2.739 . . . . 10.0 112.405 175.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.704 ' HB3' HD13 ' A' ' 54' ' ' LEU . . . -62.23 129.09 39.17 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.343 -1.354 . . . . 10.0 107.343 168.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.88 0.75 86.05 Favored Glycine 0 N--CA 1.441 -1.004 0 O-C-N 125.498 1.749 . . . . 10.0 113.088 -175.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.639 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 3.9 tmtp? -144.46 99.86 3.44 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.147 0.974 . . . . 10.0 112.047 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 39' ' ' CYS . . . -171.2 139.39 1.34 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.407 -1.27 . . . . 10.0 112.972 175.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.639 ' HA ' ' HB3' ' A' ' 39' ' ' CYS . 17.0 m -170.74 -66.88 0.0 OUTLIER Pre-proline 0 N--CA 1.437 -1.094 0 O-C-N 124.322 1.014 . . . . 10.0 110.813 178.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.72 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 86.3 Cg_endo -105.84 129.48 0.06 OUTLIER 'Trans proline' 0 N--CA 1.425 -2.511 0 N-CA-C 117.621 2.123 . . . . 10.0 117.621 -148.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 1.112 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 20.44 -83.87 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.412 0 CA-C-N 109.474 -3.512 . . . . 10.0 115.152 166.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.801 ' HD3' ' HB2' ' A' ' 21' ' ' ALA . 93.1 Cg_exo -39.39 -55.85 1.44 Allowed 'Trans proline' 0 C--N 1.382 2.308 0 CA-C-N 122.561 1.95 . . . . 10.0 112.489 -174.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.856 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 40.3 Cg_endo -91.02 116.1 0.47 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.822 1.681 . . . . 10.0 111.026 154.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.856 ' HB ' ' O ' ' A' ' 23' ' ' PRO . 4.0 t 111.1 -42.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 C-N-CA 119.013 -1.075 . . . . 10.0 109.152 156.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 1.112 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -49.82 -75.11 0.22 Allowed Glycine 0 CA--C 1.523 0.583 0 CA-C-N 113.369 -1.741 . . . . 10.0 113.77 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.68 ' HA ' ' HG3' ' A' ' 30' ' ' GLN . 31.4 Cg_exo -54.79 -33.94 82.92 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.638 2.225 . . . . 10.0 111.39 175.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 24' ' ' VAL . . . -51.72 -98.08 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.113 0.412 . . . . 10.0 112.113 175.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.905 HD22 HD12 ' A' ' 35' ' ' ILE 0.319 0.0 OUTLIER -72.88 -28.09 62.29 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 117.596 -1.642 . . . . 10.0 112.943 -174.412 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.746 ' N ' HD21 ' A' ' 28' ' ' LEU . . . -68.58 -39.36 86.69 Favored Glycine 0 N--CA 1.464 0.501 0 C-N-CA 120.736 -0.745 . . . . 10.0 112.967 -176.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.68 ' HG3' ' HA ' ' A' ' 26' ' ' PRO . 23.5 mt-30 -65.38 -12.6 53.73 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.166 -1.014 . . . . 10.0 110.736 174.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.408 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 96.0 m-70 -100.46 18.28 19.45 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.944 -0.702 . . . . 10.0 109.809 173.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.57 1.94 70.7 Favored Glycine 0 CA--C 1.5 -0.887 0 CA-C-N 114.824 -1.08 . . . . 10.0 113.695 169.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.875 HG11 ' CD2' ' A' ' 66' ' ' PHE . 3.4 t -85.41 146.65 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 113.623 0.971 . . . . 10.0 113.623 -170.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -68.67 100.96 1.21 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.226 0.536 . . . . 10.0 110.95 171.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.905 HD12 HD22 ' A' ' 28' ' ' LEU . 8.7 mm -53.15 -39.94 36.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.943 -1.026 . . . . 10.0 111.217 174.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.89 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 3.7 mpp? -64.02 -47.35 80.6 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 113.357 -1.747 . . . . 10.0 111.076 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.588 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 18.5 tp10 -56.75 -45.01 82.29 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.873 -0.731 . . . . 10.0 110.234 173.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.569 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . 85.0 t80 -55.81 -60.07 3.98 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.661 1.356 . . . . 10.0 114.661 173.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.89 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 24.8 p -61.57 -49.19 77.65 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 114.838 -1.074 . . . . 10.0 112.02 -175.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.471 ' HD3' ' HA ' ' A' ' 40' ' ' LYS . 28.1 mmtp -65.66 -21.26 66.54 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.543 -0.863 . . . . 10.0 109.762 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.795 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 5.7 mtp180 -71.6 -65.35 0.77 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 119.357 -0.937 . . . . 10.0 111.436 167.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.52 ' HE2' ' O ' ' A' ' 14' ' ' PRO . 66.8 t80 -52.8 -47.01 67.9 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.602 -171.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.621 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.8 OUTLIER -60.01 -52.78 63.92 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.944 -1.026 . . . . 10.0 110.254 -176.361 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.9 96.09 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 118.884 -1.127 . . . . 10.0 112.187 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.795 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 9.6 mt-10 -68.74 -37.2 79.24 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 121.583 0.706 . . . . 10.0 111.172 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.611 HG22 HD12 ' A' ' 54' ' ' LEU . 73.0 p -89.14 0.22 56.91 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.125 -0.943 . . . . 10.0 112.567 -173.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.95 -38.34 7.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.007 -0.997 . . . . 10.0 113.008 -175.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -76.05 -36.57 58.98 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.718 -0.673 . . . . 10.0 111.138 -174.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -100.88 23.1 11.09 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 123.013 0.525 . . . . 10.0 109.903 -176.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -52.31 143.83 14.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.158 -0.928 . . . . 10.0 112.789 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.87 20.08 24.95 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 114.948 -1.024 . . . . 10.0 110.57 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.484 ' HB2' HD22 ' A' ' 54' ' ' LEU . 67.4 mtt -138.41 123.41 19.0 Favored 'General case' 0 C--O 1.208 -1.084 0 C-N-CA 117.243 -1.783 . . . . 10.0 114.262 -168.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.0 mm -65.68 91.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 118.626 0.648 . . . . 10.0 109.674 172.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.704 HD13 ' HB3' ' A' ' 15' ' ' ALA . 8.6 mt -81.06 131.49 59.41 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.178 -0.675 . . . . 10.0 109.178 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -71.83 106.54 2.01 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 C-N-CA 122.306 2.004 . . . . 10.0 110.962 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.37 151.63 5.86 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-N 119.449 1.022 . . . . 10.0 111.221 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 95.2 t -134.32 116.79 23.02 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 N-CA-C 110.288 -0.264 . . . . 10.0 110.288 175.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.599 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 14.9 mt -104.19 142.6 17.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.723 0.773 . . . . 10.0 109.623 -172.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 84.5 m -126.6 95.57 4.39 Favored 'General case' 0 N--CA 1.411 -2.383 0 CA-C-N 114.659 -1.155 . . . . 10.0 108.998 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 65' ' ' SER . 1.5 p -89.95 137.49 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.122 0 CA-C-N 119.386 0.994 . . . . 10.0 110.581 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -95.59 179.54 5.1 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.621 -0.718 . . . . 10.0 112.486 -176.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -53.12 -33.16 51.07 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 124.87 1.268 . . . . 10.0 112.444 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.555 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 35.5 t70 -80.85 -9.58 59.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.698 -1.137 . . . . 10.0 111.568 -168.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.555 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 0.2 OUTLIER 81.3 6.6 1.24 Allowed 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 122.632 1.206 . . . . 10.0 110.823 -166.135 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.567 ' O ' HG22 ' A' ' 60' ' ' VAL . 58.6 m -71.4 172.01 10.21 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 112.796 -2.002 . . . . 10.0 107.693 168.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.875 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -168.68 -176.25 2.69 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 119.948 1.249 . . . . 10.0 109.525 175.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.4 p -158.65 166.67 31.5 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 102.79 -3.041 . . . . 10.0 102.79 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 49.4 p90 -161.06 156.88 25.24 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 176.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.0 mt -116.47 167.23 9.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.058 -1.46 . . . . 10.0 107.058 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.3 mt -142.22 114.21 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 107.691 -1.226 . . . . 10.0 107.691 -175.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.547 ' HB3' ' HG2' ' A' ' 73' ' ' PRO . 12.9 mmtp -72.41 99.18 2.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.414 1.102 . . . . 10.0 112.493 -166.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.771 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 14.6 t -62.6 -33.98 13.24 Favored Pre-proline 0 CA--C 1.569 1.693 0 CA-C-N 113.197 -1.82 . . . . 10.0 112.178 169.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.771 ' HD2' ' N ' ' A' ' 72' ' ' THR . 1.0 OUTLIER -40.18 -43.82 3.85 Favored 'Trans proline' 0 C--N 1.386 2.5 0 C-N-CA 124.867 3.711 . . . . 10.0 117.976 -175.245 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 71' ' ' LYS . 40.8 Cg_exo -37.44 -29.7 0.11 Allowed 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 123.52 2.813 . . . . 10.0 114.47 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 1.076 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . . . 75.59 -45.73 0.55 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.997 0.74 . . . . 10.0 112.997 169.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 43.7 t -47.1 -37.11 9.17 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 123.841 0.713 . . . . 10.0 111.728 -175.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -47.24 -56.52 6.57 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.814 0.816 . . . . 10.0 111.534 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.538 HD21 HG23 ' A' ' 111' ' ' THR . 10.8 mp -98.54 -18.72 18.01 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.678 0.752 . . . . 10.0 109.689 -171.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.537 HD23 ' HB1' ' A' ' 132' ' ' ALA . 2.5 tp -64.85 -36.58 84.8 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 114.827 -1.078 . . . . 10.0 108.444 174.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.564 ' C ' ' H ' ' A' ' 82' ' ' ALA . 47.4 mtmt -64.1 -40.27 95.87 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.617 168.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.802 ' HA ' ' HE2' ' A' ' 81' ' ' LYS . 7.0 mmpt? -61.98 33.58 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.982 0.913 . . . . 10.0 113.15 171.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.606 ' HB1' HG13 ' A' ' 100' ' ' VAL . . . -171.42 -48.76 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 122.328 1.061 . . . . 10.0 109.394 -172.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.543 ' HB2' HG12 ' A' ' 85' ' ' ILE . . . -62.3 -41.91 98.91 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 112.846 -1.979 . . . . 10.0 109.326 171.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 97.99 -20.01 52.26 Favored Glycine 0 C--N 1.316 -0.578 0 CA-C-N 115.271 -0.877 . . . . 10.0 111.042 175.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.543 HG12 ' HB2' ' A' ' 83' ' ' ALA . 25.5 pt -60.68 143.17 14.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.325 -0.937 . . . . 10.0 112.337 177.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 85' ' ' ILE . 21.5 mm-40 -160.59 23.63 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.351 -0.84 . . . . 10.0 109.103 175.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -169.04 -59.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.573 -0.74 . . . . 10.0 110.009 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 148.53 -175.06 27.99 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.931 -0.652 . . . . 10.0 111.82 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.414 ' C ' ' H ' ' A' ' 91' ' ' GLU . 49.4 m -160.41 170.03 21.84 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.515 -0.55 . . . . 10.0 109.515 -177.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.4 p -75.63 33.68 0.11 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.504 0.557 . . . . 10.0 112.504 -177.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.414 ' H ' ' C ' ' A' ' 89' ' ' SER . 70.8 mt-10 32.77 72.26 0.62 Allowed Pre-proline 0 N--CA 1.472 0.625 0 C-N-CA 124.349 1.06 . . . . 10.0 113.291 -175.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.52 -170.36 0.99 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.848 2.365 . . . . 10.0 110.944 174.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.858 ' HB2' ' HB ' ' A' ' 96' ' ' ILE . 17.4 mmmt 57.55 -154.35 0.35 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.992 -0.373 . . . . 10.0 109.992 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 30.4 ttt180 -79.77 62.45 4.03 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.17 -0.307 . . . . 10.0 110.17 173.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.471 ' HD3' ' HA ' ' A' ' 95' ' ' LYS . 45.6 mmtt 67.12 29.43 7.86 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.429 0.633 . . . . 10.0 110.458 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.858 ' HB ' ' HB2' ' A' ' 93' ' ' LYS . 11.8 mt -91.37 176.34 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.167 -0.924 . . . . 10.0 109.42 -178.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 136' ' ' GLY . 7.8 p -139.01 -47.16 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 120.929 0.395 . . . . 10.0 111.305 -175.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.615 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -159.29 172.1 35.9 Favored Glycine 0 CA--C 1.493 -1.293 0 N-CA-C 108.08 -2.008 . . . . 10.0 108.08 170.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.912 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -143.13 167.51 21.93 Favored 'General case' 0 CA--C 1.479 -1.759 0 CA-C-O 122.664 1.221 . . . . 10.0 111.119 -169.152 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.749 HG11 ' HB2' ' A' ' 104' ' ' GLN . 2.1 t -131.53 -150.53 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.409 -2.478 0 CA-C-N 111.834 -2.439 . . . . 10.0 107.054 -173.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 0.3 OUTLIER -167.42 133.98 2.21 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 105.894 -1.891 . . . . 10.0 105.894 -164.486 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.481 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 13.1 tpp180 -40.67 -44.91 2.26 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 125.055 1.472 . . . . 10.0 110.939 -171.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.52 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 16.9 tppt? -58.06 -42.94 86.56 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.398 0.888 . . . . 10.0 113.398 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.749 ' HB2' HG11 ' A' ' 100' ' ' VAL . 20.1 mm-40 -66.9 -52.02 48.36 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.089 -0.708 . . . . 10.0 109.089 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.837 HG23 ' HG3' ' A' ' 129' ' ' GLU . 28.7 mm -35.2 -55.29 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 O-C-N 124.074 0.859 . . . . 10.0 110.592 165.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.683 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 23.2 tt0 -50.36 -56.48 11.18 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.815 1.246 . . . . 10.0 113.12 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.531 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 12.5 mm-40 -54.58 -57.64 10.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.826 -1.079 . . . . 10.0 110.703 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.584 ' O ' HG22 ' A' ' 111' ' ' THR . 45.2 mt -50.19 -51.43 17.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.596 -1.183 . . . . 10.0 110.528 173.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.5 ' HB1' HG13 ' A' ' 128' ' ' ILE . . . -53.23 -34.26 56.39 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 112.582 0.586 . . . . 10.0 112.582 174.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.683 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 96.8 mttt -69.7 -52.29 26.89 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 120.853 0.359 . . . . 10.0 111.081 -177.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 108' ' ' ILE . 4.2 t -56.11 -29.12 60.19 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.944 -0.571 . . . . 10.0 111.606 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 1.076 ' HE3' ' HA ' ' A' ' 75' ' ' ALA . 49.7 mttm -103.89 -5.15 22.6 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 112.253 0.464 . . . . 10.0 112.253 -175.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.616 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 14.5 ptp -53.66 -32.87 11.94 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 112.985 0.735 . . . . 10.0 112.985 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 113' ' ' MET . 32.4 Cg_endo -62.83 -31.05 78.12 Favored 'Trans proline' 0 C--N 1.371 1.762 0 CA-C-N 120.651 1.268 . . . . 10.0 111.518 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.62 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 1.0 OUTLIER -102.78 -40.25 6.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.589 -1.187 . . . . 10.0 114.04 -169.357 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.571 ' HG ' HD11 ' A' ' 127' ' ' ILE . 0.9 OUTLIER -63.77 38.66 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 114.258 -1.337 . . . . 10.0 113.264 -174.315 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 43.4 t30 23.0 44.9 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 O-C-N 124.141 0.901 . . . . 10.0 111.024 -168.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.66 ' O ' ' HB2' ' A' ' 119' ' ' ASN . . . -73.88 -82.15 0.06 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.817 -1.083 . . . . 10.0 113.358 -169.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.66 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 5.7 m-20 101.26 -29.92 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 O-C-N 125.203 1.565 . . . . 10.0 110.412 -173.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 41.7 p -155.26 141.01 18.08 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.814 -1.18 . . . . 10.0 107.814 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.55 ' O ' ' HG3' ' A' ' 125' ' ' MET . 3.4 tm? -53.61 -44.05 69.15 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.832 1.049 . . . . 10.0 113.832 -175.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -53.64 -37.09 62.76 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.165 0.507 . . . . 10.0 111.507 174.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.575 ' O ' ' HG3' ' A' ' 126' ' ' LYS . . . -67.07 -47.24 71.87 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 118.241 -1.384 . . . . 10.0 110.276 174.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.538 ' HA ' HD12 ' A' ' 127' ' ' ILE . . . -55.99 -34.38 65.72 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.012 -0.675 . . . . 10.0 110.839 175.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.55 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 80.0 mtp -55.9 -45.38 78.66 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.175 0.805 . . . . 10.0 113.175 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.628 ' HD2' HG13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -63.6 -37.3 86.81 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.709 -0.478 . . . . 10.0 109.709 -178.338 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.628 HG13 ' HD2' ' A' ' 126' ' ' LYS . 83.6 mt -55.72 -64.04 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 CA-C-O 121.85 0.833 . . . . 10.0 111.569 175.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.5 HG13 ' HB1' ' A' ' 109' ' ' ALA . 25.0 mm -50.22 -59.67 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 CA-C-N 113.437 -1.71 . . . . 10.0 111.691 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.837 ' HG3' HG23 ' A' ' 105' ' ' ILE . 6.3 mt-10 -53.2 -40.39 64.4 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.454 -0.793 . . . . 10.0 110.091 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -71.36 -45.17 49.29 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.356 -0.926 . . . . 10.0 111.715 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.439 HG23 ' HB2' ' A' ' 75' ' ' ALA . 97.8 m -46.5 -61.17 1.93 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.185 -1.008 . . . . 10.0 108.906 169.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.537 ' HB1' HD23 ' A' ' 79' ' ' LEU . . . -50.74 -47.99 59.21 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.761 -0.654 . . . . 10.0 111.826 177.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 18.2 ttpt -44.44 -56.41 4.28 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 124.025 0.828 . . . . 10.0 110.448 176.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.5 m -64.54 -30.0 71.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.717 -0.674 . . . . 10.0 111.666 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.475 ' HE1' HD21 ' A' ' 79' ' ' LEU . 29.9 mtm -81.38 3.46 24.33 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 114.077 1.139 . . . . 10.0 114.077 -176.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.518 ' O ' HG12 ' A' ' 97' ' ' VAL . . . 84.07 20.04 59.93 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 120.066 1.303 . . . . 10.0 111.748 -177.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.685 ' CG2' HG23 ' A' ' 100' ' ' VAL . 1.8 mp -107.17 126.23 63.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.683 0.754 . . . . 10.0 112.079 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.912 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -90.31 158.87 16.94 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.522 -1.217 . . . . 10.0 108.997 175.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.472 HG12 HG13 ' A' ' 105' ' ' ILE . 19.1 m -114.71 124.3 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.216 0 N-CA-C 108.002 -1.111 . . . . 10.0 108.002 170.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 100' ' ' VAL . 5.0 m -108.52 157.24 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 CA-C-N 114.194 -1.366 . . . . 10.0 109.723 178.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.3 t70 . . . . . 0 C--N 1.287 -2.15 0 CA-C-N 113.057 -1.883 . . . . 10.0 110.28 174.073 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.624 ' HA ' ' HE1' ' A' ' 1' ' ' MET . 3.7 tpt . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 110.135 -0.32 . . . . 10.0 110.135 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.56 79.58 0.41 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.142 -0.481 . . . . 10.0 111.797 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -133.51 108.57 8.71 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 115.891 -0.595 . . . . 10.0 109.916 172.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.773 ' HD3' ' H ' ' A' ' 4' ' ' LYS . 0.3 OUTLIER -75.69 75.47 2.67 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.573 -0.74 . . . . 10.0 109.618 174.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 93.1 t -79.41 133.33 30.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.64 -0.504 . . . . 10.0 109.64 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.454 ' HB1' ' HA ' ' A' ' 62' ' ' GLU . . . -98.5 -37.54 9.53 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.115 -0.698 . . . . 10.0 109.115 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -164.67 -171.28 2.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 122.026 0.917 . . . . 10.0 113.423 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 54.6 mt-30 -137.83 132.95 33.37 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.737 -1.574 . . . . 10.0 108.316 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.571 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -119.9 80.91 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.88 -0.785 . . . . 10.0 108.88 179.199 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -81.83 122.41 27.68 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 120.063 1.301 . . . . 10.0 107.847 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.617 HD12 HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -156.84 130.3 8.08 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.163 0.982 . . . . 10.0 111.812 -171.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -81.99 120.93 25.88 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.297 -1.32 . . . . 10.0 110.225 -172.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.617 HD22 HD12 ' A' ' 11' ' ' LEU . 73.8 mt -138.57 135.32 17.92 Favored Pre-proline 0 CA--C 1.505 -0.752 0 CA-C-O 121.65 0.738 . . . . 10.0 112.051 -173.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.54 ' HB2' ' CB ' ' A' ' 17' ' ' LYS . 34.3 Cg_exo -54.94 123.6 14.19 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.641 2.894 . . . . 10.0 112.189 174.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.544 ' HB3' HD11 ' A' ' 54' ' ' LEU . . . -62.4 126.56 27.74 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.536 -1.283 . . . . 10.0 107.536 170.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.96 -1.06 85.93 Favored Glycine 0 CA--C 1.529 0.906 0 O-C-N 125.755 1.909 . . . . 10.0 113.238 -173.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.54 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . 6.0 tmtt? -142.81 95.85 2.84 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.185 0.993 . . . . 10.0 112.284 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 39' ' ' CYS . . . -169.61 137.49 1.77 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.41 -1.268 . . . . 10.0 112.644 175.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.532 ' HA ' ' CB ' ' A' ' 39' ' ' CYS . 1.8 t -178.05 -48.93 0.0 OUTLIER Pre-proline 0 N--CA 1.435 -1.182 0 CA-C-N 114.81 -1.086 . . . . 10.0 112.275 174.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.729 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 83.5 Cg_endo -101.53 134.64 0.15 Allowed 'Trans proline' 0 N--CA 1.407 -3.596 0 N-CA-C 116.231 1.589 . . . . 10.0 116.231 -150.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 1.008 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . 16.53 -64.94 0.0 OUTLIER Pre-proline 0 C--N 1.286 -2.184 0 CA-C-N 109.005 -3.725 . . . . 10.0 117.639 154.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.758 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 47.0 Cg_exo -53.87 -63.64 0.21 Allowed 'Trans proline' 0 CA--C 1.565 2.061 0 CA-C-N 123.606 2.324 . . . . 10.0 115.398 -176.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.758 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 58.3 Cg_endo -77.33 -52.24 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.607 2.204 . . . . 10.0 112.553 175.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.936 HG13 HD12 ' A' ' 35' ' ' ILE . 67.4 t -83.48 -44.95 18.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 111.896 -2.411 . . . . 10.0 111.957 -165.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.706 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -45.28 -53.36 7.94 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 114.259 -1.337 . . . . 10.0 114.234 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 1.008 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 50.5 Cg_exo -66.58 -49.29 1.75 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.228 2.619 . . . . 10.0 111.82 177.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.495 ' HB1' ' CG2' ' A' ' 9' ' ' ILE . . . -49.01 -74.85 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.323 0.583 . . . . 10.0 110.911 -177.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.791 HD21 ' HE2' ' A' ' 66' ' ' PHE . 3.5 mt -71.29 -44.99 64.12 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.649 0.981 . . . . 10.0 113.649 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.64 -41.45 98.91 Favored Glycine 0 N--CA 1.459 0.203 0 CA-C-N 116.237 -0.438 . . . . 10.0 113.359 -172.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -61.57 -26.52 68.01 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.94 -0.304 . . . . 10.0 110.491 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -99.06 17.37 19.94 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.847 -0.741 . . . . 10.0 109.982 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.417 ' HA3' ' HZ2' ' A' ' 64' ' ' LYS . . . 77.01 11.91 85.14 Favored Glycine 0 CA--C 1.499 -0.944 0 CA-C-N 114.708 -1.133 . . . . 10.0 112.894 168.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.858 HG11 ' CD2' ' A' ' 66' ' ' PHE . 1.8 t -83.7 148.02 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 113.738 1.014 . . . . 10.0 113.738 -174.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -69.93 95.51 0.94 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.739 0.816 . . . . 10.0 110.606 174.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.936 HD12 HG13 ' A' ' 24' ' ' VAL . 22.0 mm -49.74 -43.27 18.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 114.722 -1.127 . . . . 10.0 111.783 177.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.857 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 10.7 ptm -66.05 -49.53 67.34 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 112.766 -2.016 . . . . 10.0 113.03 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.511 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 36.2 mt-10 -59.41 -32.99 70.69 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.114 -1.035 . . . . 10.0 110.912 176.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.727 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 72.1 t80 -63.49 -59.65 4.38 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 114.485 1.291 . . . . 10.0 114.485 169.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.857 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 23.7 p -60.07 -48.85 79.99 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 114.37 -1.287 . . . . 10.0 111.917 -175.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -65.32 -20.79 66.56 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.198 -0.667 . . . . 10.0 109.198 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.651 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 10.0 mtp180 -77.63 -64.25 1.19 Allowed 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 119.379 -0.928 . . . . 10.0 113.338 169.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.585 ' HZ ' ' HB2' ' A' ' 54' ' ' LEU . 45.3 t80 -55.9 -45.47 78.64 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 120.912 0.387 . . . . 10.0 110.113 -173.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.453 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.9 OUTLIER -59.01 -50.35 74.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.547 -0.751 . . . . 10.0 110.09 -179.587 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.69 96.26 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 118.816 -1.154 . . . . 10.0 112.649 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 5.1 pt-20 -73.78 -32.02 63.58 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 119.622 -0.831 . . . . 10.0 112.545 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.756 HG23 HD13 ' A' ' 54' ' ' LEU . 68.6 p -88.16 1.66 53.9 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 115.674 -0.694 . . . . 10.0 111.213 -177.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -47.56 -37.22 11.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.957 -1.02 . . . . 10.0 111.961 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.44 -45.39 39.0 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 114.194 -1.366 . . . . 10.0 110.538 -174.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.833 ' HD2' ' HZ ' ' A' ' 77' ' ' PHE . 30.2 mtmm -101.14 29.08 4.88 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 121.808 0.813 . . . . 10.0 109.472 -175.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.526 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -56.72 157.58 5.31 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 113.615 -1.63 . . . . 10.0 113.482 177.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.0 20.92 44.3 Favored Glycine 0 CA--C 1.505 -0.538 0 N-CA-C 109.883 -1.287 . . . . 10.0 109.883 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.616 ' HB2' HD22 ' A' ' 54' ' ' LEU . 14.6 mmt -137.28 123.14 20.08 Favored 'General case' 0 C--O 1.21 -1.018 0 C-N-CA 117.31 -1.756 . . . . 10.0 113.401 -167.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.7 mm -64.15 91.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.926 -0.768 . . . . 10.0 108.926 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.756 HD13 HG23 ' A' ' 46' ' ' THR . 6.7 mt -79.19 127.11 80.24 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.552 -0.536 . . . . 10.0 109.552 -176.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.679 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 15.3 Cg_exo -70.85 99.63 0.88 Allowed 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 121.895 1.73 . . . . 10.0 110.397 172.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.12 148.82 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 119.57 1.077 . . . . 10.0 111.315 -172.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.421 ' HB ' ' CD1' ' A' ' 69' ' ' ILE . 71.5 t -126.53 115.01 40.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 120.866 -0.334 . . . . 10.0 110.521 171.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.748 HD13 HD22 ' A' ' 28' ' ' LEU . 17.7 mt -106.47 140.25 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 108.052 -1.092 . . . . 10.0 108.052 -175.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 94.0 m -123.81 99.32 6.22 Favored 'General case' 0 C--N 1.276 -2.607 0 CA-C-N 115.163 -0.926 . . . . 10.0 108.717 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 65' ' ' SER . 2.4 p -86.24 136.76 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.002 0 CA-C-N 118.897 0.771 . . . . 10.0 110.118 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 93.2 m-85 -93.96 170.5 9.49 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.076 -0.966 . . . . 10.0 112.507 -177.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.504 ' HG3' ' C ' ' A' ' 4' ' ' LYS . 16.3 mt-10 -63.28 -20.24 65.29 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.203 -1.362 . . . . 10.0 111.654 -177.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -78.97 -8.87 59.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.404 -0.816 . . . . 10.0 110.51 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.417 ' HZ2' ' HA3' ' A' ' 32' ' ' GLY . 13.1 mmmm 83.15 0.75 1.13 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.442 1.097 . . . . 10.0 110.423 -171.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.517 ' O ' HG22 ' A' ' 60' ' ' VAL . 18.5 m -70.01 -178.77 1.68 Allowed 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 114.915 -1.038 . . . . 10.0 109.117 171.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.858 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -170.32 -175.89 2.05 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 119.679 1.127 . . . . 10.0 110.242 174.622 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.1 p -161.21 166.44 27.78 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 103.302 -2.851 . . . . 10.0 103.302 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.437 ' CB ' HG12 ' A' ' 58' ' ' ILE . 49.1 p90 -161.6 157.08 24.14 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 109.137 -0.69 . . . . 10.0 109.137 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.421 ' CD1' ' HB ' ' A' ' 57' ' ' VAL . 2.0 pp -136.55 152.59 29.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.327 -0.99 . . . . 10.0 108.327 -177.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.728 HG21 HD12 ' A' ' 54' ' ' LEU . 1.8 mm -100.9 132.07 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 108.089 -1.078 . . . . 10.0 108.089 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.679 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 32.4 mmmt -80.42 99.07 7.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.981 0.896 . . . . 10.0 112.194 -171.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.866 ' HB ' ' HB3' ' A' ' 112' ' ' LYS . 78.6 p -64.32 -29.35 3.74 Favored Pre-proline 0 CA--C 1.569 1.681 0 CA-C-N 113.778 -1.556 . . . . 10.0 114.852 172.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.64 ' HG3' ' HB3' ' A' ' 115' ' ' ASP . 72.9 Cg_exo -40.8 -48.36 4.57 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 123.909 3.073 . . . . 10.0 116.925 -172.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.523 ' HD3' ' HB2' ' A' ' 73' ' ' PRO . 88.7 Cg_exo -48.11 -30.29 14.06 Favored 'Trans proline' 0 C--N 1.363 1.323 0 C-N-CA 122.159 1.906 . . . . 10.0 112.733 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 68.44 -44.35 0.51 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.933 0.893 . . . . 10.0 112.865 176.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.534 ' HA ' ' HB2' ' A' ' 79' ' ' LEU . 7.4 m -49.6 -33.47 15.32 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 122.852 0.461 . . . . 10.0 110.468 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.833 ' HZ ' ' HD2' ' A' ' 49' ' ' LYS . 20.9 t80 -43.93 -58.82 2.57 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.92 -1.036 . . . . 10.0 111.822 172.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.833 ' HB3' HG21 ' A' ' 108' ' ' ILE . 6.3 tp -95.98 -14.33 23.11 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.46 -0.496 . . . . 10.0 110.333 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.75 HD23 HG22 ' A' ' 128' ' ' ILE . 2.3 mm? -64.62 -44.31 90.95 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 109.243 -0.651 . . . . 10.0 109.243 171.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.557 ' HD2' ' O ' ' A' ' 80' ' ' LYS . 1.7 tmmm? -63.52 -30.58 71.68 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 115.51 -0.768 . . . . 10.0 109.434 174.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.484 ' HB2' ' HA ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -60.28 -40.17 89.46 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.991 0.737 . . . . 10.0 112.991 173.44 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.64 ' HB3' HG13 ' A' ' 100' ' ' VAL . . . -66.66 -43.14 85.35 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 123.294 1.521 . . . . 10.0 110.636 171.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.53 ' HB2' HG12 ' A' ' 85' ' ' ILE . . . -76.51 164.72 25.68 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 111.125 -2.762 . . . . 10.0 108.563 -175.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -112.52 -3.35 25.59 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 118.665 -1.731 . . . . 10.0 110.876 163.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.685 HG21 HG13 ' A' ' 97' ' ' VAL . 46.9 pt -61.04 113.91 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.586 0.708 . . . . 10.0 111.462 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -76.55 -174.02 2.77 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.929 -0.578 . . . . 10.0 110.956 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -76.77 -15.18 59.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.066 0.46 . . . . 10.0 110.678 -170.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.06 54.07 3.83 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.539 -0.755 . . . . 10.0 114.019 -173.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.2 t -74.73 115.97 14.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.745 0.307 . . . . 10.0 110.841 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.515 ' O ' ' HG2' ' A' ' 91' ' ' GLU . 48.4 t -77.59 -68.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.537 -0.301 . . . . 10.0 110.3 173.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 90' ' ' SER . 3.3 mm-40 -171.8 99.1 0.38 Allowed Pre-proline 0 N--CA 1.464 0.255 0 CA-C-N 115.743 -0.662 . . . . 10.0 109.959 -177.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.56 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 13.9 Cg_endo -85.52 -89.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 122.395 2.063 . . . . 10.0 109.929 172.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 93' ' ' LYS . 29.7 ttpt 50.87 24.32 1.74 Allowed 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.268 1.21 . . . . 10.0 114.268 164.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' A' ' 92' ' ' PRO . 17.2 ptm180 -166.61 -23.12 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.433 -0.792 . . . . 10.0 112.384 -178.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 47.5 mmtt -158.75 34.27 0.22 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.52 -0.548 . . . . 10.0 109.52 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.3 pt 46.6 -161.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 124.402 1.064 . . . . 10.0 113.009 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.685 HG13 HG21 ' A' ' 85' ' ' ILE . 8.3 p -150.83 -43.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 112.384 0.513 . . . . 10.0 112.384 -168.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -166.93 161.27 35.1 Favored Glycine 0 CA--C 1.5 -0.885 0 N-CA-C 109.452 -1.459 . . . . 10.0 109.452 173.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.743 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -145.32 177.85 8.52 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 122.676 1.227 . . . . 10.0 111.649 -165.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.742 ' O ' HG21 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -157.68 -143.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 CA-C-N 111.813 -2.449 . . . . 10.0 105.465 -177.388 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -163.32 143.37 8.84 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 108.117 -1.068 . . . . 10.0 108.117 -157.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.611 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 6.7 tpp180 -42.21 -38.86 1.87 Allowed 'General case' 0 CA--C 1.548 0.876 0 O-C-N 124.727 1.267 . . . . 10.0 110.921 -174.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -57.86 -44.94 86.9 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.178 0.807 . . . . 10.0 113.178 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.526 ' O ' HG13 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -61.39 -47.39 86.02 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.529 -0.915 . . . . 10.0 108.529 177.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.834 HG22 ' HB ' ' A' ' 128' ' ' ILE . 1.9 mp -40.44 -56.51 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 CA-C-N 115.044 -0.98 . . . . 10.0 112.274 168.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.812 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 16.9 tt0 -47.15 -57.86 4.66 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 124.74 1.216 . . . . 10.0 111.835 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.626 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 68.5 mm-40 -52.91 -55.38 23.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.969 -1.014 . . . . 10.0 110.986 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.833 HG21 ' HB3' ' A' ' 78' ' ' LEU . 32.4 mt -51.57 -54.84 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.902 -0.59 . . . . 10.0 109.925 174.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.484 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -50.6 -42.42 55.86 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 124.047 0.842 . . . . 10.0 112.63 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.812 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 70.1 mttt -67.43 -49.68 62.66 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 122.187 0.994 . . . . 10.0 108.876 -176.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 98.5 m -53.02 -22.29 5.59 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 113.302 -1.772 . . . . 10.0 112.77 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.866 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 1.2 ptpp? -131.11 11.2 5.02 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 113.886 1.069 . . . . 10.0 113.886 -178.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.714 ' HG3' ' HD3' ' A' ' 114' ' ' PRO . 8.7 ptp -48.95 -38.35 25.5 Favored Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 118.714 0.688 . . . . 10.0 112.6 167.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.714 ' HD3' ' HG3' ' A' ' 113' ' ' MET . 34.3 Cg_endo -63.06 -27.83 74.0 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 121.42 1.413 . . . . 10.0 112.316 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.64 ' HB3' ' HG3' ' A' ' 73' ' ' PRO . 4.7 m-20 -95.99 -47.48 6.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.041 -0.981 . . . . 10.0 111.838 -175.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.601 HD23 ' HG3' ' A' ' 112' ' ' LYS . 7.5 mp -64.12 -1.92 1.79 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.002 -1.454 . . . . 10.0 111.053 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.44 ' H ' ' C ' ' A' ' 115' ' ' ASP . 0.2 OUTLIER 63.79 45.53 4.4 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.773 -1.558 . . . . 10.0 109.733 176.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.602 ' HB2' ' HB2' ' A' ' 113' ' ' MET . . . -82.5 114.7 21.1 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 113.703 -1.589 . . . . 10.0 112.198 -175.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -66.7 -33.48 75.73 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.246 -0.65 . . . . 10.0 109.246 169.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 45.7 t -150.83 144.46 25.06 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.007 -1.479 . . . . 10.0 107.007 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.592 ' O ' HD13 ' A' ' 121' ' ' LEU . 2.5 tm? -51.61 -34.51 37.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.824 -1.08 . . . . 10.0 112.433 -176.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.546 ' HA ' ' HG3' ' A' ' 125' ' ' MET . 14.4 mm-40 -48.23 -42.7 31.06 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.425 0.631 . . . . 10.0 111.152 174.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.09 -46.45 77.62 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 118.708 -1.197 . . . . 10.0 110.34 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.495 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -57.33 -37.42 72.5 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.149 176.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.546 ' HG3' ' HA ' ' A' ' 122' ' ' GLU . 19.9 mtp -54.74 -38.83 67.64 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.61 0.243 . . . . 10.0 111.505 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.481 ' HE2' ' O ' ' A' ' 122' ' ' GLU . 61.7 mmtt -63.66 -47.97 79.12 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.831 -0.803 . . . . 10.0 108.831 -178.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' A' ' 124' ' ' ALA . 78.9 mt -51.1 -62.86 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-O 121.659 0.742 . . . . 10.0 110.614 176.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.834 ' HB ' HG22 ' A' ' 105' ' ' ILE . 32.9 mm -53.4 -56.66 7.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 113.949 -1.478 . . . . 10.0 112.636 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.405 ' HG3' ' N ' ' A' ' 130' ' ' GLY . 0.0 OUTLIER -54.98 -39.36 68.92 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.546 -0.909 . . . . 10.0 108.546 -179.198 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.452 ' HA2' ' HE2' ' A' ' 133' ' ' LYS . . . -70.73 -46.78 44.28 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.531 -0.758 . . . . 10.0 111.657 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 84.3 m -46.2 -63.49 0.98 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.334 -0.933 . . . . 10.0 109.28 170.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.08 -49.81 39.9 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.873 -0.603 . . . . 10.0 111.358 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.452 ' HE2' ' HA2' ' A' ' 130' ' ' GLY . 26.8 ttpt -48.61 -53.22 19.33 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.711 -1.131 . . . . 10.0 111.55 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 43.5 m -67.63 -28.12 67.46 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 111.792 0.293 . . . . 10.0 111.792 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.512 ' HE3' ' CD1' ' A' ' 137' ' ' ILE . 7.4 mtm -80.05 6.41 11.55 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.614 0.968 . . . . 10.0 113.614 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 81.09 10.81 84.42 Favored Glycine 0 N--CA 1.452 -0.261 0 CA-C-N 119.504 1.047 . . . . 10.0 111.55 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 32.1 mt -100.57 126.54 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-O 121.165 0.507 . . . . 10.0 111.005 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.743 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -85.25 154.01 22.23 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.205 -0.998 . . . . 10.0 109.15 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.7 m -111.21 120.63 62.25 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.488 0 N-CA-C 107.314 -1.365 . . . . 10.0 107.314 169.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.742 HG21 ' O ' ' A' ' 100' ' ' VAL . 29.9 m -101.39 152.11 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 CA-C-N 114.123 -1.399 . . . . 10.0 108.76 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 26.3 t0 . . . . . 0 C--N 1.294 -1.823 0 CA-C-N 112.874 -1.966 . . . . 10.0 112.876 -173.646 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mpp? . . . . . 0 N--CA 1.481 1.087 0 CA-C-O 120.768 0.318 . . . . 10.0 110.204 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.13 -147.52 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.945 -0.761 . . . . 10.0 108.945 -176.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.8 80.33 1.14 Allowed 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.836 0.827 . . . . 10.0 109.816 173.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.434 ' HB3' ' OE2' ' A' ' 62' ' ' GLU . 47.9 tttp -118.1 133.3 56.03 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.667 -1.151 . . . . 10.0 107.929 174.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.2 t -62.12 124.94 17.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 120.721 0.296 . . . . 10.0 110.498 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -99.68 -28.73 13.04 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.454 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -165.93 -167.6 1.11 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.166 -0.924 . . . . 10.0 112.811 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 9.7 pt20 -148.19 135.77 20.69 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.134 -1.394 . . . . 10.0 109.462 178.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.567 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -120.88 80.56 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 109.022 -0.733 . . . . 10.0 109.022 -178.301 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 30.8 tttt -79.61 125.19 29.3 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 120.101 1.318 . . . . 10.0 108.154 177.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.555 HD11 HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.8 130.48 7.35 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 122.024 0.916 . . . . 10.0 111.978 -172.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -82.91 120.8 26.15 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.24 -1.345 . . . . 10.0 110.105 -173.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.555 HD22 HD11 ' A' ' 11' ' ' LEU . 47.4 mt -136.56 137.69 24.6 Favored Pre-proline 0 N--CA 1.443 -0.82 0 CA-C-O 121.696 0.76 . . . . 10.0 112.213 -171.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.596 ' HB2' ' CB ' ' A' ' 17' ' ' LYS . 22.9 Cg_exo -58.91 122.83 12.27 Favored 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 123.603 2.869 . . . . 10.0 111.663 173.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.639 ' HB2' HD13 ' A' ' 54' ' ' LEU . . . -62.08 128.95 38.55 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.176 -1.046 . . . . 10.0 108.176 171.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.71 0.78 81.78 Favored Glycine 0 N--CA 1.442 -0.944 0 O-C-N 126.122 2.139 . . . . 10.0 112.786 -174.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.596 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . 5.9 tmtt? -142.05 91.58 2.36 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.86 0.838 . . . . 10.0 112.024 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.36 135.58 5.18 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.449 -1.25 . . . . 10.0 112.588 175.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.5 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 1.4 t -178.29 -50.52 0.0 OUTLIER Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.191 -0.913 . . . . 10.0 112.37 173.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.655 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 84.9 Cg_endo -101.42 125.59 0.11 Allowed 'Trans proline' 0 N--CA 1.414 -3.197 0 N-CA-C 115.726 1.395 . . . . 10.0 115.726 -154.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 1.11 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 12.04 -89.99 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.534 0 CA-C-N 109.347 -3.569 . . . . 10.0 114.713 168.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.772 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 47.7 Cg_exo -26.72 -56.51 0.1 OUTLIER 'Trans proline' 0 CA--C 1.559 1.742 0 C-N-CA 123.041 2.494 . . . . 10.0 115.824 -161.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.772 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 37.4 Cg_endo -77.75 -72.7 0.01 OUTLIER 'Trans proline' 0 CA--C 1.551 1.327 0 C-N-CA 122.267 1.978 . . . . 10.0 112.327 168.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.946 HG11 HD12 ' A' ' 35' ' ' ILE . 74.9 t -59.55 -54.85 28.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 112.218 -2.264 . . . . 10.0 114.734 -173.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 1.11 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -46.44 -70.27 0.7 Allowed Glycine 0 C--O 1.22 -0.763 0 CA-C-N 114.808 -1.087 . . . . 10.0 113.787 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.588 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 23.5 Cg_exo -47.76 -46.7 20.53 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.489 2.793 . . . . 10.0 112.701 173.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.13 -77.34 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.319 0.581 . . . . 10.0 111.361 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.809 HD21 HD12 ' A' ' 58' ' ' ILE . 3.3 mt -69.39 -52.05 30.68 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 114.088 1.144 . . . . 10.0 114.088 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.2 -40.13 83.24 Favored Glycine 0 N--CA 1.462 0.367 0 CA-C-N 115.562 -0.744 . . . . 10.0 113.374 -172.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -60.11 -26.3 66.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.851 0.358 . . . . 10.0 110.408 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -99.97 17.02 22.01 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 120.008 -0.677 . . . . 10.0 109.771 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.492 ' HA3' ' HD3' ' A' ' 64' ' ' LYS . . . 82.99 7.57 86.98 Favored Glycine 0 CA--C 1.499 -0.941 0 CA-C-N 114.639 -1.164 . . . . 10.0 113.292 167.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.852 HG11 ' CD2' ' A' ' 66' ' ' PHE . 1.6 t -83.1 145.78 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 113.763 1.023 . . . . 10.0 113.763 -173.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.559 ' HB3' ' HG2' ' A' ' 37' ' ' GLU . 55.0 t-20 -70.58 100.28 1.8 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.452 0.644 . . . . 10.0 110.384 173.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.946 HD12 HG11 ' A' ' 24' ' ' VAL . 23.2 mm -53.54 -40.35 41.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 114.753 -1.112 . . . . 10.0 112.036 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 77.0 mtp -65.5 -53.01 48.55 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.189 -1.823 . . . . 10.0 112.434 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.559 ' HG2' ' HB3' ' A' ' 34' ' ' ASN . 7.0 pt-20 -61.52 -31.17 71.17 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 118.168 -1.413 . . . . 10.0 109.99 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.655 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 68.7 t80 -59.52 -58.97 6.26 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 119.502 -0.879 . . . . 10.0 112.849 168.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.448 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -56.22 -50.02 72.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 113.896 -1.502 . . . . 10.0 111.792 -178.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -64.85 -22.42 66.99 Favored 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 118.945 -1.102 . . . . 10.0 108.529 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.794 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 62.9 mtt180 -76.97 -64.3 1.16 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.032 -1.067 . . . . 10.0 111.863 169.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.556 ' CZ ' HG21 ' A' ' 46' ' ' THR . 76.8 t80 -54.18 -48.64 70.71 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-N 119.052 0.842 . . . . 10.0 110.784 -171.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -60.27 -51.75 68.22 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.768 -1.105 . . . . 10.0 110.328 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.07 -37.51 87.5 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.172 -1.011 . . . . 10.0 111.53 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.794 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 15.5 mm-40 -63.44 -45.34 91.33 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 122.02 0.914 . . . . 10.0 110.399 177.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.581 ' CG2' HD12 ' A' ' 54' ' ' LEU . 73.0 p -90.12 3.89 52.0 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.279 -1.328 . . . . 10.0 112.43 -167.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -47.1 -39.04 12.41 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.912 -1.04 . . . . 10.0 111.497 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.95 -48.09 77.89 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 114.125 -1.398 . . . . 10.0 111.532 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -98.84 21.96 10.78 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 123.217 0.607 . . . . 10.0 110.291 -172.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -51.99 133.05 32.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.066 -0.97 . . . . 10.0 112.634 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.37 19.27 10.08 Favored Glycine 0 CA--C 1.504 -0.599 0 N-CA-C 110.707 -0.957 . . . . 10.0 110.707 -176.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.569 ' HB2' HD22 ' A' ' 54' ' ' LEU . 66.9 mtt -138.74 125.5 20.91 Favored 'General case' 0 C--O 1.212 -0.885 0 C-N-CA 117.272 -1.771 . . . . 10.0 114.102 -168.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.6 mm -66.17 89.63 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 109.259 -0.645 . . . . 10.0 109.259 171.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.639 HD13 ' HB2' ' A' ' 15' ' ' ALA . 8.2 mt -79.22 137.44 56.44 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.285 -0.635 . . . . 10.0 109.285 -177.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 54' ' ' LEU . 6.5 Cg_exo -76.28 106.12 2.2 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.13 1.887 . . . . 10.0 110.592 172.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.429 HG23 HG12 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -105.74 153.61 7.18 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-N 119.775 1.17 . . . . 10.0 110.731 -175.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 60.1 t -134.79 119.11 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 C-N-CA 120.789 -0.365 . . . . 10.0 110.244 173.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.809 HD12 HD21 ' A' ' 28' ' ' LEU . 15.7 mt -108.0 140.95 24.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 C-N-CA 119.861 -0.735 . . . . 10.0 109.132 -174.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.8 m -124.91 101.05 6.88 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 114.776 -1.102 . . . . 10.0 108.947 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.533 HG21 ' O ' ' A' ' 65' ' ' SER . 2.6 p -90.0 135.77 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.673 0 C-N-CA 124.016 0.927 . . . . 10.0 111.102 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -96.69 -177.05 3.78 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.746 -0.661 . . . . 10.0 112.572 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.434 ' OE2' ' HB3' ' A' ' 4' ' ' LYS . 29.3 mt-10 -55.07 -32.36 61.88 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.411 -1.268 . . . . 10.0 113.182 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.85 -11.25 59.87 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.611 -0.722 . . . . 10.0 111.334 -170.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.492 ' HD3' ' HA3' ' A' ' 32' ' ' GLY . 11.9 mmpt? 84.21 3.78 0.77 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.184 -1.043 . . . . 10.0 108.184 -164.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.533 ' O ' HG21 ' A' ' 60' ' ' VAL . 73.3 m -71.82 174.46 6.86 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.997 -1.456 . . . . 10.0 108.651 172.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.852 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -168.91 -175.45 2.36 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 119.655 1.116 . . . . 10.0 110.259 175.336 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 p -159.74 166.47 30.39 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 102.821 -3.029 . . . . 10.0 102.821 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.457 ' CB ' HG12 ' A' ' 58' ' ' ILE . 48.2 p90 -163.27 155.1 17.61 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.464 0.649 . . . . 10.0 109.492 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 9.4 pt -120.39 165.94 15.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 114.697 -1.138 . . . . 10.0 108.353 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.429 HG12 HG23 ' A' ' 56' ' ' VAL . 19.8 mt -138.46 113.13 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 107.152 -1.425 . . . . 10.0 107.152 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.577 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 11.6 mmmm -75.78 104.38 6.29 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 122.079 0.942 . . . . 10.0 112.676 -160.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.525 ' O ' ' HD2' ' A' ' 112' ' ' LYS . 65.6 p -64.5 -24.97 1.35 Allowed Pre-proline 0 CA--C 1.566 1.56 0 CA-C-N 113.52 -1.673 . . . . 10.0 114.48 171.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.587 ' HD3' ' CG ' ' A' ' 115' ' ' ASP . 74.9 Cg_exo -38.83 -53.3 1.94 Allowed 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 122.993 2.462 . . . . 10.0 115.005 -173.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.459 ' CD ' ' HB2' ' A' ' 73' ' ' PRO . 19.5 Cg_endo -59.13 99.33 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 121.502 1.468 . . . . 10.0 110.618 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.689 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . . . -72.44 -8.48 55.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.113 -0.494 . . . . 10.0 111.115 -174.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.63 -38.58 46.9 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.916 0.76 . . . . 10.0 112.094 -175.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.532 ' HB3' ' SD ' ' A' ' 52' ' ' MET . 36.2 m-85 -70.7 -54.89 10.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.548 0.69 . . . . 10.0 111.223 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.715 ' HB3' HD11 ' A' ' 108' ' ' ILE . 3.7 mm? -74.86 -30.51 61.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.598 0.713 . . . . 10.0 110.109 -173.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.56 ' HB3' ' HE3' ' A' ' 135' ' ' MET . 0.8 OUTLIER -62.07 -39.08 91.2 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.933 -0.766 . . . . 10.0 108.933 175.311 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.698 ' HG2' HG13 ' A' ' 85' ' ' ILE . 84.0 mttt -62.27 -20.39 64.22 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.042 -0.526 . . . . 10.0 111.775 172.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.491 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 13.5 tptp -62.88 -44.31 96.46 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.553 -0.859 . . . . 10.0 110.848 173.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.506 ' CB ' HG12 ' A' ' 100' ' ' VAL . . . -76.87 -53.09 8.35 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.273 1.429 . . . . 10.0 112.024 171.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.412 ' C ' ' H ' ' A' ' 85' ' ' ILE . . . -73.36 116.66 14.18 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 111.655 -2.52 . . . . 10.0 107.752 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.92 16.95 24.62 Favored Glycine 0 CA--C 1.507 -0.451 0 CA-C-N 120.557 1.526 . . . . 10.0 111.745 -160.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.698 HG13 ' HG2' ' A' ' 80' ' ' LYS . 31.6 pt -68.35 90.9 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-N 114.463 -0.869 . . . . 10.0 111.881 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -158.04 49.87 0.4 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.541 0.686 . . . . 10.0 110.533 -176.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.656 ' HB2' ' HZ3' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -164.54 23.06 0.06 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.496 -0.775 . . . . 10.0 110.783 -178.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.86 49.29 4.12 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.781 -0.723 . . . . 10.0 113.761 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.4 m 41.53 66.18 0.73 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.996 0.739 . . . . 10.0 112.996 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 91' ' ' GLU . 23.7 p -80.5 118.39 22.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.337 -0.392 . . . . 10.0 111.561 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 90' ' ' SER . 39.1 tt0 85.23 99.83 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 124.141 0.9 . . . . 10.0 111.585 171.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.25 111.26 1.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.206 2.604 . . . . 10.0 112.388 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.443 ' HB3' ' H ' ' A' ' 94' ' ' ARG . 31.2 mmtp -79.67 -154.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.972 0.415 . . . . 10.0 111.632 178.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.443 ' H ' ' HB3' ' A' ' 93' ' ' LYS . 21.5 mmt180 -65.1 -35.51 81.36 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.702 -174.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -171.51 18.28 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.693 173.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.565 HD13 ' HB3' ' A' ' 138' ' ' GLU . 25.6 pt -138.03 -175.37 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 120.675 -0.41 . . . . 10.0 110.931 -174.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.523 HG23 ' CG2' ' A' ' 85' ' ' ILE . 11.5 p -156.09 -50.37 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 N-CA-C 112.583 0.586 . . . . 10.0 112.583 -168.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -96.07 149.82 19.44 Favored Glycine 0 CA--C 1.503 -0.695 0 N-CA-C 109.818 -1.313 . . . . 10.0 109.818 171.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.977 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -143.63 141.49 30.61 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 122.668 1.223 . . . . 10.0 110.841 168.554 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.844 ' HB ' ' HG2' ' A' ' 104' ' ' GLN . 1.7 m -163.34 -145.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 111.436 -2.62 . . . . 10.0 106.858 -165.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.455 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 1.3 t -163.84 141.81 7.38 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 120.478 -0.489 . . . . 10.0 110.363 -160.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.603 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 0.0 OUTLIER -44.07 -29.82 0.66 Allowed 'General case' 0 CA--C 1.555 1.137 0 O-C-N 124.606 1.192 . . . . 10.0 112.51 -172.626 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.573 ' N ' ' HD3' ' A' ' 102' ' ' ARG . 17.6 tppt? -60.14 -45.15 93.98 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.688 0.625 . . . . 10.0 112.688 175.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.844 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 0.7 OUTLIER -56.6 -47.14 80.25 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.725 -1.213 . . . . 10.0 107.725 178.26 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.931 HG21 ' HB ' ' A' ' 128' ' ' ILE . 2.0 mp -43.69 -51.16 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.654 0 CA-C-N 114.29 -1.323 . . . . 10.0 112.174 172.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.813 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 23.0 tt0 -52.48 -55.6 20.83 Favored 'General case' 0 CA--C 1.506 -0.724 0 O-C-N 124.287 0.992 . . . . 10.0 111.718 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.73 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 66.1 mm-40 -52.58 -57.21 10.71 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 114.408 -1.269 . . . . 10.0 109.993 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.715 HD11 ' HB3' ' A' ' 78' ' ' LEU . 16.4 mm -52.0 -50.4 34.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.496 -0.774 . . . . 10.0 110.534 175.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.463 ' HB3' HD11 ' A' ' 121' ' ' LEU . . . -53.33 -39.06 63.8 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.711 -0.677 . . . . 10.0 112.736 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.813 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 64.5 mttt -72.42 -50.38 26.75 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 122.045 0.926 . . . . 10.0 109.226 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.9 m -51.32 -34.03 31.71 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 113.522 -1.672 . . . . 10.0 113.325 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.689 ' HE2' ' HA ' ' A' ' 75' ' ' ALA . 5.6 mtmp? -119.16 17.2 13.21 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.506 0.67 . . . . 10.0 109.229 -172.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.813 ' HG3' ' HB2' ' A' ' 118' ' ' ALA . 43.5 ttm -50.66 -47.0 86.01 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 114.708 -1.133 . . . . 10.0 113.048 177.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 113' ' ' MET . 20.3 Cg_endo -57.9 -24.44 64.64 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.168 1.912 . . . . 10.0 112.384 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.587 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 4.3 m-20 -94.26 -49.81 5.55 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.206 -0.906 . . . . 10.0 112.317 -177.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.516 ' CD1' ' HA ' ' A' ' 73' ' ' PRO . 10.1 mp -65.6 38.28 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 114.396 -1.274 . . . . 10.0 113.014 -177.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.422 ' H ' ' C ' ' A' ' 115' ' ' ASP . 9.4 t30 19.59 51.12 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 O-C-N 124.843 1.34 . . . . 10.0 112.025 -171.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.813 ' HB2' ' HG3' ' A' ' 113' ' ' MET . . . -80.93 107.56 13.85 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.131 0.789 . . . . 10.0 113.131 -173.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.45 -37.6 85.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.624 0.726 . . . . 10.0 109.282 169.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.8 p -151.87 144.25 24.08 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.203 -1.406 . . . . 10.0 107.203 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.631 ' O ' ' HG2' ' A' ' 125' ' ' MET . 62.3 tp -51.93 -31.75 30.0 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 114.311 1.226 . . . . 10.0 114.311 -175.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -49.87 -39.76 40.43 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.681 0.753 . . . . 10.0 110.074 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.616 ' O ' ' HG3' ' A' ' 126' ' ' LYS . . . -66.93 -49.46 65.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.771 -1.104 . . . . 10.0 111.186 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.584 ' HB2' HD13 ' A' ' 121' ' ' LEU . . . -56.19 -34.96 66.71 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.92 -0.712 . . . . 10.0 110.719 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.729 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 50.6 mmm -56.64 -45.25 81.7 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.058 0.762 . . . . 10.0 113.058 178.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.746 ' HD3' ' N ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -65.14 -36.36 84.01 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.776 -0.453 . . . . 10.0 109.776 -177.853 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.746 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 73.4 mt -54.37 -65.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-O 121.571 0.7 . . . . 10.0 110.707 174.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.931 ' HB ' HG21 ' A' ' 105' ' ' ILE . 20.5 mm -51.05 -54.26 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 CA-C-N 113.853 -1.521 . . . . 10.0 112.365 -177.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.565 ' HG2' ' HA ' ' A' ' 126' ' ' LYS . 6.6 pt-20 -56.45 -44.58 80.63 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.382 -0.599 . . . . 10.0 109.382 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.519 ' HA2' ' HD2' ' A' ' 133' ' ' LYS . . . -69.33 -46.9 54.92 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.869 -0.605 . . . . 10.0 111.81 -175.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.564 HG21 ' HB2' ' A' ' 75' ' ' ALA . 64.8 m -44.99 -61.29 1.68 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.648 -0.871 . . . . 10.0 108.648 168.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.56 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -49.06 -46.23 44.13 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.895 -0.593 . . . . 10.0 112.353 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.519 ' HD2' ' HA2' ' A' ' 130' ' ' GLY . 65.2 mttm -49.88 -53.64 24.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.815 176.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 9.4 m -67.23 -31.79 72.38 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.482 0.658 . . . . 10.0 110.476 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.56 ' HE3' ' HB3' ' A' ' 79' ' ' LEU . 26.0 mtp -77.67 -1.15 29.59 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 114.071 1.137 . . . . 10.0 114.071 -177.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.419 ' O ' HG11 ' A' ' 97' ' ' VAL . . . 77.66 28.8 56.55 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 119.403 1.001 . . . . 10.0 111.949 -178.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.56 ' HB ' ' HB1' ' A' ' 132' ' ' ALA . 1.7 mp -107.11 124.75 63.1 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.076 0 CA-C-O 121.612 0.72 . . . . 10.0 109.993 176.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.977 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 1.3 pt-20 -87.42 149.89 24.15 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.268 -1.382 . . . . 10.0 107.268 176.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 23.7 m -118.88 136.92 54.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.03 -1.1 . . . . 10.0 108.03 174.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 100' ' ' VAL . 8.2 m -135.65 71.48 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 113.801 1.037 . . . . 10.0 113.801 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.833 -1.08 . . . . 10.0 112.564 141.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 109.491 -0.559 . . . . 10.0 109.491 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.69 -42.83 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 112.483 0.549 . . . . 10.0 112.483 -175.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -100.2 164.35 12.0 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.586 0.588 . . . . 10.0 112.586 -167.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -100.44 115.32 29.78 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.173 -0.922 . . . . 10.0 110.742 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 50.1 t -66.84 138.15 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 122.812 0.445 . . . . 10.0 111.356 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -108.92 -40.91 4.88 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.727 -0.471 . . . . 10.0 109.727 173.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.455 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -156.73 151.03 25.26 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 113.656 0.984 . . . . 10.0 113.656 -176.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -95.27 134.63 37.83 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.842 -1.072 . . . . 10.0 108.26 171.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.6 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.5 OUTLIER -119.95 81.77 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 108.662 -0.866 . . . . 10.0 108.662 171.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -79.05 126.63 30.95 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 120.69 1.587 . . . . 10.0 108.098 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.516 HD21 HD12 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.42 128.56 6.72 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 122.331 1.062 . . . . 10.0 111.603 -176.09 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -83.06 119.07 24.01 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 113.816 -1.538 . . . . 10.0 110.086 -171.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.516 HD12 HD21 ' A' ' 11' ' ' LEU . 58.2 mt -137.73 137.84 22.67 Favored Pre-proline 0 CA--C 1.507 -0.688 0 CA-C-O 121.697 0.76 . . . . 10.0 112.427 -170.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.755 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 33.8 Cg_exo -56.05 123.8 14.72 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.752 2.968 . . . . 10.0 112.131 173.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.691 ' HB1' HD11 ' A' ' 54' ' ' LEU . . . -61.82 127.01 29.37 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 107.538 -1.282 . . . . 10.0 107.538 170.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.18 -5.78 81.84 Favored Glycine 0 N--CA 1.441 -1.014 0 O-C-N 125.765 1.916 . . . . 10.0 113.242 -175.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.755 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 2.2 mmmp? -138.47 104.65 5.21 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.562 1.181 . . . . 10.0 112.247 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -167.76 133.29 1.95 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.049 -1.432 . . . . 10.0 111.712 173.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.652 ' HA ' ' HB2' ' A' ' 39' ' ' CYS . 1.8 t -179.01 -40.66 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.102 -0.954 . . . . 10.0 113.075 177.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.667 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 85.0 Cg_endo -105.75 124.43 0.05 OUTLIER 'Trans proline' 0 N--CA 1.415 -3.146 0 N-CA-C 115.821 1.431 . . . . 10.0 115.821 -161.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 1.099 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 9.75 -84.56 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.545 0 CA-C-N 109.745 -3.389 . . . . 10.0 115.084 165.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.976 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 39.4 Cg_exo -28.74 -57.27 0.13 Allowed 'Trans proline' 0 CA--C 1.562 1.88 0 C-N-CA 122.912 2.408 . . . . 10.0 115.898 -164.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.976 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 6.0 Cg_exo -81.38 -55.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 123.102 2.534 . . . . 10.0 111.919 171.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.97 HG13 HD11 ' A' ' 35' ' ' ILE . 49.6 t -81.01 -52.49 14.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 112.209 -2.269 . . . . 10.0 113.659 -166.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 1.099 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -48.0 -74.07 0.28 Allowed Glycine 0 C--O 1.214 -1.122 0 CA-C-N 114.702 -1.135 . . . . 10.0 113.681 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.635 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 34.7 Cg_exo -46.9 -42.86 24.91 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.514 2.809 . . . . 10.0 112.833 175.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.04 -79.95 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.248 0.547 . . . . 10.0 111.011 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.777 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . 2.2 mt -67.65 -47.1 70.53 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 114.178 1.177 . . . . 10.0 114.178 -177.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.78 -37.24 92.16 Favored Glycine 0 C--N 1.32 -0.351 0 CA-C-N 115.606 -0.724 . . . . 10.0 113.432 -173.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.54 -26.73 67.11 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.848 -0.427 . . . . 10.0 109.848 175.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -99.86 16.66 23.03 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 120.055 -0.658 . . . . 10.0 110.09 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.9 9.21 85.7 Favored Glycine 0 CA--C 1.503 -0.658 0 CA-C-N 114.809 -1.087 . . . . 10.0 113.532 168.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.725 HG13 ' CD2' ' A' ' 66' ' ' PHE . 11.4 t -81.77 147.14 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 114.078 1.14 . . . . 10.0 114.078 -172.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -69.03 96.93 0.82 Allowed 'General case' 0 C--N 1.347 0.457 0 C-N-CA 123.38 0.672 . . . . 10.0 110.765 171.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.97 HD11 HG13 ' A' ' 24' ' ' VAL . 20.0 mm -55.52 -38.41 49.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 121.983 0.897 . . . . 10.0 112.163 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -46.94 74.31 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.611 -1.631 . . . . 10.0 112.076 175.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.648 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 17.7 mt-10 -58.83 -43.74 90.73 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 118.66 -1.216 . . . . 10.0 110.479 174.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.573 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 79.3 t80 -54.71 -56.82 15.15 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 113.599 0.963 . . . . 10.0 113.599 173.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.652 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -55.92 -52.36 64.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.001 -1.454 . . . . 10.0 111.666 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -65.79 -21.61 66.51 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 119.097 -1.041 . . . . 10.0 109.02 -176.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.76 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 85.9 mtt180 -78.13 -63.53 1.37 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 115.311 -0.859 . . . . 10.0 112.144 171.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.559 ' CZ ' HG22 ' A' ' 46' ' ' THR . 75.3 t80 -55.15 -44.38 75.06 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 121.251 0.548 . . . . 10.0 110.367 -172.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.626 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.8 OUTLIER -60.48 -49.25 78.32 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.056 -0.974 . . . . 10.0 109.911 -178.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.17 96.76 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.035 -1.066 . . . . 10.0 112.349 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.76 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 4.6 mm-40 -65.43 -43.37 90.71 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.951 0.882 . . . . 10.0 110.756 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.657 HG22 HD13 ' A' ' 54' ' ' LEU . 71.6 p -92.52 4.66 53.12 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 114.223 -1.353 . . . . 10.0 112.136 -171.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -47.22 -36.89 9.44 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.809 -1.087 . . . . 10.0 112.548 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -81.33 -40.69 23.2 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.678 -0.692 . . . . 10.0 111.823 -176.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.0 mttp -92.01 18.54 7.81 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 108.822 -0.807 . . . . 10.0 108.822 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.42 147.64 7.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.803 -1.089 . . . . 10.0 113.393 -177.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.49 18.96 31.32 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 114.813 -1.085 . . . . 10.0 110.513 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.564 ' HB2' HD22 ' A' ' 54' ' ' LEU . 61.6 mtt -138.34 127.65 24.49 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 116.693 -2.003 . . . . 10.0 114.866 -167.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.4 mm -65.23 91.71 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 O-C-N 121.787 -0.57 . . . . 10.0 109.58 170.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.691 HD11 ' HB1' ' A' ' 15' ' ' ALA . 8.3 mt -84.63 130.65 52.42 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.928 -0.768 . . . . 10.0 108.928 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.507 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 14.3 Cg_exo -71.79 105.91 1.89 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.557 1.505 . . . . 10.0 110.635 173.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.22 142.81 13.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 119.9 1.227 . . . . 10.0 110.597 -174.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 89.4 t -119.71 111.83 34.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 120.332 -0.547 . . . . 10.0 110.431 171.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.771 ' CD1' HD21 ' A' ' 28' ' ' LEU . 15.5 mt -105.8 139.22 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.932 0 N-CA-C 107.972 -1.122 . . . . 10.0 107.972 -174.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.8 m -123.24 97.31 5.36 Favored 'General case' 0 N--CA 1.402 -2.836 0 CA-C-N 114.793 -1.094 . . . . 10.0 108.787 178.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 65' ' ' SER . 4.4 p -86.66 137.37 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.956 0 CA-C-N 119.402 1.001 . . . . 10.0 110.089 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -95.8 172.11 8.23 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.777 0.799 . . . . 10.0 112.857 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -60.38 -22.96 63.93 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.249 -1.341 . . . . 10.0 111.841 -177.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 10.7 m-20 -77.68 -10.47 59.54 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.353 -0.839 . . . . 10.0 111.527 -176.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 55.1 mtpt 83.85 2.5 0.91 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 124.35 1.031 . . . . 10.0 109.459 -166.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.466 ' O ' HG22 ' A' ' 60' ' ' VAL . 14.6 t -73.74 172.13 12.03 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 113.924 -1.489 . . . . 10.0 107.369 174.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.725 ' CD2' HG13 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -169.75 -178.82 3.1 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 120.45 1.477 . . . . 10.0 109.692 175.582 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.3 p -161.83 169.41 21.37 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 103.542 -2.762 . . . . 10.0 103.542 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.435 ' CB ' HG12 ' A' ' 58' ' ' ILE . 49.8 p90 -162.5 159.3 24.75 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.545 -0.539 . . . . 10.0 109.545 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.9 mt -119.62 166.66 13.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 107.256 -1.387 . . . . 10.0 107.256 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.471 HD12 ' CE1' ' A' ' 42' ' ' PHE . 6.4 mm -126.42 122.18 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 107.004 -1.48 . . . . 10.0 107.004 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.594 ' C ' ' HD2' ' A' ' 73' ' ' PRO . 10.5 mmtp -76.64 96.82 4.25 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 122.188 0.994 . . . . 10.0 112.288 -169.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.721 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 3.4 t -59.46 -35.08 26.67 Favored Pre-proline 0 CA--C 1.56 1.362 0 CA-C-N 113.189 -1.823 . . . . 10.0 112.891 166.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.721 ' HD2' ' N ' ' A' ' 72' ' ' THR . 1.2 Cg_endo -39.69 -47.1 3.61 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 124.33 3.354 . . . . 10.0 116.114 -173.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.573 ' HD3' ' HG2' ' A' ' 73' ' ' PRO . 27.9 Cg_exo -61.62 88.57 0.1 OUTLIER 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 121.267 1.311 . . . . 10.0 111.061 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.562 ' HB1' HG22 ' A' ' 131' ' ' THR . . . -62.54 -17.54 60.07 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.404 -0.816 . . . . 10.0 110.923 -177.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.747 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 17.1 m -54.06 -37.93 64.71 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.868 -0.605 . . . . 10.0 111.331 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -75.08 -50.27 16.98 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.22 0.533 . . . . 10.0 111.27 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.758 ' HB3' HD13 ' A' ' 108' ' ' ILE . 3.5 mm? -70.93 -27.53 63.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.186 0.517 . . . . 10.0 110.377 -176.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 62.1 mt -75.16 -21.66 58.63 Favored 'General case' 0 C--O 1.209 -1.039 0 CA-C-N 115.954 -0.566 . . . . 10.0 110.619 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.747 ' HG2' ' O ' ' A' ' 76' ' ' SER . 75.2 mmtt -61.84 -36.82 82.32 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.349 0.595 . . . . 10.0 109.676 171.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -60.8 -51.13 70.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.581 -0.736 . . . . 10.0 112.43 176.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.733 ' CB ' HG12 ' A' ' 100' ' ' VAL . . . -75.08 -64.99 0.93 Allowed 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 123.149 1.452 . . . . 10.0 110.715 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.58 116.64 16.5 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 111.514 -2.584 . . . . 10.0 108.427 176.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -96.53 32.58 6.38 Favored Glycine 0 C--N 1.318 -0.463 0 C-N-CA 118.264 -1.922 . . . . 10.0 111.049 -163.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.478 ' O ' HG13 ' A' ' 85' ' ' ILE . 49.6 pt -70.61 66.5 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 113.412 0.893 . . . . 10.0 113.412 -173.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -72.11 75.55 0.95 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.2 0.524 . . . . 10.0 110.641 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -167.39 -44.72 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.843 -1.071 . . . . 10.0 108.637 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 116.22 -47.66 1.02 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.493 -0.776 . . . . 10.0 111.953 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.9 t 78.89 112.93 0.07 Allowed 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.467 0.707 . . . . 10.0 110.838 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 44.9 m -159.65 38.01 0.19 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.789 -0.819 . . . . 10.0 108.789 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.604 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 7.2 tp10 -171.62 -58.91 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 114.914 -1.039 . . . . 10.0 110.643 -173.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' A' ' 91' ' ' GLU . 88.7 Cg_endo -79.4 33.53 0.5 Allowed 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.161 1.907 . . . . 10.0 113.18 -175.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -76.8 68.8 3.07 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.397 -0.594 . . . . 10.0 109.397 177.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -162.52 -60.7 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.605 -0.725 . . . . 10.0 109.223 -175.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -77.13 -14.21 59.83 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.491 -0.929 . . . . 10.0 108.491 176.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.801 HG23 ' HB3' ' A' ' 138' ' ' GLU . 50.1 mm 73.25 111.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 114.007 -1.451 . . . . 10.0 111.358 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.477 HG22 HG23 ' A' ' 85' ' ' ILE . 4.2 p -58.12 -49.89 80.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 113.761 -1.563 . . . . 10.0 112.167 -173.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.444 ' C ' ' HG3' ' A' ' 99' ' ' LYS . . . -168.95 173.59 43.48 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 108.852 -1.699 . . . . 10.0 108.852 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.665 ' O ' HG13 ' A' ' 100' ' ' VAL . 16.9 mtmt -149.15 177.85 9.26 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-N 117.37 0.585 . . . . 10.0 109.981 -159.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.733 HG12 ' CB ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -166.5 111.55 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.496 -1.108 0 CA-C-O 122.643 1.211 . . . . 10.0 111.816 167.241 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.718 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 1.1 t -41.58 147.27 0.19 Allowed 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 112.071 -2.331 . . . . 10.0 113.954 173.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.56 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 11.5 mmm180 -39.21 -37.78 0.44 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 111.725 -2.489 . . . . 10.0 112.911 -170.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -57.46 -48.39 79.29 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.651 0.611 . . . . 10.0 112.651 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.649 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.5 OUTLIER -59.28 -46.01 89.7 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.115 -0.698 . . . . 10.0 109.115 -178.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.682 HG22 ' HB ' ' A' ' 128' ' ' ILE . 30.6 mm -40.49 -56.89 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 114.883 -1.053 . . . . 10.0 112.448 168.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.83 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 26.6 tt0 -44.51 -60.15 2.1 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.165 0.802 . . . . 10.0 113.165 -178.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 110' ' ' LYS . 25.9 mt-10 -56.11 -49.66 73.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.619 -0.719 . . . . 10.0 110.653 -175.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.758 HD13 ' HB3' ' A' ' 78' ' ' LEU . 21.2 mm -50.62 -55.71 5.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.366 -0.834 . . . . 10.0 110.206 172.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.475 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -49.9 -47.19 52.26 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.298 0.851 . . . . 10.0 113.298 177.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.83 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 12.5 mtpp -67.16 -49.33 65.14 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.664 0.745 . . . . 10.0 109.923 -173.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.582 HG23 ' HG1' ' A' ' 72' ' ' THR . 1.3 m -58.31 -29.92 66.26 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 114.557 -1.201 . . . . 10.0 112.003 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.73 ' HB3' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -93.24 -16.27 24.97 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.589 0.755 . . . . 10.0 110.759 -176.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.971 ' HG3' ' HB1' ' A' ' 118' ' ' ALA . 5.1 ttp -48.75 -44.46 68.71 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 113.448 0.907 . . . . 10.0 113.448 -175.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 113' ' ' MET . 12.6 Cg_endo -56.06 -30.28 77.97 Favored 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 121.836 1.691 . . . . 10.0 111.615 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.435 ' CB ' ' HD3' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -93.34 -45.86 7.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.525 -1.216 . . . . 10.0 111.875 -176.417 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.73 HD22 ' HB3' ' A' ' 112' ' ' LYS . 3.6 mp -63.49 -2.95 1.78 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.127 -1.397 . . . . 10.0 112.218 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 61.0 t30 61.69 45.43 7.96 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.297 -1.32 . . . . 10.0 109.548 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.971 ' HB1' ' HG3' ' A' ' 113' ' ' MET . . . -86.35 121.0 28.31 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.691 -1.595 . . . . 10.0 112.289 -176.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -67.6 -33.22 74.56 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.225 -0.657 . . . . 10.0 109.225 171.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.0 t -154.96 143.87 20.85 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.965 -1.494 . . . . 10.0 106.965 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.575 ' HB2' ' HE3' ' A' ' 113' ' ' MET . 29.7 tp -53.45 -31.11 44.06 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.19 1.552 . . . . 10.0 115.19 -172.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -48.89 -40.16 28.72 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.722 0.692 . . . . 10.0 110.083 175.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.4 -47.82 66.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.622 -1.172 . . . . 10.0 111.04 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.552 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -57.93 -36.61 72.75 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.624 -0.43 . . . . 10.0 110.429 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.53 ' HG3' ' HG ' ' A' ' 121' ' ' LEU . 64.7 mtp -61.82 -34.75 76.5 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.361 0.6 . . . . 10.0 110.169 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -64.12 -51.23 64.92 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.682 -1.144 . . . . 10.0 109.465 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.525 HG21 ' HG ' ' A' ' 116' ' ' LEU . 76.1 mt -50.98 -62.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 CA-C-N 115.266 -0.879 . . . . 10.0 110.727 177.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.682 ' HB ' HG22 ' A' ' 105' ' ' ILE . 26.5 mm -50.36 -54.51 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.078 0 CA-C-N 114.779 -1.1 . . . . 10.0 111.153 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 133' ' ' LYS . 42.5 tt0 -53.56 -44.83 69.6 Favored 'General case' 0 N--CA 1.435 -1.214 0 O-C-N 124.119 0.887 . . . . 10.0 109.227 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.543 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -72.45 -45.93 35.22 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.618 -0.801 . . . . 10.0 111.698 -175.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.562 HG22 ' HB1' ' A' ' 75' ' ' ALA . 85.8 m -46.48 -60.1 2.56 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.359 -0.92 . . . . 10.0 109.575 171.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -48.24 -48.14 35.49 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.396 -0.82 . . . . 10.0 111.926 175.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 130' ' ' GLY . 47.9 mtpt -47.62 -54.25 12.43 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.755 0.659 . . . . 10.0 111.52 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 44.9 m -64.58 -30.82 71.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.879 0.371 . . . . 10.0 111.019 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.42 ' HE2' HD13 ' A' ' 137' ' ' ILE . 43.5 mtm -79.65 7.94 7.47 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.502 0.927 . . . . 10.0 113.502 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.7 3.74 80.3 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 119.436 1.016 . . . . 10.0 111.564 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.475 HG21 ' HA ' ' A' ' 99' ' ' LYS . 39.9 mt -99.29 134.93 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-O 121.712 0.767 . . . . 10.0 112.58 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.801 ' HB3' HG23 ' A' ' 96' ' ' ILE . 0.0 OUTLIER -96.89 160.03 14.59 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.704 -1.135 . . . . 10.0 109.571 177.279 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.3 m -107.66 131.63 57.39 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.647 0 N-CA-C 106.68 -1.6 . . . . 10.0 106.68 170.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.718 ' O ' ' HA ' ' A' ' 101' ' ' THR . 3.4 m -117.22 -178.9 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-N 114.809 -1.087 . . . . 10.0 109.661 -174.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 38.9 t70 . . . . . 0 C--N 1.281 -2.407 0 CA-C-N 112.635 -2.075 . . . . 10.0 109.026 163.961 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.481 1.102 0 CA-C-O 120.829 0.347 . . . . 10.0 110.207 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.39 103.73 4.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.314 -0.403 . . . . 10.0 110.244 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.853 ' HZ2' ' HH ' ' A' ' 61' ' ' TYR . 44.8 mtmt -82.28 152.44 26.33 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.353 0.597 . . . . 10.0 110.402 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.594 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -144.23 112.57 6.46 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.1 -0.955 . . . . 10.0 109.225 -175.549 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.02 139.96 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 122.671 0.388 . . . . 10.0 111.874 -173.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.511 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . . . -112.07 -36.58 5.32 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.134 -0.485 . . . . 10.0 109.708 172.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.467 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -155.4 143.03 19.69 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.25 0.833 . . . . 10.0 113.25 -177.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -93.16 130.1 38.94 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.648 -1.241 . . . . 10.0 107.648 170.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.615 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -119.95 81.66 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.051 -0.722 . . . . 10.0 109.051 176.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.579 ' HZ3' ' HB2' ' A' ' 10' ' ' LYS . 9.6 mtmp? -79.13 127.39 31.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 120.137 1.335 . . . . 10.0 108.413 175.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.68 HD13 HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.3 127.62 6.4 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.295 1.045 . . . . 10.0 111.731 -175.025 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -83.13 121.62 27.29 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.172 -1.377 . . . . 10.0 110.117 -172.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.68 HD22 HD13 ' A' ' 11' ' ' LEU . 69.3 mt -139.16 139.88 24.57 Favored Pre-proline 0 CA--C 1.506 -0.728 0 CA-C-O 121.737 0.78 . . . . 10.0 111.963 -170.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.783 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 11.9 Cg_exo -59.61 124.65 15.9 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 123.426 2.751 . . . . 10.0 111.506 173.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.663 ' HB1' HD11 ' A' ' 54' ' ' LEU . . . -61.87 126.98 29.24 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 107.956 -1.127 . . . . 10.0 107.956 170.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.85 -2.23 88.34 Favored Glycine 0 N--CA 1.44 -1.093 0 O-C-N 125.66 1.85 . . . . 10.0 112.933 -175.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.783 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 74.9 mmtt -140.27 107.74 5.57 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 118.007 0.904 . . . . 10.0 112.422 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -169.77 134.41 1.35 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.92 -1.491 . . . . 10.0 112.052 171.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.532 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 1.6 t 178.92 -39.61 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.542 0 O-C-N 124.157 0.911 . . . . 10.0 113.169 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.726 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 71.8 Cg_endo -103.71 122.44 0.07 OUTLIER 'Trans proline' 0 N--CA 1.417 -2.983 0 N-CA-C 115.935 1.475 . . . . 10.0 115.935 -161.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.948 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 9.12 -82.91 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.451 0 CA-C-N 110.283 -3.144 . . . . 10.0 115.06 162.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.753 ' HD3' ' HB1' ' A' ' 21' ' ' ALA . 70.1 Cg_exo -33.16 -56.97 0.34 Allowed 'Trans proline' 0 CA--C 1.564 2.019 0 C-N-CA 122.182 1.921 . . . . 10.0 115.676 -164.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.726 ' HD2' ' O ' ' A' ' 20' ' ' PRO . 58.2 Cg_endo -78.62 -59.24 0.04 OUTLIER 'Trans proline' 0 CA--C 1.553 1.457 0 C-N-CA 122.734 2.29 . . . . 10.0 113.158 170.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.468 HG11 HG23 ' A' ' 35' ' ' ILE . 3.9 t -80.89 -36.81 15.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 112.441 -2.163 . . . . 10.0 113.388 -165.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.948 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -53.92 -69.03 1.35 Allowed Glycine 0 C--N 1.305 -1.142 0 CA-C-N 113.514 -1.676 . . . . 10.0 112.471 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.467 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 70.2 Cg_exo -50.87 -43.41 47.21 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.845 2.363 . . . . 10.0 112.117 172.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.451 ' O ' ' HD2' ' A' ' 31' ' ' HIS . . . -50.81 -96.54 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 112.372 0.508 . . . . 10.0 112.372 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.698 HD23 ' N ' ' A' ' 29' ' ' GLY 0.307 0.0 OUTLIER -75.11 -26.36 59.19 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 118.152 -1.419 . . . . 10.0 113.573 -176.233 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.698 ' N ' HD23 ' A' ' 28' ' ' LEU . . . -68.53 -40.99 85.99 Favored Glycine 0 N--CA 1.465 0.589 0 C-N-CA 120.926 -0.654 . . . . 10.0 112.68 -175.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -60.96 -21.41 63.45 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.112 -0.635 . . . . 10.0 110.099 175.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.451 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 97.8 m-70 -99.09 19.81 14.53 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.629 -0.828 . . . . 10.0 110.215 178.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.555 ' HA3' ' HD2' ' A' ' 64' ' ' LYS . . . 86.59 4.61 82.82 Favored Glycine 0 CA--C 1.501 -0.785 0 CA-C-N 115.201 -0.909 . . . . 10.0 113.363 167.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.659 HG12 ' CD2' ' A' ' 66' ' ' PHE . 4.6 t -83.01 146.2 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 113.414 0.894 . . . . 10.0 113.414 -172.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.434 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 0.6 OUTLIER -69.07 99.96 1.18 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.818 0.447 . . . . 10.0 110.321 171.731 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.533 ' CD1' ' HA2' ' A' ' 25' ' ' GLY . 83.2 mt -53.0 -40.14 35.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.807 0.813 . . . . 10.0 111.594 175.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 72.2 mtm -68.04 -46.66 70.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.67 -1.605 . . . . 10.0 111.783 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.555 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 10.4 tp10 -56.13 -45.25 79.64 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.298 -0.561 . . . . 10.0 109.758 174.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.573 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 48.0 t80 -57.04 -55.34 35.92 Favored 'General case' 0 C--O 1.212 -0.877 0 N-CA-C 113.97 1.1 . . . . 10.0 113.97 171.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -50.35 71.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.663 -1.153 . . . . 10.0 111.886 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.72 -22.76 66.63 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 119.368 -0.933 . . . . 10.0 108.753 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.737 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 87.2 mtt180 -76.95 -64.18 1.19 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.264 -0.88 . . . . 10.0 112.168 171.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.557 ' CZ ' HG23 ' A' ' 46' ' ' THR . 80.2 t80 -55.27 -47.38 75.58 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.419 0.628 . . . . 10.0 110.094 -171.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.625 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.8 OUTLIER -61.02 -48.24 82.72 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.489 -1.232 . . . . 10.0 110.317 -177.46 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.48 91.25 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.076 -1.05 . . . . 10.0 112.119 177.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.737 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 7.7 mm-40 -65.62 -40.35 92.48 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.823 0.821 . . . . 10.0 110.751 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.616 ' HB ' ' CB ' ' A' ' 15' ' ' ALA . 73.0 p -93.11 2.87 56.52 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 114.436 -1.256 . . . . 10.0 112.835 -170.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.11 -35.4 11.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.993 -1.003 . . . . 10.0 112.281 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -81.43 -43.1 19.4 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 115.314 -0.857 . . . . 10.0 111.561 -176.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -92.17 20.65 5.75 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.799 -0.815 . . . . 10.0 108.799 -176.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.3 149.21 7.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.952 -1.022 . . . . 10.0 113.09 -178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.41 18.95 36.91 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.937 -1.029 . . . . 10.0 110.671 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.718 ' SD ' ' HB2' ' A' ' 77' ' ' PHE . 59.8 mtt -140.38 125.55 18.64 Favored 'General case' 0 C--O 1.212 -0.902 0 C-N-CA 117.419 -1.712 . . . . 10.0 113.941 -165.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 50.1 mm -66.82 90.73 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 118.657 0.662 . . . . 10.0 109.665 172.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.663 HD11 ' HB1' ' A' ' 15' ' ' ALA . 10.0 mt -81.7 140.12 47.39 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.426 -0.583 . . . . 10.0 109.426 -177.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.701 ' HG2' ' HG2' ' A' ' 74' ' ' PRO . 3.6 Cg_exo -79.35 103.85 1.67 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.228 1.952 . . . . 10.0 110.896 172.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.99 155.64 3.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 119.885 1.22 . . . . 10.0 111.178 -175.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.448 HG12 ' HG2' ' A' ' 10' ' ' LYS . 96.7 t -134.79 112.51 15.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.015 174.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.615 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 24.4 mt -102.63 142.27 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.716 0 N-CA-C 108.133 -1.062 . . . . 10.0 108.133 -174.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.7 m -124.77 96.63 4.95 Favored 'General case' 0 N--CA 1.406 -2.648 0 CA-C-N 115.011 -0.995 . . . . 10.0 108.861 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.499 ' HA ' ' CB ' ' A' ' 66' ' ' PHE . 2.0 p -90.5 135.85 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 CA-C-N 119.479 1.036 . . . . 10.0 110.268 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.853 ' HH ' ' HZ2' ' A' ' 3' ' ' LYS . 82.8 m-85 -91.86 170.6 9.75 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.99 -1.004 . . . . 10.0 112.635 -176.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.594 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 14.2 mt-10 -60.4 -20.78 60.9 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.684 -1.598 . . . . 10.0 112.03 -176.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.441 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 2.9 m-20 -85.53 -4.72 59.24 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.329 -0.85 . . . . 10.0 112.09 -176.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.555 ' HD2' ' HA3' ' A' ' 32' ' ' GLY . 40.2 mmtt 81.99 0.65 1.45 Allowed 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 122.188 0.994 . . . . 10.0 110.334 -169.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.449 ' O ' HG23 ' A' ' 60' ' ' VAL . 17.4 m -70.83 168.43 16.8 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.736 -1.574 . . . . 10.0 107.289 173.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.659 ' CD2' HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -168.94 -177.12 2.87 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 120.687 1.585 . . . . 10.0 109.818 176.115 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.2 p -162.6 169.35 20.34 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 103.077 -2.935 . . . . 10.0 103.077 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.435 ' CB ' HG12 ' A' ' 58' ' ' ILE . 42.4 p90 -163.39 159.91 22.92 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.756 -0.831 . . . . 10.0 108.756 177.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 23.7 pt -129.19 161.57 38.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.468 -1.308 . . . . 10.0 107.468 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.414 HD11 ' CG2' ' A' ' 46' ' ' THR . 7.6 mt -126.95 120.15 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 106.568 -1.641 . . . . 10.0 106.568 -176.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.785 ' HE2' ' HA ' ' A' ' 71' ' ' LYS . 5.7 mmmm -76.4 98.2 4.49 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 122.325 1.06 . . . . 10.0 113.042 -160.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.615 ' O ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -44.6 -44.45 20.68 Favored Pre-proline 0 CA--C 1.56 1.337 0 CA-C-N 112.682 -2.054 . . . . 10.0 114.997 164.607 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.632 ' HD3' ' CG ' ' A' ' 115' ' ' ASP . 2.4 Cg_endo -39.43 -56.01 1.41 Allowed 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 124.268 3.312 . . . . 10.0 116.205 -171.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.701 ' HG2' ' HG2' ' A' ' 55' ' ' PRO . 88.9 Cg_exo -43.5 -34.74 5.35 Favored 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 123.207 2.604 . . . . 10.0 113.729 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.614 ' HB2' HD21 ' A' ' 79' ' ' LEU . . . 73.98 -31.77 0.22 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.679 0.992 . . . . 10.0 113.679 170.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.678 ' O ' ' HD3' ' A' ' 80' ' ' LYS . 47.9 t -42.24 -56.96 2.72 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 123.753 0.658 . . . . 10.0 111.958 -175.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.718 ' HB2' ' SD ' ' A' ' 52' ' ' MET . 32.7 p90 -55.9 -37.02 68.33 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.574 0.583 . . . . 10.0 112.574 -175.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 78' ' ' LEU . 1.3 tp -88.55 -32.2 18.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.871 0.367 . . . . 10.0 110.595 -174.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.614 HD21 ' HB2' ' A' ' 75' ' ' ALA . 4.3 mm? -63.8 -33.15 75.03 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.47 -0.567 . . . . 10.0 109.47 172.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.678 ' HD3' ' O ' ' A' ' 76' ' ' SER . 3.9 mptp? -56.04 -46.47 78.87 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.816 -0.629 . . . . 10.0 110.12 172.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 81' ' ' LYS . 2.8 mmtm -57.23 -43.42 82.86 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.509 0.929 . . . . 10.0 113.509 -176.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.491 ' HB3' HG13 ' A' ' 100' ' ' VAL . . . -65.94 -49.0 69.47 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 123.044 1.402 . . . . 10.0 110.086 175.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.489 ' HB2' ' HA3' ' A' ' 98' ' ' GLY . . . -63.61 -30.02 71.19 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 111.306 -2.679 . . . . 10.0 110.358 -171.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 96.47 -14.58 64.1 Favored Glycine 0 CA--C 1.491 -1.466 0 C-N-CA 120.448 -0.882 . . . . 10.0 111.424 172.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.564 HG13 ' HG3' ' A' ' 80' ' ' LYS . 6.0 pt -60.73 -162.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 114.4 -0.9 . . . . 10.0 111.693 170.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.43 ' H ' ' HB ' ' A' ' 85' ' ' ILE . 1.9 tm-20 87.62 80.3 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.31 -1.313 . . . . 10.0 109.5 -174.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -179.49 -41.32 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.062 -1.427 . . . . 10.0 107.702 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 171.93 155.96 11.61 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 114.294 -1.321 . . . . 10.0 110.727 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.9 m -161.88 -86.11 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.333 -0.617 . . . . 10.0 109.333 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.1 m 50.06 35.26 9.57 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.287 0.847 . . . . 10.0 113.287 171.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.527 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 1.5 tm-20 -171.72 -56.66 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 119.257 -0.402 . . . . 10.0 111.727 -178.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 91' ' ' GLU . 21.6 Cg_exo -66.93 20.37 0.1 Allowed 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 122.953 2.435 . . . . 10.0 114.817 -171.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.652 ' HZ2' ' HB3' ' A' ' 93' ' ' LYS . 8.7 mtpm? -79.68 67.86 5.57 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.842 -0.799 . . . . 10.0 108.842 173.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.403 ' C ' ' H ' ' A' ' 96' ' ' ILE . 6.7 ttp180 -160.31 -80.43 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.526 -170.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.533 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 46.5 tttp -86.39 35.24 0.65 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.211 -0.663 . . . . 10.0 109.211 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.533 ' HB ' ' O ' ' A' ' 95' ' ' LYS . 5.1 mt 75.4 170.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 114.865 -1.061 . . . . 10.0 110.569 -175.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.478 ' N ' ' CG2' ' A' ' 96' ' ' ILE . 7.3 p -149.84 -53.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 112.358 0.503 . . . . 10.0 112.358 -172.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.767 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -111.17 154.72 16.52 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 109.16 -1.576 . . . . 10.0 109.16 169.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.752 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 21.1 pttp -153.8 153.43 32.14 Favored 'General case' 0 CA--C 1.474 -1.958 0 CA-C-O 122.358 1.075 . . . . 10.0 109.865 164.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.61 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.7 OUTLIER -164.62 -162.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.414 -2.251 0 CA-C-N 111.976 -2.374 . . . . 10.0 105.958 -167.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.54 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 9.6 p -119.49 159.37 24.42 Favored 'General case' 0 C--N 1.275 -2.639 0 C-N-CA 119.494 -0.882 . . . . 10.0 111.838 -170.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.665 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 29.0 mmt180 -44.0 -41.92 5.69 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.193 -1.367 . . . . 10.0 110.334 170.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 3.1 tppp? -59.03 -44.8 91.8 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.672 0.619 . . . . 10.0 112.672 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.62 ' O ' HG12 ' A' ' 108' ' ' ILE . 58.9 mm-40 -58.33 -52.85 63.87 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.763 -0.829 . . . . 10.0 108.763 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.665 ' HB ' ' O ' ' A' ' 102' ' ' ARG . 31.4 mm -38.04 -51.68 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.704 0 CA-C-N 114.318 -1.31 . . . . 10.0 111.899 167.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.749 ' HA ' ' SD ' ' A' ' 125' ' ' MET . 34.2 tt0 -52.95 -58.7 6.07 Favored 'General case' 0 C--O 1.215 -0.746 0 C-N-CA 124.627 1.171 . . . . 10.0 113.55 -177.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -58.36 -47.08 84.95 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 119.913 -0.715 . . . . 10.0 110.554 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.62 HG12 ' O ' ' A' ' 104' ' ' GLN . 19.8 mm -48.46 -60.75 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.558 166.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.545 ' HB1' HG13 ' A' ' 128' ' ' ILE . . . -51.33 -38.01 50.81 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.138 0.422 . . . . 10.0 112.138 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.679 ' O ' ' HG2' ' A' ' 113' ' ' MET . 83.4 mttt -70.36 -54.44 12.49 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.854 -174.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.718 HG22 ' HG3' ' A' ' 112' ' ' LYS . 5.8 t -57.05 -24.65 55.36 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.804 -0.635 . . . . 10.0 111.208 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.88 ' HZ1' HD13 ' A' ' 116' ' ' LEU . 5.8 mtpm? -105.98 -11.0 16.32 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.69 0.626 . . . . 10.0 112.69 -175.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.679 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 22.7 ptm -51.82 -31.5 6.36 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 113.845 1.054 . . . . 10.0 113.845 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 113' ' ' MET . 31.6 Cg_endo -63.02 -28.02 74.45 Favored 'Trans proline' 0 C--N 1.368 1.558 0 CA-C-N 121.063 1.415 . . . . 10.0 111.31 174.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.632 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -100.19 -38.51 8.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.406 -1.27 . . . . 10.0 113.431 -172.115 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.88 HD13 ' HZ1' ' A' ' 112' ' ' LYS . 3.0 mp -62.93 -1.37 0.88 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.928 -1.033 . . . . 10.0 112.021 -175.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.439 ' H ' ' C ' ' A' ' 115' ' ' ASP . 56.7 t30 58.38 65.56 1.24 Allowed 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.084 -1.417 . . . . 10.0 109.596 175.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.537 ' HB2' ' HB1' ' A' ' 123' ' ' ALA . . . -142.86 143.07 31.93 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.88 -1.054 . . . . 10.0 112.142 -171.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.444 ' C ' HD21 ' A' ' 119' ' ' ASN . 0.2 OUTLIER -65.72 -74.93 0.1 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.444 -1.253 . . . . 10.0 109.553 176.139 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.7 m -82.52 147.79 28.46 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.371 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.656 HD11 ' C ' ' A' ' 121' ' ' LEU . 1.5 tm? -55.11 -34.36 63.62 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.462 -0.57 . . . . 10.0 109.462 163.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -50.78 -38.51 48.58 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.307 0.575 . . . . 10.0 111.102 173.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -67.61 -45.57 75.04 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 118.635 -1.226 . . . . 10.0 110.466 175.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.56 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -56.29 -32.78 64.9 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.487 -0.324 . . . . 10.0 110.848 175.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.749 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 84.0 mmm -58.17 -37.09 74.06 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.017 0.437 . . . . 10.0 110.89 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.521 ' HA ' ' HG2' ' A' ' 129' ' ' GLU . 3.5 mptp? -62.56 -54.28 42.13 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.233 -0.894 . . . . 10.0 111.933 177.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.626 HD11 HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -51.55 -57.93 2.75 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 C-N-CA 119.178 -1.009 . . . . 10.0 110.595 178.375 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.593 ' HB ' HG23 ' A' ' 105' ' ' ILE . 24.1 mm -50.73 -58.41 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 114.578 -1.192 . . . . 10.0 112.448 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.521 ' HG2' ' HA ' ' A' ' 126' ' ' LYS . 11.6 pt-20 -53.42 -44.32 68.68 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.862 -0.792 . . . . 10.0 108.862 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.4 -47.77 55.66 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.779 -0.725 . . . . 10.0 111.329 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.529 HG23 ' HE3' ' A' ' 135' ' ' MET . 69.6 m -43.07 -67.18 0.3 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.105 -1.048 . . . . 10.0 108.727 170.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.528 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . . . -51.18 -48.63 61.9 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.851 -0.613 . . . . 10.0 112.331 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -47.81 -52.81 17.53 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.95 -0.568 . . . . 10.0 111.919 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 28.9 t -64.72 -29.36 70.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.752 0.31 . . . . 10.0 110.98 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.529 ' HE3' HG23 ' A' ' 131' ' ' THR . 56.9 mtm -82.45 2.25 33.61 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 114.29 1.218 . . . . 10.0 114.29 -175.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.78 10.9 69.02 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 120.148 1.34 . . . . 10.0 111.777 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.767 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 2.7 mp -99.09 125.26 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 CA-C-O 121.64 0.733 . . . . 10.0 110.593 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.752 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -91.26 157.12 17.33 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.618 -1.174 . . . . 10.0 108.915 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.43 ' C ' HG11 ' A' ' 140' ' ' VAL . 17.6 m -117.47 127.84 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.726 -0.472 . . . . 10.0 109.726 174.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 100' ' ' VAL . 18.5 m -147.28 74.49 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 N-CA-C 116.151 1.908 . . . . 10.0 116.151 -170.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.501 ' OD1' ' HB2' ' A' ' 102' ' ' ARG . 1.3 m-20 . . . . . 0 C--N 1.289 -2.043 0 C-N-CA 119.823 -0.751 . . . . 10.0 110.844 145.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 120.805 0.336 . . . . 10.0 110.759 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.91 141.28 22.4 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 173.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -140.9 90.36 2.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.848 0.356 . . . . 10.0 110.688 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.652 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . 61.4 tttp -107.15 125.12 50.67 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.274 -0.639 . . . . 10.0 109.274 175.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.4 t -61.21 124.7 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 120.813 0.34 . . . . 10.0 110.528 -174.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.97 -27.0 8.6 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 120.54 -0.464 . . . . 10.0 110.344 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.588 ' HB2' ' CG1' ' A' ' 60' ' ' VAL . . . -160.45 174.64 13.8 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.222 0.823 . . . . 10.0 113.222 177.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.509 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 23.2 mm-40 -129.86 127.32 39.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.399 -1.273 . . . . 10.0 108.244 177.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.779 HG23 ' HG ' ' A' ' 28' ' ' LEU . 1.4 mm -116.2 87.01 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.121 -0.696 . . . . 10.0 109.121 -178.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.41 ' HG2' HG22 ' A' ' 57' ' ' VAL . 15.4 mtpp -78.28 142.68 37.63 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 121.097 1.771 . . . . 10.0 110.255 175.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 24' ' ' VAL . 1.0 OUTLIER -156.81 135.48 11.6 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.649 -0.705 . . . . 10.0 109.115 -176.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -96.3 113.22 24.79 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.635 -0.876 . . . . 10.0 108.635 172.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.469 HD11 HD21 ' A' ' 11' ' ' LEU . 31.5 mt -132.51 145.87 59.08 Favored Pre-proline 0 CA--C 1.501 -0.913 0 CA-C-O 121.147 0.499 . . . . 10.0 111.269 -169.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.738 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 5.8 Cg_exo -71.66 123.15 9.19 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 123.102 2.534 . . . . 10.0 111.31 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.637 ' HB1' HD13 ' A' ' 54' ' ' LEU . . . -60.32 127.41 31.65 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 107.936 -1.135 . . . . 10.0 107.936 172.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.22 -1.05 89.34 Favored Glycine 0 N--CA 1.438 -1.19 0 O-C-N 125.671 1.857 . . . . 10.0 112.354 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.738 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 45.2 tptt -139.52 110.76 6.97 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 122.943 1.354 . . . . 10.0 112.588 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.415 ' CB ' HD22 ' A' ' 43' ' ' ASN . . . -161.4 128.95 4.13 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.669 -2.06 . . . . 10.0 108.753 168.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.49 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 25.3 p -158.7 66.8 3.21 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 105.897 -1.89 . . . . 10.0 105.897 -174.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.685 ' HG3' HG23 ' A' ' 35' ' ' ILE . 5.7 Cg_exo 12.37 49.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.659 1 C-N-CA 130.673 7.582 . . . . 10.0 116.814 -175.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.586 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -57.6 167.75 1.26 Allowed Pre-proline 0 N--CA 1.441 -0.916 0 CA-C-N 112.545 -2.116 . . . . 10.0 109.601 164.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.586 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 72.9 Cg_exo -36.97 -44.35 1.12 Allowed 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 123.648 2.899 . . . . 10.0 114.967 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 22' ' ' PRO . 18.7 Cg_exo -36.29 -66.14 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.808 3.005 . . . . 10.0 114.508 168.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.967 HG13 HD13 ' A' ' 35' ' ' ILE . 58.9 t -85.61 -56.27 5.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 114.433 -1.258 . . . . 10.0 114.02 -164.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.22 -67.67 1.28 Allowed Glycine 0 CA--C 1.521 0.455 0 O-C-N 124.37 1.044 . . . . 10.0 113.276 -174.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.431 ' HD2' ' O ' ' A' ' 22' ' ' PRO . 90.5 Cg_exo -52.03 -46.23 33.8 Favored 'Trans proline' 0 C--O 1.222 -0.289 0 C-N-CA 123.876 3.051 . . . . 10.0 112.8 174.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.5 -79.28 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.296 0.569 . . . . 10.0 111.799 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.889 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . 1.5 mt -67.73 -45.03 76.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.793 -0.64 . . . . 10.0 112.694 -176.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.49 -38.16 90.28 Favored Glycine 0 C--N 1.324 -0.126 0 CA-C-N 115.912 -0.585 . . . . 10.0 112.674 -173.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -65.07 -21.89 66.89 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.915 0.388 . . . . 10.0 110.752 177.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -98.86 16.62 21.75 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.345 0.593 . . . . 10.0 109.958 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.0 2.9 89.42 Favored Glycine 0 CA--C 1.503 -0.68 0 CA-C-N 115.092 -0.958 . . . . 10.0 113.657 168.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.654 HG11 ' CD2' ' A' ' 66' ' ' PHE . 2.0 t -78.96 148.06 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 113.009 0.744 . . . . 10.0 113.009 -173.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.512 ' OD1' ' HB3' ' A' ' 37' ' ' GLU . 0.3 OUTLIER -71.06 90.71 0.86 Allowed 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.919 0.866 . . . . 10.0 109.997 172.532 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.967 HD13 HG13 ' A' ' 24' ' ' VAL . 11.5 mm -53.54 -40.87 43.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 113.818 -1.537 . . . . 10.0 112.081 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 50.6 mtm -66.0 -47.15 75.43 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.594 -1.639 . . . . 10.0 111.967 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.606 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 32.3 tt0 -58.71 -37.68 76.66 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 118.661 -1.216 . . . . 10.0 109.612 173.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.579 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 81.6 t80 -54.61 -58.95 5.5 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 119.554 -0.859 . . . . 10.0 112.767 170.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -54.51 -53.34 55.72 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 114.069 -1.423 . . . . 10.0 111.324 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -67.05 -21.9 65.89 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 119.694 -0.803 . . . . 10.0 109.749 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.8 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 13.7 mtm180 -76.56 -62.48 1.61 Allowed 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 119.543 -0.863 . . . . 10.0 112.286 169.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.524 ' CZ ' HG21 ' A' ' 46' ' ' THR . 63.9 t80 -52.41 -42.06 63.74 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 118.006 0.366 . . . . 10.0 110.536 -172.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.536 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.9 OUTLIER -60.86 -50.08 74.87 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.817 179.512 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.72 -41.58 99.23 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.742 -0.783 . . . . 10.0 112.341 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.8 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 4.4 mm-40 -65.82 -44.23 86.21 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.751 0.786 . . . . 10.0 110.81 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.652 HG21 HD12 ' A' ' 54' ' ' LEU . 76.8 p -89.79 5.09 47.62 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.534 -1.212 . . . . 10.0 111.85 -170.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.88 -40.22 9.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.955 -1.02 . . . . 10.0 112.224 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.88 -32.7 65.58 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.692 -0.685 . . . . 10.0 111.166 -176.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.419 ' HB3' ' HE3' ' A' ' 52' ' ' MET . 59.1 mttp -99.42 17.64 19.74 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.791 0.837 . . . . 10.0 110.105 -175.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -50.26 142.3 10.24 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.172 -0.922 . . . . 10.0 112.873 -176.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.31 18.92 31.86 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.541 -0.754 . . . . 10.0 111.456 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.603 ' SD ' ' HB2' ' A' ' 77' ' ' PHE . 45.7 mtm -141.15 129.72 22.68 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 116.853 -1.939 . . . . 10.0 114.386 -167.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.3 mm -67.52 92.06 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.567 -0.531 . . . . 10.0 109.567 172.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.652 HD12 HG21 ' A' ' 46' ' ' THR . 6.5 mt -81.2 130.02 64.43 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 109.697 -0.483 . . . . 10.0 109.697 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.822 ' HG2' ' HG3' ' A' ' 74' ' ' PRO . 18.0 Cg_exo -71.31 103.02 1.34 Allowed 'Trans proline' 0 C--N 1.331 -0.347 0 C-N-CA 122.571 2.181 . . . . 10.0 111.233 172.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.09 156.48 3.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 119.505 1.048 . . . . 10.0 111.706 -175.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.41 HG22 ' HG2' ' A' ' 10' ' ' LYS . 96.0 t -135.98 117.75 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.209 170.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.778 HG21 HD23 ' A' ' 28' ' ' LEU . 12.6 mt -109.93 135.04 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.705 0 N-CA-C 108.595 -0.891 . . . . 10.0 108.595 -175.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.0 m -117.7 95.47 4.95 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 114.954 -1.021 . . . . 10.0 108.308 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.588 ' CG1' ' HB2' ' A' ' 7' ' ' ALA . 2.7 p -86.73 138.11 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.012 0 CA-C-N 119.61 1.095 . . . . 10.0 110.784 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -92.87 163.85 13.55 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.514 -0.766 . . . . 10.0 111.745 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.652 ' HG2' ' HB3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -60.7 -19.9 59.79 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.605 -1.18 . . . . 10.0 112.093 -179.132 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.33 -4.69 52.04 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.317 -0.856 . . . . 10.0 111.861 -177.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 83.24 -1.74 1.2 Allowed 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 124.318 1.011 . . . . 10.0 109.443 -170.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.6 m -72.6 168.71 18.08 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.572 -1.194 . . . . 10.0 108.327 174.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.654 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -169.47 -179.99 3.63 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 120.477 1.49 . . . . 10.0 109.471 176.088 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.1 p -160.54 168.67 24.55 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 103.241 -2.874 . . . . 10.0 103.241 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.536 ' HE1' ' HE ' ' A' ' 41' ' ' ARG . 51.4 p90 -163.56 155.94 17.85 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.759 -0.83 . . . . 10.0 108.759 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mt -124.19 167.58 17.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 106.922 -1.51 . . . . 10.0 106.922 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.624 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 2.6 mm -121.84 124.69 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 N-CA-C 106.485 -1.672 . . . . 10.0 106.485 177.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.685 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 32.0 mmmt -78.73 101.51 7.59 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.943 0.878 . . . . 10.0 111.897 -165.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.753 ' HB ' ' HG2' ' A' ' 112' ' ' LYS . 8.3 p -56.6 -34.73 28.24 Favored Pre-proline 0 CA--C 1.562 1.423 0 CA-C-N 113.449 -1.705 . . . . 10.0 113.974 169.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.731 ' HD2' ' N ' ' A' ' 72' ' ' THR . 4.8 Cg_exo -35.68 -52.15 0.93 Allowed 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 124.838 3.692 . . . . 10.0 115.907 -176.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.822 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 16.7 Cg_endo -58.76 103.45 0.16 Allowed 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.401 1.401 . . . . 10.0 110.495 173.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.613 ' O ' ' HB2' ' A' ' 79' ' ' LEU . . . -81.13 0.39 36.45 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.245 -0.434 . . . . 10.0 111.364 -171.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.7 t -61.7 -55.29 31.99 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.141 -0.481 . . . . 10.0 111.451 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.667 ' HE1' ' HG2' ' A' ' 74' ' ' PRO . 37.7 p90 -77.77 -27.51 50.31 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.609 0.596 . . . . 10.0 112.609 -171.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.497 ' HB3' HD11 ' A' ' 108' ' ' ILE . 1.1 mm? -75.14 -46.54 33.62 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.416 0.626 . . . . 10.0 110.721 174.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.613 ' HB2' ' O ' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -64.16 -35.6 81.31 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.808 -0.442 . . . . 10.0 109.808 -179.27 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.594 ' HA ' ' HB1' ' A' ' 83' ' ' ALA . 20.2 ttpt -60.61 -31.86 71.02 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.819 -0.628 . . . . 10.0 110.262 173.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 21.9 ttpp -52.56 -44.84 66.11 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 110.439 -0.208 . . . . 10.0 110.439 177.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.657 ' HB1' ' HG2' ' A' ' 104' ' ' GLN . . . -73.52 -46.81 45.52 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.81 1.644 . . . . 10.0 111.657 172.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.594 ' HB1' ' HA ' ' A' ' 80' ' ' LYS . . . -62.94 -38.91 92.91 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 111.532 -2.576 . . . . 10.0 111.718 -168.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 85.48 -14.93 48.79 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.028 -1.082 . . . . 10.0 111.596 173.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.529 HG13 ' HG3' ' A' ' 80' ' ' LYS . 14.9 pt -59.35 131.35 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 114.25 -0.975 . . . . 10.0 111.675 174.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.413 ' HG3' ' HD2' ' A' ' 80' ' ' LYS . 4.5 tt0 -172.42 31.81 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.424 0.63 . . . . 10.0 109.324 172.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -166.66 -56.52 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.296 -0.865 . . . . 10.0 109.672 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -177.62 -114.73 0.41 Allowed Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.564 -0.743 . . . . 10.0 111.573 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.9 t -165.52 136.39 3.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.943 0.402 . . . . 10.0 111.238 -177.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.2 m -78.98 -8.35 58.84 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.629 -0.714 . . . . 10.0 111.162 175.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -173.39 99.48 0.32 Allowed Pre-proline 0 C--O 1.234 0.281 0 CA-C-O 120.916 0.389 . . . . 10.0 111.257 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -88.75 109.09 0.5 Allowed 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.633 2.222 . . . . 10.0 110.771 171.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -72.63 -106.71 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.437 -0.347 . . . . 10.0 111.66 -176.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.14 -36.62 40.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.184 0.516 . . . . 10.0 110.703 177.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -171.9 -5.23 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.47 -0.787 . . . . 10.0 111.793 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.514 HD13 ' HB2' ' A' ' 138' ' ' GLU . 4.5 mt -83.56 176.82 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 122.061 -0.399 . . . . 10.0 109.946 -176.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 136' ' ' GLY . 12.4 p -138.82 -45.88 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 112.286 0.476 . . . . 10.0 112.286 -165.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.56 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -165.2 155.12 26.3 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 109.439 -1.464 . . . . 10.0 109.439 175.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.676 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 9.2 ptpt -137.87 169.75 17.24 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-O 122.734 1.254 . . . . 10.0 111.71 -161.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.695 ' O ' HG22 ' A' ' 140' ' ' VAL . 0.8 OUTLIER -159.5 -144.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 111.456 -2.611 . . . . 10.0 106.132 -174.087 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.475 HG22 ' CG2' ' A' ' 140' ' ' VAL . 28.5 p -154.64 148.21 25.26 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.127 -1.805 . . . . 10.0 106.127 -157.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.656 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 38.3 mmt180 -43.7 -42.47 5.37 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 123.895 0.747 . . . . 10.0 109.894 174.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -57.46 -44.04 84.49 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.69 0.626 . . . . 10.0 112.69 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.657 ' HG2' ' HB1' ' A' ' 82' ' ' ALA . 1.1 mp0 -60.35 -50.04 75.21 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 109.157 -0.683 . . . . 10.0 109.157 177.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.949 HG21 ' HB ' ' A' ' 128' ' ' ILE . 33.0 mm -40.59 -54.1 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.446 -1.252 . . . . 10.0 111.398 169.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.715 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 23.7 tt0 -49.17 -51.37 33.0 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.837 -1.074 . . . . 10.0 112.382 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -51.27 -60.76 2.76 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.131 -0.941 . . . . 10.0 110.016 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.584 HG12 ' O ' ' A' ' 104' ' ' GLN . 13.4 mm -47.53 -53.0 4.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 113.811 -1.54 . . . . 10.0 110.552 174.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -52.84 -34.4 53.97 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.663 0.616 . . . . 10.0 112.663 175.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.715 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 64.3 mttm -73.54 -53.86 9.57 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 116.468 -0.333 . . . . 10.0 110.976 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.754 HG23 ' HG3' ' A' ' 112' ' ' LYS . 11.4 t -56.74 -33.68 66.79 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.293 -0.412 . . . . 10.0 111.704 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.754 ' HG3' HG23 ' A' ' 111' ' ' THR . 17.7 mtpp -96.87 -1.31 46.23 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 122.736 0.414 . . . . 10.0 111.321 -177.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.682 ' HE3' ' HB2' ' A' ' 121' ' ' LEU . 52.6 ttm -49.33 -47.34 76.95 Favored Pre-proline 0 N--CA 1.468 0.446 0 N-CA-C 112.836 0.68 . . . . 10.0 112.836 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 113' ' ' MET . 32.8 Cg_endo -63.26 -26.55 71.96 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 121.443 1.429 . . . . 10.0 111.979 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.506 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -97.97 -44.45 6.66 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.952 -1.022 . . . . 10.0 113.576 -171.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.644 ' HG ' HD13 ' A' ' 127' ' ' ILE . 2.2 mp -66.22 42.22 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.708 -1.133 . . . . 10.0 113.232 -177.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 65.9 t30 14.64 53.0 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 O-C-N 124.776 1.298 . . . . 10.0 112.28 -167.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.407 ' O ' ' CB ' ' A' ' 119' ' ' ASN . . . -65.8 -78.8 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.612 0.967 . . . . 10.0 113.612 -165.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 118' ' ' ALA . 38.5 t-20 99.72 -41.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.883 1.273 . . . . 10.0 108.323 -175.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 47.6 t -148.81 139.54 22.77 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 106.758 -1.571 . . . . 10.0 106.758 173.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.682 ' HB2' ' HE3' ' A' ' 113' ' ' MET . 3.2 tm? -53.19 -33.76 54.06 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.157 -0.928 . . . . 10.0 113.324 -177.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -50.02 -42.62 49.73 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.749 0.785 . . . . 10.0 110.697 173.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.49 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . . . -65.7 -49.09 69.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.487 -1.233 . . . . 10.0 110.719 -178.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.573 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -54.93 -37.9 66.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.527 178.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.638 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 78.4 mmm -52.96 -40.34 63.62 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.138 0.792 . . . . 10.0 113.138 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.49 ' HD2' ' HA ' ' A' ' 123' ' ' ALA . 10.3 mttt -63.25 -46.8 85.19 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.291 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.644 HD13 ' HG ' ' A' ' 116' ' ' LEU . 73.2 mt -50.19 -62.58 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-N 115.6 -0.727 . . . . 10.0 110.012 175.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.949 ' HB ' HG21 ' A' ' 105' ' ' ILE . 10.5 mm -53.18 -58.03 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-N 114.058 -1.428 . . . . 10.0 111.441 -176.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.56 -44.01 62.58 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 123.849 0.718 . . . . 10.0 109.584 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -69.9 -45.84 55.49 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.415 -0.897 . . . . 10.0 111.881 -177.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.544 HG21 ' HB2' ' A' ' 75' ' ' ALA . 22.4 m -48.2 -58.12 4.96 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.486 -0.857 . . . . 10.0 109.762 171.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.543 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -53.38 -44.57 68.74 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 111.812 0.301 . . . . 10.0 111.812 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 34.7 tttp -45.33 -55.15 6.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.491 -0.777 . . . . 10.0 110.956 174.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.0 m -64.58 -31.56 72.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.984 0.421 . . . . 10.0 111.529 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 10.7 mtm -78.61 -8.84 59.05 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.272 0.841 . . . . 10.0 113.272 -174.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.571 ' O ' HG13 ' A' ' 97' ' ' VAL . . . 88.72 14.36 61.38 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 119.587 1.085 . . . . 10.0 111.74 -178.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 2.0 mp -96.95 124.84 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.95 0 CA-C-O 121.624 0.726 . . . . 10.0 111.062 -177.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.676 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.3 OUTLIER -84.03 146.68 27.83 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.611 -1.177 . . . . 10.0 109.323 177.544 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.7 m -116.64 124.02 72.29 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.782 0 N-CA-C 106.458 -1.682 . . . . 10.0 106.458 174.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.695 HG22 ' O ' ' A' ' 100' ' ' VAL . 33.1 m -106.88 170.01 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.149 0 CA-C-N 113.753 -1.567 . . . . 10.0 110.063 -175.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 . . . . . 0 C--N 1.288 -2.078 0 CA-C-N 113.148 -1.842 . . . . 10.0 108.482 -177.451 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 121.211 0.529 . . . . 10.0 110.632 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.28 158.64 43.78 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.496 -0.774 . . . . 10.0 109.058 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.521 ' O ' ' HG3' ' A' ' 3' ' ' LYS . 21.9 pttm -115.41 106.11 13.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.337 1.065 . . . . 10.0 112.118 -178.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.431 ' HB3' ' HG3' ' A' ' 62' ' ' GLU . 21.2 ttpt -144.94 133.59 22.15 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.371 -1.344 . . . . 10.0 107.371 168.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.5 t -62.6 127.29 22.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 O-C-N 123.376 0.422 . . . . 10.0 111.148 -174.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -102.51 -28.55 12.11 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.091 -0.707 . . . . 10.0 109.091 176.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.515 ' HB1' ' CG1' ' A' ' 60' ' ' VAL . . . -162.52 177.85 9.1 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.295 0.85 . . . . 10.0 113.295 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 78.3 mt-30 -134.65 129.63 35.14 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 114.493 -1.23 . . . . 10.0 107.963 175.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.631 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 5.4 mt -124.1 87.24 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 109.038 -0.727 . . . . 10.0 109.038 -175.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.497 ' HG3' HG22 ' A' ' 57' ' ' VAL . 3.2 mppt? -78.37 146.39 34.66 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 120.991 -1.068 . . . . 10.0 110.178 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.426 ' CD2' HG22 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -156.77 137.16 12.97 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.088 -0.505 . . . . 10.0 109.902 -175.573 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.411 ' HB3' ' CG2' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -93.84 113.28 25.28 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.312 -0.996 . . . . 10.0 108.312 169.528 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.461 HD12 HG22 ' A' ' 24' ' ' VAL . 15.5 mt -132.1 152.88 80.97 Favored Pre-proline 0 C--O 1.212 -0.909 0 CA-C-O 121.31 0.576 . . . . 10.0 111.652 -171.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.608 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 5.5 Cg_exo -78.63 123.59 5.96 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 123.244 2.629 . . . . 10.0 111.784 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.547 ' HB2' HD12 ' A' ' 54' ' ' LEU . . . -61.75 126.67 28.15 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.987 -1.116 . . . . 10.0 107.987 172.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.03 1.79 90.4 Favored Glycine 0 N--CA 1.438 -1.192 0 O-C-N 126.043 2.089 . . . . 10.0 112.108 -177.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.608 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 9.6 tptp -141.56 113.45 7.88 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 122.999 1.381 . . . . 10.0 112.102 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.434 ' CB ' HD22 ' A' ' 43' ' ' ASN . . . -159.04 140.56 13.26 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 112.869 -1.969 . . . . 10.0 108.561 164.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.407 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 48.0 p -157.64 61.02 2.12 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 105.837 -1.912 . . . . 10.0 105.837 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.68 ' HG3' ' CG2' ' A' ' 35' ' ' ILE . 0.1 OUTLIER 15.41 49.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.692 1 C-N-CA 129.687 6.925 . . . . 10.0 116.11 -178.011 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.63 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . . . -56.08 170.58 0.44 Allowed Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 111.553 -2.567 . . . . 10.0 109.736 165.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.63 ' HD2' ' HB2' ' A' ' 21' ' ' ALA . 79.6 Cg_exo -37.39 -44.76 1.46 Allowed 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 123.291 2.661 . . . . 10.0 114.814 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 22' ' ' PRO . 6.4 Cg_exo -38.18 -62.56 0.3 Allowed 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 123.346 2.697 . . . . 10.0 114.374 170.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.953 HG13 HD11 ' A' ' 35' ' ' ILE . 61.6 t -87.44 -56.58 5.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 114.207 1.188 . . . . 10.0 114.207 -163.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.48 -66.52 2.2 Favored Glycine 0 C--O 1.226 -0.348 0 O-C-N 124.02 0.825 . . . . 10.0 113.366 -174.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.441 ' HD2' ' O ' ' A' ' 22' ' ' PRO . 86.4 Cg_exo -53.01 -42.41 64.77 Favored 'Trans proline' 0 C--O 1.225 -0.141 0 C-N-CA 123.262 2.641 . . . . 10.0 112.577 174.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.478 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . . . -53.17 -79.76 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.401 0.619 . . . . 10.0 111.433 177.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.871 HD23 HG21 ' A' ' 58' ' ' ILE . 2.5 mt -67.17 -46.77 72.97 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.521 -0.763 . . . . 10.0 113.016 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.9 -35.6 87.39 Favored Glycine 0 C--O 1.228 -0.232 0 CA-C-N 116.428 -0.351 . . . . 10.0 112.931 -173.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -64.2 -22.72 67.05 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.72 0.295 . . . . 10.0 110.222 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -99.87 15.53 26.73 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.408 0.623 . . . . 10.0 109.603 175.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.457 ' HA3' ' CE ' ' A' ' 64' ' ' LYS . . . 74.28 14.47 80.68 Favored Glycine 0 CA--C 1.501 -0.799 0 CA-C-N 114.687 -1.142 . . . . 10.0 113.692 170.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.585 HG12 ' CD2' ' A' ' 66' ' ' PHE . 0.9 OUTLIER -82.74 148.88 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 C-N-CA 120.252 -0.579 . . . . 10.0 112.474 -177.074 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -71.11 92.78 0.99 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.701 0.762 . . . . 10.0 110.296 174.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.953 HD11 HG13 ' A' ' 24' ' ' VAL . 14.6 mm -53.94 -40.02 43.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 114.422 -1.263 . . . . 10.0 112.35 178.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.417 ' SD ' ' N ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -68.95 -41.88 77.42 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 113.909 -1.496 . . . . 10.0 111.613 177.267 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.571 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 22.2 mt-10 -55.77 -44.71 77.94 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 118.932 -1.107 . . . . 10.0 109.611 169.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.571 ' HB2' ' HE2' ' A' ' 66' ' ' PHE . 84.6 t80 -52.74 -58.62 6.26 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.076 1.139 . . . . 10.0 114.076 172.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 39.9 t -56.9 -51.6 68.47 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 114.75 -1.114 . . . . 10.0 110.924 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.478 ' HA ' ' HD3' ' A' ' 40' ' ' LYS . 28.7 mmtp -67.47 -20.88 65.53 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 119.269 -0.972 . . . . 10.0 110.297 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.604 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 92.7 mtt180 -73.85 -62.85 1.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.912 -0.715 . . . . 10.0 112.103 170.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.487 ' HE2' ' O ' ' A' ' 14' ' ' PRO . 73.3 t80 -56.42 -48.55 76.72 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-N 115.572 -0.74 . . . . 10.0 110.415 -173.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.452 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.9 OUTLIER -59.7 -49.44 77.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.308 -0.86 . . . . 10.0 110.286 -176.739 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.81 -46.08 91.06 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.169 -1.013 . . . . 10.0 112.71 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 9.5 pt-20 -71.32 -31.25 67.17 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 120.16 -0.616 . . . . 10.0 112.355 -176.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.539 HG21 HD11 ' A' ' 54' ' ' LEU . 63.3 p -91.06 2.88 55.99 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.45 -0.795 . . . . 10.0 111.591 -175.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.74 -38.71 7.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.001 -0.999 . . . . 10.0 112.934 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.521 ' OD1' ' HG3' ' A' ' 49' ' ' LYS . 0.5 OUTLIER -81.94 -26.49 33.98 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.729 -0.669 . . . . 10.0 112.199 -174.44 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.521 ' HG3' ' OD1' ' A' ' 48' ' ' ASP . 36.4 mttp -101.72 18.55 20.13 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.473 0.654 . . . . 10.0 109.437 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -50.32 140.95 12.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.704 -1.134 . . . . 10.0 112.928 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.59 18.08 26.7 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 114.984 -1.007 . . . . 10.0 110.774 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.45 ' HB2' HD22 ' A' ' 54' ' ' LEU . 65.6 mtt -137.12 127.23 26.09 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 117.137 -1.825 . . . . 10.0 113.92 -167.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.411 ' CG2' ' HB3' ' A' ' 12' ' ' GLN . 50.9 mm -68.97 90.61 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.268 -0.641 . . . . 10.0 109.268 171.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.547 HD12 ' HB2' ' A' ' 15' ' ' ALA . 6.6 mt -77.74 140.03 62.99 Favored Pre-proline 0 N--CA 1.449 -0.482 0 N-CA-C 108.665 -0.865 . . . . 10.0 108.665 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 54' ' ' LEU . 5.3 Cg_exo -77.92 104.78 1.91 Allowed 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.59 2.193 . . . . 10.0 110.889 172.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.54 151.26 4.9 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 CA-C-N 118.893 0.769 . . . . 10.0 111.324 -174.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.497 HG22 ' HG3' ' A' ' 10' ' ' LYS . 99.3 t -135.58 119.81 26.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.981 -0.377 . . . . 10.0 109.981 172.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.871 HG21 HD23 ' A' ' 28' ' ' LEU . 13.0 mt -108.81 137.55 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 N-CA-C 108.36 -0.978 . . . . 10.0 108.36 -174.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.0 m -123.07 96.57 5.06 Favored 'General case' 0 N--CA 1.407 -2.601 0 CA-C-N 114.688 -1.142 . . . . 10.0 108.818 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 65' ' ' SER . 4.3 p -85.73 137.28 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 CA-C-N 119.298 0.953 . . . . 10.0 110.436 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -100.71 178.17 4.78 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.797 0.808 . . . . 10.0 113.056 -176.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.431 ' HG3' ' HB3' ' A' ' 4' ' ' LYS . 28.0 mt-10 -50.57 -33.59 22.43 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.796 -1.547 . . . . 10.0 113.718 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.7 -6.51 57.34 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.517 0.562 . . . . 10.0 112.517 -172.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.457 ' CE ' ' HA3' ' A' ' 32' ' ' GLY . 26.9 mmmt 83.51 5.51 0.79 Allowed 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 124.643 1.214 . . . . 10.0 108.569 -168.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.55 ' O ' HG23 ' A' ' 60' ' ' VAL . 22.0 t -73.74 175.79 6.88 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 113.355 -1.748 . . . . 10.0 107.67 173.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.585 ' CD2' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -170.0 -178.93 3.03 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 120.523 1.51 . . . . 10.0 109.866 176.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.9 p -157.64 170.31 22.68 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 103.233 -2.876 . . . . 10.0 103.233 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.437 ' HB3' HG12 ' A' ' 58' ' ' ILE . 48.7 p90 -163.4 157.58 20.11 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.802 -0.814 . . . . 10.0 108.802 174.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.47 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 29.2 pt -122.77 167.77 16.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.014 -1.106 . . . . 10.0 108.014 -176.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.451 HD13 ' CE1' ' A' ' 42' ' ' PHE . 1.9 mm -135.39 117.61 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 107.093 -1.447 . . . . 10.0 107.093 -176.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.619 ' HE2' ' HA ' ' A' ' 71' ' ' LYS . 9.4 mmmm -75.41 97.92 3.76 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.228 -0.589 . . . . 10.0 110.761 -172.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.26 98.0 0.16 Allowed Pre-proline 0 C--N 1.317 -0.809 0 O-C-N 124.639 1.212 . . . . 10.0 109.342 169.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.607 ' HG3' ' CD2' ' A' ' 77' ' ' PHE . 54.3 Cg_endo -67.54 137.29 42.22 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.409 2.073 . . . . 10.0 112.681 -162.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.84 ' HA ' HD11 ' A' ' 116' ' ' LEU . 85.1 Cg_exo -47.29 88.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.746 2.964 . . . . 10.0 113.689 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.627 ' H ' ' HD3' ' A' ' 112' ' ' LYS . . . 70.59 -41.82 0.51 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.073 -0.967 . . . . 10.0 113.569 174.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.9 p -40.83 -73.73 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.3 1.222 . . . . 10.0 114.3 -167.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.607 ' CD2' ' HG3' ' A' ' 73' ' ' PRO . 8.5 m-30 -61.97 -21.81 65.13 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.349 0.87 . . . . 10.0 113.349 -172.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 1.034 ' HB3' HD12 ' A' ' 108' ' ' ILE . 6.3 mp -101.02 -12.77 18.6 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 119.499 -0.88 . . . . 10.0 111.288 -178.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.413 ' CD1' ' HB3' ' A' ' 75' ' ' ALA . 50.6 mt -76.99 -26.48 53.92 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.07 -1.085 . . . . 10.0 108.07 165.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 61.5 mmtt -59.79 -38.72 82.68 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.207 -0.906 . . . . 10.0 109.5 167.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.538 ' HD3' ' HA ' ' A' ' 81' ' ' LYS . 53.5 mmtt -64.25 -44.64 91.17 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.528 0.936 . . . . 10.0 113.528 175.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.624 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -71.61 -56.31 6.1 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.562 1.945 . . . . 10.0 112.966 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.537 ' C ' ' H ' ' A' ' 85' ' ' ILE . . . -76.31 137.99 40.22 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 111.069 -2.787 . . . . 10.0 105.872 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.07 22.64 5.82 Favored Glycine 0 C--N 1.32 -0.341 0 CA-C-N 121.609 2.004 . . . . 10.0 110.776 -173.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.641 HG22 HG21 ' A' ' 97' ' ' VAL . 27.2 pt -68.1 103.71 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 113.407 -1.397 . . . . 10.0 112.614 -173.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -74.95 4.46 6.53 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 122.089 0.947 . . . . 10.0 110.068 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.43 ' H ' ' C ' ' A' ' 85' ' ' ILE . 39.8 ttmt -172.11 -60.07 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.303 -1.317 . . . . 10.0 109.002 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.05 -110.44 4.02 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.477 -0.783 . . . . 10.0 111.386 -178.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.7 m -163.66 -94.34 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.509 -0.552 . . . . 10.0 109.509 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.455 ' O ' ' HG3' ' A' ' 91' ' ' GLU . 46.7 m -165.14 -43.74 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.827 -0.805 . . . . 10.0 108.827 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.809 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 35.6 mt-10 -164.59 -58.3 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 114.928 -1.033 . . . . 10.0 109.58 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.809 ' HD3' ' HB2' ' A' ' 91' ' ' GLU . 55.7 Cg_endo -96.17 106.16 0.1 Allowed 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.179 1.919 . . . . 10.0 112.515 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.502 ' HG3' ' HB ' ' A' ' 97' ' ' VAL . 5.3 tmtp? -80.8 -100.78 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.473 -1.306 . . . . 10.0 107.473 171.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.492 ' H ' ' HB3' ' A' ' 93' ' ' LYS . 13.1 ttm180 -178.49 -59.57 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 170.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.431 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 47.1 mttp -87.73 10.19 19.11 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.234 -1.348 . . . . 10.0 110.503 -177.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.569 HG22 ' HB3' ' A' ' 138' ' ' GLU . 3.6 mt 72.45 116.98 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-O 123.457 1.599 . . . . 10.0 112.208 -170.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.641 HG21 HG22 ' A' ' 85' ' ' ILE . 8.2 p -74.83 88.04 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 CA-C-N 111.404 -2.635 . . . . 10.0 111.308 -174.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 33.07 -168.76 0.01 OUTLIER Glycine 0 CA--C 1.533 1.204 0 CA-C-N 113.942 -1.481 . . . . 10.0 115.171 -165.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.682 ' CB ' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -160.85 178.26 9.59 Favored 'General case' 0 CA--C 1.488 -1.413 0 CA-C-O 121.791 0.805 . . . . 10.0 112.044 -172.122 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.624 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -159.8 -166.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 113.502 -1.681 . . . . 10.0 111.938 -179.451 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 39.0 p -97.56 143.29 28.4 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 112.734 -2.03 . . . . 10.0 111.473 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.639 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 0.4 OUTLIER -47.87 -41.18 23.58 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.599 -0.728 . . . . 10.0 109.925 166.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.06 -43.3 77.8 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.655 0.382 . . . . 10.0 111.758 175.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.592 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -57.52 -50.74 72.09 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.411 -0.959 . . . . 10.0 108.411 174.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.759 HG23 ' HB ' ' A' ' 128' ' ' ILE . 27.9 mm -44.2 -49.82 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 114.522 -1.217 . . . . 10.0 111.53 174.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.715 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 27.6 tt0 -50.88 -57.16 9.18 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.766 1.227 . . . . 10.0 112.356 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.691 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 70.0 mm-40 -51.66 -58.59 5.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.347 -1.297 . . . . 10.0 110.17 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 1.034 HD12 ' HB3' ' A' ' 78' ' ' LEU . 22.8 mm -48.33 -51.6 9.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.318 -0.855 . . . . 10.0 110.742 173.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.509 ' HB1' HG13 ' A' ' 128' ' ' ILE . . . -51.89 -42.66 62.89 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.499 0.555 . . . . 10.0 112.499 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.715 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 73.6 mttt -68.21 -52.58 32.67 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 122.045 0.926 . . . . 10.0 109.261 -177.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 85.5 m -51.46 -23.8 4.35 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 113.506 -1.679 . . . . 10.0 112.514 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.772 ' HZ1' HD11 ' A' ' 78' ' ' LEU . 29.5 mttp -122.63 1.19 9.44 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 113.171 0.804 . . . . 10.0 113.171 -175.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.553 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 23.3 ptm -50.18 -36.81 22.62 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 113.149 0.796 . . . . 10.0 113.149 176.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 113' ' ' MET . 58.7 Cg_endo -69.55 -29.76 24.33 Favored 'Trans proline' 0 C--N 1.367 1.515 0 CA-C-N 120.989 1.389 . . . . 10.0 111.912 178.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.616 ' OD2' ' HE2' ' A' ' 71' ' ' LYS . 2.7 t70 -87.24 -46.02 10.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.132 0.968 . . . . 10.0 110.454 -173.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.84 HD11 ' HA ' ' A' ' 74' ' ' PRO . 4.9 mp -65.1 -1.1 1.94 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 113.68 -1.6 . . . . 10.0 112.191 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 115' ' ' ASP . 26.0 m-80 58.98 50.39 8.39 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.853 -1.067 . . . . 10.0 109.247 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.413 ' O ' ' CB ' ' A' ' 119' ' ' ASN . . . -65.98 -74.78 0.1 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.28 -1.327 . . . . 10.0 113.099 -166.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 118' ' ' ALA . 27.3 t-20 102.43 -40.52 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.545 0 O-C-N 124.929 1.393 . . . . 10.0 109.354 -176.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.5 t -151.41 133.96 15.5 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 103.584 -2.747 . . . . 10.0 103.584 174.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.499 ' O ' ' HG3' ' A' ' 125' ' ' MET . 2.8 tm? -52.97 -35.05 58.59 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.386 0.884 . . . . 10.0 113.386 -173.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.581 ' HA ' ' HG3' ' A' ' 125' ' ' MET . 2.2 mp0 -51.46 -33.78 32.54 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 118.691 0.678 . . . . 10.0 110.734 175.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.42 -47.4 60.93 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 118.581 -1.247 . . . . 10.0 110.575 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.499 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -54.95 -39.01 68.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.835 -0.62 . . . . 10.0 110.305 175.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.581 ' HG3' ' HA ' ' A' ' 122' ' ' GLU . 17.2 mtp -54.96 -38.43 67.75 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 112.124 0.416 . . . . 10.0 112.124 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -62.19 -47.51 84.15 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 108.929 -0.767 . . . . 10.0 108.929 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.459 HD11 ' HA ' ' A' ' 124' ' ' ALA . 67.3 mt -50.92 -64.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 114.996 -1.002 . . . . 10.0 110.284 175.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.759 ' HB ' HG23 ' A' ' 105' ' ' ILE . 16.0 mm -52.81 -60.54 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 CA-C-N 114.496 -1.229 . . . . 10.0 111.394 -176.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.581 ' HB3' ' O ' ' A' ' 125' ' ' MET . 0.0 OUTLIER -51.75 -43.47 62.94 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.264 -0.88 . . . . 10.0 109.732 179.299 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.63 -45.25 29.35 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.717 -0.754 . . . . 10.0 111.909 -175.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.523 HG23 ' HB1' ' A' ' 75' ' ' ALA . 51.9 m -50.5 -56.97 9.23 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.513 -0.844 . . . . 10.0 109.765 173.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.99 -57.28 7.88 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 120.969 0.414 . . . . 10.0 111.031 175.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -46.45 -59.01 3.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.954 -1.021 . . . . 10.0 112.253 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.8 p -66.59 -24.5 66.34 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.057 0.391 . . . . 10.0 112.057 -174.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.534 ' O ' ' HG3' ' A' ' 135' ' ' MET . 0.0 OUTLIER -84.43 -3.41 58.33 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 112.936 0.717 . . . . 10.0 112.936 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.552 ' C ' HG11 ' A' ' 97' ' ' VAL . . . 105.05 -5.85 42.63 Favored Glycine 0 N--CA 1.441 -1.007 0 O-C-N 121.001 -1.062 . . . . 10.0 112.688 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.464 HD12 ' HE2' ' A' ' 135' ' ' MET . 70.6 mt -87.43 129.87 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 CA-C-N 117.516 0.658 . . . . 10.0 111.093 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.682 ' HG2' ' CB ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -85.58 156.98 20.5 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.029 -0.987 . . . . 10.0 109.282 177.345 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 22.2 m -119.43 136.34 56.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.078 -1.082 . . . . 10.0 108.078 168.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.3 m -136.26 69.99 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 115.573 1.694 . . . . 10.0 115.573 -176.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.3 t70 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.113 -0.946 . . . . 10.0 109.296 138.928 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.538 0.208 . . . . 10.0 111.169 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.0 -77.96 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.832 0.349 . . . . 10.0 110.509 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -136.44 167.51 21.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.043 -0.526 . . . . 10.0 109.91 177.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 4' ' ' LYS . 29.5 mtpt -80.74 119.84 23.85 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.435 -0.348 . . . . 10.0 110.071 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 38.0 t -67.15 145.0 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.895 0.378 . . . . 10.0 111.389 -177.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.79 -36.41 4.51 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.27 173.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.45 ' HB1' ' CG1' ' A' ' 60' ' ' VAL . . . -159.61 151.17 20.1 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.272 1.212 . . . . 10.0 114.272 -177.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -93.71 129.19 40.12 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.303 -1.369 . . . . 10.0 107.303 168.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.62 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.8 OUTLIER -120.94 82.36 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.786 -0.82 . . . . 10.0 108.786 175.119 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -78.9 146.13 33.73 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 120.895 1.679 . . . . 10.0 109.42 177.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -156.11 134.63 11.64 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.313 -0.625 . . . . 10.0 109.313 -174.308 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.546 ' OE1' ' HA ' ' A' ' 55' ' ' PRO . 10.9 mm100 -91.82 112.26 24.11 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.018 -1.105 . . . . 10.0 108.018 171.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.447 HD12 HD21 ' A' ' 11' ' ' LEU . 28.8 mt -131.54 133.97 24.99 Favored Pre-proline 0 CA--C 1.504 -0.803 0 CA-C-O 121.644 0.735 . . . . 10.0 112.463 -170.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.634 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 18.5 Cg_exo -56.75 122.18 11.37 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 123.292 2.661 . . . . 10.0 111.846 174.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.633 ' HB1' HD11 ' A' ' 54' ' ' LEU . . . -61.62 126.78 28.57 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 107.514 -1.291 . . . . 10.0 107.514 169.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.39 0.21 89.64 Favored Glycine 0 N--CA 1.44 -1.1 0 O-C-N 125.883 1.989 . . . . 10.0 112.998 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.634 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 18.6 tptp -142.8 98.88 3.37 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 118.331 1.066 . . . . 10.0 111.979 175.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.18 136.87 9.03 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.433 -1.258 . . . . 10.0 112.121 176.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.548 ' HA ' ' HB2' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -179.98 -54.96 0.0 OUTLIER Pre-proline 0 N--CA 1.443 -0.81 0 CA-C-N 115.318 -0.856 . . . . 10.0 111.836 174.677 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.638 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 73.5 Cg_endo -99.16 129.66 0.19 Allowed 'Trans proline' 0 N--CA 1.411 -3.372 0 N-CA-C 115.67 1.373 . . . . 10.0 115.67 -153.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 1.071 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 12.13 -83.54 0.0 OUTLIER Pre-proline 0 C--N 1.294 -1.842 0 CA-C-N 108.604 -3.907 . . . . 10.0 115.489 166.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.97 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 65.5 Cg_exo -30.53 -55.16 0.21 Allowed 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 122.963 2.442 . . . . 10.0 115.709 -164.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.97 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 5.2 Cg_exo -84.09 -56.55 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.438 2.759 . . . . 10.0 112.094 170.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.909 HG13 HD11 ' A' ' 35' ' ' ILE . 89.3 t -80.37 -53.76 12.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 112.719 -2.037 . . . . 10.0 114.922 -167.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 1.071 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -50.65 -74.48 0.28 Allowed Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.203 -0.908 . . . . 10.0 113.452 -173.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.818 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 17.0 Cg_exo -42.79 -43.99 8.95 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.77 2.98 . . . . 10.0 112.441 171.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.567 ' HB1' ' O ' ' A' ' 24' ' ' VAL . . . -50.06 -98.94 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 123.793 0.683 . . . . 10.0 112.43 177.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.886 HD23 HD13 ' A' ' 35' ' ' ILE 0.341 0.0 OUTLIER -73.18 -34.33 65.94 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 117.555 -1.658 . . . . 10.0 113.138 -173.472 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.72 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -67.5 -39.53 91.11 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 121.164 -0.541 . . . . 10.0 113.505 -175.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.727 ' HG3' ' HA ' ' A' ' 26' ' ' PRO . 26.9 mt-30 -68.43 -6.46 24.85 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 118.635 -1.226 . . . . 10.0 111.212 175.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.559 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 72.6 m-70 -102.04 22.98 12.21 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.381 0.61 . . . . 10.0 109.584 168.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.28 -3.69 76.35 Favored Glycine 0 CA--C 1.503 -0.699 0 CA-C-N 115.306 -0.861 . . . . 10.0 113.567 168.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.842 HG13 ' CD2' ' A' ' 66' ' ' PHE . 5.0 t -82.99 149.79 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 113.785 1.031 . . . . 10.0 113.785 -170.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.462 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -71.39 99.3 1.95 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.001 0.429 . . . . 10.0 110.687 170.756 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.909 HD11 HG13 ' A' ' 24' ' ' VAL . 16.4 mm -51.49 -37.15 18.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 122.21 1.005 . . . . 10.0 111.643 172.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.588 ' HE2' ' HA ' ' A' ' 36' ' ' MET . 5.9 mmt -65.7 -50.31 65.35 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.312 -1.767 . . . . 10.0 111.957 174.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 34' ' ' ASN . 5.6 tp10 -56.09 -41.09 74.64 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.079 -0.648 . . . . 10.0 110.211 174.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.556 ' CA ' ' HZ ' ' A' ' 66' ' ' PHE . 89.9 t80 -56.24 -58.79 6.48 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 113.899 1.074 . . . . 10.0 113.899 171.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.548 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -62.72 -50.3 71.64 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 114.368 -1.287 . . . . 10.0 111.87 -175.415 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -62.88 -23.06 67.15 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 119.223 -0.991 . . . . 10.0 108.911 -177.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.833 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 63.0 mtt180 -75.5 -64.82 0.99 Allowed 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 119.252 -0.979 . . . . 10.0 111.798 166.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.515 ' CZ ' HG21 ' A' ' 46' ' ' THR . 60.3 t80 -50.99 -49.72 59.75 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.09 0.859 . . . . 10.0 111.571 -170.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -60.09 -49.88 75.92 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.514 -0.766 . . . . 10.0 110.425 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.05 -39.81 95.84 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.069 -1.052 . . . . 10.0 112.081 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.833 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 5.9 mm-40 -66.89 -41.76 86.65 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.841 0.829 . . . . 10.0 111.047 -178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.515 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 81.7 p -90.91 1.5 56.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.414 -1.266 . . . . 10.0 112.056 -170.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.46 -37.23 5.01 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.995 -1.002 . . . . 10.0 112.921 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -82.19 -24.96 34.65 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.807 -0.633 . . . . 10.0 112.491 -174.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.4 mttp -104.5 19.06 21.01 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.487 0.66 . . . . 10.0 109.305 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -48.73 143.5 5.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.404 -1.271 . . . . 10.0 112.565 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.99 20.89 27.01 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 114.846 -1.07 . . . . 10.0 110.917 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.499 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 64.2 mtt -138.53 128.87 25.9 Favored 'General case' 0 C--O 1.206 -1.189 0 C-N-CA 117.083 -1.847 . . . . 10.0 114.154 -169.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.8 mm -70.01 93.2 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 121.586 -0.696 . . . . 10.0 109.754 172.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.766 HD22 ' HE2' ' A' ' 77' ' ' PHE . 3.3 mt -80.45 130.04 66.68 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.15 -0.315 . . . . 10.0 110.15 -176.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.546 ' HA ' ' OE1' ' A' ' 12' ' ' GLN . 21.1 Cg_exo -69.68 103.48 1.16 Allowed 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 122.683 2.256 . . . . 10.0 111.44 171.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 69' ' ' ILE . 0.5 OUTLIER -101.9 160.32 4.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 119.402 1.001 . . . . 10.0 112.217 -174.539 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.4 t -137.09 119.98 20.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.034 -0.53 . . . . 10.0 110.561 173.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.62 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 14.8 mt -110.65 138.2 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.596 0 N-CA-C 108.012 -1.107 . . . . 10.0 108.012 -178.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.4 m -123.48 96.57 5.03 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 114.837 -1.074 . . . . 10.0 108.801 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.493 HG21 ' O ' ' A' ' 65' ' ' SER . 2.3 p -89.04 139.03 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 CA-C-N 119.481 1.037 . . . . 10.0 110.568 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 70.2 m-85 -96.06 167.86 10.96 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 112.747 0.647 . . . . 10.0 112.747 -177.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -56.66 -23.55 42.48 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 124.271 1.029 . . . . 10.0 112.808 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 6.7 m-20 -80.12 -7.43 58.9 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.683 -1.144 . . . . 10.0 111.287 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 3.2 mptt 79.99 3.4 2.01 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 114.645 -1.161 . . . . 10.0 111.974 -171.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.493 ' O ' HG21 ' A' ' 60' ' ' VAL . 15.6 m -73.11 173.89 8.73 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 107.498 -1.297 . . . . 10.0 107.498 170.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.842 ' CD2' HG13 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -168.81 -176.73 2.79 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 120.293 1.406 . . . . 10.0 108.778 174.505 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 p -159.77 168.85 24.93 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 102.759 -3.052 . . . . 10.0 102.759 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.434 ' CB ' HG12 ' A' ' 58' ' ' ILE . 53.3 p90 -163.24 152.89 15.25 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.933 -1.136 . . . . 10.0 107.933 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' ' 56' ' ' VAL . 1.9 mt -116.47 168.84 7.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 106.232 -1.766 . . . . 10.0 106.232 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.8 mt -137.75 113.76 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 N-CA-C 106.306 -1.738 . . . . 10.0 106.306 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 71' ' ' LYS . 3.6 mptp? -77.3 102.12 6.59 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.604 -166.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 111' ' ' THR . 0.2 OUTLIER -58.28 91.24 0.03 OUTLIER Pre-proline 0 C--N 1.315 -0.906 0 O-C-N 124.733 1.271 . . . . 10.0 108.786 165.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.77 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 49.3 Cg_endo -93.7 -166.63 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 123.541 2.828 . . . . 10.0 112.742 -156.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.77 ' HD2' ' HB2' ' A' ' 73' ' ' PRO . 67.5 Cg_exo -30.05 133.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 123.316 2.677 . . . . 10.0 111.785 168.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.522 ' HB2' HG23 ' A' ' 131' ' ' THR . . . -60.52 -8.97 3.14 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.289 0.848 . . . . 10.0 113.289 -166.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.648 ' HA ' ' HE2' ' A' ' 135' ' ' MET . 1.2 m -50.31 -29.23 9.32 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.604 0.716 . . . . 10.0 110.253 174.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.766 ' HE2' HD22 ' A' ' 54' ' ' LEU . 36.4 t80 -56.01 -66.03 0.5 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.532 -1.213 . . . . 10.0 111.441 176.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.639 HD23 ' HE2' ' A' ' 112' ' ' LYS . 2.7 mm? -82.19 -13.67 56.78 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.903 -0.498 . . . . 10.0 110.233 -175.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.621 HD12 HD13 ' A' ' 137' ' ' ILE . 3.0 mm? -72.9 -23.71 60.75 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 109.341 -0.614 . . . . 10.0 109.341 171.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.833 ' HE2' ' H ' ' A' ' 87' ' ' LYS . 21.4 mmtp -61.89 -40.73 96.43 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.423 -0.584 . . . . 10.0 109.423 167.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.489 ' HD3' ' HA ' ' A' ' 81' ' ' LYS . 24.9 mmtp -62.96 -48.25 79.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.581 -0.736 . . . . 10.0 112.839 174.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.57 ' HB2' ' OE1' ' A' ' 104' ' ' GLN . . . -72.23 -62.68 1.35 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 127.328 2.251 . . . . 10.0 113.564 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.514 ' HB2' HG12 ' A' ' 85' ' ' ILE . . . -76.6 145.97 38.58 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 110.864 -2.88 . . . . 10.0 106.941 -175.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.42 2.22 73.87 Favored Glycine 0 C--N 1.317 -0.479 0 CA-C-N 120.895 1.68 . . . . 10.0 111.246 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.71 HG22 HG21 ' A' ' 97' ' ' VAL . 27.0 pt -68.38 101.7 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.673 -0.763 . . . . 10.0 113.017 -176.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 9.1 tp10 -72.04 101.63 2.78 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.394 -0.595 . . . . 10.0 109.394 170.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.833 ' H ' ' HE2' ' A' ' 80' ' ' LYS . 9.7 mtmp? 90.8 -49.75 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.095 1.358 . . . . 10.0 108.776 -177.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.628 ' HA3' HD12 ' A' ' 85' ' ' ILE . . . 72.08 -137.55 25.45 Favored Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.391 -0.822 . . . . 10.0 112.582 173.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 36.7 p -165.36 89.9 0.47 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.039 0.447 . . . . 10.0 110.339 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.5 p -77.22 -46.47 23.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.728 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.846 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 12.0 mm-40 -68.3 -61.58 3.83 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 115.843 -0.617 . . . . 10.0 111.515 -176.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.846 ' HD3' ' HB2' ' A' ' 91' ' ' GLU . 94.4 Cg_endo -92.91 154.86 2.73 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.273 1.982 . . . . 10.0 112.471 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -165.08 128.05 2.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.086 0.469 . . . . 10.0 110.049 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -162.9 -47.82 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.259 -0.645 . . . . 10.0 109.259 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -71.7 -33.27 68.65 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.177 -1.416 . . . . 10.0 107.177 173.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mt 72.25 143.44 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.414 0 CA-C-O 123.503 1.621 . . . . 10.0 112.632 173.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.71 HG21 HG22 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -94.94 171.92 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.404 -2.739 0 CA-C-N 111.708 -2.496 . . . . 10.0 111.177 -160.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.406 ' N ' HG13 ' A' ' 97' ' ' VAL . . . -57.92 179.51 1.06 Allowed Glycine 0 C--N 1.308 -0.981 0 CA-C-N 113.819 -1.537 . . . . 10.0 113.088 176.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.454 ' HE2' ' HB3' ' A' ' 99' ' ' LYS . 9.8 ptpt -154.26 172.37 17.74 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 122.693 1.235 . . . . 10.0 111.883 -159.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.609 ' O ' HG22 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -160.6 -146.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 111.889 -2.414 . . . . 10.0 105.965 -171.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.582 ' O ' ' HG3' ' A' ' 104' ' ' GLN . 1.7 t -162.06 139.73 8.67 Favored 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 119.834 -0.747 . . . . 10.0 109.511 -152.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.648 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 0.0 OUTLIER -43.14 -48.61 6.4 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 114.36 -1.291 . . . . 10.0 111.535 -173.509 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -56.63 -46.09 81.18 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.127 0.788 . . . . 10.0 113.127 178.201 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.615 ' O ' HG13 ' A' ' 108' ' ' ILE . 3.7 pp0? -67.74 -37.26 81.91 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.454 -0.943 . . . . 10.0 108.454 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.888 HG23 ' HB ' ' A' ' 128' ' ' ILE . 23.3 mm -47.26 -51.01 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 115.503 -0.771 . . . . 10.0 110.862 168.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.655 ' HG2' ' HE3' ' A' ' 110' ' ' LYS . 23.8 tt0 -50.36 -57.34 8.15 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.296 1.438 . . . . 10.0 113.191 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.487 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 4.3 pt-20 -59.09 -43.55 91.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.355 -0.839 . . . . 10.0 111.199 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.615 HG13 ' O ' ' A' ' 104' ' ' GLN . 56.9 mt -51.71 -58.57 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 120.7 0.286 . . . . 10.0 110.919 166.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.528 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . . . -44.69 -35.11 2.49 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 123.556 0.742 . . . . 10.0 112.334 177.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.655 ' HE3' ' HG2' ' A' ' 106' ' ' GLU . 96.6 mttt -74.45 -53.65 9.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.548 -0.751 . . . . 10.0 111.557 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.544 HG21 ' O ' ' A' ' 108' ' ' ILE . 2.1 t -59.41 -8.74 1.91 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.298 0.851 . . . . 10.0 113.298 -177.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.639 ' HE2' HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -129.94 13.73 5.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.247 0.546 . . . . 10.0 110.379 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.499 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 1.8 ttt -50.65 -46.91 85.95 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 114.844 -1.071 . . . . 10.0 112.389 178.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 113' ' ' MET . 60.6 Cg_endo -69.2 -22.27 34.91 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 121.726 1.617 . . . . 10.0 113.299 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -87.94 -55.15 3.88 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 122.344 1.068 . . . . 10.0 110.537 -175.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.619 HD23 ' HD3' ' A' ' 112' ' ' LYS . 7.1 mp -67.87 178.61 1.69 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 113.267 -1.788 . . . . 10.0 113.746 -168.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -96.72 41.88 1.1 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 112.002 -2.363 . . . . 10.0 112.645 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 119' ' ' ASN . . . -63.38 -99.68 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 113.756 1.021 . . . . 10.0 113.756 174.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.597 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 5.0 m120 105.16 -78.01 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.8 1.64 . . . . 10.0 107.768 -168.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.439 ' HB3' ' OE1' ' A' ' 122' ' ' GLU . 47.2 m -81.54 146.65 30.05 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.735 -0.839 . . . . 10.0 108.735 163.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.754 ' O ' ' HG3' ' A' ' 125' ' ' MET . 61.1 tp -59.66 -37.68 79.42 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.15 -1.02 . . . . 10.0 110.548 167.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 126' ' ' LYS . 3.4 mp0 -51.21 -36.68 42.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.674 0.749 . . . . 10.0 109.617 171.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.555 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . . . -69.38 -46.96 65.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.577 -1.192 . . . . 10.0 110.735 177.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.574 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -55.7 -41.29 73.56 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 110.179 -0.304 . . . . 10.0 110.179 176.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.754 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 75.2 mtp -55.75 -33.42 64.27 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.762 0.425 . . . . 10.0 111.827 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' A' ' 123' ' ' ALA . 42.6 mtmt -63.86 -50.77 67.51 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.629 -0.508 . . . . 10.0 109.629 178.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.455 ' CD1' HD22 ' A' ' 116' ' ' LEU . 47.5 mt -49.32 -63.86 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 121.49 0.662 . . . . 10.0 110.379 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.888 ' HB ' HG23 ' A' ' 105' ' ' ILE . 4.9 mm -52.13 -55.07 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 CA-C-N 113.843 -1.526 . . . . 10.0 111.306 -177.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.583 ' CD ' ' HE ' ' A' ' 102' ' ' ARG . 49.2 mt-10 -54.49 -44.51 72.72 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 109.923 -0.399 . . . . 10.0 109.923 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -69.62 -46.01 56.51 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.708 -0.758 . . . . 10.0 111.748 -174.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.522 HG23 ' HB2' ' A' ' 75' ' ' ALA . 51.6 m -50.09 -58.62 5.13 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.536 -0.832 . . . . 10.0 109.379 171.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.402 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -50.71 -53.4 31.69 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.008 0.433 . . . . 10.0 111.22 176.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -47.84 -48.43 30.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.198 -0.91 . . . . 10.0 111.32 176.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 27.2 t -63.61 -35.85 81.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.0 0.428 . . . . 10.0 110.732 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.648 ' HE2' ' HA ' ' A' ' 76' ' ' SER . 53.4 mtm -84.66 10.68 10.58 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.579 0.955 . . . . 10.0 113.579 -174.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 81.55 8.19 87.28 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 119.341 0.973 . . . . 10.0 112.127 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.621 HD13 HD12 ' A' ' 79' ' ' LEU . 47.4 mt -94.73 124.93 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 CA-C-O 121.39 0.614 . . . . 10.0 112.017 -176.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.416 ' HG2' ' HD3' ' A' ' 99' ' ' LYS . 2.0 tt0 -84.38 151.79 24.47 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.125 -1.03 . . . . 10.0 110.943 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.403 HG13 HG13 ' A' ' 105' ' ' ILE . 16.6 m -113.45 126.44 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.045 0 N-CA-C 107.8 -1.185 . . . . 10.0 107.8 168.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.609 HG22 ' O ' ' A' ' 100' ' ' VAL . 2.9 m -104.83 138.54 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-N 114.44 -1.255 . . . . 10.0 109.302 176.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 C--N 1.29 -2.003 0 CA-C-N 114.678 -1.146 . . . . 10.0 109.821 -177.09 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 120.609 0.243 . . . . 10.0 110.424 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.484 ' HB1' ' HE3' ' A' ' 4' ' ' LYS . . . 82.11 79.37 0.03 OUTLIER 'General case' 0 C--O 1.232 0.143 0 O-C-N 124.331 1.02 . . . . 10.0 113.398 168.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.481 ' HG3' ' HE1' ' A' ' 61' ' ' TYR . 20.5 tptt -83.75 89.9 7.24 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 106.754 -1.573 . . . . 10.0 106.754 162.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 10.3 mmtp -76.73 70.1 3.17 Favored 'General case' 0 C--O 1.196 -1.749 0 C-N-CA 120.316 -0.553 . . . . 10.0 110.25 -174.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.1 t -74.58 119.42 22.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 119.153 0.888 . . . . 10.0 109.863 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.415 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . . . -98.13 -35.18 10.48 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.83 -0.804 . . . . 10.0 108.83 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -161.29 -174.06 4.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.037 -0.983 . . . . 10.0 112.801 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 26.8 mt-30 -141.56 131.3 24.21 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.123 -1.399 . . . . 10.0 108.649 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.582 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.9 OUTLIER -120.89 80.98 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 108.945 -0.761 . . . . 10.0 108.945 -176.391 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 56' ' ' VAL . 57.4 tttp -79.43 128.5 33.43 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 119.82 1.191 . . . . 10.0 108.339 176.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.644 HD11 HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.85 127.98 6.18 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 122.116 0.96 . . . . 10.0 111.471 -174.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.56 119.32 22.37 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.226 -1.352 . . . . 10.0 109.749 -172.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.644 HD22 HD11 ' A' ' 11' ' ' LEU . 46.8 mt -135.52 140.31 33.7 Favored Pre-proline 0 CA--C 1.502 -0.896 0 N-CA-C 113.138 0.792 . . . . 10.0 113.138 -170.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.612 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 14.7 Cg_exo -61.87 122.44 10.98 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 123.325 2.683 . . . . 10.0 111.241 174.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.513 ' HB1' HD12 ' A' ' 54' ' ' LEU . . . -60.84 125.11 22.49 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.637 -1.246 . . . . 10.0 107.637 169.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.83 1.83 89.82 Favored Glycine 0 N--CA 1.442 -0.905 0 O-C-N 126.015 2.072 . . . . 10.0 113.115 -173.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.612 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 7.6 tppt? -144.07 105.27 4.24 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.334 1.067 . . . . 10.0 113.14 177.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 39' ' ' CYS . . . -172.47 128.89 0.55 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.776 -1.556 . . . . 10.0 111.202 170.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.48 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 15.6 m -174.06 -43.46 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.132 0.895 . . . . 10.0 112.166 -174.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.811 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 44.2 Cg_endo -98.68 122.3 0.14 Allowed 'Trans proline' 0 N--CA 1.434 -2.008 0 C-N-CA 121.104 1.203 . . . . 10.0 114.892 -166.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 1.096 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . -3.51 -80.05 0.0 OUTLIER Pre-proline 0 C--O 1.212 -0.919 0 CA-C-N 111.658 -2.519 . . . . 10.0 114.542 166.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.867 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 52.4 Cg_exo -22.33 -55.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.978 3.119 . . . . 10.0 115.995 -165.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.867 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 10.0 Cg_endo -81.81 -75.97 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 122.347 2.031 . . . . 10.0 112.151 168.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.421 ' O ' ' HB1' ' A' ' 27' ' ' ALA . 92.7 t -60.95 -46.73 96.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 112.542 -2.117 . . . . 10.0 114.919 -171.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 1.096 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -49.55 -73.41 0.36 Allowed Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 114.472 -1.24 . . . . 10.0 113.225 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.655 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 11.2 Cg_exo -45.89 -43.17 19.86 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.885 3.057 . . . . 10.0 112.737 171.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.46 ' O ' ' HD2' ' A' ' 31' ' ' HIS . . . -49.22 -98.23 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.567 0.58 . . . . 10.0 112.567 175.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.554 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.297 0.0 OUTLIER -70.41 -25.38 63.19 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 118.278 -1.369 . . . . 10.0 113.529 -174.872 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.27 -35.54 90.47 Favored Glycine 0 N--CA 1.464 0.521 0 C-N-CA 121.285 -0.483 . . . . 10.0 112.513 -177.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -58.83 -25.93 63.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.136 0.493 . . . . 10.0 109.72 173.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.46 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 71.7 m-70 -99.55 17.89 19.3 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.584 0.707 . . . . 10.0 109.488 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.471 ' HA3' ' HE2' ' A' ' 64' ' ' LYS . . . 85.62 6.39 83.26 Favored Glycine 0 CA--C 1.5 -0.88 0 CA-C-N 114.492 -1.231 . . . . 10.0 113.411 168.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.779 HG11 ' CD2' ' A' ' 66' ' ' PHE . 1.9 t -86.66 147.74 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 114.044 1.127 . . . . 10.0 114.044 -172.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -68.08 102.97 1.41 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.546 0.738 . . . . 10.0 111.348 174.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.577 ' O ' ' HB3' ' A' ' 39' ' ' CYS . 90.2 mt -50.72 -45.84 27.76 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 CA-C-O 122.526 1.155 . . . . 10.0 110.6 172.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -67.2 -52.21 43.97 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 111.833 -2.44 . . . . 10.0 112.898 -177.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -56.12 -38.51 70.87 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 120.035 -0.666 . . . . 10.0 110.05 177.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.766 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 20.9 t80 -59.8 -59.29 5.66 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 114.045 1.128 . . . . 10.0 114.045 168.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.577 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -54.86 -53.36 56.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.498 -1.683 . . . . 10.0 112.11 -176.222 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.436 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 12.3 tppt? -68.63 -19.25 64.41 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.611 -0.836 . . . . 10.0 109.101 -176.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.78 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 64.9 mtt180 -79.91 -62.53 1.65 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.115 -1.034 . . . . 10.0 112.907 168.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CZ ' HG22 ' A' ' 46' ' ' THR . 66.3 t80 -53.99 -45.69 71.5 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 119.213 0.915 . . . . 10.0 110.11 -174.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.606 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.9 OUTLIER -61.45 -51.36 69.01 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.536 -1.211 . . . . 10.0 110.874 -178.04 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.96 -37.38 86.85 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 118.815 -1.154 . . . . 10.0 111.811 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.78 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 7.6 mm-40 -67.48 -45.31 76.28 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.896 0.855 . . . . 10.0 110.882 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.683 HG22 HD11 ' A' ' 54' ' ' LEU . 82.7 p -85.67 2.77 43.93 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-N 114.567 -1.197 . . . . 10.0 112.111 -171.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.3 -36.59 14.49 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.812 -1.085 . . . . 10.0 112.318 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -83.4 -34.74 25.46 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.008 -0.996 . . . . 10.0 110.888 -174.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mtpp -97.6 20.84 11.17 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.804 -0.813 . . . . 10.0 108.804 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.485 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -55.1 152.21 8.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.524 -1.216 . . . . 10.0 113.582 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.16 16.26 44.77 Favored Glycine 0 CA--C 1.507 -0.462 0 N-CA-C 109.879 -1.288 . . . . 10.0 109.879 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.455 ' HB2' HD22 ' A' ' 54' ' ' LEU . 45.7 mtm -137.97 125.8 22.5 Favored 'General case' 0 C--O 1.213 -0.859 0 C-N-CA 116.385 -2.126 . . . . 10.0 114.562 -166.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.0 mm -66.1 90.22 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.514 -0.55 . . . . 10.0 109.514 172.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.683 HD11 HG22 ' A' ' 46' ' ' THR . 7.9 mt -79.4 128.69 74.49 Favored Pre-proline 0 N--CA 1.447 -0.61 0 N-CA-C 108.972 -0.751 . . . . 10.0 108.972 -177.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.648 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 11.0 Cg_exo -72.33 95.02 0.76 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.002 1.802 . . . . 10.0 110.756 174.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.486 ' O ' ' HG3' ' A' ' 10' ' ' LYS . 0.4 OUTLIER -92.38 157.74 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 119.125 0.875 . . . . 10.0 111.417 -171.06 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.417 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 89.4 t -135.04 117.53 22.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 110.278 -0.268 . . . . 10.0 110.278 172.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.582 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 24.0 mt -106.59 139.5 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 108.027 -1.101 . . . . 10.0 108.027 -175.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.7 m -123.44 98.36 5.82 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 108.481 -0.933 . . . . 10.0 108.481 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 65' ' ' SER . 1.5 p -87.03 136.0 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.07 0 CA-C-N 118.979 0.809 . . . . 10.0 111.286 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.582 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 89.5 m-85 -94.12 170.19 9.71 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 114.989 -1.005 . . . . 10.0 113.011 -175.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.445 ' HG3' ' HB3' ' A' ' 4' ' ' LYS . 28.9 mt-10 -63.17 -17.61 62.57 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.535 -1.211 . . . . 10.0 111.824 -176.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.429 ' HB2' ' HG ' ' A' ' 65' ' ' SER . 5.8 m-20 -78.0 -10.78 59.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.136 175.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.471 ' HE2' ' HA3' ' A' ' 32' ' ' GLY . 1.6 mtpt 80.69 2.28 1.79 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.416 1.086 . . . . 10.0 109.527 -169.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.548 ' O ' HG23 ' A' ' 60' ' ' VAL . 21.2 p -69.26 -179.24 1.54 Allowed 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.776 -1.556 . . . . 10.0 108.616 170.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.779 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -171.02 -175.1 1.65 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 120.032 1.287 . . . . 10.0 110.538 174.096 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 p -157.9 170.45 22.3 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 102.875 -3.009 . . . . 10.0 102.875 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -158.69 156.5 30.05 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.423 -0.954 . . . . 10.0 108.423 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.417 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 24.8 pt -128.71 153.26 37.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.272 -1.381 . . . . 10.0 107.272 -177.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.58 HG22 HD13 ' A' ' 54' ' ' LEU . 3.6 mm -107.87 132.0 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 N-CA-C 107.626 -1.25 . . . . 10.0 107.626 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.648 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 5.1 mmtp -77.32 85.54 3.74 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 118.942 -1.103 . . . . 10.0 109.337 176.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.818 HG22 ' HB3' ' A' ' 112' ' ' LYS . 15.3 t -63.99 -21.62 0.76 Allowed Pre-proline 0 CA--C 1.558 1.26 0 CA-C-N 112.745 -2.025 . . . . 10.0 113.151 174.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.872 ' HB3' ' HB2' ' A' ' 112' ' ' LYS . 56.8 Cg_endo -101.91 55.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.22 1.947 . . . . 10.0 117.144 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.562 ' HD3' ' O ' ' A' ' 71' ' ' LYS . 17.0 Cg_exo -71.86 -17.52 28.89 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 N-CA-C 107.9 -1.616 . . . . 10.0 107.9 154.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 69.19 -55.34 0.56 Allowed 'General case' 0 C--N 1.343 0.307 0 CA-C-N 113.335 -1.757 . . . . 10.0 111.481 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.589 ' HA ' ' HE1' ' A' ' 135' ' ' MET . 13.5 p -56.87 -40.17 75.69 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.055 -0.52 . . . . 10.0 111.923 -176.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.62 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -74.75 -33.74 62.37 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.106 0.479 . . . . 10.0 111.697 -173.086 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.744 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 3.7 tp -89.57 -17.8 27.83 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.533 -0.867 . . . . 10.0 108.905 177.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.532 HD23 ' HB2' ' A' ' 132' ' ' ALA . 8.7 tp -72.05 -23.26 61.34 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.316 -0.994 . . . . 10.0 108.316 168.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.62 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 24.0 mmtm -64.04 -27.5 69.15 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-O 121.195 0.521 . . . . 10.0 109.769 167.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.744 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -60.33 -45.18 94.34 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.484 -0.486 . . . . 10.0 111.508 171.665 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.649 ' HB3' HG13 ' A' ' 100' ' ' VAL . . . -71.07 -55.85 7.38 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.642 1.577 . . . . 10.0 112.075 173.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.7 122.25 22.95 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 111.907 -2.406 . . . . 10.0 107.63 -176.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 86' ' ' GLU . . . -85.65 11.12 62.55 Favored Glycine 0 C--N 1.32 -0.307 0 CA-C-N 120.815 1.643 . . . . 10.0 111.284 -164.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.474 ' C ' ' H ' ' A' ' 87' ' ' LYS . 36.8 pt -69.66 30.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 124.241 1.017 . . . . 10.0 113.118 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.451 ' H ' ' C ' ' A' ' 84' ' ' GLY . 2.2 tp10 -72.12 11.84 0.51 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.334 0.588 . . . . 10.0 111.452 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.474 ' H ' ' C ' ' A' ' 85' ' ' ILE . 66.4 mttm -161.04 90.39 0.83 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.178 -1.045 . . . . 10.0 108.178 -173.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.33 96.89 2.44 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.285 -0.959 . . . . 10.0 111.436 -175.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 91' ' ' GLU . 6.3 p -163.54 77.4 0.4 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.472 0.653 . . . . 10.0 110.868 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.543 ' O ' ' HB2' ' A' ' 91' ' ' GLU . 13.0 m -79.29 22.81 0.41 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.69 -0.686 . . . . 10.0 111.149 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 90' ' ' SER . 23.3 mm-40 78.29 80.34 0.12 Allowed Pre-proline 0 N--CA 1.467 0.417 0 O-C-N 124.116 0.885 . . . . 10.0 109.825 -171.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.445 ' HG2' HG13 ' A' ' 97' ' ' VAL . 83.6 Cg_endo -92.61 150.41 2.86 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.129 2.552 . . . . 10.0 113.622 -173.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 95' ' ' LYS . 24.5 pttm -165.36 174.32 10.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.855 -0.611 . . . . 10.0 109.967 175.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.465 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 0.1 OUTLIER 78.41 -80.33 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.277 0.631 . . . . 10.0 111.337 170.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.493 ' HD3' ' O ' ' A' ' 93' ' ' LYS . 0.4 OUTLIER -72.73 -13.6 61.37 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 107.705 -1.22 . . . . 10.0 107.705 179.193 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.467 ' CG2' ' N ' ' A' ' 97' ' ' VAL . 4.7 mt 75.56 174.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 113.447 -1.706 . . . . 10.0 109.924 175.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.467 ' N ' ' CG2' ' A' ' 96' ' ' ILE . 11.4 p -141.86 -50.98 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 113.648 0.981 . . . . 10.0 113.648 -168.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.637 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -156.56 165.93 33.13 Favored Glycine 0 N--CA 1.44 -1.084 0 N-CA-C 109.461 -1.456 . . . . 10.0 109.461 176.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.647 ' HB3' ' HZ1' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -154.1 170.86 20.15 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-O 122.197 0.999 . . . . 10.0 110.57 -163.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.649 HG13 ' HB3' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -159.37 -143.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-N 112.834 -1.985 . . . . 10.0 106.584 -172.56 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.584 ' OG1' ' HG2' ' A' ' 104' ' ' GLN . 17.2 p -153.9 143.98 22.05 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 107.618 -1.253 . . . . 10.0 107.618 -153.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.621 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 12.9 tpt180 -42.62 -41.24 3.0 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 114.854 -1.066 . . . . 10.0 110.034 177.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.542 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 3.5 tmtm? -60.15 -46.26 90.28 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.403 0.52 . . . . 10.0 112.403 177.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.584 ' HG2' ' OG1' ' A' ' 101' ' ' THR . 14.0 mm100 -66.02 -42.82 89.16 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.982 -0.747 . . . . 10.0 108.982 -177.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.856 HG22 ' HB ' ' A' ' 128' ' ' ILE . 30.8 mm -40.53 -58.11 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 114.604 -1.18 . . . . 10.0 110.832 164.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.621 ' HG2' ' HE3' ' A' ' 110' ' ' LYS . 31.7 tt0 -47.79 -50.35 26.07 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 114.633 -1.167 . . . . 10.0 112.917 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.418 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 35.2 mm-40 -54.45 -58.1 8.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.303 -0.862 . . . . 10.0 111.143 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.677 ' O ' HG21 ' A' ' 111' ' ' THR . 11.8 mm -48.97 -53.58 7.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-O 121.932 0.873 . . . . 10.0 109.95 172.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.548 ' HB2' ' HB1' ' A' ' 124' ' ' ALA . . . -48.67 -36.68 16.57 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.02 -0.991 . . . . 10.0 112.354 176.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.621 ' HE3' ' HG2' ' A' ' 106' ' ' GLU . 84.1 mttt -74.95 -54.02 7.95 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.409 -0.36 . . . . 10.0 111.44 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.677 HG21 ' O ' ' A' ' 108' ' ' ILE . 7.1 t -51.52 -22.93 3.53 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.242 1.201 . . . . 10.0 114.242 -171.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.872 ' HB2' ' HB3' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -130.01 19.4 5.48 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.576 0.703 . . . . 10.0 109.404 -174.593 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.653 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 54.8 ttm -52.21 -43.17 89.87 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 114.712 -1.131 . . . . 10.0 111.855 169.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.653 ' HD2' ' N ' ' A' ' 113' ' ' MET . 10.9 Cg_endo -52.64 -29.77 42.73 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.706 2.27 . . . . 10.0 112.259 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.5 ' CB ' ' HG3' ' A' ' 73' ' ' PRO . 21.1 t70 -91.19 -43.8 9.63 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.926 -1.034 . . . . 10.0 111.454 -176.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.648 HD21 ' NZ ' ' A' ' 112' ' ' LYS . 3.2 mp -69.02 178.26 2.31 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.723 -1.581 . . . . 10.0 114.509 -167.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -94.29 29.55 2.17 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 111.303 -2.68 . . . . 10.0 112.209 171.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.533 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . . . -73.97 92.03 2.08 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.346 0.499 . . . . 10.0 112.346 175.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -66.28 -28.71 68.91 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.609 -0.885 . . . . 10.0 108.609 172.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.7 t -152.96 140.92 20.24 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 105.441 -2.059 . . . . 10.0 105.441 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.775 ' O ' ' HG3' ' A' ' 125' ' ' MET . 45.0 tp -53.07 -32.56 47.72 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.117 1.154 . . . . 10.0 114.117 -172.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -50.17 -35.92 28.2 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.591 0.71 . . . . 10.0 110.243 173.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.75 -50.56 56.6 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.236 -0.986 . . . . 10.0 110.969 176.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.697 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -60.23 -31.99 70.7 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 119.734 -0.786 . . . . 10.0 110.738 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.775 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 75.5 mtp -58.0 -36.42 72.63 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.701 0.286 . . . . 10.0 110.746 176.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -64.24 -54.06 39.43 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.101 0.56 . . . . 10.0 111.726 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.757 HD11 HD13 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -51.48 -57.72 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 121.33 0.586 . . . . 10.0 110.739 179.005 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.856 ' HB ' HG22 ' A' ' 105' ' ' ILE . 21.5 mm -51.2 -54.06 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 CA-C-N 114.745 -1.116 . . . . 10.0 111.879 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.623 ' HG3' HG21 ' A' ' 105' ' ' ILE . 80.8 mt-10 -54.8 -40.97 70.04 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 123.325 0.391 . . . . 10.0 110.031 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -69.8 -46.8 51.56 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.194 -1.003 . . . . 10.0 111.015 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.53 HG23 ' HE3' ' A' ' 135' ' ' MET . 86.3 m -44.59 -64.12 0.76 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 113.98 -1.11 . . . . 10.0 109.308 169.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.532 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -48.13 -50.3 29.14 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.008 -0.542 . . . . 10.0 111.775 177.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -49.05 -52.82 23.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.972 -1.013 . . . . 10.0 111.324 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 22.8 t -64.04 -33.02 74.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.868 0.366 . . . . 10.0 111.262 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.589 ' HE1' ' HA ' ' A' ' 76' ' ' SER . 67.9 mtm -84.46 8.07 17.63 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 114.316 1.228 . . . . 10.0 114.316 -174.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.462 ' O ' HG22 ' A' ' 96' ' ' ILE . . . 78.9 15.34 80.83 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 119.815 1.188 . . . . 10.0 111.603 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.637 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 19.4 mt -100.43 122.74 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 CA-C-O 121.5 0.667 . . . . 10.0 111.228 178.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.61 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -88.51 156.2 19.22 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 115.0 -1.0 . . . . 10.0 109.569 -179.217 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 17.1 m -115.47 121.22 66.78 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 CA-C-O 122.141 0.972 . . . . 10.0 108.517 172.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.645 HG21 ' O ' ' A' ' 100' ' ' VAL . 4.9 m -105.21 148.91 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 CA-C-N 113.752 -1.567 . . . . 10.0 108.544 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 34.2 t70 . . . . . 0 C--N 1.286 -2.168 0 CA-C-N 113.718 -1.583 . . . . 10.0 110.571 179.684 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtm . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 120.993 0.425 . . . . 10.0 110.225 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.79 153.94 30.52 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.968 -0.56 . . . . 10.0 109.737 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.417 ' HB2' ' CG ' ' A' ' 61' ' ' TYR . 22.3 pttm -69.11 117.72 11.11 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.427 0.632 . . . . 10.0 111.324 -178.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -99.09 140.58 33.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.419 -0.809 . . . . 10.0 109.81 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.32 130.13 25.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.771 0.32 . . . . 10.0 111.272 -176.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.63 -40.58 5.72 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.576 -0.527 . . . . 10.0 109.576 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.469 ' HB1' ' CG1' ' A' ' 60' ' ' VAL . . . -155.37 155.52 33.78 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 113.861 1.06 . . . . 10.0 113.861 -176.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -92.64 136.25 33.39 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.424 -1.262 . . . . 10.0 109.145 170.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.629 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -123.62 79.56 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.299 -1.0 . . . . 10.0 108.299 165.317 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.448 ' HG2' HG12 ' A' ' 57' ' ' VAL . 52.9 mttm -81.33 125.58 30.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 120.531 1.514 . . . . 10.0 107.751 175.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.588 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -158.15 131.35 7.49 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 122.485 1.136 . . . . 10.0 112.562 -172.155 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.506 ' HB3' HG22 ' A' ' 53' ' ' ILE . 23.2 mt-30 -84.04 116.51 22.88 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 113.79 -1.55 . . . . 10.0 111.489 -173.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.588 HD21 HD11 ' A' ' 11' ' ' LEU . 80.0 mt -136.65 140.73 32.96 Favored Pre-proline 0 C--O 1.219 -0.542 0 N-CA-C 113.262 0.838 . . . . 10.0 113.262 -172.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.768 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 36.0 Cg_exo -63.28 131.95 34.23 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 C-N-CA 124.443 3.429 . . . . 10.0 113.445 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.515 ' O ' ' HA2' ' A' ' 51' ' ' GLY . . . -56.73 124.41 18.32 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 108.447 -0.945 . . . . 10.0 108.447 167.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.33 7.16 82.13 Favored Glycine 0 N--CA 1.444 -0.818 0 O-C-N 125.356 1.66 . . . . 10.0 113.507 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.768 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 24.5 mmtp -142.49 97.95 3.21 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.236 1.018 . . . . 10.0 112.798 178.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.617 ' O ' ' HB2' ' A' ' 39' ' ' CYS . . . -171.35 135.84 0.98 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.321 -1.309 . . . . 10.0 112.967 172.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.625 HG21 ' HD3' ' A' ' 20' ' ' PRO . 1.1 t -179.04 -45.3 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 114.894 -1.048 . . . . 10.0 113.354 175.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.794 ' HD2' ' H ' ' A' ' 21' ' ' ALA . 69.6 Cg_endo -118.34 -46.54 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.257 0 N-CA-C 117.002 1.885 . . . . 10.0 117.002 -171.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.794 ' H ' ' HD2' ' A' ' 20' ' ' PRO . . . -47.48 154.74 0.82 Allowed Pre-proline 0 N--CA 1.467 0.392 0 N-CA-C 113.688 0.995 . . . . 10.0 113.688 -165.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.534 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 53.5 Cg_exo -38.94 -41.18 1.71 Allowed 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 124.583 3.522 . . . . 10.0 115.075 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.51 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 3.1 Cg_exo -41.26 -54.69 2.49 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.542 2.161 . . . . 10.0 112.448 167.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.408 HG11 HD13 ' A' ' 28' ' ' LEU . 89.2 t -89.68 -55.54 6.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.59 -1.186 . . . . 10.0 113.887 -170.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.501 ' HA2' ' CD1' ' A' ' 35' ' ' ILE . . . -45.61 -73.2 0.3 Allowed Glycine 0 C--N 1.337 0.59 0 CA-C-N 114.247 -1.342 . . . . 10.0 113.668 -175.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.534 ' HD2' ' O ' ' A' ' 22' ' ' PRO . 88.9 Cg_exo -51.27 -44.44 43.03 Favored 'Trans proline' 0 C--O 1.225 -0.133 0 C-N-CA 123.561 2.84 . . . . 10.0 112.667 173.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 23' ' ' PRO . . . -50.71 -76.19 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.496 0.665 . . . . 10.0 111.38 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.69 HD21 ' CD1' ' A' ' 58' ' ' ILE . 3.8 mt -69.34 -44.33 71.85 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.331 -0.849 . . . . 10.0 113.098 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.44 -44.35 97.75 Favored Glycine 0 C--O 1.229 -0.159 0 CA-C-N 116.253 -0.431 . . . . 10.0 112.949 -173.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -62.06 -25.43 67.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.647 0.261 . . . . 10.0 110.565 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -101.34 13.64 34.43 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 120.113 -0.635 . . . . 10.0 110.787 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.34 12.94 83.83 Favored Glycine 0 CA--C 1.503 -0.707 0 CA-C-N 114.947 -1.024 . . . . 10.0 113.036 169.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.56 ' HB ' ' HB3' ' A' ' 28' ' ' LEU . 48.3 t -81.78 142.39 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 115.194 -0.503 . . . . 10.0 111.992 -173.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.407 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 81.6 m-20 -67.29 90.27 0.22 Allowed 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.025 0.441 . . . . 10.0 110.022 175.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.688 HG12 ' HB2' ' A' ' 28' ' ' LEU . 33.7 mt -55.24 -39.65 52.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.767 0.794 . . . . 10.0 111.463 177.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.676 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 62.9 mtm -64.55 -50.61 66.6 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.903 -1.498 . . . . 10.0 111.113 176.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.597 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 20.2 tt0 -55.66 -50.05 71.27 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.05 -0.66 . . . . 10.0 110.313 174.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.631 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . 61.9 t80 -55.65 -54.97 37.67 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 113.732 1.012 . . . . 10.0 113.732 176.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.676 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 8.8 p -56.19 -48.11 77.02 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.346 -0.843 . . . . 10.0 110.662 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.419 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 46.5 mmtm -67.69 -22.32 65.28 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.712 -0.795 . . . . 10.0 109.925 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.808 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 29.9 mtp180 -75.77 -63.75 1.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.651 -0.704 . . . . 10.0 111.559 171.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.602 ' CZ ' HG23 ' A' ' 46' ' ' THR . 79.3 t80 -55.33 -47.16 76.1 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.481 0.658 . . . . 10.0 110.619 -173.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.595 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.9 OUTLIER -61.06 -48.3 82.38 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.674 -1.148 . . . . 10.0 110.539 -176.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.94 93.68 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 118.901 -1.12 . . . . 10.0 111.737 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.808 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 11.4 mm-40 -66.53 -39.21 88.49 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.711 0.767 . . . . 10.0 111.786 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.624 ' CG2' HD12 ' A' ' 54' ' ' LEU . 64.6 p -92.6 -10.96 35.58 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 114.096 1.146 . . . . 10.0 114.096 -166.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.52 -37.19 37.8 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 113.575 0.954 . . . . 10.0 113.575 -171.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -75.35 -35.99 61.08 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.576 -0.738 . . . . 10.0 109.268 -175.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.453 ' O ' ' HE2' ' A' ' 52' ' ' MET . 4.3 mppt? -93.87 49.33 1.33 Allowed 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 122.926 0.49 . . . . 10.0 110.848 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.914 ' HB3' ' HG3' ' A' ' 52' ' ' MET . . . 100.0 -152.84 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 114.885 1.439 . . . . 10.0 114.885 146.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 15' ' ' ALA . . . -123.99 83.6 0.36 Allowed Glycine 0 N--CA 1.419 -2.466 0 N-CA-C 105.491 -3.043 . . . . 10.0 105.491 164.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.914 ' HG3' ' HB3' ' A' ' 50' ' ' ALA . 29.3 mtm -139.1 131.15 27.93 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 116.214 1.931 . . . . 10.0 116.214 -160.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.506 HG22 ' HB3' ' A' ' 12' ' ' GLN . 0.4 OUTLIER -67.94 94.29 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 119.38 -0.928 . . . . 10.0 110.225 171.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.624 HD12 ' CG2' ' A' ' 46' ' ' THR . 11.4 mt -83.36 128.53 64.08 Favored Pre-proline 0 N--CA 1.437 -1.108 0 CA-C-N 115.139 -0.937 . . . . 10.0 108.788 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.408 ' O ' ' HD3' ' A' ' 71' ' ' LYS . 26.9 Cg_exo -64.88 98.05 0.29 Allowed 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.216 1.944 . . . . 10.0 110.946 175.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.47 153.74 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 119.011 0.823 . . . . 10.0 110.946 -173.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.448 HG12 ' HG2' ' A' ' 10' ' ' LYS . 92.4 t -134.27 114.23 18.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 C-N-CA 121.015 -0.274 . . . . 10.0 110.359 173.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.69 ' CD1' HD21 ' A' ' 28' ' ' LEU . 22.8 mt -106.66 137.49 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.795 0 N-CA-C 108.003 -1.11 . . . . 10.0 108.003 -173.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 31.6 m -121.76 95.53 4.71 Favored 'General case' 0 N--CA 1.405 -2.675 0 CA-C-N 114.707 -1.133 . . . . 10.0 108.642 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.484 HG21 HG23 ' A' ' 33' ' ' VAL . 3.1 p -86.64 137.14 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-N 119.28 0.945 . . . . 10.0 110.599 -178.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.496 ' HH ' ' HG1' ' A' ' 67' ' ' THR . 66.0 m-85 -96.28 172.49 7.92 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 113.001 0.741 . . . . 10.0 113.001 -176.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -53.86 -27.25 28.82 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.03 -1.441 . . . . 10.0 112.602 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.579 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 4.0 m-20 -77.61 -10.76 59.69 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.371 -0.832 . . . . 10.0 111.591 -173.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.579 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 51.5 mtpt 83.3 -0.16 1.13 Allowed 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.276 1.036 . . . . 10.0 109.537 -164.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.6 m -70.89 170.77 11.95 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 113.626 -1.624 . . . . 10.0 108.234 173.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.631 ' CZ ' ' HB2' ' A' ' 38' ' ' PHE . 6.0 p90 -168.44 -176.12 2.74 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 120.372 1.442 . . . . 10.0 110.373 175.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.496 ' HG1' ' HH ' ' A' ' 61' ' ' TYR . 32.6 p -157.72 171.74 19.77 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 103.1 -2.926 . . . . 10.0 103.1 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.431 ' CB ' HG12 ' A' ' 58' ' ' ILE . 38.1 p90 -161.41 155.62 22.56 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.404 -0.962 . . . . 10.0 108.404 177.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 29.9 pt -128.53 166.97 24.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.289 -1.375 . . . . 10.0 107.289 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.464 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 2.5 mt -138.1 119.02 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 107.544 -1.28 . . . . 10.0 107.544 -177.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.408 ' HD3' ' O ' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -83.44 67.55 9.38 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.597 -0.89 . . . . 10.0 108.597 -176.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.473 ' HB ' ' HB3' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -20.59 96.37 0.05 OUTLIER Pre-proline 0 C--O 1.224 -0.24 0 O-C-N 125.879 1.987 . . . . 10.0 112.244 176.005 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.403 ' CB ' ' HD2' ' A' ' 77' ' ' PHE . 3.8 Cg_exo -36.65 124.3 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 124.406 3.404 . . . . 10.0 113.65 -167.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.535 ' HA ' ' HZ1' ' A' ' 112' ' ' LYS . 86.1 Cg_exo -48.09 86.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.17 3.247 . . . . 10.0 114.085 -176.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 1.061 ' H ' ' HE2' ' A' ' 112' ' ' LYS . . . 72.49 -49.75 0.7 Allowed 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 124.708 1.203 . . . . 10.0 112.509 173.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.554 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 8.0 p -37.39 -65.29 0.32 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 114.116 1.154 . . . . 10.0 114.116 -171.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.713 ' HB3' ' SD ' ' A' ' 52' ' ' MET . 41.6 m-85 -72.32 -40.75 67.22 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.26 0.837 . . . . 10.0 113.26 -171.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.788 ' HB3' HD13 ' A' ' 108' ' ' ILE . 2.7 mm? -68.32 -30.62 69.64 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.547 -0.721 . . . . 10.0 109.863 177.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.416 ' CD1' ' HB1' ' A' ' 75' ' ' ALA . 28.0 mt -70.94 -25.41 62.73 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.967 -0.56 . . . . 10.0 110.914 175.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.743 ' HA ' HG13 ' A' ' 85' ' ' ILE . 25.1 mmmt -54.15 -49.28 69.62 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 108.638 -0.875 . . . . 10.0 108.638 174.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -58.33 -44.99 88.92 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.881 0.697 . . . . 10.0 112.881 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.693 ' HB3' ' HG2' ' A' ' 104' ' ' GLN . . . -65.86 -55.57 16.35 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 123.031 1.396 . . . . 10.0 110.165 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.597 ' HB1' HG12 ' A' ' 85' ' ' ILE . . . -63.84 -33.12 74.97 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 111.119 -2.764 . . . . 10.0 110.597 -172.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.09 -15.33 56.66 Favored Glycine 0 C--N 1.309 -0.932 0 C-N-CA 120.154 -1.022 . . . . 10.0 110.934 177.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.743 HG13 ' HA ' ' A' ' 80' ' ' LYS . 3.5 pt -57.11 97.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 121.555 0.693 . . . . 10.0 110.63 170.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -165.92 131.36 2.43 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.034 -0.984 . . . . 10.0 108.827 -173.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 58.6 tttp 84.08 -33.42 0.07 Allowed 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 123.942 0.897 . . . . 10.0 109.555 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 176.29 -49.71 0.11 Allowed Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.038 -1.077 . . . . 10.0 113.448 172.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.5 p 49.88 104.44 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.741 0.816 . . . . 10.0 112.301 -174.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.0 m -73.02 12.68 0.5 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.623 -0.717 . . . . 10.0 112.923 -173.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 66.88 89.8 0.09 OUTLIER Pre-proline 0 C--O 1.235 0.312 0 CA-C-O 120.963 0.411 . . . . 10.0 110.781 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.755 ' HD2' ' HA ' ' A' ' 97' ' ' VAL . 72.4 Cg_endo -78.85 106.51 2.1 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.572 2.182 . . . . 10.0 111.886 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -77.71 76.33 4.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.017 0.436 . . . . 10.0 111.231 -174.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -164.18 -45.13 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.078 -0.964 . . . . 10.0 108.413 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.825 ' HD2' ' HE2' ' A' ' 99' ' ' LYS . 24.3 mmtp -79.22 -95.07 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 106.837 -1.542 . . . . 10.0 106.837 173.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.557 ' HB ' ' O ' ' A' ' 136' ' ' GLY . 1.6 mt -153.14 -61.69 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.49 -1.351 0 N-CA-C 106.468 -1.679 . . . . 10.0 106.468 164.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.755 ' HA ' ' HD2' ' A' ' 92' ' ' PRO . 3.3 p -157.59 -51.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 CA-C-N 112.38 -2.191 . . . . 10.0 108.41 168.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -133.92 147.99 19.26 Favored Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 109.325 -1.51 . . . . 10.0 109.325 164.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.825 ' HE2' ' HD2' ' A' ' 95' ' ' LYS . 64.4 pttt -148.11 160.95 42.36 Favored 'General case' 0 CA--C 1.472 -2.022 0 CA-C-O 122.144 0.973 . . . . 10.0 108.803 172.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.511 HG13 ' HB3' ' A' ' 82' ' ' ALA . 1.2 m -161.18 -162.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.411 -2.399 0 CA-C-N 112.486 -2.143 . . . . 10.0 106.772 -166.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.564 HG22 HG23 ' A' ' 140' ' ' VAL . 15.9 p -121.7 159.06 27.36 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 114.543 -1.208 . . . . 10.0 111.106 -173.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.66 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 16.2 tpt180 -43.12 -44.84 5.16 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.919 -1.492 . . . . 10.0 110.165 171.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -58.01 -44.29 87.17 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.801 0.667 . . . . 10.0 112.801 177.429 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.693 ' HG2' ' HB3' ' A' ' 82' ' ' ALA . 1.4 tp60 -55.63 -54.86 38.92 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.895 -0.78 . . . . 10.0 108.895 177.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.743 HG23 ' HB ' ' A' ' 128' ' ' ILE . 45.5 mm -35.96 -52.93 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-N 113.985 -1.461 . . . . 10.0 112.604 167.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.689 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 25.5 tt0 -47.57 -59.63 3.12 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.529 1.132 . . . . 10.0 113.183 -175.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -55.94 -49.82 72.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.129 -0.941 . . . . 10.0 110.519 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.788 HD13 ' HB3' ' A' ' 78' ' ' LEU . 13.8 mm -49.86 -57.42 2.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.652 -0.704 . . . . 10.0 110.641 171.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.512 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -52.23 -35.65 50.19 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.923 -0.581 . . . . 10.0 112.371 177.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.689 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 46.9 mttt -74.97 -56.09 5.1 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.707 -0.679 . . . . 10.0 111.42 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.464 HG23 ' CG ' ' A' ' 112' ' ' LYS . 13.2 t -54.47 -30.41 53.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.931 -0.577 . . . . 10.0 112.375 -176.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 1.061 ' HE2' ' H ' ' A' ' 75' ' ' ALA . 0.8 OUTLIER -113.48 23.71 12.92 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 121.062 -0.255 . . . . 10.0 110.888 -178.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.762 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 46.5 ttm -48.48 -44.3 64.85 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.359 -0.382 . . . . 10.0 111.696 175.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 113' ' ' MET . 56.7 Cg_endo -68.04 -20.64 44.11 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.587 1.525 . . . . 10.0 113.172 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 117' ' ' ASN . 12.4 t70 -83.55 -54.95 4.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.604 -0.726 . . . . 10.0 110.441 -176.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.646 HD21 HD12 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -65.43 -0.32 1.86 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.686 -1.143 . . . . 10.0 112.618 -177.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' ' 115' ' ' ASP . 15.5 m120 60.25 46.93 9.72 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.717 -1.128 . . . . 10.0 109.309 -177.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.762 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -79.84 113.63 18.14 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.358 -1.292 . . . . 10.0 112.625 -173.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -67.39 -36.04 80.52 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.148 -0.686 . . . . 10.0 109.148 169.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.5 p -150.59 146.4 26.52 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.955 -1.128 . . . . 10.0 107.955 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.591 ' O ' ' HG2' ' A' ' 125' ' ' MET . 39.6 tp -53.06 -40.47 64.03 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 114.446 1.276 . . . . 10.0 114.446 -177.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -51.13 -35.19 34.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.309 0.576 . . . . 10.0 111.026 176.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.587 ' O ' ' HG3' ' A' ' 126' ' ' LYS . . . -67.64 -49.08 64.69 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 118.816 -1.153 . . . . 10.0 110.607 173.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.645 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -56.86 -29.05 62.53 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.684 -0.806 . . . . 10.0 110.328 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.657 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 82.8 mmm -61.55 -41.55 97.52 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 113.06 0.763 . . . . 10.0 113.06 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.74 ' HD3' ' N ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -66.7 -45.27 79.31 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 122.161 -0.337 . . . . 10.0 111.816 178.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.74 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -55.12 -60.59 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 C-N-CA 120.164 -0.614 . . . . 10.0 110.662 178.443 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.743 ' HB ' HG23 ' A' ' 105' ' ' ILE . 19.8 mm -50.36 -55.02 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.219 0 CA-C-N 115.614 -0.721 . . . . 10.0 110.774 -177.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.465 ' HG2' ' HZ2' ' A' ' 133' ' ' LYS . 36.6 tt0 -54.46 -44.3 72.44 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 114.753 -1.112 . . . . 10.0 108.898 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.59 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -72.07 -46.2 37.08 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 121.154 -0.546 . . . . 10.0 112.166 -174.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.557 HG23 ' HB2' ' A' ' 75' ' ' ALA . 68.1 m -46.96 -57.69 4.73 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.483 0.658 . . . . 10.0 109.431 171.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.6 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -49.08 -43.26 40.96 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 114.94 -1.027 . . . . 10.0 111.876 175.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.59 ' HB2' ' O ' ' A' ' 130' ' ' GLY . 58.6 mttp -48.74 -53.02 20.64 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.439 0.462 . . . . 10.0 110.876 176.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.9 m -66.96 -32.87 74.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.024 0.44 . . . . 10.0 111.446 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.461 ' HE2' ' HA ' ' A' ' 76' ' ' SER . 38.3 mtm -79.85 -1.05 37.31 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.934 1.087 . . . . 10.0 113.934 -175.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.557 ' O ' ' HB ' ' A' ' 96' ' ' ILE . . . 83.49 23.78 52.76 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 119.619 1.1 . . . . 10.0 112.142 -177.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.6 ' HB ' ' HB1' ' A' ' 132' ' ' ALA . 3.0 mp -109.26 126.63 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 CA-C-O 121.525 0.679 . . . . 10.0 111.043 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.706 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -91.9 157.86 16.6 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.553 -1.203 . . . . 10.0 108.906 179.31 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 19.5 m -119.02 134.52 62.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.177 -0.675 . . . . 10.0 109.177 171.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.564 HG23 HG22 ' A' ' 101' ' ' THR . 28.7 m -133.85 71.07 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 116.052 1.871 . . . . 10.0 116.052 -173.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 20.5 t0 . . . . . 0 C--N 1.3 -1.571 0 CA-C-N 114.321 -1.309 . . . . 10.0 109.041 138.791 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.804 ' HE2' ' HA ' ' A' ' 1' ' ' MET . 10.0 mmt . . . . . 0 N--CA 1.485 1.289 0 N-CA-C 109.694 -0.484 . . . . 10.0 109.694 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.16 -108.72 0.43 Allowed 'General case' 0 C--N 1.331 -0.221 0 O-C-N 123.716 0.635 . . . . 10.0 110.108 -173.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -141.51 110.26 6.11 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.857 -0.423 . . . . 10.0 109.857 171.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.475 ' HB2' ' HZ3' ' A' ' 4' ' ' LYS . 10.3 mtmp? -102.31 143.69 31.76 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.776 -0.453 . . . . 10.0 109.776 177.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.462 HG11 HG23 ' A' ' 59' ' ' THR . 45.2 t -62.13 131.53 27.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 116.222 -0.444 . . . . 10.0 111.155 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.93 -35.39 7.31 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.687 -0.486 . . . . 10.0 109.687 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.495 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -154.11 141.27 19.45 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.327 0.862 . . . . 10.0 113.327 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -94.2 126.96 39.76 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 106.654 -1.61 . . . . 10.0 106.654 171.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.604 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 1.9 mt -125.67 85.59 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 120.241 -0.584 . . . . 10.0 109.864 -177.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.553 ' HG2' HG23 ' A' ' 57' ' ' VAL . 58.1 mttp -75.92 132.86 40.53 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 120.338 -0.545 . . . . 10.0 109.85 176.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.771 HD13 HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -158.34 127.21 5.55 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.154 0.978 . . . . 10.0 111.607 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -85.92 122.87 30.59 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.502 -1.226 . . . . 10.0 110.724 -172.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.771 HD22 HD13 ' A' ' 11' ' ' LEU . 94.0 mt -141.56 135.66 14.96 Favored Pre-proline 0 CA--C 1.51 -0.584 0 CA-C-O 121.659 0.742 . . . . 10.0 112.044 -172.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.604 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 53.1 Cg_exo -49.94 124.34 12.4 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.818 3.012 . . . . 10.0 112.943 170.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.651 ' HB3' HD12 ' A' ' 54' ' ' LEU . . . -62.73 128.76 37.44 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.599 -1.259 . . . . 10.0 107.599 170.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.35 0.48 78.35 Favored Glycine 0 N--CA 1.446 -0.693 0 O-C-N 125.513 1.758 . . . . 10.0 112.992 -174.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.604 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -143.84 96.08 2.84 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.941 0.877 . . . . 10.0 112.038 -178.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.524 ' O ' ' HB2' ' A' ' 39' ' ' CYS . . . -170.62 135.85 1.19 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.073 -1.422 . . . . 10.0 112.733 177.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.643 ' H ' ' HD3' ' A' ' 20' ' ' PRO . 5.9 t -179.61 -36.26 0.0 OUTLIER Pre-proline 0 N--CA 1.443 -0.777 0 CA-C-N 115.236 -0.893 . . . . 10.0 113.357 176.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.726 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 89.3 Cg_endo -104.04 129.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.409 -3.476 0 N-CA-C 116.492 1.689 . . . . 10.0 116.492 -157.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.954 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . 13.09 -58.24 0.0 OUTLIER Pre-proline 0 C--N 1.288 -2.078 0 CA-C-N 109.228 -3.624 . . . . 10.0 118.546 152.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.754 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 45.3 Cg_exo -57.69 -63.9 0.14 Allowed 'Trans proline' 0 CA--C 1.566 2.115 0 CA-C-N 123.576 2.313 . . . . 10.0 115.409 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.754 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 58.6 Cg_endo -77.42 -52.04 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.681 2.254 . . . . 10.0 112.74 176.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.981 HG12 HD11 ' A' ' 35' ' ' ILE . 77.5 t -81.89 -49.46 17.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 111.702 -2.499 . . . . 10.0 111.894 -166.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.697 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -44.15 -52.97 6.83 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 113.968 -1.469 . . . . 10.0 113.39 178.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.954 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 23.9 Cg_exo -71.96 -43.82 1.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.179 2.586 . . . . 10.0 111.236 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.514 ' O ' ' HD2' ' A' ' 31' ' ' HIS . . . -50.58 -93.81 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.434 0.459 . . . . 10.0 111.897 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.765 HD23 HD13 ' A' ' 35' ' ' ILE 0.356 0.0 OUTLIER -77.15 -19.24 57.12 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 117.306 -1.758 . . . . 10.0 113.797 -174.535 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.55 -39.48 60.84 Favored Glycine 0 N--CA 1.467 0.714 0 C-N-CA 120.666 -0.778 . . . . 10.0 113.092 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.592 ' HB3' ' O ' ' A' ' 26' ' ' PRO . 13.0 tt0 -56.61 -26.14 54.83 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.746 0.308 . . . . 10.0 110.628 175.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.514 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 70.0 m-70 -96.47 23.63 6.62 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.739 -0.784 . . . . 10.0 109.86 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.44 ' HA3' ' CE ' ' A' ' 64' ' ' LYS . . . 81.66 6.92 88.72 Favored Glycine 0 CA--C 1.494 -1.232 0 CA-C-N 115.27 -0.877 . . . . 10.0 112.813 167.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.881 HG11 ' CD2' ' A' ' 66' ' ' PHE . 2.4 t -85.26 146.97 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 113.628 0.973 . . . . 10.0 113.628 -175.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.6 ' ND2' ' HB3' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -69.97 101.71 1.84 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.649 0.737 . . . . 10.0 111.477 174.321 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.981 HD11 HG12 ' A' ' 24' ' ' VAL . 21.2 mm -53.49 -39.25 35.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 114.152 -1.385 . . . . 10.0 112.175 176.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.797 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 3.2 mpp? -66.13 -51.38 58.5 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.335 -1.757 . . . . 10.0 111.907 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.6 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 44.0 tt0 -57.83 -40.13 79.28 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.109 -1.036 . . . . 10.0 110.23 176.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.642 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 89.0 t80 -57.47 -58.97 5.95 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 113.877 1.066 . . . . 10.0 113.877 171.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.797 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 19.8 p -60.08 -47.43 85.91 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 114.563 -1.199 . . . . 10.0 111.36 -175.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -65.26 -24.29 67.28 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.988 -0.745 . . . . 10.0 108.988 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.776 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 19.2 mtp180 -74.2 -64.48 1.01 Allowed 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.598 -0.841 . . . . 10.0 112.35 170.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.55 ' CZ ' HG23 ' A' ' 46' ' ' THR . 76.5 t80 -53.37 -45.18 69.11 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 121.157 0.503 . . . . 10.0 110.376 -172.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.63 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.8 OUTLIER -59.18 -51.01 71.85 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.026 -0.988 . . . . 10.0 110.235 -177.685 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.27 -41.67 99.04 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.209 -0.996 . . . . 10.0 112.232 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.776 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 10.6 mt-10 -68.6 -40.33 80.47 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.795 0.807 . . . . 10.0 111.166 -176.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.685 HG23 HD11 ' A' ' 54' ' ' LEU . 75.4 p -87.81 0.54 55.64 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 114.778 -1.101 . . . . 10.0 112.28 -173.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.04 -35.27 2.9 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.231 1.013 . . . . 10.0 113.233 -175.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -86.91 -33.54 19.69 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.806 -0.634 . . . . 10.0 112.391 -173.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.569 ' HB3' ' HZ ' ' A' ' 77' ' ' PHE . 39.3 mttm -96.94 20.45 11.12 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.181 -0.674 . . . . 10.0 109.181 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.569 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -54.36 157.74 2.65 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 125.223 1.409 . . . . 10.0 114.128 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.05 22.07 43.39 Favored Glycine 0 CA--C 1.501 -0.812 0 N-CA-C 109.121 -1.592 . . . . 10.0 109.121 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.587 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 40.4 tpp -140.99 120.21 12.94 Favored 'General case' 0 C--O 1.205 -1.242 0 C-N-CA 117.42 -1.712 . . . . 10.0 114.737 -159.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.6 mm -63.11 92.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 121.688 -0.632 . . . . 10.0 109.999 172.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.685 HD11 HG23 ' A' ' 46' ' ' THR . 7.2 mt -82.65 129.37 62.73 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.71 -0.478 . . . . 10.0 109.71 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.407 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 14.9 Cg_exo -71.51 103.37 1.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 121.918 1.746 . . . . 10.0 110.262 171.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.02 153.79 3.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 119.726 1.148 . . . . 10.0 110.903 -173.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.553 HG23 ' HG2' ' A' ' 10' ' ' LYS . 61.5 t -133.09 111.66 16.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 176.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.604 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 17.2 mt -102.9 140.66 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.789 0 N-CA-C 108.534 -0.913 . . . . 10.0 108.534 -172.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.462 HG23 HG11 ' A' ' 5' ' ' VAL . 57.2 m -125.19 94.45 4.17 Favored 'General case' 0 N--CA 1.402 -2.863 0 CA-C-N 114.774 -1.103 . . . . 10.0 108.873 177.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 65' ' ' SER . 2.2 p -89.82 134.67 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 O-C-N 121.264 -0.898 . . . . 10.0 110.16 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -91.84 172.34 8.53 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.69 -0.686 . . . . 10.0 112.658 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -63.75 -19.25 64.82 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.298 -0.865 . . . . 10.0 111.393 -178.799 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.48 ' HB3' ' HG ' ' A' ' 65' ' ' SER . 27.3 t70 -77.55 -10.45 59.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.811 -1.086 . . . . 10.0 111.237 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.44 ' CE ' ' HA3' ' A' ' 32' ' ' GLY . 28.1 mmmt 82.55 -3.76 1.38 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.328 1.051 . . . . 10.0 110.961 -172.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.596 ' O ' HG23 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -68.93 179.45 1.83 Allowed 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.661 -0.866 . . . . 10.0 108.661 170.843 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.881 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -166.06 -176.51 3.78 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 119.851 1.205 . . . . 10.0 109.828 175.128 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.3 p -158.12 166.84 31.45 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 102.275 -3.231 . . . . 10.0 102.275 178.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.416 ' CB ' HG12 ' A' ' 58' ' ' ILE . 45.1 p90 -163.66 154.64 16.23 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.207 -1.035 . . . . 10.0 108.207 175.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.507 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 29.2 pt -117.01 164.14 13.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.613 -1.254 . . . . 10.0 107.613 -177.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.466 HG23 HD13 ' A' ' 54' ' ' LEU . 10.5 mm -117.22 126.27 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 106.561 -1.644 . . . . 10.0 106.561 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 71' ' ' LYS . 50.3 mmtt -72.47 104.29 3.76 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 119.576 -0.85 . . . . 10.0 109.988 -177.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.676 ' O ' ' HE2' ' A' ' 112' ' ' LYS . 8.2 p -41.57 139.06 1.55 Allowed Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 112.973 -1.921 . . . . 10.0 109.27 174.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.455 ' HB3' ' HB3' ' A' ' 77' ' ' PHE . 8.7 Cg_exo -32.59 104.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 124.192 3.262 . . . . 10.0 113.256 -174.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.445 ' O ' ' HB1' ' A' ' 75' ' ' ALA . 74.6 Cg_exo -38.85 -47.66 2.76 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.064 2.509 . . . . 10.0 110.565 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.524 ' CB ' HG21 ' A' ' 131' ' ' THR . . . 174.91 -47.58 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 113.824 -1.534 . . . . 10.0 109.364 159.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.65 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 83.9 p -64.68 -30.46 71.48 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 109.817 -0.438 . . . . 10.0 109.817 -178.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.676 ' HE2' HD21 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -41.89 -70.27 0.11 Allowed 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.87 0.868 . . . . 10.0 111.122 175.478 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.78 ' HB3' HD11 ' A' ' 108' ' ' ILE . 12.5 tp -90.25 -17.48 27.39 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.078 -0.51 . . . . 10.0 109.849 -170.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.7 mt -69.2 -33.16 72.92 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.259 172.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.65 ' HG3' ' O ' ' A' ' 76' ' ' SER . 48.5 mttp -60.81 -41.52 95.85 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.35 -0.611 . . . . 10.0 109.35 171.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -58.4 -39.91 80.98 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.851 -0.613 . . . . 10.0 112.422 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.578 ' CB ' HG11 ' A' ' 100' ' ' VAL . . . -69.96 -53.03 19.6 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.975 1.369 . . . . 10.0 110.875 174.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.87 -37.93 89.27 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 111.473 -2.603 . . . . 10.0 111.437 -171.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 87.36 66.21 1.35 Allowed Glycine 0 C--N 1.311 -0.813 0 C-N-CA 120.005 -1.093 . . . . 10.0 110.836 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.4 pt -159.01 69.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 122.294 1.045 . . . . 10.0 109.304 -173.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 18.3 mt-10 -73.48 74.26 1.42 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.196 -1.365 . . . . 10.0 111.8 -173.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.597 ' HZ3' ' HB3' ' A' ' 87' ' ' LYS . 10.0 mtpm? 82.35 7.11 0.93 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.627 -0.715 . . . . 10.0 109.91 172.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.92 8.92 74.18 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.012 -0.994 . . . . 10.0 112.08 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.0 p -75.66 -168.04 0.79 Allowed 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 122.628 0.371 . . . . 10.0 111.474 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.3 t 76.59 29.46 0.67 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.91 175.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.744 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 31.1 tt0 -172.1 -55.58 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.625 176.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.744 ' HD3' ' HB3' ' A' ' 91' ' ' GLU . 20.6 Cg_exo -66.88 102.69 0.65 Allowed 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.892 1.728 . . . . 10.0 112.474 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -159.86 95.95 1.21 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.982 -0.554 . . . . 10.0 110.491 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.5 ' C ' ' H ' ' A' ' 96' ' ' ILE . 56.1 ttm-85 -170.17 -64.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.888 0.375 . . . . 10.0 110.442 172.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -77.36 9.36 3.26 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.719 0.771 . . . . 10.0 109.322 -177.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.5 ' H ' ' C ' ' A' ' 94' ' ' ARG . 1.4 mt 72.78 104.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.182 -1.372 . . . . 10.0 111.68 -174.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 97' ' ' VAL . 7.1 p -62.31 101.85 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 112.582 -2.099 . . . . 10.0 111.694 -175.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 38.92 -161.83 0.01 OUTLIER Glycine 0 C--N 1.323 -0.181 0 CA-C-N 114.21 -1.359 . . . . 10.0 112.656 -170.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.549 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 8.4 ptpp? -158.85 177.58 11.01 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 122.273 1.035 . . . . 10.0 111.022 177.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.735 ' O ' HG23 ' A' ' 140' ' ' VAL . 1.0 OUTLIER -155.54 -145.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-N 112.285 -2.234 . . . . 10.0 105.981 -176.147 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.565 HG22 HE21 ' A' ' 104' ' ' GLN . 0.1 OUTLIER -162.77 142.72 9.32 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 109.048 -0.723 . . . . 10.0 109.048 -157.44 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.725 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 1.5 tpt180 -43.31 -39.97 3.33 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 124.934 1.396 . . . . 10.0 110.795 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.544 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 17.8 tppt? -60.13 -44.42 94.93 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.521 0.563 . . . . 10.0 112.521 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.65 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -63.81 -47.96 78.76 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.758 -0.83 . . . . 10.0 108.758 178.509 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.725 ' HB ' ' O ' ' A' ' 102' ' ' ARG . 43.2 mm -35.53 -58.15 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 114.949 -1.023 . . . . 10.0 111.544 163.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.664 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 33.1 tt0 -47.33 -54.65 10.54 Favored 'General case' 0 C--O 1.209 -1.07 0 C-N-CA 124.636 1.174 . . . . 10.0 113.146 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -53.2 -58.15 8.03 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 123.743 0.652 . . . . 10.0 110.971 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.78 HD11 ' HB3' ' A' ' 78' ' ' LEU . 7.7 mm -46.79 -55.86 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.243 -0.889 . . . . 10.0 109.963 172.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.565 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -53.27 -38.08 62.74 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.684 -0.689 . . . . 10.0 112.833 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.664 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 76.4 mttt -72.2 -56.92 4.73 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 116.109 -0.496 . . . . 10.0 111.052 -173.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 72' ' ' THR . 1.8 t -54.61 -33.3 60.22 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.171 -0.922 . . . . 10.0 110.168 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 1.108 ' HD2' HD12 ' A' ' 116' ' ' LEU . 4.5 mmtt -91.74 -12.22 34.57 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 112.64 0.607 . . . . 10.0 112.64 -177.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 45.7 ttm -37.27 -52.7 2.27 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 113.25 0.833 . . . . 10.0 113.25 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -64.49 -22.74 65.19 Favored 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 121.456 1.437 . . . . 10.0 112.988 -178.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.712 ' HB3' ' HD3' ' A' ' 112' ' ' LYS . 3.6 t70 -99.25 -42.19 7.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.819 0.818 . . . . 10.0 112.152 -175.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 1.108 HD12 ' HD2' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -63.82 -0.22 1.0 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.105 -1.407 . . . . 10.0 111.815 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.444 ' H ' ' C ' ' A' ' 115' ' ' ASP . 2.6 p-10 56.85 43.88 24.21 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 113.971 -1.468 . . . . 10.0 108.886 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 119' ' ' ASN . . . -65.39 -74.62 0.1 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 112.7 -2.045 . . . . 10.0 113.272 -166.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 118' ' ' ALA . 28.7 t-20 103.57 -42.87 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 O-C-N 125.08 1.488 . . . . 10.0 109.096 -173.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.5 t -153.79 139.75 18.23 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.391 -1.707 . . . . 10.0 106.391 173.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.616 HD11 ' O ' ' A' ' 121' ' ' LEU . 1.5 tm? -50.47 -35.26 28.18 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.34 0.867 . . . . 10.0 113.34 -174.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.518 ' HA ' ' HG3' ' A' ' 125' ' ' MET . 1.6 mp0 -51.15 -41.31 60.03 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.584 0.707 . . . . 10.0 111.013 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.93 -47.37 74.94 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 118.787 -1.165 . . . . 10.0 110.488 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.469 ' HA ' HG22 ' A' ' 127' ' ' ILE . . . -58.6 -29.86 66.78 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.837 -0.345 . . . . 10.0 111.0 176.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.526 ' O ' ' HB2' ' A' ' 129' ' ' GLU . 5.0 mtp -54.92 -41.02 70.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.903 0.382 . . . . 10.0 111.087 175.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -63.37 -54.68 33.03 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.632 -0.713 . . . . 10.0 112.173 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.947 HD13 HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -52.29 -59.35 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 120.212 -0.595 . . . . 10.0 111.144 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.634 ' HB ' HG22 ' A' ' 105' ' ' ILE . 27.4 mm -51.7 -56.65 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 CA-C-N 114.841 -1.072 . . . . 10.0 111.676 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.542 ' HG3' HG21 ' A' ' 105' ' ' ILE . 5.3 mt-10 -51.95 -44.15 63.8 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 123.824 0.702 . . . . 10.0 109.143 177.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.73 -45.97 63.18 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.393 -0.908 . . . . 10.0 111.08 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.524 HG21 ' CB ' ' A' ' 75' ' ' ALA . 49.9 m -46.75 -64.77 0.68 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.144 -1.028 . . . . 10.0 109.148 169.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -47.49 -52.62 16.67 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.147 0.499 . . . . 10.0 111.561 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -52.19 -53.5 42.47 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.943 -1.026 . . . . 10.0 112.163 178.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 22.9 p -68.34 -25.5 65.14 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.044 0.45 . . . . 10.0 110.599 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.495 ' HE3' HD13 ' A' ' 137' ' ' ILE . 45.1 mtm -75.42 -8.41 56.63 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 112.731 0.641 . . . . 10.0 112.731 178.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.427 ' O ' HG12 ' A' ' 96' ' ' ILE . . . 96.48 2.65 60.11 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 118.995 0.816 . . . . 10.0 111.765 179.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.495 HD13 ' HE3' ' A' ' 135' ' ' MET . 51.7 mt -95.02 136.38 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 CA-C-N 117.54 0.67 . . . . 10.0 112.029 -178.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.574 ' HG3' ' N ' ' A' ' 139' ' ' VAL . 0.0 OUTLIER -84.7 156.28 21.54 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 119.097 -1.041 . . . . 10.0 110.544 177.22 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.574 ' N ' ' HG3' ' A' ' 138' ' ' GLU . 17.3 m -120.03 126.21 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.55 0 N-CA-C 107.561 -1.274 . . . . 10.0 107.561 170.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 100' ' ' VAL . 26.2 m -107.2 167.95 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 CA-C-N 113.555 -1.657 . . . . 10.0 108.415 176.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 . . . . . 0 C--N 1.285 -2.198 0 CA-C-N 113.921 -1.49 . . . . 10.0 110.814 178.563 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ppp? . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 112.195 0.443 . . . . 10.0 112.195 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.37 -58.4 7.21 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 120.975 0.417 . . . . 10.0 110.958 -177.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -135.98 154.66 51.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.017 -0.538 . . . . 10.0 109.773 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -73.0 114.88 11.64 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.003 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.7 t -65.61 141.3 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 122.737 0.415 . . . . 10.0 111.097 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -109.48 -46.77 3.48 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.198 175.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -156.39 156.98 34.8 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 114.034 1.124 . . . . 10.0 114.034 -173.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -92.05 136.31 33.27 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.244 -1.344 . . . . 10.0 108.357 169.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.6 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -122.73 82.0 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 108.799 -0.815 . . . . 10.0 108.799 169.478 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.466 ' HG2' HG23 ' A' ' 57' ' ' VAL . 48.1 mtpt -78.9 130.97 36.21 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 120.444 1.474 . . . . 10.0 108.396 172.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.543 HD12 HD23 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -159.21 129.59 5.82 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.95 0.881 . . . . 10.0 111.255 -178.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -83.23 119.71 24.9 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.346 -1.297 . . . . 10.0 109.941 -172.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.543 HD23 HD12 ' A' ' 11' ' ' LEU . 55.2 mt -137.07 135.54 19.89 Favored Pre-proline 0 CA--C 1.5 -0.97 0 CA-C-O 121.878 0.847 . . . . 10.0 112.659 -171.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.721 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 25.2 Cg_exo -54.35 123.12 12.81 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 123.622 2.882 . . . . 10.0 111.486 172.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.586 ' CB ' ' HB ' ' A' ' 46' ' ' THR . . . -61.35 125.45 23.81 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.158 -1.423 . . . . 10.0 107.158 168.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.0 -0.97 89.3 Favored Glycine 0 N--CA 1.44 -1.039 0 O-C-N 125.774 1.921 . . . . 10.0 113.233 -175.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.721 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 19.4 tptm -143.47 109.34 5.22 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.296 1.048 . . . . 10.0 112.705 176.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -171.69 142.21 1.54 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.256 -1.338 . . . . 10.0 112.747 172.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.526 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 2.7 t 179.44 -43.02 0.0 OUTLIER Pre-proline 0 C--O 1.207 -1.165 0 O-C-N 124.059 0.85 . . . . 10.0 113.129 175.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.669 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 85.6 Cg_endo -103.25 131.19 0.1 OUTLIER 'Trans proline' 0 N--CA 1.413 -3.259 0 N-CA-C 117.175 1.952 . . . . 10.0 117.175 -153.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.942 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . 13.96 -57.37 0.0 OUTLIER Pre-proline 0 C--N 1.289 -2.041 0 CA-C-N 108.615 -3.902 . . . . 10.0 119.275 153.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.691 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 32.5 Cg_exo -60.46 -63.33 0.12 Allowed 'Trans proline' 0 CA--C 1.562 1.888 0 CA-C-N 123.415 2.255 . . . . 10.0 115.252 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.691 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 55.7 Cg_endo -75.16 -52.86 0.1 Allowed 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.412 2.075 . . . . 10.0 112.239 174.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.735 HG11 HD13 ' A' ' 35' ' ' ILE . 83.1 t -83.26 -47.27 18.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 111.622 -2.535 . . . . 10.0 112.155 -166.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.838 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -42.67 -53.23 5.27 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 114.241 -1.345 . . . . 10.0 114.232 176.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.942 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 32.5 Cg_exo -70.01 -45.73 1.36 Allowed 'Trans proline' 0 CA--C 1.51 -0.719 0 C-N-CA 123.249 2.633 . . . . 10.0 111.324 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.514 ' HB3' ' CG2' ' A' ' 9' ' ' ILE . . . -51.33 -68.42 0.17 Allowed 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.376 0.608 . . . . 10.0 111.061 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.601 HD23 ' CD1' ' A' ' 58' ' ' ILE . 5.9 mt -78.0 -51.62 10.07 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.84 1.052 . . . . 10.0 113.84 -176.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.19 -42.01 96.97 Favored Glycine 0 N--CA 1.461 0.304 0 CA-C-N 116.117 -0.492 . . . . 10.0 113.314 -171.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -60.27 -25.93 66.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.716 0.294 . . . . 10.0 110.646 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -102.3 16.75 25.29 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.641 -0.824 . . . . 10.0 110.623 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.48 9.25 87.1 Favored Glycine 0 CA--C 1.501 -0.797 0 CA-C-N 114.904 -1.043 . . . . 10.0 113.2 168.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.719 HG11 ' CD2' ' A' ' 66' ' ' PHE . 1.9 t -83.06 147.83 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 113.357 0.873 . . . . 10.0 113.357 -174.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -68.64 100.41 1.13 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.224 0.535 . . . . 10.0 111.132 172.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.735 HD13 HG11 ' A' ' 24' ' ' VAL . 1.4 mm -52.12 -42.03 34.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.684 -1.144 . . . . 10.0 111.132 173.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 82.9 mtp -64.75 -53.18 51.24 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 112.973 -1.921 . . . . 10.0 111.749 177.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.523 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 40.9 mt-10 -57.09 -41.21 78.45 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 118.945 -1.102 . . . . 10.0 110.93 177.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.662 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 75.5 t80 -57.83 -57.87 10.88 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 113.701 1.0 . . . . 10.0 113.701 172.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -56.15 -49.57 73.57 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.339 -1.301 . . . . 10.0 111.366 -178.561 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.458 ' HD3' ' O ' ' A' ' 40' ' ' LYS . 12.7 tmtt? -66.96 -22.83 65.91 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.665 -0.865 . . . . 10.0 108.665 -178.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.764 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 26.8 mtt180 -75.93 -64.45 1.08 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.062 -1.055 . . . . 10.0 112.253 170.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.56 ' CZ ' HG21 ' A' ' 46' ' ' THR . 70.1 t80 -55.98 -45.72 78.89 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.032 0.444 . . . . 10.0 110.883 -172.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.588 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.9 OUTLIER -61.09 -48.99 79.12 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.246 -0.888 . . . . 10.0 110.191 -178.106 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.43 -36.96 85.46 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 118.971 -1.092 . . . . 10.0 112.084 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.764 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 42.4 mm-40 -64.01 -47.84 78.72 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.933 0.873 . . . . 10.0 110.687 178.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.65 HG21 HD11 ' A' ' 54' ' ' LEU . 73.3 p -89.44 5.88 43.31 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.017 -1.447 . . . . 10.0 112.209 -168.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -47.9 -35.86 11.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.488 -1.233 . . . . 10.0 112.616 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -86.39 -36.39 19.2 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 115.491 -0.777 . . . . 10.0 111.487 -174.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -95.91 20.11 10.48 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.673 -0.862 . . . . 10.0 108.673 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.436 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -53.75 150.1 7.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.06 -1.427 . . . . 10.0 112.73 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.92 20.32 28.76 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 114.759 -1.11 . . . . 10.0 110.36 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.5 ' HB2' HD22 ' A' ' 54' ' ' LEU . 63.3 mtt -138.88 127.32 23.0 Favored 'General case' 0 C--O 1.208 -1.094 0 C-N-CA 117.527 -1.669 . . . . 10.0 114.595 -168.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.3 mm -67.15 91.93 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 118.773 0.715 . . . . 10.0 109.213 169.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.65 HD11 HG21 ' A' ' 46' ' ' THR . 9.4 mt -80.67 136.8 51.37 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.059 -0.719 . . . . 10.0 109.059 -176.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.488 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 7.4 Cg_exo -75.7 104.25 1.87 Allowed 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.202 1.935 . . . . 10.0 110.682 172.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.86 152.99 4.53 Favored 'Isoleucine or valine' 0 C--N 1.344 0.363 0 CA-C-N 119.706 1.139 . . . . 10.0 111.112 -174.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.466 HG23 ' HG2' ' A' ' 10' ' ' LYS . 97.1 t -134.15 113.57 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 110.106 -0.331 . . . . 10.0 110.106 174.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.601 ' CD1' HD23 ' A' ' 28' ' ' LEU . 20.6 mt -108.14 139.96 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 108.099 -1.074 . . . . 10.0 108.099 -174.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 60.5 m -122.31 97.08 5.3 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 114.833 -1.076 . . . . 10.0 108.88 176.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.496 HG21 ' O ' ' A' ' 65' ' ' SER . 2.6 p -87.86 138.12 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.186 0 O-C-N 121.017 -1.052 . . . . 10.0 110.461 -178.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -93.78 172.12 8.45 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.179 -0.919 . . . . 10.0 112.961 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -62.96 -21.31 66.01 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 113.813 -1.539 . . . . 10.0 111.43 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -76.89 -12.9 60.02 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 113.905 -1.498 . . . . 10.0 110.997 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.578 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 8.5 mmpt? 83.77 -3.26 1.13 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.244 1.018 . . . . 10.0 110.11 -170.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.496 ' O ' HG21 ' A' ' 60' ' ' VAL . 31.6 m -69.57 179.2 2.19 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.349 -0.841 . . . . 10.0 109.349 171.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.719 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -170.25 -176.25 2.17 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 119.639 1.109 . . . . 10.0 110.174 175.379 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.5 p -158.36 164.26 36.5 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 102.987 -2.968 . . . . 10.0 102.987 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.431 ' CB ' HG12 ' A' ' 58' ' ' ILE . 50.7 p90 -161.31 157.29 25.24 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.403 0.62 . . . . 10.0 109.539 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.414 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 23.1 pt -127.99 165.86 26.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 114.846 -1.07 . . . . 10.0 108.31 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.441 HD12 ' CE1' ' A' ' 42' ' ' PHE . 1.7 mm -127.86 130.46 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 108.396 -0.965 . . . . 10.0 108.396 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 65.1 mmtt -77.88 83.26 4.22 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.025 -0.731 . . . . 10.0 109.025 176.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.4 ' OG1' ' HA ' ' A' ' 112' ' ' LYS . 18.8 p -30.01 101.17 0.15 Allowed Pre-proline 0 C--N 1.326 -0.437 0 O-C-N 125.845 1.965 . . . . 10.0 110.934 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.59 ' HB2' HD13 ' A' ' 78' ' ' LEU . 50.9 Cg_exo -20.52 106.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.13 1 C-N-CA 125.432 4.088 . . . . 10.0 114.326 -164.032 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.565 ' O ' ' HD3' ' A' ' 112' ' ' LYS . 24.8 Cg_exo -23.64 -54.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.361 1.189 1 C-N-CA 126.143 4.562 . . . . 10.0 115.229 -169.781 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.462 ' HB1' HG23 ' A' ' 131' ' ' THR . . . -176.6 -43.68 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 120.46 0.171 . . . . 10.0 111.313 171.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.639 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 23.1 t -57.34 -35.53 70.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.05 -0.523 . . . . 10.0 112.152 -171.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -70.32 -40.27 74.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.922 0.392 . . . . 10.0 111.552 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.833 HD23 ' HZ1' ' A' ' 112' ' ' LYS . 8.5 mp -82.53 -26.62 32.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.252 0.549 . . . . 10.0 110.071 -178.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.4 mt -60.56 -40.42 91.55 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.91 -0.774 . . . . 10.0 108.91 170.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.72 ' HG2' HG22 ' A' ' 85' ' ' ILE . 59.0 mttp -63.46 -23.35 67.36 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.481 -0.327 . . . . 10.0 111.189 175.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.561 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -58.02 -52.43 65.55 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 121.005 -0.278 . . . . 10.0 110.594 174.024 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.757 ' HB1' ' HG3' ' A' ' 104' ' ' GLN . . . -84.52 -62.48 1.54 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.466 1.506 . . . . 10.0 112.113 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.67 123.61 22.31 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 111.329 -2.668 . . . . 10.0 107.929 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -88.04 33.02 4.14 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 119.059 -1.543 . . . . 10.0 111.939 -169.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.72 HG22 ' HG2' ' A' ' 80' ' ' LYS . 14.2 tt -61.8 108.79 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 CA-C-O 121.836 0.826 . . . . 10.0 110.011 174.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.459 ' C ' ' HD3' ' A' ' 87' ' ' LYS . 23.5 tt0 -161.77 29.11 0.12 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 122.488 1.137 . . . . 10.0 108.083 -170.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.459 ' HD3' ' C ' ' A' ' 86' ' ' GLU . 4.3 mppt? -151.57 20.82 0.72 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 113.882 -1.508 . . . . 10.0 107.94 -176.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.53 -178.16 53.88 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 114.693 -1.14 . . . . 10.0 112.402 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.7 t -163.88 134.49 4.38 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.785 -0.82 . . . . 10.0 108.785 174.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.9 t -161.77 36.13 0.13 Allowed 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.661 -0.866 . . . . 10.0 108.661 -176.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.566 ' HG2' ' HD3' ' A' ' 95' ' ' LYS . 18.7 tp10 -167.82 78.8 0.89 Allowed Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 114.813 -1.085 . . . . 10.0 109.56 -175.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.623 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 29.0 Cg_endo -91.93 136.51 1.72 Allowed 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 123.342 2.694 . . . . 10.0 111.322 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.945 ' HG3' ' HG3' ' A' ' 94' ' ' ARG . 13.3 ptpt 64.48 167.02 0.16 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.374 1.07 . . . . 10.0 110.42 -172.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.945 ' HG3' ' HG3' ' A' ' 93' ' ' LYS . 40.6 mtm180 70.28 -13.6 0.44 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.13 0.572 . . . . 10.0 112.265 178.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.566 ' HD3' ' HG2' ' A' ' 91' ' ' GLU . 64.2 tttm -170.67 -48.0 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.367 -0.133 . . . . 10.0 110.878 -167.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.431 ' HB ' ' O ' ' A' ' 136' ' ' GLY . 27.8 pt 48.25 -165.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.792 0.837 . . . . 10.0 113.079 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 136' ' ' GLY . 7.7 p -141.34 -49.49 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.954 0.724 . . . . 10.0 112.954 -169.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -169.57 152.28 19.24 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.263 -1.135 . . . . 10.0 110.263 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.671 ' CB ' ' HB3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -148.21 177.42 9.41 Favored 'General case' 0 CA--C 1.48 -1.739 0 CA-C-O 122.625 1.202 . . . . 10.0 110.491 -166.17 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.58 HG12 ' CB ' ' A' ' 82' ' ' ALA . 0.7 OUTLIER -164.89 -163.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 CA-C-N 111.308 -2.678 . . . . 10.0 105.639 -166.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.443 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 0.5 OUTLIER -127.98 156.26 42.97 Favored 'General case' 0 C--N 1.269 -2.901 0 C-N-CA 118.41 -1.316 . . . . 10.0 112.816 -169.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.667 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 8.4 tpp180 -40.37 -41.54 1.4 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 113.635 -1.621 . . . . 10.0 110.958 177.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -57.45 -44.15 84.53 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.922 0.712 . . . . 10.0 112.922 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.757 ' HG3' ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -61.75 -50.2 73.33 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.601 -0.84 . . . . 10.0 108.804 176.057 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.95 HG21 ' HG3' ' A' ' 129' ' ' GLU . 27.3 mm -38.32 -56.56 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.703 -1.135 . . . . 10.0 110.897 170.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 109' ' ' ALA . 28.9 tt0 -50.68 -60.89 2.57 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.744 1.218 . . . . 10.0 113.222 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 31.4 mt-10 -57.97 -55.86 29.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.366 -1.288 . . . . 10.0 111.338 -176.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.58 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 46.8 mt -47.71 -50.05 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 116.651 -0.25 . . . . 10.0 110.568 171.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.52 ' HB2' HD13 ' A' ' 121' ' ' LEU . . . -49.46 -51.03 38.51 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.109 0.781 . . . . 10.0 113.109 176.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.552 ' HB3' HD11 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -76.07 -30.1 58.21 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.057 0.391 . . . . 10.0 112.057 -174.011 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.4 m -54.39 -46.38 73.09 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.033 0.444 . . . . 10.0 111.153 173.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.833 ' HZ1' HD23 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -100.4 17.69 20.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.867 -0.606 . . . . 10.0 111.026 -176.192 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.954 ' HG3' ' HB1' ' A' ' 118' ' ' ALA . 45.2 ttm -47.64 -46.71 61.0 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.017 -0.538 . . . . 10.0 112.229 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 113' ' ' MET . 33.2 Cg_endo -64.79 -21.7 64.37 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.521 1.481 . . . . 10.0 113.493 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.479 ' OD1' ' HD2' ' A' ' 71' ' ' LYS . 24.6 t70 -90.12 -53.2 4.58 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.812 0.815 . . . . 10.0 110.872 -178.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.506 HD12 ' HB2' ' A' ' 112' ' ' LYS . 10.3 mp -63.61 -2.96 1.88 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 113.72 -1.582 . . . . 10.0 111.49 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 115' ' ' ASP . 2.9 t-20 60.92 48.19 6.92 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.852 -1.522 . . . . 10.0 109.644 176.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.954 ' HB1' ' HG3' ' A' ' 113' ' ' MET . . . -80.47 114.36 19.31 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.134 -1.394 . . . . 10.0 112.522 -173.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -67.59 -36.22 80.48 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.455 0.645 . . . . 10.0 110.028 171.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.7 p -151.22 143.5 24.11 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 106.841 -1.54 . . . . 10.0 106.841 176.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.67 ' O ' ' HG3' ' A' ' 125' ' ' MET . 58.6 tp -54.27 -34.84 61.72 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 113.794 1.035 . . . . 10.0 113.794 -175.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -48.73 -39.78 26.06 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.59 0.709 . . . . 10.0 110.326 173.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.575 ' HA ' ' HD3' ' A' ' 126' ' ' LYS . . . -66.64 -49.61 65.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.927 -1.033 . . . . 10.0 110.836 176.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.573 ' HB1' HD12 ' A' ' 121' ' ' LEU . . . -57.16 -36.47 70.79 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.632 0.253 . . . . 10.0 110.381 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.67 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 83.1 mtp -55.48 -35.65 65.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.183 -0.462 . . . . 10.0 111.981 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.575 ' HD3' ' HA ' ' A' ' 123' ' ' ALA . 0.1 OUTLIER -64.52 -49.3 71.85 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 110.026 -0.361 . . . . 10.0 110.026 177.397 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 124' ' ' ALA . 55.8 mt -50.68 -63.64 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-O 121.336 0.589 . . . . 10.0 110.846 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.825 ' HB ' HG22 ' A' ' 105' ' ' ILE . 27.5 mm -50.76 -55.53 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 CA-C-N 114.45 -1.25 . . . . 10.0 111.687 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.95 ' HG3' HG21 ' A' ' 105' ' ' ILE . 7.1 mt-10 -52.83 -45.36 67.28 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 123.811 0.695 . . . . 10.0 109.72 178.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -71.6 -44.78 48.55 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.468 -0.872 . . . . 10.0 111.71 -174.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.462 HG23 ' HB1' ' A' ' 75' ' ' ALA . 90.9 m -45.75 -61.49 1.69 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.253 -0.973 . . . . 10.0 109.943 170.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.64 -49.39 47.34 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.565 -1.198 . . . . 10.0 111.876 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -48.37 -54.57 13.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.555 -0.748 . . . . 10.0 111.55 178.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.4 t -63.23 -31.47 72.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.572 0.701 . . . . 10.0 110.382 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.459 ' HE2' ' CD1' ' A' ' 137' ' ' ILE . 35.8 mtp -80.06 7.72 8.57 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.897 1.073 . . . . 10.0 113.897 -176.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.518 ' O ' HG13 ' A' ' 97' ' ' VAL . . . 84.64 3.8 88.0 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 119.478 1.035 . . . . 10.0 111.789 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.504 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 33.3 mt -96.78 127.79 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 CA-C-O 121.959 0.885 . . . . 10.0 111.83 -176.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.671 ' HB3' ' CB ' ' A' ' 99' ' ' LYS . 39.1 tt0 -88.21 159.43 18.15 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.156 -1.384 . . . . 10.0 108.768 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.47 HG12 HG13 ' A' ' 105' ' ' ILE . 17.9 m -117.92 134.1 62.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 108.341 -0.985 . . . . 10.0 108.341 167.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 100' ' ' VAL . 26.9 m -138.62 69.37 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 114.784 1.401 . . . . 10.0 114.784 -174.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.9 t70 . . . . . 0 C--N 1.298 -1.673 0 CA-C-O 117.771 -1.109 . . . . 10.0 110.257 145.455 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 121.057 0.456 . . . . 10.0 111.428 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.55 107.67 2.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.168 -0.924 . . . . 10.0 108.83 174.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.565 ' HB3' ' CG ' ' A' ' 61' ' ' TYR . 35.7 mtmm -67.62 123.55 20.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.181 0.515 . . . . 10.0 111.973 -173.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 2.3 mtpp -99.17 132.98 44.1 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.339 -0.846 . . . . 10.0 109.723 175.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.5 t -62.93 138.61 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 122.833 0.453 . . . . 10.0 111.719 -176.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.61 -38.47 5.17 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 173.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.508 ' HB2' ' CG1' ' A' ' 60' ' ' VAL . . . -154.28 141.34 19.35 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.857 0.688 . . . . 10.0 112.857 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -98.67 115.65 29.15 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.053 -1.462 . . . . 10.0 107.053 173.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.578 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 3.7 mt -113.9 85.45 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.051 0 N-CA-C 108.803 -0.814 . . . . 10.0 108.803 -174.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.772 ' HZ3' ' HB2' ' A' ' 10' ' ' LYS . 10.1 mtmp? -77.85 148.26 34.75 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 119.136 0.88 . . . . 10.0 110.304 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.403 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 0.8 OUTLIER -156.38 135.3 11.88 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.003 -0.74 . . . . 10.0 109.003 -178.226 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -93.79 111.46 23.16 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.199 -1.038 . . . . 10.0 108.199 169.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 15.0 mt -127.94 135.21 27.16 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 121.594 0.711 . . . . 10.0 112.324 -166.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.529 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 22.1 Cg_exo -57.88 121.2 9.61 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.532 2.821 . . . . 10.0 111.861 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.594 ' HB2' HD12 ' A' ' 54' ' ' LEU . . . -61.72 127.48 31.66 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 107.768 -1.197 . . . . 10.0 107.768 170.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.9 0.36 89.38 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 125.695 1.872 . . . . 10.0 112.625 -174.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.529 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 4.6 tmtp? -141.09 100.95 3.93 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.992 0.901 . . . . 10.0 111.911 177.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.84 132.24 3.67 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.421 -1.263 . . . . 10.0 112.395 176.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.462 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -177.03 -53.68 0.0 OUTLIER Pre-proline 0 N--CA 1.448 -0.537 0 N-CA-C 112.697 0.629 . . . . 10.0 112.697 178.5 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.586 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 80.6 Cg_endo -104.53 128.09 0.07 OUTLIER 'Trans proline' 0 N--CA 1.416 -3.044 0 N-CA-C 116.211 1.581 . . . . 10.0 116.211 -154.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 1.092 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 16.04 -84.11 0.0 OUTLIER Pre-proline 0 C--N 1.294 -1.806 0 CA-C-N 108.58 -3.918 . . . . 10.0 116.251 165.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 3.2 Cg_exo -31.31 -56.79 0.23 Allowed 'Trans proline' 0 CA--C 1.558 1.679 0 C-N-CA 122.906 2.404 . . . . 10.0 115.419 -165.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 5.4 Cg_exo -83.95 -49.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 123.346 2.697 . . . . 10.0 112.237 171.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.849 HG11 HD11 ' A' ' 35' ' ' ILE . 57.9 t -88.87 -45.68 15.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 112.449 -2.16 . . . . 10.0 113.484 -163.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 1.092 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -47.56 -80.6 0.05 OUTLIER Glycine 0 C--O 1.221 -0.692 0 CA-C-N 114.609 -1.178 . . . . 10.0 114.304 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.592 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 13.0 Cg_exo -43.28 -41.2 9.97 Favored 'Trans proline' 0 CA--C 1.52 -0.223 0 C-N-CA 123.544 2.83 . . . . 10.0 112.316 174.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.489 ' HB1' ' CG2' ' A' ' 9' ' ' ILE . . . -52.47 -77.94 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.644 0.735 . . . . 10.0 111.255 176.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.668 HD22 ' CD1' ' A' ' 58' ' ' ILE . 6.9 mt -75.55 -42.74 51.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.961 -1.018 . . . . 10.0 113.725 -173.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.9 -38.22 95.77 Favored Glycine 0 N--CA 1.463 0.489 0 CA-C-N 116.526 -0.306 . . . . 10.0 113.214 -176.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -63.87 -21.18 66.33 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 119.506 -0.877 . . . . 10.0 109.699 175.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -103.91 7.17 36.78 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.888 -0.725 . . . . 10.0 111.861 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.81 ' HA3' ' HZ2' ' A' ' 64' ' ' LYS . . . 56.79 37.44 77.48 Favored Glycine 0 CA--C 1.509 -0.31 0 CA-C-N 115.309 -0.86 . . . . 10.0 112.899 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.648 HG12 ' CD1' ' A' ' 66' ' ' PHE . 55.8 t -74.72 -32.15 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 115.734 1.753 . . . . 10.0 115.734 -169.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 90.06 78.17 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 125.3 1.44 . . . . 10.0 109.581 -169.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.849 HD11 HG11 ' A' ' 24' ' ' VAL . 1.4 mt -51.92 -40.63 28.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 113.046 -1.888 . . . . 10.0 113.336 176.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 87.5 mtp -63.04 -47.18 84.11 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 117.523 -1.671 . . . . 10.0 111.495 173.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.598 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 21.7 tp10 -60.0 -43.47 95.16 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 118.979 -1.088 . . . . 10.0 110.252 176.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.584 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 71.7 t80 -56.5 -57.04 14.05 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 113.928 1.084 . . . . 10.0 113.928 172.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.43 -50.14 73.98 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.882 0.873 . . . . 10.0 111.729 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -63.29 -22.88 67.15 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.244 -0.982 . . . . 10.0 108.756 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.826 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 33.1 mtm-85 -78.53 -64.31 1.2 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 118.228 -0.892 . . . . 10.0 112.192 168.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.525 ' CZ ' HG21 ' A' ' 46' ' ' THR . 69.8 t80 -53.11 -48.0 68.18 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 119.477 1.035 . . . . 10.0 110.224 -169.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -60.02 -50.24 74.52 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.037 -0.983 . . . . 10.0 110.326 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.72 93.71 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 119.157 -1.017 . . . . 10.0 111.943 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.826 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 7.0 mm-40 -66.26 -44.72 82.86 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 122.203 1.002 . . . . 10.0 110.713 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.612 ' CG2' HD11 ' A' ' 54' ' ' LEU . 81.6 p -89.76 0.5 56.96 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 113.963 -1.472 . . . . 10.0 111.986 -171.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.08 -38.81 8.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.307 -0.86 . . . . 10.0 112.44 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -79.44 -25.63 41.96 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.551 -0.75 . . . . 10.0 111.206 -173.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -108.41 21.66 17.0 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.555 0.742 . . . . 10.0 109.955 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -52.64 148.19 7.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.991 -1.004 . . . . 10.0 112.868 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.9 19.27 31.8 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 110.816 -0.914 . . . . 10.0 110.816 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.681 ' SD ' ' HB3' ' A' ' 77' ' ' PHE . 67.4 mtt -139.28 126.21 20.97 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 117.211 -1.796 . . . . 10.0 114.555 -166.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.3 mm -68.13 91.51 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.255 -0.646 . . . . 10.0 109.255 172.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.612 HD11 ' CG2' ' A' ' 46' ' ' THR . 7.7 mt -82.45 131.68 54.77 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.619 -0.511 . . . . 10.0 109.619 -177.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.573 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 17.1 Cg_exo -69.62 102.82 1.05 Allowed 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.394 2.063 . . . . 10.0 111.196 172.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.486 HG21 HG12 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -101.03 156.84 4.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 119.501 1.046 . . . . 10.0 111.016 -175.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.474 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 86.9 t -136.23 116.1 17.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.085 -0.507 . . . . 10.0 110.508 172.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.668 ' CD1' HD22 ' A' ' 28' ' ' LEU . 18.1 mt -105.57 140.39 23.78 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.925 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 -175.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.3 m -126.96 95.88 4.45 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 114.962 -1.017 . . . . 10.0 109.14 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.508 ' CG1' ' HB2' ' A' ' 7' ' ' ALA . 3.3 p -85.99 136.0 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 119.124 0.875 . . . . 10.0 109.827 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.565 ' CG ' ' HB3' ' A' ' 3' ' ' LYS . 82.2 m-85 -94.51 173.33 7.68 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.496 0.665 . . . . 10.0 112.55 -176.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 24.8 mt-10 -62.14 -19.33 62.92 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.638 -1.164 . . . . 10.0 112.285 -177.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 4.6 m-20 -78.35 -11.55 59.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.588 -0.733 . . . . 10.0 111.041 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.81 ' HZ2' ' HA3' ' A' ' 32' ' ' GLY . 18.6 mtpp 82.04 1.19 1.42 Allowed 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 114.654 -1.157 . . . . 10.0 110.329 -167.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.434 ' O ' HG21 ' A' ' 60' ' ' VAL . 51.0 m -70.53 174.7 5.5 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.369 -1.287 . . . . 10.0 108.184 172.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.648 ' CD1' HG12 ' A' ' 33' ' ' VAL . 8.8 p90 -167.99 -179.02 3.97 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 121.394 1.906 . . . . 10.0 110.326 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.5 p -161.51 171.88 17.37 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 103.791 -2.67 . . . . 10.0 103.791 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 50.7 p90 -163.52 157.76 20.02 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.757 -0.831 . . . . 10.0 108.757 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.474 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 31.3 pt -127.77 164.9 28.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 107.767 -1.197 . . . . 10.0 107.767 -178.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.486 HG12 HG21 ' A' ' 56' ' ' VAL . 8.2 mt -138.84 123.17 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 108.034 -1.099 . . . . 10.0 108.034 -174.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.646 ' C ' ' HD2' ' A' ' 73' ' ' PRO . 41.5 mmtt -75.93 95.07 3.47 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.896 1.331 . . . . 10.0 113.531 -168.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.647 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -59.83 -33.46 16.03 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-N 112.554 -2.112 . . . . 10.0 114.743 167.605 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.768 ' HD3' ' HB3' ' A' ' 115' ' ' ASP . 9.2 Cg_endo -50.11 -42.19 46.96 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.683 2.922 . . . . 10.0 117.282 -171.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.582 ' HD3' ' HG2' ' A' ' 73' ' ' PRO . 82.9 Cg_exo -44.98 -31.33 5.33 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 122.366 2.044 . . . . 10.0 113.141 -178.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.761 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . . . 70.32 -38.47 0.41 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.72 1.007 . . . . 10.0 113.72 170.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -50.04 -31.21 12.44 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 122.982 0.513 . . . . 10.0 111.85 -175.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.681 ' HB3' ' SD ' ' A' ' 52' ' ' MET . 73.6 m-85 -61.19 -55.58 30.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.165 0.507 . . . . 10.0 111.257 178.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.8 HD23 ' HZ3' ' A' ' 112' ' ' LYS . 3.3 mm? -78.72 -27.03 44.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.912 -175.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.85 HD21 HG22 ' A' ' 108' ' ' ILE . 3.5 mm? -59.56 -50.24 74.65 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.716 -0.475 . . . . 10.0 109.716 174.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.526 ' HA ' ' HB1' ' A' ' 83' ' ' ALA . 63.3 mttp -66.47 -15.39 63.32 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.557 177.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 3.1 tppp? -61.69 -38.77 89.07 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 120.778 -0.369 . . . . 10.0 110.294 171.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.51 ' CB ' HG13 ' A' ' 100' ' ' VAL . . . -85.44 -57.31 3.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.428 1.891 . . . . 10.0 112.394 172.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.526 ' HB1' ' HA ' ' A' ' 80' ' ' LYS . . . -62.22 111.68 2.08 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 110.76 -2.927 . . . . 10.0 107.268 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.15 14.71 63.81 Favored Glycine 0 CA--C 1.501 -0.834 0 C-N-CA 118.605 -1.759 . . . . 10.0 111.619 -157.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 33.2 pt -62.74 153.82 6.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 114.257 -0.972 . . . . 10.0 112.109 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -163.28 66.33 0.19 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.065 -0.971 . . . . 10.0 108.871 175.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.1 tttp 79.19 -55.05 0.43 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 114.576 -1.193 . . . . 10.0 112.185 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -93.6 17.22 59.0 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 115.553 0.981 . . . . 10.0 115.553 -166.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.7 t -74.49 -71.7 0.33 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 118.374 1.087 . . . . 10.0 108.851 172.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.1 m 73.32 -30.33 0.21 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 114.646 1.35 . . . . 10.0 114.646 165.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -168.3 85.6 0.71 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 118.389 0.54 . . . . 10.0 111.834 -170.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -101.9 -12.13 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.433 2.755 . . . . 10.0 113.778 172.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -161.79 -79.13 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.898 0.703 . . . . 10.0 112.898 -176.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.571 ' HD3' ' O ' ' A' ' 94' ' ' ARG . 4.2 tmt_? -158.74 84.74 0.82 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.434 0.635 . . . . 10.0 109.306 -175.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.787 ' HA ' ' HE3' ' A' ' 95' ' ' LYS . 1.2 tpmt? 78.74 -7.18 1.82 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.07 -1.423 . . . . 10.0 109.989 173.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 97' ' ' VAL . 8.0 mt -85.99 176.0 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 108.678 -0.86 . . . . 10.0 108.678 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.476 ' N ' ' CG2' ' A' ' 96' ' ' ILE . 14.5 p -139.56 -46.03 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 112.311 0.486 . . . . 10.0 112.311 -174.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.734 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -159.18 165.49 34.3 Favored Glycine 0 CA--C 1.497 -1.059 0 N-CA-C 109.034 -1.627 . . . . 10.0 109.034 174.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.735 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 13.4 pttm -152.01 169.75 21.58 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 122.394 1.092 . . . . 10.0 110.771 -166.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.532 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -161.9 -145.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-N 112.119 -2.31 . . . . 10.0 105.807 -169.331 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 0.1 OUTLIER -162.49 144.99 10.99 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.372 -0.931 . . . . 10.0 108.937 -155.876 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.644 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 16.0 mmm180 -41.68 -50.14 4.21 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 124.57 1.169 . . . . 10.0 111.562 -177.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 24.8 tptp -56.31 -43.7 79.2 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.223 0.453 . . . . 10.0 112.223 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.56 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -61.39 -49.05 78.45 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.149 -0.686 . . . . 10.0 109.149 177.378 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.807 HG22 ' HG3' ' A' ' 129' ' ' GLU . 25.8 mm -40.26 -53.6 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 114.948 -1.024 . . . . 10.0 111.017 170.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.73 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 21.7 tt0 -51.02 -56.54 12.0 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 114.935 -1.029 . . . . 10.0 112.872 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.518 ' OE2' ' HE3' ' A' ' 110' ' ' LYS . 19.2 mm-40 -51.82 -58.49 6.28 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.119 -0.946 . . . . 10.0 110.551 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.85 HG22 HD21 ' A' ' 79' ' ' LEU . 26.3 mm -50.2 -50.37 20.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.851 -1.068 . . . . 10.0 110.679 173.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.512 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -51.19 -36.24 40.34 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 112.578 0.584 . . . . 10.0 112.578 175.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.73 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 39.7 mttm -71.74 -54.0 11.66 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.256 -177.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.569 HG21 ' O ' ' A' ' 108' ' ' ILE . 6.1 t -53.5 -28.51 31.43 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.666 0.617 . . . . 10.0 112.666 -175.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.832 ' HB3' ' HZ1' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -118.07 17.59 14.03 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.904 -0.497 . . . . 10.0 111.55 -177.727 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.667 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 48.6 ttm -49.17 -47.26 76.15 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.706 -0.679 . . . . 10.0 112.342 175.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 113' ' ' MET . 33.6 Cg_endo -61.53 -25.58 79.7 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 122.099 1.866 . . . . 10.0 112.418 -177.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.768 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 2.0 m-20 -93.96 -45.76 7.46 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.074 -0.966 . . . . 10.0 112.143 -173.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.784 HD22 HD11 ' A' ' 127' ' ' ILE . 5.3 mp -62.12 -4.35 1.66 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 114.661 -1.154 . . . . 10.0 111.268 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 115' ' ' ASP . 14.2 m120 64.23 43.86 4.67 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.87 -1.514 . . . . 10.0 109.066 177.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.667 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -80.64 109.13 14.88 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.942 -1.481 . . . . 10.0 112.331 -174.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -68.48 -36.43 78.94 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.902 -0.777 . . . . 10.0 108.902 173.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 87.3 p -145.88 143.42 29.57 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.089 -1.448 . . . . 10.0 107.089 172.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.602 ' O ' ' HG3' ' A' ' 125' ' ' MET . 41.1 tp -53.45 -29.46 35.73 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.944 1.461 . . . . 10.0 114.944 -174.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -50.67 -33.9 24.39 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 122.016 0.913 . . . . 10.0 110.067 174.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.9 -49.81 41.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.133 -1.394 . . . . 10.0 110.264 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.606 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -57.35 -35.29 69.73 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.991 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.602 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 79.8 mtp -55.61 -39.47 70.82 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 122.249 -0.282 . . . . 10.0 111.639 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -64.13 -52.34 59.58 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.447 0.536 . . . . 10.0 112.447 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.784 HD11 HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -52.24 -58.87 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 C-N-CA 119.879 -0.728 . . . . 10.0 110.412 177.649 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.712 ' HB ' HG23 ' A' ' 105' ' ' ILE . 22.9 mm -49.81 -55.92 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 CA-C-N 115.184 -0.916 . . . . 10.0 111.473 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.807 ' HG3' HG22 ' A' ' 105' ' ' ILE . 8.0 mt-10 -52.69 -42.64 64.96 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 123.718 0.636 . . . . 10.0 109.828 177.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -75.02 -46.02 18.12 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 121.215 -0.517 . . . . 10.0 112.643 -174.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.531 HG21 ' HE3' ' A' ' 135' ' ' MET . 53.7 m -46.31 -59.74 2.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.942 -0.762 . . . . 10.0 108.942 170.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.473 ' HB2' ' CG2' ' A' ' 137' ' ' ILE . . . -52.17 -50.02 62.66 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.232 -0.44 . . . . 10.0 111.959 174.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 50.4 tttm -46.11 -50.8 14.96 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 123.656 0.598 . . . . 10.0 111.45 176.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.8 m -60.97 -38.3 85.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.39 -0.368 . . . . 10.0 111.845 -175.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.795 ' HG3' HD12 ' A' ' 137' ' ' ILE . 14.9 ptt? -91.4 17.7 8.16 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.274 1.213 . . . . 10.0 114.274 -174.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.47 ' O ' HG13 ' A' ' 97' ' ' VAL . . . 89.22 13.04 62.48 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 120.043 1.292 . . . . 10.0 112.99 175.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.795 HD12 ' HG3' ' A' ' 135' ' ' MET . 2.4 mp -98.99 126.72 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-O 121.683 0.754 . . . . 10.0 111.375 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.735 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -87.81 156.22 19.51 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.574 -1.194 . . . . 10.0 109.476 177.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.473 HG13 HG13 ' A' ' 105' ' ' ILE . 17.0 m -115.87 125.48 73.02 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.536 0 N-CA-C 108.14 -1.059 . . . . 10.0 108.14 169.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 100' ' ' VAL . 28.3 m -105.24 152.82 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 CA-C-N 113.753 -1.567 . . . . 10.0 107.693 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 . . . . . 0 C--N 1.275 -2.639 0 CA-C-N 114.048 -1.433 . . . . 10.0 111.101 -175.468 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.1 ttm . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 111.391 0.145 . . . . 10.0 111.391 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.31 134.55 33.78 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.748 0.309 . . . . 10.0 110.404 -178.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -110.06 124.27 51.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.743 0.782 . . . . 10.0 112.495 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.535 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 2.9 tppp? -138.68 145.93 40.99 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 106.453 -1.684 . . . . 10.0 106.453 170.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.5 t -61.47 126.82 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.521 0.6 . . . . 10.0 111.579 -171.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.27 -39.28 5.73 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.852 -0.613 . . . . 10.0 109.518 176.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.505 ' HB1' ' CG1' ' A' ' 60' ' ' VAL . . . -154.88 144.68 21.57 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.463 0.912 . . . . 10.0 113.463 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -92.37 133.65 35.67 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 107.436 -1.32 . . . . 10.0 107.436 169.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.619 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -121.53 82.72 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.717 -0.846 . . . . 10.0 108.717 175.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -77.67 126.54 31.04 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 120.199 1.363 . . . . 10.0 107.826 175.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.731 HD11 HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -156.96 123.56 5.03 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 122.868 1.318 . . . . 10.0 111.92 -175.387 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -85.22 122.36 29.3 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.257 -1.792 . . . . 10.0 110.387 -171.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.731 HD22 HD11 ' A' ' 11' ' ' LEU . 85.6 mt -140.46 145.32 40.37 Favored Pre-proline 0 C--O 1.214 -0.764 0 CA-C-O 121.197 0.523 . . . . 10.0 111.903 -170.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.744 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 2.8 Cg_exo -67.75 127.27 15.96 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 123.815 3.01 . . . . 10.0 111.816 177.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.671 ' HB2' HD13 ' A' ' 54' ' ' LEU . . . -62.1 129.77 42.36 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 172.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.02 -2.38 84.07 Favored Glycine 0 N--CA 1.441 -0.974 0 O-C-N 125.619 1.824 . . . . 10.0 112.574 -175.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.744 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 28.8 mmtp -138.79 102.78 4.65 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.743 0.782 . . . . 10.0 111.639 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.669 ' O ' ' HB2' ' A' ' 39' ' ' CYS . . . -170.27 133.97 1.15 Allowed 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.174 -1.375 . . . . 10.0 111.951 172.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.613 ' HA ' ' CB ' ' A' ' 39' ' ' CYS . 3.4 t 179.69 -39.79 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 114.694 -1.139 . . . . 10.0 112.939 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.783 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 97.4 Cg_endo -104.31 124.44 0.07 OUTLIER 'Trans proline' 0 N--CA 1.411 -3.352 0 N-CA-C 115.659 1.369 . . . . 10.0 115.659 -161.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 1.013 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 6.18 -82.08 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.552 0 CA-C-N 109.799 -3.364 . . . . 10.0 114.606 161.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.843 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 68.3 Cg_exo -30.01 -56.62 0.18 Allowed 'Trans proline' 0 CA--C 1.56 1.804 0 C-N-CA 122.791 2.327 . . . . 10.0 115.521 -164.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.843 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 38.2 Cg_endo -82.19 -71.98 0.01 OUTLIER 'Trans proline' 0 CA--C 1.552 1.417 0 C-N-CA 122.817 2.345 . . . . 10.0 112.321 168.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.909 HG11 HD12 ' A' ' 35' ' ' ILE . 96.0 t -53.93 -52.84 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 127.869 2.467 . . . . 10.0 114.756 -175.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 1.013 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -45.44 -69.69 0.74 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 114.493 -1.231 . . . . 10.0 112.939 -178.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.62 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 24.0 Cg_exo -47.75 -49.63 13.21 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.206 2.604 . . . . 10.0 112.99 172.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.466 ' O ' ' HD2' ' A' ' 31' ' ' HIS . . . -43.61 -100.2 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 O-C-N 124.285 0.99 . . . . 10.0 112.789 176.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.884 HD21 HD11 ' A' ' 35' ' ' ILE 0.342 0.0 OUTLIER -76.43 -27.28 56.17 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 117.759 -1.577 . . . . 10.0 113.838 -175.067 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.527 ' N ' HD23 ' A' ' 28' ' ' LEU . . . -69.69 -40.4 76.64 Favored Glycine 0 CA--C 1.527 0.787 0 O-C-N 121.781 -0.575 . . . . 10.0 113.279 -174.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.456 ' HB3' ' O ' ' A' ' 26' ' ' PRO . 29.1 tt0 -59.87 -19.5 51.63 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 120.471 -0.492 . . . . 10.0 109.902 175.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.466 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 83.7 m-70 -98.92 24.53 7.6 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.201 -0.599 . . . . 10.0 110.334 176.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.826 ' HA3' ' HD2' ' A' ' 64' ' ' LYS . . . 89.17 -1.44 82.7 Favored Glycine 0 CA--C 1.495 -1.164 0 CA-C-N 115.48 -0.782 . . . . 10.0 112.608 166.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.874 HG11 ' CD2' ' A' ' 66' ' ' PHE . 3.1 t -83.44 148.64 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 114.107 1.151 . . . . 10.0 114.107 -170.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.438 ' N ' HG13 ' A' ' 33' ' ' VAL . 4.9 m-20 -67.67 96.57 0.56 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.361 0.664 . . . . 10.0 110.56 172.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.909 HD12 HG11 ' A' ' 24' ' ' VAL . 17.2 mm -52.43 -39.24 28.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 122.005 0.907 . . . . 10.0 111.444 173.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.822 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 71.0 mtm -66.22 -50.4 63.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.447 -1.706 . . . . 10.0 112.087 175.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.537 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 1.6 tt0 -58.34 -40.16 81.43 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.138 -1.025 . . . . 10.0 110.128 176.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.59 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 90.8 t80 -56.15 -57.89 10.28 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 114.009 1.114 . . . . 10.0 114.009 170.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.822 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 14.2 p -59.63 -50.42 73.92 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 114.093 -1.412 . . . . 10.0 111.759 -176.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.409 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 58.5 tttm -66.42 -21.18 66.21 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 119.914 -0.714 . . . . 10.0 109.367 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.794 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 3.8 mtp180 -73.59 -65.65 0.8 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.352 -0.939 . . . . 10.0 112.146 169.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.515 ' CZ ' HG22 ' A' ' 46' ' ' THR . 72.9 t80 -53.58 -45.04 69.81 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.806 -171.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.593 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.9 OUTLIER -59.62 -52.34 65.95 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.113 -0.949 . . . . 10.0 110.724 -178.301 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.03 96.28 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 118.817 -1.153 . . . . 10.0 112.385 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.794 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 13.1 mt-10 -67.55 -41.81 83.65 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.868 0.842 . . . . 10.0 111.142 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.572 ' CG2' HD12 ' A' ' 54' ' ' LEU . 80.1 p -88.84 4.56 47.3 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.782 -1.099 . . . . 10.0 112.155 -172.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.95 -42.65 18.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.106 -0.952 . . . . 10.0 112.168 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.68 -47.7 84.59 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 114.517 -1.22 . . . . 10.0 111.574 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.676 ' HZ3' HD12 ' A' ' 78' ' ' LEU . 39.6 mttm -101.36 24.1 10.07 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.268 0.556 . . . . 10.0 110.265 -171.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -53.23 145.09 14.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.695 -1.138 . . . . 10.0 112.622 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.34 16.75 36.4 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.844 -0.902 . . . . 10.0 110.844 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.523 ' SD ' ' HD1' ' A' ' 77' ' ' PHE . 41.0 mtm -141.88 127.37 18.91 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 117.675 -1.61 . . . . 10.0 115.144 -165.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.0 mm -65.9 92.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 O-C-N 121.759 -0.588 . . . . 10.0 109.947 174.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.671 HD13 ' HB2' ' A' ' 15' ' ' ALA . 6.9 mt -83.51 129.83 58.53 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 108.2 -1.037 . . . . 10.0 108.2 178.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -71.5 111.41 3.11 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 C-N-CA 121.8 1.666 . . . . 10.0 110.619 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -100.11 153.56 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 119.997 1.272 . . . . 10.0 111.133 -176.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.406 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 77.1 t -134.1 116.8 23.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 109.786 -0.45 . . . . 10.0 109.786 174.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.619 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 17.5 mt -107.6 140.86 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 N-CA-C 108.704 -0.85 . . . . 10.0 108.704 -173.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.5 m -123.48 100.68 6.93 Favored 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 114.942 -1.026 . . . . 10.0 108.621 173.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 65' ' ' SER . 1.6 p -91.89 136.56 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.815 0 CA-C-N 119.227 0.921 . . . . 10.0 110.35 -177.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -95.7 172.52 7.99 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.041 0.448 . . . . 10.0 112.055 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 58.7 mt-10 -57.22 -20.59 28.14 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 113.996 -1.457 . . . . 10.0 111.959 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -73.69 -18.02 61.06 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.618 -1.173 . . . . 10.0 110.919 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.826 ' HD2' ' HA3' ' A' ' 32' ' ' GLY . 23.8 mtmt 82.27 -3.98 1.44 Allowed 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 124.205 1.002 . . . . 10.0 110.173 -164.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.589 ' O ' HG22 ' A' ' 60' ' ' VAL . 28.6 t -68.25 176.5 2.73 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.506 -0.924 . . . . 10.0 108.506 171.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.874 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -166.98 -176.84 3.54 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 120.124 1.329 . . . . 10.0 110.11 176.502 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.4 p -162.08 161.0 28.1 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 103.018 -2.956 . . . . 10.0 103.018 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.443 ' CB ' HG12 ' A' ' 58' ' ' ILE . 47.0 p90 -160.96 158.17 27.61 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 109.045 -0.724 . . . . 10.0 109.045 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.406 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 30.4 pt -119.95 165.98 14.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 114.443 -1.253 . . . . 10.0 108.059 -175.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.439 HD13 ' CE1' ' A' ' 42' ' ' PHE . 4.4 mm -125.09 119.93 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 106.704 -1.591 . . . . 10.0 106.704 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.7 ' C ' ' HD2' ' A' ' 73' ' ' PRO . 29.5 mmmt -77.28 86.87 3.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.671 0.748 . . . . 10.0 110.731 -169.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.739 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 12.7 t -67.71 -13.9 0.25 Allowed Pre-proline 0 CA--C 1.57 1.748 0 CA-C-N 114.04 -1.437 . . . . 10.0 114.597 174.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.992 ' HD3' ' HB3' ' A' ' 115' ' ' ASP . 3.9 Cg_exo -34.76 -51.89 0.68 Allowed 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 124.057 3.171 . . . . 10.0 115.298 174.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.44 ' HD2' ' O ' ' A' ' 71' ' ' LYS . 27.2 Cg_exo -62.49 112.03 1.48 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 CA-C-N 120.633 1.262 . . . . 10.0 110.987 173.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.491 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -80.35 3.69 20.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.844 0.355 . . . . 10.0 110.582 -178.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.668 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 1.4 m -56.16 -36.61 68.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.561 -0.745 . . . . 10.0 111.306 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.589 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 24.7 m-85 -65.54 -57.22 8.74 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 122.194 0.997 . . . . 10.0 111.433 -176.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.676 HD12 ' HZ3' ' A' ' 49' ' ' LYS . 0.8 OUTLIER -73.82 -23.72 59.7 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.123 -0.944 . . . . 10.0 109.894 -173.434 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 49.2 mt -83.01 -13.71 55.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.698 -0.683 . . . . 10.0 110.9 174.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' A' ' 76' ' ' SER . 28.4 mmtp -56.15 -60.87 2.87 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.833 -0.803 . . . . 10.0 108.833 170.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -63.71 -45.11 91.48 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.86 -0.609 . . . . 10.0 112.064 178.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.616 ' HB3' HG12 ' A' ' 100' ' ' VAL . . . -61.77 -57.95 9.89 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 123.137 1.446 . . . . 10.0 110.115 -171.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.76 -33.54 75.86 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 111.472 -2.604 . . . . 10.0 110.067 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.64 1.82 70.67 Favored Glycine 0 CA--C 1.499 -0.938 0 N-CA-C 110.536 -1.026 . . . . 10.0 110.536 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.505 HG23 ' CG2' ' A' ' 97' ' ' VAL . 34.1 pt -68.18 161.86 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 CA-C-N 113.797 -1.201 . . . . 10.0 112.904 -176.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -149.08 27.59 0.85 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.108 -1.405 . . . . 10.0 108.299 172.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -168.64 -29.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.779 -1.101 . . . . 10.0 110.463 -174.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.404 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . 85.97 -130.56 9.98 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.359 -1.096 . . . . 10.0 110.359 -178.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.699 ' HB3' ' HA3' ' A' ' 136' ' ' GLY . 27.3 t -160.81 101.42 1.3 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.265 0.555 . . . . 10.0 109.932 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.4 p -70.91 105.8 3.4 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.179 -0.674 . . . . 10.0 109.179 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 82.47 90.6 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.259 0 O-C-N 124.489 1.118 . . . . 10.0 108.824 -173.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -88.44 77.55 1.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.872 2.382 . . . . 10.0 114.417 -167.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.56 137.8 4.15 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.019 -0.363 . . . . 10.0 110.019 173.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 73.84 -43.95 0.56 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.183 0.993 . . . . 10.0 111.705 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -71.75 -67.74 0.51 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.538 -0.912 . . . . 10.0 108.538 176.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 8.6 mt 47.28 92.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 113.372 -1.74 . . . . 10.0 112.347 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.505 ' CG2' HG23 ' A' ' 85' ' ' ILE . 3.4 p -44.67 -59.04 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 113.242 -1.799 . . . . 10.0 113.692 -166.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.446 ' N ' HG12 ' A' ' 97' ' ' VAL . . . -171.26 173.64 44.82 Favored Glycine 0 CA--C 1.49 -1.509 0 N-CA-C 108.621 -1.792 . . . . 10.0 108.621 -171.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.661 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -150.56 -179.8 7.53 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 122.853 1.311 . . . . 10.0 112.223 -160.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.761 ' O ' HG22 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -155.33 -144.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-N 111.527 -2.579 . . . . 10.0 105.182 -176.429 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 1.4 t -166.02 142.84 5.23 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 107.087 -1.449 . . . . 10.0 107.087 -155.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.675 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 23.1 tpp180 -41.62 -42.03 2.36 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 124.732 1.27 . . . . 10.0 111.204 -171.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.482 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 25.3 tptp -59.91 -46.44 89.33 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.737 1.014 . . . . 10.0 113.737 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.597 ' O ' HG13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -60.09 -45.66 92.18 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.189 -1.041 . . . . 10.0 108.189 178.691 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 1.006 HG21 ' HB ' ' A' ' 128' ' ' ILE . 39.4 mm -43.13 -52.77 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 CA-C-N 114.393 -1.276 . . . . 10.0 111.25 170.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.801 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 16.9 tt0 -48.52 -61.84 1.81 Allowed 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.967 -1.015 . . . . 10.0 112.967 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.541 ' HA ' ' HD3' ' A' ' 110' ' ' LYS . 37.7 mt-10 -56.62 -46.67 80.79 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.695 -1.139 . . . . 10.0 110.844 -175.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.685 HG21 ' HD3' ' A' ' 112' ' ' LYS . 34.2 mt -52.8 -58.43 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 115.759 -0.655 . . . . 10.0 110.085 169.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.468 ' HB1' HD12 ' A' ' 121' ' ' LEU . . . -45.48 -40.6 8.59 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.473 0.709 . . . . 10.0 112.695 177.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.801 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 38.9 mtpt -73.22 -48.76 32.29 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.737 -0.665 . . . . 10.0 111.368 -175.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.51 HG21 ' O ' ' A' ' 108' ' ' ILE . 1.1 t -57.2 -38.41 73.63 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 112.573 0.583 . . . . 10.0 112.573 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.685 ' HD3' HG21 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -98.21 6.46 47.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 122.602 0.361 . . . . 10.0 111.172 -174.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.686 ' HA ' HD13 ' A' ' 116' ' ' LEU . 54.1 ttm -50.25 -38.86 42.29 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.491 -0.777 . . . . 10.0 112.669 176.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' A' ' 113' ' ' MET . 35.1 Cg_endo -61.28 -31.74 89.51 Favored 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 121.726 1.617 . . . . 10.0 111.782 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.992 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 0.4 OUTLIER -93.71 -52.99 4.21 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.891 -1.504 . . . . 10.0 112.719 -170.263 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.686 HD13 ' HA ' ' A' ' 113' ' ' MET . 0.3 OUTLIER -72.99 -177.46 2.43 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 123.034 1.397 . . . . 10.0 113.871 -173.18 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -96.46 49.03 1.1 Allowed 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 112.443 -2.162 . . . . 10.0 113.088 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.566 ' HB1' ' HB2' ' A' ' 124' ' ' ALA . . . -64.66 -102.64 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.811 1.041 . . . . 10.0 113.811 173.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 118' ' ' ALA . 24.5 t-20 107.12 -78.42 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.829 1.652 . . . . 10.0 107.789 -167.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.2 t -87.15 147.86 25.44 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.622 -1.251 . . . . 10.0 107.622 162.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.654 ' O ' ' HG2' ' A' ' 125' ' ' MET . 61.8 tp -56.25 -34.7 66.64 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.673 -0.811 . . . . 10.0 110.938 166.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 32.2 mt-10 -48.35 -40.46 25.51 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.564 0.697 . . . . 10.0 110.38 173.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.25 -47.73 63.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.545 -1.207 . . . . 10.0 110.959 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.631 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -56.83 -40.35 75.87 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.405 -0.518 . . . . 10.0 110.122 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.792 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 74.7 mmm -53.35 -40.24 64.75 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.387 0.675 . . . . 10.0 110.727 176.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.64 ' HA ' ' HG2' ' A' ' 129' ' ' GLU . 13.6 mmmm -68.32 -45.07 73.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.06 -0.973 . . . . 10.0 110.234 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.453 ' CD1' HD22 ' A' ' 116' ' ' LEU . 92.8 mt -49.73 -65.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-O 121.178 0.514 . . . . 10.0 110.175 173.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 1.006 ' HB ' HG21 ' A' ' 105' ' ' ILE . 12.5 mm -50.79 -56.19 5.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.711 -1.131 . . . . 10.0 112.399 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.657 ' HG3' ' N ' ' A' ' 130' ' ' GLY . 0.3 OUTLIER -56.51 -41.86 77.39 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 109.14 -0.689 . . . . 10.0 109.14 -177.793 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.657 ' N ' ' HG3' ' A' ' 129' ' ' GLU . . . -72.83 -47.62 24.96 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.58 -0.736 . . . . 10.0 111.563 -175.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.491 HG21 ' HB3' ' A' ' 75' ' ' ALA . 35.3 m -46.25 -61.8 1.62 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.099 -1.051 . . . . 10.0 109.691 170.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.412 ' HB3' ' HB ' ' A' ' 137' ' ' ILE . . . -48.17 -47.84 34.83 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.0 -0.545 . . . . 10.0 111.97 174.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.58 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 79.1 tttt -48.53 -54.22 15.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.938 -1.028 . . . . 10.0 111.593 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.5 m -66.85 -29.28 69.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.044 0.45 . . . . 10.0 111.197 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.466 ' HE2' HD13 ' A' ' 137' ' ' ILE . 49.8 mtm -80.44 4.49 17.97 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.52 0.933 . . . . 10.0 113.52 -177.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.699 ' HA3' ' HB3' ' A' ' 89' ' ' SER . . . 83.97 11.43 79.01 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 119.364 0.984 . . . . 10.0 111.784 178.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.466 HD13 ' HE2' ' A' ' 135' ' ' MET . 27.4 mt -101.66 131.33 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 CA-C-O 121.509 0.671 . . . . 10.0 112.411 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.661 ' HB3' ' HB2' ' A' ' 99' ' ' LYS . 7.8 tp10 -84.79 156.61 21.29 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 115.188 -0.915 . . . . 10.0 110.279 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.7 m -117.98 121.88 68.37 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.218 0 N-CA-C 107.889 -1.152 . . . . 10.0 107.889 165.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.761 HG22 ' O ' ' A' ' 100' ' ' VAL . 25.1 m -101.52 143.17 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 CA-C-N 113.961 -1.472 . . . . 10.0 108.265 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.7 t70 . . . . . 0 C--N 1.286 -2.163 0 CA-C-N 113.48 -1.691 . . . . 10.0 109.98 -173.378 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.4 mtm . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 110.25 -0.278 . . . . 10.0 110.25 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.75 101.3 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.082 0.771 . . . . 10.0 113.082 174.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.788 ' HB2' ' CE1' ' A' ' 61' ' ' TYR . 37.3 mmtt -100.87 167.15 10.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.734 -0.666 . . . . 10.0 109.321 173.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.478 ' HB3' ' HG3' ' A' ' 62' ' ' GLU . 30.5 mmtm -69.67 91.75 0.63 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.77 -0.195 . . . . 10.0 111.26 178.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.1 t -63.24 140.36 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.027 0.531 . . . . 10.0 111.329 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.46 -37.67 4.26 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 120.84 -0.344 . . . . 10.0 110.306 174.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.462 ' HB3' HG12 ' A' ' 60' ' ' VAL . . . -153.67 153.0 31.47 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.19 0.811 . . . . 10.0 113.19 -176.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -95.6 134.07 38.91 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.023 -1.103 . . . . 10.0 108.023 170.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.651 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.7 OUTLIER -120.65 80.19 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 168.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -82.52 127.61 33.49 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 120.265 1.393 . . . . 10.0 108.482 176.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.709 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.27 128.75 6.91 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.959 0.885 . . . . 10.0 111.412 -174.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -78.52 122.67 26.17 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.311 -1.313 . . . . 10.0 110.141 -172.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.709 HD21 HD11 ' A' ' 11' ' ' LEU . 89.2 mt -140.43 133.66 14.93 Favored Pre-proline 0 N--CA 1.443 -0.817 0 CA-C-O 121.805 0.812 . . . . 10.0 112.072 -173.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.697 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 50.1 Cg_exo -52.0 125.08 16.19 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 124.072 3.181 . . . . 10.0 112.62 171.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.619 ' HB3' HD13 ' A' ' 54' ' ' LEU . . . -62.13 127.29 30.69 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 107.696 -1.224 . . . . 10.0 107.696 169.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.85 -2.72 82.6 Favored Glycine 0 N--CA 1.443 -0.888 0 O-C-N 125.987 2.055 . . . . 10.0 112.744 -174.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.697 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 15.9 mmtp -140.16 99.62 3.71 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.083 0.944 . . . . 10.0 112.553 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -168.29 134.72 1.96 Allowed 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 114.073 -1.421 . . . . 10.0 111.767 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.658 ' HA ' ' HB2' ' A' ' 39' ' ' CYS . 1.6 t -178.11 -48.46 0.0 OUTLIER Pre-proline 0 N--CA 1.438 -1.06 0 CA-C-N 115.154 -0.93 . . . . 10.0 112.674 176.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.718 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 83.0 Cg_endo -104.62 133.25 0.09 OUTLIER 'Trans proline' 0 N--CA 1.409 -3.468 0 N-CA-C 117.049 1.903 . . . . 10.0 117.049 -152.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.895 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . 12.67 -63.3 0.0 OUTLIER Pre-proline 0 C--N 1.284 -2.243 0 CA-C-N 108.473 -3.967 . . . . 10.0 117.52 154.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.786 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 52.8 Cg_exo -52.63 -63.88 0.22 Allowed 'Trans proline' 0 CA--C 1.566 2.096 0 CA-C-N 123.964 2.451 . . . . 10.0 114.513 -177.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.786 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 60.4 Cg_endo -78.05 -52.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 122.624 2.216 . . . . 10.0 113.109 174.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.811 HG13 HD11 ' A' ' 35' ' ' ILE . 79.8 t -80.99 -45.27 21.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-N 111.995 -2.366 . . . . 10.0 112.689 -166.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.74 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -40.57 -64.75 1.13 Allowed Glycine 0 CA--C 1.521 0.448 0 O-C-N 124.808 1.318 . . . . 10.0 113.32 178.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.895 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 80.1 Cg_exo -58.77 -48.4 14.91 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.798 2.999 . . . . 10.0 111.39 177.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.634 ' O ' ' HD2' ' A' ' 31' ' ' HIS . . . -48.4 -94.22 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 124.344 1.028 . . . . 10.0 111.764 -176.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.634 HD21 ' HA ' ' A' ' 35' ' ' ILE 0.314 0.0 OUTLIER -81.02 -28.55 35.4 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 118.119 -1.432 . . . . 10.0 114.198 -174.946 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.556 ' N ' HD23 ' A' ' 28' ' ' LEU . . . -68.75 -40.84 85.01 Favored Glycine 0 N--CA 1.468 0.769 0 O-C-N 121.17 -0.956 . . . . 10.0 113.248 -176.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.573 ' HG3' ' HA ' ' A' ' 26' ' ' PRO . 27.5 mt-30 -66.26 -6.8 15.07 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 118.639 -1.225 . . . . 10.0 110.603 175.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.634 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 88.2 m-70 -105.82 16.26 25.48 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 120.496 -0.482 . . . . 10.0 111.49 171.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.726 ' HA3' ' HD2' ' A' ' 64' ' ' LYS . . . 69.65 22.74 76.81 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.763 -0.653 . . . . 10.0 113.862 172.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.593 HG12 ' CD1' ' A' ' 66' ' ' PHE . 73.9 t -75.22 -30.02 22.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -167.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 91.18 79.27 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 122.868 1.318 . . . . 10.0 109.982 -172.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.811 HD11 HG13 ' A' ' 24' ' ' VAL . 1.1 mm -47.36 -49.19 9.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 112.055 -2.339 . . . . 10.0 113.579 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 79.4 mtp -64.33 -46.63 82.68 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.587 -1.642 . . . . 10.0 111.31 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.721 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 21.3 tt0 -62.52 -42.21 99.37 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 117.955 -1.498 . . . . 10.0 110.589 178.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.673 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . 38.6 t80 -56.87 -53.38 58.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.457 0.91 . . . . 10.0 113.457 172.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.658 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -57.48 -47.1 82.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.286 -0.87 . . . . 10.0 111.16 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -65.57 -22.11 66.66 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.138 -1.025 . . . . 10.0 109.357 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.747 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 94.2 mtt180 -76.91 -65.55 0.93 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.444 -0.798 . . . . 10.0 112.3 173.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.536 ' HE1' ' O ' ' A' ' 14' ' ' PRO . 67.4 t80 -57.28 -42.43 81.63 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.108 0.48 . . . . 10.0 110.305 -171.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.576 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.8 OUTLIER -58.87 -52.17 66.9 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.316 -0.856 . . . . 10.0 109.916 179.491 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.87 92.73 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 119.476 -0.89 . . . . 10.0 112.229 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.747 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 27.9 mm-40 -64.21 -47.66 78.87 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 122.034 0.921 . . . . 10.0 110.887 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.768 HG23 HD12 ' A' ' 54' ' ' LEU . 63.1 p -89.13 3.3 52.31 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.104 -1.407 . . . . 10.0 112.026 -169.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.21 -41.12 12.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.139 -0.937 . . . . 10.0 113.043 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.96 -19.86 29.8 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.794 -0.639 . . . . 10.0 111.573 -171.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.755 ' HB3' ' HZ3' ' A' ' 49' ' ' LYS . 6.1 mtpm? -109.18 21.57 16.97 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 123.605 0.762 . . . . 10.0 109.194 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.03 150.91 3.99 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.936 -1.029 . . . . 10.0 113.09 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.6 20.36 32.09 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 110.564 -1.014 . . . . 10.0 110.564 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.618 ' HB2' HD23 ' A' ' 54' ' ' LEU . 66.9 mtt -137.75 124.45 21.05 Favored 'General case' 0 C--O 1.211 -0.924 0 C-N-CA 117.203 -1.799 . . . . 10.0 113.829 -168.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 50.3 mm -65.77 91.7 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.928 -0.767 . . . . 10.0 108.928 171.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.768 HD12 HG23 ' A' ' 46' ' ' THR . 8.9 mt -84.69 126.42 68.66 Favored Pre-proline 0 N--CA 1.448 -0.534 0 N-CA-C 108.79 -0.819 . . . . 10.0 108.79 -178.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.752 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 20.6 Cg_exo -68.52 106.77 1.49 Allowed 'Trans proline' 0 C--N 1.329 -0.458 0 C-N-CA 121.654 1.569 . . . . 10.0 110.619 172.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -96.67 142.98 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 120.254 1.388 . . . . 10.0 110.891 -174.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 58.3 t -116.67 111.23 34.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 120.594 -0.442 . . . . 10.0 110.654 171.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.651 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 28.6 mt -105.11 138.38 30.27 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.829 0 N-CA-C 107.139 -1.43 . . . . 10.0 107.139 -176.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.7 m -122.95 95.08 4.48 Favored 'General case' 0 N--CA 1.408 -2.559 0 CA-C-N 115.009 -0.996 . . . . 10.0 108.849 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.494 HG22 HG22 ' A' ' 33' ' ' VAL . 1.5 p -87.8 135.21 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.819 0 CA-C-N 119.425 1.011 . . . . 10.0 110.804 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.788 ' CE1' ' HB2' ' A' ' 3' ' ' LYS . 70.4 m-85 -93.47 177.58 5.98 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.576 -0.738 . . . . 10.0 112.689 -173.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.478 ' HG3' ' HB3' ' A' ' 4' ' ' LYS . 5.9 mm-40 -55.63 -24.75 35.29 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 113.896 -1.502 . . . . 10.0 112.652 -178.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.511 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 20.0 t70 -79.37 -15.81 57.28 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.988 -1.005 . . . . 10.0 111.163 -177.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.726 ' HD2' ' HA3' ' A' ' 32' ' ' GLY . 28.6 mtmm 82.3 5.35 1.08 Allowed 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 114.764 -1.107 . . . . 10.0 110.339 -160.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.438 ' O ' HG23 ' A' ' 60' ' ' VAL . 21.5 t -71.26 173.08 8.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.002 -1.851 . . . . 10.0 106.002 175.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.673 ' CZ ' ' HB2' ' A' ' 38' ' ' PHE . 29.9 p90 -169.86 -177.18 2.56 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 121.994 2.179 . . . . 10.0 111.391 177.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.9 p -157.39 175.08 14.46 Favored 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 103.156 -2.905 . . . . 10.0 103.156 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.499 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 21.6 p90 -163.84 159.42 21.13 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.549 -0.908 . . . . 10.0 108.549 177.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.3 161.64 41.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.299 -1.371 . . . . 10.0 107.299 177.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.695 HG22 HD11 ' A' ' 54' ' ' LEU . 4.9 mm -109.52 134.06 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 108.228 -1.027 . . . . 10.0 108.228 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 1.122 ' HZ2' ' HA ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -81.88 91.05 6.48 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.179 0.514 . . . . 10.0 109.964 178.083 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.921 ' HB ' ' HG3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -50.16 104.17 0.41 Allowed Pre-proline 0 C--N 1.312 -1.037 0 CA-C-N 113.846 -1.524 . . . . 10.0 110.144 173.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.519 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 39.1 Cg_endo -66.5 149.35 84.46 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.608 2.206 . . . . 10.0 112.683 -169.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.784 ' HA ' HD12 ' A' ' 116' ' ' LEU . 47.5 Cg_exo -33.45 -61.24 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 124.098 3.199 . . . . 10.0 113.507 -178.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.509 ' HB1' HG23 ' A' ' 131' ' ' THR . . . -174.28 10.8 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 112.853 0.686 . . . . 10.0 112.853 176.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.5 t -60.06 -64.24 1.02 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.068 0.461 . . . . 10.0 111.383 -174.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.456 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 80.7 m-85 -71.66 -28.61 63.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.179 -0.464 . . . . 10.0 111.231 -176.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.658 ' O ' ' HB3' ' A' ' 81' ' ' LYS . 3.0 mm? -84.21 -28.4 27.33 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.094 0.474 . . . . 10.0 111.098 -173.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 75' ' ' ALA . 11.3 mt -72.68 -36.33 67.86 Favored 'General case' 0 C--O 1.211 -0.952 0 C-N-CA 120.048 -0.661 . . . . 10.0 109.685 175.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -65.98 -21.34 66.4 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.02 0.438 . . . . 10.0 110.557 174.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.658 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 1.8 tmtp? -57.6 -50.25 73.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.391 -0.368 . . . . 10.0 110.536 171.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.675 ' HB3' ' HG3' ' A' ' 104' ' ' GLN . . . -79.12 -55.2 5.29 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.288 1.835 . . . . 10.0 113.208 176.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.21 121.88 22.8 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 111.152 -2.749 . . . . 10.0 107.453 -177.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -87.45 18.57 37.02 Favored Glycine 0 C--N 1.317 -0.496 0 C-N-CA 118.575 -1.774 . . . . 10.0 111.184 -166.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.44 HG21 HG22 ' A' ' 97' ' ' VAL . 19.2 pt -64.19 147.24 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 114.181 -1.01 . . . . 10.0 112.196 -176.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -159.76 32.15 0.19 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.039 -0.982 . . . . 10.0 108.524 175.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -160.38 -46.44 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.605 -1.634 . . . . 10.0 106.619 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.7 -178.63 44.12 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.875 -1.057 . . . . 10.0 113.701 166.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.6 p -78.68 -171.37 2.5 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.617 -0.791 . . . . 10.0 111.491 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.68 ' O ' ' HG3' ' A' ' 91' ' ' GLU . 47.1 p -154.84 12.1 0.37 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.231 -1.026 . . . . 10.0 108.231 174.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.68 ' HG3' ' O ' ' A' ' 90' ' ' SER . 6.3 mt-10 -172.18 119.36 0.43 Allowed Pre-proline 0 N--CA 1.454 -0.246 0 CA-C-N 113.749 -1.569 . . . . 10.0 107.206 -168.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 91' ' ' GLU . 1.5 Cg_endo -82.66 24.17 0.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.62 2.213 . . . . 10.0 113.586 -172.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -155.69 133.71 11.38 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.336 0.254 . . . . 10.0 110.761 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 70.05 -69.36 0.17 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 124.213 0.946 . . . . 10.0 111.802 174.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -72.54 64.87 0.64 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.655 0.74 . . . . 10.0 110.404 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 136' ' ' GLY . 46.8 pt -85.06 -167.86 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.408 -0.814 . . . . 10.0 110.87 174.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.44 HG22 HG21 ' A' ' 85' ' ' ILE . 7.2 p -141.99 -47.41 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 113.001 0.741 . . . . 10.0 113.001 -163.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -169.75 168.34 41.26 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 110.517 -1.033 . . . . 10.0 110.517 177.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.62 ' O ' HG12 ' A' ' 100' ' ' VAL . 0.7 OUTLIER -158.19 173.97 15.89 Favored 'General case' 0 CA--C 1.481 -1.705 0 CA-C-O 121.23 0.538 . . . . 10.0 110.847 -160.737 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.647 HG11 ' CB ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -164.36 -169.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 113.769 -1.559 . . . . 10.0 110.631 -171.513 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.8 p -104.86 141.48 36.45 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 114.252 -1.34 . . . . 10.0 112.3 -169.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.684 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 5.0 ttp180 -46.53 -38.69 9.71 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.717 -0.674 . . . . 10.0 110.207 171.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 20.1 tptm -58.17 -45.42 87.53 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.211 -0.45 . . . . 10.0 111.658 174.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.675 ' HG3' ' HB3' ' A' ' 82' ' ' ALA . 2.2 tm0? -60.13 -56.73 18.02 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.339 -0.615 . . . . 10.0 109.339 175.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.785 HG22 ' HB ' ' A' ' 128' ' ' ILE . 24.3 mm -26.72 -57.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 123.812 0.695 . . . . 10.0 112.317 162.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.738 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 30.1 tt0 -50.35 -58.07 6.5 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.008 0.923 . . . . 10.0 112.904 178.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.972 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 8.5 mt-10 -55.61 -46.43 77.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.488 -0.778 . . . . 10.0 110.767 -178.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.561 HD12 ' HB3' ' A' ' 78' ' ' LEU . 31.4 mm -58.88 -50.38 79.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.455 -0.793 . . . . 10.0 109.407 175.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.448 ' HB1' ' CB ' ' A' ' 124' ' ' ALA . . . -53.81 -40.53 66.44 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.158 -0.928 . . . . 10.0 113.248 176.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.972 ' HD2' ' HA ' ' A' ' 107' ' ' GLU . 36.4 mttm -63.87 -50.04 70.38 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 121.693 0.758 . . . . 10.0 109.125 -177.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 89.4 m -49.12 -59.46 3.63 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 113.786 -1.552 . . . . 10.0 111.926 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.921 ' HG3' ' HB ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -93.51 16.57 13.3 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.691 0.997 . . . . 10.0 113.691 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.617 ' HG3' ' HB1' ' A' ' 118' ' ' ALA . 47.6 ttm -41.94 -50.9 10.37 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 118.593 0.633 . . . . 10.0 111.902 168.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 113' ' ' MET . 42.5 Cg_endo -66.69 -20.9 52.44 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 121.583 1.522 . . . . 10.0 113.321 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.418 ' C ' ' H ' ' A' ' 117' ' ' ASN . 0.7 OUTLIER -91.94 -49.73 6.08 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.647 0.737 . . . . 10.0 111.26 -177.368 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.784 HD12 ' HA ' ' A' ' 74' ' ' PRO . 7.2 mp -62.58 -3.23 1.37 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.235 -1.348 . . . . 10.0 111.494 178.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.418 ' H ' ' C ' ' A' ' 115' ' ' ASP . 58.5 t30 64.03 45.34 4.21 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.108 -1.406 . . . . 10.0 109.268 177.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.617 ' HB1' ' HG3' ' A' ' 113' ' ' MET . . . -85.13 119.76 25.88 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 113.448 -1.705 . . . . 10.0 113.041 -174.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -65.36 -42.92 92.26 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.782 -0.822 . . . . 10.0 108.782 167.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.2 p -143.88 149.26 36.65 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.957 -1.127 . . . . 10.0 107.957 -177.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -50.42 -39.8 48.42 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 114.753 -1.112 . . . . 10.0 112.041 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.547 ' HA ' ' HG3' ' A' ' 125' ' ' MET . 1.8 mp0 -47.88 -42.11 26.01 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.786 0.803 . . . . 10.0 111.135 177.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.89 -48.0 70.07 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 118.428 -1.309 . . . . 10.0 110.831 177.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -55.59 -38.26 69.17 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.007 177.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.679 ' O ' ' HB2' ' A' ' 129' ' ' GLU . 20.6 mtp -55.06 -39.4 69.19 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.59 0.709 . . . . 10.0 110.076 -176.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.69 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 0.3 OUTLIER -65.34 -46.66 79.36 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.153 -1.385 . . . . 10.0 110.441 -178.281 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 124' ' ' ALA . 63.6 mt -52.37 -62.81 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-N 116.165 -0.471 . . . . 10.0 111.112 175.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.785 ' HB ' HG22 ' A' ' 105' ' ' ILE . 11.8 mm -53.67 -54.44 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.121 0 CA-C-N 115.08 -0.964 . . . . 10.0 110.349 -177.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.679 ' HB2' ' O ' ' A' ' 125' ' ' MET . 0.8 OUTLIER -53.24 -41.68 65.68 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.076 -0.965 . . . . 10.0 110.097 178.342 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.547 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -75.21 -44.41 22.9 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.843 -0.694 . . . . 10.0 111.86 -176.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.509 HG23 ' HB1' ' A' ' 75' ' ' ALA . 93.0 m -47.5 -59.8 2.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.099 -1.051 . . . . 10.0 109.28 170.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.486 ' HB3' ' HB ' ' A' ' 137' ' ' ILE . . . -50.51 -51.33 48.51 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.739 -0.664 . . . . 10.0 111.274 174.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 77.3 tttt -44.75 -56.04 4.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.854 -1.066 . . . . 10.0 111.792 175.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.3 t -64.11 -31.22 72.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.108 0.48 . . . . 10.0 111.176 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.471 ' HE1' ' CD1' ' A' ' 137' ' ' ILE . 50.3 mtm -83.12 4.52 26.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.837 1.051 . . . . 10.0 113.837 -176.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.428 ' O ' ' HB ' ' A' ' 96' ' ' ILE . . . 83.75 12.68 77.04 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 120.161 1.346 . . . . 10.0 111.929 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 25.6 mt -101.79 124.14 55.41 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 CA-C-O 121.579 0.705 . . . . 10.0 111.29 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.413 ' HG3' ' N ' ' A' ' 139' ' ' VAL . 0.0 OUTLIER -88.58 158.44 18.27 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 114.549 -1.205 . . . . 10.0 109.317 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.413 ' N ' ' HG3' ' A' ' 138' ' ' GLU . 17.6 m -115.08 135.16 55.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 108.093 -1.077 . . . . 10.0 108.093 169.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.4 m -133.17 69.43 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 114.869 1.433 . . . . 10.0 114.869 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.5 t70 . . . . . 0 C--N 1.31 -1.117 0 CA-C-O 118.666 -0.683 . . . . 10.0 110.657 140.788 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.6 mmm . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.806 0.336 . . . . 10.0 110.732 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.13 179.33 6.97 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.237 -0.438 . . . . 10.0 109.945 176.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -78.39 162.84 26.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.855 -175.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.402 ' HB2' ' OE2' ' A' ' 62' ' ' GLU . 60.2 mttm -90.0 139.79 30.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.002 0.43 . . . . 10.0 111.136 -174.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.8 132.75 28.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.297 -0.865 . . . . 10.0 111.552 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' A' ' 62' ' ' GLU . . . -102.98 -37.2 7.9 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.089 -0.708 . . . . 10.0 109.089 173.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.444 ' HB1' ' CG1' ' A' ' 60' ' ' VAL . . . -154.89 -175.2 5.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.899 0.857 . . . . 10.0 112.66 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 4.1 pt20 -142.0 130.48 22.51 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.087 -1.415 . . . . 10.0 108.241 178.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.568 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -119.77 84.13 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 109.406 -0.591 . . . . 10.0 109.406 -176.579 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.761 ' HB2' ' HZ2' ' A' ' 10' ' ' LYS . 8.0 mtmp? -77.56 130.27 36.71 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 120.664 1.574 . . . . 10.0 107.72 176.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.768 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.87 124.84 4.99 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 122.379 1.085 . . . . 10.0 111.594 -176.607 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -82.85 120.18 25.33 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.878 -1.51 . . . . 10.0 109.716 -172.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.768 HD21 HD11 ' A' ' 11' ' ' LEU . 92.1 mt -137.34 138.73 25.76 Favored Pre-proline 0 CA--C 1.5 -0.953 0 CA-C-O 121.512 0.672 . . . . 10.0 112.036 -172.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.802 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 40.1 Cg_exo -55.71 124.88 17.37 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 123.204 2.603 . . . . 10.0 111.646 171.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.683 ' HB1' HD11 ' A' ' 54' ' ' LEU . . . -62.02 126.39 27.17 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 106.996 -1.483 . . . . 10.0 106.996 168.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.29 -5.04 79.08 Favored Glycine 0 CA--C 1.529 0.909 0 O-C-N 125.515 1.759 . . . . 10.0 113.599 -175.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.802 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 31.9 mmtp -139.89 102.59 4.45 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.519 1.159 . . . . 10.0 111.674 178.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 39' ' ' CYS . . . -170.17 130.7 0.96 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.17 -1.377 . . . . 10.0 111.927 175.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 65.0 m -166.7 -59.38 0.01 OUTLIER Pre-proline 0 N--CA 1.437 -1.122 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.907 -177.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.798 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 84.1 Cg_endo -108.05 136.22 0.05 OUTLIER 'Trans proline' 0 N--CA 1.421 -2.778 0 N-CA-C 117.05 1.904 . . . . 10.0 117.05 -157.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 1.045 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 11.69 -85.63 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.585 1 CA-C-N 108.393 -4.003 . . . . 10.0 115.335 167.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.862 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 56.9 Cg_exo -32.08 -54.43 0.32 Allowed 'Trans proline' 0 CA--C 1.558 1.711 0 C-N-CA 122.662 2.242 . . . . 10.0 115.579 -163.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.862 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 32.0 Cg_endo -84.54 -53.63 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 122.516 2.144 . . . . 10.0 112.651 168.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.783 HG11 ' CD1' ' A' ' 35' ' ' ILE . 75.9 t -81.53 -55.98 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 113.331 -1.759 . . . . 10.0 113.991 -167.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 1.045 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -43.1 -77.46 0.09 OUTLIER Glycine 0 CA--C 1.519 0.335 0 CA-C-N 114.736 -1.12 . . . . 10.0 114.1 -177.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.779 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 22.8 Cg_exo -45.09 -41.82 16.18 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.817 3.011 . . . . 10.0 112.681 173.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.565 ' HB1' ' O ' ' A' ' 24' ' ' VAL . . . -51.08 -101.52 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 123.475 0.484 . . . . 10.0 111.858 176.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.674 HD22 ' C ' ' A' ' 28' ' ' LEU 0.308 0.0 OUTLIER -73.33 -25.8 60.77 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 117.511 -1.676 . . . . 10.0 112.951 -172.422 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.594 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -71.83 -40.78 57.34 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.098 -0.572 . . . . 10.0 113.024 -176.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -63.09 -16.71 60.86 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 119.178 -1.009 . . . . 10.0 109.712 175.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.529 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 95.7 m-70 -98.88 20.1 13.78 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 120.12 -0.632 . . . . 10.0 110.102 176.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.47 -1.64 76.39 Favored Glycine 0 CA--C 1.5 -0.872 0 CA-C-N 115.201 -0.909 . . . . 10.0 113.126 167.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.732 HG12 ' CD2' ' A' ' 66' ' ' PHE . 11.3 t -82.48 147.1 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 113.305 0.854 . . . . 10.0 113.305 -172.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.408 ' N ' HG11 ' A' ' 33' ' ' VAL . 95.7 m-20 -69.69 98.91 1.25 Allowed 'General case' 0 C--N 1.341 0.219 0 CA-C-O 121.291 0.567 . . . . 10.0 110.868 172.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.783 ' CD1' HG11 ' A' ' 24' ' ' VAL . 2.5 mm -52.31 -39.25 27.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.867 -1.061 . . . . 10.0 111.464 174.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.741 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 85.3 mtp -64.61 -52.1 59.24 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 113.244 -1.798 . . . . 10.0 111.618 176.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.636 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 31.1 mt-10 -58.49 -40.12 81.92 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.11 -1.036 . . . . 10.0 111.024 176.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.552 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 90.3 t80 -58.33 -59.74 4.87 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.929 1.085 . . . . 10.0 113.929 172.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.741 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 18.3 p -58.82 -48.05 82.64 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 114.832 -1.077 . . . . 10.0 111.761 -177.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -65.22 -22.74 66.92 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.824 -0.806 . . . . 10.0 108.824 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.737 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 10.7 mtm180 -78.45 -63.26 1.44 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 119.321 -0.952 . . . . 10.0 112.899 170.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.511 ' CZ ' HG21 ' A' ' 46' ' ' THR . 67.4 t80 -55.2 -43.61 74.59 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 118.717 0.689 . . . . 10.0 110.403 -172.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.621 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.8 OUTLIER -59.8 -51.38 69.97 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.311 -0.858 . . . . 10.0 109.851 -179.625 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.98 -40.25 97.18 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 119.239 -0.985 . . . . 10.0 112.182 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.737 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 23.5 mt-10 -67.92 -45.24 74.93 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.578 0.704 . . . . 10.0 111.079 -178.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.694 HG21 HD13 ' A' ' 54' ' ' LEU . 72.3 p -86.93 6.2 33.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.998 -1.001 . . . . 10.0 112.209 -172.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.7 -34.61 5.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.632 -1.167 . . . . 10.0 112.561 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -79.63 -38.54 33.6 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.585 -0.734 . . . . 10.0 112.053 -176.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -94.14 18.66 10.42 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 109.127 -0.694 . . . . 10.0 109.127 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -50.46 133.88 24.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.08 -0.963 . . . . 10.0 112.661 -178.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.05 19.48 10.1 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 114.786 -1.097 . . . . 10.0 110.799 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.608 ' HB2' HD23 ' A' ' 54' ' ' LEU . 67.3 mtt -137.5 127.48 25.81 Favored 'General case' 0 C--O 1.208 -1.108 0 C-N-CA 117.457 -1.697 . . . . 10.0 114.295 -169.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.2 mm -65.94 91.74 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 118.688 0.676 . . . . 10.0 109.372 169.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.694 HD13 HG21 ' A' ' 46' ' ' THR . 6.9 mt -81.08 138.06 49.41 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 -177.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 54' ' ' LEU . 3.7 Cg_exo -78.67 104.84 1.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.95 1.766 . . . . 10.0 110.472 172.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -101.01 144.14 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 119.716 1.144 . . . . 10.0 110.995 -175.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 85.0 t -119.4 118.51 57.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 116.224 -0.444 . . . . 10.0 110.475 171.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.568 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 16.4 mt -104.94 141.29 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.722 0 N-CA-C 108.515 -0.921 . . . . 10.0 108.515 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.8 m -127.68 97.89 5.0 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 114.714 -1.13 . . . . 10.0 109.134 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 65' ' ' SER . 2.1 p -91.3 136.03 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 O-C-N 121.276 -0.89 . . . . 10.0 110.618 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -92.48 171.14 9.23 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.586 -0.734 . . . . 10.0 112.292 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.408 ' HA ' ' HB3' ' A' ' 6' ' ' ALA . 39.7 mt-10 -58.38 -23.51 57.22 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.594 -1.184 . . . . 10.0 112.77 -177.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.53 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 2.8 m-20 -81.27 -6.41 58.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.872 -0.604 . . . . 10.0 112.568 -176.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 53.5 mtpt 83.97 1.31 0.95 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.967 0.889 . . . . 10.0 110.011 -167.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.453 ' O ' HG22 ' A' ' 60' ' ' VAL . 8.5 t -72.01 172.23 10.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.313 -1.312 . . . . 10.0 108.016 172.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.732 ' CD2' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -167.6 -177.48 3.55 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 120.241 1.382 . . . . 10.0 109.501 176.207 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.482 ' HA ' HH22 ' A' ' 41' ' ' ARG . 22.2 p -157.82 169.95 23.46 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 103.217 -2.883 . . . . 10.0 103.217 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.426 ' HB3' HG12 ' A' ' 58' ' ' ILE . 56.2 p90 -164.18 153.86 14.24 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.622 -0.881 . . . . 10.0 108.622 176.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.5 pt -131.89 153.24 38.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 108.178 -1.045 . . . . 10.0 108.178 -176.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.537 HG23 HD12 ' A' ' 54' ' ' LEU . 1.6 mm -107.39 131.76 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.389 -1.338 . . . . 10.0 107.389 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.655 ' C ' ' HD2' ' A' ' 73' ' ' PRO . 13.9 mmmm -77.71 90.2 4.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.033 0.92 . . . . 10.0 110.999 -177.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.586 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -60.63 -32.93 12.52 Favored Pre-proline 0 CA--C 1.562 1.434 0 CA-C-N 113.758 -1.564 . . . . 10.0 115.134 172.49 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.661 ' HG2' ' HD3' ' A' ' 74' ' ' PRO . 14.0 Cg_endo -54.8 -36.69 91.61 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.377 2.718 . . . . 10.0 117.281 -170.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.661 ' HD3' ' HG2' ' A' ' 73' ' ' PRO . 79.8 Cg_exo -47.14 -29.25 8.72 Favored 'Trans proline' 0 C--N 1.366 1.481 0 C-N-CA 121.963 1.776 . . . . 10.0 112.504 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.46 ' HB2' HG21 ' A' ' 131' ' ' THR . . . 73.04 -42.33 0.53 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.474 0.916 . . . . 10.0 113.474 169.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.2 p -45.43 -35.65 3.84 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.575 0.75 . . . . 10.0 112.69 -175.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.553 ' HB3' ' SD ' ' A' ' 52' ' ' MET . 75.3 m-85 -55.14 -50.31 69.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.545 0.688 . . . . 10.0 111.34 178.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.75 ' HB3' HD12 ' A' ' 108' ' ' ILE . 4.8 mp -93.25 -12.58 29.83 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.081 -0.648 . . . . 10.0 111.591 -174.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.43 ' HA ' HD13 ' A' ' 79' ' ' LEU . 3.3 mm? -62.12 -37.28 84.52 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.17 -1.048 . . . . 10.0 108.17 166.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -56.74 -43.17 80.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.104 -0.953 . . . . 10.0 110.185 172.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? -54.94 -46.71 75.0 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.517 -0.765 . . . . 10.0 112.33 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.505 ' CB ' HG13 ' A' ' 100' ' ' VAL . . . -70.44 -49.17 51.48 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.087 1.355 . . . . 10.0 111.678 174.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.57 ' HB3' HG12 ' A' ' 85' ' ' ILE . . . -64.59 -30.92 71.95 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 111.413 -2.63 . . . . 10.0 111.298 -167.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.632 ' C ' ' H ' ' A' ' 86' ' ' GLU . . . 93.7 -31.99 6.12 Favored Glycine 0 CA--C 1.501 -0.838 0 N-CA-C 110.209 -1.156 . . . . 10.0 110.209 174.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.57 HG12 ' HB3' ' A' ' 83' ' ' ALA . 40.5 pt -47.48 17.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 115.676 1.732 . . . . 10.0 115.676 166.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.632 ' H ' ' C ' ' A' ' 84' ' ' GLY . 28.9 tt0 -75.01 60.06 0.97 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.8 -0.815 . . . . 10.0 108.8 171.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -173.69 -38.29 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.698 -1.137 . . . . 10.0 109.048 -173.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 142.01 -72.02 0.4 Allowed Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.187 -0.915 . . . . 10.0 111.426 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.3 m 65.33 114.19 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.442 0.639 . . . . 10.0 111.186 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.16 43.59 0.2 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.129 -0.693 . . . . 10.0 109.129 -174.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.742 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 38.8 mt-10 -162.03 -50.21 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 114.613 -1.176 . . . . 10.0 108.921 -174.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.742 ' HD3' ' HB2' ' A' ' 91' ' ' GLU . 4.8 Cg_exo -75.3 108.12 2.63 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.687 1.591 . . . . 10.0 110.628 169.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.647 ' HB2' ' HA ' ' A' ' 97' ' ' VAL . 28.1 mmtp 66.63 -170.96 0.19 Allowed 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.287 -0.635 . . . . 10.0 109.287 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -165.62 -44.29 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.791 0.329 . . . . 10.0 110.378 174.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.692 ' HG2' HG23 ' A' ' 96' ' ' ILE . 0.0 OUTLIER -66.82 -30.63 70.87 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.41 -0.516 . . . . 10.0 111.135 -172.768 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.835 HD13 ' HB3' ' A' ' 138' ' ' GLU . 2.4 pp -138.39 1.81 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.609 174.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.647 ' HA ' ' HB2' ' A' ' 93' ' ' LYS . 13.5 p 49.08 -57.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 116.118 1.895 . . . . 10.0 116.118 176.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 96' ' ' ILE . . . -152.39 162.04 29.7 Favored Glycine 0 N--CA 1.431 -1.661 0 N-CA-C 109.793 -1.323 . . . . 10.0 109.793 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.762 ' CB ' ' HG2' ' A' ' 138' ' ' GLU . 0.1 OUTLIER -139.93 168.53 19.6 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 122.851 1.31 . . . . 10.0 111.187 -170.478 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.628 ' O ' HG21 ' A' ' 140' ' ' VAL . 2.6 m -156.37 -146.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 CA-C-N 111.516 -2.583 . . . . 10.0 104.732 -171.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.417 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 6.6 t -164.5 156.84 16.55 Favored 'General case' 0 C--N 1.282 -2.344 0 C-N-CA 117.693 -1.603 . . . . 10.0 110.71 -163.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.601 ' NH1' ' HE3' ' A' ' 125' ' ' MET . 1.3 tmt_? -41.79 -42.94 2.79 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 112.718 -2.037 . . . . 10.0 110.628 -175.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -59.27 -44.22 92.46 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.032 0.753 . . . . 10.0 113.032 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.653 ' O ' HG12 ' A' ' 108' ' ' ILE . 3.1 mp0 -60.7 -51.76 67.99 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.392 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.684 HG22 ' HB ' ' A' ' 128' ' ' ILE . 39.3 mm -36.95 -53.32 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 CA-C-N 114.806 -1.088 . . . . 10.0 111.309 167.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.796 ' HA ' ' SD ' ' A' ' 125' ' ' MET . 4.9 tt0 -50.81 -60.25 3.25 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.833 -1.076 . . . . 10.0 113.168 -177.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -55.97 -48.97 74.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.157 -0.928 . . . . 10.0 110.502 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.75 HD12 ' HB3' ' A' ' 78' ' ' LEU . 18.4 mm -51.77 -56.58 5.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.593 171.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.507 ' HB3' HG13 ' A' ' 128' ' ' ILE . . . -50.83 -35.19 31.13 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.371 0.508 . . . . 10.0 112.371 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.768 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 92.7 mttt -76.91 -51.59 10.94 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 116.004 -0.544 . . . . 10.0 111.113 -178.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.632 HG21 ' O ' ' A' ' 108' ' ' ILE . 10.3 t -57.26 -17.73 13.13 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.145 0.794 . . . . 10.0 113.145 -176.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.748 ' HZ2' ' HB3' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -132.21 18.84 4.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.374 0.607 . . . . 10.0 110.011 -179.248 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.632 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 46.5 ttm -48.52 -45.63 69.14 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 114.798 -1.092 . . . . 10.0 112.307 175.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 113' ' ' MET . 19.0 Cg_endo -55.8 -23.62 42.7 Favored 'Trans proline' 0 C--N 1.363 1.291 0 C-N-CA 122.364 2.043 . . . . 10.0 112.338 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.608 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 5.0 m-20 -96.8 -46.44 6.26 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.883 -1.053 . . . . 10.0 112.85 -173.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.589 ' CD2' HD13 ' A' ' 127' ' ' ILE . 6.6 mp -63.92 36.92 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 114.525 -1.216 . . . . 10.0 112.986 -176.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.465 ' H ' ' C ' ' A' ' 115' ' ' ASP . 0.2 OUTLIER 17.96 54.34 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.181 1.392 . . . . 10.0 112.279 -172.099 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -103.23 123.27 46.43 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.464 0.913 . . . . 10.0 113.464 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -67.64 -33.55 75.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.34 0.59 . . . . 10.0 109.854 169.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.1 p -148.43 145.41 27.99 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.569 -0.9 . . . . 10.0 108.569 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.666 ' O ' ' HG2' ' A' ' 125' ' ' MET . 56.7 tp -51.85 -38.44 55.97 Favored 'General case' 0 C--O 1.219 -0.542 0 N-CA-C 114.52 1.304 . . . . 10.0 114.52 -176.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.535 ' O ' ' HD3' ' A' ' 126' ' ' LYS . 19.8 mm-40 -49.66 -37.14 27.31 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.24 0.543 . . . . 10.0 110.931 176.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.04 -47.8 70.28 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 118.651 -1.22 . . . . 10.0 110.574 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.544 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -59.06 -30.98 68.45 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.212 0.53 . . . . 10.0 110.658 177.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.796 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 86.8 mmm -58.21 -38.71 77.31 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.495 0.664 . . . . 10.0 110.771 178.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.535 ' HD3' ' O ' ' A' ' 122' ' ' GLU . 4.0 mptp? -65.14 -52.04 57.59 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.954 -1.021 . . . . 10.0 111.846 177.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.589 HD13 ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -52.36 -58.83 2.0 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.688 0 C-N-CA 119.803 -0.759 . . . . 10.0 110.806 178.504 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.684 ' HB ' HG22 ' A' ' 105' ' ' ILE . 27.4 mm -50.75 -58.96 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.88 0 C-N-CA 123.801 0.84 . . . . 10.0 111.746 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.601 ' HG3' HG21 ' A' ' 105' ' ' ILE . 4.3 mt-10 -52.76 -43.68 65.97 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.548 -0.751 . . . . 10.0 109.453 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.489 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -71.5 -46.66 39.08 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.461 -0.876 . . . . 10.0 111.481 -176.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.46 HG21 ' HB2' ' A' ' 75' ' ' ALA . 51.7 m -46.63 -62.41 1.39 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.972 -1.114 . . . . 10.0 110.047 173.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.587 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . . . -50.91 -48.64 60.55 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.845 -0.616 . . . . 10.0 111.699 174.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 58.7 tttm -47.31 -54.99 9.62 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.366 -0.834 . . . . 10.0 111.037 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.7 m -65.91 -28.56 69.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.061 0.457 . . . . 10.0 110.637 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 43.6 mtm -81.29 -2.26 48.33 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.507 0.928 . . . . 10.0 113.507 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 80.88 44.58 8.2 Favored Glycine 0 C--O 1.216 -1.01 0 CA-C-N 119.696 1.135 . . . . 10.0 112.219 -177.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.587 ' HB ' ' HB2' ' A' ' 132' ' ' ALA . 1.9 mm -119.86 127.12 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.67 0 CA-C-O 121.389 0.614 . . . . 10.0 110.475 175.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.835 ' HB3' HD13 ' A' ' 96' ' ' ILE . 0.0 OUTLIER -87.49 145.76 26.11 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 114.948 -1.024 . . . . 10.0 109.326 176.104 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 18.9 m -113.46 134.62 55.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 107.634 -1.247 . . . . 10.0 107.634 171.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.628 HG21 ' O ' ' A' ' 100' ' ' VAL . 12.9 m -129.65 72.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 114.674 1.361 . . . . 10.0 114.674 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.024 0 N-CA-C 114.216 1.191 . . . . 10.0 114.216 140.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 tpt . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.591 0.234 . . . . 10.0 110.869 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.89 145.67 44.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.601 -0.272 . . . . 10.0 110.605 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -128.66 155.83 44.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.999 0.428 . . . . 10.0 110.83 177.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.514 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 27.4 mtpp -136.14 119.98 17.39 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.051 -0.722 . . . . 10.0 109.051 177.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.4 t -62.97 133.97 28.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 122.392 0.277 . . . . 10.0 110.679 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.53 -38.61 6.39 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.394 -0.595 . . . . 10.0 109.394 174.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.516 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -157.44 159.02 36.9 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 113.58 0.955 . . . . 10.0 113.58 -175.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.749 HE21 ' HA ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -100.88 135.45 42.3 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.53 -1.214 . . . . 10.0 108.416 170.208 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.579 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -120.16 80.15 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 108.317 -0.994 . . . . 10.0 108.317 167.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.439 ' HG2' HG12 ' A' ' 57' ' ' VAL . 36.2 mttm -80.79 129.69 34.66 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 121.08 1.764 . . . . 10.0 107.484 176.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.51 HD22 HD12 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -158.09 130.28 7.01 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 122.209 1.004 . . . . 10.0 111.601 -176.603 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -81.75 119.13 23.47 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.026 -1.443 . . . . 10.0 109.664 -172.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.51 HD12 HD22 ' A' ' 11' ' ' LEU . 33.2 mt -136.06 133.97 20.02 Favored Pre-proline 0 CA--C 1.504 -0.822 0 CA-C-O 121.495 0.664 . . . . 10.0 112.578 -169.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.573 ' HB2' ' CB ' ' A' ' 17' ' ' LYS . 39.8 Cg_exo -56.05 122.97 12.71 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 123.534 2.823 . . . . 10.0 111.866 172.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.607 ' CB ' ' HB ' ' A' ' 46' ' ' THR . . . -60.38 128.53 37.17 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 107.814 -1.18 . . . . 10.0 107.814 170.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.6 1.29 82.53 Favored Glycine 0 CA--C 1.527 0.832 0 O-C-N 125.808 1.942 . . . . 10.0 112.972 -175.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.573 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . 0.7 OUTLIER -142.01 88.66 2.12 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.022 0.911 . . . . 10.0 112.089 -177.773 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.75 133.02 3.95 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.898 -1.046 . . . . 10.0 112.514 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.556 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 4.5 t 175.07 -42.86 0.0 OUTLIER Pre-proline 0 C--O 1.22 -0.487 0 O-C-N 124.349 1.031 . . . . 10.0 112.615 177.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.676 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 56.5 Cg_endo -99.07 121.45 0.12 Allowed 'Trans proline' 0 N--CA 1.42 -2.845 0 CA-C-N 120.612 1.254 . . . . 10.0 115.24 -159.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 1.086 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 10.65 -85.19 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 109.907 -3.315 . . . . 10.0 115.26 167.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.84 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 26.2 Cg_exo -25.11 -57.52 0.07 OUTLIER 'Trans proline' 0 CA--C 1.561 1.83 0 C-N-CA 123.543 2.829 . . . . 10.0 115.913 -165.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.84 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 1.0 OUTLIER -86.16 -59.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.363 1.309 0 C-N-CA 123.365 2.71 . . . . 10.0 112.474 171.401 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.417 HG12 HG23 ' A' ' 35' ' ' ILE . 36.7 t -73.95 -43.07 52.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 112.159 -2.292 . . . . 10.0 113.759 -168.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 1.086 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -54.74 -71.8 0.66 Allowed Glycine 0 C--O 1.218 -0.857 0 CA-C-N 114.588 -1.187 . . . . 10.0 113.221 -177.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.583 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 17.1 Cg_exo -46.15 -46.27 16.7 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.52 2.813 . . . . 10.0 112.653 173.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.7 -75.25 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.437 0.637 . . . . 10.0 111.375 177.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.699 HD22 ' CD1' ' A' ' 58' ' ' ILE . 5.0 mt -69.65 -46.96 64.94 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.512 0.93 . . . . 10.0 113.512 -177.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.43 -40.33 97.49 Favored Glycine 0 C--N 1.32 -0.35 0 CA-C-N 115.462 -0.79 . . . . 10.0 113.481 -172.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -63.44 -27.14 69.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.057 0.456 . . . . 10.0 110.327 178.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -99.11 13.18 33.79 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.379 0.609 . . . . 10.0 110.353 177.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.492 ' O ' ' HE3' ' A' ' 64' ' ' LYS . . . 76.45 11.41 85.15 Favored Glycine 0 CA--C 1.501 -0.799 0 CA-C-N 114.883 -1.053 . . . . 10.0 113.319 171.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.781 HG12 ' CD1' ' A' ' 66' ' ' PHE . 59.6 t -80.92 139.58 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 112.117 0.414 . . . . 10.0 112.117 -172.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.5 100.52 1.81 Allowed 'General case' 0 C--N 1.343 0.284 0 CA-C-O 121.586 0.708 . . . . 10.0 110.875 178.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.484 ' CD1' ' HA2' ' A' ' 25' ' ' GLY . 92.9 mt -51.0 -45.9 29.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 114.604 -1.18 . . . . 10.0 111.931 175.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.8 mtm -64.73 -54.68 27.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 112.997 -1.91 . . . . 10.0 111.246 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -53.37 -44.02 68.25 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 121.172 -0.211 . . . . 10.0 110.432 177.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.592 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 56.7 t80 -59.79 -56.24 24.26 Favored 'General case' 0 C--O 1.213 -0.834 0 N-CA-C 114.052 1.131 . . . . 10.0 114.052 171.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.455 ' SG ' ' HB ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -57.59 -49.79 75.24 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.968 0.907 . . . . 10.0 111.968 -177.739 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -65.46 -21.18 66.61 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 119.471 -0.892 . . . . 10.0 108.853 -176.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.652 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 46.9 mtt180 -78.9 -62.04 1.82 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.221 -0.9 . . . . 10.0 112.652 168.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.561 ' CZ ' HG21 ' A' ' 46' ' ' THR . 79.4 t80 -53.27 -48.4 68.34 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.535 0.683 . . . . 10.0 110.065 -173.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.632 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.8 OUTLIER -61.16 -47.78 84.61 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.674 -1.148 . . . . 10.0 110.27 -176.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.79 -38.91 92.51 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 119.163 -1.015 . . . . 10.0 112.077 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.652 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 37.1 mm-40 -63.24 -45.84 89.71 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.147 0.975 . . . . 10.0 110.303 178.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.607 ' HB ' ' CB ' ' A' ' 15' ' ' ALA . 70.0 p -90.87 -0.48 57.74 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.15 -1.386 . . . . 10.0 112.477 -167.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.35 -37.09 7.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.15 -0.932 . . . . 10.0 112.577 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -83.64 -24.76 31.26 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.337 -0.847 . . . . 10.0 111.429 -172.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.7 mtmm -113.23 25.84 10.99 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.54 0.686 . . . . 10.0 109.959 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.414 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -54.13 154.92 3.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.39 -1.277 . . . . 10.0 113.257 177.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.95 21.06 40.57 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.574 -1.01 . . . . 10.0 110.574 -177.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.535 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 67.3 mtt -139.47 125.23 19.52 Favored 'General case' 0 C--O 1.209 -1.065 0 C-N-CA 116.866 -1.934 . . . . 10.0 114.653 -166.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.6 mm -66.88 91.39 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 109.409 -0.589 . . . . 10.0 109.409 172.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.59 HD12 ' HB3' ' A' ' 15' ' ' ALA . 7.2 mt -82.2 131.49 56.07 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.62 -0.511 . . . . 10.0 109.62 -177.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.508 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 13.5 Cg_exo -72.06 96.04 0.77 Allowed 'Trans proline' 0 C--N 1.331 -0.377 0 C-N-CA 122.5 2.133 . . . . 10.0 111.265 173.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.45 HG22 HG12 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -92.96 157.65 2.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 119.586 1.084 . . . . 10.0 111.579 -174.668 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.487 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 95.2 t -135.39 115.94 18.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.4 173.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.699 ' CD1' HD22 ' A' ' 28' ' ' LEU . 25.5 mt -108.81 138.0 37.98 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.742 0 N-CA-C 107.953 -1.129 . . . . 10.0 107.953 -174.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.3 m -123.13 92.83 3.78 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 114.845 -1.07 . . . . 10.0 109.102 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.516 ' CG1' ' HB3' ' A' ' 7' ' ' ALA . 2.6 p -86.0 134.8 26.43 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 O-C-N 121.258 -0.901 . . . . 10.0 110.817 -177.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -91.98 173.58 7.77 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.748 0.785 . . . . 10.0 112.939 -176.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.514 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 59.7 mt-10 -61.71 -15.98 45.19 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.122 -1.399 . . . . 10.0 112.506 -178.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.611 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 7.1 m-20 -75.52 -17.41 60.1 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.51 -0.476 . . . . 10.0 110.692 177.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.611 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 42.1 mtpt 82.41 1.62 1.28 Allowed 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 124.492 1.12 . . . . 10.0 109.993 -160.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.7 t -73.43 174.32 8.34 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 113.313 -1.767 . . . . 10.0 106.846 173.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.781 ' CD1' HG12 ' A' ' 33' ' ' VAL . 55.7 p90 -169.35 -176.1 2.42 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 122.077 2.217 . . . . 10.0 110.764 177.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 58' ' ' ILE . 25.4 p -157.32 174.91 14.71 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 103.022 -2.955 . . . . 10.0 103.022 179.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.43 ' CB ' HG12 ' A' ' 58' ' ' ILE . 35.8 p90 -163.72 157.92 19.69 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.472 -0.936 . . . . 10.0 108.472 177.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.487 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 38.8 pt -127.74 166.99 23.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 106.702 -1.592 . . . . 10.0 106.702 177.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.454 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 8.9 mt -134.17 124.8 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 107.514 -1.291 . . . . 10.0 107.514 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 30.4 mmmt -76.93 81.78 3.48 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.721 -0.844 . . . . 10.0 108.721 -176.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.723 HG22 ' HA ' ' A' ' 112' ' ' LYS . 1.7 t -50.66 116.5 7.03 Favored Pre-proline 0 C--N 1.312 -1.035 0 N-CA-C 107.057 -1.46 . . . . 10.0 107.057 174.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.706 ' HG3' ' CE1' ' A' ' 77' ' ' PHE . 61.3 Cg_endo -65.87 166.46 20.39 Favored 'Trans proline' 0 CA--C 1.517 -0.331 0 C-N-CA 123.451 2.767 . . . . 10.0 114.939 -153.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.794 ' HA ' HD23 ' A' ' 116' ' ' LEU . 19.7 Cg_exo -67.63 55.67 0.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.141 2.56 . . . . 10.0 111.14 170.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.447 ' HB3' HD12 ' A' ' 128' ' ' ILE . . . 75.46 -22.33 0.27 Allowed 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 113.572 0.952 . . . . 10.0 113.572 173.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.2 p -38.06 -78.89 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.571 1.322 . . . . 10.0 114.571 -167.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.706 ' CE1' ' HG3' ' A' ' 73' ' ' PRO . 3.2 p90 -82.51 -18.84 40.13 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.009 0.744 . . . . 10.0 113.009 -173.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.613 ' HB3' HD12 ' A' ' 108' ' ' ILE . 2.7 mm? -67.99 -36.19 79.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.399 0.618 . . . . 10.0 109.765 172.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.448 HD23 HG22 ' A' ' 128' ' ' ILE . 27.0 mt -62.56 -39.48 93.78 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.683 -0.69 . . . . 10.0 110.837 176.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.434 ' HA ' ' HB2' ' A' ' 83' ' ' ALA . 37.0 ttpt -66.04 -17.4 64.66 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.37 -0.532 . . . . 10.0 111.01 176.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.541 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 11.3 mmmm -64.56 -39.47 93.81 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 121.572 -0.705 . . . . 10.0 111.117 169.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.697 ' HB3' ' HG3' ' A' ' 104' ' ' GLN . . . -78.5 -56.33 4.52 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.492 1.917 . . . . 10.0 112.277 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.434 ' HB2' ' HA ' ' A' ' 80' ' ' LYS . . . -61.76 119.47 8.8 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 110.825 -2.898 . . . . 10.0 105.844 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.77 6.03 59.87 Favored Glycine 0 N--CA 1.46 0.25 0 CA-C-N 121.814 2.097 . . . . 10.0 110.484 -169.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.622 ' CD1' ' HA3' ' A' ' 98' ' ' GLY . 0.9 OUTLIER -58.48 139.34 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.004 0 C-N-CA 125.317 1.447 . . . . 10.0 114.114 -179.775 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 0.7 OUTLIER -170.64 51.65 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.945 -1.479 . . . . 10.0 107.283 168.461 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 86' ' ' GLU . 24.1 tptm 90.07 79.46 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.053 -1.43 . . . . 10.0 108.499 -172.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.66 62.56 0.24 Allowed Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.338 -0.847 . . . . 10.0 112.035 -174.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.6 p -168.71 170.54 9.31 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.461 -0.57 . . . . 10.0 109.461 -178.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.9 p -165.98 -79.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.45 0.167 . . . . 10.0 111.037 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.658 ' N ' ' HD2' ' A' ' 92' ' ' PRO . 1.7 mp0 -62.63 -45.29 88.49 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 112.18 0.437 . . . . 10.0 112.18 176.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.729 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 54.7 Cg_exo -25.62 144.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.6 1 C-N-CA 125.379 4.052 . . . . 10.0 116.166 176.491 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -69.95 138.8 52.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.059 -0.973 . . . . 10.0 110.989 -176.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.84 18.96 8.48 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.266 -0.879 . . . . 10.0 109.568 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.2 tttm 80.58 -9.91 1.31 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 114.581 -1.19 . . . . 10.0 111.19 175.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.768 HG21 ' HA3' ' A' ' 136' ' ' GLY . 1.0 OUTLIER -151.95 109.72 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.749 0 CA-C-O 122.725 1.25 . . . . 10.0 112.802 -178.654 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.729 ' HB ' ' HB3' ' A' ' 92' ' ' PRO . 3.9 p -61.35 -41.42 89.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 117.027 2.232 . . . . 10.0 117.027 177.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.622 ' HA3' ' CD1' ' A' ' 85' ' ' ILE . . . -58.32 160.13 13.89 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 114.593 0.597 . . . . 10.0 114.593 -158.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.829 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -154.79 172.34 18.13 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 115.593 -0.303 . . . . 10.0 111.201 -157.901 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.682 HG11 ' O ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -168.29 114.16 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-O 122.887 1.327 . . . . 10.0 111.869 179.511 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.677 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 1.2 t -39.78 143.62 0.23 Allowed 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 111.458 -2.61 . . . . 10.0 114.149 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.753 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 26.6 mtt180 -46.34 -32.63 3.28 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 112.243 -2.253 . . . . 10.0 113.732 -170.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.5 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 17.5 tppt? -57.67 -44.22 85.58 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.859 -0.526 . . . . 10.0 111.742 178.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.697 ' HG3' ' HB3' ' A' ' 82' ' ' ALA . 0.6 OUTLIER -56.95 -47.99 79.38 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.603 -0.888 . . . . 10.0 108.603 176.21 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.982 HG21 ' HB ' ' A' ' 128' ' ' ILE . 32.7 mm -43.09 -49.41 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.141 -1.391 . . . . 10.0 111.852 173.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.808 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 28.8 tt0 -46.86 -62.17 1.52 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.093 0.957 . . . . 10.0 113.262 175.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.618 ' HA ' ' HD3' ' A' ' 110' ' ' LYS . 47.7 mt-10 -52.73 -54.8 28.69 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.232 -0.895 . . . . 10.0 110.803 -176.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.627 ' O ' HG21 ' A' ' 111' ' ' THR . 24.5 mm -47.42 -55.43 2.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.124 -0.944 . . . . 10.0 110.126 170.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.616 ' O ' ' HE2' ' A' ' 112' ' ' LYS . . . -49.19 -36.95 21.1 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.888 0.699 . . . . 10.0 112.888 176.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.808 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 51.4 mtpt -72.58 -49.24 33.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.832 -0.622 . . . . 10.0 111.299 -174.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.627 HG21 ' O ' ' A' ' 108' ' ' ILE . 6.1 t -53.67 -36.57 62.28 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.091 0.404 . . . . 10.0 112.091 -177.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.86 ' HD2' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -106.71 13.5 27.97 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 113.336 0.865 . . . . 10.0 113.336 -174.792 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.698 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 14.6 ptp -55.2 -39.37 76.69 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 113.056 0.762 . . . . 10.0 113.056 176.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.596 ' HD3' ' HG3' ' A' ' 113' ' ' MET . 73.2 Cg_endo -71.13 -28.94 18.25 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 121.326 1.35 . . . . 10.0 112.112 -179.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -95.88 -42.48 8.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.825 -1.079 . . . . 10.0 113.673 -170.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.86 HD22 ' HD2' ' A' ' 112' ' ' LYS . 1.1 mp -71.16 9.64 0.71 Allowed 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.118 -0.946 . . . . 10.0 113.272 -177.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 63.77 36.44 10.54 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 122.21 1.005 . . . . 10.0 108.529 174.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 119' ' ' ASN . . . -69.56 -69.85 0.32 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 113.9 -1.5 . . . . 10.0 113.076 -167.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' A' ' 118' ' ' ALA . 27.3 t-20 100.87 -38.88 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.659 1.224 . . . . 10.0 110.412 -178.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 89.2 p -145.92 144.76 30.37 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.023 -1.473 . . . . 10.0 107.023 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.567 ' O ' ' HG3' ' A' ' 125' ' ' MET . 50.8 tp -58.59 -41.98 87.02 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.915 0.709 . . . . 10.0 112.915 178.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -48.23 -43.64 32.45 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.394 0.616 . . . . 10.0 109.687 174.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.592 ' O ' ' HG3' ' A' ' 126' ' ' LYS . . . -62.88 -51.93 65.09 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.624 -1.171 . . . . 10.0 111.292 173.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.706 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -55.34 -30.49 60.38 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.252 -0.905 . . . . 10.0 111.652 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.567 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 83.4 mtp -61.55 -46.33 90.35 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.791 1.034 . . . . 10.0 113.791 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.739 ' HD3' ' N ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -62.83 -40.02 96.12 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.094 0.405 . . . . 10.0 112.094 -178.04 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.739 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -55.11 -59.33 2.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 C-N-CA 118.785 -1.166 . . . . 10.0 109.779 174.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.982 ' HB ' HG21 ' A' ' 105' ' ' ILE . 12.9 mm -49.47 -57.85 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 CA-C-N 114.82 -1.082 . . . . 10.0 111.856 -175.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' A' ' 125' ' ' MET . 6.8 pt-20 -55.77 -44.71 77.97 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.118 -0.633 . . . . 10.0 109.948 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -69.15 -49.2 41.81 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.601 -0.727 . . . . 10.0 112.396 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 74' ' ' PRO . 44.9 m -45.72 -62.04 1.46 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.853 -0.673 . . . . 10.0 109.904 171.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.592 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . . . -49.37 -51.09 36.99 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.222 -0.444 . . . . 10.0 111.235 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -48.29 -48.61 35.74 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 123.911 0.757 . . . . 10.0 111.759 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.1 m -62.53 -39.69 94.38 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.636 0.255 . . . . 10.0 111.254 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.729 ' HG3' HD12 ' A' ' 137' ' ' ILE . 23.6 ptt? -90.63 15.69 10.5 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.477 0.917 . . . . 10.0 113.477 -173.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.768 ' HA3' HG21 ' A' ' 96' ' ' ILE . . . 103.5 -21.78 38.01 Favored Glycine 0 C--N 1.331 0.273 0 CA-C-N 119.627 1.103 . . . . 10.0 112.759 177.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.729 HD12 ' HG3' ' A' ' 135' ' ' MET . 2.0 mp -83.15 128.33 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 CA-C-O 122.94 1.353 . . . . 10.0 111.33 -169.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.829 ' HB3' ' HB3' ' A' ' 99' ' ' LYS . 3.3 tp10 -85.64 157.93 20.22 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 112.288 -2.233 . . . . 10.0 109.196 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.462 ' N ' ' HG3' ' A' ' 138' ' ' GLU . 17.1 m -116.49 124.73 72.99 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.371 0 N-CA-C 107.59 -1.263 . . . . 10.0 107.59 168.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' A' ' 101' ' ' THR . 1.8 m -98.28 160.12 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 C-N-CA 119.143 -1.023 . . . . 10.0 109.409 -175.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 C--N 1.297 -1.694 0 CA-C-N 115.059 -0.973 . . . . 10.0 110.085 179.735 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 ppp? . . . . . 0 N--CA 1.484 1.262 0 CA-C-O 119.689 -0.196 . . . . 10.0 110.542 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -41.49 121.59 1.71 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.232 0.613 . . . . 10.0 112.196 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.55 ' HB3' ' CG ' ' A' ' 61' ' ' TYR . 80.9 mttt -99.24 119.49 37.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.712 -0.676 . . . . 10.0 112.192 -170.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -117.63 142.69 46.93 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.279 -1.008 . . . . 10.0 108.279 167.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.22 129.52 25.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.689 0.28 . . . . 10.0 110.851 -174.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.56 -36.3 7.16 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 175.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.531 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -158.91 178.26 10.28 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.177 0.806 . . . . 10.0 113.177 -177.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 93.9 mt-30 -129.32 132.73 47.17 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.182 -1.372 . . . . 10.0 109.184 174.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.576 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.4 OUTLIER -116.47 81.14 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 N-CA-C 108.452 -0.944 . . . . 10.0 108.452 176.303 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -81.63 123.58 28.81 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 120.256 -1.527 . . . . 10.0 108.412 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.626 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.7 132.93 8.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.986 0.898 . . . . 10.0 111.881 -173.061 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -87.13 123.57 32.32 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.726 -1.125 . . . . 10.0 110.815 -172.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.626 HD21 HD11 ' A' ' 11' ' ' LEU . 82.7 mt -138.82 137.94 20.69 Favored Pre-proline 0 C--O 1.218 -0.564 0 CA-C-O 121.51 0.671 . . . . 10.0 112.648 -174.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.74 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 23.6 Cg_exo -58.45 134.18 59.52 Favored 'Trans proline' 0 C--N 1.327 -0.583 0 C-N-CA 124.238 3.292 . . . . 10.0 112.518 174.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 46' ' ' THR . . . -56.1 133.93 52.37 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.131 -1.433 . . . . 10.0 107.131 166.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.33 0.06 50.99 Favored Glycine 0 N--CA 1.443 -0.897 0 O-C-N 125.448 1.717 . . . . 10.0 113.449 174.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.74 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 14.0 mmmm -138.41 77.45 1.63 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.481 1.141 . . . . 10.0 111.017 -178.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 39' ' ' CYS . . . -156.96 130.73 8.21 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.907 -0.717 . . . . 10.0 112.027 176.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.553 ' HA ' ' HB3' ' A' ' 39' ' ' CYS . 1.5 t -179.27 -41.66 0.0 OUTLIER Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 114.092 -1.413 . . . . 10.0 112.328 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.703 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 98.7 Cg_endo -103.08 127.31 0.09 OUTLIER 'Trans proline' 0 N--CA 1.408 -3.51 0 N-CA-C 115.503 1.309 . . . . 10.0 115.503 -161.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 1.057 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 11.09 -86.54 0.0 OUTLIER Pre-proline 0 C--N 1.295 -1.764 0 CA-C-N 109.12 -3.673 . . . . 10.0 115.605 166.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.916 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 51.3 Cg_exo -30.88 -55.09 0.23 Allowed 'Trans proline' 0 CA--C 1.559 1.773 0 C-N-CA 122.863 2.376 . . . . 10.0 115.74 -162.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.916 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 5.0 Cg_exo -81.53 -57.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.791 2.327 . . . . 10.0 112.246 171.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 1.071 HG12 HD12 ' A' ' 35' ' ' ILE . 57.5 t -79.83 -52.01 15.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 112.556 -2.111 . . . . 10.0 114.187 -167.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 1.057 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -50.73 -74.51 0.28 Allowed Glycine 0 C--O 1.216 -0.982 0 CA-C-N 114.831 -1.077 . . . . 10.0 113.537 -176.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.714 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 19.9 Cg_exo -45.01 -43.88 15.29 Favored 'Trans proline' 0 CA--C 1.517 -0.344 0 C-N-CA 123.777 2.985 . . . . 10.0 112.993 174.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.413 ' HB1' ' O ' ' A' ' 24' ' ' VAL . . . -50.24 -77.23 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.498 0.666 . . . . 10.0 111.271 175.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.764 HD23 ' CD1' ' A' ' 58' ' ' ILE . 3.3 mt -69.65 -48.49 59.64 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.872 1.064 . . . . 10.0 113.872 -176.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.62 -37.21 88.72 Favored Glycine 0 C--N 1.32 -0.353 0 CA-C-N 115.416 -0.811 . . . . 10.0 113.261 -174.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -63.75 -24.92 67.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.706 0.289 . . . . 10.0 110.559 176.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -100.47 16.52 24.32 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.652 0.739 . . . . 10.0 109.899 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.14 3.39 88.96 Favored Glycine 0 CA--C 1.5 -0.858 0 CA-C-N 114.549 -1.205 . . . . 10.0 113.59 168.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.843 HG11 ' CD2' ' A' ' 66' ' ' PHE . 2.9 t -80.56 146.45 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 113.664 0.987 . . . . 10.0 113.664 -171.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.856 HD21 ' HG2' ' A' ' 37' ' ' GLU . 54.5 t30 -74.27 104.17 4.94 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.643 0.735 . . . . 10.0 110.973 174.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 1.071 HD12 HG12 ' A' ' 24' ' ' VAL . 22.3 mm -53.91 -38.14 35.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 114.092 -1.413 . . . . 10.0 112.413 177.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.858 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -61.8 -56.83 15.37 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 113.503 -1.68 . . . . 10.0 112.038 176.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.856 ' HG2' HD21 ' A' ' 34' ' ' ASN . 21.1 mm-40 -56.64 -35.28 68.17 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.737 -1.185 . . . . 10.0 110.46 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.611 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 87.3 t80 -60.11 -60.53 3.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.187 1.18 . . . . 10.0 114.187 171.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.858 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 20.9 p -60.84 -47.01 88.3 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.005 -0.998 . . . . 10.0 111.706 -176.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.57 ' HE2' ' HB3' ' A' ' 36' ' ' MET . 52.5 mtmt -63.83 -23.69 67.46 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.416 -0.914 . . . . 10.0 109.59 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.749 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 20.3 mtp180 -73.98 -65.09 0.88 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 119.658 -0.817 . . . . 10.0 111.504 168.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.644 ' HZ ' ' HB2' ' A' ' 54' ' ' LEU . 71.4 t80 -54.34 -48.58 71.26 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.17 0.51 . . . . 10.0 110.559 -170.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.653 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.8 OUTLIER -61.2 -50.89 71.29 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.265 -0.879 . . . . 10.0 110.32 -176.712 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.0 -38.83 87.44 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 118.88 -1.128 . . . . 10.0 111.77 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.749 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 13.3 mt-10 -67.48 -42.52 82.82 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.769 0.795 . . . . 10.0 111.296 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.61 HG23 HD13 ' A' ' 54' ' ' LEU . 68.0 p -89.62 -2.17 58.23 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 114.877 -1.056 . . . . 10.0 112.342 -169.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -44.51 -37.54 3.57 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 124.098 0.874 . . . . 10.0 112.696 -174.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -80.8 -21.06 41.23 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.298 -0.864 . . . . 10.0 111.357 -172.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.907 ' HB3' ' HZ ' ' A' ' 77' ' ' PHE . 51.8 mttp -100.97 23.52 10.58 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 123.399 1.571 . . . . 10.0 109.238 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . 0.382 . . 49.03 -90.24 0.02 OUTLIER 'General case' 0 CA--C 1.47 -2.122 0 N-CA-C 119.641 3.2 . . . . 10.0 119.641 165.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -137.99 76.6 0.35 Allowed Glycine 0 N--CA 1.429 -1.822 0 N-CA-C 109.9 -1.28 . . . . 10.0 109.9 -171.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.653 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 24.9 mmt -138.61 126.38 22.24 Favored 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 116.907 -1.917 . . . . 10.0 114.177 -164.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.2 mm -64.7 85.53 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 109.432 -0.581 . . . . 10.0 109.432 175.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.644 ' HB2' ' HZ ' ' A' ' 42' ' ' PHE . 9.8 mt -80.88 132.3 57.68 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.434 -0.58 . . . . 10.0 109.434 -175.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 54' ' ' LEU . 16.1 Cg_exo -71.33 93.91 0.66 Allowed 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.753 2.302 . . . . 10.0 111.888 176.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.461 HG22 HG12 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -92.69 154.66 3.18 Favored 'Isoleucine or valine' 0 C--N 1.345 0.383 0 CA-C-N 119.081 0.855 . . . . 10.0 111.236 -174.591 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.423 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 90.3 t -134.68 116.22 20.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.332 -0.395 . . . . 10.0 110.181 172.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.764 ' CD1' HD23 ' A' ' 28' ' ' LEU . 16.1 mt -105.62 140.24 24.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.16 -1.052 . . . . 10.0 108.16 -173.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.8 m -124.52 95.38 4.51 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 114.927 -1.033 . . . . 10.0 108.611 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.572 HG21 ' O ' ' A' ' 65' ' ' SER . 3.5 p -85.28 137.52 20.69 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 CA-C-N 119.167 0.894 . . . . 10.0 110.827 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.55 ' CG ' ' HB3' ' A' ' 3' ' ' LYS . 85.0 m-85 -95.91 170.87 9.0 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 112.855 0.687 . . . . 10.0 112.855 -177.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -60.89 -20.98 62.86 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.688 -1.142 . . . . 10.0 112.259 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.701 ' HB3' ' HG ' ' A' ' 65' ' ' SER . 7.2 t70 -73.96 -15.35 61.11 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.137 -0.938 . . . . 10.0 110.934 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 44.5 mtpt 84.54 0.77 0.87 Allowed 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 114.722 -1.127 . . . . 10.0 110.782 -169.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.701 ' HG ' ' HB3' ' A' ' 63' ' ' ASP . 8.8 p -73.85 -177.08 2.67 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 114.87 -1.059 . . . . 10.0 108.777 170.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.843 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -170.22 -176.92 2.35 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 120.38 1.446 . . . . 10.0 109.483 176.171 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.1 p -159.44 173.04 16.82 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 103.127 -2.916 . . . . 10.0 103.127 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.434 ' CB ' HG12 ' A' ' 58' ' ' ILE . 47.8 p90 -164.48 162.74 22.08 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.361 -0.607 . . . . 10.0 109.361 175.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.423 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 24.9 pt -130.71 167.73 25.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 107.206 -1.405 . . . . 10.0 107.206 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.518 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 4.3 mt -137.24 121.98 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 108.058 -1.09 . . . . 10.0 108.058 -178.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -84.46 72.63 10.6 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.073 -0.714 . . . . 10.0 109.073 -176.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.407 ' OG1' ' HE2' ' A' ' 112' ' ' LYS . 6.7 t -30.98 99.09 0.12 Allowed Pre-proline 0 C--N 1.318 -0.796 0 O-C-N 126.078 2.111 . . . . 10.0 110.762 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.656 ' HG2' ' HD2' ' A' ' 77' ' ' PHE . 3.3 Cg_endo -47.1 139.26 15.49 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 124.237 3.291 . . . . 10.0 114.214 -163.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.573 ' HA ' HD11 ' A' ' 116' ' ' LEU . 94.9 Cg_exo -20.8 -79.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.844 1 C-N-CA 126.245 4.63 . . . . 10.0 115.387 -168.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.57 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -143.48 -39.01 0.32 Allowed 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.033 -0.667 . . . . 10.0 111.501 -178.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.67 ' HA ' ' HE1' ' A' ' 135' ' ' MET . 1.7 p -41.96 -56.15 2.88 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 124.221 0.951 . . . . 10.0 112.697 -174.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.907 ' HZ ' ' HB3' ' A' ' 49' ' ' LYS . 0.7 OUTLIER -53.87 -65.93 0.48 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.012 -0.54 . . . . 10.0 112.242 -179.378 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.676 HD22 ' HE2' ' A' ' 112' ' ' LYS . 1.3 mm? -76.88 -12.62 59.98 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.25 -0.98 . . . . 10.0 111.789 -172.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.441 HD21 ' HA ' ' A' ' 79' ' ' LEU . 13.5 mt -67.15 -30.55 70.56 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.106 -0.702 . . . . 10.0 109.106 168.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.541 ' HG3' ' O ' ' A' ' 76' ' ' SER . 98.1 mttt -64.37 -23.65 67.37 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.481 171.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.517 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 6.7 mmmt -63.48 -48.01 79.39 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.432 0.53 . . . . 10.0 112.432 170.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.64 ' CB ' HG11 ' A' ' 100' ' ' VAL . . . -68.59 -41.0 80.25 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.373 1.869 . . . . 10.0 111.665 174.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.426 ' HB1' HG21 ' A' ' 85' ' ' ILE . . . -79.84 156.83 27.19 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 111.644 -2.525 . . . . 10.0 108.081 -177.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -95.0 12.41 68.49 Favored Glycine 0 N--CA 1.463 0.454 0 C-N-CA 118.493 -1.813 . . . . 10.0 111.754 172.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.765 HG22 HG21 ' A' ' 97' ' ' VAL . 23.7 pt -69.66 35.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 114.903 1.445 . . . . 10.0 114.903 -172.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 4.7 tt0 -71.35 9.75 0.73 Allowed 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.638 -0.664 . . . . 10.0 112.296 -177.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.42 ' H ' ' C ' ' A' ' 85' ' ' ILE . 12.8 ptmm? -167.05 -28.86 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 O-C-N 122.179 -0.326 . . . . 10.0 110.97 -175.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 131.44 159.82 9.62 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.396 -0.907 . . . . 10.0 112.533 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.3 m -163.69 158.68 20.68 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.742 -0.466 . . . . 10.0 109.742 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.9 p -159.14 18.23 0.18 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.65 0.738 . . . . 10.0 109.291 175.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.429 ' O ' ' HE2' ' A' ' 93' ' ' LYS . 2.2 mm-40 -65.6 -47.12 68.13 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 114.445 -1.252 . . . . 10.0 111.913 -174.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.404 ' HD3' ' HB2' ' A' ' 91' ' ' GLU . 73.8 Cg_exo -54.48 -28.84 56.58 Favored 'Trans proline' 0 C--N 1.361 1.192 0 C-N-CA 122.437 2.091 . . . . 10.0 113.152 178.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 91' ' ' GLU . 40.5 mtmt 60.19 73.69 0.47 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.394 0.616 . . . . 10.0 111.505 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 4.1 tpp180 -164.68 21.81 0.06 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.784 -0.821 . . . . 10.0 108.784 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 9.3 mptt 74.04 -17.81 0.43 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.325 -0.852 . . . . 10.0 111.335 -171.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.476 ' HB ' ' O ' ' A' ' 136' ' ' GLY . 5.7 pt -82.7 174.43 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 C-N-CA 120.163 -0.615 . . . . 10.0 110.401 -176.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.765 HG21 HG22 ' A' ' 85' ' ' ILE . 4.8 p -150.88 -54.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 115.907 -0.588 . . . . 10.0 111.772 -163.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -113.31 162.43 12.37 Favored Glycine 0 CA--C 1.495 -1.157 0 N-CA-C 108.714 -1.754 . . . . 10.0 108.714 166.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.791 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 11.3 ptpt -151.58 156.17 39.92 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-O 122.41 1.1 . . . . 10.0 109.574 168.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.64 HG11 ' CB ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -160.0 -144.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-N 112.278 -2.237 . . . . 10.0 106.538 -168.158 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.513 ' HB ' HG21 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -165.19 146.91 7.68 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 108.359 -0.978 . . . . 10.0 108.359 -155.294 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.716 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 1.6 mmt85 -43.97 -40.94 5.0 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 124.219 0.95 . . . . 10.0 111.638 -175.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.419 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 2.1 tmtt? -55.54 -50.59 69.61 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.133 0.492 . . . . 10.0 111.621 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.633 ' O ' HG12 ' A' ' 108' ' ' ILE . 18.5 mm-40 -62.28 -44.94 95.37 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 108.665 -0.865 . . . . 10.0 108.665 -178.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.716 ' HB ' ' O ' ' A' ' 102' ' ' ARG . 38.9 mm -41.07 -54.64 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 114.297 -1.32 . . . . 10.0 111.596 166.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.709 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 45.5 tt0 -49.79 -53.16 26.92 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.803 0.841 . . . . 10.0 112.359 177.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.706 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 47.3 mm-40 -51.74 -55.56 18.94 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 114.958 -1.019 . . . . 10.0 109.996 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.633 HG12 ' O ' ' A' ' 104' ' ' GLN . 10.5 mm -49.61 -58.51 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.285 -0.87 . . . . 10.0 110.098 172.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.48 ' HB1' ' HB2' ' A' ' 124' ' ' ALA . . . -50.8 -33.56 23.98 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.032 0.753 . . . . 10.0 113.032 -178.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.709 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 53.7 mttm -67.52 -57.24 6.85 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.915 0.864 . . . . 10.0 109.165 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 90.5 m -53.42 -36.07 61.11 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 113.716 -1.584 . . . . 10.0 111.995 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.676 ' HE2' HD22 ' A' ' 78' ' ' LEU . 32.3 mmtp -96.45 -7.88 33.71 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.741 0.645 . . . . 10.0 112.741 -173.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.403 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 43.4 ttm -39.18 -49.28 4.45 Favored Pre-proline 0 CA--C 1.532 0.282 0 O-C-N 123.565 0.54 . . . . 10.0 112.386 175.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 113' ' ' MET . 61.6 Cg_endo -70.61 -23.45 26.89 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 120.991 1.128 . . . . 10.0 113.625 -177.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -88.21 -53.34 4.75 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.108 0.48 . . . . 10.0 110.991 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.673 ' CD2' HD11 ' A' ' 127' ' ' ILE . 1.6 mp -65.02 34.3 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.153 -1.385 . . . . 10.0 113.018 -175.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 19.78 51.86 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 O-C-N 124.51 1.131 . . . . 10.0 111.816 -167.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.433 ' O ' ' CB ' ' A' ' 119' ' ' ASN . . . -66.3 -79.13 0.05 OUTLIER 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 113.62 0.97 . . . . 10.0 113.62 -165.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 118' ' ' ALA . 3.1 t-20 101.94 -42.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 O-C-N 125.527 1.767 . . . . 10.0 108.947 -172.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.3 t -146.72 145.29 29.92 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.004 -1.11 . . . . 10.0 108.004 176.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.433 ' O ' ' HG3' ' A' ' 125' ' ' MET . 0.6 OUTLIER -51.68 -46.04 63.68 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.514 -0.766 . . . . 10.0 112.729 -179.132 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.432 ' H ' ' CD ' ' A' ' 122' ' ' GLU . 2.4 mp0 -50.22 -37.39 35.17 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.597 0.713 . . . . 10.0 110.781 178.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.38 -47.05 65.41 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 118.429 -1.308 . . . . 10.0 111.143 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.723 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -57.71 -34.88 69.94 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.66 -0.7 . . . . 10.0 110.769 175.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.433 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 7.7 mtt -53.74 -40.77 66.43 Favored 'General case' 0 N--CA 1.463 0.186 0 O-C-N 121.985 -0.447 . . . . 10.0 112.01 176.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -62.06 -51.83 66.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.017 -0.538 . . . . 10.0 111.761 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.673 HD11 ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -53.47 -56.67 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 119.81 -0.756 . . . . 10.0 110.475 177.459 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.723 HG12 ' O ' ' A' ' 124' ' ' ALA . 11.8 mm -50.74 -51.49 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 CA-C-N 115.138 -0.937 . . . . 10.0 110.949 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 125' ' ' MET . 49.4 mt-10 -51.97 -42.72 63.14 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 120.44 -0.504 . . . . 10.0 110.087 177.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -69.79 -49.65 34.65 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.612 -0.804 . . . . 10.0 111.358 -175.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.57 HG21 ' HB3' ' A' ' 75' ' ' ALA . 99.2 m -49.26 -60.5 2.76 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.267 -0.966 . . . . 10.0 109.827 173.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.21 -50.04 40.08 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.433 -0.349 . . . . 10.0 111.358 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 88.1 tttt -45.7 -59.27 2.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.553 -0.748 . . . . 10.0 111.951 174.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.1 t -65.04 -28.07 69.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.801 0.334 . . . . 10.0 111.305 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.67 ' HE1' ' HA ' ' A' ' 76' ' ' SER . 54.0 mtm -80.43 -6.14 57.62 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.936 0.717 . . . . 10.0 112.936 -177.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.476 ' O ' ' HB ' ' A' ' 96' ' ' ILE . . . 82.83 29.15 35.78 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 118.966 0.803 . . . . 10.0 111.852 -177.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.56 ' CD1' ' HE2' ' A' ' 135' ' ' MET . 8.4 mt -112.69 123.75 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.256 0 CA-C-O 121.608 0.718 . . . . 10.0 110.764 177.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.791 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -84.84 150.61 24.89 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.552 -1.204 . . . . 10.0 109.633 -179.13 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.435 HG12 HG13 ' A' ' 105' ' ' ILE . 18.2 m -115.43 131.26 68.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.052 -1.092 . . . . 10.0 108.052 170.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.513 HG21 ' HB ' ' A' ' 101' ' ' THR . 30.6 m -123.63 62.84 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 114.657 1.354 . . . . 10.0 114.657 -177.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.45 ' OXT' ' HB2' ' A' ' 102' ' ' ARG . 9.6 t70 . . . . . 0 C--N 1.291 -1.943 0 CA-C-N 114.303 -1.317 . . . . 10.0 109.627 143.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.793 ' HD2' ' HG3' ' A' ' 62' ' ' GLU . 17.1 mmtt . . . . . 0 N--CA 1.438 -1.027 0 N-CA-C 108.695 -0.854 . . . . 10.0 108.695 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.0 t -72.97 122.99 26.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 110.251 -0.277 . . . . 10.0 110.251 -174.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.57 -32.82 11.24 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.961 -0.755 . . . . 10.0 108.961 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -168.02 -168.28 0.95 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.33 -0.85 . . . . 10.0 113.214 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.528 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 78.5 mt-30 -143.84 135.54 26.2 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 114.015 -1.448 . . . . 10.0 108.689 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.917 HG21 ' HG ' ' A' ' 28' ' ' LEU . 1.3 mm -122.89 83.52 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 119.03 -0.509 . . . . 10.0 109.767 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -78.0 138.72 38.97 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 120.513 1.506 . . . . 10.0 109.231 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.797 HD23 HD11 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -154.15 132.0 11.59 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.333 -0.618 . . . . 10.0 109.333 -171.725 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.522 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 19.8 pt20 -94.04 109.87 21.6 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.525 -0.917 . . . . 10.0 108.525 171.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.797 HD11 HD23 ' A' ' 11' ' ' LEU . 94.7 mt -130.1 135.95 28.26 Favored Pre-proline 0 CA--C 1.496 -1.097 0 CA-C-O 121.553 0.692 . . . . 10.0 112.51 -165.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.698 ' HB2' ' CB ' ' A' ' 17' ' ' LYS . 28.0 Cg_exo -58.56 120.67 8.7 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 123.054 2.503 . . . . 10.0 111.914 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.525 ' CB ' ' HA ' ' A' ' 50' ' ' ALA . . . -62.77 127.66 32.3 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 114.696 -1.138 . . . . 10.0 108.139 171.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.71 4.4 65.96 Favored Glycine 0 CA--C 1.525 0.704 0 O-C-N 126.003 2.064 . . . . 10.0 113.123 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.698 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . 2.6 mmmm -147.32 29.52 0.96 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.393 1.257 . . . . 10.0 114.393 -172.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.44 ' HB3' ' OD1' ' A' ' 43' ' ' ASN . . . -76.47 150.41 36.67 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.472 1.033 . . . . 10.0 110.155 175.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.513 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 15.3 t -177.69 140.3 0.43 Allowed Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 121.422 0.629 . . . . 10.0 110.861 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.555 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 2.8 Cg_endo -42.17 23.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.478 0.581 1 C-N-CA 129.474 6.783 . . . . 10.0 117.463 176.18 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.644 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -57.88 174.22 0.34 Allowed Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 107.997 -1.112 . . . . 10.0 107.997 163.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.644 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 57.5 Cg_exo -37.3 -42.69 1.04 Allowed 'Trans proline' 0 CA--C 1.548 1.184 0 C-N-CA 122.407 2.071 . . . . 10.0 114.043 177.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.565 ' HB2' HG23 ' A' ' 24' ' ' VAL . 27.2 Cg_exo -38.11 -71.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 123.744 2.962 . . . . 10.0 115.572 167.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.05 HG12 HD12 ' A' ' 35' ' ' ILE . 62.0 t -89.05 -54.68 7.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 114.013 -1.448 . . . . 10.0 114.043 -159.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.443 ' H ' ' HA ' ' A' ' 20' ' ' PRO . . . -50.17 -65.41 2.94 Favored Glycine 0 C--O 1.228 -0.222 0 CA-C-N 114.616 -1.174 . . . . 10.0 112.992 -175.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -55.84 -43.75 54.13 Favored 'Trans proline' 0 C--O 1.222 -0.312 0 C-N-CA 123.092 2.528 . . . . 10.0 112.429 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.492 ' HB1' ' CG2' ' A' ' 9' ' ' ILE . . . -53.28 -78.09 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.401 0.619 . . . . 10.0 111.414 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.917 ' HG ' HG21 ' A' ' 9' ' ' ILE . 2.1 mt -66.94 -45.89 76.4 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.172 0.804 . . . . 10.0 113.172 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.26 -39.98 96.76 Favored Glycine 0 N--CA 1.459 0.18 0 CA-C-N 116.103 -0.499 . . . . 10.0 112.899 -174.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -60.84 -26.69 67.53 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.233 -0.284 . . . . 10.0 110.233 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -99.25 16.58 22.42 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.47 0.652 . . . . 10.0 109.895 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.26 4.57 86.23 Favored Glycine 0 CA--C 1.499 -0.957 0 CA-C-N 114.748 -1.115 . . . . 10.0 113.216 167.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.709 HG11 ' CD2' ' A' ' 66' ' ' PHE . 3.4 t -81.33 146.36 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 113.301 0.852 . . . . 10.0 113.301 -172.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 37' ' ' GLU . 90.8 m-20 -70.31 96.7 1.15 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.256 0.622 . . . . 10.0 110.5 172.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.05 HD12 HG12 ' A' ' 24' ' ' VAL . 13.7 mm -55.54 -38.67 50.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-O 122.078 0.942 . . . . 10.0 112.188 177.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.407 ' SD ' ' N ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -70.01 -43.25 71.73 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 113.476 -1.693 . . . . 10.0 112.432 177.191 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.604 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 14.2 mt-10 -54.81 -50.0 69.62 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 118.988 -1.085 . . . . 10.0 109.437 170.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.606 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 77.8 t80 -53.87 -56.5 17.12 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 114.031 1.123 . . . . 10.0 114.031 175.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.3 t -58.71 -48.31 81.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.719 -1.128 . . . . 10.0 111.193 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.414 ' HE3' ' HB2' ' A' ' 40' ' ' LYS . 49.3 mtmt -66.86 -23.34 66.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 118.602 -1.239 . . . . 10.0 108.971 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.805 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 55.2 mtt180 -74.54 -64.68 0.98 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.093 -0.958 . . . . 10.0 111.776 173.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.736 ' HZ ' ' HB2' ' A' ' 54' ' ' LEU . 67.2 t80 -55.05 -45.6 75.27 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-O 121.165 0.507 . . . . 10.0 110.554 -174.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.44 ' OD1' ' HB3' ' A' ' 18' ' ' ALA . 3.8 m-20 -59.69 -52.49 65.26 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.209 -0.905 . . . . 10.0 110.23 -177.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.82 -39.75 95.25 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 119.56 -0.856 . . . . 10.0 112.014 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.805 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 11.2 mt-10 -69.02 -36.72 78.09 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.635 0.731 . . . . 10.0 111.407 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.548 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 72.7 p -91.34 4.33 52.66 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.856 -1.066 . . . . 10.0 112.036 -173.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.53 -36.48 15.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.764 -1.107 . . . . 10.0 112.543 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.2 p-10 -81.99 -37.36 26.72 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 115.224 -0.898 . . . . 10.0 111.434 -175.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.518 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 36.8 mttp -95.41 22.17 7.26 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.039 -0.726 . . . . 10.0 109.039 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.525 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -56.51 154.81 8.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.662 -1.154 . . . . 10.0 113.581 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.47 17.2 53.5 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 110.035 -1.226 . . . . 10.0 110.035 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.528 ' HB2' HD21 ' A' ' 54' ' ' LEU . 22.0 mmt -136.11 126.66 26.98 Favored 'General case' 0 C--O 1.207 -1.164 0 C-N-CA 116.11 -2.236 . . . . 10.0 114.032 -165.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.49 HG22 ' HB2' ' A' ' 12' ' ' GLN . 46.2 mm -67.09 91.0 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 121.763 -0.586 . . . . 10.0 109.549 170.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.736 ' HB2' ' HZ ' ' A' ' 42' ' ' PHE . 3.7 mt -76.96 130.7 74.91 Favored Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 122.183 0.193 . . . . 10.0 110.593 -176.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -74.94 95.34 0.97 Allowed 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.384 2.056 . . . . 10.0 111.553 173.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.423 HG23 HG12 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -99.52 158.2 3.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 119.016 0.826 . . . . 10.0 111.972 -172.41 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.43 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 96.3 t -135.42 120.17 27.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.312 -0.403 . . . . 10.0 110.207 171.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.655 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 14.8 mt -106.15 141.68 20.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 119.595 -0.842 . . . . 10.0 108.897 -175.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 68.1 m -125.39 99.98 6.29 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.043 -0.981 . . . . 10.0 109.024 175.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.562 HG21 HG22 ' A' ' 33' ' ' VAL . 2.8 p -89.18 137.94 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.003 0 C-N-CA 123.653 0.781 . . . . 10.0 111.095 -178.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.466 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 84.8 m-85 -98.94 171.05 8.3 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 122.17 0.986 . . . . 10.0 112.753 -176.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.793 ' HG3' ' HD2' ' A' ' 4' ' ' LYS . 3.0 mm-40 -53.15 -26.24 16.27 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.389 -1.732 . . . . 10.0 113.2 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 28.7 m-20 -78.09 -12.38 59.99 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.485 -0.486 . . . . 10.0 111.14 -176.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.47 ' HE3' ' HA ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 84.1 4.94 0.72 Allowed 'General case' 0 CA--C 1.508 -0.672 0 O-C-N 124.558 1.161 . . . . 10.0 108.917 -163.237 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.487 ' O ' HG23 ' A' ' 60' ' ' VAL . 6.2 p -71.02 172.5 8.98 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 113.504 -1.68 . . . . 10.0 107.916 171.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.709 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -169.86 -176.31 2.31 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 120.147 1.339 . . . . 10.0 109.825 174.277 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.6 p -160.11 168.61 25.12 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 102.944 -2.984 . . . . 10.0 102.944 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.44 ' HB3' HG12 ' A' ' 58' ' ' ILE . 45.6 p90 -161.43 158.79 27.27 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 109.125 -0.694 . . . . 10.0 109.125 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.43 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 22.2 pt -128.04 162.06 34.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 106.923 -1.51 . . . . 10.0 106.923 -176.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.544 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 2.6 mt -135.8 117.39 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 107.379 -1.341 . . . . 10.0 107.379 -175.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.62 ' HA ' ' OD1' ' A' ' 115' ' ' ASP . 0.3 OUTLIER -79.27 84.77 5.17 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 123.408 0.442 . . . . 10.0 110.516 -171.069 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.705 ' HB ' ' HG2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -49.17 99.04 0.2 Allowed Pre-proline 0 C--N 1.313 -0.981 0 CA-C-N 114.413 -1.267 . . . . 10.0 108.989 167.202 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.53 ' HG2' ' HB2' ' A' ' 77' ' ' PHE . 38.3 Cg_endo -74.74 174.22 13.06 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.136 2.558 . . . . 10.0 113.932 -158.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.464 ' HD2' ' CB ' ' A' ' 73' ' ' PRO . 86.8 Cg_exo -26.21 -60.69 0.07 OUTLIER 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 125.129 3.886 . . . . 10.0 114.466 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.597 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -171.43 -23.95 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.519 0.933 . . . . 10.0 113.519 175.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.559 ' HA ' ' HE1' ' A' ' 135' ' ' MET . 35.3 p -47.03 -43.35 19.63 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.177 0.513 . . . . 10.0 111.914 -173.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.571 ' HB3' HD22 ' A' ' 78' ' ' LEU . 13.0 t80 -47.79 -68.02 0.22 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.631 -1.168 . . . . 10.0 112.574 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.959 ' HB3' HD12 ' A' ' 108' ' ' ILE . 2.3 mm? -85.02 -11.31 55.7 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.567 -171.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.6 mt -72.33 -25.42 61.55 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.344 -0.543 . . . . 10.0 109.549 172.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 76' ' ' SER . 34.7 mmtp -59.32 -50.88 72.29 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.788 -1.19 . . . . 10.0 107.788 166.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -67.76 33.05 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 114.057 -1.428 . . . . 10.0 113.578 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.714 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -170.48 -60.35 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.668 0.747 . . . . 10.0 112.732 -172.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.289 -2.027 0 CA-C-N 113.464 -1.698 . . . . 10.0 108.942 179.663 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.58 HG13 ' H ' ' A' ' 98' ' ' GLY . 2.7 p . . . . . 0 CA--C 1.538 0.489 0 CA-C-O 121.278 0.561 . . . . 10.0 112.094 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.58 ' H ' HG13 ' A' ' 97' ' ' VAL . . . -160.13 174.07 36.85 Favored Glycine 0 CA--C 1.5 -0.894 0 N-CA-C 107.929 -2.069 . . . . 10.0 107.929 178.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.881 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -149.37 173.02 13.98 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-O 122.629 1.204 . . . . 10.0 111.429 -164.207 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.732 ' O ' HG22 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -150.73 -143.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 CA-C-N 111.982 -2.372 . . . . 10.0 105.986 -173.378 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.541 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 0.1 OUTLIER -164.93 144.66 7.05 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 107.48 -1.304 . . . . 10.0 107.48 -160.188 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.594 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 9.0 mmm180 -44.27 -43.5 7.39 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 124.241 0.963 . . . . 10.0 111.741 -177.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -57.89 -44.72 86.88 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.329 0.585 . . . . 10.0 111.539 176.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.724 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.1 OUTLIER -60.04 -47.25 86.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.219 -0.901 . . . . 10.0 108.702 178.781 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.909 HG23 ' HB ' ' A' ' 128' ' ' ILE . 26.2 mm -43.31 -55.34 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 CA-C-N 115.093 -0.958 . . . . 10.0 110.939 171.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.793 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 8.4 tt0 -49.2 -57.36 6.85 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 114.494 -1.23 . . . . 10.0 112.946 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -53.4 -59.63 4.33 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 124.057 0.848 . . . . 10.0 110.878 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.959 HD12 ' HB3' ' A' ' 78' ' ' LEU . 10.0 mm -46.88 -51.88 4.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.992 -1.004 . . . . 10.0 110.646 172.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.507 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -53.31 -40.29 64.67 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.655 -0.702 . . . . 10.0 112.554 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.793 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 50.3 mttm -70.87 -53.42 15.22 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.172 -0.467 . . . . 10.0 110.561 -174.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.678 HG23 ' HG3' ' A' ' 112' ' ' LYS . 7.7 t -55.99 -35.32 66.65 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.727 -0.67 . . . . 10.0 112.567 -176.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.756 ' HD3' HD23 ' A' ' 78' ' ' LEU . 8.7 mtmp? -103.08 17.36 24.24 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.057 0.456 . . . . 10.0 110.762 -176.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.735 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 50.4 ttm -49.65 -45.33 78.73 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.374 -0.83 . . . . 10.0 112.372 176.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 113' ' ' MET . 42.2 Cg_endo -64.62 -25.67 61.86 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 121.65 1.567 . . . . 10.0 112.569 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.62 ' OD1' ' HA ' ' A' ' 71' ' ' LYS . 12.8 m-20 -89.46 -50.9 5.83 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 114.936 -1.029 . . . . 10.0 111.16 -175.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.457 HD11 ' HZ3' ' A' ' 112' ' ' LYS . 9.1 mp -64.06 -3.55 2.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.441 -1.254 . . . . 10.0 111.754 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 64.4 t30 59.6 51.42 6.42 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.262 -1.335 . . . . 10.0 109.851 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.735 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -80.78 116.64 20.88 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 113.873 -1.512 . . . . 10.0 112.651 -172.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -65.91 -41.88 90.89 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.314 -0.995 . . . . 10.0 108.314 168.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.0 p -149.76 143.54 25.47 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 106.922 -1.511 . . . . 10.0 106.922 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.611 HD12 ' HB3' ' A' ' 124' ' ' ALA . 66.9 tp -52.16 -33.02 38.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.225 1.195 . . . . 10.0 114.225 -176.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -50.15 -37.76 36.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.329 0.585 . . . . 10.0 110.885 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.14 -50.17 56.33 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 119.047 -1.061 . . . . 10.0 110.916 175.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.611 ' HB3' HD12 ' A' ' 121' ' ' LEU . . . -57.49 -38.7 75.01 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 120.762 -0.375 . . . . 10.0 110.736 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.55 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 89.1 mtp -56.0 -37.22 68.84 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.674 0.39 . . . . 10.0 111.425 177.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -63.08 -48.34 79.02 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.04 -0.527 . . . . 10.0 109.729 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.5 mt -51.17 -62.67 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 CA-C-O 121.464 0.65 . . . . 10.0 111.245 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.909 ' HB ' HG23 ' A' ' 105' ' ' ILE . 15.9 mm -49.84 -57.02 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 CA-C-N 114.189 -1.368 . . . . 10.0 111.152 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.632 ' HG3' HG13 ' A' ' 105' ' ' ILE . 3.9 mt-10 -54.04 -47.28 71.74 Favored 'General case' 0 N--CA 1.436 -1.149 0 O-C-N 124.097 0.873 . . . . 10.0 110.069 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.5 -46.64 61.65 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.463 -0.875 . . . . 10.0 111.51 -173.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.597 HG21 ' HB3' ' A' ' 75' ' ' ALA . 90.2 m -47.6 -60.29 2.65 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.188 -1.006 . . . . 10.0 108.601 170.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -48.0 -53.07 17.37 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.954 0.502 . . . . 10.0 111.852 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.608 ' HG3' ' O ' ' A' ' 129' ' ' GLU . 43.4 mtpt -50.23 -50.28 50.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.002 178.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.8 m -66.31 -31.39 72.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.945 0.403 . . . . 10.0 111.031 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.559 ' HE1' ' HA ' ' A' ' 76' ' ' SER . 48.8 mtm -81.4 4.08 22.14 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.795 1.035 . . . . 10.0 113.795 -178.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 81.0 18.83 68.75 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 119.657 1.117 . . . . 10.0 111.586 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.503 HG23 ' HA ' ' A' ' 99' ' ' LYS . 23.3 mt -105.21 127.69 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 CA-C-O 121.146 0.498 . . . . 10.0 111.513 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.881 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -89.14 157.13 18.4 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.475 -0.784 . . . . 10.0 109.585 179.843 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.7 m -116.35 132.1 66.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.5 -0.926 . . . . 10.0 108.5 170.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 100' ' ' VAL . 26.9 m -133.94 69.65 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 116.057 1.873 . . . . 10.0 116.057 -175.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.605 ' HB2' ' O ' ' A' ' 140' ' ' VAL . 3.6 t0 . . . . . 0 C--N 1.296 -1.745 0 CA-C-O 117.864 -1.065 . . . . 10.0 109.012 141.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.464 0 CA-C-O 121.501 0.667 . . . . 10.0 110.699 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.2 t -73.79 141.3 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.581 -0.736 . . . . 10.0 110.649 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.31 -45.51 4.08 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.307 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.54 152.17 25.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.51 1.3 . . . . 10.0 114.51 -174.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -92.55 133.14 36.24 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.514 -1.221 . . . . 10.0 107.852 170.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.685 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -123.09 83.16 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.348 -0.612 . . . . 10.0 109.348 174.365 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.437 ' HG2' HG22 ' A' ' 57' ' ' VAL . 52.8 mttp -77.27 132.24 38.57 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 120.807 1.639 . . . . 10.0 108.921 172.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.687 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -158.58 125.6 4.86 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 122.336 1.065 . . . . 10.0 111.689 -179.236 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.432 ' HG2' ' HA ' ' A' ' 55' ' ' PRO . 80.2 mt-30 -83.5 121.56 27.36 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.132 -1.395 . . . . 10.0 110.59 -172.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.687 HD21 HD11 ' A' ' 11' ' ' LEU . 88.2 mt -138.64 144.36 41.78 Favored Pre-proline 0 CA--C 1.507 -0.687 0 CA-C-O 121.484 0.659 . . . . 10.0 111.96 -170.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.834 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 4.3 Cg_exo -65.98 126.97 16.77 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 123.467 2.778 . . . . 10.0 111.655 176.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.597 ' HB2' HD11 ' A' ' 54' ' ' LEU . . . -62.12 128.46 36.22 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 108.062 -1.088 . . . . 10.0 108.062 171.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.95 -1.04 87.72 Favored Glycine 0 N--CA 1.443 -0.882 0 O-C-N 125.612 1.82 . . . . 10.0 112.74 -174.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.834 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 15.1 tppt? -140.46 102.59 4.37 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 122.359 1.076 . . . . 10.0 111.835 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -170.33 129.66 0.88 Allowed 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 113.405 -1.725 . . . . 10.0 110.856 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.71 ' HA ' ' HB2' ' A' ' 39' ' ' CYS . 2.1 t -176.87 -44.87 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 115.046 -0.979 . . . . 10.0 113.112 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.726 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 72.6 Cg_endo -103.93 124.4 0.07 OUTLIER 'Trans proline' 0 N--CA 1.413 -3.244 0 N-CA-C 115.557 1.329 . . . . 10.0 115.557 -162.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.062 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 9.63 -87.15 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.392 0 CA-C-N 109.664 -3.425 . . . . 10.0 114.824 166.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.64 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 11.4 Cg_exo -26.07 -55.99 0.09 OUTLIER 'Trans proline' 0 CA--C 1.559 1.734 0 C-N-CA 123.74 2.96 . . . . 10.0 115.722 -162.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.726 ' HD2' ' O ' ' A' ' 20' ' ' PRO . 37.4 Cg_endo -80.48 -73.96 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.277 0 C-N-CA 122.419 2.079 . . . . 10.0 112.083 168.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.077 HG12 HD12 ' A' ' 35' ' ' ILE . 53.5 t -57.37 -54.73 27.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 127.564 2.346 . . . . 10.0 114.672 -173.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 1.062 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -48.41 -72.55 0.43 Allowed Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.107 -0.952 . . . . 10.0 113.173 -175.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.729 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 16.5 Cg_exo -44.98 -47.98 11.42 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.523 2.816 . . . . 10.0 112.272 171.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 24' ' ' VAL . . . -46.37 -98.51 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 123.624 0.578 . . . . 10.0 112.376 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.869 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.351 0.0 OUTLIER -73.87 -38.84 64.3 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 117.176 -1.81 . . . . 10.0 113.363 -174.684 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.691 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -66.15 -39.34 94.54 Favored Glycine 0 N--CA 1.462 0.407 0 C-N-CA 121.43 -0.414 . . . . 10.0 113.859 -173.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.513 ' HB2' ' HA ' ' A' ' 26' ' ' PRO . 56.1 tt0 -67.82 -7.19 25.76 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.541 -0.864 . . . . 10.0 111.172 176.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -99.94 22.92 10.49 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.624 -0.716 . . . . 10.0 109.284 168.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.19 -6.89 63.99 Favored Glycine 0 CA--C 1.503 -0.712 0 CA-C-N 115.341 -0.845 . . . . 10.0 113.112 167.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.869 ' HB ' HD23 ' A' ' 28' ' ' LEU . 3.4 t -83.29 148.75 4.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 114.619 1.34 . . . . 10.0 114.619 -169.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.544 ' HB3' ' HB2' ' A' ' 37' ' ' GLU . 44.7 t-20 -70.75 98.68 1.58 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.468 0.707 . . . . 10.0 110.639 172.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.077 HD12 HG12 ' A' ' 24' ' ' VAL . 19.4 mm -53.78 -36.28 29.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.155 -0.929 . . . . 10.0 112.164 175.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 66.8 mtm -65.19 -52.78 52.76 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.62 -1.627 . . . . 10.0 111.699 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.544 ' HB2' ' HB3' ' A' ' 34' ' ' ASN . 12.7 mm-40 -56.88 -38.8 73.27 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.615 -0.834 . . . . 10.0 110.927 175.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.558 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . 91.3 t80 -57.85 -58.7 7.21 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 113.506 0.928 . . . . 10.0 113.506 170.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -57.7 -52.26 66.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 113.988 -1.46 . . . . 10.0 112.039 -177.535 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.501 ' HB3' ' HE3' ' A' ' 40' ' ' LYS . 0.7 OUTLIER -66.47 -21.71 66.19 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.554 -0.858 . . . . 10.0 108.691 -176.082 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.684 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 12.9 mtp180 -74.09 -63.9 1.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.662 -0.699 . . . . 10.0 112.074 168.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.601 ' CZ ' HG21 ' A' ' 46' ' ' THR . 71.1 t80 -54.33 -45.52 72.69 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-O 121.082 0.468 . . . . 10.0 110.682 -172.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -58.97 -51.62 69.27 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.074 -0.966 . . . . 10.0 109.771 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.96 98.97 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 119.034 -1.066 . . . . 10.0 112.186 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.684 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 7.3 mt-10 -66.9 -39.31 87.41 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.823 0.821 . . . . 10.0 110.834 -178.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.605 ' CG2' HD12 ' A' ' 54' ' ' LEU . 72.1 p -92.13 -0.4 57.44 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.735 -1.121 . . . . 10.0 112.748 -172.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.96 -39.62 12.76 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.915 0.886 . . . . 10.0 112.777 -174.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -75.78 -34.13 60.2 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.506 -0.77 . . . . 10.0 110.958 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.431 ' HB3' ' CE ' ' A' ' 52' ' ' MET . 36.7 mttp -97.15 17.88 16.19 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.828 0.851 . . . . 10.0 109.998 -175.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -52.07 145.47 10.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.205 -0.907 . . . . 10.0 113.232 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.68 15.85 35.79 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 110.604 -0.998 . . . . 10.0 110.604 -177.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.716 ' SD ' ' HB2' ' A' ' 77' ' ' PHE . 51.3 mtm -138.12 125.81 22.29 Favored 'General case' 0 C--O 1.211 -0.94 0 C-N-CA 116.274 -2.171 . . . . 10.0 115.193 -166.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.3 mm -66.55 91.78 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 118.313 0.506 . . . . 10.0 109.639 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.605 HD12 ' CG2' ' A' ' 46' ' ' THR . 8.0 mt -83.2 135.85 44.07 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.852 -0.796 . . . . 10.0 108.852 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.561 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 8.0 Cg_exo -75.86 108.94 2.79 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.237 1.958 . . . . 10.0 111.016 174.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -100.58 155.08 4.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 119.833 1.197 . . . . 10.0 111.573 -174.71 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.437 HG22 ' HG2' ' A' ' 10' ' ' LYS . 93.6 t -134.81 115.58 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 CA-C-N 116.662 -0.244 . . . . 10.0 110.447 175.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.685 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 16.0 mt -107.07 141.93 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.554 0 CA-C-O 121.669 0.747 . . . . 10.0 109.157 -174.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.7 m -124.8 99.15 6.02 Favored 'General case' 0 C--N 1.28 -2.453 0 CA-C-N 114.665 -1.152 . . . . 10.0 108.869 174.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 65' ' ' SER . 2.4 p -89.61 140.17 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 CA-C-N 119.43 1.014 . . . . 10.0 110.19 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.417 ' HE2' ' HG1' ' A' ' 67' ' ' THR . 73.4 m-85 -98.51 160.67 14.13 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.548 -0.751 . . . . 10.0 111.55 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.417 ' OE1' ' HB2' ' A' ' 4' ' ' LYS . 16.6 mt-10 -54.22 -19.13 4.68 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 124.37 1.068 . . . . 10.0 113.142 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 26.5 t70 -75.46 -13.71 60.39 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.572 -0.74 . . . . 10.0 110.472 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.771 ' HE3' ' HA ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 83.33 1.2 1.07 Allowed 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 114.448 -1.251 . . . . 10.0 110.379 -167.897 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.517 ' O ' HG23 ' A' ' 60' ' ' VAL . 57.9 m -71.68 174.86 6.21 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 114.753 -1.112 . . . . 10.0 108.846 169.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.866 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -171.09 -176.79 2.02 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 119.394 0.997 . . . . 10.0 109.307 174.747 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.417 ' HG1' ' HE2' ' A' ' 61' ' ' TYR . 1.3 p -162.58 162.54 27.25 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 103.434 -2.802 . . . . 10.0 103.434 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CB ' HG12 ' A' ' 58' ' ' ILE . 47.6 p90 -162.11 158.09 24.24 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.522 0.677 . . . . 10.0 109.233 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.9 pt -128.45 158.78 40.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.543 0 CA-C-N 114.612 -1.176 . . . . 10.0 108.503 -175.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.482 HD12 ' CE1' ' A' ' 42' ' ' PHE . 2.8 mm -112.75 127.27 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 108.016 -1.105 . . . . 10.0 108.016 -178.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.633 ' C ' ' HD2' ' A' ' 73' ' ' PRO . 4.2 mptp? -80.16 93.3 5.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.024 0.916 . . . . 10.0 112.211 -172.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.729 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 9.2 t -59.55 -34.6 23.2 Favored Pre-proline 0 CA--C 1.569 1.693 0 CA-C-N 113.569 -1.651 . . . . 10.0 113.332 169.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.729 ' HD2' ' N ' ' A' ' 72' ' ' THR . 2.7 Cg_endo -41.9 -49.26 5.69 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 124.519 3.479 . . . . 10.0 117.331 -171.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.553 ' HD3' ' HG2' ' A' ' 73' ' ' PRO . 73.7 Cg_exo -42.33 -35.06 3.35 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.858 2.372 . . . . 10.0 113.47 -174.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.515 ' HB2' ' HE2' ' A' ' 112' ' ' LYS . . . 72.51 -25.59 0.18 Allowed 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 113.723 1.009 . . . . 10.0 113.723 168.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.5 m -50.63 -46.91 58.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.167 0.508 . . . . 10.0 110.92 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.716 ' HB2' ' SD ' ' A' ' 52' ' ' MET . 8.6 p90 -72.23 -29.46 63.96 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.765 -0.652 . . . . 10.0 111.428 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.762 ' O ' ' HB3' ' A' ' 81' ' ' LYS . 1.8 tp -86.0 -28.18 24.36 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.233 0.54 . . . . 10.0 111.255 -175.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.457 ' HA ' HD13 ' A' ' 79' ' ' LEU . 3.7 mm? -59.39 -35.1 73.3 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 107.993 -1.114 . . . . 10.0 107.993 168.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.489 ' HA ' ' HB3' ' A' ' 83' ' ' ALA . 7.3 ttpm? -70.31 -12.26 61.47 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.756 -0.656 . . . . 10.0 111.921 172.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.762 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 17.0 tptm -56.72 -50.75 71.28 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.25 -0.907 . . . . 10.0 109.103 165.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.656 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -72.56 -49.58 31.52 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.964 1.706 . . . . 10.0 112.755 170.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.489 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . . . . . . . . 0 C--N 1.293 -1.887 0 CA-C-N 112.688 -2.051 . . . . 10.0 109.326 -169.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.563 HG13 ' N ' ' A' ' 98' ' ' GLY . 7.1 p . . . . . 0 CA--C 1.536 0.435 0 CA-C-O 121.393 0.616 . . . . 10.0 111.512 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -166.88 161.37 35.18 Favored Glycine 0 CA--C 1.497 -1.078 0 N-CA-C 108.725 -1.75 . . . . 10.0 108.725 -174.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.603 ' HB2' ' O ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -143.73 177.72 8.31 Favored 'General case' 0 CA--C 1.473 -2.004 0 CA-C-O 122.359 1.075 . . . . 10.0 110.767 -169.522 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.656 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -163.76 -165.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.404 -2.73 0 CA-C-N 111.793 -2.458 . . . . 10.0 106.184 -170.55 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 19.0 p -109.83 150.39 28.46 Favored 'General case' 0 C--N 1.268 -2.968 0 CA-C-N 114.753 -1.112 . . . . 10.0 111.833 -170.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.68 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 22.4 tpp180 -43.62 -43.73 5.9 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 113.588 -1.642 . . . . 10.0 109.688 168.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.507 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 18.4 tppt? -58.35 -43.15 88.19 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.153 0.501 . . . . 10.0 112.168 176.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.65 ' O ' HG12 ' A' ' 108' ' ' ILE . 57.6 mt-30 -67.22 -38.72 85.74 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.407 -0.59 . . . . 10.0 109.407 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.68 ' HB ' ' O ' ' A' ' 102' ' ' ARG . 34.9 mm -46.83 -51.15 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.589 -0.732 . . . . 10.0 111.012 166.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.686 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 31.8 tt0 -48.28 -54.26 14.31 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.283 -1.326 . . . . 10.0 112.836 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -52.48 -57.88 8.51 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 123.925 0.766 . . . . 10.0 110.151 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.65 HG12 ' O ' ' A' ' 104' ' ' GLN . 5.5 mm -46.19 -59.97 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 114.328 -1.305 . . . . 10.0 109.923 173.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.547 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -50.62 -37.28 39.47 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 123.686 0.616 . . . . 10.0 112.44 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.686 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 39.4 mttt -71.09 -58.67 3.33 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.004 -0.544 . . . . 10.0 111.478 -175.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.603 HG21 HD21 ' A' ' 78' ' ' LEU . 4.7 t -55.4 -34.83 64.73 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 113.011 0.745 . . . . 10.0 113.011 -175.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 1.0 ' HD3' HD11 ' A' ' 128' ' ' ILE . 0.1 OUTLIER -99.03 7.38 46.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 120.931 0.396 . . . . 10.0 110.828 -173.36 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.812 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 40.1 ttm -48.11 -41.32 41.55 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.231 -0.895 . . . . 10.0 112.424 175.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 113' ' ' MET . 26.7 Cg_endo -59.61 -32.48 96.05 Favored 'Trans proline' 0 C--N 1.366 1.471 0 C-N-CA 121.787 1.658 . . . . 10.0 112.128 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.561 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 0.8 OUTLIER -91.44 -47.89 7.19 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 114.788 -1.096 . . . . 10.0 112.34 -173.39 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.874 HD22 ' HG3' ' A' ' 112' ' ' LYS . 7.0 mp -64.18 2.05 0.63 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.527 -1.215 . . . . 10.0 111.871 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 115' ' ' ASP . 8.7 p30 54.75 45.67 26.22 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.164 -1.38 . . . . 10.0 109.662 177.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.812 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -80.8 118.17 22.09 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 112.805 -1.998 . . . . 10.0 112.103 -172.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -67.22 -37.61 83.88 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.75 -0.659 . . . . 10.0 109.874 170.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.2 p -155.41 144.66 20.95 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.442 -0.947 . . . . 10.0 108.442 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.544 ' O ' ' HG2' ' A' ' 125' ' ' MET . 62.6 tp -52.08 -40.39 61.14 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 115.077 1.51 . . . . 10.0 115.077 -173.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -51.63 -33.08 31.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.148 0.499 . . . . 10.0 111.045 176.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.18 -49.26 65.31 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 118.797 -1.161 . . . . 10.0 110.865 172.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.626 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -57.78 -33.68 68.79 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.91 0.386 . . . . 10.0 110.652 178.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.635 ' O ' ' HB3' ' A' ' 129' ' ' GLU . 80.1 mmm -56.36 -39.02 72.2 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.73 0.3 . . . . 10.0 111.425 176.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -61.21 -56.68 17.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.832 -0.622 . . . . 10.0 111.432 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.871 HD12 HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -50.98 -57.9 2.4 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 C-N-CA 119.994 -0.683 . . . . 10.0 111.146 -178.465 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 1.0 HD11 ' HD3' ' A' ' 112' ' ' LYS . 25.4 mm -50.56 -57.23 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 CA-C-N 114.649 -1.16 . . . . 10.0 111.801 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.635 ' HB3' ' O ' ' A' ' 125' ' ' MET . 0.0 OUTLIER -53.33 -41.38 65.67 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.748 -0.66 . . . . 10.0 109.272 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.669 ' HA2' ' HE2' ' A' ' 133' ' ' LYS . . . -71.36 -46.47 41.29 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.739 -0.744 . . . . 10.0 111.862 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 62.7 m -44.37 -65.6 0.49 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 114.561 -0.82 . . . . 10.0 109.011 169.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.513 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -48.77 -50.71 32.75 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.026 -0.534 . . . . 10.0 111.312 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.669 ' HE2' ' HA2' ' A' ' 130' ' ' GLY . 17.0 ttpt -47.98 -53.95 14.48 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.75 -1.114 . . . . 10.0 111.499 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.1 m -66.13 -30.91 71.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.341 0.591 . . . . 10.0 110.69 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 46.8 mtp -80.31 5.64 14.2 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.701 1.0 . . . . 10.0 113.701 -177.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.46 6.15 84.0 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 119.351 0.978 . . . . 10.0 111.548 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.572 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 37.4 mt -97.21 127.27 49.61 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.834 0 CA-C-O 121.672 0.749 . . . . 10.0 111.777 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.603 ' O ' ' HB2' ' A' ' 99' ' ' LYS . 0.7 OUTLIER -88.56 158.87 18.15 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.514 -1.221 . . . . 10.0 108.868 178.134 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.3 m -117.44 127.01 74.97 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.518 0 CA-C-O 122.213 1.006 . . . . 10.0 108.348 171.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 101' ' ' THR . 19.3 m -112.54 154.62 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.231 0 CA-C-N 113.676 -1.602 . . . . 10.0 107.676 176.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 31.9 t70 . . . . . 0 C--N 1.276 -2.608 0 CA-C-N 114.534 -1.212 . . . . 10.0 110.872 -177.065 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.401 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 49.8 mtmt . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.659 0.266 . . . . 10.0 110.895 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.0 t -63.11 139.19 21.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.576 -0.738 . . . . 10.0 110.992 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.86 -32.0 5.93 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.288 -0.414 . . . . 10.0 110.521 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.499 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -158.97 152.98 23.47 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.161 1.171 . . . . 10.0 114.161 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -99.51 133.17 44.22 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.885 -1.052 . . . . 10.0 108.36 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.664 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -124.6 82.21 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 120.063 -0.655 . . . . 10.0 110.099 174.395 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 46.1 tttm -78.25 128.9 34.4 Favored 'General case' 0 C--N 1.314 -0.944 0 O-C-N 120.368 -1.458 . . . . 10.0 109.754 175.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.67 HD21 HD11 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -158.76 131.11 6.82 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 122.139 0.971 . . . . 10.0 112.262 -176.758 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -88.63 126.23 35.19 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.746 -1.116 . . . . 10.0 111.423 -174.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.67 HD11 HD21 ' A' ' 11' ' ' LEU . 63.7 mt -143.88 145.07 29.1 Favored Pre-proline 0 CA--C 1.511 -0.538 0 CA-C-O 121.098 0.475 . . . . 10.0 112.09 -174.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.706 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 24.8 Cg_exo -61.17 129.68 29.46 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.408 2.739 . . . . 10.0 112.405 175.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.605 ' HB2' HD11 ' A' ' 54' ' ' LEU . . . -62.23 129.09 39.17 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.343 -1.354 . . . . 10.0 107.343 168.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.88 0.75 86.05 Favored Glycine 0 N--CA 1.441 -1.004 0 O-C-N 125.498 1.749 . . . . 10.0 113.088 -175.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.706 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 3.9 tmtp? -144.46 99.86 3.44 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.147 0.974 . . . . 10.0 112.047 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 39' ' ' CYS . . . -171.2 139.39 1.34 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.407 -1.27 . . . . 10.0 112.972 175.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.653 ' HA ' ' HB3' ' A' ' 39' ' ' CYS . 17.0 m -170.74 -66.88 0.0 OUTLIER Pre-proline 0 N--CA 1.437 -1.094 0 O-C-N 124.322 1.014 . . . . 10.0 110.813 178.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.706 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 86.3 Cg_endo -105.84 129.48 0.06 OUTLIER 'Trans proline' 0 N--CA 1.425 -2.511 0 N-CA-C 117.621 2.123 . . . . 10.0 117.621 -148.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.118 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 20.44 -83.87 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.412 0 CA-C-N 109.474 -3.512 . . . . 10.0 115.152 166.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.679 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 93.1 Cg_exo -39.39 -55.85 1.44 Allowed 'Trans proline' 0 C--N 1.382 2.308 0 CA-C-N 122.561 1.95 . . . . 10.0 112.489 -174.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.873 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 40.3 Cg_endo -91.02 116.1 0.47 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.822 1.681 . . . . 10.0 111.026 154.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.921 HG12 HD12 ' A' ' 35' ' ' ILE . 4.0 t 111.1 -42.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 C-N-CA 119.013 -1.075 . . . . 10.0 109.152 156.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 1.118 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -49.82 -75.11 0.22 Allowed Glycine 0 CA--C 1.523 0.583 0 CA-C-N 113.369 -1.741 . . . . 10.0 113.77 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.69 ' HA ' ' HG3' ' A' ' 30' ' ' GLN . 31.4 Cg_exo -54.79 -33.94 82.92 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.638 2.225 . . . . 10.0 111.39 175.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 24' ' ' VAL . . . -51.72 -98.08 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.113 0.412 . . . . 10.0 112.113 175.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.869 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.319 0.0 OUTLIER -72.88 -28.09 62.29 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 117.596 -1.642 . . . . 10.0 112.943 -174.412 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.555 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -68.58 -39.36 86.69 Favored Glycine 0 N--CA 1.464 0.501 0 C-N-CA 120.736 -0.745 . . . . 10.0 112.967 -176.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.69 ' HG3' ' HA ' ' A' ' 26' ' ' PRO . 78.1 mt-30 -65.38 -12.6 53.73 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.166 -1.014 . . . . 10.0 110.736 174.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -100.46 18.28 19.45 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.944 -0.702 . . . . 10.0 109.809 173.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.57 1.94 70.7 Favored Glycine 0 CA--C 1.5 -0.887 0 CA-C-N 114.824 -1.08 . . . . 10.0 113.695 169.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.891 HG11 ' CD2' ' A' ' 66' ' ' PHE . 3.4 t -85.41 146.65 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 113.623 0.971 . . . . 10.0 113.623 -170.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -68.67 100.96 1.21 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.226 0.536 . . . . 10.0 110.95 171.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.921 HD12 HG12 ' A' ' 24' ' ' VAL . 8.7 mm -53.15 -39.94 36.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.943 -1.026 . . . . 10.0 111.217 174.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.824 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 3.7 mpp? -64.02 -47.35 80.6 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 113.357 -1.747 . . . . 10.0 111.076 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.584 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 18.5 tp10 -56.75 -45.01 82.29 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.873 -0.731 . . . . 10.0 110.234 173.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . 85.0 t80 -55.81 -60.07 3.98 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.661 1.356 . . . . 10.0 114.661 173.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.824 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 24.8 p -61.57 -49.19 77.65 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 114.838 -1.074 . . . . 10.0 112.02 -175.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.502 ' HA ' ' HD3' ' A' ' 40' ' ' LYS . 28.1 mmtp -65.66 -21.26 66.54 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.543 -0.863 . . . . 10.0 109.762 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.801 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 5.7 mtp180 -71.6 -65.35 0.77 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 119.357 -0.937 . . . . 10.0 111.436 167.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.545 ' CZ ' HG21 ' A' ' 46' ' ' THR . 66.8 t80 -52.8 -47.01 67.9 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.602 -171.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -60.01 -52.78 63.92 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.944 -1.026 . . . . 10.0 110.254 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.9 96.09 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 118.884 -1.127 . . . . 10.0 112.187 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.801 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 9.6 mt-10 -68.74 -37.2 79.24 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 121.583 0.706 . . . . 10.0 111.172 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.582 ' CG2' HD12 ' A' ' 54' ' ' LEU . 73.0 p -89.14 0.22 56.91 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.125 -0.943 . . . . 10.0 112.567 -173.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.95 -38.34 7.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.007 -0.997 . . . . 10.0 113.008 -175.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -76.05 -36.57 58.98 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.718 -0.673 . . . . 10.0 111.138 -174.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 34.4 mtmm -100.88 23.1 11.09 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 123.013 0.525 . . . . 10.0 109.903 -176.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -52.31 143.83 14.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.158 -0.928 . . . . 10.0 112.789 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.87 20.08 24.95 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 114.948 -1.024 . . . . 10.0 110.57 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.551 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 67.4 mtt -138.41 123.41 19.0 Favored 'General case' 0 C--O 1.208 -1.084 0 C-N-CA 117.243 -1.783 . . . . 10.0 114.262 -168.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.0 mm -65.68 91.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 118.626 0.648 . . . . 10.0 109.674 172.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.605 HD11 ' HB2' ' A' ' 15' ' ' ALA . 8.6 mt -81.06 131.49 59.41 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.178 -0.675 . . . . 10.0 109.178 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -71.83 106.54 2.01 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 C-N-CA 122.306 2.004 . . . . 10.0 110.962 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.37 151.63 5.86 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-N 119.449 1.022 . . . . 10.0 111.221 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 95.2 t -134.32 116.79 23.02 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 N-CA-C 110.288 -0.264 . . . . 10.0 110.288 175.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.664 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 14.9 mt -104.19 142.6 17.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.723 0.773 . . . . 10.0 109.623 -172.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 84.5 m -126.6 95.57 4.39 Favored 'General case' 0 N--CA 1.411 -2.383 0 CA-C-N 114.659 -1.155 . . . . 10.0 108.998 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 65' ' ' SER . 1.5 p -89.95 137.49 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.122 0 CA-C-N 119.386 0.994 . . . . 10.0 110.581 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -95.59 179.54 5.1 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.621 -0.718 . . . . 10.0 112.486 -176.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.401 ' HG3' ' HB2' ' A' ' 4' ' ' LYS . 5.9 mm-40 -53.12 -33.16 51.07 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 124.87 1.268 . . . . 10.0 112.444 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.547 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 35.5 t70 -80.85 -9.58 59.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.698 -1.137 . . . . 10.0 111.568 -168.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 0.2 OUTLIER 81.3 6.6 1.24 Allowed 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 122.632 1.206 . . . . 10.0 110.823 -166.135 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.622 ' O ' HG23 ' A' ' 60' ' ' VAL . 58.6 m -71.4 172.01 10.21 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 112.796 -2.002 . . . . 10.0 107.693 168.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.891 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -168.68 -176.25 2.69 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 119.948 1.249 . . . . 10.0 109.525 175.779 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.4 p -158.65 166.67 31.5 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 102.79 -3.041 . . . . 10.0 102.79 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.483 ' HB3' HG12 ' A' ' 58' ' ' ILE . 49.4 p90 -161.06 156.88 25.24 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 176.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.0 mt -116.47 167.23 9.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.058 -1.46 . . . . 10.0 107.058 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.3 mt -142.22 114.21 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 107.691 -1.226 . . . . 10.0 107.691 -175.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.552 ' HB3' ' HG2' ' A' ' 73' ' ' PRO . 12.9 mmtp -72.41 99.18 2.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.414 1.102 . . . . 10.0 112.493 -166.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.778 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 14.6 t -62.6 -33.98 13.24 Favored Pre-proline 0 CA--C 1.569 1.693 0 CA-C-N 113.197 -1.82 . . . . 10.0 112.178 169.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.778 ' HD2' ' N ' ' A' ' 72' ' ' THR . 1.0 OUTLIER -40.18 -43.82 3.85 Favored 'Trans proline' 0 C--N 1.386 2.5 0 C-N-CA 124.867 3.711 . . . . 10.0 117.976 -175.245 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 71' ' ' LYS . 40.8 Cg_exo -37.44 -29.7 0.11 Allowed 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 123.52 2.813 . . . . 10.0 114.47 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 1.08 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . . . 75.59 -45.73 0.55 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.997 0.74 . . . . 10.0 112.997 169.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 43.7 t -47.1 -37.11 9.17 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 123.841 0.713 . . . . 10.0 111.728 -175.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -47.24 -56.52 6.57 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.814 0.816 . . . . 10.0 111.534 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.585 HD22 HG21 ' A' ' 111' ' ' THR . 10.8 mp -98.54 -18.72 18.01 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.678 0.752 . . . . 10.0 109.689 -171.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.641 HD21 ' HB2' ' A' ' 132' ' ' ALA . 2.5 tp -64.85 -36.58 84.8 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 114.827 -1.078 . . . . 10.0 108.444 174.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.515 ' C ' ' H ' ' A' ' 82' ' ' ALA . 47.4 mtmt -64.1 -40.27 95.87 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.617 168.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.818 ' HA ' ' HE2' ' A' ' 81' ' ' LYS . 7.0 mmpt? -61.98 33.58 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.982 0.913 . . . . 10.0 113.15 171.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.923 ' HB1' HG13 ' A' ' 100' ' ' VAL . . . -171.42 -48.76 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 122.328 1.061 . . . . 10.0 109.394 -172.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.29 -2.01 0 CA-C-N 112.846 -1.979 . . . . 10.0 109.326 171.715 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.517 HG13 ' N ' ' A' ' 98' ' ' GLY . 7.8 p . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 120.929 0.395 . . . . 10.0 111.305 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.612 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -159.29 172.1 35.9 Favored Glycine 0 CA--C 1.493 -1.293 0 N-CA-C 108.08 -2.008 . . . . 10.0 108.08 170.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.947 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -143.13 167.51 21.93 Favored 'General case' 0 CA--C 1.479 -1.759 0 CA-C-O 122.664 1.221 . . . . 10.0 111.119 -169.152 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.923 HG13 ' HB1' ' A' ' 82' ' ' ALA . 2.1 t -131.53 -150.53 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.409 -2.478 0 CA-C-N 111.834 -2.439 . . . . 10.0 107.054 -173.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.645 ' H ' HG12 ' A' ' 100' ' ' VAL . 0.3 OUTLIER -167.42 133.98 2.21 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 105.894 -1.891 . . . . 10.0 105.894 -164.486 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.491 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 13.1 tpp180 -40.67 -44.91 2.26 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 125.055 1.472 . . . . 10.0 110.939 -171.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 16.9 tppt? -58.06 -42.94 86.56 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.398 0.888 . . . . 10.0 113.398 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.735 ' HB2' HG12 ' A' ' 100' ' ' VAL . 20.1 mm-40 -66.9 -52.02 48.36 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.089 -0.708 . . . . 10.0 109.089 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.849 HG21 ' HG3' ' A' ' 129' ' ' GLU . 28.7 mm -35.2 -55.29 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 O-C-N 124.074 0.859 . . . . 10.0 110.592 165.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.679 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 23.2 tt0 -50.36 -56.48 11.18 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.815 1.246 . . . . 10.0 113.12 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.53 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 12.5 mm-40 -54.58 -57.64 10.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.826 -1.079 . . . . 10.0 110.703 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.621 ' O ' HG22 ' A' ' 111' ' ' THR . 45.2 mt -50.19 -51.43 17.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.596 -1.183 . . . . 10.0 110.528 173.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.542 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -53.23 -34.26 56.39 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 112.582 0.586 . . . . 10.0 112.582 174.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.679 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 96.8 mttt -69.7 -52.29 26.89 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 120.853 0.359 . . . . 10.0 111.081 -177.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.621 HG22 ' O ' ' A' ' 108' ' ' ILE . 4.2 t -56.11 -29.12 60.19 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.944 -0.571 . . . . 10.0 111.606 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 1.08 ' HE3' ' HA ' ' A' ' 75' ' ' ALA . 49.7 mttm -103.89 -5.15 22.6 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 112.253 0.464 . . . . 10.0 112.253 -175.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.622 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 14.5 ptp -53.66 -32.87 11.94 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 112.985 0.735 . . . . 10.0 112.985 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 113' ' ' MET . 32.4 Cg_endo -62.83 -31.05 78.12 Favored 'Trans proline' 0 C--N 1.371 1.762 0 CA-C-N 120.651 1.268 . . . . 10.0 111.518 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.626 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 1.0 OUTLIER -102.78 -40.25 6.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.589 -1.187 . . . . 10.0 114.04 -169.357 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.558 ' HG ' HD13 ' A' ' 127' ' ' ILE . 0.9 OUTLIER -63.77 38.66 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 114.258 -1.337 . . . . 10.0 113.264 -174.315 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 43.4 t30 23.0 44.9 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 O-C-N 124.141 0.901 . . . . 10.0 111.024 -168.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.65 ' O ' ' HB2' ' A' ' 119' ' ' ASN . . . -73.88 -82.15 0.06 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.817 -1.083 . . . . 10.0 113.358 -169.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.65 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 5.7 m-20 101.26 -29.92 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 O-C-N 125.203 1.565 . . . . 10.0 110.412 -173.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 41.7 p -155.26 141.01 18.08 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.814 -1.18 . . . . 10.0 107.814 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.566 ' O ' ' HG3' ' A' ' 125' ' ' MET . 3.4 tm? -53.61 -44.05 69.15 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.832 1.049 . . . . 10.0 113.832 -175.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -53.64 -37.09 62.76 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.165 0.507 . . . . 10.0 111.507 174.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.574 ' O ' ' HG3' ' A' ' 126' ' ' LYS . . . -67.07 -47.24 71.87 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 118.241 -1.384 . . . . 10.0 110.276 174.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.546 ' HA ' HD12 ' A' ' 127' ' ' ILE . . . -55.99 -34.38 65.72 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.012 -0.675 . . . . 10.0 110.839 175.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.566 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 80.0 mtp -55.9 -45.38 78.66 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.175 0.805 . . . . 10.0 113.175 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.642 ' HD2' HG13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -63.6 -37.3 86.81 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.709 -0.478 . . . . 10.0 109.709 -178.338 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.642 HG13 ' HD2' ' A' ' 126' ' ' LYS . 83.6 mt -55.72 -64.04 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 CA-C-O 121.85 0.833 . . . . 10.0 111.569 175.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.542 HG13 ' HB2' ' A' ' 109' ' ' ALA . 25.0 mm -50.22 -59.67 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 CA-C-N 113.437 -1.71 . . . . 10.0 111.691 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.849 ' HG3' HG21 ' A' ' 105' ' ' ILE . 6.3 mt-10 -53.2 -40.39 64.4 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.454 -0.793 . . . . 10.0 110.091 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -71.36 -45.17 49.29 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.356 -0.926 . . . . 10.0 111.715 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.433 HG21 ' HB3' ' A' ' 75' ' ' ALA . 97.8 m -46.5 -61.17 1.93 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.185 -1.008 . . . . 10.0 108.906 169.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.641 ' HB2' HD21 ' A' ' 79' ' ' LEU . . . -50.74 -47.99 59.21 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.761 -0.654 . . . . 10.0 111.826 177.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 18.2 ttpt -44.44 -56.41 4.28 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 124.025 0.828 . . . . 10.0 110.448 176.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.5 m -64.54 -30.0 71.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.717 -0.674 . . . . 10.0 111.666 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 29.9 mtm -81.38 3.46 24.33 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 114.077 1.139 . . . . 10.0 114.077 -176.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.46 ' O ' HG12 ' A' ' 97' ' ' VAL . . . 84.07 20.04 59.93 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 120.066 1.303 . . . . 10.0 111.748 -177.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.702 ' CG2' HG23 ' A' ' 100' ' ' VAL . 1.8 mp -107.17 126.23 63.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.683 0.754 . . . . 10.0 112.079 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.947 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -90.31 158.87 16.94 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.522 -1.217 . . . . 10.0 108.997 175.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.5 HG11 ' HG2' ' A' ' 129' ' ' GLU . 19.1 m -114.71 124.3 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.216 0 N-CA-C 108.002 -1.111 . . . . 10.0 108.002 170.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 100' ' ' VAL . 5.0 m -108.52 157.24 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 CA-C-N 114.194 -1.366 . . . . 10.0 109.723 178.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.3 t70 . . . . . 0 C--N 1.287 -2.15 0 CA-C-N 113.057 -1.883 . . . . 10.0 110.28 174.073 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.511 ' C ' ' HG3' ' A' ' 62' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.442 -0.867 0 N-CA-C 109.618 -0.512 . . . . 10.0 109.618 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 93.1 t -79.41 133.33 30.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.64 -0.504 . . . . 10.0 109.64 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . . . -98.5 -37.54 9.53 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.115 -0.698 . . . . 10.0 109.115 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.4 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -164.67 -171.28 2.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 122.026 0.917 . . . . 10.0 113.423 -177.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 54.6 mt-30 -137.83 132.95 33.37 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.737 -1.574 . . . . 10.0 108.316 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.629 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -119.9 80.91 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.88 -0.785 . . . . 10.0 108.88 179.199 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -81.83 122.41 27.68 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 120.063 1.301 . . . . 10.0 107.847 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.605 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -156.84 130.3 8.08 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.163 0.982 . . . . 10.0 111.812 -171.829 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -81.99 120.93 25.88 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.297 -1.32 . . . . 10.0 110.225 -172.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.605 HD21 HD11 ' A' ' 11' ' ' LEU . 73.8 mt -138.57 135.32 17.92 Favored Pre-proline 0 CA--C 1.505 -0.752 0 CA-C-O 121.65 0.738 . . . . 10.0 112.051 -173.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.575 ' HB2' ' CB ' ' A' ' 17' ' ' LYS . 34.3 Cg_exo -54.94 123.6 14.19 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.641 2.894 . . . . 10.0 112.189 174.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.569 ' CB ' ' HA ' ' A' ' 50' ' ' ALA . . . -62.4 126.56 27.74 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.536 -1.283 . . . . 10.0 107.536 170.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.96 -1.06 85.93 Favored Glycine 0 CA--C 1.529 0.906 0 O-C-N 125.755 1.909 . . . . 10.0 113.238 -173.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.575 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . 6.0 tmtt? -142.81 95.85 2.84 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.185 0.993 . . . . 10.0 112.284 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.652 ' H ' HD22 ' A' ' 43' ' ' ASN . . . -169.61 137.49 1.77 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.41 -1.268 . . . . 10.0 112.644 175.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.564 ' H ' ' HD3' ' A' ' 20' ' ' PRO . 1.8 t -178.05 -48.93 0.0 OUTLIER Pre-proline 0 N--CA 1.435 -1.182 0 CA-C-N 114.81 -1.086 . . . . 10.0 112.275 174.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.723 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 83.5 Cg_endo -101.53 134.64 0.15 Allowed 'Trans proline' 0 N--CA 1.407 -3.596 0 N-CA-C 116.231 1.589 . . . . 10.0 116.231 -150.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.025 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . 16.53 -64.94 0.0 OUTLIER Pre-proline 0 C--N 1.286 -2.184 0 CA-C-N 109.005 -3.725 . . . . 10.0 117.639 154.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.778 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 47.0 Cg_exo -53.87 -63.64 0.21 Allowed 'Trans proline' 0 CA--C 1.565 2.061 0 CA-C-N 123.606 2.324 . . . . 10.0 115.398 -176.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.778 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 58.3 Cg_endo -77.33 -52.24 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.607 2.204 . . . . 10.0 112.553 175.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.066 HG12 HD12 ' A' ' 35' ' ' ILE . 67.4 t -83.48 -44.95 18.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 111.896 -2.411 . . . . 10.0 111.957 -165.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.778 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -45.28 -53.36 7.94 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 114.259 -1.337 . . . . 10.0 114.234 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 1.025 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 50.5 Cg_exo -66.58 -49.29 1.75 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.228 2.619 . . . . 10.0 111.82 177.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.536 ' HB1' ' CG2' ' A' ' 9' ' ' ILE . . . -49.01 -74.85 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.323 0.583 . . . . 10.0 110.911 -177.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.773 HD22 ' HE2' ' A' ' 66' ' ' PHE . 3.5 mt -71.29 -44.99 64.12 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.649 0.981 . . . . 10.0 113.649 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.64 -41.45 98.91 Favored Glycine 0 N--CA 1.459 0.203 0 CA-C-N 116.237 -0.438 . . . . 10.0 113.359 -172.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -61.57 -26.52 68.01 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.94 -0.304 . . . . 10.0 110.491 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -99.06 17.37 19.94 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.847 -0.741 . . . . 10.0 109.982 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.01 11.91 85.14 Favored Glycine 0 CA--C 1.499 -0.944 0 CA-C-N 114.708 -1.133 . . . . 10.0 112.894 168.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.887 HG11 ' CD2' ' A' ' 66' ' ' PHE . 1.8 t -83.7 148.02 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 113.738 1.014 . . . . 10.0 113.738 -174.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -69.93 95.51 0.94 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.739 0.816 . . . . 10.0 110.606 174.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.066 HD12 HG12 ' A' ' 24' ' ' VAL . 22.0 mm -49.74 -43.27 18.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 114.722 -1.127 . . . . 10.0 111.783 177.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.806 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 10.7 ptm -66.05 -49.53 67.34 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 112.766 -2.016 . . . . 10.0 113.03 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.498 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 36.2 mt-10 -59.41 -32.99 70.69 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.114 -1.035 . . . . 10.0 110.912 176.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.745 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 72.1 t80 -63.49 -59.65 4.38 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 114.485 1.291 . . . . 10.0 114.485 169.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.806 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 23.7 p -60.07 -48.85 79.99 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 114.37 -1.287 . . . . 10.0 111.917 -175.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -65.32 -20.79 66.56 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.198 -0.667 . . . . 10.0 109.198 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.669 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 10.0 mtp180 -77.63 -64.25 1.19 Allowed 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 119.379 -0.928 . . . . 10.0 113.338 169.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.619 ' CE2' HG21 ' A' ' 46' ' ' THR . 45.3 t80 -55.9 -45.47 78.64 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 120.912 0.387 . . . . 10.0 110.113 -173.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.652 HD22 ' H ' ' A' ' 18' ' ' ALA . 4.8 m-20 -59.01 -50.35 74.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.547 -0.751 . . . . 10.0 110.09 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.69 96.26 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 118.816 -1.154 . . . . 10.0 112.649 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.669 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 5.1 pt-20 -73.78 -32.02 63.58 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 119.622 -0.831 . . . . 10.0 112.545 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.619 HG21 ' CE2' ' A' ' 42' ' ' PHE . 68.6 p -88.16 1.66 53.9 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 115.674 -0.694 . . . . 10.0 111.213 -177.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -47.56 -37.22 11.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.957 -1.02 . . . . 10.0 111.961 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.44 -45.39 39.0 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 114.194 -1.366 . . . . 10.0 110.538 -174.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.831 ' HD2' ' HZ ' ' A' ' 77' ' ' PHE . 30.2 mtmm -101.14 29.08 4.88 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 121.808 0.813 . . . . 10.0 109.472 -175.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.569 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -56.72 157.58 5.31 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 113.615 -1.63 . . . . 10.0 113.482 177.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.0 20.92 44.3 Favored Glycine 0 CA--C 1.505 -0.538 0 N-CA-C 109.883 -1.287 . . . . 10.0 109.883 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.616 ' HB2' HD21 ' A' ' 54' ' ' LEU . 14.6 mmt -137.28 123.14 20.08 Favored 'General case' 0 C--O 1.21 -1.018 0 C-N-CA 117.31 -1.756 . . . . 10.0 113.401 -167.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.7 mm -64.15 91.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.926 -0.768 . . . . 10.0 108.926 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.791 HD13 HG21 ' A' ' 70' ' ' ILE . 6.7 mt -79.19 127.11 80.24 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.552 -0.536 . . . . 10.0 109.552 -176.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.698 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 15.3 Cg_exo -70.85 99.63 0.88 Allowed 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 121.895 1.73 . . . . 10.0 110.397 172.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.419 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -97.12 148.82 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 119.57 1.077 . . . . 10.0 111.315 -172.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.433 ' HB ' ' CD1' ' A' ' 69' ' ' ILE . 71.5 t -126.53 115.01 40.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 120.866 -0.334 . . . . 10.0 110.521 171.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.726 ' CD1' HD21 ' A' ' 28' ' ' LEU . 17.7 mt -106.47 140.25 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 108.052 -1.092 . . . . 10.0 108.052 -175.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 94.0 m -123.81 99.32 6.22 Favored 'General case' 0 C--N 1.276 -2.607 0 CA-C-N 115.163 -0.926 . . . . 10.0 108.717 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 65' ' ' SER . 2.4 p -86.24 136.76 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.002 0 CA-C-N 118.897 0.771 . . . . 10.0 110.118 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 93.2 m-85 -93.96 170.5 9.49 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.076 -0.966 . . . . 10.0 112.507 -177.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.511 ' HG3' ' C ' ' A' ' 4' ' ' LYS . 16.3 mt-10 -63.28 -20.24 65.29 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.203 -1.362 . . . . 10.0 111.654 -177.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -78.97 -8.87 59.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.404 -0.816 . . . . 10.0 110.51 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm 83.15 0.75 1.13 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.442 1.097 . . . . 10.0 110.423 -171.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.53 ' O ' HG23 ' A' ' 60' ' ' VAL . 18.5 m -70.01 -178.77 1.68 Allowed 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 114.915 -1.038 . . . . 10.0 109.117 171.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.887 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -170.32 -175.89 2.05 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 119.679 1.127 . . . . 10.0 110.242 174.622 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.1 p -161.21 166.44 27.78 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 103.302 -2.851 . . . . 10.0 103.302 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.449 ' CB ' HG12 ' A' ' 58' ' ' ILE . 49.1 p90 -161.6 157.08 24.14 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 109.137 -0.69 . . . . 10.0 109.137 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.433 ' CD1' ' HB ' ' A' ' 57' ' ' VAL . 2.0 pp -136.55 152.59 29.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.327 -0.99 . . . . 10.0 108.327 -177.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.791 HG21 HD13 ' A' ' 54' ' ' LEU . 1.8 mm -100.9 132.07 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 108.089 -1.078 . . . . 10.0 108.089 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.698 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 32.4 mmmt -80.42 99.07 7.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.981 0.896 . . . . 10.0 112.194 -171.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.89 ' HB ' ' HB3' ' A' ' 112' ' ' LYS . 78.6 p -64.32 -29.35 3.74 Favored Pre-proline 0 CA--C 1.569 1.681 0 CA-C-N 113.778 -1.556 . . . . 10.0 114.852 172.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.642 ' HG3' ' HB3' ' A' ' 115' ' ' ASP . 72.9 Cg_exo -40.8 -48.36 4.57 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 123.909 3.073 . . . . 10.0 116.925 -172.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.503 ' HD3' ' HB2' ' A' ' 73' ' ' PRO . 88.7 Cg_exo -48.11 -30.29 14.06 Favored 'Trans proline' 0 C--N 1.363 1.323 0 C-N-CA 122.159 1.906 . . . . 10.0 112.733 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.407 ' HB1' HD23 ' A' ' 79' ' ' LEU . . . 68.44 -44.35 0.51 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.933 0.893 . . . . 10.0 112.865 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.557 ' HA ' ' HB2' ' A' ' 79' ' ' LEU . 7.4 m -49.6 -33.47 15.32 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 122.852 0.461 . . . . 10.0 110.468 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.831 ' HZ ' ' HD2' ' A' ' 49' ' ' LYS . 20.9 t80 -43.93 -58.82 2.57 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.92 -1.036 . . . . 10.0 111.822 172.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.889 ' HB3' HG23 ' A' ' 108' ' ' ILE . 6.3 tp -95.98 -14.33 23.11 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.46 -0.496 . . . . 10.0 110.333 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.733 HD21 HG23 ' A' ' 128' ' ' ILE . 2.3 mm? -64.62 -44.31 90.95 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 109.243 -0.651 . . . . 10.0 109.243 171.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.553 ' HD2' ' O ' ' A' ' 80' ' ' LYS . 1.7 tmmm? -63.52 -30.58 71.68 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 115.51 -0.768 . . . . 10.0 109.434 174.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.512 ' HG3' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -60.28 -40.17 89.46 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.991 0.737 . . . . 10.0 112.991 173.44 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.828 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -66.66 -43.14 85.35 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 123.294 1.521 . . . . 10.0 110.636 171.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.402 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . . . . . . . . 0 C--N 1.281 -2.39 0 CA-C-N 111.125 -2.762 . . . . 10.0 108.563 -175.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.466 HG13 ' N ' ' A' ' 98' ' ' GLY . 8.3 p . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 112.384 0.513 . . . . 10.0 112.384 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.594 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -166.93 161.27 35.1 Favored Glycine 0 CA--C 1.5 -0.885 0 N-CA-C 109.452 -1.459 . . . . 10.0 109.452 173.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.746 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -145.32 177.85 8.52 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 122.676 1.227 . . . . 10.0 111.649 -165.86 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.828 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -157.68 -143.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 CA-C-N 111.813 -2.449 . . . . 10.0 105.465 -177.388 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.454 ' H ' ' HB ' ' A' ' 100' ' ' VAL . 0.9 OUTLIER -163.32 143.37 8.84 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 108.117 -1.068 . . . . 10.0 108.117 -157.107 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.631 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 6.7 tpp180 -42.21 -38.86 1.87 Allowed 'General case' 0 CA--C 1.548 0.876 0 O-C-N 124.727 1.267 . . . . 10.0 110.921 -174.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -57.86 -44.94 86.9 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.178 0.807 . . . . 10.0 113.178 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.512 ' O ' HG13 ' A' ' 108' ' ' ILE . 0.1 OUTLIER -61.39 -47.39 86.02 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.529 -0.915 . . . . 10.0 108.529 177.796 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.847 HG23 ' HB ' ' A' ' 128' ' ' ILE . 1.9 mp -40.44 -56.51 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 CA-C-N 115.044 -0.98 . . . . 10.0 112.274 168.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.8 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 16.9 tt0 -47.15 -57.86 4.66 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 124.74 1.216 . . . . 10.0 111.835 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.615 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 68.5 mm-40 -52.91 -55.38 23.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.969 -1.014 . . . . 10.0 110.986 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.889 HG23 ' HB3' ' A' ' 78' ' ' LEU . 32.4 mt -51.57 -54.84 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.902 -0.59 . . . . 10.0 109.925 174.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.512 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -50.6 -42.42 55.86 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 124.047 0.842 . . . . 10.0 112.63 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.8 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 70.1 mttt -67.43 -49.68 62.66 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 122.187 0.994 . . . . 10.0 108.876 -176.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 98.5 m -53.02 -22.29 5.59 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 113.302 -1.772 . . . . 10.0 112.77 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.89 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 1.2 ptpp? -131.11 11.2 5.02 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 113.886 1.069 . . . . 10.0 113.886 -178.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.747 ' HG3' ' HD3' ' A' ' 114' ' ' PRO . 8.7 ptp -48.95 -38.35 25.5 Favored Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 118.714 0.688 . . . . 10.0 112.6 167.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.747 ' HD3' ' HG3' ' A' ' 113' ' ' MET . 34.3 Cg_endo -63.06 -27.83 74.0 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 121.42 1.413 . . . . 10.0 112.316 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.642 ' HB3' ' HG3' ' A' ' 73' ' ' PRO . 4.7 m-20 -95.99 -47.48 6.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.041 -0.981 . . . . 10.0 111.838 -175.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.598 HD13 ' HB2' ' A' ' 112' ' ' LYS . 7.5 mp -64.12 -1.92 1.79 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.002 -1.454 . . . . 10.0 111.053 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.439 ' H ' ' C ' ' A' ' 115' ' ' ASP . 0.9 OUTLIER 63.79 45.53 4.4 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.773 -1.558 . . . . 10.0 109.733 176.767 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.626 ' HB3' ' HB2' ' A' ' 113' ' ' MET . . . -82.5 114.7 21.1 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 113.703 -1.589 . . . . 10.0 112.198 -175.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -66.7 -33.48 75.73 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.246 -0.65 . . . . 10.0 109.246 169.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 45.7 t -150.83 144.46 25.06 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.007 -1.479 . . . . 10.0 107.007 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.567 ' O ' HD13 ' A' ' 121' ' ' LEU . 2.5 tm? -51.61 -34.51 37.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.824 -1.08 . . . . 10.0 112.433 -176.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.579 ' HA ' ' HG3' ' A' ' 125' ' ' MET . 14.4 mm-40 -48.23 -42.7 31.06 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.425 0.631 . . . . 10.0 111.152 174.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.09 -46.45 77.62 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 118.708 -1.197 . . . . 10.0 110.34 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.511 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -57.33 -37.42 72.5 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.149 176.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.579 ' HG3' ' HA ' ' A' ' 122' ' ' GLU . 19.9 mtp -54.74 -38.83 67.64 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.61 0.243 . . . . 10.0 111.505 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' A' ' 122' ' ' GLU . 61.7 mmtt -63.66 -47.97 79.12 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.831 -0.803 . . . . 10.0 108.831 -178.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.509 HD12 ' HA ' ' A' ' 124' ' ' ALA . 78.9 mt -51.1 -62.86 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-O 121.659 0.742 . . . . 10.0 110.614 176.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.847 ' HB ' HG23 ' A' ' 105' ' ' ILE . 32.9 mm -53.4 -56.66 7.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 113.949 -1.478 . . . . 10.0 112.636 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.98 -39.36 68.92 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.546 -0.909 . . . . 10.0 108.546 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.469 ' HA2' ' HE2' ' A' ' 133' ' ' LYS . . . -70.73 -46.78 44.28 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.531 -0.758 . . . . 10.0 111.657 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 84.3 m -46.2 -63.49 0.98 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.334 -0.933 . . . . 10.0 109.28 170.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.08 -49.81 39.9 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.873 -0.603 . . . . 10.0 111.358 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.469 ' HE2' ' HA2' ' A' ' 130' ' ' GLY . 26.8 ttpt -48.61 -53.22 19.33 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.711 -1.131 . . . . 10.0 111.55 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 43.5 m -67.63 -28.12 67.46 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 111.792 0.293 . . . . 10.0 111.792 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.444 ' HB2' HD12 ' A' ' 137' ' ' ILE . 7.4 mtm -80.05 6.41 11.55 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.614 0.968 . . . . 10.0 113.614 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 81.09 10.81 84.42 Favored Glycine 0 N--CA 1.452 -0.261 0 CA-C-N 119.504 1.047 . . . . 10.0 111.55 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 32.1 mt -100.57 126.54 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-O 121.165 0.507 . . . . 10.0 111.005 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.746 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -85.25 154.01 22.23 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.205 -0.998 . . . . 10.0 109.15 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.464 HG12 HD11 ' A' ' 105' ' ' ILE . 27.7 m -111.21 120.63 62.25 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.488 0 N-CA-C 107.314 -1.365 . . . . 10.0 107.314 169.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 100' ' ' VAL . 29.9 m -101.39 152.11 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 CA-C-N 114.123 -1.399 . . . . 10.0 108.76 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 26.3 t0 . . . . . 0 C--N 1.294 -1.823 0 CA-C-N 112.874 -1.966 . . . . 10.0 112.876 -173.646 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.448 ' HB3' ' OE2' ' A' ' 62' ' ' GLU . 47.9 tttp . . . . . 0 N--CA 1.442 -0.857 0 N-CA-C 107.929 -1.138 . . . . 10.0 107.929 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.2 t -62.12 124.94 17.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 120.721 0.296 . . . . 10.0 110.498 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -99.68 -28.73 13.04 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.462 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -165.93 -167.6 1.11 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.166 -0.924 . . . . 10.0 112.811 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 9.7 pt20 -148.19 135.77 20.69 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.134 -1.394 . . . . 10.0 109.462 178.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.62 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -120.88 80.56 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 109.022 -0.733 . . . . 10.0 109.022 -178.301 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 30.8 tttt -79.61 125.19 29.3 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 120.101 1.318 . . . . 10.0 108.154 177.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.612 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.8 130.48 7.35 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 122.024 0.916 . . . . 10.0 111.978 -172.872 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -82.91 120.8 26.15 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.24 -1.345 . . . . 10.0 110.105 -173.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.612 HD21 HD11 ' A' ' 11' ' ' LEU . 47.4 mt -136.56 137.69 24.6 Favored Pre-proline 0 N--CA 1.443 -0.82 0 CA-C-O 121.696 0.76 . . . . 10.0 112.213 -171.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.631 ' HB2' ' CB ' ' A' ' 17' ' ' LYS . 22.9 Cg_exo -58.91 122.83 12.27 Favored 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 123.603 2.869 . . . . 10.0 111.663 173.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.603 ' HB1' ' HB ' ' A' ' 46' ' ' THR . . . -62.08 128.95 38.55 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.176 -1.046 . . . . 10.0 108.176 171.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.71 0.78 81.78 Favored Glycine 0 N--CA 1.442 -0.944 0 O-C-N 126.122 2.139 . . . . 10.0 112.786 -174.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.631 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . 5.9 tmtt? -142.05 91.58 2.36 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.86 0.838 . . . . 10.0 112.024 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.36 135.58 5.18 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.449 -1.25 . . . . 10.0 112.588 175.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.506 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 1.4 t -178.29 -50.52 0.0 OUTLIER Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.191 -0.913 . . . . 10.0 112.37 173.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.659 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 84.9 Cg_endo -101.42 125.59 0.11 Allowed 'Trans proline' 0 N--CA 1.414 -3.197 0 N-CA-C 115.726 1.395 . . . . 10.0 115.726 -154.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.125 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 12.04 -89.99 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.534 0 CA-C-N 109.347 -3.569 . . . . 10.0 114.713 168.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.78 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 47.7 Cg_exo -26.72 -56.51 0.1 OUTLIER 'Trans proline' 0 CA--C 1.559 1.742 0 C-N-CA 123.041 2.494 . . . . 10.0 115.824 -161.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.78 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 37.4 Cg_endo -77.75 -72.7 0.01 OUTLIER 'Trans proline' 0 CA--C 1.551 1.327 0 C-N-CA 122.267 1.978 . . . . 10.0 112.327 168.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.993 HG12 HD12 ' A' ' 35' ' ' ILE . 74.9 t -59.55 -54.85 28.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 112.218 -2.264 . . . . 10.0 114.734 -173.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 1.125 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -46.44 -70.27 0.7 Allowed Glycine 0 C--O 1.22 -0.763 0 CA-C-N 114.808 -1.087 . . . . 10.0 113.787 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.625 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 23.5 Cg_exo -47.76 -46.7 20.53 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.489 2.793 . . . . 10.0 112.701 173.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.13 -77.34 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.319 0.581 . . . . 10.0 111.361 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.753 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . 3.3 mt -69.39 -52.05 30.68 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 114.088 1.144 . . . . 10.0 114.088 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.2 -40.13 83.24 Favored Glycine 0 N--CA 1.462 0.367 0 CA-C-N 115.562 -0.744 . . . . 10.0 113.374 -172.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -60.11 -26.3 66.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.851 0.358 . . . . 10.0 110.408 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -99.97 17.02 22.01 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 120.008 -0.677 . . . . 10.0 109.771 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.52 ' HA3' ' HD3' ' A' ' 64' ' ' LYS . . . 82.99 7.57 86.98 Favored Glycine 0 CA--C 1.499 -0.941 0 CA-C-N 114.639 -1.164 . . . . 10.0 113.292 167.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.874 HG11 ' CD2' ' A' ' 66' ' ' PHE . 1.6 t -83.1 145.78 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 113.763 1.023 . . . . 10.0 113.763 -173.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.572 ' HB3' ' HG2' ' A' ' 37' ' ' GLU . 55.0 t-20 -70.58 100.28 1.8 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.452 0.644 . . . . 10.0 110.384 173.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.993 HD12 HG12 ' A' ' 24' ' ' VAL . 23.2 mm -53.54 -40.35 41.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 114.753 -1.112 . . . . 10.0 112.036 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 77.0 mtp -65.5 -53.01 48.55 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.189 -1.823 . . . . 10.0 112.434 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.572 ' HG2' ' HB3' ' A' ' 34' ' ' ASN . 7.0 pt-20 -61.52 -31.17 71.17 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 118.168 -1.413 . . . . 10.0 109.99 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.667 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 68.7 t80 -59.52 -58.97 6.26 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 119.502 -0.879 . . . . 10.0 112.849 168.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -56.22 -50.02 72.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 113.896 -1.502 . . . . 10.0 111.792 -178.669 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -64.85 -22.42 66.99 Favored 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 118.945 -1.102 . . . . 10.0 108.529 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.801 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 62.9 mtt180 -76.97 -64.3 1.16 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.032 -1.067 . . . . 10.0 111.863 169.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.604 ' CZ ' HG21 ' A' ' 46' ' ' THR . 76.8 t80 -54.18 -48.64 70.71 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-N 119.052 0.842 . . . . 10.0 110.784 -171.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -60.27 -51.75 68.22 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.768 -1.105 . . . . 10.0 110.328 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.07 -37.51 87.5 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.172 -1.011 . . . . 10.0 111.53 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.801 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 15.5 mm-40 -63.44 -45.34 91.33 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 122.02 0.914 . . . . 10.0 110.399 177.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.604 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 73.0 p -90.12 3.89 52.0 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.279 -1.328 . . . . 10.0 112.43 -167.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -47.1 -39.04 12.41 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.912 -1.04 . . . . 10.0 111.497 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.95 -48.09 77.89 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 114.125 -1.398 . . . . 10.0 111.532 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 45.1 mttp -98.84 21.96 10.78 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 123.217 0.607 . . . . 10.0 110.291 -172.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -51.99 133.05 32.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.066 -0.97 . . . . 10.0 112.634 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.37 19.27 10.08 Favored Glycine 0 CA--C 1.504 -0.599 0 N-CA-C 110.707 -0.957 . . . . 10.0 110.707 -176.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.582 ' HB2' HD21 ' A' ' 54' ' ' LEU . 66.9 mtt -138.74 125.5 20.91 Favored 'General case' 0 C--O 1.212 -0.885 0 C-N-CA 117.272 -1.771 . . . . 10.0 114.102 -168.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.6 mm -66.17 89.63 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 109.259 -0.645 . . . . 10.0 109.259 171.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.593 HD12 ' CG2' ' A' ' 46' ' ' THR . 8.2 mt -79.22 137.44 56.44 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.285 -0.635 . . . . 10.0 109.285 -177.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 54' ' ' LEU . 6.5 Cg_exo -76.28 106.12 2.2 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.13 1.887 . . . . 10.0 110.592 172.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.418 HG23 HG12 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -105.74 153.61 7.18 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-N 119.775 1.17 . . . . 10.0 110.731 -175.65 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 60.1 t -134.79 119.11 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 C-N-CA 120.789 -0.365 . . . . 10.0 110.244 173.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.75 ' CD1' HD21 ' A' ' 28' ' ' LEU . 15.7 mt -108.0 140.95 24.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 C-N-CA 119.861 -0.735 . . . . 10.0 109.132 -174.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.8 m -124.91 101.05 6.88 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 114.776 -1.102 . . . . 10.0 108.947 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 65' ' ' SER . 2.6 p -90.0 135.77 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.673 0 C-N-CA 124.016 0.927 . . . . 10.0 111.102 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -96.69 -177.05 3.78 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.746 -0.661 . . . . 10.0 112.572 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.448 ' OE2' ' HB3' ' A' ' 4' ' ' LYS . 29.3 mt-10 -55.07 -32.36 61.88 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.411 -1.268 . . . . 10.0 113.182 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.85 -11.25 59.87 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.611 -0.722 . . . . 10.0 111.334 -170.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.527 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 11.9 mmpt? 84.21 3.78 0.77 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.184 -1.043 . . . . 10.0 108.184 -164.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.541 ' O ' HG23 ' A' ' 60' ' ' VAL . 73.3 m -71.82 174.46 6.86 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.997 -1.456 . . . . 10.0 108.651 172.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.874 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -168.91 -175.45 2.36 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 119.655 1.116 . . . . 10.0 110.259 175.336 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 p -159.74 166.47 30.39 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 102.821 -3.029 . . . . 10.0 102.821 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.472 ' CB ' HG12 ' A' ' 58' ' ' ILE . 48.2 p90 -163.27 155.1 17.61 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.464 0.649 . . . . 10.0 109.492 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.405 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 9.4 pt -120.39 165.94 15.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 114.697 -1.138 . . . . 10.0 108.353 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.418 HG12 HG23 ' A' ' 56' ' ' VAL . 19.8 mt -138.46 113.13 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 107.152 -1.425 . . . . 10.0 107.152 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.585 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 11.6 mmmm -75.78 104.38 6.29 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 122.079 0.942 . . . . 10.0 112.676 -160.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.525 ' O ' ' HD2' ' A' ' 112' ' ' LYS . 65.6 p -64.5 -24.97 1.35 Allowed Pre-proline 0 CA--C 1.566 1.56 0 CA-C-N 113.52 -1.673 . . . . 10.0 114.48 171.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.599 ' HD3' ' CG ' ' A' ' 115' ' ' ASP . 74.9 Cg_exo -38.83 -53.3 1.94 Allowed 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 122.993 2.462 . . . . 10.0 115.005 -173.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.433 ' CD ' ' HB2' ' A' ' 73' ' ' PRO . 19.5 Cg_endo -59.13 99.33 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 121.502 1.468 . . . . 10.0 110.618 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.683 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . . . -72.44 -8.48 55.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.113 -0.494 . . . . 10.0 111.115 -174.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.63 -38.58 46.9 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.916 0.76 . . . . 10.0 112.094 -175.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.531 ' HB3' ' SD ' ' A' ' 52' ' ' MET . 36.2 m-85 -70.7 -54.89 10.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.548 0.69 . . . . 10.0 111.223 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.734 ' HB3' HD12 ' A' ' 108' ' ' ILE . 3.7 mm? -74.86 -30.51 61.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.598 0.713 . . . . 10.0 110.109 -173.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.624 HD11 ' HB2' ' A' ' 132' ' ' ALA . 0.8 OUTLIER -62.07 -39.08 91.2 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.933 -0.766 . . . . 10.0 108.933 175.311 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -62.27 -20.39 64.22 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.042 -0.526 . . . . 10.0 111.775 172.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.445 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 13.5 tptp -62.88 -44.31 96.46 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.553 -0.859 . . . . 10.0 110.848 173.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.75 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -76.87 -53.09 8.35 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.273 1.429 . . . . 10.0 112.024 171.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.805 0 CA-C-N 111.655 -2.52 . . . . 10.0 107.752 -177.689 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.548 HG13 ' N ' ' A' ' 98' ' ' GLY . 11.5 p . . . . . 0 CA--C 1.55 0.957 0 N-CA-C 112.583 0.586 . . . . 10.0 112.583 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.548 ' N ' HG13 ' A' ' 97' ' ' VAL . . . -96.07 149.82 19.44 Favored Glycine 0 CA--C 1.503 -0.695 0 N-CA-C 109.818 -1.313 . . . . 10.0 109.818 171.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.891 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -143.63 141.49 30.61 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 122.668 1.223 . . . . 10.0 110.841 168.554 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.869 ' HB ' ' HG2' ' A' ' 104' ' ' GLN . 1.7 m -163.34 -145.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 111.436 -2.62 . . . . 10.0 106.858 -165.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.483 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 1.3 t -163.84 141.81 7.38 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 120.478 -0.489 . . . . 10.0 110.363 -160.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.617 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 0.0 OUTLIER -44.07 -29.82 0.66 Allowed 'General case' 0 CA--C 1.555 1.137 0 O-C-N 124.606 1.192 . . . . 10.0 112.51 -172.626 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.56 ' N ' ' HD3' ' A' ' 102' ' ' ARG . 17.6 tppt? -60.14 -45.15 93.98 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.688 0.625 . . . . 10.0 112.688 175.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.869 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 0.7 OUTLIER -56.6 -47.14 80.25 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.725 -1.213 . . . . 10.0 107.725 178.26 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.953 HG23 ' HB ' ' A' ' 128' ' ' ILE . 2.0 mp -43.69 -51.16 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.654 0 CA-C-N 114.29 -1.323 . . . . 10.0 112.174 172.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.804 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 23.0 tt0 -52.48 -55.6 20.83 Favored 'General case' 0 CA--C 1.506 -0.724 0 O-C-N 124.287 0.992 . . . . 10.0 111.718 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.718 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 66.1 mm-40 -52.58 -57.21 10.71 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 114.408 -1.269 . . . . 10.0 109.993 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.734 HD12 ' HB3' ' A' ' 78' ' ' LEU . 16.4 mm -52.0 -50.4 34.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.496 -0.774 . . . . 10.0 110.534 175.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.415 ' HB3' HD11 ' A' ' 121' ' ' LEU . . . -53.33 -39.06 63.8 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.711 -0.677 . . . . 10.0 112.736 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.804 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 64.5 mttt -72.42 -50.38 26.75 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 122.045 0.926 . . . . 10.0 109.226 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.9 m -51.32 -34.03 31.71 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 113.522 -1.672 . . . . 10.0 113.325 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.683 ' HE2' ' HA ' ' A' ' 75' ' ' ALA . 5.6 mtmp? -119.16 17.2 13.21 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.506 0.67 . . . . 10.0 109.229 -172.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.817 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 43.5 ttm -50.66 -47.0 86.01 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 114.708 -1.133 . . . . 10.0 113.048 177.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 113' ' ' MET . 20.3 Cg_endo -57.9 -24.44 64.64 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.168 1.912 . . . . 10.0 112.384 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.599 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 4.3 m-20 -94.26 -49.81 5.55 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.206 -0.906 . . . . 10.0 112.317 -177.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.542 ' CD1' ' HA ' ' A' ' 73' ' ' PRO . 10.1 mp -65.6 38.28 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 114.396 -1.274 . . . . 10.0 113.014 -177.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.437 ' H ' ' C ' ' A' ' 115' ' ' ASP . 9.4 t30 19.59 51.12 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 O-C-N 124.843 1.34 . . . . 10.0 112.025 -171.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.817 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -80.93 107.56 13.85 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.131 0.789 . . . . 10.0 113.131 -173.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -66.45 -37.6 85.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.624 0.726 . . . . 10.0 109.282 169.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.8 p -151.87 144.25 24.08 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.203 -1.406 . . . . 10.0 107.203 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.656 ' O ' ' HG2' ' A' ' 125' ' ' MET . 62.3 tp -51.93 -31.75 30.0 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 114.311 1.226 . . . . 10.0 114.311 -175.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -49.87 -39.76 40.43 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.681 0.753 . . . . 10.0 110.074 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.619 ' O ' ' HG3' ' A' ' 126' ' ' LYS . . . -66.93 -49.46 65.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.771 -1.104 . . . . 10.0 111.186 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.591 ' HB3' HD12 ' A' ' 121' ' ' LEU . . . -56.19 -34.96 66.71 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.92 -0.712 . . . . 10.0 110.719 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.732 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 50.6 mmm -56.64 -45.25 81.7 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.058 0.762 . . . . 10.0 113.058 178.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.738 ' HD3' ' N ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -65.14 -36.36 84.01 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.776 -0.453 . . . . 10.0 109.776 -177.853 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.738 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 73.4 mt -54.37 -65.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-O 121.571 0.7 . . . . 10.0 110.707 174.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.953 ' HB ' HG23 ' A' ' 105' ' ' ILE . 20.5 mm -51.05 -54.26 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 CA-C-N 113.853 -1.521 . . . . 10.0 112.365 -177.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.549 ' HG2' ' HA ' ' A' ' 126' ' ' LYS . 6.6 pt-20 -56.45 -44.58 80.63 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.382 -0.599 . . . . 10.0 109.382 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.531 ' HA2' ' HD2' ' A' ' 133' ' ' LYS . . . -69.33 -46.9 54.92 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.869 -0.605 . . . . 10.0 111.81 -175.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.584 HG21 ' HB3' ' A' ' 75' ' ' ALA . 64.8 m -44.99 -61.29 1.68 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.648 -0.871 . . . . 10.0 108.648 168.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.624 ' HB2' HD11 ' A' ' 79' ' ' LEU . . . -49.06 -46.23 44.13 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.895 -0.593 . . . . 10.0 112.353 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.531 ' HD2' ' HA2' ' A' ' 130' ' ' GLY . 65.2 mttm -49.88 -53.64 24.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.815 176.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 9.4 m -67.23 -31.79 72.38 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.482 0.658 . . . . 10.0 110.476 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.549 ' SD ' HG22 ' A' ' 131' ' ' THR . 26.0 mtp -77.67 -1.15 29.59 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 114.071 1.137 . . . . 10.0 114.071 -177.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.66 28.8 56.55 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 119.403 1.001 . . . . 10.0 111.949 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.531 ' CG2' ' HB1' ' A' ' 132' ' ' ALA . 1.7 mp -107.11 124.75 63.1 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.076 0 CA-C-O 121.612 0.72 . . . . 10.0 109.993 176.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.891 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 1.3 pt-20 -87.42 149.89 24.15 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.268 -1.382 . . . . 10.0 107.268 176.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 23.7 m -118.88 136.92 54.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.03 -1.1 . . . . 10.0 108.03 174.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.648 HG22 ' O ' ' A' ' 100' ' ' VAL . 8.2 m -135.65 71.48 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 113.801 1.037 . . . . 10.0 113.801 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.833 -1.08 . . . . 10.0 112.564 141.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? . . . . . 0 C--O 1.226 -0.184 0 CA-C-O 120.369 0.128 . . . . 10.0 110.742 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 50.1 t -66.84 138.15 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 122.812 0.445 . . . . 10.0 111.356 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -108.92 -40.91 4.88 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.727 -0.471 . . . . 10.0 109.727 173.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.467 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -156.73 151.03 25.26 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 113.656 0.984 . . . . 10.0 113.656 -176.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -95.27 134.63 37.83 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.842 -1.072 . . . . 10.0 108.26 171.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.675 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.5 OUTLIER -119.95 81.77 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 108.662 -0.866 . . . . 10.0 108.662 171.762 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -79.05 126.63 30.95 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 120.69 1.587 . . . . 10.0 108.098 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.545 HD21 HD11 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.42 128.56 6.72 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 122.331 1.062 . . . . 10.0 111.603 -176.09 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -83.06 119.07 24.01 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 113.816 -1.538 . . . . 10.0 110.086 -171.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.545 HD11 HD21 ' A' ' 11' ' ' LEU . 58.2 mt -137.73 137.84 22.67 Favored Pre-proline 0 CA--C 1.507 -0.688 0 CA-C-O 121.697 0.76 . . . . 10.0 112.427 -170.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.818 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 33.8 Cg_exo -56.05 123.8 14.72 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.752 2.968 . . . . 10.0 112.131 173.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.612 ' HB2' HD11 ' A' ' 54' ' ' LEU . . . -61.82 127.01 29.37 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 107.538 -1.282 . . . . 10.0 107.538 170.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.18 -5.78 81.84 Favored Glycine 0 N--CA 1.441 -1.014 0 O-C-N 125.765 1.916 . . . . 10.0 113.242 -175.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.818 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 2.2 mmmp? -138.47 104.65 5.21 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.562 1.181 . . . . 10.0 112.247 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -167.76 133.29 1.95 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.049 -1.432 . . . . 10.0 111.712 173.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.697 ' HA ' ' HB2' ' A' ' 39' ' ' CYS . 1.8 t -179.01 -40.66 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.102 -0.954 . . . . 10.0 113.075 177.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.692 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 85.0 Cg_endo -105.75 124.43 0.05 OUTLIER 'Trans proline' 0 N--CA 1.415 -3.146 0 N-CA-C 115.821 1.431 . . . . 10.0 115.821 -161.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.11 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 9.75 -84.56 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.545 0 CA-C-N 109.745 -3.389 . . . . 10.0 115.084 165.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.944 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 39.4 Cg_exo -28.74 -57.27 0.13 Allowed 'Trans proline' 0 CA--C 1.562 1.88 0 C-N-CA 122.912 2.408 . . . . 10.0 115.898 -164.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.944 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 6.0 Cg_exo -81.38 -55.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 123.102 2.534 . . . . 10.0 111.919 171.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.08 HG12 HD12 ' A' ' 35' ' ' ILE . 49.6 t -81.01 -52.49 14.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 112.209 -2.269 . . . . 10.0 113.659 -166.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 1.11 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -48.0 -74.07 0.28 Allowed Glycine 0 C--O 1.214 -1.122 0 CA-C-N 114.702 -1.135 . . . . 10.0 113.681 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.677 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 34.7 Cg_exo -46.9 -42.86 24.91 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.514 2.809 . . . . 10.0 112.833 175.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.04 -79.95 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.248 0.547 . . . . 10.0 111.011 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.817 ' HB2' HD11 ' A' ' 35' ' ' ILE . 2.2 mt -67.65 -47.1 70.53 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 114.178 1.177 . . . . 10.0 114.178 -177.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.78 -37.24 92.16 Favored Glycine 0 C--N 1.32 -0.351 0 CA-C-N 115.606 -0.724 . . . . 10.0 113.432 -173.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.54 -26.73 67.11 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.848 -0.427 . . . . 10.0 109.848 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -99.86 16.66 23.03 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 120.055 -0.658 . . . . 10.0 110.09 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.9 9.21 85.7 Favored Glycine 0 CA--C 1.503 -0.658 0 CA-C-N 114.809 -1.087 . . . . 10.0 113.532 168.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.749 HG11 ' CD2' ' A' ' 66' ' ' PHE . 11.4 t -81.77 147.14 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 114.078 1.14 . . . . 10.0 114.078 -172.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -69.03 96.93 0.82 Allowed 'General case' 0 C--N 1.347 0.457 0 C-N-CA 123.38 0.672 . . . . 10.0 110.765 171.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.08 HD12 HG12 ' A' ' 24' ' ' VAL . 20.0 mm -55.52 -38.41 49.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 121.983 0.897 . . . . 10.0 112.163 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -46.94 74.31 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.611 -1.631 . . . . 10.0 112.076 175.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.631 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 17.7 mt-10 -58.83 -43.74 90.73 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 118.66 -1.216 . . . . 10.0 110.479 174.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.576 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 79.3 t80 -54.71 -56.82 15.15 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 113.599 0.963 . . . . 10.0 113.599 173.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.697 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -55.92 -52.36 64.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.001 -1.454 . . . . 10.0 111.666 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -65.79 -21.61 66.51 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 119.097 -1.041 . . . . 10.0 109.02 -176.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.768 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 85.9 mtt180 -78.13 -63.53 1.37 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 115.311 -0.859 . . . . 10.0 112.144 171.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.638 ' CZ ' HG21 ' A' ' 46' ' ' THR . 75.3 t80 -55.15 -44.38 75.06 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 121.251 0.548 . . . . 10.0 110.367 -172.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -60.48 -49.25 78.32 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.056 -0.974 . . . . 10.0 109.911 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.17 96.76 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.035 -1.066 . . . . 10.0 112.349 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.768 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 4.6 mm-40 -65.43 -43.37 90.71 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.951 0.882 . . . . 10.0 110.756 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.639 ' CG2' HD12 ' A' ' 54' ' ' LEU . 71.6 p -92.52 4.66 53.12 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 114.223 -1.353 . . . . 10.0 112.136 -171.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -47.22 -36.89 9.44 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.809 -1.087 . . . . 10.0 112.548 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -81.33 -40.69 23.2 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.678 -0.692 . . . . 10.0 111.823 -176.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.0 mttp -92.01 18.54 7.81 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 108.822 -0.807 . . . . 10.0 108.822 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.429 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -52.42 147.64 7.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.803 -1.089 . . . . 10.0 113.393 -177.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.49 18.96 31.32 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 114.813 -1.085 . . . . 10.0 110.513 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.557 ' HB2' HD21 ' A' ' 54' ' ' LEU . 61.6 mtt -138.34 127.65 24.49 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 116.693 -2.003 . . . . 10.0 114.866 -167.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.4 mm -65.23 91.71 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 O-C-N 121.787 -0.57 . . . . 10.0 109.58 170.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.639 HD12 ' CG2' ' A' ' 46' ' ' THR . 8.3 mt -84.63 130.65 52.42 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.928 -0.768 . . . . 10.0 108.928 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.506 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 14.3 Cg_exo -71.79 105.91 1.89 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.557 1.505 . . . . 10.0 110.635 173.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -97.22 142.81 13.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 119.9 1.227 . . . . 10.0 110.597 -174.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 89.4 t -119.71 111.83 34.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 120.332 -0.547 . . . . 10.0 110.431 171.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.783 ' CD1' HD21 ' A' ' 28' ' ' LEU . 15.5 mt -105.8 139.22 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.932 0 N-CA-C 107.972 -1.122 . . . . 10.0 107.972 -174.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.8 m -123.24 97.31 5.36 Favored 'General case' 0 N--CA 1.402 -2.836 0 CA-C-N 114.793 -1.094 . . . . 10.0 108.787 178.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.518 HG21 HG22 ' A' ' 33' ' ' VAL . 4.4 p -86.66 137.37 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.956 0 CA-C-N 119.402 1.001 . . . . 10.0 110.089 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.448 ' HE2' ' HG1' ' A' ' 67' ' ' THR . 77.9 m-85 -95.8 172.11 8.23 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.777 0.799 . . . . 10.0 112.857 -177.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -60.38 -22.96 63.93 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.249 -1.341 . . . . 10.0 111.841 -177.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.485 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 10.7 m-20 -77.68 -10.47 59.54 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.353 -0.839 . . . . 10.0 111.527 -176.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 55.1 mtpt 83.85 2.5 0.91 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 124.35 1.031 . . . . 10.0 109.459 -166.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.51 ' O ' HG23 ' A' ' 60' ' ' VAL . 14.6 t -73.74 172.13 12.03 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 113.924 -1.489 . . . . 10.0 107.369 174.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.749 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -169.75 -178.82 3.1 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 120.45 1.477 . . . . 10.0 109.692 175.582 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.448 ' HG1' ' HE2' ' A' ' 61' ' ' TYR . 5.3 p -161.83 169.41 21.37 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 103.542 -2.762 . . . . 10.0 103.542 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.449 ' CB ' HG12 ' A' ' 58' ' ' ILE . 49.8 p90 -162.5 159.3 24.75 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.545 -0.539 . . . . 10.0 109.545 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.9 mt -119.62 166.66 13.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 107.256 -1.387 . . . . 10.0 107.256 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.483 HD12 ' CE1' ' A' ' 42' ' ' PHE . 6.4 mm -126.42 122.18 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 107.004 -1.48 . . . . 10.0 107.004 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.586 ' C ' ' HD2' ' A' ' 73' ' ' PRO . 10.5 mmtp -76.64 96.82 4.25 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 122.188 0.994 . . . . 10.0 112.288 -169.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.733 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 3.4 t -59.46 -35.08 26.67 Favored Pre-proline 0 CA--C 1.56 1.362 0 CA-C-N 113.189 -1.823 . . . . 10.0 112.891 166.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.733 ' HD2' ' N ' ' A' ' 72' ' ' THR . 1.2 Cg_endo -39.69 -47.1 3.61 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 124.33 3.354 . . . . 10.0 116.114 -173.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.566 ' HD3' ' HG2' ' A' ' 73' ' ' PRO . 27.9 Cg_exo -61.62 88.57 0.1 OUTLIER 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 121.267 1.311 . . . . 10.0 111.061 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.656 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -62.54 -17.54 60.07 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.404 -0.816 . . . . 10.0 110.923 -177.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.759 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 17.1 m -54.06 -37.93 64.71 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.868 -0.605 . . . . 10.0 111.331 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -75.08 -50.27 16.98 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.22 0.533 . . . . 10.0 111.27 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.784 ' HB3' HD12 ' A' ' 108' ' ' ILE . 3.5 mm? -70.93 -27.53 63.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.186 0.517 . . . . 10.0 110.377 -176.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.429 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 62.1 mt -75.16 -21.66 58.63 Favored 'General case' 0 C--O 1.209 -1.039 0 CA-C-N 115.954 -0.566 . . . . 10.0 110.619 175.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.759 ' HG2' ' O ' ' A' ' 76' ' ' SER . 75.2 mmtt -61.84 -36.82 82.32 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.349 0.595 . . . . 10.0 109.676 171.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -60.8 -51.13 70.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.581 -0.736 . . . . 10.0 112.43 176.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 1.069 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -75.08 -64.99 0.93 Allowed 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 123.149 1.452 . . . . 10.0 110.715 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 79' ' ' LEU . . . . . . . . 0 C--N 1.295 -1.775 0 CA-C-N 111.514 -2.584 . . . . 10.0 108.427 176.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.465 HG13 ' N ' ' A' ' 98' ' ' GLY . 4.2 p . . . . . 0 CA--C 1.533 0.292 0 CA-C-O 121.225 0.536 . . . . 10.0 112.167 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.465 ' N ' HG13 ' A' ' 97' ' ' VAL . . . -168.95 173.59 43.48 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 108.852 -1.699 . . . . 10.0 108.852 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.636 ' O ' HG13 ' A' ' 100' ' ' VAL . 16.9 mtmt -149.15 177.85 9.26 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-N 117.37 0.585 . . . . 10.0 109.981 -159.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 1.069 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -166.5 111.55 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.496 -1.108 0 CA-C-O 122.643 1.211 . . . . 10.0 111.816 167.241 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 1.1 t -41.58 147.27 0.19 Allowed 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 112.071 -2.331 . . . . 10.0 113.954 173.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.569 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 11.5 mmm180 -39.21 -37.78 0.44 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 111.725 -2.489 . . . . 10.0 112.911 -170.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -57.46 -48.39 79.29 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.651 0.611 . . . . 10.0 112.651 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.658 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -59.28 -46.01 89.7 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.115 -0.698 . . . . 10.0 109.115 -178.81 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.692 HG23 ' HB ' ' A' ' 128' ' ' ILE . 30.6 mm -40.49 -56.89 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 114.883 -1.053 . . . . 10.0 112.448 168.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.821 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 26.6 tt0 -44.51 -60.15 2.1 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.165 0.802 . . . . 10.0 113.165 -178.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.499 ' HA ' ' HD3' ' A' ' 110' ' ' LYS . 25.9 mt-10 -56.11 -49.66 73.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.619 -0.719 . . . . 10.0 110.653 -175.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.784 HD12 ' HB3' ' A' ' 78' ' ' LEU . 21.2 mm -50.62 -55.71 5.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.366 -0.834 . . . . 10.0 110.206 172.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.525 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -49.9 -47.19 52.26 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.298 0.851 . . . . 10.0 113.298 177.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.821 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 12.5 mtpp -67.16 -49.33 65.14 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.664 0.745 . . . . 10.0 109.923 -173.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.3 m -58.31 -29.92 66.26 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 114.557 -1.201 . . . . 10.0 112.003 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.739 ' HB3' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -93.24 -16.27 24.97 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.589 0.755 . . . . 10.0 110.759 -176.766 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.965 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 5.1 ttp -48.75 -44.46 68.71 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 113.448 0.907 . . . . 10.0 113.448 -175.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 113' ' ' MET . 12.6 Cg_endo -56.06 -30.28 77.97 Favored 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 121.836 1.691 . . . . 10.0 111.615 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.435 ' CB ' ' HD3' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -93.34 -45.86 7.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.525 -1.216 . . . . 10.0 111.875 -176.417 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.739 HD22 ' HB3' ' A' ' 112' ' ' LYS . 3.6 mp -63.49 -2.95 1.78 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.127 -1.397 . . . . 10.0 112.218 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 61.0 t30 61.69 45.43 7.96 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.297 -1.32 . . . . 10.0 109.548 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.965 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -86.35 121.0 28.31 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.691 -1.595 . . . . 10.0 112.289 -176.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -67.6 -33.22 74.56 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.225 -0.657 . . . . 10.0 109.225 171.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.0 t -154.96 143.87 20.85 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.965 -1.494 . . . . 10.0 106.965 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' A' ' 124' ' ' ALA . 29.7 tp -53.45 -31.11 44.06 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.19 1.552 . . . . 10.0 115.19 -172.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -48.89 -40.16 28.72 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.722 0.692 . . . . 10.0 110.083 175.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.4 -47.82 66.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.622 -1.172 . . . . 10.0 111.04 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.571 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -57.93 -36.61 72.75 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.624 -0.43 . . . . 10.0 110.429 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.554 ' HG3' ' HG ' ' A' ' 121' ' ' LEU . 64.7 mtp -61.82 -34.75 76.5 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.361 0.6 . . . . 10.0 110.169 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -64.12 -51.23 64.92 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.682 -1.144 . . . . 10.0 109.465 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.531 HG21 ' HG ' ' A' ' 116' ' ' LEU . 76.1 mt -50.98 -62.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 CA-C-N 115.266 -0.879 . . . . 10.0 110.727 177.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.692 ' HB ' HG23 ' A' ' 105' ' ' ILE . 26.5 mm -50.36 -54.51 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.078 0 CA-C-N 114.779 -1.1 . . . . 10.0 111.153 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' A' ' 133' ' ' LYS . 42.5 tt0 -53.56 -44.83 69.6 Favored 'General case' 0 N--CA 1.435 -1.214 0 O-C-N 124.119 0.887 . . . . 10.0 109.227 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -72.45 -45.93 35.22 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.618 -0.801 . . . . 10.0 111.698 -175.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.656 HG21 ' HB3' ' A' ' 75' ' ' ALA . 85.8 m -46.48 -60.1 2.56 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.359 -0.92 . . . . 10.0 109.575 171.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -48.24 -48.14 35.49 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.396 -0.82 . . . . 10.0 111.926 175.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 130' ' ' GLY . 47.9 mtpt -47.62 -54.25 12.43 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.755 0.659 . . . . 10.0 111.52 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 44.9 m -64.58 -30.82 71.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.879 0.371 . . . . 10.0 111.019 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.416 ' HE1' ' HA ' ' A' ' 76' ' ' SER . 43.5 mtm -79.65 7.94 7.47 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.502 0.927 . . . . 10.0 113.502 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.7 3.74 80.3 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 119.436 1.016 . . . . 10.0 111.564 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.523 HG23 ' HA ' ' A' ' 99' ' ' LYS . 39.9 mt -99.29 134.93 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-O 121.712 0.767 . . . . 10.0 112.58 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.477 ' HG2' ' HG2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -96.89 160.03 14.59 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.704 -1.135 . . . . 10.0 109.571 177.279 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.3 m -107.66 131.63 57.39 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.647 0 N-CA-C 106.68 -1.6 . . . . 10.0 106.68 170.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 101' ' ' THR . 3.4 m -117.22 -178.9 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-N 114.809 -1.087 . . . . 10.0 109.661 -174.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 38.9 t70 . . . . . 0 C--N 1.281 -2.407 0 CA-C-N 112.635 -2.075 . . . . 10.0 109.026 163.961 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.607 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.525 0 N-CA-C 109.225 -0.657 . . . . 10.0 109.225 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.02 139.96 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 122.671 0.388 . . . . 10.0 111.874 -173.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.526 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . . . -112.07 -36.58 5.32 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.134 -0.485 . . . . 10.0 109.708 172.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.478 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -155.4 143.03 19.69 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.25 0.833 . . . . 10.0 113.25 -177.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -93.16 130.1 38.94 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.648 -1.241 . . . . 10.0 107.648 170.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.683 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -119.95 81.66 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.051 -0.722 . . . . 10.0 109.051 176.852 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.462 ' HG2' HG13 ' A' ' 57' ' ' VAL . 9.6 mtmp? -79.13 127.39 31.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 120.137 1.335 . . . . 10.0 108.413 175.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.632 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.3 127.62 6.4 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.295 1.045 . . . . 10.0 111.731 -175.025 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -83.13 121.62 27.29 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.172 -1.377 . . . . 10.0 110.117 -172.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.632 HD21 HD11 ' A' ' 11' ' ' LEU . 69.3 mt -139.16 139.88 24.57 Favored Pre-proline 0 CA--C 1.506 -0.728 0 CA-C-O 121.737 0.78 . . . . 10.0 111.963 -170.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.853 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 11.9 Cg_exo -59.61 124.65 15.9 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 123.426 2.751 . . . . 10.0 111.506 173.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.625 ' CB ' ' HB ' ' A' ' 46' ' ' THR . . . -61.87 126.98 29.24 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 107.956 -1.127 . . . . 10.0 107.956 170.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.85 -2.23 88.34 Favored Glycine 0 N--CA 1.44 -1.093 0 O-C-N 125.66 1.85 . . . . 10.0 112.933 -175.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.853 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 74.9 mmtt -140.27 107.74 5.57 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 118.007 0.904 . . . . 10.0 112.422 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.528 ' H ' HD22 ' A' ' 43' ' ' ASN . . . -169.77 134.41 1.35 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.92 -1.491 . . . . 10.0 112.052 171.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.546 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 1.6 t 178.92 -39.61 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.542 0 O-C-N 124.157 0.911 . . . . 10.0 113.169 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.725 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 71.8 Cg_endo -103.71 122.44 0.07 OUTLIER 'Trans proline' 0 N--CA 1.417 -2.983 0 N-CA-C 115.935 1.475 . . . . 10.0 115.935 -161.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.966 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 9.12 -82.91 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.451 0 CA-C-N 110.283 -3.144 . . . . 10.0 115.06 162.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.714 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 70.1 Cg_exo -33.16 -56.97 0.34 Allowed 'Trans proline' 0 CA--C 1.564 2.019 0 C-N-CA 122.182 1.921 . . . . 10.0 115.676 -164.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.725 ' HD2' ' O ' ' A' ' 20' ' ' PRO . 58.2 Cg_endo -78.62 -59.24 0.04 OUTLIER 'Trans proline' 0 CA--C 1.553 1.457 0 C-N-CA 122.734 2.29 . . . . 10.0 113.158 170.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.9 t -80.89 -36.81 15.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 112.441 -2.163 . . . . 10.0 113.388 -165.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.966 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -53.92 -69.03 1.35 Allowed Glycine 0 C--N 1.305 -1.142 0 CA-C-N 113.514 -1.676 . . . . 10.0 112.471 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 70.2 Cg_exo -50.87 -43.41 47.21 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.845 2.363 . . . . 10.0 112.117 172.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.81 -96.54 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 112.372 0.508 . . . . 10.0 112.372 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.787 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.307 0.0 OUTLIER -75.11 -26.36 59.19 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 118.152 -1.419 . . . . 10.0 113.573 -176.233 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.577 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -68.53 -40.99 85.99 Favored Glycine 0 N--CA 1.465 0.589 0 C-N-CA 120.926 -0.654 . . . . 10.0 112.68 -175.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -60.96 -21.41 63.45 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.112 -0.635 . . . . 10.0 110.099 175.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -99.09 19.81 14.53 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.629 -0.828 . . . . 10.0 110.215 178.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.559 ' HA3' ' HD2' ' A' ' 64' ' ' LYS . . . 86.59 4.61 82.82 Favored Glycine 0 CA--C 1.501 -0.785 0 CA-C-N 115.201 -0.909 . . . . 10.0 113.363 167.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.787 ' HB ' HD23 ' A' ' 28' ' ' LEU . 4.6 t -83.01 146.2 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 113.414 0.894 . . . . 10.0 113.414 -172.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 0.6 OUTLIER -69.07 99.96 1.18 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.818 0.447 . . . . 10.0 110.321 171.731 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.667 HD11 ' HA2' ' A' ' 25' ' ' GLY . 83.2 mt -53.0 -40.14 35.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.807 0.813 . . . . 10.0 111.594 175.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 72.2 mtm -68.04 -46.66 70.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.67 -1.605 . . . . 10.0 111.783 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.541 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 10.4 tp10 -56.13 -45.25 79.64 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.298 -0.561 . . . . 10.0 109.758 174.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.576 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 48.0 t80 -57.04 -55.34 35.92 Favored 'General case' 0 C--O 1.212 -0.877 0 N-CA-C 113.97 1.1 . . . . 10.0 113.97 171.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -50.35 71.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.663 -1.153 . . . . 10.0 111.886 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.72 -22.76 66.63 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 119.368 -0.933 . . . . 10.0 108.753 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.745 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 87.2 mtt180 -76.95 -64.18 1.19 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.264 -0.88 . . . . 10.0 112.168 171.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.62 ' CZ ' HG21 ' A' ' 46' ' ' THR . 80.2 t80 -55.27 -47.38 75.58 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.419 0.628 . . . . 10.0 110.094 -171.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.528 HD22 ' H ' ' A' ' 18' ' ' ALA . 4.3 m-20 -61.02 -48.24 82.72 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.489 -1.232 . . . . 10.0 110.317 -177.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.48 91.25 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.076 -1.05 . . . . 10.0 112.119 177.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.745 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 7.7 mm-40 -65.62 -40.35 92.48 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.823 0.821 . . . . 10.0 110.751 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.625 ' HB ' ' CB ' ' A' ' 15' ' ' ALA . 73.0 p -93.11 2.87 56.52 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 114.436 -1.256 . . . . 10.0 112.835 -170.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.11 -35.4 11.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.993 -1.003 . . . . 10.0 112.281 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -81.43 -43.1 19.4 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 115.314 -0.857 . . . . 10.0 111.561 -176.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -92.17 20.65 5.75 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.799 -0.815 . . . . 10.0 108.799 -176.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.416 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -53.3 149.21 7.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.952 -1.022 . . . . 10.0 113.09 -178.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.41 18.95 36.91 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.937 -1.029 . . . . 10.0 110.671 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.736 ' SD ' ' HB2' ' A' ' 77' ' ' PHE . 59.8 mtt -140.38 125.55 18.64 Favored 'General case' 0 C--O 1.212 -0.902 0 C-N-CA 117.419 -1.712 . . . . 10.0 113.941 -165.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 50.1 mm -66.82 90.73 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 118.657 0.662 . . . . 10.0 109.665 172.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.598 HD12 ' CG2' ' A' ' 46' ' ' THR . 10.0 mt -81.7 140.12 47.39 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.426 -0.583 . . . . 10.0 109.426 -177.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.744 ' HG2' ' HG2' ' A' ' 74' ' ' PRO . 3.6 Cg_exo -79.35 103.85 1.67 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.228 1.952 . . . . 10.0 110.896 172.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.408 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -97.99 155.64 3.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 119.885 1.22 . . . . 10.0 111.178 -175.748 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.462 HG13 ' HG2' ' A' ' 10' ' ' LYS . 96.7 t -134.79 112.51 15.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.015 174.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.683 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 24.4 mt -102.63 142.27 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.716 0 N-CA-C 108.133 -1.062 . . . . 10.0 108.133 -174.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.7 m -124.77 96.63 4.95 Favored 'General case' 0 N--CA 1.406 -2.648 0 CA-C-N 115.011 -0.995 . . . . 10.0 108.861 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.602 HG21 HG22 ' A' ' 33' ' ' VAL . 2.0 p -90.5 135.85 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 CA-C-N 119.479 1.036 . . . . 10.0 110.268 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -91.86 170.6 9.75 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.99 -1.004 . . . . 10.0 112.635 -176.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.607 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 14.2 mt-10 -60.4 -20.78 60.9 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.684 -1.598 . . . . 10.0 112.03 -176.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 2.9 m-20 -85.53 -4.72 59.24 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.329 -0.85 . . . . 10.0 112.09 -176.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.559 ' HD2' ' HA3' ' A' ' 32' ' ' GLY . 40.2 mmtt 81.99 0.65 1.45 Allowed 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 122.188 0.994 . . . . 10.0 110.334 -169.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.52 ' O ' HG23 ' A' ' 60' ' ' VAL . 17.4 m -70.83 168.43 16.8 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.736 -1.574 . . . . 10.0 107.289 173.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.675 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -168.94 -177.12 2.87 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 120.687 1.585 . . . . 10.0 109.818 176.115 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.2 p -162.6 169.35 20.34 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 103.077 -2.935 . . . . 10.0 103.077 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.445 ' CB ' HG12 ' A' ' 58' ' ' ILE . 42.4 p90 -163.39 159.91 22.92 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.756 -0.831 . . . . 10.0 108.756 177.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 23.7 pt -129.19 161.57 38.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.468 -1.308 . . . . 10.0 107.468 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.417 HD13 ' CG2' ' A' ' 46' ' ' THR . 7.6 mt -126.95 120.15 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 106.568 -1.641 . . . . 10.0 106.568 -176.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.789 ' HE2' ' HA ' ' A' ' 71' ' ' LYS . 5.7 mmmm -76.4 98.2 4.49 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 122.325 1.06 . . . . 10.0 113.042 -160.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.623 ' O ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -44.6 -44.45 20.68 Favored Pre-proline 0 CA--C 1.56 1.337 0 CA-C-N 112.682 -2.054 . . . . 10.0 114.997 164.607 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.653 ' HD3' ' CG ' ' A' ' 115' ' ' ASP . 2.4 Cg_endo -39.43 -56.01 1.41 Allowed 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 124.268 3.312 . . . . 10.0 116.205 -171.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.744 ' HG2' ' HG2' ' A' ' 55' ' ' PRO . 88.9 Cg_exo -43.5 -34.74 5.35 Favored 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 123.207 2.604 . . . . 10.0 113.729 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.684 ' HB1' HD23 ' A' ' 79' ' ' LEU . . . 73.98 -31.77 0.22 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.679 0.992 . . . . 10.0 113.679 170.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.695 ' O ' ' HD3' ' A' ' 80' ' ' LYS . 47.9 t -42.24 -56.96 2.72 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 123.753 0.658 . . . . 10.0 111.958 -175.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.736 ' HB2' ' SD ' ' A' ' 52' ' ' MET . 32.7 p90 -55.9 -37.02 68.33 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.574 0.583 . . . . 10.0 112.574 -175.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 78' ' ' LEU . 1.3 tp -88.55 -32.2 18.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.871 0.367 . . . . 10.0 110.595 -174.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.684 HD23 ' HB1' ' A' ' 75' ' ' ALA . 4.3 mm? -63.8 -33.15 75.03 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.47 -0.567 . . . . 10.0 109.47 172.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.695 ' HD3' ' O ' ' A' ' 76' ' ' SER . 3.9 mptp? -56.04 -46.47 78.87 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.816 -0.629 . . . . 10.0 110.12 172.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.411 ' HD3' ' HA ' ' A' ' 81' ' ' LYS . 2.8 mmtm -57.23 -43.42 82.86 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.509 0.929 . . . . 10.0 113.509 -176.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.68 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -65.94 -49.0 69.47 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 123.044 1.402 . . . . 10.0 110.086 175.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.526 ' HB1' ' HA3' ' A' ' 98' ' ' GLY . . . . . . . . 0 C--N 1.291 -1.942 0 CA-C-N 111.306 -2.679 . . . . 10.0 110.358 -171.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.653 HG13 ' H ' ' A' ' 98' ' ' GLY . 7.3 p . . . . . 0 CA--C 1.537 0.463 0 N-CA-C 112.358 0.503 . . . . 10.0 112.358 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.765 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -111.17 154.72 16.52 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 109.16 -1.576 . . . . 10.0 109.16 169.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.805 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 21.1 pttp -153.8 153.43 32.14 Favored 'General case' 0 CA--C 1.474 -1.958 0 CA-C-O 122.358 1.075 . . . . 10.0 109.865 164.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.68 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.7 OUTLIER -164.62 -162.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.414 -2.251 0 CA-C-N 111.976 -2.374 . . . . 10.0 105.958 -167.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.598 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 9.6 p -119.49 159.37 24.42 Favored 'General case' 0 C--N 1.275 -2.639 0 C-N-CA 119.494 -0.882 . . . . 10.0 111.838 -170.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.674 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 29.0 mmt180 -44.0 -41.92 5.69 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.193 -1.367 . . . . 10.0 110.334 170.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.489 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 3.1 tppp? -59.03 -44.8 91.8 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.672 0.619 . . . . 10.0 112.672 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.631 ' O ' HG12 ' A' ' 108' ' ' ILE . 58.9 mm-40 -58.33 -52.85 63.87 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.763 -0.829 . . . . 10.0 108.763 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.712 HD12 HG22 ' A' ' 128' ' ' ILE . 31.4 mm -38.04 -51.68 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.704 0 CA-C-N 114.318 -1.31 . . . . 10.0 111.899 167.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.748 ' HA ' ' SD ' ' A' ' 125' ' ' MET . 34.2 tt0 -52.95 -58.7 6.07 Favored 'General case' 0 C--O 1.215 -0.746 0 C-N-CA 124.627 1.171 . . . . 10.0 113.55 -177.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -58.36 -47.08 84.95 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 119.913 -0.715 . . . . 10.0 110.554 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.631 HG12 ' O ' ' A' ' 104' ' ' GLN . 19.8 mm -48.46 -60.75 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.558 166.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.577 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -51.33 -38.01 50.81 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.138 0.422 . . . . 10.0 112.138 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.683 ' O ' ' HG2' ' A' ' 113' ' ' MET . 83.4 mttt -70.36 -54.44 12.49 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.854 -174.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.74 HG23 ' HG3' ' A' ' 112' ' ' LYS . 5.8 t -57.05 -24.65 55.36 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.804 -0.635 . . . . 10.0 111.208 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.74 ' HG3' HG23 ' A' ' 111' ' ' THR . 5.8 mtpm? -105.98 -11.0 16.32 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.69 0.626 . . . . 10.0 112.69 -175.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.683 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 22.7 ptm -51.82 -31.5 6.36 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 113.845 1.054 . . . . 10.0 113.845 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 113' ' ' MET . 31.6 Cg_endo -63.02 -28.02 74.45 Favored 'Trans proline' 0 C--N 1.368 1.558 0 CA-C-N 121.063 1.415 . . . . 10.0 111.31 174.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.653 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -100.19 -38.51 8.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.406 -1.27 . . . . 10.0 113.431 -172.115 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.68 HD11 ' NZ ' ' A' ' 112' ' ' LYS . 3.0 mp -62.93 -1.37 0.88 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.928 -1.033 . . . . 10.0 112.021 -175.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 115' ' ' ASP . 56.7 t30 58.38 65.56 1.24 Allowed 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.084 -1.417 . . . . 10.0 109.596 175.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.537 ' HB1' ' HB3' ' A' ' 123' ' ' ALA . . . -142.86 143.07 31.93 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.88 -1.054 . . . . 10.0 112.142 -171.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -65.72 -74.93 0.1 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.444 -1.253 . . . . 10.0 109.553 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.7 m -82.52 147.79 28.46 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.371 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.671 HD13 ' C ' ' A' ' 121' ' ' LEU . 1.5 tm? -55.11 -34.36 63.62 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.462 -0.57 . . . . 10.0 109.462 163.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -50.78 -38.51 48.58 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.307 0.575 . . . . 10.0 111.102 173.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.537 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . . . -67.61 -45.57 75.04 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 118.635 -1.226 . . . . 10.0 110.466 175.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.579 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -56.29 -32.78 64.9 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.487 -0.324 . . . . 10.0 110.848 175.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.748 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 84.0 mmm -58.17 -37.09 74.06 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.017 0.437 . . . . 10.0 110.89 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.532 ' HA ' ' HG2' ' A' ' 129' ' ' GLU . 3.5 mptp? -62.56 -54.28 42.13 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.233 -0.894 . . . . 10.0 111.933 177.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.552 HD12 ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -51.55 -57.93 2.75 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 C-N-CA 119.178 -1.009 . . . . 10.0 110.595 178.375 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.712 HG22 HD12 ' A' ' 105' ' ' ILE . 24.1 mm -50.73 -58.41 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 114.578 -1.192 . . . . 10.0 112.448 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.532 ' HG2' ' HA ' ' A' ' 126' ' ' LYS . 11.6 pt-20 -53.42 -44.32 68.68 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.862 -0.792 . . . . 10.0 108.862 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.4 -47.77 55.66 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.779 -0.725 . . . . 10.0 111.329 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 69.6 m -43.07 -67.18 0.3 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.105 -1.048 . . . . 10.0 108.727 170.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.551 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -51.18 -48.63 61.9 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.851 -0.613 . . . . 10.0 112.331 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -47.81 -52.81 17.53 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.95 -0.568 . . . . 10.0 111.919 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 28.9 t -64.72 -29.36 70.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.752 0.31 . . . . 10.0 110.98 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.495 ' HE2' ' HA ' ' A' ' 132' ' ' ALA . 56.9 mtm -82.45 2.25 33.61 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 114.29 1.218 . . . . 10.0 114.29 -175.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.78 10.9 69.02 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 120.148 1.34 . . . . 10.0 111.777 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.765 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 2.7 mp -99.09 125.26 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 CA-C-O 121.64 0.733 . . . . 10.0 110.593 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.805 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -91.26 157.12 17.33 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.618 -1.174 . . . . 10.0 108.915 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 17.6 m -117.47 127.84 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.726 -0.472 . . . . 10.0 109.726 174.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.598 ' H ' ' HA ' ' A' ' 101' ' ' THR . 18.5 m -147.28 74.49 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 N-CA-C 116.151 1.908 . . . . 10.0 116.151 -170.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.498 ' OD1' ' HB2' ' A' ' 102' ' ' ARG . 1.3 m-20 . . . . . 0 C--N 1.289 -2.043 0 C-N-CA 119.823 -0.751 . . . . 10.0 110.844 145.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.682 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . 61.4 tttp . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 109.274 -0.639 . . . . 10.0 109.274 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.4 t -61.21 124.7 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 120.813 0.34 . . . . 10.0 110.528 -174.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.97 -27.0 8.6 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 120.54 -0.464 . . . . 10.0 110.344 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.594 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -160.45 174.64 13.8 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.222 0.823 . . . . 10.0 113.222 177.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.51 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 23.2 mm-40 -129.86 127.32 39.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.399 -1.273 . . . . 10.0 108.244 177.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.799 HG21 ' HG ' ' A' ' 28' ' ' LEU . 1.4 mm -116.2 87.01 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.121 -0.696 . . . . 10.0 109.121 -178.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.433 ' HG2' HG22 ' A' ' 57' ' ' VAL . 15.4 mtpp -78.28 142.68 37.63 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 121.097 1.771 . . . . 10.0 110.255 175.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 24' ' ' VAL . 1.0 OUTLIER -156.81 135.48 11.6 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.649 -0.705 . . . . 10.0 109.115 -176.723 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -96.3 113.22 24.79 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.635 -0.876 . . . . 10.0 108.635 172.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.537 HD11 HD23 ' A' ' 11' ' ' LEU . 31.5 mt -132.51 145.87 59.08 Favored Pre-proline 0 CA--C 1.501 -0.913 0 CA-C-O 121.147 0.499 . . . . 10.0 111.269 -169.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.808 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 5.8 Cg_exo -71.66 123.15 9.19 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 123.102 2.534 . . . . 10.0 111.31 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.543 ' HB2' HD11 ' A' ' 54' ' ' LEU . . . -60.32 127.41 31.65 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 107.936 -1.135 . . . . 10.0 107.936 172.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.22 -1.05 89.34 Favored Glycine 0 N--CA 1.438 -1.19 0 O-C-N 125.671 1.857 . . . . 10.0 112.354 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.808 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 45.2 tptt -139.52 110.76 6.97 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 122.943 1.354 . . . . 10.0 112.588 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.421 ' H ' HD22 ' A' ' 43' ' ' ASN . . . -161.4 128.95 4.13 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.669 -2.06 . . . . 10.0 108.753 168.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.417 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 25.3 p -158.7 66.8 3.21 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 105.897 -1.89 . . . . 10.0 105.897 -174.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.748 ' HG3' HG22 ' A' ' 35' ' ' ILE . 5.7 Cg_exo 12.37 49.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.659 1 C-N-CA 130.673 7.582 . . . . 10.0 116.814 -175.637 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.584 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -57.6 167.75 1.26 Allowed Pre-proline 0 N--CA 1.441 -0.916 0 CA-C-N 112.545 -2.116 . . . . 10.0 109.601 164.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.584 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 72.9 Cg_exo -36.97 -44.35 1.12 Allowed 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 123.648 2.899 . . . . 10.0 114.967 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 22' ' ' PRO . 18.7 Cg_exo -36.29 -66.14 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.808 3.005 . . . . 10.0 114.508 168.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.99 HG12 HD12 ' A' ' 35' ' ' ILE . 58.9 t -85.61 -56.27 5.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 114.433 -1.258 . . . . 10.0 114.02 -164.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.22 -67.67 1.28 Allowed Glycine 0 CA--C 1.521 0.455 0 O-C-N 124.37 1.044 . . . . 10.0 113.276 -174.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.433 ' HD2' ' O ' ' A' ' 22' ' ' PRO . 90.5 Cg_exo -52.03 -46.23 33.8 Favored 'Trans proline' 0 C--O 1.222 -0.289 0 C-N-CA 123.876 3.051 . . . . 10.0 112.8 174.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.5 -79.28 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.296 0.569 . . . . 10.0 111.799 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.902 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . 1.5 mt -67.73 -45.03 76.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.793 -0.64 . . . . 10.0 112.694 -176.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.49 -38.16 90.28 Favored Glycine 0 C--N 1.324 -0.126 0 CA-C-N 115.912 -0.585 . . . . 10.0 112.674 -173.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -65.07 -21.89 66.89 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.915 0.388 . . . . 10.0 110.752 177.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -98.86 16.62 21.75 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.345 0.593 . . . . 10.0 109.958 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.0 2.9 89.42 Favored Glycine 0 CA--C 1.503 -0.68 0 CA-C-N 115.092 -0.958 . . . . 10.0 113.657 168.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.682 HG11 ' CD2' ' A' ' 66' ' ' PHE . 2.0 t -78.96 148.06 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 113.009 0.744 . . . . 10.0 113.009 -173.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.529 ' OD1' ' HB3' ' A' ' 37' ' ' GLU . 0.3 OUTLIER -71.06 90.71 0.86 Allowed 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.919 0.866 . . . . 10.0 109.997 172.532 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.99 HD12 HG12 ' A' ' 24' ' ' VAL . 11.5 mm -53.54 -40.87 43.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 113.818 -1.537 . . . . 10.0 112.081 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 50.6 mtm -66.0 -47.15 75.43 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.594 -1.639 . . . . 10.0 111.967 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.606 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 32.3 tt0 -58.71 -37.68 76.66 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 118.661 -1.216 . . . . 10.0 109.612 173.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.577 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 81.6 t80 -54.61 -58.95 5.5 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 119.554 -0.859 . . . . 10.0 112.767 170.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -54.51 -53.34 55.72 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 114.069 -1.423 . . . . 10.0 111.324 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -67.05 -21.9 65.89 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 119.694 -0.803 . . . . 10.0 109.749 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.816 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 13.7 mtm180 -76.56 -62.48 1.61 Allowed 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 119.543 -0.863 . . . . 10.0 112.286 169.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.618 ' CZ ' HG21 ' A' ' 46' ' ' THR . 63.9 t80 -52.41 -42.06 63.74 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 118.006 0.366 . . . . 10.0 110.536 -172.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.421 HD22 ' H ' ' A' ' 18' ' ' ALA . 4.9 m-20 -60.86 -50.08 74.87 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.817 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.72 -41.58 99.23 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.742 -0.783 . . . . 10.0 112.341 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.816 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 4.4 mm-40 -65.82 -44.23 86.21 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.751 0.786 . . . . 10.0 110.81 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.618 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 76.8 p -89.79 5.09 47.62 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.534 -1.212 . . . . 10.0 111.85 -170.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.88 -40.22 9.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.955 -1.02 . . . . 10.0 112.224 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.88 -32.7 65.58 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.692 -0.685 . . . . 10.0 111.166 -176.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -99.42 17.64 19.74 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.791 0.837 . . . . 10.0 110.105 -175.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -50.26 142.3 10.24 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.172 -0.922 . . . . 10.0 112.873 -176.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.31 18.92 31.86 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.541 -0.754 . . . . 10.0 111.456 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.617 ' SD ' ' HB2' ' A' ' 77' ' ' PHE . 45.7 mtm -141.15 129.72 22.68 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 116.853 -1.939 . . . . 10.0 114.386 -167.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.3 mm -67.52 92.06 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.567 -0.531 . . . . 10.0 109.567 172.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.638 ' HB3' ' CG2' ' A' ' 70' ' ' ILE . 6.5 mt -81.2 130.02 64.43 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 109.697 -0.483 . . . . 10.0 109.697 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.865 ' HG2' ' HG3' ' A' ' 74' ' ' PRO . 18.0 Cg_exo -71.31 103.02 1.34 Allowed 'Trans proline' 0 C--N 1.331 -0.347 0 C-N-CA 122.571 2.181 . . . . 10.0 111.233 172.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.09 156.48 3.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 119.505 1.048 . . . . 10.0 111.706 -175.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.433 HG22 ' HG2' ' A' ' 10' ' ' LYS . 96.0 t -135.98 117.75 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.209 170.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.806 HG21 HD21 ' A' ' 28' ' ' LEU . 12.6 mt -109.93 135.04 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.705 0 N-CA-C 108.595 -0.891 . . . . 10.0 108.595 -175.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.0 m -117.7 95.47 4.95 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 114.954 -1.021 . . . . 10.0 108.308 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.594 ' CG1' ' HB3' ' A' ' 7' ' ' ALA . 2.7 p -86.73 138.11 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.012 0 CA-C-N 119.61 1.095 . . . . 10.0 110.784 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.403 ' HE2' ' HG1' ' A' ' 67' ' ' THR . 59.8 m-85 -92.87 163.85 13.55 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.514 -0.766 . . . . 10.0 111.745 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.682 ' HG2' ' HB3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -60.7 -19.9 59.79 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.605 -1.18 . . . . 10.0 112.093 -179.132 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.33 -4.69 52.04 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.317 -0.856 . . . . 10.0 111.861 -177.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 83.24 -1.74 1.2 Allowed 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 124.318 1.011 . . . . 10.0 109.443 -170.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.6 m -72.6 168.71 18.08 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.572 -1.194 . . . . 10.0 108.327 174.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.682 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -169.47 -179.99 3.63 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 120.477 1.49 . . . . 10.0 109.471 176.088 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.403 ' HG1' ' HE2' ' A' ' 61' ' ' TYR . 1.1 p -160.54 168.67 24.55 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 103.241 -2.874 . . . . 10.0 103.241 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.573 ' HE1' ' HE ' ' A' ' 41' ' ' ARG . 51.4 p90 -163.56 155.94 17.85 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.759 -0.83 . . . . 10.0 108.759 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mt -124.19 167.58 17.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 106.922 -1.51 . . . . 10.0 106.922 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.638 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 2.6 mm -121.84 124.69 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 N-CA-C 106.485 -1.672 . . . . 10.0 106.485 177.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.702 ' HB3' ' HG2' ' A' ' 73' ' ' PRO . 32.0 mmmt -78.73 101.51 7.59 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.943 0.878 . . . . 10.0 111.897 -165.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.787 ' HB ' ' HG2' ' A' ' 112' ' ' LYS . 8.3 p -56.6 -34.73 28.24 Favored Pre-proline 0 CA--C 1.562 1.423 0 CA-C-N 113.449 -1.705 . . . . 10.0 113.974 169.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.738 ' HD2' ' N ' ' A' ' 72' ' ' THR . 4.8 Cg_exo -35.68 -52.15 0.93 Allowed 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 124.838 3.692 . . . . 10.0 115.907 -176.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.865 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 16.7 Cg_endo -58.76 103.45 0.16 Allowed 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.401 1.401 . . . . 10.0 110.495 173.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.709 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -81.13 0.39 36.45 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.245 -0.434 . . . . 10.0 111.364 -171.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.7 t -61.7 -55.29 31.99 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.141 -0.481 . . . . 10.0 111.451 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.683 ' HE1' ' HG2' ' A' ' 74' ' ' PRO . 37.7 p90 -77.77 -27.51 50.31 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.609 0.596 . . . . 10.0 112.609 -171.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.523 ' HB3' HD12 ' A' ' 108' ' ' ILE . 1.1 mm? -75.14 -46.54 33.62 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.416 0.626 . . . . 10.0 110.721 174.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.625 ' HB2' ' O ' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -64.16 -35.6 81.31 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.808 -0.442 . . . . 10.0 109.808 -179.27 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.647 ' HA ' ' HB3' ' A' ' 83' ' ' ALA . 20.2 ttpt -60.61 -31.86 71.02 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.819 -0.628 . . . . 10.0 110.262 173.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 21.9 ttpp -52.56 -44.84 66.11 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 110.439 -0.208 . . . . 10.0 110.439 177.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 1.005 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -73.52 -46.81 45.52 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.81 1.644 . . . . 10.0 111.657 172.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.647 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . . . . . . . . 0 C--N 1.288 -2.071 0 CA-C-N 111.532 -2.576 . . . . 10.0 111.718 -168.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 136' ' ' GLY . 12.4 p . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 112.286 0.476 . . . . 10.0 112.286 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -165.2 155.12 26.3 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 109.439 -1.464 . . . . 10.0 109.439 175.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.69 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 9.2 ptpt -137.87 169.75 17.24 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-O 122.734 1.254 . . . . 10.0 111.71 -161.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 1.005 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -159.5 -144.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 111.456 -2.611 . . . . 10.0 106.132 -174.087 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.49 HG22 ' CG2' ' A' ' 140' ' ' VAL . 28.5 p -154.64 148.21 25.26 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.127 -1.805 . . . . 10.0 106.127 -157.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.668 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 38.3 mmt180 -43.7 -42.47 5.37 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 123.895 0.747 . . . . 10.0 109.894 174.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -57.46 -44.04 84.49 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.69 0.626 . . . . 10.0 112.69 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.591 ' O ' HG12 ' A' ' 108' ' ' ILE . 1.1 mp0 -60.35 -50.04 75.21 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 109.157 -0.683 . . . . 10.0 109.157 177.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.944 HG23 ' HB ' ' A' ' 128' ' ' ILE . 33.0 mm -40.59 -54.1 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.446 -1.252 . . . . 10.0 111.398 169.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.709 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 23.7 tt0 -49.17 -51.37 33.0 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.837 -1.074 . . . . 10.0 112.382 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -51.27 -60.76 2.76 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.131 -0.941 . . . . 10.0 110.016 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.601 HG22 ' HD3' ' A' ' 112' ' ' LYS . 13.4 mm -47.53 -53.0 4.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 113.811 -1.54 . . . . 10.0 110.552 174.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.428 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -52.84 -34.4 53.97 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.663 0.616 . . . . 10.0 112.663 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.709 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 64.3 mttm -73.54 -53.86 9.57 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 116.468 -0.333 . . . . 10.0 110.976 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.76 HG23 ' HG3' ' A' ' 112' ' ' LYS . 11.4 t -56.74 -33.68 66.79 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.293 -0.412 . . . . 10.0 111.704 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.787 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 17.7 mtpp -96.87 -1.31 46.23 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 122.736 0.414 . . . . 10.0 111.321 -177.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.543 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 52.6 ttm -49.33 -47.34 76.95 Favored Pre-proline 0 N--CA 1.468 0.446 0 N-CA-C 112.836 0.68 . . . . 10.0 112.836 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 113' ' ' MET . 32.8 Cg_endo -63.26 -26.55 71.96 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 121.443 1.429 . . . . 10.0 111.979 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.523 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -97.97 -44.45 6.66 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.952 -1.022 . . . . 10.0 113.576 -171.825 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.695 HD13 ' HB3' ' A' ' 112' ' ' LYS . 2.2 mp -66.22 42.22 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.708 -1.133 . . . . 10.0 113.232 -177.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 65.9 t30 14.64 53.0 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 O-C-N 124.776 1.298 . . . . 10.0 112.28 -167.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.407 ' O ' ' CB ' ' A' ' 119' ' ' ASN . . . -65.8 -78.8 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.612 0.967 . . . . 10.0 113.612 -165.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 118' ' ' ALA . 38.5 t-20 99.72 -41.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.883 1.273 . . . . 10.0 108.323 -175.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 47.6 t -148.81 139.54 22.77 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 106.758 -1.571 . . . . 10.0 106.758 173.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.623 ' O ' ' HG2' ' A' ' 125' ' ' MET . 3.2 tm? -53.19 -33.76 54.06 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.157 -0.928 . . . . 10.0 113.324 -177.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -50.02 -42.62 49.73 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.749 0.785 . . . . 10.0 110.697 173.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.494 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . . . -65.7 -49.09 69.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.487 -1.233 . . . . 10.0 110.719 -178.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.579 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -54.93 -37.9 66.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.527 178.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.625 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 78.4 mmm -52.96 -40.34 63.62 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.138 0.792 . . . . 10.0 113.138 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.494 ' HD2' ' HA ' ' A' ' 123' ' ' ALA . 10.3 mttt -63.25 -46.8 85.19 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.291 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.667 HD13 ' HG ' ' A' ' 116' ' ' LEU . 73.2 mt -50.19 -62.58 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-N 115.6 -0.727 . . . . 10.0 110.012 175.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.944 ' HB ' HG23 ' A' ' 105' ' ' ILE . 10.5 mm -53.18 -58.03 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-N 114.058 -1.428 . . . . 10.0 111.441 -176.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.56 -44.01 62.58 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 123.849 0.718 . . . . 10.0 109.584 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -69.9 -45.84 55.49 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.415 -0.897 . . . . 10.0 111.881 -177.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.709 HG21 ' HB3' ' A' ' 75' ' ' ALA . 22.4 m -48.2 -58.12 4.96 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.486 -0.857 . . . . 10.0 109.762 171.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.495 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -53.38 -44.57 68.74 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 111.812 0.301 . . . . 10.0 111.812 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 34.7 tttp -45.33 -55.15 6.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.491 -0.777 . . . . 10.0 110.956 174.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.0 m -64.58 -31.56 72.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.984 0.421 . . . . 10.0 111.529 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.429 ' HE1' ' HB3' ' A' ' 79' ' ' LEU . 10.7 mtm -78.61 -8.84 59.05 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.272 0.841 . . . . 10.0 113.272 -174.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.557 ' O ' HG12 ' A' ' 97' ' ' VAL . . . 88.72 14.36 61.38 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 119.587 1.085 . . . . 10.0 111.74 -178.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 2.0 mp -96.95 124.84 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.95 0 CA-C-O 121.624 0.726 . . . . 10.0 111.062 -177.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.69 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.3 OUTLIER -84.03 146.68 27.83 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.611 -1.177 . . . . 10.0 109.323 177.544 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.7 m -116.64 124.02 72.29 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.782 0 N-CA-C 106.458 -1.682 . . . . 10.0 106.458 174.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 100' ' ' VAL . 33.1 m -106.88 170.01 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.149 0 CA-C-N 113.753 -1.567 . . . . 10.0 110.063 -175.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 . . . . . 0 C--N 1.288 -2.078 0 CA-C-N 113.148 -1.842 . . . . 10.0 108.482 -177.451 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.448 ' HB3' ' HG3' ' A' ' 62' ' ' GLU . 21.2 ttpt . . . . . 0 N--CA 1.448 -0.544 0 N-CA-C 107.371 -1.344 . . . . 10.0 107.371 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.5 t -62.6 127.29 22.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 O-C-N 123.376 0.422 . . . . 10.0 111.148 -174.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -102.51 -28.55 12.11 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.091 -0.707 . . . . 10.0 109.091 176.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.542 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -162.52 177.85 9.1 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.295 0.85 . . . . 10.0 113.295 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 78.3 mt-30 -134.65 129.63 35.14 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 114.493 -1.23 . . . . 10.0 107.963 175.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.665 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 5.4 mt -124.1 87.24 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 109.038 -0.727 . . . . 10.0 109.038 -175.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.524 ' HG3' HG22 ' A' ' 57' ' ' VAL . 3.2 mppt? -78.37 146.39 34.66 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 120.991 -1.068 . . . . 10.0 110.178 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 10' ' ' LYS . 0.9 OUTLIER -156.77 137.16 12.97 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.088 -0.505 . . . . 10.0 109.902 -175.573 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.424 ' HB3' ' CG2' ' A' ' 53' ' ' ILE . 11.4 mm-40 -93.84 113.28 25.28 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.312 -0.996 . . . . 10.0 108.312 169.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.491 HD11 HG22 ' A' ' 24' ' ' VAL . 15.5 mt -132.1 152.88 80.97 Favored Pre-proline 0 C--O 1.212 -0.909 0 CA-C-O 121.31 0.576 . . . . 10.0 111.652 -171.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.677 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 5.5 Cg_exo -78.63 123.59 5.96 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 123.244 2.629 . . . . 10.0 111.784 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 50' ' ' ALA . . . -61.75 126.67 28.15 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.987 -1.116 . . . . 10.0 107.987 172.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.03 1.79 90.4 Favored Glycine 0 N--CA 1.438 -1.192 0 O-C-N 126.043 2.089 . . . . 10.0 112.108 -177.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.677 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 9.6 tptp -141.56 113.45 7.88 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 122.999 1.381 . . . . 10.0 112.102 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.535 ' H ' HD22 ' A' ' 43' ' ' ASN . . . -159.04 140.56 13.26 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 112.869 -1.969 . . . . 10.0 108.561 164.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.0 p -157.64 61.02 2.12 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 105.837 -1.912 . . . . 10.0 105.837 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.695 ' HG3' ' CG2' ' A' ' 35' ' ' ILE . 0.1 OUTLIER 15.41 49.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.692 1 C-N-CA 129.687 6.925 . . . . 10.0 116.11 -178.011 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.64 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -56.08 170.58 0.44 Allowed Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 111.553 -2.567 . . . . 10.0 109.736 165.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.64 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 79.6 Cg_exo -37.39 -44.76 1.46 Allowed 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 123.291 2.661 . . . . 10.0 114.814 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 22' ' ' PRO . 6.4 Cg_exo -38.18 -62.56 0.3 Allowed 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 123.346 2.697 . . . . 10.0 114.374 170.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.942 HG12 HD12 ' A' ' 35' ' ' ILE . 61.6 t -87.44 -56.58 5.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 114.207 1.188 . . . . 10.0 114.207 -163.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.48 -66.52 2.2 Favored Glycine 0 C--O 1.226 -0.348 0 O-C-N 124.02 0.825 . . . . 10.0 113.366 -174.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.435 ' HD2' ' O ' ' A' ' 22' ' ' PRO . 86.4 Cg_exo -53.01 -42.41 64.77 Favored 'Trans proline' 0 C--O 1.225 -0.141 0 C-N-CA 123.262 2.641 . . . . 10.0 112.577 174.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.517 ' HB1' ' CG2' ' A' ' 9' ' ' ILE . . . -53.17 -79.76 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.401 0.619 . . . . 10.0 111.433 177.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.87 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . 2.5 mt -67.17 -46.77 72.97 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.521 -0.763 . . . . 10.0 113.016 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.9 -35.6 87.39 Favored Glycine 0 C--O 1.228 -0.232 0 CA-C-N 116.428 -0.351 . . . . 10.0 112.931 -173.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -64.2 -22.72 67.05 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.72 0.295 . . . . 10.0 110.222 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -99.87 15.53 26.73 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.408 0.623 . . . . 10.0 109.603 175.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.462 ' HA3' ' CE ' ' A' ' 64' ' ' LYS . . . 74.28 14.47 80.68 Favored Glycine 0 CA--C 1.501 -0.799 0 CA-C-N 114.687 -1.142 . . . . 10.0 113.692 170.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.605 HG11 ' CD2' ' A' ' 66' ' ' PHE . 0.9 OUTLIER -82.74 148.88 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 C-N-CA 120.252 -0.579 . . . . 10.0 112.474 -177.074 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -71.11 92.78 0.99 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.701 0.762 . . . . 10.0 110.296 174.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.942 HD12 HG12 ' A' ' 24' ' ' VAL . 14.6 mm -53.94 -40.02 43.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 114.422 -1.263 . . . . 10.0 112.35 178.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -41.88 77.42 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 113.909 -1.496 . . . . 10.0 111.613 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.551 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 22.2 mt-10 -55.77 -44.71 77.94 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 118.932 -1.107 . . . . 10.0 109.611 169.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.673 ' CE1' HD11 ' A' ' 58' ' ' ILE . 84.6 t80 -52.74 -58.62 6.26 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.076 1.139 . . . . 10.0 114.076 172.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 39.9 t -56.9 -51.6 68.47 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 114.75 -1.114 . . . . 10.0 110.924 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.51 ' HA ' ' HD3' ' A' ' 40' ' ' LYS . 28.7 mmtp -67.47 -20.88 65.53 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 119.269 -0.972 . . . . 10.0 110.297 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.613 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 92.7 mtt180 -73.85 -62.85 1.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.912 -0.715 . . . . 10.0 112.103 170.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.514 ' CZ ' HG21 ' A' ' 46' ' ' THR . 73.3 t80 -56.42 -48.55 76.72 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-N 115.572 -0.74 . . . . 10.0 110.415 -173.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.535 HD22 ' H ' ' A' ' 18' ' ' ALA . 5.3 m-20 -59.7 -49.44 77.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.308 -0.86 . . . . 10.0 110.286 -176.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.81 -46.08 91.06 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.169 -1.013 . . . . 10.0 112.71 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 9.5 pt-20 -71.32 -31.25 67.17 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 120.16 -0.616 . . . . 10.0 112.355 -176.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.523 ' CG2' HD12 ' A' ' 54' ' ' LEU . 63.3 p -91.06 2.88 55.99 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.45 -0.795 . . . . 10.0 111.591 -175.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.74 -38.71 7.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.001 -0.999 . . . . 10.0 112.934 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.535 ' OD1' ' HG3' ' A' ' 49' ' ' LYS . 0.5 OUTLIER -81.94 -26.49 33.98 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.729 -0.669 . . . . 10.0 112.199 -174.44 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.535 ' HG3' ' OD1' ' A' ' 48' ' ' ASP . 36.4 mttp -101.72 18.55 20.13 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.473 0.654 . . . . 10.0 109.437 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -50.32 140.95 12.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.704 -1.134 . . . . 10.0 112.928 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.59 18.08 26.7 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 114.984 -1.007 . . . . 10.0 110.774 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.453 ' HB2' HD21 ' A' ' 54' ' ' LEU . 65.6 mtt -137.12 127.23 26.09 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 117.137 -1.825 . . . . 10.0 113.92 -167.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.424 ' CG2' ' HB3' ' A' ' 12' ' ' GLN . 50.9 mm -68.97 90.61 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.268 -0.641 . . . . 10.0 109.268 171.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.523 HD12 ' CG2' ' A' ' 46' ' ' THR . 6.6 mt -77.74 140.03 62.99 Favored Pre-proline 0 N--CA 1.449 -0.482 0 N-CA-C 108.665 -0.865 . . . . 10.0 108.665 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 54' ' ' LEU . 5.3 Cg_exo -77.92 104.78 1.91 Allowed 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.59 2.193 . . . . 10.0 110.889 172.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.54 151.26 4.9 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 CA-C-N 118.893 0.769 . . . . 10.0 111.324 -174.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.524 HG22 ' HG3' ' A' ' 10' ' ' LYS . 99.3 t -135.58 119.81 26.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.981 -0.377 . . . . 10.0 109.981 172.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.842 HG21 HD21 ' A' ' 28' ' ' LEU . 13.0 mt -108.81 137.55 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 N-CA-C 108.36 -0.978 . . . . 10.0 108.36 -174.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.0 m -123.07 96.57 5.06 Favored 'General case' 0 N--CA 1.407 -2.601 0 CA-C-N 114.688 -1.142 . . . . 10.0 108.818 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 65' ' ' SER . 4.3 p -85.73 137.28 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 CA-C-N 119.298 0.953 . . . . 10.0 110.436 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -100.71 178.17 4.78 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.797 0.808 . . . . 10.0 113.056 -176.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.448 ' HG3' ' HB3' ' A' ' 4' ' ' LYS . 28.0 mt-10 -50.57 -33.59 22.43 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.796 -1.547 . . . . 10.0 113.718 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.7 -6.51 57.34 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.517 0.562 . . . . 10.0 112.517 -172.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.462 ' CE ' ' HA3' ' A' ' 32' ' ' GLY . 26.9 mmmt 83.51 5.51 0.79 Allowed 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 124.643 1.214 . . . . 10.0 108.569 -168.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.546 ' O ' HG23 ' A' ' 60' ' ' VAL . 22.0 t -73.74 175.79 6.88 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 113.355 -1.748 . . . . 10.0 107.67 173.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.605 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -170.0 -178.93 3.03 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 120.523 1.51 . . . . 10.0 109.866 176.848 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.9 p -157.64 170.31 22.68 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 103.233 -2.876 . . . . 10.0 103.233 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.46 ' HB3' HG12 ' A' ' 58' ' ' ILE . 48.7 p90 -163.4 157.58 20.11 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.802 -0.814 . . . . 10.0 108.802 174.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.481 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 29.2 pt -122.77 167.77 16.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.014 -1.106 . . . . 10.0 108.014 -176.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.463 HD12 ' CE1' ' A' ' 42' ' ' PHE . 1.9 mm -135.39 117.61 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 107.093 -1.447 . . . . 10.0 107.093 -176.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.629 ' HE2' ' OD2' ' A' ' 115' ' ' ASP . 9.4 mmmm -75.41 97.92 3.76 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.228 -0.589 . . . . 10.0 110.761 -172.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.26 98.0 0.16 Allowed Pre-proline 0 C--N 1.317 -0.809 0 O-C-N 124.639 1.212 . . . . 10.0 109.342 169.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.631 ' HG3' ' CD2' ' A' ' 77' ' ' PHE . 54.3 Cg_endo -67.54 137.29 42.22 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.409 2.073 . . . . 10.0 112.681 -162.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.932 ' HA ' HD11 ' A' ' 116' ' ' LEU . 85.1 Cg_exo -47.29 88.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.746 2.964 . . . . 10.0 113.689 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.68 ' H ' ' HD3' ' A' ' 112' ' ' LYS . . . 70.59 -41.82 0.51 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.073 -0.967 . . . . 10.0 113.569 174.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.9 p -40.83 -73.73 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.3 1.222 . . . . 10.0 114.3 -167.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.631 ' CD2' ' HG3' ' A' ' 73' ' ' PRO . 8.5 m-30 -61.97 -21.81 65.13 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.349 0.87 . . . . 10.0 113.349 -172.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.033 ' HB3' HD12 ' A' ' 108' ' ' ILE . 6.3 mp -101.02 -12.77 18.6 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 119.499 -0.88 . . . . 10.0 111.288 -178.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.463 ' CD1' ' HB1' ' A' ' 75' ' ' ALA . 50.6 mt -76.99 -26.48 53.92 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.07 -1.085 . . . . 10.0 108.07 165.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 61.5 mmtt -59.79 -38.72 82.68 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.207 -0.906 . . . . 10.0 109.5 167.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.538 ' HD3' ' HA ' ' A' ' 81' ' ' LYS . 53.5 mmtt -64.25 -44.64 91.17 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.528 0.936 . . . . 10.0 113.528 175.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.912 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -71.61 -56.31 6.1 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.562 1.945 . . . . 10.0 112.966 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.285 -2.224 0 CA-C-N 111.069 -2.787 . . . . 10.0 105.872 -179.565 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.606 HG13 ' O ' ' A' ' 97' ' ' VAL . 8.2 p . . . . . 0 CA--C 1.553 1.061 0 CA-C-O 122.635 1.207 . . . . 10.0 111.308 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 33.07 -168.76 0.01 OUTLIER Glycine 0 CA--C 1.533 1.204 0 CA-C-N 113.942 -1.481 . . . . 10.0 115.171 -165.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.668 ' CB ' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -160.85 178.26 9.59 Favored 'General case' 0 CA--C 1.488 -1.413 0 CA-C-O 121.791 0.805 . . . . 10.0 112.044 -172.122 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.912 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -159.8 -166.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 113.502 -1.681 . . . . 10.0 111.938 -179.451 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 39.0 p -97.56 143.29 28.4 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 112.734 -2.03 . . . . 10.0 111.473 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.649 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 0.4 OUTLIER -47.87 -41.18 23.58 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.599 -0.728 . . . . 10.0 109.925 166.576 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.06 -43.3 77.8 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.655 0.382 . . . . 10.0 111.758 175.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.597 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -57.52 -50.74 72.09 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.411 -0.959 . . . . 10.0 108.411 174.936 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.753 HG23 ' HB ' ' A' ' 128' ' ' ILE . 27.9 mm -44.2 -49.82 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 114.522 -1.217 . . . . 10.0 111.53 174.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.714 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 27.6 tt0 -50.88 -57.16 9.18 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.766 1.227 . . . . 10.0 112.356 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.686 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 70.0 mm-40 -51.66 -58.59 5.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.347 -1.297 . . . . 10.0 110.17 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.033 HD12 ' HB3' ' A' ' 78' ' ' LEU . 22.8 mm -48.33 -51.6 9.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.318 -0.855 . . . . 10.0 110.742 173.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.567 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -51.89 -42.66 62.89 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.499 0.555 . . . . 10.0 112.499 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.714 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 73.6 mttt -68.21 -52.58 32.67 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 122.045 0.926 . . . . 10.0 109.261 -177.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 85.5 m -51.46 -23.8 4.35 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 113.506 -1.679 . . . . 10.0 112.514 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.763 ' HB3' HD13 ' A' ' 116' ' ' LEU . 29.5 mttp -122.63 1.19 9.44 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 113.171 0.804 . . . . 10.0 113.171 -175.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.55 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 23.3 ptm -50.18 -36.81 22.62 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 113.149 0.796 . . . . 10.0 113.149 176.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 113' ' ' MET . 58.7 Cg_endo -69.55 -29.76 24.33 Favored 'Trans proline' 0 C--N 1.367 1.515 0 CA-C-N 120.989 1.389 . . . . 10.0 111.912 178.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.629 ' OD2' ' HE2' ' A' ' 71' ' ' LYS . 2.7 t70 -87.24 -46.02 10.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.132 0.968 . . . . 10.0 110.454 -173.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.932 HD11 ' HA ' ' A' ' 74' ' ' PRO . 4.9 mp -65.1 -1.1 1.94 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 113.68 -1.6 . . . . 10.0 112.191 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.401 ' H ' ' C ' ' A' ' 115' ' ' ASP . 26.0 m-80 58.98 50.39 8.39 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.853 -1.067 . . . . 10.0 109.247 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.413 ' O ' ' CB ' ' A' ' 119' ' ' ASN . . . -65.98 -74.78 0.1 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.28 -1.327 . . . . 10.0 113.099 -166.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 118' ' ' ALA . 27.3 t-20 102.43 -40.52 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.545 0 O-C-N 124.929 1.393 . . . . 10.0 109.354 -176.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.5 t -151.41 133.96 15.5 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 103.584 -2.747 . . . . 10.0 103.584 174.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.586 HD22 ' HB3' ' A' ' 124' ' ' ALA . 2.8 tm? -52.97 -35.05 58.59 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.386 0.884 . . . . 10.0 113.386 -173.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.588 ' HA ' ' HG3' ' A' ' 125' ' ' MET . 2.2 mp0 -51.46 -33.78 32.54 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 118.691 0.678 . . . . 10.0 110.734 175.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.42 -47.4 60.93 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 118.581 -1.247 . . . . 10.0 110.575 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.586 ' HB3' HD22 ' A' ' 121' ' ' LEU . . . -54.95 -39.01 68.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.835 -0.62 . . . . 10.0 110.305 175.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.589 ' O ' ' HB3' ' A' ' 129' ' ' GLU . 17.2 mtp -54.96 -38.43 67.75 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 112.124 0.416 . . . . 10.0 112.124 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -62.19 -47.51 84.15 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 108.929 -0.767 . . . . 10.0 108.929 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 124' ' ' ALA . 67.3 mt -50.92 -64.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 114.996 -1.002 . . . . 10.0 110.284 175.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.753 ' HB ' HG23 ' A' ' 105' ' ' ILE . 16.0 mm -52.81 -60.54 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 CA-C-N 114.496 -1.229 . . . . 10.0 111.394 -176.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.589 ' HB3' ' O ' ' A' ' 125' ' ' MET . 0.0 OUTLIER -51.75 -43.47 62.94 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.264 -0.88 . . . . 10.0 109.732 179.299 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.63 -45.25 29.35 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.717 -0.754 . . . . 10.0 111.909 -175.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.525 HG21 ' HB3' ' A' ' 75' ' ' ALA . 51.9 m -50.5 -56.97 9.23 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.513 -0.844 . . . . 10.0 109.765 173.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.99 -57.28 7.88 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 120.969 0.414 . . . . 10.0 111.031 175.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -46.45 -59.01 3.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.954 -1.021 . . . . 10.0 112.253 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.8 p -66.59 -24.5 66.34 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.057 0.391 . . . . 10.0 112.057 -174.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.54 ' O ' ' HG3' ' A' ' 135' ' ' MET . 0.0 OUTLIER -84.43 -3.41 58.33 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 112.936 0.717 . . . . 10.0 112.936 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.541 ' C ' HG12 ' A' ' 97' ' ' VAL . . . 105.05 -5.85 42.63 Favored Glycine 0 N--CA 1.441 -1.007 0 O-C-N 121.001 -1.062 . . . . 10.0 112.688 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.437 HG23 ' HA ' ' A' ' 99' ' ' LYS . 70.6 mt -87.43 129.87 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 CA-C-N 117.516 0.658 . . . . 10.0 111.093 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.668 ' HG2' ' CB ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -85.58 156.98 20.5 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.029 -0.987 . . . . 10.0 109.282 177.345 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 22.2 m -119.43 136.34 56.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.078 -1.082 . . . . 10.0 108.078 168.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.3 m -136.26 69.99 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 115.573 1.694 . . . . 10.0 115.573 -176.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.3 t70 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.113 -0.946 . . . . 10.0 109.296 138.928 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 4' ' ' LYS . 29.5 mtpt . . . . . 0 C--O 1.221 -0.44 0 N-CA-C 110.071 -0.344 . . . . 10.0 110.071 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 38.0 t -67.15 145.0 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.895 0.378 . . . . 10.0 111.389 -177.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.79 -36.41 4.51 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.27 173.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.464 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -159.61 151.17 20.1 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.272 1.212 . . . . 10.0 114.272 -177.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -93.71 129.19 40.12 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.303 -1.369 . . . . 10.0 107.303 168.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.697 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.8 OUTLIER -120.94 82.36 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.786 -0.82 . . . . 10.0 108.786 175.119 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -78.9 146.13 33.73 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 120.895 1.679 . . . . 10.0 109.42 177.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.487 HD23 HD11 ' A' ' 13' ' ' LEU . 0.8 OUTLIER -156.11 134.63 11.64 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.313 -0.625 . . . . 10.0 109.313 -174.308 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.523 ' OE1' ' HA ' ' A' ' 55' ' ' PRO . 10.9 mm100 -91.82 112.26 24.11 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.018 -1.105 . . . . 10.0 108.018 171.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.487 HD11 HD23 ' A' ' 11' ' ' LEU . 28.8 mt -131.54 133.97 24.99 Favored Pre-proline 0 CA--C 1.504 -0.803 0 CA-C-O 121.644 0.735 . . . . 10.0 112.463 -170.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.7 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 18.5 Cg_exo -56.75 122.18 11.37 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 123.292 2.661 . . . . 10.0 111.846 174.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.532 ' HB2' HD11 ' A' ' 54' ' ' LEU . . . -61.62 126.78 28.57 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 107.514 -1.291 . . . . 10.0 107.514 169.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.39 0.21 89.64 Favored Glycine 0 N--CA 1.44 -1.1 0 O-C-N 125.883 1.989 . . . . 10.0 112.998 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.7 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 18.6 tptp -142.8 98.88 3.37 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 118.331 1.066 . . . . 10.0 111.979 175.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.18 136.87 9.03 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.433 -1.258 . . . . 10.0 112.121 176.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.603 ' HA ' ' HB2' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -179.98 -54.96 0.0 OUTLIER Pre-proline 0 N--CA 1.443 -0.81 0 CA-C-N 115.318 -0.856 . . . . 10.0 111.836 174.677 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.67 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 73.5 Cg_endo -99.16 129.66 0.19 Allowed 'Trans proline' 0 N--CA 1.411 -3.372 0 N-CA-C 115.67 1.373 . . . . 10.0 115.67 -153.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.053 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 12.13 -83.54 0.0 OUTLIER Pre-proline 0 C--N 1.294 -1.842 0 CA-C-N 108.604 -3.907 . . . . 10.0 115.489 166.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.955 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 65.5 Cg_exo -30.53 -55.16 0.21 Allowed 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 122.963 2.442 . . . . 10.0 115.709 -164.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.955 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 5.2 Cg_exo -84.09 -56.55 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.438 2.759 . . . . 10.0 112.094 170.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.005 HG12 HD12 ' A' ' 35' ' ' ILE . 89.3 t -80.37 -53.76 12.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 112.719 -2.037 . . . . 10.0 114.922 -167.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 1.053 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -50.65 -74.48 0.28 Allowed Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.203 -0.908 . . . . 10.0 113.452 -173.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.837 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 17.0 Cg_exo -42.79 -43.99 8.95 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.77 2.98 . . . . 10.0 112.441 171.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 24' ' ' VAL . . . -50.06 -98.94 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 123.793 0.683 . . . . 10.0 112.43 177.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.931 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.341 0.0 OUTLIER -73.18 -34.33 65.94 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 117.555 -1.658 . . . . 10.0 113.138 -173.472 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.65 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -67.5 -39.53 91.11 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 121.164 -0.541 . . . . 10.0 113.505 -175.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.745 ' HG3' ' HA ' ' A' ' 26' ' ' PRO . 87.9 mt-30 -68.43 -6.46 24.85 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 118.635 -1.226 . . . . 10.0 111.212 175.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -102.04 22.98 12.21 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.381 0.61 . . . . 10.0 109.584 168.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.28 -3.69 76.35 Favored Glycine 0 CA--C 1.503 -0.699 0 CA-C-N 115.306 -0.861 . . . . 10.0 113.567 168.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.931 ' HB ' HD23 ' A' ' 28' ' ' LEU . 5.0 t -82.99 149.79 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 113.785 1.031 . . . . 10.0 113.785 -170.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.507 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -71.39 99.3 1.95 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.001 0.429 . . . . 10.0 110.687 170.756 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.005 HD12 HG12 ' A' ' 24' ' ' VAL . 16.4 mm -51.49 -37.15 18.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 122.21 1.005 . . . . 10.0 111.643 172.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.662 ' HE2' ' HA ' ' A' ' 36' ' ' MET . 5.9 mmt -65.7 -50.31 65.35 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.312 -1.767 . . . . 10.0 111.957 174.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.507 ' HB3' ' HB3' ' A' ' 34' ' ' ASN . 5.6 tp10 -56.09 -41.09 74.64 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.079 -0.648 . . . . 10.0 110.211 174.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.726 ' CE1' HD11 ' A' ' 58' ' ' ILE . 89.9 t80 -56.24 -58.79 6.48 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 113.899 1.074 . . . . 10.0 113.899 171.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.603 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -62.72 -50.3 71.64 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 114.368 -1.287 . . . . 10.0 111.87 -175.415 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -62.88 -23.06 67.15 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 119.223 -0.991 . . . . 10.0 108.911 -177.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.842 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 63.0 mtt180 -75.5 -64.82 0.99 Allowed 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 119.252 -0.979 . . . . 10.0 111.798 166.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.537 ' CZ ' HG21 ' A' ' 46' ' ' THR . 60.3 t80 -50.99 -49.72 59.75 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.09 0.859 . . . . 10.0 111.571 -170.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -60.09 -49.88 75.92 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.514 -0.766 . . . . 10.0 110.425 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.05 -39.81 95.84 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.069 -1.052 . . . . 10.0 112.081 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.842 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 5.9 mm-40 -66.89 -41.76 86.65 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.841 0.829 . . . . 10.0 111.047 -178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.537 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 81.7 p -90.91 1.5 56.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.414 -1.266 . . . . 10.0 112.056 -170.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.46 -37.23 5.01 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.995 -1.002 . . . . 10.0 112.921 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -82.19 -24.96 34.65 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.807 -0.633 . . . . 10.0 112.491 -174.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.4 mttp -104.5 19.06 21.01 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.487 0.66 . . . . 10.0 109.305 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -48.73 143.5 5.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.404 -1.271 . . . . 10.0 112.565 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.99 20.89 27.01 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 114.846 -1.07 . . . . 10.0 110.917 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.554 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 64.2 mtt -138.53 128.87 25.9 Favored 'General case' 0 C--O 1.206 -1.189 0 C-N-CA 117.083 -1.847 . . . . 10.0 114.154 -169.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.8 mm -70.01 93.2 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 121.586 -0.696 . . . . 10.0 109.754 172.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.768 HD22 ' HE2' ' A' ' 77' ' ' PHE . 3.3 mt -80.45 130.04 66.68 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.15 -0.315 . . . . 10.0 110.15 -176.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.523 ' HA ' ' OE1' ' A' ' 12' ' ' GLN . 21.1 Cg_exo -69.68 103.48 1.16 Allowed 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 122.683 2.256 . . . . 10.0 111.44 171.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 69' ' ' ILE . 0.5 OUTLIER -101.9 160.32 4.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 119.402 1.001 . . . . 10.0 112.217 -174.539 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 79.4 t -137.09 119.98 20.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.034 -0.53 . . . . 10.0 110.561 173.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.726 HD11 ' CE1' ' A' ' 38' ' ' PHE . 14.8 mt -110.65 138.2 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.596 0 N-CA-C 108.012 -1.107 . . . . 10.0 108.012 -178.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.4 m -123.48 96.57 5.03 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 114.837 -1.074 . . . . 10.0 108.801 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 65' ' ' SER . 2.3 p -89.04 139.03 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 CA-C-N 119.481 1.037 . . . . 10.0 110.568 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.499 ' HE2' ' HG1' ' A' ' 67' ' ' THR . 70.2 m-85 -96.06 167.86 10.96 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 112.747 0.647 . . . . 10.0 112.747 -177.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -56.66 -23.55 42.48 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 124.271 1.029 . . . . 10.0 112.808 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 6.7 m-20 -80.12 -7.43 58.9 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.683 -1.144 . . . . 10.0 111.287 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 3.2 mptt 79.99 3.4 2.01 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 114.645 -1.161 . . . . 10.0 111.974 -171.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.563 ' O ' HG23 ' A' ' 60' ' ' VAL . 15.6 m -73.11 173.89 8.73 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 107.498 -1.297 . . . . 10.0 107.498 170.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.88 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -168.81 -176.73 2.79 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 120.293 1.406 . . . . 10.0 108.778 174.505 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.499 ' HG1' ' HE2' ' A' ' 61' ' ' TYR . 1.3 p -159.77 168.85 24.93 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 102.759 -3.052 . . . . 10.0 102.759 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.447 ' CB ' HG12 ' A' ' 58' ' ' ILE . 53.3 p90 -163.24 152.89 15.25 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.933 -1.136 . . . . 10.0 107.933 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.514 ' O ' HG22 ' A' ' 56' ' ' VAL . 1.9 mt -116.47 168.84 7.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 106.232 -1.766 . . . . 10.0 106.232 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.8 mt -137.75 113.76 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 N-CA-C 106.306 -1.738 . . . . 10.0 106.306 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 55' ' ' PRO . 3.6 mptp? -77.3 102.12 6.59 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.604 -166.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.489 HG21 ' O ' ' A' ' 111' ' ' THR . 0.2 OUTLIER -58.28 91.24 0.03 OUTLIER Pre-proline 0 C--N 1.315 -0.906 0 O-C-N 124.733 1.271 . . . . 10.0 108.786 165.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.754 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 49.3 Cg_endo -93.7 -166.63 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 123.541 2.828 . . . . 10.0 112.742 -156.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.754 ' HD2' ' HB2' ' A' ' 73' ' ' PRO . 67.5 Cg_exo -30.05 133.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 123.316 2.677 . . . . 10.0 111.785 168.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.691 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -60.52 -8.97 3.14 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.289 0.848 . . . . 10.0 113.289 -166.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 m -50.31 -29.23 9.32 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.604 0.716 . . . . 10.0 110.253 174.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.768 ' HE2' HD22 ' A' ' 54' ' ' LEU . 36.4 t80 -56.01 -66.03 0.5 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.532 -1.213 . . . . 10.0 111.441 176.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.659 HD23 ' HE2' ' A' ' 112' ' ' LYS . 2.7 mm? -82.19 -13.67 56.78 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.903 -0.498 . . . . 10.0 110.233 -175.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.637 HD12 HD13 ' A' ' 137' ' ' ILE . 3.0 mm? -72.9 -23.71 60.75 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 109.341 -0.614 . . . . 10.0 109.341 171.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 21.4 mmtp -61.89 -40.73 96.43 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.423 -0.584 . . . . 10.0 109.423 167.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.488 ' HD3' ' HA ' ' A' ' 81' ' ' LYS . 24.9 mmtp -62.96 -48.25 79.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.581 -0.736 . . . . 10.0 112.839 174.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.889 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -72.23 -62.68 1.35 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 127.328 2.251 . . . . 10.0 113.564 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 79' ' ' LEU . . . . . . . . 0 C--N 1.284 -2.259 0 CA-C-N 110.864 -2.88 . . . . 10.0 106.941 -175.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.475 HG13 ' N ' ' A' ' 98' ' ' GLY . 0.9 OUTLIER . . . . . 0 N--CA 1.404 -2.739 0 CA-C-O 121.799 0.809 . . . . 10.0 111.177 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.475 ' N ' HG13 ' A' ' 97' ' ' VAL . . . -57.92 179.51 1.06 Allowed Glycine 0 C--N 1.308 -0.981 0 CA-C-N 113.819 -1.537 . . . . 10.0 113.088 176.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.457 ' HE2' ' HB3' ' A' ' 99' ' ' LYS . 9.8 ptpt -154.26 172.37 17.74 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 122.693 1.235 . . . . 10.0 111.883 -159.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.889 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -160.6 -146.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 111.889 -2.414 . . . . 10.0 105.965 -171.656 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.604 ' O ' ' HG3' ' A' ' 104' ' ' GLN . 1.7 t -162.06 139.73 8.67 Favored 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 119.834 -0.747 . . . . 10.0 109.511 -152.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.663 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 0.0 OUTLIER -43.14 -48.61 6.4 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 114.36 -1.291 . . . . 10.0 111.535 -173.509 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.531 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -56.63 -46.09 81.18 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.127 0.788 . . . . 10.0 113.127 178.201 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.604 ' HG3' ' O ' ' A' ' 101' ' ' THR . 3.7 pp0? -67.74 -37.26 81.91 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.454 -0.943 . . . . 10.0 108.454 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.878 HG23 ' HB ' ' A' ' 128' ' ' ILE . 23.3 mm -47.26 -51.01 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 115.503 -0.771 . . . . 10.0 110.862 168.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.683 ' HG2' ' HE3' ' A' ' 110' ' ' LYS . 23.8 tt0 -50.36 -57.34 8.15 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.296 1.438 . . . . 10.0 113.191 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.491 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 4.3 pt-20 -59.09 -43.55 91.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.355 -0.839 . . . . 10.0 111.199 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.629 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 56.9 mt -51.71 -58.57 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 120.7 0.286 . . . . 10.0 110.919 166.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.489 ' HB3' HD11 ' A' ' 121' ' ' LEU . . . -44.69 -35.11 2.49 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 123.556 0.742 . . . . 10.0 112.334 177.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.683 ' HE3' ' HG2' ' A' ' 106' ' ' GLU . 96.6 mttt -74.45 -53.65 9.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.548 -0.751 . . . . 10.0 111.557 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 108' ' ' ILE . 2.1 t -59.41 -8.74 1.91 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.298 0.851 . . . . 10.0 113.298 -177.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.659 ' HE2' HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -129.94 13.73 5.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.247 0.546 . . . . 10.0 110.379 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.514 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 1.8 ttt -50.65 -46.91 85.95 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 114.844 -1.071 . . . . 10.0 112.389 178.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 113' ' ' MET . 60.6 Cg_endo -69.2 -22.27 34.91 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 121.726 1.617 . . . . 10.0 113.299 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -87.94 -55.15 3.88 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 122.344 1.068 . . . . 10.0 110.537 -175.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.597 HD22 ' HD3' ' A' ' 112' ' ' LYS . 7.1 mp -67.87 178.61 1.69 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 113.267 -1.788 . . . . 10.0 113.746 -168.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -96.72 41.88 1.1 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 112.002 -2.363 . . . . 10.0 112.645 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.613 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . . . -63.38 -99.68 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 113.756 1.021 . . . . 10.0 113.756 174.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.585 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 71.4 m-20 105.16 -78.01 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.8 1.64 . . . . 10.0 107.768 -168.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.449 ' HB3' ' OE1' ' A' ' 122' ' ' GLU . 47.2 m -81.54 146.65 30.05 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.735 -0.839 . . . . 10.0 108.735 163.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.759 ' O ' ' HG3' ' A' ' 125' ' ' MET . 61.1 tp -59.66 -37.68 79.42 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.15 -1.02 . . . . 10.0 110.548 167.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 126' ' ' LYS . 3.4 mp0 -51.21 -36.68 42.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.674 0.749 . . . . 10.0 109.617 171.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.605 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . . . -69.38 -46.96 65.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.577 -1.192 . . . . 10.0 110.735 177.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.613 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . . . -55.7 -41.29 73.56 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 110.179 -0.304 . . . . 10.0 110.179 176.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.759 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 75.2 mtp -55.75 -33.42 64.27 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.762 0.425 . . . . 10.0 111.827 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.605 ' HE2' ' HA ' ' A' ' 123' ' ' ALA . 42.6 mtmt -63.86 -50.77 67.51 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.629 -0.508 . . . . 10.0 109.629 178.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.457 ' CD1' HD23 ' A' ' 116' ' ' LEU . 47.5 mt -49.32 -63.86 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 121.49 0.662 . . . . 10.0 110.379 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.878 ' HB ' HG23 ' A' ' 105' ' ' ILE . 4.9 mm -52.13 -55.07 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 CA-C-N 113.843 -1.526 . . . . 10.0 111.306 -177.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.59 ' CD ' ' HE ' ' A' ' 102' ' ' ARG . 49.2 mt-10 -54.49 -44.51 72.72 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 109.923 -0.399 . . . . 10.0 109.923 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -69.62 -46.01 56.51 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.708 -0.758 . . . . 10.0 111.748 -174.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.691 HG21 ' HB3' ' A' ' 75' ' ' ALA . 51.6 m -50.09 -58.62 5.13 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.536 -0.832 . . . . 10.0 109.379 171.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.422 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -50.71 -53.4 31.69 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.008 0.433 . . . . 10.0 111.22 176.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -47.84 -48.43 30.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.198 -0.91 . . . . 10.0 111.32 176.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 27.2 t -63.61 -35.85 81.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.0 0.428 . . . . 10.0 110.732 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 53.4 mtm -84.66 10.68 10.58 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.579 0.955 . . . . 10.0 113.579 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 81.55 8.19 87.28 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 119.341 0.973 . . . . 10.0 112.127 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.637 HD13 HD12 ' A' ' 79' ' ' LEU . 47.4 mt -94.73 124.93 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 CA-C-O 121.39 0.614 . . . . 10.0 112.017 -176.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -84.38 151.79 24.47 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.125 -1.03 . . . . 10.0 110.943 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 16.6 m -113.45 126.44 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.045 0 N-CA-C 107.8 -1.185 . . . . 10.0 107.8 168.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 100' ' ' VAL . 2.9 m -104.83 138.54 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-N 114.44 -1.255 . . . . 10.0 109.302 176.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 C--N 1.29 -2.003 0 CA-C-N 114.678 -1.146 . . . . 10.0 109.821 -177.09 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.597 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 10.3 mmtp . . . . . 0 C--O 1.196 -1.749 0 CA-C-O 119.484 -0.293 . . . . 10.0 110.25 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.1 t -74.58 119.42 22.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 119.153 0.888 . . . . 10.0 109.863 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.427 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . . . -98.13 -35.18 10.48 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.83 -0.804 . . . . 10.0 108.83 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.401 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -161.29 -174.06 4.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.037 -0.983 . . . . 10.0 112.801 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 78.6 mt-30 -141.56 131.3 24.21 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.123 -1.399 . . . . 10.0 108.649 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.627 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.9 OUTLIER -120.89 80.98 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 108.945 -0.761 . . . . 10.0 108.945 -176.391 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 56' ' ' VAL . 57.4 tttp -79.43 128.5 33.43 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 119.82 1.191 . . . . 10.0 108.339 176.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.624 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.85 127.98 6.18 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 122.116 0.96 . . . . 10.0 111.471 -174.826 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.56 119.32 22.37 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.226 -1.352 . . . . 10.0 109.749 -172.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.624 HD21 HD11 ' A' ' 11' ' ' LEU . 46.8 mt -135.52 140.31 33.7 Favored Pre-proline 0 CA--C 1.502 -0.896 0 N-CA-C 113.138 0.792 . . . . 10.0 113.138 -170.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.679 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 14.7 Cg_exo -61.87 122.44 10.98 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 123.325 2.683 . . . . 10.0 111.241 174.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.523 ' CB ' ' HA ' ' A' ' 50' ' ' ALA . . . -60.84 125.11 22.49 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.637 -1.246 . . . . 10.0 107.637 169.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.83 1.83 89.82 Favored Glycine 0 N--CA 1.442 -0.905 0 O-C-N 126.015 2.072 . . . . 10.0 113.115 -173.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.679 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 7.6 tppt? -144.07 105.27 4.24 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.334 1.067 . . . . 10.0 113.14 177.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.937 ' H ' HD22 ' A' ' 43' ' ' ASN . . . -172.47 128.89 0.55 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.776 -1.556 . . . . 10.0 111.202 170.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.543 ' H ' ' CD ' ' A' ' 20' ' ' PRO . 15.6 m -174.06 -43.46 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.132 0.895 . . . . 10.0 112.166 -174.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.828 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 44.2 Cg_endo -98.68 122.3 0.14 Allowed 'Trans proline' 0 N--CA 1.434 -2.008 0 C-N-CA 121.104 1.203 . . . . 10.0 114.892 -166.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.083 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . -3.51 -80.05 0.0 OUTLIER Pre-proline 0 C--O 1.212 -0.919 0 CA-C-N 111.658 -2.519 . . . . 10.0 114.542 166.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.871 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 52.4 Cg_exo -22.33 -55.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.978 3.119 . . . . 10.0 115.995 -165.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.871 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 10.0 Cg_endo -81.81 -75.97 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 122.347 2.031 . . . . 10.0 112.151 168.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.449 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 92.7 t -60.95 -46.73 96.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 112.542 -2.117 . . . . 10.0 114.919 -171.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 1.083 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -49.55 -73.41 0.36 Allowed Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 114.472 -1.24 . . . . 10.0 113.225 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.693 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 11.2 Cg_exo -45.89 -43.17 19.86 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.885 3.057 . . . . 10.0 112.737 171.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 24' ' ' VAL . . . -49.22 -98.23 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.567 0.58 . . . . 10.0 112.567 175.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.675 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.297 0.0 OUTLIER -70.41 -25.38 63.19 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 118.278 -1.369 . . . . 10.0 113.529 -174.872 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.535 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -66.27 -35.54 90.47 Favored Glycine 0 N--CA 1.464 0.521 0 C-N-CA 121.285 -0.483 . . . . 10.0 112.513 -177.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -58.83 -25.93 63.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.136 0.493 . . . . 10.0 109.72 173.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -99.55 17.89 19.3 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.584 0.707 . . . . 10.0 109.488 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.455 ' HA3' ' HE2' ' A' ' 64' ' ' LYS . . . 85.62 6.39 83.26 Favored Glycine 0 CA--C 1.5 -0.88 0 CA-C-N 114.492 -1.231 . . . . 10.0 113.411 168.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.78 HG11 ' CD2' ' A' ' 66' ' ' PHE . 1.9 t -86.66 147.74 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 114.044 1.127 . . . . 10.0 114.044 -172.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 88.5 m-20 -68.08 102.97 1.41 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.546 0.738 . . . . 10.0 111.348 174.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.589 ' CD1' ' HA2' ' A' ' 25' ' ' GLY . 90.2 mt -50.72 -45.84 27.76 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 CA-C-O 122.526 1.155 . . . . 10.0 110.6 172.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.419 ' SD ' ' N ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -67.2 -52.21 43.97 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 111.833 -2.44 . . . . 10.0 112.898 -177.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 34' ' ' ASN . 82.0 tt0 -56.12 -38.51 70.87 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 120.035 -0.666 . . . . 10.0 110.05 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.787 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 20.9 t80 -59.8 -59.29 5.66 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 114.045 1.128 . . . . 10.0 114.045 168.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.589 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -54.86 -53.36 56.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.498 -1.683 . . . . 10.0 112.11 -176.222 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.436 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 12.3 tppt? -68.63 -19.25 64.41 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.611 -0.836 . . . . 10.0 109.101 -176.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.782 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 64.9 mtt180 -79.91 -62.53 1.65 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.115 -1.034 . . . . 10.0 112.907 168.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.567 ' CZ ' HG21 ' A' ' 46' ' ' THR . 66.3 t80 -53.99 -45.69 71.5 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 119.213 0.915 . . . . 10.0 110.11 -174.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.937 HD22 ' H ' ' A' ' 18' ' ' ALA . 5.4 m-20 -61.45 -51.36 69.01 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.536 -1.211 . . . . 10.0 110.874 -178.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.96 -37.38 86.85 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 118.815 -1.154 . . . . 10.0 111.811 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.782 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 7.6 mm-40 -67.48 -45.31 76.28 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.896 0.855 . . . . 10.0 110.882 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.596 ' CG2' HD12 ' A' ' 54' ' ' LEU . 82.7 p -85.67 2.77 43.93 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-N 114.567 -1.197 . . . . 10.0 112.111 -171.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.3 -36.59 14.49 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.812 -1.085 . . . . 10.0 112.318 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -83.4 -34.74 25.46 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.008 -0.996 . . . . 10.0 110.888 -174.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mtpp -97.6 20.84 11.17 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.804 -0.813 . . . . 10.0 108.804 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.523 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -55.1 152.21 8.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.524 -1.216 . . . . 10.0 113.582 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.16 16.26 44.77 Favored Glycine 0 CA--C 1.507 -0.462 0 N-CA-C 109.879 -1.288 . . . . 10.0 109.879 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.46 ' HB2' HD21 ' A' ' 54' ' ' LEU . 45.7 mtm -137.97 125.8 22.5 Favored 'General case' 0 C--O 1.213 -0.859 0 C-N-CA 116.385 -2.126 . . . . 10.0 114.562 -166.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.0 mm -66.1 90.22 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.514 -0.55 . . . . 10.0 109.514 172.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.627 HD13 HG21 ' A' ' 70' ' ' ILE . 7.9 mt -79.4 128.69 74.49 Favored Pre-proline 0 N--CA 1.447 -0.61 0 N-CA-C 108.972 -0.751 . . . . 10.0 108.972 -177.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.659 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 11.0 Cg_exo -72.33 95.02 0.76 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.002 1.802 . . . . 10.0 110.756 174.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.503 ' O ' ' HG3' ' A' ' 10' ' ' LYS . 0.4 OUTLIER -92.38 157.74 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 119.125 0.875 . . . . 10.0 111.417 -171.06 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.426 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 89.4 t -135.04 117.53 22.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 110.278 -0.268 . . . . 10.0 110.278 172.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.627 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 24.0 mt -106.59 139.5 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 108.027 -1.101 . . . . 10.0 108.027 -175.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.7 m -123.44 98.36 5.82 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 108.481 -0.933 . . . . 10.0 108.481 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 65' ' ' SER . 1.5 p -87.03 136.0 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.07 0 CA-C-N 118.979 0.809 . . . . 10.0 111.286 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.597 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 89.5 m-85 -94.12 170.19 9.71 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 114.989 -1.005 . . . . 10.0 113.011 -175.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.437 ' HG3' ' HB3' ' A' ' 4' ' ' LYS . 28.9 mt-10 -63.17 -17.61 62.57 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.535 -1.211 . . . . 10.0 111.824 -176.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -78.0 -10.78 59.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.136 175.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.455 ' HE2' ' HA3' ' A' ' 32' ' ' GLY . 1.6 mtpt 80.69 2.28 1.79 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.416 1.086 . . . . 10.0 109.527 -169.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.571 ' O ' HG23 ' A' ' 60' ' ' VAL . 21.2 p -69.26 -179.24 1.54 Allowed 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.776 -1.556 . . . . 10.0 108.616 170.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.787 ' CE2' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -171.02 -175.1 1.65 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 120.032 1.287 . . . . 10.0 110.538 174.096 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 p -157.9 170.45 22.3 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 102.875 -3.009 . . . . 10.0 102.875 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -158.69 156.5 30.05 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.423 -0.954 . . . . 10.0 108.423 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.426 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 24.8 pt -128.71 153.26 37.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.272 -1.381 . . . . 10.0 107.272 -177.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.627 HG21 HD13 ' A' ' 54' ' ' LEU . 3.6 mm -107.87 132.0 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 N-CA-C 107.626 -1.25 . . . . 10.0 107.626 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.659 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 5.1 mmtp -77.32 85.54 3.74 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 118.942 -1.103 . . . . 10.0 109.337 176.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.835 HG23 ' HB3' ' A' ' 112' ' ' LYS . 15.3 t -63.99 -21.62 0.76 Allowed Pre-proline 0 CA--C 1.558 1.26 0 CA-C-N 112.745 -2.025 . . . . 10.0 113.151 174.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.888 ' HB3' ' HB2' ' A' ' 112' ' ' LYS . 56.8 Cg_endo -101.91 55.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.22 1.947 . . . . 10.0 117.144 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.572 ' HD3' ' O ' ' A' ' 71' ' ' LYS . 17.0 Cg_exo -71.86 -17.52 28.89 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 N-CA-C 107.9 -1.616 . . . . 10.0 107.9 154.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 69.19 -55.34 0.56 Allowed 'General case' 0 C--N 1.343 0.307 0 CA-C-N 113.335 -1.757 . . . . 10.0 111.481 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.547 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 13.5 p -56.87 -40.17 75.69 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.055 -0.52 . . . . 10.0 111.923 -176.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.622 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -74.75 -33.74 62.37 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.106 0.479 . . . . 10.0 111.697 -173.086 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.751 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 3.7 tp -89.57 -17.8 27.83 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.533 -0.867 . . . . 10.0 108.905 177.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.651 HD21 ' HB2' ' A' ' 132' ' ' ALA . 8.7 tp -72.05 -23.26 61.34 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.316 -0.994 . . . . 10.0 108.316 168.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.622 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 24.0 mmtm -64.04 -27.5 69.15 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-O 121.195 0.521 . . . . 10.0 109.769 167.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.751 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -60.33 -45.18 94.34 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.484 -0.486 . . . . 10.0 111.508 171.665 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 1.001 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -71.07 -55.85 7.38 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.642 1.577 . . . . 10.0 112.075 173.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.289 -2.023 0 CA-C-N 111.907 -2.406 . . . . 10.0 107.63 -176.85 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.556 HG13 ' N ' ' A' ' 98' ' ' GLY . 11.4 p . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 113.648 0.981 . . . . 10.0 113.648 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.625 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -156.56 165.93 33.13 Favored Glycine 0 N--CA 1.44 -1.084 0 N-CA-C 109.461 -1.456 . . . . 10.0 109.461 176.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.617 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -154.1 170.86 20.15 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-O 122.197 0.999 . . . . 10.0 110.57 -163.976 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 1.001 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -159.37 -143.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-N 112.834 -1.985 . . . . 10.0 106.584 -172.56 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.603 ' OG1' ' HG2' ' A' ' 104' ' ' GLN . 17.2 p -153.9 143.98 22.05 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 107.618 -1.253 . . . . 10.0 107.618 -153.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.629 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 12.9 tpt180 -42.62 -41.24 3.0 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 114.854 -1.066 . . . . 10.0 110.034 177.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 3.5 tmtm? -60.15 -46.26 90.28 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.403 0.52 . . . . 10.0 112.403 177.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.603 ' HG2' ' OG1' ' A' ' 101' ' ' THR . 14.0 mm100 -66.02 -42.82 89.16 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.982 -0.747 . . . . 10.0 108.982 -177.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.865 HG23 ' HB ' ' A' ' 128' ' ' ILE . 30.8 mm -40.53 -58.11 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 114.604 -1.18 . . . . 10.0 110.832 164.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.638 ' HG2' ' HE3' ' A' ' 110' ' ' LYS . 31.7 tt0 -47.79 -50.35 26.07 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 114.633 -1.167 . . . . 10.0 112.917 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.426 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 35.2 mm-40 -54.45 -58.1 8.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.303 -0.862 . . . . 10.0 111.143 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.682 ' O ' HG22 ' A' ' 111' ' ' THR . 11.8 mm -48.97 -53.58 7.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-O 121.932 0.873 . . . . 10.0 109.95 172.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.524 ' CB ' HD11 ' A' ' 121' ' ' LEU . . . -48.67 -36.68 16.57 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.02 -0.991 . . . . 10.0 112.354 176.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.638 ' HE3' ' HG2' ' A' ' 106' ' ' GLU . 84.1 mttt -74.95 -54.02 7.95 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.409 -0.36 . . . . 10.0 111.44 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.682 HG22 ' O ' ' A' ' 108' ' ' ILE . 7.1 t -51.52 -22.93 3.53 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.242 1.201 . . . . 10.0 114.242 -171.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.888 ' HB2' ' HB3' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -130.01 19.4 5.48 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.576 0.703 . . . . 10.0 109.404 -174.593 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.66 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 54.8 ttm -52.21 -43.17 89.87 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 114.712 -1.131 . . . . 10.0 111.855 169.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 113' ' ' MET . 10.9 Cg_endo -52.64 -29.77 42.73 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.706 2.27 . . . . 10.0 112.259 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.528 ' CB ' ' HG3' ' A' ' 73' ' ' PRO . 21.1 t70 -91.19 -43.8 9.63 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.926 -1.034 . . . . 10.0 111.454 -176.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.867 HD21 HD12 ' A' ' 127' ' ' ILE . 3.2 mp -69.02 178.26 2.31 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.723 -1.581 . . . . 10.0 114.509 -167.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -94.29 29.55 2.17 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 111.303 -2.68 . . . . 10.0 112.209 171.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.659 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . . . -73.97 92.03 2.08 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.346 0.499 . . . . 10.0 112.346 175.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -66.28 -28.71 68.91 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.609 -0.885 . . . . 10.0 108.609 172.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.7 t -152.96 140.92 20.24 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 105.441 -2.059 . . . . 10.0 105.441 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.784 ' O ' ' HG3' ' A' ' 125' ' ' MET . 45.0 tp -53.07 -32.56 47.72 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.117 1.154 . . . . 10.0 114.117 -172.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -50.17 -35.92 28.2 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.591 0.71 . . . . 10.0 110.243 173.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.75 -50.56 56.6 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.236 -0.986 . . . . 10.0 110.969 176.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.716 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -60.23 -31.99 70.7 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 119.734 -0.786 . . . . 10.0 110.738 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.784 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 75.5 mtp -58.0 -36.42 72.63 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.701 0.286 . . . . 10.0 110.746 176.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -64.24 -54.06 39.43 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.101 0.56 . . . . 10.0 111.726 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.867 HD12 HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -51.48 -57.72 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 121.33 0.586 . . . . 10.0 110.739 179.005 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.865 ' HB ' HG23 ' A' ' 105' ' ' ILE . 21.5 mm -51.2 -54.06 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 CA-C-N 114.745 -1.116 . . . . 10.0 111.879 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.619 ' HG3' HG21 ' A' ' 105' ' ' ILE . 80.8 mt-10 -54.8 -40.97 70.04 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 123.325 0.391 . . . . 10.0 110.031 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -69.8 -46.8 51.56 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.194 -1.003 . . . . 10.0 111.015 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 86.3 m -44.59 -64.12 0.76 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 113.98 -1.11 . . . . 10.0 109.308 169.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.651 ' HB2' HD21 ' A' ' 79' ' ' LEU . . . -48.13 -50.3 29.14 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.008 -0.542 . . . . 10.0 111.775 177.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -49.05 -52.82 23.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.972 -1.013 . . . . 10.0 111.324 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 22.8 t -64.04 -33.02 74.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.868 0.366 . . . . 10.0 111.262 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.516 ' CE ' HD23 ' A' ' 79' ' ' LEU . 67.9 mtm -84.46 8.07 17.63 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 114.316 1.228 . . . . 10.0 114.316 -174.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 78.9 15.34 80.83 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 119.815 1.188 . . . . 10.0 111.603 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 19.4 mt -100.43 122.74 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 CA-C-O 121.5 0.667 . . . . 10.0 111.228 178.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.617 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -88.51 156.2 19.22 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 115.0 -1.0 . . . . 10.0 109.569 -179.217 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 17.1 m -115.47 121.22 66.78 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 CA-C-O 122.141 0.972 . . . . 10.0 108.517 172.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.646 HG22 ' O ' ' A' ' 100' ' ' VAL . 4.9 m -105.21 148.91 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 CA-C-N 113.752 -1.567 . . . . 10.0 108.544 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 34.2 t70 . . . . . 0 C--N 1.286 -2.168 0 CA-C-N 113.718 -1.583 . . . . 10.0 110.571 179.684 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.8 tptt . . . . . 0 C--O 1.223 -0.333 0 N-CA-C 109.81 -0.441 . . . . 10.0 109.81 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.32 130.13 25.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.771 0.32 . . . . 10.0 111.272 -176.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.63 -40.58 5.72 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.576 -0.527 . . . . 10.0 109.576 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.478 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -155.37 155.52 33.78 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 113.861 1.06 . . . . 10.0 113.861 -176.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -92.64 136.25 33.39 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.424 -1.262 . . . . 10.0 109.145 170.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.702 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -123.62 79.56 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.299 -1.0 . . . . 10.0 108.299 165.317 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.477 ' HG2' HG13 ' A' ' 57' ' ' VAL . 52.9 mttm -81.33 125.58 30.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 120.531 1.514 . . . . 10.0 107.751 175.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.587 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -158.15 131.35 7.49 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 122.485 1.136 . . . . 10.0 112.562 -172.155 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.721 ' HB3' HG23 ' A' ' 53' ' ' ILE . 95.0 mt-30 -84.04 116.51 22.88 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 113.79 -1.55 . . . . 10.0 111.489 -173.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.587 HD21 HD11 ' A' ' 11' ' ' LEU . 80.0 mt -136.65 140.73 32.96 Favored Pre-proline 0 C--O 1.219 -0.542 0 N-CA-C 113.262 0.838 . . . . 10.0 113.262 -172.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.843 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 36.0 Cg_exo -63.28 131.95 34.23 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 C-N-CA 124.443 3.429 . . . . 10.0 113.445 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.517 ' O ' ' HA2' ' A' ' 51' ' ' GLY . . . -56.73 124.41 18.32 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 108.447 -0.945 . . . . 10.0 108.447 167.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.33 7.16 82.13 Favored Glycine 0 N--CA 1.444 -0.818 0 O-C-N 125.356 1.66 . . . . 10.0 113.507 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.843 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 24.5 mmtp -142.49 97.95 3.21 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.236 1.018 . . . . 10.0 112.798 178.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.708 ' H ' HD22 ' A' ' 43' ' ' ASN . . . -171.35 135.84 0.98 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.321 -1.309 . . . . 10.0 112.967 172.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.624 HG23 ' HD3' ' A' ' 20' ' ' PRO . 1.1 t -179.04 -45.3 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 114.894 -1.048 . . . . 10.0 113.354 175.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.744 ' HD2' ' H ' ' A' ' 21' ' ' ALA . 69.6 Cg_endo -118.34 -46.54 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.257 0 N-CA-C 117.002 1.885 . . . . 10.0 117.002 -171.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.744 ' H ' ' HD2' ' A' ' 20' ' ' PRO . . . -47.48 154.74 0.82 Allowed Pre-proline 0 N--CA 1.467 0.392 0 N-CA-C 113.688 0.995 . . . . 10.0 113.688 -165.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.527 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 53.5 Cg_exo -38.94 -41.18 1.71 Allowed 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 124.583 3.522 . . . . 10.0 115.075 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 22' ' ' PRO . 3.1 Cg_exo -41.26 -54.69 2.49 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.542 2.161 . . . . 10.0 112.448 167.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.632 HG13 HD12 ' A' ' 28' ' ' LEU . 89.2 t -89.68 -55.54 6.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.59 -1.186 . . . . 10.0 113.887 -170.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.511 ' HA2' ' CD1' ' A' ' 35' ' ' ILE . . . -45.61 -73.2 0.3 Allowed Glycine 0 C--N 1.337 0.59 0 CA-C-N 114.247 -1.342 . . . . 10.0 113.668 -175.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 22' ' ' PRO . 88.9 Cg_exo -51.27 -44.44 43.03 Favored 'Trans proline' 0 C--O 1.225 -0.133 0 C-N-CA 123.561 2.84 . . . . 10.0 112.667 173.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 23' ' ' PRO . . . -50.71 -76.19 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.496 0.665 . . . . 10.0 111.38 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.712 ' HB2' HG12 ' A' ' 35' ' ' ILE . 3.8 mt -69.34 -44.33 71.85 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.331 -0.849 . . . . 10.0 113.098 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.44 -44.35 97.75 Favored Glycine 0 C--O 1.229 -0.159 0 CA-C-N 116.253 -0.431 . . . . 10.0 112.949 -173.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -62.06 -25.43 67.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.647 0.261 . . . . 10.0 110.565 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -101.34 13.64 34.43 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 120.113 -0.635 . . . . 10.0 110.787 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.34 12.94 83.83 Favored Glycine 0 CA--C 1.503 -0.707 0 CA-C-N 114.947 -1.024 . . . . 10.0 113.036 169.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.599 HG22 HG21 ' A' ' 60' ' ' VAL . 48.3 t -81.78 142.39 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 115.194 -0.503 . . . . 10.0 111.992 -173.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 81.6 m-20 -67.29 90.27 0.22 Allowed 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.025 0.441 . . . . 10.0 110.022 175.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.712 HG12 ' HB2' ' A' ' 28' ' ' LEU . 33.7 mt -55.24 -39.65 52.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.767 0.794 . . . . 10.0 111.463 177.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.616 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 62.9 mtm -64.55 -50.61 66.6 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.903 -1.498 . . . . 10.0 111.113 176.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.586 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 20.2 tt0 -55.66 -50.05 71.27 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.05 -0.66 . . . . 10.0 110.313 174.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.644 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . 61.9 t80 -55.65 -54.97 37.67 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 113.732 1.012 . . . . 10.0 113.732 176.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.641 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 8.8 p -56.19 -48.11 77.02 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.346 -0.843 . . . . 10.0 110.662 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.419 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 46.5 mmtm -67.69 -22.32 65.28 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.712 -0.795 . . . . 10.0 109.925 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.82 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 29.9 mtp180 -75.77 -63.75 1.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.651 -0.704 . . . . 10.0 111.559 171.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.644 ' CZ ' HG21 ' A' ' 46' ' ' THR . 79.3 t80 -55.33 -47.16 76.1 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.481 0.658 . . . . 10.0 110.619 -173.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.708 HD22 ' H ' ' A' ' 18' ' ' ALA . 5.4 m-20 -61.06 -48.3 82.38 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.674 -1.148 . . . . 10.0 110.539 -176.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.94 93.68 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 118.901 -1.12 . . . . 10.0 111.737 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.82 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 11.4 mm-40 -66.53 -39.21 88.49 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.711 0.767 . . . . 10.0 111.786 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.648 ' CG2' HD12 ' A' ' 54' ' ' LEU . 64.6 p -92.6 -10.96 35.58 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 114.096 1.146 . . . . 10.0 114.096 -166.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.52 -37.19 37.8 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 113.575 0.954 . . . . 10.0 113.575 -171.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -75.35 -35.99 61.08 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.576 -0.738 . . . . 10.0 109.268 -175.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.515 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 4.3 mppt? -93.87 49.33 1.33 Allowed 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 122.926 0.49 . . . . 10.0 110.848 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.815 ' CB ' ' HG3' ' A' ' 52' ' ' MET . . . 100.0 -152.84 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 114.885 1.439 . . . . 10.0 114.885 146.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 15' ' ' ALA . . . -123.99 83.6 0.36 Allowed Glycine 0 N--CA 1.419 -2.466 0 N-CA-C 105.491 -3.043 . . . . 10.0 105.491 164.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.815 ' HG3' ' CB ' ' A' ' 50' ' ' ALA . 29.3 mtm -139.1 131.15 27.93 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 116.214 1.931 . . . . 10.0 116.214 -160.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.721 HG23 ' HB3' ' A' ' 12' ' ' GLN . 0.4 OUTLIER -67.94 94.29 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 119.38 -0.928 . . . . 10.0 110.225 171.933 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.648 HD12 ' CG2' ' A' ' 46' ' ' THR . 11.4 mt -83.36 128.53 64.08 Favored Pre-proline 0 N--CA 1.437 -1.108 0 CA-C-N 115.139 -0.937 . . . . 10.0 108.788 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.427 ' HD2' ' HD3' ' A' ' 73' ' ' PRO . 26.9 Cg_exo -64.88 98.05 0.29 Allowed 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.216 1.944 . . . . 10.0 110.946 175.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -97.47 153.74 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 119.011 0.823 . . . . 10.0 110.946 -173.451 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.477 HG13 ' HG2' ' A' ' 10' ' ' LYS . 92.4 t -134.27 114.23 18.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 C-N-CA 121.015 -0.274 . . . . 10.0 110.359 173.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.702 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 22.8 mt -106.66 137.49 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.795 0 N-CA-C 108.003 -1.11 . . . . 10.0 108.003 -173.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 31.6 m -121.76 95.53 4.71 Favored 'General case' 0 N--CA 1.405 -2.675 0 CA-C-N 114.707 -1.133 . . . . 10.0 108.642 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.599 HG21 HG22 ' A' ' 33' ' ' VAL . 3.1 p -86.64 137.14 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-N 119.28 0.945 . . . . 10.0 110.599 -178.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.452 ' CD2' ' HA ' ' A' ' 66' ' ' PHE . 66.0 m-85 -96.28 172.49 7.92 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 113.001 0.741 . . . . 10.0 113.001 -176.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -53.86 -27.25 28.82 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.03 -1.441 . . . . 10.0 112.602 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.572 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 4.0 m-20 -77.61 -10.76 59.69 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.371 -0.832 . . . . 10.0 111.591 -173.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 51.5 mtpt 83.3 -0.16 1.13 Allowed 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.276 1.036 . . . . 10.0 109.537 -164.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.488 ' O ' HG23 ' A' ' 60' ' ' VAL . 50.6 m -70.89 170.77 11.95 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 113.626 -1.624 . . . . 10.0 108.234 173.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.644 ' CZ ' ' HB2' ' A' ' 38' ' ' PHE . 6.0 p90 -168.44 -176.12 2.74 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 120.372 1.442 . . . . 10.0 110.373 175.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.6 p -157.72 171.74 19.77 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 103.1 -2.926 . . . . 10.0 103.1 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.442 ' CB ' HG12 ' A' ' 58' ' ' ILE . 38.1 p90 -161.41 155.62 22.56 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.404 -0.962 . . . . 10.0 108.404 177.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.408 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 29.9 pt -128.53 166.97 24.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.289 -1.375 . . . . 10.0 107.289 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.482 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 2.5 mt -138.1 119.02 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 107.544 -1.28 . . . . 10.0 107.544 -177.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.421 ' HZ2' ' HB2' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -83.44 67.55 9.38 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.597 -0.89 . . . . 10.0 108.597 -176.702 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -20.59 96.37 0.05 OUTLIER Pre-proline 0 C--O 1.224 -0.24 0 O-C-N 125.879 1.987 . . . . 10.0 112.244 176.005 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.427 ' HD3' ' HD2' ' A' ' 55' ' ' PRO . 3.8 Cg_exo -36.65 124.3 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 124.406 3.404 . . . . 10.0 113.65 -167.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.872 ' HA ' ' HZ1' ' A' ' 112' ' ' LYS . 86.1 Cg_exo -48.09 86.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.17 3.247 . . . . 10.0 114.085 -176.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 1.092 ' H ' ' HE2' ' A' ' 112' ' ' LYS . . . 72.49 -49.75 0.7 Allowed 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 124.708 1.203 . . . . 10.0 112.509 173.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.675 ' HA ' ' HE1' ' A' ' 135' ' ' MET . 8.0 p -37.39 -65.29 0.32 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 114.116 1.154 . . . . 10.0 114.116 -171.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.714 ' HB3' ' SD ' ' A' ' 52' ' ' MET . 41.6 m-85 -72.32 -40.75 67.22 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.26 0.837 . . . . 10.0 113.26 -171.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.812 ' HB3' HD12 ' A' ' 108' ' ' ILE . 2.7 mm? -68.32 -30.62 69.64 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.547 -0.721 . . . . 10.0 109.863 177.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.538 HD13 ' HB2' ' A' ' 132' ' ' ALA . 28.0 mt -70.94 -25.41 62.73 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.967 -0.56 . . . . 10.0 110.914 175.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.58 ' HG2' ' HA ' ' A' ' 77' ' ' PHE . 25.1 mmmt -54.15 -49.28 69.62 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 108.638 -0.875 . . . . 10.0 108.638 174.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -58.33 -44.99 88.92 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.881 0.697 . . . . 10.0 112.881 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.751 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -65.86 -55.57 16.35 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 123.031 1.396 . . . . 10.0 110.165 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.559 ' HB1' ' HA3' ' A' ' 98' ' ' GLY . . . . . . . . 0 C--N 1.286 -2.164 0 CA-C-N 111.119 -2.764 . . . . 10.0 110.597 -172.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.625 HG13 ' H ' ' A' ' 98' ' ' GLY . 3.3 p . . . . . 0 N--CA 1.434 -1.262 0 N-CA-C 108.41 -0.959 . . . . 10.0 108.41 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.625 ' H ' HG13 ' A' ' 97' ' ' VAL . . . -133.92 147.99 19.26 Favored Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 109.325 -1.51 . . . . 10.0 109.325 164.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.753 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 64.4 pttt -148.11 160.95 42.36 Favored 'General case' 0 CA--C 1.472 -2.022 0 CA-C-O 122.144 0.973 . . . . 10.0 108.803 172.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.751 HG11 ' HB1' ' A' ' 82' ' ' ALA . 1.2 m -161.18 -162.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.411 -2.399 0 CA-C-N 112.486 -2.143 . . . . 10.0 106.772 -166.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.521 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 15.9 p -121.7 159.06 27.36 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 114.543 -1.208 . . . . 10.0 111.106 -173.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.672 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 16.2 tpt180 -43.12 -44.84 5.16 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.919 -1.492 . . . . 10.0 110.165 171.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.52 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -58.01 -44.29 87.17 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.801 0.667 . . . . 10.0 112.801 177.429 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.579 ' HG2' ' HB1' ' A' ' 82' ' ' ALA . 1.4 tp60 -55.63 -54.86 38.92 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.895 -0.78 . . . . 10.0 108.895 177.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.744 HG23 ' HB ' ' A' ' 128' ' ' ILE . 45.5 mm -35.96 -52.93 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-N 113.985 -1.461 . . . . 10.0 112.604 167.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.673 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 25.5 tt0 -47.57 -59.63 3.12 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.529 1.132 . . . . 10.0 113.183 -175.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -55.94 -49.82 72.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.129 -0.941 . . . . 10.0 110.519 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.812 HD12 ' HB3' ' A' ' 78' ' ' LEU . 13.8 mm -49.86 -57.42 2.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.652 -0.704 . . . . 10.0 110.641 171.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.556 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -52.23 -35.65 50.19 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.923 -0.581 . . . . 10.0 112.371 177.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.673 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 46.9 mttt -74.97 -56.09 5.1 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.707 -0.679 . . . . 10.0 111.42 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.47 HG23 ' CG ' ' A' ' 112' ' ' LYS . 13.2 t -54.47 -30.41 53.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.931 -0.577 . . . . 10.0 112.375 -176.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 1.092 ' HE2' ' H ' ' A' ' 75' ' ' ALA . 0.8 OUTLIER -113.48 23.71 12.92 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 121.062 -0.255 . . . . 10.0 110.888 -178.844 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.761 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 46.5 ttm -48.48 -44.3 64.85 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.359 -0.382 . . . . 10.0 111.696 175.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 113' ' ' MET . 56.7 Cg_endo -68.04 -20.64 44.11 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.587 1.525 . . . . 10.0 113.172 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -83.55 -54.95 4.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.604 -0.726 . . . . 10.0 110.441 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.602 ' HG ' HG21 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -65.43 -0.32 1.86 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.686 -1.143 . . . . 10.0 112.618 -177.935 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 15.5 m120 60.25 46.93 9.72 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.717 -1.128 . . . . 10.0 109.309 -177.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.761 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -79.84 113.63 18.14 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.358 -1.292 . . . . 10.0 112.625 -173.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -67.39 -36.04 80.52 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.148 -0.686 . . . . 10.0 109.148 169.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.5 p -150.59 146.4 26.52 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.955 -1.128 . . . . 10.0 107.955 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.609 ' O ' ' HG2' ' A' ' 125' ' ' MET . 39.6 tp -53.06 -40.47 64.03 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 114.446 1.276 . . . . 10.0 114.446 -177.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -51.13 -35.19 34.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.309 0.576 . . . . 10.0 111.026 176.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.587 ' O ' ' HG3' ' A' ' 126' ' ' LYS . . . -67.64 -49.08 64.69 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 118.816 -1.153 . . . . 10.0 110.607 173.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.668 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -56.86 -29.05 62.53 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.684 -0.806 . . . . 10.0 110.328 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.649 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 82.8 mmm -61.55 -41.55 97.52 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 113.06 0.763 . . . . 10.0 113.06 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.737 ' HD3' ' N ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -66.7 -45.27 79.31 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 122.161 -0.337 . . . . 10.0 111.816 178.588 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.737 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -55.12 -60.59 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 C-N-CA 120.164 -0.614 . . . . 10.0 110.662 178.443 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.744 ' HB ' HG23 ' A' ' 105' ' ' ILE . 19.8 mm -50.36 -55.02 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.219 0 CA-C-N 115.614 -0.721 . . . . 10.0 110.774 -177.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -54.46 -44.3 72.44 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 114.753 -1.112 . . . . 10.0 108.898 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.594 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -72.07 -46.2 37.08 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 121.154 -0.546 . . . . 10.0 112.166 -174.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.621 HG21 ' HB3' ' A' ' 75' ' ' ALA . 68.1 m -46.96 -57.69 4.73 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.483 0.658 . . . . 10.0 109.431 171.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.563 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -49.08 -43.26 40.96 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 114.94 -1.027 . . . . 10.0 111.876 175.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 130' ' ' GLY . 58.6 mttp -48.74 -53.02 20.64 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.439 0.462 . . . . 10.0 110.876 176.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.9 m -66.96 -32.87 74.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.024 0.44 . . . . 10.0 111.446 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.675 ' HE1' ' HA ' ' A' ' 76' ' ' SER . 38.3 mtm -79.85 -1.05 37.31 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.934 1.087 . . . . 10.0 113.934 -175.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.49 23.78 52.76 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 119.619 1.1 . . . . 10.0 112.142 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 3.0 mp -109.26 126.63 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 CA-C-O 121.525 0.679 . . . . 10.0 111.043 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.753 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -91.9 157.86 16.6 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.553 -1.203 . . . . 10.0 108.906 179.31 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 19.5 m -119.02 134.52 62.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.177 -0.675 . . . . 10.0 109.177 171.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.64 HG22 ' O ' ' A' ' 100' ' ' VAL . 28.7 m -133.85 71.07 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 116.052 1.871 . . . . 10.0 116.052 -173.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 20.5 t0 . . . . . 0 C--N 1.3 -1.571 0 CA-C-N 114.321 -1.309 . . . . 10.0 109.041 138.791 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 10.3 mtmp? . . . . . 0 CA--C 1.52 -0.188 0 N-CA-C 109.776 -0.453 . . . . 10.0 109.776 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.442 HG13 HG23 ' A' ' 59' ' ' THR . 45.2 t -62.13 131.53 27.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 116.222 -0.444 . . . . 10.0 111.155 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.93 -35.39 7.31 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.687 -0.486 . . . . 10.0 109.687 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.512 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -154.11 141.27 19.45 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.327 0.862 . . . . 10.0 113.327 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -94.2 126.96 39.76 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 106.654 -1.61 . . . . 10.0 106.654 171.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.648 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 1.9 mt -125.67 85.59 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 120.241 -0.584 . . . . 10.0 109.864 -177.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.566 ' HG2' HG22 ' A' ' 57' ' ' VAL . 58.1 mttp -75.92 132.86 40.53 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 120.338 -0.545 . . . . 10.0 109.85 176.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.697 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -158.34 127.21 5.55 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.154 0.978 . . . . 10.0 111.607 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -85.92 122.87 30.59 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.502 -1.226 . . . . 10.0 110.724 -172.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.697 HD21 HD11 ' A' ' 11' ' ' LEU . 94.0 mt -141.56 135.66 14.96 Favored Pre-proline 0 CA--C 1.51 -0.584 0 CA-C-O 121.659 0.742 . . . . 10.0 112.044 -172.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.671 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 53.1 Cg_exo -49.94 124.34 12.4 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.818 3.012 . . . . 10.0 112.943 170.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.61 ' CB ' ' HA ' ' A' ' 50' ' ' ALA . . . -62.73 128.76 37.44 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.599 -1.259 . . . . 10.0 107.599 170.021 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.35 0.48 78.35 Favored Glycine 0 N--CA 1.446 -0.693 0 O-C-N 125.513 1.758 . . . . 10.0 112.992 -174.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.671 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -143.84 96.08 2.84 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.941 0.877 . . . . 10.0 112.038 -178.521 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' A' ' 39' ' ' CYS . . . -170.62 135.85 1.19 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.073 -1.422 . . . . 10.0 112.733 177.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.74 ' H ' ' HD3' ' A' ' 20' ' ' PRO . 5.9 t -179.61 -36.26 0.0 OUTLIER Pre-proline 0 N--CA 1.443 -0.777 0 CA-C-N 115.236 -0.893 . . . . 10.0 113.357 176.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.74 ' HD3' ' H ' ' A' ' 19' ' ' THR . 89.3 Cg_endo -104.04 129.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.409 -3.476 0 N-CA-C 116.492 1.689 . . . . 10.0 116.492 -157.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.962 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . 13.09 -58.24 0.0 OUTLIER Pre-proline 0 C--N 1.288 -2.078 0 CA-C-N 109.228 -3.624 . . . . 10.0 118.546 152.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.771 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 45.3 Cg_exo -57.69 -63.9 0.14 Allowed 'Trans proline' 0 CA--C 1.566 2.115 0 CA-C-N 123.576 2.313 . . . . 10.0 115.409 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.771 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 58.6 Cg_endo -77.42 -52.04 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.681 2.254 . . . . 10.0 112.74 176.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.013 HG12 HD12 ' A' ' 35' ' ' ILE . 77.5 t -81.89 -49.46 17.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 111.702 -2.499 . . . . 10.0 111.894 -166.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.766 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -44.15 -52.97 6.83 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 113.968 -1.469 . . . . 10.0 113.39 178.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.962 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 23.9 Cg_exo -71.96 -43.82 1.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.179 2.586 . . . . 10.0 111.236 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.58 -93.81 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.434 0.459 . . . . 10.0 111.897 178.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.778 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.356 0.0 OUTLIER -77.15 -19.24 57.12 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 117.306 -1.758 . . . . 10.0 113.797 -174.535 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.55 -39.48 60.84 Favored Glycine 0 N--CA 1.467 0.714 0 C-N-CA 120.666 -0.778 . . . . 10.0 113.092 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.608 ' HB3' ' O ' ' A' ' 26' ' ' PRO . 13.0 tt0 -56.61 -26.14 54.83 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.746 0.308 . . . . 10.0 110.628 175.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -96.47 23.63 6.62 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.739 -0.784 . . . . 10.0 109.86 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.444 ' HA3' ' CE ' ' A' ' 64' ' ' LYS . . . 81.66 6.92 88.72 Favored Glycine 0 CA--C 1.494 -1.232 0 CA-C-N 115.27 -0.877 . . . . 10.0 112.813 167.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.888 HG11 ' CD2' ' A' ' 66' ' ' PHE . 2.4 t -85.26 146.97 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 113.628 0.973 . . . . 10.0 113.628 -175.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.446 ' OD1' ' HB3' ' A' ' 37' ' ' GLU . 2.0 p30 -69.97 101.71 1.84 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.649 0.737 . . . . 10.0 111.477 174.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.013 HD12 HG12 ' A' ' 24' ' ' VAL . 21.2 mm -53.49 -39.25 35.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 114.152 -1.385 . . . . 10.0 112.175 176.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.735 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 3.2 mpp? -66.13 -51.38 58.5 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.335 -1.757 . . . . 10.0 111.907 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.498 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 44.0 tt0 -57.83 -40.13 79.28 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.109 -1.036 . . . . 10.0 110.23 176.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.65 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 89.0 t80 -57.47 -58.97 5.95 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 113.877 1.066 . . . . 10.0 113.877 171.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.735 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 19.8 p -60.08 -47.43 85.91 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 114.563 -1.199 . . . . 10.0 111.36 -175.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -65.26 -24.29 67.28 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.988 -0.745 . . . . 10.0 108.988 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.782 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 19.2 mtp180 -74.2 -64.48 1.01 Allowed 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.598 -0.841 . . . . 10.0 112.35 170.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.625 ' CZ ' HG21 ' A' ' 46' ' ' THR . 76.5 t80 -53.37 -45.18 69.11 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 121.157 0.503 . . . . 10.0 110.376 -172.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -59.18 -51.01 71.85 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.026 -0.988 . . . . 10.0 110.235 -177.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.27 -41.67 99.04 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.209 -0.996 . . . . 10.0 112.232 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.782 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 10.6 mt-10 -68.6 -40.33 80.47 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.795 0.807 . . . . 10.0 111.166 -176.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.625 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 75.4 p -87.81 0.54 55.64 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 114.778 -1.101 . . . . 10.0 112.28 -173.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.04 -35.27 2.9 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.231 1.013 . . . . 10.0 113.233 -175.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -86.91 -33.54 19.69 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.806 -0.634 . . . . 10.0 112.391 -173.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.575 ' HB3' ' HZ ' ' A' ' 77' ' ' PHE . 39.3 mttm -96.94 20.45 11.12 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.181 -0.674 . . . . 10.0 109.181 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.61 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -54.36 157.74 2.65 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 125.223 1.409 . . . . 10.0 114.128 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.05 22.07 43.39 Favored Glycine 0 CA--C 1.501 -0.812 0 N-CA-C 109.121 -1.592 . . . . 10.0 109.121 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.615 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 40.4 tpp -140.99 120.21 12.94 Favored 'General case' 0 C--O 1.205 -1.242 0 C-N-CA 117.42 -1.712 . . . . 10.0 114.737 -159.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.6 mm -63.11 92.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 121.688 -0.632 . . . . 10.0 109.999 172.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.768 HD22 ' HE2' ' A' ' 77' ' ' PHE . 7.2 mt -82.65 129.37 62.73 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.71 -0.478 . . . . 10.0 109.71 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.405 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 14.9 Cg_exo -71.51 103.37 1.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 121.918 1.746 . . . . 10.0 110.262 171.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.02 153.79 3.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 119.726 1.148 . . . . 10.0 110.903 -173.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.566 HG22 ' HG2' ' A' ' 10' ' ' LYS . 61.5 t -133.09 111.66 16.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 176.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.648 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 17.2 mt -102.9 140.66 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.789 0 N-CA-C 108.534 -0.913 . . . . 10.0 108.534 -172.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.442 HG23 HG13 ' A' ' 5' ' ' VAL . 57.2 m -125.19 94.45 4.17 Favored 'General case' 0 N--CA 1.402 -2.863 0 CA-C-N 114.774 -1.103 . . . . 10.0 108.873 177.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 65' ' ' SER . 2.2 p -89.82 134.67 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 O-C-N 121.264 -0.898 . . . . 10.0 110.16 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -91.84 172.34 8.53 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.69 -0.686 . . . . 10.0 112.658 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -63.75 -19.25 64.82 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.298 -0.865 . . . . 10.0 111.393 -178.799 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.442 ' HB3' ' OG ' ' A' ' 65' ' ' SER . 27.3 t70 -77.55 -10.45 59.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.811 -1.086 . . . . 10.0 111.237 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.444 ' CE ' ' HA3' ' A' ' 32' ' ' GLY . 28.1 mmmt 82.55 -3.76 1.38 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.328 1.051 . . . . 10.0 110.961 -172.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.606 ' O ' HG23 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -68.93 179.45 1.83 Allowed 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.661 -0.866 . . . . 10.0 108.661 170.843 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.888 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -166.06 -176.51 3.78 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 119.851 1.205 . . . . 10.0 109.828 175.128 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.3 p -158.12 166.84 31.45 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 102.275 -3.231 . . . . 10.0 102.275 178.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.428 ' CB ' HG12 ' A' ' 58' ' ' ILE . 45.1 p90 -163.66 154.64 16.23 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.207 -1.035 . . . . 10.0 108.207 175.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.518 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 29.2 pt -117.01 164.14 13.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.613 -1.254 . . . . 10.0 107.613 -177.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.488 HG21 HD13 ' A' ' 54' ' ' LEU . 10.5 mm -117.22 126.27 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 106.561 -1.644 . . . . 10.0 106.561 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.465 ' HD3' ' HA ' ' A' ' 71' ' ' LYS . 50.3 mmtt -72.47 104.29 3.76 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 119.576 -0.85 . . . . 10.0 109.988 -177.081 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.692 ' O ' ' HE2' ' A' ' 112' ' ' LYS . 8.2 p -41.57 139.06 1.55 Allowed Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 112.973 -1.921 . . . . 10.0 109.27 174.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.446 ' HB3' ' HB3' ' A' ' 77' ' ' PHE . 8.7 Cg_exo -32.59 104.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 124.192 3.262 . . . . 10.0 113.256 -174.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -38.85 -47.66 2.76 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.064 2.509 . . . . 10.0 110.565 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.585 ' CB ' HG21 ' A' ' 131' ' ' THR . . . 174.91 -47.58 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 113.824 -1.534 . . . . 10.0 109.364 159.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.643 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 83.9 p -64.68 -30.46 71.48 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 109.817 -0.438 . . . . 10.0 109.817 -178.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.768 ' HE2' HD22 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -41.89 -70.27 0.11 Allowed 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.87 0.868 . . . . 10.0 111.122 175.478 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.781 ' HB3' HD12 ' A' ' 108' ' ' ILE . 12.5 tp -90.25 -17.48 27.39 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.078 -0.51 . . . . 10.0 109.849 -170.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.7 mt -69.2 -33.16 72.92 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.259 172.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.643 ' HG3' ' O ' ' A' ' 76' ' ' SER . 48.5 mttp -60.81 -41.52 95.85 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.35 -0.611 . . . . 10.0 109.35 171.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -58.4 -39.91 80.98 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.851 -0.613 . . . . 10.0 112.422 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.814 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -69.96 -53.03 19.6 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.975 1.369 . . . . 10.0 110.875 174.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.292 -1.922 0 CA-C-N 111.473 -2.603 . . . . 10.0 111.437 -171.243 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 97' ' ' VAL . 7.1 p . . . . . 0 CA--C 1.54 0.593 0 CA-C-O 121.98 0.895 . . . . 10.0 111.694 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 38.92 -161.83 0.01 OUTLIER Glycine 0 C--N 1.323 -0.181 0 CA-C-N 114.21 -1.359 . . . . 10.0 112.656 -170.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.573 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 8.4 ptpp? -158.85 177.58 11.01 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 122.273 1.035 . . . . 10.0 111.022 177.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.814 HG11 ' HB1' ' A' ' 82' ' ' ALA . 1.0 OUTLIER -155.54 -145.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-N 112.285 -2.234 . . . . 10.0 105.981 -176.147 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 0.1 OUTLIER -162.77 142.72 9.32 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 109.048 -0.723 . . . . 10.0 109.048 -157.44 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.732 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 1.5 tpt180 -43.31 -39.97 3.33 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 124.934 1.396 . . . . 10.0 110.795 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.557 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 17.8 tppt? -60.13 -44.42 94.93 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.521 0.563 . . . . 10.0 112.521 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.65 ' O ' HG12 ' A' ' 108' ' ' ILE . 1.2 mp0 -63.81 -47.96 78.76 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.758 -0.83 . . . . 10.0 108.758 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.732 ' HB ' ' O ' ' A' ' 102' ' ' ARG . 43.2 mm -35.53 -58.15 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 114.949 -1.023 . . . . 10.0 111.544 163.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.647 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 33.1 tt0 -47.33 -54.65 10.54 Favored 'General case' 0 C--O 1.209 -1.07 0 C-N-CA 124.636 1.174 . . . . 10.0 113.146 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -53.2 -58.15 8.03 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 123.743 0.652 . . . . 10.0 110.971 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.781 HD12 ' HB3' ' A' ' 78' ' ' LEU . 7.7 mm -46.79 -55.86 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.243 -0.889 . . . . 10.0 109.963 172.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.618 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -53.27 -38.08 62.74 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.684 -0.689 . . . . 10.0 112.833 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.647 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 76.4 mttt -72.2 -56.92 4.73 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 116.109 -0.496 . . . . 10.0 111.052 -173.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.457 ' O ' HG21 ' A' ' 72' ' ' THR . 1.8 t -54.61 -33.3 60.22 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.171 -0.922 . . . . 10.0 110.168 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 1.063 ' HD2' HD13 ' A' ' 116' ' ' LEU . 4.5 mmtt -91.74 -12.22 34.57 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 112.64 0.607 . . . . 10.0 112.64 -177.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.4 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 45.7 ttm -37.27 -52.7 2.27 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 113.25 0.833 . . . . 10.0 113.25 177.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 113' ' ' MET . 30.7 Cg_endo -64.49 -22.74 65.19 Favored 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 121.456 1.437 . . . . 10.0 112.988 -178.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.751 ' HB3' ' HD3' ' A' ' 112' ' ' LYS . 3.6 t70 -99.25 -42.19 7.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.819 0.818 . . . . 10.0 112.152 -175.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 1.063 HD13 ' HD2' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -63.82 -0.22 1.0 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.105 -1.407 . . . . 10.0 111.815 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.447 ' H ' ' C ' ' A' ' 115' ' ' ASP . 2.6 p-10 56.85 43.88 24.21 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 113.971 -1.468 . . . . 10.0 108.886 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 119' ' ' ASN . . . -65.39 -74.62 0.1 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 112.7 -2.045 . . . . 10.0 113.272 -166.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 118' ' ' ALA . 28.7 t-20 103.57 -42.87 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 O-C-N 125.08 1.488 . . . . 10.0 109.096 -173.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.5 t -153.79 139.75 18.23 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.391 -1.707 . . . . 10.0 106.391 173.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.597 ' O ' HD13 ' A' ' 121' ' ' LEU . 1.5 tm? -50.47 -35.26 28.18 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.34 0.867 . . . . 10.0 113.34 -174.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.536 ' HA ' ' HG3' ' A' ' 125' ' ' MET . 1.6 mp0 -51.15 -41.31 60.03 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.584 0.707 . . . . 10.0 111.013 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.93 -47.37 74.94 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 118.787 -1.165 . . . . 10.0 110.488 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.482 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -58.6 -29.86 66.78 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.837 -0.345 . . . . 10.0 111.0 176.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.536 ' HG3' ' HA ' ' A' ' 122' ' ' GLU . 5.0 mtp -54.92 -41.02 70.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.903 0.382 . . . . 10.0 111.087 175.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -63.37 -54.68 33.03 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.632 -0.713 . . . . 10.0 112.173 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.944 HD12 HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -52.29 -59.35 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 120.212 -0.595 . . . . 10.0 111.144 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.632 ' HB ' HG23 ' A' ' 105' ' ' ILE . 27.4 mm -51.7 -56.65 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 CA-C-N 114.841 -1.072 . . . . 10.0 111.676 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.56 ' HG3' HG21 ' A' ' 105' ' ' ILE . 5.3 mt-10 -51.95 -44.15 63.8 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 123.824 0.702 . . . . 10.0 109.143 177.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.73 -45.97 63.18 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.393 -0.908 . . . . 10.0 111.08 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.585 HG21 ' CB ' ' A' ' 75' ' ' ALA . 49.9 m -46.75 -64.77 0.68 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.144 -1.028 . . . . 10.0 109.148 169.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -47.49 -52.62 16.67 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.147 0.499 . . . . 10.0 111.561 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -52.19 -53.5 42.47 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.943 -1.026 . . . . 10.0 112.163 178.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 22.9 p -68.34 -25.5 65.14 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.044 0.45 . . . . 10.0 110.599 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.406 ' HG3' ' O ' ' A' ' 131' ' ' THR . 45.1 mtm -75.42 -8.41 56.63 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 112.731 0.641 . . . . 10.0 112.731 178.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 96.48 2.65 60.11 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 118.995 0.816 . . . . 10.0 111.765 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.7 mt -95.02 136.38 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 CA-C-N 117.54 0.67 . . . . 10.0 112.029 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.577 ' HG3' ' N ' ' A' ' 139' ' ' VAL . 0.0 OUTLIER -84.7 156.28 21.54 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 119.097 -1.041 . . . . 10.0 110.544 177.22 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.577 ' N ' ' HG3' ' A' ' 138' ' ' GLU . 17.3 m -120.03 126.21 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.55 0 N-CA-C 107.561 -1.274 . . . . 10.0 107.561 170.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 100' ' ' VAL . 26.2 m -107.2 167.95 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 CA-C-N 113.555 -1.657 . . . . 10.0 108.415 176.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 . . . . . 0 C--N 1.285 -2.198 0 CA-C-N 113.921 -1.49 . . . . 10.0 110.814 178.563 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.0 mttt . . . . . 0 C--O 1.218 -0.584 0 N-CA-C 110.003 -0.369 . . . . 10.0 110.003 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.7 t -65.61 141.3 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 122.737 0.415 . . . . 10.0 111.097 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -109.48 -46.77 3.48 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.198 175.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.401 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -156.39 156.98 34.8 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 114.034 1.124 . . . . 10.0 114.034 -173.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -92.05 136.31 33.27 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.244 -1.344 . . . . 10.0 108.357 169.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.678 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -122.73 82.0 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 108.799 -0.815 . . . . 10.0 108.799 169.478 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.469 ' HG2' HG22 ' A' ' 57' ' ' VAL . 48.1 mtpt -78.9 130.97 36.21 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 120.444 1.474 . . . . 10.0 108.396 172.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.576 HD21 HD11 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -159.21 129.59 5.82 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.95 0.881 . . . . 10.0 111.255 -178.966 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -83.23 119.71 24.9 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.346 -1.297 . . . . 10.0 109.941 -172.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.576 HD11 HD21 ' A' ' 11' ' ' LEU . 55.2 mt -137.07 135.54 19.89 Favored Pre-proline 0 CA--C 1.5 -0.97 0 CA-C-O 121.878 0.847 . . . . 10.0 112.659 -171.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.786 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 25.2 Cg_exo -54.35 123.12 12.81 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 123.622 2.882 . . . . 10.0 111.486 172.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.595 ' CB ' ' HB ' ' A' ' 46' ' ' THR . . . -61.35 125.45 23.81 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.158 -1.423 . . . . 10.0 107.158 168.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.0 -0.97 89.3 Favored Glycine 0 N--CA 1.44 -1.039 0 O-C-N 125.774 1.921 . . . . 10.0 113.233 -175.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.786 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 19.4 tptm -143.47 109.34 5.22 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.296 1.048 . . . . 10.0 112.705 176.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.638 ' H ' HD22 ' A' ' 43' ' ' ASN . . . -171.69 142.21 1.54 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.256 -1.338 . . . . 10.0 112.747 172.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.575 ' H ' ' HD3' ' A' ' 20' ' ' PRO . 2.7 t 179.44 -43.02 0.0 OUTLIER Pre-proline 0 C--O 1.207 -1.165 0 O-C-N 124.059 0.85 . . . . 10.0 113.129 175.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.655 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 85.6 Cg_endo -103.25 131.19 0.1 OUTLIER 'Trans proline' 0 N--CA 1.413 -3.259 0 N-CA-C 117.175 1.952 . . . . 10.0 117.175 -153.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.938 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . 13.96 -57.37 0.0 OUTLIER Pre-proline 0 C--N 1.289 -2.041 0 CA-C-N 108.615 -3.902 . . . . 10.0 119.275 153.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.708 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 32.5 Cg_exo -60.46 -63.33 0.12 Allowed 'Trans proline' 0 CA--C 1.562 1.888 0 CA-C-N 123.415 2.255 . . . . 10.0 115.252 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.708 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 55.7 Cg_endo -75.16 -52.86 0.1 Allowed 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.412 2.075 . . . . 10.0 112.239 174.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.765 HG12 HD13 ' A' ' 35' ' ' ILE . 83.1 t -83.26 -47.27 18.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 111.622 -2.535 . . . . 10.0 112.155 -166.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.924 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -42.67 -53.23 5.27 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 114.241 -1.345 . . . . 10.0 114.232 176.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.938 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 32.5 Cg_exo -70.01 -45.73 1.36 Allowed 'Trans proline' 0 CA--C 1.51 -0.719 0 C-N-CA 123.249 2.633 . . . . 10.0 111.324 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.536 ' HB1' ' CG2' ' A' ' 9' ' ' ILE . . . -51.33 -68.42 0.17 Allowed 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.376 0.608 . . . . 10.0 111.061 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.674 HD12 HG13 ' A' ' 24' ' ' VAL . 5.9 mt -78.0 -51.62 10.07 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.84 1.052 . . . . 10.0 113.84 -176.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.19 -42.01 96.97 Favored Glycine 0 N--CA 1.461 0.304 0 CA-C-N 116.117 -0.492 . . . . 10.0 113.314 -171.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -60.27 -25.93 66.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.716 0.294 . . . . 10.0 110.646 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -102.3 16.75 25.29 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.641 -0.824 . . . . 10.0 110.623 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.48 9.25 87.1 Favored Glycine 0 CA--C 1.501 -0.797 0 CA-C-N 114.904 -1.043 . . . . 10.0 113.2 168.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.743 HG11 ' CD2' ' A' ' 66' ' ' PHE . 1.9 t -83.06 147.83 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 113.357 0.873 . . . . 10.0 113.357 -174.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -68.64 100.41 1.13 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.224 0.535 . . . . 10.0 111.132 172.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.765 HD13 HG12 ' A' ' 24' ' ' VAL . 1.4 mm -52.12 -42.03 34.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.684 -1.144 . . . . 10.0 111.132 173.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 82.9 mtp -64.75 -53.18 51.24 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 112.973 -1.921 . . . . 10.0 111.749 177.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 40.9 mt-10 -57.09 -41.21 78.45 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 118.945 -1.102 . . . . 10.0 110.93 177.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.673 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 75.5 t80 -57.83 -57.87 10.88 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 113.701 1.0 . . . . 10.0 113.701 172.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -56.15 -49.57 73.57 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.339 -1.301 . . . . 10.0 111.366 -178.561 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.451 ' HD3' ' O ' ' A' ' 40' ' ' LYS . 12.7 tmtt? -66.96 -22.83 65.91 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.665 -0.865 . . . . 10.0 108.665 -178.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.765 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 26.8 mtt180 -75.93 -64.45 1.08 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.062 -1.055 . . . . 10.0 112.253 170.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.626 ' CZ ' HG21 ' A' ' 46' ' ' THR . 70.1 t80 -55.98 -45.72 78.89 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.032 0.444 . . . . 10.0 110.883 -172.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.638 HD22 ' H ' ' A' ' 18' ' ' ALA . 4.4 m-20 -61.09 -48.99 79.12 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.246 -0.888 . . . . 10.0 110.191 -178.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.43 -36.96 85.46 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 118.971 -1.092 . . . . 10.0 112.084 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.765 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 42.4 mm-40 -64.01 -47.84 78.72 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.933 0.873 . . . . 10.0 110.687 178.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.626 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 73.3 p -89.44 5.88 43.31 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.017 -1.447 . . . . 10.0 112.209 -168.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -47.9 -35.86 11.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.488 -1.233 . . . . 10.0 112.616 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -86.39 -36.39 19.2 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 115.491 -0.777 . . . . 10.0 111.487 -174.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -95.91 20.11 10.48 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.673 -0.862 . . . . 10.0 108.673 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.467 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -53.75 150.1 7.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.06 -1.427 . . . . 10.0 112.73 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.92 20.32 28.76 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 114.759 -1.11 . . . . 10.0 110.36 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.547 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 63.3 mtt -138.88 127.32 23.0 Favored 'General case' 0 C--O 1.208 -1.094 0 C-N-CA 117.527 -1.669 . . . . 10.0 114.595 -168.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.3 mm -67.15 91.93 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 118.773 0.715 . . . . 10.0 109.213 169.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.592 HD12 ' CG2' ' A' ' 46' ' ' THR . 9.4 mt -80.67 136.8 51.37 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.059 -0.719 . . . . 10.0 109.059 -176.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.487 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 7.4 Cg_exo -75.7 104.25 1.87 Allowed 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.202 1.935 . . . . 10.0 110.682 172.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.457 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -99.86 152.99 4.53 Favored 'Isoleucine or valine' 0 C--N 1.344 0.363 0 CA-C-N 119.706 1.139 . . . . 10.0 111.112 -174.701 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.469 HG22 ' HG2' ' A' ' 10' ' ' LYS . 97.1 t -134.15 113.57 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 110.106 -0.331 . . . . 10.0 110.106 174.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.678 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 20.6 mt -108.14 139.96 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 108.099 -1.074 . . . . 10.0 108.099 -174.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 60.5 m -122.31 97.08 5.3 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 114.833 -1.076 . . . . 10.0 108.88 176.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 65' ' ' SER . 2.6 p -87.86 138.12 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.186 0 O-C-N 121.017 -1.052 . . . . 10.0 110.461 -178.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.409 ' CD2' ' HA ' ' A' ' 66' ' ' PHE . 72.9 m-85 -93.78 172.12 8.45 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.179 -0.919 . . . . 10.0 112.961 -177.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -62.96 -21.31 66.01 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 113.813 -1.539 . . . . 10.0 111.43 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -76.89 -12.9 60.02 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 113.905 -1.498 . . . . 10.0 110.997 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.68 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 8.5 mmpt? 83.77 -3.26 1.13 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.244 1.018 . . . . 10.0 110.11 -170.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.524 ' O ' HG23 ' A' ' 60' ' ' VAL . 31.6 m -69.57 179.2 2.19 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.349 -0.841 . . . . 10.0 109.349 171.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.743 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -170.25 -176.25 2.17 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 119.639 1.109 . . . . 10.0 110.174 175.379 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.5 p -158.36 164.26 36.5 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 102.987 -2.968 . . . . 10.0 102.987 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.445 ' CB ' HG12 ' A' ' 58' ' ' ILE . 50.7 p90 -161.31 157.29 25.24 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.403 0.62 . . . . 10.0 109.539 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.425 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 23.1 pt -127.99 165.86 26.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 114.846 -1.07 . . . . 10.0 108.31 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.448 HD12 ' CE1' ' A' ' 42' ' ' PHE . 1.7 mm -127.86 130.46 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 108.396 -0.965 . . . . 10.0 108.396 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 65.1 mmtt -77.88 83.26 4.22 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.025 -0.731 . . . . 10.0 109.025 176.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.401 ' OG1' ' HA ' ' A' ' 112' ' ' LYS . 18.8 p -30.01 101.17 0.15 Allowed Pre-proline 0 C--N 1.326 -0.437 0 O-C-N 125.845 1.965 . . . . 10.0 110.934 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.618 ' HB2' HD13 ' A' ' 78' ' ' LEU . 50.9 Cg_exo -20.52 106.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.13 1 C-N-CA 125.432 4.088 . . . . 10.0 114.326 -164.032 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.576 ' O ' ' HD3' ' A' ' 112' ' ' LYS . 24.8 Cg_exo -23.64 -54.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.361 1.189 1 C-N-CA 126.143 4.562 . . . . 10.0 115.229 -169.781 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -176.6 -43.68 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 120.46 0.171 . . . . 10.0 111.313 171.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.64 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 23.1 t -57.34 -35.53 70.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.05 -0.523 . . . . 10.0 112.152 -171.031 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -70.32 -40.27 74.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.922 0.392 . . . . 10.0 111.552 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.618 HD13 ' HB2' ' A' ' 73' ' ' PRO . 8.5 mp -82.53 -26.62 32.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.252 0.549 . . . . 10.0 110.071 -178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.4 mt -60.56 -40.42 91.55 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.91 -0.774 . . . . 10.0 108.91 170.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.64 ' HG3' ' O ' ' A' ' 76' ' ' SER . 59.0 mttp -63.46 -23.35 67.36 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.481 -0.327 . . . . 10.0 111.189 175.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.577 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -58.02 -52.43 65.55 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 121.005 -0.278 . . . . 10.0 110.594 174.024 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.823 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -84.52 -62.48 1.54 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.466 1.506 . . . . 10.0 112.113 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.718 0 CA-C-N 111.329 -2.668 . . . . 10.0 107.929 -178.814 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.551 HG13 ' N ' ' A' ' 98' ' ' GLY . 7.7 p . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 112.954 0.724 . . . . 10.0 112.954 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.551 ' N ' HG13 ' A' ' 97' ' ' VAL . . . -169.57 152.28 19.24 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.263 -1.135 . . . . 10.0 110.263 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.677 ' CB ' ' HB3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -148.21 177.42 9.41 Favored 'General case' 0 CA--C 1.48 -1.739 0 CA-C-O 122.625 1.202 . . . . 10.0 110.491 -166.17 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.823 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.7 OUTLIER -164.89 -163.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 CA-C-N 111.308 -2.678 . . . . 10.0 105.639 -166.659 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.481 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 0.5 OUTLIER -127.98 156.26 42.97 Favored 'General case' 0 C--N 1.269 -2.901 0 C-N-CA 118.41 -1.316 . . . . 10.0 112.816 -169.821 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.673 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 8.4 tpp180 -40.37 -41.54 1.4 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 113.635 -1.621 . . . . 10.0 110.958 177.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -57.45 -44.15 84.53 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.922 0.712 . . . . 10.0 112.922 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.7 ' NE2' ' HB3' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -61.75 -50.2 73.33 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.601 -0.84 . . . . 10.0 108.804 176.057 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.941 HG21 ' HG3' ' A' ' 129' ' ' GLU . 27.3 mm -38.32 -56.56 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.703 -1.135 . . . . 10.0 110.897 170.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.512 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 28.9 tt0 -50.68 -60.89 2.57 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.744 1.218 . . . . 10.0 113.222 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 31.4 mt-10 -57.97 -55.86 29.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.366 -1.288 . . . . 10.0 111.338 -176.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.585 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 46.8 mt -47.71 -50.05 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 116.651 -0.25 . . . . 10.0 110.568 171.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.534 ' HB3' HD11 ' A' ' 121' ' ' LEU . . . -49.46 -51.03 38.51 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.109 0.781 . . . . 10.0 113.109 176.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.595 ' HB3' HD13 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -76.07 -30.1 58.21 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.057 0.391 . . . . 10.0 112.057 -174.011 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.4 m -54.39 -46.38 73.09 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.033 0.444 . . . . 10.0 111.153 173.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 0.5 OUTLIER -100.4 17.69 20.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.867 -0.606 . . . . 10.0 111.026 -176.192 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.965 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 45.2 ttm -47.64 -46.71 61.0 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.017 -0.538 . . . . 10.0 112.229 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 113' ' ' MET . 33.2 Cg_endo -64.79 -21.7 64.37 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.521 1.481 . . . . 10.0 113.493 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.48 ' OD1' ' HD2' ' A' ' 71' ' ' LYS . 24.6 t70 -90.12 -53.2 4.58 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.812 0.815 . . . . 10.0 110.872 -178.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.5 HD13 ' HB2' ' A' ' 112' ' ' LYS . 10.3 mp -63.61 -2.96 1.88 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 113.72 -1.582 . . . . 10.0 111.49 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 63.9 t30 60.92 48.19 6.92 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.852 -1.522 . . . . 10.0 109.644 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.965 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -80.47 114.36 19.31 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.134 -1.394 . . . . 10.0 112.522 -173.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -67.59 -36.22 80.48 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.455 0.645 . . . . 10.0 110.028 171.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.7 p -151.22 143.5 24.11 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 106.841 -1.54 . . . . 10.0 106.841 176.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.679 ' O ' ' HG3' ' A' ' 125' ' ' MET . 58.6 tp -54.27 -34.84 61.72 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 113.794 1.035 . . . . 10.0 113.794 -175.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -48.73 -39.78 26.06 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.59 0.709 . . . . 10.0 110.326 173.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.558 ' HA ' ' HD3' ' A' ' 126' ' ' LYS . . . -66.64 -49.61 65.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.927 -1.033 . . . . 10.0 110.836 176.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.579 ' HB3' HD12 ' A' ' 121' ' ' LEU . . . -57.16 -36.47 70.79 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.632 0.253 . . . . 10.0 110.381 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.679 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 83.1 mtp -55.48 -35.65 65.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.183 -0.462 . . . . 10.0 111.981 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.558 ' HD3' ' HA ' ' A' ' 123' ' ' ALA . 0.1 OUTLIER -64.52 -49.3 71.85 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 110.026 -0.361 . . . . 10.0 110.026 177.397 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.431 ' H ' HG13 ' A' ' 127' ' ' ILE . 55.8 mt -50.68 -63.64 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-O 121.336 0.589 . . . . 10.0 110.846 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.827 ' HB ' HG23 ' A' ' 105' ' ' ILE . 27.5 mm -50.76 -55.53 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 CA-C-N 114.45 -1.25 . . . . 10.0 111.687 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.941 ' HG3' HG21 ' A' ' 105' ' ' ILE . 7.1 mt-10 -52.83 -45.36 67.28 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 123.811 0.695 . . . . 10.0 109.72 178.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -71.6 -44.78 48.55 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.468 -0.872 . . . . 10.0 111.71 -174.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 90.9 m -45.75 -61.49 1.69 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.253 -0.973 . . . . 10.0 109.943 170.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.64 -49.39 47.34 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.565 -1.198 . . . . 10.0 111.876 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 19.6 ttmm -48.37 -54.57 13.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.555 -0.748 . . . . 10.0 111.55 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.4 t -63.23 -31.47 72.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.572 0.701 . . . . 10.0 110.382 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 35.8 mtp -80.06 7.72 8.57 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.897 1.073 . . . . 10.0 113.897 -176.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.493 ' O ' HG12 ' A' ' 97' ' ' VAL . . . 84.64 3.8 88.0 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 119.478 1.035 . . . . 10.0 111.789 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 33.3 mt -96.78 127.79 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 CA-C-O 121.959 0.885 . . . . 10.0 111.83 -176.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.677 ' HB3' ' CB ' ' A' ' 99' ' ' LYS . 39.1 tt0 -88.21 159.43 18.15 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.156 -1.384 . . . . 10.0 108.768 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.54 HG11 ' HG2' ' A' ' 129' ' ' GLU . 17.9 m -117.92 134.1 62.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 108.341 -0.985 . . . . 10.0 108.341 167.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 100' ' ' VAL . 26.9 m -138.62 69.37 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 114.784 1.401 . . . . 10.0 114.784 -174.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.9 t70 . . . . . 0 C--N 1.298 -1.673 0 CA-C-O 117.771 -1.109 . . . . 10.0 110.257 145.455 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 2.3 mtpp . . . . . 0 C--O 1.222 -0.358 0 N-CA-C 109.723 -0.473 . . . . 10.0 109.723 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.5 t -62.93 138.61 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 122.833 0.453 . . . . 10.0 111.719 -176.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.61 -38.47 5.17 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 173.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.527 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -154.28 141.34 19.35 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.857 0.688 . . . . 10.0 112.857 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -98.67 115.65 29.15 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.053 -1.462 . . . . 10.0 107.053 173.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.615 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 3.7 mt -113.9 85.45 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.051 0 N-CA-C 108.803 -0.814 . . . . 10.0 108.803 -174.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.469 ' O ' HD12 ' A' ' 11' ' ' LEU . 10.1 mtmp? -77.85 148.26 34.75 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 119.136 0.88 . . . . 10.0 110.304 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 10' ' ' LYS . 0.8 OUTLIER -156.38 135.3 11.88 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.003 -0.74 . . . . 10.0 109.003 -178.226 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -93.79 111.46 23.16 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.199 -1.038 . . . . 10.0 108.199 169.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 15.0 mt -127.94 135.21 27.16 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 121.594 0.711 . . . . 10.0 112.324 -166.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.592 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 22.1 Cg_exo -57.88 121.2 9.61 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.532 2.821 . . . . 10.0 111.861 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.564 ' CB ' ' HB ' ' A' ' 46' ' ' THR . . . -61.72 127.48 31.66 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 107.768 -1.197 . . . . 10.0 107.768 170.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.9 0.36 89.38 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 125.695 1.872 . . . . 10.0 112.625 -174.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.592 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 4.6 tmtp? -141.09 100.95 3.93 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.992 0.901 . . . . 10.0 111.911 177.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.84 132.24 3.67 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.421 -1.263 . . . . 10.0 112.395 176.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.469 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -177.03 -53.68 0.0 OUTLIER Pre-proline 0 N--CA 1.448 -0.537 0 N-CA-C 112.697 0.629 . . . . 10.0 112.697 178.5 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.619 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 80.6 Cg_endo -104.53 128.09 0.07 OUTLIER 'Trans proline' 0 N--CA 1.416 -3.044 0 N-CA-C 116.211 1.581 . . . . 10.0 116.211 -154.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.02 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 16.04 -84.11 0.0 OUTLIER Pre-proline 0 C--N 1.294 -1.806 0 CA-C-N 108.58 -3.918 . . . . 10.0 116.251 165.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.593 ' CB ' ' HD3' ' A' ' 23' ' ' PRO . 3.2 Cg_exo -31.31 -56.79 0.23 Allowed 'Trans proline' 0 CA--C 1.558 1.679 0 C-N-CA 122.906 2.404 . . . . 10.0 115.419 -165.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.619 ' HD2' ' O ' ' A' ' 20' ' ' PRO . 5.4 Cg_exo -83.95 -49.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 123.346 2.697 . . . . 10.0 112.237 171.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.972 HG12 HD13 ' A' ' 35' ' ' ILE . 57.9 t -88.87 -45.68 15.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 112.449 -2.16 . . . . 10.0 113.484 -163.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 1.02 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -47.56 -80.6 0.05 OUTLIER Glycine 0 C--O 1.221 -0.692 0 CA-C-N 114.609 -1.178 . . . . 10.0 114.304 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.632 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 13.0 Cg_exo -43.28 -41.2 9.97 Favored 'Trans proline' 0 CA--C 1.52 -0.223 0 C-N-CA 123.544 2.83 . . . . 10.0 112.316 174.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 24' ' ' VAL . . . -52.47 -77.94 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.644 0.735 . . . . 10.0 111.255 176.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.778 HD12 HG13 ' A' ' 24' ' ' VAL . 6.9 mt -75.55 -42.74 51.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.961 -1.018 . . . . 10.0 113.725 -173.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.9 -38.22 95.77 Favored Glycine 0 N--CA 1.463 0.489 0 CA-C-N 116.526 -0.306 . . . . 10.0 113.214 -176.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -63.87 -21.18 66.33 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 119.506 -0.877 . . . . 10.0 109.699 175.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -103.91 7.17 36.78 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.888 -0.725 . . . . 10.0 111.861 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.65 ' HA3' ' NZ ' ' A' ' 64' ' ' LYS . . . 56.79 37.44 77.48 Favored Glycine 0 CA--C 1.509 -0.31 0 CA-C-N 115.309 -0.86 . . . . 10.0 112.899 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.645 HG11 HD22 ' A' ' 28' ' ' LEU . 55.8 t -74.72 -32.15 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 115.734 1.753 . . . . 10.0 115.734 -169.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 90.06 78.17 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 125.3 1.44 . . . . 10.0 109.581 -169.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.972 HD13 HG12 ' A' ' 24' ' ' VAL . 1.4 mt -51.92 -40.63 28.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 113.046 -1.888 . . . . 10.0 113.336 176.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 87.5 mtp -63.04 -47.18 84.11 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 117.523 -1.671 . . . . 10.0 111.495 173.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.603 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 21.7 tp10 -60.0 -43.47 95.16 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 118.979 -1.088 . . . . 10.0 110.252 176.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.577 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 71.7 t80 -56.5 -57.04 14.05 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 113.928 1.084 . . . . 10.0 113.928 172.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.43 -50.14 73.98 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.882 0.873 . . . . 10.0 111.729 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -63.29 -22.88 67.15 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.244 -0.982 . . . . 10.0 108.756 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.831 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 33.1 mtm-85 -78.53 -64.31 1.2 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 118.228 -0.892 . . . . 10.0 112.192 168.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.598 ' CZ ' HG21 ' A' ' 46' ' ' THR . 69.8 t80 -53.11 -48.0 68.18 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 119.477 1.035 . . . . 10.0 110.224 -169.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -60.02 -50.24 74.52 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.037 -0.983 . . . . 10.0 110.326 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.72 93.71 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 119.157 -1.017 . . . . 10.0 111.943 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.831 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 7.0 mm-40 -66.26 -44.72 82.86 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 122.203 1.002 . . . . 10.0 110.713 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.61 ' CG2' HD12 ' A' ' 54' ' ' LEU . 81.6 p -89.76 0.5 56.96 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 113.963 -1.472 . . . . 10.0 111.986 -171.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.08 -38.81 8.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.307 -0.86 . . . . 10.0 112.44 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -79.44 -25.63 41.96 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.551 -0.75 . . . . 10.0 111.206 -173.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -108.41 21.66 17.0 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.555 0.742 . . . . 10.0 109.955 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -52.64 148.19 7.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.991 -1.004 . . . . 10.0 112.868 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.9 19.27 31.8 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 110.816 -0.914 . . . . 10.0 110.816 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.688 ' SD ' ' HB3' ' A' ' 77' ' ' PHE . 67.4 mtt -139.28 126.21 20.97 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 117.211 -1.796 . . . . 10.0 114.555 -166.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.3 mm -68.13 91.51 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.255 -0.646 . . . . 10.0 109.255 172.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.61 HD12 ' CG2' ' A' ' 46' ' ' THR . 7.7 mt -82.45 131.68 54.77 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.619 -0.511 . . . . 10.0 109.619 -177.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.587 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 17.1 Cg_exo -69.62 102.82 1.05 Allowed 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.394 2.063 . . . . 10.0 111.196 172.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.486 HG23 HG12 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -101.03 156.84 4.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 119.501 1.046 . . . . 10.0 111.016 -175.767 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.483 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 86.9 t -136.23 116.1 17.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.085 -0.507 . . . . 10.0 110.508 172.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.738 HD13 HD21 ' A' ' 28' ' ' LEU . 18.1 mt -105.57 140.39 23.78 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.925 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 -175.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.3 m -126.96 95.88 4.45 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 114.962 -1.017 . . . . 10.0 109.14 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.527 ' CG1' ' HB3' ' A' ' 7' ' ' ALA . 3.3 p -85.99 136.0 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 119.124 0.875 . . . . 10.0 109.827 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.642 ' HE2' ' HG1' ' A' ' 67' ' ' THR . 82.2 m-85 -94.51 173.33 7.68 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.496 0.665 . . . . 10.0 112.55 -176.009 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 24.8 mt-10 -62.14 -19.33 62.92 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.638 -1.164 . . . . 10.0 112.285 -177.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 4.6 m-20 -78.35 -11.55 59.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.588 -0.733 . . . . 10.0 111.041 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.65 ' NZ ' ' HA3' ' A' ' 32' ' ' GLY . 18.6 mtpp 82.04 1.19 1.42 Allowed 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 114.654 -1.157 . . . . 10.0 110.329 -167.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.502 ' O ' HG23 ' A' ' 60' ' ' VAL . 51.0 m -70.53 174.7 5.5 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.369 -1.287 . . . . 10.0 108.184 172.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.614 ' CD1' HG13 ' A' ' 33' ' ' VAL . 8.8 p90 -167.99 -179.02 3.97 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 121.394 1.906 . . . . 10.0 110.326 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.642 ' HG1' ' HE2' ' A' ' 61' ' ' TYR . 1.5 p -161.51 171.88 17.37 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 103.791 -2.67 . . . . 10.0 103.791 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 50.7 p90 -163.52 157.76 20.02 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.757 -0.831 . . . . 10.0 108.757 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.483 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 31.3 pt -127.77 164.9 28.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 107.767 -1.197 . . . . 10.0 107.767 -178.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.497 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 8.2 mt -138.84 123.17 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 108.034 -1.099 . . . . 10.0 108.034 -174.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.647 ' C ' ' HD2' ' A' ' 73' ' ' PRO . 41.5 mmtt -75.93 95.07 3.47 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.896 1.331 . . . . 10.0 113.531 -168.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.66 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -59.83 -33.46 16.03 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-N 112.554 -2.112 . . . . 10.0 114.743 167.605 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.741 ' HD3' ' HB3' ' A' ' 115' ' ' ASP . 9.2 Cg_endo -50.11 -42.19 46.96 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.683 2.922 . . . . 10.0 117.282 -171.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.587 ' HD3' ' HG2' ' A' ' 73' ' ' PRO . 82.9 Cg_exo -44.98 -31.33 5.33 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 122.366 2.044 . . . . 10.0 113.141 -178.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.731 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . . . 70.32 -38.47 0.41 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.72 1.007 . . . . 10.0 113.72 170.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.45 ' HA ' ' HE1' ' A' ' 135' ' ' MET . 49.8 m -50.04 -31.21 12.44 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 122.982 0.513 . . . . 10.0 111.85 -175.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.688 ' HB3' ' SD ' ' A' ' 52' ' ' MET . 73.6 m-85 -61.19 -55.58 30.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.165 0.507 . . . . 10.0 111.257 178.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.642 HD23 ' HZ1' ' A' ' 112' ' ' LYS . 3.3 mm? -78.72 -27.03 44.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.912 -175.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.871 HD22 HG21 ' A' ' 108' ' ' ILE . 3.5 mm? -59.56 -50.24 74.65 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.716 -0.475 . . . . 10.0 109.716 174.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.541 ' HA ' ' HB3' ' A' ' 83' ' ' ALA . 63.3 mttp -66.47 -15.39 63.32 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.557 177.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.52 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 3.1 tppp? -61.69 -38.77 89.07 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 120.778 -0.369 . . . . 10.0 110.294 171.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.875 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -85.44 -57.31 3.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.428 1.891 . . . . 10.0 112.394 172.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.541 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . . . . . . . . 0 C--N 1.3 -1.572 0 CA-C-N 110.76 -2.927 . . . . 10.0 107.268 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.501 HG13 ' N ' ' A' ' 98' ' ' GLY . 14.5 p . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 112.311 0.486 . . . . 10.0 112.311 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.721 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -159.18 165.49 34.3 Favored Glycine 0 CA--C 1.497 -1.059 0 N-CA-C 109.034 -1.627 . . . . 10.0 109.034 174.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.754 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 13.4 pttm -152.01 169.75 21.58 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 122.394 1.092 . . . . 10.0 110.771 -166.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.875 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -161.9 -145.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-N 112.119 -2.31 . . . . 10.0 105.807 -169.331 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 0.1 OUTLIER -162.49 144.99 10.99 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.372 -0.931 . . . . 10.0 108.937 -155.876 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.65 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 16.0 mmm180 -41.68 -50.14 4.21 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 124.57 1.169 . . . . 10.0 111.562 -177.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 24.8 tptp -56.31 -43.7 79.2 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.223 0.453 . . . . 10.0 112.223 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.57 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -61.39 -49.05 78.45 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.149 -0.686 . . . . 10.0 109.149 177.378 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.812 HG21 ' HG3' ' A' ' 129' ' ' GLU . 25.8 mm -40.26 -53.6 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 114.948 -1.024 . . . . 10.0 111.017 170.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.722 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 21.7 tt0 -51.02 -56.54 12.0 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 114.935 -1.029 . . . . 10.0 112.872 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.541 ' OE2' ' HE3' ' A' ' 110' ' ' LYS . 19.2 mm-40 -51.82 -58.49 6.28 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.119 -0.946 . . . . 10.0 110.551 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.871 HG21 HD22 ' A' ' 79' ' ' LEU . 26.3 mm -50.2 -50.37 20.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.851 -1.068 . . . . 10.0 110.679 173.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.547 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -51.19 -36.24 40.34 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 112.578 0.584 . . . . 10.0 112.578 175.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.722 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 39.7 mttm -71.74 -54.0 11.66 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.256 -177.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.606 HG22 ' O ' ' A' ' 108' ' ' ILE . 6.1 t -53.5 -28.51 31.43 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.666 0.617 . . . . 10.0 112.666 -175.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.731 ' HE3' ' HA ' ' A' ' 75' ' ' ALA . 0.2 OUTLIER -118.07 17.59 14.03 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.904 -0.497 . . . . 10.0 111.55 -177.727 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.686 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 48.6 ttm -49.17 -47.26 76.15 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.706 -0.679 . . . . 10.0 112.342 175.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 113' ' ' MET . 33.6 Cg_endo -61.53 -25.58 79.7 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 122.099 1.866 . . . . 10.0 112.418 -177.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.741 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 2.0 m-20 -93.96 -45.76 7.46 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.074 -0.966 . . . . 10.0 112.143 -173.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.691 HD21 HD12 ' A' ' 127' ' ' ILE . 5.3 mp -62.12 -4.35 1.66 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 114.661 -1.154 . . . . 10.0 111.268 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 115' ' ' ASP . 85.8 m-20 64.23 43.86 4.67 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.87 -1.514 . . . . 10.0 109.066 177.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.686 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -80.64 109.13 14.88 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.942 -1.481 . . . . 10.0 112.331 -174.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -68.48 -36.43 78.94 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.902 -0.777 . . . . 10.0 108.902 173.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 87.3 p -145.88 143.42 29.57 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.089 -1.448 . . . . 10.0 107.089 172.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.608 ' O ' ' HG3' ' A' ' 125' ' ' MET . 41.1 tp -53.45 -29.46 35.73 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.944 1.461 . . . . 10.0 114.944 -174.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 122' ' ' GLU . 3.2 mp0 -50.67 -33.9 24.39 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 122.016 0.913 . . . . 10.0 110.067 174.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.9 -49.81 41.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.133 -1.394 . . . . 10.0 110.264 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.631 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -57.35 -35.29 69.73 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.991 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.608 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 79.8 mtp -55.61 -39.47 70.82 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 122.249 -0.282 . . . . 10.0 111.639 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -64.13 -52.34 59.58 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.447 0.536 . . . . 10.0 112.447 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.691 HD12 HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -52.24 -58.87 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 C-N-CA 119.879 -0.728 . . . . 10.0 110.412 177.649 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.711 ' HB ' HG23 ' A' ' 105' ' ' ILE . 22.9 mm -49.81 -55.92 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 CA-C-N 115.184 -0.916 . . . . 10.0 111.473 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.812 ' HG3' HG21 ' A' ' 105' ' ' ILE . 8.0 mt-10 -52.69 -42.64 64.96 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 123.718 0.636 . . . . 10.0 109.828 177.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -75.02 -46.02 18.12 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 121.215 -0.517 . . . . 10.0 112.643 -174.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.435 HG21 ' HB3' ' A' ' 75' ' ' ALA . 53.7 m -46.31 -59.74 2.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.942 -0.762 . . . . 10.0 108.942 170.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.503 ' HB1' ' CG2' ' A' ' 137' ' ' ILE . . . -52.17 -50.02 62.66 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.232 -0.44 . . . . 10.0 111.959 174.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.459 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 50.4 tttm -46.11 -50.8 14.96 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 123.656 0.598 . . . . 10.0 111.45 176.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.8 m -60.97 -38.3 85.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.39 -0.368 . . . . 10.0 111.845 -175.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.783 ' HG3' HD13 ' A' ' 137' ' ' ILE . 14.9 ptt? -91.4 17.7 8.16 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.274 1.213 . . . . 10.0 114.274 -174.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.46 ' O ' HG12 ' A' ' 97' ' ' VAL . . . 89.22 13.04 62.48 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 120.043 1.292 . . . . 10.0 112.99 175.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.783 HD13 ' HG3' ' A' ' 135' ' ' MET . 2.4 mp -98.99 126.72 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-O 121.683 0.754 . . . . 10.0 111.375 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.754 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -87.81 156.22 19.51 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.574 -1.194 . . . . 10.0 109.476 177.894 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.477 HG11 ' HG2' ' A' ' 129' ' ' GLU . 17.0 m -115.87 125.48 73.02 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.536 0 N-CA-C 108.14 -1.059 . . . . 10.0 108.14 169.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 100' ' ' VAL . 28.3 m -105.24 152.82 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 CA-C-N 113.753 -1.567 . . . . 10.0 107.693 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 . . . . . 0 C--N 1.275 -2.639 0 CA-C-N 114.048 -1.433 . . . . 10.0 111.101 -175.468 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.545 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 2.9 tppp? . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 106.453 -1.684 . . . . 10.0 106.453 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.5 t -61.47 126.82 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.521 0.6 . . . . 10.0 111.579 -171.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.27 -39.28 5.73 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.852 -0.613 . . . . 10.0 109.518 176.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.506 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -154.88 144.68 21.57 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.463 0.912 . . . . 10.0 113.463 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -92.37 133.65 35.67 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 107.436 -1.32 . . . . 10.0 107.436 169.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.695 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -121.53 82.72 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.717 -0.846 . . . . 10.0 108.717 175.932 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -77.67 126.54 31.04 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 120.199 1.363 . . . . 10.0 107.826 175.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.665 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -156.96 123.56 5.03 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 122.868 1.318 . . . . 10.0 111.92 -175.387 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -85.22 122.36 29.3 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.257 -1.792 . . . . 10.0 110.387 -171.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.665 HD21 HD11 ' A' ' 11' ' ' LEU . 85.6 mt -140.46 145.32 40.37 Favored Pre-proline 0 C--O 1.214 -0.764 0 CA-C-O 121.197 0.523 . . . . 10.0 111.903 -170.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.806 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 2.8 Cg_exo -67.75 127.27 15.96 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 123.815 3.01 . . . . 10.0 111.816 177.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.574 ' HB2' HD11 ' A' ' 54' ' ' LEU . . . -62.1 129.77 42.36 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 172.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.02 -2.38 84.07 Favored Glycine 0 N--CA 1.441 -0.974 0 O-C-N 125.619 1.824 . . . . 10.0 112.574 -175.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.806 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 28.8 mmtp -138.79 102.78 4.65 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.743 0.782 . . . . 10.0 111.639 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.688 ' O ' ' HB2' ' A' ' 39' ' ' CYS . . . -170.27 133.97 1.15 Allowed 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.174 -1.375 . . . . 10.0 111.951 172.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.637 ' HA ' ' CB ' ' A' ' 39' ' ' CYS . 3.4 t 179.69 -39.79 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 114.694 -1.139 . . . . 10.0 112.939 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.791 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 97.4 Cg_endo -104.31 124.44 0.07 OUTLIER 'Trans proline' 0 N--CA 1.411 -3.352 0 N-CA-C 115.659 1.369 . . . . 10.0 115.659 -161.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.012 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 6.18 -82.08 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.552 0 CA-C-N 109.799 -3.364 . . . . 10.0 114.606 161.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.864 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 68.3 Cg_exo -30.01 -56.62 0.18 Allowed 'Trans proline' 0 CA--C 1.56 1.804 0 C-N-CA 122.791 2.327 . . . . 10.0 115.521 -164.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.864 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 38.2 Cg_endo -82.19 -71.98 0.01 OUTLIER 'Trans proline' 0 CA--C 1.552 1.417 0 C-N-CA 122.817 2.345 . . . . 10.0 112.321 168.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.986 HG12 HD12 ' A' ' 35' ' ' ILE . 96.0 t -53.93 -52.84 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 127.869 2.467 . . . . 10.0 114.756 -175.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 1.012 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -45.44 -69.69 0.74 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 114.493 -1.231 . . . . 10.0 112.939 -178.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.651 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 24.0 Cg_exo -47.75 -49.63 13.21 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.206 2.604 . . . . 10.0 112.99 172.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 24' ' ' VAL . . . -43.61 -100.2 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 O-C-N 124.285 0.99 . . . . 10.0 112.789 176.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.844 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.342 0.0 OUTLIER -76.43 -27.28 56.17 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 117.759 -1.577 . . . . 10.0 113.838 -175.067 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.501 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -69.69 -40.4 76.64 Favored Glycine 0 CA--C 1.527 0.787 0 O-C-N 121.781 -0.575 . . . . 10.0 113.279 -174.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.473 ' HB3' ' O ' ' A' ' 26' ' ' PRO . 29.1 tt0 -59.87 -19.5 51.63 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 120.471 -0.492 . . . . 10.0 109.902 175.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -98.92 24.53 7.6 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.201 -0.599 . . . . 10.0 110.334 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.849 ' HA3' ' HD2' ' A' ' 64' ' ' LYS . . . 89.17 -1.44 82.7 Favored Glycine 0 CA--C 1.495 -1.164 0 CA-C-N 115.48 -0.782 . . . . 10.0 112.608 166.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.905 HG11 ' CD2' ' A' ' 66' ' ' PHE . 3.1 t -83.44 148.64 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 114.107 1.151 . . . . 10.0 114.107 -170.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.418 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 4.9 m-20 -67.67 96.57 0.56 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.361 0.664 . . . . 10.0 110.56 172.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.986 HD12 HG12 ' A' ' 24' ' ' VAL . 17.2 mm -52.43 -39.24 28.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 122.005 0.907 . . . . 10.0 111.444 173.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.756 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 71.0 mtm -66.22 -50.4 63.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.447 -1.706 . . . . 10.0 112.087 175.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.53 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 1.6 tt0 -58.34 -40.16 81.43 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.138 -1.025 . . . . 10.0 110.128 176.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.59 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 90.8 t80 -56.15 -57.89 10.28 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 114.009 1.114 . . . . 10.0 114.009 170.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.756 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 14.2 p -59.63 -50.42 73.92 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 114.093 -1.412 . . . . 10.0 111.759 -176.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.409 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 58.5 tttm -66.42 -21.18 66.21 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 119.914 -0.714 . . . . 10.0 109.367 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.802 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 3.8 mtp180 -73.59 -65.65 0.8 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.352 -0.939 . . . . 10.0 112.146 169.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.577 ' CZ ' HG21 ' A' ' 46' ' ' THR . 72.9 t80 -53.58 -45.04 69.81 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.806 -171.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -59.62 -52.34 65.95 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.113 -0.949 . . . . 10.0 110.724 -178.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.03 96.28 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 118.817 -1.153 . . . . 10.0 112.385 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.802 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 13.1 mt-10 -67.55 -41.81 83.65 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.868 0.842 . . . . 10.0 111.142 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.602 ' CG2' HD12 ' A' ' 54' ' ' LEU . 80.1 p -88.84 4.56 47.3 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.782 -1.099 . . . . 10.0 112.155 -172.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.95 -42.65 18.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.106 -0.952 . . . . 10.0 112.168 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.68 -47.7 84.59 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 114.517 -1.22 . . . . 10.0 111.574 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.514 ' HB3' ' HE3' ' A' ' 52' ' ' MET . 39.6 mttm -101.36 24.1 10.07 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.268 0.556 . . . . 10.0 110.265 -171.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -53.23 145.09 14.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.695 -1.138 . . . . 10.0 112.622 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.34 16.75 36.4 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.844 -0.902 . . . . 10.0 110.844 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.519 ' SD ' ' HD1' ' A' ' 77' ' ' PHE . 41.0 mtm -141.88 127.37 18.91 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 117.675 -1.61 . . . . 10.0 115.144 -165.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.0 mm -65.9 92.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 O-C-N 121.759 -0.588 . . . . 10.0 109.947 174.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.602 HD12 ' CG2' ' A' ' 46' ' ' THR . 6.9 mt -83.51 129.83 58.53 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 108.2 -1.037 . . . . 10.0 108.2 178.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -71.5 111.41 3.11 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 C-N-CA 121.8 1.666 . . . . 10.0 110.619 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -100.11 153.56 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 119.997 1.272 . . . . 10.0 111.133 -176.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.417 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 77.1 t -134.1 116.8 23.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 109.786 -0.45 . . . . 10.0 109.786 174.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.695 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 17.5 mt -107.6 140.86 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 N-CA-C 108.704 -0.85 . . . . 10.0 108.704 -173.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.5 m -123.48 100.68 6.93 Favored 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 114.942 -1.026 . . . . 10.0 108.621 173.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 65' ' ' SER . 1.6 p -91.89 136.56 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.815 0 CA-C-N 119.227 0.921 . . . . 10.0 110.35 -177.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -95.7 172.52 7.99 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.041 0.448 . . . . 10.0 112.055 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.545 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 58.7 mt-10 -57.22 -20.59 28.14 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 113.996 -1.457 . . . . 10.0 111.959 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -73.69 -18.02 61.06 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.618 -1.173 . . . . 10.0 110.919 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.849 ' HD2' ' HA3' ' A' ' 32' ' ' GLY . 23.8 mtmt 82.27 -3.98 1.44 Allowed 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 124.205 1.002 . . . . 10.0 110.173 -164.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.607 ' O ' HG23 ' A' ' 60' ' ' VAL . 28.6 t -68.25 176.5 2.73 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.506 -0.924 . . . . 10.0 108.506 171.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.905 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -166.98 -176.84 3.54 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 120.124 1.329 . . . . 10.0 110.11 176.502 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.4 p -162.08 161.0 28.1 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 103.018 -2.956 . . . . 10.0 103.018 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.46 ' CB ' HG12 ' A' ' 58' ' ' ILE . 47.0 p90 -160.96 158.17 27.61 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 109.045 -0.724 . . . . 10.0 109.045 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.417 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 30.4 pt -119.95 165.98 14.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 114.443 -1.253 . . . . 10.0 108.059 -175.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.453 HD12 ' CE1' ' A' ' 42' ' ' PHE . 4.4 mm -125.09 119.93 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 106.704 -1.591 . . . . 10.0 106.704 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.691 ' C ' ' HD2' ' A' ' 73' ' ' PRO . 29.5 mmmt -77.28 86.87 3.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.671 0.748 . . . . 10.0 110.731 -169.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.746 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 12.7 t -67.71 -13.9 0.25 Allowed Pre-proline 0 CA--C 1.57 1.748 0 CA-C-N 114.04 -1.437 . . . . 10.0 114.597 174.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 1.028 ' HD3' ' HB3' ' A' ' 115' ' ' ASP . 3.9 Cg_exo -34.76 -51.89 0.68 Allowed 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 124.057 3.171 . . . . 10.0 115.298 174.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.462 ' HD2' ' O ' ' A' ' 71' ' ' LYS . 27.2 Cg_exo -62.49 112.03 1.48 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 CA-C-N 120.633 1.262 . . . . 10.0 110.987 173.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.574 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -80.35 3.69 20.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.844 0.355 . . . . 10.0 110.582 -178.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.673 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 1.4 m -56.16 -36.61 68.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.561 -0.745 . . . . 10.0 111.306 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.588 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 24.7 m-85 -65.54 -57.22 8.74 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 122.194 0.997 . . . . 10.0 111.433 -176.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.582 ' H ' HD22 ' A' ' 78' ' ' LEU . 0.8 OUTLIER -73.82 -23.72 59.7 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.123 -0.944 . . . . 10.0 109.894 -173.434 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . 49.2 mt -83.01 -13.71 55.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.698 -0.683 . . . . 10.0 110.9 174.158 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.673 ' HG2' ' O ' ' A' ' 76' ' ' SER . 28.4 mmtp -56.15 -60.87 2.87 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.833 -0.803 . . . . 10.0 108.833 170.042 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -63.71 -45.11 91.48 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.86 -0.609 . . . . 10.0 112.064 178.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.98 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -61.77 -57.95 9.89 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 123.137 1.446 . . . . 10.0 110.115 -171.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 79' ' ' LEU . . . . . . . . 0 C--N 1.291 -1.962 0 CA-C-N 111.472 -2.604 . . . . 10.0 110.067 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.588 HG13 ' H ' ' A' ' 98' ' ' GLY . 3.4 p . . . . . 0 CA--C 1.537 0.45 0 N-CA-C 113.692 0.997 . . . . 10.0 113.692 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.588 ' H ' HG13 ' A' ' 97' ' ' VAL . . . -171.26 173.64 44.82 Favored Glycine 0 CA--C 1.49 -1.509 0 N-CA-C 108.621 -1.792 . . . . 10.0 108.621 -171.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.689 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -150.56 -179.8 7.53 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 122.853 1.311 . . . . 10.0 112.223 -160.963 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.98 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -155.33 -144.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-N 111.527 -2.579 . . . . 10.0 105.182 -176.429 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 1.4 t -166.02 142.84 5.23 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 107.087 -1.449 . . . . 10.0 107.087 -155.046 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.686 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 23.1 tpp180 -41.62 -42.03 2.36 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 124.732 1.27 . . . . 10.0 111.204 -171.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 25.3 tptp -59.91 -46.44 89.33 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.737 1.014 . . . . 10.0 113.737 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.569 ' O ' HG13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -60.09 -45.66 92.18 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.189 -1.041 . . . . 10.0 108.189 178.691 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 1.002 HG23 ' HB ' ' A' ' 128' ' ' ILE . 39.4 mm -43.13 -52.77 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 CA-C-N 114.393 -1.276 . . . . 10.0 111.25 170.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.799 ' HG2' ' HD2' ' A' ' 110' ' ' LYS . 16.9 tt0 -48.52 -61.84 1.81 Allowed 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.967 -1.015 . . . . 10.0 112.967 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.566 ' HA ' ' HD3' ' A' ' 110' ' ' LYS . 37.7 mt-10 -56.62 -46.67 80.79 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.695 -1.139 . . . . 10.0 110.844 -175.014 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.72 HG22 ' HD3' ' A' ' 112' ' ' LYS . 34.2 mt -52.8 -58.43 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 115.759 -0.655 . . . . 10.0 110.085 169.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.487 ' HB3' HD11 ' A' ' 121' ' ' LEU . . . -45.48 -40.6 8.59 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.473 0.709 . . . . 10.0 112.695 177.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.799 ' HD2' ' HG2' ' A' ' 106' ' ' GLU . 38.9 mtpt -73.22 -48.76 32.29 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.737 -0.665 . . . . 10.0 111.368 -175.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 108' ' ' ILE . 1.1 t -57.2 -38.41 73.63 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 112.573 0.583 . . . . 10.0 112.573 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.72 ' HD3' HG22 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -98.21 6.46 47.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 122.602 0.361 . . . . 10.0 111.172 -174.902 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.636 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 54.1 ttm -50.25 -38.86 42.29 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.491 -0.777 . . . . 10.0 112.669 176.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 113' ' ' MET . 35.1 Cg_endo -61.28 -31.74 89.51 Favored 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 121.726 1.617 . . . . 10.0 111.782 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 1.028 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 0.4 OUTLIER -93.71 -52.99 4.21 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.891 -1.504 . . . . 10.0 112.719 -170.263 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.517 HD11 ' HA ' ' A' ' 113' ' ' MET . 0.3 OUTLIER -72.99 -177.46 2.43 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 123.034 1.397 . . . . 10.0 113.871 -173.18 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -96.46 49.03 1.1 Allowed 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 112.443 -2.162 . . . . 10.0 113.088 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.695 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . . . -64.66 -102.64 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.811 1.041 . . . . 10.0 113.811 173.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 118' ' ' ALA . 24.5 t-20 107.12 -78.42 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.829 1.652 . . . . 10.0 107.789 -167.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.2 t -87.15 147.86 25.44 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.622 -1.251 . . . . 10.0 107.622 162.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.679 ' O ' ' HG2' ' A' ' 125' ' ' MET . 61.8 tp -56.25 -34.7 66.64 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.673 -0.811 . . . . 10.0 110.938 166.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 32.2 mt-10 -48.35 -40.46 25.51 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.564 0.697 . . . . 10.0 110.38 173.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.25 -47.73 63.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.545 -1.207 . . . . 10.0 110.959 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.695 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . . . -56.83 -40.35 75.87 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.405 -0.518 . . . . 10.0 110.122 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.792 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 74.7 mmm -53.35 -40.24 64.75 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.387 0.675 . . . . 10.0 110.727 176.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.662 ' HA ' ' HG2' ' A' ' 129' ' ' GLU . 13.6 mmmm -68.32 -45.07 73.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.06 -0.973 . . . . 10.0 110.234 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.466 ' CD1' HD22 ' A' ' 116' ' ' LEU . 92.8 mt -49.73 -65.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-O 121.178 0.514 . . . . 10.0 110.175 173.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 1.002 ' HB ' HG23 ' A' ' 105' ' ' ILE . 12.5 mm -50.79 -56.19 5.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.711 -1.131 . . . . 10.0 112.399 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.662 ' HG2' ' HA ' ' A' ' 126' ' ' LYS . 0.3 OUTLIER -56.51 -41.86 77.39 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 109.14 -0.689 . . . . 10.0 109.14 -177.793 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.659 ' N ' ' HG3' ' A' ' 129' ' ' GLU . . . -72.83 -47.62 24.96 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.58 -0.736 . . . . 10.0 111.563 -175.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.574 HG21 ' HB3' ' A' ' 75' ' ' ALA . 35.3 m -46.25 -61.8 1.62 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.099 -1.051 . . . . 10.0 109.691 170.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.427 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -48.17 -47.84 34.83 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.0 -0.545 . . . . 10.0 111.97 174.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.589 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 79.1 tttt -48.53 -54.22 15.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.938 -1.028 . . . . 10.0 111.593 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.5 m -66.85 -29.28 69.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.044 0.45 . . . . 10.0 111.197 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 49.8 mtm -80.44 4.49 17.97 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.52 0.933 . . . . 10.0 113.52 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.97 11.43 79.01 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 119.364 0.984 . . . . 10.0 111.784 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.427 ' HB ' ' HB1' ' A' ' 132' ' ' ALA . 27.4 mt -101.66 131.33 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 CA-C-O 121.509 0.671 . . . . 10.0 112.411 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.689 ' HB3' ' HB2' ' A' ' 99' ' ' LYS . 7.8 tp10 -84.79 156.61 21.29 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 115.188 -0.915 . . . . 10.0 110.279 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.7 m -117.98 121.88 68.37 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.218 0 N-CA-C 107.889 -1.152 . . . . 10.0 107.889 165.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.803 HG22 ' O ' ' A' ' 100' ' ' VAL . 25.1 m -101.52 143.17 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 CA-C-N 113.961 -1.472 . . . . 10.0 108.265 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.7 t70 . . . . . 0 C--N 1.286 -2.163 0 CA-C-N 113.48 -1.691 . . . . 10.0 109.98 -173.378 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.509 ' HB3' ' HG3' ' A' ' 62' ' ' GLU . 30.5 mmtm . . . . . 0 CA--C 1.533 0.298 0 N-CA-C 111.26 0.096 . . . . 10.0 111.26 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.1 t -63.24 140.36 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.027 0.531 . . . . 10.0 111.329 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.46 -37.67 4.26 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 120.84 -0.344 . . . . 10.0 110.306 174.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.491 ' HB3' HG13 ' A' ' 60' ' ' VAL . . . -153.67 153.0 31.47 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.19 0.811 . . . . 10.0 113.19 -176.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -95.6 134.07 38.91 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.023 -1.103 . . . . 10.0 108.023 170.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.717 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.7 OUTLIER -120.65 80.19 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 168.99 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.415 ' HG2' HG13 ' A' ' 57' ' ' VAL . 55.5 mtmt -82.52 127.61 33.49 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 120.265 1.393 . . . . 10.0 108.482 176.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.663 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.27 128.75 6.91 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.959 0.885 . . . . 10.0 111.412 -174.841 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -78.52 122.67 26.17 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.311 -1.313 . . . . 10.0 110.141 -172.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.663 HD21 HD11 ' A' ' 11' ' ' LEU . 89.2 mt -140.43 133.66 14.93 Favored Pre-proline 0 N--CA 1.443 -0.817 0 CA-C-O 121.805 0.812 . . . . 10.0 112.072 -173.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.775 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 50.1 Cg_exo -52.0 125.08 16.19 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 124.072 3.181 . . . . 10.0 112.62 171.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.538 ' CB ' ' HB ' ' A' ' 46' ' ' THR . . . -62.13 127.29 30.69 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 107.696 -1.224 . . . . 10.0 107.696 169.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.85 -2.72 82.6 Favored Glycine 0 N--CA 1.443 -0.888 0 O-C-N 125.987 2.055 . . . . 10.0 112.744 -174.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.775 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 15.9 mmtp -140.16 99.62 3.71 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.083 0.944 . . . . 10.0 112.553 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -168.29 134.72 1.96 Allowed 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 114.073 -1.421 . . . . 10.0 111.767 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.707 ' HA ' ' HB2' ' A' ' 39' ' ' CYS . 1.6 t -178.11 -48.46 0.0 OUTLIER Pre-proline 0 N--CA 1.438 -1.06 0 CA-C-N 115.154 -0.93 . . . . 10.0 112.674 176.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.707 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 83.0 Cg_endo -104.62 133.25 0.09 OUTLIER 'Trans proline' 0 N--CA 1.409 -3.468 0 N-CA-C 117.049 1.903 . . . . 10.0 117.049 -152.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.92 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . 12.67 -63.3 0.0 OUTLIER Pre-proline 0 C--N 1.284 -2.243 0 CA-C-N 108.473 -3.967 . . . . 10.0 117.52 154.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.806 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 52.8 Cg_exo -52.63 -63.88 0.22 Allowed 'Trans proline' 0 CA--C 1.566 2.096 0 CA-C-N 123.964 2.451 . . . . 10.0 114.513 -177.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.806 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 60.4 Cg_endo -78.05 -52.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 122.624 2.216 . . . . 10.0 113.109 174.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.921 HG12 HD13 ' A' ' 35' ' ' ILE . 79.8 t -80.99 -45.27 21.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-N 111.995 -2.366 . . . . 10.0 112.689 -166.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.833 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -40.57 -64.75 1.13 Allowed Glycine 0 CA--C 1.521 0.448 0 O-C-N 124.808 1.318 . . . . 10.0 113.32 178.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.92 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 80.1 Cg_exo -58.77 -48.4 14.91 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.798 2.999 . . . . 10.0 111.39 177.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.4 -94.22 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 124.344 1.028 . . . . 10.0 111.764 -176.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.658 HD13 ' H ' ' A' ' 28' ' ' LEU 0.314 0.0 OUTLIER -81.02 -28.55 35.4 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 118.119 -1.432 . . . . 10.0 114.198 -174.946 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.544 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -68.75 -40.84 85.01 Favored Glycine 0 N--CA 1.468 0.769 0 O-C-N 121.17 -0.956 . . . . 10.0 113.248 -176.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.578 ' HG3' ' HA ' ' A' ' 26' ' ' PRO . 91.2 mt-30 -66.26 -6.8 15.07 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 118.639 -1.225 . . . . 10.0 110.603 175.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -105.82 16.26 25.48 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 120.496 -0.482 . . . . 10.0 111.49 171.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.75 ' HA3' ' HD2' ' A' ' 64' ' ' LYS . . . 69.65 22.74 76.81 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.763 -0.653 . . . . 10.0 113.862 172.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.634 HG13 ' CD1' ' A' ' 66' ' ' PHE . 73.9 t -75.22 -30.02 22.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -167.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 91.18 79.27 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 122.868 1.318 . . . . 10.0 109.982 -172.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.921 HD13 HG12 ' A' ' 24' ' ' VAL . 1.1 mm -47.36 -49.19 9.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 112.055 -2.339 . . . . 10.0 113.579 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 79.4 mtp -64.33 -46.63 82.68 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.587 -1.642 . . . . 10.0 111.31 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.709 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 21.3 tt0 -62.52 -42.21 99.37 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 117.955 -1.498 . . . . 10.0 110.589 178.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.688 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . 38.6 t80 -56.87 -53.38 58.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.457 0.91 . . . . 10.0 113.457 172.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.707 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -57.48 -47.1 82.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.286 -0.87 . . . . 10.0 111.16 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -65.57 -22.11 66.66 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.138 -1.025 . . . . 10.0 109.357 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.752 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 94.2 mtt180 -76.91 -65.55 0.93 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.444 -0.798 . . . . 10.0 112.3 173.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.634 ' CZ ' HG21 ' A' ' 46' ' ' THR . 67.4 t80 -57.28 -42.43 81.63 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.108 0.48 . . . . 10.0 110.305 -171.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -58.87 -52.17 66.9 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.316 -0.856 . . . . 10.0 109.916 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.87 92.73 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 119.476 -0.89 . . . . 10.0 112.229 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.752 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 27.9 mm-40 -64.21 -47.66 78.87 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 122.034 0.921 . . . . 10.0 110.887 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.663 ' CG2' HD12 ' A' ' 54' ' ' LEU . 63.1 p -89.13 3.3 52.31 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.104 -1.407 . . . . 10.0 112.026 -169.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.21 -41.12 12.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.139 -0.937 . . . . 10.0 113.043 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.96 -19.86 29.8 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.794 -0.639 . . . . 10.0 111.573 -171.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.438 ' NZ ' ' HB3' ' A' ' 49' ' ' LYS . 6.1 mtpm? -109.18 21.57 16.97 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 123.605 0.762 . . . . 10.0 109.194 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.03 150.91 3.99 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.936 -1.029 . . . . 10.0 113.09 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.6 20.36 32.09 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 110.564 -1.014 . . . . 10.0 110.564 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.596 ' HB2' HD21 ' A' ' 54' ' ' LEU . 66.9 mtt -137.75 124.45 21.05 Favored 'General case' 0 C--O 1.211 -0.924 0 C-N-CA 117.203 -1.799 . . . . 10.0 113.829 -168.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 50.3 mm -65.77 91.7 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.928 -0.767 . . . . 10.0 108.928 171.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.735 HD13 HG21 ' A' ' 70' ' ' ILE . 8.9 mt -84.69 126.42 68.66 Favored Pre-proline 0 N--CA 1.448 -0.534 0 N-CA-C 108.79 -0.819 . . . . 10.0 108.79 -178.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.762 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 20.6 Cg_exo -68.52 106.77 1.49 Allowed 'Trans proline' 0 C--N 1.329 -0.458 0 C-N-CA 121.654 1.569 . . . . 10.0 110.619 172.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -96.67 142.98 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 120.254 1.388 . . . . 10.0 110.891 -174.698 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 58.3 t -116.67 111.23 34.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 120.594 -0.442 . . . . 10.0 110.654 171.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.717 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 28.6 mt -105.11 138.38 30.27 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.829 0 N-CA-C 107.139 -1.43 . . . . 10.0 107.139 -176.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.7 m -122.95 95.08 4.48 Favored 'General case' 0 N--CA 1.408 -2.559 0 CA-C-N 115.009 -0.996 . . . . 10.0 108.849 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.538 HG21 HG22 ' A' ' 33' ' ' VAL . 1.5 p -87.8 135.21 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.819 0 CA-C-N 119.425 1.011 . . . . 10.0 110.804 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -93.47 177.58 5.98 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.576 -0.738 . . . . 10.0 112.689 -173.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.509 ' HG3' ' HB3' ' A' ' 4' ' ' LYS . 5.9 mm-40 -55.63 -24.75 35.29 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 113.896 -1.502 . . . . 10.0 112.652 -178.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 20.0 t70 -79.37 -15.81 57.28 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.988 -1.005 . . . . 10.0 111.163 -177.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.75 ' HD2' ' HA3' ' A' ' 32' ' ' GLY . 28.6 mtmm 82.3 5.35 1.08 Allowed 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 114.764 -1.107 . . . . 10.0 110.339 -160.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.481 ' O ' HG23 ' A' ' 60' ' ' VAL . 21.5 t -71.26 173.08 8.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.002 -1.851 . . . . 10.0 106.002 175.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.688 ' CZ ' ' HB2' ' A' ' 38' ' ' PHE . 29.9 p90 -169.86 -177.18 2.56 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 121.994 2.179 . . . . 10.0 111.391 177.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.9 p -157.39 175.08 14.46 Favored 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 103.156 -2.905 . . . . 10.0 103.156 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 21.6 p90 -163.84 159.42 21.13 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.549 -0.908 . . . . 10.0 108.549 177.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.3 161.64 41.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.299 -1.371 . . . . 10.0 107.299 177.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.735 HG21 HD13 ' A' ' 54' ' ' LEU . 4.9 mm -109.52 134.06 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 108.228 -1.027 . . . . 10.0 108.228 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.823 ' NZ ' ' HA ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -81.88 91.05 6.48 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.179 0.514 . . . . 10.0 109.964 178.083 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.951 ' HB ' ' HG3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -50.16 104.17 0.41 Allowed Pre-proline 0 C--N 1.312 -1.037 0 CA-C-N 113.846 -1.524 . . . . 10.0 110.144 173.953 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.521 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 39.1 Cg_endo -66.5 149.35 84.46 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.608 2.206 . . . . 10.0 112.683 -169.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.877 ' HA ' HD11 ' A' ' 116' ' ' LEU . 47.5 Cg_exo -33.45 -61.24 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 124.098 3.199 . . . . 10.0 113.507 -178.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.54 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -174.28 10.8 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 112.853 0.686 . . . . 10.0 112.853 176.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.5 t -60.06 -64.24 1.02 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.068 0.461 . . . . 10.0 111.383 -174.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.48 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 80.7 m-85 -71.66 -28.61 63.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.179 -0.464 . . . . 10.0 111.231 -176.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.671 ' O ' ' HB3' ' A' ' 81' ' ' LYS . 3.0 mm? -84.21 -28.4 27.33 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.094 0.474 . . . . 10.0 111.098 -173.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 75' ' ' ALA . 11.3 mt -72.68 -36.33 67.86 Favored 'General case' 0 C--O 1.211 -0.952 0 C-N-CA 120.048 -0.661 . . . . 10.0 109.685 175.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -65.98 -21.34 66.4 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.02 0.438 . . . . 10.0 110.557 174.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.671 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 1.8 tmtp? -57.6 -50.25 73.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.391 -0.368 . . . . 10.0 110.536 171.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 1.069 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -79.12 -55.2 5.29 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.288 1.835 . . . . 10.0 113.208 176.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.29 -2.005 0 CA-C-N 111.152 -2.749 . . . . 10.0 107.453 -177.806 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.52 HG13 ' N ' ' A' ' 98' ' ' GLY . 7.2 p . . . . . 0 N--CA 1.447 -0.602 0 N-CA-C 113.001 0.741 . . . . 10.0 113.001 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -169.75 168.34 41.26 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 110.517 -1.033 . . . . 10.0 110.517 177.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.539 ' O ' HG13 ' A' ' 100' ' ' VAL . 0.7 OUTLIER -158.19 173.97 15.89 Favored 'General case' 0 CA--C 1.481 -1.705 0 CA-C-O 121.23 0.538 . . . . 10.0 110.847 -160.737 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 1.069 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -164.36 -169.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 113.769 -1.559 . . . . 10.0 110.631 -171.513 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.8 p -104.86 141.48 36.45 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 114.252 -1.34 . . . . 10.0 112.3 -169.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.699 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 5.0 ttp180 -46.53 -38.69 9.71 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.717 -0.674 . . . . 10.0 110.207 171.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 20.1 tptm -58.17 -45.42 87.53 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.211 -0.45 . . . . 10.0 111.658 174.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.553 ' HG3' ' CB ' ' A' ' 82' ' ' ALA . 2.2 tm0? -60.13 -56.73 18.02 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.339 -0.615 . . . . 10.0 109.339 175.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.799 HG23 ' HB ' ' A' ' 128' ' ' ILE . 24.3 mm -26.72 -57.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 123.812 0.695 . . . . 10.0 112.317 162.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.733 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 30.1 tt0 -50.35 -58.07 6.5 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.008 0.923 . . . . 10.0 112.904 178.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.96 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 8.5 mt-10 -55.61 -46.43 77.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.488 -0.778 . . . . 10.0 110.767 -178.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.573 HD12 ' HB3' ' A' ' 78' ' ' LEU . 31.4 mm -58.88 -50.38 79.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.455 -0.793 . . . . 10.0 109.407 175.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.447 ' HB1' ' CB ' ' A' ' 124' ' ' ALA . . . -53.81 -40.53 66.44 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.158 -0.928 . . . . 10.0 113.248 176.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.96 ' HD2' ' HA ' ' A' ' 107' ' ' GLU . 36.4 mttm -63.87 -50.04 70.38 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 121.693 0.758 . . . . 10.0 109.125 -177.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 89.4 m -49.12 -59.46 3.63 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 113.786 -1.552 . . . . 10.0 111.926 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.951 ' HG3' ' HB ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -93.51 16.57 13.3 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.691 0.997 . . . . 10.0 113.691 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.616 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 47.6 ttm -41.94 -50.9 10.37 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 118.593 0.633 . . . . 10.0 111.902 168.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 113' ' ' MET . 42.5 Cg_endo -66.69 -20.9 52.44 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 121.583 1.522 . . . . 10.0 113.321 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' A' ' 117' ' ' ASN . 0.7 OUTLIER -91.94 -49.73 6.08 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.647 0.737 . . . . 10.0 111.26 -177.368 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.877 HD11 ' HA ' ' A' ' 74' ' ' PRO . 7.2 mp -62.58 -3.23 1.37 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.235 -1.348 . . . . 10.0 111.494 178.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' A' ' 115' ' ' ASP . 58.5 t30 64.03 45.34 4.21 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.108 -1.406 . . . . 10.0 109.268 177.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.616 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -85.13 119.76 25.88 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 113.448 -1.705 . . . . 10.0 113.041 -174.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -65.36 -42.92 92.26 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.782 -0.822 . . . . 10.0 108.782 167.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.2 p -143.88 149.26 36.65 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.957 -1.127 . . . . 10.0 107.957 -177.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.519 HD11 ' HA ' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -50.42 -39.8 48.42 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 114.753 -1.112 . . . . 10.0 112.041 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.562 ' HA ' ' HG3' ' A' ' 125' ' ' MET . 1.8 mp0 -47.88 -42.11 26.01 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.786 0.803 . . . . 10.0 111.135 177.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.89 -48.0 70.07 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 118.428 -1.309 . . . . 10.0 110.831 177.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.496 ' HA ' HD12 ' A' ' 127' ' ' ILE . . . -55.59 -38.26 69.17 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.007 177.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.686 ' O ' ' HB2' ' A' ' 129' ' ' GLU . 20.6 mtp -55.06 -39.4 69.19 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.59 0.709 . . . . 10.0 110.076 -176.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.669 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 0.3 OUTLIER -65.34 -46.66 79.36 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.153 -1.385 . . . . 10.0 110.441 -178.281 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 124' ' ' ALA . 63.6 mt -52.37 -62.81 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-N 116.165 -0.471 . . . . 10.0 111.112 175.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.799 ' HB ' HG23 ' A' ' 105' ' ' ILE . 11.8 mm -53.67 -54.44 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.121 0 CA-C-N 115.08 -0.964 . . . . 10.0 110.349 -177.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.686 ' HB2' ' O ' ' A' ' 125' ' ' MET . 0.8 OUTLIER -53.24 -41.68 65.68 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.076 -0.965 . . . . 10.0 110.097 178.342 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.55 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -75.21 -44.41 22.9 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.843 -0.694 . . . . 10.0 111.86 -176.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.54 HG21 ' HB3' ' A' ' 75' ' ' ALA . 93.0 m -47.5 -59.8 2.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.099 -1.051 . . . . 10.0 109.28 170.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.512 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -50.51 -51.33 48.51 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.739 -0.664 . . . . 10.0 111.274 174.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.55 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 77.3 tttt -44.75 -56.04 4.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.854 -1.066 . . . . 10.0 111.792 175.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.3 t -64.11 -31.22 72.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.108 0.48 . . . . 10.0 111.176 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 50.3 mtm -83.12 4.52 26.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.837 1.051 . . . . 10.0 113.837 -176.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.75 12.68 77.04 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 120.161 1.346 . . . . 10.0 111.929 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 25.6 mt -101.79 124.14 55.41 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 CA-C-O 121.579 0.705 . . . . 10.0 111.29 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 139' ' ' VAL . 0.0 OUTLIER -88.58 158.44 18.27 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 114.549 -1.205 . . . . 10.0 109.317 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.424 ' N ' ' HG3' ' A' ' 138' ' ' GLU . 17.6 m -115.08 135.16 55.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 108.093 -1.077 . . . . 10.0 108.093 169.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.4 m -133.17 69.43 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 114.869 1.433 . . . . 10.0 114.869 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.5 t70 . . . . . 0 C--N 1.31 -1.117 0 CA-C-O 118.666 -0.683 . . . . 10.0 110.657 140.788 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.414 ' HB2' ' OE2' ' A' ' 62' ' ' GLU . 60.2 mttm . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 121.002 0.43 . . . . 10.0 111.136 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.8 132.75 28.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.297 -0.865 . . . . 10.0 111.552 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.453 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . . . -102.98 -37.2 7.9 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.089 -0.708 . . . . 10.0 109.089 173.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.447 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -154.89 -175.2 5.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.899 0.857 . . . . 10.0 112.66 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 24.7 pt20 -142.0 130.48 22.51 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.087 -1.415 . . . . 10.0 108.241 178.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.626 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -119.77 84.13 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 109.406 -0.591 . . . . 10.0 109.406 -176.579 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.418 ' NZ ' ' HB2' ' A' ' 10' ' ' LYS . 8.0 mtmp? -77.56 130.27 36.71 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 120.664 1.574 . . . . 10.0 107.72 176.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.706 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.87 124.84 4.99 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 122.379 1.085 . . . . 10.0 111.594 -176.607 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -82.85 120.18 25.33 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.878 -1.51 . . . . 10.0 109.716 -172.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.706 HD21 HD11 ' A' ' 11' ' ' LEU . 92.1 mt -137.34 138.73 25.76 Favored Pre-proline 0 CA--C 1.5 -0.953 0 CA-C-O 121.512 0.672 . . . . 10.0 112.036 -172.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.875 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 40.1 Cg_exo -55.71 124.88 17.37 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 123.204 2.603 . . . . 10.0 111.646 171.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.565 ' O ' ' HA ' ' A' ' 50' ' ' ALA . . . -62.02 126.39 27.17 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 106.996 -1.483 . . . . 10.0 106.996 168.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.29 -5.04 79.08 Favored Glycine 0 CA--C 1.529 0.909 0 O-C-N 125.515 1.759 . . . . 10.0 113.599 -175.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.875 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 31.9 mmtp -139.89 102.59 4.45 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.519 1.159 . . . . 10.0 111.674 178.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 39' ' ' CYS . . . -170.17 130.7 0.96 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.17 -1.377 . . . . 10.0 111.927 175.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 65.0 m -166.7 -59.38 0.01 OUTLIER Pre-proline 0 N--CA 1.437 -1.122 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.907 -177.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.808 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 84.1 Cg_endo -108.05 136.22 0.05 OUTLIER 'Trans proline' 0 N--CA 1.421 -2.778 0 N-CA-C 117.05 1.904 . . . . 10.0 117.05 -157.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.064 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 11.69 -85.63 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.585 1 CA-C-N 108.393 -4.003 . . . . 10.0 115.335 167.845 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.853 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 56.9 Cg_exo -32.08 -54.43 0.32 Allowed 'Trans proline' 0 CA--C 1.558 1.711 0 C-N-CA 122.662 2.242 . . . . 10.0 115.579 -163.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.853 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 32.0 Cg_endo -84.54 -53.63 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 122.516 2.144 . . . . 10.0 112.651 168.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.808 HG12 ' CD1' ' A' ' 35' ' ' ILE . 75.9 t -81.53 -55.98 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 113.331 -1.759 . . . . 10.0 113.991 -167.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 1.064 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -43.1 -77.46 0.09 OUTLIER Glycine 0 CA--C 1.519 0.335 0 CA-C-N 114.736 -1.12 . . . . 10.0 114.1 -177.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.808 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 22.8 Cg_exo -45.09 -41.82 16.18 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.817 3.011 . . . . 10.0 112.681 173.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 24' ' ' VAL . . . -51.08 -101.52 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 123.475 0.484 . . . . 10.0 111.858 176.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.824 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.308 0.0 OUTLIER -73.33 -25.8 60.77 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 117.511 -1.676 . . . . 10.0 112.951 -172.422 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.536 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -71.83 -40.78 57.34 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.098 -0.572 . . . . 10.0 113.024 -176.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.409 ' HB3' ' O ' ' A' ' 26' ' ' PRO . 60.7 tt0 -63.09 -16.71 60.86 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 119.178 -1.009 . . . . 10.0 109.712 175.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -98.88 20.1 13.78 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 120.12 -0.632 . . . . 10.0 110.102 176.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.47 -1.64 76.39 Favored Glycine 0 CA--C 1.5 -0.872 0 CA-C-N 115.201 -0.909 . . . . 10.0 113.126 167.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.824 ' HB ' HD23 ' A' ' 28' ' ' LEU . 11.3 t -82.48 147.1 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 113.305 0.854 . . . . 10.0 113.305 -172.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -69.69 98.91 1.25 Allowed 'General case' 0 C--N 1.341 0.219 0 CA-C-O 121.291 0.567 . . . . 10.0 110.868 172.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.808 ' CD1' HG12 ' A' ' 24' ' ' VAL . 2.5 mm -52.31 -39.25 27.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.867 -1.061 . . . . 10.0 111.464 174.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.702 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 85.3 mtp -64.61 -52.1 59.24 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 113.244 -1.798 . . . . 10.0 111.618 176.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.64 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 31.1 mt-10 -58.49 -40.12 81.92 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.11 -1.036 . . . . 10.0 111.024 176.127 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.62 ' CE1' HD11 ' A' ' 58' ' ' ILE . 90.3 t80 -58.33 -59.74 4.87 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.929 1.085 . . . . 10.0 113.929 172.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.702 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 18.3 p -58.82 -48.05 82.64 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 114.832 -1.077 . . . . 10.0 111.761 -177.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -65.22 -22.74 66.92 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.824 -0.806 . . . . 10.0 108.824 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.743 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 10.7 mtm180 -78.45 -63.26 1.44 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 119.321 -0.952 . . . . 10.0 112.899 170.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.582 ' CZ ' HG21 ' A' ' 46' ' ' THR . 67.4 t80 -55.2 -43.61 74.59 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 118.717 0.689 . . . . 10.0 110.403 -172.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -59.8 -51.38 69.97 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.311 -0.858 . . . . 10.0 109.851 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.98 -40.25 97.18 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 119.239 -0.985 . . . . 10.0 112.182 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.743 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 23.5 mt-10 -67.92 -45.24 74.93 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.578 0.704 . . . . 10.0 111.079 -178.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.584 ' CG2' HD12 ' A' ' 54' ' ' LEU . 72.3 p -86.93 6.2 33.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.998 -1.001 . . . . 10.0 112.209 -172.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.7 -34.61 5.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.632 -1.167 . . . . 10.0 112.561 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -79.63 -38.54 33.6 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.585 -0.734 . . . . 10.0 112.053 -176.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -94.14 18.66 10.42 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 109.127 -0.694 . . . . 10.0 109.127 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -50.46 133.88 24.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.08 -0.963 . . . . 10.0 112.661 -178.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.05 19.48 10.1 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 114.786 -1.097 . . . . 10.0 110.799 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.587 ' HB2' HD21 ' A' ' 54' ' ' LEU . 67.3 mtt -137.5 127.48 25.81 Favored 'General case' 0 C--O 1.208 -1.108 0 C-N-CA 117.457 -1.697 . . . . 10.0 114.295 -169.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.2 mm -65.94 91.74 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 118.688 0.676 . . . . 10.0 109.372 169.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.593 HD13 HG21 ' A' ' 70' ' ' ILE . 6.9 mt -81.08 138.06 49.41 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 -177.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 54' ' ' LEU . 3.7 Cg_exo -78.67 104.84 1.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.95 1.766 . . . . 10.0 110.472 172.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -101.01 144.14 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 119.716 1.144 . . . . 10.0 110.995 -175.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 85.0 t -119.4 118.51 57.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 116.224 -0.444 . . . . 10.0 110.475 171.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.626 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 16.4 mt -104.94 141.29 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.722 0 N-CA-C 108.515 -0.921 . . . . 10.0 108.515 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.8 m -127.68 97.89 5.0 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 114.714 -1.13 . . . . 10.0 109.134 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 65' ' ' SER . 2.1 p -91.3 136.03 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 O-C-N 121.276 -0.89 . . . . 10.0 110.618 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.437 ' HE2' HG23 ' A' ' 67' ' ' THR . 65.2 m-85 -92.48 171.14 9.23 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.586 -0.734 . . . . 10.0 112.292 -175.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.453 ' HA ' ' HB2' ' A' ' 6' ' ' ALA . 39.7 mt-10 -58.38 -23.51 57.22 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.594 -1.184 . . . . 10.0 112.77 -177.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 2.8 m-20 -81.27 -6.41 58.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.872 -0.604 . . . . 10.0 112.568 -176.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 53.5 mtpt 83.97 1.31 0.95 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.967 0.889 . . . . 10.0 110.011 -167.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.598 ' O ' HG23 ' A' ' 60' ' ' VAL . 8.5 t -72.01 172.23 10.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.313 -1.312 . . . . 10.0 108.016 172.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.801 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -167.6 -177.48 3.55 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 120.241 1.382 . . . . 10.0 109.501 176.207 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.505 ' HA ' HH22 ' A' ' 41' ' ' ARG . 22.2 p -157.82 169.95 23.46 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 103.217 -2.883 . . . . 10.0 103.217 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.447 ' HB3' HG12 ' A' ' 58' ' ' ILE . 56.2 p90 -164.18 153.86 14.24 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.622 -0.881 . . . . 10.0 108.622 176.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.5 pt -131.89 153.24 38.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 108.178 -1.045 . . . . 10.0 108.178 -176.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.593 HG21 HD13 ' A' ' 54' ' ' LEU . 1.6 mm -107.39 131.76 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.389 -1.338 . . . . 10.0 107.389 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.662 ' C ' ' HD2' ' A' ' 73' ' ' PRO . 13.9 mmmm -77.71 90.2 4.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.033 0.92 . . . . 10.0 110.999 -177.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.602 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -60.63 -32.93 12.52 Favored Pre-proline 0 CA--C 1.562 1.434 0 CA-C-N 113.758 -1.564 . . . . 10.0 115.134 172.49 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.664 ' HG2' ' HD3' ' A' ' 74' ' ' PRO . 14.0 Cg_endo -54.8 -36.69 91.61 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.377 2.718 . . . . 10.0 117.281 -170.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.664 ' HD3' ' HG2' ' A' ' 73' ' ' PRO . 79.8 Cg_exo -47.14 -29.25 8.72 Favored 'Trans proline' 0 C--N 1.366 1.481 0 C-N-CA 121.963 1.776 . . . . 10.0 112.504 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.411 ' HB3' HG21 ' A' ' 131' ' ' THR . . . 73.04 -42.33 0.53 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.474 0.916 . . . . 10.0 113.474 169.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.2 p -45.43 -35.65 3.84 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.575 0.75 . . . . 10.0 112.69 -175.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.556 ' HB3' ' SD ' ' A' ' 52' ' ' MET . 75.3 m-85 -55.14 -50.31 69.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.545 0.688 . . . . 10.0 111.34 178.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.774 ' HB3' HD12 ' A' ' 108' ' ' ILE . 4.8 mp -93.25 -12.58 29.83 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.081 -0.648 . . . . 10.0 111.591 -174.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 79' ' ' LEU . 3.3 mm? -62.12 -37.28 84.52 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.17 -1.048 . . . . 10.0 108.17 166.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -56.74 -43.17 80.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.104 -0.953 . . . . 10.0 110.185 172.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? -54.94 -46.71 75.0 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.517 -0.765 . . . . 10.0 112.33 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.75 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -70.44 -49.17 51.48 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.087 1.355 . . . . 10.0 111.678 174.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.288 -2.08 0 CA-C-N 111.413 -2.63 . . . . 10.0 111.298 -167.82 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' ' 98' ' ' GLY . 13.5 p . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 116.118 1.895 . . . . 10.0 116.118 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.469 ' N ' HG13 ' A' ' 97' ' ' VAL . . . -152.39 162.04 29.7 Favored Glycine 0 N--CA 1.431 -1.661 0 N-CA-C 109.793 -1.323 . . . . 10.0 109.793 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.754 ' CB ' ' HG2' ' A' ' 138' ' ' GLU . 0.1 OUTLIER -139.93 168.53 19.6 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 122.851 1.31 . . . . 10.0 111.187 -170.478 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.75 HG11 ' HB1' ' A' ' 82' ' ' ALA . 2.6 m -156.37 -146.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 CA-C-N 111.516 -2.583 . . . . 10.0 104.732 -171.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.419 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 6.6 t -164.5 156.84 16.55 Favored 'General case' 0 C--N 1.282 -2.344 0 C-N-CA 117.693 -1.603 . . . . 10.0 110.71 -163.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.558 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 1.3 tmt_? -41.79 -42.94 2.79 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 112.718 -2.037 . . . . 10.0 110.628 -175.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -59.27 -44.22 92.46 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.032 0.753 . . . . 10.0 113.032 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.663 ' O ' HG12 ' A' ' 108' ' ' ILE . 3.1 mp0 -60.7 -51.76 67.99 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.392 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.706 HG23 ' HB ' ' A' ' 128' ' ' ILE . 39.3 mm -36.95 -53.32 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 CA-C-N 114.806 -1.088 . . . . 10.0 111.309 167.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.796 ' HA ' ' SD ' ' A' ' 125' ' ' MET . 4.9 tt0 -50.81 -60.25 3.25 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.833 -1.076 . . . . 10.0 113.168 -177.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -55.97 -48.97 74.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.157 -0.928 . . . . 10.0 110.502 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.774 HD12 ' HB3' ' A' ' 78' ' ' LEU . 18.4 mm -51.77 -56.58 5.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.593 171.003 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.545 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -50.83 -35.19 31.13 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.371 0.508 . . . . 10.0 112.371 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.757 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 92.7 mttt -76.91 -51.59 10.94 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 116.004 -0.544 . . . . 10.0 111.113 -178.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 108' ' ' ILE . 10.3 t -57.26 -17.73 13.13 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.145 0.794 . . . . 10.0 113.145 -176.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 0.1 OUTLIER -132.21 18.84 4.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.374 0.607 . . . . 10.0 110.011 -179.248 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.64 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 46.5 ttm -48.52 -45.63 69.14 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 114.798 -1.092 . . . . 10.0 112.307 175.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 113' ' ' MET . 19.0 Cg_endo -55.8 -23.62 42.7 Favored 'Trans proline' 0 C--N 1.363 1.291 0 C-N-CA 122.364 2.043 . . . . 10.0 112.338 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.625 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 5.0 m-20 -96.8 -46.44 6.26 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.883 -1.053 . . . . 10.0 112.85 -173.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.595 ' CD2' HD12 ' A' ' 127' ' ' ILE . 6.6 mp -63.92 36.92 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 114.525 -1.216 . . . . 10.0 112.986 -176.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.484 ' H ' ' C ' ' A' ' 115' ' ' ASP . 28.2 t-20 17.96 54.34 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.181 1.392 . . . . 10.0 112.279 -172.099 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -103.23 123.27 46.43 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.464 0.913 . . . . 10.0 113.464 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -67.64 -33.55 75.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.34 0.59 . . . . 10.0 109.854 169.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.1 p -148.43 145.41 27.99 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.569 -0.9 . . . . 10.0 108.569 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.678 ' O ' ' HG2' ' A' ' 125' ' ' MET . 56.7 tp -51.85 -38.44 55.97 Favored 'General case' 0 C--O 1.219 -0.542 0 N-CA-C 114.52 1.304 . . . . 10.0 114.52 -176.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.556 ' O ' ' HD3' ' A' ' 126' ' ' LYS . 19.8 mm-40 -49.66 -37.14 27.31 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.24 0.543 . . . . 10.0 110.931 176.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.04 -47.8 70.28 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 118.651 -1.22 . . . . 10.0 110.574 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.564 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -59.06 -30.98 68.45 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.212 0.53 . . . . 10.0 110.658 177.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.796 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 86.8 mmm -58.21 -38.71 77.31 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.495 0.664 . . . . 10.0 110.771 178.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.556 ' HD3' ' O ' ' A' ' 122' ' ' GLU . 4.0 mptp? -65.14 -52.04 57.59 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.954 -1.021 . . . . 10.0 111.846 177.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.595 HD12 ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -52.36 -58.83 2.0 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.688 0 C-N-CA 119.803 -0.759 . . . . 10.0 110.806 178.504 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.706 ' HB ' HG23 ' A' ' 105' ' ' ILE . 27.4 mm -50.75 -58.96 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.88 0 C-N-CA 123.801 0.84 . . . . 10.0 111.746 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.667 ' HG3' HG21 ' A' ' 105' ' ' ILE . 4.3 mt-10 -52.76 -43.68 65.97 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.548 -0.751 . . . . 10.0 109.453 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -71.5 -46.66 39.08 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.461 -0.876 . . . . 10.0 111.481 -176.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.411 HG21 ' HB3' ' A' ' 75' ' ' ALA . 51.7 m -46.63 -62.41 1.39 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.972 -1.114 . . . . 10.0 110.047 173.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.81 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -50.91 -48.64 60.55 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.845 -0.616 . . . . 10.0 111.699 174.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 58.7 tttm -47.31 -54.99 9.62 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.366 -0.834 . . . . 10.0 111.037 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.7 m -65.91 -28.56 69.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.061 0.457 . . . . 10.0 110.637 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 43.6 mtm -81.29 -2.26 48.33 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.507 0.928 . . . . 10.0 113.507 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 80.88 44.58 8.2 Favored Glycine 0 C--O 1.216 -1.01 0 CA-C-N 119.696 1.135 . . . . 10.0 112.219 -177.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.81 ' HB ' ' HB1' ' A' ' 132' ' ' ALA . 1.9 mm -119.86 127.12 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.67 0 CA-C-O 121.389 0.614 . . . . 10.0 110.475 175.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.754 ' HG2' ' CB ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -87.49 145.76 26.11 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 114.948 -1.024 . . . . 10.0 109.326 176.104 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 18.9 m -113.46 134.62 55.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 107.634 -1.247 . . . . 10.0 107.634 171.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.632 HG22 ' O ' ' A' ' 100' ' ' VAL . 12.9 m -129.65 72.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 114.674 1.361 . . . . 10.0 114.674 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.024 0 N-CA-C 114.216 1.191 . . . . 10.0 114.216 140.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.524 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 27.4 mtpp . . . . . 0 C--O 1.221 -0.447 0 N-CA-C 109.051 -0.722 . . . . 10.0 109.051 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.4 t -62.97 133.97 28.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 122.392 0.277 . . . . 10.0 110.679 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.53 -38.61 6.39 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.394 -0.595 . . . . 10.0 109.394 174.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.522 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -157.44 159.02 36.9 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 113.58 0.955 . . . . 10.0 113.58 -175.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -100.88 135.45 42.3 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.53 -1.214 . . . . 10.0 108.416 170.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.643 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -120.16 80.15 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 108.317 -0.994 . . . . 10.0 108.317 167.802 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.466 ' HG2' HG13 ' A' ' 57' ' ' VAL . 36.2 mttm -80.79 129.69 34.66 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 121.08 1.764 . . . . 10.0 107.484 176.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.519 HD21 HD11 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -158.09 130.28 7.01 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 122.209 1.004 . . . . 10.0 111.601 -176.603 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -81.75 119.13 23.47 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.026 -1.443 . . . . 10.0 109.664 -172.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.519 HD11 HD21 ' A' ' 11' ' ' LEU . 33.2 mt -136.06 133.97 20.02 Favored Pre-proline 0 CA--C 1.504 -0.822 0 CA-C-O 121.495 0.664 . . . . 10.0 112.578 -169.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.605 ' HB2' ' CB ' ' A' ' 17' ' ' LYS . 39.8 Cg_exo -56.05 122.97 12.71 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 123.534 2.823 . . . . 10.0 111.866 172.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.648 ' HB1' ' HB ' ' A' ' 46' ' ' THR . . . -60.38 128.53 37.17 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 107.814 -1.18 . . . . 10.0 107.814 170.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.6 1.29 82.53 Favored Glycine 0 CA--C 1.527 0.832 0 O-C-N 125.808 1.942 . . . . 10.0 112.972 -175.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.605 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . 0.7 OUTLIER -142.01 88.66 2.12 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.022 0.911 . . . . 10.0 112.089 -177.773 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.75 133.02 3.95 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.898 -1.046 . . . . 10.0 112.514 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.566 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 4.5 t 175.07 -42.86 0.0 OUTLIER Pre-proline 0 C--O 1.22 -0.487 0 O-C-N 124.349 1.031 . . . . 10.0 112.615 177.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.7 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 56.5 Cg_endo -99.07 121.45 0.12 Allowed 'Trans proline' 0 N--CA 1.42 -2.845 0 CA-C-N 120.612 1.254 . . . . 10.0 115.24 -159.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.067 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 10.65 -85.19 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 109.907 -3.315 . . . . 10.0 115.26 167.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.805 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 26.2 Cg_exo -25.11 -57.52 0.07 OUTLIER 'Trans proline' 0 CA--C 1.561 1.83 0 C-N-CA 123.543 2.829 . . . . 10.0 115.913 -165.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.805 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 1.0 OUTLIER -86.16 -59.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.363 1.309 0 C-N-CA 123.365 2.71 . . . . 10.0 112.474 171.401 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.664 HG13 HD12 ' A' ' 28' ' ' LEU . 36.7 t -73.95 -43.07 52.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 112.159 -2.292 . . . . 10.0 113.759 -168.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 1.067 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -54.74 -71.8 0.66 Allowed Glycine 0 C--O 1.218 -0.857 0 CA-C-N 114.588 -1.187 . . . . 10.0 113.221 -177.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.619 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 17.1 Cg_exo -46.15 -46.27 16.7 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.52 2.813 . . . . 10.0 112.653 173.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.7 -75.25 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.437 0.637 . . . . 10.0 111.375 177.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.699 HD21 ' CD1' ' A' ' 58' ' ' ILE . 5.0 mt -69.65 -46.96 64.94 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.512 0.93 . . . . 10.0 113.512 -177.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.43 -40.33 97.49 Favored Glycine 0 C--N 1.32 -0.35 0 CA-C-N 115.462 -0.79 . . . . 10.0 113.481 -172.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -63.44 -27.14 69.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.057 0.456 . . . . 10.0 110.327 178.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -99.11 13.18 33.79 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.379 0.609 . . . . 10.0 110.353 177.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.511 ' O ' ' HE3' ' A' ' 64' ' ' LYS . . . 76.45 11.41 85.15 Favored Glycine 0 CA--C 1.501 -0.799 0 CA-C-N 114.883 -1.053 . . . . 10.0 113.319 171.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.811 HG13 ' CD1' ' A' ' 66' ' ' PHE . 59.6 t -80.92 139.58 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 112.117 0.414 . . . . 10.0 112.117 -172.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.434 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 1.2 m-20 -70.5 100.52 1.81 Allowed 'General case' 0 C--N 1.343 0.284 0 CA-C-O 121.586 0.708 . . . . 10.0 110.875 178.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.504 ' CD1' ' HA2' ' A' ' 25' ' ' GLY . 92.9 mt -51.0 -45.9 29.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 114.604 -1.18 . . . . 10.0 111.931 175.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.8 mtm -64.73 -54.68 27.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 112.997 -1.91 . . . . 10.0 111.246 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 34' ' ' ASN . 9.1 tp10 -53.37 -44.02 68.25 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 121.172 -0.211 . . . . 10.0 110.432 177.014 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.59 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 56.7 t80 -59.79 -56.24 24.26 Favored 'General case' 0 C--O 1.213 -0.834 0 N-CA-C 114.052 1.131 . . . . 10.0 114.052 171.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.468 ' SG ' ' HB ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -57.59 -49.79 75.24 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.968 0.907 . . . . 10.0 111.968 -177.739 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -65.46 -21.18 66.61 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 119.471 -0.892 . . . . 10.0 108.853 -176.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.661 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 46.9 mtt180 -78.9 -62.04 1.82 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.221 -0.9 . . . . 10.0 112.652 168.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.621 ' CZ ' HG21 ' A' ' 46' ' ' THR . 79.4 t80 -53.27 -48.4 68.34 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.535 0.683 . . . . 10.0 110.065 -173.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -61.16 -47.78 84.61 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.674 -1.148 . . . . 10.0 110.27 -176.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.79 -38.91 92.51 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 119.163 -1.015 . . . . 10.0 112.077 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.661 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 37.1 mm-40 -63.24 -45.84 89.71 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.147 0.975 . . . . 10.0 110.303 178.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.648 ' HB ' ' HB1' ' A' ' 15' ' ' ALA . 70.0 p -90.87 -0.48 57.74 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.15 -1.386 . . . . 10.0 112.477 -167.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.35 -37.09 7.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.15 -0.932 . . . . 10.0 112.577 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -83.64 -24.76 31.26 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.337 -0.847 . . . . 10.0 111.429 -172.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.7 mtmm -113.23 25.84 10.99 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.54 0.686 . . . . 10.0 109.959 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.458 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -54.13 154.92 3.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.39 -1.277 . . . . 10.0 113.257 177.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.95 21.06 40.57 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.574 -1.01 . . . . 10.0 110.574 -177.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.602 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 67.3 mtt -139.47 125.23 19.52 Favored 'General case' 0 C--O 1.209 -1.065 0 C-N-CA 116.866 -1.934 . . . . 10.0 114.653 -166.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.6 mm -66.88 91.39 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 109.409 -0.589 . . . . 10.0 109.409 172.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.613 HD12 ' CG2' ' A' ' 46' ' ' THR . 7.2 mt -82.2 131.49 56.07 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.62 -0.511 . . . . 10.0 109.62 -177.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.509 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 13.5 Cg_exo -72.06 96.04 0.77 Allowed 'Trans proline' 0 C--N 1.331 -0.377 0 C-N-CA 122.5 2.133 . . . . 10.0 111.265 173.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -92.96 157.65 2.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 119.586 1.084 . . . . 10.0 111.579 -174.668 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.497 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 95.2 t -135.39 115.94 18.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.4 173.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.699 ' CD1' HD21 ' A' ' 28' ' ' LEU . 25.5 mt -108.81 138.0 37.98 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.742 0 N-CA-C 107.953 -1.129 . . . . 10.0 107.953 -174.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.3 m -123.13 92.83 3.78 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 114.845 -1.07 . . . . 10.0 109.102 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.611 HG21 HG22 ' A' ' 33' ' ' VAL . 2.6 p -86.0 134.8 26.43 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 O-C-N 121.258 -0.901 . . . . 10.0 110.817 -177.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -91.98 173.58 7.77 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.748 0.785 . . . . 10.0 112.939 -176.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 59.7 mt-10 -61.71 -15.98 45.19 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.122 -1.399 . . . . 10.0 112.506 -178.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.61 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 7.1 m-20 -75.52 -17.41 60.1 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.51 -0.476 . . . . 10.0 110.692 177.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 42.1 mtpt 82.41 1.62 1.28 Allowed 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 124.492 1.12 . . . . 10.0 109.993 -160.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.51 ' O ' HG23 ' A' ' 60' ' ' VAL . 28.7 t -73.43 174.32 8.34 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 113.313 -1.767 . . . . 10.0 106.846 173.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.811 ' CD1' HG13 ' A' ' 33' ' ' VAL . 55.7 p90 -169.35 -176.1 2.42 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 122.077 2.217 . . . . 10.0 110.764 177.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.4 p -157.32 174.91 14.71 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 103.022 -2.955 . . . . 10.0 103.022 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.444 ' CB ' HG12 ' A' ' 58' ' ' ILE . 35.8 p90 -163.72 157.92 19.69 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.472 -0.936 . . . . 10.0 108.472 177.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.497 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 38.8 pt -127.74 166.99 23.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 106.702 -1.592 . . . . 10.0 106.702 177.081 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.469 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 8.9 mt -134.17 124.8 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 107.514 -1.291 . . . . 10.0 107.514 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 30.4 mmmt -76.93 81.78 3.48 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.721 -0.844 . . . . 10.0 108.721 -176.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.709 ' CG2' ' HA ' ' A' ' 112' ' ' LYS . 1.7 t -50.66 116.5 7.03 Favored Pre-proline 0 C--N 1.312 -1.035 0 N-CA-C 107.057 -1.46 . . . . 10.0 107.057 174.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.706 ' HG3' ' CE1' ' A' ' 77' ' ' PHE . 61.3 Cg_endo -65.87 166.46 20.39 Favored 'Trans proline' 0 CA--C 1.517 -0.331 0 C-N-CA 123.451 2.767 . . . . 10.0 114.939 -153.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.878 ' HA ' HD21 ' A' ' 116' ' ' LEU . 19.7 Cg_exo -67.63 55.67 0.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.141 2.56 . . . . 10.0 111.14 170.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.496 ' HB2' HD13 ' A' ' 128' ' ' ILE . . . 75.46 -22.33 0.27 Allowed 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 113.572 0.952 . . . . 10.0 113.572 173.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.2 p -38.06 -78.89 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.571 1.322 . . . . 10.0 114.571 -167.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.706 ' CE1' ' HG3' ' A' ' 73' ' ' PRO . 3.2 p90 -82.51 -18.84 40.13 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.009 0.744 . . . . 10.0 113.009 -173.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.616 ' HB3' HD12 ' A' ' 108' ' ' ILE . 2.7 mm? -67.99 -36.19 79.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.399 0.618 . . . . 10.0 109.765 172.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.714 HD13 ' HB2' ' A' ' 132' ' ' ALA . 27.0 mt -62.56 -39.48 93.78 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.683 -0.69 . . . . 10.0 110.837 176.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.497 ' HA ' ' HB3' ' A' ' 83' ' ' ALA . 37.0 ttpt -66.04 -17.4 64.66 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.37 -0.532 . . . . 10.0 111.01 176.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.542 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 11.3 mmmm -64.56 -39.47 93.81 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 121.572 -0.705 . . . . 10.0 111.117 169.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 1.02 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -78.5 -56.33 4.52 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.492 1.917 . . . . 10.0 112.277 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.497 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . . . . . . . . 0 C--N 1.294 -1.808 0 CA-C-N 110.825 -2.898 . . . . 10.0 105.844 177.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.57 HG13 ' N ' ' A' ' 98' ' ' GLY . 3.9 p . . . . . 0 CA--C 1.544 0.733 0 N-CA-C 117.027 2.232 . . . . 10.0 117.027 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -58.32 160.13 13.89 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 114.593 0.597 . . . . 10.0 114.593 -158.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.863 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -154.79 172.34 18.13 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 115.593 -0.303 . . . . 10.0 111.201 -157.901 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 1.02 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -168.29 114.16 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-O 122.887 1.327 . . . . 10.0 111.869 179.511 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 1.2 t -39.78 143.62 0.23 Allowed 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 111.458 -2.61 . . . . 10.0 114.149 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.764 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 26.6 mtt180 -46.34 -32.63 3.28 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 112.243 -2.253 . . . . 10.0 113.732 -170.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.517 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 17.5 tppt? -57.67 -44.22 85.58 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.859 -0.526 . . . . 10.0 111.742 178.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.521 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.6 OUTLIER -56.95 -47.99 79.38 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.603 -0.888 . . . . 10.0 108.603 176.21 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.999 HG23 ' HB ' ' A' ' 128' ' ' ILE . 32.7 mm -43.09 -49.41 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.141 -1.391 . . . . 10.0 111.852 173.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.8 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 28.8 tt0 -46.86 -62.17 1.52 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.093 0.957 . . . . 10.0 113.262 175.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.641 ' HA ' ' HD3' ' A' ' 110' ' ' LYS . 47.7 mt-10 -52.73 -54.8 28.69 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.232 -0.895 . . . . 10.0 110.803 -176.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.652 ' O ' HG22 ' A' ' 111' ' ' THR . 24.5 mm -47.42 -55.43 2.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.124 -0.944 . . . . 10.0 110.126 170.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.633 ' O ' ' HE2' ' A' ' 112' ' ' LYS . . . -49.19 -36.95 21.1 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.888 0.699 . . . . 10.0 112.888 176.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.8 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 51.4 mtpt -72.58 -49.24 33.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.832 -0.622 . . . . 10.0 111.299 -174.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.652 HG22 ' O ' ' A' ' 108' ' ' ILE . 6.1 t -53.67 -36.57 62.28 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.091 0.404 . . . . 10.0 112.091 -177.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.815 ' HD2' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -106.71 13.5 27.97 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 113.336 0.865 . . . . 10.0 113.336 -174.792 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.701 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 14.6 ptp -55.2 -39.37 76.69 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 113.056 0.762 . . . . 10.0 113.056 176.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.626 ' HD3' ' HG3' ' A' ' 113' ' ' MET . 73.2 Cg_endo -71.13 -28.94 18.25 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 121.326 1.35 . . . . 10.0 112.112 -179.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -95.88 -42.48 8.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.825 -1.079 . . . . 10.0 113.673 -170.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.878 HD21 ' HA ' ' A' ' 74' ' ' PRO . 1.1 mp -71.16 9.64 0.71 Allowed 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.118 -0.946 . . . . 10.0 113.272 -177.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 63.77 36.44 10.54 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 122.21 1.005 . . . . 10.0 108.529 174.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 119' ' ' ASN . . . -69.56 -69.85 0.32 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 113.9 -1.5 . . . . 10.0 113.076 -167.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.431 ' HB3' ' O ' ' A' ' 118' ' ' ALA . 27.3 t-20 100.87 -38.88 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.659 1.224 . . . . 10.0 110.412 -178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 89.2 p -145.92 144.76 30.37 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.023 -1.473 . . . . 10.0 107.023 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.574 ' O ' ' HG3' ' A' ' 125' ' ' MET . 50.8 tp -58.59 -41.98 87.02 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.915 0.709 . . . . 10.0 112.915 178.033 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -48.23 -43.64 32.45 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.394 0.616 . . . . 10.0 109.687 174.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.59 ' O ' ' HG3' ' A' ' 126' ' ' LYS . . . -62.88 -51.93 65.09 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.624 -1.171 . . . . 10.0 111.292 173.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.716 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -55.34 -30.49 60.38 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.252 -0.905 . . . . 10.0 111.652 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.574 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 83.4 mtp -61.55 -46.33 90.35 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.791 1.034 . . . . 10.0 113.791 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.74 ' HD3' ' N ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -62.83 -40.02 96.12 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.094 0.405 . . . . 10.0 112.094 -178.04 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.74 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -55.11 -59.33 2.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 C-N-CA 118.785 -1.166 . . . . 10.0 109.779 174.876 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.999 ' HB ' HG23 ' A' ' 105' ' ' ILE . 12.9 mm -49.47 -57.85 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 CA-C-N 114.82 -1.082 . . . . 10.0 111.856 -175.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' A' ' 125' ' ' MET . 6.8 pt-20 -55.77 -44.71 77.97 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.118 -0.633 . . . . 10.0 109.948 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -69.15 -49.2 41.81 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.601 -0.727 . . . . 10.0 112.396 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.514 HG21 ' O ' ' A' ' 74' ' ' PRO . 44.9 m -45.72 -62.04 1.46 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.853 -0.673 . . . . 10.0 109.904 171.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.714 ' HB2' HD13 ' A' ' 79' ' ' LEU . . . -49.37 -51.09 36.99 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.222 -0.444 . . . . 10.0 111.235 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -48.29 -48.61 35.74 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 123.911 0.757 . . . . 10.0 111.759 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.1 m -62.53 -39.69 94.38 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.636 0.255 . . . . 10.0 111.254 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.668 ' HG3' HD13 ' A' ' 137' ' ' ILE . 23.6 ptt? -90.63 15.69 10.5 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.477 0.917 . . . . 10.0 113.477 -173.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 103.5 -21.78 38.01 Favored Glycine 0 C--N 1.331 0.273 0 CA-C-N 119.627 1.103 . . . . 10.0 112.759 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.668 HD13 ' HG3' ' A' ' 135' ' ' MET . 2.0 mp -83.15 128.33 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 CA-C-O 122.94 1.353 . . . . 10.0 111.33 -169.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.863 ' HB3' ' HB3' ' A' ' 99' ' ' LYS . 3.3 tp10 -85.64 157.93 20.22 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 112.288 -2.233 . . . . 10.0 109.196 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.458 ' N ' ' HG3' ' A' ' 138' ' ' GLU . 17.1 m -116.49 124.73 72.99 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.371 0 N-CA-C 107.59 -1.263 . . . . 10.0 107.59 168.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 101' ' ' THR . 1.8 m -98.28 160.12 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 C-N-CA 119.143 -1.023 . . . . 10.0 109.409 -175.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 C--N 1.297 -1.694 0 CA-C-N 115.059 -0.973 . . . . 10.0 110.085 179.735 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 75.8 mmtt . . . . . 0 C--O 1.223 -0.3 0 N-CA-C 108.279 -1.008 . . . . 10.0 108.279 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.22 129.52 25.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.689 0.28 . . . . 10.0 110.851 -174.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.56 -36.3 7.16 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 175.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.541 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -158.91 178.26 10.28 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.177 0.806 . . . . 10.0 113.177 -177.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.53 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 93.9 mt-30 -129.32 132.73 47.17 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.182 -1.372 . . . . 10.0 109.184 174.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.633 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.4 OUTLIER -116.47 81.14 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 N-CA-C 108.452 -0.944 . . . . 10.0 108.452 176.303 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -81.63 123.58 28.81 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 120.256 -1.527 . . . . 10.0 108.412 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.655 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.7 132.93 8.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.986 0.898 . . . . 10.0 111.881 -173.061 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.404 ' HB3' ' CG2' ' A' ' 53' ' ' ILE . 0.2 OUTLIER -87.13 123.57 32.32 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.726 -1.125 . . . . 10.0 110.815 -172.668 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.655 HD21 HD11 ' A' ' 11' ' ' LEU . 82.7 mt -138.82 137.94 20.69 Favored Pre-proline 0 C--O 1.218 -0.564 0 CA-C-O 121.51 0.671 . . . . 10.0 112.648 -174.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.8 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 23.6 Cg_exo -58.45 134.18 59.52 Favored 'Trans proline' 0 C--N 1.327 -0.583 0 C-N-CA 124.238 3.292 . . . . 10.0 112.518 174.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.512 ' HB1' ' O ' ' A' ' 46' ' ' THR . . . -56.1 133.93 52.37 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.131 -1.433 . . . . 10.0 107.131 166.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.33 0.06 50.99 Favored Glycine 0 N--CA 1.443 -0.897 0 O-C-N 125.448 1.717 . . . . 10.0 113.449 174.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.8 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 14.0 mmmm -138.41 77.45 1.63 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.481 1.141 . . . . 10.0 111.017 -178.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.653 ' H ' HD22 ' A' ' 43' ' ' ASN . . . -156.96 130.73 8.21 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.907 -0.717 . . . . 10.0 112.027 176.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.586 ' HA ' ' HB3' ' A' ' 39' ' ' CYS . 1.5 t -179.27 -41.66 0.0 OUTLIER Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 114.092 -1.413 . . . . 10.0 112.328 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.723 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 98.7 Cg_endo -103.08 127.31 0.09 OUTLIER 'Trans proline' 0 N--CA 1.408 -3.51 0 N-CA-C 115.503 1.309 . . . . 10.0 115.503 -161.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 1.085 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 11.09 -86.54 0.0 OUTLIER Pre-proline 0 C--N 1.295 -1.764 0 CA-C-N 109.12 -3.673 . . . . 10.0 115.605 166.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.906 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 51.3 Cg_exo -30.88 -55.09 0.23 Allowed 'Trans proline' 0 CA--C 1.559 1.773 0 C-N-CA 122.863 2.376 . . . . 10.0 115.74 -162.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.906 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 5.0 Cg_exo -81.53 -57.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.791 2.327 . . . . 10.0 112.246 171.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.022 HG12 HD12 ' A' ' 35' ' ' ILE . 57.5 t -79.83 -52.01 15.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 112.556 -2.111 . . . . 10.0 114.187 -167.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 1.085 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -50.73 -74.51 0.28 Allowed Glycine 0 C--O 1.216 -0.982 0 CA-C-N 114.831 -1.077 . . . . 10.0 113.537 -176.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.751 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 19.9 Cg_exo -45.01 -43.88 15.29 Favored 'Trans proline' 0 CA--C 1.517 -0.344 0 C-N-CA 123.777 2.985 . . . . 10.0 112.993 174.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 24' ' ' VAL . . . -50.24 -77.23 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.498 0.666 . . . . 10.0 111.271 175.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.772 HD21 ' CD1' ' A' ' 58' ' ' ILE . 3.3 mt -69.65 -48.49 59.64 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.872 1.064 . . . . 10.0 113.872 -176.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.62 -37.21 88.72 Favored Glycine 0 C--N 1.32 -0.353 0 CA-C-N 115.416 -0.811 . . . . 10.0 113.261 -174.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -63.75 -24.92 67.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.706 0.289 . . . . 10.0 110.559 176.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -100.47 16.52 24.32 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.652 0.739 . . . . 10.0 109.899 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.14 3.39 88.96 Favored Glycine 0 CA--C 1.5 -0.858 0 CA-C-N 114.549 -1.205 . . . . 10.0 113.59 168.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.864 HG11 ' CD2' ' A' ' 66' ' ' PHE . 2.9 t -80.56 146.45 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 113.664 0.987 . . . . 10.0 113.664 -171.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.601 ' OD1' ' HG2' ' A' ' 37' ' ' GLU . 1.6 t-20 -74.27 104.17 4.94 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.643 0.735 . . . . 10.0 110.973 174.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.022 HD12 HG12 ' A' ' 24' ' ' VAL . 22.3 mm -53.91 -38.14 35.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 114.092 -1.413 . . . . 10.0 112.413 177.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.806 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -61.8 -56.83 15.37 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 113.503 -1.68 . . . . 10.0 112.038 176.977 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.601 ' HG2' ' OD1' ' A' ' 34' ' ' ASN . 21.1 mm-40 -56.64 -35.28 68.17 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.737 -1.185 . . . . 10.0 110.46 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.621 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 87.3 t80 -60.11 -60.53 3.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.187 1.18 . . . . 10.0 114.187 171.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.806 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 20.9 p -60.84 -47.01 88.3 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.005 -0.998 . . . . 10.0 111.706 -176.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.575 ' HE2' ' HB3' ' A' ' 36' ' ' MET . 52.5 mtmt -63.83 -23.69 67.46 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.416 -0.914 . . . . 10.0 109.59 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.762 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 20.3 mtp180 -73.98 -65.09 0.88 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 119.658 -0.817 . . . . 10.0 111.504 168.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.65 ' HZ ' ' HB2' ' A' ' 54' ' ' LEU . 71.4 t80 -54.34 -48.58 71.26 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.17 0.51 . . . . 10.0 110.559 -170.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.653 HD22 ' H ' ' A' ' 18' ' ' ALA . 4.1 m-20 -61.2 -50.89 71.29 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.265 -0.879 . . . . 10.0 110.32 -176.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.0 -38.83 87.44 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 118.88 -1.128 . . . . 10.0 111.77 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.762 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 13.3 mt-10 -67.48 -42.52 82.82 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.769 0.795 . . . . 10.0 111.296 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.624 ' CG2' HD12 ' A' ' 54' ' ' LEU . 68.0 p -89.62 -2.17 58.23 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 114.877 -1.056 . . . . 10.0 112.342 -169.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -44.51 -37.54 3.57 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 124.098 0.874 . . . . 10.0 112.696 -174.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -80.8 -21.06 41.23 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.298 -0.864 . . . . 10.0 111.357 -172.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.908 ' HB3' ' HZ ' ' A' ' 77' ' ' PHE . 51.8 mttp -100.97 23.52 10.58 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 123.399 1.571 . . . . 10.0 109.238 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . 0.382 . . 49.03 -90.24 0.02 OUTLIER 'General case' 0 CA--C 1.47 -2.122 0 N-CA-C 119.641 3.2 . . . . 10.0 119.641 165.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -137.99 76.6 0.35 Allowed Glycine 0 N--CA 1.429 -1.822 0 N-CA-C 109.9 -1.28 . . . . 10.0 109.9 -171.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.756 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 24.9 mmt -138.61 126.38 22.24 Favored 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 116.907 -1.917 . . . . 10.0 114.177 -164.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.404 ' CG2' ' HB3' ' A' ' 12' ' ' GLN . 32.2 mm -64.7 85.53 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 109.432 -0.581 . . . . 10.0 109.432 175.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.65 ' HB2' ' HZ ' ' A' ' 42' ' ' PHE . 9.8 mt -80.88 132.3 57.68 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.434 -0.58 . . . . 10.0 109.434 -175.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 54' ' ' LEU . 16.1 Cg_exo -71.33 93.91 0.66 Allowed 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.753 2.302 . . . . 10.0 111.888 176.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.45 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -92.69 154.66 3.18 Favored 'Isoleucine or valine' 0 C--N 1.345 0.383 0 CA-C-N 119.081 0.855 . . . . 10.0 111.236 -174.591 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.434 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 90.3 t -134.68 116.22 20.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.332 -0.395 . . . . 10.0 110.181 172.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.772 ' CD1' HD21 ' A' ' 28' ' ' LEU . 16.1 mt -105.62 140.24 24.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.16 -1.052 . . . . 10.0 108.16 -173.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.8 m -124.52 95.38 4.51 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 114.927 -1.033 . . . . 10.0 108.611 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 65' ' ' SER . 3.5 p -85.28 137.52 20.69 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 CA-C-N 119.167 0.894 . . . . 10.0 110.827 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -95.91 170.87 9.0 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 112.855 0.687 . . . . 10.0 112.855 -177.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 24.5 mt-10 -60.89 -20.98 62.86 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.688 -1.142 . . . . 10.0 112.259 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.526 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 7.2 t70 -73.96 -15.35 61.11 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.137 -0.938 . . . . 10.0 110.934 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 44.5 mtpt 84.54 0.77 0.87 Allowed 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 114.722 -1.127 . . . . 10.0 110.782 -169.049 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.582 ' O ' HG23 ' A' ' 60' ' ' VAL . 8.8 p -73.85 -177.08 2.67 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 114.87 -1.059 . . . . 10.0 108.777 170.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.864 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -170.22 -176.92 2.35 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 120.38 1.446 . . . . 10.0 109.483 176.171 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.1 p -159.44 173.04 16.82 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 103.127 -2.916 . . . . 10.0 103.127 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.451 ' CB ' HG12 ' A' ' 58' ' ' ILE . 47.8 p90 -164.48 162.74 22.08 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.361 -0.607 . . . . 10.0 109.361 175.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.434 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 24.9 pt -130.71 167.73 25.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 107.206 -1.405 . . . . 10.0 107.206 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.532 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 4.3 mt -137.24 121.98 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 108.058 -1.09 . . . . 10.0 108.058 -178.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -84.46 72.63 10.6 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.073 -0.714 . . . . 10.0 109.073 -176.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.425 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . 6.7 t -30.98 99.09 0.12 Allowed Pre-proline 0 C--N 1.318 -0.796 0 O-C-N 126.078 2.111 . . . . 10.0 110.762 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.668 ' HG2' ' HD2' ' A' ' 77' ' ' PHE . 3.3 Cg_endo -47.1 139.26 15.49 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 124.237 3.291 . . . . 10.0 114.214 -163.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.736 ' HA ' HD11 ' A' ' 116' ' ' LEU . 94.9 Cg_exo -20.8 -79.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.844 1 C-N-CA 126.245 4.63 . . . . 10.0 115.387 -168.952 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.615 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -143.48 -39.01 0.32 Allowed 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.033 -0.667 . . . . 10.0 111.501 -178.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.774 ' HA ' ' HE1' ' A' ' 135' ' ' MET . 1.7 p -41.96 -56.15 2.88 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 124.221 0.951 . . . . 10.0 112.697 -174.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.908 ' HZ ' ' HB3' ' A' ' 49' ' ' LYS . 0.7 OUTLIER -53.87 -65.93 0.48 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.012 -0.54 . . . . 10.0 112.242 -179.378 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.706 HD23 ' HE2' ' A' ' 112' ' ' LYS . 1.3 mm? -76.88 -12.62 59.98 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.25 -0.98 . . . . 10.0 111.789 -172.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 79' ' ' LEU . 13.5 mt -67.15 -30.55 70.56 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.106 -0.702 . . . . 10.0 109.106 168.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 76' ' ' SER . 98.1 mttt -64.37 -23.65 67.37 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.481 171.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 6.7 mmmt -63.48 -48.01 79.39 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.432 0.53 . . . . 10.0 112.432 170.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 1.049 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -68.59 -41.0 80.25 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.373 1.869 . . . . 10.0 111.665 174.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.417 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . . . . . . . . 0 C--N 1.288 -2.099 0 CA-C-N 111.644 -2.525 . . . . 10.0 108.081 -177.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.777 HG13 ' H ' ' A' ' 98' ' ' GLY . 4.8 p . . . . . 0 N--CA 1.443 -0.807 0 N-CA-C 111.772 0.286 . . . . 10.0 111.772 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.777 ' H ' HG13 ' A' ' 97' ' ' VAL . . . -113.31 162.43 12.37 Favored Glycine 0 CA--C 1.495 -1.157 0 N-CA-C 108.714 -1.754 . . . . 10.0 108.714 166.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.799 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 11.3 ptpt -151.58 156.17 39.92 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-O 122.41 1.1 . . . . 10.0 109.574 168.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 1.049 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -160.0 -144.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-N 112.278 -2.237 . . . . 10.0 106.538 -168.158 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.495 ' H ' ' HB ' ' A' ' 100' ' ' VAL . 0.1 OUTLIER -165.19 146.91 7.68 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 108.359 -0.978 . . . . 10.0 108.359 -155.294 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.722 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 1.6 mmt85 -43.97 -40.94 5.0 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 124.219 0.95 . . . . 10.0 111.638 -175.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 2.1 tmtt? -55.54 -50.59 69.61 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.133 0.492 . . . . 10.0 111.621 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.634 ' O ' HG12 ' A' ' 108' ' ' ILE . 18.5 mm-40 -62.28 -44.94 95.37 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 108.665 -0.865 . . . . 10.0 108.665 -178.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.722 ' HB ' ' O ' ' A' ' 102' ' ' ARG . 38.9 mm -41.07 -54.64 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 114.297 -1.32 . . . . 10.0 111.596 166.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.694 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 45.5 tt0 -49.79 -53.16 26.92 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.803 0.841 . . . . 10.0 112.359 177.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.702 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 47.3 mm-40 -51.74 -55.56 18.94 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 114.958 -1.019 . . . . 10.0 109.996 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.634 HG12 ' O ' ' A' ' 104' ' ' GLN . 10.5 mm -49.61 -58.51 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.285 -0.87 . . . . 10.0 110.098 172.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.454 ' HB1' ' HB3' ' A' ' 124' ' ' ALA . . . -50.8 -33.56 23.98 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.032 0.753 . . . . 10.0 113.032 -178.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.702 ' HD2' ' HA ' ' A' ' 107' ' ' GLU . 53.7 mttm -67.52 -57.24 6.85 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.915 0.864 . . . . 10.0 109.165 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 90.5 m -53.42 -36.07 61.11 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 113.716 -1.584 . . . . 10.0 111.995 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.706 ' HE2' HD23 ' A' ' 78' ' ' LEU . 32.3 mmtp -96.45 -7.88 33.71 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.741 0.645 . . . . 10.0 112.741 -173.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.412 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 43.4 ttm -39.18 -49.28 4.45 Favored Pre-proline 0 CA--C 1.532 0.282 0 O-C-N 123.565 0.54 . . . . 10.0 112.386 175.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 113' ' ' MET . 61.6 Cg_endo -70.61 -23.45 26.89 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 120.991 1.128 . . . . 10.0 113.625 -177.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -88.21 -53.34 4.75 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.108 0.48 . . . . 10.0 110.991 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.736 HD11 ' HA ' ' A' ' 74' ' ' PRO . 1.6 mp -65.02 34.3 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.153 -1.385 . . . . 10.0 113.018 -175.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 19.78 51.86 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 O-C-N 124.51 1.131 . . . . 10.0 111.816 -167.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.433 ' O ' ' CB ' ' A' ' 119' ' ' ASN . . . -66.3 -79.13 0.05 OUTLIER 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 113.62 0.97 . . . . 10.0 113.62 -165.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 118' ' ' ALA . 57.3 t30 101.94 -42.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 O-C-N 125.527 1.767 . . . . 10.0 108.947 -172.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.3 t -146.72 145.29 29.92 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.004 -1.11 . . . . 10.0 108.004 176.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.449 ' O ' ' HG3' ' A' ' 125' ' ' MET . 0.6 OUTLIER -51.68 -46.04 63.68 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.514 -0.766 . . . . 10.0 112.729 -179.132 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.517 ' H ' ' CD ' ' A' ' 122' ' ' GLU . 2.4 mp0 -50.22 -37.39 35.17 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.597 0.713 . . . . 10.0 110.781 178.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.38 -47.05 65.41 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 118.429 -1.308 . . . . 10.0 111.143 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.738 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -57.71 -34.88 69.94 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.66 -0.7 . . . . 10.0 110.769 175.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.449 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 7.7 mtt -53.74 -40.77 66.43 Favored 'General case' 0 N--CA 1.463 0.186 0 O-C-N 121.985 -0.447 . . . . 10.0 112.01 176.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -62.06 -51.83 66.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.017 -0.538 . . . . 10.0 111.761 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.7 HD12 ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -53.47 -56.67 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 119.81 -0.756 . . . . 10.0 110.475 177.459 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.738 HG12 ' O ' ' A' ' 124' ' ' ALA . 11.8 mm -50.74 -51.49 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 CA-C-N 115.138 -0.937 . . . . 10.0 110.949 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 125' ' ' MET . 49.4 mt-10 -51.97 -42.72 63.14 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 120.44 -0.504 . . . . 10.0 110.087 177.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -69.79 -49.65 34.65 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.612 -0.804 . . . . 10.0 111.358 -175.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.615 HG21 ' HB3' ' A' ' 75' ' ' ALA . 99.2 m -49.26 -60.5 2.76 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.267 -0.966 . . . . 10.0 109.827 173.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.21 -50.04 40.08 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.433 -0.349 . . . . 10.0 111.358 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 88.1 tttt -45.7 -59.27 2.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.553 -0.748 . . . . 10.0 111.951 174.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.1 t -65.04 -28.07 69.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.801 0.334 . . . . 10.0 111.305 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.774 ' HE1' ' HA ' ' A' ' 76' ' ' SER . 54.0 mtm -80.43 -6.14 57.62 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.936 0.717 . . . . 10.0 112.936 -177.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.83 29.15 35.78 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 118.966 0.803 . . . . 10.0 111.852 -177.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 8.4 mt -112.69 123.75 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.256 0 CA-C-O 121.608 0.718 . . . . 10.0 110.764 177.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.799 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -84.84 150.61 24.89 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.552 -1.204 . . . . 10.0 109.633 -179.13 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 18.2 m -115.43 131.26 68.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.052 -1.092 . . . . 10.0 108.052 170.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 100' ' ' VAL . 30.6 m -123.63 62.84 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 114.657 1.354 . . . . 10.0 114.657 -177.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.462 ' OXT' ' HB2' ' A' ' 102' ' ' ARG . 9.6 t70 . . . . . 0 C--N 1.291 -1.943 0 CA-C-N 114.303 -1.317 . . . . 10.0 109.627 143.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.9 ttm . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -51.21 111.4 0.56 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.296 0.85 . . . . 10.0 113.296 -174.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -127.52 126.01 41.44 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 115.648 -0.706 . . . . 10.0 109.729 168.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.793 ' HD2' ' HG3' ' A' ' 62' ' ' GLU . 17.1 mmtt -134.48 71.3 1.45 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.695 -0.854 . . . . 10.0 108.695 169.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.0 t -72.97 122.99 26.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 110.251 -0.277 . . . . 10.0 110.251 -174.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.57 -32.82 11.24 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.961 -0.755 . . . . 10.0 108.961 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -168.02 -168.28 0.95 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.33 -0.85 . . . . 10.0 113.214 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.528 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 78.5 mt-30 -143.84 135.54 26.2 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 114.015 -1.448 . . . . 10.0 108.689 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.917 HG21 ' HG ' ' A' ' 28' ' ' LEU . 1.3 mm -122.89 83.52 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 119.03 -0.509 . . . . 10.0 109.767 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -78.0 138.72 38.97 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 120.513 1.506 . . . . 10.0 109.231 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.797 HD23 HD11 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -154.15 132.0 11.59 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.333 -0.618 . . . . 10.0 109.333 -171.725 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.522 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 19.8 pt20 -94.04 109.87 21.6 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.525 -0.917 . . . . 10.0 108.525 171.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.797 HD11 HD23 ' A' ' 11' ' ' LEU . 94.7 mt -130.1 135.95 28.26 Favored Pre-proline 0 CA--C 1.496 -1.097 0 CA-C-O 121.553 0.692 . . . . 10.0 112.51 -165.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.698 ' HB2' ' CB ' ' A' ' 17' ' ' LYS . 28.0 Cg_exo -58.56 120.67 8.7 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 123.054 2.503 . . . . 10.0 111.914 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.525 ' CB ' ' HA ' ' A' ' 50' ' ' ALA . . . -62.77 127.66 32.3 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 114.696 -1.138 . . . . 10.0 108.139 171.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.71 4.4 65.96 Favored Glycine 0 CA--C 1.525 0.704 0 O-C-N 126.003 2.064 . . . . 10.0 113.123 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.698 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . 2.6 mmmm -147.32 29.52 0.96 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.393 1.257 . . . . 10.0 114.393 -172.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.44 ' HB3' ' OD1' ' A' ' 43' ' ' ASN . . . -76.47 150.41 36.67 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.472 1.033 . . . . 10.0 110.155 175.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.513 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 15.3 t -177.69 140.3 0.43 Allowed Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 121.422 0.629 . . . . 10.0 110.861 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.555 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 2.8 Cg_endo -42.17 23.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.478 0.581 1 C-N-CA 129.474 6.783 . . . . 10.0 117.463 176.18 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.644 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -57.88 174.22 0.34 Allowed Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 107.997 -1.112 . . . . 10.0 107.997 163.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.644 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 57.5 Cg_exo -37.3 -42.69 1.04 Allowed 'Trans proline' 0 CA--C 1.548 1.184 0 C-N-CA 122.407 2.071 . . . . 10.0 114.043 177.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.565 ' HB2' HG23 ' A' ' 24' ' ' VAL . 27.2 Cg_exo -38.11 -71.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 123.744 2.962 . . . . 10.0 115.572 167.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.05 HG12 HD12 ' A' ' 35' ' ' ILE . 62.0 t -89.05 -54.68 7.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 114.013 -1.448 . . . . 10.0 114.043 -159.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.443 ' H ' ' HA ' ' A' ' 20' ' ' PRO . . . -50.17 -65.41 2.94 Favored Glycine 0 C--O 1.228 -0.222 0 CA-C-N 114.616 -1.174 . . . . 10.0 112.992 -175.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -55.84 -43.75 54.13 Favored 'Trans proline' 0 C--O 1.222 -0.312 0 C-N-CA 123.092 2.528 . . . . 10.0 112.429 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.492 ' HB1' ' CG2' ' A' ' 9' ' ' ILE . . . -53.28 -78.09 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.401 0.619 . . . . 10.0 111.414 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.917 ' HG ' HG21 ' A' ' 9' ' ' ILE . 2.1 mt -66.94 -45.89 76.4 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.172 0.804 . . . . 10.0 113.172 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.26 -39.98 96.76 Favored Glycine 0 N--CA 1.459 0.18 0 CA-C-N 116.103 -0.499 . . . . 10.0 112.899 -174.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -60.84 -26.69 67.53 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.233 -0.284 . . . . 10.0 110.233 176.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -99.25 16.58 22.42 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.47 0.652 . . . . 10.0 109.895 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.26 4.57 86.23 Favored Glycine 0 CA--C 1.499 -0.957 0 CA-C-N 114.748 -1.115 . . . . 10.0 113.216 167.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.709 HG11 ' CD2' ' A' ' 66' ' ' PHE . 3.4 t -81.33 146.36 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 113.301 0.852 . . . . 10.0 113.301 -172.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 37' ' ' GLU . 90.8 m-20 -70.31 96.7 1.15 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.256 0.622 . . . . 10.0 110.5 172.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.05 HD12 HG12 ' A' ' 24' ' ' VAL . 13.7 mm -55.54 -38.67 50.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-O 122.078 0.942 . . . . 10.0 112.188 177.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.407 ' SD ' ' N ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -70.01 -43.25 71.73 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 113.476 -1.693 . . . . 10.0 112.432 177.191 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.604 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 14.2 mt-10 -54.81 -50.0 69.62 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 118.988 -1.085 . . . . 10.0 109.437 170.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.606 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 77.8 t80 -53.87 -56.5 17.12 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 114.031 1.123 . . . . 10.0 114.031 175.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.3 t -58.71 -48.31 81.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.719 -1.128 . . . . 10.0 111.193 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.414 ' HE3' ' HB2' ' A' ' 40' ' ' LYS . 49.3 mtmt -66.86 -23.34 66.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 118.602 -1.239 . . . . 10.0 108.971 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.805 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 55.2 mtt180 -74.54 -64.68 0.98 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.093 -0.958 . . . . 10.0 111.776 173.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.736 ' HZ ' ' HB2' ' A' ' 54' ' ' LEU . 67.2 t80 -55.05 -45.6 75.27 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-O 121.165 0.507 . . . . 10.0 110.554 -174.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.44 ' OD1' ' HB3' ' A' ' 18' ' ' ALA . 3.8 m-20 -59.69 -52.49 65.26 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.209 -0.905 . . . . 10.0 110.23 -177.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.82 -39.75 95.25 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 119.56 -0.856 . . . . 10.0 112.014 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.805 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 11.2 mt-10 -69.02 -36.72 78.09 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.635 0.731 . . . . 10.0 111.407 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.548 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 72.7 p -91.34 4.33 52.66 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.856 -1.066 . . . . 10.0 112.036 -173.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.53 -36.48 15.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.764 -1.107 . . . . 10.0 112.543 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.2 p-10 -81.99 -37.36 26.72 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 115.224 -0.898 . . . . 10.0 111.434 -175.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.518 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 36.8 mttp -95.41 22.17 7.26 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.039 -0.726 . . . . 10.0 109.039 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.525 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -56.51 154.81 8.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.662 -1.154 . . . . 10.0 113.581 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.47 17.2 53.5 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 110.035 -1.226 . . . . 10.0 110.035 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.528 ' HB2' HD21 ' A' ' 54' ' ' LEU . 22.0 mmt -136.11 126.66 26.98 Favored 'General case' 0 C--O 1.207 -1.164 0 C-N-CA 116.11 -2.236 . . . . 10.0 114.032 -165.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.49 HG22 ' HB2' ' A' ' 12' ' ' GLN . 46.2 mm -67.09 91.0 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 121.763 -0.586 . . . . 10.0 109.549 170.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.736 ' HB2' ' HZ ' ' A' ' 42' ' ' PHE . 3.7 mt -76.96 130.7 74.91 Favored Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 122.183 0.193 . . . . 10.0 110.593 -176.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -74.94 95.34 0.97 Allowed 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.384 2.056 . . . . 10.0 111.553 173.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.423 HG23 HG12 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -99.52 158.2 3.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 119.016 0.826 . . . . 10.0 111.972 -172.41 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.43 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 96.3 t -135.42 120.17 27.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.312 -0.403 . . . . 10.0 110.207 171.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.655 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 14.8 mt -106.15 141.68 20.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 119.595 -0.842 . . . . 10.0 108.897 -175.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 68.1 m -125.39 99.98 6.29 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.043 -0.981 . . . . 10.0 109.024 175.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.562 HG21 HG22 ' A' ' 33' ' ' VAL . 2.8 p -89.18 137.94 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.003 0 C-N-CA 123.653 0.781 . . . . 10.0 111.095 -178.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.466 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 84.8 m-85 -98.94 171.05 8.3 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 122.17 0.986 . . . . 10.0 112.753 -176.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.793 ' HG3' ' HD2' ' A' ' 4' ' ' LYS . 3.0 mm-40 -53.15 -26.24 16.27 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.389 -1.732 . . . . 10.0 113.2 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 28.7 m-20 -78.09 -12.38 59.99 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.485 -0.486 . . . . 10.0 111.14 -176.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.47 ' HE3' ' HA ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 84.1 4.94 0.72 Allowed 'General case' 0 CA--C 1.508 -0.672 0 O-C-N 124.558 1.161 . . . . 10.0 108.917 -163.237 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.487 ' O ' HG23 ' A' ' 60' ' ' VAL . 6.2 p -71.02 172.5 8.98 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 113.504 -1.68 . . . . 10.0 107.916 171.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.709 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -169.86 -176.31 2.31 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 120.147 1.339 . . . . 10.0 109.825 174.277 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.6 p -160.11 168.61 25.12 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 102.944 -2.984 . . . . 10.0 102.944 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.44 ' HB3' HG12 ' A' ' 58' ' ' ILE . 45.6 p90 -161.43 158.79 27.27 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 109.125 -0.694 . . . . 10.0 109.125 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.43 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 22.2 pt -128.04 162.06 34.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 106.923 -1.51 . . . . 10.0 106.923 -176.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.544 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 2.6 mt -135.8 117.39 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 107.379 -1.341 . . . . 10.0 107.379 -175.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.62 ' HA ' ' OD1' ' A' ' 115' ' ' ASP . 0.3 OUTLIER -79.27 84.77 5.17 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 123.408 0.442 . . . . 10.0 110.516 -171.069 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.705 ' HB ' ' HG2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -49.17 99.04 0.2 Allowed Pre-proline 0 C--N 1.313 -0.981 0 CA-C-N 114.413 -1.267 . . . . 10.0 108.989 167.202 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.53 ' HG2' ' HB2' ' A' ' 77' ' ' PHE . 38.3 Cg_endo -74.74 174.22 13.06 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.136 2.558 . . . . 10.0 113.932 -158.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.464 ' HD2' ' CB ' ' A' ' 73' ' ' PRO . 86.8 Cg_exo -26.21 -60.69 0.07 OUTLIER 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 125.129 3.886 . . . . 10.0 114.466 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.597 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -171.43 -23.95 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.519 0.933 . . . . 10.0 113.519 175.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.559 ' HA ' ' HE1' ' A' ' 135' ' ' MET . 35.3 p -47.03 -43.35 19.63 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.177 0.513 . . . . 10.0 111.914 -173.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.571 ' HB3' HD22 ' A' ' 78' ' ' LEU . 13.0 t80 -47.79 -68.02 0.22 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.631 -1.168 . . . . 10.0 112.574 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.959 ' HB3' HD12 ' A' ' 108' ' ' ILE . 2.3 mm? -85.02 -11.31 55.7 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.567 -171.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.6 mt -72.33 -25.42 61.55 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.344 -0.543 . . . . 10.0 109.549 172.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 76' ' ' SER . 34.7 mmtp -59.32 -50.88 72.29 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.788 -1.19 . . . . 10.0 107.788 166.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -67.76 33.05 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 114.057 -1.428 . . . . 10.0 113.578 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.714 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -170.48 -60.35 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.668 0.747 . . . . 10.0 112.732 -172.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.55 -27.47 66.25 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 113.464 -1.698 . . . . 10.0 108.942 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.82 59.44 1.79 Allowed Glycine 0 CA--C 1.498 -1.031 0 C-N-CA 119.871 -1.157 . . . . 10.0 110.241 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.535 ' C ' ' H ' ' A' ' 87' ' ' LYS . 29.4 pt -153.18 32.66 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.011 -1.107 . . . . 10.0 108.011 -169.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -69.8 7.0 0.98 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 113.663 -1.608 . . . . 10.0 109.881 174.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.535 ' H ' ' C ' ' A' ' 85' ' ' ILE . 6.3 tmtm? -169.22 -46.42 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.66 -1.609 . . . . 10.0 106.71 -178.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 146.98 166.08 12.13 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.055 -0.975 . . . . 10.0 111.389 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.3 p -75.86 164.47 26.18 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.219 -0.66 . . . . 10.0 109.219 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.6 p -68.75 -35.58 77.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.681 0.277 . . . . 10.0 111.002 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.581 ' N ' ' HD2' ' A' ' 92' ' ' PRO . 14.2 tp10 -175.5 -46.35 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.318 -178.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 91' ' ' GLU . 5.8 Cg_exo -39.67 109.79 0.1 OUTLIER 'Trans proline' 0 C--N 1.364 1.356 0 C-N-CA 123.183 2.589 . . . . 10.0 113.129 173.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.405 ' C ' ' H ' ' A' ' 95' ' ' LYS . 25.9 mtpp -155.48 74.95 0.91 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.416 -0.811 . . . . 10.0 108.945 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.568 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 52.2 ttm-85 -78.94 41.09 0.42 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.56 -0.533 . . . . 10.0 109.56 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 1.2 mppt? 84.31 -37.81 0.06 Allowed 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 107.9 -1.148 . . . . 10.0 107.9 -172.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.791 HG21 ' HB3' ' A' ' 138' ' ' GLU . 58.1 mt -88.1 94.43 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 114.929 -1.032 . . . . 10.0 109.608 171.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.58 HG13 ' H ' ' A' ' 98' ' ' GLY . 2.7 p -50.81 -54.78 8.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.773 -0.649 . . . . 10.0 112.094 -175.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.58 ' H ' HG13 ' A' ' 97' ' ' VAL . . . -160.13 174.07 36.85 Favored Glycine 0 CA--C 1.5 -0.894 0 N-CA-C 107.929 -2.069 . . . . 10.0 107.929 178.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.881 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -149.37 173.02 13.98 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-O 122.629 1.204 . . . . 10.0 111.429 -164.207 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.732 ' O ' HG22 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -150.73 -143.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 CA-C-N 111.982 -2.372 . . . . 10.0 105.986 -173.378 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.541 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 0.1 OUTLIER -164.93 144.66 7.05 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 107.48 -1.304 . . . . 10.0 107.48 -160.188 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.594 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 9.0 mmm180 -44.27 -43.5 7.39 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 124.241 0.963 . . . . 10.0 111.741 -177.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -57.89 -44.72 86.88 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.329 0.585 . . . . 10.0 111.539 176.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.724 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.1 OUTLIER -60.04 -47.25 86.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.219 -0.901 . . . . 10.0 108.702 178.781 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.909 HG23 ' HB ' ' A' ' 128' ' ' ILE . 26.2 mm -43.31 -55.34 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 CA-C-N 115.093 -0.958 . . . . 10.0 110.939 171.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.793 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 8.4 tt0 -49.2 -57.36 6.85 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 114.494 -1.23 . . . . 10.0 112.946 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -53.4 -59.63 4.33 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 124.057 0.848 . . . . 10.0 110.878 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.959 HD12 ' HB3' ' A' ' 78' ' ' LEU . 10.0 mm -46.88 -51.88 4.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.992 -1.004 . . . . 10.0 110.646 172.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.507 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -53.31 -40.29 64.67 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.655 -0.702 . . . . 10.0 112.554 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.793 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 50.3 mttm -70.87 -53.42 15.22 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.172 -0.467 . . . . 10.0 110.561 -174.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.678 HG23 ' HG3' ' A' ' 112' ' ' LYS . 7.7 t -55.99 -35.32 66.65 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.727 -0.67 . . . . 10.0 112.567 -176.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.756 ' HD3' HD23 ' A' ' 78' ' ' LEU . 8.7 mtmp? -103.08 17.36 24.24 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.057 0.456 . . . . 10.0 110.762 -176.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.735 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 50.4 ttm -49.65 -45.33 78.73 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.374 -0.83 . . . . 10.0 112.372 176.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 113' ' ' MET . 42.2 Cg_endo -64.62 -25.67 61.86 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 121.65 1.567 . . . . 10.0 112.569 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.62 ' OD1' ' HA ' ' A' ' 71' ' ' LYS . 12.8 m-20 -89.46 -50.9 5.83 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 114.936 -1.029 . . . . 10.0 111.16 -175.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.457 HD11 ' HZ3' ' A' ' 112' ' ' LYS . 9.1 mp -64.06 -3.55 2.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.441 -1.254 . . . . 10.0 111.754 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 64.4 t30 59.6 51.42 6.42 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.262 -1.335 . . . . 10.0 109.851 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.735 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -80.78 116.64 20.88 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 113.873 -1.512 . . . . 10.0 112.651 -172.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -65.91 -41.88 90.89 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.314 -0.995 . . . . 10.0 108.314 168.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.0 p -149.76 143.54 25.47 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 106.922 -1.511 . . . . 10.0 106.922 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.611 HD12 ' HB3' ' A' ' 124' ' ' ALA . 66.9 tp -52.16 -33.02 38.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.225 1.195 . . . . 10.0 114.225 -176.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -50.15 -37.76 36.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.329 0.585 . . . . 10.0 110.885 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.14 -50.17 56.33 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 119.047 -1.061 . . . . 10.0 110.916 175.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.611 ' HB3' HD12 ' A' ' 121' ' ' LEU . . . -57.49 -38.7 75.01 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 120.762 -0.375 . . . . 10.0 110.736 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.55 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 89.1 mtp -56.0 -37.22 68.84 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.674 0.39 . . . . 10.0 111.425 177.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -63.08 -48.34 79.02 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.04 -0.527 . . . . 10.0 109.729 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.5 mt -51.17 -62.67 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 CA-C-O 121.464 0.65 . . . . 10.0 111.245 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.909 ' HB ' HG23 ' A' ' 105' ' ' ILE . 15.9 mm -49.84 -57.02 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 CA-C-N 114.189 -1.368 . . . . 10.0 111.152 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.632 ' HG3' HG13 ' A' ' 105' ' ' ILE . 3.9 mt-10 -54.04 -47.28 71.74 Favored 'General case' 0 N--CA 1.436 -1.149 0 O-C-N 124.097 0.873 . . . . 10.0 110.069 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.5 -46.64 61.65 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.463 -0.875 . . . . 10.0 111.51 -173.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.597 HG21 ' HB3' ' A' ' 75' ' ' ALA . 90.2 m -47.6 -60.29 2.65 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.188 -1.006 . . . . 10.0 108.601 170.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -48.0 -53.07 17.37 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.954 0.502 . . . . 10.0 111.852 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.608 ' HG3' ' O ' ' A' ' 129' ' ' GLU . 43.4 mtpt -50.23 -50.28 50.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.002 178.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.8 m -66.31 -31.39 72.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.945 0.403 . . . . 10.0 111.031 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.559 ' HE1' ' HA ' ' A' ' 76' ' ' SER . 48.8 mtm -81.4 4.08 22.14 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.795 1.035 . . . . 10.0 113.795 -178.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.584 ' O ' ' HA ' ' A' ' 96' ' ' ILE . . . 81.0 18.83 68.75 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 119.657 1.117 . . . . 10.0 111.586 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.503 HG23 ' HA ' ' A' ' 99' ' ' LYS . 23.3 mt -105.21 127.69 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 CA-C-O 121.146 0.498 . . . . 10.0 111.513 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.881 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -89.14 157.13 18.4 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.475 -0.784 . . . . 10.0 109.585 179.843 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.7 m -116.35 132.1 66.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.5 -0.926 . . . . 10.0 108.5 170.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 100' ' ' VAL . 26.9 m -133.94 69.65 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 116.057 1.873 . . . . 10.0 116.057 -175.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.605 ' HB2' ' O ' ' A' ' 140' ' ' VAL . 3.6 t0 . . . . . 0 C--N 1.296 -1.745 0 CA-C-O 117.864 -1.065 . . . . 10.0 109.012 141.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 mmt . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 120.643 0.259 . . . . 10.0 110.404 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.08 -12.75 34.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.245 0.545 . . . . 10.0 110.552 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.456 ' HE3' ' CE1' ' A' ' 61' ' ' TYR . 46.7 mtmt -78.33 155.77 29.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.646 -0.706 . . . . 10.0 109.841 176.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.591 ' HD3' ' H ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -75.48 94.32 3.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.501 0.667 . . . . 10.0 110.699 -179.55 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.2 t -73.79 141.3 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.581 -0.736 . . . . 10.0 110.649 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.31 -45.51 4.08 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.307 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.54 152.17 25.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.51 1.3 . . . . 10.0 114.51 -174.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -92.55 133.14 36.24 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.514 -1.221 . . . . 10.0 107.852 170.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.685 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -123.09 83.16 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.348 -0.612 . . . . 10.0 109.348 174.365 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.437 ' HG2' HG22 ' A' ' 57' ' ' VAL . 52.8 mttp -77.27 132.24 38.57 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 120.807 1.639 . . . . 10.0 108.921 172.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.687 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -158.58 125.6 4.86 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 122.336 1.065 . . . . 10.0 111.689 -179.236 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.432 ' HG2' ' HA ' ' A' ' 55' ' ' PRO . 80.2 mt-30 -83.5 121.56 27.36 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.132 -1.395 . . . . 10.0 110.59 -172.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.687 HD21 HD11 ' A' ' 11' ' ' LEU . 88.2 mt -138.64 144.36 41.78 Favored Pre-proline 0 CA--C 1.507 -0.687 0 CA-C-O 121.484 0.659 . . . . 10.0 111.96 -170.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.834 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 4.3 Cg_exo -65.98 126.97 16.77 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 123.467 2.778 . . . . 10.0 111.655 176.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.597 ' HB2' HD11 ' A' ' 54' ' ' LEU . . . -62.12 128.46 36.22 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 108.062 -1.088 . . . . 10.0 108.062 171.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.95 -1.04 87.72 Favored Glycine 0 N--CA 1.443 -0.882 0 O-C-N 125.612 1.82 . . . . 10.0 112.74 -174.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.834 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 15.1 tppt? -140.46 102.59 4.37 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 122.359 1.076 . . . . 10.0 111.835 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -170.33 129.66 0.88 Allowed 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 113.405 -1.725 . . . . 10.0 110.856 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.71 ' HA ' ' HB2' ' A' ' 39' ' ' CYS . 2.1 t -176.87 -44.87 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 115.046 -0.979 . . . . 10.0 113.112 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.726 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 72.6 Cg_endo -103.93 124.4 0.07 OUTLIER 'Trans proline' 0 N--CA 1.413 -3.244 0 N-CA-C 115.557 1.329 . . . . 10.0 115.557 -162.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.062 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 9.63 -87.15 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.392 0 CA-C-N 109.664 -3.425 . . . . 10.0 114.824 166.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.64 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 11.4 Cg_exo -26.07 -55.99 0.09 OUTLIER 'Trans proline' 0 CA--C 1.559 1.734 0 C-N-CA 123.74 2.96 . . . . 10.0 115.722 -162.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.726 ' HD2' ' O ' ' A' ' 20' ' ' PRO . 37.4 Cg_endo -80.48 -73.96 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.277 0 C-N-CA 122.419 2.079 . . . . 10.0 112.083 168.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.077 HG12 HD12 ' A' ' 35' ' ' ILE . 53.5 t -57.37 -54.73 27.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 127.564 2.346 . . . . 10.0 114.672 -173.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 1.062 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -48.41 -72.55 0.43 Allowed Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.107 -0.952 . . . . 10.0 113.173 -175.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.729 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 16.5 Cg_exo -44.98 -47.98 11.42 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.523 2.816 . . . . 10.0 112.272 171.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 24' ' ' VAL . . . -46.37 -98.51 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 123.624 0.578 . . . . 10.0 112.376 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.869 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.351 0.0 OUTLIER -73.87 -38.84 64.3 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 117.176 -1.81 . . . . 10.0 113.363 -174.684 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.691 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -66.15 -39.34 94.54 Favored Glycine 0 N--CA 1.462 0.407 0 C-N-CA 121.43 -0.414 . . . . 10.0 113.859 -173.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.513 ' HB2' ' HA ' ' A' ' 26' ' ' PRO . 56.1 tt0 -67.82 -7.19 25.76 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.541 -0.864 . . . . 10.0 111.172 176.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -99.94 22.92 10.49 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.624 -0.716 . . . . 10.0 109.284 168.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.19 -6.89 63.99 Favored Glycine 0 CA--C 1.503 -0.712 0 CA-C-N 115.341 -0.845 . . . . 10.0 113.112 167.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.869 ' HB ' HD23 ' A' ' 28' ' ' LEU . 3.4 t -83.29 148.75 4.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 114.619 1.34 . . . . 10.0 114.619 -169.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.544 ' HB3' ' HB2' ' A' ' 37' ' ' GLU . 44.7 t-20 -70.75 98.68 1.58 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.468 0.707 . . . . 10.0 110.639 172.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.077 HD12 HG12 ' A' ' 24' ' ' VAL . 19.4 mm -53.78 -36.28 29.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.155 -0.929 . . . . 10.0 112.164 175.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 66.8 mtm -65.19 -52.78 52.76 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.62 -1.627 . . . . 10.0 111.699 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.544 ' HB2' ' HB3' ' A' ' 34' ' ' ASN . 12.7 mm-40 -56.88 -38.8 73.27 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.615 -0.834 . . . . 10.0 110.927 175.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.558 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . 91.3 t80 -57.85 -58.7 7.21 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 113.506 0.928 . . . . 10.0 113.506 170.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -57.7 -52.26 66.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 113.988 -1.46 . . . . 10.0 112.039 -177.535 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.501 ' HB3' ' HE3' ' A' ' 40' ' ' LYS . 0.7 OUTLIER -66.47 -21.71 66.19 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.554 -0.858 . . . . 10.0 108.691 -176.082 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.684 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 12.9 mtp180 -74.09 -63.9 1.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.662 -0.699 . . . . 10.0 112.074 168.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.601 ' CZ ' HG21 ' A' ' 46' ' ' THR . 71.1 t80 -54.33 -45.52 72.69 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-O 121.082 0.468 . . . . 10.0 110.682 -172.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -58.97 -51.62 69.27 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.074 -0.966 . . . . 10.0 109.771 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.96 98.97 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 119.034 -1.066 . . . . 10.0 112.186 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.684 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 7.3 mt-10 -66.9 -39.31 87.41 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.823 0.821 . . . . 10.0 110.834 -178.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.605 ' CG2' HD12 ' A' ' 54' ' ' LEU . 72.1 p -92.13 -0.4 57.44 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.735 -1.121 . . . . 10.0 112.748 -172.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.96 -39.62 12.76 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.915 0.886 . . . . 10.0 112.777 -174.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -75.78 -34.13 60.2 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.506 -0.77 . . . . 10.0 110.958 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.431 ' HB3' ' CE ' ' A' ' 52' ' ' MET . 36.7 mttp -97.15 17.88 16.19 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.828 0.851 . . . . 10.0 109.998 -175.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -52.07 145.47 10.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.205 -0.907 . . . . 10.0 113.232 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.68 15.85 35.79 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 110.604 -0.998 . . . . 10.0 110.604 -177.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.716 ' SD ' ' HB2' ' A' ' 77' ' ' PHE . 51.3 mtm -138.12 125.81 22.29 Favored 'General case' 0 C--O 1.211 -0.94 0 C-N-CA 116.274 -2.171 . . . . 10.0 115.193 -166.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.3 mm -66.55 91.78 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 118.313 0.506 . . . . 10.0 109.639 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.605 HD12 ' CG2' ' A' ' 46' ' ' THR . 8.0 mt -83.2 135.85 44.07 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.852 -0.796 . . . . 10.0 108.852 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.561 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 8.0 Cg_exo -75.86 108.94 2.79 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.237 1.958 . . . . 10.0 111.016 174.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -100.58 155.08 4.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 119.833 1.197 . . . . 10.0 111.573 -174.71 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.437 HG22 ' HG2' ' A' ' 10' ' ' LYS . 93.6 t -134.81 115.58 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 CA-C-N 116.662 -0.244 . . . . 10.0 110.447 175.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.685 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 16.0 mt -107.07 141.93 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.554 0 CA-C-O 121.669 0.747 . . . . 10.0 109.157 -174.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.7 m -124.8 99.15 6.02 Favored 'General case' 0 C--N 1.28 -2.453 0 CA-C-N 114.665 -1.152 . . . . 10.0 108.869 174.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 65' ' ' SER . 2.4 p -89.61 140.17 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 CA-C-N 119.43 1.014 . . . . 10.0 110.19 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.456 ' CE1' ' HE3' ' A' ' 3' ' ' LYS . 73.4 m-85 -98.51 160.67 14.13 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.548 -0.751 . . . . 10.0 111.55 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.417 ' OE1' ' HB2' ' A' ' 4' ' ' LYS . 16.6 mt-10 -54.22 -19.13 4.68 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 124.37 1.068 . . . . 10.0 113.142 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 26.5 t70 -75.46 -13.71 60.39 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.572 -0.74 . . . . 10.0 110.472 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.771 ' HE3' ' HA ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 83.33 1.2 1.07 Allowed 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 114.448 -1.251 . . . . 10.0 110.379 -167.897 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.517 ' O ' HG23 ' A' ' 60' ' ' VAL . 57.9 m -71.68 174.86 6.21 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 114.753 -1.112 . . . . 10.0 108.846 169.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.866 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -171.09 -176.79 2.02 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 119.394 0.997 . . . . 10.0 109.307 174.747 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.417 ' HG1' ' HE2' ' A' ' 61' ' ' TYR . 1.3 p -162.58 162.54 27.25 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 103.434 -2.802 . . . . 10.0 103.434 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CB ' HG12 ' A' ' 58' ' ' ILE . 47.6 p90 -162.11 158.09 24.24 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.522 0.677 . . . . 10.0 109.233 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.9 pt -128.45 158.78 40.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.543 0 CA-C-N 114.612 -1.176 . . . . 10.0 108.503 -175.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.482 HD12 ' CE1' ' A' ' 42' ' ' PHE . 2.8 mm -112.75 127.27 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 108.016 -1.105 . . . . 10.0 108.016 -178.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.633 ' C ' ' HD2' ' A' ' 73' ' ' PRO . 4.2 mptp? -80.16 93.3 5.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.024 0.916 . . . . 10.0 112.211 -172.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.729 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 9.2 t -59.55 -34.6 23.2 Favored Pre-proline 0 CA--C 1.569 1.693 0 CA-C-N 113.569 -1.651 . . . . 10.0 113.332 169.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.729 ' HD2' ' N ' ' A' ' 72' ' ' THR . 2.7 Cg_endo -41.9 -49.26 5.69 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 124.519 3.479 . . . . 10.0 117.331 -171.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.553 ' HD3' ' HG2' ' A' ' 73' ' ' PRO . 73.7 Cg_exo -42.33 -35.06 3.35 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.858 2.372 . . . . 10.0 113.47 -174.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.515 ' HB2' ' HE2' ' A' ' 112' ' ' LYS . . . 72.51 -25.59 0.18 Allowed 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 113.723 1.009 . . . . 10.0 113.723 168.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.5 m -50.63 -46.91 58.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.167 0.508 . . . . 10.0 110.92 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.716 ' HB2' ' SD ' ' A' ' 52' ' ' MET . 8.6 p90 -72.23 -29.46 63.96 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.765 -0.652 . . . . 10.0 111.428 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.762 ' O ' ' HB3' ' A' ' 81' ' ' LYS . 1.8 tp -86.0 -28.18 24.36 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.233 0.54 . . . . 10.0 111.255 -175.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.457 ' HA ' HD13 ' A' ' 79' ' ' LEU . 3.7 mm? -59.39 -35.1 73.3 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 107.993 -1.114 . . . . 10.0 107.993 168.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.788 ' HD3' ' HB2' ' A' ' 86' ' ' GLU . 7.3 ttpm? -70.31 -12.26 61.47 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.756 -0.656 . . . . 10.0 111.921 172.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.762 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 17.0 tptm -56.72 -50.75 71.28 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.25 -0.907 . . . . 10.0 109.103 165.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.656 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -72.56 -49.58 31.52 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.964 1.706 . . . . 10.0 112.755 170.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.489 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . . . -80.12 159.24 26.14 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 112.688 -2.051 . . . . 10.0 109.326 -169.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.81 -21.52 12.16 Favored Glycine 0 C--N 1.31 -0.876 0 C-N-CA 118.318 -1.896 . . . . 10.0 110.746 165.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.587 HG21 HG22 ' A' ' 97' ' ' VAL . 2.1 pp -64.25 145.17 14.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 113.741 1.015 . . . . 10.0 113.741 -177.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.788 ' HB2' ' HD3' ' A' ' 80' ' ' LYS . 31.0 tt0 -171.41 40.27 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.099 -0.955 . . . . 10.0 108.882 164.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -162.77 16.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.114 -0.948 . . . . 10.0 110.355 177.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -124.89 5.94 8.37 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.655 -0.783 . . . . 10.0 112.134 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.1 m -76.17 -33.62 59.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.079 0.466 . . . . 10.0 110.812 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.9 p -78.69 1.18 23.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.988 -0.551 . . . . 10.0 111.436 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -174.82 96.35 0.29 Allowed Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 108.683 -0.858 . . . . 10.0 108.683 176.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.29 -174.68 2.35 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 123.006 2.47 . . . . 10.0 113.038 -173.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 93' ' ' LYS . 68.8 mmtt -72.33 -36.07 68.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.009 -0.542 . . . . 10.0 110.691 178.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -166.36 -37.12 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.362 0.601 . . . . 10.0 109.634 175.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -160.34 8.98 0.1 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.092 -0.958 . . . . 10.0 110.256 176.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 136' ' ' GLY . 1.3 mt -156.16 167.66 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 109.034 -0.728 . . . . 10.0 109.034 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.587 HG22 HG21 ' A' ' 85' ' ' ILE . 7.1 p -112.22 -61.3 2.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.393 0.616 . . . . 10.0 111.512 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -166.88 161.37 35.18 Favored Glycine 0 CA--C 1.497 -1.078 0 N-CA-C 108.725 -1.75 . . . . 10.0 108.725 -174.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.603 ' HB2' ' O ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -143.73 177.72 8.31 Favored 'General case' 0 CA--C 1.473 -2.004 0 CA-C-O 122.359 1.075 . . . . 10.0 110.767 -169.522 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.656 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -163.76 -165.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.404 -2.73 0 CA-C-N 111.793 -2.458 . . . . 10.0 106.184 -170.55 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 19.0 p -109.83 150.39 28.46 Favored 'General case' 0 C--N 1.268 -2.968 0 CA-C-N 114.753 -1.112 . . . . 10.0 111.833 -170.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.68 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 22.4 tpp180 -43.62 -43.73 5.9 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 113.588 -1.642 . . . . 10.0 109.688 168.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.507 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 18.4 tppt? -58.35 -43.15 88.19 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.153 0.501 . . . . 10.0 112.168 176.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.65 ' O ' HG12 ' A' ' 108' ' ' ILE . 57.6 mt-30 -67.22 -38.72 85.74 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.407 -0.59 . . . . 10.0 109.407 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.68 ' HB ' ' O ' ' A' ' 102' ' ' ARG . 34.9 mm -46.83 -51.15 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.589 -0.732 . . . . 10.0 111.012 166.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.686 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 31.8 tt0 -48.28 -54.26 14.31 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.283 -1.326 . . . . 10.0 112.836 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -52.48 -57.88 8.51 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 123.925 0.766 . . . . 10.0 110.151 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.65 HG12 ' O ' ' A' ' 104' ' ' GLN . 5.5 mm -46.19 -59.97 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 114.328 -1.305 . . . . 10.0 109.923 173.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.547 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -50.62 -37.28 39.47 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 123.686 0.616 . . . . 10.0 112.44 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.686 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 39.4 mttt -71.09 -58.67 3.33 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.004 -0.544 . . . . 10.0 111.478 -175.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.603 HG21 HD21 ' A' ' 78' ' ' LEU . 4.7 t -55.4 -34.83 64.73 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 113.011 0.745 . . . . 10.0 113.011 -175.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 1.0 ' HD3' HD11 ' A' ' 128' ' ' ILE . 0.1 OUTLIER -99.03 7.38 46.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 120.931 0.396 . . . . 10.0 110.828 -173.36 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.812 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 40.1 ttm -48.11 -41.32 41.55 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.231 -0.895 . . . . 10.0 112.424 175.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 113' ' ' MET . 26.7 Cg_endo -59.61 -32.48 96.05 Favored 'Trans proline' 0 C--N 1.366 1.471 0 C-N-CA 121.787 1.658 . . . . 10.0 112.128 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.561 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 0.8 OUTLIER -91.44 -47.89 7.19 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 114.788 -1.096 . . . . 10.0 112.34 -173.39 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.874 HD22 ' HG3' ' A' ' 112' ' ' LYS . 7.0 mp -64.18 2.05 0.63 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.527 -1.215 . . . . 10.0 111.871 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 115' ' ' ASP . 8.7 p30 54.75 45.67 26.22 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.164 -1.38 . . . . 10.0 109.662 177.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.812 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -80.8 118.17 22.09 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 112.805 -1.998 . . . . 10.0 112.103 -172.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -67.22 -37.61 83.88 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.75 -0.659 . . . . 10.0 109.874 170.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.2 p -155.41 144.66 20.95 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.442 -0.947 . . . . 10.0 108.442 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.544 ' O ' ' HG2' ' A' ' 125' ' ' MET . 62.6 tp -52.08 -40.39 61.14 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 115.077 1.51 . . . . 10.0 115.077 -173.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -51.63 -33.08 31.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.148 0.499 . . . . 10.0 111.045 176.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.18 -49.26 65.31 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 118.797 -1.161 . . . . 10.0 110.865 172.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.626 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -57.78 -33.68 68.79 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.91 0.386 . . . . 10.0 110.652 178.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.635 ' O ' ' HB3' ' A' ' 129' ' ' GLU . 80.1 mmm -56.36 -39.02 72.2 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.73 0.3 . . . . 10.0 111.425 176.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -61.21 -56.68 17.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.832 -0.622 . . . . 10.0 111.432 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.871 HD12 HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -50.98 -57.9 2.4 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 C-N-CA 119.994 -0.683 . . . . 10.0 111.146 -178.465 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 1.0 HD11 ' HD3' ' A' ' 112' ' ' LYS . 25.4 mm -50.56 -57.23 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 CA-C-N 114.649 -1.16 . . . . 10.0 111.801 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.635 ' HB3' ' O ' ' A' ' 125' ' ' MET . 0.0 OUTLIER -53.33 -41.38 65.67 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.748 -0.66 . . . . 10.0 109.272 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.669 ' HA2' ' HE2' ' A' ' 133' ' ' LYS . . . -71.36 -46.47 41.29 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.739 -0.744 . . . . 10.0 111.862 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 62.7 m -44.37 -65.6 0.49 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 114.561 -0.82 . . . . 10.0 109.011 169.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.513 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -48.77 -50.71 32.75 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.026 -0.534 . . . . 10.0 111.312 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.669 ' HE2' ' HA2' ' A' ' 130' ' ' GLY . 17.0 ttpt -47.98 -53.95 14.48 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.75 -1.114 . . . . 10.0 111.499 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.1 m -66.13 -30.91 71.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.341 0.591 . . . . 10.0 110.69 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 46.8 mtp -80.31 5.64 14.2 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.701 1.0 . . . . 10.0 113.701 -177.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.47 ' O ' HG23 ' A' ' 96' ' ' ILE . . . 85.46 6.15 84.0 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 119.351 0.978 . . . . 10.0 111.548 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.572 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 37.4 mt -97.21 127.27 49.61 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.834 0 CA-C-O 121.672 0.749 . . . . 10.0 111.777 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.603 ' O ' ' HB2' ' A' ' 99' ' ' LYS . 0.7 OUTLIER -88.56 158.87 18.15 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.514 -1.221 . . . . 10.0 108.868 178.134 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.3 m -117.44 127.01 74.97 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.518 0 CA-C-O 122.213 1.006 . . . . 10.0 108.348 171.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 101' ' ' THR . 19.3 m -112.54 154.62 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.231 0 CA-C-N 113.676 -1.602 . . . . 10.0 107.676 176.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 31.9 t70 . . . . . 0 C--N 1.276 -2.608 0 CA-C-N 114.534 -1.212 . . . . 10.0 110.872 -177.065 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtt . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 110.185 -0.302 . . . . 10.0 110.185 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.12 175.04 9.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.707 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -93.29 103.75 15.97 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.802 0.334 . . . . 10.0 110.121 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.401 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 49.8 mtmt -83.18 127.13 33.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.345 -0.389 . . . . 10.0 110.895 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.0 t -63.11 139.19 21.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.576 -0.738 . . . . 10.0 110.992 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.86 -32.0 5.93 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.288 -0.414 . . . . 10.0 110.521 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.499 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -158.97 152.98 23.47 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.161 1.171 . . . . 10.0 114.161 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -99.51 133.17 44.22 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.885 -1.052 . . . . 10.0 108.36 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.664 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -124.6 82.21 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 120.063 -0.655 . . . . 10.0 110.099 174.395 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 46.1 tttm -78.25 128.9 34.4 Favored 'General case' 0 C--N 1.314 -0.944 0 O-C-N 120.368 -1.458 . . . . 10.0 109.754 175.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.67 HD21 HD11 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -158.76 131.11 6.82 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 122.139 0.971 . . . . 10.0 112.262 -176.758 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -88.63 126.23 35.19 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.746 -1.116 . . . . 10.0 111.423 -174.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.67 HD11 HD21 ' A' ' 11' ' ' LEU . 63.7 mt -143.88 145.07 29.1 Favored Pre-proline 0 CA--C 1.511 -0.538 0 CA-C-O 121.098 0.475 . . . . 10.0 112.09 -174.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.706 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 24.8 Cg_exo -61.17 129.68 29.46 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.408 2.739 . . . . 10.0 112.405 175.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.605 ' HB2' HD11 ' A' ' 54' ' ' LEU . . . -62.23 129.09 39.17 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.343 -1.354 . . . . 10.0 107.343 168.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.88 0.75 86.05 Favored Glycine 0 N--CA 1.441 -1.004 0 O-C-N 125.498 1.749 . . . . 10.0 113.088 -175.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.706 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 3.9 tmtp? -144.46 99.86 3.44 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.147 0.974 . . . . 10.0 112.047 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 39' ' ' CYS . . . -171.2 139.39 1.34 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.407 -1.27 . . . . 10.0 112.972 175.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.653 ' HA ' ' HB3' ' A' ' 39' ' ' CYS . 17.0 m -170.74 -66.88 0.0 OUTLIER Pre-proline 0 N--CA 1.437 -1.094 0 O-C-N 124.322 1.014 . . . . 10.0 110.813 178.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.706 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 86.3 Cg_endo -105.84 129.48 0.06 OUTLIER 'Trans proline' 0 N--CA 1.425 -2.511 0 N-CA-C 117.621 2.123 . . . . 10.0 117.621 -148.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.118 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 20.44 -83.87 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.412 0 CA-C-N 109.474 -3.512 . . . . 10.0 115.152 166.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.679 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 93.1 Cg_exo -39.39 -55.85 1.44 Allowed 'Trans proline' 0 C--N 1.382 2.308 0 CA-C-N 122.561 1.95 . . . . 10.0 112.489 -174.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.873 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 40.3 Cg_endo -91.02 116.1 0.47 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.822 1.681 . . . . 10.0 111.026 154.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.921 HG12 HD12 ' A' ' 35' ' ' ILE . 4.0 t 111.1 -42.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 C-N-CA 119.013 -1.075 . . . . 10.0 109.152 156.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 1.118 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -49.82 -75.11 0.22 Allowed Glycine 0 CA--C 1.523 0.583 0 CA-C-N 113.369 -1.741 . . . . 10.0 113.77 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.69 ' HA ' ' HG3' ' A' ' 30' ' ' GLN . 31.4 Cg_exo -54.79 -33.94 82.92 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.638 2.225 . . . . 10.0 111.39 175.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 24' ' ' VAL . . . -51.72 -98.08 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.113 0.412 . . . . 10.0 112.113 175.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.869 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.319 0.0 OUTLIER -72.88 -28.09 62.29 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 117.596 -1.642 . . . . 10.0 112.943 -174.412 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.555 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -68.58 -39.36 86.69 Favored Glycine 0 N--CA 1.464 0.501 0 C-N-CA 120.736 -0.745 . . . . 10.0 112.967 -176.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.69 ' HG3' ' HA ' ' A' ' 26' ' ' PRO . 78.1 mt-30 -65.38 -12.6 53.73 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.166 -1.014 . . . . 10.0 110.736 174.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 69.9 m80 -100.46 18.28 19.45 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.944 -0.702 . . . . 10.0 109.809 173.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.57 1.94 70.7 Favored Glycine 0 CA--C 1.5 -0.887 0 CA-C-N 114.824 -1.08 . . . . 10.0 113.695 169.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.891 HG11 ' CD2' ' A' ' 66' ' ' PHE . 3.4 t -85.41 146.65 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 113.623 0.971 . . . . 10.0 113.623 -170.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -68.67 100.96 1.21 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.226 0.536 . . . . 10.0 110.95 171.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.921 HD12 HG12 ' A' ' 24' ' ' VAL . 8.7 mm -53.15 -39.94 36.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.943 -1.026 . . . . 10.0 111.217 174.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.824 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 3.7 mpp? -64.02 -47.35 80.6 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 113.357 -1.747 . . . . 10.0 111.076 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.584 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 18.5 tp10 -56.75 -45.01 82.29 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.873 -0.731 . . . . 10.0 110.234 173.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . 85.0 t80 -55.81 -60.07 3.98 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.661 1.356 . . . . 10.0 114.661 173.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.824 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 24.8 p -61.57 -49.19 77.65 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 114.838 -1.074 . . . . 10.0 112.02 -175.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.502 ' HA ' ' HD3' ' A' ' 40' ' ' LYS . 28.1 mmtp -65.66 -21.26 66.54 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.543 -0.863 . . . . 10.0 109.762 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.801 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 5.7 mtp180 -71.6 -65.35 0.77 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 119.357 -0.937 . . . . 10.0 111.436 167.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.545 ' CZ ' HG21 ' A' ' 46' ' ' THR . 66.8 t80 -52.8 -47.01 67.9 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.602 -171.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -60.01 -52.78 63.92 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.944 -1.026 . . . . 10.0 110.254 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.9 96.09 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 118.884 -1.127 . . . . 10.0 112.187 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.801 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 9.6 mt-10 -68.74 -37.2 79.24 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 121.583 0.706 . . . . 10.0 111.172 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.582 ' CG2' HD12 ' A' ' 54' ' ' LEU . 73.0 p -89.14 0.22 56.91 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.125 -0.943 . . . . 10.0 112.567 -173.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.95 -38.34 7.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.007 -0.997 . . . . 10.0 113.008 -175.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -76.05 -36.57 58.98 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.718 -0.673 . . . . 10.0 111.138 -174.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 34.4 mtmm -100.88 23.1 11.09 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 123.013 0.525 . . . . 10.0 109.903 -176.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -52.31 143.83 14.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.158 -0.928 . . . . 10.0 112.789 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.87 20.08 24.95 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 114.948 -1.024 . . . . 10.0 110.57 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.551 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 67.4 mtt -138.41 123.41 19.0 Favored 'General case' 0 C--O 1.208 -1.084 0 C-N-CA 117.243 -1.783 . . . . 10.0 114.262 -168.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.0 mm -65.68 91.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 118.626 0.648 . . . . 10.0 109.674 172.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.605 HD11 ' HB2' ' A' ' 15' ' ' ALA . 8.6 mt -81.06 131.49 59.41 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.178 -0.675 . . . . 10.0 109.178 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -71.83 106.54 2.01 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 C-N-CA 122.306 2.004 . . . . 10.0 110.962 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.37 151.63 5.86 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-N 119.449 1.022 . . . . 10.0 111.221 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 95.2 t -134.32 116.79 23.02 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 N-CA-C 110.288 -0.264 . . . . 10.0 110.288 175.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.664 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 14.9 mt -104.19 142.6 17.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.723 0.773 . . . . 10.0 109.623 -172.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 84.5 m -126.6 95.57 4.39 Favored 'General case' 0 N--CA 1.411 -2.383 0 CA-C-N 114.659 -1.155 . . . . 10.0 108.998 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 65' ' ' SER . 1.5 p -89.95 137.49 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.122 0 CA-C-N 119.386 0.994 . . . . 10.0 110.581 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -95.59 179.54 5.1 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.621 -0.718 . . . . 10.0 112.486 -176.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.401 ' HG3' ' HB2' ' A' ' 4' ' ' LYS . 5.9 mm-40 -53.12 -33.16 51.07 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 124.87 1.268 . . . . 10.0 112.444 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.547 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 35.5 t70 -80.85 -9.58 59.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.698 -1.137 . . . . 10.0 111.568 -168.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 0.2 OUTLIER 81.3 6.6 1.24 Allowed 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 122.632 1.206 . . . . 10.0 110.823 -166.135 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.622 ' O ' HG23 ' A' ' 60' ' ' VAL . 58.6 m -71.4 172.01 10.21 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 112.796 -2.002 . . . . 10.0 107.693 168.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.891 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -168.68 -176.25 2.69 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 119.948 1.249 . . . . 10.0 109.525 175.779 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.4 p -158.65 166.67 31.5 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 102.79 -3.041 . . . . 10.0 102.79 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.483 ' HB3' HG12 ' A' ' 58' ' ' ILE . 49.4 p90 -161.06 156.88 25.24 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 176.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.0 mt -116.47 167.23 9.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.058 -1.46 . . . . 10.0 107.058 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.3 mt -142.22 114.21 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 107.691 -1.226 . . . . 10.0 107.691 -175.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.552 ' HB3' ' HG2' ' A' ' 73' ' ' PRO . 12.9 mmtp -72.41 99.18 2.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.414 1.102 . . . . 10.0 112.493 -166.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.778 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 14.6 t -62.6 -33.98 13.24 Favored Pre-proline 0 CA--C 1.569 1.693 0 CA-C-N 113.197 -1.82 . . . . 10.0 112.178 169.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.778 ' HD2' ' N ' ' A' ' 72' ' ' THR . 1.0 OUTLIER -40.18 -43.82 3.85 Favored 'Trans proline' 0 C--N 1.386 2.5 0 C-N-CA 124.867 3.711 . . . . 10.0 117.976 -175.245 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 71' ' ' LYS . 40.8 Cg_exo -37.44 -29.7 0.11 Allowed 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 123.52 2.813 . . . . 10.0 114.47 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 1.08 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . . . 75.59 -45.73 0.55 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.997 0.74 . . . . 10.0 112.997 169.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 43.7 t -47.1 -37.11 9.17 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 123.841 0.713 . . . . 10.0 111.728 -175.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -47.24 -56.52 6.57 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.814 0.816 . . . . 10.0 111.534 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.585 HD22 HG21 ' A' ' 111' ' ' THR . 10.8 mp -98.54 -18.72 18.01 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.678 0.752 . . . . 10.0 109.689 -171.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.641 HD21 ' HB2' ' A' ' 132' ' ' ALA . 2.5 tp -64.85 -36.58 84.8 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 114.827 -1.078 . . . . 10.0 108.444 174.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.515 ' C ' ' H ' ' A' ' 82' ' ' ALA . 47.4 mtmt -64.1 -40.27 95.87 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.617 168.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.818 ' HA ' ' HE2' ' A' ' 81' ' ' LYS . 7.0 mmpt? -61.98 33.58 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.982 0.913 . . . . 10.0 113.15 171.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.923 ' HB1' HG13 ' A' ' 100' ' ' VAL . . . -171.42 -48.76 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 122.328 1.061 . . . . 10.0 109.394 -172.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.3 -41.91 98.91 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 112.846 -1.979 . . . . 10.0 109.326 171.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 97.99 -20.01 52.26 Favored Glycine 0 C--N 1.316 -0.578 0 CA-C-N 115.271 -0.877 . . . . 10.0 111.042 175.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.48 HG13 ' HG2' ' A' ' 80' ' ' LYS . 25.5 pt -60.68 143.17 14.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.325 -0.937 . . . . 10.0 112.337 177.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -160.59 23.63 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.351 -0.84 . . . . 10.0 109.103 175.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -169.04 -59.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.573 -0.74 . . . . 10.0 110.009 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 148.53 -175.06 27.99 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.931 -0.652 . . . . 10.0 111.82 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.4 m -160.41 170.03 21.84 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.515 -0.55 . . . . 10.0 109.515 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.4 p -75.63 33.68 0.11 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.504 0.557 . . . . 10.0 112.504 -177.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 32.77 72.26 0.62 Allowed Pre-proline 0 N--CA 1.472 0.625 0 C-N-CA 124.349 1.06 . . . . 10.0 113.291 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.52 -170.36 0.99 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.848 2.365 . . . . 10.0 110.944 174.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.87 ' HB2' ' HB ' ' A' ' 96' ' ' ILE . 17.4 mmmt 57.55 -154.35 0.35 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.992 -0.373 . . . . 10.0 109.992 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 94' ' ' ARG . 30.4 ttt180 -79.77 62.45 4.03 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.17 -0.307 . . . . 10.0 110.17 173.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.489 ' HD3' ' HA ' ' A' ' 95' ' ' LYS . 45.6 mmtt 67.12 29.43 7.86 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.429 0.633 . . . . 10.0 110.458 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.87 ' HB ' ' HB2' ' A' ' 93' ' ' LYS . 11.8 mt -91.37 176.34 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.167 -0.924 . . . . 10.0 109.42 -178.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.517 HG13 ' N ' ' A' ' 98' ' ' GLY . 7.8 p -139.01 -47.16 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 120.929 0.395 . . . . 10.0 111.305 -175.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.612 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -159.29 172.1 35.9 Favored Glycine 0 CA--C 1.493 -1.293 0 N-CA-C 108.08 -2.008 . . . . 10.0 108.08 170.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.947 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -143.13 167.51 21.93 Favored 'General case' 0 CA--C 1.479 -1.759 0 CA-C-O 122.664 1.221 . . . . 10.0 111.119 -169.152 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.923 HG13 ' HB1' ' A' ' 82' ' ' ALA . 2.1 t -131.53 -150.53 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.409 -2.478 0 CA-C-N 111.834 -2.439 . . . . 10.0 107.054 -173.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.645 ' H ' HG12 ' A' ' 100' ' ' VAL . 0.3 OUTLIER -167.42 133.98 2.21 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 105.894 -1.891 . . . . 10.0 105.894 -164.486 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.491 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 13.1 tpp180 -40.67 -44.91 2.26 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 125.055 1.472 . . . . 10.0 110.939 -171.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 16.9 tppt? -58.06 -42.94 86.56 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.398 0.888 . . . . 10.0 113.398 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.735 ' HB2' HG12 ' A' ' 100' ' ' VAL . 20.1 mm-40 -66.9 -52.02 48.36 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.089 -0.708 . . . . 10.0 109.089 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.849 HG21 ' HG3' ' A' ' 129' ' ' GLU . 28.7 mm -35.2 -55.29 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 O-C-N 124.074 0.859 . . . . 10.0 110.592 165.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.679 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 23.2 tt0 -50.36 -56.48 11.18 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.815 1.246 . . . . 10.0 113.12 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.53 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 12.5 mm-40 -54.58 -57.64 10.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.826 -1.079 . . . . 10.0 110.703 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.621 ' O ' HG22 ' A' ' 111' ' ' THR . 45.2 mt -50.19 -51.43 17.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.596 -1.183 . . . . 10.0 110.528 173.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.542 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -53.23 -34.26 56.39 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 112.582 0.586 . . . . 10.0 112.582 174.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.679 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 96.8 mttt -69.7 -52.29 26.89 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 120.853 0.359 . . . . 10.0 111.081 -177.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.621 HG22 ' O ' ' A' ' 108' ' ' ILE . 4.2 t -56.11 -29.12 60.19 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.944 -0.571 . . . . 10.0 111.606 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 1.08 ' HE3' ' HA ' ' A' ' 75' ' ' ALA . 49.7 mttm -103.89 -5.15 22.6 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 112.253 0.464 . . . . 10.0 112.253 -175.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.622 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 14.5 ptp -53.66 -32.87 11.94 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 112.985 0.735 . . . . 10.0 112.985 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 113' ' ' MET . 32.4 Cg_endo -62.83 -31.05 78.12 Favored 'Trans proline' 0 C--N 1.371 1.762 0 CA-C-N 120.651 1.268 . . . . 10.0 111.518 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.626 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 1.0 OUTLIER -102.78 -40.25 6.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.589 -1.187 . . . . 10.0 114.04 -169.357 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.558 ' HG ' HD13 ' A' ' 127' ' ' ILE . 0.9 OUTLIER -63.77 38.66 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 114.258 -1.337 . . . . 10.0 113.264 -174.315 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 43.4 t30 23.0 44.9 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 O-C-N 124.141 0.901 . . . . 10.0 111.024 -168.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.65 ' O ' ' HB2' ' A' ' 119' ' ' ASN . . . -73.88 -82.15 0.06 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.817 -1.083 . . . . 10.0 113.358 -169.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.65 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 5.7 m-20 101.26 -29.92 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 O-C-N 125.203 1.565 . . . . 10.0 110.412 -173.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 41.7 p -155.26 141.01 18.08 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.814 -1.18 . . . . 10.0 107.814 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.566 ' O ' ' HG3' ' A' ' 125' ' ' MET . 3.4 tm? -53.61 -44.05 69.15 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.832 1.049 . . . . 10.0 113.832 -175.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -53.64 -37.09 62.76 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.165 0.507 . . . . 10.0 111.507 174.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.574 ' O ' ' HG3' ' A' ' 126' ' ' LYS . . . -67.07 -47.24 71.87 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 118.241 -1.384 . . . . 10.0 110.276 174.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.546 ' HA ' HD12 ' A' ' 127' ' ' ILE . . . -55.99 -34.38 65.72 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.012 -0.675 . . . . 10.0 110.839 175.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.566 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 80.0 mtp -55.9 -45.38 78.66 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.175 0.805 . . . . 10.0 113.175 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.642 ' HD2' HG13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -63.6 -37.3 86.81 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.709 -0.478 . . . . 10.0 109.709 -178.338 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.642 HG13 ' HD2' ' A' ' 126' ' ' LYS . 83.6 mt -55.72 -64.04 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 CA-C-O 121.85 0.833 . . . . 10.0 111.569 175.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.542 HG13 ' HB2' ' A' ' 109' ' ' ALA . 25.0 mm -50.22 -59.67 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 CA-C-N 113.437 -1.71 . . . . 10.0 111.691 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.849 ' HG3' HG21 ' A' ' 105' ' ' ILE . 6.3 mt-10 -53.2 -40.39 64.4 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.454 -0.793 . . . . 10.0 110.091 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -71.36 -45.17 49.29 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.356 -0.926 . . . . 10.0 111.715 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.433 HG21 ' HB3' ' A' ' 75' ' ' ALA . 97.8 m -46.5 -61.17 1.93 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.185 -1.008 . . . . 10.0 108.906 169.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.641 ' HB2' HD21 ' A' ' 79' ' ' LEU . . . -50.74 -47.99 59.21 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.761 -0.654 . . . . 10.0 111.826 177.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 18.2 ttpt -44.44 -56.41 4.28 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 124.025 0.828 . . . . 10.0 110.448 176.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.5 m -64.54 -30.0 71.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.717 -0.674 . . . . 10.0 111.666 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 29.9 mtm -81.38 3.46 24.33 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 114.077 1.139 . . . . 10.0 114.077 -176.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.46 ' O ' HG12 ' A' ' 97' ' ' VAL . . . 84.07 20.04 59.93 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 120.066 1.303 . . . . 10.0 111.748 -177.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.702 ' CG2' HG23 ' A' ' 100' ' ' VAL . 1.8 mp -107.17 126.23 63.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.683 0.754 . . . . 10.0 112.079 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.947 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -90.31 158.87 16.94 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.522 -1.217 . . . . 10.0 108.997 175.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.5 HG11 ' HG2' ' A' ' 129' ' ' GLU . 19.1 m -114.71 124.3 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.216 0 N-CA-C 108.002 -1.111 . . . . 10.0 108.002 170.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 100' ' ' VAL . 5.0 m -108.52 157.24 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 CA-C-N 114.194 -1.366 . . . . 10.0 109.723 178.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.3 t70 . . . . . 0 C--N 1.287 -2.15 0 CA-C-N 113.057 -1.883 . . . . 10.0 110.28 174.073 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.421 ' HA ' ' HE3' ' A' ' 1' ' ' MET . 3.7 tpt . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 110.135 -0.32 . . . . 10.0 110.135 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.56 79.58 0.41 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.142 -0.481 . . . . 10.0 111.797 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -133.51 108.57 8.71 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 115.891 -0.595 . . . . 10.0 109.916 172.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.864 ' HD3' ' H ' ' A' ' 4' ' ' LYS . 0.3 OUTLIER -75.69 75.47 2.67 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.573 -0.74 . . . . 10.0 109.618 174.775 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 93.1 t -79.41 133.33 30.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.64 -0.504 . . . . 10.0 109.64 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . . . -98.5 -37.54 9.53 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.115 -0.698 . . . . 10.0 109.115 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.4 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -164.67 -171.28 2.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 122.026 0.917 . . . . 10.0 113.423 -177.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 54.6 mt-30 -137.83 132.95 33.37 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.737 -1.574 . . . . 10.0 108.316 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.629 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -119.9 80.91 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.88 -0.785 . . . . 10.0 108.88 179.199 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -81.83 122.41 27.68 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 120.063 1.301 . . . . 10.0 107.847 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.605 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -156.84 130.3 8.08 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.163 0.982 . . . . 10.0 111.812 -171.829 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -81.99 120.93 25.88 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.297 -1.32 . . . . 10.0 110.225 -172.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.605 HD21 HD11 ' A' ' 11' ' ' LEU . 73.8 mt -138.57 135.32 17.92 Favored Pre-proline 0 CA--C 1.505 -0.752 0 CA-C-O 121.65 0.738 . . . . 10.0 112.051 -173.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.575 ' HB2' ' CB ' ' A' ' 17' ' ' LYS . 34.3 Cg_exo -54.94 123.6 14.19 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.641 2.894 . . . . 10.0 112.189 174.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.569 ' CB ' ' HA ' ' A' ' 50' ' ' ALA . . . -62.4 126.56 27.74 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.536 -1.283 . . . . 10.0 107.536 170.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.96 -1.06 85.93 Favored Glycine 0 CA--C 1.529 0.906 0 O-C-N 125.755 1.909 . . . . 10.0 113.238 -173.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.575 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . 6.0 tmtt? -142.81 95.85 2.84 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.185 0.993 . . . . 10.0 112.284 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.652 ' H ' HD22 ' A' ' 43' ' ' ASN . . . -169.61 137.49 1.77 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.41 -1.268 . . . . 10.0 112.644 175.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.564 ' H ' ' HD3' ' A' ' 20' ' ' PRO . 1.8 t -178.05 -48.93 0.0 OUTLIER Pre-proline 0 N--CA 1.435 -1.182 0 CA-C-N 114.81 -1.086 . . . . 10.0 112.275 174.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.723 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 83.5 Cg_endo -101.53 134.64 0.15 Allowed 'Trans proline' 0 N--CA 1.407 -3.596 0 N-CA-C 116.231 1.589 . . . . 10.0 116.231 -150.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.025 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . 16.53 -64.94 0.0 OUTLIER Pre-proline 0 C--N 1.286 -2.184 0 CA-C-N 109.005 -3.725 . . . . 10.0 117.639 154.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.778 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 47.0 Cg_exo -53.87 -63.64 0.21 Allowed 'Trans proline' 0 CA--C 1.565 2.061 0 CA-C-N 123.606 2.324 . . . . 10.0 115.398 -176.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.778 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 58.3 Cg_endo -77.33 -52.24 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.607 2.204 . . . . 10.0 112.553 175.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.066 HG12 HD12 ' A' ' 35' ' ' ILE . 67.4 t -83.48 -44.95 18.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 111.896 -2.411 . . . . 10.0 111.957 -165.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.778 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -45.28 -53.36 7.94 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 114.259 -1.337 . . . . 10.0 114.234 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 1.025 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 50.5 Cg_exo -66.58 -49.29 1.75 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.228 2.619 . . . . 10.0 111.82 177.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.536 ' HB1' ' CG2' ' A' ' 9' ' ' ILE . . . -49.01 -74.85 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.323 0.583 . . . . 10.0 110.911 -177.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.773 HD22 ' HE2' ' A' ' 66' ' ' PHE . 3.5 mt -71.29 -44.99 64.12 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.649 0.981 . . . . 10.0 113.649 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.64 -41.45 98.91 Favored Glycine 0 N--CA 1.459 0.203 0 CA-C-N 116.237 -0.438 . . . . 10.0 113.359 -172.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -61.57 -26.52 68.01 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.94 -0.304 . . . . 10.0 110.491 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -99.06 17.37 19.94 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.847 -0.741 . . . . 10.0 109.982 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.01 11.91 85.14 Favored Glycine 0 CA--C 1.499 -0.944 0 CA-C-N 114.708 -1.133 . . . . 10.0 112.894 168.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.887 HG11 ' CD2' ' A' ' 66' ' ' PHE . 1.8 t -83.7 148.02 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 113.738 1.014 . . . . 10.0 113.738 -174.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -69.93 95.51 0.94 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.739 0.816 . . . . 10.0 110.606 174.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.066 HD12 HG12 ' A' ' 24' ' ' VAL . 22.0 mm -49.74 -43.27 18.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 114.722 -1.127 . . . . 10.0 111.783 177.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.806 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 10.7 ptm -66.05 -49.53 67.34 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 112.766 -2.016 . . . . 10.0 113.03 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.498 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 36.2 mt-10 -59.41 -32.99 70.69 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.114 -1.035 . . . . 10.0 110.912 176.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.745 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 72.1 t80 -63.49 -59.65 4.38 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 114.485 1.291 . . . . 10.0 114.485 169.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.806 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 23.7 p -60.07 -48.85 79.99 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 114.37 -1.287 . . . . 10.0 111.917 -175.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -65.32 -20.79 66.56 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.198 -0.667 . . . . 10.0 109.198 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.669 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 10.0 mtp180 -77.63 -64.25 1.19 Allowed 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 119.379 -0.928 . . . . 10.0 113.338 169.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.619 ' CE2' HG21 ' A' ' 46' ' ' THR . 45.3 t80 -55.9 -45.47 78.64 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 120.912 0.387 . . . . 10.0 110.113 -173.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.652 HD22 ' H ' ' A' ' 18' ' ' ALA . 4.8 m-20 -59.01 -50.35 74.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.547 -0.751 . . . . 10.0 110.09 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.69 96.26 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 118.816 -1.154 . . . . 10.0 112.649 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.669 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 5.1 pt-20 -73.78 -32.02 63.58 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 119.622 -0.831 . . . . 10.0 112.545 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.619 HG21 ' CE2' ' A' ' 42' ' ' PHE . 68.6 p -88.16 1.66 53.9 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 115.674 -0.694 . . . . 10.0 111.213 -177.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -47.56 -37.22 11.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.957 -1.02 . . . . 10.0 111.961 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.44 -45.39 39.0 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 114.194 -1.366 . . . . 10.0 110.538 -174.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.831 ' HD2' ' HZ ' ' A' ' 77' ' ' PHE . 30.2 mtmm -101.14 29.08 4.88 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 121.808 0.813 . . . . 10.0 109.472 -175.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.569 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -56.72 157.58 5.31 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 113.615 -1.63 . . . . 10.0 113.482 177.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.0 20.92 44.3 Favored Glycine 0 CA--C 1.505 -0.538 0 N-CA-C 109.883 -1.287 . . . . 10.0 109.883 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.616 ' HB2' HD21 ' A' ' 54' ' ' LEU . 14.6 mmt -137.28 123.14 20.08 Favored 'General case' 0 C--O 1.21 -1.018 0 C-N-CA 117.31 -1.756 . . . . 10.0 113.401 -167.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.7 mm -64.15 91.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.926 -0.768 . . . . 10.0 108.926 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.791 HD13 HG21 ' A' ' 70' ' ' ILE . 6.7 mt -79.19 127.11 80.24 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.552 -0.536 . . . . 10.0 109.552 -176.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.698 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 15.3 Cg_exo -70.85 99.63 0.88 Allowed 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 121.895 1.73 . . . . 10.0 110.397 172.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.419 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -97.12 148.82 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 119.57 1.077 . . . . 10.0 111.315 -172.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.433 ' HB ' ' CD1' ' A' ' 69' ' ' ILE . 71.5 t -126.53 115.01 40.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 120.866 -0.334 . . . . 10.0 110.521 171.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.726 ' CD1' HD21 ' A' ' 28' ' ' LEU . 17.7 mt -106.47 140.25 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 108.052 -1.092 . . . . 10.0 108.052 -175.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 94.0 m -123.81 99.32 6.22 Favored 'General case' 0 C--N 1.276 -2.607 0 CA-C-N 115.163 -0.926 . . . . 10.0 108.717 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 65' ' ' SER . 2.4 p -86.24 136.76 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.002 0 CA-C-N 118.897 0.771 . . . . 10.0 110.118 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 93.2 m-85 -93.96 170.5 9.49 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.076 -0.966 . . . . 10.0 112.507 -177.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.511 ' HG3' ' C ' ' A' ' 4' ' ' LYS . 16.3 mt-10 -63.28 -20.24 65.29 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.203 -1.362 . . . . 10.0 111.654 -177.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -78.97 -8.87 59.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.404 -0.816 . . . . 10.0 110.51 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm 83.15 0.75 1.13 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.442 1.097 . . . . 10.0 110.423 -171.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.53 ' O ' HG23 ' A' ' 60' ' ' VAL . 18.5 m -70.01 -178.77 1.68 Allowed 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 114.915 -1.038 . . . . 10.0 109.117 171.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.887 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -170.32 -175.89 2.05 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 119.679 1.127 . . . . 10.0 110.242 174.622 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.1 p -161.21 166.44 27.78 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 103.302 -2.851 . . . . 10.0 103.302 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.449 ' CB ' HG12 ' A' ' 58' ' ' ILE . 49.1 p90 -161.6 157.08 24.14 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 109.137 -0.69 . . . . 10.0 109.137 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.433 ' CD1' ' HB ' ' A' ' 57' ' ' VAL . 2.0 pp -136.55 152.59 29.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.327 -0.99 . . . . 10.0 108.327 -177.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.791 HG21 HD13 ' A' ' 54' ' ' LEU . 1.8 mm -100.9 132.07 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 108.089 -1.078 . . . . 10.0 108.089 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.698 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 32.4 mmmt -80.42 99.07 7.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.981 0.896 . . . . 10.0 112.194 -171.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.89 ' HB ' ' HB3' ' A' ' 112' ' ' LYS . 78.6 p -64.32 -29.35 3.74 Favored Pre-proline 0 CA--C 1.569 1.681 0 CA-C-N 113.778 -1.556 . . . . 10.0 114.852 172.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.642 ' HG3' ' HB3' ' A' ' 115' ' ' ASP . 72.9 Cg_exo -40.8 -48.36 4.57 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 123.909 3.073 . . . . 10.0 116.925 -172.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.503 ' HD3' ' HB2' ' A' ' 73' ' ' PRO . 88.7 Cg_exo -48.11 -30.29 14.06 Favored 'Trans proline' 0 C--N 1.363 1.323 0 C-N-CA 122.159 1.906 . . . . 10.0 112.733 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.407 ' HB1' HD23 ' A' ' 79' ' ' LEU . . . 68.44 -44.35 0.51 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.933 0.893 . . . . 10.0 112.865 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.557 ' HA ' ' HB2' ' A' ' 79' ' ' LEU . 7.4 m -49.6 -33.47 15.32 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 122.852 0.461 . . . . 10.0 110.468 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.831 ' HZ ' ' HD2' ' A' ' 49' ' ' LYS . 20.9 t80 -43.93 -58.82 2.57 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.92 -1.036 . . . . 10.0 111.822 172.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.889 ' HB3' HG23 ' A' ' 108' ' ' ILE . 6.3 tp -95.98 -14.33 23.11 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.46 -0.496 . . . . 10.0 110.333 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.733 HD21 HG23 ' A' ' 128' ' ' ILE . 2.3 mm? -64.62 -44.31 90.95 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 109.243 -0.651 . . . . 10.0 109.243 171.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.553 ' HD2' ' O ' ' A' ' 80' ' ' LYS . 1.7 tmmm? -63.52 -30.58 71.68 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 115.51 -0.768 . . . . 10.0 109.434 174.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.512 ' HG3' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -60.28 -40.17 89.46 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.991 0.737 . . . . 10.0 112.991 173.44 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.828 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -66.66 -43.14 85.35 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 123.294 1.521 . . . . 10.0 110.636 171.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.599 ' HB1' HG12 ' A' ' 85' ' ' ILE . . . -76.51 164.72 25.68 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 111.125 -2.762 . . . . 10.0 108.563 -175.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -112.52 -3.35 25.59 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 118.665 -1.731 . . . . 10.0 110.876 163.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.639 HG21 HG13 ' A' ' 97' ' ' VAL . 46.9 pt -61.04 113.91 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.586 0.708 . . . . 10.0 111.462 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -76.55 -174.02 2.77 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.929 -0.578 . . . . 10.0 110.956 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -76.77 -15.18 59.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.066 0.46 . . . . 10.0 110.678 -170.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.06 54.07 3.83 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.539 -0.755 . . . . 10.0 114.019 -173.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.2 t -74.73 115.97 14.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.745 0.307 . . . . 10.0 110.841 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.511 ' O ' ' HG2' ' A' ' 91' ' ' GLU . 48.4 t -77.59 -68.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.537 -0.301 . . . . 10.0 110.3 173.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 90' ' ' SER . 3.3 mm-40 -171.8 99.1 0.38 Allowed Pre-proline 0 N--CA 1.464 0.255 0 CA-C-N 115.743 -0.662 . . . . 10.0 109.959 -177.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.564 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 13.9 Cg_endo -85.52 -89.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 122.395 2.063 . . . . 10.0 109.929 172.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' A' ' 93' ' ' LYS . 29.7 ttpt 50.87 24.32 1.74 Allowed 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.268 1.21 . . . . 10.0 114.268 164.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.564 ' HG2' ' O ' ' A' ' 92' ' ' PRO . 17.2 ptm180 -166.61 -23.12 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.433 -0.792 . . . . 10.0 112.384 -178.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 95' ' ' LYS . 47.5 mmtt -158.75 34.27 0.22 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.52 -0.548 . . . . 10.0 109.52 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.3 pt 46.6 -161.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 124.402 1.064 . . . . 10.0 113.009 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.639 HG13 HG21 ' A' ' 85' ' ' ILE . 8.3 p -150.83 -43.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 112.384 0.513 . . . . 10.0 112.384 -168.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.594 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -166.93 161.27 35.1 Favored Glycine 0 CA--C 1.5 -0.885 0 N-CA-C 109.452 -1.459 . . . . 10.0 109.452 173.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.746 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -145.32 177.85 8.52 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 122.676 1.227 . . . . 10.0 111.649 -165.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.828 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -157.68 -143.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 CA-C-N 111.813 -2.449 . . . . 10.0 105.465 -177.388 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.454 ' H ' ' HB ' ' A' ' 100' ' ' VAL . 0.9 OUTLIER -163.32 143.37 8.84 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 108.117 -1.068 . . . . 10.0 108.117 -157.107 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.631 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 6.7 tpp180 -42.21 -38.86 1.87 Allowed 'General case' 0 CA--C 1.548 0.876 0 O-C-N 124.727 1.267 . . . . 10.0 110.921 -174.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -57.86 -44.94 86.9 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.178 0.807 . . . . 10.0 113.178 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.512 ' O ' HG13 ' A' ' 108' ' ' ILE . 0.1 OUTLIER -61.39 -47.39 86.02 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.529 -0.915 . . . . 10.0 108.529 177.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.847 HG23 ' HB ' ' A' ' 128' ' ' ILE . 1.9 mp -40.44 -56.51 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 CA-C-N 115.044 -0.98 . . . . 10.0 112.274 168.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.8 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 16.9 tt0 -47.15 -57.86 4.66 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 124.74 1.216 . . . . 10.0 111.835 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.615 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 68.5 mm-40 -52.91 -55.38 23.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.969 -1.014 . . . . 10.0 110.986 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.889 HG23 ' HB3' ' A' ' 78' ' ' LEU . 32.4 mt -51.57 -54.84 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.902 -0.59 . . . . 10.0 109.925 174.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.512 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -50.6 -42.42 55.86 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 124.047 0.842 . . . . 10.0 112.63 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.8 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 70.1 mttt -67.43 -49.68 62.66 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 122.187 0.994 . . . . 10.0 108.876 -176.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 98.5 m -53.02 -22.29 5.59 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 113.302 -1.772 . . . . 10.0 112.77 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.89 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 1.2 ptpp? -131.11 11.2 5.02 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 113.886 1.069 . . . . 10.0 113.886 -178.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.747 ' HG3' ' HD3' ' A' ' 114' ' ' PRO . 8.7 ptp -48.95 -38.35 25.5 Favored Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 118.714 0.688 . . . . 10.0 112.6 167.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.747 ' HD3' ' HG3' ' A' ' 113' ' ' MET . 34.3 Cg_endo -63.06 -27.83 74.0 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 121.42 1.413 . . . . 10.0 112.316 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.642 ' HB3' ' HG3' ' A' ' 73' ' ' PRO . 4.7 m-20 -95.99 -47.48 6.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.041 -0.981 . . . . 10.0 111.838 -175.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.598 HD13 ' HB2' ' A' ' 112' ' ' LYS . 7.5 mp -64.12 -1.92 1.79 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.002 -1.454 . . . . 10.0 111.053 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.439 ' H ' ' C ' ' A' ' 115' ' ' ASP . 0.9 OUTLIER 63.79 45.53 4.4 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.773 -1.558 . . . . 10.0 109.733 176.767 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.626 ' HB3' ' HB2' ' A' ' 113' ' ' MET . . . -82.5 114.7 21.1 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 113.703 -1.589 . . . . 10.0 112.198 -175.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -66.7 -33.48 75.73 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.246 -0.65 . . . . 10.0 109.246 169.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 45.7 t -150.83 144.46 25.06 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.007 -1.479 . . . . 10.0 107.007 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.567 ' O ' HD13 ' A' ' 121' ' ' LEU . 2.5 tm? -51.61 -34.51 37.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.824 -1.08 . . . . 10.0 112.433 -176.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.579 ' HA ' ' HG3' ' A' ' 125' ' ' MET . 14.4 mm-40 -48.23 -42.7 31.06 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.425 0.631 . . . . 10.0 111.152 174.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.09 -46.45 77.62 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 118.708 -1.197 . . . . 10.0 110.34 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.511 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -57.33 -37.42 72.5 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.149 176.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.579 ' HG3' ' HA ' ' A' ' 122' ' ' GLU . 19.9 mtp -54.74 -38.83 67.64 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.61 0.243 . . . . 10.0 111.505 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' A' ' 122' ' ' GLU . 61.7 mmtt -63.66 -47.97 79.12 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.831 -0.803 . . . . 10.0 108.831 -178.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.509 HD12 ' HA ' ' A' ' 124' ' ' ALA . 78.9 mt -51.1 -62.86 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-O 121.659 0.742 . . . . 10.0 110.614 176.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.847 ' HB ' HG23 ' A' ' 105' ' ' ILE . 32.9 mm -53.4 -56.66 7.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 113.949 -1.478 . . . . 10.0 112.636 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.98 -39.36 68.92 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.546 -0.909 . . . . 10.0 108.546 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.469 ' HA2' ' HE2' ' A' ' 133' ' ' LYS . . . -70.73 -46.78 44.28 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.531 -0.758 . . . . 10.0 111.657 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 84.3 m -46.2 -63.49 0.98 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.334 -0.933 . . . . 10.0 109.28 170.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.08 -49.81 39.9 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.873 -0.603 . . . . 10.0 111.358 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.469 ' HE2' ' HA2' ' A' ' 130' ' ' GLY . 26.8 ttpt -48.61 -53.22 19.33 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.711 -1.131 . . . . 10.0 111.55 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 43.5 m -67.63 -28.12 67.46 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 111.792 0.293 . . . . 10.0 111.792 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.444 ' HB2' HD12 ' A' ' 137' ' ' ILE . 7.4 mtm -80.05 6.41 11.55 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.614 0.968 . . . . 10.0 113.614 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 81.09 10.81 84.42 Favored Glycine 0 N--CA 1.452 -0.261 0 CA-C-N 119.504 1.047 . . . . 10.0 111.55 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 32.1 mt -100.57 126.54 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-O 121.165 0.507 . . . . 10.0 111.005 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.746 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -85.25 154.01 22.23 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.205 -0.998 . . . . 10.0 109.15 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.464 HG12 HD11 ' A' ' 105' ' ' ILE . 27.7 m -111.21 120.63 62.25 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.488 0 N-CA-C 107.314 -1.365 . . . . 10.0 107.314 169.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 100' ' ' VAL . 29.9 m -101.39 152.11 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 CA-C-N 114.123 -1.399 . . . . 10.0 108.76 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 26.3 t0 . . . . . 0 C--N 1.294 -1.823 0 CA-C-N 112.874 -1.966 . . . . 10.0 112.876 -173.646 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mpp? . . . . . 0 N--CA 1.481 1.087 0 CA-C-O 120.768 0.318 . . . . 10.0 110.204 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.13 -147.52 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.945 -0.761 . . . . 10.0 108.945 -176.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.8 80.33 1.14 Allowed 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.836 0.827 . . . . 10.0 109.816 173.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.448 ' HB3' ' OE2' ' A' ' 62' ' ' GLU . 47.9 tttp -118.1 133.3 56.03 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.667 -1.151 . . . . 10.0 107.929 174.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.2 t -62.12 124.94 17.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 120.721 0.296 . . . . 10.0 110.498 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -99.68 -28.73 13.04 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.462 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -165.93 -167.6 1.11 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.166 -0.924 . . . . 10.0 112.811 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 9.7 pt20 -148.19 135.77 20.69 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.134 -1.394 . . . . 10.0 109.462 178.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.62 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -120.88 80.56 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 109.022 -0.733 . . . . 10.0 109.022 -178.301 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 30.8 tttt -79.61 125.19 29.3 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 120.101 1.318 . . . . 10.0 108.154 177.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.612 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.8 130.48 7.35 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 122.024 0.916 . . . . 10.0 111.978 -172.872 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -82.91 120.8 26.15 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.24 -1.345 . . . . 10.0 110.105 -173.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.612 HD21 HD11 ' A' ' 11' ' ' LEU . 47.4 mt -136.56 137.69 24.6 Favored Pre-proline 0 N--CA 1.443 -0.82 0 CA-C-O 121.696 0.76 . . . . 10.0 112.213 -171.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.631 ' HB2' ' CB ' ' A' ' 17' ' ' LYS . 22.9 Cg_exo -58.91 122.83 12.27 Favored 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 123.603 2.869 . . . . 10.0 111.663 173.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.603 ' HB1' ' HB ' ' A' ' 46' ' ' THR . . . -62.08 128.95 38.55 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.176 -1.046 . . . . 10.0 108.176 171.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.71 0.78 81.78 Favored Glycine 0 N--CA 1.442 -0.944 0 O-C-N 126.122 2.139 . . . . 10.0 112.786 -174.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.631 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . 5.9 tmtt? -142.05 91.58 2.36 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.86 0.838 . . . . 10.0 112.024 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.36 135.58 5.18 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.449 -1.25 . . . . 10.0 112.588 175.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.506 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 1.4 t -178.29 -50.52 0.0 OUTLIER Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.191 -0.913 . . . . 10.0 112.37 173.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.659 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 84.9 Cg_endo -101.42 125.59 0.11 Allowed 'Trans proline' 0 N--CA 1.414 -3.197 0 N-CA-C 115.726 1.395 . . . . 10.0 115.726 -154.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.125 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 12.04 -89.99 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.534 0 CA-C-N 109.347 -3.569 . . . . 10.0 114.713 168.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.78 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 47.7 Cg_exo -26.72 -56.51 0.1 OUTLIER 'Trans proline' 0 CA--C 1.559 1.742 0 C-N-CA 123.041 2.494 . . . . 10.0 115.824 -161.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.78 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 37.4 Cg_endo -77.75 -72.7 0.01 OUTLIER 'Trans proline' 0 CA--C 1.551 1.327 0 C-N-CA 122.267 1.978 . . . . 10.0 112.327 168.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.993 HG12 HD12 ' A' ' 35' ' ' ILE . 74.9 t -59.55 -54.85 28.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 112.218 -2.264 . . . . 10.0 114.734 -173.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 1.125 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -46.44 -70.27 0.7 Allowed Glycine 0 C--O 1.22 -0.763 0 CA-C-N 114.808 -1.087 . . . . 10.0 113.787 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.625 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 23.5 Cg_exo -47.76 -46.7 20.53 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.489 2.793 . . . . 10.0 112.701 173.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.13 -77.34 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.319 0.581 . . . . 10.0 111.361 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.753 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . 3.3 mt -69.39 -52.05 30.68 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 114.088 1.144 . . . . 10.0 114.088 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.2 -40.13 83.24 Favored Glycine 0 N--CA 1.462 0.367 0 CA-C-N 115.562 -0.744 . . . . 10.0 113.374 -172.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -60.11 -26.3 66.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.851 0.358 . . . . 10.0 110.408 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -99.97 17.02 22.01 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 120.008 -0.677 . . . . 10.0 109.771 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.52 ' HA3' ' HD3' ' A' ' 64' ' ' LYS . . . 82.99 7.57 86.98 Favored Glycine 0 CA--C 1.499 -0.941 0 CA-C-N 114.639 -1.164 . . . . 10.0 113.292 167.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.874 HG11 ' CD2' ' A' ' 66' ' ' PHE . 1.6 t -83.1 145.78 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 113.763 1.023 . . . . 10.0 113.763 -173.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.572 ' HB3' ' HG2' ' A' ' 37' ' ' GLU . 55.0 t-20 -70.58 100.28 1.8 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.452 0.644 . . . . 10.0 110.384 173.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.993 HD12 HG12 ' A' ' 24' ' ' VAL . 23.2 mm -53.54 -40.35 41.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 114.753 -1.112 . . . . 10.0 112.036 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 77.0 mtp -65.5 -53.01 48.55 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.189 -1.823 . . . . 10.0 112.434 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.572 ' HG2' ' HB3' ' A' ' 34' ' ' ASN . 7.0 pt-20 -61.52 -31.17 71.17 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 118.168 -1.413 . . . . 10.0 109.99 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.667 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 68.7 t80 -59.52 -58.97 6.26 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 119.502 -0.879 . . . . 10.0 112.849 168.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -56.22 -50.02 72.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 113.896 -1.502 . . . . 10.0 111.792 -178.669 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -64.85 -22.42 66.99 Favored 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 118.945 -1.102 . . . . 10.0 108.529 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.801 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 62.9 mtt180 -76.97 -64.3 1.16 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.032 -1.067 . . . . 10.0 111.863 169.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.604 ' CZ ' HG21 ' A' ' 46' ' ' THR . 76.8 t80 -54.18 -48.64 70.71 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-N 119.052 0.842 . . . . 10.0 110.784 -171.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -60.27 -51.75 68.22 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.768 -1.105 . . . . 10.0 110.328 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.07 -37.51 87.5 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.172 -1.011 . . . . 10.0 111.53 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.801 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 15.5 mm-40 -63.44 -45.34 91.33 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 122.02 0.914 . . . . 10.0 110.399 177.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.604 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 73.0 p -90.12 3.89 52.0 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.279 -1.328 . . . . 10.0 112.43 -167.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -47.1 -39.04 12.41 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.912 -1.04 . . . . 10.0 111.497 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.95 -48.09 77.89 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 114.125 -1.398 . . . . 10.0 111.532 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 45.1 mttp -98.84 21.96 10.78 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 123.217 0.607 . . . . 10.0 110.291 -172.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -51.99 133.05 32.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.066 -0.97 . . . . 10.0 112.634 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.37 19.27 10.08 Favored Glycine 0 CA--C 1.504 -0.599 0 N-CA-C 110.707 -0.957 . . . . 10.0 110.707 -176.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.582 ' HB2' HD21 ' A' ' 54' ' ' LEU . 66.9 mtt -138.74 125.5 20.91 Favored 'General case' 0 C--O 1.212 -0.885 0 C-N-CA 117.272 -1.771 . . . . 10.0 114.102 -168.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.6 mm -66.17 89.63 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 109.259 -0.645 . . . . 10.0 109.259 171.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.593 HD12 ' CG2' ' A' ' 46' ' ' THR . 8.2 mt -79.22 137.44 56.44 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.285 -0.635 . . . . 10.0 109.285 -177.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 54' ' ' LEU . 6.5 Cg_exo -76.28 106.12 2.2 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.13 1.887 . . . . 10.0 110.592 172.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.418 HG23 HG12 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -105.74 153.61 7.18 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-N 119.775 1.17 . . . . 10.0 110.731 -175.65 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 60.1 t -134.79 119.11 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 C-N-CA 120.789 -0.365 . . . . 10.0 110.244 173.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.75 ' CD1' HD21 ' A' ' 28' ' ' LEU . 15.7 mt -108.0 140.95 24.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 C-N-CA 119.861 -0.735 . . . . 10.0 109.132 -174.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.8 m -124.91 101.05 6.88 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 114.776 -1.102 . . . . 10.0 108.947 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 65' ' ' SER . 2.6 p -90.0 135.77 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.673 0 C-N-CA 124.016 0.927 . . . . 10.0 111.102 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -96.69 -177.05 3.78 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.746 -0.661 . . . . 10.0 112.572 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.448 ' OE2' ' HB3' ' A' ' 4' ' ' LYS . 29.3 mt-10 -55.07 -32.36 61.88 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.411 -1.268 . . . . 10.0 113.182 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.85 -11.25 59.87 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.611 -0.722 . . . . 10.0 111.334 -170.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.527 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 11.9 mmpt? 84.21 3.78 0.77 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.184 -1.043 . . . . 10.0 108.184 -164.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.541 ' O ' HG23 ' A' ' 60' ' ' VAL . 73.3 m -71.82 174.46 6.86 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.997 -1.456 . . . . 10.0 108.651 172.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.874 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -168.91 -175.45 2.36 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 119.655 1.116 . . . . 10.0 110.259 175.336 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 p -159.74 166.47 30.39 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 102.821 -3.029 . . . . 10.0 102.821 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.472 ' CB ' HG12 ' A' ' 58' ' ' ILE . 48.2 p90 -163.27 155.1 17.61 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.464 0.649 . . . . 10.0 109.492 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.405 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 9.4 pt -120.39 165.94 15.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 114.697 -1.138 . . . . 10.0 108.353 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.418 HG12 HG23 ' A' ' 56' ' ' VAL . 19.8 mt -138.46 113.13 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 107.152 -1.425 . . . . 10.0 107.152 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.585 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 11.6 mmmm -75.78 104.38 6.29 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 122.079 0.942 . . . . 10.0 112.676 -160.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.525 ' O ' ' HD2' ' A' ' 112' ' ' LYS . 65.6 p -64.5 -24.97 1.35 Allowed Pre-proline 0 CA--C 1.566 1.56 0 CA-C-N 113.52 -1.673 . . . . 10.0 114.48 171.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.599 ' HD3' ' CG ' ' A' ' 115' ' ' ASP . 74.9 Cg_exo -38.83 -53.3 1.94 Allowed 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 122.993 2.462 . . . . 10.0 115.005 -173.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.433 ' CD ' ' HB2' ' A' ' 73' ' ' PRO . 19.5 Cg_endo -59.13 99.33 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 121.502 1.468 . . . . 10.0 110.618 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.683 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . . . -72.44 -8.48 55.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.113 -0.494 . . . . 10.0 111.115 -174.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.63 -38.58 46.9 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.916 0.76 . . . . 10.0 112.094 -175.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.531 ' HB3' ' SD ' ' A' ' 52' ' ' MET . 36.2 m-85 -70.7 -54.89 10.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.548 0.69 . . . . 10.0 111.223 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.734 ' HB3' HD12 ' A' ' 108' ' ' ILE . 3.7 mm? -74.86 -30.51 61.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.598 0.713 . . . . 10.0 110.109 -173.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.624 HD11 ' HB2' ' A' ' 132' ' ' ALA . 0.8 OUTLIER -62.07 -39.08 91.2 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.933 -0.766 . . . . 10.0 108.933 175.311 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.71 ' HG2' HG13 ' A' ' 85' ' ' ILE . 84.0 mttt -62.27 -20.39 64.22 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.042 -0.526 . . . . 10.0 111.775 172.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.445 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 13.5 tptp -62.88 -44.31 96.46 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.553 -0.859 . . . . 10.0 110.848 173.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.75 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -76.87 -53.09 8.35 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.273 1.429 . . . . 10.0 112.024 171.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.36 116.66 14.18 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 111.655 -2.52 . . . . 10.0 107.752 -177.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.92 16.95 24.62 Favored Glycine 0 CA--C 1.507 -0.451 0 CA-C-N 120.557 1.526 . . . . 10.0 111.745 -160.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.71 HG13 ' HG2' ' A' ' 80' ' ' LYS . 31.6 pt -68.35 90.9 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-N 114.463 -0.869 . . . . 10.0 111.881 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -158.04 49.87 0.4 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.541 0.686 . . . . 10.0 110.533 -176.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.54 23.06 0.06 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.496 -0.775 . . . . 10.0 110.783 -178.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.86 49.29 4.12 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.781 -0.723 . . . . 10.0 113.761 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.4 m 41.53 66.18 0.73 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.996 0.739 . . . . 10.0 112.996 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.452 ' O ' ' HB3' ' A' ' 91' ' ' GLU . 23.7 p -80.5 118.39 22.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.337 -0.392 . . . . 10.0 111.561 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 90' ' ' SER . 39.1 tt0 85.23 99.83 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 124.141 0.9 . . . . 10.0 111.585 171.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.25 111.26 1.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.206 2.604 . . . . 10.0 112.388 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.429 ' HE3' ' OE2' ' A' ' 91' ' ' GLU . 31.2 mmtp -79.67 -154.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.972 0.415 . . . . 10.0 111.632 178.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -65.1 -35.51 81.36 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.702 -174.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -171.51 18.28 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.693 173.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 138' ' ' GLU . 25.6 pt -138.03 -175.37 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 120.675 -0.41 . . . . 10.0 110.931 -174.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.548 HG13 ' N ' ' A' ' 98' ' ' GLY . 11.5 p -156.09 -50.37 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 N-CA-C 112.583 0.586 . . . . 10.0 112.583 -168.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.548 ' N ' HG13 ' A' ' 97' ' ' VAL . . . -96.07 149.82 19.44 Favored Glycine 0 CA--C 1.503 -0.695 0 N-CA-C 109.818 -1.313 . . . . 10.0 109.818 171.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.891 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -143.63 141.49 30.61 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 122.668 1.223 . . . . 10.0 110.841 168.554 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.869 ' HB ' ' HG2' ' A' ' 104' ' ' GLN . 1.7 m -163.34 -145.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 111.436 -2.62 . . . . 10.0 106.858 -165.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.483 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 1.3 t -163.84 141.81 7.38 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 120.478 -0.489 . . . . 10.0 110.363 -160.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.617 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 0.0 OUTLIER -44.07 -29.82 0.66 Allowed 'General case' 0 CA--C 1.555 1.137 0 O-C-N 124.606 1.192 . . . . 10.0 112.51 -172.626 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.56 ' N ' ' HD3' ' A' ' 102' ' ' ARG . 17.6 tppt? -60.14 -45.15 93.98 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.688 0.625 . . . . 10.0 112.688 175.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.869 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 0.7 OUTLIER -56.6 -47.14 80.25 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.725 -1.213 . . . . 10.0 107.725 178.26 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.953 HG23 ' HB ' ' A' ' 128' ' ' ILE . 2.0 mp -43.69 -51.16 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.654 0 CA-C-N 114.29 -1.323 . . . . 10.0 112.174 172.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.804 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 23.0 tt0 -52.48 -55.6 20.83 Favored 'General case' 0 CA--C 1.506 -0.724 0 O-C-N 124.287 0.992 . . . . 10.0 111.718 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.718 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 66.1 mm-40 -52.58 -57.21 10.71 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 114.408 -1.269 . . . . 10.0 109.993 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.734 HD12 ' HB3' ' A' ' 78' ' ' LEU . 16.4 mm -52.0 -50.4 34.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.496 -0.774 . . . . 10.0 110.534 175.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.415 ' HB3' HD11 ' A' ' 121' ' ' LEU . . . -53.33 -39.06 63.8 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.711 -0.677 . . . . 10.0 112.736 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.804 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 64.5 mttt -72.42 -50.38 26.75 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 122.045 0.926 . . . . 10.0 109.226 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.9 m -51.32 -34.03 31.71 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 113.522 -1.672 . . . . 10.0 113.325 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.683 ' HE2' ' HA ' ' A' ' 75' ' ' ALA . 5.6 mtmp? -119.16 17.2 13.21 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.506 0.67 . . . . 10.0 109.229 -172.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.817 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 43.5 ttm -50.66 -47.0 86.01 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 114.708 -1.133 . . . . 10.0 113.048 177.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 113' ' ' MET . 20.3 Cg_endo -57.9 -24.44 64.64 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.168 1.912 . . . . 10.0 112.384 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.599 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 4.3 m-20 -94.26 -49.81 5.55 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.206 -0.906 . . . . 10.0 112.317 -177.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.542 ' CD1' ' HA ' ' A' ' 73' ' ' PRO . 10.1 mp -65.6 38.28 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 114.396 -1.274 . . . . 10.0 113.014 -177.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.437 ' H ' ' C ' ' A' ' 115' ' ' ASP . 9.4 t30 19.59 51.12 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 O-C-N 124.843 1.34 . . . . 10.0 112.025 -171.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.817 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -80.93 107.56 13.85 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.131 0.789 . . . . 10.0 113.131 -173.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -66.45 -37.6 85.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.624 0.726 . . . . 10.0 109.282 169.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.8 p -151.87 144.25 24.08 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.203 -1.406 . . . . 10.0 107.203 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.656 ' O ' ' HG2' ' A' ' 125' ' ' MET . 62.3 tp -51.93 -31.75 30.0 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 114.311 1.226 . . . . 10.0 114.311 -175.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -49.87 -39.76 40.43 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.681 0.753 . . . . 10.0 110.074 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.619 ' O ' ' HG3' ' A' ' 126' ' ' LYS . . . -66.93 -49.46 65.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.771 -1.104 . . . . 10.0 111.186 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.591 ' HB3' HD12 ' A' ' 121' ' ' LEU . . . -56.19 -34.96 66.71 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.92 -0.712 . . . . 10.0 110.719 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.732 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 50.6 mmm -56.64 -45.25 81.7 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.058 0.762 . . . . 10.0 113.058 178.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.738 ' HD3' ' N ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -65.14 -36.36 84.01 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.776 -0.453 . . . . 10.0 109.776 -177.853 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.738 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 73.4 mt -54.37 -65.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-O 121.571 0.7 . . . . 10.0 110.707 174.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.953 ' HB ' HG23 ' A' ' 105' ' ' ILE . 20.5 mm -51.05 -54.26 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 CA-C-N 113.853 -1.521 . . . . 10.0 112.365 -177.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.549 ' HG2' ' HA ' ' A' ' 126' ' ' LYS . 6.6 pt-20 -56.45 -44.58 80.63 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.382 -0.599 . . . . 10.0 109.382 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.531 ' HA2' ' HD2' ' A' ' 133' ' ' LYS . . . -69.33 -46.9 54.92 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.869 -0.605 . . . . 10.0 111.81 -175.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.584 HG21 ' HB3' ' A' ' 75' ' ' ALA . 64.8 m -44.99 -61.29 1.68 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.648 -0.871 . . . . 10.0 108.648 168.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.624 ' HB2' HD11 ' A' ' 79' ' ' LEU . . . -49.06 -46.23 44.13 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.895 -0.593 . . . . 10.0 112.353 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.531 ' HD2' ' HA2' ' A' ' 130' ' ' GLY . 65.2 mttm -49.88 -53.64 24.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.815 176.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 9.4 m -67.23 -31.79 72.38 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.482 0.658 . . . . 10.0 110.476 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.549 ' SD ' HG22 ' A' ' 131' ' ' THR . 26.0 mtp -77.67 -1.15 29.59 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 114.071 1.137 . . . . 10.0 114.071 -177.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.66 28.8 56.55 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 119.403 1.001 . . . . 10.0 111.949 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.531 ' CG2' ' HB1' ' A' ' 132' ' ' ALA . 1.7 mp -107.11 124.75 63.1 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.076 0 CA-C-O 121.612 0.72 . . . . 10.0 109.993 176.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.891 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 1.3 pt-20 -87.42 149.89 24.15 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.268 -1.382 . . . . 10.0 107.268 176.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 23.7 m -118.88 136.92 54.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.03 -1.1 . . . . 10.0 108.03 174.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.648 HG22 ' O ' ' A' ' 100' ' ' VAL . 8.2 m -135.65 71.48 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 113.801 1.037 . . . . 10.0 113.801 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.833 -1.08 . . . . 10.0 112.564 141.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 109.491 -0.559 . . . . 10.0 109.491 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.69 -42.83 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 112.483 0.549 . . . . 10.0 112.483 -175.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -100.2 164.35 12.0 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.586 0.588 . . . . 10.0 112.586 -167.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -100.44 115.32 29.78 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.173 -0.922 . . . . 10.0 110.742 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 50.1 t -66.84 138.15 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 122.812 0.445 . . . . 10.0 111.356 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -108.92 -40.91 4.88 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.727 -0.471 . . . . 10.0 109.727 173.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.467 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -156.73 151.03 25.26 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 113.656 0.984 . . . . 10.0 113.656 -176.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -95.27 134.63 37.83 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.842 -1.072 . . . . 10.0 108.26 171.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.675 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.5 OUTLIER -119.95 81.77 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 108.662 -0.866 . . . . 10.0 108.662 171.762 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -79.05 126.63 30.95 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 120.69 1.587 . . . . 10.0 108.098 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.545 HD21 HD11 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.42 128.56 6.72 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 122.331 1.062 . . . . 10.0 111.603 -176.09 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -83.06 119.07 24.01 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 113.816 -1.538 . . . . 10.0 110.086 -171.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.545 HD11 HD21 ' A' ' 11' ' ' LEU . 58.2 mt -137.73 137.84 22.67 Favored Pre-proline 0 CA--C 1.507 -0.688 0 CA-C-O 121.697 0.76 . . . . 10.0 112.427 -170.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.818 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 33.8 Cg_exo -56.05 123.8 14.72 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.752 2.968 . . . . 10.0 112.131 173.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.612 ' HB2' HD11 ' A' ' 54' ' ' LEU . . . -61.82 127.01 29.37 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 107.538 -1.282 . . . . 10.0 107.538 170.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.18 -5.78 81.84 Favored Glycine 0 N--CA 1.441 -1.014 0 O-C-N 125.765 1.916 . . . . 10.0 113.242 -175.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.818 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 2.2 mmmp? -138.47 104.65 5.21 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.562 1.181 . . . . 10.0 112.247 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -167.76 133.29 1.95 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.049 -1.432 . . . . 10.0 111.712 173.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.697 ' HA ' ' HB2' ' A' ' 39' ' ' CYS . 1.8 t -179.01 -40.66 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.102 -0.954 . . . . 10.0 113.075 177.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.692 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 85.0 Cg_endo -105.75 124.43 0.05 OUTLIER 'Trans proline' 0 N--CA 1.415 -3.146 0 N-CA-C 115.821 1.431 . . . . 10.0 115.821 -161.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.11 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 9.75 -84.56 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.545 0 CA-C-N 109.745 -3.389 . . . . 10.0 115.084 165.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.944 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 39.4 Cg_exo -28.74 -57.27 0.13 Allowed 'Trans proline' 0 CA--C 1.562 1.88 0 C-N-CA 122.912 2.408 . . . . 10.0 115.898 -164.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.944 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 6.0 Cg_exo -81.38 -55.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 123.102 2.534 . . . . 10.0 111.919 171.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.08 HG12 HD12 ' A' ' 35' ' ' ILE . 49.6 t -81.01 -52.49 14.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 112.209 -2.269 . . . . 10.0 113.659 -166.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 1.11 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -48.0 -74.07 0.28 Allowed Glycine 0 C--O 1.214 -1.122 0 CA-C-N 114.702 -1.135 . . . . 10.0 113.681 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.677 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 34.7 Cg_exo -46.9 -42.86 24.91 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.514 2.809 . . . . 10.0 112.833 175.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.04 -79.95 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.248 0.547 . . . . 10.0 111.011 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.817 ' HB2' HD11 ' A' ' 35' ' ' ILE . 2.2 mt -67.65 -47.1 70.53 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 114.178 1.177 . . . . 10.0 114.178 -177.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.78 -37.24 92.16 Favored Glycine 0 C--N 1.32 -0.351 0 CA-C-N 115.606 -0.724 . . . . 10.0 113.432 -173.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.54 -26.73 67.11 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.848 -0.427 . . . . 10.0 109.848 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -99.86 16.66 23.03 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 120.055 -0.658 . . . . 10.0 110.09 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.9 9.21 85.7 Favored Glycine 0 CA--C 1.503 -0.658 0 CA-C-N 114.809 -1.087 . . . . 10.0 113.532 168.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.749 HG11 ' CD2' ' A' ' 66' ' ' PHE . 11.4 t -81.77 147.14 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 114.078 1.14 . . . . 10.0 114.078 -172.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -69.03 96.93 0.82 Allowed 'General case' 0 C--N 1.347 0.457 0 C-N-CA 123.38 0.672 . . . . 10.0 110.765 171.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.08 HD12 HG12 ' A' ' 24' ' ' VAL . 20.0 mm -55.52 -38.41 49.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 121.983 0.897 . . . . 10.0 112.163 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -46.94 74.31 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.611 -1.631 . . . . 10.0 112.076 175.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.631 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 17.7 mt-10 -58.83 -43.74 90.73 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 118.66 -1.216 . . . . 10.0 110.479 174.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.576 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 79.3 t80 -54.71 -56.82 15.15 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 113.599 0.963 . . . . 10.0 113.599 173.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.697 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -55.92 -52.36 64.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.001 -1.454 . . . . 10.0 111.666 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -65.79 -21.61 66.51 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 119.097 -1.041 . . . . 10.0 109.02 -176.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.768 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 85.9 mtt180 -78.13 -63.53 1.37 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 115.311 -0.859 . . . . 10.0 112.144 171.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.638 ' CZ ' HG21 ' A' ' 46' ' ' THR . 75.3 t80 -55.15 -44.38 75.06 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 121.251 0.548 . . . . 10.0 110.367 -172.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -60.48 -49.25 78.32 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.056 -0.974 . . . . 10.0 109.911 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.17 96.76 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.035 -1.066 . . . . 10.0 112.349 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.768 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 4.6 mm-40 -65.43 -43.37 90.71 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.951 0.882 . . . . 10.0 110.756 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.639 ' CG2' HD12 ' A' ' 54' ' ' LEU . 71.6 p -92.52 4.66 53.12 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 114.223 -1.353 . . . . 10.0 112.136 -171.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -47.22 -36.89 9.44 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.809 -1.087 . . . . 10.0 112.548 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -81.33 -40.69 23.2 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.678 -0.692 . . . . 10.0 111.823 -176.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.0 mttp -92.01 18.54 7.81 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 108.822 -0.807 . . . . 10.0 108.822 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.429 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -52.42 147.64 7.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.803 -1.089 . . . . 10.0 113.393 -177.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.49 18.96 31.32 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 114.813 -1.085 . . . . 10.0 110.513 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.557 ' HB2' HD21 ' A' ' 54' ' ' LEU . 61.6 mtt -138.34 127.65 24.49 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 116.693 -2.003 . . . . 10.0 114.866 -167.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.4 mm -65.23 91.71 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 O-C-N 121.787 -0.57 . . . . 10.0 109.58 170.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.639 HD12 ' CG2' ' A' ' 46' ' ' THR . 8.3 mt -84.63 130.65 52.42 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.928 -0.768 . . . . 10.0 108.928 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.506 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 14.3 Cg_exo -71.79 105.91 1.89 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.557 1.505 . . . . 10.0 110.635 173.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -97.22 142.81 13.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 119.9 1.227 . . . . 10.0 110.597 -174.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 89.4 t -119.71 111.83 34.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 120.332 -0.547 . . . . 10.0 110.431 171.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.783 ' CD1' HD21 ' A' ' 28' ' ' LEU . 15.5 mt -105.8 139.22 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.932 0 N-CA-C 107.972 -1.122 . . . . 10.0 107.972 -174.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.8 m -123.24 97.31 5.36 Favored 'General case' 0 N--CA 1.402 -2.836 0 CA-C-N 114.793 -1.094 . . . . 10.0 108.787 178.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.518 HG21 HG22 ' A' ' 33' ' ' VAL . 4.4 p -86.66 137.37 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.956 0 CA-C-N 119.402 1.001 . . . . 10.0 110.089 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.448 ' HE2' ' HG1' ' A' ' 67' ' ' THR . 77.9 m-85 -95.8 172.11 8.23 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.777 0.799 . . . . 10.0 112.857 -177.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -60.38 -22.96 63.93 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.249 -1.341 . . . . 10.0 111.841 -177.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.485 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 10.7 m-20 -77.68 -10.47 59.54 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.353 -0.839 . . . . 10.0 111.527 -176.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 55.1 mtpt 83.85 2.5 0.91 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 124.35 1.031 . . . . 10.0 109.459 -166.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.51 ' O ' HG23 ' A' ' 60' ' ' VAL . 14.6 t -73.74 172.13 12.03 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 113.924 -1.489 . . . . 10.0 107.369 174.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.749 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -169.75 -178.82 3.1 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 120.45 1.477 . . . . 10.0 109.692 175.582 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.448 ' HG1' ' HE2' ' A' ' 61' ' ' TYR . 5.3 p -161.83 169.41 21.37 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 103.542 -2.762 . . . . 10.0 103.542 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.449 ' CB ' HG12 ' A' ' 58' ' ' ILE . 49.8 p90 -162.5 159.3 24.75 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.545 -0.539 . . . . 10.0 109.545 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.9 mt -119.62 166.66 13.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 107.256 -1.387 . . . . 10.0 107.256 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.483 HD12 ' CE1' ' A' ' 42' ' ' PHE . 6.4 mm -126.42 122.18 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 107.004 -1.48 . . . . 10.0 107.004 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.586 ' C ' ' HD2' ' A' ' 73' ' ' PRO . 10.5 mmtp -76.64 96.82 4.25 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 122.188 0.994 . . . . 10.0 112.288 -169.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.733 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 3.4 t -59.46 -35.08 26.67 Favored Pre-proline 0 CA--C 1.56 1.362 0 CA-C-N 113.189 -1.823 . . . . 10.0 112.891 166.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.733 ' HD2' ' N ' ' A' ' 72' ' ' THR . 1.2 Cg_endo -39.69 -47.1 3.61 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 124.33 3.354 . . . . 10.0 116.114 -173.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.566 ' HD3' ' HG2' ' A' ' 73' ' ' PRO . 27.9 Cg_exo -61.62 88.57 0.1 OUTLIER 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 121.267 1.311 . . . . 10.0 111.061 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.656 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -62.54 -17.54 60.07 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.404 -0.816 . . . . 10.0 110.923 -177.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.759 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 17.1 m -54.06 -37.93 64.71 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.868 -0.605 . . . . 10.0 111.331 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -75.08 -50.27 16.98 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.22 0.533 . . . . 10.0 111.27 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.784 ' HB3' HD12 ' A' ' 108' ' ' ILE . 3.5 mm? -70.93 -27.53 63.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.186 0.517 . . . . 10.0 110.377 -176.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.429 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 62.1 mt -75.16 -21.66 58.63 Favored 'General case' 0 C--O 1.209 -1.039 0 CA-C-N 115.954 -0.566 . . . . 10.0 110.619 175.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.759 ' HG2' ' O ' ' A' ' 76' ' ' SER . 75.2 mmtt -61.84 -36.82 82.32 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.349 0.595 . . . . 10.0 109.676 171.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -60.8 -51.13 70.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.581 -0.736 . . . . 10.0 112.43 176.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 1.069 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -75.08 -64.99 0.93 Allowed 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 123.149 1.452 . . . . 10.0 110.715 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 79' ' ' LEU . . . -75.58 116.64 16.5 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 111.514 -2.584 . . . . 10.0 108.427 176.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -96.53 32.58 6.38 Favored Glycine 0 C--N 1.318 -0.463 0 C-N-CA 118.264 -1.922 . . . . 10.0 111.049 -163.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.495 HG22 HG22 ' A' ' 97' ' ' VAL . 49.6 pt -70.61 66.5 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 113.412 0.893 . . . . 10.0 113.412 -173.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 87' ' ' LYS . 16.2 mt-10 -72.11 75.55 0.95 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.2 0.524 . . . . 10.0 110.641 174.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 75.4 mttt -167.39 -44.72 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.843 -1.071 . . . . 10.0 108.637 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 116.22 -47.66 1.02 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.493 -0.776 . . . . 10.0 111.953 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.9 t 78.89 112.93 0.07 Allowed 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.467 0.707 . . . . 10.0 110.838 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 44.9 m -159.65 38.01 0.19 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.789 -0.819 . . . . 10.0 108.789 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.619 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 7.2 tp10 -171.62 -58.91 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 114.914 -1.039 . . . . 10.0 110.643 -173.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.619 ' HD3' ' HB3' ' A' ' 91' ' ' GLU . 88.7 Cg_endo -79.4 33.53 0.5 Allowed 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.161 1.907 . . . . 10.0 113.18 -175.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -76.8 68.8 3.07 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.397 -0.594 . . . . 10.0 109.397 177.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -162.52 -60.7 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.605 -0.725 . . . . 10.0 109.223 -175.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -77.13 -14.21 59.83 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.491 -0.929 . . . . 10.0 108.491 176.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.818 HG21 ' HB3' ' A' ' 138' ' ' GLU . 50.1 mm 73.25 111.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 114.007 -1.451 . . . . 10.0 111.358 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.495 HG22 HG22 ' A' ' 85' ' ' ILE . 4.2 p -58.12 -49.89 80.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 113.761 -1.563 . . . . 10.0 112.167 -173.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.465 ' N ' HG13 ' A' ' 97' ' ' VAL . . . -168.95 173.59 43.48 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 108.852 -1.699 . . . . 10.0 108.852 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.636 ' O ' HG13 ' A' ' 100' ' ' VAL . 16.9 mtmt -149.15 177.85 9.26 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-N 117.37 0.585 . . . . 10.0 109.981 -159.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 1.069 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -166.5 111.55 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.496 -1.108 0 CA-C-O 122.643 1.211 . . . . 10.0 111.816 167.241 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 1.1 t -41.58 147.27 0.19 Allowed 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 112.071 -2.331 . . . . 10.0 113.954 173.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.569 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 11.5 mmm180 -39.21 -37.78 0.44 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 111.725 -2.489 . . . . 10.0 112.911 -170.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -57.46 -48.39 79.29 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.651 0.611 . . . . 10.0 112.651 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.658 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -59.28 -46.01 89.7 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.115 -0.698 . . . . 10.0 109.115 -178.81 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.692 HG23 ' HB ' ' A' ' 128' ' ' ILE . 30.6 mm -40.49 -56.89 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 114.883 -1.053 . . . . 10.0 112.448 168.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.821 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 26.6 tt0 -44.51 -60.15 2.1 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.165 0.802 . . . . 10.0 113.165 -178.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.499 ' HA ' ' HD3' ' A' ' 110' ' ' LYS . 25.9 mt-10 -56.11 -49.66 73.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.619 -0.719 . . . . 10.0 110.653 -175.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.784 HD12 ' HB3' ' A' ' 78' ' ' LEU . 21.2 mm -50.62 -55.71 5.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.366 -0.834 . . . . 10.0 110.206 172.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.525 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -49.9 -47.19 52.26 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.298 0.851 . . . . 10.0 113.298 177.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.821 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 12.5 mtpp -67.16 -49.33 65.14 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.664 0.745 . . . . 10.0 109.923 -173.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.3 m -58.31 -29.92 66.26 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 114.557 -1.201 . . . . 10.0 112.003 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.739 ' HB3' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -93.24 -16.27 24.97 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.589 0.755 . . . . 10.0 110.759 -176.766 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.965 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 5.1 ttp -48.75 -44.46 68.71 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 113.448 0.907 . . . . 10.0 113.448 -175.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 113' ' ' MET . 12.6 Cg_endo -56.06 -30.28 77.97 Favored 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 121.836 1.691 . . . . 10.0 111.615 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.435 ' CB ' ' HD3' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -93.34 -45.86 7.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.525 -1.216 . . . . 10.0 111.875 -176.417 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.739 HD22 ' HB3' ' A' ' 112' ' ' LYS . 3.6 mp -63.49 -2.95 1.78 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.127 -1.397 . . . . 10.0 112.218 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 61.0 t30 61.69 45.43 7.96 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.297 -1.32 . . . . 10.0 109.548 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.965 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -86.35 121.0 28.31 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.691 -1.595 . . . . 10.0 112.289 -176.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -67.6 -33.22 74.56 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.225 -0.657 . . . . 10.0 109.225 171.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.0 t -154.96 143.87 20.85 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.965 -1.494 . . . . 10.0 106.965 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' A' ' 124' ' ' ALA . 29.7 tp -53.45 -31.11 44.06 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.19 1.552 . . . . 10.0 115.19 -172.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -48.89 -40.16 28.72 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.722 0.692 . . . . 10.0 110.083 175.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.4 -47.82 66.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.622 -1.172 . . . . 10.0 111.04 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.571 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -57.93 -36.61 72.75 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.624 -0.43 . . . . 10.0 110.429 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.554 ' HG3' ' HG ' ' A' ' 121' ' ' LEU . 64.7 mtp -61.82 -34.75 76.5 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.361 0.6 . . . . 10.0 110.169 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -64.12 -51.23 64.92 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.682 -1.144 . . . . 10.0 109.465 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.531 HG21 ' HG ' ' A' ' 116' ' ' LEU . 76.1 mt -50.98 -62.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 CA-C-N 115.266 -0.879 . . . . 10.0 110.727 177.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.692 ' HB ' HG23 ' A' ' 105' ' ' ILE . 26.5 mm -50.36 -54.51 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.078 0 CA-C-N 114.779 -1.1 . . . . 10.0 111.153 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' A' ' 133' ' ' LYS . 42.5 tt0 -53.56 -44.83 69.6 Favored 'General case' 0 N--CA 1.435 -1.214 0 O-C-N 124.119 0.887 . . . . 10.0 109.227 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -72.45 -45.93 35.22 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.618 -0.801 . . . . 10.0 111.698 -175.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.656 HG21 ' HB3' ' A' ' 75' ' ' ALA . 85.8 m -46.48 -60.1 2.56 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.359 -0.92 . . . . 10.0 109.575 171.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -48.24 -48.14 35.49 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.396 -0.82 . . . . 10.0 111.926 175.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 130' ' ' GLY . 47.9 mtpt -47.62 -54.25 12.43 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.755 0.659 . . . . 10.0 111.52 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 44.9 m -64.58 -30.82 71.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.879 0.371 . . . . 10.0 111.019 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.416 ' HE1' ' HA ' ' A' ' 76' ' ' SER . 43.5 mtm -79.65 7.94 7.47 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.502 0.927 . . . . 10.0 113.502 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.7 3.74 80.3 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 119.436 1.016 . . . . 10.0 111.564 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.523 HG23 ' HA ' ' A' ' 99' ' ' LYS . 39.9 mt -99.29 134.93 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-O 121.712 0.767 . . . . 10.0 112.58 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.818 ' HB3' HG21 ' A' ' 96' ' ' ILE . 0.0 OUTLIER -96.89 160.03 14.59 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.704 -1.135 . . . . 10.0 109.571 177.279 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.3 m -107.66 131.63 57.39 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.647 0 N-CA-C 106.68 -1.6 . . . . 10.0 106.68 170.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 101' ' ' THR . 3.4 m -117.22 -178.9 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-N 114.809 -1.087 . . . . 10.0 109.661 -174.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 38.9 t70 . . . . . 0 C--N 1.281 -2.407 0 CA-C-N 112.635 -2.075 . . . . 10.0 109.026 163.961 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.481 1.102 0 CA-C-O 120.829 0.347 . . . . 10.0 110.207 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.39 103.73 4.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.314 -0.403 . . . . 10.0 110.244 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.425 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 44.8 mtmt -82.28 152.44 26.33 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.353 0.597 . . . . 10.0 110.402 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.607 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -144.23 112.57 6.46 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.1 -0.955 . . . . 10.0 109.225 -175.549 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.02 139.96 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 122.671 0.388 . . . . 10.0 111.874 -173.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.526 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . . . -112.07 -36.58 5.32 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.134 -0.485 . . . . 10.0 109.708 172.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.478 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -155.4 143.03 19.69 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.25 0.833 . . . . 10.0 113.25 -177.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -93.16 130.1 38.94 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.648 -1.241 . . . . 10.0 107.648 170.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.683 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -119.95 81.66 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.051 -0.722 . . . . 10.0 109.051 176.852 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.462 ' HG2' HG13 ' A' ' 57' ' ' VAL . 9.6 mtmp? -79.13 127.39 31.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 120.137 1.335 . . . . 10.0 108.413 175.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.632 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.3 127.62 6.4 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.295 1.045 . . . . 10.0 111.731 -175.025 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -83.13 121.62 27.29 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.172 -1.377 . . . . 10.0 110.117 -172.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.632 HD21 HD11 ' A' ' 11' ' ' LEU . 69.3 mt -139.16 139.88 24.57 Favored Pre-proline 0 CA--C 1.506 -0.728 0 CA-C-O 121.737 0.78 . . . . 10.0 111.963 -170.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.853 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 11.9 Cg_exo -59.61 124.65 15.9 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 123.426 2.751 . . . . 10.0 111.506 173.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.625 ' CB ' ' HB ' ' A' ' 46' ' ' THR . . . -61.87 126.98 29.24 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 107.956 -1.127 . . . . 10.0 107.956 170.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.85 -2.23 88.34 Favored Glycine 0 N--CA 1.44 -1.093 0 O-C-N 125.66 1.85 . . . . 10.0 112.933 -175.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.853 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 74.9 mmtt -140.27 107.74 5.57 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 118.007 0.904 . . . . 10.0 112.422 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.528 ' H ' HD22 ' A' ' 43' ' ' ASN . . . -169.77 134.41 1.35 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.92 -1.491 . . . . 10.0 112.052 171.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.546 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 1.6 t 178.92 -39.61 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.542 0 O-C-N 124.157 0.911 . . . . 10.0 113.169 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.725 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 71.8 Cg_endo -103.71 122.44 0.07 OUTLIER 'Trans proline' 0 N--CA 1.417 -2.983 0 N-CA-C 115.935 1.475 . . . . 10.0 115.935 -161.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.966 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 9.12 -82.91 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.451 0 CA-C-N 110.283 -3.144 . . . . 10.0 115.06 162.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.714 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 70.1 Cg_exo -33.16 -56.97 0.34 Allowed 'Trans proline' 0 CA--C 1.564 2.019 0 C-N-CA 122.182 1.921 . . . . 10.0 115.676 -164.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.725 ' HD2' ' O ' ' A' ' 20' ' ' PRO . 58.2 Cg_endo -78.62 -59.24 0.04 OUTLIER 'Trans proline' 0 CA--C 1.553 1.457 0 C-N-CA 122.734 2.29 . . . . 10.0 113.158 170.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.9 t -80.89 -36.81 15.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 112.441 -2.163 . . . . 10.0 113.388 -165.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.966 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -53.92 -69.03 1.35 Allowed Glycine 0 C--N 1.305 -1.142 0 CA-C-N 113.514 -1.676 . . . . 10.0 112.471 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 70.2 Cg_exo -50.87 -43.41 47.21 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.845 2.363 . . . . 10.0 112.117 172.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.81 -96.54 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 112.372 0.508 . . . . 10.0 112.372 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.787 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.307 0.0 OUTLIER -75.11 -26.36 59.19 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 118.152 -1.419 . . . . 10.0 113.573 -176.233 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.577 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -68.53 -40.99 85.99 Favored Glycine 0 N--CA 1.465 0.589 0 C-N-CA 120.926 -0.654 . . . . 10.0 112.68 -175.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -60.96 -21.41 63.45 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.112 -0.635 . . . . 10.0 110.099 175.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -99.09 19.81 14.53 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.629 -0.828 . . . . 10.0 110.215 178.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.559 ' HA3' ' HD2' ' A' ' 64' ' ' LYS . . . 86.59 4.61 82.82 Favored Glycine 0 CA--C 1.501 -0.785 0 CA-C-N 115.201 -0.909 . . . . 10.0 113.363 167.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.787 ' HB ' HD23 ' A' ' 28' ' ' LEU . 4.6 t -83.01 146.2 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 113.414 0.894 . . . . 10.0 113.414 -172.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 0.6 OUTLIER -69.07 99.96 1.18 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.818 0.447 . . . . 10.0 110.321 171.731 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.667 HD11 ' HA2' ' A' ' 25' ' ' GLY . 83.2 mt -53.0 -40.14 35.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.807 0.813 . . . . 10.0 111.594 175.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 72.2 mtm -68.04 -46.66 70.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.67 -1.605 . . . . 10.0 111.783 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.541 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 10.4 tp10 -56.13 -45.25 79.64 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.298 -0.561 . . . . 10.0 109.758 174.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.576 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 48.0 t80 -57.04 -55.34 35.92 Favored 'General case' 0 C--O 1.212 -0.877 0 N-CA-C 113.97 1.1 . . . . 10.0 113.97 171.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -50.35 71.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.663 -1.153 . . . . 10.0 111.886 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.72 -22.76 66.63 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 119.368 -0.933 . . . . 10.0 108.753 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.745 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 87.2 mtt180 -76.95 -64.18 1.19 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.264 -0.88 . . . . 10.0 112.168 171.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.62 ' CZ ' HG21 ' A' ' 46' ' ' THR . 80.2 t80 -55.27 -47.38 75.58 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.419 0.628 . . . . 10.0 110.094 -171.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.528 HD22 ' H ' ' A' ' 18' ' ' ALA . 4.3 m-20 -61.02 -48.24 82.72 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.489 -1.232 . . . . 10.0 110.317 -177.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.48 91.25 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.076 -1.05 . . . . 10.0 112.119 177.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.745 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 7.7 mm-40 -65.62 -40.35 92.48 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.823 0.821 . . . . 10.0 110.751 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.625 ' HB ' ' CB ' ' A' ' 15' ' ' ALA . 73.0 p -93.11 2.87 56.52 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 114.436 -1.256 . . . . 10.0 112.835 -170.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.11 -35.4 11.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.993 -1.003 . . . . 10.0 112.281 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -81.43 -43.1 19.4 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 115.314 -0.857 . . . . 10.0 111.561 -176.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -92.17 20.65 5.75 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.799 -0.815 . . . . 10.0 108.799 -176.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.416 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -53.3 149.21 7.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.952 -1.022 . . . . 10.0 113.09 -178.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.41 18.95 36.91 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.937 -1.029 . . . . 10.0 110.671 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.736 ' SD ' ' HB2' ' A' ' 77' ' ' PHE . 59.8 mtt -140.38 125.55 18.64 Favored 'General case' 0 C--O 1.212 -0.902 0 C-N-CA 117.419 -1.712 . . . . 10.0 113.941 -165.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 50.1 mm -66.82 90.73 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 118.657 0.662 . . . . 10.0 109.665 172.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.598 HD12 ' CG2' ' A' ' 46' ' ' THR . 10.0 mt -81.7 140.12 47.39 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.426 -0.583 . . . . 10.0 109.426 -177.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.744 ' HG2' ' HG2' ' A' ' 74' ' ' PRO . 3.6 Cg_exo -79.35 103.85 1.67 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.228 1.952 . . . . 10.0 110.896 172.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.408 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -97.99 155.64 3.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 119.885 1.22 . . . . 10.0 111.178 -175.748 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.462 HG13 ' HG2' ' A' ' 10' ' ' LYS . 96.7 t -134.79 112.51 15.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.015 174.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.683 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 24.4 mt -102.63 142.27 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.716 0 N-CA-C 108.133 -1.062 . . . . 10.0 108.133 -174.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.7 m -124.77 96.63 4.95 Favored 'General case' 0 N--CA 1.406 -2.648 0 CA-C-N 115.011 -0.995 . . . . 10.0 108.861 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.602 HG21 HG22 ' A' ' 33' ' ' VAL . 2.0 p -90.5 135.85 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 CA-C-N 119.479 1.036 . . . . 10.0 110.268 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.425 ' CD1' ' HB3' ' A' ' 3' ' ' LYS . 82.8 m-85 -91.86 170.6 9.75 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.99 -1.004 . . . . 10.0 112.635 -176.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.607 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 14.2 mt-10 -60.4 -20.78 60.9 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.684 -1.598 . . . . 10.0 112.03 -176.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 2.9 m-20 -85.53 -4.72 59.24 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.329 -0.85 . . . . 10.0 112.09 -176.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.559 ' HD2' ' HA3' ' A' ' 32' ' ' GLY . 40.2 mmtt 81.99 0.65 1.45 Allowed 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 122.188 0.994 . . . . 10.0 110.334 -169.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.52 ' O ' HG23 ' A' ' 60' ' ' VAL . 17.4 m -70.83 168.43 16.8 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.736 -1.574 . . . . 10.0 107.289 173.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.675 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -168.94 -177.12 2.87 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 120.687 1.585 . . . . 10.0 109.818 176.115 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.2 p -162.6 169.35 20.34 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 103.077 -2.935 . . . . 10.0 103.077 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.445 ' CB ' HG12 ' A' ' 58' ' ' ILE . 42.4 p90 -163.39 159.91 22.92 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.756 -0.831 . . . . 10.0 108.756 177.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 23.7 pt -129.19 161.57 38.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.468 -1.308 . . . . 10.0 107.468 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.417 HD13 ' CG2' ' A' ' 46' ' ' THR . 7.6 mt -126.95 120.15 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 106.568 -1.641 . . . . 10.0 106.568 -176.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.789 ' HE2' ' HA ' ' A' ' 71' ' ' LYS . 5.7 mmmm -76.4 98.2 4.49 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 122.325 1.06 . . . . 10.0 113.042 -160.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.623 ' O ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -44.6 -44.45 20.68 Favored Pre-proline 0 CA--C 1.56 1.337 0 CA-C-N 112.682 -2.054 . . . . 10.0 114.997 164.607 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.653 ' HD3' ' CG ' ' A' ' 115' ' ' ASP . 2.4 Cg_endo -39.43 -56.01 1.41 Allowed 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 124.268 3.312 . . . . 10.0 116.205 -171.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.744 ' HG2' ' HG2' ' A' ' 55' ' ' PRO . 88.9 Cg_exo -43.5 -34.74 5.35 Favored 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 123.207 2.604 . . . . 10.0 113.729 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.684 ' HB1' HD23 ' A' ' 79' ' ' LEU . . . 73.98 -31.77 0.22 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.679 0.992 . . . . 10.0 113.679 170.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.695 ' O ' ' HD3' ' A' ' 80' ' ' LYS . 47.9 t -42.24 -56.96 2.72 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 123.753 0.658 . . . . 10.0 111.958 -175.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.736 ' HB2' ' SD ' ' A' ' 52' ' ' MET . 32.7 p90 -55.9 -37.02 68.33 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.574 0.583 . . . . 10.0 112.574 -175.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 78' ' ' LEU . 1.3 tp -88.55 -32.2 18.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.871 0.367 . . . . 10.0 110.595 -174.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.684 HD23 ' HB1' ' A' ' 75' ' ' ALA . 4.3 mm? -63.8 -33.15 75.03 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.47 -0.567 . . . . 10.0 109.47 172.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.695 ' HD3' ' O ' ' A' ' 76' ' ' SER . 3.9 mptp? -56.04 -46.47 78.87 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.816 -0.629 . . . . 10.0 110.12 172.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.411 ' HD3' ' HA ' ' A' ' 81' ' ' LYS . 2.8 mmtm -57.23 -43.42 82.86 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.509 0.929 . . . . 10.0 113.509 -176.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.68 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -65.94 -49.0 69.47 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 123.044 1.402 . . . . 10.0 110.086 175.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.526 ' HB1' ' HA3' ' A' ' 98' ' ' GLY . . . -63.61 -30.02 71.19 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 111.306 -2.679 . . . . 10.0 110.358 -171.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 96.47 -14.58 64.1 Favored Glycine 0 CA--C 1.491 -1.466 0 C-N-CA 120.448 -0.882 . . . . 10.0 111.424 172.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.558 HG13 ' HG3' ' A' ' 80' ' ' LYS . 6.0 pt -60.73 -162.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 114.4 -0.9 . . . . 10.0 111.693 170.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.448 ' H ' ' HB ' ' A' ' 85' ' ' ILE . 1.9 tm-20 87.62 80.3 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.31 -1.313 . . . . 10.0 109.5 -174.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -179.49 -41.32 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.062 -1.427 . . . . 10.0 107.702 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 171.93 155.96 11.61 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 114.294 -1.321 . . . . 10.0 110.727 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.9 m -161.88 -86.11 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.333 -0.617 . . . . 10.0 109.333 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.1 m 50.06 35.26 9.57 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.287 0.847 . . . . 10.0 113.287 171.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.521 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 1.5 tm-20 -171.72 -56.66 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 119.257 -0.402 . . . . 10.0 111.727 -178.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.521 ' HD3' ' HB3' ' A' ' 91' ' ' GLU . 21.6 Cg_exo -66.93 20.37 0.1 Allowed 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 122.953 2.435 . . . . 10.0 114.817 -171.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -79.68 67.86 5.57 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.842 -0.799 . . . . 10.0 108.842 173.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -160.31 -80.43 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.526 -170.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.554 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 46.5 tttp -86.39 35.24 0.65 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.211 -0.663 . . . . 10.0 109.211 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 95' ' ' LYS . 5.1 mt 75.4 170.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 114.865 -1.061 . . . . 10.0 110.569 -175.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.653 HG13 ' H ' ' A' ' 98' ' ' GLY . 7.3 p -149.84 -53.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 112.358 0.503 . . . . 10.0 112.358 -172.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.765 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -111.17 154.72 16.52 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 109.16 -1.576 . . . . 10.0 109.16 169.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.805 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 21.1 pttp -153.8 153.43 32.14 Favored 'General case' 0 CA--C 1.474 -1.958 0 CA-C-O 122.358 1.075 . . . . 10.0 109.865 164.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.68 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.7 OUTLIER -164.62 -162.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.414 -2.251 0 CA-C-N 111.976 -2.374 . . . . 10.0 105.958 -167.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.598 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 9.6 p -119.49 159.37 24.42 Favored 'General case' 0 C--N 1.275 -2.639 0 C-N-CA 119.494 -0.882 . . . . 10.0 111.838 -170.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.674 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 29.0 mmt180 -44.0 -41.92 5.69 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.193 -1.367 . . . . 10.0 110.334 170.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.489 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 3.1 tppp? -59.03 -44.8 91.8 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.672 0.619 . . . . 10.0 112.672 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.631 ' O ' HG12 ' A' ' 108' ' ' ILE . 58.9 mm-40 -58.33 -52.85 63.87 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.763 -0.829 . . . . 10.0 108.763 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.712 HD12 HG22 ' A' ' 128' ' ' ILE . 31.4 mm -38.04 -51.68 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.704 0 CA-C-N 114.318 -1.31 . . . . 10.0 111.899 167.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.748 ' HA ' ' SD ' ' A' ' 125' ' ' MET . 34.2 tt0 -52.95 -58.7 6.07 Favored 'General case' 0 C--O 1.215 -0.746 0 C-N-CA 124.627 1.171 . . . . 10.0 113.55 -177.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -58.36 -47.08 84.95 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 119.913 -0.715 . . . . 10.0 110.554 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.631 HG12 ' O ' ' A' ' 104' ' ' GLN . 19.8 mm -48.46 -60.75 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.558 166.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.577 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -51.33 -38.01 50.81 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.138 0.422 . . . . 10.0 112.138 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.683 ' O ' ' HG2' ' A' ' 113' ' ' MET . 83.4 mttt -70.36 -54.44 12.49 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.854 -174.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.74 HG23 ' HG3' ' A' ' 112' ' ' LYS . 5.8 t -57.05 -24.65 55.36 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.804 -0.635 . . . . 10.0 111.208 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.74 ' HG3' HG23 ' A' ' 111' ' ' THR . 5.8 mtpm? -105.98 -11.0 16.32 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.69 0.626 . . . . 10.0 112.69 -175.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.683 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 22.7 ptm -51.82 -31.5 6.36 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 113.845 1.054 . . . . 10.0 113.845 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 113' ' ' MET . 31.6 Cg_endo -63.02 -28.02 74.45 Favored 'Trans proline' 0 C--N 1.368 1.558 0 CA-C-N 121.063 1.415 . . . . 10.0 111.31 174.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.653 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -100.19 -38.51 8.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.406 -1.27 . . . . 10.0 113.431 -172.115 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.68 HD11 ' NZ ' ' A' ' 112' ' ' LYS . 3.0 mp -62.93 -1.37 0.88 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.928 -1.033 . . . . 10.0 112.021 -175.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 115' ' ' ASP . 56.7 t30 58.38 65.56 1.24 Allowed 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.084 -1.417 . . . . 10.0 109.596 175.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.537 ' HB1' ' HB3' ' A' ' 123' ' ' ALA . . . -142.86 143.07 31.93 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.88 -1.054 . . . . 10.0 112.142 -171.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -65.72 -74.93 0.1 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.444 -1.253 . . . . 10.0 109.553 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.7 m -82.52 147.79 28.46 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.371 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.671 HD13 ' C ' ' A' ' 121' ' ' LEU . 1.5 tm? -55.11 -34.36 63.62 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.462 -0.57 . . . . 10.0 109.462 163.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -50.78 -38.51 48.58 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.307 0.575 . . . . 10.0 111.102 173.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.537 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . . . -67.61 -45.57 75.04 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 118.635 -1.226 . . . . 10.0 110.466 175.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.579 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -56.29 -32.78 64.9 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.487 -0.324 . . . . 10.0 110.848 175.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.748 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 84.0 mmm -58.17 -37.09 74.06 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.017 0.437 . . . . 10.0 110.89 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.532 ' HA ' ' HG2' ' A' ' 129' ' ' GLU . 3.5 mptp? -62.56 -54.28 42.13 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.233 -0.894 . . . . 10.0 111.933 177.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.552 HD12 ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -51.55 -57.93 2.75 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 C-N-CA 119.178 -1.009 . . . . 10.0 110.595 178.375 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.712 HG22 HD12 ' A' ' 105' ' ' ILE . 24.1 mm -50.73 -58.41 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 114.578 -1.192 . . . . 10.0 112.448 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.532 ' HG2' ' HA ' ' A' ' 126' ' ' LYS . 11.6 pt-20 -53.42 -44.32 68.68 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.862 -0.792 . . . . 10.0 108.862 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.4 -47.77 55.66 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.779 -0.725 . . . . 10.0 111.329 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 69.6 m -43.07 -67.18 0.3 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.105 -1.048 . . . . 10.0 108.727 170.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.551 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -51.18 -48.63 61.9 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.851 -0.613 . . . . 10.0 112.331 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -47.81 -52.81 17.53 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.95 -0.568 . . . . 10.0 111.919 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 28.9 t -64.72 -29.36 70.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.752 0.31 . . . . 10.0 110.98 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.495 ' HE2' ' HA ' ' A' ' 132' ' ' ALA . 56.9 mtm -82.45 2.25 33.61 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 114.29 1.218 . . . . 10.0 114.29 -175.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.78 10.9 69.02 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 120.148 1.34 . . . . 10.0 111.777 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.765 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 2.7 mp -99.09 125.26 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 CA-C-O 121.64 0.733 . . . . 10.0 110.593 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.805 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -91.26 157.12 17.33 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.618 -1.174 . . . . 10.0 108.915 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 17.6 m -117.47 127.84 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.726 -0.472 . . . . 10.0 109.726 174.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.598 ' H ' ' HA ' ' A' ' 101' ' ' THR . 18.5 m -147.28 74.49 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 N-CA-C 116.151 1.908 . . . . 10.0 116.151 -170.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.498 ' OD1' ' HB2' ' A' ' 102' ' ' ARG . 1.3 m-20 . . . . . 0 C--N 1.289 -2.043 0 C-N-CA 119.823 -0.751 . . . . 10.0 110.844 145.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 120.805 0.336 . . . . 10.0 110.759 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.91 141.28 22.4 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 173.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -140.9 90.36 2.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.848 0.356 . . . . 10.0 110.688 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.682 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . 61.4 tttp -107.15 125.12 50.67 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.274 -0.639 . . . . 10.0 109.274 175.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.4 t -61.21 124.7 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 120.813 0.34 . . . . 10.0 110.528 -174.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.97 -27.0 8.6 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 120.54 -0.464 . . . . 10.0 110.344 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.594 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -160.45 174.64 13.8 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.222 0.823 . . . . 10.0 113.222 177.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.51 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 23.2 mm-40 -129.86 127.32 39.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.399 -1.273 . . . . 10.0 108.244 177.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.799 HG21 ' HG ' ' A' ' 28' ' ' LEU . 1.4 mm -116.2 87.01 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.121 -0.696 . . . . 10.0 109.121 -178.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.433 ' HG2' HG22 ' A' ' 57' ' ' VAL . 15.4 mtpp -78.28 142.68 37.63 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 121.097 1.771 . . . . 10.0 110.255 175.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 24' ' ' VAL . 1.0 OUTLIER -156.81 135.48 11.6 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.649 -0.705 . . . . 10.0 109.115 -176.723 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -96.3 113.22 24.79 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.635 -0.876 . . . . 10.0 108.635 172.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.537 HD11 HD23 ' A' ' 11' ' ' LEU . 31.5 mt -132.51 145.87 59.08 Favored Pre-proline 0 CA--C 1.501 -0.913 0 CA-C-O 121.147 0.499 . . . . 10.0 111.269 -169.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.808 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 5.8 Cg_exo -71.66 123.15 9.19 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 123.102 2.534 . . . . 10.0 111.31 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.543 ' HB2' HD11 ' A' ' 54' ' ' LEU . . . -60.32 127.41 31.65 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 107.936 -1.135 . . . . 10.0 107.936 172.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.22 -1.05 89.34 Favored Glycine 0 N--CA 1.438 -1.19 0 O-C-N 125.671 1.857 . . . . 10.0 112.354 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.808 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 45.2 tptt -139.52 110.76 6.97 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 122.943 1.354 . . . . 10.0 112.588 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.421 ' H ' HD22 ' A' ' 43' ' ' ASN . . . -161.4 128.95 4.13 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.669 -2.06 . . . . 10.0 108.753 168.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.417 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 25.3 p -158.7 66.8 3.21 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 105.897 -1.89 . . . . 10.0 105.897 -174.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.748 ' HG3' HG22 ' A' ' 35' ' ' ILE . 5.7 Cg_exo 12.37 49.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.659 1 C-N-CA 130.673 7.582 . . . . 10.0 116.814 -175.637 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.584 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -57.6 167.75 1.26 Allowed Pre-proline 0 N--CA 1.441 -0.916 0 CA-C-N 112.545 -2.116 . . . . 10.0 109.601 164.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.584 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 72.9 Cg_exo -36.97 -44.35 1.12 Allowed 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 123.648 2.899 . . . . 10.0 114.967 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 22' ' ' PRO . 18.7 Cg_exo -36.29 -66.14 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.808 3.005 . . . . 10.0 114.508 168.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.99 HG12 HD12 ' A' ' 35' ' ' ILE . 58.9 t -85.61 -56.27 5.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 114.433 -1.258 . . . . 10.0 114.02 -164.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.22 -67.67 1.28 Allowed Glycine 0 CA--C 1.521 0.455 0 O-C-N 124.37 1.044 . . . . 10.0 113.276 -174.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.433 ' HD2' ' O ' ' A' ' 22' ' ' PRO . 90.5 Cg_exo -52.03 -46.23 33.8 Favored 'Trans proline' 0 C--O 1.222 -0.289 0 C-N-CA 123.876 3.051 . . . . 10.0 112.8 174.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.5 -79.28 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.296 0.569 . . . . 10.0 111.799 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.902 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . 1.5 mt -67.73 -45.03 76.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.793 -0.64 . . . . 10.0 112.694 -176.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.49 -38.16 90.28 Favored Glycine 0 C--N 1.324 -0.126 0 CA-C-N 115.912 -0.585 . . . . 10.0 112.674 -173.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -65.07 -21.89 66.89 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.915 0.388 . . . . 10.0 110.752 177.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -98.86 16.62 21.75 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.345 0.593 . . . . 10.0 109.958 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.0 2.9 89.42 Favored Glycine 0 CA--C 1.503 -0.68 0 CA-C-N 115.092 -0.958 . . . . 10.0 113.657 168.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.682 HG11 ' CD2' ' A' ' 66' ' ' PHE . 2.0 t -78.96 148.06 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 113.009 0.744 . . . . 10.0 113.009 -173.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.529 ' OD1' ' HB3' ' A' ' 37' ' ' GLU . 0.3 OUTLIER -71.06 90.71 0.86 Allowed 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.919 0.866 . . . . 10.0 109.997 172.532 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.99 HD12 HG12 ' A' ' 24' ' ' VAL . 11.5 mm -53.54 -40.87 43.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 113.818 -1.537 . . . . 10.0 112.081 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 50.6 mtm -66.0 -47.15 75.43 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.594 -1.639 . . . . 10.0 111.967 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.606 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 32.3 tt0 -58.71 -37.68 76.66 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 118.661 -1.216 . . . . 10.0 109.612 173.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.577 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 81.6 t80 -54.61 -58.95 5.5 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 119.554 -0.859 . . . . 10.0 112.767 170.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -54.51 -53.34 55.72 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 114.069 -1.423 . . . . 10.0 111.324 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -67.05 -21.9 65.89 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 119.694 -0.803 . . . . 10.0 109.749 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.816 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 13.7 mtm180 -76.56 -62.48 1.61 Allowed 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 119.543 -0.863 . . . . 10.0 112.286 169.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.618 ' CZ ' HG21 ' A' ' 46' ' ' THR . 63.9 t80 -52.41 -42.06 63.74 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 118.006 0.366 . . . . 10.0 110.536 -172.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.421 HD22 ' H ' ' A' ' 18' ' ' ALA . 4.9 m-20 -60.86 -50.08 74.87 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.817 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.72 -41.58 99.23 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.742 -0.783 . . . . 10.0 112.341 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.816 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 4.4 mm-40 -65.82 -44.23 86.21 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.751 0.786 . . . . 10.0 110.81 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.618 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 76.8 p -89.79 5.09 47.62 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.534 -1.212 . . . . 10.0 111.85 -170.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.88 -40.22 9.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.955 -1.02 . . . . 10.0 112.224 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.88 -32.7 65.58 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.692 -0.685 . . . . 10.0 111.166 -176.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -99.42 17.64 19.74 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.791 0.837 . . . . 10.0 110.105 -175.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -50.26 142.3 10.24 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.172 -0.922 . . . . 10.0 112.873 -176.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.31 18.92 31.86 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.541 -0.754 . . . . 10.0 111.456 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.617 ' SD ' ' HB2' ' A' ' 77' ' ' PHE . 45.7 mtm -141.15 129.72 22.68 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 116.853 -1.939 . . . . 10.0 114.386 -167.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.3 mm -67.52 92.06 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.567 -0.531 . . . . 10.0 109.567 172.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.638 ' HB3' ' CG2' ' A' ' 70' ' ' ILE . 6.5 mt -81.2 130.02 64.43 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 109.697 -0.483 . . . . 10.0 109.697 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.865 ' HG2' ' HG3' ' A' ' 74' ' ' PRO . 18.0 Cg_exo -71.31 103.02 1.34 Allowed 'Trans proline' 0 C--N 1.331 -0.347 0 C-N-CA 122.571 2.181 . . . . 10.0 111.233 172.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.09 156.48 3.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 119.505 1.048 . . . . 10.0 111.706 -175.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.433 HG22 ' HG2' ' A' ' 10' ' ' LYS . 96.0 t -135.98 117.75 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.209 170.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.806 HG21 HD21 ' A' ' 28' ' ' LEU . 12.6 mt -109.93 135.04 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.705 0 N-CA-C 108.595 -0.891 . . . . 10.0 108.595 -175.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.0 m -117.7 95.47 4.95 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 114.954 -1.021 . . . . 10.0 108.308 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.594 ' CG1' ' HB3' ' A' ' 7' ' ' ALA . 2.7 p -86.73 138.11 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.012 0 CA-C-N 119.61 1.095 . . . . 10.0 110.784 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.421 ' HE2' ' HG1' ' A' ' 67' ' ' THR . 59.8 m-85 -92.87 163.85 13.55 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.514 -0.766 . . . . 10.0 111.745 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.682 ' HG2' ' HB3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -60.7 -19.9 59.79 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.605 -1.18 . . . . 10.0 112.093 -179.132 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.33 -4.69 52.04 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.317 -0.856 . . . . 10.0 111.861 -177.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 83.24 -1.74 1.2 Allowed 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 124.318 1.011 . . . . 10.0 109.443 -170.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.6 m -72.6 168.71 18.08 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.572 -1.194 . . . . 10.0 108.327 174.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.682 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -169.47 -179.99 3.63 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 120.477 1.49 . . . . 10.0 109.471 176.088 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.421 ' HG1' ' HE2' ' A' ' 61' ' ' TYR . 1.1 p -160.54 168.67 24.55 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 103.241 -2.874 . . . . 10.0 103.241 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.573 ' HE1' ' HE ' ' A' ' 41' ' ' ARG . 51.4 p90 -163.56 155.94 17.85 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.759 -0.83 . . . . 10.0 108.759 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mt -124.19 167.58 17.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 106.922 -1.51 . . . . 10.0 106.922 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.638 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 2.6 mm -121.84 124.69 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 N-CA-C 106.485 -1.672 . . . . 10.0 106.485 177.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.702 ' HB3' ' HG2' ' A' ' 73' ' ' PRO . 32.0 mmmt -78.73 101.51 7.59 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.943 0.878 . . . . 10.0 111.897 -165.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.787 ' HB ' ' HG2' ' A' ' 112' ' ' LYS . 8.3 p -56.6 -34.73 28.24 Favored Pre-proline 0 CA--C 1.562 1.423 0 CA-C-N 113.449 -1.705 . . . . 10.0 113.974 169.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.738 ' HD2' ' N ' ' A' ' 72' ' ' THR . 4.8 Cg_exo -35.68 -52.15 0.93 Allowed 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 124.838 3.692 . . . . 10.0 115.907 -176.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.865 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 16.7 Cg_endo -58.76 103.45 0.16 Allowed 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.401 1.401 . . . . 10.0 110.495 173.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.709 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -81.13 0.39 36.45 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.245 -0.434 . . . . 10.0 111.364 -171.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.7 t -61.7 -55.29 31.99 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.141 -0.481 . . . . 10.0 111.451 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.683 ' HE1' ' HG2' ' A' ' 74' ' ' PRO . 37.7 p90 -77.77 -27.51 50.31 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.609 0.596 . . . . 10.0 112.609 -171.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.523 ' HB3' HD12 ' A' ' 108' ' ' ILE . 1.1 mm? -75.14 -46.54 33.62 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.416 0.626 . . . . 10.0 110.721 174.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.625 ' HB2' ' O ' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -64.16 -35.6 81.31 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.808 -0.442 . . . . 10.0 109.808 -179.27 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.647 ' HA ' ' HB3' ' A' ' 83' ' ' ALA . 20.2 ttpt -60.61 -31.86 71.02 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.819 -0.628 . . . . 10.0 110.262 173.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 21.9 ttpp -52.56 -44.84 66.11 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 110.439 -0.208 . . . . 10.0 110.439 177.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 1.005 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -73.52 -46.81 45.52 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.81 1.644 . . . . 10.0 111.657 172.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.647 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . . . -62.94 -38.91 92.91 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 111.532 -2.576 . . . . 10.0 111.718 -168.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 85.48 -14.93 48.79 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.028 -1.082 . . . . 10.0 111.596 173.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.554 HG13 ' HG3' ' A' ' 80' ' ' LYS . 14.9 pt -59.35 131.35 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 114.25 -0.975 . . . . 10.0 111.675 174.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.429 ' HG3' ' HD2' ' A' ' 80' ' ' LYS . 4.5 tt0 -172.42 31.81 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.424 0.63 . . . . 10.0 109.324 172.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -166.66 -56.52 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.296 -0.865 . . . . 10.0 109.672 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -177.62 -114.73 0.41 Allowed Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.564 -0.743 . . . . 10.0 111.573 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.9 t -165.52 136.39 3.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.943 0.402 . . . . 10.0 111.238 -177.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.2 m -78.98 -8.35 58.84 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.629 -0.714 . . . . 10.0 111.162 175.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -173.39 99.48 0.32 Allowed Pre-proline 0 C--O 1.234 0.281 0 CA-C-O 120.916 0.389 . . . . 10.0 111.257 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -88.75 109.09 0.5 Allowed 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.633 2.222 . . . . 10.0 110.771 171.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.413 ' HD3' ' NH2' ' A' ' 94' ' ' ARG . 12.2 ptpt -72.63 -106.71 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.437 -0.347 . . . . 10.0 111.66 -176.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.413 ' NH2' ' HD3' ' A' ' 93' ' ' LYS . 0.5 OUTLIER -79.14 -36.62 40.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.184 0.516 . . . . 10.0 110.703 177.027 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.404 ' H ' ' H ' ' A' ' 96' ' ' ILE . 26.3 tptp -171.9 -5.23 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.47 -0.787 . . . . 10.0 111.793 -177.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.556 HD13 ' HB2' ' A' ' 138' ' ' GLU . 4.5 mt -83.56 176.82 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 122.061 -0.399 . . . . 10.0 109.946 -176.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 136' ' ' GLY . 12.4 p -138.82 -45.88 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 112.286 0.476 . . . . 10.0 112.286 -165.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -165.2 155.12 26.3 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 109.439 -1.464 . . . . 10.0 109.439 175.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.69 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 9.2 ptpt -137.87 169.75 17.24 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-O 122.734 1.254 . . . . 10.0 111.71 -161.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 1.005 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -159.5 -144.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 111.456 -2.611 . . . . 10.0 106.132 -174.087 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.49 HG22 ' CG2' ' A' ' 140' ' ' VAL . 28.5 p -154.64 148.21 25.26 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.127 -1.805 . . . . 10.0 106.127 -157.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.668 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 38.3 mmt180 -43.7 -42.47 5.37 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 123.895 0.747 . . . . 10.0 109.894 174.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -57.46 -44.04 84.49 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.69 0.626 . . . . 10.0 112.69 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.591 ' O ' HG12 ' A' ' 108' ' ' ILE . 1.1 mp0 -60.35 -50.04 75.21 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 109.157 -0.683 . . . . 10.0 109.157 177.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.944 HG23 ' HB ' ' A' ' 128' ' ' ILE . 33.0 mm -40.59 -54.1 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.446 -1.252 . . . . 10.0 111.398 169.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.709 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 23.7 tt0 -49.17 -51.37 33.0 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.837 -1.074 . . . . 10.0 112.382 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -51.27 -60.76 2.76 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.131 -0.941 . . . . 10.0 110.016 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.601 HG22 ' HD3' ' A' ' 112' ' ' LYS . 13.4 mm -47.53 -53.0 4.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 113.811 -1.54 . . . . 10.0 110.552 174.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.428 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -52.84 -34.4 53.97 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.663 0.616 . . . . 10.0 112.663 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.709 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 64.3 mttm -73.54 -53.86 9.57 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 116.468 -0.333 . . . . 10.0 110.976 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.76 HG23 ' HG3' ' A' ' 112' ' ' LYS . 11.4 t -56.74 -33.68 66.79 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.293 -0.412 . . . . 10.0 111.704 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.787 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 17.7 mtpp -96.87 -1.31 46.23 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 122.736 0.414 . . . . 10.0 111.321 -177.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.543 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 52.6 ttm -49.33 -47.34 76.95 Favored Pre-proline 0 N--CA 1.468 0.446 0 N-CA-C 112.836 0.68 . . . . 10.0 112.836 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 113' ' ' MET . 32.8 Cg_endo -63.26 -26.55 71.96 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 121.443 1.429 . . . . 10.0 111.979 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.523 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -97.97 -44.45 6.66 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.952 -1.022 . . . . 10.0 113.576 -171.825 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.695 HD13 ' HB3' ' A' ' 112' ' ' LYS . 2.2 mp -66.22 42.22 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.708 -1.133 . . . . 10.0 113.232 -177.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 65.9 t30 14.64 53.0 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 O-C-N 124.776 1.298 . . . . 10.0 112.28 -167.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.407 ' O ' ' CB ' ' A' ' 119' ' ' ASN . . . -65.8 -78.8 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.612 0.967 . . . . 10.0 113.612 -165.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 118' ' ' ALA . 38.5 t-20 99.72 -41.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.883 1.273 . . . . 10.0 108.323 -175.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 47.6 t -148.81 139.54 22.77 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 106.758 -1.571 . . . . 10.0 106.758 173.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.623 ' O ' ' HG2' ' A' ' 125' ' ' MET . 3.2 tm? -53.19 -33.76 54.06 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.157 -0.928 . . . . 10.0 113.324 -177.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -50.02 -42.62 49.73 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.749 0.785 . . . . 10.0 110.697 173.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.494 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . . . -65.7 -49.09 69.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.487 -1.233 . . . . 10.0 110.719 -178.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.579 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -54.93 -37.9 66.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.527 178.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.625 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 78.4 mmm -52.96 -40.34 63.62 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.138 0.792 . . . . 10.0 113.138 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.494 ' HD2' ' HA ' ' A' ' 123' ' ' ALA . 10.3 mttt -63.25 -46.8 85.19 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.291 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.667 HD13 ' HG ' ' A' ' 116' ' ' LEU . 73.2 mt -50.19 -62.58 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-N 115.6 -0.727 . . . . 10.0 110.012 175.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.944 ' HB ' HG23 ' A' ' 105' ' ' ILE . 10.5 mm -53.18 -58.03 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-N 114.058 -1.428 . . . . 10.0 111.441 -176.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.56 -44.01 62.58 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 123.849 0.718 . . . . 10.0 109.584 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -69.9 -45.84 55.49 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.415 -0.897 . . . . 10.0 111.881 -177.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.709 HG21 ' HB3' ' A' ' 75' ' ' ALA . 22.4 m -48.2 -58.12 4.96 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.486 -0.857 . . . . 10.0 109.762 171.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.495 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -53.38 -44.57 68.74 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 111.812 0.301 . . . . 10.0 111.812 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 34.7 tttp -45.33 -55.15 6.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.491 -0.777 . . . . 10.0 110.956 174.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.0 m -64.58 -31.56 72.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.984 0.421 . . . . 10.0 111.529 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.429 ' HE1' ' HB3' ' A' ' 79' ' ' LEU . 10.7 mtm -78.61 -8.84 59.05 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.272 0.841 . . . . 10.0 113.272 -174.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.557 ' O ' HG12 ' A' ' 97' ' ' VAL . . . 88.72 14.36 61.38 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 119.587 1.085 . . . . 10.0 111.74 -178.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 2.0 mp -96.95 124.84 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.95 0 CA-C-O 121.624 0.726 . . . . 10.0 111.062 -177.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.69 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.3 OUTLIER -84.03 146.68 27.83 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.611 -1.177 . . . . 10.0 109.323 177.544 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.7 m -116.64 124.02 72.29 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.782 0 N-CA-C 106.458 -1.682 . . . . 10.0 106.458 174.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 100' ' ' VAL . 33.1 m -106.88 170.01 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.149 0 CA-C-N 113.753 -1.567 . . . . 10.0 110.063 -175.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 . . . . . 0 C--N 1.288 -2.078 0 CA-C-N 113.148 -1.842 . . . . 10.0 108.482 -177.451 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 121.211 0.529 . . . . 10.0 110.632 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.28 158.64 43.78 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.496 -0.774 . . . . 10.0 109.058 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.529 ' O ' ' HG3' ' A' ' 3' ' ' LYS . 21.9 pttm -115.41 106.11 13.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.337 1.065 . . . . 10.0 112.118 -178.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.448 ' HB3' ' HG3' ' A' ' 62' ' ' GLU . 21.2 ttpt -144.94 133.59 22.15 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.371 -1.344 . . . . 10.0 107.371 168.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.5 t -62.6 127.29 22.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 O-C-N 123.376 0.422 . . . . 10.0 111.148 -174.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -102.51 -28.55 12.11 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.091 -0.707 . . . . 10.0 109.091 176.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.542 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -162.52 177.85 9.1 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.295 0.85 . . . . 10.0 113.295 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 78.3 mt-30 -134.65 129.63 35.14 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 114.493 -1.23 . . . . 10.0 107.963 175.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.665 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 5.4 mt -124.1 87.24 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 109.038 -0.727 . . . . 10.0 109.038 -175.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.524 ' HG3' HG22 ' A' ' 57' ' ' VAL . 3.2 mppt? -78.37 146.39 34.66 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 120.991 -1.068 . . . . 10.0 110.178 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 10' ' ' LYS . 0.9 OUTLIER -156.77 137.16 12.97 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.088 -0.505 . . . . 10.0 109.902 -175.573 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.424 ' HB3' ' CG2' ' A' ' 53' ' ' ILE . 11.4 mm-40 -93.84 113.28 25.28 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.312 -0.996 . . . . 10.0 108.312 169.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.491 HD11 HG22 ' A' ' 24' ' ' VAL . 15.5 mt -132.1 152.88 80.97 Favored Pre-proline 0 C--O 1.212 -0.909 0 CA-C-O 121.31 0.576 . . . . 10.0 111.652 -171.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.677 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 5.5 Cg_exo -78.63 123.59 5.96 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 123.244 2.629 . . . . 10.0 111.784 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 50' ' ' ALA . . . -61.75 126.67 28.15 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.987 -1.116 . . . . 10.0 107.987 172.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.03 1.79 90.4 Favored Glycine 0 N--CA 1.438 -1.192 0 O-C-N 126.043 2.089 . . . . 10.0 112.108 -177.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.677 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 9.6 tptp -141.56 113.45 7.88 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 122.999 1.381 . . . . 10.0 112.102 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.535 ' H ' HD22 ' A' ' 43' ' ' ASN . . . -159.04 140.56 13.26 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 112.869 -1.969 . . . . 10.0 108.561 164.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.0 p -157.64 61.02 2.12 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 105.837 -1.912 . . . . 10.0 105.837 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.695 ' HG3' ' CG2' ' A' ' 35' ' ' ILE . 0.1 OUTLIER 15.41 49.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.692 1 C-N-CA 129.687 6.925 . . . . 10.0 116.11 -178.011 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.64 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -56.08 170.58 0.44 Allowed Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 111.553 -2.567 . . . . 10.0 109.736 165.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.64 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 79.6 Cg_exo -37.39 -44.76 1.46 Allowed 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 123.291 2.661 . . . . 10.0 114.814 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 22' ' ' PRO . 6.4 Cg_exo -38.18 -62.56 0.3 Allowed 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 123.346 2.697 . . . . 10.0 114.374 170.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.942 HG12 HD12 ' A' ' 35' ' ' ILE . 61.6 t -87.44 -56.58 5.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 114.207 1.188 . . . . 10.0 114.207 -163.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.48 -66.52 2.2 Favored Glycine 0 C--O 1.226 -0.348 0 O-C-N 124.02 0.825 . . . . 10.0 113.366 -174.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.435 ' HD2' ' O ' ' A' ' 22' ' ' PRO . 86.4 Cg_exo -53.01 -42.41 64.77 Favored 'Trans proline' 0 C--O 1.225 -0.141 0 C-N-CA 123.262 2.641 . . . . 10.0 112.577 174.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.517 ' HB1' ' CG2' ' A' ' 9' ' ' ILE . . . -53.17 -79.76 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.401 0.619 . . . . 10.0 111.433 177.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.87 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . 2.5 mt -67.17 -46.77 72.97 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.521 -0.763 . . . . 10.0 113.016 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.9 -35.6 87.39 Favored Glycine 0 C--O 1.228 -0.232 0 CA-C-N 116.428 -0.351 . . . . 10.0 112.931 -173.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -64.2 -22.72 67.05 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.72 0.295 . . . . 10.0 110.222 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -99.87 15.53 26.73 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.408 0.623 . . . . 10.0 109.603 175.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.462 ' HA3' ' CE ' ' A' ' 64' ' ' LYS . . . 74.28 14.47 80.68 Favored Glycine 0 CA--C 1.501 -0.799 0 CA-C-N 114.687 -1.142 . . . . 10.0 113.692 170.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.605 HG11 ' CD2' ' A' ' 66' ' ' PHE . 0.9 OUTLIER -82.74 148.88 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 C-N-CA 120.252 -0.579 . . . . 10.0 112.474 -177.074 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -71.11 92.78 0.99 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.701 0.762 . . . . 10.0 110.296 174.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.942 HD12 HG12 ' A' ' 24' ' ' VAL . 14.6 mm -53.94 -40.02 43.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 114.422 -1.263 . . . . 10.0 112.35 178.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -41.88 77.42 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 113.909 -1.496 . . . . 10.0 111.613 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.551 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 22.2 mt-10 -55.77 -44.71 77.94 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 118.932 -1.107 . . . . 10.0 109.611 169.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.673 ' CE1' HD11 ' A' ' 58' ' ' ILE . 84.6 t80 -52.74 -58.62 6.26 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.076 1.139 . . . . 10.0 114.076 172.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 39.9 t -56.9 -51.6 68.47 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 114.75 -1.114 . . . . 10.0 110.924 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.51 ' HA ' ' HD3' ' A' ' 40' ' ' LYS . 28.7 mmtp -67.47 -20.88 65.53 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 119.269 -0.972 . . . . 10.0 110.297 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.613 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 92.7 mtt180 -73.85 -62.85 1.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.912 -0.715 . . . . 10.0 112.103 170.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.514 ' CZ ' HG21 ' A' ' 46' ' ' THR . 73.3 t80 -56.42 -48.55 76.72 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-N 115.572 -0.74 . . . . 10.0 110.415 -173.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.535 HD22 ' H ' ' A' ' 18' ' ' ALA . 5.3 m-20 -59.7 -49.44 77.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.308 -0.86 . . . . 10.0 110.286 -176.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.81 -46.08 91.06 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.169 -1.013 . . . . 10.0 112.71 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 9.5 pt-20 -71.32 -31.25 67.17 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 120.16 -0.616 . . . . 10.0 112.355 -176.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.523 ' CG2' HD12 ' A' ' 54' ' ' LEU . 63.3 p -91.06 2.88 55.99 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.45 -0.795 . . . . 10.0 111.591 -175.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.74 -38.71 7.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.001 -0.999 . . . . 10.0 112.934 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.535 ' OD1' ' HG3' ' A' ' 49' ' ' LYS . 0.5 OUTLIER -81.94 -26.49 33.98 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.729 -0.669 . . . . 10.0 112.199 -174.44 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.535 ' HG3' ' OD1' ' A' ' 48' ' ' ASP . 36.4 mttp -101.72 18.55 20.13 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.473 0.654 . . . . 10.0 109.437 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -50.32 140.95 12.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.704 -1.134 . . . . 10.0 112.928 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.59 18.08 26.7 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 114.984 -1.007 . . . . 10.0 110.774 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.453 ' HB2' HD21 ' A' ' 54' ' ' LEU . 65.6 mtt -137.12 127.23 26.09 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 117.137 -1.825 . . . . 10.0 113.92 -167.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.424 ' CG2' ' HB3' ' A' ' 12' ' ' GLN . 50.9 mm -68.97 90.61 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.268 -0.641 . . . . 10.0 109.268 171.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.523 HD12 ' CG2' ' A' ' 46' ' ' THR . 6.6 mt -77.74 140.03 62.99 Favored Pre-proline 0 N--CA 1.449 -0.482 0 N-CA-C 108.665 -0.865 . . . . 10.0 108.665 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 54' ' ' LEU . 5.3 Cg_exo -77.92 104.78 1.91 Allowed 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.59 2.193 . . . . 10.0 110.889 172.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.54 151.26 4.9 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 CA-C-N 118.893 0.769 . . . . 10.0 111.324 -174.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.524 HG22 ' HG3' ' A' ' 10' ' ' LYS . 99.3 t -135.58 119.81 26.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.981 -0.377 . . . . 10.0 109.981 172.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.842 HG21 HD21 ' A' ' 28' ' ' LEU . 13.0 mt -108.81 137.55 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 N-CA-C 108.36 -0.978 . . . . 10.0 108.36 -174.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.0 m -123.07 96.57 5.06 Favored 'General case' 0 N--CA 1.407 -2.601 0 CA-C-N 114.688 -1.142 . . . . 10.0 108.818 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 65' ' ' SER . 4.3 p -85.73 137.28 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 CA-C-N 119.298 0.953 . . . . 10.0 110.436 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -100.71 178.17 4.78 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.797 0.808 . . . . 10.0 113.056 -176.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.448 ' HG3' ' HB3' ' A' ' 4' ' ' LYS . 28.0 mt-10 -50.57 -33.59 22.43 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.796 -1.547 . . . . 10.0 113.718 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.7 -6.51 57.34 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.517 0.562 . . . . 10.0 112.517 -172.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.462 ' CE ' ' HA3' ' A' ' 32' ' ' GLY . 26.9 mmmt 83.51 5.51 0.79 Allowed 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 124.643 1.214 . . . . 10.0 108.569 -168.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.546 ' O ' HG23 ' A' ' 60' ' ' VAL . 22.0 t -73.74 175.79 6.88 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 113.355 -1.748 . . . . 10.0 107.67 173.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.605 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -170.0 -178.93 3.03 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 120.523 1.51 . . . . 10.0 109.866 176.848 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.9 p -157.64 170.31 22.68 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 103.233 -2.876 . . . . 10.0 103.233 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.46 ' HB3' HG12 ' A' ' 58' ' ' ILE . 48.7 p90 -163.4 157.58 20.11 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.802 -0.814 . . . . 10.0 108.802 174.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.481 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 29.2 pt -122.77 167.77 16.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.014 -1.106 . . . . 10.0 108.014 -176.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.463 HD12 ' CE1' ' A' ' 42' ' ' PHE . 1.9 mm -135.39 117.61 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 107.093 -1.447 . . . . 10.0 107.093 -176.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.629 ' HE2' ' OD2' ' A' ' 115' ' ' ASP . 9.4 mmmm -75.41 97.92 3.76 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.228 -0.589 . . . . 10.0 110.761 -172.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.26 98.0 0.16 Allowed Pre-proline 0 C--N 1.317 -0.809 0 O-C-N 124.639 1.212 . . . . 10.0 109.342 169.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.631 ' HG3' ' CD2' ' A' ' 77' ' ' PHE . 54.3 Cg_endo -67.54 137.29 42.22 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.409 2.073 . . . . 10.0 112.681 -162.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.932 ' HA ' HD11 ' A' ' 116' ' ' LEU . 85.1 Cg_exo -47.29 88.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.746 2.964 . . . . 10.0 113.689 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.68 ' H ' ' HD3' ' A' ' 112' ' ' LYS . . . 70.59 -41.82 0.51 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.073 -0.967 . . . . 10.0 113.569 174.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.9 p -40.83 -73.73 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.3 1.222 . . . . 10.0 114.3 -167.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.631 ' CD2' ' HG3' ' A' ' 73' ' ' PRO . 8.5 m-30 -61.97 -21.81 65.13 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.349 0.87 . . . . 10.0 113.349 -172.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.033 ' HB3' HD12 ' A' ' 108' ' ' ILE . 6.3 mp -101.02 -12.77 18.6 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 119.499 -0.88 . . . . 10.0 111.288 -178.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.463 ' CD1' ' HB1' ' A' ' 75' ' ' ALA . 50.6 mt -76.99 -26.48 53.92 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.07 -1.085 . . . . 10.0 108.07 165.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 61.5 mmtt -59.79 -38.72 82.68 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.207 -0.906 . . . . 10.0 109.5 167.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.538 ' HD3' ' HA ' ' A' ' 81' ' ' LYS . 53.5 mmtt -64.25 -44.64 91.17 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.528 0.936 . . . . 10.0 113.528 175.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.912 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -71.61 -56.31 6.1 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.562 1.945 . . . . 10.0 112.966 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.49 ' C ' ' H ' ' A' ' 85' ' ' ILE . . . -76.31 137.99 40.22 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 111.069 -2.787 . . . . 10.0 105.872 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.07 22.64 5.82 Favored Glycine 0 C--N 1.32 -0.341 0 CA-C-N 121.609 2.004 . . . . 10.0 110.776 -173.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.64 HG22 HG22 ' A' ' 97' ' ' VAL . 27.2 pt -68.1 103.71 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 113.407 -1.397 . . . . 10.0 112.614 -173.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -74.95 4.46 6.53 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 122.089 0.947 . . . . 10.0 110.068 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -172.11 -60.07 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.303 -1.317 . . . . 10.0 109.002 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.05 -110.44 4.02 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.477 -0.783 . . . . 10.0 111.386 -178.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.7 m -163.66 -94.34 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.509 -0.552 . . . . 10.0 109.509 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.468 ' O ' ' HG3' ' A' ' 91' ' ' GLU . 46.7 m -165.14 -43.74 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.827 -0.805 . . . . 10.0 108.827 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.822 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 35.6 mt-10 -164.59 -58.3 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 114.928 -1.033 . . . . 10.0 109.58 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.822 ' HD3' ' HB2' ' A' ' 91' ' ' GLU . 55.7 Cg_endo -96.17 106.16 0.1 Allowed 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.179 1.919 . . . . 10.0 112.515 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.51 ' HG3' ' HB ' ' A' ' 97' ' ' VAL . 5.3 tmtp? -80.8 -100.78 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.473 -1.306 . . . . 10.0 107.473 171.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.495 ' H ' ' HB3' ' A' ' 93' ' ' LYS . 13.1 ttm180 -178.49 -59.57 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 170.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.424 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 47.1 mttp -87.73 10.19 19.11 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.234 -1.348 . . . . 10.0 110.503 -177.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.625 HG21 ' HB3' ' A' ' 138' ' ' GLU . 3.6 mt 72.45 116.98 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-O 123.457 1.599 . . . . 10.0 112.208 -170.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.64 HG22 HG22 ' A' ' 85' ' ' ILE . 8.2 p -74.83 88.04 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 CA-C-N 111.404 -2.635 . . . . 10.0 111.308 -174.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 33.07 -168.76 0.01 OUTLIER Glycine 0 CA--C 1.533 1.204 0 CA-C-N 113.942 -1.481 . . . . 10.0 115.171 -165.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.668 ' CB ' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -160.85 178.26 9.59 Favored 'General case' 0 CA--C 1.488 -1.413 0 CA-C-O 121.791 0.805 . . . . 10.0 112.044 -172.122 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.912 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -159.8 -166.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 113.502 -1.681 . . . . 10.0 111.938 -179.451 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 39.0 p -97.56 143.29 28.4 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 112.734 -2.03 . . . . 10.0 111.473 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.649 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 0.4 OUTLIER -47.87 -41.18 23.58 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.599 -0.728 . . . . 10.0 109.925 166.576 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.06 -43.3 77.8 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.655 0.382 . . . . 10.0 111.758 175.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.597 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -57.52 -50.74 72.09 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.411 -0.959 . . . . 10.0 108.411 174.936 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.753 HG23 ' HB ' ' A' ' 128' ' ' ILE . 27.9 mm -44.2 -49.82 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 114.522 -1.217 . . . . 10.0 111.53 174.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.714 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 27.6 tt0 -50.88 -57.16 9.18 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.766 1.227 . . . . 10.0 112.356 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.686 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 70.0 mm-40 -51.66 -58.59 5.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.347 -1.297 . . . . 10.0 110.17 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.033 HD12 ' HB3' ' A' ' 78' ' ' LEU . 22.8 mm -48.33 -51.6 9.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.318 -0.855 . . . . 10.0 110.742 173.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.567 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -51.89 -42.66 62.89 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.499 0.555 . . . . 10.0 112.499 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.714 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 73.6 mttt -68.21 -52.58 32.67 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 122.045 0.926 . . . . 10.0 109.261 -177.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 85.5 m -51.46 -23.8 4.35 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 113.506 -1.679 . . . . 10.0 112.514 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.763 ' HB3' HD13 ' A' ' 116' ' ' LEU . 29.5 mttp -122.63 1.19 9.44 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 113.171 0.804 . . . . 10.0 113.171 -175.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.55 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 23.3 ptm -50.18 -36.81 22.62 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 113.149 0.796 . . . . 10.0 113.149 176.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 113' ' ' MET . 58.7 Cg_endo -69.55 -29.76 24.33 Favored 'Trans proline' 0 C--N 1.367 1.515 0 CA-C-N 120.989 1.389 . . . . 10.0 111.912 178.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.629 ' OD2' ' HE2' ' A' ' 71' ' ' LYS . 2.7 t70 -87.24 -46.02 10.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.132 0.968 . . . . 10.0 110.454 -173.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.932 HD11 ' HA ' ' A' ' 74' ' ' PRO . 4.9 mp -65.1 -1.1 1.94 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 113.68 -1.6 . . . . 10.0 112.191 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.401 ' H ' ' C ' ' A' ' 115' ' ' ASP . 26.0 m-80 58.98 50.39 8.39 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.853 -1.067 . . . . 10.0 109.247 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.413 ' O ' ' CB ' ' A' ' 119' ' ' ASN . . . -65.98 -74.78 0.1 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.28 -1.327 . . . . 10.0 113.099 -166.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 118' ' ' ALA . 27.3 t-20 102.43 -40.52 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.545 0 O-C-N 124.929 1.393 . . . . 10.0 109.354 -176.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.5 t -151.41 133.96 15.5 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 103.584 -2.747 . . . . 10.0 103.584 174.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.586 HD22 ' HB3' ' A' ' 124' ' ' ALA . 2.8 tm? -52.97 -35.05 58.59 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.386 0.884 . . . . 10.0 113.386 -173.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.588 ' HA ' ' HG3' ' A' ' 125' ' ' MET . 2.2 mp0 -51.46 -33.78 32.54 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 118.691 0.678 . . . . 10.0 110.734 175.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.42 -47.4 60.93 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 118.581 -1.247 . . . . 10.0 110.575 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.586 ' HB3' HD22 ' A' ' 121' ' ' LEU . . . -54.95 -39.01 68.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.835 -0.62 . . . . 10.0 110.305 175.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.589 ' O ' ' HB3' ' A' ' 129' ' ' GLU . 17.2 mtp -54.96 -38.43 67.75 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 112.124 0.416 . . . . 10.0 112.124 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -62.19 -47.51 84.15 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 108.929 -0.767 . . . . 10.0 108.929 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 124' ' ' ALA . 67.3 mt -50.92 -64.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 114.996 -1.002 . . . . 10.0 110.284 175.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.753 ' HB ' HG23 ' A' ' 105' ' ' ILE . 16.0 mm -52.81 -60.54 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 CA-C-N 114.496 -1.229 . . . . 10.0 111.394 -176.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.589 ' HB3' ' O ' ' A' ' 125' ' ' MET . 0.0 OUTLIER -51.75 -43.47 62.94 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.264 -0.88 . . . . 10.0 109.732 179.299 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.63 -45.25 29.35 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.717 -0.754 . . . . 10.0 111.909 -175.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.525 HG21 ' HB3' ' A' ' 75' ' ' ALA . 51.9 m -50.5 -56.97 9.23 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.513 -0.844 . . . . 10.0 109.765 173.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.99 -57.28 7.88 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 120.969 0.414 . . . . 10.0 111.031 175.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -46.45 -59.01 3.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.954 -1.021 . . . . 10.0 112.253 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.8 p -66.59 -24.5 66.34 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.057 0.391 . . . . 10.0 112.057 -174.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.54 ' O ' ' HG3' ' A' ' 135' ' ' MET . 0.0 OUTLIER -84.43 -3.41 58.33 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 112.936 0.717 . . . . 10.0 112.936 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.541 ' C ' HG12 ' A' ' 97' ' ' VAL . . . 105.05 -5.85 42.63 Favored Glycine 0 N--CA 1.441 -1.007 0 O-C-N 121.001 -1.062 . . . . 10.0 112.688 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.437 HG23 ' HA ' ' A' ' 99' ' ' LYS . 70.6 mt -87.43 129.87 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 CA-C-N 117.516 0.658 . . . . 10.0 111.093 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.668 ' HG2' ' CB ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -85.58 156.98 20.5 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.029 -0.987 . . . . 10.0 109.282 177.345 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 22.2 m -119.43 136.34 56.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.078 -1.082 . . . . 10.0 108.078 168.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.3 m -136.26 69.99 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 115.573 1.694 . . . . 10.0 115.573 -176.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.3 t70 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.113 -0.946 . . . . 10.0 109.296 138.928 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.538 0.208 . . . . 10.0 111.169 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.0 -77.96 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.832 0.349 . . . . 10.0 110.509 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -136.44 167.51 21.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.043 -0.526 . . . . 10.0 109.91 177.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 4' ' ' LYS . 29.5 mtpt -80.74 119.84 23.85 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.435 -0.348 . . . . 10.0 110.071 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 38.0 t -67.15 145.0 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.895 0.378 . . . . 10.0 111.389 -177.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.79 -36.41 4.51 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.27 173.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.464 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -159.61 151.17 20.1 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.272 1.212 . . . . 10.0 114.272 -177.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -93.71 129.19 40.12 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.303 -1.369 . . . . 10.0 107.303 168.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.697 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.8 OUTLIER -120.94 82.36 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.786 -0.82 . . . . 10.0 108.786 175.119 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -78.9 146.13 33.73 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 120.895 1.679 . . . . 10.0 109.42 177.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.487 HD23 HD11 ' A' ' 13' ' ' LEU . 0.8 OUTLIER -156.11 134.63 11.64 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.313 -0.625 . . . . 10.0 109.313 -174.308 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.523 ' OE1' ' HA ' ' A' ' 55' ' ' PRO . 10.9 mm100 -91.82 112.26 24.11 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.018 -1.105 . . . . 10.0 108.018 171.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.487 HD11 HD23 ' A' ' 11' ' ' LEU . 28.8 mt -131.54 133.97 24.99 Favored Pre-proline 0 CA--C 1.504 -0.803 0 CA-C-O 121.644 0.735 . . . . 10.0 112.463 -170.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.7 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 18.5 Cg_exo -56.75 122.18 11.37 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 123.292 2.661 . . . . 10.0 111.846 174.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.532 ' HB2' HD11 ' A' ' 54' ' ' LEU . . . -61.62 126.78 28.57 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 107.514 -1.291 . . . . 10.0 107.514 169.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.39 0.21 89.64 Favored Glycine 0 N--CA 1.44 -1.1 0 O-C-N 125.883 1.989 . . . . 10.0 112.998 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.7 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 18.6 tptp -142.8 98.88 3.37 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 118.331 1.066 . . . . 10.0 111.979 175.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.18 136.87 9.03 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.433 -1.258 . . . . 10.0 112.121 176.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.603 ' HA ' ' HB2' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -179.98 -54.96 0.0 OUTLIER Pre-proline 0 N--CA 1.443 -0.81 0 CA-C-N 115.318 -0.856 . . . . 10.0 111.836 174.677 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.67 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 73.5 Cg_endo -99.16 129.66 0.19 Allowed 'Trans proline' 0 N--CA 1.411 -3.372 0 N-CA-C 115.67 1.373 . . . . 10.0 115.67 -153.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.053 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 12.13 -83.54 0.0 OUTLIER Pre-proline 0 C--N 1.294 -1.842 0 CA-C-N 108.604 -3.907 . . . . 10.0 115.489 166.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.955 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 65.5 Cg_exo -30.53 -55.16 0.21 Allowed 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 122.963 2.442 . . . . 10.0 115.709 -164.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.955 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 5.2 Cg_exo -84.09 -56.55 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.438 2.759 . . . . 10.0 112.094 170.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.005 HG12 HD12 ' A' ' 35' ' ' ILE . 89.3 t -80.37 -53.76 12.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 112.719 -2.037 . . . . 10.0 114.922 -167.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 1.053 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -50.65 -74.48 0.28 Allowed Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.203 -0.908 . . . . 10.0 113.452 -173.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.837 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 17.0 Cg_exo -42.79 -43.99 8.95 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.77 2.98 . . . . 10.0 112.441 171.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 24' ' ' VAL . . . -50.06 -98.94 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 123.793 0.683 . . . . 10.0 112.43 177.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.931 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.341 0.0 OUTLIER -73.18 -34.33 65.94 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 117.555 -1.658 . . . . 10.0 113.138 -173.472 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.65 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -67.5 -39.53 91.11 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 121.164 -0.541 . . . . 10.0 113.505 -175.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.745 ' HG3' ' HA ' ' A' ' 26' ' ' PRO . 87.9 mt-30 -68.43 -6.46 24.85 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 118.635 -1.226 . . . . 10.0 111.212 175.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -102.04 22.98 12.21 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.381 0.61 . . . . 10.0 109.584 168.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.28 -3.69 76.35 Favored Glycine 0 CA--C 1.503 -0.699 0 CA-C-N 115.306 -0.861 . . . . 10.0 113.567 168.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.931 ' HB ' HD23 ' A' ' 28' ' ' LEU . 5.0 t -82.99 149.79 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 113.785 1.031 . . . . 10.0 113.785 -170.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.507 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 1.0 OUTLIER -71.39 99.3 1.95 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.001 0.429 . . . . 10.0 110.687 170.756 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.005 HD12 HG12 ' A' ' 24' ' ' VAL . 16.4 mm -51.49 -37.15 18.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 122.21 1.005 . . . . 10.0 111.643 172.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.662 ' HE2' ' HA ' ' A' ' 36' ' ' MET . 5.9 mmt -65.7 -50.31 65.35 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.312 -1.767 . . . . 10.0 111.957 174.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.507 ' HB3' ' HB3' ' A' ' 34' ' ' ASN . 5.6 tp10 -56.09 -41.09 74.64 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.079 -0.648 . . . . 10.0 110.211 174.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.726 ' CE1' HD11 ' A' ' 58' ' ' ILE . 89.9 t80 -56.24 -58.79 6.48 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 113.899 1.074 . . . . 10.0 113.899 171.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.603 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -62.72 -50.3 71.64 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 114.368 -1.287 . . . . 10.0 111.87 -175.415 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -62.88 -23.06 67.15 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 119.223 -0.991 . . . . 10.0 108.911 -177.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.842 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 63.0 mtt180 -75.5 -64.82 0.99 Allowed 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 119.252 -0.979 . . . . 10.0 111.798 166.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.537 ' CZ ' HG21 ' A' ' 46' ' ' THR . 60.3 t80 -50.99 -49.72 59.75 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.09 0.859 . . . . 10.0 111.571 -170.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -60.09 -49.88 75.92 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.514 -0.766 . . . . 10.0 110.425 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.05 -39.81 95.84 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.069 -1.052 . . . . 10.0 112.081 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.842 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 5.9 mm-40 -66.89 -41.76 86.65 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.841 0.829 . . . . 10.0 111.047 -178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.537 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 81.7 p -90.91 1.5 56.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.414 -1.266 . . . . 10.0 112.056 -170.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.46 -37.23 5.01 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.995 -1.002 . . . . 10.0 112.921 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -82.19 -24.96 34.65 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.807 -0.633 . . . . 10.0 112.491 -174.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.4 mttp -104.5 19.06 21.01 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.487 0.66 . . . . 10.0 109.305 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -48.73 143.5 5.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.404 -1.271 . . . . 10.0 112.565 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.99 20.89 27.01 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 114.846 -1.07 . . . . 10.0 110.917 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.554 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 64.2 mtt -138.53 128.87 25.9 Favored 'General case' 0 C--O 1.206 -1.189 0 C-N-CA 117.083 -1.847 . . . . 10.0 114.154 -169.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.8 mm -70.01 93.2 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 121.586 -0.696 . . . . 10.0 109.754 172.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.768 HD22 ' HE2' ' A' ' 77' ' ' PHE . 3.3 mt -80.45 130.04 66.68 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.15 -0.315 . . . . 10.0 110.15 -176.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.523 ' HA ' ' OE1' ' A' ' 12' ' ' GLN . 21.1 Cg_exo -69.68 103.48 1.16 Allowed 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 122.683 2.256 . . . . 10.0 111.44 171.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 69' ' ' ILE . 0.5 OUTLIER -101.9 160.32 4.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 119.402 1.001 . . . . 10.0 112.217 -174.539 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 79.4 t -137.09 119.98 20.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.034 -0.53 . . . . 10.0 110.561 173.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.726 HD11 ' CE1' ' A' ' 38' ' ' PHE . 14.8 mt -110.65 138.2 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.596 0 N-CA-C 108.012 -1.107 . . . . 10.0 108.012 -178.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.4 m -123.48 96.57 5.03 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 114.837 -1.074 . . . . 10.0 108.801 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 65' ' ' SER . 2.3 p -89.04 139.03 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 CA-C-N 119.481 1.037 . . . . 10.0 110.568 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.499 ' HE2' ' HG1' ' A' ' 67' ' ' THR . 70.2 m-85 -96.06 167.86 10.96 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 112.747 0.647 . . . . 10.0 112.747 -177.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -56.66 -23.55 42.48 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 124.271 1.029 . . . . 10.0 112.808 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 6.7 m-20 -80.12 -7.43 58.9 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.683 -1.144 . . . . 10.0 111.287 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 3.2 mptt 79.99 3.4 2.01 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 114.645 -1.161 . . . . 10.0 111.974 -171.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.563 ' O ' HG23 ' A' ' 60' ' ' VAL . 15.6 m -73.11 173.89 8.73 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 107.498 -1.297 . . . . 10.0 107.498 170.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.88 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -168.81 -176.73 2.79 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 120.293 1.406 . . . . 10.0 108.778 174.505 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.499 ' HG1' ' HE2' ' A' ' 61' ' ' TYR . 1.3 p -159.77 168.85 24.93 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 102.759 -3.052 . . . . 10.0 102.759 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.447 ' CB ' HG12 ' A' ' 58' ' ' ILE . 53.3 p90 -163.24 152.89 15.25 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.933 -1.136 . . . . 10.0 107.933 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.514 ' O ' HG22 ' A' ' 56' ' ' VAL . 1.9 mt -116.47 168.84 7.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 106.232 -1.766 . . . . 10.0 106.232 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.8 mt -137.75 113.76 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 N-CA-C 106.306 -1.738 . . . . 10.0 106.306 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 55' ' ' PRO . 3.6 mptp? -77.3 102.12 6.59 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.604 -166.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.489 HG21 ' O ' ' A' ' 111' ' ' THR . 0.2 OUTLIER -58.28 91.24 0.03 OUTLIER Pre-proline 0 C--N 1.315 -0.906 0 O-C-N 124.733 1.271 . . . . 10.0 108.786 165.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.754 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 49.3 Cg_endo -93.7 -166.63 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 123.541 2.828 . . . . 10.0 112.742 -156.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.754 ' HD2' ' HB2' ' A' ' 73' ' ' PRO . 67.5 Cg_exo -30.05 133.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 123.316 2.677 . . . . 10.0 111.785 168.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.691 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -60.52 -8.97 3.14 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.289 0.848 . . . . 10.0 113.289 -166.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 m -50.31 -29.23 9.32 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.604 0.716 . . . . 10.0 110.253 174.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.768 ' HE2' HD22 ' A' ' 54' ' ' LEU . 36.4 t80 -56.01 -66.03 0.5 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.532 -1.213 . . . . 10.0 111.441 176.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.659 HD23 ' HE2' ' A' ' 112' ' ' LYS . 2.7 mm? -82.19 -13.67 56.78 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.903 -0.498 . . . . 10.0 110.233 -175.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.637 HD12 HD13 ' A' ' 137' ' ' ILE . 3.0 mm? -72.9 -23.71 60.75 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 109.341 -0.614 . . . . 10.0 109.341 171.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.929 ' HE2' ' H ' ' A' ' 87' ' ' LYS . 21.4 mmtp -61.89 -40.73 96.43 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.423 -0.584 . . . . 10.0 109.423 167.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.488 ' HD3' ' HA ' ' A' ' 81' ' ' LYS . 24.9 mmtp -62.96 -48.25 79.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.581 -0.736 . . . . 10.0 112.839 174.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.889 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -72.23 -62.68 1.35 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 127.328 2.251 . . . . 10.0 113.564 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.563 ' HB1' HG12 ' A' ' 85' ' ' ILE . . . -76.6 145.97 38.58 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 110.864 -2.88 . . . . 10.0 106.941 -175.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.42 2.22 73.87 Favored Glycine 0 C--N 1.317 -0.479 0 CA-C-N 120.895 1.68 . . . . 10.0 111.246 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.78 HG21 HG22 ' A' ' 97' ' ' VAL . 27.0 pt -68.38 101.7 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.673 -0.763 . . . . 10.0 113.017 -176.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 9.1 tp10 -72.04 101.63 2.78 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.394 -0.595 . . . . 10.0 109.394 170.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.929 ' H ' ' HE2' ' A' ' 80' ' ' LYS . 9.7 mtmp? 90.8 -49.75 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.095 1.358 . . . . 10.0 108.776 -177.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.696 ' HA3' HD12 ' A' ' 85' ' ' ILE . . . 72.08 -137.55 25.45 Favored Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.391 -0.822 . . . . 10.0 112.582 173.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 36.7 p -165.36 89.9 0.47 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.039 0.447 . . . . 10.0 110.339 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.5 p -77.22 -46.47 23.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.728 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.842 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 12.0 mm-40 -68.3 -61.58 3.83 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 115.843 -0.617 . . . . 10.0 111.515 -176.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.842 ' HD3' ' HB2' ' A' ' 91' ' ' GLU . 94.4 Cg_endo -92.91 154.86 2.73 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.273 1.982 . . . . 10.0 112.471 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -165.08 128.05 2.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.086 0.469 . . . . 10.0 110.049 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -162.9 -47.82 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.259 -0.645 . . . . 10.0 109.259 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -71.7 -33.27 68.65 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.177 -1.416 . . . . 10.0 107.177 173.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mt 72.25 143.44 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.414 0 CA-C-O 123.503 1.621 . . . . 10.0 112.632 173.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.78 HG22 HG21 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -94.94 171.92 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.404 -2.739 0 CA-C-N 111.708 -2.496 . . . . 10.0 111.177 -160.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.475 ' N ' HG13 ' A' ' 97' ' ' VAL . . . -57.92 179.51 1.06 Allowed Glycine 0 C--N 1.308 -0.981 0 CA-C-N 113.819 -1.537 . . . . 10.0 113.088 176.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.457 ' HE2' ' HB3' ' A' ' 99' ' ' LYS . 9.8 ptpt -154.26 172.37 17.74 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 122.693 1.235 . . . . 10.0 111.883 -159.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.889 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -160.6 -146.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 111.889 -2.414 . . . . 10.0 105.965 -171.656 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.604 ' O ' ' HG3' ' A' ' 104' ' ' GLN . 1.7 t -162.06 139.73 8.67 Favored 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 119.834 -0.747 . . . . 10.0 109.511 -152.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.663 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 0.0 OUTLIER -43.14 -48.61 6.4 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 114.36 -1.291 . . . . 10.0 111.535 -173.509 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.531 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -56.63 -46.09 81.18 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.127 0.788 . . . . 10.0 113.127 178.201 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.604 ' HG3' ' O ' ' A' ' 101' ' ' THR . 3.7 pp0? -67.74 -37.26 81.91 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.454 -0.943 . . . . 10.0 108.454 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.878 HG23 ' HB ' ' A' ' 128' ' ' ILE . 23.3 mm -47.26 -51.01 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 115.503 -0.771 . . . . 10.0 110.862 168.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.683 ' HG2' ' HE3' ' A' ' 110' ' ' LYS . 23.8 tt0 -50.36 -57.34 8.15 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.296 1.438 . . . . 10.0 113.191 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.491 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 4.3 pt-20 -59.09 -43.55 91.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.355 -0.839 . . . . 10.0 111.199 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.629 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 56.9 mt -51.71 -58.57 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 120.7 0.286 . . . . 10.0 110.919 166.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.489 ' HB3' HD11 ' A' ' 121' ' ' LEU . . . -44.69 -35.11 2.49 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 123.556 0.742 . . . . 10.0 112.334 177.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.683 ' HE3' ' HG2' ' A' ' 106' ' ' GLU . 96.6 mttt -74.45 -53.65 9.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.548 -0.751 . . . . 10.0 111.557 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 108' ' ' ILE . 2.1 t -59.41 -8.74 1.91 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.298 0.851 . . . . 10.0 113.298 -177.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.659 ' HE2' HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -129.94 13.73 5.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.247 0.546 . . . . 10.0 110.379 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.514 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 1.8 ttt -50.65 -46.91 85.95 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 114.844 -1.071 . . . . 10.0 112.389 178.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 113' ' ' MET . 60.6 Cg_endo -69.2 -22.27 34.91 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 121.726 1.617 . . . . 10.0 113.299 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -87.94 -55.15 3.88 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 122.344 1.068 . . . . 10.0 110.537 -175.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.597 HD22 ' HD3' ' A' ' 112' ' ' LYS . 7.1 mp -67.87 178.61 1.69 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 113.267 -1.788 . . . . 10.0 113.746 -168.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -96.72 41.88 1.1 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 112.002 -2.363 . . . . 10.0 112.645 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.613 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . . . -63.38 -99.68 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 113.756 1.021 . . . . 10.0 113.756 174.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.585 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 71.4 m-20 105.16 -78.01 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.8 1.64 . . . . 10.0 107.768 -168.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.449 ' HB3' ' OE1' ' A' ' 122' ' ' GLU . 47.2 m -81.54 146.65 30.05 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.735 -0.839 . . . . 10.0 108.735 163.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.759 ' O ' ' HG3' ' A' ' 125' ' ' MET . 61.1 tp -59.66 -37.68 79.42 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.15 -1.02 . . . . 10.0 110.548 167.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 126' ' ' LYS . 3.4 mp0 -51.21 -36.68 42.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.674 0.749 . . . . 10.0 109.617 171.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.605 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . . . -69.38 -46.96 65.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.577 -1.192 . . . . 10.0 110.735 177.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.613 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . . . -55.7 -41.29 73.56 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 110.179 -0.304 . . . . 10.0 110.179 176.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.759 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 75.2 mtp -55.75 -33.42 64.27 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.762 0.425 . . . . 10.0 111.827 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.605 ' HE2' ' HA ' ' A' ' 123' ' ' ALA . 42.6 mtmt -63.86 -50.77 67.51 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.629 -0.508 . . . . 10.0 109.629 178.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.457 ' CD1' HD23 ' A' ' 116' ' ' LEU . 47.5 mt -49.32 -63.86 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 121.49 0.662 . . . . 10.0 110.379 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.878 ' HB ' HG23 ' A' ' 105' ' ' ILE . 4.9 mm -52.13 -55.07 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 CA-C-N 113.843 -1.526 . . . . 10.0 111.306 -177.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.59 ' CD ' ' HE ' ' A' ' 102' ' ' ARG . 49.2 mt-10 -54.49 -44.51 72.72 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 109.923 -0.399 . . . . 10.0 109.923 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -69.62 -46.01 56.51 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.708 -0.758 . . . . 10.0 111.748 -174.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.691 HG21 ' HB3' ' A' ' 75' ' ' ALA . 51.6 m -50.09 -58.62 5.13 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.536 -0.832 . . . . 10.0 109.379 171.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.422 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -50.71 -53.4 31.69 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.008 0.433 . . . . 10.0 111.22 176.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -47.84 -48.43 30.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.198 -0.91 . . . . 10.0 111.32 176.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 27.2 t -63.61 -35.85 81.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.0 0.428 . . . . 10.0 110.732 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 53.4 mtm -84.66 10.68 10.58 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.579 0.955 . . . . 10.0 113.579 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 81.55 8.19 87.28 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 119.341 0.973 . . . . 10.0 112.127 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.637 HD13 HD12 ' A' ' 79' ' ' LEU . 47.4 mt -94.73 124.93 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 CA-C-O 121.39 0.614 . . . . 10.0 112.017 -176.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -84.38 151.79 24.47 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.125 -1.03 . . . . 10.0 110.943 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 16.6 m -113.45 126.44 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.045 0 N-CA-C 107.8 -1.185 . . . . 10.0 107.8 168.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 100' ' ' VAL . 2.9 m -104.83 138.54 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-N 114.44 -1.255 . . . . 10.0 109.302 176.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 C--N 1.29 -2.003 0 CA-C-N 114.678 -1.146 . . . . 10.0 109.821 -177.09 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 120.609 0.243 . . . . 10.0 110.424 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.528 ' HB1' ' HE3' ' A' ' 4' ' ' LYS . . . 82.11 79.37 0.03 OUTLIER 'General case' 0 C--O 1.232 0.143 0 O-C-N 124.331 1.02 . . . . 10.0 113.398 168.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.507 ' HG3' ' HE1' ' A' ' 61' ' ' TYR . 20.5 tptt -83.75 89.9 7.24 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 106.754 -1.573 . . . . 10.0 106.754 162.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.597 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 10.3 mmtp -76.73 70.1 3.17 Favored 'General case' 0 C--O 1.196 -1.749 0 C-N-CA 120.316 -0.553 . . . . 10.0 110.25 -174.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.1 t -74.58 119.42 22.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 119.153 0.888 . . . . 10.0 109.863 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.427 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . . . -98.13 -35.18 10.48 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.83 -0.804 . . . . 10.0 108.83 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.401 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -161.29 -174.06 4.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.037 -0.983 . . . . 10.0 112.801 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 78.6 mt-30 -141.56 131.3 24.21 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.123 -1.399 . . . . 10.0 108.649 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.627 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.9 OUTLIER -120.89 80.98 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 108.945 -0.761 . . . . 10.0 108.945 -176.391 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 56' ' ' VAL . 57.4 tttp -79.43 128.5 33.43 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 119.82 1.191 . . . . 10.0 108.339 176.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.624 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.85 127.98 6.18 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 122.116 0.96 . . . . 10.0 111.471 -174.826 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.56 119.32 22.37 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.226 -1.352 . . . . 10.0 109.749 -172.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.624 HD21 HD11 ' A' ' 11' ' ' LEU . 46.8 mt -135.52 140.31 33.7 Favored Pre-proline 0 CA--C 1.502 -0.896 0 N-CA-C 113.138 0.792 . . . . 10.0 113.138 -170.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.679 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 14.7 Cg_exo -61.87 122.44 10.98 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 123.325 2.683 . . . . 10.0 111.241 174.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.523 ' CB ' ' HA ' ' A' ' 50' ' ' ALA . . . -60.84 125.11 22.49 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.637 -1.246 . . . . 10.0 107.637 169.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.83 1.83 89.82 Favored Glycine 0 N--CA 1.442 -0.905 0 O-C-N 126.015 2.072 . . . . 10.0 113.115 -173.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.679 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 7.6 tppt? -144.07 105.27 4.24 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.334 1.067 . . . . 10.0 113.14 177.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.937 ' H ' HD22 ' A' ' 43' ' ' ASN . . . -172.47 128.89 0.55 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.776 -1.556 . . . . 10.0 111.202 170.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.543 ' H ' ' CD ' ' A' ' 20' ' ' PRO . 15.6 m -174.06 -43.46 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.132 0.895 . . . . 10.0 112.166 -174.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.828 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 44.2 Cg_endo -98.68 122.3 0.14 Allowed 'Trans proline' 0 N--CA 1.434 -2.008 0 C-N-CA 121.104 1.203 . . . . 10.0 114.892 -166.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.083 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . -3.51 -80.05 0.0 OUTLIER Pre-proline 0 C--O 1.212 -0.919 0 CA-C-N 111.658 -2.519 . . . . 10.0 114.542 166.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.871 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 52.4 Cg_exo -22.33 -55.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.978 3.119 . . . . 10.0 115.995 -165.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.871 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 10.0 Cg_endo -81.81 -75.97 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 122.347 2.031 . . . . 10.0 112.151 168.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.449 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 92.7 t -60.95 -46.73 96.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 112.542 -2.117 . . . . 10.0 114.919 -171.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 1.083 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -49.55 -73.41 0.36 Allowed Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 114.472 -1.24 . . . . 10.0 113.225 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.693 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 11.2 Cg_exo -45.89 -43.17 19.86 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.885 3.057 . . . . 10.0 112.737 171.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 24' ' ' VAL . . . -49.22 -98.23 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.567 0.58 . . . . 10.0 112.567 175.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.675 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.297 0.0 OUTLIER -70.41 -25.38 63.19 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 118.278 -1.369 . . . . 10.0 113.529 -174.872 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.535 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -66.27 -35.54 90.47 Favored Glycine 0 N--CA 1.464 0.521 0 C-N-CA 121.285 -0.483 . . . . 10.0 112.513 -177.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -58.83 -25.93 63.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.136 0.493 . . . . 10.0 109.72 173.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -99.55 17.89 19.3 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.584 0.707 . . . . 10.0 109.488 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.455 ' HA3' ' HE2' ' A' ' 64' ' ' LYS . . . 85.62 6.39 83.26 Favored Glycine 0 CA--C 1.5 -0.88 0 CA-C-N 114.492 -1.231 . . . . 10.0 113.411 168.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.78 HG11 ' CD2' ' A' ' 66' ' ' PHE . 1.9 t -86.66 147.74 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 114.044 1.127 . . . . 10.0 114.044 -172.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 88.5 m-20 -68.08 102.97 1.41 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.546 0.738 . . . . 10.0 111.348 174.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.589 ' CD1' ' HA2' ' A' ' 25' ' ' GLY . 90.2 mt -50.72 -45.84 27.76 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 CA-C-O 122.526 1.155 . . . . 10.0 110.6 172.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.419 ' SD ' ' N ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -67.2 -52.21 43.97 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 111.833 -2.44 . . . . 10.0 112.898 -177.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 34' ' ' ASN . 82.0 tt0 -56.12 -38.51 70.87 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 120.035 -0.666 . . . . 10.0 110.05 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.787 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 20.9 t80 -59.8 -59.29 5.66 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 114.045 1.128 . . . . 10.0 114.045 168.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.589 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -54.86 -53.36 56.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.498 -1.683 . . . . 10.0 112.11 -176.222 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.436 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 12.3 tppt? -68.63 -19.25 64.41 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.611 -0.836 . . . . 10.0 109.101 -176.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.782 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 64.9 mtt180 -79.91 -62.53 1.65 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.115 -1.034 . . . . 10.0 112.907 168.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.567 ' CZ ' HG21 ' A' ' 46' ' ' THR . 66.3 t80 -53.99 -45.69 71.5 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 119.213 0.915 . . . . 10.0 110.11 -174.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.937 HD22 ' H ' ' A' ' 18' ' ' ALA . 5.4 m-20 -61.45 -51.36 69.01 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.536 -1.211 . . . . 10.0 110.874 -178.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.96 -37.38 86.85 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 118.815 -1.154 . . . . 10.0 111.811 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.782 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 7.6 mm-40 -67.48 -45.31 76.28 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.896 0.855 . . . . 10.0 110.882 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.596 ' CG2' HD12 ' A' ' 54' ' ' LEU . 82.7 p -85.67 2.77 43.93 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-N 114.567 -1.197 . . . . 10.0 112.111 -171.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.3 -36.59 14.49 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.812 -1.085 . . . . 10.0 112.318 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -83.4 -34.74 25.46 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.008 -0.996 . . . . 10.0 110.888 -174.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mtpp -97.6 20.84 11.17 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.804 -0.813 . . . . 10.0 108.804 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.523 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -55.1 152.21 8.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.524 -1.216 . . . . 10.0 113.582 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.16 16.26 44.77 Favored Glycine 0 CA--C 1.507 -0.462 0 N-CA-C 109.879 -1.288 . . . . 10.0 109.879 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.46 ' HB2' HD21 ' A' ' 54' ' ' LEU . 45.7 mtm -137.97 125.8 22.5 Favored 'General case' 0 C--O 1.213 -0.859 0 C-N-CA 116.385 -2.126 . . . . 10.0 114.562 -166.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.0 mm -66.1 90.22 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.514 -0.55 . . . . 10.0 109.514 172.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.627 HD13 HG21 ' A' ' 70' ' ' ILE . 7.9 mt -79.4 128.69 74.49 Favored Pre-proline 0 N--CA 1.447 -0.61 0 N-CA-C 108.972 -0.751 . . . . 10.0 108.972 -177.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.659 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 11.0 Cg_exo -72.33 95.02 0.76 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.002 1.802 . . . . 10.0 110.756 174.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.503 ' O ' ' HG3' ' A' ' 10' ' ' LYS . 0.4 OUTLIER -92.38 157.74 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 119.125 0.875 . . . . 10.0 111.417 -171.06 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.426 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 89.4 t -135.04 117.53 22.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 110.278 -0.268 . . . . 10.0 110.278 172.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.627 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 24.0 mt -106.59 139.5 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 108.027 -1.101 . . . . 10.0 108.027 -175.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.7 m -123.44 98.36 5.82 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 108.481 -0.933 . . . . 10.0 108.481 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 65' ' ' SER . 1.5 p -87.03 136.0 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.07 0 CA-C-N 118.979 0.809 . . . . 10.0 111.286 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.597 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 89.5 m-85 -94.12 170.19 9.71 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 114.989 -1.005 . . . . 10.0 113.011 -175.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.437 ' HG3' ' HB3' ' A' ' 4' ' ' LYS . 28.9 mt-10 -63.17 -17.61 62.57 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.535 -1.211 . . . . 10.0 111.824 -176.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -78.0 -10.78 59.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.136 175.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.455 ' HE2' ' HA3' ' A' ' 32' ' ' GLY . 1.6 mtpt 80.69 2.28 1.79 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.416 1.086 . . . . 10.0 109.527 -169.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.571 ' O ' HG23 ' A' ' 60' ' ' VAL . 21.2 p -69.26 -179.24 1.54 Allowed 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.776 -1.556 . . . . 10.0 108.616 170.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.787 ' CE2' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -171.02 -175.1 1.65 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 120.032 1.287 . . . . 10.0 110.538 174.096 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 p -157.9 170.45 22.3 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 102.875 -3.009 . . . . 10.0 102.875 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -158.69 156.5 30.05 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.423 -0.954 . . . . 10.0 108.423 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.426 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 24.8 pt -128.71 153.26 37.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.272 -1.381 . . . . 10.0 107.272 -177.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.627 HG21 HD13 ' A' ' 54' ' ' LEU . 3.6 mm -107.87 132.0 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 N-CA-C 107.626 -1.25 . . . . 10.0 107.626 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.659 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 5.1 mmtp -77.32 85.54 3.74 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 118.942 -1.103 . . . . 10.0 109.337 176.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.835 HG23 ' HB3' ' A' ' 112' ' ' LYS . 15.3 t -63.99 -21.62 0.76 Allowed Pre-proline 0 CA--C 1.558 1.26 0 CA-C-N 112.745 -2.025 . . . . 10.0 113.151 174.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.888 ' HB3' ' HB2' ' A' ' 112' ' ' LYS . 56.8 Cg_endo -101.91 55.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.22 1.947 . . . . 10.0 117.144 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.572 ' HD3' ' O ' ' A' ' 71' ' ' LYS . 17.0 Cg_exo -71.86 -17.52 28.89 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 N-CA-C 107.9 -1.616 . . . . 10.0 107.9 154.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 69.19 -55.34 0.56 Allowed 'General case' 0 C--N 1.343 0.307 0 CA-C-N 113.335 -1.757 . . . . 10.0 111.481 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.547 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 13.5 p -56.87 -40.17 75.69 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.055 -0.52 . . . . 10.0 111.923 -176.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.622 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -74.75 -33.74 62.37 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.106 0.479 . . . . 10.0 111.697 -173.086 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.751 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 3.7 tp -89.57 -17.8 27.83 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.533 -0.867 . . . . 10.0 108.905 177.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.651 HD21 ' HB2' ' A' ' 132' ' ' ALA . 8.7 tp -72.05 -23.26 61.34 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.316 -0.994 . . . . 10.0 108.316 168.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.622 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 24.0 mmtm -64.04 -27.5 69.15 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-O 121.195 0.521 . . . . 10.0 109.769 167.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.751 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -60.33 -45.18 94.34 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.484 -0.486 . . . . 10.0 111.508 171.665 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 1.001 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -71.07 -55.85 7.38 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.642 1.577 . . . . 10.0 112.075 173.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.7 122.25 22.95 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 111.907 -2.406 . . . . 10.0 107.63 -176.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 86' ' ' GLU . . . -85.65 11.12 62.55 Favored Glycine 0 C--N 1.32 -0.307 0 CA-C-N 120.815 1.643 . . . . 10.0 111.284 -164.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.432 ' C ' ' H ' ' A' ' 87' ' ' LYS . 36.8 pt -69.66 30.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 124.241 1.017 . . . . 10.0 113.118 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.419 ' H ' ' C ' ' A' ' 84' ' ' GLY . 2.2 tp10 -72.12 11.84 0.51 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.334 0.588 . . . . 10.0 111.452 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.432 ' H ' ' C ' ' A' ' 85' ' ' ILE . 66.4 mttm -161.04 90.39 0.83 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.178 -1.045 . . . . 10.0 108.178 -173.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.33 96.89 2.44 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.285 -0.959 . . . . 10.0 111.436 -175.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.3 p -163.54 77.4 0.4 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.472 0.653 . . . . 10.0 110.868 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.537 ' O ' ' HB2' ' A' ' 91' ' ' GLU . 13.0 m -79.29 22.81 0.41 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.69 -0.686 . . . . 10.0 111.149 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 90' ' ' SER . 23.3 mm-40 78.29 80.34 0.12 Allowed Pre-proline 0 N--CA 1.467 0.417 0 O-C-N 124.116 0.885 . . . . 10.0 109.825 -171.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -92.61 150.41 2.86 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.129 2.552 . . . . 10.0 113.622 -173.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.507 ' O ' ' HD3' ' A' ' 95' ' ' LYS . 24.5 pttm -165.36 174.32 10.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.855 -0.611 . . . . 10.0 109.967 175.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.477 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 0.1 OUTLIER 78.41 -80.33 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.277 0.631 . . . . 10.0 111.337 170.863 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.507 ' HD3' ' O ' ' A' ' 93' ' ' LYS . 0.4 OUTLIER -72.73 -13.6 61.37 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 107.705 -1.22 . . . . 10.0 107.705 179.193 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.492 HG23 ' H ' ' A' ' 97' ' ' VAL . 4.7 mt 75.56 174.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 113.447 -1.706 . . . . 10.0 109.924 175.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.556 HG13 ' N ' ' A' ' 98' ' ' GLY . 11.4 p -141.86 -50.98 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 113.648 0.981 . . . . 10.0 113.648 -168.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.625 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -156.56 165.93 33.13 Favored Glycine 0 N--CA 1.44 -1.084 0 N-CA-C 109.461 -1.456 . . . . 10.0 109.461 176.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.617 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -154.1 170.86 20.15 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-O 122.197 0.999 . . . . 10.0 110.57 -163.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 1.001 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -159.37 -143.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-N 112.834 -1.985 . . . . 10.0 106.584 -172.56 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.603 ' OG1' ' HG2' ' A' ' 104' ' ' GLN . 17.2 p -153.9 143.98 22.05 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 107.618 -1.253 . . . . 10.0 107.618 -153.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.629 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 12.9 tpt180 -42.62 -41.24 3.0 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 114.854 -1.066 . . . . 10.0 110.034 177.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 3.5 tmtm? -60.15 -46.26 90.28 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.403 0.52 . . . . 10.0 112.403 177.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.603 ' HG2' ' OG1' ' A' ' 101' ' ' THR . 14.0 mm100 -66.02 -42.82 89.16 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.982 -0.747 . . . . 10.0 108.982 -177.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.865 HG23 ' HB ' ' A' ' 128' ' ' ILE . 30.8 mm -40.53 -58.11 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 114.604 -1.18 . . . . 10.0 110.832 164.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.638 ' HG2' ' HE3' ' A' ' 110' ' ' LYS . 31.7 tt0 -47.79 -50.35 26.07 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 114.633 -1.167 . . . . 10.0 112.917 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.426 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 35.2 mm-40 -54.45 -58.1 8.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.303 -0.862 . . . . 10.0 111.143 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.682 ' O ' HG22 ' A' ' 111' ' ' THR . 11.8 mm -48.97 -53.58 7.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-O 121.932 0.873 . . . . 10.0 109.95 172.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.524 ' CB ' HD11 ' A' ' 121' ' ' LEU . . . -48.67 -36.68 16.57 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.02 -0.991 . . . . 10.0 112.354 176.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.638 ' HE3' ' HG2' ' A' ' 106' ' ' GLU . 84.1 mttt -74.95 -54.02 7.95 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.409 -0.36 . . . . 10.0 111.44 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.682 HG22 ' O ' ' A' ' 108' ' ' ILE . 7.1 t -51.52 -22.93 3.53 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.242 1.201 . . . . 10.0 114.242 -171.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.888 ' HB2' ' HB3' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -130.01 19.4 5.48 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.576 0.703 . . . . 10.0 109.404 -174.593 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.66 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 54.8 ttm -52.21 -43.17 89.87 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 114.712 -1.131 . . . . 10.0 111.855 169.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 113' ' ' MET . 10.9 Cg_endo -52.64 -29.77 42.73 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.706 2.27 . . . . 10.0 112.259 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.528 ' CB ' ' HG3' ' A' ' 73' ' ' PRO . 21.1 t70 -91.19 -43.8 9.63 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.926 -1.034 . . . . 10.0 111.454 -176.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.867 HD21 HD12 ' A' ' 127' ' ' ILE . 3.2 mp -69.02 178.26 2.31 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.723 -1.581 . . . . 10.0 114.509 -167.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -94.29 29.55 2.17 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 111.303 -2.68 . . . . 10.0 112.209 171.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.659 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . . . -73.97 92.03 2.08 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.346 0.499 . . . . 10.0 112.346 175.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -66.28 -28.71 68.91 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.609 -0.885 . . . . 10.0 108.609 172.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.7 t -152.96 140.92 20.24 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 105.441 -2.059 . . . . 10.0 105.441 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.784 ' O ' ' HG3' ' A' ' 125' ' ' MET . 45.0 tp -53.07 -32.56 47.72 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.117 1.154 . . . . 10.0 114.117 -172.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -50.17 -35.92 28.2 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.591 0.71 . . . . 10.0 110.243 173.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.75 -50.56 56.6 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.236 -0.986 . . . . 10.0 110.969 176.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.716 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -60.23 -31.99 70.7 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 119.734 -0.786 . . . . 10.0 110.738 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.784 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 75.5 mtp -58.0 -36.42 72.63 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.701 0.286 . . . . 10.0 110.746 176.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -64.24 -54.06 39.43 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.101 0.56 . . . . 10.0 111.726 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.867 HD12 HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -51.48 -57.72 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 121.33 0.586 . . . . 10.0 110.739 179.005 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.865 ' HB ' HG23 ' A' ' 105' ' ' ILE . 21.5 mm -51.2 -54.06 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 CA-C-N 114.745 -1.116 . . . . 10.0 111.879 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.619 ' HG3' HG21 ' A' ' 105' ' ' ILE . 80.8 mt-10 -54.8 -40.97 70.04 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 123.325 0.391 . . . . 10.0 110.031 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -69.8 -46.8 51.56 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.194 -1.003 . . . . 10.0 111.015 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 86.3 m -44.59 -64.12 0.76 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 113.98 -1.11 . . . . 10.0 109.308 169.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.651 ' HB2' HD21 ' A' ' 79' ' ' LEU . . . -48.13 -50.3 29.14 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.008 -0.542 . . . . 10.0 111.775 177.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -49.05 -52.82 23.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.972 -1.013 . . . . 10.0 111.324 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 22.8 t -64.04 -33.02 74.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.868 0.366 . . . . 10.0 111.262 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.516 ' CE ' HD23 ' A' ' 79' ' ' LEU . 67.9 mtm -84.46 8.07 17.63 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 114.316 1.228 . . . . 10.0 114.316 -174.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.452 ' O ' HG23 ' A' ' 96' ' ' ILE . . . 78.9 15.34 80.83 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 119.815 1.188 . . . . 10.0 111.603 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 19.4 mt -100.43 122.74 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 CA-C-O 121.5 0.667 . . . . 10.0 111.228 178.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.617 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -88.51 156.2 19.22 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 115.0 -1.0 . . . . 10.0 109.569 -179.217 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 17.1 m -115.47 121.22 66.78 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 CA-C-O 122.141 0.972 . . . . 10.0 108.517 172.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.646 HG22 ' O ' ' A' ' 100' ' ' VAL . 4.9 m -105.21 148.91 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 CA-C-N 113.752 -1.567 . . . . 10.0 108.544 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 34.2 t70 . . . . . 0 C--N 1.286 -2.168 0 CA-C-N 113.718 -1.583 . . . . 10.0 110.571 179.684 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtm . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 120.993 0.425 . . . . 10.0 110.225 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.79 153.94 30.52 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.968 -0.56 . . . . 10.0 109.737 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.417 ' HB2' ' CG ' ' A' ' 61' ' ' TYR . 22.3 pttm -69.11 117.72 11.11 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.427 0.632 . . . . 10.0 111.324 -178.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -99.09 140.58 33.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.419 -0.809 . . . . 10.0 109.81 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.32 130.13 25.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.771 0.32 . . . . 10.0 111.272 -176.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.63 -40.58 5.72 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.576 -0.527 . . . . 10.0 109.576 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.478 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -155.37 155.52 33.78 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 113.861 1.06 . . . . 10.0 113.861 -176.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -92.64 136.25 33.39 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.424 -1.262 . . . . 10.0 109.145 170.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.702 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -123.62 79.56 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.299 -1.0 . . . . 10.0 108.299 165.317 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.477 ' HG2' HG13 ' A' ' 57' ' ' VAL . 52.9 mttm -81.33 125.58 30.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 120.531 1.514 . . . . 10.0 107.751 175.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.587 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -158.15 131.35 7.49 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 122.485 1.136 . . . . 10.0 112.562 -172.155 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.721 ' HB3' HG23 ' A' ' 53' ' ' ILE . 95.0 mt-30 -84.04 116.51 22.88 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 113.79 -1.55 . . . . 10.0 111.489 -173.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.587 HD21 HD11 ' A' ' 11' ' ' LEU . 80.0 mt -136.65 140.73 32.96 Favored Pre-proline 0 C--O 1.219 -0.542 0 N-CA-C 113.262 0.838 . . . . 10.0 113.262 -172.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.843 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 36.0 Cg_exo -63.28 131.95 34.23 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 C-N-CA 124.443 3.429 . . . . 10.0 113.445 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.517 ' O ' ' HA2' ' A' ' 51' ' ' GLY . . . -56.73 124.41 18.32 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 108.447 -0.945 . . . . 10.0 108.447 167.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.33 7.16 82.13 Favored Glycine 0 N--CA 1.444 -0.818 0 O-C-N 125.356 1.66 . . . . 10.0 113.507 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.843 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 24.5 mmtp -142.49 97.95 3.21 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.236 1.018 . . . . 10.0 112.798 178.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.708 ' H ' HD22 ' A' ' 43' ' ' ASN . . . -171.35 135.84 0.98 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.321 -1.309 . . . . 10.0 112.967 172.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.624 HG23 ' HD3' ' A' ' 20' ' ' PRO . 1.1 t -179.04 -45.3 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 114.894 -1.048 . . . . 10.0 113.354 175.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.744 ' HD2' ' H ' ' A' ' 21' ' ' ALA . 69.6 Cg_endo -118.34 -46.54 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.257 0 N-CA-C 117.002 1.885 . . . . 10.0 117.002 -171.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.744 ' H ' ' HD2' ' A' ' 20' ' ' PRO . . . -47.48 154.74 0.82 Allowed Pre-proline 0 N--CA 1.467 0.392 0 N-CA-C 113.688 0.995 . . . . 10.0 113.688 -165.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.527 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 53.5 Cg_exo -38.94 -41.18 1.71 Allowed 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 124.583 3.522 . . . . 10.0 115.075 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 22' ' ' PRO . 3.1 Cg_exo -41.26 -54.69 2.49 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.542 2.161 . . . . 10.0 112.448 167.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.632 HG13 HD12 ' A' ' 28' ' ' LEU . 89.2 t -89.68 -55.54 6.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.59 -1.186 . . . . 10.0 113.887 -170.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.511 ' HA2' ' CD1' ' A' ' 35' ' ' ILE . . . -45.61 -73.2 0.3 Allowed Glycine 0 C--N 1.337 0.59 0 CA-C-N 114.247 -1.342 . . . . 10.0 113.668 -175.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 22' ' ' PRO . 88.9 Cg_exo -51.27 -44.44 43.03 Favored 'Trans proline' 0 C--O 1.225 -0.133 0 C-N-CA 123.561 2.84 . . . . 10.0 112.667 173.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 23' ' ' PRO . . . -50.71 -76.19 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.496 0.665 . . . . 10.0 111.38 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.712 ' HB2' HG12 ' A' ' 35' ' ' ILE . 3.8 mt -69.34 -44.33 71.85 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.331 -0.849 . . . . 10.0 113.098 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.44 -44.35 97.75 Favored Glycine 0 C--O 1.229 -0.159 0 CA-C-N 116.253 -0.431 . . . . 10.0 112.949 -173.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -62.06 -25.43 67.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.647 0.261 . . . . 10.0 110.565 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -101.34 13.64 34.43 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 120.113 -0.635 . . . . 10.0 110.787 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.34 12.94 83.83 Favored Glycine 0 CA--C 1.503 -0.707 0 CA-C-N 114.947 -1.024 . . . . 10.0 113.036 169.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.599 HG22 HG21 ' A' ' 60' ' ' VAL . 48.3 t -81.78 142.39 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 115.194 -0.503 . . . . 10.0 111.992 -173.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 81.6 m-20 -67.29 90.27 0.22 Allowed 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.025 0.441 . . . . 10.0 110.022 175.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.712 HG12 ' HB2' ' A' ' 28' ' ' LEU . 33.7 mt -55.24 -39.65 52.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.767 0.794 . . . . 10.0 111.463 177.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.616 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 62.9 mtm -64.55 -50.61 66.6 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.903 -1.498 . . . . 10.0 111.113 176.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.586 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 20.2 tt0 -55.66 -50.05 71.27 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.05 -0.66 . . . . 10.0 110.313 174.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.644 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . 61.9 t80 -55.65 -54.97 37.67 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 113.732 1.012 . . . . 10.0 113.732 176.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.641 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 8.8 p -56.19 -48.11 77.02 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.346 -0.843 . . . . 10.0 110.662 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.419 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 46.5 mmtm -67.69 -22.32 65.28 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.712 -0.795 . . . . 10.0 109.925 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.82 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 29.9 mtp180 -75.77 -63.75 1.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.651 -0.704 . . . . 10.0 111.559 171.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.644 ' CZ ' HG21 ' A' ' 46' ' ' THR . 79.3 t80 -55.33 -47.16 76.1 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.481 0.658 . . . . 10.0 110.619 -173.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.708 HD22 ' H ' ' A' ' 18' ' ' ALA . 5.4 m-20 -61.06 -48.3 82.38 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.674 -1.148 . . . . 10.0 110.539 -176.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.94 93.68 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 118.901 -1.12 . . . . 10.0 111.737 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.82 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 11.4 mm-40 -66.53 -39.21 88.49 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.711 0.767 . . . . 10.0 111.786 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.648 ' CG2' HD12 ' A' ' 54' ' ' LEU . 64.6 p -92.6 -10.96 35.58 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 114.096 1.146 . . . . 10.0 114.096 -166.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.52 -37.19 37.8 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 113.575 0.954 . . . . 10.0 113.575 -171.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -75.35 -35.99 61.08 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.576 -0.738 . . . . 10.0 109.268 -175.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.515 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 4.3 mppt? -93.87 49.33 1.33 Allowed 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 122.926 0.49 . . . . 10.0 110.848 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.815 ' CB ' ' HG3' ' A' ' 52' ' ' MET . . . 100.0 -152.84 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 114.885 1.439 . . . . 10.0 114.885 146.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 15' ' ' ALA . . . -123.99 83.6 0.36 Allowed Glycine 0 N--CA 1.419 -2.466 0 N-CA-C 105.491 -3.043 . . . . 10.0 105.491 164.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.815 ' HG3' ' CB ' ' A' ' 50' ' ' ALA . 29.3 mtm -139.1 131.15 27.93 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 116.214 1.931 . . . . 10.0 116.214 -160.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.721 HG23 ' HB3' ' A' ' 12' ' ' GLN . 0.4 OUTLIER -67.94 94.29 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 119.38 -0.928 . . . . 10.0 110.225 171.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.648 HD12 ' CG2' ' A' ' 46' ' ' THR . 11.4 mt -83.36 128.53 64.08 Favored Pre-proline 0 N--CA 1.437 -1.108 0 CA-C-N 115.139 -0.937 . . . . 10.0 108.788 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.427 ' HD2' ' HD3' ' A' ' 73' ' ' PRO . 26.9 Cg_exo -64.88 98.05 0.29 Allowed 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.216 1.944 . . . . 10.0 110.946 175.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -97.47 153.74 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 119.011 0.823 . . . . 10.0 110.946 -173.451 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.477 HG13 ' HG2' ' A' ' 10' ' ' LYS . 92.4 t -134.27 114.23 18.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 C-N-CA 121.015 -0.274 . . . . 10.0 110.359 173.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.702 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 22.8 mt -106.66 137.49 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.795 0 N-CA-C 108.003 -1.11 . . . . 10.0 108.003 -173.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 31.6 m -121.76 95.53 4.71 Favored 'General case' 0 N--CA 1.405 -2.675 0 CA-C-N 114.707 -1.133 . . . . 10.0 108.642 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.599 HG21 HG22 ' A' ' 33' ' ' VAL . 3.1 p -86.64 137.14 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-N 119.28 0.945 . . . . 10.0 110.599 -178.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.452 ' CD2' ' HA ' ' A' ' 66' ' ' PHE . 66.0 m-85 -96.28 172.49 7.92 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 113.001 0.741 . . . . 10.0 113.001 -176.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -53.86 -27.25 28.82 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.03 -1.441 . . . . 10.0 112.602 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.572 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 4.0 m-20 -77.61 -10.76 59.69 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.371 -0.832 . . . . 10.0 111.591 -173.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 51.5 mtpt 83.3 -0.16 1.13 Allowed 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.276 1.036 . . . . 10.0 109.537 -164.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.488 ' O ' HG23 ' A' ' 60' ' ' VAL . 50.6 m -70.89 170.77 11.95 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 113.626 -1.624 . . . . 10.0 108.234 173.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.644 ' CZ ' ' HB2' ' A' ' 38' ' ' PHE . 6.0 p90 -168.44 -176.12 2.74 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 120.372 1.442 . . . . 10.0 110.373 175.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.6 p -157.72 171.74 19.77 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 103.1 -2.926 . . . . 10.0 103.1 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.442 ' CB ' HG12 ' A' ' 58' ' ' ILE . 38.1 p90 -161.41 155.62 22.56 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.404 -0.962 . . . . 10.0 108.404 177.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.408 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 29.9 pt -128.53 166.97 24.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.289 -1.375 . . . . 10.0 107.289 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.482 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 2.5 mt -138.1 119.02 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 107.544 -1.28 . . . . 10.0 107.544 -177.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.421 ' HZ2' ' HB2' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -83.44 67.55 9.38 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.597 -0.89 . . . . 10.0 108.597 -176.702 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -20.59 96.37 0.05 OUTLIER Pre-proline 0 C--O 1.224 -0.24 0 O-C-N 125.879 1.987 . . . . 10.0 112.244 176.005 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.427 ' HD3' ' HD2' ' A' ' 55' ' ' PRO . 3.8 Cg_exo -36.65 124.3 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 124.406 3.404 . . . . 10.0 113.65 -167.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.872 ' HA ' ' HZ1' ' A' ' 112' ' ' LYS . 86.1 Cg_exo -48.09 86.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.17 3.247 . . . . 10.0 114.085 -176.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 1.092 ' H ' ' HE2' ' A' ' 112' ' ' LYS . . . 72.49 -49.75 0.7 Allowed 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 124.708 1.203 . . . . 10.0 112.509 173.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.675 ' HA ' ' HE1' ' A' ' 135' ' ' MET . 8.0 p -37.39 -65.29 0.32 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 114.116 1.154 . . . . 10.0 114.116 -171.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.714 ' HB3' ' SD ' ' A' ' 52' ' ' MET . 41.6 m-85 -72.32 -40.75 67.22 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.26 0.837 . . . . 10.0 113.26 -171.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.812 ' HB3' HD12 ' A' ' 108' ' ' ILE . 2.7 mm? -68.32 -30.62 69.64 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.547 -0.721 . . . . 10.0 109.863 177.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.538 HD13 ' HB2' ' A' ' 132' ' ' ALA . 28.0 mt -70.94 -25.41 62.73 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.967 -0.56 . . . . 10.0 110.914 175.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.774 ' HA ' HG13 ' A' ' 85' ' ' ILE . 25.1 mmmt -54.15 -49.28 69.62 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 108.638 -0.875 . . . . 10.0 108.638 174.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -58.33 -44.99 88.92 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.881 0.697 . . . . 10.0 112.881 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.751 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -65.86 -55.57 16.35 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 123.031 1.396 . . . . 10.0 110.165 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.559 ' HB1' ' HA3' ' A' ' 98' ' ' GLY . . . -63.84 -33.12 74.97 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 111.119 -2.764 . . . . 10.0 110.597 -172.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.09 -15.33 56.66 Favored Glycine 0 C--N 1.309 -0.932 0 C-N-CA 120.154 -1.022 . . . . 10.0 110.934 177.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.774 HG13 ' HA ' ' A' ' 80' ' ' LYS . 3.5 pt -57.11 97.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 121.555 0.693 . . . . 10.0 110.63 170.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -165.92 131.36 2.43 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.034 -0.984 . . . . 10.0 108.827 -173.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 58.6 tttp 84.08 -33.42 0.07 Allowed 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 123.942 0.897 . . . . 10.0 109.555 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 176.29 -49.71 0.11 Allowed Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.038 -1.077 . . . . 10.0 113.448 172.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.5 p 49.88 104.44 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.741 0.816 . . . . 10.0 112.301 -174.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.0 m -73.02 12.68 0.5 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.623 -0.717 . . . . 10.0 112.923 -173.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 66.88 89.8 0.09 OUTLIER Pre-proline 0 C--O 1.235 0.312 0 CA-C-O 120.963 0.411 . . . . 10.0 110.781 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.786 ' HD2' ' HA ' ' A' ' 97' ' ' VAL . 72.4 Cg_endo -78.85 106.51 2.1 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.572 2.182 . . . . 10.0 111.886 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -77.71 76.33 4.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.017 0.436 . . . . 10.0 111.231 -174.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -164.18 -45.13 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.078 -0.964 . . . . 10.0 108.413 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.849 ' HD2' ' HE2' ' A' ' 99' ' ' LYS . 24.3 mmtp -79.22 -95.07 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 106.837 -1.542 . . . . 10.0 106.837 173.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.567 ' HB ' ' O ' ' A' ' 136' ' ' GLY . 1.6 mt -153.14 -61.69 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.49 -1.351 0 N-CA-C 106.468 -1.679 . . . . 10.0 106.468 164.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.786 ' HA ' ' HD2' ' A' ' 92' ' ' PRO . 3.3 p -157.59 -51.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 CA-C-N 112.38 -2.191 . . . . 10.0 108.41 168.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.625 ' H ' HG13 ' A' ' 97' ' ' VAL . . . -133.92 147.99 19.26 Favored Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 109.325 -1.51 . . . . 10.0 109.325 164.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.849 ' HE2' ' HD2' ' A' ' 95' ' ' LYS . 64.4 pttt -148.11 160.95 42.36 Favored 'General case' 0 CA--C 1.472 -2.022 0 CA-C-O 122.144 0.973 . . . . 10.0 108.803 172.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.751 HG11 ' HB1' ' A' ' 82' ' ' ALA . 1.2 m -161.18 -162.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.411 -2.399 0 CA-C-N 112.486 -2.143 . . . . 10.0 106.772 -166.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.521 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 15.9 p -121.7 159.06 27.36 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 114.543 -1.208 . . . . 10.0 111.106 -173.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.672 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 16.2 tpt180 -43.12 -44.84 5.16 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.919 -1.492 . . . . 10.0 110.165 171.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.52 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -58.01 -44.29 87.17 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.801 0.667 . . . . 10.0 112.801 177.429 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.579 ' HG2' ' HB1' ' A' ' 82' ' ' ALA . 1.4 tp60 -55.63 -54.86 38.92 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.895 -0.78 . . . . 10.0 108.895 177.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.744 HG23 ' HB ' ' A' ' 128' ' ' ILE . 45.5 mm -35.96 -52.93 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-N 113.985 -1.461 . . . . 10.0 112.604 167.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.673 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 25.5 tt0 -47.57 -59.63 3.12 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.529 1.132 . . . . 10.0 113.183 -175.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -55.94 -49.82 72.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.129 -0.941 . . . . 10.0 110.519 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.812 HD12 ' HB3' ' A' ' 78' ' ' LEU . 13.8 mm -49.86 -57.42 2.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.652 -0.704 . . . . 10.0 110.641 171.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.556 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -52.23 -35.65 50.19 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.923 -0.581 . . . . 10.0 112.371 177.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.673 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 46.9 mttt -74.97 -56.09 5.1 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.707 -0.679 . . . . 10.0 111.42 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.47 HG23 ' CG ' ' A' ' 112' ' ' LYS . 13.2 t -54.47 -30.41 53.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.931 -0.577 . . . . 10.0 112.375 -176.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 1.092 ' HE2' ' H ' ' A' ' 75' ' ' ALA . 0.8 OUTLIER -113.48 23.71 12.92 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 121.062 -0.255 . . . . 10.0 110.888 -178.844 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.761 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 46.5 ttm -48.48 -44.3 64.85 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.359 -0.382 . . . . 10.0 111.696 175.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 113' ' ' MET . 56.7 Cg_endo -68.04 -20.64 44.11 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.587 1.525 . . . . 10.0 113.172 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -83.55 -54.95 4.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.604 -0.726 . . . . 10.0 110.441 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.602 ' HG ' HG21 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -65.43 -0.32 1.86 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.686 -1.143 . . . . 10.0 112.618 -177.935 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 15.5 m120 60.25 46.93 9.72 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.717 -1.128 . . . . 10.0 109.309 -177.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.761 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -79.84 113.63 18.14 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.358 -1.292 . . . . 10.0 112.625 -173.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -67.39 -36.04 80.52 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.148 -0.686 . . . . 10.0 109.148 169.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.5 p -150.59 146.4 26.52 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.955 -1.128 . . . . 10.0 107.955 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.609 ' O ' ' HG2' ' A' ' 125' ' ' MET . 39.6 tp -53.06 -40.47 64.03 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 114.446 1.276 . . . . 10.0 114.446 -177.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -51.13 -35.19 34.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.309 0.576 . . . . 10.0 111.026 176.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.587 ' O ' ' HG3' ' A' ' 126' ' ' LYS . . . -67.64 -49.08 64.69 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 118.816 -1.153 . . . . 10.0 110.607 173.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.668 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -56.86 -29.05 62.53 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.684 -0.806 . . . . 10.0 110.328 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.649 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 82.8 mmm -61.55 -41.55 97.52 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 113.06 0.763 . . . . 10.0 113.06 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.737 ' HD3' ' N ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -66.7 -45.27 79.31 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 122.161 -0.337 . . . . 10.0 111.816 178.588 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.737 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -55.12 -60.59 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 C-N-CA 120.164 -0.614 . . . . 10.0 110.662 178.443 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.744 ' HB ' HG23 ' A' ' 105' ' ' ILE . 19.8 mm -50.36 -55.02 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.219 0 CA-C-N 115.614 -0.721 . . . . 10.0 110.774 -177.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -54.46 -44.3 72.44 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 114.753 -1.112 . . . . 10.0 108.898 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.594 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -72.07 -46.2 37.08 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 121.154 -0.546 . . . . 10.0 112.166 -174.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.621 HG21 ' HB3' ' A' ' 75' ' ' ALA . 68.1 m -46.96 -57.69 4.73 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.483 0.658 . . . . 10.0 109.431 171.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.563 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -49.08 -43.26 40.96 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 114.94 -1.027 . . . . 10.0 111.876 175.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 130' ' ' GLY . 58.6 mttp -48.74 -53.02 20.64 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.439 0.462 . . . . 10.0 110.876 176.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.9 m -66.96 -32.87 74.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.024 0.44 . . . . 10.0 111.446 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.675 ' HE1' ' HA ' ' A' ' 76' ' ' SER . 38.3 mtm -79.85 -1.05 37.31 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.934 1.087 . . . . 10.0 113.934 -175.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.567 ' O ' ' HB ' ' A' ' 96' ' ' ILE . . . 83.49 23.78 52.76 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 119.619 1.1 . . . . 10.0 112.142 -177.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 3.0 mp -109.26 126.63 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 CA-C-O 121.525 0.679 . . . . 10.0 111.043 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.753 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -91.9 157.86 16.6 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.553 -1.203 . . . . 10.0 108.906 179.31 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 19.5 m -119.02 134.52 62.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.177 -0.675 . . . . 10.0 109.177 171.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.64 HG22 ' O ' ' A' ' 100' ' ' VAL . 28.7 m -133.85 71.07 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 116.052 1.871 . . . . 10.0 116.052 -173.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 20.5 t0 . . . . . 0 C--N 1.3 -1.571 0 CA-C-N 114.321 -1.309 . . . . 10.0 109.041 138.791 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.435 ' CE ' ' HA ' ' A' ' 1' ' ' MET . 10.0 mmt . . . . . 0 N--CA 1.485 1.289 0 N-CA-C 109.694 -0.484 . . . . 10.0 109.694 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.16 -108.72 0.43 Allowed 'General case' 0 C--N 1.331 -0.221 0 O-C-N 123.716 0.635 . . . . 10.0 110.108 -173.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -141.51 110.26 6.11 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.857 -0.423 . . . . 10.0 109.857 171.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 10.3 mtmp? -102.31 143.69 31.76 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.776 -0.453 . . . . 10.0 109.776 177.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.442 HG13 HG23 ' A' ' 59' ' ' THR . 45.2 t -62.13 131.53 27.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 116.222 -0.444 . . . . 10.0 111.155 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.93 -35.39 7.31 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.687 -0.486 . . . . 10.0 109.687 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.512 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -154.11 141.27 19.45 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.327 0.862 . . . . 10.0 113.327 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -94.2 126.96 39.76 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 106.654 -1.61 . . . . 10.0 106.654 171.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.648 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 1.9 mt -125.67 85.59 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 120.241 -0.584 . . . . 10.0 109.864 -177.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.566 ' HG2' HG22 ' A' ' 57' ' ' VAL . 58.1 mttp -75.92 132.86 40.53 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 120.338 -0.545 . . . . 10.0 109.85 176.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.697 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -158.34 127.21 5.55 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.154 0.978 . . . . 10.0 111.607 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -85.92 122.87 30.59 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.502 -1.226 . . . . 10.0 110.724 -172.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.697 HD21 HD11 ' A' ' 11' ' ' LEU . 94.0 mt -141.56 135.66 14.96 Favored Pre-proline 0 CA--C 1.51 -0.584 0 CA-C-O 121.659 0.742 . . . . 10.0 112.044 -172.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.671 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 53.1 Cg_exo -49.94 124.34 12.4 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.818 3.012 . . . . 10.0 112.943 170.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.61 ' CB ' ' HA ' ' A' ' 50' ' ' ALA . . . -62.73 128.76 37.44 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.599 -1.259 . . . . 10.0 107.599 170.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.35 0.48 78.35 Favored Glycine 0 N--CA 1.446 -0.693 0 O-C-N 125.513 1.758 . . . . 10.0 112.992 -174.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.671 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -143.84 96.08 2.84 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.941 0.877 . . . . 10.0 112.038 -178.521 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' A' ' 39' ' ' CYS . . . -170.62 135.85 1.19 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.073 -1.422 . . . . 10.0 112.733 177.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.74 ' H ' ' HD3' ' A' ' 20' ' ' PRO . 5.9 t -179.61 -36.26 0.0 OUTLIER Pre-proline 0 N--CA 1.443 -0.777 0 CA-C-N 115.236 -0.893 . . . . 10.0 113.357 176.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.74 ' HD3' ' H ' ' A' ' 19' ' ' THR . 89.3 Cg_endo -104.04 129.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.409 -3.476 0 N-CA-C 116.492 1.689 . . . . 10.0 116.492 -157.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.962 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . 13.09 -58.24 0.0 OUTLIER Pre-proline 0 C--N 1.288 -2.078 0 CA-C-N 109.228 -3.624 . . . . 10.0 118.546 152.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.771 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 45.3 Cg_exo -57.69 -63.9 0.14 Allowed 'Trans proline' 0 CA--C 1.566 2.115 0 CA-C-N 123.576 2.313 . . . . 10.0 115.409 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.771 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 58.6 Cg_endo -77.42 -52.04 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.681 2.254 . . . . 10.0 112.74 176.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.013 HG12 HD12 ' A' ' 35' ' ' ILE . 77.5 t -81.89 -49.46 17.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 111.702 -2.499 . . . . 10.0 111.894 -166.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.766 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -44.15 -52.97 6.83 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 113.968 -1.469 . . . . 10.0 113.39 178.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.962 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 23.9 Cg_exo -71.96 -43.82 1.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.179 2.586 . . . . 10.0 111.236 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.58 -93.81 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.434 0.459 . . . . 10.0 111.897 178.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.778 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.356 0.0 OUTLIER -77.15 -19.24 57.12 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 117.306 -1.758 . . . . 10.0 113.797 -174.535 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.55 -39.48 60.84 Favored Glycine 0 N--CA 1.467 0.714 0 C-N-CA 120.666 -0.778 . . . . 10.0 113.092 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.608 ' HB3' ' O ' ' A' ' 26' ' ' PRO . 13.0 tt0 -56.61 -26.14 54.83 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.746 0.308 . . . . 10.0 110.628 175.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 56.2 m80 -96.47 23.63 6.62 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.739 -0.784 . . . . 10.0 109.86 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.444 ' HA3' ' CE ' ' A' ' 64' ' ' LYS . . . 81.66 6.92 88.72 Favored Glycine 0 CA--C 1.494 -1.232 0 CA-C-N 115.27 -0.877 . . . . 10.0 112.813 167.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.888 HG11 ' CD2' ' A' ' 66' ' ' PHE . 2.4 t -85.26 146.97 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 113.628 0.973 . . . . 10.0 113.628 -175.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.446 ' OD1' ' HB3' ' A' ' 37' ' ' GLU . 2.0 p30 -69.97 101.71 1.84 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.649 0.737 . . . . 10.0 111.477 174.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.013 HD12 HG12 ' A' ' 24' ' ' VAL . 21.2 mm -53.49 -39.25 35.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 114.152 -1.385 . . . . 10.0 112.175 176.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.735 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 3.2 mpp? -66.13 -51.38 58.5 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.335 -1.757 . . . . 10.0 111.907 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.498 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 44.0 tt0 -57.83 -40.13 79.28 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.109 -1.036 . . . . 10.0 110.23 176.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.65 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 89.0 t80 -57.47 -58.97 5.95 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 113.877 1.066 . . . . 10.0 113.877 171.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.735 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 19.8 p -60.08 -47.43 85.91 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 114.563 -1.199 . . . . 10.0 111.36 -175.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -65.26 -24.29 67.28 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.988 -0.745 . . . . 10.0 108.988 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.782 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 19.2 mtp180 -74.2 -64.48 1.01 Allowed 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.598 -0.841 . . . . 10.0 112.35 170.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.625 ' CZ ' HG21 ' A' ' 46' ' ' THR . 76.5 t80 -53.37 -45.18 69.11 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 121.157 0.503 . . . . 10.0 110.376 -172.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -59.18 -51.01 71.85 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.026 -0.988 . . . . 10.0 110.235 -177.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.27 -41.67 99.04 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.209 -0.996 . . . . 10.0 112.232 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.782 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 10.6 mt-10 -68.6 -40.33 80.47 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.795 0.807 . . . . 10.0 111.166 -176.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.625 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 75.4 p -87.81 0.54 55.64 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 114.778 -1.101 . . . . 10.0 112.28 -173.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.04 -35.27 2.9 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.231 1.013 . . . . 10.0 113.233 -175.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -86.91 -33.54 19.69 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.806 -0.634 . . . . 10.0 112.391 -173.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.575 ' HB3' ' HZ ' ' A' ' 77' ' ' PHE . 39.3 mttm -96.94 20.45 11.12 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.181 -0.674 . . . . 10.0 109.181 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.61 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -54.36 157.74 2.65 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 125.223 1.409 . . . . 10.0 114.128 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.05 22.07 43.39 Favored Glycine 0 CA--C 1.501 -0.812 0 N-CA-C 109.121 -1.592 . . . . 10.0 109.121 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.615 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 40.4 tpp -140.99 120.21 12.94 Favored 'General case' 0 C--O 1.205 -1.242 0 C-N-CA 117.42 -1.712 . . . . 10.0 114.737 -159.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.6 mm -63.11 92.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 121.688 -0.632 . . . . 10.0 109.999 172.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.768 HD22 ' HE2' ' A' ' 77' ' ' PHE . 7.2 mt -82.65 129.37 62.73 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.71 -0.478 . . . . 10.0 109.71 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.405 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 14.9 Cg_exo -71.51 103.37 1.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 121.918 1.746 . . . . 10.0 110.262 171.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.02 153.79 3.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 119.726 1.148 . . . . 10.0 110.903 -173.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.566 HG22 ' HG2' ' A' ' 10' ' ' LYS . 61.5 t -133.09 111.66 16.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 176.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.648 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 17.2 mt -102.9 140.66 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.789 0 N-CA-C 108.534 -0.913 . . . . 10.0 108.534 -172.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.442 HG23 HG13 ' A' ' 5' ' ' VAL . 57.2 m -125.19 94.45 4.17 Favored 'General case' 0 N--CA 1.402 -2.863 0 CA-C-N 114.774 -1.103 . . . . 10.0 108.873 177.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 65' ' ' SER . 2.2 p -89.82 134.67 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 O-C-N 121.264 -0.898 . . . . 10.0 110.16 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -91.84 172.34 8.53 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.69 -0.686 . . . . 10.0 112.658 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -63.75 -19.25 64.82 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.298 -0.865 . . . . 10.0 111.393 -178.799 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.442 ' HB3' ' OG ' ' A' ' 65' ' ' SER . 27.3 t70 -77.55 -10.45 59.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.811 -1.086 . . . . 10.0 111.237 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.444 ' CE ' ' HA3' ' A' ' 32' ' ' GLY . 28.1 mmmt 82.55 -3.76 1.38 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.328 1.051 . . . . 10.0 110.961 -172.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.606 ' O ' HG23 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -68.93 179.45 1.83 Allowed 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.661 -0.866 . . . . 10.0 108.661 170.843 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.888 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -166.06 -176.51 3.78 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 119.851 1.205 . . . . 10.0 109.828 175.128 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.3 p -158.12 166.84 31.45 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 102.275 -3.231 . . . . 10.0 102.275 178.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.428 ' CB ' HG12 ' A' ' 58' ' ' ILE . 45.1 p90 -163.66 154.64 16.23 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.207 -1.035 . . . . 10.0 108.207 175.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.518 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 29.2 pt -117.01 164.14 13.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.613 -1.254 . . . . 10.0 107.613 -177.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.488 HG21 HD13 ' A' ' 54' ' ' LEU . 10.5 mm -117.22 126.27 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 106.561 -1.644 . . . . 10.0 106.561 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.465 ' HD3' ' HA ' ' A' ' 71' ' ' LYS . 50.3 mmtt -72.47 104.29 3.76 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 119.576 -0.85 . . . . 10.0 109.988 -177.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.692 ' O ' ' HE2' ' A' ' 112' ' ' LYS . 8.2 p -41.57 139.06 1.55 Allowed Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 112.973 -1.921 . . . . 10.0 109.27 174.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.446 ' HB3' ' HB3' ' A' ' 77' ' ' PHE . 8.7 Cg_exo -32.59 104.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 124.192 3.262 . . . . 10.0 113.256 -174.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -38.85 -47.66 2.76 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.064 2.509 . . . . 10.0 110.565 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.585 ' CB ' HG21 ' A' ' 131' ' ' THR . . . 174.91 -47.58 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 113.824 -1.534 . . . . 10.0 109.364 159.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.643 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 83.9 p -64.68 -30.46 71.48 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 109.817 -0.438 . . . . 10.0 109.817 -178.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.768 ' HE2' HD22 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -41.89 -70.27 0.11 Allowed 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.87 0.868 . . . . 10.0 111.122 175.478 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.781 ' HB3' HD12 ' A' ' 108' ' ' ILE . 12.5 tp -90.25 -17.48 27.39 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.078 -0.51 . . . . 10.0 109.849 -170.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.7 mt -69.2 -33.16 72.92 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.259 172.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.643 ' HG3' ' O ' ' A' ' 76' ' ' SER . 48.5 mttp -60.81 -41.52 95.85 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.35 -0.611 . . . . 10.0 109.35 171.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -58.4 -39.91 80.98 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.851 -0.613 . . . . 10.0 112.422 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.814 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -69.96 -53.03 19.6 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.975 1.369 . . . . 10.0 110.875 174.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.87 -37.93 89.27 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 111.473 -2.603 . . . . 10.0 111.437 -171.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 87.36 66.21 1.35 Allowed Glycine 0 C--N 1.311 -0.813 0 C-N-CA 120.005 -1.093 . . . . 10.0 110.836 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.4 pt -159.01 69.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 122.294 1.045 . . . . 10.0 109.304 -173.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 18.3 mt-10 -73.48 74.26 1.42 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.196 -1.365 . . . . 10.0 111.8 -173.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 86' ' ' GLU . 10.0 mtpm? 82.35 7.11 0.93 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.627 -0.715 . . . . 10.0 109.91 172.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.92 8.92 74.18 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.012 -0.994 . . . . 10.0 112.08 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.0 p -75.66 -168.04 0.79 Allowed 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 122.628 0.371 . . . . 10.0 111.474 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.3 t 76.59 29.46 0.67 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.91 175.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.746 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 31.1 tt0 -172.1 -55.58 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.625 176.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.746 ' HD3' ' HB3' ' A' ' 91' ' ' GLU . 20.6 Cg_exo -66.88 102.69 0.65 Allowed 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.892 1.728 . . . . 10.0 112.474 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -159.86 95.95 1.21 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.982 -0.554 . . . . 10.0 110.491 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.466 ' C ' ' H ' ' A' ' 96' ' ' ILE . 56.1 ttm-85 -170.17 -64.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.888 0.375 . . . . 10.0 110.442 172.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.404 ' HD2' ' HA ' ' A' ' 95' ' ' LYS . 46.7 tptt -77.36 9.36 3.26 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.719 0.771 . . . . 10.0 109.322 -177.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.466 ' H ' ' C ' ' A' ' 94' ' ' ARG . 1.4 mt 72.78 104.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.182 -1.372 . . . . 10.0 111.68 -174.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 97' ' ' VAL . 7.1 p -62.31 101.85 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 112.582 -2.099 . . . . 10.0 111.694 -175.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 38.92 -161.83 0.01 OUTLIER Glycine 0 C--N 1.323 -0.181 0 CA-C-N 114.21 -1.359 . . . . 10.0 112.656 -170.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.573 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 8.4 ptpp? -158.85 177.58 11.01 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 122.273 1.035 . . . . 10.0 111.022 177.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.814 HG11 ' HB1' ' A' ' 82' ' ' ALA . 1.0 OUTLIER -155.54 -145.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-N 112.285 -2.234 . . . . 10.0 105.981 -176.147 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 0.1 OUTLIER -162.77 142.72 9.32 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 109.048 -0.723 . . . . 10.0 109.048 -157.44 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.732 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 1.5 tpt180 -43.31 -39.97 3.33 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 124.934 1.396 . . . . 10.0 110.795 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.557 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 17.8 tppt? -60.13 -44.42 94.93 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.521 0.563 . . . . 10.0 112.521 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.65 ' O ' HG12 ' A' ' 108' ' ' ILE . 1.2 mp0 -63.81 -47.96 78.76 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.758 -0.83 . . . . 10.0 108.758 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.732 ' HB ' ' O ' ' A' ' 102' ' ' ARG . 43.2 mm -35.53 -58.15 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 114.949 -1.023 . . . . 10.0 111.544 163.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.647 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 33.1 tt0 -47.33 -54.65 10.54 Favored 'General case' 0 C--O 1.209 -1.07 0 C-N-CA 124.636 1.174 . . . . 10.0 113.146 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -53.2 -58.15 8.03 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 123.743 0.652 . . . . 10.0 110.971 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.781 HD12 ' HB3' ' A' ' 78' ' ' LEU . 7.7 mm -46.79 -55.86 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.243 -0.889 . . . . 10.0 109.963 172.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.618 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -53.27 -38.08 62.74 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.684 -0.689 . . . . 10.0 112.833 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.647 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 76.4 mttt -72.2 -56.92 4.73 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 116.109 -0.496 . . . . 10.0 111.052 -173.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.457 ' O ' HG21 ' A' ' 72' ' ' THR . 1.8 t -54.61 -33.3 60.22 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.171 -0.922 . . . . 10.0 110.168 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 1.063 ' HD2' HD13 ' A' ' 116' ' ' LEU . 4.5 mmtt -91.74 -12.22 34.57 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 112.64 0.607 . . . . 10.0 112.64 -177.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.4 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 45.7 ttm -37.27 -52.7 2.27 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 113.25 0.833 . . . . 10.0 113.25 177.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 113' ' ' MET . 30.7 Cg_endo -64.49 -22.74 65.19 Favored 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 121.456 1.437 . . . . 10.0 112.988 -178.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.751 ' HB3' ' HD3' ' A' ' 112' ' ' LYS . 3.6 t70 -99.25 -42.19 7.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.819 0.818 . . . . 10.0 112.152 -175.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 1.063 HD13 ' HD2' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -63.82 -0.22 1.0 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.105 -1.407 . . . . 10.0 111.815 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.447 ' H ' ' C ' ' A' ' 115' ' ' ASP . 2.6 p-10 56.85 43.88 24.21 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 113.971 -1.468 . . . . 10.0 108.886 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 119' ' ' ASN . . . -65.39 -74.62 0.1 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 112.7 -2.045 . . . . 10.0 113.272 -166.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 118' ' ' ALA . 28.7 t-20 103.57 -42.87 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 O-C-N 125.08 1.488 . . . . 10.0 109.096 -173.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.5 t -153.79 139.75 18.23 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.391 -1.707 . . . . 10.0 106.391 173.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.597 ' O ' HD13 ' A' ' 121' ' ' LEU . 1.5 tm? -50.47 -35.26 28.18 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.34 0.867 . . . . 10.0 113.34 -174.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.536 ' HA ' ' HG3' ' A' ' 125' ' ' MET . 1.6 mp0 -51.15 -41.31 60.03 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.584 0.707 . . . . 10.0 111.013 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.93 -47.37 74.94 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 118.787 -1.165 . . . . 10.0 110.488 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.482 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -58.6 -29.86 66.78 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.837 -0.345 . . . . 10.0 111.0 176.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.536 ' HG3' ' HA ' ' A' ' 122' ' ' GLU . 5.0 mtp -54.92 -41.02 70.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.903 0.382 . . . . 10.0 111.087 175.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -63.37 -54.68 33.03 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.632 -0.713 . . . . 10.0 112.173 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.944 HD12 HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -52.29 -59.35 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 120.212 -0.595 . . . . 10.0 111.144 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.632 ' HB ' HG23 ' A' ' 105' ' ' ILE . 27.4 mm -51.7 -56.65 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 CA-C-N 114.841 -1.072 . . . . 10.0 111.676 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.56 ' HG3' HG21 ' A' ' 105' ' ' ILE . 5.3 mt-10 -51.95 -44.15 63.8 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 123.824 0.702 . . . . 10.0 109.143 177.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.73 -45.97 63.18 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.393 -0.908 . . . . 10.0 111.08 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.585 HG21 ' CB ' ' A' ' 75' ' ' ALA . 49.9 m -46.75 -64.77 0.68 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.144 -1.028 . . . . 10.0 109.148 169.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -47.49 -52.62 16.67 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.147 0.499 . . . . 10.0 111.561 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -52.19 -53.5 42.47 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.943 -1.026 . . . . 10.0 112.163 178.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 22.9 p -68.34 -25.5 65.14 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.044 0.45 . . . . 10.0 110.599 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.406 ' HG3' ' O ' ' A' ' 131' ' ' THR . 45.1 mtm -75.42 -8.41 56.63 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 112.731 0.641 . . . . 10.0 112.731 178.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 96' ' ' ILE . . . 96.48 2.65 60.11 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 118.995 0.816 . . . . 10.0 111.765 179.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.7 mt -95.02 136.38 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 CA-C-N 117.54 0.67 . . . . 10.0 112.029 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.577 ' HG3' ' N ' ' A' ' 139' ' ' VAL . 0.0 OUTLIER -84.7 156.28 21.54 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 119.097 -1.041 . . . . 10.0 110.544 177.22 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.577 ' N ' ' HG3' ' A' ' 138' ' ' GLU . 17.3 m -120.03 126.21 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.55 0 N-CA-C 107.561 -1.274 . . . . 10.0 107.561 170.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 100' ' ' VAL . 26.2 m -107.2 167.95 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 CA-C-N 113.555 -1.657 . . . . 10.0 108.415 176.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 . . . . . 0 C--N 1.285 -2.198 0 CA-C-N 113.921 -1.49 . . . . 10.0 110.814 178.563 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ppp? . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 112.195 0.443 . . . . 10.0 112.195 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.37 -58.4 7.21 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 120.975 0.417 . . . . 10.0 110.958 -177.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -135.98 154.66 51.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.017 -0.538 . . . . 10.0 109.773 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -73.0 114.88 11.64 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.003 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.7 t -65.61 141.3 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 122.737 0.415 . . . . 10.0 111.097 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -109.48 -46.77 3.48 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.198 175.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.401 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -156.39 156.98 34.8 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 114.034 1.124 . . . . 10.0 114.034 -173.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -92.05 136.31 33.27 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.244 -1.344 . . . . 10.0 108.357 169.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.678 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -122.73 82.0 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 108.799 -0.815 . . . . 10.0 108.799 169.478 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.469 ' HG2' HG22 ' A' ' 57' ' ' VAL . 48.1 mtpt -78.9 130.97 36.21 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 120.444 1.474 . . . . 10.0 108.396 172.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.576 HD21 HD11 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -159.21 129.59 5.82 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.95 0.881 . . . . 10.0 111.255 -178.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -83.23 119.71 24.9 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.346 -1.297 . . . . 10.0 109.941 -172.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.576 HD11 HD21 ' A' ' 11' ' ' LEU . 55.2 mt -137.07 135.54 19.89 Favored Pre-proline 0 CA--C 1.5 -0.97 0 CA-C-O 121.878 0.847 . . . . 10.0 112.659 -171.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.786 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 25.2 Cg_exo -54.35 123.12 12.81 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 123.622 2.882 . . . . 10.0 111.486 172.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.595 ' CB ' ' HB ' ' A' ' 46' ' ' THR . . . -61.35 125.45 23.81 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.158 -1.423 . . . . 10.0 107.158 168.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.0 -0.97 89.3 Favored Glycine 0 N--CA 1.44 -1.039 0 O-C-N 125.774 1.921 . . . . 10.0 113.233 -175.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.786 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 19.4 tptm -143.47 109.34 5.22 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.296 1.048 . . . . 10.0 112.705 176.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.638 ' H ' HD22 ' A' ' 43' ' ' ASN . . . -171.69 142.21 1.54 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.256 -1.338 . . . . 10.0 112.747 172.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.575 ' H ' ' HD3' ' A' ' 20' ' ' PRO . 2.7 t 179.44 -43.02 0.0 OUTLIER Pre-proline 0 C--O 1.207 -1.165 0 O-C-N 124.059 0.85 . . . . 10.0 113.129 175.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.655 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 85.6 Cg_endo -103.25 131.19 0.1 OUTLIER 'Trans proline' 0 N--CA 1.413 -3.259 0 N-CA-C 117.175 1.952 . . . . 10.0 117.175 -153.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.938 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . 13.96 -57.37 0.0 OUTLIER Pre-proline 0 C--N 1.289 -2.041 0 CA-C-N 108.615 -3.902 . . . . 10.0 119.275 153.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.708 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 32.5 Cg_exo -60.46 -63.33 0.12 Allowed 'Trans proline' 0 CA--C 1.562 1.888 0 CA-C-N 123.415 2.255 . . . . 10.0 115.252 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.708 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 55.7 Cg_endo -75.16 -52.86 0.1 Allowed 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.412 2.075 . . . . 10.0 112.239 174.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.765 HG12 HD13 ' A' ' 35' ' ' ILE . 83.1 t -83.26 -47.27 18.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 111.622 -2.535 . . . . 10.0 112.155 -166.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.924 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -42.67 -53.23 5.27 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 114.241 -1.345 . . . . 10.0 114.232 176.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.938 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 32.5 Cg_exo -70.01 -45.73 1.36 Allowed 'Trans proline' 0 CA--C 1.51 -0.719 0 C-N-CA 123.249 2.633 . . . . 10.0 111.324 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.536 ' HB1' ' CG2' ' A' ' 9' ' ' ILE . . . -51.33 -68.42 0.17 Allowed 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.376 0.608 . . . . 10.0 111.061 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.674 HD12 HG13 ' A' ' 24' ' ' VAL . 5.9 mt -78.0 -51.62 10.07 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.84 1.052 . . . . 10.0 113.84 -176.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.19 -42.01 96.97 Favored Glycine 0 N--CA 1.461 0.304 0 CA-C-N 116.117 -0.492 . . . . 10.0 113.314 -171.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -60.27 -25.93 66.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.716 0.294 . . . . 10.0 110.646 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 35.1 m170 -102.3 16.75 25.29 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.641 -0.824 . . . . 10.0 110.623 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.48 9.25 87.1 Favored Glycine 0 CA--C 1.501 -0.797 0 CA-C-N 114.904 -1.043 . . . . 10.0 113.2 168.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.743 HG11 ' CD2' ' A' ' 66' ' ' PHE . 1.9 t -83.06 147.83 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 113.357 0.873 . . . . 10.0 113.357 -174.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -68.64 100.41 1.13 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.224 0.535 . . . . 10.0 111.132 172.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.765 HD13 HG12 ' A' ' 24' ' ' VAL . 1.4 mm -52.12 -42.03 34.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.684 -1.144 . . . . 10.0 111.132 173.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 82.9 mtp -64.75 -53.18 51.24 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 112.973 -1.921 . . . . 10.0 111.749 177.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 40.9 mt-10 -57.09 -41.21 78.45 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 118.945 -1.102 . . . . 10.0 110.93 177.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.673 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 75.5 t80 -57.83 -57.87 10.88 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 113.701 1.0 . . . . 10.0 113.701 172.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -56.15 -49.57 73.57 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.339 -1.301 . . . . 10.0 111.366 -178.561 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.451 ' HD3' ' O ' ' A' ' 40' ' ' LYS . 12.7 tmtt? -66.96 -22.83 65.91 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.665 -0.865 . . . . 10.0 108.665 -178.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.765 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 26.8 mtt180 -75.93 -64.45 1.08 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.062 -1.055 . . . . 10.0 112.253 170.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.626 ' CZ ' HG21 ' A' ' 46' ' ' THR . 70.1 t80 -55.98 -45.72 78.89 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.032 0.444 . . . . 10.0 110.883 -172.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.638 HD22 ' H ' ' A' ' 18' ' ' ALA . 4.4 m-20 -61.09 -48.99 79.12 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.246 -0.888 . . . . 10.0 110.191 -178.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.43 -36.96 85.46 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 118.971 -1.092 . . . . 10.0 112.084 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.765 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 42.4 mm-40 -64.01 -47.84 78.72 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.933 0.873 . . . . 10.0 110.687 178.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.626 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 73.3 p -89.44 5.88 43.31 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.017 -1.447 . . . . 10.0 112.209 -168.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -47.9 -35.86 11.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.488 -1.233 . . . . 10.0 112.616 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -86.39 -36.39 19.2 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 115.491 -0.777 . . . . 10.0 111.487 -174.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -95.91 20.11 10.48 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.673 -0.862 . . . . 10.0 108.673 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.467 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -53.75 150.1 7.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.06 -1.427 . . . . 10.0 112.73 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.92 20.32 28.76 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 114.759 -1.11 . . . . 10.0 110.36 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.547 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 63.3 mtt -138.88 127.32 23.0 Favored 'General case' 0 C--O 1.208 -1.094 0 C-N-CA 117.527 -1.669 . . . . 10.0 114.595 -168.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.3 mm -67.15 91.93 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 118.773 0.715 . . . . 10.0 109.213 169.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.592 HD12 ' CG2' ' A' ' 46' ' ' THR . 9.4 mt -80.67 136.8 51.37 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.059 -0.719 . . . . 10.0 109.059 -176.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.487 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 7.4 Cg_exo -75.7 104.25 1.87 Allowed 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.202 1.935 . . . . 10.0 110.682 172.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.457 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -99.86 152.99 4.53 Favored 'Isoleucine or valine' 0 C--N 1.344 0.363 0 CA-C-N 119.706 1.139 . . . . 10.0 111.112 -174.701 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.469 HG22 ' HG2' ' A' ' 10' ' ' LYS . 97.1 t -134.15 113.57 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 110.106 -0.331 . . . . 10.0 110.106 174.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.678 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 20.6 mt -108.14 139.96 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 108.099 -1.074 . . . . 10.0 108.099 -174.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 60.5 m -122.31 97.08 5.3 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 114.833 -1.076 . . . . 10.0 108.88 176.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 65' ' ' SER . 2.6 p -87.86 138.12 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.186 0 O-C-N 121.017 -1.052 . . . . 10.0 110.461 -178.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.409 ' CD2' ' HA ' ' A' ' 66' ' ' PHE . 72.9 m-85 -93.78 172.12 8.45 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.179 -0.919 . . . . 10.0 112.961 -177.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -62.96 -21.31 66.01 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 113.813 -1.539 . . . . 10.0 111.43 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -76.89 -12.9 60.02 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 113.905 -1.498 . . . . 10.0 110.997 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.68 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 8.5 mmpt? 83.77 -3.26 1.13 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.244 1.018 . . . . 10.0 110.11 -170.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.524 ' O ' HG23 ' A' ' 60' ' ' VAL . 31.6 m -69.57 179.2 2.19 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.349 -0.841 . . . . 10.0 109.349 171.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.743 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -170.25 -176.25 2.17 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 119.639 1.109 . . . . 10.0 110.174 175.379 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.5 p -158.36 164.26 36.5 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 102.987 -2.968 . . . . 10.0 102.987 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.445 ' CB ' HG12 ' A' ' 58' ' ' ILE . 50.7 p90 -161.31 157.29 25.24 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.403 0.62 . . . . 10.0 109.539 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.425 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 23.1 pt -127.99 165.86 26.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 114.846 -1.07 . . . . 10.0 108.31 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.448 HD12 ' CE1' ' A' ' 42' ' ' PHE . 1.7 mm -127.86 130.46 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 108.396 -0.965 . . . . 10.0 108.396 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 65.1 mmtt -77.88 83.26 4.22 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.025 -0.731 . . . . 10.0 109.025 176.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.401 ' OG1' ' HA ' ' A' ' 112' ' ' LYS . 18.8 p -30.01 101.17 0.15 Allowed Pre-proline 0 C--N 1.326 -0.437 0 O-C-N 125.845 1.965 . . . . 10.0 110.934 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.618 ' HB2' HD13 ' A' ' 78' ' ' LEU . 50.9 Cg_exo -20.52 106.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.13 1 C-N-CA 125.432 4.088 . . . . 10.0 114.326 -164.032 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.576 ' O ' ' HD3' ' A' ' 112' ' ' LYS . 24.8 Cg_exo -23.64 -54.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.361 1.189 1 C-N-CA 126.143 4.562 . . . . 10.0 115.229 -169.781 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -176.6 -43.68 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 120.46 0.171 . . . . 10.0 111.313 171.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.64 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 23.1 t -57.34 -35.53 70.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.05 -0.523 . . . . 10.0 112.152 -171.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -70.32 -40.27 74.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.922 0.392 . . . . 10.0 111.552 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.618 HD13 ' HB2' ' A' ' 73' ' ' PRO . 8.5 mp -82.53 -26.62 32.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.252 0.549 . . . . 10.0 110.071 -178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.4 mt -60.56 -40.42 91.55 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.91 -0.774 . . . . 10.0 108.91 170.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.741 ' HG2' HG23 ' A' ' 85' ' ' ILE . 59.0 mttp -63.46 -23.35 67.36 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.481 -0.327 . . . . 10.0 111.189 175.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.577 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -58.02 -52.43 65.55 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 121.005 -0.278 . . . . 10.0 110.594 174.024 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.823 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -84.52 -62.48 1.54 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.466 1.506 . . . . 10.0 112.113 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.67 123.61 22.31 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 111.329 -2.668 . . . . 10.0 107.929 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -88.04 33.02 4.14 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 119.059 -1.543 . . . . 10.0 111.939 -169.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.741 HG23 ' HG2' ' A' ' 80' ' ' LYS . 14.2 tt -61.8 108.79 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 CA-C-O 121.836 0.826 . . . . 10.0 110.011 174.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.462 ' C ' ' HD3' ' A' ' 87' ' ' LYS . 23.5 tt0 -161.77 29.11 0.12 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 122.488 1.137 . . . . 10.0 108.083 -170.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.462 ' HD3' ' C ' ' A' ' 86' ' ' GLU . 4.3 mppt? -151.57 20.82 0.72 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 113.882 -1.508 . . . . 10.0 107.94 -176.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.53 -178.16 53.88 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 114.693 -1.14 . . . . 10.0 112.402 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.7 t -163.88 134.49 4.38 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.785 -0.82 . . . . 10.0 108.785 174.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.9 t -161.77 36.13 0.13 Allowed 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.661 -0.866 . . . . 10.0 108.661 -176.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.601 ' HG2' ' HD3' ' A' ' 95' ' ' LYS . 18.7 tp10 -167.82 78.8 0.89 Allowed Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 114.813 -1.085 . . . . 10.0 109.56 -175.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.63 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 29.0 Cg_endo -91.93 136.51 1.72 Allowed 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 123.342 2.694 . . . . 10.0 111.322 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.962 ' HG3' ' HG3' ' A' ' 94' ' ' ARG . 13.3 ptpt 64.48 167.02 0.16 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.374 1.07 . . . . 10.0 110.42 -172.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.962 ' HG3' ' HG3' ' A' ' 93' ' ' LYS . 40.6 mtm180 70.28 -13.6 0.44 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.13 0.572 . . . . 10.0 112.265 178.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.601 ' HD3' ' HG2' ' A' ' 91' ' ' GLU . 64.2 tttm -170.67 -48.0 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.367 -0.133 . . . . 10.0 110.878 -167.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.423 ' HB ' ' O ' ' A' ' 136' ' ' GLY . 27.8 pt 48.25 -165.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.792 0.837 . . . . 10.0 113.079 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.551 HG13 ' N ' ' A' ' 98' ' ' GLY . 7.7 p -141.34 -49.49 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.954 0.724 . . . . 10.0 112.954 -169.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.551 ' N ' HG13 ' A' ' 97' ' ' VAL . . . -169.57 152.28 19.24 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.263 -1.135 . . . . 10.0 110.263 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.677 ' CB ' ' HB3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -148.21 177.42 9.41 Favored 'General case' 0 CA--C 1.48 -1.739 0 CA-C-O 122.625 1.202 . . . . 10.0 110.491 -166.17 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.823 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.7 OUTLIER -164.89 -163.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 CA-C-N 111.308 -2.678 . . . . 10.0 105.639 -166.659 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.481 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 0.5 OUTLIER -127.98 156.26 42.97 Favored 'General case' 0 C--N 1.269 -2.901 0 C-N-CA 118.41 -1.316 . . . . 10.0 112.816 -169.821 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.673 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 8.4 tpp180 -40.37 -41.54 1.4 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 113.635 -1.621 . . . . 10.0 110.958 177.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -57.45 -44.15 84.53 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.922 0.712 . . . . 10.0 112.922 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.7 ' NE2' ' HB3' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -61.75 -50.2 73.33 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.601 -0.84 . . . . 10.0 108.804 176.057 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.941 HG21 ' HG3' ' A' ' 129' ' ' GLU . 27.3 mm -38.32 -56.56 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.703 -1.135 . . . . 10.0 110.897 170.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.512 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 28.9 tt0 -50.68 -60.89 2.57 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.744 1.218 . . . . 10.0 113.222 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 31.4 mt-10 -57.97 -55.86 29.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.366 -1.288 . . . . 10.0 111.338 -176.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.585 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 46.8 mt -47.71 -50.05 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 116.651 -0.25 . . . . 10.0 110.568 171.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.534 ' HB3' HD11 ' A' ' 121' ' ' LEU . . . -49.46 -51.03 38.51 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.109 0.781 . . . . 10.0 113.109 176.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.595 ' HB3' HD13 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -76.07 -30.1 58.21 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.057 0.391 . . . . 10.0 112.057 -174.011 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.4 m -54.39 -46.38 73.09 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.033 0.444 . . . . 10.0 111.153 173.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 0.5 OUTLIER -100.4 17.69 20.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.867 -0.606 . . . . 10.0 111.026 -176.192 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.965 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 45.2 ttm -47.64 -46.71 61.0 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.017 -0.538 . . . . 10.0 112.229 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 113' ' ' MET . 33.2 Cg_endo -64.79 -21.7 64.37 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.521 1.481 . . . . 10.0 113.493 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.48 ' OD1' ' HD2' ' A' ' 71' ' ' LYS . 24.6 t70 -90.12 -53.2 4.58 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.812 0.815 . . . . 10.0 110.872 -178.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.5 HD13 ' HB2' ' A' ' 112' ' ' LYS . 10.3 mp -63.61 -2.96 1.88 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 113.72 -1.582 . . . . 10.0 111.49 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 63.9 t30 60.92 48.19 6.92 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.852 -1.522 . . . . 10.0 109.644 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.965 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -80.47 114.36 19.31 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.134 -1.394 . . . . 10.0 112.522 -173.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -67.59 -36.22 80.48 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.455 0.645 . . . . 10.0 110.028 171.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.7 p -151.22 143.5 24.11 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 106.841 -1.54 . . . . 10.0 106.841 176.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.679 ' O ' ' HG3' ' A' ' 125' ' ' MET . 58.6 tp -54.27 -34.84 61.72 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 113.794 1.035 . . . . 10.0 113.794 -175.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -48.73 -39.78 26.06 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.59 0.709 . . . . 10.0 110.326 173.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.558 ' HA ' ' HD3' ' A' ' 126' ' ' LYS . . . -66.64 -49.61 65.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.927 -1.033 . . . . 10.0 110.836 176.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.579 ' HB3' HD12 ' A' ' 121' ' ' LEU . . . -57.16 -36.47 70.79 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.632 0.253 . . . . 10.0 110.381 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.679 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 83.1 mtp -55.48 -35.65 65.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.183 -0.462 . . . . 10.0 111.981 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.558 ' HD3' ' HA ' ' A' ' 123' ' ' ALA . 0.1 OUTLIER -64.52 -49.3 71.85 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 110.026 -0.361 . . . . 10.0 110.026 177.397 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.431 ' H ' HG13 ' A' ' 127' ' ' ILE . 55.8 mt -50.68 -63.64 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-O 121.336 0.589 . . . . 10.0 110.846 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.827 ' HB ' HG23 ' A' ' 105' ' ' ILE . 27.5 mm -50.76 -55.53 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 CA-C-N 114.45 -1.25 . . . . 10.0 111.687 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.941 ' HG3' HG21 ' A' ' 105' ' ' ILE . 7.1 mt-10 -52.83 -45.36 67.28 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 123.811 0.695 . . . . 10.0 109.72 178.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -71.6 -44.78 48.55 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.468 -0.872 . . . . 10.0 111.71 -174.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 90.9 m -45.75 -61.49 1.69 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.253 -0.973 . . . . 10.0 109.943 170.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.64 -49.39 47.34 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.565 -1.198 . . . . 10.0 111.876 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 19.6 ttmm -48.37 -54.57 13.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.555 -0.748 . . . . 10.0 111.55 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.4 t -63.23 -31.47 72.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.572 0.701 . . . . 10.0 110.382 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 35.8 mtp -80.06 7.72 8.57 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.897 1.073 . . . . 10.0 113.897 -176.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.493 ' O ' HG12 ' A' ' 97' ' ' VAL . . . 84.64 3.8 88.0 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 119.478 1.035 . . . . 10.0 111.789 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 33.3 mt -96.78 127.79 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 CA-C-O 121.959 0.885 . . . . 10.0 111.83 -176.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.677 ' HB3' ' CB ' ' A' ' 99' ' ' LYS . 39.1 tt0 -88.21 159.43 18.15 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.156 -1.384 . . . . 10.0 108.768 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.54 HG11 ' HG2' ' A' ' 129' ' ' GLU . 17.9 m -117.92 134.1 62.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 108.341 -0.985 . . . . 10.0 108.341 167.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 100' ' ' VAL . 26.9 m -138.62 69.37 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 114.784 1.401 . . . . 10.0 114.784 -174.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.9 t70 . . . . . 0 C--N 1.298 -1.673 0 CA-C-O 117.771 -1.109 . . . . 10.0 110.257 145.455 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 121.057 0.456 . . . . 10.0 111.428 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.55 107.67 2.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.168 -0.924 . . . . 10.0 108.83 174.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.575 ' HB3' ' CG ' ' A' ' 61' ' ' TYR . 35.7 mtmm -67.62 123.55 20.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.181 0.515 . . . . 10.0 111.973 -173.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 2.3 mtpp -99.17 132.98 44.1 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.339 -0.846 . . . . 10.0 109.723 175.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.5 t -62.93 138.61 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 122.833 0.453 . . . . 10.0 111.719 -176.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.61 -38.47 5.17 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 173.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.527 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -154.28 141.34 19.35 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.857 0.688 . . . . 10.0 112.857 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -98.67 115.65 29.15 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.053 -1.462 . . . . 10.0 107.053 173.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.615 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 3.7 mt -113.9 85.45 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.051 0 N-CA-C 108.803 -0.814 . . . . 10.0 108.803 -174.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.469 ' O ' HD12 ' A' ' 11' ' ' LEU . 10.1 mtmp? -77.85 148.26 34.75 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 119.136 0.88 . . . . 10.0 110.304 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 10' ' ' LYS . 0.8 OUTLIER -156.38 135.3 11.88 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.003 -0.74 . . . . 10.0 109.003 -178.226 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -93.79 111.46 23.16 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.199 -1.038 . . . . 10.0 108.199 169.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 15.0 mt -127.94 135.21 27.16 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 121.594 0.711 . . . . 10.0 112.324 -166.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.592 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 22.1 Cg_exo -57.88 121.2 9.61 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.532 2.821 . . . . 10.0 111.861 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.564 ' CB ' ' HB ' ' A' ' 46' ' ' THR . . . -61.72 127.48 31.66 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 107.768 -1.197 . . . . 10.0 107.768 170.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.9 0.36 89.38 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 125.695 1.872 . . . . 10.0 112.625 -174.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.592 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 4.6 tmtp? -141.09 100.95 3.93 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.992 0.901 . . . . 10.0 111.911 177.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.84 132.24 3.67 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.421 -1.263 . . . . 10.0 112.395 176.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.469 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -177.03 -53.68 0.0 OUTLIER Pre-proline 0 N--CA 1.448 -0.537 0 N-CA-C 112.697 0.629 . . . . 10.0 112.697 178.5 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.619 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 80.6 Cg_endo -104.53 128.09 0.07 OUTLIER 'Trans proline' 0 N--CA 1.416 -3.044 0 N-CA-C 116.211 1.581 . . . . 10.0 116.211 -154.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.02 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 16.04 -84.11 0.0 OUTLIER Pre-proline 0 C--N 1.294 -1.806 0 CA-C-N 108.58 -3.918 . . . . 10.0 116.251 165.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.593 ' CB ' ' HD3' ' A' ' 23' ' ' PRO . 3.2 Cg_exo -31.31 -56.79 0.23 Allowed 'Trans proline' 0 CA--C 1.558 1.679 0 C-N-CA 122.906 2.404 . . . . 10.0 115.419 -165.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.619 ' HD2' ' O ' ' A' ' 20' ' ' PRO . 5.4 Cg_exo -83.95 -49.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 123.346 2.697 . . . . 10.0 112.237 171.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.972 HG12 HD13 ' A' ' 35' ' ' ILE . 57.9 t -88.87 -45.68 15.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 112.449 -2.16 . . . . 10.0 113.484 -163.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 1.02 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -47.56 -80.6 0.05 OUTLIER Glycine 0 C--O 1.221 -0.692 0 CA-C-N 114.609 -1.178 . . . . 10.0 114.304 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.632 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 13.0 Cg_exo -43.28 -41.2 9.97 Favored 'Trans proline' 0 CA--C 1.52 -0.223 0 C-N-CA 123.544 2.83 . . . . 10.0 112.316 174.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 24' ' ' VAL . . . -52.47 -77.94 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.644 0.735 . . . . 10.0 111.255 176.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.778 HD12 HG13 ' A' ' 24' ' ' VAL . 6.9 mt -75.55 -42.74 51.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.961 -1.018 . . . . 10.0 113.725 -173.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.9 -38.22 95.77 Favored Glycine 0 N--CA 1.463 0.489 0 CA-C-N 116.526 -0.306 . . . . 10.0 113.214 -176.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -63.87 -21.18 66.33 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 119.506 -0.877 . . . . 10.0 109.699 175.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -103.91 7.17 36.78 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.888 -0.725 . . . . 10.0 111.861 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.65 ' HA3' ' NZ ' ' A' ' 64' ' ' LYS . . . 56.79 37.44 77.48 Favored Glycine 0 CA--C 1.509 -0.31 0 CA-C-N 115.309 -0.86 . . . . 10.0 112.899 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.645 HG11 HD22 ' A' ' 28' ' ' LEU . 55.8 t -74.72 -32.15 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 115.734 1.753 . . . . 10.0 115.734 -169.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 90.06 78.17 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 125.3 1.44 . . . . 10.0 109.581 -169.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.972 HD13 HG12 ' A' ' 24' ' ' VAL . 1.4 mt -51.92 -40.63 28.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 113.046 -1.888 . . . . 10.0 113.336 176.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 87.5 mtp -63.04 -47.18 84.11 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 117.523 -1.671 . . . . 10.0 111.495 173.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.603 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 21.7 tp10 -60.0 -43.47 95.16 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 118.979 -1.088 . . . . 10.0 110.252 176.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.577 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 71.7 t80 -56.5 -57.04 14.05 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 113.928 1.084 . . . . 10.0 113.928 172.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.43 -50.14 73.98 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.882 0.873 . . . . 10.0 111.729 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -63.29 -22.88 67.15 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.244 -0.982 . . . . 10.0 108.756 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.831 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 33.1 mtm-85 -78.53 -64.31 1.2 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 118.228 -0.892 . . . . 10.0 112.192 168.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.598 ' CZ ' HG21 ' A' ' 46' ' ' THR . 69.8 t80 -53.11 -48.0 68.18 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 119.477 1.035 . . . . 10.0 110.224 -169.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -60.02 -50.24 74.52 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.037 -0.983 . . . . 10.0 110.326 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.72 93.71 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 119.157 -1.017 . . . . 10.0 111.943 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.831 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 7.0 mm-40 -66.26 -44.72 82.86 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 122.203 1.002 . . . . 10.0 110.713 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.61 ' CG2' HD12 ' A' ' 54' ' ' LEU . 81.6 p -89.76 0.5 56.96 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 113.963 -1.472 . . . . 10.0 111.986 -171.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.08 -38.81 8.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.307 -0.86 . . . . 10.0 112.44 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -79.44 -25.63 41.96 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.551 -0.75 . . . . 10.0 111.206 -173.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -108.41 21.66 17.0 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.555 0.742 . . . . 10.0 109.955 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -52.64 148.19 7.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.991 -1.004 . . . . 10.0 112.868 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.9 19.27 31.8 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 110.816 -0.914 . . . . 10.0 110.816 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.688 ' SD ' ' HB3' ' A' ' 77' ' ' PHE . 67.4 mtt -139.28 126.21 20.97 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 117.211 -1.796 . . . . 10.0 114.555 -166.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.3 mm -68.13 91.51 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.255 -0.646 . . . . 10.0 109.255 172.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.61 HD12 ' CG2' ' A' ' 46' ' ' THR . 7.7 mt -82.45 131.68 54.77 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.619 -0.511 . . . . 10.0 109.619 -177.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.587 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 17.1 Cg_exo -69.62 102.82 1.05 Allowed 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.394 2.063 . . . . 10.0 111.196 172.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.486 HG23 HG12 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -101.03 156.84 4.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 119.501 1.046 . . . . 10.0 111.016 -175.767 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.483 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 86.9 t -136.23 116.1 17.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.085 -0.507 . . . . 10.0 110.508 172.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.738 HD13 HD21 ' A' ' 28' ' ' LEU . 18.1 mt -105.57 140.39 23.78 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.925 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 -175.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.3 m -126.96 95.88 4.45 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 114.962 -1.017 . . . . 10.0 109.14 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.527 ' CG1' ' HB3' ' A' ' 7' ' ' ALA . 3.3 p -85.99 136.0 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 119.124 0.875 . . . . 10.0 109.827 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.642 ' HE2' ' HG1' ' A' ' 67' ' ' THR . 82.2 m-85 -94.51 173.33 7.68 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.496 0.665 . . . . 10.0 112.55 -176.009 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 24.8 mt-10 -62.14 -19.33 62.92 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.638 -1.164 . . . . 10.0 112.285 -177.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 4.6 m-20 -78.35 -11.55 59.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.588 -0.733 . . . . 10.0 111.041 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.65 ' NZ ' ' HA3' ' A' ' 32' ' ' GLY . 18.6 mtpp 82.04 1.19 1.42 Allowed 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 114.654 -1.157 . . . . 10.0 110.329 -167.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.502 ' O ' HG23 ' A' ' 60' ' ' VAL . 51.0 m -70.53 174.7 5.5 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.369 -1.287 . . . . 10.0 108.184 172.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.614 ' CD1' HG13 ' A' ' 33' ' ' VAL . 8.8 p90 -167.99 -179.02 3.97 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 121.394 1.906 . . . . 10.0 110.326 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.642 ' HG1' ' HE2' ' A' ' 61' ' ' TYR . 1.5 p -161.51 171.88 17.37 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 103.791 -2.67 . . . . 10.0 103.791 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 50.7 p90 -163.52 157.76 20.02 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.757 -0.831 . . . . 10.0 108.757 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.483 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 31.3 pt -127.77 164.9 28.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 107.767 -1.197 . . . . 10.0 107.767 -178.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.497 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 8.2 mt -138.84 123.17 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 108.034 -1.099 . . . . 10.0 108.034 -174.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.647 ' C ' ' HD2' ' A' ' 73' ' ' PRO . 41.5 mmtt -75.93 95.07 3.47 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.896 1.331 . . . . 10.0 113.531 -168.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.66 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -59.83 -33.46 16.03 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-N 112.554 -2.112 . . . . 10.0 114.743 167.605 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.741 ' HD3' ' HB3' ' A' ' 115' ' ' ASP . 9.2 Cg_endo -50.11 -42.19 46.96 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.683 2.922 . . . . 10.0 117.282 -171.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.587 ' HD3' ' HG2' ' A' ' 73' ' ' PRO . 82.9 Cg_exo -44.98 -31.33 5.33 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 122.366 2.044 . . . . 10.0 113.141 -178.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.731 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . . . 70.32 -38.47 0.41 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.72 1.007 . . . . 10.0 113.72 170.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.45 ' HA ' ' HE1' ' A' ' 135' ' ' MET . 49.8 m -50.04 -31.21 12.44 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 122.982 0.513 . . . . 10.0 111.85 -175.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.688 ' HB3' ' SD ' ' A' ' 52' ' ' MET . 73.6 m-85 -61.19 -55.58 30.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.165 0.507 . . . . 10.0 111.257 178.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.642 HD23 ' HZ1' ' A' ' 112' ' ' LYS . 3.3 mm? -78.72 -27.03 44.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.912 -175.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.871 HD22 HG21 ' A' ' 108' ' ' ILE . 3.5 mm? -59.56 -50.24 74.65 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.716 -0.475 . . . . 10.0 109.716 174.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.541 ' HA ' ' HB3' ' A' ' 83' ' ' ALA . 63.3 mttp -66.47 -15.39 63.32 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.557 177.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.52 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 3.1 tppp? -61.69 -38.77 89.07 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 120.778 -0.369 . . . . 10.0 110.294 171.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.875 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -85.44 -57.31 3.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.428 1.891 . . . . 10.0 112.394 172.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.541 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . . . -62.22 111.68 2.08 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 110.76 -2.927 . . . . 10.0 107.268 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.15 14.71 63.81 Favored Glycine 0 CA--C 1.501 -0.834 0 C-N-CA 118.605 -1.759 . . . . 10.0 111.619 -157.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 33.2 pt -62.74 153.82 6.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 114.257 -0.972 . . . . 10.0 112.109 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -163.28 66.33 0.19 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.065 -0.971 . . . . 10.0 108.871 175.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.1 tttp 79.19 -55.05 0.43 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 114.576 -1.193 . . . . 10.0 112.185 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -93.6 17.22 59.0 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 115.553 0.981 . . . . 10.0 115.553 -166.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.7 t -74.49 -71.7 0.33 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 118.374 1.087 . . . . 10.0 108.851 172.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.1 m 73.32 -30.33 0.21 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 114.646 1.35 . . . . 10.0 114.646 165.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -168.3 85.6 0.71 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 118.389 0.54 . . . . 10.0 111.834 -170.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -101.9 -12.13 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.433 2.755 . . . . 10.0 113.778 172.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -161.79 -79.13 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.898 0.703 . . . . 10.0 112.898 -176.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.576 ' HD3' ' O ' ' A' ' 94' ' ' ARG . 4.2 tmt_? -158.74 84.74 0.82 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.434 0.635 . . . . 10.0 109.306 -175.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.828 ' HA ' ' HE3' ' A' ' 95' ' ' LYS . 1.2 tpmt? 78.74 -7.18 1.82 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.07 -1.423 . . . . 10.0 109.989 173.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 97' ' ' VAL . 8.0 mt -85.99 176.0 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 108.678 -0.86 . . . . 10.0 108.678 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.501 HG13 ' N ' ' A' ' 98' ' ' GLY . 14.5 p -139.56 -46.03 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 112.311 0.486 . . . . 10.0 112.311 -174.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.721 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -159.18 165.49 34.3 Favored Glycine 0 CA--C 1.497 -1.059 0 N-CA-C 109.034 -1.627 . . . . 10.0 109.034 174.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.754 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 13.4 pttm -152.01 169.75 21.58 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 122.394 1.092 . . . . 10.0 110.771 -166.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.875 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -161.9 -145.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-N 112.119 -2.31 . . . . 10.0 105.807 -169.331 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 0.1 OUTLIER -162.49 144.99 10.99 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.372 -0.931 . . . . 10.0 108.937 -155.876 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.65 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 16.0 mmm180 -41.68 -50.14 4.21 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 124.57 1.169 . . . . 10.0 111.562 -177.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 24.8 tptp -56.31 -43.7 79.2 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.223 0.453 . . . . 10.0 112.223 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.57 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -61.39 -49.05 78.45 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.149 -0.686 . . . . 10.0 109.149 177.378 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.812 HG21 ' HG3' ' A' ' 129' ' ' GLU . 25.8 mm -40.26 -53.6 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 114.948 -1.024 . . . . 10.0 111.017 170.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.722 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 21.7 tt0 -51.02 -56.54 12.0 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 114.935 -1.029 . . . . 10.0 112.872 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.541 ' OE2' ' HE3' ' A' ' 110' ' ' LYS . 19.2 mm-40 -51.82 -58.49 6.28 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.119 -0.946 . . . . 10.0 110.551 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.871 HG21 HD22 ' A' ' 79' ' ' LEU . 26.3 mm -50.2 -50.37 20.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.851 -1.068 . . . . 10.0 110.679 173.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.547 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -51.19 -36.24 40.34 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 112.578 0.584 . . . . 10.0 112.578 175.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.722 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 39.7 mttm -71.74 -54.0 11.66 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.256 -177.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.606 HG22 ' O ' ' A' ' 108' ' ' ILE . 6.1 t -53.5 -28.51 31.43 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.666 0.617 . . . . 10.0 112.666 -175.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.731 ' HE3' ' HA ' ' A' ' 75' ' ' ALA . 0.2 OUTLIER -118.07 17.59 14.03 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.904 -0.497 . . . . 10.0 111.55 -177.727 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.686 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 48.6 ttm -49.17 -47.26 76.15 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.706 -0.679 . . . . 10.0 112.342 175.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 113' ' ' MET . 33.6 Cg_endo -61.53 -25.58 79.7 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 122.099 1.866 . . . . 10.0 112.418 -177.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.741 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 2.0 m-20 -93.96 -45.76 7.46 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.074 -0.966 . . . . 10.0 112.143 -173.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.691 HD21 HD12 ' A' ' 127' ' ' ILE . 5.3 mp -62.12 -4.35 1.66 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 114.661 -1.154 . . . . 10.0 111.268 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 115' ' ' ASP . 85.8 m-20 64.23 43.86 4.67 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.87 -1.514 . . . . 10.0 109.066 177.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.686 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -80.64 109.13 14.88 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.942 -1.481 . . . . 10.0 112.331 -174.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -68.48 -36.43 78.94 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.902 -0.777 . . . . 10.0 108.902 173.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 87.3 p -145.88 143.42 29.57 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.089 -1.448 . . . . 10.0 107.089 172.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.608 ' O ' ' HG3' ' A' ' 125' ' ' MET . 41.1 tp -53.45 -29.46 35.73 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.944 1.461 . . . . 10.0 114.944 -174.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 122' ' ' GLU . 3.2 mp0 -50.67 -33.9 24.39 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 122.016 0.913 . . . . 10.0 110.067 174.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.9 -49.81 41.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.133 -1.394 . . . . 10.0 110.264 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.631 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -57.35 -35.29 69.73 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.991 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.608 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 79.8 mtp -55.61 -39.47 70.82 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 122.249 -0.282 . . . . 10.0 111.639 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -64.13 -52.34 59.58 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.447 0.536 . . . . 10.0 112.447 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.691 HD12 HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -52.24 -58.87 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 C-N-CA 119.879 -0.728 . . . . 10.0 110.412 177.649 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.711 ' HB ' HG23 ' A' ' 105' ' ' ILE . 22.9 mm -49.81 -55.92 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 CA-C-N 115.184 -0.916 . . . . 10.0 111.473 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.812 ' HG3' HG21 ' A' ' 105' ' ' ILE . 8.0 mt-10 -52.69 -42.64 64.96 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 123.718 0.636 . . . . 10.0 109.828 177.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -75.02 -46.02 18.12 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 121.215 -0.517 . . . . 10.0 112.643 -174.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.435 HG21 ' HB3' ' A' ' 75' ' ' ALA . 53.7 m -46.31 -59.74 2.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.942 -0.762 . . . . 10.0 108.942 170.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.503 ' HB1' ' CG2' ' A' ' 137' ' ' ILE . . . -52.17 -50.02 62.66 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.232 -0.44 . . . . 10.0 111.959 174.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.459 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 50.4 tttm -46.11 -50.8 14.96 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 123.656 0.598 . . . . 10.0 111.45 176.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.8 m -60.97 -38.3 85.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.39 -0.368 . . . . 10.0 111.845 -175.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.783 ' HG3' HD13 ' A' ' 137' ' ' ILE . 14.9 ptt? -91.4 17.7 8.16 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.274 1.213 . . . . 10.0 114.274 -174.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.46 ' O ' HG12 ' A' ' 97' ' ' VAL . . . 89.22 13.04 62.48 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 120.043 1.292 . . . . 10.0 112.99 175.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.783 HD13 ' HG3' ' A' ' 135' ' ' MET . 2.4 mp -98.99 126.72 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-O 121.683 0.754 . . . . 10.0 111.375 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.754 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -87.81 156.22 19.51 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.574 -1.194 . . . . 10.0 109.476 177.894 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.477 HG11 ' HG2' ' A' ' 129' ' ' GLU . 17.0 m -115.87 125.48 73.02 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.536 0 N-CA-C 108.14 -1.059 . . . . 10.0 108.14 169.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 100' ' ' VAL . 28.3 m -105.24 152.82 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 CA-C-N 113.753 -1.567 . . . . 10.0 107.693 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 . . . . . 0 C--N 1.275 -2.639 0 CA-C-N 114.048 -1.433 . . . . 10.0 111.101 -175.468 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.1 ttm . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 111.391 0.145 . . . . 10.0 111.391 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.31 134.55 33.78 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.748 0.309 . . . . 10.0 110.404 -178.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -110.06 124.27 51.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.743 0.782 . . . . 10.0 112.495 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.545 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 2.9 tppp? -138.68 145.93 40.99 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 106.453 -1.684 . . . . 10.0 106.453 170.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.5 t -61.47 126.82 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.521 0.6 . . . . 10.0 111.579 -171.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.27 -39.28 5.73 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.852 -0.613 . . . . 10.0 109.518 176.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.506 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -154.88 144.68 21.57 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.463 0.912 . . . . 10.0 113.463 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -92.37 133.65 35.67 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 107.436 -1.32 . . . . 10.0 107.436 169.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.695 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -121.53 82.72 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.717 -0.846 . . . . 10.0 108.717 175.932 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -77.67 126.54 31.04 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 120.199 1.363 . . . . 10.0 107.826 175.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.665 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -156.96 123.56 5.03 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 122.868 1.318 . . . . 10.0 111.92 -175.387 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -85.22 122.36 29.3 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.257 -1.792 . . . . 10.0 110.387 -171.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.665 HD21 HD11 ' A' ' 11' ' ' LEU . 85.6 mt -140.46 145.32 40.37 Favored Pre-proline 0 C--O 1.214 -0.764 0 CA-C-O 121.197 0.523 . . . . 10.0 111.903 -170.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.806 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 2.8 Cg_exo -67.75 127.27 15.96 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 123.815 3.01 . . . . 10.0 111.816 177.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.574 ' HB2' HD11 ' A' ' 54' ' ' LEU . . . -62.1 129.77 42.36 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 172.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.02 -2.38 84.07 Favored Glycine 0 N--CA 1.441 -0.974 0 O-C-N 125.619 1.824 . . . . 10.0 112.574 -175.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.806 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 28.8 mmtp -138.79 102.78 4.65 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.743 0.782 . . . . 10.0 111.639 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.688 ' O ' ' HB2' ' A' ' 39' ' ' CYS . . . -170.27 133.97 1.15 Allowed 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.174 -1.375 . . . . 10.0 111.951 172.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.637 ' HA ' ' CB ' ' A' ' 39' ' ' CYS . 3.4 t 179.69 -39.79 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 114.694 -1.139 . . . . 10.0 112.939 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.791 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 97.4 Cg_endo -104.31 124.44 0.07 OUTLIER 'Trans proline' 0 N--CA 1.411 -3.352 0 N-CA-C 115.659 1.369 . . . . 10.0 115.659 -161.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.012 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 6.18 -82.08 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.552 0 CA-C-N 109.799 -3.364 . . . . 10.0 114.606 161.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.864 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 68.3 Cg_exo -30.01 -56.62 0.18 Allowed 'Trans proline' 0 CA--C 1.56 1.804 0 C-N-CA 122.791 2.327 . . . . 10.0 115.521 -164.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.864 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 38.2 Cg_endo -82.19 -71.98 0.01 OUTLIER 'Trans proline' 0 CA--C 1.552 1.417 0 C-N-CA 122.817 2.345 . . . . 10.0 112.321 168.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.986 HG12 HD12 ' A' ' 35' ' ' ILE . 96.0 t -53.93 -52.84 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 127.869 2.467 . . . . 10.0 114.756 -175.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 1.012 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -45.44 -69.69 0.74 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 114.493 -1.231 . . . . 10.0 112.939 -178.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.651 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 24.0 Cg_exo -47.75 -49.63 13.21 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.206 2.604 . . . . 10.0 112.99 172.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 24' ' ' VAL . . . -43.61 -100.2 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 O-C-N 124.285 0.99 . . . . 10.0 112.789 176.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.844 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.342 0.0 OUTLIER -76.43 -27.28 56.17 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 117.759 -1.577 . . . . 10.0 113.838 -175.067 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.501 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -69.69 -40.4 76.64 Favored Glycine 0 CA--C 1.527 0.787 0 O-C-N 121.781 -0.575 . . . . 10.0 113.279 -174.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.473 ' HB3' ' O ' ' A' ' 26' ' ' PRO . 29.1 tt0 -59.87 -19.5 51.63 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 120.471 -0.492 . . . . 10.0 109.902 175.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -98.92 24.53 7.6 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.201 -0.599 . . . . 10.0 110.334 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.849 ' HA3' ' HD2' ' A' ' 64' ' ' LYS . . . 89.17 -1.44 82.7 Favored Glycine 0 CA--C 1.495 -1.164 0 CA-C-N 115.48 -0.782 . . . . 10.0 112.608 166.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.905 HG11 ' CD2' ' A' ' 66' ' ' PHE . 3.1 t -83.44 148.64 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 114.107 1.151 . . . . 10.0 114.107 -170.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.418 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 4.9 m-20 -67.67 96.57 0.56 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.361 0.664 . . . . 10.0 110.56 172.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.986 HD12 HG12 ' A' ' 24' ' ' VAL . 17.2 mm -52.43 -39.24 28.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 122.005 0.907 . . . . 10.0 111.444 173.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.756 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 71.0 mtm -66.22 -50.4 63.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.447 -1.706 . . . . 10.0 112.087 175.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.53 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 1.6 tt0 -58.34 -40.16 81.43 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.138 -1.025 . . . . 10.0 110.128 176.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.59 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 90.8 t80 -56.15 -57.89 10.28 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 114.009 1.114 . . . . 10.0 114.009 170.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.756 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 14.2 p -59.63 -50.42 73.92 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 114.093 -1.412 . . . . 10.0 111.759 -176.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.409 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 58.5 tttm -66.42 -21.18 66.21 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 119.914 -0.714 . . . . 10.0 109.367 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.802 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 3.8 mtp180 -73.59 -65.65 0.8 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.352 -0.939 . . . . 10.0 112.146 169.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.577 ' CZ ' HG21 ' A' ' 46' ' ' THR . 72.9 t80 -53.58 -45.04 69.81 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.806 -171.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -59.62 -52.34 65.95 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.113 -0.949 . . . . 10.0 110.724 -178.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.03 96.28 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 118.817 -1.153 . . . . 10.0 112.385 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.802 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 13.1 mt-10 -67.55 -41.81 83.65 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.868 0.842 . . . . 10.0 111.142 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.602 ' CG2' HD12 ' A' ' 54' ' ' LEU . 80.1 p -88.84 4.56 47.3 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.782 -1.099 . . . . 10.0 112.155 -172.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.95 -42.65 18.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.106 -0.952 . . . . 10.0 112.168 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.68 -47.7 84.59 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 114.517 -1.22 . . . . 10.0 111.574 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.514 ' HB3' ' HE3' ' A' ' 52' ' ' MET . 39.6 mttm -101.36 24.1 10.07 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.268 0.556 . . . . 10.0 110.265 -171.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -53.23 145.09 14.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.695 -1.138 . . . . 10.0 112.622 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.34 16.75 36.4 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.844 -0.902 . . . . 10.0 110.844 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.519 ' SD ' ' HD1' ' A' ' 77' ' ' PHE . 41.0 mtm -141.88 127.37 18.91 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 117.675 -1.61 . . . . 10.0 115.144 -165.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.0 mm -65.9 92.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 O-C-N 121.759 -0.588 . . . . 10.0 109.947 174.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.602 HD12 ' CG2' ' A' ' 46' ' ' THR . 6.9 mt -83.51 129.83 58.53 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 108.2 -1.037 . . . . 10.0 108.2 178.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -71.5 111.41 3.11 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 C-N-CA 121.8 1.666 . . . . 10.0 110.619 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -100.11 153.56 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 119.997 1.272 . . . . 10.0 111.133 -176.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.417 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 77.1 t -134.1 116.8 23.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 109.786 -0.45 . . . . 10.0 109.786 174.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.695 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 17.5 mt -107.6 140.86 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 N-CA-C 108.704 -0.85 . . . . 10.0 108.704 -173.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.5 m -123.48 100.68 6.93 Favored 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 114.942 -1.026 . . . . 10.0 108.621 173.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 65' ' ' SER . 1.6 p -91.89 136.56 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.815 0 CA-C-N 119.227 0.921 . . . . 10.0 110.35 -177.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -95.7 172.52 7.99 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.041 0.448 . . . . 10.0 112.055 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.545 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 58.7 mt-10 -57.22 -20.59 28.14 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 113.996 -1.457 . . . . 10.0 111.959 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -73.69 -18.02 61.06 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.618 -1.173 . . . . 10.0 110.919 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.849 ' HD2' ' HA3' ' A' ' 32' ' ' GLY . 23.8 mtmt 82.27 -3.98 1.44 Allowed 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 124.205 1.002 . . . . 10.0 110.173 -164.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.607 ' O ' HG23 ' A' ' 60' ' ' VAL . 28.6 t -68.25 176.5 2.73 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.506 -0.924 . . . . 10.0 108.506 171.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.905 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -166.98 -176.84 3.54 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 120.124 1.329 . . . . 10.0 110.11 176.502 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.4 p -162.08 161.0 28.1 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 103.018 -2.956 . . . . 10.0 103.018 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.46 ' CB ' HG12 ' A' ' 58' ' ' ILE . 47.0 p90 -160.96 158.17 27.61 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 109.045 -0.724 . . . . 10.0 109.045 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.417 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 30.4 pt -119.95 165.98 14.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 114.443 -1.253 . . . . 10.0 108.059 -175.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.453 HD12 ' CE1' ' A' ' 42' ' ' PHE . 4.4 mm -125.09 119.93 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 106.704 -1.591 . . . . 10.0 106.704 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.691 ' C ' ' HD2' ' A' ' 73' ' ' PRO . 29.5 mmmt -77.28 86.87 3.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.671 0.748 . . . . 10.0 110.731 -169.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.746 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 12.7 t -67.71 -13.9 0.25 Allowed Pre-proline 0 CA--C 1.57 1.748 0 CA-C-N 114.04 -1.437 . . . . 10.0 114.597 174.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 1.028 ' HD3' ' HB3' ' A' ' 115' ' ' ASP . 3.9 Cg_exo -34.76 -51.89 0.68 Allowed 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 124.057 3.171 . . . . 10.0 115.298 174.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.462 ' HD2' ' O ' ' A' ' 71' ' ' LYS . 27.2 Cg_exo -62.49 112.03 1.48 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 CA-C-N 120.633 1.262 . . . . 10.0 110.987 173.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.574 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -80.35 3.69 20.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.844 0.355 . . . . 10.0 110.582 -178.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.673 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 1.4 m -56.16 -36.61 68.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.561 -0.745 . . . . 10.0 111.306 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.588 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 24.7 m-85 -65.54 -57.22 8.74 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 122.194 0.997 . . . . 10.0 111.433 -176.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.582 ' H ' HD22 ' A' ' 78' ' ' LEU . 0.8 OUTLIER -73.82 -23.72 59.7 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.123 -0.944 . . . . 10.0 109.894 -173.434 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . 49.2 mt -83.01 -13.71 55.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.698 -0.683 . . . . 10.0 110.9 174.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.673 ' HG2' ' O ' ' A' ' 76' ' ' SER . 28.4 mmtp -56.15 -60.87 2.87 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.833 -0.803 . . . . 10.0 108.833 170.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -63.71 -45.11 91.48 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.86 -0.609 . . . . 10.0 112.064 178.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.98 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -61.77 -57.95 9.89 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 123.137 1.446 . . . . 10.0 110.115 -171.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 79' ' ' LEU . . . -66.76 -33.54 75.86 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 111.472 -2.604 . . . . 10.0 110.067 178.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.64 1.82 70.67 Favored Glycine 0 CA--C 1.499 -0.938 0 N-CA-C 110.536 -1.026 . . . . 10.0 110.536 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.519 HG22 ' CG2' ' A' ' 97' ' ' VAL . 34.1 pt -68.18 161.86 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 CA-C-N 113.797 -1.201 . . . . 10.0 112.904 -176.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -149.08 27.59 0.85 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.108 -1.405 . . . . 10.0 108.299 172.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -168.64 -29.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.779 -1.101 . . . . 10.0 110.463 -174.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.412 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . 85.97 -130.56 9.98 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.359 -1.096 . . . . 10.0 110.359 -178.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.719 ' HB3' ' HA3' ' A' ' 136' ' ' GLY . 27.3 t -160.81 101.42 1.3 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.265 0.555 . . . . 10.0 109.932 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.4 p -70.91 105.8 3.4 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.179 -0.674 . . . . 10.0 109.179 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 82.47 90.6 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.259 0 O-C-N 124.489 1.118 . . . . 10.0 108.824 -173.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -88.44 77.55 1.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.872 2.382 . . . . 10.0 114.417 -167.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.56 137.8 4.15 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.019 -0.363 . . . . 10.0 110.019 173.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 73.84 -43.95 0.56 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.183 0.993 . . . . 10.0 111.705 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -71.75 -67.74 0.51 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.538 -0.912 . . . . 10.0 108.538 176.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.405 ' O ' HG22 ' A' ' 96' ' ' ILE . 8.6 mt 47.28 92.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 113.372 -1.74 . . . . 10.0 112.347 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.588 HG13 ' H ' ' A' ' 98' ' ' GLY . 3.4 p -44.67 -59.04 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 113.242 -1.799 . . . . 10.0 113.692 -166.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.588 ' H ' HG13 ' A' ' 97' ' ' VAL . . . -171.26 173.64 44.82 Favored Glycine 0 CA--C 1.49 -1.509 0 N-CA-C 108.621 -1.792 . . . . 10.0 108.621 -171.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.689 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -150.56 -179.8 7.53 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 122.853 1.311 . . . . 10.0 112.223 -160.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.98 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -155.33 -144.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-N 111.527 -2.579 . . . . 10.0 105.182 -176.429 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 1.4 t -166.02 142.84 5.23 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 107.087 -1.449 . . . . 10.0 107.087 -155.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.686 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 23.1 tpp180 -41.62 -42.03 2.36 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 124.732 1.27 . . . . 10.0 111.204 -171.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 25.3 tptp -59.91 -46.44 89.33 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.737 1.014 . . . . 10.0 113.737 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.569 ' O ' HG13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -60.09 -45.66 92.18 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.189 -1.041 . . . . 10.0 108.189 178.691 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 1.002 HG23 ' HB ' ' A' ' 128' ' ' ILE . 39.4 mm -43.13 -52.77 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 CA-C-N 114.393 -1.276 . . . . 10.0 111.25 170.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.799 ' HG2' ' HD2' ' A' ' 110' ' ' LYS . 16.9 tt0 -48.52 -61.84 1.81 Allowed 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.967 -1.015 . . . . 10.0 112.967 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.566 ' HA ' ' HD3' ' A' ' 110' ' ' LYS . 37.7 mt-10 -56.62 -46.67 80.79 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.695 -1.139 . . . . 10.0 110.844 -175.014 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.72 HG22 ' HD3' ' A' ' 112' ' ' LYS . 34.2 mt -52.8 -58.43 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 115.759 -0.655 . . . . 10.0 110.085 169.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.487 ' HB3' HD11 ' A' ' 121' ' ' LEU . . . -45.48 -40.6 8.59 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.473 0.709 . . . . 10.0 112.695 177.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.799 ' HD2' ' HG2' ' A' ' 106' ' ' GLU . 38.9 mtpt -73.22 -48.76 32.29 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.737 -0.665 . . . . 10.0 111.368 -175.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 108' ' ' ILE . 1.1 t -57.2 -38.41 73.63 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 112.573 0.583 . . . . 10.0 112.573 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.72 ' HD3' HG22 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -98.21 6.46 47.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 122.602 0.361 . . . . 10.0 111.172 -174.902 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.636 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 54.1 ttm -50.25 -38.86 42.29 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.491 -0.777 . . . . 10.0 112.669 176.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 113' ' ' MET . 35.1 Cg_endo -61.28 -31.74 89.51 Favored 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 121.726 1.617 . . . . 10.0 111.782 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 1.028 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 0.4 OUTLIER -93.71 -52.99 4.21 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.891 -1.504 . . . . 10.0 112.719 -170.263 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.517 HD11 ' HA ' ' A' ' 113' ' ' MET . 0.3 OUTLIER -72.99 -177.46 2.43 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 123.034 1.397 . . . . 10.0 113.871 -173.18 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -96.46 49.03 1.1 Allowed 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 112.443 -2.162 . . . . 10.0 113.088 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.695 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . . . -64.66 -102.64 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.811 1.041 . . . . 10.0 113.811 173.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 118' ' ' ALA . 24.5 t-20 107.12 -78.42 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.829 1.652 . . . . 10.0 107.789 -167.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.2 t -87.15 147.86 25.44 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.622 -1.251 . . . . 10.0 107.622 162.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.679 ' O ' ' HG2' ' A' ' 125' ' ' MET . 61.8 tp -56.25 -34.7 66.64 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.673 -0.811 . . . . 10.0 110.938 166.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 32.2 mt-10 -48.35 -40.46 25.51 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.564 0.697 . . . . 10.0 110.38 173.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.25 -47.73 63.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.545 -1.207 . . . . 10.0 110.959 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.695 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . . . -56.83 -40.35 75.87 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.405 -0.518 . . . . 10.0 110.122 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.792 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 74.7 mmm -53.35 -40.24 64.75 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.387 0.675 . . . . 10.0 110.727 176.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.662 ' HA ' ' HG2' ' A' ' 129' ' ' GLU . 13.6 mmmm -68.32 -45.07 73.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.06 -0.973 . . . . 10.0 110.234 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.466 ' CD1' HD22 ' A' ' 116' ' ' LEU . 92.8 mt -49.73 -65.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-O 121.178 0.514 . . . . 10.0 110.175 173.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 1.002 ' HB ' HG23 ' A' ' 105' ' ' ILE . 12.5 mm -50.79 -56.19 5.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.711 -1.131 . . . . 10.0 112.399 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.662 ' HG2' ' HA ' ' A' ' 126' ' ' LYS . 0.3 OUTLIER -56.51 -41.86 77.39 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 109.14 -0.689 . . . . 10.0 109.14 -177.793 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.659 ' N ' ' HG3' ' A' ' 129' ' ' GLU . . . -72.83 -47.62 24.96 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.58 -0.736 . . . . 10.0 111.563 -175.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.574 HG21 ' HB3' ' A' ' 75' ' ' ALA . 35.3 m -46.25 -61.8 1.62 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.099 -1.051 . . . . 10.0 109.691 170.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.427 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -48.17 -47.84 34.83 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.0 -0.545 . . . . 10.0 111.97 174.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.589 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 79.1 tttt -48.53 -54.22 15.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.938 -1.028 . . . . 10.0 111.593 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.5 m -66.85 -29.28 69.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.044 0.45 . . . . 10.0 111.197 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 49.8 mtm -80.44 4.49 17.97 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.52 0.933 . . . . 10.0 113.52 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.719 ' HA3' ' HB3' ' A' ' 89' ' ' SER . . . 83.97 11.43 79.01 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 119.364 0.984 . . . . 10.0 111.784 178.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.498 HD11 HD13 ' A' ' 85' ' ' ILE . 27.4 mt -101.66 131.33 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 CA-C-O 121.509 0.671 . . . . 10.0 112.411 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.689 ' HB3' ' HB2' ' A' ' 99' ' ' LYS . 7.8 tp10 -84.79 156.61 21.29 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 115.188 -0.915 . . . . 10.0 110.279 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.7 m -117.98 121.88 68.37 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.218 0 N-CA-C 107.889 -1.152 . . . . 10.0 107.889 165.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.803 HG22 ' O ' ' A' ' 100' ' ' VAL . 25.1 m -101.52 143.17 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 CA-C-N 113.961 -1.472 . . . . 10.0 108.265 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.7 t70 . . . . . 0 C--N 1.286 -2.163 0 CA-C-N 113.48 -1.691 . . . . 10.0 109.98 -173.378 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.4 mtm . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 110.25 -0.278 . . . . 10.0 110.25 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.75 101.3 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.082 0.771 . . . . 10.0 113.082 174.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.8 ' HB2' ' CE1' ' A' ' 61' ' ' TYR . 37.3 mmtt -100.87 167.15 10.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.734 -0.666 . . . . 10.0 109.321 173.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.509 ' HB3' ' HG3' ' A' ' 62' ' ' GLU . 30.5 mmtm -69.67 91.75 0.63 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.77 -0.195 . . . . 10.0 111.26 178.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.1 t -63.24 140.36 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.027 0.531 . . . . 10.0 111.329 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.46 -37.67 4.26 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 120.84 -0.344 . . . . 10.0 110.306 174.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.491 ' HB3' HG13 ' A' ' 60' ' ' VAL . . . -153.67 153.0 31.47 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.19 0.811 . . . . 10.0 113.19 -176.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -95.6 134.07 38.91 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.023 -1.103 . . . . 10.0 108.023 170.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.717 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.7 OUTLIER -120.65 80.19 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 168.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.415 ' HG2' HG13 ' A' ' 57' ' ' VAL . 55.5 mtmt -82.52 127.61 33.49 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 120.265 1.393 . . . . 10.0 108.482 176.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.663 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.27 128.75 6.91 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.959 0.885 . . . . 10.0 111.412 -174.841 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -78.52 122.67 26.17 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.311 -1.313 . . . . 10.0 110.141 -172.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.663 HD21 HD11 ' A' ' 11' ' ' LEU . 89.2 mt -140.43 133.66 14.93 Favored Pre-proline 0 N--CA 1.443 -0.817 0 CA-C-O 121.805 0.812 . . . . 10.0 112.072 -173.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.775 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 50.1 Cg_exo -52.0 125.08 16.19 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 124.072 3.181 . . . . 10.0 112.62 171.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.538 ' CB ' ' HB ' ' A' ' 46' ' ' THR . . . -62.13 127.29 30.69 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 107.696 -1.224 . . . . 10.0 107.696 169.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.85 -2.72 82.6 Favored Glycine 0 N--CA 1.443 -0.888 0 O-C-N 125.987 2.055 . . . . 10.0 112.744 -174.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.775 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 15.9 mmtp -140.16 99.62 3.71 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.083 0.944 . . . . 10.0 112.553 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -168.29 134.72 1.96 Allowed 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 114.073 -1.421 . . . . 10.0 111.767 174.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.707 ' HA ' ' HB2' ' A' ' 39' ' ' CYS . 1.6 t -178.11 -48.46 0.0 OUTLIER Pre-proline 0 N--CA 1.438 -1.06 0 CA-C-N 115.154 -0.93 . . . . 10.0 112.674 176.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.707 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 83.0 Cg_endo -104.62 133.25 0.09 OUTLIER 'Trans proline' 0 N--CA 1.409 -3.468 0 N-CA-C 117.049 1.903 . . . . 10.0 117.049 -152.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.92 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . 12.67 -63.3 0.0 OUTLIER Pre-proline 0 C--N 1.284 -2.243 0 CA-C-N 108.473 -3.967 . . . . 10.0 117.52 154.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.806 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 52.8 Cg_exo -52.63 -63.88 0.22 Allowed 'Trans proline' 0 CA--C 1.566 2.096 0 CA-C-N 123.964 2.451 . . . . 10.0 114.513 -177.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.806 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 60.4 Cg_endo -78.05 -52.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 122.624 2.216 . . . . 10.0 113.109 174.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.921 HG12 HD13 ' A' ' 35' ' ' ILE . 79.8 t -80.99 -45.27 21.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-N 111.995 -2.366 . . . . 10.0 112.689 -166.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.833 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -40.57 -64.75 1.13 Allowed Glycine 0 CA--C 1.521 0.448 0 O-C-N 124.808 1.318 . . . . 10.0 113.32 178.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.92 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 80.1 Cg_exo -58.77 -48.4 14.91 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.798 2.999 . . . . 10.0 111.39 177.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.4 -94.22 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 124.344 1.028 . . . . 10.0 111.764 -176.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.658 HD13 ' H ' ' A' ' 28' ' ' LEU 0.314 0.0 OUTLIER -81.02 -28.55 35.4 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 118.119 -1.432 . . . . 10.0 114.198 -174.946 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.544 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -68.75 -40.84 85.01 Favored Glycine 0 N--CA 1.468 0.769 0 O-C-N 121.17 -0.956 . . . . 10.0 113.248 -176.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.578 ' HG3' ' HA ' ' A' ' 26' ' ' PRO . 91.2 mt-30 -66.26 -6.8 15.07 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 118.639 -1.225 . . . . 10.0 110.603 175.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -105.82 16.26 25.48 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 120.496 -0.482 . . . . 10.0 111.49 171.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.75 ' HA3' ' HD2' ' A' ' 64' ' ' LYS . . . 69.65 22.74 76.81 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.763 -0.653 . . . . 10.0 113.862 172.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.634 HG13 ' CD1' ' A' ' 66' ' ' PHE . 73.9 t -75.22 -30.02 22.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -167.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 91.18 79.27 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 122.868 1.318 . . . . 10.0 109.982 -172.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.921 HD13 HG12 ' A' ' 24' ' ' VAL . 1.1 mm -47.36 -49.19 9.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 112.055 -2.339 . . . . 10.0 113.579 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 79.4 mtp -64.33 -46.63 82.68 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.587 -1.642 . . . . 10.0 111.31 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.709 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 21.3 tt0 -62.52 -42.21 99.37 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 117.955 -1.498 . . . . 10.0 110.589 178.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.688 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . 38.6 t80 -56.87 -53.38 58.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.457 0.91 . . . . 10.0 113.457 172.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.707 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -57.48 -47.1 82.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.286 -0.87 . . . . 10.0 111.16 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -65.57 -22.11 66.66 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.138 -1.025 . . . . 10.0 109.357 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.752 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 94.2 mtt180 -76.91 -65.55 0.93 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.444 -0.798 . . . . 10.0 112.3 173.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.634 ' CZ ' HG21 ' A' ' 46' ' ' THR . 67.4 t80 -57.28 -42.43 81.63 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.108 0.48 . . . . 10.0 110.305 -171.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -58.87 -52.17 66.9 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.316 -0.856 . . . . 10.0 109.916 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.87 92.73 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 119.476 -0.89 . . . . 10.0 112.229 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.752 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 27.9 mm-40 -64.21 -47.66 78.87 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 122.034 0.921 . . . . 10.0 110.887 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.663 ' CG2' HD12 ' A' ' 54' ' ' LEU . 63.1 p -89.13 3.3 52.31 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.104 -1.407 . . . . 10.0 112.026 -169.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.21 -41.12 12.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.139 -0.937 . . . . 10.0 113.043 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.96 -19.86 29.8 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.794 -0.639 . . . . 10.0 111.573 -171.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.438 ' NZ ' ' HB3' ' A' ' 49' ' ' LYS . 6.1 mtpm? -109.18 21.57 16.97 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 123.605 0.762 . . . . 10.0 109.194 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.03 150.91 3.99 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.936 -1.029 . . . . 10.0 113.09 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.6 20.36 32.09 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 110.564 -1.014 . . . . 10.0 110.564 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.596 ' HB2' HD21 ' A' ' 54' ' ' LEU . 66.9 mtt -137.75 124.45 21.05 Favored 'General case' 0 C--O 1.211 -0.924 0 C-N-CA 117.203 -1.799 . . . . 10.0 113.829 -168.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 50.3 mm -65.77 91.7 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.928 -0.767 . . . . 10.0 108.928 171.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.735 HD13 HG21 ' A' ' 70' ' ' ILE . 8.9 mt -84.69 126.42 68.66 Favored Pre-proline 0 N--CA 1.448 -0.534 0 N-CA-C 108.79 -0.819 . . . . 10.0 108.79 -178.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.762 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 20.6 Cg_exo -68.52 106.77 1.49 Allowed 'Trans proline' 0 C--N 1.329 -0.458 0 C-N-CA 121.654 1.569 . . . . 10.0 110.619 172.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -96.67 142.98 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 120.254 1.388 . . . . 10.0 110.891 -174.698 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 58.3 t -116.67 111.23 34.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 120.594 -0.442 . . . . 10.0 110.654 171.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.717 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 28.6 mt -105.11 138.38 30.27 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.829 0 N-CA-C 107.139 -1.43 . . . . 10.0 107.139 -176.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.7 m -122.95 95.08 4.48 Favored 'General case' 0 N--CA 1.408 -2.559 0 CA-C-N 115.009 -0.996 . . . . 10.0 108.849 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.538 HG21 HG22 ' A' ' 33' ' ' VAL . 1.5 p -87.8 135.21 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.819 0 CA-C-N 119.425 1.011 . . . . 10.0 110.804 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.8 ' CE1' ' HB2' ' A' ' 3' ' ' LYS . 70.4 m-85 -93.47 177.58 5.98 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.576 -0.738 . . . . 10.0 112.689 -173.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.509 ' HG3' ' HB3' ' A' ' 4' ' ' LYS . 5.9 mm-40 -55.63 -24.75 35.29 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 113.896 -1.502 . . . . 10.0 112.652 -178.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 20.0 t70 -79.37 -15.81 57.28 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.988 -1.005 . . . . 10.0 111.163 -177.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.75 ' HD2' ' HA3' ' A' ' 32' ' ' GLY . 28.6 mtmm 82.3 5.35 1.08 Allowed 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 114.764 -1.107 . . . . 10.0 110.339 -160.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.481 ' O ' HG23 ' A' ' 60' ' ' VAL . 21.5 t -71.26 173.08 8.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.002 -1.851 . . . . 10.0 106.002 175.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.688 ' CZ ' ' HB2' ' A' ' 38' ' ' PHE . 29.9 p90 -169.86 -177.18 2.56 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 121.994 2.179 . . . . 10.0 111.391 177.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.9 p -157.39 175.08 14.46 Favored 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 103.156 -2.905 . . . . 10.0 103.156 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 21.6 p90 -163.84 159.42 21.13 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.549 -0.908 . . . . 10.0 108.549 177.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.3 161.64 41.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.299 -1.371 . . . . 10.0 107.299 177.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.735 HG21 HD13 ' A' ' 54' ' ' LEU . 4.9 mm -109.52 134.06 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 108.228 -1.027 . . . . 10.0 108.228 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.823 ' NZ ' ' HA ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -81.88 91.05 6.48 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.179 0.514 . . . . 10.0 109.964 178.083 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.951 ' HB ' ' HG3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -50.16 104.17 0.41 Allowed Pre-proline 0 C--N 1.312 -1.037 0 CA-C-N 113.846 -1.524 . . . . 10.0 110.144 173.953 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.521 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 39.1 Cg_endo -66.5 149.35 84.46 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.608 2.206 . . . . 10.0 112.683 -169.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.877 ' HA ' HD11 ' A' ' 116' ' ' LEU . 47.5 Cg_exo -33.45 -61.24 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 124.098 3.199 . . . . 10.0 113.507 -178.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.54 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -174.28 10.8 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 112.853 0.686 . . . . 10.0 112.853 176.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.5 t -60.06 -64.24 1.02 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.068 0.461 . . . . 10.0 111.383 -174.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.48 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 80.7 m-85 -71.66 -28.61 63.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.179 -0.464 . . . . 10.0 111.231 -176.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.671 ' O ' ' HB3' ' A' ' 81' ' ' LYS . 3.0 mm? -84.21 -28.4 27.33 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.094 0.474 . . . . 10.0 111.098 -173.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 75' ' ' ALA . 11.3 mt -72.68 -36.33 67.86 Favored 'General case' 0 C--O 1.211 -0.952 0 C-N-CA 120.048 -0.661 . . . . 10.0 109.685 175.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -65.98 -21.34 66.4 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.02 0.438 . . . . 10.0 110.557 174.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.671 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 1.8 tmtp? -57.6 -50.25 73.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.391 -0.368 . . . . 10.0 110.536 171.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 1.069 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -79.12 -55.2 5.29 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.288 1.835 . . . . 10.0 113.208 176.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.21 121.88 22.8 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 111.152 -2.749 . . . . 10.0 107.453 -177.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -87.45 18.57 37.02 Favored Glycine 0 C--N 1.317 -0.496 0 C-N-CA 118.575 -1.774 . . . . 10.0 111.184 -166.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.442 HG22 HG22 ' A' ' 97' ' ' VAL . 19.2 pt -64.19 147.24 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 114.181 -1.01 . . . . 10.0 112.196 -176.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -159.76 32.15 0.19 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.039 -0.982 . . . . 10.0 108.524 175.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -160.38 -46.44 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.605 -1.634 . . . . 10.0 106.619 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.7 -178.63 44.12 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.875 -1.057 . . . . 10.0 113.701 166.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.6 p -78.68 -171.37 2.5 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.617 -0.791 . . . . 10.0 111.491 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.682 ' O ' ' HG3' ' A' ' 91' ' ' GLU . 47.1 p -154.84 12.1 0.37 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.231 -1.026 . . . . 10.0 108.231 174.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.682 ' HG3' ' O ' ' A' ' 90' ' ' SER . 6.3 mt-10 -172.18 119.36 0.43 Allowed Pre-proline 0 N--CA 1.454 -0.246 0 CA-C-N 113.749 -1.569 . . . . 10.0 107.206 -168.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 91' ' ' GLU . 1.5 Cg_endo -82.66 24.17 0.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.62 2.213 . . . . 10.0 113.586 -172.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -155.69 133.71 11.38 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.336 0.254 . . . . 10.0 110.761 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 70.05 -69.36 0.17 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 124.213 0.946 . . . . 10.0 111.802 174.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -72.54 64.87 0.64 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.655 0.74 . . . . 10.0 110.404 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.422 ' HB ' ' O ' ' A' ' 136' ' ' GLY . 46.8 pt -85.06 -167.86 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.408 -0.814 . . . . 10.0 110.87 174.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.52 HG13 ' N ' ' A' ' 98' ' ' GLY . 7.2 p -141.99 -47.41 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 113.001 0.741 . . . . 10.0 113.001 -163.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -169.75 168.34 41.26 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 110.517 -1.033 . . . . 10.0 110.517 177.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.539 ' O ' HG13 ' A' ' 100' ' ' VAL . 0.7 OUTLIER -158.19 173.97 15.89 Favored 'General case' 0 CA--C 1.481 -1.705 0 CA-C-O 121.23 0.538 . . . . 10.0 110.847 -160.737 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 1.069 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -164.36 -169.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 113.769 -1.559 . . . . 10.0 110.631 -171.513 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.8 p -104.86 141.48 36.45 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 114.252 -1.34 . . . . 10.0 112.3 -169.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.699 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 5.0 ttp180 -46.53 -38.69 9.71 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.717 -0.674 . . . . 10.0 110.207 171.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 20.1 tptm -58.17 -45.42 87.53 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.211 -0.45 . . . . 10.0 111.658 174.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.553 ' HG3' ' CB ' ' A' ' 82' ' ' ALA . 2.2 tm0? -60.13 -56.73 18.02 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.339 -0.615 . . . . 10.0 109.339 175.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.799 HG23 ' HB ' ' A' ' 128' ' ' ILE . 24.3 mm -26.72 -57.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 123.812 0.695 . . . . 10.0 112.317 162.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.733 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 30.1 tt0 -50.35 -58.07 6.5 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.008 0.923 . . . . 10.0 112.904 178.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.96 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 8.5 mt-10 -55.61 -46.43 77.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.488 -0.778 . . . . 10.0 110.767 -178.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.573 HD12 ' HB3' ' A' ' 78' ' ' LEU . 31.4 mm -58.88 -50.38 79.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.455 -0.793 . . . . 10.0 109.407 175.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.447 ' HB1' ' CB ' ' A' ' 124' ' ' ALA . . . -53.81 -40.53 66.44 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.158 -0.928 . . . . 10.0 113.248 176.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.96 ' HD2' ' HA ' ' A' ' 107' ' ' GLU . 36.4 mttm -63.87 -50.04 70.38 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 121.693 0.758 . . . . 10.0 109.125 -177.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 89.4 m -49.12 -59.46 3.63 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 113.786 -1.552 . . . . 10.0 111.926 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.951 ' HG3' ' HB ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -93.51 16.57 13.3 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.691 0.997 . . . . 10.0 113.691 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.616 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 47.6 ttm -41.94 -50.9 10.37 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 118.593 0.633 . . . . 10.0 111.902 168.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 113' ' ' MET . 42.5 Cg_endo -66.69 -20.9 52.44 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 121.583 1.522 . . . . 10.0 113.321 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' A' ' 117' ' ' ASN . 0.7 OUTLIER -91.94 -49.73 6.08 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.647 0.737 . . . . 10.0 111.26 -177.368 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.877 HD11 ' HA ' ' A' ' 74' ' ' PRO . 7.2 mp -62.58 -3.23 1.37 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.235 -1.348 . . . . 10.0 111.494 178.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' A' ' 115' ' ' ASP . 58.5 t30 64.03 45.34 4.21 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.108 -1.406 . . . . 10.0 109.268 177.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.616 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -85.13 119.76 25.88 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 113.448 -1.705 . . . . 10.0 113.041 -174.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -65.36 -42.92 92.26 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.782 -0.822 . . . . 10.0 108.782 167.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.2 p -143.88 149.26 36.65 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.957 -1.127 . . . . 10.0 107.957 -177.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.519 HD11 ' HA ' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -50.42 -39.8 48.42 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 114.753 -1.112 . . . . 10.0 112.041 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.562 ' HA ' ' HG3' ' A' ' 125' ' ' MET . 1.8 mp0 -47.88 -42.11 26.01 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.786 0.803 . . . . 10.0 111.135 177.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.89 -48.0 70.07 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 118.428 -1.309 . . . . 10.0 110.831 177.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.496 ' HA ' HD12 ' A' ' 127' ' ' ILE . . . -55.59 -38.26 69.17 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.007 177.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.686 ' O ' ' HB2' ' A' ' 129' ' ' GLU . 20.6 mtp -55.06 -39.4 69.19 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.59 0.709 . . . . 10.0 110.076 -176.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.669 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 0.3 OUTLIER -65.34 -46.66 79.36 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.153 -1.385 . . . . 10.0 110.441 -178.281 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 124' ' ' ALA . 63.6 mt -52.37 -62.81 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-N 116.165 -0.471 . . . . 10.0 111.112 175.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.799 ' HB ' HG23 ' A' ' 105' ' ' ILE . 11.8 mm -53.67 -54.44 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.121 0 CA-C-N 115.08 -0.964 . . . . 10.0 110.349 -177.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.686 ' HB2' ' O ' ' A' ' 125' ' ' MET . 0.8 OUTLIER -53.24 -41.68 65.68 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.076 -0.965 . . . . 10.0 110.097 178.342 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.55 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -75.21 -44.41 22.9 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.843 -0.694 . . . . 10.0 111.86 -176.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.54 HG21 ' HB3' ' A' ' 75' ' ' ALA . 93.0 m -47.5 -59.8 2.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.099 -1.051 . . . . 10.0 109.28 170.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.512 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -50.51 -51.33 48.51 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.739 -0.664 . . . . 10.0 111.274 174.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.55 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 77.3 tttt -44.75 -56.04 4.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.854 -1.066 . . . . 10.0 111.792 175.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.3 t -64.11 -31.22 72.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.108 0.48 . . . . 10.0 111.176 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 50.3 mtm -83.12 4.52 26.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.837 1.051 . . . . 10.0 113.837 -176.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.422 ' O ' ' HB ' ' A' ' 96' ' ' ILE . . . 83.75 12.68 77.04 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 120.161 1.346 . . . . 10.0 111.929 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 25.6 mt -101.79 124.14 55.41 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 CA-C-O 121.579 0.705 . . . . 10.0 111.29 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 139' ' ' VAL . 0.0 OUTLIER -88.58 158.44 18.27 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 114.549 -1.205 . . . . 10.0 109.317 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.424 ' N ' ' HG3' ' A' ' 138' ' ' GLU . 17.6 m -115.08 135.16 55.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 108.093 -1.077 . . . . 10.0 108.093 169.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.4 m -133.17 69.43 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 114.869 1.433 . . . . 10.0 114.869 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.5 t70 . . . . . 0 C--N 1.31 -1.117 0 CA-C-O 118.666 -0.683 . . . . 10.0 110.657 140.788 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.6 mmm . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.806 0.336 . . . . 10.0 110.732 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.13 179.33 6.97 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.237 -0.438 . . . . 10.0 109.945 176.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -78.39 162.84 26.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.855 -175.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.414 ' HB2' ' OE2' ' A' ' 62' ' ' GLU . 60.2 mttm -90.0 139.79 30.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.002 0.43 . . . . 10.0 111.136 -174.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.8 132.75 28.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.297 -0.865 . . . . 10.0 111.552 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.453 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . . . -102.98 -37.2 7.9 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.089 -0.708 . . . . 10.0 109.089 173.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.447 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -154.89 -175.2 5.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.899 0.857 . . . . 10.0 112.66 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 24.7 pt20 -142.0 130.48 22.51 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.087 -1.415 . . . . 10.0 108.241 178.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.626 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -119.77 84.13 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 109.406 -0.591 . . . . 10.0 109.406 -176.579 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.418 ' NZ ' ' HB2' ' A' ' 10' ' ' LYS . 8.0 mtmp? -77.56 130.27 36.71 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 120.664 1.574 . . . . 10.0 107.72 176.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.706 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.87 124.84 4.99 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 122.379 1.085 . . . . 10.0 111.594 -176.607 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -82.85 120.18 25.33 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.878 -1.51 . . . . 10.0 109.716 -172.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.706 HD21 HD11 ' A' ' 11' ' ' LEU . 92.1 mt -137.34 138.73 25.76 Favored Pre-proline 0 CA--C 1.5 -0.953 0 CA-C-O 121.512 0.672 . . . . 10.0 112.036 -172.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.875 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 40.1 Cg_exo -55.71 124.88 17.37 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 123.204 2.603 . . . . 10.0 111.646 171.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.565 ' O ' ' HA ' ' A' ' 50' ' ' ALA . . . -62.02 126.39 27.17 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 106.996 -1.483 . . . . 10.0 106.996 168.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.29 -5.04 79.08 Favored Glycine 0 CA--C 1.529 0.909 0 O-C-N 125.515 1.759 . . . . 10.0 113.599 -175.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.875 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 31.9 mmtp -139.89 102.59 4.45 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.519 1.159 . . . . 10.0 111.674 178.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 39' ' ' CYS . . . -170.17 130.7 0.96 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.17 -1.377 . . . . 10.0 111.927 175.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 65.0 m -166.7 -59.38 0.01 OUTLIER Pre-proline 0 N--CA 1.437 -1.122 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.907 -177.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.808 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 84.1 Cg_endo -108.05 136.22 0.05 OUTLIER 'Trans proline' 0 N--CA 1.421 -2.778 0 N-CA-C 117.05 1.904 . . . . 10.0 117.05 -157.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.064 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 11.69 -85.63 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.585 1 CA-C-N 108.393 -4.003 . . . . 10.0 115.335 167.845 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.853 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 56.9 Cg_exo -32.08 -54.43 0.32 Allowed 'Trans proline' 0 CA--C 1.558 1.711 0 C-N-CA 122.662 2.242 . . . . 10.0 115.579 -163.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.853 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 32.0 Cg_endo -84.54 -53.63 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 122.516 2.144 . . . . 10.0 112.651 168.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.808 HG12 ' CD1' ' A' ' 35' ' ' ILE . 75.9 t -81.53 -55.98 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 113.331 -1.759 . . . . 10.0 113.991 -167.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 1.064 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -43.1 -77.46 0.09 OUTLIER Glycine 0 CA--C 1.519 0.335 0 CA-C-N 114.736 -1.12 . . . . 10.0 114.1 -177.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.808 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 22.8 Cg_exo -45.09 -41.82 16.18 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.817 3.011 . . . . 10.0 112.681 173.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 24' ' ' VAL . . . -51.08 -101.52 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 123.475 0.484 . . . . 10.0 111.858 176.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.824 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.308 0.0 OUTLIER -73.33 -25.8 60.77 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 117.511 -1.676 . . . . 10.0 112.951 -172.422 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.536 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -71.83 -40.78 57.34 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.098 -0.572 . . . . 10.0 113.024 -176.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.409 ' HB3' ' O ' ' A' ' 26' ' ' PRO . 60.7 tt0 -63.09 -16.71 60.86 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 119.178 -1.009 . . . . 10.0 109.712 175.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -98.88 20.1 13.78 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 120.12 -0.632 . . . . 10.0 110.102 176.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.47 -1.64 76.39 Favored Glycine 0 CA--C 1.5 -0.872 0 CA-C-N 115.201 -0.909 . . . . 10.0 113.126 167.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.824 ' HB ' HD23 ' A' ' 28' ' ' LEU . 11.3 t -82.48 147.1 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 113.305 0.854 . . . . 10.0 113.305 -172.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -69.69 98.91 1.25 Allowed 'General case' 0 C--N 1.341 0.219 0 CA-C-O 121.291 0.567 . . . . 10.0 110.868 172.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.808 ' CD1' HG12 ' A' ' 24' ' ' VAL . 2.5 mm -52.31 -39.25 27.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.867 -1.061 . . . . 10.0 111.464 174.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.702 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 85.3 mtp -64.61 -52.1 59.24 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 113.244 -1.798 . . . . 10.0 111.618 176.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.64 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 31.1 mt-10 -58.49 -40.12 81.92 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.11 -1.036 . . . . 10.0 111.024 176.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.62 ' CE1' HD11 ' A' ' 58' ' ' ILE . 90.3 t80 -58.33 -59.74 4.87 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.929 1.085 . . . . 10.0 113.929 172.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.702 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 18.3 p -58.82 -48.05 82.64 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 114.832 -1.077 . . . . 10.0 111.761 -177.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -65.22 -22.74 66.92 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.824 -0.806 . . . . 10.0 108.824 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.743 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 10.7 mtm180 -78.45 -63.26 1.44 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 119.321 -0.952 . . . . 10.0 112.899 170.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.582 ' CZ ' HG21 ' A' ' 46' ' ' THR . 67.4 t80 -55.2 -43.61 74.59 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 118.717 0.689 . . . . 10.0 110.403 -172.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -59.8 -51.38 69.97 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.311 -0.858 . . . . 10.0 109.851 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.98 -40.25 97.18 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 119.239 -0.985 . . . . 10.0 112.182 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.743 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 23.5 mt-10 -67.92 -45.24 74.93 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.578 0.704 . . . . 10.0 111.079 -178.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.584 ' CG2' HD12 ' A' ' 54' ' ' LEU . 72.3 p -86.93 6.2 33.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.998 -1.001 . . . . 10.0 112.209 -172.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.7 -34.61 5.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.632 -1.167 . . . . 10.0 112.561 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -79.63 -38.54 33.6 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.585 -0.734 . . . . 10.0 112.053 -176.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -94.14 18.66 10.42 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 109.127 -0.694 . . . . 10.0 109.127 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -50.46 133.88 24.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.08 -0.963 . . . . 10.0 112.661 -178.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.05 19.48 10.1 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 114.786 -1.097 . . . . 10.0 110.799 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.587 ' HB2' HD21 ' A' ' 54' ' ' LEU . 67.3 mtt -137.5 127.48 25.81 Favored 'General case' 0 C--O 1.208 -1.108 0 C-N-CA 117.457 -1.697 . . . . 10.0 114.295 -169.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.2 mm -65.94 91.74 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 118.688 0.676 . . . . 10.0 109.372 169.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.593 HD13 HG21 ' A' ' 70' ' ' ILE . 6.9 mt -81.08 138.06 49.41 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 -177.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 54' ' ' LEU . 3.7 Cg_exo -78.67 104.84 1.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.95 1.766 . . . . 10.0 110.472 172.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -101.01 144.14 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 119.716 1.144 . . . . 10.0 110.995 -175.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 85.0 t -119.4 118.51 57.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 116.224 -0.444 . . . . 10.0 110.475 171.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.626 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 16.4 mt -104.94 141.29 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.722 0 N-CA-C 108.515 -0.921 . . . . 10.0 108.515 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.8 m -127.68 97.89 5.0 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 114.714 -1.13 . . . . 10.0 109.134 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 65' ' ' SER . 2.1 p -91.3 136.03 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 O-C-N 121.276 -0.89 . . . . 10.0 110.618 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.437 ' HE2' HG23 ' A' ' 67' ' ' THR . 65.2 m-85 -92.48 171.14 9.23 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.586 -0.734 . . . . 10.0 112.292 -175.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.453 ' HA ' ' HB2' ' A' ' 6' ' ' ALA . 39.7 mt-10 -58.38 -23.51 57.22 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.594 -1.184 . . . . 10.0 112.77 -177.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 2.8 m-20 -81.27 -6.41 58.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.872 -0.604 . . . . 10.0 112.568 -176.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 53.5 mtpt 83.97 1.31 0.95 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.967 0.889 . . . . 10.0 110.011 -167.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.598 ' O ' HG23 ' A' ' 60' ' ' VAL . 8.5 t -72.01 172.23 10.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.313 -1.312 . . . . 10.0 108.016 172.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.801 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -167.6 -177.48 3.55 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 120.241 1.382 . . . . 10.0 109.501 176.207 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.505 ' HA ' HH22 ' A' ' 41' ' ' ARG . 22.2 p -157.82 169.95 23.46 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 103.217 -2.883 . . . . 10.0 103.217 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.447 ' HB3' HG12 ' A' ' 58' ' ' ILE . 56.2 p90 -164.18 153.86 14.24 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.622 -0.881 . . . . 10.0 108.622 176.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.5 pt -131.89 153.24 38.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 108.178 -1.045 . . . . 10.0 108.178 -176.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.593 HG21 HD13 ' A' ' 54' ' ' LEU . 1.6 mm -107.39 131.76 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.389 -1.338 . . . . 10.0 107.389 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.662 ' C ' ' HD2' ' A' ' 73' ' ' PRO . 13.9 mmmm -77.71 90.2 4.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.033 0.92 . . . . 10.0 110.999 -177.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.602 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -60.63 -32.93 12.52 Favored Pre-proline 0 CA--C 1.562 1.434 0 CA-C-N 113.758 -1.564 . . . . 10.0 115.134 172.49 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.664 ' HG2' ' HD3' ' A' ' 74' ' ' PRO . 14.0 Cg_endo -54.8 -36.69 91.61 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.377 2.718 . . . . 10.0 117.281 -170.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.664 ' HD3' ' HG2' ' A' ' 73' ' ' PRO . 79.8 Cg_exo -47.14 -29.25 8.72 Favored 'Trans proline' 0 C--N 1.366 1.481 0 C-N-CA 121.963 1.776 . . . . 10.0 112.504 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.411 ' HB3' HG21 ' A' ' 131' ' ' THR . . . 73.04 -42.33 0.53 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.474 0.916 . . . . 10.0 113.474 169.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.2 p -45.43 -35.65 3.84 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.575 0.75 . . . . 10.0 112.69 -175.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.556 ' HB3' ' SD ' ' A' ' 52' ' ' MET . 75.3 m-85 -55.14 -50.31 69.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.545 0.688 . . . . 10.0 111.34 178.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.774 ' HB3' HD12 ' A' ' 108' ' ' ILE . 4.8 mp -93.25 -12.58 29.83 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.081 -0.648 . . . . 10.0 111.591 -174.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 79' ' ' LEU . 3.3 mm? -62.12 -37.28 84.52 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.17 -1.048 . . . . 10.0 108.17 166.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -56.74 -43.17 80.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.104 -0.953 . . . . 10.0 110.185 172.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? -54.94 -46.71 75.0 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.517 -0.765 . . . . 10.0 112.33 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.75 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -70.44 -49.17 51.48 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.087 1.355 . . . . 10.0 111.678 174.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.513 ' HB3' HG12 ' A' ' 85' ' ' ILE . . . -64.59 -30.92 71.95 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 111.413 -2.63 . . . . 10.0 111.298 -167.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.594 ' C ' ' H ' ' A' ' 86' ' ' GLU . . . 93.7 -31.99 6.12 Favored Glycine 0 CA--C 1.501 -0.838 0 N-CA-C 110.209 -1.156 . . . . 10.0 110.209 174.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.513 HG12 ' HB3' ' A' ' 83' ' ' ALA . 40.5 pt -47.48 17.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 115.676 1.732 . . . . 10.0 115.676 166.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.594 ' H ' ' C ' ' A' ' 84' ' ' GLY . 28.9 tt0 -75.01 60.06 0.97 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.8 -0.815 . . . . 10.0 108.8 171.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -173.69 -38.29 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.698 -1.137 . . . . 10.0 109.048 -173.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 142.01 -72.02 0.4 Allowed Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.187 -0.915 . . . . 10.0 111.426 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.3 m 65.33 114.19 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.442 0.639 . . . . 10.0 111.186 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.16 43.59 0.2 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.129 -0.693 . . . . 10.0 109.129 -174.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.748 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 38.8 mt-10 -162.03 -50.21 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 114.613 -1.176 . . . . 10.0 108.921 -174.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.748 ' HD3' ' HB2' ' A' ' 91' ' ' GLU . 4.8 Cg_exo -75.3 108.12 2.63 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.687 1.591 . . . . 10.0 110.628 169.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.749 ' HB2' ' HA ' ' A' ' 97' ' ' VAL . 28.1 mmtp 66.63 -170.96 0.19 Allowed 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.287 -0.635 . . . . 10.0 109.287 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -165.62 -44.29 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.791 0.329 . . . . 10.0 110.378 174.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.724 ' HG2' HG23 ' A' ' 96' ' ' ILE . 0.0 OUTLIER -66.82 -30.63 70.87 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.41 -0.516 . . . . 10.0 111.135 -172.768 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.847 HD13 ' HB3' ' A' ' 138' ' ' GLU . 2.4 pp -138.39 1.81 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.609 174.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.749 ' HA ' ' HB2' ' A' ' 93' ' ' LYS . 13.5 p 49.08 -57.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 116.118 1.895 . . . . 10.0 116.118 176.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 96' ' ' ILE . . . -152.39 162.04 29.7 Favored Glycine 0 N--CA 1.431 -1.661 0 N-CA-C 109.793 -1.323 . . . . 10.0 109.793 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.754 ' CB ' ' HG2' ' A' ' 138' ' ' GLU . 0.1 OUTLIER -139.93 168.53 19.6 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 122.851 1.31 . . . . 10.0 111.187 -170.478 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.75 HG11 ' HB1' ' A' ' 82' ' ' ALA . 2.6 m -156.37 -146.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 CA-C-N 111.516 -2.583 . . . . 10.0 104.732 -171.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.419 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 6.6 t -164.5 156.84 16.55 Favored 'General case' 0 C--N 1.282 -2.344 0 C-N-CA 117.693 -1.603 . . . . 10.0 110.71 -163.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.558 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 1.3 tmt_? -41.79 -42.94 2.79 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 112.718 -2.037 . . . . 10.0 110.628 -175.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -59.27 -44.22 92.46 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.032 0.753 . . . . 10.0 113.032 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.663 ' O ' HG12 ' A' ' 108' ' ' ILE . 3.1 mp0 -60.7 -51.76 67.99 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.392 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.706 HG23 ' HB ' ' A' ' 128' ' ' ILE . 39.3 mm -36.95 -53.32 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 CA-C-N 114.806 -1.088 . . . . 10.0 111.309 167.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.796 ' HA ' ' SD ' ' A' ' 125' ' ' MET . 4.9 tt0 -50.81 -60.25 3.25 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.833 -1.076 . . . . 10.0 113.168 -177.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -55.97 -48.97 74.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.157 -0.928 . . . . 10.0 110.502 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.774 HD12 ' HB3' ' A' ' 78' ' ' LEU . 18.4 mm -51.77 -56.58 5.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.593 171.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.545 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -50.83 -35.19 31.13 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.371 0.508 . . . . 10.0 112.371 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.757 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 92.7 mttt -76.91 -51.59 10.94 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 116.004 -0.544 . . . . 10.0 111.113 -178.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 108' ' ' ILE . 10.3 t -57.26 -17.73 13.13 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.145 0.794 . . . . 10.0 113.145 -176.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 0.1 OUTLIER -132.21 18.84 4.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.374 0.607 . . . . 10.0 110.011 -179.248 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.64 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 46.5 ttm -48.52 -45.63 69.14 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 114.798 -1.092 . . . . 10.0 112.307 175.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 113' ' ' MET . 19.0 Cg_endo -55.8 -23.62 42.7 Favored 'Trans proline' 0 C--N 1.363 1.291 0 C-N-CA 122.364 2.043 . . . . 10.0 112.338 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.625 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 5.0 m-20 -96.8 -46.44 6.26 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.883 -1.053 . . . . 10.0 112.85 -173.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.595 ' CD2' HD12 ' A' ' 127' ' ' ILE . 6.6 mp -63.92 36.92 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 114.525 -1.216 . . . . 10.0 112.986 -176.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.484 ' H ' ' C ' ' A' ' 115' ' ' ASP . 28.2 t-20 17.96 54.34 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.181 1.392 . . . . 10.0 112.279 -172.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -103.23 123.27 46.43 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.464 0.913 . . . . 10.0 113.464 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -67.64 -33.55 75.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.34 0.59 . . . . 10.0 109.854 169.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.1 p -148.43 145.41 27.99 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.569 -0.9 . . . . 10.0 108.569 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.678 ' O ' ' HG2' ' A' ' 125' ' ' MET . 56.7 tp -51.85 -38.44 55.97 Favored 'General case' 0 C--O 1.219 -0.542 0 N-CA-C 114.52 1.304 . . . . 10.0 114.52 -176.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.556 ' O ' ' HD3' ' A' ' 126' ' ' LYS . 19.8 mm-40 -49.66 -37.14 27.31 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.24 0.543 . . . . 10.0 110.931 176.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.04 -47.8 70.28 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 118.651 -1.22 . . . . 10.0 110.574 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.564 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -59.06 -30.98 68.45 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.212 0.53 . . . . 10.0 110.658 177.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.796 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 86.8 mmm -58.21 -38.71 77.31 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.495 0.664 . . . . 10.0 110.771 178.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.556 ' HD3' ' O ' ' A' ' 122' ' ' GLU . 4.0 mptp? -65.14 -52.04 57.59 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.954 -1.021 . . . . 10.0 111.846 177.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.595 HD12 ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -52.36 -58.83 2.0 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.688 0 C-N-CA 119.803 -0.759 . . . . 10.0 110.806 178.504 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.706 ' HB ' HG23 ' A' ' 105' ' ' ILE . 27.4 mm -50.75 -58.96 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.88 0 C-N-CA 123.801 0.84 . . . . 10.0 111.746 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.667 ' HG3' HG21 ' A' ' 105' ' ' ILE . 4.3 mt-10 -52.76 -43.68 65.97 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.548 -0.751 . . . . 10.0 109.453 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -71.5 -46.66 39.08 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.461 -0.876 . . . . 10.0 111.481 -176.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.411 HG21 ' HB3' ' A' ' 75' ' ' ALA . 51.7 m -46.63 -62.41 1.39 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.972 -1.114 . . . . 10.0 110.047 173.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.81 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -50.91 -48.64 60.55 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.845 -0.616 . . . . 10.0 111.699 174.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 58.7 tttm -47.31 -54.99 9.62 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.366 -0.834 . . . . 10.0 111.037 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.7 m -65.91 -28.56 69.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.061 0.457 . . . . 10.0 110.637 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 43.6 mtm -81.29 -2.26 48.33 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.507 0.928 . . . . 10.0 113.507 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 80.88 44.58 8.2 Favored Glycine 0 C--O 1.216 -1.01 0 CA-C-N 119.696 1.135 . . . . 10.0 112.219 -177.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.81 ' HB ' ' HB1' ' A' ' 132' ' ' ALA . 1.9 mm -119.86 127.12 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.67 0 CA-C-O 121.389 0.614 . . . . 10.0 110.475 175.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.847 ' HB3' HD13 ' A' ' 96' ' ' ILE . 0.0 OUTLIER -87.49 145.76 26.11 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 114.948 -1.024 . . . . 10.0 109.326 176.104 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 18.9 m -113.46 134.62 55.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 107.634 -1.247 . . . . 10.0 107.634 171.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.632 HG22 ' O ' ' A' ' 100' ' ' VAL . 12.9 m -129.65 72.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 114.674 1.361 . . . . 10.0 114.674 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.024 0 N-CA-C 114.216 1.191 . . . . 10.0 114.216 140.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 tpt . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.591 0.234 . . . . 10.0 110.869 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.89 145.67 44.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.601 -0.272 . . . . 10.0 110.605 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -128.66 155.83 44.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.999 0.428 . . . . 10.0 110.83 177.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.524 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 27.4 mtpp -136.14 119.98 17.39 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.051 -0.722 . . . . 10.0 109.051 177.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.4 t -62.97 133.97 28.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 122.392 0.277 . . . . 10.0 110.679 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.53 -38.61 6.39 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.394 -0.595 . . . . 10.0 109.394 174.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.522 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -157.44 159.02 36.9 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 113.58 0.955 . . . . 10.0 113.58 -175.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -100.88 135.45 42.3 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.53 -1.214 . . . . 10.0 108.416 170.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.643 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -120.16 80.15 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 108.317 -0.994 . . . . 10.0 108.317 167.802 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.466 ' HG2' HG13 ' A' ' 57' ' ' VAL . 36.2 mttm -80.79 129.69 34.66 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 121.08 1.764 . . . . 10.0 107.484 176.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.519 HD21 HD11 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -158.09 130.28 7.01 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 122.209 1.004 . . . . 10.0 111.601 -176.603 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -81.75 119.13 23.47 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.026 -1.443 . . . . 10.0 109.664 -172.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.519 HD11 HD21 ' A' ' 11' ' ' LEU . 33.2 mt -136.06 133.97 20.02 Favored Pre-proline 0 CA--C 1.504 -0.822 0 CA-C-O 121.495 0.664 . . . . 10.0 112.578 -169.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.605 ' HB2' ' CB ' ' A' ' 17' ' ' LYS . 39.8 Cg_exo -56.05 122.97 12.71 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 123.534 2.823 . . . . 10.0 111.866 172.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.648 ' HB1' ' HB ' ' A' ' 46' ' ' THR . . . -60.38 128.53 37.17 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 107.814 -1.18 . . . . 10.0 107.814 170.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.6 1.29 82.53 Favored Glycine 0 CA--C 1.527 0.832 0 O-C-N 125.808 1.942 . . . . 10.0 112.972 -175.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.605 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . 0.7 OUTLIER -142.01 88.66 2.12 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.022 0.911 . . . . 10.0 112.089 -177.773 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.75 133.02 3.95 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.898 -1.046 . . . . 10.0 112.514 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.566 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 4.5 t 175.07 -42.86 0.0 OUTLIER Pre-proline 0 C--O 1.22 -0.487 0 O-C-N 124.349 1.031 . . . . 10.0 112.615 177.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.7 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 56.5 Cg_endo -99.07 121.45 0.12 Allowed 'Trans proline' 0 N--CA 1.42 -2.845 0 CA-C-N 120.612 1.254 . . . . 10.0 115.24 -159.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.067 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 10.65 -85.19 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 109.907 -3.315 . . . . 10.0 115.26 167.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.805 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 26.2 Cg_exo -25.11 -57.52 0.07 OUTLIER 'Trans proline' 0 CA--C 1.561 1.83 0 C-N-CA 123.543 2.829 . . . . 10.0 115.913 -165.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.805 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 1.0 OUTLIER -86.16 -59.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.363 1.309 0 C-N-CA 123.365 2.71 . . . . 10.0 112.474 171.401 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.664 HG13 HD12 ' A' ' 28' ' ' LEU . 36.7 t -73.95 -43.07 52.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 112.159 -2.292 . . . . 10.0 113.759 -168.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 1.067 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -54.74 -71.8 0.66 Allowed Glycine 0 C--O 1.218 -0.857 0 CA-C-N 114.588 -1.187 . . . . 10.0 113.221 -177.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.619 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 17.1 Cg_exo -46.15 -46.27 16.7 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.52 2.813 . . . . 10.0 112.653 173.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.7 -75.25 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.437 0.637 . . . . 10.0 111.375 177.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.699 HD21 ' CD1' ' A' ' 58' ' ' ILE . 5.0 mt -69.65 -46.96 64.94 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.512 0.93 . . . . 10.0 113.512 -177.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.43 -40.33 97.49 Favored Glycine 0 C--N 1.32 -0.35 0 CA-C-N 115.462 -0.79 . . . . 10.0 113.481 -172.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -63.44 -27.14 69.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.057 0.456 . . . . 10.0 110.327 178.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -99.11 13.18 33.79 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.379 0.609 . . . . 10.0 110.353 177.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.511 ' O ' ' HE3' ' A' ' 64' ' ' LYS . . . 76.45 11.41 85.15 Favored Glycine 0 CA--C 1.501 -0.799 0 CA-C-N 114.883 -1.053 . . . . 10.0 113.319 171.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.811 HG13 ' CD1' ' A' ' 66' ' ' PHE . 59.6 t -80.92 139.58 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 112.117 0.414 . . . . 10.0 112.117 -172.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.434 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 1.2 m-20 -70.5 100.52 1.81 Allowed 'General case' 0 C--N 1.343 0.284 0 CA-C-O 121.586 0.708 . . . . 10.0 110.875 178.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.504 ' CD1' ' HA2' ' A' ' 25' ' ' GLY . 92.9 mt -51.0 -45.9 29.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 114.604 -1.18 . . . . 10.0 111.931 175.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.8 mtm -64.73 -54.68 27.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 112.997 -1.91 . . . . 10.0 111.246 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 34' ' ' ASN . 9.1 tp10 -53.37 -44.02 68.25 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 121.172 -0.211 . . . . 10.0 110.432 177.014 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.59 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 56.7 t80 -59.79 -56.24 24.26 Favored 'General case' 0 C--O 1.213 -0.834 0 N-CA-C 114.052 1.131 . . . . 10.0 114.052 171.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.468 ' SG ' ' HB ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -57.59 -49.79 75.24 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.968 0.907 . . . . 10.0 111.968 -177.739 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -65.46 -21.18 66.61 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 119.471 -0.892 . . . . 10.0 108.853 -176.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.661 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 46.9 mtt180 -78.9 -62.04 1.82 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.221 -0.9 . . . . 10.0 112.652 168.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.621 ' CZ ' HG21 ' A' ' 46' ' ' THR . 79.4 t80 -53.27 -48.4 68.34 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.535 0.683 . . . . 10.0 110.065 -173.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -61.16 -47.78 84.61 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.674 -1.148 . . . . 10.0 110.27 -176.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.79 -38.91 92.51 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 119.163 -1.015 . . . . 10.0 112.077 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.661 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 37.1 mm-40 -63.24 -45.84 89.71 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.147 0.975 . . . . 10.0 110.303 178.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.648 ' HB ' ' HB1' ' A' ' 15' ' ' ALA . 70.0 p -90.87 -0.48 57.74 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.15 -1.386 . . . . 10.0 112.477 -167.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.35 -37.09 7.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.15 -0.932 . . . . 10.0 112.577 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -83.64 -24.76 31.26 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.337 -0.847 . . . . 10.0 111.429 -172.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.7 mtmm -113.23 25.84 10.99 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.54 0.686 . . . . 10.0 109.959 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.458 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -54.13 154.92 3.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.39 -1.277 . . . . 10.0 113.257 177.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.95 21.06 40.57 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.574 -1.01 . . . . 10.0 110.574 -177.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.602 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 67.3 mtt -139.47 125.23 19.52 Favored 'General case' 0 C--O 1.209 -1.065 0 C-N-CA 116.866 -1.934 . . . . 10.0 114.653 -166.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.6 mm -66.88 91.39 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 109.409 -0.589 . . . . 10.0 109.409 172.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.613 HD12 ' CG2' ' A' ' 46' ' ' THR . 7.2 mt -82.2 131.49 56.07 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.62 -0.511 . . . . 10.0 109.62 -177.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.509 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 13.5 Cg_exo -72.06 96.04 0.77 Allowed 'Trans proline' 0 C--N 1.331 -0.377 0 C-N-CA 122.5 2.133 . . . . 10.0 111.265 173.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -92.96 157.65 2.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 119.586 1.084 . . . . 10.0 111.579 -174.668 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.497 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 95.2 t -135.39 115.94 18.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.4 173.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.699 ' CD1' HD21 ' A' ' 28' ' ' LEU . 25.5 mt -108.81 138.0 37.98 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.742 0 N-CA-C 107.953 -1.129 . . . . 10.0 107.953 -174.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.3 m -123.13 92.83 3.78 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 114.845 -1.07 . . . . 10.0 109.102 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.611 HG21 HG22 ' A' ' 33' ' ' VAL . 2.6 p -86.0 134.8 26.43 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 O-C-N 121.258 -0.901 . . . . 10.0 110.817 -177.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -91.98 173.58 7.77 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.748 0.785 . . . . 10.0 112.939 -176.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 59.7 mt-10 -61.71 -15.98 45.19 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.122 -1.399 . . . . 10.0 112.506 -178.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.61 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 7.1 m-20 -75.52 -17.41 60.1 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.51 -0.476 . . . . 10.0 110.692 177.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 42.1 mtpt 82.41 1.62 1.28 Allowed 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 124.492 1.12 . . . . 10.0 109.993 -160.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.51 ' O ' HG23 ' A' ' 60' ' ' VAL . 28.7 t -73.43 174.32 8.34 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 113.313 -1.767 . . . . 10.0 106.846 173.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.811 ' CD1' HG13 ' A' ' 33' ' ' VAL . 55.7 p90 -169.35 -176.1 2.42 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 122.077 2.217 . . . . 10.0 110.764 177.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.4 p -157.32 174.91 14.71 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 103.022 -2.955 . . . . 10.0 103.022 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.444 ' CB ' HG12 ' A' ' 58' ' ' ILE . 35.8 p90 -163.72 157.92 19.69 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.472 -0.936 . . . . 10.0 108.472 177.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.497 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 38.8 pt -127.74 166.99 23.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 106.702 -1.592 . . . . 10.0 106.702 177.081 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.469 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 8.9 mt -134.17 124.8 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 107.514 -1.291 . . . . 10.0 107.514 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 30.4 mmmt -76.93 81.78 3.48 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.721 -0.844 . . . . 10.0 108.721 -176.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.709 ' CG2' ' HA ' ' A' ' 112' ' ' LYS . 1.7 t -50.66 116.5 7.03 Favored Pre-proline 0 C--N 1.312 -1.035 0 N-CA-C 107.057 -1.46 . . . . 10.0 107.057 174.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.706 ' HG3' ' CE1' ' A' ' 77' ' ' PHE . 61.3 Cg_endo -65.87 166.46 20.39 Favored 'Trans proline' 0 CA--C 1.517 -0.331 0 C-N-CA 123.451 2.767 . . . . 10.0 114.939 -153.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.878 ' HA ' HD21 ' A' ' 116' ' ' LEU . 19.7 Cg_exo -67.63 55.67 0.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.141 2.56 . . . . 10.0 111.14 170.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.496 ' HB2' HD13 ' A' ' 128' ' ' ILE . . . 75.46 -22.33 0.27 Allowed 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 113.572 0.952 . . . . 10.0 113.572 173.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.2 p -38.06 -78.89 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.571 1.322 . . . . 10.0 114.571 -167.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.706 ' CE1' ' HG3' ' A' ' 73' ' ' PRO . 3.2 p90 -82.51 -18.84 40.13 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.009 0.744 . . . . 10.0 113.009 -173.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.616 ' HB3' HD12 ' A' ' 108' ' ' ILE . 2.7 mm? -67.99 -36.19 79.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.399 0.618 . . . . 10.0 109.765 172.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.714 HD13 ' HB2' ' A' ' 132' ' ' ALA . 27.0 mt -62.56 -39.48 93.78 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.683 -0.69 . . . . 10.0 110.837 176.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.497 ' HA ' ' HB3' ' A' ' 83' ' ' ALA . 37.0 ttpt -66.04 -17.4 64.66 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.37 -0.532 . . . . 10.0 111.01 176.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.542 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 11.3 mmmm -64.56 -39.47 93.81 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 121.572 -0.705 . . . . 10.0 111.117 169.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 1.02 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -78.5 -56.33 4.52 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.492 1.917 . . . . 10.0 112.277 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.497 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . . . -61.76 119.47 8.8 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 110.825 -2.898 . . . . 10.0 105.844 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.77 6.03 59.87 Favored Glycine 0 N--CA 1.46 0.25 0 CA-C-N 121.814 2.097 . . . . 10.0 110.484 -169.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.631 ' CD1' ' HA3' ' A' ' 98' ' ' GLY . 0.9 OUTLIER -58.48 139.34 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.004 0 C-N-CA 125.317 1.447 . . . . 10.0 114.114 -179.775 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 0.7 OUTLIER -170.64 51.65 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.945 -1.479 . . . . 10.0 107.283 168.461 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 86' ' ' GLU . 24.1 tptm 90.07 79.46 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.053 -1.43 . . . . 10.0 108.499 -172.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.66 62.56 0.24 Allowed Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.338 -0.847 . . . . 10.0 112.035 -174.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.6 p -168.71 170.54 9.31 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.461 -0.57 . . . . 10.0 109.461 -178.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.9 p -165.98 -79.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.45 0.167 . . . . 10.0 111.037 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.664 ' N ' ' HD2' ' A' ' 92' ' ' PRO . 1.7 mp0 -62.63 -45.29 88.49 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 112.18 0.437 . . . . 10.0 112.18 176.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.754 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 54.7 Cg_exo -25.62 144.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.6 1 C-N-CA 125.379 4.052 . . . . 10.0 116.166 176.491 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -69.95 138.8 52.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.059 -0.973 . . . . 10.0 110.989 -176.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.84 18.96 8.48 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.266 -0.879 . . . . 10.0 109.568 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.2 tttm 80.58 -9.91 1.31 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 114.581 -1.19 . . . . 10.0 111.19 175.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.807 HG23 ' HA3' ' A' ' 136' ' ' GLY . 1.0 OUTLIER -151.95 109.72 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.749 0 CA-C-O 122.725 1.25 . . . . 10.0 112.802 -178.654 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.754 ' HB ' ' HB3' ' A' ' 92' ' ' PRO . 3.9 p -61.35 -41.42 89.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 117.027 2.232 . . . . 10.0 117.027 177.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.631 ' HA3' ' CD1' ' A' ' 85' ' ' ILE . . . -58.32 160.13 13.89 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 114.593 0.597 . . . . 10.0 114.593 -158.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.863 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -154.79 172.34 18.13 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 115.593 -0.303 . . . . 10.0 111.201 -157.901 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 1.02 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -168.29 114.16 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-O 122.887 1.327 . . . . 10.0 111.869 179.511 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 1.2 t -39.78 143.62 0.23 Allowed 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 111.458 -2.61 . . . . 10.0 114.149 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.764 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 26.6 mtt180 -46.34 -32.63 3.28 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 112.243 -2.253 . . . . 10.0 113.732 -170.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.517 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 17.5 tppt? -57.67 -44.22 85.58 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.859 -0.526 . . . . 10.0 111.742 178.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.521 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.6 OUTLIER -56.95 -47.99 79.38 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.603 -0.888 . . . . 10.0 108.603 176.21 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.999 HG23 ' HB ' ' A' ' 128' ' ' ILE . 32.7 mm -43.09 -49.41 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.141 -1.391 . . . . 10.0 111.852 173.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.8 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 28.8 tt0 -46.86 -62.17 1.52 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.093 0.957 . . . . 10.0 113.262 175.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.641 ' HA ' ' HD3' ' A' ' 110' ' ' LYS . 47.7 mt-10 -52.73 -54.8 28.69 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.232 -0.895 . . . . 10.0 110.803 -176.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.652 ' O ' HG22 ' A' ' 111' ' ' THR . 24.5 mm -47.42 -55.43 2.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.124 -0.944 . . . . 10.0 110.126 170.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.633 ' O ' ' HE2' ' A' ' 112' ' ' LYS . . . -49.19 -36.95 21.1 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.888 0.699 . . . . 10.0 112.888 176.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.8 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 51.4 mtpt -72.58 -49.24 33.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.832 -0.622 . . . . 10.0 111.299 -174.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.652 HG22 ' O ' ' A' ' 108' ' ' ILE . 6.1 t -53.67 -36.57 62.28 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.091 0.404 . . . . 10.0 112.091 -177.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.815 ' HD2' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -106.71 13.5 27.97 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 113.336 0.865 . . . . 10.0 113.336 -174.792 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.701 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 14.6 ptp -55.2 -39.37 76.69 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 113.056 0.762 . . . . 10.0 113.056 176.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.626 ' HD3' ' HG3' ' A' ' 113' ' ' MET . 73.2 Cg_endo -71.13 -28.94 18.25 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 121.326 1.35 . . . . 10.0 112.112 -179.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -95.88 -42.48 8.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.825 -1.079 . . . . 10.0 113.673 -170.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.878 HD21 ' HA ' ' A' ' 74' ' ' PRO . 1.1 mp -71.16 9.64 0.71 Allowed 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.118 -0.946 . . . . 10.0 113.272 -177.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 63.77 36.44 10.54 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 122.21 1.005 . . . . 10.0 108.529 174.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 119' ' ' ASN . . . -69.56 -69.85 0.32 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 113.9 -1.5 . . . . 10.0 113.076 -167.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.431 ' HB3' ' O ' ' A' ' 118' ' ' ALA . 27.3 t-20 100.87 -38.88 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.659 1.224 . . . . 10.0 110.412 -178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 89.2 p -145.92 144.76 30.37 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.023 -1.473 . . . . 10.0 107.023 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.574 ' O ' ' HG3' ' A' ' 125' ' ' MET . 50.8 tp -58.59 -41.98 87.02 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.915 0.709 . . . . 10.0 112.915 178.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -48.23 -43.64 32.45 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.394 0.616 . . . . 10.0 109.687 174.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.59 ' O ' ' HG3' ' A' ' 126' ' ' LYS . . . -62.88 -51.93 65.09 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.624 -1.171 . . . . 10.0 111.292 173.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.716 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -55.34 -30.49 60.38 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.252 -0.905 . . . . 10.0 111.652 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.574 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 83.4 mtp -61.55 -46.33 90.35 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.791 1.034 . . . . 10.0 113.791 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.74 ' HD3' ' N ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -62.83 -40.02 96.12 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.094 0.405 . . . . 10.0 112.094 -178.04 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.74 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -55.11 -59.33 2.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 C-N-CA 118.785 -1.166 . . . . 10.0 109.779 174.876 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.999 ' HB ' HG23 ' A' ' 105' ' ' ILE . 12.9 mm -49.47 -57.85 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 CA-C-N 114.82 -1.082 . . . . 10.0 111.856 -175.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' A' ' 125' ' ' MET . 6.8 pt-20 -55.77 -44.71 77.97 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.118 -0.633 . . . . 10.0 109.948 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -69.15 -49.2 41.81 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.601 -0.727 . . . . 10.0 112.396 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.514 HG21 ' O ' ' A' ' 74' ' ' PRO . 44.9 m -45.72 -62.04 1.46 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.853 -0.673 . . . . 10.0 109.904 171.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.714 ' HB2' HD13 ' A' ' 79' ' ' LEU . . . -49.37 -51.09 36.99 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.222 -0.444 . . . . 10.0 111.235 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -48.29 -48.61 35.74 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 123.911 0.757 . . . . 10.0 111.759 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.1 m -62.53 -39.69 94.38 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.636 0.255 . . . . 10.0 111.254 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.668 ' HG3' HD13 ' A' ' 137' ' ' ILE . 23.6 ptt? -90.63 15.69 10.5 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.477 0.917 . . . . 10.0 113.477 -173.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.807 ' HA3' HG23 ' A' ' 96' ' ' ILE . . . 103.5 -21.78 38.01 Favored Glycine 0 C--N 1.331 0.273 0 CA-C-N 119.627 1.103 . . . . 10.0 112.759 177.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.668 HD13 ' HG3' ' A' ' 135' ' ' MET . 2.0 mp -83.15 128.33 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 CA-C-O 122.94 1.353 . . . . 10.0 111.33 -169.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.863 ' HB3' ' HB3' ' A' ' 99' ' ' LYS . 3.3 tp10 -85.64 157.93 20.22 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 112.288 -2.233 . . . . 10.0 109.196 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.458 ' N ' ' HG3' ' A' ' 138' ' ' GLU . 17.1 m -116.49 124.73 72.99 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.371 0 N-CA-C 107.59 -1.263 . . . . 10.0 107.59 168.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 101' ' ' THR . 1.8 m -98.28 160.12 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 C-N-CA 119.143 -1.023 . . . . 10.0 109.409 -175.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 C--N 1.297 -1.694 0 CA-C-N 115.059 -0.973 . . . . 10.0 110.085 179.735 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 ppp? . . . . . 0 N--CA 1.484 1.262 0 CA-C-O 119.689 -0.196 . . . . 10.0 110.542 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -41.49 121.59 1.71 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.232 0.613 . . . . 10.0 112.196 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.558 ' HB3' ' CG ' ' A' ' 61' ' ' TYR . 80.9 mttt -99.24 119.49 37.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.712 -0.676 . . . . 10.0 112.192 -170.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 75.8 mmtt -117.63 142.69 46.93 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.279 -1.008 . . . . 10.0 108.279 167.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.22 129.52 25.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.689 0.28 . . . . 10.0 110.851 -174.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.56 -36.3 7.16 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 175.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.541 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -158.91 178.26 10.28 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.177 0.806 . . . . 10.0 113.177 -177.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.53 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 93.9 mt-30 -129.32 132.73 47.17 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.182 -1.372 . . . . 10.0 109.184 174.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.633 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.4 OUTLIER -116.47 81.14 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 N-CA-C 108.452 -0.944 . . . . 10.0 108.452 176.303 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -81.63 123.58 28.81 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 120.256 -1.527 . . . . 10.0 108.412 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.655 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.7 132.93 8.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.986 0.898 . . . . 10.0 111.881 -173.061 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.404 ' HB3' ' CG2' ' A' ' 53' ' ' ILE . 0.2 OUTLIER -87.13 123.57 32.32 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.726 -1.125 . . . . 10.0 110.815 -172.668 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.655 HD21 HD11 ' A' ' 11' ' ' LEU . 82.7 mt -138.82 137.94 20.69 Favored Pre-proline 0 C--O 1.218 -0.564 0 CA-C-O 121.51 0.671 . . . . 10.0 112.648 -174.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.8 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 23.6 Cg_exo -58.45 134.18 59.52 Favored 'Trans proline' 0 C--N 1.327 -0.583 0 C-N-CA 124.238 3.292 . . . . 10.0 112.518 174.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.512 ' HB1' ' O ' ' A' ' 46' ' ' THR . . . -56.1 133.93 52.37 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.131 -1.433 . . . . 10.0 107.131 166.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.33 0.06 50.99 Favored Glycine 0 N--CA 1.443 -0.897 0 O-C-N 125.448 1.717 . . . . 10.0 113.449 174.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.8 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 14.0 mmmm -138.41 77.45 1.63 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.481 1.141 . . . . 10.0 111.017 -178.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.653 ' H ' HD22 ' A' ' 43' ' ' ASN . . . -156.96 130.73 8.21 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.907 -0.717 . . . . 10.0 112.027 176.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.586 ' HA ' ' HB3' ' A' ' 39' ' ' CYS . 1.5 t -179.27 -41.66 0.0 OUTLIER Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 114.092 -1.413 . . . . 10.0 112.328 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.723 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 98.7 Cg_endo -103.08 127.31 0.09 OUTLIER 'Trans proline' 0 N--CA 1.408 -3.51 0 N-CA-C 115.503 1.309 . . . . 10.0 115.503 -161.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 1.085 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 11.09 -86.54 0.0 OUTLIER Pre-proline 0 C--N 1.295 -1.764 0 CA-C-N 109.12 -3.673 . . . . 10.0 115.605 166.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.906 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 51.3 Cg_exo -30.88 -55.09 0.23 Allowed 'Trans proline' 0 CA--C 1.559 1.773 0 C-N-CA 122.863 2.376 . . . . 10.0 115.74 -162.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.906 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 5.0 Cg_exo -81.53 -57.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.791 2.327 . . . . 10.0 112.246 171.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.022 HG12 HD12 ' A' ' 35' ' ' ILE . 57.5 t -79.83 -52.01 15.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 112.556 -2.111 . . . . 10.0 114.187 -167.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 1.085 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -50.73 -74.51 0.28 Allowed Glycine 0 C--O 1.216 -0.982 0 CA-C-N 114.831 -1.077 . . . . 10.0 113.537 -176.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.751 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 19.9 Cg_exo -45.01 -43.88 15.29 Favored 'Trans proline' 0 CA--C 1.517 -0.344 0 C-N-CA 123.777 2.985 . . . . 10.0 112.993 174.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 24' ' ' VAL . . . -50.24 -77.23 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.498 0.666 . . . . 10.0 111.271 175.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.772 HD21 ' CD1' ' A' ' 58' ' ' ILE . 3.3 mt -69.65 -48.49 59.64 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.872 1.064 . . . . 10.0 113.872 -176.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.62 -37.21 88.72 Favored Glycine 0 C--N 1.32 -0.353 0 CA-C-N 115.416 -0.811 . . . . 10.0 113.261 -174.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -63.75 -24.92 67.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.706 0.289 . . . . 10.0 110.559 176.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -100.47 16.52 24.32 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.652 0.739 . . . . 10.0 109.899 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.14 3.39 88.96 Favored Glycine 0 CA--C 1.5 -0.858 0 CA-C-N 114.549 -1.205 . . . . 10.0 113.59 168.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.864 HG11 ' CD2' ' A' ' 66' ' ' PHE . 2.9 t -80.56 146.45 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 113.664 0.987 . . . . 10.0 113.664 -171.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.601 ' OD1' ' HG2' ' A' ' 37' ' ' GLU . 1.6 t-20 -74.27 104.17 4.94 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.643 0.735 . . . . 10.0 110.973 174.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.022 HD12 HG12 ' A' ' 24' ' ' VAL . 22.3 mm -53.91 -38.14 35.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 114.092 -1.413 . . . . 10.0 112.413 177.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.806 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -61.8 -56.83 15.37 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 113.503 -1.68 . . . . 10.0 112.038 176.977 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.601 ' HG2' ' OD1' ' A' ' 34' ' ' ASN . 21.1 mm-40 -56.64 -35.28 68.17 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.737 -1.185 . . . . 10.0 110.46 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.621 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 87.3 t80 -60.11 -60.53 3.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.187 1.18 . . . . 10.0 114.187 171.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.806 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 20.9 p -60.84 -47.01 88.3 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.005 -0.998 . . . . 10.0 111.706 -176.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.575 ' HE2' ' HB3' ' A' ' 36' ' ' MET . 52.5 mtmt -63.83 -23.69 67.46 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.416 -0.914 . . . . 10.0 109.59 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.762 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 20.3 mtp180 -73.98 -65.09 0.88 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 119.658 -0.817 . . . . 10.0 111.504 168.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.65 ' HZ ' ' HB2' ' A' ' 54' ' ' LEU . 71.4 t80 -54.34 -48.58 71.26 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.17 0.51 . . . . 10.0 110.559 -170.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.653 HD22 ' H ' ' A' ' 18' ' ' ALA . 4.1 m-20 -61.2 -50.89 71.29 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.265 -0.879 . . . . 10.0 110.32 -176.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.0 -38.83 87.44 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 118.88 -1.128 . . . . 10.0 111.77 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.762 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 13.3 mt-10 -67.48 -42.52 82.82 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.769 0.795 . . . . 10.0 111.296 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.624 ' CG2' HD12 ' A' ' 54' ' ' LEU . 68.0 p -89.62 -2.17 58.23 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 114.877 -1.056 . . . . 10.0 112.342 -169.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -44.51 -37.54 3.57 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 124.098 0.874 . . . . 10.0 112.696 -174.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -80.8 -21.06 41.23 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.298 -0.864 . . . . 10.0 111.357 -172.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.908 ' HB3' ' HZ ' ' A' ' 77' ' ' PHE . 51.8 mttp -100.97 23.52 10.58 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 123.399 1.571 . . . . 10.0 109.238 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . 0.382 . . 49.03 -90.24 0.02 OUTLIER 'General case' 0 CA--C 1.47 -2.122 0 N-CA-C 119.641 3.2 . . . . 10.0 119.641 165.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -137.99 76.6 0.35 Allowed Glycine 0 N--CA 1.429 -1.822 0 N-CA-C 109.9 -1.28 . . . . 10.0 109.9 -171.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.756 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 24.9 mmt -138.61 126.38 22.24 Favored 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 116.907 -1.917 . . . . 10.0 114.177 -164.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.404 ' CG2' ' HB3' ' A' ' 12' ' ' GLN . 32.2 mm -64.7 85.53 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 109.432 -0.581 . . . . 10.0 109.432 175.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.65 ' HB2' ' HZ ' ' A' ' 42' ' ' PHE . 9.8 mt -80.88 132.3 57.68 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.434 -0.58 . . . . 10.0 109.434 -175.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 54' ' ' LEU . 16.1 Cg_exo -71.33 93.91 0.66 Allowed 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.753 2.302 . . . . 10.0 111.888 176.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.45 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -92.69 154.66 3.18 Favored 'Isoleucine or valine' 0 C--N 1.345 0.383 0 CA-C-N 119.081 0.855 . . . . 10.0 111.236 -174.591 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.434 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 90.3 t -134.68 116.22 20.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.332 -0.395 . . . . 10.0 110.181 172.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.772 ' CD1' HD21 ' A' ' 28' ' ' LEU . 16.1 mt -105.62 140.24 24.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.16 -1.052 . . . . 10.0 108.16 -173.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.8 m -124.52 95.38 4.51 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 114.927 -1.033 . . . . 10.0 108.611 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 65' ' ' SER . 3.5 p -85.28 137.52 20.69 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 CA-C-N 119.167 0.894 . . . . 10.0 110.827 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.558 ' CG ' ' HB3' ' A' ' 3' ' ' LYS . 85.0 m-85 -95.91 170.87 9.0 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 112.855 0.687 . . . . 10.0 112.855 -177.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 24.5 mt-10 -60.89 -20.98 62.86 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.688 -1.142 . . . . 10.0 112.259 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.526 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 7.2 t70 -73.96 -15.35 61.11 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.137 -0.938 . . . . 10.0 110.934 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 44.5 mtpt 84.54 0.77 0.87 Allowed 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 114.722 -1.127 . . . . 10.0 110.782 -169.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.582 ' O ' HG23 ' A' ' 60' ' ' VAL . 8.8 p -73.85 -177.08 2.67 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 114.87 -1.059 . . . . 10.0 108.777 170.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.864 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -170.22 -176.92 2.35 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 120.38 1.446 . . . . 10.0 109.483 176.171 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.1 p -159.44 173.04 16.82 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 103.127 -2.916 . . . . 10.0 103.127 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.451 ' CB ' HG12 ' A' ' 58' ' ' ILE . 47.8 p90 -164.48 162.74 22.08 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.361 -0.607 . . . . 10.0 109.361 175.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.434 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 24.9 pt -130.71 167.73 25.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 107.206 -1.405 . . . . 10.0 107.206 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.532 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 4.3 mt -137.24 121.98 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 108.058 -1.09 . . . . 10.0 108.058 -178.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -84.46 72.63 10.6 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.073 -0.714 . . . . 10.0 109.073 -176.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.425 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . 6.7 t -30.98 99.09 0.12 Allowed Pre-proline 0 C--N 1.318 -0.796 0 O-C-N 126.078 2.111 . . . . 10.0 110.762 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.668 ' HG2' ' HD2' ' A' ' 77' ' ' PHE . 3.3 Cg_endo -47.1 139.26 15.49 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 124.237 3.291 . . . . 10.0 114.214 -163.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.736 ' HA ' HD11 ' A' ' 116' ' ' LEU . 94.9 Cg_exo -20.8 -79.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.844 1 C-N-CA 126.245 4.63 . . . . 10.0 115.387 -168.952 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.615 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -143.48 -39.01 0.32 Allowed 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.033 -0.667 . . . . 10.0 111.501 -178.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.774 ' HA ' ' HE1' ' A' ' 135' ' ' MET . 1.7 p -41.96 -56.15 2.88 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 124.221 0.951 . . . . 10.0 112.697 -174.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.908 ' HZ ' ' HB3' ' A' ' 49' ' ' LYS . 0.7 OUTLIER -53.87 -65.93 0.48 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.012 -0.54 . . . . 10.0 112.242 -179.378 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.706 HD23 ' HE2' ' A' ' 112' ' ' LYS . 1.3 mm? -76.88 -12.62 59.98 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.25 -0.98 . . . . 10.0 111.789 -172.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 79' ' ' LEU . 13.5 mt -67.15 -30.55 70.56 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.106 -0.702 . . . . 10.0 109.106 168.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 76' ' ' SER . 98.1 mttt -64.37 -23.65 67.37 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.481 171.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 6.7 mmmt -63.48 -48.01 79.39 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.432 0.53 . . . . 10.0 112.432 170.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 1.049 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -68.59 -41.0 80.25 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.373 1.869 . . . . 10.0 111.665 174.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.535 ' HB1' HG23 ' A' ' 85' ' ' ILE . . . -79.84 156.83 27.19 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 111.644 -2.525 . . . . 10.0 108.081 -177.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -95.0 12.41 68.49 Favored Glycine 0 N--CA 1.463 0.454 0 C-N-CA 118.493 -1.813 . . . . 10.0 111.754 172.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.782 HG22 HG22 ' A' ' 97' ' ' VAL . 23.7 pt -69.66 35.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 114.903 1.445 . . . . 10.0 114.903 -172.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 4.7 tt0 -71.35 9.75 0.73 Allowed 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.638 -0.664 . . . . 10.0 112.296 -177.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -167.05 -28.86 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 O-C-N 122.179 -0.326 . . . . 10.0 110.97 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 131.44 159.82 9.62 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.396 -0.907 . . . . 10.0 112.533 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.3 m -163.69 158.68 20.68 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.742 -0.466 . . . . 10.0 109.742 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.9 p -159.14 18.23 0.18 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.65 0.738 . . . . 10.0 109.291 175.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.447 ' O ' ' HE2' ' A' ' 93' ' ' LYS . 2.2 mm-40 -65.6 -47.12 68.13 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 114.445 -1.252 . . . . 10.0 111.913 -174.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -54.48 -28.84 56.58 Favored 'Trans proline' 0 C--N 1.361 1.192 0 C-N-CA 122.437 2.091 . . . . 10.0 113.152 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 91' ' ' GLU . 40.5 mtmt 60.19 73.69 0.47 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.394 0.616 . . . . 10.0 111.505 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 4.1 tpp180 -164.68 21.81 0.06 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.784 -0.821 . . . . 10.0 108.784 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 9.3 mptt 74.04 -17.81 0.43 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.325 -0.852 . . . . 10.0 111.335 -171.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 136' ' ' GLY . 5.7 pt -82.7 174.43 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 C-N-CA 120.163 -0.615 . . . . 10.0 110.401 -176.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.782 HG22 HG22 ' A' ' 85' ' ' ILE . 4.8 p -150.88 -54.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 115.907 -0.588 . . . . 10.0 111.772 -163.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.777 ' H ' HG13 ' A' ' 97' ' ' VAL . . . -113.31 162.43 12.37 Favored Glycine 0 CA--C 1.495 -1.157 0 N-CA-C 108.714 -1.754 . . . . 10.0 108.714 166.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.799 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 11.3 ptpt -151.58 156.17 39.92 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-O 122.41 1.1 . . . . 10.0 109.574 168.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 1.049 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -160.0 -144.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-N 112.278 -2.237 . . . . 10.0 106.538 -168.158 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.495 ' H ' ' HB ' ' A' ' 100' ' ' VAL . 0.1 OUTLIER -165.19 146.91 7.68 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 108.359 -0.978 . . . . 10.0 108.359 -155.294 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.722 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 1.6 mmt85 -43.97 -40.94 5.0 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 124.219 0.95 . . . . 10.0 111.638 -175.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 2.1 tmtt? -55.54 -50.59 69.61 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.133 0.492 . . . . 10.0 111.621 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.634 ' O ' HG12 ' A' ' 108' ' ' ILE . 18.5 mm-40 -62.28 -44.94 95.37 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 108.665 -0.865 . . . . 10.0 108.665 -178.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.722 ' HB ' ' O ' ' A' ' 102' ' ' ARG . 38.9 mm -41.07 -54.64 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 114.297 -1.32 . . . . 10.0 111.596 166.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.694 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 45.5 tt0 -49.79 -53.16 26.92 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.803 0.841 . . . . 10.0 112.359 177.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.702 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 47.3 mm-40 -51.74 -55.56 18.94 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 114.958 -1.019 . . . . 10.0 109.996 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.634 HG12 ' O ' ' A' ' 104' ' ' GLN . 10.5 mm -49.61 -58.51 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.285 -0.87 . . . . 10.0 110.098 172.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.454 ' HB1' ' HB3' ' A' ' 124' ' ' ALA . . . -50.8 -33.56 23.98 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.032 0.753 . . . . 10.0 113.032 -178.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.702 ' HD2' ' HA ' ' A' ' 107' ' ' GLU . 53.7 mttm -67.52 -57.24 6.85 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.915 0.864 . . . . 10.0 109.165 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 90.5 m -53.42 -36.07 61.11 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 113.716 -1.584 . . . . 10.0 111.995 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.706 ' HE2' HD23 ' A' ' 78' ' ' LEU . 32.3 mmtp -96.45 -7.88 33.71 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.741 0.645 . . . . 10.0 112.741 -173.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.412 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 43.4 ttm -39.18 -49.28 4.45 Favored Pre-proline 0 CA--C 1.532 0.282 0 O-C-N 123.565 0.54 . . . . 10.0 112.386 175.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 113' ' ' MET . 61.6 Cg_endo -70.61 -23.45 26.89 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 120.991 1.128 . . . . 10.0 113.625 -177.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -88.21 -53.34 4.75 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.108 0.48 . . . . 10.0 110.991 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.736 HD11 ' HA ' ' A' ' 74' ' ' PRO . 1.6 mp -65.02 34.3 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.153 -1.385 . . . . 10.0 113.018 -175.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 19.78 51.86 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 O-C-N 124.51 1.131 . . . . 10.0 111.816 -167.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.433 ' O ' ' CB ' ' A' ' 119' ' ' ASN . . . -66.3 -79.13 0.05 OUTLIER 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 113.62 0.97 . . . . 10.0 113.62 -165.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 118' ' ' ALA . 57.3 t30 101.94 -42.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 O-C-N 125.527 1.767 . . . . 10.0 108.947 -172.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.3 t -146.72 145.29 29.92 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.004 -1.11 . . . . 10.0 108.004 176.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.449 ' O ' ' HG3' ' A' ' 125' ' ' MET . 0.6 OUTLIER -51.68 -46.04 63.68 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.514 -0.766 . . . . 10.0 112.729 -179.132 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.517 ' H ' ' CD ' ' A' ' 122' ' ' GLU . 2.4 mp0 -50.22 -37.39 35.17 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.597 0.713 . . . . 10.0 110.781 178.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.38 -47.05 65.41 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 118.429 -1.308 . . . . 10.0 111.143 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.738 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -57.71 -34.88 69.94 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.66 -0.7 . . . . 10.0 110.769 175.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.449 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 7.7 mtt -53.74 -40.77 66.43 Favored 'General case' 0 N--CA 1.463 0.186 0 O-C-N 121.985 -0.447 . . . . 10.0 112.01 176.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -62.06 -51.83 66.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.017 -0.538 . . . . 10.0 111.761 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.7 HD12 ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -53.47 -56.67 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 119.81 -0.756 . . . . 10.0 110.475 177.459 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.738 HG12 ' O ' ' A' ' 124' ' ' ALA . 11.8 mm -50.74 -51.49 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 CA-C-N 115.138 -0.937 . . . . 10.0 110.949 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 125' ' ' MET . 49.4 mt-10 -51.97 -42.72 63.14 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 120.44 -0.504 . . . . 10.0 110.087 177.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -69.79 -49.65 34.65 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.612 -0.804 . . . . 10.0 111.358 -175.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.615 HG21 ' HB3' ' A' ' 75' ' ' ALA . 99.2 m -49.26 -60.5 2.76 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.267 -0.966 . . . . 10.0 109.827 173.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.21 -50.04 40.08 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.433 -0.349 . . . . 10.0 111.358 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 88.1 tttt -45.7 -59.27 2.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.553 -0.748 . . . . 10.0 111.951 174.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.1 t -65.04 -28.07 69.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.801 0.334 . . . . 10.0 111.305 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.774 ' HE1' ' HA ' ' A' ' 76' ' ' SER . 54.0 mtm -80.43 -6.14 57.62 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.936 0.717 . . . . 10.0 112.936 -177.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.473 ' O ' ' HB ' ' A' ' 96' ' ' ILE . . . 82.83 29.15 35.78 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 118.966 0.803 . . . . 10.0 111.852 -177.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 8.4 mt -112.69 123.75 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.256 0 CA-C-O 121.608 0.718 . . . . 10.0 110.764 177.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.799 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -84.84 150.61 24.89 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.552 -1.204 . . . . 10.0 109.633 -179.13 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 18.2 m -115.43 131.26 68.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.052 -1.092 . . . . 10.0 108.052 170.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 100' ' ' VAL . 30.6 m -123.63 62.84 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 114.657 1.354 . . . . 10.0 114.657 -177.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.462 ' OXT' ' HB2' ' A' ' 102' ' ' ARG . 9.6 t70 . . . . . 0 C--N 1.291 -1.943 0 CA-C-N 114.303 -1.317 . . . . 10.0 109.627 143.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.793 ' HD2' ' HG3' ' A' ' 62' ' ' GLU . 17.1 mmtt . . . . . 0 N--CA 1.438 -1.027 0 N-CA-C 108.695 -0.854 . . . . 10.0 108.695 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.0 t -72.97 122.99 26.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 110.251 -0.277 . . . . 10.0 110.251 -174.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.57 -32.82 11.24 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.961 -0.755 . . . . 10.0 108.961 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -168.02 -168.28 0.95 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.33 -0.85 . . . . 10.0 113.214 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.528 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 78.5 mt-30 -143.84 135.54 26.2 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 114.015 -1.448 . . . . 10.0 108.689 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.917 HG21 ' HG ' ' A' ' 28' ' ' LEU . 1.3 mm -122.89 83.52 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 119.03 -0.509 . . . . 10.0 109.767 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -78.0 138.72 38.97 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 120.513 1.506 . . . . 10.0 109.231 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.797 HD23 HD11 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -154.15 132.0 11.59 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.333 -0.618 . . . . 10.0 109.333 -171.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.522 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 19.8 pt20 -94.04 109.87 21.6 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.525 -0.917 . . . . 10.0 108.525 171.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.797 HD11 HD23 ' A' ' 11' ' ' LEU . 94.7 mt -130.1 135.95 28.26 Favored Pre-proline 0 CA--C 1.496 -1.097 0 CA-C-O 121.553 0.692 . . . . 10.0 112.51 -165.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.698 ' HB2' ' CB ' ' A' ' 17' ' ' LYS . 28.0 Cg_exo -58.56 120.67 8.7 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 123.054 2.503 . . . . 10.0 111.914 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.525 ' CB ' ' HA ' ' A' ' 50' ' ' ALA . . . -62.77 127.66 32.3 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 114.696 -1.138 . . . . 10.0 108.139 171.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.71 4.4 65.96 Favored Glycine 0 CA--C 1.525 0.704 0 O-C-N 126.003 2.064 . . . . 10.0 113.123 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.698 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . 2.6 mmmm -147.32 29.52 0.96 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.393 1.257 . . . . 10.0 114.393 -172.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.817 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -76.47 150.41 36.67 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.472 1.033 . . . . 10.0 110.155 175.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.513 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 15.3 t -177.69 140.3 0.43 Allowed Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 121.422 0.629 . . . . 10.0 110.861 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.555 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 2.8 Cg_endo -42.17 23.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.478 0.581 1 C-N-CA 129.474 6.783 . . . . 10.0 117.463 176.18 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.644 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -57.88 174.22 0.34 Allowed Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 107.997 -1.112 . . . . 10.0 107.997 163.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.644 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 57.5 Cg_exo -37.3 -42.69 1.04 Allowed 'Trans proline' 0 CA--C 1.548 1.184 0 C-N-CA 122.407 2.071 . . . . 10.0 114.043 177.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.565 ' HB2' HG23 ' A' ' 24' ' ' VAL . 27.2 Cg_exo -38.11 -71.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 123.744 2.962 . . . . 10.0 115.572 167.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.05 HG12 HD12 ' A' ' 35' ' ' ILE . 62.0 t -89.05 -54.68 7.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 114.013 -1.448 . . . . 10.0 114.043 -159.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.443 ' H ' ' HA ' ' A' ' 20' ' ' PRO . . . -50.17 -65.41 2.94 Favored Glycine 0 C--O 1.228 -0.222 0 CA-C-N 114.616 -1.174 . . . . 10.0 112.992 -175.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -55.84 -43.75 54.13 Favored 'Trans proline' 0 C--O 1.222 -0.312 0 C-N-CA 123.092 2.528 . . . . 10.0 112.429 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.492 ' HB1' ' CG2' ' A' ' 9' ' ' ILE . . . -53.28 -78.09 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.401 0.619 . . . . 10.0 111.414 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.917 ' HG ' HG21 ' A' ' 9' ' ' ILE . 2.1 mt -66.94 -45.89 76.4 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.172 0.804 . . . . 10.0 113.172 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.26 -39.98 96.76 Favored Glycine 0 N--CA 1.459 0.18 0 CA-C-N 116.103 -0.499 . . . . 10.0 112.899 -174.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.402 ' HB3' HE21 ' A' ' 30' ' ' GLN . 7.9 tt0 -60.84 -26.69 67.53 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.233 -0.284 . . . . 10.0 110.233 176.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -99.25 16.58 22.42 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.47 0.652 . . . . 10.0 109.895 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.26 4.57 86.23 Favored Glycine 0 CA--C 1.499 -0.957 0 CA-C-N 114.748 -1.115 . . . . 10.0 113.216 167.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.709 HG11 ' CD2' ' A' ' 66' ' ' PHE . 3.4 t -81.33 146.36 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 113.301 0.852 . . . . 10.0 113.301 -172.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 37' ' ' GLU . 90.8 m-20 -70.31 96.7 1.15 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.256 0.622 . . . . 10.0 110.5 172.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.05 HD12 HG12 ' A' ' 24' ' ' VAL . 13.7 mm -55.54 -38.67 50.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-O 122.078 0.942 . . . . 10.0 112.188 177.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.407 ' SD ' ' N ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -70.01 -43.25 71.73 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 113.476 -1.693 . . . . 10.0 112.432 177.191 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.604 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 14.2 mt-10 -54.81 -50.0 69.62 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 118.988 -1.085 . . . . 10.0 109.437 170.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.606 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 77.8 t80 -53.87 -56.5 17.12 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 114.031 1.123 . . . . 10.0 114.031 175.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.3 t -58.71 -48.31 81.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.719 -1.128 . . . . 10.0 111.193 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.414 ' HE3' ' HB2' ' A' ' 40' ' ' LYS . 49.3 mtmt -66.86 -23.34 66.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 118.602 -1.239 . . . . 10.0 108.971 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.805 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 55.2 mtt180 -74.54 -64.68 0.98 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.093 -0.958 . . . . 10.0 111.776 173.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.736 ' HZ ' ' HB2' ' A' ' 54' ' ' LEU . 67.2 t80 -55.05 -45.6 75.27 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-O 121.165 0.507 . . . . 10.0 110.554 -174.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.817 HD21 ' HB3' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -59.69 -52.49 65.26 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.209 -0.905 . . . . 10.0 110.23 -177.319 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.82 -39.75 95.25 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 119.56 -0.856 . . . . 10.0 112.014 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.805 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 11.2 mt-10 -69.02 -36.72 78.09 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.635 0.731 . . . . 10.0 111.407 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.548 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 72.7 p -91.34 4.33 52.66 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.856 -1.066 . . . . 10.0 112.036 -173.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.53 -36.48 15.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.764 -1.107 . . . . 10.0 112.543 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.2 p-10 -81.99 -37.36 26.72 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 115.224 -0.898 . . . . 10.0 111.434 -175.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.518 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 36.8 mttp -95.41 22.17 7.26 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.039 -0.726 . . . . 10.0 109.039 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.525 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -56.51 154.81 8.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.662 -1.154 . . . . 10.0 113.581 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.47 17.2 53.5 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 110.035 -1.226 . . . . 10.0 110.035 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.528 ' HB2' HD21 ' A' ' 54' ' ' LEU . 22.0 mmt -136.11 126.66 26.98 Favored 'General case' 0 C--O 1.207 -1.164 0 C-N-CA 116.11 -2.236 . . . . 10.0 114.032 -165.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.49 HG22 ' HB2' ' A' ' 12' ' ' GLN . 46.2 mm -67.09 91.0 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 121.763 -0.586 . . . . 10.0 109.549 170.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.736 ' HB2' ' HZ ' ' A' ' 42' ' ' PHE . 3.7 mt -76.96 130.7 74.91 Favored Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 122.183 0.193 . . . . 10.0 110.593 -176.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -74.94 95.34 0.97 Allowed 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.384 2.056 . . . . 10.0 111.553 173.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.423 HG23 HG12 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -99.52 158.2 3.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 119.016 0.826 . . . . 10.0 111.972 -172.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.43 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 96.3 t -135.42 120.17 27.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.312 -0.403 . . . . 10.0 110.207 171.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.655 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 14.8 mt -106.15 141.68 20.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 119.595 -0.842 . . . . 10.0 108.897 -175.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 68.1 m -125.39 99.98 6.29 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.043 -0.981 . . . . 10.0 109.024 175.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.562 HG21 HG22 ' A' ' 33' ' ' VAL . 2.8 p -89.18 137.94 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.003 0 C-N-CA 123.653 0.781 . . . . 10.0 111.095 -178.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.466 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 84.8 m-85 -98.94 171.05 8.3 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 122.17 0.986 . . . . 10.0 112.753 -176.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.793 ' HG3' ' HD2' ' A' ' 4' ' ' LYS . 3.0 mm-40 -53.15 -26.24 16.27 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.389 -1.732 . . . . 10.0 113.2 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 28.7 m-20 -78.09 -12.38 59.99 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.485 -0.486 . . . . 10.0 111.14 -176.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.47 ' HE3' ' HA ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 84.1 4.94 0.72 Allowed 'General case' 0 CA--C 1.508 -0.672 0 O-C-N 124.558 1.161 . . . . 10.0 108.917 -163.237 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.487 ' O ' HG23 ' A' ' 60' ' ' VAL . 6.2 p -71.02 172.5 8.98 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 113.504 -1.68 . . . . 10.0 107.916 171.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.709 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -169.86 -176.31 2.31 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 120.147 1.339 . . . . 10.0 109.825 174.277 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.6 p -160.11 168.61 25.12 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 102.944 -2.984 . . . . 10.0 102.944 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.44 ' HB3' HG12 ' A' ' 58' ' ' ILE . 45.6 p90 -161.43 158.79 27.27 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 109.125 -0.694 . . . . 10.0 109.125 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.43 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 22.2 pt -128.04 162.06 34.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 106.923 -1.51 . . . . 10.0 106.923 -176.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.544 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 2.6 mt -135.8 117.39 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 107.379 -1.341 . . . . 10.0 107.379 -175.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.62 ' HA ' ' OD1' ' A' ' 115' ' ' ASP . 0.3 OUTLIER -79.27 84.77 5.17 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 123.408 0.442 . . . . 10.0 110.516 -171.069 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.705 ' HB ' ' HG2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -49.17 99.04 0.2 Allowed Pre-proline 0 C--N 1.313 -0.981 0 CA-C-N 114.413 -1.267 . . . . 10.0 108.989 167.202 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.53 ' HG2' ' HB2' ' A' ' 77' ' ' PHE . 38.3 Cg_endo -74.74 174.22 13.06 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.136 2.558 . . . . 10.0 113.932 -158.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.464 ' HD2' ' CB ' ' A' ' 73' ' ' PRO . 86.8 Cg_exo -26.21 -60.69 0.07 OUTLIER 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 125.129 3.886 . . . . 10.0 114.466 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.597 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -171.43 -23.95 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.519 0.933 . . . . 10.0 113.519 175.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.559 ' HA ' ' HE1' ' A' ' 135' ' ' MET . 35.3 p -47.03 -43.35 19.63 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.177 0.513 . . . . 10.0 111.914 -173.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.571 ' HB3' HD22 ' A' ' 78' ' ' LEU . 13.0 t80 -47.79 -68.02 0.22 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.631 -1.168 . . . . 10.0 112.574 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.959 ' HB3' HD12 ' A' ' 108' ' ' ILE . 2.3 mm? -85.02 -11.31 55.7 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.567 -171.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.6 mt -72.33 -25.42 61.55 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.344 -0.543 . . . . 10.0 109.549 172.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 76' ' ' SER . 34.7 mmtp -59.32 -50.88 72.29 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.788 -1.19 . . . . 10.0 107.788 166.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -67.76 33.05 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 114.057 -1.428 . . . . 10.0 113.578 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.714 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -170.48 -60.35 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.668 0.747 . . . . 10.0 112.732 -172.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.289 -2.027 0 CA-C-N 113.464 -1.698 . . . . 10.0 108.942 179.663 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.58 HG13 ' H ' ' A' ' 98' ' ' GLY . 2.7 p . . . . . 0 CA--C 1.538 0.489 0 CA-C-O 121.278 0.561 . . . . 10.0 112.094 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.58 ' H ' HG13 ' A' ' 97' ' ' VAL . . . -160.13 174.07 36.85 Favored Glycine 0 CA--C 1.5 -0.894 0 N-CA-C 107.929 -2.069 . . . . 10.0 107.929 178.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.881 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -149.37 173.02 13.98 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-O 122.629 1.204 . . . . 10.0 111.429 -164.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.732 ' O ' HG22 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -150.73 -143.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 CA-C-N 111.982 -2.372 . . . . 10.0 105.986 -173.378 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.541 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 0.1 OUTLIER -164.93 144.66 7.05 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 107.48 -1.304 . . . . 10.0 107.48 -160.188 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.594 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 9.0 mmm180 -44.27 -43.5 7.39 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 124.241 0.963 . . . . 10.0 111.741 -177.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -57.89 -44.72 86.88 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.329 0.585 . . . . 10.0 111.539 176.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.724 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.1 OUTLIER -60.04 -47.25 86.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.219 -0.901 . . . . 10.0 108.702 178.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.909 HG23 ' HB ' ' A' ' 128' ' ' ILE . 26.2 mm -43.31 -55.34 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 CA-C-N 115.093 -0.958 . . . . 10.0 110.939 171.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.793 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 8.4 tt0 -49.2 -57.36 6.85 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 114.494 -1.23 . . . . 10.0 112.946 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -53.4 -59.63 4.33 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 124.057 0.848 . . . . 10.0 110.878 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.959 HD12 ' HB3' ' A' ' 78' ' ' LEU . 10.0 mm -46.88 -51.88 4.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.992 -1.004 . . . . 10.0 110.646 172.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.507 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -53.31 -40.29 64.67 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.655 -0.702 . . . . 10.0 112.554 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.793 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 50.3 mttm -70.87 -53.42 15.22 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.172 -0.467 . . . . 10.0 110.561 -174.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.678 HG23 ' HG3' ' A' ' 112' ' ' LYS . 7.7 t -55.99 -35.32 66.65 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.727 -0.67 . . . . 10.0 112.567 -176.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.756 ' HD3' HD23 ' A' ' 78' ' ' LEU . 8.7 mtmp? -103.08 17.36 24.24 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.057 0.456 . . . . 10.0 110.762 -176.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.735 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 50.4 ttm -49.65 -45.33 78.73 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.374 -0.83 . . . . 10.0 112.372 176.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 113' ' ' MET . 42.2 Cg_endo -64.62 -25.67 61.86 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 121.65 1.567 . . . . 10.0 112.569 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.62 ' OD1' ' HA ' ' A' ' 71' ' ' LYS . 12.8 m-20 -89.46 -50.9 5.83 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 114.936 -1.029 . . . . 10.0 111.16 -175.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.457 HD11 ' HZ3' ' A' ' 112' ' ' LYS . 9.1 mp -64.06 -3.55 2.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.441 -1.254 . . . . 10.0 111.754 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 64.4 t30 59.6 51.42 6.42 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.262 -1.335 . . . . 10.0 109.851 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.735 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -80.78 116.64 20.88 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 113.873 -1.512 . . . . 10.0 112.651 -172.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -65.91 -41.88 90.89 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.314 -0.995 . . . . 10.0 108.314 168.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.0 p -149.76 143.54 25.47 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 106.922 -1.511 . . . . 10.0 106.922 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.611 HD12 ' HB3' ' A' ' 124' ' ' ALA . 66.9 tp -52.16 -33.02 38.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.225 1.195 . . . . 10.0 114.225 -176.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -50.15 -37.76 36.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.329 0.585 . . . . 10.0 110.885 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.14 -50.17 56.33 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 119.047 -1.061 . . . . 10.0 110.916 175.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.611 ' HB3' HD12 ' A' ' 121' ' ' LEU . . . -57.49 -38.7 75.01 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 120.762 -0.375 . . . . 10.0 110.736 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.55 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 89.1 mtp -56.0 -37.22 68.84 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.674 0.39 . . . . 10.0 111.425 177.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -63.08 -48.34 79.02 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.04 -0.527 . . . . 10.0 109.729 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.5 mt -51.17 -62.67 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 CA-C-O 121.464 0.65 . . . . 10.0 111.245 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.909 ' HB ' HG23 ' A' ' 105' ' ' ILE . 15.9 mm -49.84 -57.02 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 CA-C-N 114.189 -1.368 . . . . 10.0 111.152 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.632 ' HG3' HG13 ' A' ' 105' ' ' ILE . 3.9 mt-10 -54.04 -47.28 71.74 Favored 'General case' 0 N--CA 1.436 -1.149 0 O-C-N 124.097 0.873 . . . . 10.0 110.069 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.5 -46.64 61.65 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.463 -0.875 . . . . 10.0 111.51 -173.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.597 HG21 ' HB3' ' A' ' 75' ' ' ALA . 90.2 m -47.6 -60.29 2.65 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.188 -1.006 . . . . 10.0 108.601 170.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -48.0 -53.07 17.37 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.954 0.502 . . . . 10.0 111.852 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.608 ' HG3' ' O ' ' A' ' 129' ' ' GLU . 43.4 mtpt -50.23 -50.28 50.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.002 178.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.8 m -66.31 -31.39 72.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.945 0.403 . . . . 10.0 111.031 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.559 ' HE1' ' HA ' ' A' ' 76' ' ' SER . 48.8 mtm -81.4 4.08 22.14 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.795 1.035 . . . . 10.0 113.795 -178.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 81.0 18.83 68.75 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 119.657 1.117 . . . . 10.0 111.586 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.503 HG23 ' HA ' ' A' ' 99' ' ' LYS . 23.3 mt -105.21 127.69 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 CA-C-O 121.146 0.498 . . . . 10.0 111.513 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.881 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -89.14 157.13 18.4 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.475 -0.784 . . . . 10.0 109.585 179.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.7 m -116.35 132.1 66.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.5 -0.926 . . . . 10.0 108.5 170.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 100' ' ' VAL . 26.9 m -133.94 69.65 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 116.057 1.873 . . . . 10.0 116.057 -175.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.605 ' HB2' ' O ' ' A' ' 140' ' ' VAL . 3.6 t0 . . . . . 0 C--N 1.296 -1.745 0 CA-C-O 117.864 -1.065 . . . . 10.0 109.012 141.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.464 0 CA-C-O 121.501 0.667 . . . . 10.0 110.699 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.2 t -73.79 141.3 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.581 -0.736 . . . . 10.0 110.649 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.31 -45.51 4.08 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.307 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.54 152.17 25.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.51 1.3 . . . . 10.0 114.51 -174.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.839 HE21 ' HA ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -92.55 133.14 36.24 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.514 -1.221 . . . . 10.0 107.852 170.184 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.685 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -123.09 83.16 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.348 -0.612 . . . . 10.0 109.348 174.365 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.437 ' HG2' HG22 ' A' ' 57' ' ' VAL . 52.8 mttp -77.27 132.24 38.57 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 120.807 1.639 . . . . 10.0 108.921 172.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.687 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -158.58 125.6 4.86 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 122.336 1.065 . . . . 10.0 111.689 -179.236 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.432 ' HG2' ' HA ' ' A' ' 55' ' ' PRO . 28.8 mt-30 -83.5 121.56 27.36 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.132 -1.395 . . . . 10.0 110.59 -172.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.687 HD21 HD11 ' A' ' 11' ' ' LEU . 88.2 mt -138.64 144.36 41.78 Favored Pre-proline 0 CA--C 1.507 -0.687 0 CA-C-O 121.484 0.659 . . . . 10.0 111.96 -170.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.834 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 4.3 Cg_exo -65.98 126.97 16.77 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 123.467 2.778 . . . . 10.0 111.655 176.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.597 ' HB2' HD11 ' A' ' 54' ' ' LEU . . . -62.12 128.46 36.22 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 108.062 -1.088 . . . . 10.0 108.062 171.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.95 -1.04 87.72 Favored Glycine 0 N--CA 1.443 -0.882 0 O-C-N 125.612 1.82 . . . . 10.0 112.74 -174.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.834 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 15.1 tppt? -140.46 102.59 4.37 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 122.359 1.076 . . . . 10.0 111.835 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.452 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -170.33 129.66 0.88 Allowed 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 113.405 -1.725 . . . . 10.0 110.856 174.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.71 ' HA ' ' HB2' ' A' ' 39' ' ' CYS . 2.1 t -176.87 -44.87 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 115.046 -0.979 . . . . 10.0 113.112 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.726 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 72.6 Cg_endo -103.93 124.4 0.07 OUTLIER 'Trans proline' 0 N--CA 1.413 -3.244 0 N-CA-C 115.557 1.329 . . . . 10.0 115.557 -162.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.062 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 9.63 -87.15 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.392 0 CA-C-N 109.664 -3.425 . . . . 10.0 114.824 166.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.64 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 11.4 Cg_exo -26.07 -55.99 0.09 OUTLIER 'Trans proline' 0 CA--C 1.559 1.734 0 C-N-CA 123.74 2.96 . . . . 10.0 115.722 -162.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.726 ' HD2' ' O ' ' A' ' 20' ' ' PRO . 37.4 Cg_endo -80.48 -73.96 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.277 0 C-N-CA 122.419 2.079 . . . . 10.0 112.083 168.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.077 HG12 HD12 ' A' ' 35' ' ' ILE . 53.5 t -57.37 -54.73 27.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 127.564 2.346 . . . . 10.0 114.672 -173.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 1.062 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -48.41 -72.55 0.43 Allowed Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.107 -0.952 . . . . 10.0 113.173 -175.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.729 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 16.5 Cg_exo -44.98 -47.98 11.42 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.523 2.816 . . . . 10.0 112.272 171.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 24' ' ' VAL . . . -46.37 -98.51 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 123.624 0.578 . . . . 10.0 112.376 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.869 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.351 0.0 OUTLIER -73.87 -38.84 64.3 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 117.176 -1.81 . . . . 10.0 113.363 -174.684 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.691 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -66.15 -39.34 94.54 Favored Glycine 0 N--CA 1.462 0.407 0 C-N-CA 121.43 -0.414 . . . . 10.0 113.859 -173.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.513 ' HB2' ' HA ' ' A' ' 26' ' ' PRO . 9.0 tt0 -67.82 -7.19 25.76 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.541 -0.864 . . . . 10.0 111.172 176.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -99.94 22.92 10.49 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.624 -0.716 . . . . 10.0 109.284 168.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.19 -6.89 63.99 Favored Glycine 0 CA--C 1.503 -0.712 0 CA-C-N 115.341 -0.845 . . . . 10.0 113.112 167.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.869 ' HB ' HD23 ' A' ' 28' ' ' LEU . 3.4 t -83.29 148.75 4.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 114.619 1.34 . . . . 10.0 114.619 -169.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.544 ' HB3' ' HB2' ' A' ' 37' ' ' GLU . 44.7 t-20 -70.75 98.68 1.58 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.468 0.707 . . . . 10.0 110.639 172.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.077 HD12 HG12 ' A' ' 24' ' ' VAL . 19.4 mm -53.78 -36.28 29.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.155 -0.929 . . . . 10.0 112.164 175.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 66.8 mtm -65.19 -52.78 52.76 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.62 -1.627 . . . . 10.0 111.699 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.544 ' HB2' ' HB3' ' A' ' 34' ' ' ASN . 12.7 mm-40 -56.88 -38.8 73.27 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.615 -0.834 . . . . 10.0 110.927 175.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.558 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . 91.3 t80 -57.85 -58.7 7.21 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 113.506 0.928 . . . . 10.0 113.506 170.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -57.7 -52.26 66.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 113.988 -1.46 . . . . 10.0 112.039 -177.535 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.501 ' HB3' ' HE3' ' A' ' 40' ' ' LYS . 0.7 OUTLIER -66.47 -21.71 66.19 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.554 -0.858 . . . . 10.0 108.691 -176.082 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.684 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 12.9 mtp180 -74.09 -63.9 1.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.662 -0.699 . . . . 10.0 112.074 168.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.601 ' CZ ' HG21 ' A' ' 46' ' ' THR . 71.1 t80 -54.33 -45.52 72.69 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-O 121.082 0.468 . . . . 10.0 110.682 -172.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.61 HD22 ' N ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER -58.97 -51.62 69.27 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.074 -0.966 . . . . 10.0 109.771 -178.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.96 98.97 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 119.034 -1.066 . . . . 10.0 112.186 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.684 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 7.3 mt-10 -66.9 -39.31 87.41 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.823 0.821 . . . . 10.0 110.834 -178.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.605 ' CG2' HD12 ' A' ' 54' ' ' LEU . 72.1 p -92.13 -0.4 57.44 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.735 -1.121 . . . . 10.0 112.748 -172.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.96 -39.62 12.76 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.915 0.886 . . . . 10.0 112.777 -174.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -75.78 -34.13 60.2 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.506 -0.77 . . . . 10.0 110.958 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.431 ' HB3' ' CE ' ' A' ' 52' ' ' MET . 36.7 mttp -97.15 17.88 16.19 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.828 0.851 . . . . 10.0 109.998 -175.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -52.07 145.47 10.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.205 -0.907 . . . . 10.0 113.232 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.68 15.85 35.79 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 110.604 -0.998 . . . . 10.0 110.604 -177.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.716 ' SD ' ' HB2' ' A' ' 77' ' ' PHE . 51.3 mtm -138.12 125.81 22.29 Favored 'General case' 0 C--O 1.211 -0.94 0 C-N-CA 116.274 -2.171 . . . . 10.0 115.193 -166.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.3 mm -66.55 91.78 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 118.313 0.506 . . . . 10.0 109.639 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.605 HD12 ' CG2' ' A' ' 46' ' ' THR . 8.0 mt -83.2 135.85 44.07 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.852 -0.796 . . . . 10.0 108.852 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.561 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 8.0 Cg_exo -75.86 108.94 2.79 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.237 1.958 . . . . 10.0 111.016 174.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -100.58 155.08 4.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 119.833 1.197 . . . . 10.0 111.573 -174.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.437 HG22 ' HG2' ' A' ' 10' ' ' LYS . 93.6 t -134.81 115.58 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 CA-C-N 116.662 -0.244 . . . . 10.0 110.447 175.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.685 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 16.0 mt -107.07 141.93 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.554 0 CA-C-O 121.669 0.747 . . . . 10.0 109.157 -174.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.7 m -124.8 99.15 6.02 Favored 'General case' 0 C--N 1.28 -2.453 0 CA-C-N 114.665 -1.152 . . . . 10.0 108.869 174.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 65' ' ' SER . 2.4 p -89.61 140.17 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 CA-C-N 119.43 1.014 . . . . 10.0 110.19 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.417 ' HE2' ' HG1' ' A' ' 67' ' ' THR . 73.4 m-85 -98.51 160.67 14.13 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.548 -0.751 . . . . 10.0 111.55 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.417 ' OE1' ' HB2' ' A' ' 4' ' ' LYS . 16.6 mt-10 -54.22 -19.13 4.68 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 124.37 1.068 . . . . 10.0 113.142 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 26.5 t70 -75.46 -13.71 60.39 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.572 -0.74 . . . . 10.0 110.472 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.771 ' HE3' ' HA ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 83.33 1.2 1.07 Allowed 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 114.448 -1.251 . . . . 10.0 110.379 -167.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.517 ' O ' HG23 ' A' ' 60' ' ' VAL . 57.9 m -71.68 174.86 6.21 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 114.753 -1.112 . . . . 10.0 108.846 169.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.866 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -171.09 -176.79 2.02 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 119.394 0.997 . . . . 10.0 109.307 174.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.417 ' HG1' ' HE2' ' A' ' 61' ' ' TYR . 1.3 p -162.58 162.54 27.25 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 103.434 -2.802 . . . . 10.0 103.434 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CB ' HG12 ' A' ' 58' ' ' ILE . 47.6 p90 -162.11 158.09 24.24 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.522 0.677 . . . . 10.0 109.233 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.9 pt -128.45 158.78 40.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.543 0 CA-C-N 114.612 -1.176 . . . . 10.0 108.503 -175.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.482 HD12 ' CE1' ' A' ' 42' ' ' PHE . 2.8 mm -112.75 127.27 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 108.016 -1.105 . . . . 10.0 108.016 -178.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.633 ' C ' ' HD2' ' A' ' 73' ' ' PRO . 4.2 mptp? -80.16 93.3 5.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.024 0.916 . . . . 10.0 112.211 -172.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.729 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 9.2 t -59.55 -34.6 23.2 Favored Pre-proline 0 CA--C 1.569 1.693 0 CA-C-N 113.569 -1.651 . . . . 10.0 113.332 169.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.729 ' HD2' ' N ' ' A' ' 72' ' ' THR . 2.7 Cg_endo -41.9 -49.26 5.69 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 124.519 3.479 . . . . 10.0 117.331 -171.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.553 ' HD3' ' HG2' ' A' ' 73' ' ' PRO . 73.7 Cg_exo -42.33 -35.06 3.35 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.858 2.372 . . . . 10.0 113.47 -174.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.515 ' HB2' ' HE2' ' A' ' 112' ' ' LYS . . . 72.51 -25.59 0.18 Allowed 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 113.723 1.009 . . . . 10.0 113.723 168.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.5 m -50.63 -46.91 58.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.167 0.508 . . . . 10.0 110.92 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.716 ' HB2' ' SD ' ' A' ' 52' ' ' MET . 8.6 p90 -72.23 -29.46 63.96 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.765 -0.652 . . . . 10.0 111.428 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.762 ' O ' ' HB3' ' A' ' 81' ' ' LYS . 1.8 tp -86.0 -28.18 24.36 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.233 0.54 . . . . 10.0 111.255 -175.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.457 ' HA ' HD13 ' A' ' 79' ' ' LEU . 3.7 mm? -59.39 -35.1 73.3 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 107.993 -1.114 . . . . 10.0 107.993 168.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.489 ' HA ' ' HB3' ' A' ' 83' ' ' ALA . 7.3 ttpm? -70.31 -12.26 61.47 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.756 -0.656 . . . . 10.0 111.921 172.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.762 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 17.0 tptm -56.72 -50.75 71.28 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.25 -0.907 . . . . 10.0 109.103 165.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.656 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -72.56 -49.58 31.52 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.964 1.706 . . . . 10.0 112.755 170.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.489 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . . . . . . . . 0 C--N 1.293 -1.887 0 CA-C-N 112.688 -2.051 . . . . 10.0 109.326 -169.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.563 HG13 ' N ' ' A' ' 98' ' ' GLY . 7.1 p . . . . . 0 CA--C 1.536 0.435 0 CA-C-O 121.393 0.616 . . . . 10.0 111.512 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -166.88 161.37 35.18 Favored Glycine 0 CA--C 1.497 -1.078 0 N-CA-C 108.725 -1.75 . . . . 10.0 108.725 -174.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.603 ' HB2' ' O ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -143.73 177.72 8.31 Favored 'General case' 0 CA--C 1.473 -2.004 0 CA-C-O 122.359 1.075 . . . . 10.0 110.767 -169.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.656 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -163.76 -165.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.404 -2.73 0 CA-C-N 111.793 -2.458 . . . . 10.0 106.184 -170.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 19.0 p -109.83 150.39 28.46 Favored 'General case' 0 C--N 1.268 -2.968 0 CA-C-N 114.753 -1.112 . . . . 10.0 111.833 -170.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.68 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 22.4 tpp180 -43.62 -43.73 5.9 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 113.588 -1.642 . . . . 10.0 109.688 168.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.507 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 18.4 tppt? -58.35 -43.15 88.19 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.153 0.501 . . . . 10.0 112.168 176.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.65 ' O ' HG12 ' A' ' 108' ' ' ILE . 57.6 mt-30 -67.22 -38.72 85.74 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.407 -0.59 . . . . 10.0 109.407 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.68 ' HB ' ' O ' ' A' ' 102' ' ' ARG . 34.9 mm -46.83 -51.15 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.589 -0.732 . . . . 10.0 111.012 166.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.686 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 31.8 tt0 -48.28 -54.26 14.31 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.283 -1.326 . . . . 10.0 112.836 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -52.48 -57.88 8.51 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 123.925 0.766 . . . . 10.0 110.151 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.65 HG12 ' O ' ' A' ' 104' ' ' GLN . 5.5 mm -46.19 -59.97 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 114.328 -1.305 . . . . 10.0 109.923 173.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.547 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -50.62 -37.28 39.47 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 123.686 0.616 . . . . 10.0 112.44 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.686 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 39.4 mttt -71.09 -58.67 3.33 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.004 -0.544 . . . . 10.0 111.478 -175.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.603 HG21 HD21 ' A' ' 78' ' ' LEU . 4.7 t -55.4 -34.83 64.73 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 113.011 0.745 . . . . 10.0 113.011 -175.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 1.0 ' HD3' HD11 ' A' ' 128' ' ' ILE . 0.1 OUTLIER -99.03 7.38 46.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 120.931 0.396 . . . . 10.0 110.828 -173.36 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.812 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 40.1 ttm -48.11 -41.32 41.55 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.231 -0.895 . . . . 10.0 112.424 175.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 113' ' ' MET . 26.7 Cg_endo -59.61 -32.48 96.05 Favored 'Trans proline' 0 C--N 1.366 1.471 0 C-N-CA 121.787 1.658 . . . . 10.0 112.128 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.561 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 0.8 OUTLIER -91.44 -47.89 7.19 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 114.788 -1.096 . . . . 10.0 112.34 -173.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.874 HD22 ' HG3' ' A' ' 112' ' ' LYS . 7.0 mp -64.18 2.05 0.63 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.527 -1.215 . . . . 10.0 111.871 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 115' ' ' ASP . 8.7 p30 54.75 45.67 26.22 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.164 -1.38 . . . . 10.0 109.662 177.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.812 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -80.8 118.17 22.09 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 112.805 -1.998 . . . . 10.0 112.103 -172.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.22 -37.61 83.88 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.75 -0.659 . . . . 10.0 109.874 170.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.2 p -155.41 144.66 20.95 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.442 -0.947 . . . . 10.0 108.442 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.544 ' O ' ' HG2' ' A' ' 125' ' ' MET . 62.6 tp -52.08 -40.39 61.14 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 115.077 1.51 . . . . 10.0 115.077 -173.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -51.63 -33.08 31.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.148 0.499 . . . . 10.0 111.045 176.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.18 -49.26 65.31 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 118.797 -1.161 . . . . 10.0 110.865 172.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.626 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -57.78 -33.68 68.79 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.91 0.386 . . . . 10.0 110.652 178.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.635 ' O ' ' HB3' ' A' ' 129' ' ' GLU . 80.1 mmm -56.36 -39.02 72.2 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.73 0.3 . . . . 10.0 111.425 176.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -61.21 -56.68 17.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.832 -0.622 . . . . 10.0 111.432 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.871 HD12 HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -50.98 -57.9 2.4 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 C-N-CA 119.994 -0.683 . . . . 10.0 111.146 -178.465 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 1.0 HD11 ' HD3' ' A' ' 112' ' ' LYS . 25.4 mm -50.56 -57.23 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 CA-C-N 114.649 -1.16 . . . . 10.0 111.801 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.635 ' HB3' ' O ' ' A' ' 125' ' ' MET . 0.0 OUTLIER -53.33 -41.38 65.67 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.748 -0.66 . . . . 10.0 109.272 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.669 ' HA2' ' HE2' ' A' ' 133' ' ' LYS . . . -71.36 -46.47 41.29 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.739 -0.744 . . . . 10.0 111.862 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 62.7 m -44.37 -65.6 0.49 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 114.561 -0.82 . . . . 10.0 109.011 169.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.513 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -48.77 -50.71 32.75 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.026 -0.534 . . . . 10.0 111.312 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.669 ' HE2' ' HA2' ' A' ' 130' ' ' GLY . 17.0 ttpt -47.98 -53.95 14.48 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.75 -1.114 . . . . 10.0 111.499 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.1 m -66.13 -30.91 71.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.341 0.591 . . . . 10.0 110.69 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 46.8 mtp -80.31 5.64 14.2 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.701 1.0 . . . . 10.0 113.701 -177.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.46 6.15 84.0 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 119.351 0.978 . . . . 10.0 111.548 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.572 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 37.4 mt -97.21 127.27 49.61 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.834 0 CA-C-O 121.672 0.749 . . . . 10.0 111.777 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.603 ' O ' ' HB2' ' A' ' 99' ' ' LYS . 0.7 OUTLIER -88.56 158.87 18.15 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.514 -1.221 . . . . 10.0 108.868 178.134 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.3 m -117.44 127.01 74.97 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.518 0 CA-C-O 122.213 1.006 . . . . 10.0 108.348 171.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 101' ' ' THR . 19.3 m -112.54 154.62 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.231 0 CA-C-N 113.676 -1.602 . . . . 10.0 107.676 176.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 31.9 t70 . . . . . 0 C--N 1.276 -2.608 0 CA-C-N 114.534 -1.212 . . . . 10.0 110.872 -177.065 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.401 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 49.8 mtmt . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.659 0.266 . . . . 10.0 110.895 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.0 t -63.11 139.19 21.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.576 -0.738 . . . . 10.0 110.992 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.86 -32.0 5.93 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.288 -0.414 . . . . 10.0 110.521 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.499 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -158.97 152.98 23.47 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.161 1.171 . . . . 10.0 114.161 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.841 HE21 ' HA ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -99.51 133.17 44.22 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.885 -1.052 . . . . 10.0 108.36 173.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.664 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -124.6 82.21 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 120.063 -0.655 . . . . 10.0 110.099 174.395 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 46.1 tttm -78.25 128.9 34.4 Favored 'General case' 0 C--N 1.314 -0.944 0 O-C-N 120.368 -1.458 . . . . 10.0 109.754 175.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.67 HD21 HD11 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -158.76 131.11 6.82 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 122.139 0.971 . . . . 10.0 112.262 -176.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -88.63 126.23 35.19 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.746 -1.116 . . . . 10.0 111.423 -174.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.67 HD11 HD21 ' A' ' 11' ' ' LEU . 63.7 mt -143.88 145.07 29.1 Favored Pre-proline 0 CA--C 1.511 -0.538 0 CA-C-O 121.098 0.475 . . . . 10.0 112.09 -174.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.706 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 24.8 Cg_exo -61.17 129.68 29.46 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.408 2.739 . . . . 10.0 112.405 175.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.605 ' HB2' HD11 ' A' ' 54' ' ' LEU . . . -62.23 129.09 39.17 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.343 -1.354 . . . . 10.0 107.343 168.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.88 0.75 86.05 Favored Glycine 0 N--CA 1.441 -1.004 0 O-C-N 125.498 1.749 . . . . 10.0 113.088 -175.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.706 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 3.9 tmtp? -144.46 99.86 3.44 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.147 0.974 . . . . 10.0 112.047 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.462 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -171.2 139.39 1.34 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.407 -1.27 . . . . 10.0 112.972 175.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.653 ' HA ' ' HB3' ' A' ' 39' ' ' CYS . 17.0 m -170.74 -66.88 0.0 OUTLIER Pre-proline 0 N--CA 1.437 -1.094 0 O-C-N 124.322 1.014 . . . . 10.0 110.813 178.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.706 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 86.3 Cg_endo -105.84 129.48 0.06 OUTLIER 'Trans proline' 0 N--CA 1.425 -2.511 0 N-CA-C 117.621 2.123 . . . . 10.0 117.621 -148.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.118 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 20.44 -83.87 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.412 0 CA-C-N 109.474 -3.512 . . . . 10.0 115.152 166.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.679 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 93.1 Cg_exo -39.39 -55.85 1.44 Allowed 'Trans proline' 0 C--N 1.382 2.308 0 CA-C-N 122.561 1.95 . . . . 10.0 112.489 -174.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.873 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 40.3 Cg_endo -91.02 116.1 0.47 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.822 1.681 . . . . 10.0 111.026 154.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.921 HG12 HD12 ' A' ' 35' ' ' ILE . 4.0 t 111.1 -42.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 C-N-CA 119.013 -1.075 . . . . 10.0 109.152 156.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 1.118 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -49.82 -75.11 0.22 Allowed Glycine 0 CA--C 1.523 0.583 0 CA-C-N 113.369 -1.741 . . . . 10.0 113.77 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.69 ' HA ' ' HG3' ' A' ' 30' ' ' GLN . 31.4 Cg_exo -54.79 -33.94 82.92 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.638 2.225 . . . . 10.0 111.39 175.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 24' ' ' VAL . . . -51.72 -98.08 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.113 0.412 . . . . 10.0 112.113 175.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.869 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.319 0.0 OUTLIER -72.88 -28.09 62.29 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 117.596 -1.642 . . . . 10.0 112.943 -174.412 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.555 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -68.58 -39.36 86.69 Favored Glycine 0 N--CA 1.464 0.501 0 C-N-CA 120.736 -0.745 . . . . 10.0 112.967 -176.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.69 ' HG3' ' HA ' ' A' ' 26' ' ' PRO . 23.5 mt-30 -65.38 -12.6 53.73 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.166 -1.014 . . . . 10.0 110.736 174.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.408 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 96.0 m-70 -100.46 18.28 19.45 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.944 -0.702 . . . . 10.0 109.809 173.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.57 1.94 70.7 Favored Glycine 0 CA--C 1.5 -0.887 0 CA-C-N 114.824 -1.08 . . . . 10.0 113.695 169.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.891 HG11 ' CD2' ' A' ' 66' ' ' PHE . 3.4 t -85.41 146.65 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 113.623 0.971 . . . . 10.0 113.623 -170.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -68.67 100.96 1.21 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.226 0.536 . . . . 10.0 110.95 171.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.921 HD12 HG12 ' A' ' 24' ' ' VAL . 8.7 mm -53.15 -39.94 36.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.943 -1.026 . . . . 10.0 111.217 174.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.824 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 3.7 mpp? -64.02 -47.35 80.6 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 113.357 -1.747 . . . . 10.0 111.076 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.584 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 18.5 tp10 -56.75 -45.01 82.29 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.873 -0.731 . . . . 10.0 110.234 173.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . 85.0 t80 -55.81 -60.07 3.98 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.661 1.356 . . . . 10.0 114.661 173.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.824 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 24.8 p -61.57 -49.19 77.65 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 114.838 -1.074 . . . . 10.0 112.02 -175.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.502 ' HA ' ' HD3' ' A' ' 40' ' ' LYS . 28.1 mmtp -65.66 -21.26 66.54 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.543 -0.863 . . . . 10.0 109.762 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.801 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 5.7 mtp180 -71.6 -65.35 0.77 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 119.357 -0.937 . . . . 10.0 111.436 167.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.545 ' CZ ' HG21 ' A' ' 46' ' ' THR . 66.8 t80 -52.8 -47.01 67.9 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.602 -171.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.626 HD22 ' N ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER -60.01 -52.78 63.92 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.944 -1.026 . . . . 10.0 110.254 -176.361 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.9 96.09 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 118.884 -1.127 . . . . 10.0 112.187 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.801 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 9.6 mt-10 -68.74 -37.2 79.24 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 121.583 0.706 . . . . 10.0 111.172 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.582 ' CG2' HD12 ' A' ' 54' ' ' LEU . 73.0 p -89.14 0.22 56.91 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.125 -0.943 . . . . 10.0 112.567 -173.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.95 -38.34 7.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.007 -0.997 . . . . 10.0 113.008 -175.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -76.05 -36.57 58.98 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.718 -0.673 . . . . 10.0 111.138 -174.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 34.4 mtmm -100.88 23.1 11.09 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 123.013 0.525 . . . . 10.0 109.903 -176.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -52.31 143.83 14.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.158 -0.928 . . . . 10.0 112.789 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.87 20.08 24.95 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 114.948 -1.024 . . . . 10.0 110.57 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.551 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 67.4 mtt -138.41 123.41 19.0 Favored 'General case' 0 C--O 1.208 -1.084 0 C-N-CA 117.243 -1.783 . . . . 10.0 114.262 -168.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.0 mm -65.68 91.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 118.626 0.648 . . . . 10.0 109.674 172.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.605 HD11 ' HB2' ' A' ' 15' ' ' ALA . 8.6 mt -81.06 131.49 59.41 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.178 -0.675 . . . . 10.0 109.178 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -71.83 106.54 2.01 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 C-N-CA 122.306 2.004 . . . . 10.0 110.962 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.37 151.63 5.86 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-N 119.449 1.022 . . . . 10.0 111.221 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 95.2 t -134.32 116.79 23.02 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 N-CA-C 110.288 -0.264 . . . . 10.0 110.288 175.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.664 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 14.9 mt -104.19 142.6 17.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.723 0.773 . . . . 10.0 109.623 -172.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 84.5 m -126.6 95.57 4.39 Favored 'General case' 0 N--CA 1.411 -2.383 0 CA-C-N 114.659 -1.155 . . . . 10.0 108.998 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 65' ' ' SER . 1.5 p -89.95 137.49 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.122 0 CA-C-N 119.386 0.994 . . . . 10.0 110.581 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -95.59 179.54 5.1 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.621 -0.718 . . . . 10.0 112.486 -176.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.401 ' HG3' ' HB2' ' A' ' 4' ' ' LYS . 5.9 mm-40 -53.12 -33.16 51.07 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 124.87 1.268 . . . . 10.0 112.444 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.547 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 35.5 t70 -80.85 -9.58 59.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.698 -1.137 . . . . 10.0 111.568 -168.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 0.2 OUTLIER 81.3 6.6 1.24 Allowed 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 122.632 1.206 . . . . 10.0 110.823 -166.135 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.622 ' O ' HG23 ' A' ' 60' ' ' VAL . 58.6 m -71.4 172.01 10.21 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 112.796 -2.002 . . . . 10.0 107.693 168.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.891 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -168.68 -176.25 2.69 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 119.948 1.249 . . . . 10.0 109.525 175.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.4 p -158.65 166.67 31.5 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 102.79 -3.041 . . . . 10.0 102.79 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.483 ' HB3' HG12 ' A' ' 58' ' ' ILE . 49.4 p90 -161.06 156.88 25.24 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 176.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.0 mt -116.47 167.23 9.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.058 -1.46 . . . . 10.0 107.058 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.3 mt -142.22 114.21 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 107.691 -1.226 . . . . 10.0 107.691 -175.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.552 ' HB3' ' HG2' ' A' ' 73' ' ' PRO . 12.9 mmtp -72.41 99.18 2.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.414 1.102 . . . . 10.0 112.493 -166.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.778 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 14.6 t -62.6 -33.98 13.24 Favored Pre-proline 0 CA--C 1.569 1.693 0 CA-C-N 113.197 -1.82 . . . . 10.0 112.178 169.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.778 ' HD2' ' N ' ' A' ' 72' ' ' THR . 1.0 OUTLIER -40.18 -43.82 3.85 Favored 'Trans proline' 0 C--N 1.386 2.5 0 C-N-CA 124.867 3.711 . . . . 10.0 117.976 -175.245 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 71' ' ' LYS . 40.8 Cg_exo -37.44 -29.7 0.11 Allowed 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 123.52 2.813 . . . . 10.0 114.47 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 1.08 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . . . 75.59 -45.73 0.55 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.997 0.74 . . . . 10.0 112.997 169.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 43.7 t -47.1 -37.11 9.17 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 123.841 0.713 . . . . 10.0 111.728 -175.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -47.24 -56.52 6.57 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.814 0.816 . . . . 10.0 111.534 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.585 HD22 HG21 ' A' ' 111' ' ' THR . 10.8 mp -98.54 -18.72 18.01 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.678 0.752 . . . . 10.0 109.689 -171.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.641 HD21 ' HB2' ' A' ' 132' ' ' ALA . 2.5 tp -64.85 -36.58 84.8 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 114.827 -1.078 . . . . 10.0 108.444 174.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.515 ' C ' ' H ' ' A' ' 82' ' ' ALA . 47.4 mtmt -64.1 -40.27 95.87 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.617 168.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.818 ' HA ' ' HE2' ' A' ' 81' ' ' LYS . 7.0 mmpt? -61.98 33.58 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.982 0.913 . . . . 10.0 113.15 171.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.923 ' HB1' HG13 ' A' ' 100' ' ' VAL . . . -171.42 -48.76 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 122.328 1.061 . . . . 10.0 109.394 -172.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.29 -2.01 0 CA-C-N 112.846 -1.979 . . . . 10.0 109.326 171.715 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.517 HG13 ' N ' ' A' ' 98' ' ' GLY . 7.8 p . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 120.929 0.395 . . . . 10.0 111.305 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.612 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -159.29 172.1 35.9 Favored Glycine 0 CA--C 1.493 -1.293 0 N-CA-C 108.08 -2.008 . . . . 10.0 108.08 170.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.947 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -143.13 167.51 21.93 Favored 'General case' 0 CA--C 1.479 -1.759 0 CA-C-O 122.664 1.221 . . . . 10.0 111.119 -169.152 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.923 HG13 ' HB1' ' A' ' 82' ' ' ALA . 2.1 t -131.53 -150.53 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.409 -2.478 0 CA-C-N 111.834 -2.439 . . . . 10.0 107.054 -173.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.645 ' H ' HG12 ' A' ' 100' ' ' VAL . 0.3 OUTLIER -167.42 133.98 2.21 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 105.894 -1.891 . . . . 10.0 105.894 -164.486 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.491 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 13.1 tpp180 -40.67 -44.91 2.26 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 125.055 1.472 . . . . 10.0 110.939 -171.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 16.9 tppt? -58.06 -42.94 86.56 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.398 0.888 . . . . 10.0 113.398 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.735 ' HB2' HG12 ' A' ' 100' ' ' VAL . 20.1 mm-40 -66.9 -52.02 48.36 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.089 -0.708 . . . . 10.0 109.089 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.849 HG21 ' HG3' ' A' ' 129' ' ' GLU . 28.7 mm -35.2 -55.29 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 O-C-N 124.074 0.859 . . . . 10.0 110.592 165.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.679 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 23.2 tt0 -50.36 -56.48 11.18 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.815 1.246 . . . . 10.0 113.12 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.53 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 12.5 mm-40 -54.58 -57.64 10.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.826 -1.079 . . . . 10.0 110.703 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.621 ' O ' HG22 ' A' ' 111' ' ' THR . 45.2 mt -50.19 -51.43 17.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.596 -1.183 . . . . 10.0 110.528 173.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.542 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -53.23 -34.26 56.39 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 112.582 0.586 . . . . 10.0 112.582 174.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.679 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 96.8 mttt -69.7 -52.29 26.89 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 120.853 0.359 . . . . 10.0 111.081 -177.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.621 HG22 ' O ' ' A' ' 108' ' ' ILE . 4.2 t -56.11 -29.12 60.19 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.944 -0.571 . . . . 10.0 111.606 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 1.08 ' HE3' ' HA ' ' A' ' 75' ' ' ALA . 49.7 mttm -103.89 -5.15 22.6 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 112.253 0.464 . . . . 10.0 112.253 -175.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.622 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 14.5 ptp -53.66 -32.87 11.94 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 112.985 0.735 . . . . 10.0 112.985 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 113' ' ' MET . 32.4 Cg_endo -62.83 -31.05 78.12 Favored 'Trans proline' 0 C--N 1.371 1.762 0 CA-C-N 120.651 1.268 . . . . 10.0 111.518 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.626 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 1.0 OUTLIER -102.78 -40.25 6.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.589 -1.187 . . . . 10.0 114.04 -169.357 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.558 ' HG ' HD13 ' A' ' 127' ' ' ILE . 0.9 OUTLIER -63.77 38.66 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 114.258 -1.337 . . . . 10.0 113.264 -174.315 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 43.4 t30 23.0 44.9 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 O-C-N 124.141 0.901 . . . . 10.0 111.024 -168.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.65 ' O ' ' HB2' ' A' ' 119' ' ' ASN . . . -73.88 -82.15 0.06 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.817 -1.083 . . . . 10.0 113.358 -169.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.65 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 5.7 m-20 101.26 -29.92 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 O-C-N 125.203 1.565 . . . . 10.0 110.412 -173.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 41.7 p -155.26 141.01 18.08 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.814 -1.18 . . . . 10.0 107.814 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.566 ' O ' ' HG3' ' A' ' 125' ' ' MET . 3.4 tm? -53.61 -44.05 69.15 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.832 1.049 . . . . 10.0 113.832 -175.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -53.64 -37.09 62.76 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.165 0.507 . . . . 10.0 111.507 174.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.574 ' O ' ' HG3' ' A' ' 126' ' ' LYS . . . -67.07 -47.24 71.87 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 118.241 -1.384 . . . . 10.0 110.276 174.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.546 ' HA ' HD12 ' A' ' 127' ' ' ILE . . . -55.99 -34.38 65.72 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.012 -0.675 . . . . 10.0 110.839 175.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.566 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 80.0 mtp -55.9 -45.38 78.66 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.175 0.805 . . . . 10.0 113.175 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.642 ' HD2' HG13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -63.6 -37.3 86.81 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.709 -0.478 . . . . 10.0 109.709 -178.338 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.642 HG13 ' HD2' ' A' ' 126' ' ' LYS . 83.6 mt -55.72 -64.04 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 CA-C-O 121.85 0.833 . . . . 10.0 111.569 175.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.542 HG13 ' HB2' ' A' ' 109' ' ' ALA . 25.0 mm -50.22 -59.67 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 CA-C-N 113.437 -1.71 . . . . 10.0 111.691 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.849 ' HG3' HG21 ' A' ' 105' ' ' ILE . 6.3 mt-10 -53.2 -40.39 64.4 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.454 -0.793 . . . . 10.0 110.091 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -71.36 -45.17 49.29 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.356 -0.926 . . . . 10.0 111.715 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.433 HG21 ' HB3' ' A' ' 75' ' ' ALA . 97.8 m -46.5 -61.17 1.93 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.185 -1.008 . . . . 10.0 108.906 169.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.641 ' HB2' HD21 ' A' ' 79' ' ' LEU . . . -50.74 -47.99 59.21 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.761 -0.654 . . . . 10.0 111.826 177.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 18.2 ttpt -44.44 -56.41 4.28 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 124.025 0.828 . . . . 10.0 110.448 176.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.5 m -64.54 -30.0 71.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.717 -0.674 . . . . 10.0 111.666 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 29.9 mtm -81.38 3.46 24.33 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 114.077 1.139 . . . . 10.0 114.077 -176.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.46 ' O ' HG12 ' A' ' 97' ' ' VAL . . . 84.07 20.04 59.93 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 120.066 1.303 . . . . 10.0 111.748 -177.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.702 ' CG2' HG23 ' A' ' 100' ' ' VAL . 1.8 mp -107.17 126.23 63.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.683 0.754 . . . . 10.0 112.079 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.947 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -90.31 158.87 16.94 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.522 -1.217 . . . . 10.0 108.997 175.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.5 HG11 ' HG2' ' A' ' 129' ' ' GLU . 19.1 m -114.71 124.3 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.216 0 N-CA-C 108.002 -1.111 . . . . 10.0 108.002 170.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 100' ' ' VAL . 5.0 m -108.52 157.24 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 CA-C-N 114.194 -1.366 . . . . 10.0 109.723 178.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.3 t70 . . . . . 0 C--N 1.287 -2.15 0 CA-C-N 113.057 -1.883 . . . . 10.0 110.28 174.073 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.511 ' C ' ' HG3' ' A' ' 62' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.442 -0.867 0 N-CA-C 109.618 -0.512 . . . . 10.0 109.618 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 93.1 t -79.41 133.33 30.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.64 -0.504 . . . . 10.0 109.64 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . . . -98.5 -37.54 9.53 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.115 -0.698 . . . . 10.0 109.115 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.4 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -164.67 -171.28 2.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 122.026 0.917 . . . . 10.0 113.423 -177.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 54.6 mt-30 -137.83 132.95 33.37 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.737 -1.574 . . . . 10.0 108.316 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.629 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -119.9 80.91 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.88 -0.785 . . . . 10.0 108.88 179.199 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -81.83 122.41 27.68 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 120.063 1.301 . . . . 10.0 107.847 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.605 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -156.84 130.3 8.08 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.163 0.982 . . . . 10.0 111.812 -171.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -81.99 120.93 25.88 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.297 -1.32 . . . . 10.0 110.225 -172.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.605 HD21 HD11 ' A' ' 11' ' ' LEU . 73.8 mt -138.57 135.32 17.92 Favored Pre-proline 0 CA--C 1.505 -0.752 0 CA-C-O 121.65 0.738 . . . . 10.0 112.051 -173.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.575 ' HB2' ' CB ' ' A' ' 17' ' ' LYS . 34.3 Cg_exo -54.94 123.6 14.19 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.641 2.894 . . . . 10.0 112.189 174.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.569 ' CB ' ' HA ' ' A' ' 50' ' ' ALA . . . -62.4 126.56 27.74 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.536 -1.283 . . . . 10.0 107.536 170.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.96 -1.06 85.93 Favored Glycine 0 CA--C 1.529 0.906 0 O-C-N 125.755 1.909 . . . . 10.0 113.238 -173.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.575 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . 6.0 tmtt? -142.81 95.85 2.84 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.185 0.993 . . . . 10.0 112.284 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.608 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -169.61 137.49 1.77 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.41 -1.268 . . . . 10.0 112.644 175.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.564 ' H ' ' HD3' ' A' ' 20' ' ' PRO . 1.8 t -178.05 -48.93 0.0 OUTLIER Pre-proline 0 N--CA 1.435 -1.182 0 CA-C-N 114.81 -1.086 . . . . 10.0 112.275 174.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.723 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 83.5 Cg_endo -101.53 134.64 0.15 Allowed 'Trans proline' 0 N--CA 1.407 -3.596 0 N-CA-C 116.231 1.589 . . . . 10.0 116.231 -150.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.025 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . 16.53 -64.94 0.0 OUTLIER Pre-proline 0 C--N 1.286 -2.184 0 CA-C-N 109.005 -3.725 . . . . 10.0 117.639 154.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.778 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 47.0 Cg_exo -53.87 -63.64 0.21 Allowed 'Trans proline' 0 CA--C 1.565 2.061 0 CA-C-N 123.606 2.324 . . . . 10.0 115.398 -176.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.778 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 58.3 Cg_endo -77.33 -52.24 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.607 2.204 . . . . 10.0 112.553 175.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.066 HG12 HD12 ' A' ' 35' ' ' ILE . 67.4 t -83.48 -44.95 18.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 111.896 -2.411 . . . . 10.0 111.957 -165.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.778 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -45.28 -53.36 7.94 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 114.259 -1.337 . . . . 10.0 114.234 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 1.025 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 50.5 Cg_exo -66.58 -49.29 1.75 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.228 2.619 . . . . 10.0 111.82 177.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.536 ' HB1' ' CG2' ' A' ' 9' ' ' ILE . . . -49.01 -74.85 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.323 0.583 . . . . 10.0 110.911 -177.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.773 HD22 ' HE2' ' A' ' 66' ' ' PHE . 3.5 mt -71.29 -44.99 64.12 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.649 0.981 . . . . 10.0 113.649 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.64 -41.45 98.91 Favored Glycine 0 N--CA 1.459 0.203 0 CA-C-N 116.237 -0.438 . . . . 10.0 113.359 -172.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -61.57 -26.52 68.01 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.94 -0.304 . . . . 10.0 110.491 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -99.06 17.37 19.94 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.847 -0.741 . . . . 10.0 109.982 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.01 11.91 85.14 Favored Glycine 0 CA--C 1.499 -0.944 0 CA-C-N 114.708 -1.133 . . . . 10.0 112.894 168.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.887 HG11 ' CD2' ' A' ' 66' ' ' PHE . 1.8 t -83.7 148.02 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 113.738 1.014 . . . . 10.0 113.738 -174.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -69.93 95.51 0.94 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.739 0.816 . . . . 10.0 110.606 174.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.066 HD12 HG12 ' A' ' 24' ' ' VAL . 22.0 mm -49.74 -43.27 18.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 114.722 -1.127 . . . . 10.0 111.783 177.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.806 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 10.7 ptm -66.05 -49.53 67.34 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 112.766 -2.016 . . . . 10.0 113.03 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.498 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 36.2 mt-10 -59.41 -32.99 70.69 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.114 -1.035 . . . . 10.0 110.912 176.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.745 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 72.1 t80 -63.49 -59.65 4.38 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 114.485 1.291 . . . . 10.0 114.485 169.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.806 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 23.7 p -60.07 -48.85 79.99 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 114.37 -1.287 . . . . 10.0 111.917 -175.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -65.32 -20.79 66.56 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.198 -0.667 . . . . 10.0 109.198 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.669 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 10.0 mtp180 -77.63 -64.25 1.19 Allowed 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 119.379 -0.928 . . . . 10.0 113.338 169.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.619 ' CE2' HG21 ' A' ' 46' ' ' THR . 45.3 t80 -55.9 -45.47 78.64 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 120.912 0.387 . . . . 10.0 110.113 -173.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.608 HD21 ' HB3' ' A' ' 18' ' ' ALA . 0.9 OUTLIER -59.01 -50.35 74.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.547 -0.751 . . . . 10.0 110.09 -179.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.69 96.26 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 118.816 -1.154 . . . . 10.0 112.649 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.669 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 5.1 pt-20 -73.78 -32.02 63.58 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 119.622 -0.831 . . . . 10.0 112.545 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.619 HG21 ' CE2' ' A' ' 42' ' ' PHE . 68.6 p -88.16 1.66 53.9 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 115.674 -0.694 . . . . 10.0 111.213 -177.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -47.56 -37.22 11.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.957 -1.02 . . . . 10.0 111.961 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.44 -45.39 39.0 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 114.194 -1.366 . . . . 10.0 110.538 -174.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.831 ' HD2' ' HZ ' ' A' ' 77' ' ' PHE . 30.2 mtmm -101.14 29.08 4.88 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 121.808 0.813 . . . . 10.0 109.472 -175.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.569 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -56.72 157.58 5.31 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 113.615 -1.63 . . . . 10.0 113.482 177.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.0 20.92 44.3 Favored Glycine 0 CA--C 1.505 -0.538 0 N-CA-C 109.883 -1.287 . . . . 10.0 109.883 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.616 ' HB2' HD21 ' A' ' 54' ' ' LEU . 14.6 mmt -137.28 123.14 20.08 Favored 'General case' 0 C--O 1.21 -1.018 0 C-N-CA 117.31 -1.756 . . . . 10.0 113.401 -167.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.7 mm -64.15 91.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.926 -0.768 . . . . 10.0 108.926 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.791 HD13 HG21 ' A' ' 70' ' ' ILE . 6.7 mt -79.19 127.11 80.24 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.552 -0.536 . . . . 10.0 109.552 -176.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.698 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 15.3 Cg_exo -70.85 99.63 0.88 Allowed 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 121.895 1.73 . . . . 10.0 110.397 172.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.419 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -97.12 148.82 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 119.57 1.077 . . . . 10.0 111.315 -172.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.433 ' HB ' ' CD1' ' A' ' 69' ' ' ILE . 71.5 t -126.53 115.01 40.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 120.866 -0.334 . . . . 10.0 110.521 171.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.726 ' CD1' HD21 ' A' ' 28' ' ' LEU . 17.7 mt -106.47 140.25 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 108.052 -1.092 . . . . 10.0 108.052 -175.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 94.0 m -123.81 99.32 6.22 Favored 'General case' 0 C--N 1.276 -2.607 0 CA-C-N 115.163 -0.926 . . . . 10.0 108.717 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 65' ' ' SER . 2.4 p -86.24 136.76 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.002 0 CA-C-N 118.897 0.771 . . . . 10.0 110.118 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 93.2 m-85 -93.96 170.5 9.49 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.076 -0.966 . . . . 10.0 112.507 -177.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.511 ' HG3' ' C ' ' A' ' 4' ' ' LYS . 16.3 mt-10 -63.28 -20.24 65.29 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.203 -1.362 . . . . 10.0 111.654 -177.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -78.97 -8.87 59.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.404 -0.816 . . . . 10.0 110.51 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm 83.15 0.75 1.13 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.442 1.097 . . . . 10.0 110.423 -171.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.53 ' O ' HG23 ' A' ' 60' ' ' VAL . 18.5 m -70.01 -178.77 1.68 Allowed 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 114.915 -1.038 . . . . 10.0 109.117 171.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.887 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -170.32 -175.89 2.05 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 119.679 1.127 . . . . 10.0 110.242 174.622 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.1 p -161.21 166.44 27.78 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 103.302 -2.851 . . . . 10.0 103.302 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.449 ' CB ' HG12 ' A' ' 58' ' ' ILE . 49.1 p90 -161.6 157.08 24.14 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 109.137 -0.69 . . . . 10.0 109.137 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.433 ' CD1' ' HB ' ' A' ' 57' ' ' VAL . 2.0 pp -136.55 152.59 29.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.327 -0.99 . . . . 10.0 108.327 -177.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.791 HG21 HD13 ' A' ' 54' ' ' LEU . 1.8 mm -100.9 132.07 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 108.089 -1.078 . . . . 10.0 108.089 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.698 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 32.4 mmmt -80.42 99.07 7.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.981 0.896 . . . . 10.0 112.194 -171.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.89 ' HB ' ' HB3' ' A' ' 112' ' ' LYS . 78.6 p -64.32 -29.35 3.74 Favored Pre-proline 0 CA--C 1.569 1.681 0 CA-C-N 113.778 -1.556 . . . . 10.0 114.852 172.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.642 ' HG3' ' HB3' ' A' ' 115' ' ' ASP . 72.9 Cg_exo -40.8 -48.36 4.57 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 123.909 3.073 . . . . 10.0 116.925 -172.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.503 ' HD3' ' HB2' ' A' ' 73' ' ' PRO . 88.7 Cg_exo -48.11 -30.29 14.06 Favored 'Trans proline' 0 C--N 1.363 1.323 0 C-N-CA 122.159 1.906 . . . . 10.0 112.733 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.407 ' HB1' HD23 ' A' ' 79' ' ' LEU . . . 68.44 -44.35 0.51 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.933 0.893 . . . . 10.0 112.865 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.557 ' HA ' ' HB2' ' A' ' 79' ' ' LEU . 7.4 m -49.6 -33.47 15.32 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 122.852 0.461 . . . . 10.0 110.468 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.831 ' HZ ' ' HD2' ' A' ' 49' ' ' LYS . 20.9 t80 -43.93 -58.82 2.57 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.92 -1.036 . . . . 10.0 111.822 172.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.889 ' HB3' HG23 ' A' ' 108' ' ' ILE . 6.3 tp -95.98 -14.33 23.11 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.46 -0.496 . . . . 10.0 110.333 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.733 HD21 HG23 ' A' ' 128' ' ' ILE . 2.3 mm? -64.62 -44.31 90.95 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 109.243 -0.651 . . . . 10.0 109.243 171.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.553 ' HD2' ' O ' ' A' ' 80' ' ' LYS . 1.7 tmmm? -63.52 -30.58 71.68 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 115.51 -0.768 . . . . 10.0 109.434 174.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.512 ' HG3' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -60.28 -40.17 89.46 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.991 0.737 . . . . 10.0 112.991 173.44 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.828 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -66.66 -43.14 85.35 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 123.294 1.521 . . . . 10.0 110.636 171.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.402 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . . . . . . . . 0 C--N 1.281 -2.39 0 CA-C-N 111.125 -2.762 . . . . 10.0 108.563 -175.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.466 HG13 ' N ' ' A' ' 98' ' ' GLY . 8.3 p . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 112.384 0.513 . . . . 10.0 112.384 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.594 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -166.93 161.27 35.1 Favored Glycine 0 CA--C 1.5 -0.885 0 N-CA-C 109.452 -1.459 . . . . 10.0 109.452 173.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.746 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -145.32 177.85 8.52 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 122.676 1.227 . . . . 10.0 111.649 -165.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.828 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -157.68 -143.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 CA-C-N 111.813 -2.449 . . . . 10.0 105.465 -177.388 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.454 ' H ' ' HB ' ' A' ' 100' ' ' VAL . 0.9 OUTLIER -163.32 143.37 8.84 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 108.117 -1.068 . . . . 10.0 108.117 -157.107 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.631 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 6.7 tpp180 -42.21 -38.86 1.87 Allowed 'General case' 0 CA--C 1.548 0.876 0 O-C-N 124.727 1.267 . . . . 10.0 110.921 -174.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -57.86 -44.94 86.9 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.178 0.807 . . . . 10.0 113.178 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.512 ' O ' HG13 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -61.39 -47.39 86.02 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.529 -0.915 . . . . 10.0 108.529 177.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.847 HG23 ' HB ' ' A' ' 128' ' ' ILE . 1.9 mp -40.44 -56.51 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 CA-C-N 115.044 -0.98 . . . . 10.0 112.274 168.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.8 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 16.9 tt0 -47.15 -57.86 4.66 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 124.74 1.216 . . . . 10.0 111.835 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.615 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 68.5 mm-40 -52.91 -55.38 23.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.969 -1.014 . . . . 10.0 110.986 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.889 HG23 ' HB3' ' A' ' 78' ' ' LEU . 32.4 mt -51.57 -54.84 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.902 -0.59 . . . . 10.0 109.925 174.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.512 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -50.6 -42.42 55.86 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 124.047 0.842 . . . . 10.0 112.63 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.8 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 70.1 mttt -67.43 -49.68 62.66 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 122.187 0.994 . . . . 10.0 108.876 -176.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 98.5 m -53.02 -22.29 5.59 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 113.302 -1.772 . . . . 10.0 112.77 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.89 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 1.2 ptpp? -131.11 11.2 5.02 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 113.886 1.069 . . . . 10.0 113.886 -178.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.747 ' HG3' ' HD3' ' A' ' 114' ' ' PRO . 8.7 ptp -48.95 -38.35 25.5 Favored Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 118.714 0.688 . . . . 10.0 112.6 167.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.747 ' HD3' ' HG3' ' A' ' 113' ' ' MET . 34.3 Cg_endo -63.06 -27.83 74.0 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 121.42 1.413 . . . . 10.0 112.316 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.642 ' HB3' ' HG3' ' A' ' 73' ' ' PRO . 4.7 m-20 -95.99 -47.48 6.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.041 -0.981 . . . . 10.0 111.838 -175.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.598 HD13 ' HB2' ' A' ' 112' ' ' LYS . 7.5 mp -64.12 -1.92 1.79 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.002 -1.454 . . . . 10.0 111.053 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.439 ' H ' ' C ' ' A' ' 115' ' ' ASP . 0.2 OUTLIER 63.79 45.53 4.4 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.773 -1.558 . . . . 10.0 109.733 176.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.626 ' HB3' ' HB2' ' A' ' 113' ' ' MET . . . -82.5 114.7 21.1 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 113.703 -1.589 . . . . 10.0 112.198 -175.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -66.7 -33.48 75.73 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.246 -0.65 . . . . 10.0 109.246 169.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 45.7 t -150.83 144.46 25.06 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.007 -1.479 . . . . 10.0 107.007 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.567 ' O ' HD13 ' A' ' 121' ' ' LEU . 2.5 tm? -51.61 -34.51 37.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.824 -1.08 . . . . 10.0 112.433 -176.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.579 ' HA ' ' HG3' ' A' ' 125' ' ' MET . 14.4 mm-40 -48.23 -42.7 31.06 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.425 0.631 . . . . 10.0 111.152 174.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.09 -46.45 77.62 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 118.708 -1.197 . . . . 10.0 110.34 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.511 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -57.33 -37.42 72.5 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.149 176.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.579 ' HG3' ' HA ' ' A' ' 122' ' ' GLU . 19.9 mtp -54.74 -38.83 67.64 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.61 0.243 . . . . 10.0 111.505 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' A' ' 122' ' ' GLU . 61.7 mmtt -63.66 -47.97 79.12 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.831 -0.803 . . . . 10.0 108.831 -178.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.509 HD12 ' HA ' ' A' ' 124' ' ' ALA . 78.9 mt -51.1 -62.86 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-O 121.659 0.742 . . . . 10.0 110.614 176.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.847 ' HB ' HG23 ' A' ' 105' ' ' ILE . 32.9 mm -53.4 -56.66 7.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 113.949 -1.478 . . . . 10.0 112.636 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.98 -39.36 68.92 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.546 -0.909 . . . . 10.0 108.546 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.469 ' HA2' ' HE2' ' A' ' 133' ' ' LYS . . . -70.73 -46.78 44.28 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.531 -0.758 . . . . 10.0 111.657 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 84.3 m -46.2 -63.49 0.98 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.334 -0.933 . . . . 10.0 109.28 170.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.08 -49.81 39.9 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.873 -0.603 . . . . 10.0 111.358 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.469 ' HE2' ' HA2' ' A' ' 130' ' ' GLY . 26.8 ttpt -48.61 -53.22 19.33 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.711 -1.131 . . . . 10.0 111.55 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 43.5 m -67.63 -28.12 67.46 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 111.792 0.293 . . . . 10.0 111.792 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.444 ' HB2' HD12 ' A' ' 137' ' ' ILE . 7.4 mtm -80.05 6.41 11.55 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.614 0.968 . . . . 10.0 113.614 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 81.09 10.81 84.42 Favored Glycine 0 N--CA 1.452 -0.261 0 CA-C-N 119.504 1.047 . . . . 10.0 111.55 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 32.1 mt -100.57 126.54 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-O 121.165 0.507 . . . . 10.0 111.005 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.746 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -85.25 154.01 22.23 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.205 -0.998 . . . . 10.0 109.15 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.464 HG12 HD11 ' A' ' 105' ' ' ILE . 27.7 m -111.21 120.63 62.25 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.488 0 N-CA-C 107.314 -1.365 . . . . 10.0 107.314 169.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 100' ' ' VAL . 29.9 m -101.39 152.11 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 CA-C-N 114.123 -1.399 . . . . 10.0 108.76 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 26.3 t0 . . . . . 0 C--N 1.294 -1.823 0 CA-C-N 112.874 -1.966 . . . . 10.0 112.876 -173.646 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.448 ' HB3' ' OE2' ' A' ' 62' ' ' GLU . 47.9 tttp . . . . . 0 N--CA 1.442 -0.857 0 N-CA-C 107.929 -1.138 . . . . 10.0 107.929 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.2 t -62.12 124.94 17.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 120.721 0.296 . . . . 10.0 110.498 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -99.68 -28.73 13.04 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.462 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -165.93 -167.6 1.11 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.166 -0.924 . . . . 10.0 112.811 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 9.7 pt20 -148.19 135.77 20.69 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.134 -1.394 . . . . 10.0 109.462 178.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.62 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -120.88 80.56 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 109.022 -0.733 . . . . 10.0 109.022 -178.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 30.8 tttt -79.61 125.19 29.3 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 120.101 1.318 . . . . 10.0 108.154 177.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.612 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.8 130.48 7.35 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 122.024 0.916 . . . . 10.0 111.978 -172.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -82.91 120.8 26.15 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.24 -1.345 . . . . 10.0 110.105 -173.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.612 HD21 HD11 ' A' ' 11' ' ' LEU . 47.4 mt -136.56 137.69 24.6 Favored Pre-proline 0 N--CA 1.443 -0.82 0 CA-C-O 121.696 0.76 . . . . 10.0 112.213 -171.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.631 ' HB2' ' CB ' ' A' ' 17' ' ' LYS . 22.9 Cg_exo -58.91 122.83 12.27 Favored 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 123.603 2.869 . . . . 10.0 111.663 173.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.603 ' HB1' ' HB ' ' A' ' 46' ' ' THR . . . -62.08 128.95 38.55 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.176 -1.046 . . . . 10.0 108.176 171.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.71 0.78 81.78 Favored Glycine 0 N--CA 1.442 -0.944 0 O-C-N 126.122 2.139 . . . . 10.0 112.786 -174.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.631 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . 5.9 tmtt? -142.05 91.58 2.36 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.86 0.838 . . . . 10.0 112.024 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.36 135.58 5.18 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.449 -1.25 . . . . 10.0 112.588 175.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.506 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 1.4 t -178.29 -50.52 0.0 OUTLIER Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.191 -0.913 . . . . 10.0 112.37 173.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.659 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 84.9 Cg_endo -101.42 125.59 0.11 Allowed 'Trans proline' 0 N--CA 1.414 -3.197 0 N-CA-C 115.726 1.395 . . . . 10.0 115.726 -154.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.125 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 12.04 -89.99 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.534 0 CA-C-N 109.347 -3.569 . . . . 10.0 114.713 168.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.78 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 47.7 Cg_exo -26.72 -56.51 0.1 OUTLIER 'Trans proline' 0 CA--C 1.559 1.742 0 C-N-CA 123.041 2.494 . . . . 10.0 115.824 -161.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.78 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 37.4 Cg_endo -77.75 -72.7 0.01 OUTLIER 'Trans proline' 0 CA--C 1.551 1.327 0 C-N-CA 122.267 1.978 . . . . 10.0 112.327 168.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.993 HG12 HD12 ' A' ' 35' ' ' ILE . 74.9 t -59.55 -54.85 28.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 112.218 -2.264 . . . . 10.0 114.734 -173.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 1.125 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -46.44 -70.27 0.7 Allowed Glycine 0 C--O 1.22 -0.763 0 CA-C-N 114.808 -1.087 . . . . 10.0 113.787 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.625 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 23.5 Cg_exo -47.76 -46.7 20.53 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.489 2.793 . . . . 10.0 112.701 173.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.13 -77.34 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.319 0.581 . . . . 10.0 111.361 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.753 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . 3.3 mt -69.39 -52.05 30.68 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 114.088 1.144 . . . . 10.0 114.088 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.2 -40.13 83.24 Favored Glycine 0 N--CA 1.462 0.367 0 CA-C-N 115.562 -0.744 . . . . 10.0 113.374 -172.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -60.11 -26.3 66.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.851 0.358 . . . . 10.0 110.408 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -99.97 17.02 22.01 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 120.008 -0.677 . . . . 10.0 109.771 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.52 ' HA3' ' HD3' ' A' ' 64' ' ' LYS . . . 82.99 7.57 86.98 Favored Glycine 0 CA--C 1.499 -0.941 0 CA-C-N 114.639 -1.164 . . . . 10.0 113.292 167.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.874 HG11 ' CD2' ' A' ' 66' ' ' PHE . 1.6 t -83.1 145.78 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 113.763 1.023 . . . . 10.0 113.763 -173.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.572 ' HB3' ' HG2' ' A' ' 37' ' ' GLU . 55.0 t-20 -70.58 100.28 1.8 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.452 0.644 . . . . 10.0 110.384 173.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.993 HD12 HG12 ' A' ' 24' ' ' VAL . 23.2 mm -53.54 -40.35 41.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 114.753 -1.112 . . . . 10.0 112.036 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 77.0 mtp -65.5 -53.01 48.55 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.189 -1.823 . . . . 10.0 112.434 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.572 ' HG2' ' HB3' ' A' ' 34' ' ' ASN . 7.0 pt-20 -61.52 -31.17 71.17 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 118.168 -1.413 . . . . 10.0 109.99 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.667 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 68.7 t80 -59.52 -58.97 6.26 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 119.502 -0.879 . . . . 10.0 112.849 168.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -56.22 -50.02 72.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 113.896 -1.502 . . . . 10.0 111.792 -178.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -64.85 -22.42 66.99 Favored 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 118.945 -1.102 . . . . 10.0 108.529 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.801 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 62.9 mtt180 -76.97 -64.3 1.16 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.032 -1.067 . . . . 10.0 111.863 169.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.604 ' CZ ' HG21 ' A' ' 46' ' ' THR . 76.8 t80 -54.18 -48.64 70.71 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-N 119.052 0.842 . . . . 10.0 110.784 -171.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -60.27 -51.75 68.22 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.768 -1.105 . . . . 10.0 110.328 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.07 -37.51 87.5 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.172 -1.011 . . . . 10.0 111.53 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.801 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 15.5 mm-40 -63.44 -45.34 91.33 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 122.02 0.914 . . . . 10.0 110.399 177.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.604 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 73.0 p -90.12 3.89 52.0 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.279 -1.328 . . . . 10.0 112.43 -167.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -47.1 -39.04 12.41 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.912 -1.04 . . . . 10.0 111.497 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.95 -48.09 77.89 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 114.125 -1.398 . . . . 10.0 111.532 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 45.1 mttp -98.84 21.96 10.78 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 123.217 0.607 . . . . 10.0 110.291 -172.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -51.99 133.05 32.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.066 -0.97 . . . . 10.0 112.634 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.37 19.27 10.08 Favored Glycine 0 CA--C 1.504 -0.599 0 N-CA-C 110.707 -0.957 . . . . 10.0 110.707 -176.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.582 ' HB2' HD21 ' A' ' 54' ' ' LEU . 66.9 mtt -138.74 125.5 20.91 Favored 'General case' 0 C--O 1.212 -0.885 0 C-N-CA 117.272 -1.771 . . . . 10.0 114.102 -168.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.6 mm -66.17 89.63 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 109.259 -0.645 . . . . 10.0 109.259 171.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.593 HD12 ' CG2' ' A' ' 46' ' ' THR . 8.2 mt -79.22 137.44 56.44 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.285 -0.635 . . . . 10.0 109.285 -177.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 54' ' ' LEU . 6.5 Cg_exo -76.28 106.12 2.2 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.13 1.887 . . . . 10.0 110.592 172.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.418 HG23 HG12 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -105.74 153.61 7.18 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-N 119.775 1.17 . . . . 10.0 110.731 -175.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 60.1 t -134.79 119.11 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 C-N-CA 120.789 -0.365 . . . . 10.0 110.244 173.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.75 ' CD1' HD21 ' A' ' 28' ' ' LEU . 15.7 mt -108.0 140.95 24.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 C-N-CA 119.861 -0.735 . . . . 10.0 109.132 -174.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.8 m -124.91 101.05 6.88 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 114.776 -1.102 . . . . 10.0 108.947 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 65' ' ' SER . 2.6 p -90.0 135.77 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.673 0 C-N-CA 124.016 0.927 . . . . 10.0 111.102 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -96.69 -177.05 3.78 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.746 -0.661 . . . . 10.0 112.572 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.448 ' OE2' ' HB3' ' A' ' 4' ' ' LYS . 29.3 mt-10 -55.07 -32.36 61.88 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.411 -1.268 . . . . 10.0 113.182 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.85 -11.25 59.87 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.611 -0.722 . . . . 10.0 111.334 -170.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.527 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 11.9 mmpt? 84.21 3.78 0.77 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.184 -1.043 . . . . 10.0 108.184 -164.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.541 ' O ' HG23 ' A' ' 60' ' ' VAL . 73.3 m -71.82 174.46 6.86 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.997 -1.456 . . . . 10.0 108.651 172.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.874 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -168.91 -175.45 2.36 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 119.655 1.116 . . . . 10.0 110.259 175.336 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 p -159.74 166.47 30.39 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 102.821 -3.029 . . . . 10.0 102.821 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.472 ' CB ' HG12 ' A' ' 58' ' ' ILE . 48.2 p90 -163.27 155.1 17.61 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.464 0.649 . . . . 10.0 109.492 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.405 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 9.4 pt -120.39 165.94 15.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 114.697 -1.138 . . . . 10.0 108.353 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.418 HG12 HG23 ' A' ' 56' ' ' VAL . 19.8 mt -138.46 113.13 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 107.152 -1.425 . . . . 10.0 107.152 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.585 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 11.6 mmmm -75.78 104.38 6.29 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 122.079 0.942 . . . . 10.0 112.676 -160.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.525 ' O ' ' HD2' ' A' ' 112' ' ' LYS . 65.6 p -64.5 -24.97 1.35 Allowed Pre-proline 0 CA--C 1.566 1.56 0 CA-C-N 113.52 -1.673 . . . . 10.0 114.48 171.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.599 ' HD3' ' CG ' ' A' ' 115' ' ' ASP . 74.9 Cg_exo -38.83 -53.3 1.94 Allowed 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 122.993 2.462 . . . . 10.0 115.005 -173.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.433 ' CD ' ' HB2' ' A' ' 73' ' ' PRO . 19.5 Cg_endo -59.13 99.33 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 121.502 1.468 . . . . 10.0 110.618 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.683 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . . . -72.44 -8.48 55.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.113 -0.494 . . . . 10.0 111.115 -174.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.63 -38.58 46.9 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.916 0.76 . . . . 10.0 112.094 -175.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.531 ' HB3' ' SD ' ' A' ' 52' ' ' MET . 36.2 m-85 -70.7 -54.89 10.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.548 0.69 . . . . 10.0 111.223 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.734 ' HB3' HD12 ' A' ' 108' ' ' ILE . 3.7 mm? -74.86 -30.51 61.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.598 0.713 . . . . 10.0 110.109 -173.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.624 HD11 ' HB2' ' A' ' 132' ' ' ALA . 0.8 OUTLIER -62.07 -39.08 91.2 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.933 -0.766 . . . . 10.0 108.933 175.311 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -62.27 -20.39 64.22 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.042 -0.526 . . . . 10.0 111.775 172.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.445 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 13.5 tptp -62.88 -44.31 96.46 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.553 -0.859 . . . . 10.0 110.848 173.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.75 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -76.87 -53.09 8.35 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.273 1.429 . . . . 10.0 112.024 171.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.805 0 CA-C-N 111.655 -2.52 . . . . 10.0 107.752 -177.689 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.548 HG13 ' N ' ' A' ' 98' ' ' GLY . 11.5 p . . . . . 0 CA--C 1.55 0.957 0 N-CA-C 112.583 0.586 . . . . 10.0 112.583 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.548 ' N ' HG13 ' A' ' 97' ' ' VAL . . . -96.07 149.82 19.44 Favored Glycine 0 CA--C 1.503 -0.695 0 N-CA-C 109.818 -1.313 . . . . 10.0 109.818 171.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.891 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -143.63 141.49 30.61 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 122.668 1.223 . . . . 10.0 110.841 168.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.869 ' HB ' ' HG2' ' A' ' 104' ' ' GLN . 1.7 m -163.34 -145.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 111.436 -2.62 . . . . 10.0 106.858 -165.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.483 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 1.3 t -163.84 141.81 7.38 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 120.478 -0.489 . . . . 10.0 110.363 -160.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.617 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 0.0 OUTLIER -44.07 -29.82 0.66 Allowed 'General case' 0 CA--C 1.555 1.137 0 O-C-N 124.606 1.192 . . . . 10.0 112.51 -172.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.56 ' N ' ' HD3' ' A' ' 102' ' ' ARG . 17.6 tppt? -60.14 -45.15 93.98 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.688 0.625 . . . . 10.0 112.688 175.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.869 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 0.7 OUTLIER -56.6 -47.14 80.25 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.725 -1.213 . . . . 10.0 107.725 178.26 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.953 HG23 ' HB ' ' A' ' 128' ' ' ILE . 2.0 mp -43.69 -51.16 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.654 0 CA-C-N 114.29 -1.323 . . . . 10.0 112.174 172.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.804 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 23.0 tt0 -52.48 -55.6 20.83 Favored 'General case' 0 CA--C 1.506 -0.724 0 O-C-N 124.287 0.992 . . . . 10.0 111.718 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.718 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 66.1 mm-40 -52.58 -57.21 10.71 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 114.408 -1.269 . . . . 10.0 109.993 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.734 HD12 ' HB3' ' A' ' 78' ' ' LEU . 16.4 mm -52.0 -50.4 34.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.496 -0.774 . . . . 10.0 110.534 175.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.415 ' HB3' HD11 ' A' ' 121' ' ' LEU . . . -53.33 -39.06 63.8 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.711 -0.677 . . . . 10.0 112.736 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.804 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 64.5 mttt -72.42 -50.38 26.75 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 122.045 0.926 . . . . 10.0 109.226 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.9 m -51.32 -34.03 31.71 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 113.522 -1.672 . . . . 10.0 113.325 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.683 ' HE2' ' HA ' ' A' ' 75' ' ' ALA . 5.6 mtmp? -119.16 17.2 13.21 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.506 0.67 . . . . 10.0 109.229 -172.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.817 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 43.5 ttm -50.66 -47.0 86.01 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 114.708 -1.133 . . . . 10.0 113.048 177.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 113' ' ' MET . 20.3 Cg_endo -57.9 -24.44 64.64 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.168 1.912 . . . . 10.0 112.384 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.599 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 4.3 m-20 -94.26 -49.81 5.55 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.206 -0.906 . . . . 10.0 112.317 -177.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.542 ' CD1' ' HA ' ' A' ' 73' ' ' PRO . 10.1 mp -65.6 38.28 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 114.396 -1.274 . . . . 10.0 113.014 -177.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.437 ' H ' ' C ' ' A' ' 115' ' ' ASP . 9.4 t30 19.59 51.12 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 O-C-N 124.843 1.34 . . . . 10.0 112.025 -171.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.817 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -80.93 107.56 13.85 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.131 0.789 . . . . 10.0 113.131 -173.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.45 -37.6 85.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.624 0.726 . . . . 10.0 109.282 169.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.8 p -151.87 144.25 24.08 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.203 -1.406 . . . . 10.0 107.203 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.656 ' O ' ' HG2' ' A' ' 125' ' ' MET . 62.3 tp -51.93 -31.75 30.0 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 114.311 1.226 . . . . 10.0 114.311 -175.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -49.87 -39.76 40.43 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.681 0.753 . . . . 10.0 110.074 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.619 ' O ' ' HG3' ' A' ' 126' ' ' LYS . . . -66.93 -49.46 65.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.771 -1.104 . . . . 10.0 111.186 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.591 ' HB3' HD12 ' A' ' 121' ' ' LEU . . . -56.19 -34.96 66.71 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.92 -0.712 . . . . 10.0 110.719 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.732 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 50.6 mmm -56.64 -45.25 81.7 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.058 0.762 . . . . 10.0 113.058 178.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.738 ' HD3' ' N ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -65.14 -36.36 84.01 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.776 -0.453 . . . . 10.0 109.776 -177.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.738 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 73.4 mt -54.37 -65.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-O 121.571 0.7 . . . . 10.0 110.707 174.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.953 ' HB ' HG23 ' A' ' 105' ' ' ILE . 20.5 mm -51.05 -54.26 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 CA-C-N 113.853 -1.521 . . . . 10.0 112.365 -177.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.549 ' HG2' ' HA ' ' A' ' 126' ' ' LYS . 6.6 pt-20 -56.45 -44.58 80.63 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.382 -0.599 . . . . 10.0 109.382 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.531 ' HA2' ' HD2' ' A' ' 133' ' ' LYS . . . -69.33 -46.9 54.92 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.869 -0.605 . . . . 10.0 111.81 -175.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.584 HG21 ' HB3' ' A' ' 75' ' ' ALA . 64.8 m -44.99 -61.29 1.68 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.648 -0.871 . . . . 10.0 108.648 168.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.624 ' HB2' HD11 ' A' ' 79' ' ' LEU . . . -49.06 -46.23 44.13 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.895 -0.593 . . . . 10.0 112.353 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.531 ' HD2' ' HA2' ' A' ' 130' ' ' GLY . 65.2 mttm -49.88 -53.64 24.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.815 176.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 9.4 m -67.23 -31.79 72.38 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.482 0.658 . . . . 10.0 110.476 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.549 ' SD ' HG22 ' A' ' 131' ' ' THR . 26.0 mtp -77.67 -1.15 29.59 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 114.071 1.137 . . . . 10.0 114.071 -177.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.66 28.8 56.55 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 119.403 1.001 . . . . 10.0 111.949 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.531 ' CG2' ' HB1' ' A' ' 132' ' ' ALA . 1.7 mp -107.11 124.75 63.1 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.076 0 CA-C-O 121.612 0.72 . . . . 10.0 109.993 176.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.891 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 1.3 pt-20 -87.42 149.89 24.15 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.268 -1.382 . . . . 10.0 107.268 176.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 23.7 m -118.88 136.92 54.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.03 -1.1 . . . . 10.0 108.03 174.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.648 HG22 ' O ' ' A' ' 100' ' ' VAL . 8.2 m -135.65 71.48 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 113.801 1.037 . . . . 10.0 113.801 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.833 -1.08 . . . . 10.0 112.564 141.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? . . . . . 0 C--O 1.226 -0.184 0 CA-C-O 120.369 0.128 . . . . 10.0 110.742 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 50.1 t -66.84 138.15 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 122.812 0.445 . . . . 10.0 111.356 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -108.92 -40.91 4.88 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.727 -0.471 . . . . 10.0 109.727 173.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.467 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -156.73 151.03 25.26 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 113.656 0.984 . . . . 10.0 113.656 -176.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -95.27 134.63 37.83 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.842 -1.072 . . . . 10.0 108.26 171.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.675 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.5 OUTLIER -119.95 81.77 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 108.662 -0.866 . . . . 10.0 108.662 171.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -79.05 126.63 30.95 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 120.69 1.587 . . . . 10.0 108.098 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.545 HD21 HD11 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.42 128.56 6.72 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 122.331 1.062 . . . . 10.0 111.603 -176.09 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -83.06 119.07 24.01 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 113.816 -1.538 . . . . 10.0 110.086 -171.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.545 HD11 HD21 ' A' ' 11' ' ' LEU . 58.2 mt -137.73 137.84 22.67 Favored Pre-proline 0 CA--C 1.507 -0.688 0 CA-C-O 121.697 0.76 . . . . 10.0 112.427 -170.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.818 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 33.8 Cg_exo -56.05 123.8 14.72 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.752 2.968 . . . . 10.0 112.131 173.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.612 ' HB2' HD11 ' A' ' 54' ' ' LEU . . . -61.82 127.01 29.37 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 107.538 -1.282 . . . . 10.0 107.538 170.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.18 -5.78 81.84 Favored Glycine 0 N--CA 1.441 -1.014 0 O-C-N 125.765 1.916 . . . . 10.0 113.242 -175.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.818 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 2.2 mmmp? -138.47 104.65 5.21 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.562 1.181 . . . . 10.0 112.247 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.63 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -167.76 133.29 1.95 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.049 -1.432 . . . . 10.0 111.712 173.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.697 ' HA ' ' HB2' ' A' ' 39' ' ' CYS . 1.8 t -179.01 -40.66 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.102 -0.954 . . . . 10.0 113.075 177.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.692 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 85.0 Cg_endo -105.75 124.43 0.05 OUTLIER 'Trans proline' 0 N--CA 1.415 -3.146 0 N-CA-C 115.821 1.431 . . . . 10.0 115.821 -161.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.11 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 9.75 -84.56 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.545 0 CA-C-N 109.745 -3.389 . . . . 10.0 115.084 165.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.944 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 39.4 Cg_exo -28.74 -57.27 0.13 Allowed 'Trans proline' 0 CA--C 1.562 1.88 0 C-N-CA 122.912 2.408 . . . . 10.0 115.898 -164.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.944 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 6.0 Cg_exo -81.38 -55.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 123.102 2.534 . . . . 10.0 111.919 171.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.08 HG12 HD12 ' A' ' 35' ' ' ILE . 49.6 t -81.01 -52.49 14.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 112.209 -2.269 . . . . 10.0 113.659 -166.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 1.11 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -48.0 -74.07 0.28 Allowed Glycine 0 C--O 1.214 -1.122 0 CA-C-N 114.702 -1.135 . . . . 10.0 113.681 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.677 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 34.7 Cg_exo -46.9 -42.86 24.91 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.514 2.809 . . . . 10.0 112.833 175.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.04 -79.95 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.248 0.547 . . . . 10.0 111.011 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.817 ' HB2' HD11 ' A' ' 35' ' ' ILE . 2.2 mt -67.65 -47.1 70.53 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 114.178 1.177 . . . . 10.0 114.178 -177.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.78 -37.24 92.16 Favored Glycine 0 C--N 1.32 -0.351 0 CA-C-N 115.606 -0.724 . . . . 10.0 113.432 -173.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.54 -26.73 67.11 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.848 -0.427 . . . . 10.0 109.848 175.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -99.86 16.66 23.03 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 120.055 -0.658 . . . . 10.0 110.09 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.9 9.21 85.7 Favored Glycine 0 CA--C 1.503 -0.658 0 CA-C-N 114.809 -1.087 . . . . 10.0 113.532 168.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.749 HG11 ' CD2' ' A' ' 66' ' ' PHE . 11.4 t -81.77 147.14 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 114.078 1.14 . . . . 10.0 114.078 -172.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -69.03 96.93 0.82 Allowed 'General case' 0 C--N 1.347 0.457 0 C-N-CA 123.38 0.672 . . . . 10.0 110.765 171.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.08 HD12 HG12 ' A' ' 24' ' ' VAL . 20.0 mm -55.52 -38.41 49.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 121.983 0.897 . . . . 10.0 112.163 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -46.94 74.31 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.611 -1.631 . . . . 10.0 112.076 175.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.631 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 17.7 mt-10 -58.83 -43.74 90.73 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 118.66 -1.216 . . . . 10.0 110.479 174.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.576 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 79.3 t80 -54.71 -56.82 15.15 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 113.599 0.963 . . . . 10.0 113.599 173.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.697 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -55.92 -52.36 64.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.001 -1.454 . . . . 10.0 111.666 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -65.79 -21.61 66.51 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 119.097 -1.041 . . . . 10.0 109.02 -176.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.768 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 85.9 mtt180 -78.13 -63.53 1.37 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 115.311 -0.859 . . . . 10.0 112.144 171.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.638 ' CZ ' HG21 ' A' ' 46' ' ' THR . 75.3 t80 -55.15 -44.38 75.06 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 121.251 0.548 . . . . 10.0 110.367 -172.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.631 HD22 ' N ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER -60.48 -49.25 78.32 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.056 -0.974 . . . . 10.0 109.911 -178.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.17 96.76 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.035 -1.066 . . . . 10.0 112.349 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.768 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 4.6 mm-40 -65.43 -43.37 90.71 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.951 0.882 . . . . 10.0 110.756 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.639 ' CG2' HD12 ' A' ' 54' ' ' LEU . 71.6 p -92.52 4.66 53.12 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 114.223 -1.353 . . . . 10.0 112.136 -171.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -47.22 -36.89 9.44 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.809 -1.087 . . . . 10.0 112.548 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -81.33 -40.69 23.2 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.678 -0.692 . . . . 10.0 111.823 -176.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.0 mttp -92.01 18.54 7.81 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 108.822 -0.807 . . . . 10.0 108.822 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.429 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -52.42 147.64 7.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.803 -1.089 . . . . 10.0 113.393 -177.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.49 18.96 31.32 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 114.813 -1.085 . . . . 10.0 110.513 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.557 ' HB2' HD21 ' A' ' 54' ' ' LEU . 61.6 mtt -138.34 127.65 24.49 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 116.693 -2.003 . . . . 10.0 114.866 -167.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.4 mm -65.23 91.71 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 O-C-N 121.787 -0.57 . . . . 10.0 109.58 170.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.639 HD12 ' CG2' ' A' ' 46' ' ' THR . 8.3 mt -84.63 130.65 52.42 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.928 -0.768 . . . . 10.0 108.928 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.506 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 14.3 Cg_exo -71.79 105.91 1.89 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.557 1.505 . . . . 10.0 110.635 173.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -97.22 142.81 13.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 119.9 1.227 . . . . 10.0 110.597 -174.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 89.4 t -119.71 111.83 34.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 120.332 -0.547 . . . . 10.0 110.431 171.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.783 ' CD1' HD21 ' A' ' 28' ' ' LEU . 15.5 mt -105.8 139.22 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.932 0 N-CA-C 107.972 -1.122 . . . . 10.0 107.972 -174.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.8 m -123.24 97.31 5.36 Favored 'General case' 0 N--CA 1.402 -2.836 0 CA-C-N 114.793 -1.094 . . . . 10.0 108.787 178.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.518 HG21 HG22 ' A' ' 33' ' ' VAL . 4.4 p -86.66 137.37 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.956 0 CA-C-N 119.402 1.001 . . . . 10.0 110.089 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.448 ' HE2' ' HG1' ' A' ' 67' ' ' THR . 77.9 m-85 -95.8 172.11 8.23 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.777 0.799 . . . . 10.0 112.857 -177.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -60.38 -22.96 63.93 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.249 -1.341 . . . . 10.0 111.841 -177.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.485 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 10.7 m-20 -77.68 -10.47 59.54 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.353 -0.839 . . . . 10.0 111.527 -176.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 55.1 mtpt 83.85 2.5 0.91 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 124.35 1.031 . . . . 10.0 109.459 -166.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.51 ' O ' HG23 ' A' ' 60' ' ' VAL . 14.6 t -73.74 172.13 12.03 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 113.924 -1.489 . . . . 10.0 107.369 174.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.749 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -169.75 -178.82 3.1 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 120.45 1.477 . . . . 10.0 109.692 175.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.448 ' HG1' ' HE2' ' A' ' 61' ' ' TYR . 5.3 p -161.83 169.41 21.37 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 103.542 -2.762 . . . . 10.0 103.542 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.449 ' CB ' HG12 ' A' ' 58' ' ' ILE . 49.8 p90 -162.5 159.3 24.75 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.545 -0.539 . . . . 10.0 109.545 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.9 mt -119.62 166.66 13.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 107.256 -1.387 . . . . 10.0 107.256 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.483 HD12 ' CE1' ' A' ' 42' ' ' PHE . 6.4 mm -126.42 122.18 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 107.004 -1.48 . . . . 10.0 107.004 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.586 ' C ' ' HD2' ' A' ' 73' ' ' PRO . 10.5 mmtp -76.64 96.82 4.25 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 122.188 0.994 . . . . 10.0 112.288 -169.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.733 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 3.4 t -59.46 -35.08 26.67 Favored Pre-proline 0 CA--C 1.56 1.362 0 CA-C-N 113.189 -1.823 . . . . 10.0 112.891 166.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.733 ' HD2' ' N ' ' A' ' 72' ' ' THR . 1.2 Cg_endo -39.69 -47.1 3.61 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 124.33 3.354 . . . . 10.0 116.114 -173.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.566 ' HD3' ' HG2' ' A' ' 73' ' ' PRO . 27.9 Cg_exo -61.62 88.57 0.1 OUTLIER 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 121.267 1.311 . . . . 10.0 111.061 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.656 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -62.54 -17.54 60.07 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.404 -0.816 . . . . 10.0 110.923 -177.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.759 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 17.1 m -54.06 -37.93 64.71 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.868 -0.605 . . . . 10.0 111.331 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -75.08 -50.27 16.98 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.22 0.533 . . . . 10.0 111.27 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.784 ' HB3' HD12 ' A' ' 108' ' ' ILE . 3.5 mm? -70.93 -27.53 63.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.186 0.517 . . . . 10.0 110.377 -176.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.429 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 62.1 mt -75.16 -21.66 58.63 Favored 'General case' 0 C--O 1.209 -1.039 0 CA-C-N 115.954 -0.566 . . . . 10.0 110.619 175.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.759 ' HG2' ' O ' ' A' ' 76' ' ' SER . 75.2 mmtt -61.84 -36.82 82.32 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.349 0.595 . . . . 10.0 109.676 171.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -60.8 -51.13 70.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.581 -0.736 . . . . 10.0 112.43 176.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 1.069 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -75.08 -64.99 0.93 Allowed 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 123.149 1.452 . . . . 10.0 110.715 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 79' ' ' LEU . . . . . . . . 0 C--N 1.295 -1.775 0 CA-C-N 111.514 -2.584 . . . . 10.0 108.427 176.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.465 HG13 ' N ' ' A' ' 98' ' ' GLY . 4.2 p . . . . . 0 CA--C 1.533 0.292 0 CA-C-O 121.225 0.536 . . . . 10.0 112.167 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.465 ' N ' HG13 ' A' ' 97' ' ' VAL . . . -168.95 173.59 43.48 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 108.852 -1.699 . . . . 10.0 108.852 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.636 ' O ' HG13 ' A' ' 100' ' ' VAL . 16.9 mtmt -149.15 177.85 9.26 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-N 117.37 0.585 . . . . 10.0 109.981 -159.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 1.069 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -166.5 111.55 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.496 -1.108 0 CA-C-O 122.643 1.211 . . . . 10.0 111.816 167.241 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 1.1 t -41.58 147.27 0.19 Allowed 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 112.071 -2.331 . . . . 10.0 113.954 173.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.569 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 11.5 mmm180 -39.21 -37.78 0.44 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 111.725 -2.489 . . . . 10.0 112.911 -170.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -57.46 -48.39 79.29 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.651 0.611 . . . . 10.0 112.651 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.658 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.5 OUTLIER -59.28 -46.01 89.7 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.115 -0.698 . . . . 10.0 109.115 -178.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.692 HG23 ' HB ' ' A' ' 128' ' ' ILE . 30.6 mm -40.49 -56.89 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 114.883 -1.053 . . . . 10.0 112.448 168.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.821 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 26.6 tt0 -44.51 -60.15 2.1 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.165 0.802 . . . . 10.0 113.165 -178.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.499 ' HA ' ' HD3' ' A' ' 110' ' ' LYS . 25.9 mt-10 -56.11 -49.66 73.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.619 -0.719 . . . . 10.0 110.653 -175.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.784 HD12 ' HB3' ' A' ' 78' ' ' LEU . 21.2 mm -50.62 -55.71 5.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.366 -0.834 . . . . 10.0 110.206 172.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.525 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -49.9 -47.19 52.26 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.298 0.851 . . . . 10.0 113.298 177.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.821 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 12.5 mtpp -67.16 -49.33 65.14 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.664 0.745 . . . . 10.0 109.923 -173.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.3 m -58.31 -29.92 66.26 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 114.557 -1.201 . . . . 10.0 112.003 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.739 ' HB3' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -93.24 -16.27 24.97 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.589 0.755 . . . . 10.0 110.759 -176.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.965 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 5.1 ttp -48.75 -44.46 68.71 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 113.448 0.907 . . . . 10.0 113.448 -175.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 113' ' ' MET . 12.6 Cg_endo -56.06 -30.28 77.97 Favored 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 121.836 1.691 . . . . 10.0 111.615 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.435 ' CB ' ' HD3' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -93.34 -45.86 7.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.525 -1.216 . . . . 10.0 111.875 -176.417 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.739 HD22 ' HB3' ' A' ' 112' ' ' LYS . 3.6 mp -63.49 -2.95 1.78 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.127 -1.397 . . . . 10.0 112.218 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 61.0 t30 61.69 45.43 7.96 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.297 -1.32 . . . . 10.0 109.548 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.965 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -86.35 121.0 28.31 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.691 -1.595 . . . . 10.0 112.289 -176.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -67.6 -33.22 74.56 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.225 -0.657 . . . . 10.0 109.225 171.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.0 t -154.96 143.87 20.85 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.965 -1.494 . . . . 10.0 106.965 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' A' ' 124' ' ' ALA . 29.7 tp -53.45 -31.11 44.06 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.19 1.552 . . . . 10.0 115.19 -172.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -48.89 -40.16 28.72 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.722 0.692 . . . . 10.0 110.083 175.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.4 -47.82 66.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.622 -1.172 . . . . 10.0 111.04 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.571 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -57.93 -36.61 72.75 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.624 -0.43 . . . . 10.0 110.429 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.554 ' HG3' ' HG ' ' A' ' 121' ' ' LEU . 64.7 mtp -61.82 -34.75 76.5 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.361 0.6 . . . . 10.0 110.169 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -64.12 -51.23 64.92 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.682 -1.144 . . . . 10.0 109.465 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.531 HG21 ' HG ' ' A' ' 116' ' ' LEU . 76.1 mt -50.98 -62.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 CA-C-N 115.266 -0.879 . . . . 10.0 110.727 177.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.692 ' HB ' HG23 ' A' ' 105' ' ' ILE . 26.5 mm -50.36 -54.51 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.078 0 CA-C-N 114.779 -1.1 . . . . 10.0 111.153 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' A' ' 133' ' ' LYS . 42.5 tt0 -53.56 -44.83 69.6 Favored 'General case' 0 N--CA 1.435 -1.214 0 O-C-N 124.119 0.887 . . . . 10.0 109.227 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -72.45 -45.93 35.22 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.618 -0.801 . . . . 10.0 111.698 -175.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.656 HG21 ' HB3' ' A' ' 75' ' ' ALA . 85.8 m -46.48 -60.1 2.56 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.359 -0.92 . . . . 10.0 109.575 171.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -48.24 -48.14 35.49 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.396 -0.82 . . . . 10.0 111.926 175.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 130' ' ' GLY . 47.9 mtpt -47.62 -54.25 12.43 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.755 0.659 . . . . 10.0 111.52 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 44.9 m -64.58 -30.82 71.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.879 0.371 . . . . 10.0 111.019 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.416 ' HE1' ' HA ' ' A' ' 76' ' ' SER . 43.5 mtm -79.65 7.94 7.47 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.502 0.927 . . . . 10.0 113.502 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.7 3.74 80.3 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 119.436 1.016 . . . . 10.0 111.564 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.523 HG23 ' HA ' ' A' ' 99' ' ' LYS . 39.9 mt -99.29 134.93 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-O 121.712 0.767 . . . . 10.0 112.58 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.477 ' HG2' ' HG2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -96.89 160.03 14.59 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.704 -1.135 . . . . 10.0 109.571 177.279 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.3 m -107.66 131.63 57.39 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.647 0 N-CA-C 106.68 -1.6 . . . . 10.0 106.68 170.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 101' ' ' THR . 3.4 m -117.22 -178.9 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-N 114.809 -1.087 . . . . 10.0 109.661 -174.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 38.9 t70 . . . . . 0 C--N 1.281 -2.407 0 CA-C-N 112.635 -2.075 . . . . 10.0 109.026 163.961 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.607 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.525 0 N-CA-C 109.225 -0.657 . . . . 10.0 109.225 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.02 139.96 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 122.671 0.388 . . . . 10.0 111.874 -173.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.526 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . . . -112.07 -36.58 5.32 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.134 -0.485 . . . . 10.0 109.708 172.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.478 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -155.4 143.03 19.69 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.25 0.833 . . . . 10.0 113.25 -177.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -93.16 130.1 38.94 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.648 -1.241 . . . . 10.0 107.648 170.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.683 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -119.95 81.66 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.051 -0.722 . . . . 10.0 109.051 176.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.462 ' HG2' HG13 ' A' ' 57' ' ' VAL . 9.6 mtmp? -79.13 127.39 31.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 120.137 1.335 . . . . 10.0 108.413 175.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.632 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.3 127.62 6.4 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.295 1.045 . . . . 10.0 111.731 -175.025 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -83.13 121.62 27.29 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.172 -1.377 . . . . 10.0 110.117 -172.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.632 HD21 HD11 ' A' ' 11' ' ' LEU . 69.3 mt -139.16 139.88 24.57 Favored Pre-proline 0 CA--C 1.506 -0.728 0 CA-C-O 121.737 0.78 . . . . 10.0 111.963 -170.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.853 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 11.9 Cg_exo -59.61 124.65 15.9 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 123.426 2.751 . . . . 10.0 111.506 173.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.625 ' CB ' ' HB ' ' A' ' 46' ' ' THR . . . -61.87 126.98 29.24 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 107.956 -1.127 . . . . 10.0 107.956 170.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.85 -2.23 88.34 Favored Glycine 0 N--CA 1.44 -1.093 0 O-C-N 125.66 1.85 . . . . 10.0 112.933 -175.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.853 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 74.9 mmtt -140.27 107.74 5.57 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 118.007 0.904 . . . . 10.0 112.422 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.71 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -169.77 134.41 1.35 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.92 -1.491 . . . . 10.0 112.052 171.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.546 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 1.6 t 178.92 -39.61 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.542 0 O-C-N 124.157 0.911 . . . . 10.0 113.169 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.725 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 71.8 Cg_endo -103.71 122.44 0.07 OUTLIER 'Trans proline' 0 N--CA 1.417 -2.983 0 N-CA-C 115.935 1.475 . . . . 10.0 115.935 -161.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.966 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 9.12 -82.91 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.451 0 CA-C-N 110.283 -3.144 . . . . 10.0 115.06 162.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.714 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 70.1 Cg_exo -33.16 -56.97 0.34 Allowed 'Trans proline' 0 CA--C 1.564 2.019 0 C-N-CA 122.182 1.921 . . . . 10.0 115.676 -164.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.725 ' HD2' ' O ' ' A' ' 20' ' ' PRO . 58.2 Cg_endo -78.62 -59.24 0.04 OUTLIER 'Trans proline' 0 CA--C 1.553 1.457 0 C-N-CA 122.734 2.29 . . . . 10.0 113.158 170.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.9 t -80.89 -36.81 15.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 112.441 -2.163 . . . . 10.0 113.388 -165.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.966 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -53.92 -69.03 1.35 Allowed Glycine 0 C--N 1.305 -1.142 0 CA-C-N 113.514 -1.676 . . . . 10.0 112.471 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 70.2 Cg_exo -50.87 -43.41 47.21 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.845 2.363 . . . . 10.0 112.117 172.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.45 ' O ' ' HD2' ' A' ' 31' ' ' HIS . . . -50.81 -96.54 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 112.372 0.508 . . . . 10.0 112.372 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.787 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.307 0.0 OUTLIER -75.11 -26.36 59.19 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 118.152 -1.419 . . . . 10.0 113.573 -176.233 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.577 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -68.53 -40.99 85.99 Favored Glycine 0 N--CA 1.465 0.589 0 C-N-CA 120.926 -0.654 . . . . 10.0 112.68 -175.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -60.96 -21.41 63.45 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.112 -0.635 . . . . 10.0 110.099 175.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.45 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 97.8 m-70 -99.09 19.81 14.53 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.629 -0.828 . . . . 10.0 110.215 178.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.559 ' HA3' ' HD2' ' A' ' 64' ' ' LYS . . . 86.59 4.61 82.82 Favored Glycine 0 CA--C 1.501 -0.785 0 CA-C-N 115.201 -0.909 . . . . 10.0 113.363 167.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.787 ' HB ' HD23 ' A' ' 28' ' ' LEU . 4.6 t -83.01 146.2 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 113.414 0.894 . . . . 10.0 113.414 -172.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 0.6 OUTLIER -69.07 99.96 1.18 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.818 0.447 . . . . 10.0 110.321 171.731 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.667 HD11 ' HA2' ' A' ' 25' ' ' GLY . 83.2 mt -53.0 -40.14 35.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.807 0.813 . . . . 10.0 111.594 175.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 72.2 mtm -68.04 -46.66 70.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.67 -1.605 . . . . 10.0 111.783 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.541 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 10.4 tp10 -56.13 -45.25 79.64 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.298 -0.561 . . . . 10.0 109.758 174.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.576 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 48.0 t80 -57.04 -55.34 35.92 Favored 'General case' 0 C--O 1.212 -0.877 0 N-CA-C 113.97 1.1 . . . . 10.0 113.97 171.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -50.35 71.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.663 -1.153 . . . . 10.0 111.886 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.72 -22.76 66.63 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 119.368 -0.933 . . . . 10.0 108.753 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.745 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 87.2 mtt180 -76.95 -64.18 1.19 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.264 -0.88 . . . . 10.0 112.168 171.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.62 ' CZ ' HG21 ' A' ' 46' ' ' THR . 80.2 t80 -55.27 -47.38 75.58 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.419 0.628 . . . . 10.0 110.094 -171.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.71 HD21 ' HB3' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -61.02 -48.24 82.72 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.489 -1.232 . . . . 10.0 110.317 -177.46 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.48 91.25 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.076 -1.05 . . . . 10.0 112.119 177.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.745 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 7.7 mm-40 -65.62 -40.35 92.48 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.823 0.821 . . . . 10.0 110.751 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.625 ' HB ' ' CB ' ' A' ' 15' ' ' ALA . 73.0 p -93.11 2.87 56.52 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 114.436 -1.256 . . . . 10.0 112.835 -170.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.11 -35.4 11.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.993 -1.003 . . . . 10.0 112.281 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -81.43 -43.1 19.4 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 115.314 -0.857 . . . . 10.0 111.561 -176.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -92.17 20.65 5.75 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.799 -0.815 . . . . 10.0 108.799 -176.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.416 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -53.3 149.21 7.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.952 -1.022 . . . . 10.0 113.09 -178.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.41 18.95 36.91 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.937 -1.029 . . . . 10.0 110.671 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.736 ' SD ' ' HB2' ' A' ' 77' ' ' PHE . 59.8 mtt -140.38 125.55 18.64 Favored 'General case' 0 C--O 1.212 -0.902 0 C-N-CA 117.419 -1.712 . . . . 10.0 113.941 -165.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 50.1 mm -66.82 90.73 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 118.657 0.662 . . . . 10.0 109.665 172.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.598 HD12 ' CG2' ' A' ' 46' ' ' THR . 10.0 mt -81.7 140.12 47.39 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.426 -0.583 . . . . 10.0 109.426 -177.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.744 ' HG2' ' HG2' ' A' ' 74' ' ' PRO . 3.6 Cg_exo -79.35 103.85 1.67 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.228 1.952 . . . . 10.0 110.896 172.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.408 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -97.99 155.64 3.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 119.885 1.22 . . . . 10.0 111.178 -175.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.462 HG13 ' HG2' ' A' ' 10' ' ' LYS . 96.7 t -134.79 112.51 15.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.015 174.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.683 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 24.4 mt -102.63 142.27 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.716 0 N-CA-C 108.133 -1.062 . . . . 10.0 108.133 -174.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.7 m -124.77 96.63 4.95 Favored 'General case' 0 N--CA 1.406 -2.648 0 CA-C-N 115.011 -0.995 . . . . 10.0 108.861 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.602 HG21 HG22 ' A' ' 33' ' ' VAL . 2.0 p -90.5 135.85 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 CA-C-N 119.479 1.036 . . . . 10.0 110.268 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -91.86 170.6 9.75 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.99 -1.004 . . . . 10.0 112.635 -176.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.607 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 14.2 mt-10 -60.4 -20.78 60.9 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.684 -1.598 . . . . 10.0 112.03 -176.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 2.9 m-20 -85.53 -4.72 59.24 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.329 -0.85 . . . . 10.0 112.09 -176.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.559 ' HD2' ' HA3' ' A' ' 32' ' ' GLY . 40.2 mmtt 81.99 0.65 1.45 Allowed 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 122.188 0.994 . . . . 10.0 110.334 -169.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.52 ' O ' HG23 ' A' ' 60' ' ' VAL . 17.4 m -70.83 168.43 16.8 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.736 -1.574 . . . . 10.0 107.289 173.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.675 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -168.94 -177.12 2.87 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 120.687 1.585 . . . . 10.0 109.818 176.115 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.2 p -162.6 169.35 20.34 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 103.077 -2.935 . . . . 10.0 103.077 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.445 ' CB ' HG12 ' A' ' 58' ' ' ILE . 42.4 p90 -163.39 159.91 22.92 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.756 -0.831 . . . . 10.0 108.756 177.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 23.7 pt -129.19 161.57 38.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.468 -1.308 . . . . 10.0 107.468 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.417 HD13 ' CG2' ' A' ' 46' ' ' THR . 7.6 mt -126.95 120.15 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 106.568 -1.641 . . . . 10.0 106.568 -176.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.789 ' HE2' ' HA ' ' A' ' 71' ' ' LYS . 5.7 mmmm -76.4 98.2 4.49 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 122.325 1.06 . . . . 10.0 113.042 -160.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.623 ' O ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -44.6 -44.45 20.68 Favored Pre-proline 0 CA--C 1.56 1.337 0 CA-C-N 112.682 -2.054 . . . . 10.0 114.997 164.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.653 ' HD3' ' CG ' ' A' ' 115' ' ' ASP . 2.4 Cg_endo -39.43 -56.01 1.41 Allowed 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 124.268 3.312 . . . . 10.0 116.205 -171.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.744 ' HG2' ' HG2' ' A' ' 55' ' ' PRO . 88.9 Cg_exo -43.5 -34.74 5.35 Favored 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 123.207 2.604 . . . . 10.0 113.729 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.684 ' HB1' HD23 ' A' ' 79' ' ' LEU . . . 73.98 -31.77 0.22 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.679 0.992 . . . . 10.0 113.679 170.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.695 ' O ' ' HD3' ' A' ' 80' ' ' LYS . 47.9 t -42.24 -56.96 2.72 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 123.753 0.658 . . . . 10.0 111.958 -175.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.736 ' HB2' ' SD ' ' A' ' 52' ' ' MET . 32.7 p90 -55.9 -37.02 68.33 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.574 0.583 . . . . 10.0 112.574 -175.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 78' ' ' LEU . 1.3 tp -88.55 -32.2 18.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.871 0.367 . . . . 10.0 110.595 -174.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.684 HD23 ' HB1' ' A' ' 75' ' ' ALA . 4.3 mm? -63.8 -33.15 75.03 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.47 -0.567 . . . . 10.0 109.47 172.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.695 ' HD3' ' O ' ' A' ' 76' ' ' SER . 3.9 mptp? -56.04 -46.47 78.87 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.816 -0.629 . . . . 10.0 110.12 172.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.411 ' HD3' ' HA ' ' A' ' 81' ' ' LYS . 2.8 mmtm -57.23 -43.42 82.86 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.509 0.929 . . . . 10.0 113.509 -176.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.68 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -65.94 -49.0 69.47 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 123.044 1.402 . . . . 10.0 110.086 175.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.526 ' HB1' ' HA3' ' A' ' 98' ' ' GLY . . . . . . . . 0 C--N 1.291 -1.942 0 CA-C-N 111.306 -2.679 . . . . 10.0 110.358 -171.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.653 HG13 ' H ' ' A' ' 98' ' ' GLY . 7.3 p . . . . . 0 CA--C 1.537 0.463 0 N-CA-C 112.358 0.503 . . . . 10.0 112.358 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.765 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -111.17 154.72 16.52 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 109.16 -1.576 . . . . 10.0 109.16 169.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.805 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 21.1 pttp -153.8 153.43 32.14 Favored 'General case' 0 CA--C 1.474 -1.958 0 CA-C-O 122.358 1.075 . . . . 10.0 109.865 164.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.68 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.7 OUTLIER -164.62 -162.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.414 -2.251 0 CA-C-N 111.976 -2.374 . . . . 10.0 105.958 -167.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.598 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 9.6 p -119.49 159.37 24.42 Favored 'General case' 0 C--N 1.275 -2.639 0 C-N-CA 119.494 -0.882 . . . . 10.0 111.838 -170.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.674 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 29.0 mmt180 -44.0 -41.92 5.69 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.193 -1.367 . . . . 10.0 110.334 170.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.489 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 3.1 tppp? -59.03 -44.8 91.8 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.672 0.619 . . . . 10.0 112.672 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.631 ' O ' HG12 ' A' ' 108' ' ' ILE . 58.9 mm-40 -58.33 -52.85 63.87 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.763 -0.829 . . . . 10.0 108.763 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.712 HD12 HG22 ' A' ' 128' ' ' ILE . 31.4 mm -38.04 -51.68 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.704 0 CA-C-N 114.318 -1.31 . . . . 10.0 111.899 167.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.748 ' HA ' ' SD ' ' A' ' 125' ' ' MET . 34.2 tt0 -52.95 -58.7 6.07 Favored 'General case' 0 C--O 1.215 -0.746 0 C-N-CA 124.627 1.171 . . . . 10.0 113.55 -177.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -58.36 -47.08 84.95 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 119.913 -0.715 . . . . 10.0 110.554 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.631 HG12 ' O ' ' A' ' 104' ' ' GLN . 19.8 mm -48.46 -60.75 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.558 166.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.577 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -51.33 -38.01 50.81 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.138 0.422 . . . . 10.0 112.138 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.683 ' O ' ' HG2' ' A' ' 113' ' ' MET . 83.4 mttt -70.36 -54.44 12.49 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.854 -174.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.74 HG23 ' HG3' ' A' ' 112' ' ' LYS . 5.8 t -57.05 -24.65 55.36 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.804 -0.635 . . . . 10.0 111.208 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.74 ' HG3' HG23 ' A' ' 111' ' ' THR . 5.8 mtpm? -105.98 -11.0 16.32 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.69 0.626 . . . . 10.0 112.69 -175.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.683 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 22.7 ptm -51.82 -31.5 6.36 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 113.845 1.054 . . . . 10.0 113.845 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 113' ' ' MET . 31.6 Cg_endo -63.02 -28.02 74.45 Favored 'Trans proline' 0 C--N 1.368 1.558 0 CA-C-N 121.063 1.415 . . . . 10.0 111.31 174.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.653 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -100.19 -38.51 8.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.406 -1.27 . . . . 10.0 113.431 -172.115 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.68 HD11 ' NZ ' ' A' ' 112' ' ' LYS . 3.0 mp -62.93 -1.37 0.88 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.928 -1.033 . . . . 10.0 112.021 -175.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 115' ' ' ASP . 56.7 t30 58.38 65.56 1.24 Allowed 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.084 -1.417 . . . . 10.0 109.596 175.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.537 ' HB1' ' HB3' ' A' ' 123' ' ' ALA . . . -142.86 143.07 31.93 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.88 -1.054 . . . . 10.0 112.142 -171.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.456 ' C ' HD22 ' A' ' 119' ' ' ASN . 0.2 OUTLIER -65.72 -74.93 0.1 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.444 -1.253 . . . . 10.0 109.553 176.139 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.7 m -82.52 147.79 28.46 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.371 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.671 HD13 ' C ' ' A' ' 121' ' ' LEU . 1.5 tm? -55.11 -34.36 63.62 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.462 -0.57 . . . . 10.0 109.462 163.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -50.78 -38.51 48.58 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.307 0.575 . . . . 10.0 111.102 173.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.537 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . . . -67.61 -45.57 75.04 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 118.635 -1.226 . . . . 10.0 110.466 175.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.579 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -56.29 -32.78 64.9 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.487 -0.324 . . . . 10.0 110.848 175.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.748 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 84.0 mmm -58.17 -37.09 74.06 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.017 0.437 . . . . 10.0 110.89 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.532 ' HA ' ' HG2' ' A' ' 129' ' ' GLU . 3.5 mptp? -62.56 -54.28 42.13 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.233 -0.894 . . . . 10.0 111.933 177.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.552 HD12 ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -51.55 -57.93 2.75 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 C-N-CA 119.178 -1.009 . . . . 10.0 110.595 178.375 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.712 HG22 HD12 ' A' ' 105' ' ' ILE . 24.1 mm -50.73 -58.41 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 114.578 -1.192 . . . . 10.0 112.448 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.532 ' HG2' ' HA ' ' A' ' 126' ' ' LYS . 11.6 pt-20 -53.42 -44.32 68.68 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.862 -0.792 . . . . 10.0 108.862 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.4 -47.77 55.66 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.779 -0.725 . . . . 10.0 111.329 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 69.6 m -43.07 -67.18 0.3 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.105 -1.048 . . . . 10.0 108.727 170.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.551 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -51.18 -48.63 61.9 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.851 -0.613 . . . . 10.0 112.331 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -47.81 -52.81 17.53 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.95 -0.568 . . . . 10.0 111.919 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 28.9 t -64.72 -29.36 70.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.752 0.31 . . . . 10.0 110.98 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.495 ' HE2' ' HA ' ' A' ' 132' ' ' ALA . 56.9 mtm -82.45 2.25 33.61 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 114.29 1.218 . . . . 10.0 114.29 -175.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.78 10.9 69.02 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 120.148 1.34 . . . . 10.0 111.777 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.765 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 2.7 mp -99.09 125.26 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 CA-C-O 121.64 0.733 . . . . 10.0 110.593 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.805 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -91.26 157.12 17.33 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.618 -1.174 . . . . 10.0 108.915 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 17.6 m -117.47 127.84 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.726 -0.472 . . . . 10.0 109.726 174.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.598 ' H ' ' HA ' ' A' ' 101' ' ' THR . 18.5 m -147.28 74.49 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 N-CA-C 116.151 1.908 . . . . 10.0 116.151 -170.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.498 ' OD1' ' HB2' ' A' ' 102' ' ' ARG . 1.3 m-20 . . . . . 0 C--N 1.289 -2.043 0 C-N-CA 119.823 -0.751 . . . . 10.0 110.844 145.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.682 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . 61.4 tttp . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 109.274 -0.639 . . . . 10.0 109.274 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.4 t -61.21 124.7 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 120.813 0.34 . . . . 10.0 110.528 -174.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.97 -27.0 8.6 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 120.54 -0.464 . . . . 10.0 110.344 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.594 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -160.45 174.64 13.8 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.222 0.823 . . . . 10.0 113.222 177.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.51 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 23.2 mm-40 -129.86 127.32 39.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.399 -1.273 . . . . 10.0 108.244 177.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.799 HG21 ' HG ' ' A' ' 28' ' ' LEU . 1.4 mm -116.2 87.01 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.121 -0.696 . . . . 10.0 109.121 -178.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.433 ' HG2' HG22 ' A' ' 57' ' ' VAL . 15.4 mtpp -78.28 142.68 37.63 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 121.097 1.771 . . . . 10.0 110.255 175.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 24' ' ' VAL . 1.0 OUTLIER -156.81 135.48 11.6 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.649 -0.705 . . . . 10.0 109.115 -176.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -96.3 113.22 24.79 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.635 -0.876 . . . . 10.0 108.635 172.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.537 HD11 HD23 ' A' ' 11' ' ' LEU . 31.5 mt -132.51 145.87 59.08 Favored Pre-proline 0 CA--C 1.501 -0.913 0 CA-C-O 121.147 0.499 . . . . 10.0 111.269 -169.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.808 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 5.8 Cg_exo -71.66 123.15 9.19 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 123.102 2.534 . . . . 10.0 111.31 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.543 ' HB2' HD11 ' A' ' 54' ' ' LEU . . . -60.32 127.41 31.65 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 107.936 -1.135 . . . . 10.0 107.936 172.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.22 -1.05 89.34 Favored Glycine 0 N--CA 1.438 -1.19 0 O-C-N 125.671 1.857 . . . . 10.0 112.354 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.808 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 45.2 tptt -139.52 110.76 6.97 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 122.943 1.354 . . . . 10.0 112.588 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.617 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -161.4 128.95 4.13 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.669 -2.06 . . . . 10.0 108.753 168.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.417 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 25.3 p -158.7 66.8 3.21 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 105.897 -1.89 . . . . 10.0 105.897 -174.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.748 ' HG3' HG22 ' A' ' 35' ' ' ILE . 5.7 Cg_exo 12.37 49.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.659 1 C-N-CA 130.673 7.582 . . . . 10.0 116.814 -175.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.584 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -57.6 167.75 1.26 Allowed Pre-proline 0 N--CA 1.441 -0.916 0 CA-C-N 112.545 -2.116 . . . . 10.0 109.601 164.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.584 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 72.9 Cg_exo -36.97 -44.35 1.12 Allowed 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 123.648 2.899 . . . . 10.0 114.967 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 22' ' ' PRO . 18.7 Cg_exo -36.29 -66.14 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.808 3.005 . . . . 10.0 114.508 168.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.99 HG12 HD12 ' A' ' 35' ' ' ILE . 58.9 t -85.61 -56.27 5.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 114.433 -1.258 . . . . 10.0 114.02 -164.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.22 -67.67 1.28 Allowed Glycine 0 CA--C 1.521 0.455 0 O-C-N 124.37 1.044 . . . . 10.0 113.276 -174.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.433 ' HD2' ' O ' ' A' ' 22' ' ' PRO . 90.5 Cg_exo -52.03 -46.23 33.8 Favored 'Trans proline' 0 C--O 1.222 -0.289 0 C-N-CA 123.876 3.051 . . . . 10.0 112.8 174.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.5 -79.28 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.296 0.569 . . . . 10.0 111.799 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.902 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . 1.5 mt -67.73 -45.03 76.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.793 -0.64 . . . . 10.0 112.694 -176.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.49 -38.16 90.28 Favored Glycine 0 C--N 1.324 -0.126 0 CA-C-N 115.912 -0.585 . . . . 10.0 112.674 -173.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -65.07 -21.89 66.89 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.915 0.388 . . . . 10.0 110.752 177.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -98.86 16.62 21.75 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.345 0.593 . . . . 10.0 109.958 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.0 2.9 89.42 Favored Glycine 0 CA--C 1.503 -0.68 0 CA-C-N 115.092 -0.958 . . . . 10.0 113.657 168.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.682 HG11 ' CD2' ' A' ' 66' ' ' PHE . 2.0 t -78.96 148.06 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 113.009 0.744 . . . . 10.0 113.009 -173.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.529 ' OD1' ' HB3' ' A' ' 37' ' ' GLU . 0.3 OUTLIER -71.06 90.71 0.86 Allowed 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.919 0.866 . . . . 10.0 109.997 172.532 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.99 HD12 HG12 ' A' ' 24' ' ' VAL . 11.5 mm -53.54 -40.87 43.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 113.818 -1.537 . . . . 10.0 112.081 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 50.6 mtm -66.0 -47.15 75.43 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.594 -1.639 . . . . 10.0 111.967 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.606 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 32.3 tt0 -58.71 -37.68 76.66 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 118.661 -1.216 . . . . 10.0 109.612 173.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.577 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 81.6 t80 -54.61 -58.95 5.5 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 119.554 -0.859 . . . . 10.0 112.767 170.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -54.51 -53.34 55.72 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 114.069 -1.423 . . . . 10.0 111.324 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -67.05 -21.9 65.89 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 119.694 -0.803 . . . . 10.0 109.749 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.816 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 13.7 mtm180 -76.56 -62.48 1.61 Allowed 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 119.543 -0.863 . . . . 10.0 112.286 169.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.618 ' CZ ' HG21 ' A' ' 46' ' ' THR . 63.9 t80 -52.41 -42.06 63.74 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 118.006 0.366 . . . . 10.0 110.536 -172.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.617 HD21 ' HB3' ' A' ' 18' ' ' ALA . 0.9 OUTLIER -60.86 -50.08 74.87 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.817 179.512 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.72 -41.58 99.23 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.742 -0.783 . . . . 10.0 112.341 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.816 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 4.4 mm-40 -65.82 -44.23 86.21 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.751 0.786 . . . . 10.0 110.81 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.618 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 76.8 p -89.79 5.09 47.62 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.534 -1.212 . . . . 10.0 111.85 -170.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.88 -40.22 9.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.955 -1.02 . . . . 10.0 112.224 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.88 -32.7 65.58 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.692 -0.685 . . . . 10.0 111.166 -176.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -99.42 17.64 19.74 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.791 0.837 . . . . 10.0 110.105 -175.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -50.26 142.3 10.24 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.172 -0.922 . . . . 10.0 112.873 -176.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.31 18.92 31.86 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.541 -0.754 . . . . 10.0 111.456 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.617 ' SD ' ' HB2' ' A' ' 77' ' ' PHE . 45.7 mtm -141.15 129.72 22.68 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 116.853 -1.939 . . . . 10.0 114.386 -167.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.3 mm -67.52 92.06 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.567 -0.531 . . . . 10.0 109.567 172.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.638 ' HB3' ' CG2' ' A' ' 70' ' ' ILE . 6.5 mt -81.2 130.02 64.43 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 109.697 -0.483 . . . . 10.0 109.697 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.865 ' HG2' ' HG3' ' A' ' 74' ' ' PRO . 18.0 Cg_exo -71.31 103.02 1.34 Allowed 'Trans proline' 0 C--N 1.331 -0.347 0 C-N-CA 122.571 2.181 . . . . 10.0 111.233 172.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.09 156.48 3.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 119.505 1.048 . . . . 10.0 111.706 -175.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.433 HG22 ' HG2' ' A' ' 10' ' ' LYS . 96.0 t -135.98 117.75 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.209 170.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.806 HG21 HD21 ' A' ' 28' ' ' LEU . 12.6 mt -109.93 135.04 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.705 0 N-CA-C 108.595 -0.891 . . . . 10.0 108.595 -175.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.0 m -117.7 95.47 4.95 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 114.954 -1.021 . . . . 10.0 108.308 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.594 ' CG1' ' HB3' ' A' ' 7' ' ' ALA . 2.7 p -86.73 138.11 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.012 0 CA-C-N 119.61 1.095 . . . . 10.0 110.784 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.403 ' HE2' ' HG1' ' A' ' 67' ' ' THR . 59.8 m-85 -92.87 163.85 13.55 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.514 -0.766 . . . . 10.0 111.745 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.682 ' HG2' ' HB3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -60.7 -19.9 59.79 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.605 -1.18 . . . . 10.0 112.093 -179.132 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.33 -4.69 52.04 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.317 -0.856 . . . . 10.0 111.861 -177.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 83.24 -1.74 1.2 Allowed 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 124.318 1.011 . . . . 10.0 109.443 -170.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.6 m -72.6 168.71 18.08 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.572 -1.194 . . . . 10.0 108.327 174.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.682 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -169.47 -179.99 3.63 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 120.477 1.49 . . . . 10.0 109.471 176.088 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.403 ' HG1' ' HE2' ' A' ' 61' ' ' TYR . 1.1 p -160.54 168.67 24.55 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 103.241 -2.874 . . . . 10.0 103.241 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.573 ' HE1' ' HE ' ' A' ' 41' ' ' ARG . 51.4 p90 -163.56 155.94 17.85 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.759 -0.83 . . . . 10.0 108.759 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mt -124.19 167.58 17.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 106.922 -1.51 . . . . 10.0 106.922 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.638 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 2.6 mm -121.84 124.69 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 N-CA-C 106.485 -1.672 . . . . 10.0 106.485 177.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.702 ' HB3' ' HG2' ' A' ' 73' ' ' PRO . 32.0 mmmt -78.73 101.51 7.59 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.943 0.878 . . . . 10.0 111.897 -165.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.787 ' HB ' ' HG2' ' A' ' 112' ' ' LYS . 8.3 p -56.6 -34.73 28.24 Favored Pre-proline 0 CA--C 1.562 1.423 0 CA-C-N 113.449 -1.705 . . . . 10.0 113.974 169.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.738 ' HD2' ' N ' ' A' ' 72' ' ' THR . 4.8 Cg_exo -35.68 -52.15 0.93 Allowed 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 124.838 3.692 . . . . 10.0 115.907 -176.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.865 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 16.7 Cg_endo -58.76 103.45 0.16 Allowed 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.401 1.401 . . . . 10.0 110.495 173.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.709 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -81.13 0.39 36.45 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.245 -0.434 . . . . 10.0 111.364 -171.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.7 t -61.7 -55.29 31.99 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.141 -0.481 . . . . 10.0 111.451 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.683 ' HE1' ' HG2' ' A' ' 74' ' ' PRO . 37.7 p90 -77.77 -27.51 50.31 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.609 0.596 . . . . 10.0 112.609 -171.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.523 ' HB3' HD12 ' A' ' 108' ' ' ILE . 1.1 mm? -75.14 -46.54 33.62 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.416 0.626 . . . . 10.0 110.721 174.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.625 ' HB2' ' O ' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -64.16 -35.6 81.31 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.808 -0.442 . . . . 10.0 109.808 -179.27 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.647 ' HA ' ' HB3' ' A' ' 83' ' ' ALA . 20.2 ttpt -60.61 -31.86 71.02 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.819 -0.628 . . . . 10.0 110.262 173.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 21.9 ttpp -52.56 -44.84 66.11 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 110.439 -0.208 . . . . 10.0 110.439 177.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 1.005 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -73.52 -46.81 45.52 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.81 1.644 . . . . 10.0 111.657 172.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.647 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . . . . . . . . 0 C--N 1.288 -2.071 0 CA-C-N 111.532 -2.576 . . . . 10.0 111.718 -168.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 136' ' ' GLY . 12.4 p . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 112.286 0.476 . . . . 10.0 112.286 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -165.2 155.12 26.3 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 109.439 -1.464 . . . . 10.0 109.439 175.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.69 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 9.2 ptpt -137.87 169.75 17.24 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-O 122.734 1.254 . . . . 10.0 111.71 -161.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 1.005 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -159.5 -144.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 111.456 -2.611 . . . . 10.0 106.132 -174.087 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.49 HG22 ' CG2' ' A' ' 140' ' ' VAL . 28.5 p -154.64 148.21 25.26 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.127 -1.805 . . . . 10.0 106.127 -157.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.668 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 38.3 mmt180 -43.7 -42.47 5.37 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 123.895 0.747 . . . . 10.0 109.894 174.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -57.46 -44.04 84.49 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.69 0.626 . . . . 10.0 112.69 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.591 ' O ' HG12 ' A' ' 108' ' ' ILE . 1.1 mp0 -60.35 -50.04 75.21 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 109.157 -0.683 . . . . 10.0 109.157 177.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.944 HG23 ' HB ' ' A' ' 128' ' ' ILE . 33.0 mm -40.59 -54.1 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.446 -1.252 . . . . 10.0 111.398 169.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.709 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 23.7 tt0 -49.17 -51.37 33.0 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.837 -1.074 . . . . 10.0 112.382 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -51.27 -60.76 2.76 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.131 -0.941 . . . . 10.0 110.016 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.601 HG22 ' HD3' ' A' ' 112' ' ' LYS . 13.4 mm -47.53 -53.0 4.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 113.811 -1.54 . . . . 10.0 110.552 174.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.428 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -52.84 -34.4 53.97 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.663 0.616 . . . . 10.0 112.663 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.709 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 64.3 mttm -73.54 -53.86 9.57 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 116.468 -0.333 . . . . 10.0 110.976 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.76 HG23 ' HG3' ' A' ' 112' ' ' LYS . 11.4 t -56.74 -33.68 66.79 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.293 -0.412 . . . . 10.0 111.704 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.787 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 17.7 mtpp -96.87 -1.31 46.23 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 122.736 0.414 . . . . 10.0 111.321 -177.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.543 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 52.6 ttm -49.33 -47.34 76.95 Favored Pre-proline 0 N--CA 1.468 0.446 0 N-CA-C 112.836 0.68 . . . . 10.0 112.836 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 113' ' ' MET . 32.8 Cg_endo -63.26 -26.55 71.96 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 121.443 1.429 . . . . 10.0 111.979 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.523 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -97.97 -44.45 6.66 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.952 -1.022 . . . . 10.0 113.576 -171.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.695 HD13 ' HB3' ' A' ' 112' ' ' LYS . 2.2 mp -66.22 42.22 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.708 -1.133 . . . . 10.0 113.232 -177.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 65.9 t30 14.64 53.0 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 O-C-N 124.776 1.298 . . . . 10.0 112.28 -167.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.407 ' O ' ' CB ' ' A' ' 119' ' ' ASN . . . -65.8 -78.8 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.612 0.967 . . . . 10.0 113.612 -165.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 118' ' ' ALA . 38.5 t-20 99.72 -41.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.883 1.273 . . . . 10.0 108.323 -175.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 47.6 t -148.81 139.54 22.77 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 106.758 -1.571 . . . . 10.0 106.758 173.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.623 ' O ' ' HG2' ' A' ' 125' ' ' MET . 3.2 tm? -53.19 -33.76 54.06 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.157 -0.928 . . . . 10.0 113.324 -177.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -50.02 -42.62 49.73 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.749 0.785 . . . . 10.0 110.697 173.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.494 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . . . -65.7 -49.09 69.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.487 -1.233 . . . . 10.0 110.719 -178.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.579 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -54.93 -37.9 66.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.527 178.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.625 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 78.4 mmm -52.96 -40.34 63.62 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.138 0.792 . . . . 10.0 113.138 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.494 ' HD2' ' HA ' ' A' ' 123' ' ' ALA . 10.3 mttt -63.25 -46.8 85.19 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.291 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.667 HD13 ' HG ' ' A' ' 116' ' ' LEU . 73.2 mt -50.19 -62.58 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-N 115.6 -0.727 . . . . 10.0 110.012 175.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.944 ' HB ' HG23 ' A' ' 105' ' ' ILE . 10.5 mm -53.18 -58.03 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-N 114.058 -1.428 . . . . 10.0 111.441 -176.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.56 -44.01 62.58 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 123.849 0.718 . . . . 10.0 109.584 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -69.9 -45.84 55.49 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.415 -0.897 . . . . 10.0 111.881 -177.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.709 HG21 ' HB3' ' A' ' 75' ' ' ALA . 22.4 m -48.2 -58.12 4.96 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.486 -0.857 . . . . 10.0 109.762 171.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.495 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -53.38 -44.57 68.74 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 111.812 0.301 . . . . 10.0 111.812 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 34.7 tttp -45.33 -55.15 6.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.491 -0.777 . . . . 10.0 110.956 174.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.0 m -64.58 -31.56 72.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.984 0.421 . . . . 10.0 111.529 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.429 ' HE1' ' HB3' ' A' ' 79' ' ' LEU . 10.7 mtm -78.61 -8.84 59.05 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.272 0.841 . . . . 10.0 113.272 -174.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.557 ' O ' HG12 ' A' ' 97' ' ' VAL . . . 88.72 14.36 61.38 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 119.587 1.085 . . . . 10.0 111.74 -178.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 2.0 mp -96.95 124.84 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.95 0 CA-C-O 121.624 0.726 . . . . 10.0 111.062 -177.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.69 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.3 OUTLIER -84.03 146.68 27.83 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.611 -1.177 . . . . 10.0 109.323 177.544 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.7 m -116.64 124.02 72.29 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.782 0 N-CA-C 106.458 -1.682 . . . . 10.0 106.458 174.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 100' ' ' VAL . 33.1 m -106.88 170.01 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.149 0 CA-C-N 113.753 -1.567 . . . . 10.0 110.063 -175.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 . . . . . 0 C--N 1.288 -2.078 0 CA-C-N 113.148 -1.842 . . . . 10.0 108.482 -177.451 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.448 ' HB3' ' HG3' ' A' ' 62' ' ' GLU . 21.2 ttpt . . . . . 0 N--CA 1.448 -0.544 0 N-CA-C 107.371 -1.344 . . . . 10.0 107.371 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.5 t -62.6 127.29 22.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 O-C-N 123.376 0.422 . . . . 10.0 111.148 -174.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -102.51 -28.55 12.11 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.091 -0.707 . . . . 10.0 109.091 176.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.542 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -162.52 177.85 9.1 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.295 0.85 . . . . 10.0 113.295 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 78.3 mt-30 -134.65 129.63 35.14 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 114.493 -1.23 . . . . 10.0 107.963 175.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.665 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 5.4 mt -124.1 87.24 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 109.038 -0.727 . . . . 10.0 109.038 -175.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.524 ' HG3' HG22 ' A' ' 57' ' ' VAL . 3.2 mppt? -78.37 146.39 34.66 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 120.991 -1.068 . . . . 10.0 110.178 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 10' ' ' LYS . 0.9 OUTLIER -156.77 137.16 12.97 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.088 -0.505 . . . . 10.0 109.902 -175.573 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.424 ' HB3' ' CG2' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -93.84 113.28 25.28 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.312 -0.996 . . . . 10.0 108.312 169.528 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.491 HD11 HG22 ' A' ' 24' ' ' VAL . 15.5 mt -132.1 152.88 80.97 Favored Pre-proline 0 C--O 1.212 -0.909 0 CA-C-O 121.31 0.576 . . . . 10.0 111.652 -171.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.677 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 5.5 Cg_exo -78.63 123.59 5.96 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 123.244 2.629 . . . . 10.0 111.784 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 50' ' ' ALA . . . -61.75 126.67 28.15 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.987 -1.116 . . . . 10.0 107.987 172.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.03 1.79 90.4 Favored Glycine 0 N--CA 1.438 -1.192 0 O-C-N 126.043 2.089 . . . . 10.0 112.108 -177.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.677 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 9.6 tptp -141.56 113.45 7.88 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 122.999 1.381 . . . . 10.0 112.102 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.525 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -159.04 140.56 13.26 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 112.869 -1.969 . . . . 10.0 108.561 164.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.0 p -157.64 61.02 2.12 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 105.837 -1.912 . . . . 10.0 105.837 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.695 ' HG3' ' CG2' ' A' ' 35' ' ' ILE . 0.1 OUTLIER 15.41 49.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.692 1 C-N-CA 129.687 6.925 . . . . 10.0 116.11 -178.011 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.64 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -56.08 170.58 0.44 Allowed Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 111.553 -2.567 . . . . 10.0 109.736 165.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.64 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 79.6 Cg_exo -37.39 -44.76 1.46 Allowed 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 123.291 2.661 . . . . 10.0 114.814 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 22' ' ' PRO . 6.4 Cg_exo -38.18 -62.56 0.3 Allowed 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 123.346 2.697 . . . . 10.0 114.374 170.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.942 HG12 HD12 ' A' ' 35' ' ' ILE . 61.6 t -87.44 -56.58 5.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 114.207 1.188 . . . . 10.0 114.207 -163.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.48 -66.52 2.2 Favored Glycine 0 C--O 1.226 -0.348 0 O-C-N 124.02 0.825 . . . . 10.0 113.366 -174.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.435 ' HD2' ' O ' ' A' ' 22' ' ' PRO . 86.4 Cg_exo -53.01 -42.41 64.77 Favored 'Trans proline' 0 C--O 1.225 -0.141 0 C-N-CA 123.262 2.641 . . . . 10.0 112.577 174.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.517 ' HB1' ' CG2' ' A' ' 9' ' ' ILE . . . -53.17 -79.76 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.401 0.619 . . . . 10.0 111.433 177.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.87 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . 2.5 mt -67.17 -46.77 72.97 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.521 -0.763 . . . . 10.0 113.016 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.9 -35.6 87.39 Favored Glycine 0 C--O 1.228 -0.232 0 CA-C-N 116.428 -0.351 . . . . 10.0 112.931 -173.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -64.2 -22.72 67.05 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.72 0.295 . . . . 10.0 110.222 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -99.87 15.53 26.73 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.408 0.623 . . . . 10.0 109.603 175.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.462 ' HA3' ' CE ' ' A' ' 64' ' ' LYS . . . 74.28 14.47 80.68 Favored Glycine 0 CA--C 1.501 -0.799 0 CA-C-N 114.687 -1.142 . . . . 10.0 113.692 170.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.605 HG11 ' CD2' ' A' ' 66' ' ' PHE . 0.9 OUTLIER -82.74 148.88 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 C-N-CA 120.252 -0.579 . . . . 10.0 112.474 -177.074 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -71.11 92.78 0.99 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.701 0.762 . . . . 10.0 110.296 174.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.942 HD12 HG12 ' A' ' 24' ' ' VAL . 14.6 mm -53.94 -40.02 43.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 114.422 -1.263 . . . . 10.0 112.35 178.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -41.88 77.42 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 113.909 -1.496 . . . . 10.0 111.613 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.551 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 22.2 mt-10 -55.77 -44.71 77.94 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 118.932 -1.107 . . . . 10.0 109.611 169.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.673 ' CE1' HD11 ' A' ' 58' ' ' ILE . 84.6 t80 -52.74 -58.62 6.26 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.076 1.139 . . . . 10.0 114.076 172.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 39.9 t -56.9 -51.6 68.47 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 114.75 -1.114 . . . . 10.0 110.924 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.51 ' HA ' ' HD3' ' A' ' 40' ' ' LYS . 28.7 mmtp -67.47 -20.88 65.53 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 119.269 -0.972 . . . . 10.0 110.297 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.613 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 92.7 mtt180 -73.85 -62.85 1.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.912 -0.715 . . . . 10.0 112.103 170.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.514 ' CZ ' HG21 ' A' ' 46' ' ' THR . 73.3 t80 -56.42 -48.55 76.72 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-N 115.572 -0.74 . . . . 10.0 110.415 -173.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.525 HD21 ' HB3' ' A' ' 18' ' ' ALA . 0.9 OUTLIER -59.7 -49.44 77.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.308 -0.86 . . . . 10.0 110.286 -176.739 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.81 -46.08 91.06 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.169 -1.013 . . . . 10.0 112.71 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 9.5 pt-20 -71.32 -31.25 67.17 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 120.16 -0.616 . . . . 10.0 112.355 -176.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.523 ' CG2' HD12 ' A' ' 54' ' ' LEU . 63.3 p -91.06 2.88 55.99 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.45 -0.795 . . . . 10.0 111.591 -175.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.74 -38.71 7.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.001 -0.999 . . . . 10.0 112.934 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.535 ' OD1' ' HG3' ' A' ' 49' ' ' LYS . 0.5 OUTLIER -81.94 -26.49 33.98 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.729 -0.669 . . . . 10.0 112.199 -174.44 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.535 ' HG3' ' OD1' ' A' ' 48' ' ' ASP . 36.4 mttp -101.72 18.55 20.13 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.473 0.654 . . . . 10.0 109.437 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -50.32 140.95 12.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.704 -1.134 . . . . 10.0 112.928 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.59 18.08 26.7 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 114.984 -1.007 . . . . 10.0 110.774 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.453 ' HB2' HD21 ' A' ' 54' ' ' LEU . 65.6 mtt -137.12 127.23 26.09 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 117.137 -1.825 . . . . 10.0 113.92 -167.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.424 ' CG2' ' HB3' ' A' ' 12' ' ' GLN . 50.9 mm -68.97 90.61 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.268 -0.641 . . . . 10.0 109.268 171.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.523 HD12 ' CG2' ' A' ' 46' ' ' THR . 6.6 mt -77.74 140.03 62.99 Favored Pre-proline 0 N--CA 1.449 -0.482 0 N-CA-C 108.665 -0.865 . . . . 10.0 108.665 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 54' ' ' LEU . 5.3 Cg_exo -77.92 104.78 1.91 Allowed 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.59 2.193 . . . . 10.0 110.889 172.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.54 151.26 4.9 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 CA-C-N 118.893 0.769 . . . . 10.0 111.324 -174.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.524 HG22 ' HG3' ' A' ' 10' ' ' LYS . 99.3 t -135.58 119.81 26.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.981 -0.377 . . . . 10.0 109.981 172.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.842 HG21 HD21 ' A' ' 28' ' ' LEU . 13.0 mt -108.81 137.55 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 N-CA-C 108.36 -0.978 . . . . 10.0 108.36 -174.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.0 m -123.07 96.57 5.06 Favored 'General case' 0 N--CA 1.407 -2.601 0 CA-C-N 114.688 -1.142 . . . . 10.0 108.818 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 65' ' ' SER . 4.3 p -85.73 137.28 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 CA-C-N 119.298 0.953 . . . . 10.0 110.436 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -100.71 178.17 4.78 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.797 0.808 . . . . 10.0 113.056 -176.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.448 ' HG3' ' HB3' ' A' ' 4' ' ' LYS . 28.0 mt-10 -50.57 -33.59 22.43 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.796 -1.547 . . . . 10.0 113.718 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.7 -6.51 57.34 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.517 0.562 . . . . 10.0 112.517 -172.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.462 ' CE ' ' HA3' ' A' ' 32' ' ' GLY . 26.9 mmmt 83.51 5.51 0.79 Allowed 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 124.643 1.214 . . . . 10.0 108.569 -168.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.546 ' O ' HG23 ' A' ' 60' ' ' VAL . 22.0 t -73.74 175.79 6.88 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 113.355 -1.748 . . . . 10.0 107.67 173.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.605 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -170.0 -178.93 3.03 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 120.523 1.51 . . . . 10.0 109.866 176.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.9 p -157.64 170.31 22.68 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 103.233 -2.876 . . . . 10.0 103.233 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.46 ' HB3' HG12 ' A' ' 58' ' ' ILE . 48.7 p90 -163.4 157.58 20.11 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.802 -0.814 . . . . 10.0 108.802 174.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.481 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 29.2 pt -122.77 167.77 16.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.014 -1.106 . . . . 10.0 108.014 -176.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.463 HD12 ' CE1' ' A' ' 42' ' ' PHE . 1.9 mm -135.39 117.61 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 107.093 -1.447 . . . . 10.0 107.093 -176.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.629 ' HE2' ' OD2' ' A' ' 115' ' ' ASP . 9.4 mmmm -75.41 97.92 3.76 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.228 -0.589 . . . . 10.0 110.761 -172.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.26 98.0 0.16 Allowed Pre-proline 0 C--N 1.317 -0.809 0 O-C-N 124.639 1.212 . . . . 10.0 109.342 169.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.631 ' HG3' ' CD2' ' A' ' 77' ' ' PHE . 54.3 Cg_endo -67.54 137.29 42.22 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.409 2.073 . . . . 10.0 112.681 -162.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.932 ' HA ' HD11 ' A' ' 116' ' ' LEU . 85.1 Cg_exo -47.29 88.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.746 2.964 . . . . 10.0 113.689 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.68 ' H ' ' HD3' ' A' ' 112' ' ' LYS . . . 70.59 -41.82 0.51 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.073 -0.967 . . . . 10.0 113.569 174.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.9 p -40.83 -73.73 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.3 1.222 . . . . 10.0 114.3 -167.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.631 ' CD2' ' HG3' ' A' ' 73' ' ' PRO . 8.5 m-30 -61.97 -21.81 65.13 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.349 0.87 . . . . 10.0 113.349 -172.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.033 ' HB3' HD12 ' A' ' 108' ' ' ILE . 6.3 mp -101.02 -12.77 18.6 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 119.499 -0.88 . . . . 10.0 111.288 -178.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.463 ' CD1' ' HB1' ' A' ' 75' ' ' ALA . 50.6 mt -76.99 -26.48 53.92 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.07 -1.085 . . . . 10.0 108.07 165.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 61.5 mmtt -59.79 -38.72 82.68 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.207 -0.906 . . . . 10.0 109.5 167.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.538 ' HD3' ' HA ' ' A' ' 81' ' ' LYS . 53.5 mmtt -64.25 -44.64 91.17 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.528 0.936 . . . . 10.0 113.528 175.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.912 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -71.61 -56.31 6.1 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.562 1.945 . . . . 10.0 112.966 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.285 -2.224 0 CA-C-N 111.069 -2.787 . . . . 10.0 105.872 -179.565 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.606 HG13 ' O ' ' A' ' 97' ' ' VAL . 8.2 p . . . . . 0 CA--C 1.553 1.061 0 CA-C-O 122.635 1.207 . . . . 10.0 111.308 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 33.07 -168.76 0.01 OUTLIER Glycine 0 CA--C 1.533 1.204 0 CA-C-N 113.942 -1.481 . . . . 10.0 115.171 -165.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.668 ' CB ' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -160.85 178.26 9.59 Favored 'General case' 0 CA--C 1.488 -1.413 0 CA-C-O 121.791 0.805 . . . . 10.0 112.044 -172.122 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.912 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -159.8 -166.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 113.502 -1.681 . . . . 10.0 111.938 -179.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 39.0 p -97.56 143.29 28.4 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 112.734 -2.03 . . . . 10.0 111.473 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.649 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 0.4 OUTLIER -47.87 -41.18 23.58 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.599 -0.728 . . . . 10.0 109.925 166.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.06 -43.3 77.8 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.655 0.382 . . . . 10.0 111.758 175.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.597 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -57.52 -50.74 72.09 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.411 -0.959 . . . . 10.0 108.411 174.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.753 HG23 ' HB ' ' A' ' 128' ' ' ILE . 27.9 mm -44.2 -49.82 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 114.522 -1.217 . . . . 10.0 111.53 174.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.714 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 27.6 tt0 -50.88 -57.16 9.18 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.766 1.227 . . . . 10.0 112.356 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.686 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 70.0 mm-40 -51.66 -58.59 5.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.347 -1.297 . . . . 10.0 110.17 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.033 HD12 ' HB3' ' A' ' 78' ' ' LEU . 22.8 mm -48.33 -51.6 9.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.318 -0.855 . . . . 10.0 110.742 173.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.567 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -51.89 -42.66 62.89 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.499 0.555 . . . . 10.0 112.499 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.714 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 73.6 mttt -68.21 -52.58 32.67 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 122.045 0.926 . . . . 10.0 109.261 -177.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 85.5 m -51.46 -23.8 4.35 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 113.506 -1.679 . . . . 10.0 112.514 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.763 ' HB3' HD13 ' A' ' 116' ' ' LEU . 29.5 mttp -122.63 1.19 9.44 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 113.171 0.804 . . . . 10.0 113.171 -175.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.55 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 23.3 ptm -50.18 -36.81 22.62 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 113.149 0.796 . . . . 10.0 113.149 176.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 113' ' ' MET . 58.7 Cg_endo -69.55 -29.76 24.33 Favored 'Trans proline' 0 C--N 1.367 1.515 0 CA-C-N 120.989 1.389 . . . . 10.0 111.912 178.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.629 ' OD2' ' HE2' ' A' ' 71' ' ' LYS . 2.7 t70 -87.24 -46.02 10.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.132 0.968 . . . . 10.0 110.454 -173.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.932 HD11 ' HA ' ' A' ' 74' ' ' PRO . 4.9 mp -65.1 -1.1 1.94 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 113.68 -1.6 . . . . 10.0 112.191 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.401 ' H ' ' C ' ' A' ' 115' ' ' ASP . 26.0 m-80 58.98 50.39 8.39 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.853 -1.067 . . . . 10.0 109.247 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.413 ' O ' ' CB ' ' A' ' 119' ' ' ASN . . . -65.98 -74.78 0.1 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.28 -1.327 . . . . 10.0 113.099 -166.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 118' ' ' ALA . 27.3 t-20 102.43 -40.52 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.545 0 O-C-N 124.929 1.393 . . . . 10.0 109.354 -176.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.5 t -151.41 133.96 15.5 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 103.584 -2.747 . . . . 10.0 103.584 174.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.586 HD22 ' HB3' ' A' ' 124' ' ' ALA . 2.8 tm? -52.97 -35.05 58.59 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.386 0.884 . . . . 10.0 113.386 -173.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.588 ' HA ' ' HG3' ' A' ' 125' ' ' MET . 2.2 mp0 -51.46 -33.78 32.54 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 118.691 0.678 . . . . 10.0 110.734 175.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.42 -47.4 60.93 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 118.581 -1.247 . . . . 10.0 110.575 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.586 ' HB3' HD22 ' A' ' 121' ' ' LEU . . . -54.95 -39.01 68.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.835 -0.62 . . . . 10.0 110.305 175.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.589 ' O ' ' HB3' ' A' ' 129' ' ' GLU . 17.2 mtp -54.96 -38.43 67.75 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 112.124 0.416 . . . . 10.0 112.124 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -62.19 -47.51 84.15 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 108.929 -0.767 . . . . 10.0 108.929 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 124' ' ' ALA . 67.3 mt -50.92 -64.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 114.996 -1.002 . . . . 10.0 110.284 175.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.753 ' HB ' HG23 ' A' ' 105' ' ' ILE . 16.0 mm -52.81 -60.54 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 CA-C-N 114.496 -1.229 . . . . 10.0 111.394 -176.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.589 ' HB3' ' O ' ' A' ' 125' ' ' MET . 0.0 OUTLIER -51.75 -43.47 62.94 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.264 -0.88 . . . . 10.0 109.732 179.299 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.63 -45.25 29.35 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.717 -0.754 . . . . 10.0 111.909 -175.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.525 HG21 ' HB3' ' A' ' 75' ' ' ALA . 51.9 m -50.5 -56.97 9.23 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.513 -0.844 . . . . 10.0 109.765 173.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.99 -57.28 7.88 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 120.969 0.414 . . . . 10.0 111.031 175.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -46.45 -59.01 3.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.954 -1.021 . . . . 10.0 112.253 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.8 p -66.59 -24.5 66.34 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.057 0.391 . . . . 10.0 112.057 -174.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.54 ' O ' ' HG3' ' A' ' 135' ' ' MET . 0.0 OUTLIER -84.43 -3.41 58.33 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 112.936 0.717 . . . . 10.0 112.936 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.541 ' C ' HG12 ' A' ' 97' ' ' VAL . . . 105.05 -5.85 42.63 Favored Glycine 0 N--CA 1.441 -1.007 0 O-C-N 121.001 -1.062 . . . . 10.0 112.688 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.437 HG23 ' HA ' ' A' ' 99' ' ' LYS . 70.6 mt -87.43 129.87 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 CA-C-N 117.516 0.658 . . . . 10.0 111.093 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.668 ' HG2' ' CB ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -85.58 156.98 20.5 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.029 -0.987 . . . . 10.0 109.282 177.345 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 22.2 m -119.43 136.34 56.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.078 -1.082 . . . . 10.0 108.078 168.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.3 m -136.26 69.99 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 115.573 1.694 . . . . 10.0 115.573 -176.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.3 t70 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.113 -0.946 . . . . 10.0 109.296 138.928 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 4' ' ' LYS . 29.5 mtpt . . . . . 0 C--O 1.221 -0.44 0 N-CA-C 110.071 -0.344 . . . . 10.0 110.071 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 38.0 t -67.15 145.0 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.895 0.378 . . . . 10.0 111.389 -177.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.79 -36.41 4.51 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.27 173.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.464 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -159.61 151.17 20.1 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.272 1.212 . . . . 10.0 114.272 -177.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -93.71 129.19 40.12 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.303 -1.369 . . . . 10.0 107.303 168.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.697 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.8 OUTLIER -120.94 82.36 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.786 -0.82 . . . . 10.0 108.786 175.119 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -78.9 146.13 33.73 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 120.895 1.679 . . . . 10.0 109.42 177.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.487 HD23 HD11 ' A' ' 13' ' ' LEU . 0.8 OUTLIER -156.11 134.63 11.64 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.313 -0.625 . . . . 10.0 109.313 -174.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.523 ' OE1' ' HA ' ' A' ' 55' ' ' PRO . 10.9 mm100 -91.82 112.26 24.11 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.018 -1.105 . . . . 10.0 108.018 171.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.487 HD11 HD23 ' A' ' 11' ' ' LEU . 28.8 mt -131.54 133.97 24.99 Favored Pre-proline 0 CA--C 1.504 -0.803 0 CA-C-O 121.644 0.735 . . . . 10.0 112.463 -170.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.7 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 18.5 Cg_exo -56.75 122.18 11.37 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 123.292 2.661 . . . . 10.0 111.846 174.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.532 ' HB2' HD11 ' A' ' 54' ' ' LEU . . . -61.62 126.78 28.57 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 107.514 -1.291 . . . . 10.0 107.514 169.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.39 0.21 89.64 Favored Glycine 0 N--CA 1.44 -1.1 0 O-C-N 125.883 1.989 . . . . 10.0 112.998 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.7 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 18.6 tptp -142.8 98.88 3.37 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 118.331 1.066 . . . . 10.0 111.979 175.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.18 136.87 9.03 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.433 -1.258 . . . . 10.0 112.121 176.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.603 ' HA ' ' HB2' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -179.98 -54.96 0.0 OUTLIER Pre-proline 0 N--CA 1.443 -0.81 0 CA-C-N 115.318 -0.856 . . . . 10.0 111.836 174.677 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.67 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 73.5 Cg_endo -99.16 129.66 0.19 Allowed 'Trans proline' 0 N--CA 1.411 -3.372 0 N-CA-C 115.67 1.373 . . . . 10.0 115.67 -153.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.053 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 12.13 -83.54 0.0 OUTLIER Pre-proline 0 C--N 1.294 -1.842 0 CA-C-N 108.604 -3.907 . . . . 10.0 115.489 166.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.955 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 65.5 Cg_exo -30.53 -55.16 0.21 Allowed 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 122.963 2.442 . . . . 10.0 115.709 -164.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.955 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 5.2 Cg_exo -84.09 -56.55 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.438 2.759 . . . . 10.0 112.094 170.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.005 HG12 HD12 ' A' ' 35' ' ' ILE . 89.3 t -80.37 -53.76 12.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 112.719 -2.037 . . . . 10.0 114.922 -167.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 1.053 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -50.65 -74.48 0.28 Allowed Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.203 -0.908 . . . . 10.0 113.452 -173.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.837 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 17.0 Cg_exo -42.79 -43.99 8.95 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.77 2.98 . . . . 10.0 112.441 171.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 24' ' ' VAL . . . -50.06 -98.94 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 123.793 0.683 . . . . 10.0 112.43 177.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.931 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.341 0.0 OUTLIER -73.18 -34.33 65.94 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 117.555 -1.658 . . . . 10.0 113.138 -173.472 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.65 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -67.5 -39.53 91.11 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 121.164 -0.541 . . . . 10.0 113.505 -175.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.745 ' HG3' ' HA ' ' A' ' 26' ' ' PRO . 26.9 mt-30 -68.43 -6.46 24.85 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 118.635 -1.226 . . . . 10.0 111.212 175.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.553 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 72.6 m-70 -102.04 22.98 12.21 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.381 0.61 . . . . 10.0 109.584 168.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.28 -3.69 76.35 Favored Glycine 0 CA--C 1.503 -0.699 0 CA-C-N 115.306 -0.861 . . . . 10.0 113.567 168.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.931 ' HB ' HD23 ' A' ' 28' ' ' LEU . 5.0 t -82.99 149.79 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 113.785 1.031 . . . . 10.0 113.785 -170.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.507 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -71.39 99.3 1.95 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.001 0.429 . . . . 10.0 110.687 170.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.005 HD12 HG12 ' A' ' 24' ' ' VAL . 16.4 mm -51.49 -37.15 18.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 122.21 1.005 . . . . 10.0 111.643 172.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.662 ' HE2' ' HA ' ' A' ' 36' ' ' MET . 5.9 mmt -65.7 -50.31 65.35 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.312 -1.767 . . . . 10.0 111.957 174.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.507 ' HB3' ' HB3' ' A' ' 34' ' ' ASN . 5.6 tp10 -56.09 -41.09 74.64 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.079 -0.648 . . . . 10.0 110.211 174.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.726 ' CE1' HD11 ' A' ' 58' ' ' ILE . 89.9 t80 -56.24 -58.79 6.48 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 113.899 1.074 . . . . 10.0 113.899 171.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.603 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -62.72 -50.3 71.64 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 114.368 -1.287 . . . . 10.0 111.87 -175.415 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -62.88 -23.06 67.15 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 119.223 -0.991 . . . . 10.0 108.911 -177.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.842 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 63.0 mtt180 -75.5 -64.82 0.99 Allowed 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 119.252 -0.979 . . . . 10.0 111.798 166.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.537 ' CZ ' HG21 ' A' ' 46' ' ' THR . 60.3 t80 -50.99 -49.72 59.75 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.09 0.859 . . . . 10.0 111.571 -170.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -60.09 -49.88 75.92 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.514 -0.766 . . . . 10.0 110.425 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.05 -39.81 95.84 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.069 -1.052 . . . . 10.0 112.081 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.842 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 5.9 mm-40 -66.89 -41.76 86.65 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.841 0.829 . . . . 10.0 111.047 -178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.537 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 81.7 p -90.91 1.5 56.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.414 -1.266 . . . . 10.0 112.056 -170.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.46 -37.23 5.01 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.995 -1.002 . . . . 10.0 112.921 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -82.19 -24.96 34.65 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.807 -0.633 . . . . 10.0 112.491 -174.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.4 mttp -104.5 19.06 21.01 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.487 0.66 . . . . 10.0 109.305 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -48.73 143.5 5.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.404 -1.271 . . . . 10.0 112.565 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.99 20.89 27.01 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 114.846 -1.07 . . . . 10.0 110.917 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.554 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 64.2 mtt -138.53 128.87 25.9 Favored 'General case' 0 C--O 1.206 -1.189 0 C-N-CA 117.083 -1.847 . . . . 10.0 114.154 -169.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.8 mm -70.01 93.2 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 121.586 -0.696 . . . . 10.0 109.754 172.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.768 HD22 ' HE2' ' A' ' 77' ' ' PHE . 3.3 mt -80.45 130.04 66.68 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.15 -0.315 . . . . 10.0 110.15 -176.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.523 ' HA ' ' OE1' ' A' ' 12' ' ' GLN . 21.1 Cg_exo -69.68 103.48 1.16 Allowed 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 122.683 2.256 . . . . 10.0 111.44 171.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 69' ' ' ILE . 0.5 OUTLIER -101.9 160.32 4.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 119.402 1.001 . . . . 10.0 112.217 -174.539 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 79.4 t -137.09 119.98 20.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.034 -0.53 . . . . 10.0 110.561 173.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.726 HD11 ' CE1' ' A' ' 38' ' ' PHE . 14.8 mt -110.65 138.2 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.596 0 N-CA-C 108.012 -1.107 . . . . 10.0 108.012 -178.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.4 m -123.48 96.57 5.03 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 114.837 -1.074 . . . . 10.0 108.801 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 65' ' ' SER . 2.3 p -89.04 139.03 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 CA-C-N 119.481 1.037 . . . . 10.0 110.568 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.499 ' HE2' ' HG1' ' A' ' 67' ' ' THR . 70.2 m-85 -96.06 167.86 10.96 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 112.747 0.647 . . . . 10.0 112.747 -177.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -56.66 -23.55 42.48 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 124.271 1.029 . . . . 10.0 112.808 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 6.7 m-20 -80.12 -7.43 58.9 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.683 -1.144 . . . . 10.0 111.287 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 3.2 mptt 79.99 3.4 2.01 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 114.645 -1.161 . . . . 10.0 111.974 -171.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.563 ' O ' HG23 ' A' ' 60' ' ' VAL . 15.6 m -73.11 173.89 8.73 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 107.498 -1.297 . . . . 10.0 107.498 170.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.88 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -168.81 -176.73 2.79 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 120.293 1.406 . . . . 10.0 108.778 174.505 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.499 ' HG1' ' HE2' ' A' ' 61' ' ' TYR . 1.3 p -159.77 168.85 24.93 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 102.759 -3.052 . . . . 10.0 102.759 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.447 ' CB ' HG12 ' A' ' 58' ' ' ILE . 53.3 p90 -163.24 152.89 15.25 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.933 -1.136 . . . . 10.0 107.933 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.514 ' O ' HG22 ' A' ' 56' ' ' VAL . 1.9 mt -116.47 168.84 7.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 106.232 -1.766 . . . . 10.0 106.232 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.8 mt -137.75 113.76 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 N-CA-C 106.306 -1.738 . . . . 10.0 106.306 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 55' ' ' PRO . 3.6 mptp? -77.3 102.12 6.59 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.604 -166.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.489 HG21 ' O ' ' A' ' 111' ' ' THR . 0.2 OUTLIER -58.28 91.24 0.03 OUTLIER Pre-proline 0 C--N 1.315 -0.906 0 O-C-N 124.733 1.271 . . . . 10.0 108.786 165.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.754 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 49.3 Cg_endo -93.7 -166.63 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 123.541 2.828 . . . . 10.0 112.742 -156.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.754 ' HD2' ' HB2' ' A' ' 73' ' ' PRO . 67.5 Cg_exo -30.05 133.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 123.316 2.677 . . . . 10.0 111.785 168.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.691 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -60.52 -8.97 3.14 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.289 0.848 . . . . 10.0 113.289 -166.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 m -50.31 -29.23 9.32 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.604 0.716 . . . . 10.0 110.253 174.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.768 ' HE2' HD22 ' A' ' 54' ' ' LEU . 36.4 t80 -56.01 -66.03 0.5 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.532 -1.213 . . . . 10.0 111.441 176.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.659 HD23 ' HE2' ' A' ' 112' ' ' LYS . 2.7 mm? -82.19 -13.67 56.78 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.903 -0.498 . . . . 10.0 110.233 -175.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.637 HD12 HD13 ' A' ' 137' ' ' ILE . 3.0 mm? -72.9 -23.71 60.75 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 109.341 -0.614 . . . . 10.0 109.341 171.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.561 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 21.4 mmtp -61.89 -40.73 96.43 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.423 -0.584 . . . . 10.0 109.423 167.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.488 ' HD3' ' HA ' ' A' ' 81' ' ' LYS . 24.9 mmtp -62.96 -48.25 79.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.581 -0.736 . . . . 10.0 112.839 174.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.889 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -72.23 -62.68 1.35 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 127.328 2.251 . . . . 10.0 113.564 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 79' ' ' LEU . . . . . . . . 0 C--N 1.284 -2.259 0 CA-C-N 110.864 -2.88 . . . . 10.0 106.941 -175.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.475 HG13 ' N ' ' A' ' 98' ' ' GLY . 0.9 OUTLIER . . . . . 0 N--CA 1.404 -2.739 0 CA-C-O 121.799 0.809 . . . . 10.0 111.177 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.475 ' N ' HG13 ' A' ' 97' ' ' VAL . . . -57.92 179.51 1.06 Allowed Glycine 0 C--N 1.308 -0.981 0 CA-C-N 113.819 -1.537 . . . . 10.0 113.088 176.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.457 ' HE2' ' HB3' ' A' ' 99' ' ' LYS . 9.8 ptpt -154.26 172.37 17.74 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 122.693 1.235 . . . . 10.0 111.883 -159.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.889 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -160.6 -146.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 111.889 -2.414 . . . . 10.0 105.965 -171.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.604 ' O ' ' HG3' ' A' ' 104' ' ' GLN . 1.7 t -162.06 139.73 8.67 Favored 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 119.834 -0.747 . . . . 10.0 109.511 -152.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.663 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 0.0 OUTLIER -43.14 -48.61 6.4 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 114.36 -1.291 . . . . 10.0 111.535 -173.509 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.531 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -56.63 -46.09 81.18 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.127 0.788 . . . . 10.0 113.127 178.201 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.604 ' HG3' ' O ' ' A' ' 101' ' ' THR . 3.7 pp0? -67.74 -37.26 81.91 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.454 -0.943 . . . . 10.0 108.454 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.878 HG23 ' HB ' ' A' ' 128' ' ' ILE . 23.3 mm -47.26 -51.01 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 115.503 -0.771 . . . . 10.0 110.862 168.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.683 ' HG2' ' HE3' ' A' ' 110' ' ' LYS . 23.8 tt0 -50.36 -57.34 8.15 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.296 1.438 . . . . 10.0 113.191 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.491 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 4.3 pt-20 -59.09 -43.55 91.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.355 -0.839 . . . . 10.0 111.199 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.629 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 56.9 mt -51.71 -58.57 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 120.7 0.286 . . . . 10.0 110.919 166.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.489 ' HB3' HD11 ' A' ' 121' ' ' LEU . . . -44.69 -35.11 2.49 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 123.556 0.742 . . . . 10.0 112.334 177.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.683 ' HE3' ' HG2' ' A' ' 106' ' ' GLU . 96.6 mttt -74.45 -53.65 9.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.548 -0.751 . . . . 10.0 111.557 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 108' ' ' ILE . 2.1 t -59.41 -8.74 1.91 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.298 0.851 . . . . 10.0 113.298 -177.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.659 ' HE2' HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -129.94 13.73 5.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.247 0.546 . . . . 10.0 110.379 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.514 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 1.8 ttt -50.65 -46.91 85.95 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 114.844 -1.071 . . . . 10.0 112.389 178.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 113' ' ' MET . 60.6 Cg_endo -69.2 -22.27 34.91 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 121.726 1.617 . . . . 10.0 113.299 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -87.94 -55.15 3.88 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 122.344 1.068 . . . . 10.0 110.537 -175.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.597 HD22 ' HD3' ' A' ' 112' ' ' LYS . 7.1 mp -67.87 178.61 1.69 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 113.267 -1.788 . . . . 10.0 113.746 -168.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -96.72 41.88 1.1 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 112.002 -2.363 . . . . 10.0 112.645 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.613 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . . . -63.38 -99.68 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 113.756 1.021 . . . . 10.0 113.756 174.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.585 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 5.0 m120 105.16 -78.01 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.8 1.64 . . . . 10.0 107.768 -168.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.449 ' HB3' ' OE1' ' A' ' 122' ' ' GLU . 47.2 m -81.54 146.65 30.05 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.735 -0.839 . . . . 10.0 108.735 163.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.759 ' O ' ' HG3' ' A' ' 125' ' ' MET . 61.1 tp -59.66 -37.68 79.42 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.15 -1.02 . . . . 10.0 110.548 167.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 126' ' ' LYS . 3.4 mp0 -51.21 -36.68 42.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.674 0.749 . . . . 10.0 109.617 171.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.605 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . . . -69.38 -46.96 65.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.577 -1.192 . . . . 10.0 110.735 177.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.613 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . . . -55.7 -41.29 73.56 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 110.179 -0.304 . . . . 10.0 110.179 176.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.759 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 75.2 mtp -55.75 -33.42 64.27 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.762 0.425 . . . . 10.0 111.827 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.605 ' HE2' ' HA ' ' A' ' 123' ' ' ALA . 42.6 mtmt -63.86 -50.77 67.51 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.629 -0.508 . . . . 10.0 109.629 178.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.457 ' CD1' HD23 ' A' ' 116' ' ' LEU . 47.5 mt -49.32 -63.86 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 121.49 0.662 . . . . 10.0 110.379 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.878 ' HB ' HG23 ' A' ' 105' ' ' ILE . 4.9 mm -52.13 -55.07 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 CA-C-N 113.843 -1.526 . . . . 10.0 111.306 -177.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.59 ' CD ' ' HE ' ' A' ' 102' ' ' ARG . 49.2 mt-10 -54.49 -44.51 72.72 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 109.923 -0.399 . . . . 10.0 109.923 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -69.62 -46.01 56.51 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.708 -0.758 . . . . 10.0 111.748 -174.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.691 HG21 ' HB3' ' A' ' 75' ' ' ALA . 51.6 m -50.09 -58.62 5.13 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.536 -0.832 . . . . 10.0 109.379 171.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.422 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -50.71 -53.4 31.69 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.008 0.433 . . . . 10.0 111.22 176.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -47.84 -48.43 30.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.198 -0.91 . . . . 10.0 111.32 176.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 27.2 t -63.61 -35.85 81.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.0 0.428 . . . . 10.0 110.732 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 53.4 mtm -84.66 10.68 10.58 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.579 0.955 . . . . 10.0 113.579 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 81.55 8.19 87.28 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 119.341 0.973 . . . . 10.0 112.127 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.637 HD13 HD12 ' A' ' 79' ' ' LEU . 47.4 mt -94.73 124.93 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 CA-C-O 121.39 0.614 . . . . 10.0 112.017 -176.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -84.38 151.79 24.47 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.125 -1.03 . . . . 10.0 110.943 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 16.6 m -113.45 126.44 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.045 0 N-CA-C 107.8 -1.185 . . . . 10.0 107.8 168.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 100' ' ' VAL . 2.9 m -104.83 138.54 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-N 114.44 -1.255 . . . . 10.0 109.302 176.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 C--N 1.29 -2.003 0 CA-C-N 114.678 -1.146 . . . . 10.0 109.821 -177.09 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.597 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 10.3 mmtp . . . . . 0 C--O 1.196 -1.749 0 CA-C-O 119.484 -0.293 . . . . 10.0 110.25 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.1 t -74.58 119.42 22.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 119.153 0.888 . . . . 10.0 109.863 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.427 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . . . -98.13 -35.18 10.48 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.83 -0.804 . . . . 10.0 108.83 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.401 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -161.29 -174.06 4.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.037 -0.983 . . . . 10.0 112.801 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 26.8 mt-30 -141.56 131.3 24.21 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.123 -1.399 . . . . 10.0 108.649 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.627 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.9 OUTLIER -120.89 80.98 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 108.945 -0.761 . . . . 10.0 108.945 -176.391 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 56' ' ' VAL . 57.4 tttp -79.43 128.5 33.43 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 119.82 1.191 . . . . 10.0 108.339 176.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.624 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.85 127.98 6.18 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 122.116 0.96 . . . . 10.0 111.471 -174.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.56 119.32 22.37 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.226 -1.352 . . . . 10.0 109.749 -172.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.624 HD21 HD11 ' A' ' 11' ' ' LEU . 46.8 mt -135.52 140.31 33.7 Favored Pre-proline 0 CA--C 1.502 -0.896 0 N-CA-C 113.138 0.792 . . . . 10.0 113.138 -170.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.679 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 14.7 Cg_exo -61.87 122.44 10.98 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 123.325 2.683 . . . . 10.0 111.241 174.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.523 ' CB ' ' HA ' ' A' ' 50' ' ' ALA . . . -60.84 125.11 22.49 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.637 -1.246 . . . . 10.0 107.637 169.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.83 1.83 89.82 Favored Glycine 0 N--CA 1.442 -0.905 0 O-C-N 126.015 2.072 . . . . 10.0 113.115 -173.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.679 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 7.6 tppt? -144.07 105.27 4.24 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.334 1.067 . . . . 10.0 113.14 177.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.617 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -172.47 128.89 0.55 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.776 -1.556 . . . . 10.0 111.202 170.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.543 ' H ' ' CD ' ' A' ' 20' ' ' PRO . 15.6 m -174.06 -43.46 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.132 0.895 . . . . 10.0 112.166 -174.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.828 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 44.2 Cg_endo -98.68 122.3 0.14 Allowed 'Trans proline' 0 N--CA 1.434 -2.008 0 C-N-CA 121.104 1.203 . . . . 10.0 114.892 -166.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.083 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . -3.51 -80.05 0.0 OUTLIER Pre-proline 0 C--O 1.212 -0.919 0 CA-C-N 111.658 -2.519 . . . . 10.0 114.542 166.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.871 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 52.4 Cg_exo -22.33 -55.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.978 3.119 . . . . 10.0 115.995 -165.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.871 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 10.0 Cg_endo -81.81 -75.97 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 122.347 2.031 . . . . 10.0 112.151 168.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.449 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 92.7 t -60.95 -46.73 96.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 112.542 -2.117 . . . . 10.0 114.919 -171.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 1.083 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -49.55 -73.41 0.36 Allowed Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 114.472 -1.24 . . . . 10.0 113.225 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.693 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 11.2 Cg_exo -45.89 -43.17 19.86 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.885 3.057 . . . . 10.0 112.737 171.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.458 ' O ' ' HD2' ' A' ' 31' ' ' HIS . . . -49.22 -98.23 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.567 0.58 . . . . 10.0 112.567 175.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.675 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.297 0.0 OUTLIER -70.41 -25.38 63.19 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 118.278 -1.369 . . . . 10.0 113.529 -174.872 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.535 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -66.27 -35.54 90.47 Favored Glycine 0 N--CA 1.464 0.521 0 C-N-CA 121.285 -0.483 . . . . 10.0 112.513 -177.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -58.83 -25.93 63.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.136 0.493 . . . . 10.0 109.72 173.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.458 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 71.7 m-70 -99.55 17.89 19.3 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.584 0.707 . . . . 10.0 109.488 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.455 ' HA3' ' HE2' ' A' ' 64' ' ' LYS . . . 85.62 6.39 83.26 Favored Glycine 0 CA--C 1.5 -0.88 0 CA-C-N 114.492 -1.231 . . . . 10.0 113.411 168.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.78 HG11 ' CD2' ' A' ' 66' ' ' PHE . 1.9 t -86.66 147.74 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 114.044 1.127 . . . . 10.0 114.044 -172.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 88.5 m-20 -68.08 102.97 1.41 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.546 0.738 . . . . 10.0 111.348 174.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.589 ' CD1' ' HA2' ' A' ' 25' ' ' GLY . 90.2 mt -50.72 -45.84 27.76 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 CA-C-O 122.526 1.155 . . . . 10.0 110.6 172.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.419 ' SD ' ' N ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -67.2 -52.21 43.97 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 111.833 -2.44 . . . . 10.0 112.898 -177.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 34' ' ' ASN . 82.0 tt0 -56.12 -38.51 70.87 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 120.035 -0.666 . . . . 10.0 110.05 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.787 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 20.9 t80 -59.8 -59.29 5.66 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 114.045 1.128 . . . . 10.0 114.045 168.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.589 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -54.86 -53.36 56.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.498 -1.683 . . . . 10.0 112.11 -176.222 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.436 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 12.3 tppt? -68.63 -19.25 64.41 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.611 -0.836 . . . . 10.0 109.101 -176.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.782 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 64.9 mtt180 -79.91 -62.53 1.65 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.115 -1.034 . . . . 10.0 112.907 168.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.567 ' CZ ' HG21 ' A' ' 46' ' ' THR . 66.3 t80 -53.99 -45.69 71.5 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 119.213 0.915 . . . . 10.0 110.11 -174.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.617 HD21 ' HB3' ' A' ' 18' ' ' ALA . 0.9 OUTLIER -61.45 -51.36 69.01 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.536 -1.211 . . . . 10.0 110.874 -178.04 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.96 -37.38 86.85 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 118.815 -1.154 . . . . 10.0 111.811 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.782 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 7.6 mm-40 -67.48 -45.31 76.28 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.896 0.855 . . . . 10.0 110.882 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.596 ' CG2' HD12 ' A' ' 54' ' ' LEU . 82.7 p -85.67 2.77 43.93 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-N 114.567 -1.197 . . . . 10.0 112.111 -171.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.3 -36.59 14.49 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.812 -1.085 . . . . 10.0 112.318 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -83.4 -34.74 25.46 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.008 -0.996 . . . . 10.0 110.888 -174.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mtpp -97.6 20.84 11.17 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.804 -0.813 . . . . 10.0 108.804 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.523 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -55.1 152.21 8.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.524 -1.216 . . . . 10.0 113.582 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.16 16.26 44.77 Favored Glycine 0 CA--C 1.507 -0.462 0 N-CA-C 109.879 -1.288 . . . . 10.0 109.879 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.46 ' HB2' HD21 ' A' ' 54' ' ' LEU . 45.7 mtm -137.97 125.8 22.5 Favored 'General case' 0 C--O 1.213 -0.859 0 C-N-CA 116.385 -2.126 . . . . 10.0 114.562 -166.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.0 mm -66.1 90.22 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.514 -0.55 . . . . 10.0 109.514 172.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.627 HD13 HG21 ' A' ' 70' ' ' ILE . 7.9 mt -79.4 128.69 74.49 Favored Pre-proline 0 N--CA 1.447 -0.61 0 N-CA-C 108.972 -0.751 . . . . 10.0 108.972 -177.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.659 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 11.0 Cg_exo -72.33 95.02 0.76 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.002 1.802 . . . . 10.0 110.756 174.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.503 ' O ' ' HG3' ' A' ' 10' ' ' LYS . 0.4 OUTLIER -92.38 157.74 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 119.125 0.875 . . . . 10.0 111.417 -171.06 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.426 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 89.4 t -135.04 117.53 22.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 110.278 -0.268 . . . . 10.0 110.278 172.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.627 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 24.0 mt -106.59 139.5 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 108.027 -1.101 . . . . 10.0 108.027 -175.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.7 m -123.44 98.36 5.82 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 108.481 -0.933 . . . . 10.0 108.481 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 65' ' ' SER . 1.5 p -87.03 136.0 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.07 0 CA-C-N 118.979 0.809 . . . . 10.0 111.286 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.597 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 89.5 m-85 -94.12 170.19 9.71 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 114.989 -1.005 . . . . 10.0 113.011 -175.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.437 ' HG3' ' HB3' ' A' ' 4' ' ' LYS . 28.9 mt-10 -63.17 -17.61 62.57 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.535 -1.211 . . . . 10.0 111.824 -176.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -78.0 -10.78 59.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.136 175.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.455 ' HE2' ' HA3' ' A' ' 32' ' ' GLY . 1.6 mtpt 80.69 2.28 1.79 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.416 1.086 . . . . 10.0 109.527 -169.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.571 ' O ' HG23 ' A' ' 60' ' ' VAL . 21.2 p -69.26 -179.24 1.54 Allowed 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.776 -1.556 . . . . 10.0 108.616 170.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.787 ' CE2' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -171.02 -175.1 1.65 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 120.032 1.287 . . . . 10.0 110.538 174.096 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 p -157.9 170.45 22.3 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 102.875 -3.009 . . . . 10.0 102.875 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -158.69 156.5 30.05 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.423 -0.954 . . . . 10.0 108.423 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.426 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 24.8 pt -128.71 153.26 37.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.272 -1.381 . . . . 10.0 107.272 -177.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.627 HG21 HD13 ' A' ' 54' ' ' LEU . 3.6 mm -107.87 132.0 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 N-CA-C 107.626 -1.25 . . . . 10.0 107.626 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.659 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 5.1 mmtp -77.32 85.54 3.74 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 118.942 -1.103 . . . . 10.0 109.337 176.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.835 HG23 ' HB3' ' A' ' 112' ' ' LYS . 15.3 t -63.99 -21.62 0.76 Allowed Pre-proline 0 CA--C 1.558 1.26 0 CA-C-N 112.745 -2.025 . . . . 10.0 113.151 174.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.888 ' HB3' ' HB2' ' A' ' 112' ' ' LYS . 56.8 Cg_endo -101.91 55.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.22 1.947 . . . . 10.0 117.144 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.572 ' HD3' ' O ' ' A' ' 71' ' ' LYS . 17.0 Cg_exo -71.86 -17.52 28.89 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 N-CA-C 107.9 -1.616 . . . . 10.0 107.9 154.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 69.19 -55.34 0.56 Allowed 'General case' 0 C--N 1.343 0.307 0 CA-C-N 113.335 -1.757 . . . . 10.0 111.481 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.547 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 13.5 p -56.87 -40.17 75.69 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.055 -0.52 . . . . 10.0 111.923 -176.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.622 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -74.75 -33.74 62.37 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.106 0.479 . . . . 10.0 111.697 -173.086 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.751 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 3.7 tp -89.57 -17.8 27.83 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.533 -0.867 . . . . 10.0 108.905 177.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.651 HD21 ' HB2' ' A' ' 132' ' ' ALA . 8.7 tp -72.05 -23.26 61.34 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.316 -0.994 . . . . 10.0 108.316 168.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.622 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 24.0 mmtm -64.04 -27.5 69.15 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-O 121.195 0.521 . . . . 10.0 109.769 167.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.751 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -60.33 -45.18 94.34 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.484 -0.486 . . . . 10.0 111.508 171.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 1.001 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -71.07 -55.85 7.38 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.642 1.577 . . . . 10.0 112.075 173.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.289 -2.023 0 CA-C-N 111.907 -2.406 . . . . 10.0 107.63 -176.85 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.556 HG13 ' N ' ' A' ' 98' ' ' GLY . 11.4 p . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 113.648 0.981 . . . . 10.0 113.648 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.625 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -156.56 165.93 33.13 Favored Glycine 0 N--CA 1.44 -1.084 0 N-CA-C 109.461 -1.456 . . . . 10.0 109.461 176.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.617 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -154.1 170.86 20.15 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-O 122.197 0.999 . . . . 10.0 110.57 -163.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 1.001 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -159.37 -143.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-N 112.834 -1.985 . . . . 10.0 106.584 -172.56 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.603 ' OG1' ' HG2' ' A' ' 104' ' ' GLN . 17.2 p -153.9 143.98 22.05 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 107.618 -1.253 . . . . 10.0 107.618 -153.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.629 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 12.9 tpt180 -42.62 -41.24 3.0 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 114.854 -1.066 . . . . 10.0 110.034 177.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 3.5 tmtm? -60.15 -46.26 90.28 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.403 0.52 . . . . 10.0 112.403 177.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.603 ' HG2' ' OG1' ' A' ' 101' ' ' THR . 14.0 mm100 -66.02 -42.82 89.16 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.982 -0.747 . . . . 10.0 108.982 -177.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.865 HG23 ' HB ' ' A' ' 128' ' ' ILE . 30.8 mm -40.53 -58.11 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 114.604 -1.18 . . . . 10.0 110.832 164.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.638 ' HG2' ' HE3' ' A' ' 110' ' ' LYS . 31.7 tt0 -47.79 -50.35 26.07 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 114.633 -1.167 . . . . 10.0 112.917 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.426 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 35.2 mm-40 -54.45 -58.1 8.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.303 -0.862 . . . . 10.0 111.143 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.682 ' O ' HG22 ' A' ' 111' ' ' THR . 11.8 mm -48.97 -53.58 7.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-O 121.932 0.873 . . . . 10.0 109.95 172.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.524 ' CB ' HD11 ' A' ' 121' ' ' LEU . . . -48.67 -36.68 16.57 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.02 -0.991 . . . . 10.0 112.354 176.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.638 ' HE3' ' HG2' ' A' ' 106' ' ' GLU . 84.1 mttt -74.95 -54.02 7.95 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.409 -0.36 . . . . 10.0 111.44 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.682 HG22 ' O ' ' A' ' 108' ' ' ILE . 7.1 t -51.52 -22.93 3.53 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.242 1.201 . . . . 10.0 114.242 -171.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.888 ' HB2' ' HB3' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -130.01 19.4 5.48 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.576 0.703 . . . . 10.0 109.404 -174.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.66 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 54.8 ttm -52.21 -43.17 89.87 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 114.712 -1.131 . . . . 10.0 111.855 169.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 113' ' ' MET . 10.9 Cg_endo -52.64 -29.77 42.73 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.706 2.27 . . . . 10.0 112.259 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.528 ' CB ' ' HG3' ' A' ' 73' ' ' PRO . 21.1 t70 -91.19 -43.8 9.63 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.926 -1.034 . . . . 10.0 111.454 -176.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.867 HD21 HD12 ' A' ' 127' ' ' ILE . 3.2 mp -69.02 178.26 2.31 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.723 -1.581 . . . . 10.0 114.509 -167.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -94.29 29.55 2.17 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 111.303 -2.68 . . . . 10.0 112.209 171.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.659 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . . . -73.97 92.03 2.08 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.346 0.499 . . . . 10.0 112.346 175.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -66.28 -28.71 68.91 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.609 -0.885 . . . . 10.0 108.609 172.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.7 t -152.96 140.92 20.24 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 105.441 -2.059 . . . . 10.0 105.441 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.784 ' O ' ' HG3' ' A' ' 125' ' ' MET . 45.0 tp -53.07 -32.56 47.72 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.117 1.154 . . . . 10.0 114.117 -172.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -50.17 -35.92 28.2 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.591 0.71 . . . . 10.0 110.243 173.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.75 -50.56 56.6 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.236 -0.986 . . . . 10.0 110.969 176.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.716 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -60.23 -31.99 70.7 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 119.734 -0.786 . . . . 10.0 110.738 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.784 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 75.5 mtp -58.0 -36.42 72.63 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.701 0.286 . . . . 10.0 110.746 176.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -64.24 -54.06 39.43 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.101 0.56 . . . . 10.0 111.726 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.867 HD12 HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -51.48 -57.72 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 121.33 0.586 . . . . 10.0 110.739 179.005 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.865 ' HB ' HG23 ' A' ' 105' ' ' ILE . 21.5 mm -51.2 -54.06 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 CA-C-N 114.745 -1.116 . . . . 10.0 111.879 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.619 ' HG3' HG21 ' A' ' 105' ' ' ILE . 80.8 mt-10 -54.8 -40.97 70.04 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 123.325 0.391 . . . . 10.0 110.031 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -69.8 -46.8 51.56 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.194 -1.003 . . . . 10.0 111.015 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 86.3 m -44.59 -64.12 0.76 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 113.98 -1.11 . . . . 10.0 109.308 169.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.651 ' HB2' HD21 ' A' ' 79' ' ' LEU . . . -48.13 -50.3 29.14 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.008 -0.542 . . . . 10.0 111.775 177.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -49.05 -52.82 23.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.972 -1.013 . . . . 10.0 111.324 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 22.8 t -64.04 -33.02 74.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.868 0.366 . . . . 10.0 111.262 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.516 ' CE ' HD23 ' A' ' 79' ' ' LEU . 67.9 mtm -84.46 8.07 17.63 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 114.316 1.228 . . . . 10.0 114.316 -174.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 78.9 15.34 80.83 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 119.815 1.188 . . . . 10.0 111.603 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 19.4 mt -100.43 122.74 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 CA-C-O 121.5 0.667 . . . . 10.0 111.228 178.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.617 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -88.51 156.2 19.22 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 115.0 -1.0 . . . . 10.0 109.569 -179.217 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 17.1 m -115.47 121.22 66.78 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 CA-C-O 122.141 0.972 . . . . 10.0 108.517 172.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.646 HG22 ' O ' ' A' ' 100' ' ' VAL . 4.9 m -105.21 148.91 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 CA-C-N 113.752 -1.567 . . . . 10.0 108.544 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 34.2 t70 . . . . . 0 C--N 1.286 -2.168 0 CA-C-N 113.718 -1.583 . . . . 10.0 110.571 179.684 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.8 tptt . . . . . 0 C--O 1.223 -0.333 0 N-CA-C 109.81 -0.441 . . . . 10.0 109.81 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.32 130.13 25.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.771 0.32 . . . . 10.0 111.272 -176.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.63 -40.58 5.72 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.576 -0.527 . . . . 10.0 109.576 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.478 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -155.37 155.52 33.78 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 113.861 1.06 . . . . 10.0 113.861 -176.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -92.64 136.25 33.39 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.424 -1.262 . . . . 10.0 109.145 170.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.702 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -123.62 79.56 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.299 -1.0 . . . . 10.0 108.299 165.317 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.477 ' HG2' HG13 ' A' ' 57' ' ' VAL . 52.9 mttm -81.33 125.58 30.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 120.531 1.514 . . . . 10.0 107.751 175.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.587 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -158.15 131.35 7.49 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 122.485 1.136 . . . . 10.0 112.562 -172.155 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.721 ' HB3' HG23 ' A' ' 53' ' ' ILE . 23.2 mt-30 -84.04 116.51 22.88 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 113.79 -1.55 . . . . 10.0 111.489 -173.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.587 HD21 HD11 ' A' ' 11' ' ' LEU . 80.0 mt -136.65 140.73 32.96 Favored Pre-proline 0 C--O 1.219 -0.542 0 N-CA-C 113.262 0.838 . . . . 10.0 113.262 -172.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.843 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 36.0 Cg_exo -63.28 131.95 34.23 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 C-N-CA 124.443 3.429 . . . . 10.0 113.445 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.517 ' O ' ' HA2' ' A' ' 51' ' ' GLY . . . -56.73 124.41 18.32 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 108.447 -0.945 . . . . 10.0 108.447 167.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.33 7.16 82.13 Favored Glycine 0 N--CA 1.444 -0.818 0 O-C-N 125.356 1.66 . . . . 10.0 113.507 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.843 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 24.5 mmtp -142.49 97.95 3.21 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.236 1.018 . . . . 10.0 112.798 178.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.712 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -171.35 135.84 0.98 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.321 -1.309 . . . . 10.0 112.967 172.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.624 HG23 ' HD3' ' A' ' 20' ' ' PRO . 1.1 t -179.04 -45.3 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 114.894 -1.048 . . . . 10.0 113.354 175.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.744 ' HD2' ' H ' ' A' ' 21' ' ' ALA . 69.6 Cg_endo -118.34 -46.54 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.257 0 N-CA-C 117.002 1.885 . . . . 10.0 117.002 -171.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.744 ' H ' ' HD2' ' A' ' 20' ' ' PRO . . . -47.48 154.74 0.82 Allowed Pre-proline 0 N--CA 1.467 0.392 0 N-CA-C 113.688 0.995 . . . . 10.0 113.688 -165.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.527 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 53.5 Cg_exo -38.94 -41.18 1.71 Allowed 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 124.583 3.522 . . . . 10.0 115.075 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 22' ' ' PRO . 3.1 Cg_exo -41.26 -54.69 2.49 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.542 2.161 . . . . 10.0 112.448 167.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.632 HG13 HD12 ' A' ' 28' ' ' LEU . 89.2 t -89.68 -55.54 6.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.59 -1.186 . . . . 10.0 113.887 -170.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.511 ' HA2' ' CD1' ' A' ' 35' ' ' ILE . . . -45.61 -73.2 0.3 Allowed Glycine 0 C--N 1.337 0.59 0 CA-C-N 114.247 -1.342 . . . . 10.0 113.668 -175.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 22' ' ' PRO . 88.9 Cg_exo -51.27 -44.44 43.03 Favored 'Trans proline' 0 C--O 1.225 -0.133 0 C-N-CA 123.561 2.84 . . . . 10.0 112.667 173.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 23' ' ' PRO . . . -50.71 -76.19 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.496 0.665 . . . . 10.0 111.38 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.712 ' HB2' HG12 ' A' ' 35' ' ' ILE . 3.8 mt -69.34 -44.33 71.85 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.331 -0.849 . . . . 10.0 113.098 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.44 -44.35 97.75 Favored Glycine 0 C--O 1.229 -0.159 0 CA-C-N 116.253 -0.431 . . . . 10.0 112.949 -173.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -62.06 -25.43 67.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.647 0.261 . . . . 10.0 110.565 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -101.34 13.64 34.43 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 120.113 -0.635 . . . . 10.0 110.787 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.34 12.94 83.83 Favored Glycine 0 CA--C 1.503 -0.707 0 CA-C-N 114.947 -1.024 . . . . 10.0 113.036 169.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.599 HG22 HG21 ' A' ' 60' ' ' VAL . 48.3 t -81.78 142.39 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 115.194 -0.503 . . . . 10.0 111.992 -173.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 81.6 m-20 -67.29 90.27 0.22 Allowed 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.025 0.441 . . . . 10.0 110.022 175.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.712 HG12 ' HB2' ' A' ' 28' ' ' LEU . 33.7 mt -55.24 -39.65 52.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.767 0.794 . . . . 10.0 111.463 177.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.616 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 62.9 mtm -64.55 -50.61 66.6 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.903 -1.498 . . . . 10.0 111.113 176.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.586 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 20.2 tt0 -55.66 -50.05 71.27 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.05 -0.66 . . . . 10.0 110.313 174.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.644 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . 61.9 t80 -55.65 -54.97 37.67 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 113.732 1.012 . . . . 10.0 113.732 176.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.641 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 8.8 p -56.19 -48.11 77.02 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.346 -0.843 . . . . 10.0 110.662 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.419 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 46.5 mmtm -67.69 -22.32 65.28 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.712 -0.795 . . . . 10.0 109.925 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.82 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 29.9 mtp180 -75.77 -63.75 1.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.651 -0.704 . . . . 10.0 111.559 171.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.644 ' CZ ' HG21 ' A' ' 46' ' ' THR . 79.3 t80 -55.33 -47.16 76.1 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.481 0.658 . . . . 10.0 110.619 -173.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.712 HD21 ' HB3' ' A' ' 18' ' ' ALA . 0.9 OUTLIER -61.06 -48.3 82.38 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.674 -1.148 . . . . 10.0 110.539 -176.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.94 93.68 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 118.901 -1.12 . . . . 10.0 111.737 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.82 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 11.4 mm-40 -66.53 -39.21 88.49 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.711 0.767 . . . . 10.0 111.786 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.648 ' CG2' HD12 ' A' ' 54' ' ' LEU . 64.6 p -92.6 -10.96 35.58 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 114.096 1.146 . . . . 10.0 114.096 -166.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.52 -37.19 37.8 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 113.575 0.954 . . . . 10.0 113.575 -171.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -75.35 -35.99 61.08 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.576 -0.738 . . . . 10.0 109.268 -175.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.515 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 4.3 mppt? -93.87 49.33 1.33 Allowed 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 122.926 0.49 . . . . 10.0 110.848 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.815 ' CB ' ' HG3' ' A' ' 52' ' ' MET . . . 100.0 -152.84 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 114.885 1.439 . . . . 10.0 114.885 146.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 15' ' ' ALA . . . -123.99 83.6 0.36 Allowed Glycine 0 N--CA 1.419 -2.466 0 N-CA-C 105.491 -3.043 . . . . 10.0 105.491 164.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.815 ' HG3' ' CB ' ' A' ' 50' ' ' ALA . 29.3 mtm -139.1 131.15 27.93 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 116.214 1.931 . . . . 10.0 116.214 -160.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.721 HG23 ' HB3' ' A' ' 12' ' ' GLN . 0.4 OUTLIER -67.94 94.29 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 119.38 -0.928 . . . . 10.0 110.225 171.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.648 HD12 ' CG2' ' A' ' 46' ' ' THR . 11.4 mt -83.36 128.53 64.08 Favored Pre-proline 0 N--CA 1.437 -1.108 0 CA-C-N 115.139 -0.937 . . . . 10.0 108.788 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.427 ' HD2' ' HD3' ' A' ' 73' ' ' PRO . 26.9 Cg_exo -64.88 98.05 0.29 Allowed 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.216 1.944 . . . . 10.0 110.946 175.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -97.47 153.74 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 119.011 0.823 . . . . 10.0 110.946 -173.451 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.477 HG13 ' HG2' ' A' ' 10' ' ' LYS . 92.4 t -134.27 114.23 18.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 C-N-CA 121.015 -0.274 . . . . 10.0 110.359 173.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.702 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 22.8 mt -106.66 137.49 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.795 0 N-CA-C 108.003 -1.11 . . . . 10.0 108.003 -173.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 31.6 m -121.76 95.53 4.71 Favored 'General case' 0 N--CA 1.405 -2.675 0 CA-C-N 114.707 -1.133 . . . . 10.0 108.642 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.599 HG21 HG22 ' A' ' 33' ' ' VAL . 3.1 p -86.64 137.14 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-N 119.28 0.945 . . . . 10.0 110.599 -178.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.452 ' CD2' ' HA ' ' A' ' 66' ' ' PHE . 66.0 m-85 -96.28 172.49 7.92 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 113.001 0.741 . . . . 10.0 113.001 -176.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -53.86 -27.25 28.82 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.03 -1.441 . . . . 10.0 112.602 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.572 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 4.0 m-20 -77.61 -10.76 59.69 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.371 -0.832 . . . . 10.0 111.591 -173.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 51.5 mtpt 83.3 -0.16 1.13 Allowed 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.276 1.036 . . . . 10.0 109.537 -164.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.488 ' O ' HG23 ' A' ' 60' ' ' VAL . 50.6 m -70.89 170.77 11.95 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 113.626 -1.624 . . . . 10.0 108.234 173.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.644 ' CZ ' ' HB2' ' A' ' 38' ' ' PHE . 6.0 p90 -168.44 -176.12 2.74 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 120.372 1.442 . . . . 10.0 110.373 175.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.6 p -157.72 171.74 19.77 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 103.1 -2.926 . . . . 10.0 103.1 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.442 ' CB ' HG12 ' A' ' 58' ' ' ILE . 38.1 p90 -161.41 155.62 22.56 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.404 -0.962 . . . . 10.0 108.404 177.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.408 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 29.9 pt -128.53 166.97 24.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.289 -1.375 . . . . 10.0 107.289 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.482 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 2.5 mt -138.1 119.02 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 107.544 -1.28 . . . . 10.0 107.544 -177.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.421 ' HZ2' ' HB2' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -83.44 67.55 9.38 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.597 -0.89 . . . . 10.0 108.597 -176.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -20.59 96.37 0.05 OUTLIER Pre-proline 0 C--O 1.224 -0.24 0 O-C-N 125.879 1.987 . . . . 10.0 112.244 176.005 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.427 ' HD3' ' HD2' ' A' ' 55' ' ' PRO . 3.8 Cg_exo -36.65 124.3 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 124.406 3.404 . . . . 10.0 113.65 -167.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.872 ' HA ' ' HZ1' ' A' ' 112' ' ' LYS . 86.1 Cg_exo -48.09 86.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.17 3.247 . . . . 10.0 114.085 -176.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 1.092 ' H ' ' HE2' ' A' ' 112' ' ' LYS . . . 72.49 -49.75 0.7 Allowed 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 124.708 1.203 . . . . 10.0 112.509 173.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.675 ' HA ' ' HE1' ' A' ' 135' ' ' MET . 8.0 p -37.39 -65.29 0.32 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 114.116 1.154 . . . . 10.0 114.116 -171.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.714 ' HB3' ' SD ' ' A' ' 52' ' ' MET . 41.6 m-85 -72.32 -40.75 67.22 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.26 0.837 . . . . 10.0 113.26 -171.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.812 ' HB3' HD12 ' A' ' 108' ' ' ILE . 2.7 mm? -68.32 -30.62 69.64 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.547 -0.721 . . . . 10.0 109.863 177.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.538 HD13 ' HB2' ' A' ' 132' ' ' ALA . 28.0 mt -70.94 -25.41 62.73 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.967 -0.56 . . . . 10.0 110.914 175.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.58 ' HG2' ' HA ' ' A' ' 77' ' ' PHE . 25.1 mmmt -54.15 -49.28 69.62 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 108.638 -0.875 . . . . 10.0 108.638 174.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -58.33 -44.99 88.92 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.881 0.697 . . . . 10.0 112.881 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.751 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -65.86 -55.57 16.35 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 123.031 1.396 . . . . 10.0 110.165 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.559 ' HB1' ' HA3' ' A' ' 98' ' ' GLY . . . . . . . . 0 C--N 1.286 -2.164 0 CA-C-N 111.119 -2.764 . . . . 10.0 110.597 -172.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.625 HG13 ' H ' ' A' ' 98' ' ' GLY . 3.3 p . . . . . 0 N--CA 1.434 -1.262 0 N-CA-C 108.41 -0.959 . . . . 10.0 108.41 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.625 ' H ' HG13 ' A' ' 97' ' ' VAL . . . -133.92 147.99 19.26 Favored Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 109.325 -1.51 . . . . 10.0 109.325 164.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.753 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 64.4 pttt -148.11 160.95 42.36 Favored 'General case' 0 CA--C 1.472 -2.022 0 CA-C-O 122.144 0.973 . . . . 10.0 108.803 172.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.751 HG11 ' HB1' ' A' ' 82' ' ' ALA . 1.2 m -161.18 -162.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.411 -2.399 0 CA-C-N 112.486 -2.143 . . . . 10.0 106.772 -166.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.521 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 15.9 p -121.7 159.06 27.36 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 114.543 -1.208 . . . . 10.0 111.106 -173.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.672 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 16.2 tpt180 -43.12 -44.84 5.16 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.919 -1.492 . . . . 10.0 110.165 171.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.52 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -58.01 -44.29 87.17 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.801 0.667 . . . . 10.0 112.801 177.429 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.579 ' HG2' ' HB1' ' A' ' 82' ' ' ALA . 1.4 tp60 -55.63 -54.86 38.92 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.895 -0.78 . . . . 10.0 108.895 177.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.744 HG23 ' HB ' ' A' ' 128' ' ' ILE . 45.5 mm -35.96 -52.93 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-N 113.985 -1.461 . . . . 10.0 112.604 167.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.673 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 25.5 tt0 -47.57 -59.63 3.12 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.529 1.132 . . . . 10.0 113.183 -175.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -55.94 -49.82 72.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.129 -0.941 . . . . 10.0 110.519 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.812 HD12 ' HB3' ' A' ' 78' ' ' LEU . 13.8 mm -49.86 -57.42 2.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.652 -0.704 . . . . 10.0 110.641 171.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.556 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -52.23 -35.65 50.19 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.923 -0.581 . . . . 10.0 112.371 177.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.673 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 46.9 mttt -74.97 -56.09 5.1 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.707 -0.679 . . . . 10.0 111.42 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.47 HG23 ' CG ' ' A' ' 112' ' ' LYS . 13.2 t -54.47 -30.41 53.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.931 -0.577 . . . . 10.0 112.375 -176.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 1.092 ' HE2' ' H ' ' A' ' 75' ' ' ALA . 0.8 OUTLIER -113.48 23.71 12.92 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 121.062 -0.255 . . . . 10.0 110.888 -178.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.761 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 46.5 ttm -48.48 -44.3 64.85 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.359 -0.382 . . . . 10.0 111.696 175.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 113' ' ' MET . 56.7 Cg_endo -68.04 -20.64 44.11 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.587 1.525 . . . . 10.0 113.172 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -83.55 -54.95 4.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.604 -0.726 . . . . 10.0 110.441 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.602 ' HG ' HG21 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -65.43 -0.32 1.86 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.686 -1.143 . . . . 10.0 112.618 -177.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 15.5 m120 60.25 46.93 9.72 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.717 -1.128 . . . . 10.0 109.309 -177.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.761 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -79.84 113.63 18.14 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.358 -1.292 . . . . 10.0 112.625 -173.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -67.39 -36.04 80.52 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.148 -0.686 . . . . 10.0 109.148 169.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.5 p -150.59 146.4 26.52 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.955 -1.128 . . . . 10.0 107.955 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.609 ' O ' ' HG2' ' A' ' 125' ' ' MET . 39.6 tp -53.06 -40.47 64.03 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 114.446 1.276 . . . . 10.0 114.446 -177.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -51.13 -35.19 34.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.309 0.576 . . . . 10.0 111.026 176.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.587 ' O ' ' HG3' ' A' ' 126' ' ' LYS . . . -67.64 -49.08 64.69 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 118.816 -1.153 . . . . 10.0 110.607 173.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.668 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -56.86 -29.05 62.53 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.684 -0.806 . . . . 10.0 110.328 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.649 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 82.8 mmm -61.55 -41.55 97.52 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 113.06 0.763 . . . . 10.0 113.06 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.737 ' HD3' ' N ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -66.7 -45.27 79.31 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 122.161 -0.337 . . . . 10.0 111.816 178.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.737 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -55.12 -60.59 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 C-N-CA 120.164 -0.614 . . . . 10.0 110.662 178.443 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.744 ' HB ' HG23 ' A' ' 105' ' ' ILE . 19.8 mm -50.36 -55.02 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.219 0 CA-C-N 115.614 -0.721 . . . . 10.0 110.774 -177.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -54.46 -44.3 72.44 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 114.753 -1.112 . . . . 10.0 108.898 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.594 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -72.07 -46.2 37.08 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 121.154 -0.546 . . . . 10.0 112.166 -174.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.621 HG21 ' HB3' ' A' ' 75' ' ' ALA . 68.1 m -46.96 -57.69 4.73 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.483 0.658 . . . . 10.0 109.431 171.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.563 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -49.08 -43.26 40.96 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 114.94 -1.027 . . . . 10.0 111.876 175.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 130' ' ' GLY . 58.6 mttp -48.74 -53.02 20.64 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.439 0.462 . . . . 10.0 110.876 176.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.9 m -66.96 -32.87 74.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.024 0.44 . . . . 10.0 111.446 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.675 ' HE1' ' HA ' ' A' ' 76' ' ' SER . 38.3 mtm -79.85 -1.05 37.31 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.934 1.087 . . . . 10.0 113.934 -175.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.49 23.78 52.76 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 119.619 1.1 . . . . 10.0 112.142 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 3.0 mp -109.26 126.63 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 CA-C-O 121.525 0.679 . . . . 10.0 111.043 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.753 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -91.9 157.86 16.6 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.553 -1.203 . . . . 10.0 108.906 179.31 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 19.5 m -119.02 134.52 62.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.177 -0.675 . . . . 10.0 109.177 171.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.64 HG22 ' O ' ' A' ' 100' ' ' VAL . 28.7 m -133.85 71.07 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 116.052 1.871 . . . . 10.0 116.052 -173.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 20.5 t0 . . . . . 0 C--N 1.3 -1.571 0 CA-C-N 114.321 -1.309 . . . . 10.0 109.041 138.791 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 10.3 mtmp? . . . . . 0 CA--C 1.52 -0.188 0 N-CA-C 109.776 -0.453 . . . . 10.0 109.776 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.442 HG13 HG23 ' A' ' 59' ' ' THR . 45.2 t -62.13 131.53 27.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 116.222 -0.444 . . . . 10.0 111.155 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.93 -35.39 7.31 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.687 -0.486 . . . . 10.0 109.687 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.512 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -154.11 141.27 19.45 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.327 0.862 . . . . 10.0 113.327 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -94.2 126.96 39.76 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 106.654 -1.61 . . . . 10.0 106.654 171.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.648 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 1.9 mt -125.67 85.59 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 120.241 -0.584 . . . . 10.0 109.864 -177.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.566 ' HG2' HG22 ' A' ' 57' ' ' VAL . 58.1 mttp -75.92 132.86 40.53 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 120.338 -0.545 . . . . 10.0 109.85 176.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.697 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -158.34 127.21 5.55 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.154 0.978 . . . . 10.0 111.607 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -85.92 122.87 30.59 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.502 -1.226 . . . . 10.0 110.724 -172.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.697 HD21 HD11 ' A' ' 11' ' ' LEU . 94.0 mt -141.56 135.66 14.96 Favored Pre-proline 0 CA--C 1.51 -0.584 0 CA-C-O 121.659 0.742 . . . . 10.0 112.044 -172.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.671 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 53.1 Cg_exo -49.94 124.34 12.4 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.818 3.012 . . . . 10.0 112.943 170.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.61 ' CB ' ' HA ' ' A' ' 50' ' ' ALA . . . -62.73 128.76 37.44 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.599 -1.259 . . . . 10.0 107.599 170.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.35 0.48 78.35 Favored Glycine 0 N--CA 1.446 -0.693 0 O-C-N 125.513 1.758 . . . . 10.0 112.992 -174.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.671 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -143.84 96.08 2.84 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.941 0.877 . . . . 10.0 112.038 -178.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' A' ' 39' ' ' CYS . . . -170.62 135.85 1.19 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.073 -1.422 . . . . 10.0 112.733 177.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.74 ' H ' ' HD3' ' A' ' 20' ' ' PRO . 5.9 t -179.61 -36.26 0.0 OUTLIER Pre-proline 0 N--CA 1.443 -0.777 0 CA-C-N 115.236 -0.893 . . . . 10.0 113.357 176.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.74 ' HD3' ' H ' ' A' ' 19' ' ' THR . 89.3 Cg_endo -104.04 129.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.409 -3.476 0 N-CA-C 116.492 1.689 . . . . 10.0 116.492 -157.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.962 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . 13.09 -58.24 0.0 OUTLIER Pre-proline 0 C--N 1.288 -2.078 0 CA-C-N 109.228 -3.624 . . . . 10.0 118.546 152.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.771 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 45.3 Cg_exo -57.69 -63.9 0.14 Allowed 'Trans proline' 0 CA--C 1.566 2.115 0 CA-C-N 123.576 2.313 . . . . 10.0 115.409 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.771 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 58.6 Cg_endo -77.42 -52.04 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.681 2.254 . . . . 10.0 112.74 176.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.013 HG12 HD12 ' A' ' 35' ' ' ILE . 77.5 t -81.89 -49.46 17.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 111.702 -2.499 . . . . 10.0 111.894 -166.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.766 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -44.15 -52.97 6.83 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 113.968 -1.469 . . . . 10.0 113.39 178.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.962 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 23.9 Cg_exo -71.96 -43.82 1.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.179 2.586 . . . . 10.0 111.236 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.514 ' O ' ' HD2' ' A' ' 31' ' ' HIS . . . -50.58 -93.81 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.434 0.459 . . . . 10.0 111.897 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.778 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.356 0.0 OUTLIER -77.15 -19.24 57.12 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 117.306 -1.758 . . . . 10.0 113.797 -174.535 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.55 -39.48 60.84 Favored Glycine 0 N--CA 1.467 0.714 0 C-N-CA 120.666 -0.778 . . . . 10.0 113.092 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.608 ' HB3' ' O ' ' A' ' 26' ' ' PRO . 13.0 tt0 -56.61 -26.14 54.83 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.746 0.308 . . . . 10.0 110.628 175.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.514 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 70.0 m-70 -96.47 23.63 6.62 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.739 -0.784 . . . . 10.0 109.86 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.444 ' HA3' ' CE ' ' A' ' 64' ' ' LYS . . . 81.66 6.92 88.72 Favored Glycine 0 CA--C 1.494 -1.232 0 CA-C-N 115.27 -0.877 . . . . 10.0 112.813 167.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.888 HG11 ' CD2' ' A' ' 66' ' ' PHE . 2.4 t -85.26 146.97 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 113.628 0.973 . . . . 10.0 113.628 -175.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.609 ' ND2' ' HB3' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -69.97 101.71 1.84 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.649 0.737 . . . . 10.0 111.477 174.321 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.013 HD12 HG12 ' A' ' 24' ' ' VAL . 21.2 mm -53.49 -39.25 35.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 114.152 -1.385 . . . . 10.0 112.175 176.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.735 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 3.2 mpp? -66.13 -51.38 58.5 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.335 -1.757 . . . . 10.0 111.907 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.609 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 44.0 tt0 -57.83 -40.13 79.28 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.109 -1.036 . . . . 10.0 110.23 176.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.65 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 89.0 t80 -57.47 -58.97 5.95 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 113.877 1.066 . . . . 10.0 113.877 171.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.735 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 19.8 p -60.08 -47.43 85.91 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 114.563 -1.199 . . . . 10.0 111.36 -175.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -65.26 -24.29 67.28 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.988 -0.745 . . . . 10.0 108.988 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.782 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 19.2 mtp180 -74.2 -64.48 1.01 Allowed 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.598 -0.841 . . . . 10.0 112.35 170.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.625 ' CZ ' HG21 ' A' ' 46' ' ' THR . 76.5 t80 -53.37 -45.18 69.11 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 121.157 0.503 . . . . 10.0 110.376 -172.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.628 HD22 ' N ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER -59.18 -51.01 71.85 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.026 -0.988 . . . . 10.0 110.235 -177.685 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.27 -41.67 99.04 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.209 -0.996 . . . . 10.0 112.232 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.782 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 10.6 mt-10 -68.6 -40.33 80.47 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.795 0.807 . . . . 10.0 111.166 -176.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.625 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 75.4 p -87.81 0.54 55.64 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 114.778 -1.101 . . . . 10.0 112.28 -173.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.04 -35.27 2.9 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.231 1.013 . . . . 10.0 113.233 -175.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -86.91 -33.54 19.69 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.806 -0.634 . . . . 10.0 112.391 -173.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.575 ' HB3' ' HZ ' ' A' ' 77' ' ' PHE . 39.3 mttm -96.94 20.45 11.12 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.181 -0.674 . . . . 10.0 109.181 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.61 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -54.36 157.74 2.65 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 125.223 1.409 . . . . 10.0 114.128 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.05 22.07 43.39 Favored Glycine 0 CA--C 1.501 -0.812 0 N-CA-C 109.121 -1.592 . . . . 10.0 109.121 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.615 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 40.4 tpp -140.99 120.21 12.94 Favored 'General case' 0 C--O 1.205 -1.242 0 C-N-CA 117.42 -1.712 . . . . 10.0 114.737 -159.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.6 mm -63.11 92.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 121.688 -0.632 . . . . 10.0 109.999 172.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.768 HD22 ' HE2' ' A' ' 77' ' ' PHE . 7.2 mt -82.65 129.37 62.73 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.71 -0.478 . . . . 10.0 109.71 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.405 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 14.9 Cg_exo -71.51 103.37 1.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 121.918 1.746 . . . . 10.0 110.262 171.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.02 153.79 3.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 119.726 1.148 . . . . 10.0 110.903 -173.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.566 HG22 ' HG2' ' A' ' 10' ' ' LYS . 61.5 t -133.09 111.66 16.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 176.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.648 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 17.2 mt -102.9 140.66 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.789 0 N-CA-C 108.534 -0.913 . . . . 10.0 108.534 -172.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.442 HG23 HG13 ' A' ' 5' ' ' VAL . 57.2 m -125.19 94.45 4.17 Favored 'General case' 0 N--CA 1.402 -2.863 0 CA-C-N 114.774 -1.103 . . . . 10.0 108.873 177.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 65' ' ' SER . 2.2 p -89.82 134.67 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 O-C-N 121.264 -0.898 . . . . 10.0 110.16 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -91.84 172.34 8.53 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.69 -0.686 . . . . 10.0 112.658 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -63.75 -19.25 64.82 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.298 -0.865 . . . . 10.0 111.393 -178.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.442 ' HB3' ' OG ' ' A' ' 65' ' ' SER . 27.3 t70 -77.55 -10.45 59.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.811 -1.086 . . . . 10.0 111.237 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.444 ' CE ' ' HA3' ' A' ' 32' ' ' GLY . 28.1 mmmt 82.55 -3.76 1.38 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.328 1.051 . . . . 10.0 110.961 -172.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.606 ' O ' HG23 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -68.93 179.45 1.83 Allowed 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.661 -0.866 . . . . 10.0 108.661 170.843 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.888 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -166.06 -176.51 3.78 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 119.851 1.205 . . . . 10.0 109.828 175.128 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.3 p -158.12 166.84 31.45 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 102.275 -3.231 . . . . 10.0 102.275 178.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.428 ' CB ' HG12 ' A' ' 58' ' ' ILE . 45.1 p90 -163.66 154.64 16.23 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.207 -1.035 . . . . 10.0 108.207 175.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.518 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 29.2 pt -117.01 164.14 13.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.613 -1.254 . . . . 10.0 107.613 -177.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.488 HG21 HD13 ' A' ' 54' ' ' LEU . 10.5 mm -117.22 126.27 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 106.561 -1.644 . . . . 10.0 106.561 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.465 ' HD3' ' HA ' ' A' ' 71' ' ' LYS . 50.3 mmtt -72.47 104.29 3.76 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 119.576 -0.85 . . . . 10.0 109.988 -177.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.692 ' O ' ' HE2' ' A' ' 112' ' ' LYS . 8.2 p -41.57 139.06 1.55 Allowed Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 112.973 -1.921 . . . . 10.0 109.27 174.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.446 ' HB3' ' HB3' ' A' ' 77' ' ' PHE . 8.7 Cg_exo -32.59 104.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 124.192 3.262 . . . . 10.0 113.256 -174.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -38.85 -47.66 2.76 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.064 2.509 . . . . 10.0 110.565 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.585 ' CB ' HG21 ' A' ' 131' ' ' THR . . . 174.91 -47.58 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 113.824 -1.534 . . . . 10.0 109.364 159.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.643 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 83.9 p -64.68 -30.46 71.48 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 109.817 -0.438 . . . . 10.0 109.817 -178.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.768 ' HE2' HD22 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -41.89 -70.27 0.11 Allowed 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.87 0.868 . . . . 10.0 111.122 175.478 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.781 ' HB3' HD12 ' A' ' 108' ' ' ILE . 12.5 tp -90.25 -17.48 27.39 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.078 -0.51 . . . . 10.0 109.849 -170.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.7 mt -69.2 -33.16 72.92 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.259 172.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.643 ' HG3' ' O ' ' A' ' 76' ' ' SER . 48.5 mttp -60.81 -41.52 95.85 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.35 -0.611 . . . . 10.0 109.35 171.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -58.4 -39.91 80.98 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.851 -0.613 . . . . 10.0 112.422 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.814 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -69.96 -53.03 19.6 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.975 1.369 . . . . 10.0 110.875 174.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.292 -1.922 0 CA-C-N 111.473 -2.603 . . . . 10.0 111.437 -171.243 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 97' ' ' VAL . 7.1 p . . . . . 0 CA--C 1.54 0.593 0 CA-C-O 121.98 0.895 . . . . 10.0 111.694 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 38.92 -161.83 0.01 OUTLIER Glycine 0 C--N 1.323 -0.181 0 CA-C-N 114.21 -1.359 . . . . 10.0 112.656 -170.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.573 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 8.4 ptpp? -158.85 177.58 11.01 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 122.273 1.035 . . . . 10.0 111.022 177.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.814 HG11 ' HB1' ' A' ' 82' ' ' ALA . 1.0 OUTLIER -155.54 -145.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-N 112.285 -2.234 . . . . 10.0 105.981 -176.147 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.62 HG23 HE21 ' A' ' 104' ' ' GLN . 0.1 OUTLIER -162.77 142.72 9.32 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 109.048 -0.723 . . . . 10.0 109.048 -157.44 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.732 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 1.5 tpt180 -43.31 -39.97 3.33 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 124.934 1.396 . . . . 10.0 110.795 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.557 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 17.8 tppt? -60.13 -44.42 94.93 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.521 0.563 . . . . 10.0 112.521 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.65 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -63.81 -47.96 78.76 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.758 -0.83 . . . . 10.0 108.758 178.509 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.732 ' HB ' ' O ' ' A' ' 102' ' ' ARG . 43.2 mm -35.53 -58.15 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 114.949 -1.023 . . . . 10.0 111.544 163.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.647 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 33.1 tt0 -47.33 -54.65 10.54 Favored 'General case' 0 C--O 1.209 -1.07 0 C-N-CA 124.636 1.174 . . . . 10.0 113.146 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -53.2 -58.15 8.03 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 123.743 0.652 . . . . 10.0 110.971 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.781 HD12 ' HB3' ' A' ' 78' ' ' LEU . 7.7 mm -46.79 -55.86 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.243 -0.889 . . . . 10.0 109.963 172.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.618 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -53.27 -38.08 62.74 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.684 -0.689 . . . . 10.0 112.833 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.647 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 76.4 mttt -72.2 -56.92 4.73 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 116.109 -0.496 . . . . 10.0 111.052 -173.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.457 ' O ' HG21 ' A' ' 72' ' ' THR . 1.8 t -54.61 -33.3 60.22 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.171 -0.922 . . . . 10.0 110.168 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 1.063 ' HD2' HD13 ' A' ' 116' ' ' LEU . 4.5 mmtt -91.74 -12.22 34.57 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 112.64 0.607 . . . . 10.0 112.64 -177.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.4 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 45.7 ttm -37.27 -52.7 2.27 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 113.25 0.833 . . . . 10.0 113.25 177.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 113' ' ' MET . 30.7 Cg_endo -64.49 -22.74 65.19 Favored 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 121.456 1.437 . . . . 10.0 112.988 -178.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.751 ' HB3' ' HD3' ' A' ' 112' ' ' LYS . 3.6 t70 -99.25 -42.19 7.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.819 0.818 . . . . 10.0 112.152 -175.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 1.063 HD13 ' HD2' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -63.82 -0.22 1.0 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.105 -1.407 . . . . 10.0 111.815 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.447 ' H ' ' C ' ' A' ' 115' ' ' ASP . 2.6 p-10 56.85 43.88 24.21 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 113.971 -1.468 . . . . 10.0 108.886 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 119' ' ' ASN . . . -65.39 -74.62 0.1 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 112.7 -2.045 . . . . 10.0 113.272 -166.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 118' ' ' ALA . 28.7 t-20 103.57 -42.87 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 O-C-N 125.08 1.488 . . . . 10.0 109.096 -173.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.5 t -153.79 139.75 18.23 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.391 -1.707 . . . . 10.0 106.391 173.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.597 ' O ' HD13 ' A' ' 121' ' ' LEU . 1.5 tm? -50.47 -35.26 28.18 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.34 0.867 . . . . 10.0 113.34 -174.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.536 ' HA ' ' HG3' ' A' ' 125' ' ' MET . 1.6 mp0 -51.15 -41.31 60.03 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.584 0.707 . . . . 10.0 111.013 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.93 -47.37 74.94 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 118.787 -1.165 . . . . 10.0 110.488 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.482 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -58.6 -29.86 66.78 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.837 -0.345 . . . . 10.0 111.0 176.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.536 ' HG3' ' HA ' ' A' ' 122' ' ' GLU . 5.0 mtp -54.92 -41.02 70.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.903 0.382 . . . . 10.0 111.087 175.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -63.37 -54.68 33.03 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.632 -0.713 . . . . 10.0 112.173 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.944 HD12 HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -52.29 -59.35 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 120.212 -0.595 . . . . 10.0 111.144 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.632 ' HB ' HG23 ' A' ' 105' ' ' ILE . 27.4 mm -51.7 -56.65 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 CA-C-N 114.841 -1.072 . . . . 10.0 111.676 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.56 ' HG3' HG21 ' A' ' 105' ' ' ILE . 5.3 mt-10 -51.95 -44.15 63.8 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 123.824 0.702 . . . . 10.0 109.143 177.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.73 -45.97 63.18 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.393 -0.908 . . . . 10.0 111.08 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.585 HG21 ' CB ' ' A' ' 75' ' ' ALA . 49.9 m -46.75 -64.77 0.68 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.144 -1.028 . . . . 10.0 109.148 169.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -47.49 -52.62 16.67 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.147 0.499 . . . . 10.0 111.561 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -52.19 -53.5 42.47 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.943 -1.026 . . . . 10.0 112.163 178.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 22.9 p -68.34 -25.5 65.14 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.044 0.45 . . . . 10.0 110.599 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.406 ' HG3' ' O ' ' A' ' 131' ' ' THR . 45.1 mtm -75.42 -8.41 56.63 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 112.731 0.641 . . . . 10.0 112.731 178.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 96.48 2.65 60.11 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 118.995 0.816 . . . . 10.0 111.765 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.7 mt -95.02 136.38 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 CA-C-N 117.54 0.67 . . . . 10.0 112.029 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.577 ' HG3' ' N ' ' A' ' 139' ' ' VAL . 0.0 OUTLIER -84.7 156.28 21.54 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 119.097 -1.041 . . . . 10.0 110.544 177.22 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.577 ' N ' ' HG3' ' A' ' 138' ' ' GLU . 17.3 m -120.03 126.21 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.55 0 N-CA-C 107.561 -1.274 . . . . 10.0 107.561 170.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 100' ' ' VAL . 26.2 m -107.2 167.95 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 CA-C-N 113.555 -1.657 . . . . 10.0 108.415 176.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 . . . . . 0 C--N 1.285 -2.198 0 CA-C-N 113.921 -1.49 . . . . 10.0 110.814 178.563 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.0 mttt . . . . . 0 C--O 1.218 -0.584 0 N-CA-C 110.003 -0.369 . . . . 10.0 110.003 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.7 t -65.61 141.3 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 122.737 0.415 . . . . 10.0 111.097 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -109.48 -46.77 3.48 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.198 175.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.401 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -156.39 156.98 34.8 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 114.034 1.124 . . . . 10.0 114.034 -173.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -92.05 136.31 33.27 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.244 -1.344 . . . . 10.0 108.357 169.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.678 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -122.73 82.0 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 108.799 -0.815 . . . . 10.0 108.799 169.478 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.469 ' HG2' HG22 ' A' ' 57' ' ' VAL . 48.1 mtpt -78.9 130.97 36.21 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 120.444 1.474 . . . . 10.0 108.396 172.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.576 HD21 HD11 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -159.21 129.59 5.82 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.95 0.881 . . . . 10.0 111.255 -178.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -83.23 119.71 24.9 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.346 -1.297 . . . . 10.0 109.941 -172.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.576 HD11 HD21 ' A' ' 11' ' ' LEU . 55.2 mt -137.07 135.54 19.89 Favored Pre-proline 0 CA--C 1.5 -0.97 0 CA-C-O 121.878 0.847 . . . . 10.0 112.659 -171.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.786 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 25.2 Cg_exo -54.35 123.12 12.81 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 123.622 2.882 . . . . 10.0 111.486 172.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.595 ' CB ' ' HB ' ' A' ' 46' ' ' THR . . . -61.35 125.45 23.81 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.158 -1.423 . . . . 10.0 107.158 168.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.0 -0.97 89.3 Favored Glycine 0 N--CA 1.44 -1.039 0 O-C-N 125.774 1.921 . . . . 10.0 113.233 -175.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.786 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 19.4 tptm -143.47 109.34 5.22 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.296 1.048 . . . . 10.0 112.705 176.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.719 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -171.69 142.21 1.54 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.256 -1.338 . . . . 10.0 112.747 172.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.575 ' H ' ' HD3' ' A' ' 20' ' ' PRO . 2.7 t 179.44 -43.02 0.0 OUTLIER Pre-proline 0 C--O 1.207 -1.165 0 O-C-N 124.059 0.85 . . . . 10.0 113.129 175.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.655 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 85.6 Cg_endo -103.25 131.19 0.1 OUTLIER 'Trans proline' 0 N--CA 1.413 -3.259 0 N-CA-C 117.175 1.952 . . . . 10.0 117.175 -153.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.938 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . 13.96 -57.37 0.0 OUTLIER Pre-proline 0 C--N 1.289 -2.041 0 CA-C-N 108.615 -3.902 . . . . 10.0 119.275 153.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.708 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 32.5 Cg_exo -60.46 -63.33 0.12 Allowed 'Trans proline' 0 CA--C 1.562 1.888 0 CA-C-N 123.415 2.255 . . . . 10.0 115.252 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.708 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 55.7 Cg_endo -75.16 -52.86 0.1 Allowed 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.412 2.075 . . . . 10.0 112.239 174.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.765 HG12 HD13 ' A' ' 35' ' ' ILE . 83.1 t -83.26 -47.27 18.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 111.622 -2.535 . . . . 10.0 112.155 -166.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.924 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -42.67 -53.23 5.27 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 114.241 -1.345 . . . . 10.0 114.232 176.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.938 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 32.5 Cg_exo -70.01 -45.73 1.36 Allowed 'Trans proline' 0 CA--C 1.51 -0.719 0 C-N-CA 123.249 2.633 . . . . 10.0 111.324 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.536 ' HB1' ' CG2' ' A' ' 9' ' ' ILE . . . -51.33 -68.42 0.17 Allowed 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.376 0.608 . . . . 10.0 111.061 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.674 HD12 HG13 ' A' ' 24' ' ' VAL . 5.9 mt -78.0 -51.62 10.07 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.84 1.052 . . . . 10.0 113.84 -176.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.19 -42.01 96.97 Favored Glycine 0 N--CA 1.461 0.304 0 CA-C-N 116.117 -0.492 . . . . 10.0 113.314 -171.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -60.27 -25.93 66.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.716 0.294 . . . . 10.0 110.646 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.452 ' HD2' HD13 ' A' ' 9' ' ' ILE . 15.6 m-70 -102.3 16.75 25.29 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.641 -0.824 . . . . 10.0 110.623 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.48 9.25 87.1 Favored Glycine 0 CA--C 1.501 -0.797 0 CA-C-N 114.904 -1.043 . . . . 10.0 113.2 168.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.743 HG11 ' CD2' ' A' ' 66' ' ' PHE . 1.9 t -83.06 147.83 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 113.357 0.873 . . . . 10.0 113.357 -174.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -68.64 100.41 1.13 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.224 0.535 . . . . 10.0 111.132 172.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.765 HD13 HG12 ' A' ' 24' ' ' VAL . 1.4 mm -52.12 -42.03 34.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.684 -1.144 . . . . 10.0 111.132 173.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 82.9 mtp -64.75 -53.18 51.24 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 112.973 -1.921 . . . . 10.0 111.749 177.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 40.9 mt-10 -57.09 -41.21 78.45 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 118.945 -1.102 . . . . 10.0 110.93 177.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.673 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 75.5 t80 -57.83 -57.87 10.88 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 113.701 1.0 . . . . 10.0 113.701 172.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -56.15 -49.57 73.57 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.339 -1.301 . . . . 10.0 111.366 -178.561 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.451 ' HD3' ' O ' ' A' ' 40' ' ' LYS . 12.7 tmtt? -66.96 -22.83 65.91 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.665 -0.865 . . . . 10.0 108.665 -178.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.765 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 26.8 mtt180 -75.93 -64.45 1.08 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.062 -1.055 . . . . 10.0 112.253 170.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.626 ' CZ ' HG21 ' A' ' 46' ' ' THR . 70.1 t80 -55.98 -45.72 78.89 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.032 0.444 . . . . 10.0 110.883 -172.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.719 HD21 ' HB3' ' A' ' 18' ' ' ALA . 0.9 OUTLIER -61.09 -48.99 79.12 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.246 -0.888 . . . . 10.0 110.191 -178.106 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.43 -36.96 85.46 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 118.971 -1.092 . . . . 10.0 112.084 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.765 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 42.4 mm-40 -64.01 -47.84 78.72 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.933 0.873 . . . . 10.0 110.687 178.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.626 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 73.3 p -89.44 5.88 43.31 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.017 -1.447 . . . . 10.0 112.209 -168.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -47.9 -35.86 11.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.488 -1.233 . . . . 10.0 112.616 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -86.39 -36.39 19.2 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 115.491 -0.777 . . . . 10.0 111.487 -174.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -95.91 20.11 10.48 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.673 -0.862 . . . . 10.0 108.673 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.467 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -53.75 150.1 7.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.06 -1.427 . . . . 10.0 112.73 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.92 20.32 28.76 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 114.759 -1.11 . . . . 10.0 110.36 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.547 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 63.3 mtt -138.88 127.32 23.0 Favored 'General case' 0 C--O 1.208 -1.094 0 C-N-CA 117.527 -1.669 . . . . 10.0 114.595 -168.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.3 mm -67.15 91.93 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 118.773 0.715 . . . . 10.0 109.213 169.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.592 HD12 ' CG2' ' A' ' 46' ' ' THR . 9.4 mt -80.67 136.8 51.37 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.059 -0.719 . . . . 10.0 109.059 -176.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.487 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 7.4 Cg_exo -75.7 104.25 1.87 Allowed 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.202 1.935 . . . . 10.0 110.682 172.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.457 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -99.86 152.99 4.53 Favored 'Isoleucine or valine' 0 C--N 1.344 0.363 0 CA-C-N 119.706 1.139 . . . . 10.0 111.112 -174.701 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.469 HG22 ' HG2' ' A' ' 10' ' ' LYS . 97.1 t -134.15 113.57 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 110.106 -0.331 . . . . 10.0 110.106 174.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.678 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 20.6 mt -108.14 139.96 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 108.099 -1.074 . . . . 10.0 108.099 -174.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 60.5 m -122.31 97.08 5.3 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 114.833 -1.076 . . . . 10.0 108.88 176.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 65' ' ' SER . 2.6 p -87.86 138.12 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.186 0 O-C-N 121.017 -1.052 . . . . 10.0 110.461 -178.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.409 ' CD2' ' HA ' ' A' ' 66' ' ' PHE . 72.9 m-85 -93.78 172.12 8.45 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.179 -0.919 . . . . 10.0 112.961 -177.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -62.96 -21.31 66.01 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 113.813 -1.539 . . . . 10.0 111.43 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -76.89 -12.9 60.02 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 113.905 -1.498 . . . . 10.0 110.997 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.68 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 8.5 mmpt? 83.77 -3.26 1.13 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.244 1.018 . . . . 10.0 110.11 -170.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.524 ' O ' HG23 ' A' ' 60' ' ' VAL . 31.6 m -69.57 179.2 2.19 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.349 -0.841 . . . . 10.0 109.349 171.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.743 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -170.25 -176.25 2.17 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 119.639 1.109 . . . . 10.0 110.174 175.379 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.5 p -158.36 164.26 36.5 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 102.987 -2.968 . . . . 10.0 102.987 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.445 ' CB ' HG12 ' A' ' 58' ' ' ILE . 50.7 p90 -161.31 157.29 25.24 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.403 0.62 . . . . 10.0 109.539 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.425 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 23.1 pt -127.99 165.86 26.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 114.846 -1.07 . . . . 10.0 108.31 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.448 HD12 ' CE1' ' A' ' 42' ' ' PHE . 1.7 mm -127.86 130.46 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 108.396 -0.965 . . . . 10.0 108.396 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 65.1 mmtt -77.88 83.26 4.22 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.025 -0.731 . . . . 10.0 109.025 176.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.401 ' OG1' ' HA ' ' A' ' 112' ' ' LYS . 18.8 p -30.01 101.17 0.15 Allowed Pre-proline 0 C--N 1.326 -0.437 0 O-C-N 125.845 1.965 . . . . 10.0 110.934 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.618 ' HB2' HD13 ' A' ' 78' ' ' LEU . 50.9 Cg_exo -20.52 106.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.13 1 C-N-CA 125.432 4.088 . . . . 10.0 114.326 -164.032 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.576 ' O ' ' HD3' ' A' ' 112' ' ' LYS . 24.8 Cg_exo -23.64 -54.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.361 1.189 1 C-N-CA 126.143 4.562 . . . . 10.0 115.229 -169.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -176.6 -43.68 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 120.46 0.171 . . . . 10.0 111.313 171.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.64 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 23.1 t -57.34 -35.53 70.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.05 -0.523 . . . . 10.0 112.152 -171.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -70.32 -40.27 74.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.922 0.392 . . . . 10.0 111.552 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.618 HD13 ' HB2' ' A' ' 73' ' ' PRO . 8.5 mp -82.53 -26.62 32.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.252 0.549 . . . . 10.0 110.071 -178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.4 mt -60.56 -40.42 91.55 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.91 -0.774 . . . . 10.0 108.91 170.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.64 ' HG3' ' O ' ' A' ' 76' ' ' SER . 59.0 mttp -63.46 -23.35 67.36 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.481 -0.327 . . . . 10.0 111.189 175.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.577 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -58.02 -52.43 65.55 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 121.005 -0.278 . . . . 10.0 110.594 174.024 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.823 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -84.52 -62.48 1.54 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.466 1.506 . . . . 10.0 112.113 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.718 0 CA-C-N 111.329 -2.668 . . . . 10.0 107.929 -178.814 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.551 HG13 ' N ' ' A' ' 98' ' ' GLY . 7.7 p . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 112.954 0.724 . . . . 10.0 112.954 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.551 ' N ' HG13 ' A' ' 97' ' ' VAL . . . -169.57 152.28 19.24 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.263 -1.135 . . . . 10.0 110.263 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.677 ' CB ' ' HB3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -148.21 177.42 9.41 Favored 'General case' 0 CA--C 1.48 -1.739 0 CA-C-O 122.625 1.202 . . . . 10.0 110.491 -166.17 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.823 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.7 OUTLIER -164.89 -163.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 CA-C-N 111.308 -2.678 . . . . 10.0 105.639 -166.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.481 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 0.5 OUTLIER -127.98 156.26 42.97 Favored 'General case' 0 C--N 1.269 -2.901 0 C-N-CA 118.41 -1.316 . . . . 10.0 112.816 -169.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.673 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 8.4 tpp180 -40.37 -41.54 1.4 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 113.635 -1.621 . . . . 10.0 110.958 177.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -57.45 -44.15 84.53 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.922 0.712 . . . . 10.0 112.922 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.669 ' HG3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -61.75 -50.2 73.33 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.601 -0.84 . . . . 10.0 108.804 176.057 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.941 HG21 ' HG3' ' A' ' 129' ' ' GLU . 27.3 mm -38.32 -56.56 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.703 -1.135 . . . . 10.0 110.897 170.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.512 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 28.9 tt0 -50.68 -60.89 2.57 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.744 1.218 . . . . 10.0 113.222 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 31.4 mt-10 -57.97 -55.86 29.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.366 -1.288 . . . . 10.0 111.338 -176.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.585 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 46.8 mt -47.71 -50.05 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 116.651 -0.25 . . . . 10.0 110.568 171.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.534 ' HB3' HD11 ' A' ' 121' ' ' LEU . . . -49.46 -51.03 38.51 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.109 0.781 . . . . 10.0 113.109 176.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.595 ' HB3' HD13 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -76.07 -30.1 58.21 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.057 0.391 . . . . 10.0 112.057 -174.011 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.4 m -54.39 -46.38 73.09 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.033 0.444 . . . . 10.0 111.153 173.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 0.5 OUTLIER -100.4 17.69 20.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.867 -0.606 . . . . 10.0 111.026 -176.192 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.965 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 45.2 ttm -47.64 -46.71 61.0 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.017 -0.538 . . . . 10.0 112.229 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 113' ' ' MET . 33.2 Cg_endo -64.79 -21.7 64.37 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.521 1.481 . . . . 10.0 113.493 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.48 ' OD1' ' HD2' ' A' ' 71' ' ' LYS . 24.6 t70 -90.12 -53.2 4.58 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.812 0.815 . . . . 10.0 110.872 -178.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.5 HD13 ' HB2' ' A' ' 112' ' ' LYS . 10.3 mp -63.61 -2.96 1.88 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 113.72 -1.582 . . . . 10.0 111.49 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.418 HD22 ' HA ' ' A' ' 117' ' ' ASN . 2.9 t-20 60.92 48.19 6.92 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.852 -1.522 . . . . 10.0 109.644 176.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.965 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -80.47 114.36 19.31 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.134 -1.394 . . . . 10.0 112.522 -173.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -67.59 -36.22 80.48 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.455 0.645 . . . . 10.0 110.028 171.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.7 p -151.22 143.5 24.11 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 106.841 -1.54 . . . . 10.0 106.841 176.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.679 ' O ' ' HG3' ' A' ' 125' ' ' MET . 58.6 tp -54.27 -34.84 61.72 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 113.794 1.035 . . . . 10.0 113.794 -175.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -48.73 -39.78 26.06 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.59 0.709 . . . . 10.0 110.326 173.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.558 ' HA ' ' HD3' ' A' ' 126' ' ' LYS . . . -66.64 -49.61 65.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.927 -1.033 . . . . 10.0 110.836 176.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.579 ' HB3' HD12 ' A' ' 121' ' ' LEU . . . -57.16 -36.47 70.79 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.632 0.253 . . . . 10.0 110.381 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.679 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 83.1 mtp -55.48 -35.65 65.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.183 -0.462 . . . . 10.0 111.981 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.558 ' HD3' ' HA ' ' A' ' 123' ' ' ALA . 0.1 OUTLIER -64.52 -49.3 71.85 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 110.026 -0.361 . . . . 10.0 110.026 177.397 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.431 ' H ' HG13 ' A' ' 127' ' ' ILE . 55.8 mt -50.68 -63.64 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-O 121.336 0.589 . . . . 10.0 110.846 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.827 ' HB ' HG23 ' A' ' 105' ' ' ILE . 27.5 mm -50.76 -55.53 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 CA-C-N 114.45 -1.25 . . . . 10.0 111.687 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.941 ' HG3' HG21 ' A' ' 105' ' ' ILE . 7.1 mt-10 -52.83 -45.36 67.28 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 123.811 0.695 . . . . 10.0 109.72 178.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -71.6 -44.78 48.55 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.468 -0.872 . . . . 10.0 111.71 -174.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 90.9 m -45.75 -61.49 1.69 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.253 -0.973 . . . . 10.0 109.943 170.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.64 -49.39 47.34 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.565 -1.198 . . . . 10.0 111.876 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 19.6 ttmm -48.37 -54.57 13.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.555 -0.748 . . . . 10.0 111.55 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.4 t -63.23 -31.47 72.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.572 0.701 . . . . 10.0 110.382 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 35.8 mtp -80.06 7.72 8.57 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.897 1.073 . . . . 10.0 113.897 -176.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.493 ' O ' HG12 ' A' ' 97' ' ' VAL . . . 84.64 3.8 88.0 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 119.478 1.035 . . . . 10.0 111.789 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 33.3 mt -96.78 127.79 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 CA-C-O 121.959 0.885 . . . . 10.0 111.83 -176.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.677 ' HB3' ' CB ' ' A' ' 99' ' ' LYS . 39.1 tt0 -88.21 159.43 18.15 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.156 -1.384 . . . . 10.0 108.768 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.54 HG11 ' HG2' ' A' ' 129' ' ' GLU . 17.9 m -117.92 134.1 62.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 108.341 -0.985 . . . . 10.0 108.341 167.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 100' ' ' VAL . 26.9 m -138.62 69.37 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 114.784 1.401 . . . . 10.0 114.784 -174.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.9 t70 . . . . . 0 C--N 1.298 -1.673 0 CA-C-O 117.771 -1.109 . . . . 10.0 110.257 145.455 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 2.3 mtpp . . . . . 0 C--O 1.222 -0.358 0 N-CA-C 109.723 -0.473 . . . . 10.0 109.723 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.5 t -62.93 138.61 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 122.833 0.453 . . . . 10.0 111.719 -176.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.61 -38.47 5.17 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 173.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.527 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -154.28 141.34 19.35 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.857 0.688 . . . . 10.0 112.857 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -98.67 115.65 29.15 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.053 -1.462 . . . . 10.0 107.053 173.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.615 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 3.7 mt -113.9 85.45 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.051 0 N-CA-C 108.803 -0.814 . . . . 10.0 108.803 -174.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.469 ' O ' HD12 ' A' ' 11' ' ' LEU . 10.1 mtmp? -77.85 148.26 34.75 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 119.136 0.88 . . . . 10.0 110.304 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 10' ' ' LYS . 0.8 OUTLIER -156.38 135.3 11.88 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.003 -0.74 . . . . 10.0 109.003 -178.226 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -93.79 111.46 23.16 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.199 -1.038 . . . . 10.0 108.199 169.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 15.0 mt -127.94 135.21 27.16 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 121.594 0.711 . . . . 10.0 112.324 -166.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.592 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 22.1 Cg_exo -57.88 121.2 9.61 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.532 2.821 . . . . 10.0 111.861 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.564 ' CB ' ' HB ' ' A' ' 46' ' ' THR . . . -61.72 127.48 31.66 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 107.768 -1.197 . . . . 10.0 107.768 170.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.9 0.36 89.38 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 125.695 1.872 . . . . 10.0 112.625 -174.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.592 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 4.6 tmtp? -141.09 100.95 3.93 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.992 0.901 . . . . 10.0 111.911 177.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.84 132.24 3.67 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.421 -1.263 . . . . 10.0 112.395 176.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.469 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -177.03 -53.68 0.0 OUTLIER Pre-proline 0 N--CA 1.448 -0.537 0 N-CA-C 112.697 0.629 . . . . 10.0 112.697 178.5 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.619 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 80.6 Cg_endo -104.53 128.09 0.07 OUTLIER 'Trans proline' 0 N--CA 1.416 -3.044 0 N-CA-C 116.211 1.581 . . . . 10.0 116.211 -154.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.02 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 16.04 -84.11 0.0 OUTLIER Pre-proline 0 C--N 1.294 -1.806 0 CA-C-N 108.58 -3.918 . . . . 10.0 116.251 165.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.593 ' CB ' ' HD3' ' A' ' 23' ' ' PRO . 3.2 Cg_exo -31.31 -56.79 0.23 Allowed 'Trans proline' 0 CA--C 1.558 1.679 0 C-N-CA 122.906 2.404 . . . . 10.0 115.419 -165.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.619 ' HD2' ' O ' ' A' ' 20' ' ' PRO . 5.4 Cg_exo -83.95 -49.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 123.346 2.697 . . . . 10.0 112.237 171.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.972 HG12 HD13 ' A' ' 35' ' ' ILE . 57.9 t -88.87 -45.68 15.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 112.449 -2.16 . . . . 10.0 113.484 -163.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 1.02 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -47.56 -80.6 0.05 OUTLIER Glycine 0 C--O 1.221 -0.692 0 CA-C-N 114.609 -1.178 . . . . 10.0 114.304 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.632 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 13.0 Cg_exo -43.28 -41.2 9.97 Favored 'Trans proline' 0 CA--C 1.52 -0.223 0 C-N-CA 123.544 2.83 . . . . 10.0 112.316 174.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 24' ' ' VAL . . . -52.47 -77.94 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.644 0.735 . . . . 10.0 111.255 176.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.778 HD12 HG13 ' A' ' 24' ' ' VAL . 6.9 mt -75.55 -42.74 51.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.961 -1.018 . . . . 10.0 113.725 -173.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.9 -38.22 95.77 Favored Glycine 0 N--CA 1.463 0.489 0 CA-C-N 116.526 -0.306 . . . . 10.0 113.214 -176.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -63.87 -21.18 66.33 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 119.506 -0.877 . . . . 10.0 109.699 175.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -103.91 7.17 36.78 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.888 -0.725 . . . . 10.0 111.861 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.65 ' HA3' ' NZ ' ' A' ' 64' ' ' LYS . . . 56.79 37.44 77.48 Favored Glycine 0 CA--C 1.509 -0.31 0 CA-C-N 115.309 -0.86 . . . . 10.0 112.899 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.645 HG11 HD22 ' A' ' 28' ' ' LEU . 55.8 t -74.72 -32.15 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 115.734 1.753 . . . . 10.0 115.734 -169.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 90.06 78.17 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 125.3 1.44 . . . . 10.0 109.581 -169.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.972 HD13 HG12 ' A' ' 24' ' ' VAL . 1.4 mt -51.92 -40.63 28.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 113.046 -1.888 . . . . 10.0 113.336 176.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 87.5 mtp -63.04 -47.18 84.11 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 117.523 -1.671 . . . . 10.0 111.495 173.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.603 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 21.7 tp10 -60.0 -43.47 95.16 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 118.979 -1.088 . . . . 10.0 110.252 176.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.577 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 71.7 t80 -56.5 -57.04 14.05 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 113.928 1.084 . . . . 10.0 113.928 172.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.43 -50.14 73.98 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.882 0.873 . . . . 10.0 111.729 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -63.29 -22.88 67.15 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.244 -0.982 . . . . 10.0 108.756 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.831 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 33.1 mtm-85 -78.53 -64.31 1.2 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 118.228 -0.892 . . . . 10.0 112.192 168.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.598 ' CZ ' HG21 ' A' ' 46' ' ' THR . 69.8 t80 -53.11 -48.0 68.18 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 119.477 1.035 . . . . 10.0 110.224 -169.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -60.02 -50.24 74.52 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.037 -0.983 . . . . 10.0 110.326 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.72 93.71 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 119.157 -1.017 . . . . 10.0 111.943 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.831 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 7.0 mm-40 -66.26 -44.72 82.86 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 122.203 1.002 . . . . 10.0 110.713 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.61 ' CG2' HD12 ' A' ' 54' ' ' LEU . 81.6 p -89.76 0.5 56.96 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 113.963 -1.472 . . . . 10.0 111.986 -171.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.08 -38.81 8.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.307 -0.86 . . . . 10.0 112.44 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -79.44 -25.63 41.96 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.551 -0.75 . . . . 10.0 111.206 -173.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -108.41 21.66 17.0 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.555 0.742 . . . . 10.0 109.955 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -52.64 148.19 7.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.991 -1.004 . . . . 10.0 112.868 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.9 19.27 31.8 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 110.816 -0.914 . . . . 10.0 110.816 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.688 ' SD ' ' HB3' ' A' ' 77' ' ' PHE . 67.4 mtt -139.28 126.21 20.97 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 117.211 -1.796 . . . . 10.0 114.555 -166.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.3 mm -68.13 91.51 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.255 -0.646 . . . . 10.0 109.255 172.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.61 HD12 ' CG2' ' A' ' 46' ' ' THR . 7.7 mt -82.45 131.68 54.77 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.619 -0.511 . . . . 10.0 109.619 -177.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.587 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 17.1 Cg_exo -69.62 102.82 1.05 Allowed 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.394 2.063 . . . . 10.0 111.196 172.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.486 HG23 HG12 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -101.03 156.84 4.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 119.501 1.046 . . . . 10.0 111.016 -175.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.483 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 86.9 t -136.23 116.1 17.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.085 -0.507 . . . . 10.0 110.508 172.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.738 HD13 HD21 ' A' ' 28' ' ' LEU . 18.1 mt -105.57 140.39 23.78 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.925 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 -175.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.3 m -126.96 95.88 4.45 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 114.962 -1.017 . . . . 10.0 109.14 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.527 ' CG1' ' HB3' ' A' ' 7' ' ' ALA . 3.3 p -85.99 136.0 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 119.124 0.875 . . . . 10.0 109.827 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.642 ' HE2' ' HG1' ' A' ' 67' ' ' THR . 82.2 m-85 -94.51 173.33 7.68 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.496 0.665 . . . . 10.0 112.55 -176.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 24.8 mt-10 -62.14 -19.33 62.92 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.638 -1.164 . . . . 10.0 112.285 -177.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 4.6 m-20 -78.35 -11.55 59.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.588 -0.733 . . . . 10.0 111.041 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.65 ' NZ ' ' HA3' ' A' ' 32' ' ' GLY . 18.6 mtpp 82.04 1.19 1.42 Allowed 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 114.654 -1.157 . . . . 10.0 110.329 -167.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.502 ' O ' HG23 ' A' ' 60' ' ' VAL . 51.0 m -70.53 174.7 5.5 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.369 -1.287 . . . . 10.0 108.184 172.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.614 ' CD1' HG13 ' A' ' 33' ' ' VAL . 8.8 p90 -167.99 -179.02 3.97 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 121.394 1.906 . . . . 10.0 110.326 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.642 ' HG1' ' HE2' ' A' ' 61' ' ' TYR . 1.5 p -161.51 171.88 17.37 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 103.791 -2.67 . . . . 10.0 103.791 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 50.7 p90 -163.52 157.76 20.02 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.757 -0.831 . . . . 10.0 108.757 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.483 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 31.3 pt -127.77 164.9 28.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 107.767 -1.197 . . . . 10.0 107.767 -178.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.497 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 8.2 mt -138.84 123.17 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 108.034 -1.099 . . . . 10.0 108.034 -174.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.647 ' C ' ' HD2' ' A' ' 73' ' ' PRO . 41.5 mmtt -75.93 95.07 3.47 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.896 1.331 . . . . 10.0 113.531 -168.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.66 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -59.83 -33.46 16.03 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-N 112.554 -2.112 . . . . 10.0 114.743 167.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.741 ' HD3' ' HB3' ' A' ' 115' ' ' ASP . 9.2 Cg_endo -50.11 -42.19 46.96 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.683 2.922 . . . . 10.0 117.282 -171.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.587 ' HD3' ' HG2' ' A' ' 73' ' ' PRO . 82.9 Cg_exo -44.98 -31.33 5.33 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 122.366 2.044 . . . . 10.0 113.141 -178.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.731 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . . . 70.32 -38.47 0.41 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.72 1.007 . . . . 10.0 113.72 170.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.45 ' HA ' ' HE1' ' A' ' 135' ' ' MET . 49.8 m -50.04 -31.21 12.44 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 122.982 0.513 . . . . 10.0 111.85 -175.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.688 ' HB3' ' SD ' ' A' ' 52' ' ' MET . 73.6 m-85 -61.19 -55.58 30.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.165 0.507 . . . . 10.0 111.257 178.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.642 HD23 ' HZ1' ' A' ' 112' ' ' LYS . 3.3 mm? -78.72 -27.03 44.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.912 -175.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.871 HD22 HG21 ' A' ' 108' ' ' ILE . 3.5 mm? -59.56 -50.24 74.65 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.716 -0.475 . . . . 10.0 109.716 174.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.541 ' HA ' ' HB3' ' A' ' 83' ' ' ALA . 63.3 mttp -66.47 -15.39 63.32 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.557 177.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.52 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 3.1 tppp? -61.69 -38.77 89.07 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 120.778 -0.369 . . . . 10.0 110.294 171.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.875 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -85.44 -57.31 3.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.428 1.891 . . . . 10.0 112.394 172.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.541 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . . . . . . . . 0 C--N 1.3 -1.572 0 CA-C-N 110.76 -2.927 . . . . 10.0 107.268 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.501 HG13 ' N ' ' A' ' 98' ' ' GLY . 14.5 p . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 112.311 0.486 . . . . 10.0 112.311 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.721 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -159.18 165.49 34.3 Favored Glycine 0 CA--C 1.497 -1.059 0 N-CA-C 109.034 -1.627 . . . . 10.0 109.034 174.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.754 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 13.4 pttm -152.01 169.75 21.58 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 122.394 1.092 . . . . 10.0 110.771 -166.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.875 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -161.9 -145.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-N 112.119 -2.31 . . . . 10.0 105.807 -169.331 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 0.1 OUTLIER -162.49 144.99 10.99 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.372 -0.931 . . . . 10.0 108.937 -155.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.65 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 16.0 mmm180 -41.68 -50.14 4.21 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 124.57 1.169 . . . . 10.0 111.562 -177.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 24.8 tptp -56.31 -43.7 79.2 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.223 0.453 . . . . 10.0 112.223 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.57 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -61.39 -49.05 78.45 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.149 -0.686 . . . . 10.0 109.149 177.378 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.812 HG21 ' HG3' ' A' ' 129' ' ' GLU . 25.8 mm -40.26 -53.6 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 114.948 -1.024 . . . . 10.0 111.017 170.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.722 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 21.7 tt0 -51.02 -56.54 12.0 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 114.935 -1.029 . . . . 10.0 112.872 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.541 ' OE2' ' HE3' ' A' ' 110' ' ' LYS . 19.2 mm-40 -51.82 -58.49 6.28 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.119 -0.946 . . . . 10.0 110.551 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.871 HG21 HD22 ' A' ' 79' ' ' LEU . 26.3 mm -50.2 -50.37 20.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.851 -1.068 . . . . 10.0 110.679 173.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.547 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -51.19 -36.24 40.34 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 112.578 0.584 . . . . 10.0 112.578 175.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.722 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 39.7 mttm -71.74 -54.0 11.66 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.256 -177.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.606 HG22 ' O ' ' A' ' 108' ' ' ILE . 6.1 t -53.5 -28.51 31.43 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.666 0.617 . . . . 10.0 112.666 -175.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.731 ' HE3' ' HA ' ' A' ' 75' ' ' ALA . 0.2 OUTLIER -118.07 17.59 14.03 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.904 -0.497 . . . . 10.0 111.55 -177.727 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.686 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 48.6 ttm -49.17 -47.26 76.15 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.706 -0.679 . . . . 10.0 112.342 175.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 113' ' ' MET . 33.6 Cg_endo -61.53 -25.58 79.7 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 122.099 1.866 . . . . 10.0 112.418 -177.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.741 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 2.0 m-20 -93.96 -45.76 7.46 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.074 -0.966 . . . . 10.0 112.143 -173.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.691 HD21 HD12 ' A' ' 127' ' ' ILE . 5.3 mp -62.12 -4.35 1.66 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 114.661 -1.154 . . . . 10.0 111.268 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 115' ' ' ASP . 14.2 m120 64.23 43.86 4.67 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.87 -1.514 . . . . 10.0 109.066 177.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.686 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -80.64 109.13 14.88 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.942 -1.481 . . . . 10.0 112.331 -174.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -68.48 -36.43 78.94 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.902 -0.777 . . . . 10.0 108.902 173.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 87.3 p -145.88 143.42 29.57 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.089 -1.448 . . . . 10.0 107.089 172.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.608 ' O ' ' HG3' ' A' ' 125' ' ' MET . 41.1 tp -53.45 -29.46 35.73 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.944 1.461 . . . . 10.0 114.944 -174.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 122' ' ' GLU . 3.2 mp0 -50.67 -33.9 24.39 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 122.016 0.913 . . . . 10.0 110.067 174.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.9 -49.81 41.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.133 -1.394 . . . . 10.0 110.264 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.631 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -57.35 -35.29 69.73 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.991 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.608 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 79.8 mtp -55.61 -39.47 70.82 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 122.249 -0.282 . . . . 10.0 111.639 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -64.13 -52.34 59.58 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.447 0.536 . . . . 10.0 112.447 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.691 HD12 HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -52.24 -58.87 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 C-N-CA 119.879 -0.728 . . . . 10.0 110.412 177.649 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.711 ' HB ' HG23 ' A' ' 105' ' ' ILE . 22.9 mm -49.81 -55.92 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 CA-C-N 115.184 -0.916 . . . . 10.0 111.473 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.812 ' HG3' HG21 ' A' ' 105' ' ' ILE . 8.0 mt-10 -52.69 -42.64 64.96 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 123.718 0.636 . . . . 10.0 109.828 177.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -75.02 -46.02 18.12 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 121.215 -0.517 . . . . 10.0 112.643 -174.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.435 HG21 ' HB3' ' A' ' 75' ' ' ALA . 53.7 m -46.31 -59.74 2.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.942 -0.762 . . . . 10.0 108.942 170.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.503 ' HB1' ' CG2' ' A' ' 137' ' ' ILE . . . -52.17 -50.02 62.66 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.232 -0.44 . . . . 10.0 111.959 174.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.459 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 50.4 tttm -46.11 -50.8 14.96 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 123.656 0.598 . . . . 10.0 111.45 176.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.8 m -60.97 -38.3 85.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.39 -0.368 . . . . 10.0 111.845 -175.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.783 ' HG3' HD13 ' A' ' 137' ' ' ILE . 14.9 ptt? -91.4 17.7 8.16 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.274 1.213 . . . . 10.0 114.274 -174.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.46 ' O ' HG12 ' A' ' 97' ' ' VAL . . . 89.22 13.04 62.48 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 120.043 1.292 . . . . 10.0 112.99 175.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.783 HD13 ' HG3' ' A' ' 135' ' ' MET . 2.4 mp -98.99 126.72 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-O 121.683 0.754 . . . . 10.0 111.375 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.754 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -87.81 156.22 19.51 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.574 -1.194 . . . . 10.0 109.476 177.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.477 HG11 ' HG2' ' A' ' 129' ' ' GLU . 17.0 m -115.87 125.48 73.02 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.536 0 N-CA-C 108.14 -1.059 . . . . 10.0 108.14 169.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 100' ' ' VAL . 28.3 m -105.24 152.82 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 CA-C-N 113.753 -1.567 . . . . 10.0 107.693 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 . . . . . 0 C--N 1.275 -2.639 0 CA-C-N 114.048 -1.433 . . . . 10.0 111.101 -175.468 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.545 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 2.9 tppp? . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 106.453 -1.684 . . . . 10.0 106.453 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.5 t -61.47 126.82 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.521 0.6 . . . . 10.0 111.579 -171.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.27 -39.28 5.73 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.852 -0.613 . . . . 10.0 109.518 176.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.506 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -154.88 144.68 21.57 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.463 0.912 . . . . 10.0 113.463 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -92.37 133.65 35.67 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 107.436 -1.32 . . . . 10.0 107.436 169.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.695 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -121.53 82.72 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.717 -0.846 . . . . 10.0 108.717 175.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -77.67 126.54 31.04 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 120.199 1.363 . . . . 10.0 107.826 175.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.665 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -156.96 123.56 5.03 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 122.868 1.318 . . . . 10.0 111.92 -175.387 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -85.22 122.36 29.3 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.257 -1.792 . . . . 10.0 110.387 -171.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.665 HD21 HD11 ' A' ' 11' ' ' LEU . 85.6 mt -140.46 145.32 40.37 Favored Pre-proline 0 C--O 1.214 -0.764 0 CA-C-O 121.197 0.523 . . . . 10.0 111.903 -170.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.806 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 2.8 Cg_exo -67.75 127.27 15.96 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 123.815 3.01 . . . . 10.0 111.816 177.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.574 ' HB2' HD11 ' A' ' 54' ' ' LEU . . . -62.1 129.77 42.36 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 172.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.02 -2.38 84.07 Favored Glycine 0 N--CA 1.441 -0.974 0 O-C-N 125.619 1.824 . . . . 10.0 112.574 -175.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.806 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 28.8 mmtp -138.79 102.78 4.65 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.743 0.782 . . . . 10.0 111.639 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.688 ' O ' ' HB2' ' A' ' 39' ' ' CYS . . . -170.27 133.97 1.15 Allowed 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.174 -1.375 . . . . 10.0 111.951 172.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.637 ' HA ' ' CB ' ' A' ' 39' ' ' CYS . 3.4 t 179.69 -39.79 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 114.694 -1.139 . . . . 10.0 112.939 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.791 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 97.4 Cg_endo -104.31 124.44 0.07 OUTLIER 'Trans proline' 0 N--CA 1.411 -3.352 0 N-CA-C 115.659 1.369 . . . . 10.0 115.659 -161.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.012 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 6.18 -82.08 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.552 0 CA-C-N 109.799 -3.364 . . . . 10.0 114.606 161.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.864 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 68.3 Cg_exo -30.01 -56.62 0.18 Allowed 'Trans proline' 0 CA--C 1.56 1.804 0 C-N-CA 122.791 2.327 . . . . 10.0 115.521 -164.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.864 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 38.2 Cg_endo -82.19 -71.98 0.01 OUTLIER 'Trans proline' 0 CA--C 1.552 1.417 0 C-N-CA 122.817 2.345 . . . . 10.0 112.321 168.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.986 HG12 HD12 ' A' ' 35' ' ' ILE . 96.0 t -53.93 -52.84 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 127.869 2.467 . . . . 10.0 114.756 -175.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 1.012 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -45.44 -69.69 0.74 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 114.493 -1.231 . . . . 10.0 112.939 -178.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.651 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 24.0 Cg_exo -47.75 -49.63 13.21 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.206 2.604 . . . . 10.0 112.99 172.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.466 ' O ' ' HD2' ' A' ' 31' ' ' HIS . . . -43.61 -100.2 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 O-C-N 124.285 0.99 . . . . 10.0 112.789 176.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.844 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.342 0.0 OUTLIER -76.43 -27.28 56.17 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 117.759 -1.577 . . . . 10.0 113.838 -175.067 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.501 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -69.69 -40.4 76.64 Favored Glycine 0 CA--C 1.527 0.787 0 O-C-N 121.781 -0.575 . . . . 10.0 113.279 -174.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.473 ' HB3' ' O ' ' A' ' 26' ' ' PRO . 29.1 tt0 -59.87 -19.5 51.63 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 120.471 -0.492 . . . . 10.0 109.902 175.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.466 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 83.7 m-70 -98.92 24.53 7.6 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.201 -0.599 . . . . 10.0 110.334 176.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.849 ' HA3' ' HD2' ' A' ' 64' ' ' LYS . . . 89.17 -1.44 82.7 Favored Glycine 0 CA--C 1.495 -1.164 0 CA-C-N 115.48 -0.782 . . . . 10.0 112.608 166.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.905 HG11 ' CD2' ' A' ' 66' ' ' PHE . 3.1 t -83.44 148.64 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 114.107 1.151 . . . . 10.0 114.107 -170.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.418 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 4.9 m-20 -67.67 96.57 0.56 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.361 0.664 . . . . 10.0 110.56 172.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.986 HD12 HG12 ' A' ' 24' ' ' VAL . 17.2 mm -52.43 -39.24 28.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 122.005 0.907 . . . . 10.0 111.444 173.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.756 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 71.0 mtm -66.22 -50.4 63.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.447 -1.706 . . . . 10.0 112.087 175.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.53 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 1.6 tt0 -58.34 -40.16 81.43 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.138 -1.025 . . . . 10.0 110.128 176.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.59 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 90.8 t80 -56.15 -57.89 10.28 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 114.009 1.114 . . . . 10.0 114.009 170.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.756 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 14.2 p -59.63 -50.42 73.92 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 114.093 -1.412 . . . . 10.0 111.759 -176.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.409 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 58.5 tttm -66.42 -21.18 66.21 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 119.914 -0.714 . . . . 10.0 109.367 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.802 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 3.8 mtp180 -73.59 -65.65 0.8 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.352 -0.939 . . . . 10.0 112.146 169.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.577 ' CZ ' HG21 ' A' ' 46' ' ' THR . 72.9 t80 -53.58 -45.04 69.81 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.806 -171.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.604 HD22 ' N ' ' A' ' 43' ' ' ASN . 0.9 OUTLIER -59.62 -52.34 65.95 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.113 -0.949 . . . . 10.0 110.724 -178.301 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.03 96.28 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 118.817 -1.153 . . . . 10.0 112.385 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.802 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 13.1 mt-10 -67.55 -41.81 83.65 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.868 0.842 . . . . 10.0 111.142 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.602 ' CG2' HD12 ' A' ' 54' ' ' LEU . 80.1 p -88.84 4.56 47.3 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.782 -1.099 . . . . 10.0 112.155 -172.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.95 -42.65 18.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.106 -0.952 . . . . 10.0 112.168 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.68 -47.7 84.59 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 114.517 -1.22 . . . . 10.0 111.574 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.514 ' HB3' ' HE3' ' A' ' 52' ' ' MET . 39.6 mttm -101.36 24.1 10.07 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.268 0.556 . . . . 10.0 110.265 -171.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -53.23 145.09 14.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.695 -1.138 . . . . 10.0 112.622 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.34 16.75 36.4 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.844 -0.902 . . . . 10.0 110.844 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.519 ' SD ' ' HD1' ' A' ' 77' ' ' PHE . 41.0 mtm -141.88 127.37 18.91 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 117.675 -1.61 . . . . 10.0 115.144 -165.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.0 mm -65.9 92.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 O-C-N 121.759 -0.588 . . . . 10.0 109.947 174.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.602 HD12 ' CG2' ' A' ' 46' ' ' THR . 6.9 mt -83.51 129.83 58.53 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 108.2 -1.037 . . . . 10.0 108.2 178.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -71.5 111.41 3.11 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 C-N-CA 121.8 1.666 . . . . 10.0 110.619 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -100.11 153.56 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 119.997 1.272 . . . . 10.0 111.133 -176.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.417 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 77.1 t -134.1 116.8 23.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 109.786 -0.45 . . . . 10.0 109.786 174.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.695 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 17.5 mt -107.6 140.86 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 N-CA-C 108.704 -0.85 . . . . 10.0 108.704 -173.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.5 m -123.48 100.68 6.93 Favored 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 114.942 -1.026 . . . . 10.0 108.621 173.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 65' ' ' SER . 1.6 p -91.89 136.56 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.815 0 CA-C-N 119.227 0.921 . . . . 10.0 110.35 -177.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -95.7 172.52 7.99 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.041 0.448 . . . . 10.0 112.055 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.545 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 58.7 mt-10 -57.22 -20.59 28.14 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 113.996 -1.457 . . . . 10.0 111.959 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -73.69 -18.02 61.06 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.618 -1.173 . . . . 10.0 110.919 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.849 ' HD2' ' HA3' ' A' ' 32' ' ' GLY . 23.8 mtmt 82.27 -3.98 1.44 Allowed 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 124.205 1.002 . . . . 10.0 110.173 -164.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.607 ' O ' HG23 ' A' ' 60' ' ' VAL . 28.6 t -68.25 176.5 2.73 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.506 -0.924 . . . . 10.0 108.506 171.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.905 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -166.98 -176.84 3.54 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 120.124 1.329 . . . . 10.0 110.11 176.502 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.4 p -162.08 161.0 28.1 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 103.018 -2.956 . . . . 10.0 103.018 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.46 ' CB ' HG12 ' A' ' 58' ' ' ILE . 47.0 p90 -160.96 158.17 27.61 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 109.045 -0.724 . . . . 10.0 109.045 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.417 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 30.4 pt -119.95 165.98 14.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 114.443 -1.253 . . . . 10.0 108.059 -175.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.453 HD12 ' CE1' ' A' ' 42' ' ' PHE . 4.4 mm -125.09 119.93 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 106.704 -1.591 . . . . 10.0 106.704 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.691 ' C ' ' HD2' ' A' ' 73' ' ' PRO . 29.5 mmmt -77.28 86.87 3.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.671 0.748 . . . . 10.0 110.731 -169.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.746 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 12.7 t -67.71 -13.9 0.25 Allowed Pre-proline 0 CA--C 1.57 1.748 0 CA-C-N 114.04 -1.437 . . . . 10.0 114.597 174.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 1.028 ' HD3' ' HB3' ' A' ' 115' ' ' ASP . 3.9 Cg_exo -34.76 -51.89 0.68 Allowed 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 124.057 3.171 . . . . 10.0 115.298 174.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.462 ' HD2' ' O ' ' A' ' 71' ' ' LYS . 27.2 Cg_exo -62.49 112.03 1.48 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 CA-C-N 120.633 1.262 . . . . 10.0 110.987 173.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.574 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -80.35 3.69 20.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.844 0.355 . . . . 10.0 110.582 -178.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.673 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 1.4 m -56.16 -36.61 68.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.561 -0.745 . . . . 10.0 111.306 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.588 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 24.7 m-85 -65.54 -57.22 8.74 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 122.194 0.997 . . . . 10.0 111.433 -176.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.582 ' H ' HD22 ' A' ' 78' ' ' LEU . 0.8 OUTLIER -73.82 -23.72 59.7 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.123 -0.944 . . . . 10.0 109.894 -173.434 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . 49.2 mt -83.01 -13.71 55.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.698 -0.683 . . . . 10.0 110.9 174.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.673 ' HG2' ' O ' ' A' ' 76' ' ' SER . 28.4 mmtp -56.15 -60.87 2.87 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.833 -0.803 . . . . 10.0 108.833 170.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -63.71 -45.11 91.48 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.86 -0.609 . . . . 10.0 112.064 178.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.98 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -61.77 -57.95 9.89 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 123.137 1.446 . . . . 10.0 110.115 -171.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 79' ' ' LEU . . . . . . . . 0 C--N 1.291 -1.962 0 CA-C-N 111.472 -2.604 . . . . 10.0 110.067 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.588 HG13 ' H ' ' A' ' 98' ' ' GLY . 3.4 p . . . . . 0 CA--C 1.537 0.45 0 N-CA-C 113.692 0.997 . . . . 10.0 113.692 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.588 ' H ' HG13 ' A' ' 97' ' ' VAL . . . -171.26 173.64 44.82 Favored Glycine 0 CA--C 1.49 -1.509 0 N-CA-C 108.621 -1.792 . . . . 10.0 108.621 -171.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.689 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -150.56 -179.8 7.53 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 122.853 1.311 . . . . 10.0 112.223 -160.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.98 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -155.33 -144.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-N 111.527 -2.579 . . . . 10.0 105.182 -176.429 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 1.4 t -166.02 142.84 5.23 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 107.087 -1.449 . . . . 10.0 107.087 -155.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.686 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 23.1 tpp180 -41.62 -42.03 2.36 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 124.732 1.27 . . . . 10.0 111.204 -171.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 25.3 tptp -59.91 -46.44 89.33 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.737 1.014 . . . . 10.0 113.737 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.569 ' O ' HG13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -60.09 -45.66 92.18 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.189 -1.041 . . . . 10.0 108.189 178.691 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 1.002 HG23 ' HB ' ' A' ' 128' ' ' ILE . 39.4 mm -43.13 -52.77 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 CA-C-N 114.393 -1.276 . . . . 10.0 111.25 170.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.799 ' HG2' ' HD2' ' A' ' 110' ' ' LYS . 16.9 tt0 -48.52 -61.84 1.81 Allowed 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.967 -1.015 . . . . 10.0 112.967 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.566 ' HA ' ' HD3' ' A' ' 110' ' ' LYS . 37.7 mt-10 -56.62 -46.67 80.79 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.695 -1.139 . . . . 10.0 110.844 -175.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.72 HG22 ' HD3' ' A' ' 112' ' ' LYS . 34.2 mt -52.8 -58.43 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 115.759 -0.655 . . . . 10.0 110.085 169.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.487 ' HB3' HD11 ' A' ' 121' ' ' LEU . . . -45.48 -40.6 8.59 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.473 0.709 . . . . 10.0 112.695 177.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.799 ' HD2' ' HG2' ' A' ' 106' ' ' GLU . 38.9 mtpt -73.22 -48.76 32.29 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.737 -0.665 . . . . 10.0 111.368 -175.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 108' ' ' ILE . 1.1 t -57.2 -38.41 73.63 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 112.573 0.583 . . . . 10.0 112.573 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.72 ' HD3' HG22 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -98.21 6.46 47.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 122.602 0.361 . . . . 10.0 111.172 -174.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.636 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 54.1 ttm -50.25 -38.86 42.29 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.491 -0.777 . . . . 10.0 112.669 176.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 113' ' ' MET . 35.1 Cg_endo -61.28 -31.74 89.51 Favored 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 121.726 1.617 . . . . 10.0 111.782 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 1.028 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 0.4 OUTLIER -93.71 -52.99 4.21 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.891 -1.504 . . . . 10.0 112.719 -170.263 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.517 HD11 ' HA ' ' A' ' 113' ' ' MET . 0.3 OUTLIER -72.99 -177.46 2.43 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 123.034 1.397 . . . . 10.0 113.871 -173.18 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -96.46 49.03 1.1 Allowed 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 112.443 -2.162 . . . . 10.0 113.088 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.695 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . . . -64.66 -102.64 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.811 1.041 . . . . 10.0 113.811 173.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 118' ' ' ALA . 24.5 t-20 107.12 -78.42 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.829 1.652 . . . . 10.0 107.789 -167.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.2 t -87.15 147.86 25.44 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.622 -1.251 . . . . 10.0 107.622 162.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.679 ' O ' ' HG2' ' A' ' 125' ' ' MET . 61.8 tp -56.25 -34.7 66.64 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.673 -0.811 . . . . 10.0 110.938 166.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 32.2 mt-10 -48.35 -40.46 25.51 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.564 0.697 . . . . 10.0 110.38 173.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.25 -47.73 63.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.545 -1.207 . . . . 10.0 110.959 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.695 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . . . -56.83 -40.35 75.87 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.405 -0.518 . . . . 10.0 110.122 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.792 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 74.7 mmm -53.35 -40.24 64.75 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.387 0.675 . . . . 10.0 110.727 176.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.662 ' HA ' ' HG2' ' A' ' 129' ' ' GLU . 13.6 mmmm -68.32 -45.07 73.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.06 -0.973 . . . . 10.0 110.234 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.466 ' CD1' HD22 ' A' ' 116' ' ' LEU . 92.8 mt -49.73 -65.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-O 121.178 0.514 . . . . 10.0 110.175 173.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 1.002 ' HB ' HG23 ' A' ' 105' ' ' ILE . 12.5 mm -50.79 -56.19 5.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.711 -1.131 . . . . 10.0 112.399 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.662 ' HG2' ' HA ' ' A' ' 126' ' ' LYS . 0.3 OUTLIER -56.51 -41.86 77.39 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 109.14 -0.689 . . . . 10.0 109.14 -177.793 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.659 ' N ' ' HG3' ' A' ' 129' ' ' GLU . . . -72.83 -47.62 24.96 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.58 -0.736 . . . . 10.0 111.563 -175.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.574 HG21 ' HB3' ' A' ' 75' ' ' ALA . 35.3 m -46.25 -61.8 1.62 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.099 -1.051 . . . . 10.0 109.691 170.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.427 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -48.17 -47.84 34.83 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.0 -0.545 . . . . 10.0 111.97 174.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.589 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 79.1 tttt -48.53 -54.22 15.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.938 -1.028 . . . . 10.0 111.593 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.5 m -66.85 -29.28 69.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.044 0.45 . . . . 10.0 111.197 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 49.8 mtm -80.44 4.49 17.97 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.52 0.933 . . . . 10.0 113.52 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.97 11.43 79.01 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 119.364 0.984 . . . . 10.0 111.784 178.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.427 ' HB ' ' HB1' ' A' ' 132' ' ' ALA . 27.4 mt -101.66 131.33 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 CA-C-O 121.509 0.671 . . . . 10.0 112.411 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.689 ' HB3' ' HB2' ' A' ' 99' ' ' LYS . 7.8 tp10 -84.79 156.61 21.29 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 115.188 -0.915 . . . . 10.0 110.279 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.7 m -117.98 121.88 68.37 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.218 0 N-CA-C 107.889 -1.152 . . . . 10.0 107.889 165.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.803 HG22 ' O ' ' A' ' 100' ' ' VAL . 25.1 m -101.52 143.17 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 CA-C-N 113.961 -1.472 . . . . 10.0 108.265 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.7 t70 . . . . . 0 C--N 1.286 -2.163 0 CA-C-N 113.48 -1.691 . . . . 10.0 109.98 -173.378 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.509 ' HB3' ' HG3' ' A' ' 62' ' ' GLU . 30.5 mmtm . . . . . 0 CA--C 1.533 0.298 0 N-CA-C 111.26 0.096 . . . . 10.0 111.26 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.1 t -63.24 140.36 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.027 0.531 . . . . 10.0 111.329 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.46 -37.67 4.26 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 120.84 -0.344 . . . . 10.0 110.306 174.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.491 ' HB3' HG13 ' A' ' 60' ' ' VAL . . . -153.67 153.0 31.47 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.19 0.811 . . . . 10.0 113.19 -176.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -95.6 134.07 38.91 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.023 -1.103 . . . . 10.0 108.023 170.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.717 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.7 OUTLIER -120.65 80.19 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 168.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.415 ' HG2' HG13 ' A' ' 57' ' ' VAL . 55.5 mtmt -82.52 127.61 33.49 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 120.265 1.393 . . . . 10.0 108.482 176.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.663 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.27 128.75 6.91 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.959 0.885 . . . . 10.0 111.412 -174.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -78.52 122.67 26.17 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.311 -1.313 . . . . 10.0 110.141 -172.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.663 HD21 HD11 ' A' ' 11' ' ' LEU . 89.2 mt -140.43 133.66 14.93 Favored Pre-proline 0 N--CA 1.443 -0.817 0 CA-C-O 121.805 0.812 . . . . 10.0 112.072 -173.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.775 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 50.1 Cg_exo -52.0 125.08 16.19 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 124.072 3.181 . . . . 10.0 112.62 171.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.538 ' CB ' ' HB ' ' A' ' 46' ' ' THR . . . -62.13 127.29 30.69 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 107.696 -1.224 . . . . 10.0 107.696 169.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.85 -2.72 82.6 Favored Glycine 0 N--CA 1.443 -0.888 0 O-C-N 125.987 2.055 . . . . 10.0 112.744 -174.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.775 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 15.9 mmtp -140.16 99.62 3.71 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.083 0.944 . . . . 10.0 112.553 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.435 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -168.29 134.72 1.96 Allowed 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 114.073 -1.421 . . . . 10.0 111.767 174.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.707 ' HA ' ' HB2' ' A' ' 39' ' ' CYS . 1.6 t -178.11 -48.46 0.0 OUTLIER Pre-proline 0 N--CA 1.438 -1.06 0 CA-C-N 115.154 -0.93 . . . . 10.0 112.674 176.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.707 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 83.0 Cg_endo -104.62 133.25 0.09 OUTLIER 'Trans proline' 0 N--CA 1.409 -3.468 0 N-CA-C 117.049 1.903 . . . . 10.0 117.049 -152.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.92 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . 12.67 -63.3 0.0 OUTLIER Pre-proline 0 C--N 1.284 -2.243 0 CA-C-N 108.473 -3.967 . . . . 10.0 117.52 154.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.806 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 52.8 Cg_exo -52.63 -63.88 0.22 Allowed 'Trans proline' 0 CA--C 1.566 2.096 0 CA-C-N 123.964 2.451 . . . . 10.0 114.513 -177.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.806 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 60.4 Cg_endo -78.05 -52.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 122.624 2.216 . . . . 10.0 113.109 174.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.921 HG12 HD13 ' A' ' 35' ' ' ILE . 79.8 t -80.99 -45.27 21.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-N 111.995 -2.366 . . . . 10.0 112.689 -166.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.833 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -40.57 -64.75 1.13 Allowed Glycine 0 CA--C 1.521 0.448 0 O-C-N 124.808 1.318 . . . . 10.0 113.32 178.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.92 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 80.1 Cg_exo -58.77 -48.4 14.91 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.798 2.999 . . . . 10.0 111.39 177.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.633 ' O ' ' HD2' ' A' ' 31' ' ' HIS . . . -48.4 -94.22 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 124.344 1.028 . . . . 10.0 111.764 -176.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.658 HD13 ' H ' ' A' ' 28' ' ' LEU 0.314 0.0 OUTLIER -81.02 -28.55 35.4 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 118.119 -1.432 . . . . 10.0 114.198 -174.946 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.544 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -68.75 -40.84 85.01 Favored Glycine 0 N--CA 1.468 0.769 0 O-C-N 121.17 -0.956 . . . . 10.0 113.248 -176.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.578 ' HG3' ' HA ' ' A' ' 26' ' ' PRO . 27.5 mt-30 -66.26 -6.8 15.07 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 118.639 -1.225 . . . . 10.0 110.603 175.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.633 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 88.2 m-70 -105.82 16.26 25.48 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 120.496 -0.482 . . . . 10.0 111.49 171.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.75 ' HA3' ' HD2' ' A' ' 64' ' ' LYS . . . 69.65 22.74 76.81 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.763 -0.653 . . . . 10.0 113.862 172.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.634 HG13 ' CD1' ' A' ' 66' ' ' PHE . 73.9 t -75.22 -30.02 22.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -167.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 91.18 79.27 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 122.868 1.318 . . . . 10.0 109.982 -172.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.921 HD13 HG12 ' A' ' 24' ' ' VAL . 1.1 mm -47.36 -49.19 9.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 112.055 -2.339 . . . . 10.0 113.579 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 79.4 mtp -64.33 -46.63 82.68 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.587 -1.642 . . . . 10.0 111.31 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.709 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 21.3 tt0 -62.52 -42.21 99.37 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 117.955 -1.498 . . . . 10.0 110.589 178.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.688 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . 38.6 t80 -56.87 -53.38 58.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.457 0.91 . . . . 10.0 113.457 172.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.707 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -57.48 -47.1 82.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.286 -0.87 . . . . 10.0 111.16 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -65.57 -22.11 66.66 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.138 -1.025 . . . . 10.0 109.357 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.752 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 94.2 mtt180 -76.91 -65.55 0.93 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.444 -0.798 . . . . 10.0 112.3 173.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.634 ' CZ ' HG21 ' A' ' 46' ' ' THR . 67.4 t80 -57.28 -42.43 81.63 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.108 0.48 . . . . 10.0 110.305 -171.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.58 HD22 ' N ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER -58.87 -52.17 66.9 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.316 -0.856 . . . . 10.0 109.916 179.491 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.87 92.73 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 119.476 -0.89 . . . . 10.0 112.229 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.752 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 27.9 mm-40 -64.21 -47.66 78.87 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 122.034 0.921 . . . . 10.0 110.887 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.663 ' CG2' HD12 ' A' ' 54' ' ' LEU . 63.1 p -89.13 3.3 52.31 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.104 -1.407 . . . . 10.0 112.026 -169.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.21 -41.12 12.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.139 -0.937 . . . . 10.0 113.043 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.96 -19.86 29.8 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.794 -0.639 . . . . 10.0 111.573 -171.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.438 ' NZ ' ' HB3' ' A' ' 49' ' ' LYS . 6.1 mtpm? -109.18 21.57 16.97 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 123.605 0.762 . . . . 10.0 109.194 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.03 150.91 3.99 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.936 -1.029 . . . . 10.0 113.09 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.6 20.36 32.09 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 110.564 -1.014 . . . . 10.0 110.564 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.596 ' HB2' HD21 ' A' ' 54' ' ' LEU . 66.9 mtt -137.75 124.45 21.05 Favored 'General case' 0 C--O 1.211 -0.924 0 C-N-CA 117.203 -1.799 . . . . 10.0 113.829 -168.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 50.3 mm -65.77 91.7 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.928 -0.767 . . . . 10.0 108.928 171.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.735 HD13 HG21 ' A' ' 70' ' ' ILE . 8.9 mt -84.69 126.42 68.66 Favored Pre-proline 0 N--CA 1.448 -0.534 0 N-CA-C 108.79 -0.819 . . . . 10.0 108.79 -178.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.762 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 20.6 Cg_exo -68.52 106.77 1.49 Allowed 'Trans proline' 0 C--N 1.329 -0.458 0 C-N-CA 121.654 1.569 . . . . 10.0 110.619 172.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -96.67 142.98 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 120.254 1.388 . . . . 10.0 110.891 -174.698 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 58.3 t -116.67 111.23 34.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 120.594 -0.442 . . . . 10.0 110.654 171.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.717 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 28.6 mt -105.11 138.38 30.27 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.829 0 N-CA-C 107.139 -1.43 . . . . 10.0 107.139 -176.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.7 m -122.95 95.08 4.48 Favored 'General case' 0 N--CA 1.408 -2.559 0 CA-C-N 115.009 -0.996 . . . . 10.0 108.849 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.538 HG21 HG22 ' A' ' 33' ' ' VAL . 1.5 p -87.8 135.21 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.819 0 CA-C-N 119.425 1.011 . . . . 10.0 110.804 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -93.47 177.58 5.98 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.576 -0.738 . . . . 10.0 112.689 -173.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.509 ' HG3' ' HB3' ' A' ' 4' ' ' LYS . 5.9 mm-40 -55.63 -24.75 35.29 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 113.896 -1.502 . . . . 10.0 112.652 -178.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 20.0 t70 -79.37 -15.81 57.28 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.988 -1.005 . . . . 10.0 111.163 -177.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.75 ' HD2' ' HA3' ' A' ' 32' ' ' GLY . 28.6 mtmm 82.3 5.35 1.08 Allowed 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 114.764 -1.107 . . . . 10.0 110.339 -160.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.481 ' O ' HG23 ' A' ' 60' ' ' VAL . 21.5 t -71.26 173.08 8.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.002 -1.851 . . . . 10.0 106.002 175.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.688 ' CZ ' ' HB2' ' A' ' 38' ' ' PHE . 29.9 p90 -169.86 -177.18 2.56 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 121.994 2.179 . . . . 10.0 111.391 177.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.9 p -157.39 175.08 14.46 Favored 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 103.156 -2.905 . . . . 10.0 103.156 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 21.6 p90 -163.84 159.42 21.13 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.549 -0.908 . . . . 10.0 108.549 177.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.3 161.64 41.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.299 -1.371 . . . . 10.0 107.299 177.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.735 HG21 HD13 ' A' ' 54' ' ' LEU . 4.9 mm -109.52 134.06 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 108.228 -1.027 . . . . 10.0 108.228 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.823 ' NZ ' ' HA ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -81.88 91.05 6.48 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.179 0.514 . . . . 10.0 109.964 178.083 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.951 ' HB ' ' HG3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -50.16 104.17 0.41 Allowed Pre-proline 0 C--N 1.312 -1.037 0 CA-C-N 113.846 -1.524 . . . . 10.0 110.144 173.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.521 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 39.1 Cg_endo -66.5 149.35 84.46 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.608 2.206 . . . . 10.0 112.683 -169.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.877 ' HA ' HD11 ' A' ' 116' ' ' LEU . 47.5 Cg_exo -33.45 -61.24 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 124.098 3.199 . . . . 10.0 113.507 -178.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.54 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -174.28 10.8 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 112.853 0.686 . . . . 10.0 112.853 176.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.5 t -60.06 -64.24 1.02 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.068 0.461 . . . . 10.0 111.383 -174.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.48 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 80.7 m-85 -71.66 -28.61 63.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.179 -0.464 . . . . 10.0 111.231 -176.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.671 ' O ' ' HB3' ' A' ' 81' ' ' LYS . 3.0 mm? -84.21 -28.4 27.33 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.094 0.474 . . . . 10.0 111.098 -173.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 75' ' ' ALA . 11.3 mt -72.68 -36.33 67.86 Favored 'General case' 0 C--O 1.211 -0.952 0 C-N-CA 120.048 -0.661 . . . . 10.0 109.685 175.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -65.98 -21.34 66.4 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.02 0.438 . . . . 10.0 110.557 174.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.671 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 1.8 tmtp? -57.6 -50.25 73.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.391 -0.368 . . . . 10.0 110.536 171.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 1.069 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -79.12 -55.2 5.29 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.288 1.835 . . . . 10.0 113.208 176.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.29 -2.005 0 CA-C-N 111.152 -2.749 . . . . 10.0 107.453 -177.806 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.52 HG13 ' N ' ' A' ' 98' ' ' GLY . 7.2 p . . . . . 0 N--CA 1.447 -0.602 0 N-CA-C 113.001 0.741 . . . . 10.0 113.001 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -169.75 168.34 41.26 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 110.517 -1.033 . . . . 10.0 110.517 177.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.539 ' O ' HG13 ' A' ' 100' ' ' VAL . 0.7 OUTLIER -158.19 173.97 15.89 Favored 'General case' 0 CA--C 1.481 -1.705 0 CA-C-O 121.23 0.538 . . . . 10.0 110.847 -160.737 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 1.069 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -164.36 -169.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 113.769 -1.559 . . . . 10.0 110.631 -171.513 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.8 p -104.86 141.48 36.45 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 114.252 -1.34 . . . . 10.0 112.3 -169.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.699 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 5.0 ttp180 -46.53 -38.69 9.71 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.717 -0.674 . . . . 10.0 110.207 171.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 20.1 tptm -58.17 -45.42 87.53 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.211 -0.45 . . . . 10.0 111.658 174.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.553 ' HG3' ' CB ' ' A' ' 82' ' ' ALA . 2.2 tm0? -60.13 -56.73 18.02 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.339 -0.615 . . . . 10.0 109.339 175.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.799 HG23 ' HB ' ' A' ' 128' ' ' ILE . 24.3 mm -26.72 -57.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 123.812 0.695 . . . . 10.0 112.317 162.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.733 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 30.1 tt0 -50.35 -58.07 6.5 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.008 0.923 . . . . 10.0 112.904 178.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.96 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 8.5 mt-10 -55.61 -46.43 77.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.488 -0.778 . . . . 10.0 110.767 -178.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.573 HD12 ' HB3' ' A' ' 78' ' ' LEU . 31.4 mm -58.88 -50.38 79.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.455 -0.793 . . . . 10.0 109.407 175.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.447 ' HB1' ' CB ' ' A' ' 124' ' ' ALA . . . -53.81 -40.53 66.44 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.158 -0.928 . . . . 10.0 113.248 176.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.96 ' HD2' ' HA ' ' A' ' 107' ' ' GLU . 36.4 mttm -63.87 -50.04 70.38 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 121.693 0.758 . . . . 10.0 109.125 -177.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 89.4 m -49.12 -59.46 3.63 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 113.786 -1.552 . . . . 10.0 111.926 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.951 ' HG3' ' HB ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -93.51 16.57 13.3 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.691 0.997 . . . . 10.0 113.691 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.616 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 47.6 ttm -41.94 -50.9 10.37 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 118.593 0.633 . . . . 10.0 111.902 168.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 113' ' ' MET . 42.5 Cg_endo -66.69 -20.9 52.44 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 121.583 1.522 . . . . 10.0 113.321 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' A' ' 117' ' ' ASN . 0.7 OUTLIER -91.94 -49.73 6.08 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.647 0.737 . . . . 10.0 111.26 -177.368 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.877 HD11 ' HA ' ' A' ' 74' ' ' PRO . 7.2 mp -62.58 -3.23 1.37 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.235 -1.348 . . . . 10.0 111.494 178.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' A' ' 115' ' ' ASP . 58.5 t30 64.03 45.34 4.21 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.108 -1.406 . . . . 10.0 109.268 177.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.616 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -85.13 119.76 25.88 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 113.448 -1.705 . . . . 10.0 113.041 -174.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -65.36 -42.92 92.26 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.782 -0.822 . . . . 10.0 108.782 167.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.2 p -143.88 149.26 36.65 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.957 -1.127 . . . . 10.0 107.957 -177.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.519 HD11 ' HA ' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -50.42 -39.8 48.42 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 114.753 -1.112 . . . . 10.0 112.041 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.562 ' HA ' ' HG3' ' A' ' 125' ' ' MET . 1.8 mp0 -47.88 -42.11 26.01 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.786 0.803 . . . . 10.0 111.135 177.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.89 -48.0 70.07 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 118.428 -1.309 . . . . 10.0 110.831 177.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.496 ' HA ' HD12 ' A' ' 127' ' ' ILE . . . -55.59 -38.26 69.17 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.007 177.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.686 ' O ' ' HB2' ' A' ' 129' ' ' GLU . 20.6 mtp -55.06 -39.4 69.19 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.59 0.709 . . . . 10.0 110.076 -176.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.669 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 0.3 OUTLIER -65.34 -46.66 79.36 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.153 -1.385 . . . . 10.0 110.441 -178.281 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 124' ' ' ALA . 63.6 mt -52.37 -62.81 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-N 116.165 -0.471 . . . . 10.0 111.112 175.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.799 ' HB ' HG23 ' A' ' 105' ' ' ILE . 11.8 mm -53.67 -54.44 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.121 0 CA-C-N 115.08 -0.964 . . . . 10.0 110.349 -177.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.686 ' HB2' ' O ' ' A' ' 125' ' ' MET . 0.8 OUTLIER -53.24 -41.68 65.68 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.076 -0.965 . . . . 10.0 110.097 178.342 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.55 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -75.21 -44.41 22.9 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.843 -0.694 . . . . 10.0 111.86 -176.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.54 HG21 ' HB3' ' A' ' 75' ' ' ALA . 93.0 m -47.5 -59.8 2.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.099 -1.051 . . . . 10.0 109.28 170.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.512 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -50.51 -51.33 48.51 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.739 -0.664 . . . . 10.0 111.274 174.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.55 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 77.3 tttt -44.75 -56.04 4.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.854 -1.066 . . . . 10.0 111.792 175.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.3 t -64.11 -31.22 72.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.108 0.48 . . . . 10.0 111.176 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 50.3 mtm -83.12 4.52 26.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.837 1.051 . . . . 10.0 113.837 -176.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.75 12.68 77.04 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 120.161 1.346 . . . . 10.0 111.929 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 25.6 mt -101.79 124.14 55.41 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 CA-C-O 121.579 0.705 . . . . 10.0 111.29 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 139' ' ' VAL . 0.0 OUTLIER -88.58 158.44 18.27 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 114.549 -1.205 . . . . 10.0 109.317 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.424 ' N ' ' HG3' ' A' ' 138' ' ' GLU . 17.6 m -115.08 135.16 55.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 108.093 -1.077 . . . . 10.0 108.093 169.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.4 m -133.17 69.43 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 114.869 1.433 . . . . 10.0 114.869 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.5 t70 . . . . . 0 C--N 1.31 -1.117 0 CA-C-O 118.666 -0.683 . . . . 10.0 110.657 140.788 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.414 ' HB2' ' OE2' ' A' ' 62' ' ' GLU . 60.2 mttm . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 121.002 0.43 . . . . 10.0 111.136 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.8 132.75 28.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.297 -0.865 . . . . 10.0 111.552 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.453 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . . . -102.98 -37.2 7.9 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.089 -0.708 . . . . 10.0 109.089 173.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.447 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -154.89 -175.2 5.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.899 0.857 . . . . 10.0 112.66 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 4.1 pt20 -142.0 130.48 22.51 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.087 -1.415 . . . . 10.0 108.241 178.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.626 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -119.77 84.13 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 109.406 -0.591 . . . . 10.0 109.406 -176.579 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.418 ' NZ ' ' HB2' ' A' ' 10' ' ' LYS . 8.0 mtmp? -77.56 130.27 36.71 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 120.664 1.574 . . . . 10.0 107.72 176.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.706 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.87 124.84 4.99 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 122.379 1.085 . . . . 10.0 111.594 -176.607 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -82.85 120.18 25.33 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.878 -1.51 . . . . 10.0 109.716 -172.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.706 HD21 HD11 ' A' ' 11' ' ' LEU . 92.1 mt -137.34 138.73 25.76 Favored Pre-proline 0 CA--C 1.5 -0.953 0 CA-C-O 121.512 0.672 . . . . 10.0 112.036 -172.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.875 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 40.1 Cg_exo -55.71 124.88 17.37 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 123.204 2.603 . . . . 10.0 111.646 171.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.565 ' O ' ' HA ' ' A' ' 50' ' ' ALA . . . -62.02 126.39 27.17 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 106.996 -1.483 . . . . 10.0 106.996 168.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.29 -5.04 79.08 Favored Glycine 0 CA--C 1.529 0.909 0 O-C-N 125.515 1.759 . . . . 10.0 113.599 -175.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.875 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 31.9 mmtp -139.89 102.59 4.45 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.519 1.159 . . . . 10.0 111.674 178.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.642 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -170.17 130.7 0.96 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.17 -1.377 . . . . 10.0 111.927 175.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 65.0 m -166.7 -59.38 0.01 OUTLIER Pre-proline 0 N--CA 1.437 -1.122 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.907 -177.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.808 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 84.1 Cg_endo -108.05 136.22 0.05 OUTLIER 'Trans proline' 0 N--CA 1.421 -2.778 0 N-CA-C 117.05 1.904 . . . . 10.0 117.05 -157.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.064 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 11.69 -85.63 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.585 1 CA-C-N 108.393 -4.003 . . . . 10.0 115.335 167.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.853 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 56.9 Cg_exo -32.08 -54.43 0.32 Allowed 'Trans proline' 0 CA--C 1.558 1.711 0 C-N-CA 122.662 2.242 . . . . 10.0 115.579 -163.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.853 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 32.0 Cg_endo -84.54 -53.63 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 122.516 2.144 . . . . 10.0 112.651 168.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.808 HG12 ' CD1' ' A' ' 35' ' ' ILE . 75.9 t -81.53 -55.98 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 113.331 -1.759 . . . . 10.0 113.991 -167.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 1.064 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -43.1 -77.46 0.09 OUTLIER Glycine 0 CA--C 1.519 0.335 0 CA-C-N 114.736 -1.12 . . . . 10.0 114.1 -177.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.808 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 22.8 Cg_exo -45.09 -41.82 16.18 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.817 3.011 . . . . 10.0 112.681 173.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 24' ' ' VAL . . . -51.08 -101.52 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 123.475 0.484 . . . . 10.0 111.858 176.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.824 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.308 0.0 OUTLIER -73.33 -25.8 60.77 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 117.511 -1.676 . . . . 10.0 112.951 -172.422 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.536 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -71.83 -40.78 57.34 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.098 -0.572 . . . . 10.0 113.024 -176.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.409 ' HB3' ' O ' ' A' ' 26' ' ' PRO . 10.2 tt0 -63.09 -16.71 60.86 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 119.178 -1.009 . . . . 10.0 109.712 175.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.526 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 95.7 m-70 -98.88 20.1 13.78 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 120.12 -0.632 . . . . 10.0 110.102 176.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.47 -1.64 76.39 Favored Glycine 0 CA--C 1.5 -0.872 0 CA-C-N 115.201 -0.909 . . . . 10.0 113.126 167.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.824 ' HB ' HD23 ' A' ' 28' ' ' LEU . 11.3 t -82.48 147.1 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 113.305 0.854 . . . . 10.0 113.305 -172.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -69.69 98.91 1.25 Allowed 'General case' 0 C--N 1.341 0.219 0 CA-C-O 121.291 0.567 . . . . 10.0 110.868 172.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.808 ' CD1' HG12 ' A' ' 24' ' ' VAL . 2.5 mm -52.31 -39.25 27.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.867 -1.061 . . . . 10.0 111.464 174.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.702 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 85.3 mtp -64.61 -52.1 59.24 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 113.244 -1.798 . . . . 10.0 111.618 176.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.64 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 31.1 mt-10 -58.49 -40.12 81.92 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.11 -1.036 . . . . 10.0 111.024 176.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.62 ' CE1' HD11 ' A' ' 58' ' ' ILE . 90.3 t80 -58.33 -59.74 4.87 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.929 1.085 . . . . 10.0 113.929 172.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.702 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 18.3 p -58.82 -48.05 82.64 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 114.832 -1.077 . . . . 10.0 111.761 -177.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -65.22 -22.74 66.92 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.824 -0.806 . . . . 10.0 108.824 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.743 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 10.7 mtm180 -78.45 -63.26 1.44 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 119.321 -0.952 . . . . 10.0 112.899 170.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.582 ' CZ ' HG21 ' A' ' 46' ' ' THR . 67.4 t80 -55.2 -43.61 74.59 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 118.717 0.689 . . . . 10.0 110.403 -172.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.642 HD21 ' HB3' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -59.8 -51.38 69.97 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.311 -0.858 . . . . 10.0 109.851 -179.625 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.98 -40.25 97.18 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 119.239 -0.985 . . . . 10.0 112.182 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.743 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 23.5 mt-10 -67.92 -45.24 74.93 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.578 0.704 . . . . 10.0 111.079 -178.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.584 ' CG2' HD12 ' A' ' 54' ' ' LEU . 72.3 p -86.93 6.2 33.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.998 -1.001 . . . . 10.0 112.209 -172.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.7 -34.61 5.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.632 -1.167 . . . . 10.0 112.561 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -79.63 -38.54 33.6 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.585 -0.734 . . . . 10.0 112.053 -176.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -94.14 18.66 10.42 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 109.127 -0.694 . . . . 10.0 109.127 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -50.46 133.88 24.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.08 -0.963 . . . . 10.0 112.661 -178.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.05 19.48 10.1 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 114.786 -1.097 . . . . 10.0 110.799 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.587 ' HB2' HD21 ' A' ' 54' ' ' LEU . 67.3 mtt -137.5 127.48 25.81 Favored 'General case' 0 C--O 1.208 -1.108 0 C-N-CA 117.457 -1.697 . . . . 10.0 114.295 -169.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.2 mm -65.94 91.74 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 118.688 0.676 . . . . 10.0 109.372 169.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.593 HD13 HG21 ' A' ' 70' ' ' ILE . 6.9 mt -81.08 138.06 49.41 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 -177.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 54' ' ' LEU . 3.7 Cg_exo -78.67 104.84 1.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.95 1.766 . . . . 10.0 110.472 172.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -101.01 144.14 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 119.716 1.144 . . . . 10.0 110.995 -175.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 85.0 t -119.4 118.51 57.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 116.224 -0.444 . . . . 10.0 110.475 171.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.626 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 16.4 mt -104.94 141.29 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.722 0 N-CA-C 108.515 -0.921 . . . . 10.0 108.515 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.8 m -127.68 97.89 5.0 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 114.714 -1.13 . . . . 10.0 109.134 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 65' ' ' SER . 2.1 p -91.3 136.03 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 O-C-N 121.276 -0.89 . . . . 10.0 110.618 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.437 ' HE2' HG23 ' A' ' 67' ' ' THR . 65.2 m-85 -92.48 171.14 9.23 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.586 -0.734 . . . . 10.0 112.292 -175.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.453 ' HA ' ' HB2' ' A' ' 6' ' ' ALA . 39.7 mt-10 -58.38 -23.51 57.22 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.594 -1.184 . . . . 10.0 112.77 -177.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 2.8 m-20 -81.27 -6.41 58.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.872 -0.604 . . . . 10.0 112.568 -176.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 53.5 mtpt 83.97 1.31 0.95 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.967 0.889 . . . . 10.0 110.011 -167.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.598 ' O ' HG23 ' A' ' 60' ' ' VAL . 8.5 t -72.01 172.23 10.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.313 -1.312 . . . . 10.0 108.016 172.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.801 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -167.6 -177.48 3.55 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 120.241 1.382 . . . . 10.0 109.501 176.207 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.505 ' HA ' HH22 ' A' ' 41' ' ' ARG . 22.2 p -157.82 169.95 23.46 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 103.217 -2.883 . . . . 10.0 103.217 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.447 ' HB3' HG12 ' A' ' 58' ' ' ILE . 56.2 p90 -164.18 153.86 14.24 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.622 -0.881 . . . . 10.0 108.622 176.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.5 pt -131.89 153.24 38.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 108.178 -1.045 . . . . 10.0 108.178 -176.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.593 HG21 HD13 ' A' ' 54' ' ' LEU . 1.6 mm -107.39 131.76 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.389 -1.338 . . . . 10.0 107.389 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.662 ' C ' ' HD2' ' A' ' 73' ' ' PRO . 13.9 mmmm -77.71 90.2 4.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.033 0.92 . . . . 10.0 110.999 -177.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.602 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -60.63 -32.93 12.52 Favored Pre-proline 0 CA--C 1.562 1.434 0 CA-C-N 113.758 -1.564 . . . . 10.0 115.134 172.49 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.664 ' HG2' ' HD3' ' A' ' 74' ' ' PRO . 14.0 Cg_endo -54.8 -36.69 91.61 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.377 2.718 . . . . 10.0 117.281 -170.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.664 ' HD3' ' HG2' ' A' ' 73' ' ' PRO . 79.8 Cg_exo -47.14 -29.25 8.72 Favored 'Trans proline' 0 C--N 1.366 1.481 0 C-N-CA 121.963 1.776 . . . . 10.0 112.504 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.411 ' HB3' HG21 ' A' ' 131' ' ' THR . . . 73.04 -42.33 0.53 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.474 0.916 . . . . 10.0 113.474 169.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.2 p -45.43 -35.65 3.84 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.575 0.75 . . . . 10.0 112.69 -175.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.556 ' HB3' ' SD ' ' A' ' 52' ' ' MET . 75.3 m-85 -55.14 -50.31 69.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.545 0.688 . . . . 10.0 111.34 178.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.774 ' HB3' HD12 ' A' ' 108' ' ' ILE . 4.8 mp -93.25 -12.58 29.83 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.081 -0.648 . . . . 10.0 111.591 -174.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 79' ' ' LEU . 3.3 mm? -62.12 -37.28 84.52 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.17 -1.048 . . . . 10.0 108.17 166.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -56.74 -43.17 80.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.104 -0.953 . . . . 10.0 110.185 172.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? -54.94 -46.71 75.0 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.517 -0.765 . . . . 10.0 112.33 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.75 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -70.44 -49.17 51.48 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.087 1.355 . . . . 10.0 111.678 174.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.288 -2.08 0 CA-C-N 111.413 -2.63 . . . . 10.0 111.298 -167.82 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' ' 98' ' ' GLY . 13.5 p . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 116.118 1.895 . . . . 10.0 116.118 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.469 ' N ' HG13 ' A' ' 97' ' ' VAL . . . -152.39 162.04 29.7 Favored Glycine 0 N--CA 1.431 -1.661 0 N-CA-C 109.793 -1.323 . . . . 10.0 109.793 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.754 ' CB ' ' HG2' ' A' ' 138' ' ' GLU . 0.1 OUTLIER -139.93 168.53 19.6 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 122.851 1.31 . . . . 10.0 111.187 -170.478 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.75 HG11 ' HB1' ' A' ' 82' ' ' ALA . 2.6 m -156.37 -146.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 CA-C-N 111.516 -2.583 . . . . 10.0 104.732 -171.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.419 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 6.6 t -164.5 156.84 16.55 Favored 'General case' 0 C--N 1.282 -2.344 0 C-N-CA 117.693 -1.603 . . . . 10.0 110.71 -163.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.558 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 1.3 tmt_? -41.79 -42.94 2.79 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 112.718 -2.037 . . . . 10.0 110.628 -175.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -59.27 -44.22 92.46 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.032 0.753 . . . . 10.0 113.032 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.663 ' O ' HG12 ' A' ' 108' ' ' ILE . 3.1 mp0 -60.7 -51.76 67.99 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.392 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.706 HG23 ' HB ' ' A' ' 128' ' ' ILE . 39.3 mm -36.95 -53.32 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 CA-C-N 114.806 -1.088 . . . . 10.0 111.309 167.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.796 ' HA ' ' SD ' ' A' ' 125' ' ' MET . 4.9 tt0 -50.81 -60.25 3.25 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.833 -1.076 . . . . 10.0 113.168 -177.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -55.97 -48.97 74.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.157 -0.928 . . . . 10.0 110.502 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.774 HD12 ' HB3' ' A' ' 78' ' ' LEU . 18.4 mm -51.77 -56.58 5.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.593 171.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.545 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -50.83 -35.19 31.13 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.371 0.508 . . . . 10.0 112.371 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.757 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 92.7 mttt -76.91 -51.59 10.94 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 116.004 -0.544 . . . . 10.0 111.113 -178.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 108' ' ' ILE . 10.3 t -57.26 -17.73 13.13 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.145 0.794 . . . . 10.0 113.145 -176.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 0.1 OUTLIER -132.21 18.84 4.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.374 0.607 . . . . 10.0 110.011 -179.248 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.64 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 46.5 ttm -48.52 -45.63 69.14 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 114.798 -1.092 . . . . 10.0 112.307 175.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 113' ' ' MET . 19.0 Cg_endo -55.8 -23.62 42.7 Favored 'Trans proline' 0 C--N 1.363 1.291 0 C-N-CA 122.364 2.043 . . . . 10.0 112.338 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.625 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 5.0 m-20 -96.8 -46.44 6.26 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.883 -1.053 . . . . 10.0 112.85 -173.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.595 ' CD2' HD12 ' A' ' 127' ' ' ILE . 6.6 mp -63.92 36.92 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 114.525 -1.216 . . . . 10.0 112.986 -176.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.484 ' H ' ' C ' ' A' ' 115' ' ' ASP . 0.2 OUTLIER 17.96 54.34 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.181 1.392 . . . . 10.0 112.279 -172.099 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -103.23 123.27 46.43 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.464 0.913 . . . . 10.0 113.464 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -67.64 -33.55 75.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.34 0.59 . . . . 10.0 109.854 169.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.1 p -148.43 145.41 27.99 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.569 -0.9 . . . . 10.0 108.569 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.678 ' O ' ' HG2' ' A' ' 125' ' ' MET . 56.7 tp -51.85 -38.44 55.97 Favored 'General case' 0 C--O 1.219 -0.542 0 N-CA-C 114.52 1.304 . . . . 10.0 114.52 -176.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.556 ' O ' ' HD3' ' A' ' 126' ' ' LYS . 19.8 mm-40 -49.66 -37.14 27.31 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.24 0.543 . . . . 10.0 110.931 176.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.04 -47.8 70.28 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 118.651 -1.22 . . . . 10.0 110.574 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.564 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -59.06 -30.98 68.45 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.212 0.53 . . . . 10.0 110.658 177.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.796 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 86.8 mmm -58.21 -38.71 77.31 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.495 0.664 . . . . 10.0 110.771 178.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.556 ' HD3' ' O ' ' A' ' 122' ' ' GLU . 4.0 mptp? -65.14 -52.04 57.59 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.954 -1.021 . . . . 10.0 111.846 177.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.595 HD12 ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -52.36 -58.83 2.0 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.688 0 C-N-CA 119.803 -0.759 . . . . 10.0 110.806 178.504 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.706 ' HB ' HG23 ' A' ' 105' ' ' ILE . 27.4 mm -50.75 -58.96 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.88 0 C-N-CA 123.801 0.84 . . . . 10.0 111.746 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.667 ' HG3' HG21 ' A' ' 105' ' ' ILE . 4.3 mt-10 -52.76 -43.68 65.97 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.548 -0.751 . . . . 10.0 109.453 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -71.5 -46.66 39.08 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.461 -0.876 . . . . 10.0 111.481 -176.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.411 HG21 ' HB3' ' A' ' 75' ' ' ALA . 51.7 m -46.63 -62.41 1.39 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.972 -1.114 . . . . 10.0 110.047 173.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.81 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -50.91 -48.64 60.55 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.845 -0.616 . . . . 10.0 111.699 174.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 58.7 tttm -47.31 -54.99 9.62 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.366 -0.834 . . . . 10.0 111.037 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.7 m -65.91 -28.56 69.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.061 0.457 . . . . 10.0 110.637 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 43.6 mtm -81.29 -2.26 48.33 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.507 0.928 . . . . 10.0 113.507 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 80.88 44.58 8.2 Favored Glycine 0 C--O 1.216 -1.01 0 CA-C-N 119.696 1.135 . . . . 10.0 112.219 -177.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.81 ' HB ' ' HB1' ' A' ' 132' ' ' ALA . 1.9 mm -119.86 127.12 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.67 0 CA-C-O 121.389 0.614 . . . . 10.0 110.475 175.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.754 ' HG2' ' CB ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -87.49 145.76 26.11 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 114.948 -1.024 . . . . 10.0 109.326 176.104 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 18.9 m -113.46 134.62 55.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 107.634 -1.247 . . . . 10.0 107.634 171.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.632 HG22 ' O ' ' A' ' 100' ' ' VAL . 12.9 m -129.65 72.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 114.674 1.361 . . . . 10.0 114.674 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.024 0 N-CA-C 114.216 1.191 . . . . 10.0 114.216 140.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.524 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 27.4 mtpp . . . . . 0 C--O 1.221 -0.447 0 N-CA-C 109.051 -0.722 . . . . 10.0 109.051 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.4 t -62.97 133.97 28.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 122.392 0.277 . . . . 10.0 110.679 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.53 -38.61 6.39 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.394 -0.595 . . . . 10.0 109.394 174.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.522 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -157.44 159.02 36.9 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 113.58 0.955 . . . . 10.0 113.58 -175.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.804 HE21 ' HA ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -100.88 135.45 42.3 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.53 -1.214 . . . . 10.0 108.416 170.208 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.643 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -120.16 80.15 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 108.317 -0.994 . . . . 10.0 108.317 167.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.466 ' HG2' HG13 ' A' ' 57' ' ' VAL . 36.2 mttm -80.79 129.69 34.66 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 121.08 1.764 . . . . 10.0 107.484 176.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.519 HD21 HD11 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -158.09 130.28 7.01 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 122.209 1.004 . . . . 10.0 111.601 -176.603 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -81.75 119.13 23.47 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.026 -1.443 . . . . 10.0 109.664 -172.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.519 HD11 HD21 ' A' ' 11' ' ' LEU . 33.2 mt -136.06 133.97 20.02 Favored Pre-proline 0 CA--C 1.504 -0.822 0 CA-C-O 121.495 0.664 . . . . 10.0 112.578 -169.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.605 ' HB2' ' CB ' ' A' ' 17' ' ' LYS . 39.8 Cg_exo -56.05 122.97 12.71 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 123.534 2.823 . . . . 10.0 111.866 172.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.648 ' HB1' ' HB ' ' A' ' 46' ' ' THR . . . -60.38 128.53 37.17 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 107.814 -1.18 . . . . 10.0 107.814 170.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.6 1.29 82.53 Favored Glycine 0 CA--C 1.527 0.832 0 O-C-N 125.808 1.942 . . . . 10.0 112.972 -175.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.605 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . 0.7 OUTLIER -142.01 88.66 2.12 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.022 0.911 . . . . 10.0 112.089 -177.773 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.642 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -163.75 133.02 3.95 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.898 -1.046 . . . . 10.0 112.514 177.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.566 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 4.5 t 175.07 -42.86 0.0 OUTLIER Pre-proline 0 C--O 1.22 -0.487 0 O-C-N 124.349 1.031 . . . . 10.0 112.615 177.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.7 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 56.5 Cg_endo -99.07 121.45 0.12 Allowed 'Trans proline' 0 N--CA 1.42 -2.845 0 CA-C-N 120.612 1.254 . . . . 10.0 115.24 -159.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.067 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 10.65 -85.19 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 109.907 -3.315 . . . . 10.0 115.26 167.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.805 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 26.2 Cg_exo -25.11 -57.52 0.07 OUTLIER 'Trans proline' 0 CA--C 1.561 1.83 0 C-N-CA 123.543 2.829 . . . . 10.0 115.913 -165.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.805 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 1.0 OUTLIER -86.16 -59.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.363 1.309 0 C-N-CA 123.365 2.71 . . . . 10.0 112.474 171.401 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.664 HG13 HD12 ' A' ' 28' ' ' LEU . 36.7 t -73.95 -43.07 52.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 112.159 -2.292 . . . . 10.0 113.759 -168.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 1.067 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -54.74 -71.8 0.66 Allowed Glycine 0 C--O 1.218 -0.857 0 CA-C-N 114.588 -1.187 . . . . 10.0 113.221 -177.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.619 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 17.1 Cg_exo -46.15 -46.27 16.7 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.52 2.813 . . . . 10.0 112.653 173.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.7 -75.25 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.437 0.637 . . . . 10.0 111.375 177.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.699 HD21 ' CD1' ' A' ' 58' ' ' ILE . 5.0 mt -69.65 -46.96 64.94 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.512 0.93 . . . . 10.0 113.512 -177.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.43 -40.33 97.49 Favored Glycine 0 C--N 1.32 -0.35 0 CA-C-N 115.462 -0.79 . . . . 10.0 113.481 -172.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -63.44 -27.14 69.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.057 0.456 . . . . 10.0 110.327 178.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -99.11 13.18 33.79 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.379 0.609 . . . . 10.0 110.353 177.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.511 ' O ' ' HE3' ' A' ' 64' ' ' LYS . . . 76.45 11.41 85.15 Favored Glycine 0 CA--C 1.501 -0.799 0 CA-C-N 114.883 -1.053 . . . . 10.0 113.319 171.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.811 HG13 ' CD1' ' A' ' 66' ' ' PHE . 59.6 t -80.92 139.58 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 112.117 0.414 . . . . 10.0 112.117 -172.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.434 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -70.5 100.52 1.81 Allowed 'General case' 0 C--N 1.343 0.284 0 CA-C-O 121.586 0.708 . . . . 10.0 110.875 178.363 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.504 ' CD1' ' HA2' ' A' ' 25' ' ' GLY . 92.9 mt -51.0 -45.9 29.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 114.604 -1.18 . . . . 10.0 111.931 175.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.8 mtm -64.73 -54.68 27.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 112.997 -1.91 . . . . 10.0 111.246 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 34' ' ' ASN . 9.1 tp10 -53.37 -44.02 68.25 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 121.172 -0.211 . . . . 10.0 110.432 177.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.59 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 56.7 t80 -59.79 -56.24 24.26 Favored 'General case' 0 C--O 1.213 -0.834 0 N-CA-C 114.052 1.131 . . . . 10.0 114.052 171.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.468 ' SG ' ' HB ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -57.59 -49.79 75.24 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.968 0.907 . . . . 10.0 111.968 -177.739 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -65.46 -21.18 66.61 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 119.471 -0.892 . . . . 10.0 108.853 -176.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.661 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 46.9 mtt180 -78.9 -62.04 1.82 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.221 -0.9 . . . . 10.0 112.652 168.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.621 ' CZ ' HG21 ' A' ' 46' ' ' THR . 79.4 t80 -53.27 -48.4 68.34 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.535 0.683 . . . . 10.0 110.065 -173.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.642 HD21 ' HB3' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -61.16 -47.78 84.61 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.674 -1.148 . . . . 10.0 110.27 -176.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.79 -38.91 92.51 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 119.163 -1.015 . . . . 10.0 112.077 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.661 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 37.1 mm-40 -63.24 -45.84 89.71 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.147 0.975 . . . . 10.0 110.303 178.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.648 ' HB ' ' HB1' ' A' ' 15' ' ' ALA . 70.0 p -90.87 -0.48 57.74 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.15 -1.386 . . . . 10.0 112.477 -167.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.35 -37.09 7.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.15 -0.932 . . . . 10.0 112.577 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -83.64 -24.76 31.26 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.337 -0.847 . . . . 10.0 111.429 -172.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.7 mtmm -113.23 25.84 10.99 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.54 0.686 . . . . 10.0 109.959 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.458 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -54.13 154.92 3.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.39 -1.277 . . . . 10.0 113.257 177.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.95 21.06 40.57 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.574 -1.01 . . . . 10.0 110.574 -177.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.602 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 67.3 mtt -139.47 125.23 19.52 Favored 'General case' 0 C--O 1.209 -1.065 0 C-N-CA 116.866 -1.934 . . . . 10.0 114.653 -166.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.6 mm -66.88 91.39 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 109.409 -0.589 . . . . 10.0 109.409 172.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.613 HD12 ' CG2' ' A' ' 46' ' ' THR . 7.2 mt -82.2 131.49 56.07 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.62 -0.511 . . . . 10.0 109.62 -177.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.509 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 13.5 Cg_exo -72.06 96.04 0.77 Allowed 'Trans proline' 0 C--N 1.331 -0.377 0 C-N-CA 122.5 2.133 . . . . 10.0 111.265 173.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -92.96 157.65 2.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 119.586 1.084 . . . . 10.0 111.579 -174.668 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.497 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 95.2 t -135.39 115.94 18.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.4 173.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.699 ' CD1' HD21 ' A' ' 28' ' ' LEU . 25.5 mt -108.81 138.0 37.98 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.742 0 N-CA-C 107.953 -1.129 . . . . 10.0 107.953 -174.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.3 m -123.13 92.83 3.78 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 114.845 -1.07 . . . . 10.0 109.102 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.611 HG21 HG22 ' A' ' 33' ' ' VAL . 2.6 p -86.0 134.8 26.43 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 O-C-N 121.258 -0.901 . . . . 10.0 110.817 -177.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -91.98 173.58 7.77 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.748 0.785 . . . . 10.0 112.939 -176.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 59.7 mt-10 -61.71 -15.98 45.19 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.122 -1.399 . . . . 10.0 112.506 -178.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.61 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 7.1 m-20 -75.52 -17.41 60.1 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.51 -0.476 . . . . 10.0 110.692 177.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 42.1 mtpt 82.41 1.62 1.28 Allowed 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 124.492 1.12 . . . . 10.0 109.993 -160.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.51 ' O ' HG23 ' A' ' 60' ' ' VAL . 28.7 t -73.43 174.32 8.34 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 113.313 -1.767 . . . . 10.0 106.846 173.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.811 ' CD1' HG13 ' A' ' 33' ' ' VAL . 55.7 p90 -169.35 -176.1 2.42 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 122.077 2.217 . . . . 10.0 110.764 177.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.4 p -157.32 174.91 14.71 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 103.022 -2.955 . . . . 10.0 103.022 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.444 ' CB ' HG12 ' A' ' 58' ' ' ILE . 35.8 p90 -163.72 157.92 19.69 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.472 -0.936 . . . . 10.0 108.472 177.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.497 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 38.8 pt -127.74 166.99 23.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 106.702 -1.592 . . . . 10.0 106.702 177.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.469 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 8.9 mt -134.17 124.8 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 107.514 -1.291 . . . . 10.0 107.514 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 30.4 mmmt -76.93 81.78 3.48 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.721 -0.844 . . . . 10.0 108.721 -176.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.709 ' CG2' ' HA ' ' A' ' 112' ' ' LYS . 1.7 t -50.66 116.5 7.03 Favored Pre-proline 0 C--N 1.312 -1.035 0 N-CA-C 107.057 -1.46 . . . . 10.0 107.057 174.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.706 ' HG3' ' CE1' ' A' ' 77' ' ' PHE . 61.3 Cg_endo -65.87 166.46 20.39 Favored 'Trans proline' 0 CA--C 1.517 -0.331 0 C-N-CA 123.451 2.767 . . . . 10.0 114.939 -153.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.878 ' HA ' HD21 ' A' ' 116' ' ' LEU . 19.7 Cg_exo -67.63 55.67 0.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.141 2.56 . . . . 10.0 111.14 170.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.496 ' HB2' HD13 ' A' ' 128' ' ' ILE . . . 75.46 -22.33 0.27 Allowed 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 113.572 0.952 . . . . 10.0 113.572 173.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.2 p -38.06 -78.89 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.571 1.322 . . . . 10.0 114.571 -167.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.706 ' CE1' ' HG3' ' A' ' 73' ' ' PRO . 3.2 p90 -82.51 -18.84 40.13 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.009 0.744 . . . . 10.0 113.009 -173.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.616 ' HB3' HD12 ' A' ' 108' ' ' ILE . 2.7 mm? -67.99 -36.19 79.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.399 0.618 . . . . 10.0 109.765 172.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.714 HD13 ' HB2' ' A' ' 132' ' ' ALA . 27.0 mt -62.56 -39.48 93.78 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.683 -0.69 . . . . 10.0 110.837 176.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.497 ' HA ' ' HB3' ' A' ' 83' ' ' ALA . 37.0 ttpt -66.04 -17.4 64.66 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.37 -0.532 . . . . 10.0 111.01 176.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.542 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 11.3 mmmm -64.56 -39.47 93.81 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 121.572 -0.705 . . . . 10.0 111.117 169.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 1.02 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -78.5 -56.33 4.52 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.492 1.917 . . . . 10.0 112.277 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.497 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . . . . . . . . 0 C--N 1.294 -1.808 0 CA-C-N 110.825 -2.898 . . . . 10.0 105.844 177.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.57 HG13 ' N ' ' A' ' 98' ' ' GLY . 3.9 p . . . . . 0 CA--C 1.544 0.733 0 N-CA-C 117.027 2.232 . . . . 10.0 117.027 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -58.32 160.13 13.89 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 114.593 0.597 . . . . 10.0 114.593 -158.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.863 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -154.79 172.34 18.13 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 115.593 -0.303 . . . . 10.0 111.201 -157.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 1.02 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -168.29 114.16 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-O 122.887 1.327 . . . . 10.0 111.869 179.511 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 1.2 t -39.78 143.62 0.23 Allowed 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 111.458 -2.61 . . . . 10.0 114.149 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.764 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 26.6 mtt180 -46.34 -32.63 3.28 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 112.243 -2.253 . . . . 10.0 113.732 -170.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.517 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 17.5 tppt? -57.67 -44.22 85.58 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.859 -0.526 . . . . 10.0 111.742 178.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.521 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.6 OUTLIER -56.95 -47.99 79.38 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.603 -0.888 . . . . 10.0 108.603 176.21 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.999 HG23 ' HB ' ' A' ' 128' ' ' ILE . 32.7 mm -43.09 -49.41 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.141 -1.391 . . . . 10.0 111.852 173.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.8 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 28.8 tt0 -46.86 -62.17 1.52 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.093 0.957 . . . . 10.0 113.262 175.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.641 ' HA ' ' HD3' ' A' ' 110' ' ' LYS . 47.7 mt-10 -52.73 -54.8 28.69 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.232 -0.895 . . . . 10.0 110.803 -176.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.652 ' O ' HG22 ' A' ' 111' ' ' THR . 24.5 mm -47.42 -55.43 2.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.124 -0.944 . . . . 10.0 110.126 170.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.633 ' O ' ' HE2' ' A' ' 112' ' ' LYS . . . -49.19 -36.95 21.1 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.888 0.699 . . . . 10.0 112.888 176.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.8 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 51.4 mtpt -72.58 -49.24 33.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.832 -0.622 . . . . 10.0 111.299 -174.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.652 HG22 ' O ' ' A' ' 108' ' ' ILE . 6.1 t -53.67 -36.57 62.28 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.091 0.404 . . . . 10.0 112.091 -177.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.815 ' HD2' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -106.71 13.5 27.97 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 113.336 0.865 . . . . 10.0 113.336 -174.792 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.701 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 14.6 ptp -55.2 -39.37 76.69 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 113.056 0.762 . . . . 10.0 113.056 176.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.626 ' HD3' ' HG3' ' A' ' 113' ' ' MET . 73.2 Cg_endo -71.13 -28.94 18.25 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 121.326 1.35 . . . . 10.0 112.112 -179.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -95.88 -42.48 8.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.825 -1.079 . . . . 10.0 113.673 -170.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.878 HD21 ' HA ' ' A' ' 74' ' ' PRO . 1.1 mp -71.16 9.64 0.71 Allowed 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.118 -0.946 . . . . 10.0 113.272 -177.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 63.77 36.44 10.54 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 122.21 1.005 . . . . 10.0 108.529 174.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 119' ' ' ASN . . . -69.56 -69.85 0.32 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 113.9 -1.5 . . . . 10.0 113.076 -167.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.431 ' HB3' ' O ' ' A' ' 118' ' ' ALA . 27.3 t-20 100.87 -38.88 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.659 1.224 . . . . 10.0 110.412 -178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 89.2 p -145.92 144.76 30.37 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.023 -1.473 . . . . 10.0 107.023 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.574 ' O ' ' HG3' ' A' ' 125' ' ' MET . 50.8 tp -58.59 -41.98 87.02 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.915 0.709 . . . . 10.0 112.915 178.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -48.23 -43.64 32.45 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.394 0.616 . . . . 10.0 109.687 174.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.59 ' O ' ' HG3' ' A' ' 126' ' ' LYS . . . -62.88 -51.93 65.09 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.624 -1.171 . . . . 10.0 111.292 173.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.716 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -55.34 -30.49 60.38 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.252 -0.905 . . . . 10.0 111.652 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.574 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 83.4 mtp -61.55 -46.33 90.35 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.791 1.034 . . . . 10.0 113.791 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.74 ' HD3' ' N ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -62.83 -40.02 96.12 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.094 0.405 . . . . 10.0 112.094 -178.04 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.74 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -55.11 -59.33 2.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 C-N-CA 118.785 -1.166 . . . . 10.0 109.779 174.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.999 ' HB ' HG23 ' A' ' 105' ' ' ILE . 12.9 mm -49.47 -57.85 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 CA-C-N 114.82 -1.082 . . . . 10.0 111.856 -175.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' A' ' 125' ' ' MET . 6.8 pt-20 -55.77 -44.71 77.97 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.118 -0.633 . . . . 10.0 109.948 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -69.15 -49.2 41.81 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.601 -0.727 . . . . 10.0 112.396 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.514 HG21 ' O ' ' A' ' 74' ' ' PRO . 44.9 m -45.72 -62.04 1.46 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.853 -0.673 . . . . 10.0 109.904 171.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.714 ' HB2' HD13 ' A' ' 79' ' ' LEU . . . -49.37 -51.09 36.99 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.222 -0.444 . . . . 10.0 111.235 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -48.29 -48.61 35.74 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 123.911 0.757 . . . . 10.0 111.759 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.1 m -62.53 -39.69 94.38 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.636 0.255 . . . . 10.0 111.254 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.668 ' HG3' HD13 ' A' ' 137' ' ' ILE . 23.6 ptt? -90.63 15.69 10.5 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.477 0.917 . . . . 10.0 113.477 -173.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 103.5 -21.78 38.01 Favored Glycine 0 C--N 1.331 0.273 0 CA-C-N 119.627 1.103 . . . . 10.0 112.759 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.668 HD13 ' HG3' ' A' ' 135' ' ' MET . 2.0 mp -83.15 128.33 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 CA-C-O 122.94 1.353 . . . . 10.0 111.33 -169.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.863 ' HB3' ' HB3' ' A' ' 99' ' ' LYS . 3.3 tp10 -85.64 157.93 20.22 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 112.288 -2.233 . . . . 10.0 109.196 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.458 ' N ' ' HG3' ' A' ' 138' ' ' GLU . 17.1 m -116.49 124.73 72.99 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.371 0 N-CA-C 107.59 -1.263 . . . . 10.0 107.59 168.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 101' ' ' THR . 1.8 m -98.28 160.12 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 C-N-CA 119.143 -1.023 . . . . 10.0 109.409 -175.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 C--N 1.297 -1.694 0 CA-C-N 115.059 -0.973 . . . . 10.0 110.085 179.735 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 75.8 mmtt . . . . . 0 C--O 1.223 -0.3 0 N-CA-C 108.279 -1.008 . . . . 10.0 108.279 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.22 129.52 25.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.689 0.28 . . . . 10.0 110.851 -174.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.56 -36.3 7.16 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 175.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.541 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -158.91 178.26 10.28 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.177 0.806 . . . . 10.0 113.177 -177.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.53 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 93.9 mt-30 -129.32 132.73 47.17 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.182 -1.372 . . . . 10.0 109.184 174.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.633 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.4 OUTLIER -116.47 81.14 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 N-CA-C 108.452 -0.944 . . . . 10.0 108.452 176.303 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -81.63 123.58 28.81 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 120.256 -1.527 . . . . 10.0 108.412 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.655 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.7 132.93 8.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.986 0.898 . . . . 10.0 111.881 -173.061 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.404 ' HB3' ' CG2' ' A' ' 53' ' ' ILE . 0.2 OUTLIER -87.13 123.57 32.32 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.726 -1.125 . . . . 10.0 110.815 -172.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.655 HD21 HD11 ' A' ' 11' ' ' LEU . 82.7 mt -138.82 137.94 20.69 Favored Pre-proline 0 C--O 1.218 -0.564 0 CA-C-O 121.51 0.671 . . . . 10.0 112.648 -174.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.8 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 23.6 Cg_exo -58.45 134.18 59.52 Favored 'Trans proline' 0 C--N 1.327 -0.583 0 C-N-CA 124.238 3.292 . . . . 10.0 112.518 174.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.512 ' HB1' ' O ' ' A' ' 46' ' ' THR . . . -56.1 133.93 52.37 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.131 -1.433 . . . . 10.0 107.131 166.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.33 0.06 50.99 Favored Glycine 0 N--CA 1.443 -0.897 0 O-C-N 125.448 1.717 . . . . 10.0 113.449 174.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.8 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 14.0 mmmm -138.41 77.45 1.63 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.481 1.141 . . . . 10.0 111.017 -178.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.724 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -156.96 130.73 8.21 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.907 -0.717 . . . . 10.0 112.027 176.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.586 ' HA ' ' HB3' ' A' ' 39' ' ' CYS . 1.5 t -179.27 -41.66 0.0 OUTLIER Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 114.092 -1.413 . . . . 10.0 112.328 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.723 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 98.7 Cg_endo -103.08 127.31 0.09 OUTLIER 'Trans proline' 0 N--CA 1.408 -3.51 0 N-CA-C 115.503 1.309 . . . . 10.0 115.503 -161.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 1.085 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 11.09 -86.54 0.0 OUTLIER Pre-proline 0 C--N 1.295 -1.764 0 CA-C-N 109.12 -3.673 . . . . 10.0 115.605 166.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.906 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 51.3 Cg_exo -30.88 -55.09 0.23 Allowed 'Trans proline' 0 CA--C 1.559 1.773 0 C-N-CA 122.863 2.376 . . . . 10.0 115.74 -162.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.906 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 5.0 Cg_exo -81.53 -57.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.791 2.327 . . . . 10.0 112.246 171.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.022 HG12 HD12 ' A' ' 35' ' ' ILE . 57.5 t -79.83 -52.01 15.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 112.556 -2.111 . . . . 10.0 114.187 -167.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 1.085 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -50.73 -74.51 0.28 Allowed Glycine 0 C--O 1.216 -0.982 0 CA-C-N 114.831 -1.077 . . . . 10.0 113.537 -176.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.751 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 19.9 Cg_exo -45.01 -43.88 15.29 Favored 'Trans proline' 0 CA--C 1.517 -0.344 0 C-N-CA 123.777 2.985 . . . . 10.0 112.993 174.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 24' ' ' VAL . . . -50.24 -77.23 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.498 0.666 . . . . 10.0 111.271 175.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.772 HD21 ' CD1' ' A' ' 58' ' ' ILE . 3.3 mt -69.65 -48.49 59.64 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.872 1.064 . . . . 10.0 113.872 -176.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.62 -37.21 88.72 Favored Glycine 0 C--N 1.32 -0.353 0 CA-C-N 115.416 -0.811 . . . . 10.0 113.261 -174.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -63.75 -24.92 67.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.706 0.289 . . . . 10.0 110.559 176.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -100.47 16.52 24.32 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.652 0.739 . . . . 10.0 109.899 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.14 3.39 88.96 Favored Glycine 0 CA--C 1.5 -0.858 0 CA-C-N 114.549 -1.205 . . . . 10.0 113.59 168.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.864 HG11 ' CD2' ' A' ' 66' ' ' PHE . 2.9 t -80.56 146.45 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 113.664 0.987 . . . . 10.0 113.664 -171.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.919 HD22 ' HG2' ' A' ' 37' ' ' GLU . 54.5 t30 -74.27 104.17 4.94 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.643 0.735 . . . . 10.0 110.973 174.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 1.022 HD12 HG12 ' A' ' 24' ' ' VAL . 22.3 mm -53.91 -38.14 35.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 114.092 -1.413 . . . . 10.0 112.413 177.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.806 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -61.8 -56.83 15.37 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 113.503 -1.68 . . . . 10.0 112.038 176.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.919 ' HG2' HD22 ' A' ' 34' ' ' ASN . 21.1 mm-40 -56.64 -35.28 68.17 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.737 -1.185 . . . . 10.0 110.46 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.621 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 87.3 t80 -60.11 -60.53 3.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.187 1.18 . . . . 10.0 114.187 171.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.806 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 20.9 p -60.84 -47.01 88.3 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.005 -0.998 . . . . 10.0 111.706 -176.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.575 ' HE2' ' HB3' ' A' ' 36' ' ' MET . 52.5 mtmt -63.83 -23.69 67.46 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.416 -0.914 . . . . 10.0 109.59 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.762 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 20.3 mtp180 -73.98 -65.09 0.88 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 119.658 -0.817 . . . . 10.0 111.504 168.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.65 ' HZ ' ' HB2' ' A' ' 54' ' ' LEU . 71.4 t80 -54.34 -48.58 71.26 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.17 0.51 . . . . 10.0 110.559 -170.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.724 HD21 ' HB3' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -61.2 -50.89 71.29 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.265 -0.879 . . . . 10.0 110.32 -176.712 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.0 -38.83 87.44 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 118.88 -1.128 . . . . 10.0 111.77 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.762 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 13.3 mt-10 -67.48 -42.52 82.82 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.769 0.795 . . . . 10.0 111.296 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.624 ' CG2' HD12 ' A' ' 54' ' ' LEU . 68.0 p -89.62 -2.17 58.23 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 114.877 -1.056 . . . . 10.0 112.342 -169.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -44.51 -37.54 3.57 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 124.098 0.874 . . . . 10.0 112.696 -174.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -80.8 -21.06 41.23 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.298 -0.864 . . . . 10.0 111.357 -172.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.908 ' HB3' ' HZ ' ' A' ' 77' ' ' PHE . 51.8 mttp -100.97 23.52 10.58 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 123.399 1.571 . . . . 10.0 109.238 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . 0.382 . . 49.03 -90.24 0.02 OUTLIER 'General case' 0 CA--C 1.47 -2.122 0 N-CA-C 119.641 3.2 . . . . 10.0 119.641 165.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -137.99 76.6 0.35 Allowed Glycine 0 N--CA 1.429 -1.822 0 N-CA-C 109.9 -1.28 . . . . 10.0 109.9 -171.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.756 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 24.9 mmt -138.61 126.38 22.24 Favored 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 116.907 -1.917 . . . . 10.0 114.177 -164.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.404 ' CG2' ' HB3' ' A' ' 12' ' ' GLN . 32.2 mm -64.7 85.53 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 109.432 -0.581 . . . . 10.0 109.432 175.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.65 ' HB2' ' HZ ' ' A' ' 42' ' ' PHE . 9.8 mt -80.88 132.3 57.68 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.434 -0.58 . . . . 10.0 109.434 -175.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 54' ' ' LEU . 16.1 Cg_exo -71.33 93.91 0.66 Allowed 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.753 2.302 . . . . 10.0 111.888 176.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.45 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -92.69 154.66 3.18 Favored 'Isoleucine or valine' 0 C--N 1.345 0.383 0 CA-C-N 119.081 0.855 . . . . 10.0 111.236 -174.591 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.434 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 90.3 t -134.68 116.22 20.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.332 -0.395 . . . . 10.0 110.181 172.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.772 ' CD1' HD21 ' A' ' 28' ' ' LEU . 16.1 mt -105.62 140.24 24.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.16 -1.052 . . . . 10.0 108.16 -173.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.8 m -124.52 95.38 4.51 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 114.927 -1.033 . . . . 10.0 108.611 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 65' ' ' SER . 3.5 p -85.28 137.52 20.69 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 CA-C-N 119.167 0.894 . . . . 10.0 110.827 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -95.91 170.87 9.0 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 112.855 0.687 . . . . 10.0 112.855 -177.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 24.5 mt-10 -60.89 -20.98 62.86 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.688 -1.142 . . . . 10.0 112.259 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.526 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 7.2 t70 -73.96 -15.35 61.11 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.137 -0.938 . . . . 10.0 110.934 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 44.5 mtpt 84.54 0.77 0.87 Allowed 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 114.722 -1.127 . . . . 10.0 110.782 -169.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.582 ' O ' HG23 ' A' ' 60' ' ' VAL . 8.8 p -73.85 -177.08 2.67 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 114.87 -1.059 . . . . 10.0 108.777 170.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.864 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -170.22 -176.92 2.35 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 120.38 1.446 . . . . 10.0 109.483 176.171 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.1 p -159.44 173.04 16.82 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 103.127 -2.916 . . . . 10.0 103.127 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.451 ' CB ' HG12 ' A' ' 58' ' ' ILE . 47.8 p90 -164.48 162.74 22.08 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.361 -0.607 . . . . 10.0 109.361 175.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.434 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 24.9 pt -130.71 167.73 25.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 107.206 -1.405 . . . . 10.0 107.206 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.532 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 4.3 mt -137.24 121.98 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 108.058 -1.09 . . . . 10.0 108.058 -178.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -84.46 72.63 10.6 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.073 -0.714 . . . . 10.0 109.073 -176.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.425 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . 6.7 t -30.98 99.09 0.12 Allowed Pre-proline 0 C--N 1.318 -0.796 0 O-C-N 126.078 2.111 . . . . 10.0 110.762 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.668 ' HG2' ' HD2' ' A' ' 77' ' ' PHE . 3.3 Cg_endo -47.1 139.26 15.49 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 124.237 3.291 . . . . 10.0 114.214 -163.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.736 ' HA ' HD11 ' A' ' 116' ' ' LEU . 94.9 Cg_exo -20.8 -79.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.844 1 C-N-CA 126.245 4.63 . . . . 10.0 115.387 -168.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.615 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -143.48 -39.01 0.32 Allowed 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.033 -0.667 . . . . 10.0 111.501 -178.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.774 ' HA ' ' HE1' ' A' ' 135' ' ' MET . 1.7 p -41.96 -56.15 2.88 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 124.221 0.951 . . . . 10.0 112.697 -174.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.908 ' HZ ' ' HB3' ' A' ' 49' ' ' LYS . 0.7 OUTLIER -53.87 -65.93 0.48 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.012 -0.54 . . . . 10.0 112.242 -179.378 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.706 HD23 ' HE2' ' A' ' 112' ' ' LYS . 1.3 mm? -76.88 -12.62 59.98 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.25 -0.98 . . . . 10.0 111.789 -172.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 79' ' ' LEU . 13.5 mt -67.15 -30.55 70.56 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.106 -0.702 . . . . 10.0 109.106 168.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 76' ' ' SER . 98.1 mttt -64.37 -23.65 67.37 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.481 171.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 6.7 mmmt -63.48 -48.01 79.39 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.432 0.53 . . . . 10.0 112.432 170.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 1.049 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -68.59 -41.0 80.25 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.373 1.869 . . . . 10.0 111.665 174.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.417 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . . . . . . . . 0 C--N 1.288 -2.099 0 CA-C-N 111.644 -2.525 . . . . 10.0 108.081 -177.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.777 HG13 ' H ' ' A' ' 98' ' ' GLY . 4.8 p . . . . . 0 N--CA 1.443 -0.807 0 N-CA-C 111.772 0.286 . . . . 10.0 111.772 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.777 ' H ' HG13 ' A' ' 97' ' ' VAL . . . -113.31 162.43 12.37 Favored Glycine 0 CA--C 1.495 -1.157 0 N-CA-C 108.714 -1.754 . . . . 10.0 108.714 166.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.799 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 11.3 ptpt -151.58 156.17 39.92 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-O 122.41 1.1 . . . . 10.0 109.574 168.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 1.049 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -160.0 -144.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-N 112.278 -2.237 . . . . 10.0 106.538 -168.158 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.495 ' H ' ' HB ' ' A' ' 100' ' ' VAL . 0.1 OUTLIER -165.19 146.91 7.68 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 108.359 -0.978 . . . . 10.0 108.359 -155.294 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.722 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 1.6 mmt85 -43.97 -40.94 5.0 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 124.219 0.95 . . . . 10.0 111.638 -175.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 2.1 tmtt? -55.54 -50.59 69.61 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.133 0.492 . . . . 10.0 111.621 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.634 ' O ' HG12 ' A' ' 108' ' ' ILE . 18.5 mm-40 -62.28 -44.94 95.37 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 108.665 -0.865 . . . . 10.0 108.665 -178.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.722 ' HB ' ' O ' ' A' ' 102' ' ' ARG . 38.9 mm -41.07 -54.64 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 114.297 -1.32 . . . . 10.0 111.596 166.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.694 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 45.5 tt0 -49.79 -53.16 26.92 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.803 0.841 . . . . 10.0 112.359 177.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.702 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 47.3 mm-40 -51.74 -55.56 18.94 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 114.958 -1.019 . . . . 10.0 109.996 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.634 HG12 ' O ' ' A' ' 104' ' ' GLN . 10.5 mm -49.61 -58.51 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.285 -0.87 . . . . 10.0 110.098 172.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.454 ' HB1' ' HB3' ' A' ' 124' ' ' ALA . . . -50.8 -33.56 23.98 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.032 0.753 . . . . 10.0 113.032 -178.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.702 ' HD2' ' HA ' ' A' ' 107' ' ' GLU . 53.7 mttm -67.52 -57.24 6.85 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.915 0.864 . . . . 10.0 109.165 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 90.5 m -53.42 -36.07 61.11 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 113.716 -1.584 . . . . 10.0 111.995 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.706 ' HE2' HD23 ' A' ' 78' ' ' LEU . 32.3 mmtp -96.45 -7.88 33.71 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.741 0.645 . . . . 10.0 112.741 -173.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.412 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 43.4 ttm -39.18 -49.28 4.45 Favored Pre-proline 0 CA--C 1.532 0.282 0 O-C-N 123.565 0.54 . . . . 10.0 112.386 175.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 113' ' ' MET . 61.6 Cg_endo -70.61 -23.45 26.89 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 120.991 1.128 . . . . 10.0 113.625 -177.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -88.21 -53.34 4.75 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.108 0.48 . . . . 10.0 110.991 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.736 HD11 ' HA ' ' A' ' 74' ' ' PRO . 1.6 mp -65.02 34.3 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.153 -1.385 . . . . 10.0 113.018 -175.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 19.78 51.86 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 O-C-N 124.51 1.131 . . . . 10.0 111.816 -167.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.433 ' O ' ' CB ' ' A' ' 119' ' ' ASN . . . -66.3 -79.13 0.05 OUTLIER 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 113.62 0.97 . . . . 10.0 113.62 -165.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 118' ' ' ALA . 3.1 t-20 101.94 -42.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 O-C-N 125.527 1.767 . . . . 10.0 108.947 -172.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.3 t -146.72 145.29 29.92 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.004 -1.11 . . . . 10.0 108.004 176.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.449 ' O ' ' HG3' ' A' ' 125' ' ' MET . 0.6 OUTLIER -51.68 -46.04 63.68 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.514 -0.766 . . . . 10.0 112.729 -179.132 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.517 ' H ' ' CD ' ' A' ' 122' ' ' GLU . 2.4 mp0 -50.22 -37.39 35.17 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.597 0.713 . . . . 10.0 110.781 178.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.38 -47.05 65.41 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 118.429 -1.308 . . . . 10.0 111.143 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.738 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -57.71 -34.88 69.94 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.66 -0.7 . . . . 10.0 110.769 175.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.449 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 7.7 mtt -53.74 -40.77 66.43 Favored 'General case' 0 N--CA 1.463 0.186 0 O-C-N 121.985 -0.447 . . . . 10.0 112.01 176.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -62.06 -51.83 66.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.017 -0.538 . . . . 10.0 111.761 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.7 HD12 ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -53.47 -56.67 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 119.81 -0.756 . . . . 10.0 110.475 177.459 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.738 HG12 ' O ' ' A' ' 124' ' ' ALA . 11.8 mm -50.74 -51.49 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 CA-C-N 115.138 -0.937 . . . . 10.0 110.949 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 125' ' ' MET . 49.4 mt-10 -51.97 -42.72 63.14 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 120.44 -0.504 . . . . 10.0 110.087 177.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -69.79 -49.65 34.65 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.612 -0.804 . . . . 10.0 111.358 -175.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.615 HG21 ' HB3' ' A' ' 75' ' ' ALA . 99.2 m -49.26 -60.5 2.76 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.267 -0.966 . . . . 10.0 109.827 173.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.21 -50.04 40.08 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.433 -0.349 . . . . 10.0 111.358 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 88.1 tttt -45.7 -59.27 2.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.553 -0.748 . . . . 10.0 111.951 174.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.1 t -65.04 -28.07 69.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.801 0.334 . . . . 10.0 111.305 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.774 ' HE1' ' HA ' ' A' ' 76' ' ' SER . 54.0 mtm -80.43 -6.14 57.62 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.936 0.717 . . . . 10.0 112.936 -177.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.83 29.15 35.78 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 118.966 0.803 . . . . 10.0 111.852 -177.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 8.4 mt -112.69 123.75 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.256 0 CA-C-O 121.608 0.718 . . . . 10.0 110.764 177.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.799 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -84.84 150.61 24.89 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.552 -1.204 . . . . 10.0 109.633 -179.13 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 18.2 m -115.43 131.26 68.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.052 -1.092 . . . . 10.0 108.052 170.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 100' ' ' VAL . 30.6 m -123.63 62.84 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 114.657 1.354 . . . . 10.0 114.657 -177.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.462 ' OXT' ' HB2' ' A' ' 102' ' ' ARG . 9.6 t70 . . . . . 0 C--N 1.291 -1.943 0 CA-C-N 114.303 -1.317 . . . . 10.0 109.627 143.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.9 ttm . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -51.21 111.4 0.56 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.296 0.85 . . . . 10.0 113.296 -174.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -127.52 126.01 41.44 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 115.648 -0.706 . . . . 10.0 109.729 168.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.793 ' HD2' ' HG3' ' A' ' 62' ' ' GLU . 17.1 mmtt -134.48 71.3 1.45 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.695 -0.854 . . . . 10.0 108.695 169.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.0 t -72.97 122.99 26.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 110.251 -0.277 . . . . 10.0 110.251 -174.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.57 -32.82 11.24 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.961 -0.755 . . . . 10.0 108.961 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -168.02 -168.28 0.95 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.33 -0.85 . . . . 10.0 113.214 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.528 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 78.5 mt-30 -143.84 135.54 26.2 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 114.015 -1.448 . . . . 10.0 108.689 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.917 HG21 ' HG ' ' A' ' 28' ' ' LEU . 1.3 mm -122.89 83.52 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-O 119.03 -0.509 . . . . 10.0 109.767 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -78.0 138.72 38.97 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 120.513 1.506 . . . . 10.0 109.231 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.797 HD23 HD11 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -154.15 132.0 11.59 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.333 -0.618 . . . . 10.0 109.333 -171.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.522 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 19.8 pt20 -94.04 109.87 21.6 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.525 -0.917 . . . . 10.0 108.525 171.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.797 HD11 HD23 ' A' ' 11' ' ' LEU . 94.7 mt -130.1 135.95 28.26 Favored Pre-proline 0 CA--C 1.496 -1.097 0 CA-C-O 121.553 0.692 . . . . 10.0 112.51 -165.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.698 ' HB2' ' CB ' ' A' ' 17' ' ' LYS . 28.0 Cg_exo -58.56 120.67 8.7 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 123.054 2.503 . . . . 10.0 111.914 177.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.525 ' CB ' ' HA ' ' A' ' 50' ' ' ALA . . . -62.77 127.66 32.3 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 114.696 -1.138 . . . . 10.0 108.139 171.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.71 4.4 65.96 Favored Glycine 0 CA--C 1.525 0.704 0 O-C-N 126.003 2.064 . . . . 10.0 113.123 -173.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.698 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . 2.6 mmmm -147.32 29.52 0.96 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.393 1.257 . . . . 10.0 114.393 -172.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.817 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -76.47 150.41 36.67 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.472 1.033 . . . . 10.0 110.155 175.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.513 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 15.3 t -177.69 140.3 0.43 Allowed Pre-proline 0 C--N 1.324 -0.535 0 CA-C-O 121.422 0.629 . . . . 10.0 110.861 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.555 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 2.8 Cg_endo -42.17 23.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.478 0.581 1 C-N-CA 129.474 6.783 . . . . 10.0 117.463 176.18 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.644 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -57.88 174.22 0.34 Allowed Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 107.997 -1.112 . . . . 10.0 107.997 163.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.644 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 57.5 Cg_exo -37.3 -42.69 1.04 Allowed 'Trans proline' 0 CA--C 1.548 1.184 0 C-N-CA 122.407 2.071 . . . . 10.0 114.043 177.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.565 ' HB2' HG23 ' A' ' 24' ' ' VAL . 27.2 Cg_exo -38.11 -71.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 123.744 2.962 . . . . 10.0 115.572 167.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.05 HG12 HD12 ' A' ' 35' ' ' ILE . 62.0 t -89.05 -54.68 7.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 114.013 -1.448 . . . . 10.0 114.043 -159.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.443 ' H ' ' HA ' ' A' ' 20' ' ' PRO . . . -50.17 -65.41 2.94 Favored Glycine 0 C--O 1.228 -0.222 0 CA-C-N 114.616 -1.174 . . . . 10.0 112.992 -175.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -55.84 -43.75 54.13 Favored 'Trans proline' 0 C--O 1.222 -0.312 0 C-N-CA 123.092 2.528 . . . . 10.0 112.429 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.492 ' HB1' ' CG2' ' A' ' 9' ' ' ILE . . . -53.28 -78.09 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.401 0.619 . . . . 10.0 111.414 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.917 ' HG ' HG21 ' A' ' 9' ' ' ILE . 2.1 mt -66.94 -45.89 76.4 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.172 0.804 . . . . 10.0 113.172 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.26 -39.98 96.76 Favored Glycine 0 N--CA 1.459 0.18 0 CA-C-N 116.103 -0.499 . . . . 10.0 112.899 -174.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.402 ' HB3' HE21 ' A' ' 30' ' ' GLN . 7.9 tt0 -60.84 -26.69 67.53 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.233 -0.284 . . . . 10.0 110.233 176.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -99.25 16.58 22.42 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.47 0.652 . . . . 10.0 109.895 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.26 4.57 86.23 Favored Glycine 0 CA--C 1.499 -0.957 0 CA-C-N 114.748 -1.115 . . . . 10.0 113.216 167.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.709 HG11 ' CD2' ' A' ' 66' ' ' PHE . 3.4 t -81.33 146.36 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 N-CA-C 113.301 0.852 . . . . 10.0 113.301 -172.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 37' ' ' GLU . 90.8 m-20 -70.31 96.7 1.15 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.256 0.622 . . . . 10.0 110.5 172.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.05 HD12 HG12 ' A' ' 24' ' ' VAL . 13.7 mm -55.54 -38.67 50.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-O 122.078 0.942 . . . . 10.0 112.188 177.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.407 ' SD ' ' N ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -70.01 -43.25 71.73 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 113.476 -1.693 . . . . 10.0 112.432 177.191 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.604 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 14.2 mt-10 -54.81 -50.0 69.62 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 118.988 -1.085 . . . . 10.0 109.437 170.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.606 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 77.8 t80 -53.87 -56.5 17.12 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 114.031 1.123 . . . . 10.0 114.031 175.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.3 t -58.71 -48.31 81.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.719 -1.128 . . . . 10.0 111.193 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.414 ' HE3' ' HB2' ' A' ' 40' ' ' LYS . 49.3 mtmt -66.86 -23.34 66.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 118.602 -1.239 . . . . 10.0 108.971 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.805 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 55.2 mtt180 -74.54 -64.68 0.98 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.093 -0.958 . . . . 10.0 111.776 173.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.736 ' HZ ' ' HB2' ' A' ' 54' ' ' LEU . 67.2 t80 -55.05 -45.6 75.27 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-O 121.165 0.507 . . . . 10.0 110.554 -174.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.817 HD21 ' HB3' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -59.69 -52.49 65.26 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.209 -0.905 . . . . 10.0 110.23 -177.319 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.82 -39.75 95.25 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 119.56 -0.856 . . . . 10.0 112.014 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.805 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 11.2 mt-10 -69.02 -36.72 78.09 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.635 0.731 . . . . 10.0 111.407 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.548 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 72.7 p -91.34 4.33 52.66 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.856 -1.066 . . . . 10.0 112.036 -173.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.53 -36.48 15.44 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.764 -1.107 . . . . 10.0 112.543 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.2 p-10 -81.99 -37.36 26.72 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 115.224 -0.898 . . . . 10.0 111.434 -175.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.518 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 36.8 mttp -95.41 22.17 7.26 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.039 -0.726 . . . . 10.0 109.039 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.525 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -56.51 154.81 8.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.662 -1.154 . . . . 10.0 113.581 -177.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.47 17.2 53.5 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 110.035 -1.226 . . . . 10.0 110.035 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.528 ' HB2' HD21 ' A' ' 54' ' ' LEU . 22.0 mmt -136.11 126.66 26.98 Favored 'General case' 0 C--O 1.207 -1.164 0 C-N-CA 116.11 -2.236 . . . . 10.0 114.032 -165.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.49 HG22 ' HB2' ' A' ' 12' ' ' GLN . 46.2 mm -67.09 91.0 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 121.763 -0.586 . . . . 10.0 109.549 170.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.736 ' HB2' ' HZ ' ' A' ' 42' ' ' PHE . 3.7 mt -76.96 130.7 74.91 Favored Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 122.183 0.193 . . . . 10.0 110.593 -176.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -74.94 95.34 0.97 Allowed 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.384 2.056 . . . . 10.0 111.553 173.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.423 HG23 HG12 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -99.52 158.2 3.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 119.016 0.826 . . . . 10.0 111.972 -172.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.43 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 96.3 t -135.42 120.17 27.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.312 -0.403 . . . . 10.0 110.207 171.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.655 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 14.8 mt -106.15 141.68 20.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 119.595 -0.842 . . . . 10.0 108.897 -175.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 68.1 m -125.39 99.98 6.29 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.043 -0.981 . . . . 10.0 109.024 175.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.562 HG21 HG22 ' A' ' 33' ' ' VAL . 2.8 p -89.18 137.94 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.003 0 C-N-CA 123.653 0.781 . . . . 10.0 111.095 -178.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.466 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 84.8 m-85 -98.94 171.05 8.3 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 122.17 0.986 . . . . 10.0 112.753 -176.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.793 ' HG3' ' HD2' ' A' ' 4' ' ' LYS . 3.0 mm-40 -53.15 -26.24 16.27 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 113.389 -1.732 . . . . 10.0 113.2 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 28.7 m-20 -78.09 -12.38 59.99 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.485 -0.486 . . . . 10.0 111.14 -176.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.47 ' HE3' ' HA ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 84.1 4.94 0.72 Allowed 'General case' 0 CA--C 1.508 -0.672 0 O-C-N 124.558 1.161 . . . . 10.0 108.917 -163.237 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.487 ' O ' HG23 ' A' ' 60' ' ' VAL . 6.2 p -71.02 172.5 8.98 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 113.504 -1.68 . . . . 10.0 107.916 171.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.709 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -169.86 -176.31 2.31 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 120.147 1.339 . . . . 10.0 109.825 174.277 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.6 p -160.11 168.61 25.12 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 102.944 -2.984 . . . . 10.0 102.944 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.44 ' HB3' HG12 ' A' ' 58' ' ' ILE . 45.6 p90 -161.43 158.79 27.27 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 109.125 -0.694 . . . . 10.0 109.125 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.43 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 22.2 pt -128.04 162.06 34.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 106.923 -1.51 . . . . 10.0 106.923 -176.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.544 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 2.6 mt -135.8 117.39 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 107.379 -1.341 . . . . 10.0 107.379 -175.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.62 ' HA ' ' OD1' ' A' ' 115' ' ' ASP . 0.3 OUTLIER -79.27 84.77 5.17 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 123.408 0.442 . . . . 10.0 110.516 -171.069 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.705 ' HB ' ' HG2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -49.17 99.04 0.2 Allowed Pre-proline 0 C--N 1.313 -0.981 0 CA-C-N 114.413 -1.267 . . . . 10.0 108.989 167.202 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.53 ' HG2' ' HB2' ' A' ' 77' ' ' PHE . 38.3 Cg_endo -74.74 174.22 13.06 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.136 2.558 . . . . 10.0 113.932 -158.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.464 ' HD2' ' CB ' ' A' ' 73' ' ' PRO . 86.8 Cg_exo -26.21 -60.69 0.07 OUTLIER 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 125.129 3.886 . . . . 10.0 114.466 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.597 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -171.43 -23.95 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.519 0.933 . . . . 10.0 113.519 175.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.559 ' HA ' ' HE1' ' A' ' 135' ' ' MET . 35.3 p -47.03 -43.35 19.63 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.177 0.513 . . . . 10.0 111.914 -173.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.571 ' HB3' HD22 ' A' ' 78' ' ' LEU . 13.0 t80 -47.79 -68.02 0.22 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.631 -1.168 . . . . 10.0 112.574 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.959 ' HB3' HD12 ' A' ' 108' ' ' ILE . 2.3 mm? -85.02 -11.31 55.7 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.567 -171.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.6 mt -72.33 -25.42 61.55 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.344 -0.543 . . . . 10.0 109.549 172.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 76' ' ' SER . 34.7 mmtp -59.32 -50.88 72.29 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.788 -1.19 . . . . 10.0 107.788 166.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -67.76 33.05 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 114.057 -1.428 . . . . 10.0 113.578 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.714 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -170.48 -60.35 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.668 0.747 . . . . 10.0 112.732 -172.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.55 -27.47 66.25 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 113.464 -1.698 . . . . 10.0 108.942 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.82 59.44 1.79 Allowed Glycine 0 CA--C 1.498 -1.031 0 C-N-CA 119.871 -1.157 . . . . 10.0 110.241 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.535 ' C ' ' H ' ' A' ' 87' ' ' LYS . 29.4 pt -153.18 32.66 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.011 -1.107 . . . . 10.0 108.011 -169.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -69.8 7.0 0.98 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 113.663 -1.608 . . . . 10.0 109.881 174.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.535 ' H ' ' C ' ' A' ' 85' ' ' ILE . 6.3 tmtm? -169.22 -46.42 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.66 -1.609 . . . . 10.0 106.71 -178.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 146.98 166.08 12.13 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.055 -0.975 . . . . 10.0 111.389 175.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.3 p -75.86 164.47 26.18 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.219 -0.66 . . . . 10.0 109.219 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.6 p -68.75 -35.58 77.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.681 0.277 . . . . 10.0 111.002 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.581 ' N ' ' HD2' ' A' ' 92' ' ' PRO . 14.2 tp10 -175.5 -46.35 0.0 OUTLIER Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.318 -178.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 91' ' ' GLU . 5.8 Cg_exo -39.67 109.79 0.1 OUTLIER 'Trans proline' 0 C--N 1.364 1.356 0 C-N-CA 123.183 2.589 . . . . 10.0 113.129 173.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.405 ' C ' ' H ' ' A' ' 95' ' ' LYS . 25.9 mtpp -155.48 74.95 0.91 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.416 -0.811 . . . . 10.0 108.945 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.568 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 52.2 ttm-85 -78.94 41.09 0.42 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.56 -0.533 . . . . 10.0 109.56 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 1.2 mppt? 84.31 -37.81 0.06 Allowed 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 107.9 -1.148 . . . . 10.0 107.9 -172.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.791 HG21 ' HB3' ' A' ' 138' ' ' GLU . 58.1 mt -88.1 94.43 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 CA-C-N 114.929 -1.032 . . . . 10.0 109.608 171.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.58 HG13 ' H ' ' A' ' 98' ' ' GLY . 2.7 p -50.81 -54.78 8.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.773 -0.649 . . . . 10.0 112.094 -175.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.58 ' H ' HG13 ' A' ' 97' ' ' VAL . . . -160.13 174.07 36.85 Favored Glycine 0 CA--C 1.5 -0.894 0 N-CA-C 107.929 -2.069 . . . . 10.0 107.929 178.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.881 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -149.37 173.02 13.98 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-O 122.629 1.204 . . . . 10.0 111.429 -164.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.732 ' O ' HG22 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -150.73 -143.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.152 0 CA-C-N 111.982 -2.372 . . . . 10.0 105.986 -173.378 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.541 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 0.1 OUTLIER -164.93 144.66 7.05 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 107.48 -1.304 . . . . 10.0 107.48 -160.188 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.594 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 9.0 mmm180 -44.27 -43.5 7.39 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 124.241 0.963 . . . . 10.0 111.741 -177.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -57.89 -44.72 86.88 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.329 0.585 . . . . 10.0 111.539 176.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.724 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.1 OUTLIER -60.04 -47.25 86.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.219 -0.901 . . . . 10.0 108.702 178.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.909 HG23 ' HB ' ' A' ' 128' ' ' ILE . 26.2 mm -43.31 -55.34 0.77 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.421 0 CA-C-N 115.093 -0.958 . . . . 10.0 110.939 171.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.793 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 8.4 tt0 -49.2 -57.36 6.85 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 114.494 -1.23 . . . . 10.0 112.946 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -53.4 -59.63 4.33 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 124.057 0.848 . . . . 10.0 110.878 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.959 HD12 ' HB3' ' A' ' 78' ' ' LEU . 10.0 mm -46.88 -51.88 4.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.992 -1.004 . . . . 10.0 110.646 172.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.507 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -53.31 -40.29 64.67 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.655 -0.702 . . . . 10.0 112.554 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.793 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 50.3 mttm -70.87 -53.42 15.22 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 116.172 -0.467 . . . . 10.0 110.561 -174.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.678 HG23 ' HG3' ' A' ' 112' ' ' LYS . 7.7 t -55.99 -35.32 66.65 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.727 -0.67 . . . . 10.0 112.567 -176.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.756 ' HD3' HD23 ' A' ' 78' ' ' LEU . 8.7 mtmp? -103.08 17.36 24.24 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.057 0.456 . . . . 10.0 110.762 -176.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.735 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 50.4 ttm -49.65 -45.33 78.73 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.374 -0.83 . . . . 10.0 112.372 176.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 113' ' ' MET . 42.2 Cg_endo -64.62 -25.67 61.86 Favored 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 121.65 1.567 . . . . 10.0 112.569 -177.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.62 ' OD1' ' HA ' ' A' ' 71' ' ' LYS . 12.8 m-20 -89.46 -50.9 5.83 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 114.936 -1.029 . . . . 10.0 111.16 -175.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.457 HD11 ' HZ3' ' A' ' 112' ' ' LYS . 9.1 mp -64.06 -3.55 2.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.441 -1.254 . . . . 10.0 111.754 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 64.4 t30 59.6 51.42 6.42 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.262 -1.335 . . . . 10.0 109.851 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.735 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -80.78 116.64 20.88 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 113.873 -1.512 . . . . 10.0 112.651 -172.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -65.91 -41.88 90.89 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.314 -0.995 . . . . 10.0 108.314 168.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.0 p -149.76 143.54 25.47 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 106.922 -1.511 . . . . 10.0 106.922 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.611 HD12 ' HB3' ' A' ' 124' ' ' ALA . 66.9 tp -52.16 -33.02 38.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 114.225 1.195 . . . . 10.0 114.225 -176.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -50.15 -37.76 36.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.329 0.585 . . . . 10.0 110.885 173.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.14 -50.17 56.33 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 119.047 -1.061 . . . . 10.0 110.916 175.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.611 ' HB3' HD12 ' A' ' 121' ' ' LEU . . . -57.49 -38.7 75.01 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 120.762 -0.375 . . . . 10.0 110.736 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.55 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 89.1 mtp -56.0 -37.22 68.84 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.674 0.39 . . . . 10.0 111.425 177.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -63.08 -48.34 79.02 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.04 -0.527 . . . . 10.0 109.729 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.5 mt -51.17 -62.67 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 CA-C-O 121.464 0.65 . . . . 10.0 111.245 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.909 ' HB ' HG23 ' A' ' 105' ' ' ILE . 15.9 mm -49.84 -57.02 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 CA-C-N 114.189 -1.368 . . . . 10.0 111.152 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.632 ' HG3' HG13 ' A' ' 105' ' ' ILE . 3.9 mt-10 -54.04 -47.28 71.74 Favored 'General case' 0 N--CA 1.436 -1.149 0 O-C-N 124.097 0.873 . . . . 10.0 110.069 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.5 -46.64 61.65 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.463 -0.875 . . . . 10.0 111.51 -173.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.597 HG21 ' HB3' ' A' ' 75' ' ' ALA . 90.2 m -47.6 -60.29 2.65 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.188 -1.006 . . . . 10.0 108.601 170.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -48.0 -53.07 17.37 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.954 0.502 . . . . 10.0 111.852 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.608 ' HG3' ' O ' ' A' ' 129' ' ' GLU . 43.4 mtpt -50.23 -50.28 50.33 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.002 178.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.8 m -66.31 -31.39 72.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.945 0.403 . . . . 10.0 111.031 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.559 ' HE1' ' HA ' ' A' ' 76' ' ' SER . 48.8 mtm -81.4 4.08 22.14 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.795 1.035 . . . . 10.0 113.795 -178.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.584 ' O ' ' HA ' ' A' ' 96' ' ' ILE . . . 81.0 18.83 68.75 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 119.657 1.117 . . . . 10.0 111.586 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.503 HG23 ' HA ' ' A' ' 99' ' ' LYS . 23.3 mt -105.21 127.69 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 CA-C-O 121.146 0.498 . . . . 10.0 111.513 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.881 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -89.14 157.13 18.4 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.475 -0.784 . . . . 10.0 109.585 179.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.7 m -116.35 132.1 66.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.5 -0.926 . . . . 10.0 108.5 170.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 100' ' ' VAL . 26.9 m -133.94 69.65 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 116.057 1.873 . . . . 10.0 116.057 -175.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.605 ' HB2' ' O ' ' A' ' 140' ' ' VAL . 3.6 t0 . . . . . 0 C--N 1.296 -1.745 0 CA-C-O 117.864 -1.065 . . . . 10.0 109.012 141.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 mmt . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 120.643 0.259 . . . . 10.0 110.404 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.08 -12.75 34.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.245 0.545 . . . . 10.0 110.552 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.456 ' HE3' ' CE1' ' A' ' 61' ' ' TYR . 46.7 mtmt -78.33 155.77 29.95 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.646 -0.706 . . . . 10.0 109.841 176.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.591 ' HD3' ' H ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -75.48 94.32 3.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.501 0.667 . . . . 10.0 110.699 -179.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.2 t -73.79 141.3 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.581 -0.736 . . . . 10.0 110.649 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.31 -45.51 4.08 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.307 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.54 152.17 25.22 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.51 1.3 . . . . 10.0 114.51 -174.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.839 HE21 ' HA ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -92.55 133.14 36.24 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.514 -1.221 . . . . 10.0 107.852 170.184 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.685 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -123.09 83.16 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.348 -0.612 . . . . 10.0 109.348 174.365 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.437 ' HG2' HG22 ' A' ' 57' ' ' VAL . 52.8 mttp -77.27 132.24 38.57 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 120.807 1.639 . . . . 10.0 108.921 172.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.687 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -158.58 125.6 4.86 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 122.336 1.065 . . . . 10.0 111.689 -179.236 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.432 ' HG2' ' HA ' ' A' ' 55' ' ' PRO . 28.8 mt-30 -83.5 121.56 27.36 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.132 -1.395 . . . . 10.0 110.59 -172.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.687 HD21 HD11 ' A' ' 11' ' ' LEU . 88.2 mt -138.64 144.36 41.78 Favored Pre-proline 0 CA--C 1.507 -0.687 0 CA-C-O 121.484 0.659 . . . . 10.0 111.96 -170.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.834 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 4.3 Cg_exo -65.98 126.97 16.77 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 123.467 2.778 . . . . 10.0 111.655 176.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.597 ' HB2' HD11 ' A' ' 54' ' ' LEU . . . -62.12 128.46 36.22 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 108.062 -1.088 . . . . 10.0 108.062 171.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.95 -1.04 87.72 Favored Glycine 0 N--CA 1.443 -0.882 0 O-C-N 125.612 1.82 . . . . 10.0 112.74 -174.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.834 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 15.1 tppt? -140.46 102.59 4.37 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 122.359 1.076 . . . . 10.0 111.835 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.452 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -170.33 129.66 0.88 Allowed 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 113.405 -1.725 . . . . 10.0 110.856 174.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.71 ' HA ' ' HB2' ' A' ' 39' ' ' CYS . 2.1 t -176.87 -44.87 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 115.046 -0.979 . . . . 10.0 113.112 176.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.726 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 72.6 Cg_endo -103.93 124.4 0.07 OUTLIER 'Trans proline' 0 N--CA 1.413 -3.244 0 N-CA-C 115.557 1.329 . . . . 10.0 115.557 -162.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.062 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 9.63 -87.15 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.392 0 CA-C-N 109.664 -3.425 . . . . 10.0 114.824 166.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.64 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 11.4 Cg_exo -26.07 -55.99 0.09 OUTLIER 'Trans proline' 0 CA--C 1.559 1.734 0 C-N-CA 123.74 2.96 . . . . 10.0 115.722 -162.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.726 ' HD2' ' O ' ' A' ' 20' ' ' PRO . 37.4 Cg_endo -80.48 -73.96 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.277 0 C-N-CA 122.419 2.079 . . . . 10.0 112.083 168.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.077 HG12 HD12 ' A' ' 35' ' ' ILE . 53.5 t -57.37 -54.73 27.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 127.564 2.346 . . . . 10.0 114.672 -173.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 1.062 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -48.41 -72.55 0.43 Allowed Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.107 -0.952 . . . . 10.0 113.173 -175.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.729 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 16.5 Cg_exo -44.98 -47.98 11.42 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.523 2.816 . . . . 10.0 112.272 171.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 24' ' ' VAL . . . -46.37 -98.51 0.0 OUTLIER 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 123.624 0.578 . . . . 10.0 112.376 177.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.869 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.351 0.0 OUTLIER -73.87 -38.84 64.3 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 117.176 -1.81 . . . . 10.0 113.363 -174.684 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.691 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -66.15 -39.34 94.54 Favored Glycine 0 N--CA 1.462 0.407 0 C-N-CA 121.43 -0.414 . . . . 10.0 113.859 -173.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.513 ' HB2' ' HA ' ' A' ' 26' ' ' PRO . 9.0 tt0 -67.82 -7.19 25.76 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.541 -0.864 . . . . 10.0 111.172 176.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -99.94 22.92 10.49 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.624 -0.716 . . . . 10.0 109.284 168.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.19 -6.89 63.99 Favored Glycine 0 CA--C 1.503 -0.712 0 CA-C-N 115.341 -0.845 . . . . 10.0 113.112 167.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.869 ' HB ' HD23 ' A' ' 28' ' ' LEU . 3.4 t -83.29 148.75 4.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 114.619 1.34 . . . . 10.0 114.619 -169.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.544 ' HB3' ' HB2' ' A' ' 37' ' ' GLU . 44.7 t-20 -70.75 98.68 1.58 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.468 0.707 . . . . 10.0 110.639 172.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.077 HD12 HG12 ' A' ' 24' ' ' VAL . 19.4 mm -53.78 -36.28 29.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.155 -0.929 . . . . 10.0 112.164 175.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 66.8 mtm -65.19 -52.78 52.76 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 113.62 -1.627 . . . . 10.0 111.699 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.544 ' HB2' ' HB3' ' A' ' 34' ' ' ASN . 12.7 mm-40 -56.88 -38.8 73.27 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.615 -0.834 . . . . 10.0 110.927 175.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.558 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . 91.3 t80 -57.85 -58.7 7.21 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 113.506 0.928 . . . . 10.0 113.506 170.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -57.7 -52.26 66.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 113.988 -1.46 . . . . 10.0 112.039 -177.535 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.501 ' HB3' ' HE3' ' A' ' 40' ' ' LYS . 0.7 OUTLIER -66.47 -21.71 66.19 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 119.554 -0.858 . . . . 10.0 108.691 -176.082 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.684 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 12.9 mtp180 -74.09 -63.9 1.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.662 -0.699 . . . . 10.0 112.074 168.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.601 ' CZ ' HG21 ' A' ' 46' ' ' THR . 71.1 t80 -54.33 -45.52 72.69 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-O 121.082 0.468 . . . . 10.0 110.682 -172.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.61 HD22 ' N ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER -58.97 -51.62 69.27 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.074 -0.966 . . . . 10.0 109.771 -178.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.22 -40.96 98.97 Favored 'General case' 0 C--N 1.319 -0.717 0 C-N-CA 119.034 -1.066 . . . . 10.0 112.186 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.684 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 7.3 mt-10 -66.9 -39.31 87.41 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.823 0.821 . . . . 10.0 110.834 -178.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.605 ' CG2' HD12 ' A' ' 54' ' ' LEU . 72.1 p -92.13 -0.4 57.44 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.735 -1.121 . . . . 10.0 112.748 -172.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.96 -39.62 12.76 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.915 0.886 . . . . 10.0 112.777 -174.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -75.78 -34.13 60.2 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.506 -0.77 . . . . 10.0 110.958 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.431 ' HB3' ' CE ' ' A' ' 52' ' ' MET . 36.7 mttp -97.15 17.88 16.19 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 123.828 0.851 . . . . 10.0 109.998 -175.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -52.07 145.47 10.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.205 -0.907 . . . . 10.0 113.232 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.68 15.85 35.79 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 110.604 -0.998 . . . . 10.0 110.604 -177.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.716 ' SD ' ' HB2' ' A' ' 77' ' ' PHE . 51.3 mtm -138.12 125.81 22.29 Favored 'General case' 0 C--O 1.211 -0.94 0 C-N-CA 116.274 -2.171 . . . . 10.0 115.193 -166.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.3 mm -66.55 91.78 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 118.313 0.506 . . . . 10.0 109.639 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.605 HD12 ' CG2' ' A' ' 46' ' ' THR . 8.0 mt -83.2 135.85 44.07 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 108.852 -0.796 . . . . 10.0 108.852 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.561 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 8.0 Cg_exo -75.86 108.94 2.79 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.237 1.958 . . . . 10.0 111.016 174.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -100.58 155.08 4.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 119.833 1.197 . . . . 10.0 111.573 -174.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.437 HG22 ' HG2' ' A' ' 10' ' ' LYS . 93.6 t -134.81 115.58 19.41 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 CA-C-N 116.662 -0.244 . . . . 10.0 110.447 175.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.685 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 16.0 mt -107.07 141.93 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.554 0 CA-C-O 121.669 0.747 . . . . 10.0 109.157 -174.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 26.7 m -124.8 99.15 6.02 Favored 'General case' 0 C--N 1.28 -2.453 0 CA-C-N 114.665 -1.152 . . . . 10.0 108.869 174.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 65' ' ' SER . 2.4 p -89.61 140.17 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.117 0 CA-C-N 119.43 1.014 . . . . 10.0 110.19 -178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.456 ' CE1' ' HE3' ' A' ' 3' ' ' LYS . 73.4 m-85 -98.51 160.67 14.13 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.548 -0.751 . . . . 10.0 111.55 -179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.417 ' OE1' ' HB2' ' A' ' 4' ' ' LYS . 16.6 mt-10 -54.22 -19.13 4.68 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 124.37 1.068 . . . . 10.0 113.142 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 26.5 t70 -75.46 -13.71 60.39 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.572 -0.74 . . . . 10.0 110.472 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.771 ' HE3' ' HA ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER 83.33 1.2 1.07 Allowed 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 114.448 -1.251 . . . . 10.0 110.379 -167.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.517 ' O ' HG23 ' A' ' 60' ' ' VAL . 57.9 m -71.68 174.86 6.21 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 114.753 -1.112 . . . . 10.0 108.846 169.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.866 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -171.09 -176.79 2.02 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 119.394 0.997 . . . . 10.0 109.307 174.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.417 ' HG1' ' HE2' ' A' ' 61' ' ' TYR . 1.3 p -162.58 162.54 27.25 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 103.434 -2.802 . . . . 10.0 103.434 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CB ' HG12 ' A' ' 58' ' ' ILE . 47.6 p90 -162.11 158.09 24.24 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.522 0.677 . . . . 10.0 109.233 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.9 pt -128.45 158.78 40.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.543 0 CA-C-N 114.612 -1.176 . . . . 10.0 108.503 -175.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.482 HD12 ' CE1' ' A' ' 42' ' ' PHE . 2.8 mm -112.75 127.27 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 N-CA-C 108.016 -1.105 . . . . 10.0 108.016 -178.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.633 ' C ' ' HD2' ' A' ' 73' ' ' PRO . 4.2 mptp? -80.16 93.3 5.8 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 122.024 0.916 . . . . 10.0 112.211 -172.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.729 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 9.2 t -59.55 -34.6 23.2 Favored Pre-proline 0 CA--C 1.569 1.693 0 CA-C-N 113.569 -1.651 . . . . 10.0 113.332 169.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.729 ' HD2' ' N ' ' A' ' 72' ' ' THR . 2.7 Cg_endo -41.9 -49.26 5.69 Favored 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 124.519 3.479 . . . . 10.0 117.331 -171.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.553 ' HD3' ' HG2' ' A' ' 73' ' ' PRO . 73.7 Cg_exo -42.33 -35.06 3.35 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.858 2.372 . . . . 10.0 113.47 -174.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.515 ' HB2' ' HE2' ' A' ' 112' ' ' LYS . . . 72.51 -25.59 0.18 Allowed 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 113.723 1.009 . . . . 10.0 113.723 168.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.5 m -50.63 -46.91 58.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.167 0.508 . . . . 10.0 110.92 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.716 ' HB2' ' SD ' ' A' ' 52' ' ' MET . 8.6 p90 -72.23 -29.46 63.96 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.765 -0.652 . . . . 10.0 111.428 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.762 ' O ' ' HB3' ' A' ' 81' ' ' LYS . 1.8 tp -86.0 -28.18 24.36 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.233 0.54 . . . . 10.0 111.255 -175.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.457 ' HA ' HD13 ' A' ' 79' ' ' LEU . 3.7 mm? -59.39 -35.1 73.3 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 107.993 -1.114 . . . . 10.0 107.993 168.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.788 ' HD3' ' HB2' ' A' ' 86' ' ' GLU . 7.3 ttpm? -70.31 -12.26 61.47 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.756 -0.656 . . . . 10.0 111.921 172.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.762 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 17.0 tptm -56.72 -50.75 71.28 Favored 'General case' 0 N--CA 1.468 0.434 0 O-C-N 121.25 -0.907 . . . . 10.0 109.103 165.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.656 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -72.56 -49.58 31.52 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.964 1.706 . . . . 10.0 112.755 170.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.489 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . . . -80.12 159.24 26.14 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 112.688 -2.051 . . . . 10.0 109.326 -169.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.81 -21.52 12.16 Favored Glycine 0 C--N 1.31 -0.876 0 C-N-CA 118.318 -1.896 . . . . 10.0 110.746 165.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.587 HG21 HG22 ' A' ' 97' ' ' VAL . 2.1 pp -64.25 145.17 14.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 113.741 1.015 . . . . 10.0 113.741 -177.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.788 ' HB2' ' HD3' ' A' ' 80' ' ' LYS . 31.0 tt0 -171.41 40.27 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.099 -0.955 . . . . 10.0 108.882 164.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -162.77 16.11 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.114 -0.948 . . . . 10.0 110.355 177.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -124.89 5.94 8.37 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.655 -0.783 . . . . 10.0 112.134 -178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.1 m -76.17 -33.62 59.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.079 0.466 . . . . 10.0 110.812 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.9 p -78.69 1.18 23.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.988 -0.551 . . . . 10.0 111.436 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -174.82 96.35 0.29 Allowed Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 108.683 -0.858 . . . . 10.0 108.683 176.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.29 -174.68 2.35 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 123.006 2.47 . . . . 10.0 113.038 -173.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 93' ' ' LYS . 68.8 mmtt -72.33 -36.07 68.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.009 -0.542 . . . . 10.0 110.691 178.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -166.36 -37.12 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.362 0.601 . . . . 10.0 109.634 175.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -160.34 8.98 0.1 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.092 -0.958 . . . . 10.0 110.256 176.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 136' ' ' GLY . 1.3 mt -156.16 167.66 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 109.034 -0.728 . . . . 10.0 109.034 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.587 HG22 HG21 ' A' ' 85' ' ' ILE . 7.1 p -112.22 -61.3 2.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.393 0.616 . . . . 10.0 111.512 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -166.88 161.37 35.18 Favored Glycine 0 CA--C 1.497 -1.078 0 N-CA-C 108.725 -1.75 . . . . 10.0 108.725 -174.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.603 ' HB2' ' O ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -143.73 177.72 8.31 Favored 'General case' 0 CA--C 1.473 -2.004 0 CA-C-O 122.359 1.075 . . . . 10.0 110.767 -169.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.656 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.3 OUTLIER -163.76 -165.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.404 -2.73 0 CA-C-N 111.793 -2.458 . . . . 10.0 106.184 -170.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 19.0 p -109.83 150.39 28.46 Favored 'General case' 0 C--N 1.268 -2.968 0 CA-C-N 114.753 -1.112 . . . . 10.0 111.833 -170.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.68 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 22.4 tpp180 -43.62 -43.73 5.9 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 113.588 -1.642 . . . . 10.0 109.688 168.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.507 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 18.4 tppt? -58.35 -43.15 88.19 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.153 0.501 . . . . 10.0 112.168 176.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.65 ' O ' HG12 ' A' ' 108' ' ' ILE . 57.6 mt-30 -67.22 -38.72 85.74 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.407 -0.59 . . . . 10.0 109.407 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.68 ' HB ' ' O ' ' A' ' 102' ' ' ARG . 34.9 mm -46.83 -51.15 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 115.589 -0.732 . . . . 10.0 111.012 166.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.686 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 31.8 tt0 -48.28 -54.26 14.31 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.283 -1.326 . . . . 10.0 112.836 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -52.48 -57.88 8.51 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 123.925 0.766 . . . . 10.0 110.151 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.65 HG12 ' O ' ' A' ' 104' ' ' GLN . 5.5 mm -46.19 -59.97 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 114.328 -1.305 . . . . 10.0 109.923 173.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.547 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -50.62 -37.28 39.47 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 123.686 0.616 . . . . 10.0 112.44 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.686 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 39.4 mttt -71.09 -58.67 3.33 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.004 -0.544 . . . . 10.0 111.478 -175.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.603 HG21 HD21 ' A' ' 78' ' ' LEU . 4.7 t -55.4 -34.83 64.73 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 113.011 0.745 . . . . 10.0 113.011 -175.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 1.0 ' HD3' HD11 ' A' ' 128' ' ' ILE . 0.1 OUTLIER -99.03 7.38 46.01 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 120.931 0.396 . . . . 10.0 110.828 -173.36 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.812 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 40.1 ttm -48.11 -41.32 41.55 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.231 -0.895 . . . . 10.0 112.424 175.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 113' ' ' MET . 26.7 Cg_endo -59.61 -32.48 96.05 Favored 'Trans proline' 0 C--N 1.366 1.471 0 C-N-CA 121.787 1.658 . . . . 10.0 112.128 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.561 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 0.8 OUTLIER -91.44 -47.89 7.19 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 114.788 -1.096 . . . . 10.0 112.34 -173.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.874 HD22 ' HG3' ' A' ' 112' ' ' LYS . 7.0 mp -64.18 2.05 0.63 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.527 -1.215 . . . . 10.0 111.871 -178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 115' ' ' ASP . 8.7 p30 54.75 45.67 26.22 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.164 -1.38 . . . . 10.0 109.662 177.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.812 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -80.8 118.17 22.09 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 112.805 -1.998 . . . . 10.0 112.103 -172.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.22 -37.61 83.88 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.75 -0.659 . . . . 10.0 109.874 170.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.2 p -155.41 144.66 20.95 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.442 -0.947 . . . . 10.0 108.442 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.544 ' O ' ' HG2' ' A' ' 125' ' ' MET . 62.6 tp -52.08 -40.39 61.14 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 115.077 1.51 . . . . 10.0 115.077 -173.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -51.63 -33.08 31.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.148 0.499 . . . . 10.0 111.045 176.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.18 -49.26 65.31 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 118.797 -1.161 . . . . 10.0 110.865 172.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.626 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -57.78 -33.68 68.79 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.91 0.386 . . . . 10.0 110.652 178.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.635 ' O ' ' HB3' ' A' ' 129' ' ' GLU . 80.1 mmm -56.36 -39.02 72.2 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.73 0.3 . . . . 10.0 111.425 176.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -61.21 -56.68 17.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.832 -0.622 . . . . 10.0 111.432 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.871 HD12 HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -50.98 -57.9 2.4 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 C-N-CA 119.994 -0.683 . . . . 10.0 111.146 -178.465 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 1.0 HD11 ' HD3' ' A' ' 112' ' ' LYS . 25.4 mm -50.56 -57.23 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 CA-C-N 114.649 -1.16 . . . . 10.0 111.801 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.635 ' HB3' ' O ' ' A' ' 125' ' ' MET . 0.0 OUTLIER -53.33 -41.38 65.67 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.748 -0.66 . . . . 10.0 109.272 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.669 ' HA2' ' HE2' ' A' ' 133' ' ' LYS . . . -71.36 -46.47 41.29 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.739 -0.744 . . . . 10.0 111.862 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 62.7 m -44.37 -65.6 0.49 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 114.561 -0.82 . . . . 10.0 109.011 169.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.513 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -48.77 -50.71 32.75 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.026 -0.534 . . . . 10.0 111.312 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.669 ' HE2' ' HA2' ' A' ' 130' ' ' GLY . 17.0 ttpt -47.98 -53.95 14.48 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.75 -1.114 . . . . 10.0 111.499 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.1 m -66.13 -30.91 71.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.341 0.591 . . . . 10.0 110.69 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 46.8 mtp -80.31 5.64 14.2 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.701 1.0 . . . . 10.0 113.701 -177.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.47 ' O ' HG23 ' A' ' 96' ' ' ILE . . . 85.46 6.15 84.0 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 119.351 0.978 . . . . 10.0 111.548 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.572 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 37.4 mt -97.21 127.27 49.61 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.834 0 CA-C-O 121.672 0.749 . . . . 10.0 111.777 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.603 ' O ' ' HB2' ' A' ' 99' ' ' LYS . 0.7 OUTLIER -88.56 158.87 18.15 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.514 -1.221 . . . . 10.0 108.868 178.134 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.3 m -117.44 127.01 74.97 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.518 0 CA-C-O 122.213 1.006 . . . . 10.0 108.348 171.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 101' ' ' THR . 19.3 m -112.54 154.62 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.231 0 CA-C-N 113.676 -1.602 . . . . 10.0 107.676 176.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 31.9 t70 . . . . . 0 C--N 1.276 -2.608 0 CA-C-N 114.534 -1.212 . . . . 10.0 110.872 -177.065 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtt . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 110.185 -0.302 . . . . 10.0 110.185 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.12 175.04 9.96 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.707 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -93.29 103.75 15.97 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.802 0.334 . . . . 10.0 110.121 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.401 ' HB2' ' HG3' ' A' ' 62' ' ' GLU . 49.8 mtmt -83.18 127.13 33.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.345 -0.389 . . . . 10.0 110.895 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.0 t -63.11 139.19 21.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.576 -0.738 . . . . 10.0 110.992 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.86 -32.0 5.93 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.288 -0.414 . . . . 10.0 110.521 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.499 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -158.97 152.98 23.47 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.161 1.171 . . . . 10.0 114.161 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.841 HE21 ' HA ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -99.51 133.17 44.22 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.885 -1.052 . . . . 10.0 108.36 173.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.664 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -124.6 82.21 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 120.063 -0.655 . . . . 10.0 110.099 174.395 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 46.1 tttm -78.25 128.9 34.4 Favored 'General case' 0 C--N 1.314 -0.944 0 O-C-N 120.368 -1.458 . . . . 10.0 109.754 175.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.67 HD21 HD11 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -158.76 131.11 6.82 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 122.139 0.971 . . . . 10.0 112.262 -176.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -88.63 126.23 35.19 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.746 -1.116 . . . . 10.0 111.423 -174.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.67 HD11 HD21 ' A' ' 11' ' ' LEU . 63.7 mt -143.88 145.07 29.1 Favored Pre-proline 0 CA--C 1.511 -0.538 0 CA-C-O 121.098 0.475 . . . . 10.0 112.09 -174.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.706 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 24.8 Cg_exo -61.17 129.68 29.46 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.408 2.739 . . . . 10.0 112.405 175.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.605 ' HB2' HD11 ' A' ' 54' ' ' LEU . . . -62.23 129.09 39.17 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.343 -1.354 . . . . 10.0 107.343 168.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.88 0.75 86.05 Favored Glycine 0 N--CA 1.441 -1.004 0 O-C-N 125.498 1.749 . . . . 10.0 113.088 -175.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.706 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 3.9 tmtp? -144.46 99.86 3.44 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.147 0.974 . . . . 10.0 112.047 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.462 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -171.2 139.39 1.34 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.407 -1.27 . . . . 10.0 112.972 175.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.653 ' HA ' ' HB3' ' A' ' 39' ' ' CYS . 17.0 m -170.74 -66.88 0.0 OUTLIER Pre-proline 0 N--CA 1.437 -1.094 0 O-C-N 124.322 1.014 . . . . 10.0 110.813 178.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.706 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 86.3 Cg_endo -105.84 129.48 0.06 OUTLIER 'Trans proline' 0 N--CA 1.425 -2.511 0 N-CA-C 117.621 2.123 . . . . 10.0 117.621 -148.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.118 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 20.44 -83.87 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.412 0 CA-C-N 109.474 -3.512 . . . . 10.0 115.152 166.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.679 ' HD3' ' HB3' ' A' ' 21' ' ' ALA . 93.1 Cg_exo -39.39 -55.85 1.44 Allowed 'Trans proline' 0 C--N 1.382 2.308 0 CA-C-N 122.561 1.95 . . . . 10.0 112.489 -174.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.873 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 40.3 Cg_endo -91.02 116.1 0.47 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 121.822 1.681 . . . . 10.0 111.026 154.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.921 HG12 HD12 ' A' ' 35' ' ' ILE . 4.0 t 111.1 -42.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 C-N-CA 119.013 -1.075 . . . . 10.0 109.152 156.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 1.118 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -49.82 -75.11 0.22 Allowed Glycine 0 CA--C 1.523 0.583 0 CA-C-N 113.369 -1.741 . . . . 10.0 113.77 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.69 ' HA ' ' HG3' ' A' ' 30' ' ' GLN . 31.4 Cg_exo -54.79 -33.94 82.92 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.638 2.225 . . . . 10.0 111.39 175.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 24' ' ' VAL . . . -51.72 -98.08 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 112.113 0.412 . . . . 10.0 112.113 175.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.869 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.319 0.0 OUTLIER -72.88 -28.09 62.29 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 117.596 -1.642 . . . . 10.0 112.943 -174.412 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.555 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -68.58 -39.36 86.69 Favored Glycine 0 N--CA 1.464 0.501 0 C-N-CA 120.736 -0.745 . . . . 10.0 112.967 -176.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.69 ' HG3' ' HA ' ' A' ' 26' ' ' PRO . 23.5 mt-30 -65.38 -12.6 53.73 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 119.166 -1.014 . . . . 10.0 110.736 174.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.408 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 96.0 m-70 -100.46 18.28 19.45 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.944 -0.702 . . . . 10.0 109.809 173.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.57 1.94 70.7 Favored Glycine 0 CA--C 1.5 -0.887 0 CA-C-N 114.824 -1.08 . . . . 10.0 113.695 169.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.891 HG11 ' CD2' ' A' ' 66' ' ' PHE . 3.4 t -85.41 146.65 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 113.623 0.971 . . . . 10.0 113.623 -170.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -68.67 100.96 1.21 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.226 0.536 . . . . 10.0 110.95 171.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.921 HD12 HG12 ' A' ' 24' ' ' VAL . 8.7 mm -53.15 -39.94 36.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.943 -1.026 . . . . 10.0 111.217 174.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.824 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 3.7 mpp? -64.02 -47.35 80.6 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 113.357 -1.747 . . . . 10.0 111.076 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.584 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 18.5 tp10 -56.75 -45.01 82.29 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.873 -0.731 . . . . 10.0 110.234 173.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . 85.0 t80 -55.81 -60.07 3.98 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.661 1.356 . . . . 10.0 114.661 173.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.824 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 24.8 p -61.57 -49.19 77.65 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 114.838 -1.074 . . . . 10.0 112.02 -175.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.502 ' HA ' ' HD3' ' A' ' 40' ' ' LYS . 28.1 mmtp -65.66 -21.26 66.54 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 119.543 -0.863 . . . . 10.0 109.762 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.801 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 5.7 mtp180 -71.6 -65.35 0.77 Allowed 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 119.357 -0.937 . . . . 10.0 111.436 167.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.545 ' CZ ' HG21 ' A' ' 46' ' ' THR . 66.8 t80 -52.8 -47.01 67.9 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.602 -171.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.626 HD22 ' N ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER -60.01 -52.78 63.92 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.944 -1.026 . . . . 10.0 110.254 -176.361 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.9 96.09 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 118.884 -1.127 . . . . 10.0 112.187 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.801 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 9.6 mt-10 -68.74 -37.2 79.24 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 121.583 0.706 . . . . 10.0 111.172 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.582 ' CG2' HD12 ' A' ' 54' ' ' LEU . 73.0 p -89.14 0.22 56.91 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.125 -0.943 . . . . 10.0 112.567 -173.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.95 -38.34 7.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.007 -0.997 . . . . 10.0 113.008 -175.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -76.05 -36.57 58.98 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.718 -0.673 . . . . 10.0 111.138 -174.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 34.4 mtmm -100.88 23.1 11.09 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 123.013 0.525 . . . . 10.0 109.903 -176.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -52.31 143.83 14.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.158 -0.928 . . . . 10.0 112.789 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.87 20.08 24.95 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 114.948 -1.024 . . . . 10.0 110.57 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.551 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 67.4 mtt -138.41 123.41 19.0 Favored 'General case' 0 C--O 1.208 -1.084 0 C-N-CA 117.243 -1.783 . . . . 10.0 114.262 -168.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.0 mm -65.68 91.87 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 118.626 0.648 . . . . 10.0 109.674 172.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.605 HD11 ' HB2' ' A' ' 15' ' ' ALA . 8.6 mt -81.06 131.49 59.41 Favored Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 109.178 -0.675 . . . . 10.0 109.178 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -71.83 106.54 2.01 Favored 'Trans proline' 0 C--N 1.332 -0.315 0 C-N-CA 122.306 2.004 . . . . 10.0 110.962 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.37 151.63 5.86 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-N 119.449 1.022 . . . . 10.0 111.221 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 95.2 t -134.32 116.79 23.02 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 N-CA-C 110.288 -0.264 . . . . 10.0 110.288 175.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.664 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 14.9 mt -104.19 142.6 17.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.723 0.773 . . . . 10.0 109.623 -172.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 84.5 m -126.6 95.57 4.39 Favored 'General case' 0 N--CA 1.411 -2.383 0 CA-C-N 114.659 -1.155 . . . . 10.0 108.998 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 65' ' ' SER . 1.5 p -89.95 137.49 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.122 0 CA-C-N 119.386 0.994 . . . . 10.0 110.581 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -95.59 179.54 5.1 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.621 -0.718 . . . . 10.0 112.486 -176.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.401 ' HG3' ' HB2' ' A' ' 4' ' ' LYS . 5.9 mm-40 -53.12 -33.16 51.07 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 124.87 1.268 . . . . 10.0 112.444 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.547 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 35.5 t70 -80.85 -9.58 59.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.698 -1.137 . . . . 10.0 111.568 -168.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 0.2 OUTLIER 81.3 6.6 1.24 Allowed 'General case' 0 CA--C 1.5 -0.969 0 CA-C-O 122.632 1.206 . . . . 10.0 110.823 -166.135 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.622 ' O ' HG23 ' A' ' 60' ' ' VAL . 58.6 m -71.4 172.01 10.21 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 112.796 -2.002 . . . . 10.0 107.693 168.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.891 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -168.68 -176.25 2.69 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 119.948 1.249 . . . . 10.0 109.525 175.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.4 p -158.65 166.67 31.5 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 102.79 -3.041 . . . . 10.0 102.79 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.483 ' HB3' HG12 ' A' ' 58' ' ' ILE . 49.4 p90 -161.06 156.88 25.24 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 176.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.0 mt -116.47 167.23 9.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.058 -1.46 . . . . 10.0 107.058 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.3 mt -142.22 114.21 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 N-CA-C 107.691 -1.226 . . . . 10.0 107.691 -175.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.552 ' HB3' ' HG2' ' A' ' 73' ' ' PRO . 12.9 mmtp -72.41 99.18 2.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.414 1.102 . . . . 10.0 112.493 -166.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.778 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 14.6 t -62.6 -33.98 13.24 Favored Pre-proline 0 CA--C 1.569 1.693 0 CA-C-N 113.197 -1.82 . . . . 10.0 112.178 169.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.778 ' HD2' ' N ' ' A' ' 72' ' ' THR . 1.0 OUTLIER -40.18 -43.82 3.85 Favored 'Trans proline' 0 C--N 1.386 2.5 0 C-N-CA 124.867 3.711 . . . . 10.0 117.976 -175.245 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 71' ' ' LYS . 40.8 Cg_exo -37.44 -29.7 0.11 Allowed 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 123.52 2.813 . . . . 10.0 114.47 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 1.08 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . . . 75.59 -45.73 0.55 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.997 0.74 . . . . 10.0 112.997 169.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 43.7 t -47.1 -37.11 9.17 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 123.841 0.713 . . . . 10.0 111.728 -175.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -47.24 -56.52 6.57 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.814 0.816 . . . . 10.0 111.534 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.585 HD22 HG21 ' A' ' 111' ' ' THR . 10.8 mp -98.54 -18.72 18.01 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.678 0.752 . . . . 10.0 109.689 -171.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.641 HD21 ' HB2' ' A' ' 132' ' ' ALA . 2.5 tp -64.85 -36.58 84.8 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 114.827 -1.078 . . . . 10.0 108.444 174.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.515 ' C ' ' H ' ' A' ' 82' ' ' ALA . 47.4 mtmt -64.1 -40.27 95.87 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.617 168.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.818 ' HA ' ' HE2' ' A' ' 81' ' ' LYS . 7.0 mmpt? -61.98 33.58 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.982 0.913 . . . . 10.0 113.15 171.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.923 ' HB1' HG13 ' A' ' 100' ' ' VAL . . . -171.42 -48.76 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 122.328 1.061 . . . . 10.0 109.394 -172.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.3 -41.91 98.91 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 112.846 -1.979 . . . . 10.0 109.326 171.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 97.99 -20.01 52.26 Favored Glycine 0 C--N 1.316 -0.578 0 CA-C-N 115.271 -0.877 . . . . 10.0 111.042 175.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.48 HG13 ' HG2' ' A' ' 80' ' ' LYS . 25.5 pt -60.68 143.17 14.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.325 -0.937 . . . . 10.0 112.337 177.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -160.59 23.63 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.351 -0.84 . . . . 10.0 109.103 175.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -169.04 -59.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.573 -0.74 . . . . 10.0 110.009 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 148.53 -175.06 27.99 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.931 -0.652 . . . . 10.0 111.82 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.4 m -160.41 170.03 21.84 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.515 -0.55 . . . . 10.0 109.515 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.4 p -75.63 33.68 0.11 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.504 0.557 . . . . 10.0 112.504 -177.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 32.77 72.26 0.62 Allowed Pre-proline 0 N--CA 1.472 0.625 0 C-N-CA 124.349 1.06 . . . . 10.0 113.291 -175.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.52 -170.36 0.99 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.848 2.365 . . . . 10.0 110.944 174.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.87 ' HB2' ' HB ' ' A' ' 96' ' ' ILE . 17.4 mmmt 57.55 -154.35 0.35 Allowed 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.992 -0.373 . . . . 10.0 109.992 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 94' ' ' ARG . 30.4 ttt180 -79.77 62.45 4.03 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.17 -0.307 . . . . 10.0 110.17 173.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.489 ' HD3' ' HA ' ' A' ' 95' ' ' LYS . 45.6 mmtt 67.12 29.43 7.86 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.429 0.633 . . . . 10.0 110.458 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.87 ' HB ' ' HB2' ' A' ' 93' ' ' LYS . 11.8 mt -91.37 176.34 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.167 -0.924 . . . . 10.0 109.42 -178.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.517 HG13 ' N ' ' A' ' 98' ' ' GLY . 7.8 p -139.01 -47.16 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 120.929 0.395 . . . . 10.0 111.305 -175.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.612 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -159.29 172.1 35.9 Favored Glycine 0 CA--C 1.493 -1.293 0 N-CA-C 108.08 -2.008 . . . . 10.0 108.08 170.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.947 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -143.13 167.51 21.93 Favored 'General case' 0 CA--C 1.479 -1.759 0 CA-C-O 122.664 1.221 . . . . 10.0 111.119 -169.152 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.923 HG13 ' HB1' ' A' ' 82' ' ' ALA . 2.1 t -131.53 -150.53 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.409 -2.478 0 CA-C-N 111.834 -2.439 . . . . 10.0 107.054 -173.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.645 ' H ' HG12 ' A' ' 100' ' ' VAL . 0.3 OUTLIER -167.42 133.98 2.21 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 105.894 -1.891 . . . . 10.0 105.894 -164.486 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.491 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 13.1 tpp180 -40.67 -44.91 2.26 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 125.055 1.472 . . . . 10.0 110.939 -171.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 16.9 tppt? -58.06 -42.94 86.56 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.398 0.888 . . . . 10.0 113.398 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.735 ' HB2' HG12 ' A' ' 100' ' ' VAL . 20.1 mm-40 -66.9 -52.02 48.36 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.089 -0.708 . . . . 10.0 109.089 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.849 HG21 ' HG3' ' A' ' 129' ' ' GLU . 28.7 mm -35.2 -55.29 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 O-C-N 124.074 0.859 . . . . 10.0 110.592 165.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.679 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 23.2 tt0 -50.36 -56.48 11.18 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.815 1.246 . . . . 10.0 113.12 177.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.53 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 12.5 mm-40 -54.58 -57.64 10.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.826 -1.079 . . . . 10.0 110.703 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.621 ' O ' HG22 ' A' ' 111' ' ' THR . 45.2 mt -50.19 -51.43 17.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.596 -1.183 . . . . 10.0 110.528 173.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.542 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -53.23 -34.26 56.39 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 112.582 0.586 . . . . 10.0 112.582 174.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.679 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 96.8 mttt -69.7 -52.29 26.89 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 120.853 0.359 . . . . 10.0 111.081 -177.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.621 HG22 ' O ' ' A' ' 108' ' ' ILE . 4.2 t -56.11 -29.12 60.19 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.944 -0.571 . . . . 10.0 111.606 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 1.08 ' HE3' ' HA ' ' A' ' 75' ' ' ALA . 49.7 mttm -103.89 -5.15 22.6 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 112.253 0.464 . . . . 10.0 112.253 -175.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.622 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 14.5 ptp -53.66 -32.87 11.94 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 112.985 0.735 . . . . 10.0 112.985 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 113' ' ' MET . 32.4 Cg_endo -62.83 -31.05 78.12 Favored 'Trans proline' 0 C--N 1.371 1.762 0 CA-C-N 120.651 1.268 . . . . 10.0 111.518 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.626 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 1.0 OUTLIER -102.78 -40.25 6.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.589 -1.187 . . . . 10.0 114.04 -169.357 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.558 ' HG ' HD13 ' A' ' 127' ' ' ILE . 0.9 OUTLIER -63.77 38.66 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 114.258 -1.337 . . . . 10.0 113.264 -174.315 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 43.4 t30 23.0 44.9 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 O-C-N 124.141 0.901 . . . . 10.0 111.024 -168.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.65 ' O ' ' HB2' ' A' ' 119' ' ' ASN . . . -73.88 -82.15 0.06 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.817 -1.083 . . . . 10.0 113.358 -169.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.65 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 5.7 m-20 101.26 -29.92 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 O-C-N 125.203 1.565 . . . . 10.0 110.412 -173.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 41.7 p -155.26 141.01 18.08 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.814 -1.18 . . . . 10.0 107.814 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.566 ' O ' ' HG3' ' A' ' 125' ' ' MET . 3.4 tm? -53.61 -44.05 69.15 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.832 1.049 . . . . 10.0 113.832 -175.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -53.64 -37.09 62.76 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.165 0.507 . . . . 10.0 111.507 174.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.574 ' O ' ' HG3' ' A' ' 126' ' ' LYS . . . -67.07 -47.24 71.87 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 118.241 -1.384 . . . . 10.0 110.276 174.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.546 ' HA ' HD12 ' A' ' 127' ' ' ILE . . . -55.99 -34.38 65.72 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.012 -0.675 . . . . 10.0 110.839 175.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.566 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 80.0 mtp -55.9 -45.38 78.66 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.175 0.805 . . . . 10.0 113.175 179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.642 ' HD2' HG13 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -63.6 -37.3 86.81 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.709 -0.478 . . . . 10.0 109.709 -178.338 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.642 HG13 ' HD2' ' A' ' 126' ' ' LYS . 83.6 mt -55.72 -64.04 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 CA-C-O 121.85 0.833 . . . . 10.0 111.569 175.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.542 HG13 ' HB2' ' A' ' 109' ' ' ALA . 25.0 mm -50.22 -59.67 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 CA-C-N 113.437 -1.71 . . . . 10.0 111.691 -178.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.849 ' HG3' HG21 ' A' ' 105' ' ' ILE . 6.3 mt-10 -53.2 -40.39 64.4 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.454 -0.793 . . . . 10.0 110.091 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -71.36 -45.17 49.29 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.356 -0.926 . . . . 10.0 111.715 -178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.433 HG21 ' HB3' ' A' ' 75' ' ' ALA . 97.8 m -46.5 -61.17 1.93 Allowed 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.185 -1.008 . . . . 10.0 108.906 169.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.641 ' HB2' HD21 ' A' ' 79' ' ' LEU . . . -50.74 -47.99 59.21 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.761 -0.654 . . . . 10.0 111.826 177.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 18.2 ttpt -44.44 -56.41 4.28 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 124.025 0.828 . . . . 10.0 110.448 176.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.5 m -64.54 -30.0 71.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.717 -0.674 . . . . 10.0 111.666 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 29.9 mtm -81.38 3.46 24.33 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 114.077 1.139 . . . . 10.0 114.077 -176.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.46 ' O ' HG12 ' A' ' 97' ' ' VAL . . . 84.07 20.04 59.93 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 120.066 1.303 . . . . 10.0 111.748 -177.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.702 ' CG2' HG23 ' A' ' 100' ' ' VAL . 1.8 mp -107.17 126.23 63.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.683 0.754 . . . . 10.0 112.079 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.947 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -90.31 158.87 16.94 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.522 -1.217 . . . . 10.0 108.997 175.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.5 HG11 ' HG2' ' A' ' 129' ' ' GLU . 19.1 m -114.71 124.3 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.216 0 N-CA-C 108.002 -1.111 . . . . 10.0 108.002 170.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 100' ' ' VAL . 5.0 m -108.52 157.24 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 CA-C-N 114.194 -1.366 . . . . 10.0 109.723 178.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 22.3 t70 . . . . . 0 C--N 1.287 -2.15 0 CA-C-N 113.057 -1.883 . . . . 10.0 110.28 174.073 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.421 ' HA ' ' HE3' ' A' ' 1' ' ' MET . 3.7 tpt . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 110.135 -0.32 . . . . 10.0 110.135 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.56 79.58 0.41 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.142 -0.481 . . . . 10.0 111.797 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -133.51 108.57 8.71 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 115.891 -0.595 . . . . 10.0 109.916 172.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.864 ' HD3' ' H ' ' A' ' 4' ' ' LYS . 0.3 OUTLIER -75.69 75.47 2.67 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.573 -0.74 . . . . 10.0 109.618 174.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 93.1 t -79.41 133.33 30.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.64 -0.504 . . . . 10.0 109.64 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.495 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . . . -98.5 -37.54 9.53 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.115 -0.698 . . . . 10.0 109.115 177.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.4 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -164.67 -171.28 2.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 122.026 0.917 . . . . 10.0 113.423 -177.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 54.6 mt-30 -137.83 132.95 33.37 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.737 -1.574 . . . . 10.0 108.316 177.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.629 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -119.9 80.91 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 N-CA-C 108.88 -0.785 . . . . 10.0 108.88 179.199 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -81.83 122.41 27.68 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 120.063 1.301 . . . . 10.0 107.847 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.605 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -156.84 130.3 8.08 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 122.163 0.982 . . . . 10.0 111.812 -171.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -81.99 120.93 25.88 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.297 -1.32 . . . . 10.0 110.225 -172.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.605 HD21 HD11 ' A' ' 11' ' ' LEU . 73.8 mt -138.57 135.32 17.92 Favored Pre-proline 0 CA--C 1.505 -0.752 0 CA-C-O 121.65 0.738 . . . . 10.0 112.051 -173.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.575 ' HB2' ' CB ' ' A' ' 17' ' ' LYS . 34.3 Cg_exo -54.94 123.6 14.19 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.641 2.894 . . . . 10.0 112.189 174.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.569 ' CB ' ' HA ' ' A' ' 50' ' ' ALA . . . -62.4 126.56 27.74 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.536 -1.283 . . . . 10.0 107.536 170.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.96 -1.06 85.93 Favored Glycine 0 CA--C 1.529 0.906 0 O-C-N 125.755 1.909 . . . . 10.0 113.238 -173.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.575 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . 6.0 tmtt? -142.81 95.85 2.84 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.185 0.993 . . . . 10.0 112.284 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.608 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -169.61 137.49 1.77 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.41 -1.268 . . . . 10.0 112.644 175.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.564 ' H ' ' HD3' ' A' ' 20' ' ' PRO . 1.8 t -178.05 -48.93 0.0 OUTLIER Pre-proline 0 N--CA 1.435 -1.182 0 CA-C-N 114.81 -1.086 . . . . 10.0 112.275 174.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.723 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 83.5 Cg_endo -101.53 134.64 0.15 Allowed 'Trans proline' 0 N--CA 1.407 -3.596 0 N-CA-C 116.231 1.589 . . . . 10.0 116.231 -150.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.025 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . 16.53 -64.94 0.0 OUTLIER Pre-proline 0 C--N 1.286 -2.184 0 CA-C-N 109.005 -3.725 . . . . 10.0 117.639 154.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.778 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 47.0 Cg_exo -53.87 -63.64 0.21 Allowed 'Trans proline' 0 CA--C 1.565 2.061 0 CA-C-N 123.606 2.324 . . . . 10.0 115.398 -176.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.778 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 58.3 Cg_endo -77.33 -52.24 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.607 2.204 . . . . 10.0 112.553 175.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.066 HG12 HD12 ' A' ' 35' ' ' ILE . 67.4 t -83.48 -44.95 18.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 111.896 -2.411 . . . . 10.0 111.957 -165.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.778 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -45.28 -53.36 7.94 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 114.259 -1.337 . . . . 10.0 114.234 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 1.025 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 50.5 Cg_exo -66.58 -49.29 1.75 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.228 2.619 . . . . 10.0 111.82 177.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.536 ' HB1' ' CG2' ' A' ' 9' ' ' ILE . . . -49.01 -74.85 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.323 0.583 . . . . 10.0 110.911 -177.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.773 HD22 ' HE2' ' A' ' 66' ' ' PHE . 3.5 mt -71.29 -44.99 64.12 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.649 0.981 . . . . 10.0 113.649 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.64 -41.45 98.91 Favored Glycine 0 N--CA 1.459 0.203 0 CA-C-N 116.237 -0.438 . . . . 10.0 113.359 -172.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -61.57 -26.52 68.01 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.94 -0.304 . . . . 10.0 110.491 178.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -99.06 17.37 19.94 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.847 -0.741 . . . . 10.0 109.982 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.01 11.91 85.14 Favored Glycine 0 CA--C 1.499 -0.944 0 CA-C-N 114.708 -1.133 . . . . 10.0 112.894 168.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.887 HG11 ' CD2' ' A' ' 66' ' ' PHE . 1.8 t -83.7 148.02 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 113.738 1.014 . . . . 10.0 113.738 -174.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -69.93 95.51 0.94 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.739 0.816 . . . . 10.0 110.606 174.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.066 HD12 HG12 ' A' ' 24' ' ' VAL . 22.0 mm -49.74 -43.27 18.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 114.722 -1.127 . . . . 10.0 111.783 177.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.806 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 10.7 ptm -66.05 -49.53 67.34 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 112.766 -2.016 . . . . 10.0 113.03 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.498 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 36.2 mt-10 -59.41 -32.99 70.69 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.114 -1.035 . . . . 10.0 110.912 176.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.745 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 72.1 t80 -63.49 -59.65 4.38 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 114.485 1.291 . . . . 10.0 114.485 169.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.806 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 23.7 p -60.07 -48.85 79.99 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 114.37 -1.287 . . . . 10.0 111.917 -175.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -65.32 -20.79 66.56 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.198 -0.667 . . . . 10.0 109.198 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.669 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 10.0 mtp180 -77.63 -64.25 1.19 Allowed 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 119.379 -0.928 . . . . 10.0 113.338 169.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.619 ' CE2' HG21 ' A' ' 46' ' ' THR . 45.3 t80 -55.9 -45.47 78.64 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 120.912 0.387 . . . . 10.0 110.113 -173.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.608 HD21 ' HB3' ' A' ' 18' ' ' ALA . 0.9 OUTLIER -59.01 -50.35 74.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.547 -0.751 . . . . 10.0 110.09 -179.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.69 96.26 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 118.816 -1.154 . . . . 10.0 112.649 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.669 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 5.1 pt-20 -73.78 -32.02 63.58 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 119.622 -0.831 . . . . 10.0 112.545 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.619 HG21 ' CE2' ' A' ' 42' ' ' PHE . 68.6 p -88.16 1.66 53.9 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 115.674 -0.694 . . . . 10.0 111.213 -177.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -47.56 -37.22 11.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.957 -1.02 . . . . 10.0 111.961 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.44 -45.39 39.0 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 114.194 -1.366 . . . . 10.0 110.538 -174.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.831 ' HD2' ' HZ ' ' A' ' 77' ' ' PHE . 30.2 mtmm -101.14 29.08 4.88 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 121.808 0.813 . . . . 10.0 109.472 -175.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.569 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -56.72 157.58 5.31 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 113.615 -1.63 . . . . 10.0 113.482 177.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.0 20.92 44.3 Favored Glycine 0 CA--C 1.505 -0.538 0 N-CA-C 109.883 -1.287 . . . . 10.0 109.883 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.616 ' HB2' HD21 ' A' ' 54' ' ' LEU . 14.6 mmt -137.28 123.14 20.08 Favored 'General case' 0 C--O 1.21 -1.018 0 C-N-CA 117.31 -1.756 . . . . 10.0 113.401 -167.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.7 mm -64.15 91.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.926 -0.768 . . . . 10.0 108.926 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.791 HD13 HG21 ' A' ' 70' ' ' ILE . 6.7 mt -79.19 127.11 80.24 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.552 -0.536 . . . . 10.0 109.552 -176.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.698 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 15.3 Cg_exo -70.85 99.63 0.88 Allowed 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 121.895 1.73 . . . . 10.0 110.397 172.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.419 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -97.12 148.82 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 119.57 1.077 . . . . 10.0 111.315 -172.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.433 ' HB ' ' CD1' ' A' ' 69' ' ' ILE . 71.5 t -126.53 115.01 40.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 120.866 -0.334 . . . . 10.0 110.521 171.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.726 ' CD1' HD21 ' A' ' 28' ' ' LEU . 17.7 mt -106.47 140.25 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 108.052 -1.092 . . . . 10.0 108.052 -175.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 94.0 m -123.81 99.32 6.22 Favored 'General case' 0 C--N 1.276 -2.607 0 CA-C-N 115.163 -0.926 . . . . 10.0 108.717 176.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 65' ' ' SER . 2.4 p -86.24 136.76 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.002 0 CA-C-N 118.897 0.771 . . . . 10.0 110.118 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 93.2 m-85 -93.96 170.5 9.49 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.076 -0.966 . . . . 10.0 112.507 -177.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.511 ' HG3' ' C ' ' A' ' 4' ' ' LYS . 16.3 mt-10 -63.28 -20.24 65.29 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.203 -1.362 . . . . 10.0 111.654 -177.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -78.97 -8.87 59.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.404 -0.816 . . . . 10.0 110.51 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm 83.15 0.75 1.13 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.442 1.097 . . . . 10.0 110.423 -171.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.53 ' O ' HG23 ' A' ' 60' ' ' VAL . 18.5 m -70.01 -178.77 1.68 Allowed 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 114.915 -1.038 . . . . 10.0 109.117 171.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.887 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -170.32 -175.89 2.05 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 119.679 1.127 . . . . 10.0 110.242 174.622 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.1 p -161.21 166.44 27.78 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 103.302 -2.851 . . . . 10.0 103.302 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.449 ' CB ' HG12 ' A' ' 58' ' ' ILE . 49.1 p90 -161.6 157.08 24.14 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 109.137 -0.69 . . . . 10.0 109.137 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.433 ' CD1' ' HB ' ' A' ' 57' ' ' VAL . 2.0 pp -136.55 152.59 29.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.327 -0.99 . . . . 10.0 108.327 -177.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.791 HG21 HD13 ' A' ' 54' ' ' LEU . 1.8 mm -100.9 132.07 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 N-CA-C 108.089 -1.078 . . . . 10.0 108.089 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.698 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 32.4 mmmt -80.42 99.07 7.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.981 0.896 . . . . 10.0 112.194 -171.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.89 ' HB ' ' HB3' ' A' ' 112' ' ' LYS . 78.6 p -64.32 -29.35 3.74 Favored Pre-proline 0 CA--C 1.569 1.681 0 CA-C-N 113.778 -1.556 . . . . 10.0 114.852 172.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.642 ' HG3' ' HB3' ' A' ' 115' ' ' ASP . 72.9 Cg_exo -40.8 -48.36 4.57 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 123.909 3.073 . . . . 10.0 116.925 -172.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.503 ' HD3' ' HB2' ' A' ' 73' ' ' PRO . 88.7 Cg_exo -48.11 -30.29 14.06 Favored 'Trans proline' 0 C--N 1.363 1.323 0 C-N-CA 122.159 1.906 . . . . 10.0 112.733 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.407 ' HB1' HD23 ' A' ' 79' ' ' LEU . . . 68.44 -44.35 0.51 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.933 0.893 . . . . 10.0 112.865 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.557 ' HA ' ' HB2' ' A' ' 79' ' ' LEU . 7.4 m -49.6 -33.47 15.32 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 122.852 0.461 . . . . 10.0 110.468 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.831 ' HZ ' ' HD2' ' A' ' 49' ' ' LYS . 20.9 t80 -43.93 -58.82 2.57 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.92 -1.036 . . . . 10.0 111.822 172.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.889 ' HB3' HG23 ' A' ' 108' ' ' ILE . 6.3 tp -95.98 -14.33 23.11 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.46 -0.496 . . . . 10.0 110.333 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.733 HD21 HG23 ' A' ' 128' ' ' ILE . 2.3 mm? -64.62 -44.31 90.95 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 109.243 -0.651 . . . . 10.0 109.243 171.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.553 ' HD2' ' O ' ' A' ' 80' ' ' LYS . 1.7 tmmm? -63.52 -30.58 71.68 Favored 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 115.51 -0.768 . . . . 10.0 109.434 174.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.512 ' HG3' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -60.28 -40.17 89.46 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.991 0.737 . . . . 10.0 112.991 173.44 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.828 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -66.66 -43.14 85.35 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 123.294 1.521 . . . . 10.0 110.636 171.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.599 ' HB1' HG12 ' A' ' 85' ' ' ILE . . . -76.51 164.72 25.68 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 111.125 -2.762 . . . . 10.0 108.563 -175.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -112.52 -3.35 25.59 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 118.665 -1.731 . . . . 10.0 110.876 163.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.639 HG21 HG13 ' A' ' 97' ' ' VAL . 46.9 pt -61.04 113.91 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.586 0.708 . . . . 10.0 111.462 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -76.55 -174.02 2.77 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.929 -0.578 . . . . 10.0 110.956 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -76.77 -15.18 59.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.066 0.46 . . . . 10.0 110.678 -170.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.06 54.07 3.83 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.539 -0.755 . . . . 10.0 114.019 -173.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.2 t -74.73 115.97 14.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.745 0.307 . . . . 10.0 110.841 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.511 ' O ' ' HG2' ' A' ' 91' ' ' GLU . 48.4 t -77.59 -68.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.537 -0.301 . . . . 10.0 110.3 173.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 90' ' ' SER . 3.3 mm-40 -171.8 99.1 0.38 Allowed Pre-proline 0 N--CA 1.464 0.255 0 CA-C-N 115.743 -0.662 . . . . 10.0 109.959 -177.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.564 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 13.9 Cg_endo -85.52 -89.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 122.395 2.063 . . . . 10.0 109.929 172.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' A' ' 93' ' ' LYS . 29.7 ttpt 50.87 24.32 1.74 Allowed 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.268 1.21 . . . . 10.0 114.268 164.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.564 ' HG2' ' O ' ' A' ' 92' ' ' PRO . 17.2 ptm180 -166.61 -23.12 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.433 -0.792 . . . . 10.0 112.384 -178.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 95' ' ' LYS . 47.5 mmtt -158.75 34.27 0.22 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.52 -0.548 . . . . 10.0 109.52 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.3 pt 46.6 -161.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 124.402 1.064 . . . . 10.0 113.009 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.639 HG13 HG21 ' A' ' 85' ' ' ILE . 8.3 p -150.83 -43.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 112.384 0.513 . . . . 10.0 112.384 -168.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.594 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -166.93 161.27 35.1 Favored Glycine 0 CA--C 1.5 -0.885 0 N-CA-C 109.452 -1.459 . . . . 10.0 109.452 173.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.746 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -145.32 177.85 8.52 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 122.676 1.227 . . . . 10.0 111.649 -165.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.828 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -157.68 -143.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 CA-C-N 111.813 -2.449 . . . . 10.0 105.465 -177.388 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.454 ' H ' ' HB ' ' A' ' 100' ' ' VAL . 0.9 OUTLIER -163.32 143.37 8.84 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 108.117 -1.068 . . . . 10.0 108.117 -157.107 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.631 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 6.7 tpp180 -42.21 -38.86 1.87 Allowed 'General case' 0 CA--C 1.548 0.876 0 O-C-N 124.727 1.267 . . . . 10.0 110.921 -174.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -57.86 -44.94 86.9 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.178 0.807 . . . . 10.0 113.178 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.512 ' O ' HG13 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -61.39 -47.39 86.02 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.529 -0.915 . . . . 10.0 108.529 177.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.847 HG23 ' HB ' ' A' ' 128' ' ' ILE . 1.9 mp -40.44 -56.51 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 CA-C-N 115.044 -0.98 . . . . 10.0 112.274 168.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.8 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 16.9 tt0 -47.15 -57.86 4.66 Favored 'General case' 0 C--O 1.215 -0.728 0 C-N-CA 124.74 1.216 . . . . 10.0 111.835 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.615 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 68.5 mm-40 -52.91 -55.38 23.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.969 -1.014 . . . . 10.0 110.986 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.889 HG23 ' HB3' ' A' ' 78' ' ' LEU . 32.4 mt -51.57 -54.84 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 115.902 -0.59 . . . . 10.0 109.925 174.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.512 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -50.6 -42.42 55.86 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 124.047 0.842 . . . . 10.0 112.63 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.8 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 70.1 mttt -67.43 -49.68 62.66 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 122.187 0.994 . . . . 10.0 108.876 -176.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 98.5 m -53.02 -22.29 5.59 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 113.302 -1.772 . . . . 10.0 112.77 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.89 ' HB3' ' HB ' ' A' ' 72' ' ' THR . 1.2 ptpp? -131.11 11.2 5.02 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 113.886 1.069 . . . . 10.0 113.886 -178.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.747 ' HG3' ' HD3' ' A' ' 114' ' ' PRO . 8.7 ptp -48.95 -38.35 25.5 Favored Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 118.714 0.688 . . . . 10.0 112.6 167.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.747 ' HD3' ' HG3' ' A' ' 113' ' ' MET . 34.3 Cg_endo -63.06 -27.83 74.0 Favored 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 121.42 1.413 . . . . 10.0 112.316 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.642 ' HB3' ' HG3' ' A' ' 73' ' ' PRO . 4.7 m-20 -95.99 -47.48 6.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.041 -0.981 . . . . 10.0 111.838 -175.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.598 HD13 ' HB2' ' A' ' 112' ' ' LYS . 7.5 mp -64.12 -1.92 1.79 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.002 -1.454 . . . . 10.0 111.053 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.439 ' H ' ' C ' ' A' ' 115' ' ' ASP . 0.2 OUTLIER 63.79 45.53 4.4 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.773 -1.558 . . . . 10.0 109.733 176.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.626 ' HB3' ' HB2' ' A' ' 113' ' ' MET . . . -82.5 114.7 21.1 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 113.703 -1.589 . . . . 10.0 112.198 -175.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -66.7 -33.48 75.73 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.246 -0.65 . . . . 10.0 109.246 169.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 45.7 t -150.83 144.46 25.06 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.007 -1.479 . . . . 10.0 107.007 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.567 ' O ' HD13 ' A' ' 121' ' ' LEU . 2.5 tm? -51.61 -34.51 37.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.824 -1.08 . . . . 10.0 112.433 -176.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.579 ' HA ' ' HG3' ' A' ' 125' ' ' MET . 14.4 mm-40 -48.23 -42.7 31.06 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.425 0.631 . . . . 10.0 111.152 174.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.09 -46.45 77.62 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 118.708 -1.197 . . . . 10.0 110.34 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.511 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -57.33 -37.42 72.5 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.149 176.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.579 ' HG3' ' HA ' ' A' ' 122' ' ' GLU . 19.9 mtp -54.74 -38.83 67.64 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.61 0.243 . . . . 10.0 111.505 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' A' ' 122' ' ' GLU . 61.7 mmtt -63.66 -47.97 79.12 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.831 -0.803 . . . . 10.0 108.831 -178.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.509 HD12 ' HA ' ' A' ' 124' ' ' ALA . 78.9 mt -51.1 -62.86 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-O 121.659 0.742 . . . . 10.0 110.614 176.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.847 ' HB ' HG23 ' A' ' 105' ' ' ILE . 32.9 mm -53.4 -56.66 7.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 113.949 -1.478 . . . . 10.0 112.636 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.98 -39.36 68.92 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.546 -0.909 . . . . 10.0 108.546 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.469 ' HA2' ' HE2' ' A' ' 133' ' ' LYS . . . -70.73 -46.78 44.28 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.531 -0.758 . . . . 10.0 111.657 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 84.3 m -46.2 -63.49 0.98 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 114.334 -0.933 . . . . 10.0 109.28 170.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.08 -49.81 39.9 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.873 -0.603 . . . . 10.0 111.358 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.469 ' HE2' ' HA2' ' A' ' 130' ' ' GLY . 26.8 ttpt -48.61 -53.22 19.33 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.711 -1.131 . . . . 10.0 111.55 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 43.5 m -67.63 -28.12 67.46 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 111.792 0.293 . . . . 10.0 111.792 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.444 ' HB2' HD12 ' A' ' 137' ' ' ILE . 7.4 mtm -80.05 6.41 11.55 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.614 0.968 . . . . 10.0 113.614 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 81.09 10.81 84.42 Favored Glycine 0 N--CA 1.452 -0.261 0 CA-C-N 119.504 1.047 . . . . 10.0 111.55 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.594 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 32.1 mt -100.57 126.54 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-O 121.165 0.507 . . . . 10.0 111.005 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.746 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -85.25 154.01 22.23 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.205 -0.998 . . . . 10.0 109.15 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.464 HG12 HD11 ' A' ' 105' ' ' ILE . 27.7 m -111.21 120.63 62.25 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.488 0 N-CA-C 107.314 -1.365 . . . . 10.0 107.314 169.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 100' ' ' VAL . 29.9 m -101.39 152.11 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.039 0 CA-C-N 114.123 -1.399 . . . . 10.0 108.76 178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 26.3 t0 . . . . . 0 C--N 1.294 -1.823 0 CA-C-N 112.874 -1.966 . . . . 10.0 112.876 -173.646 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mpp? . . . . . 0 N--CA 1.481 1.087 0 CA-C-O 120.768 0.318 . . . . 10.0 110.204 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.13 -147.52 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.945 -0.761 . . . . 10.0 108.945 -176.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.8 80.33 1.14 Allowed 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.836 0.827 . . . . 10.0 109.816 173.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.448 ' HB3' ' OE2' ' A' ' 62' ' ' GLU . 47.9 tttp -118.1 133.3 56.03 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.667 -1.151 . . . . 10.0 107.929 174.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.2 t -62.12 124.94 17.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 120.721 0.296 . . . . 10.0 110.498 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -99.68 -28.73 13.04 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.462 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -165.93 -167.6 1.11 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.166 -0.924 . . . . 10.0 112.811 177.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 9.7 pt20 -148.19 135.77 20.69 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.134 -1.394 . . . . 10.0 109.462 178.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.62 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -120.88 80.56 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 N-CA-C 109.022 -0.733 . . . . 10.0 109.022 -178.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 30.8 tttt -79.61 125.19 29.3 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 120.101 1.318 . . . . 10.0 108.154 177.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.612 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.8 130.48 7.35 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 122.024 0.916 . . . . 10.0 111.978 -172.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -82.91 120.8 26.15 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.24 -1.345 . . . . 10.0 110.105 -173.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.612 HD21 HD11 ' A' ' 11' ' ' LEU . 47.4 mt -136.56 137.69 24.6 Favored Pre-proline 0 N--CA 1.443 -0.82 0 CA-C-O 121.696 0.76 . . . . 10.0 112.213 -171.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.631 ' HB2' ' CB ' ' A' ' 17' ' ' LYS . 22.9 Cg_exo -58.91 122.83 12.27 Favored 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 123.603 2.869 . . . . 10.0 111.663 173.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.603 ' HB1' ' HB ' ' A' ' 46' ' ' THR . . . -62.08 128.95 38.55 Favored 'General case' 0 N--CA 1.428 -1.549 0 N-CA-C 108.176 -1.046 . . . . 10.0 108.176 171.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.71 0.78 81.78 Favored Glycine 0 N--CA 1.442 -0.944 0 O-C-N 126.122 2.139 . . . . 10.0 112.786 -174.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.631 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . 5.9 tmtt? -142.05 91.58 2.36 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.86 0.838 . . . . 10.0 112.024 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.36 135.58 5.18 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.449 -1.25 . . . . 10.0 112.588 175.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.506 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 1.4 t -178.29 -50.52 0.0 OUTLIER Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.191 -0.913 . . . . 10.0 112.37 173.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.659 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 84.9 Cg_endo -101.42 125.59 0.11 Allowed 'Trans proline' 0 N--CA 1.414 -3.197 0 N-CA-C 115.726 1.395 . . . . 10.0 115.726 -154.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.125 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 12.04 -89.99 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.534 0 CA-C-N 109.347 -3.569 . . . . 10.0 114.713 168.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.78 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 47.7 Cg_exo -26.72 -56.51 0.1 OUTLIER 'Trans proline' 0 CA--C 1.559 1.742 0 C-N-CA 123.041 2.494 . . . . 10.0 115.824 -161.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.78 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 37.4 Cg_endo -77.75 -72.7 0.01 OUTLIER 'Trans proline' 0 CA--C 1.551 1.327 0 C-N-CA 122.267 1.978 . . . . 10.0 112.327 168.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.993 HG12 HD12 ' A' ' 35' ' ' ILE . 74.9 t -59.55 -54.85 28.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 112.218 -2.264 . . . . 10.0 114.734 -173.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 1.125 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -46.44 -70.27 0.7 Allowed Glycine 0 C--O 1.22 -0.763 0 CA-C-N 114.808 -1.087 . . . . 10.0 113.787 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.625 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 23.5 Cg_exo -47.76 -46.7 20.53 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.489 2.793 . . . . 10.0 112.701 173.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.13 -77.34 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.319 0.581 . . . . 10.0 111.361 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.753 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . 3.3 mt -69.39 -52.05 30.68 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 114.088 1.144 . . . . 10.0 114.088 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.2 -40.13 83.24 Favored Glycine 0 N--CA 1.462 0.367 0 CA-C-N 115.562 -0.744 . . . . 10.0 113.374 -172.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -60.11 -26.3 66.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.851 0.358 . . . . 10.0 110.408 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -99.97 17.02 22.01 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 120.008 -0.677 . . . . 10.0 109.771 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.52 ' HA3' ' HD3' ' A' ' 64' ' ' LYS . . . 82.99 7.57 86.98 Favored Glycine 0 CA--C 1.499 -0.941 0 CA-C-N 114.639 -1.164 . . . . 10.0 113.292 167.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.874 HG11 ' CD2' ' A' ' 66' ' ' PHE . 1.6 t -83.1 145.78 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 N-CA-C 113.763 1.023 . . . . 10.0 113.763 -173.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.572 ' HB3' ' HG2' ' A' ' 37' ' ' GLU . 55.0 t-20 -70.58 100.28 1.8 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.452 0.644 . . . . 10.0 110.384 173.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.993 HD12 HG12 ' A' ' 24' ' ' VAL . 23.2 mm -53.54 -40.35 41.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 114.753 -1.112 . . . . 10.0 112.036 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 77.0 mtp -65.5 -53.01 48.55 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.189 -1.823 . . . . 10.0 112.434 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.572 ' HG2' ' HB3' ' A' ' 34' ' ' ASN . 7.0 pt-20 -61.52 -31.17 71.17 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 118.168 -1.413 . . . . 10.0 109.99 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.667 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 68.7 t80 -59.52 -58.97 6.26 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 119.502 -0.879 . . . . 10.0 112.849 168.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -56.22 -50.02 72.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 113.896 -1.502 . . . . 10.0 111.792 -178.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -64.85 -22.42 66.99 Favored 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 118.945 -1.102 . . . . 10.0 108.529 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.801 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 62.9 mtt180 -76.97 -64.3 1.16 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.032 -1.067 . . . . 10.0 111.863 169.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.604 ' CZ ' HG21 ' A' ' 46' ' ' THR . 76.8 t80 -54.18 -48.64 70.71 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-N 119.052 0.842 . . . . 10.0 110.784 -171.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -60.27 -51.75 68.22 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.768 -1.105 . . . . 10.0 110.328 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.07 -37.51 87.5 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 119.172 -1.011 . . . . 10.0 111.53 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.801 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 15.5 mm-40 -63.44 -45.34 91.33 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 122.02 0.914 . . . . 10.0 110.399 177.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.604 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 73.0 p -90.12 3.89 52.0 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.279 -1.328 . . . . 10.0 112.43 -167.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -47.1 -39.04 12.41 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 114.912 -1.04 . . . . 10.0 111.497 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.95 -48.09 77.89 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 114.125 -1.398 . . . . 10.0 111.532 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 45.1 mttp -98.84 21.96 10.78 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 123.217 0.607 . . . . 10.0 110.291 -172.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -51.99 133.05 32.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.066 -0.97 . . . . 10.0 112.634 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.37 19.27 10.08 Favored Glycine 0 CA--C 1.504 -0.599 0 N-CA-C 110.707 -0.957 . . . . 10.0 110.707 -176.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.582 ' HB2' HD21 ' A' ' 54' ' ' LEU . 66.9 mtt -138.74 125.5 20.91 Favored 'General case' 0 C--O 1.212 -0.885 0 C-N-CA 117.272 -1.771 . . . . 10.0 114.102 -168.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.6 mm -66.17 89.63 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 109.259 -0.645 . . . . 10.0 109.259 171.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.593 HD12 ' CG2' ' A' ' 46' ' ' THR . 8.2 mt -79.22 137.44 56.44 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.285 -0.635 . . . . 10.0 109.285 -177.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 54' ' ' LEU . 6.5 Cg_exo -76.28 106.12 2.2 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.13 1.887 . . . . 10.0 110.592 172.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.418 HG23 HG12 ' A' ' 70' ' ' ILE . 0.5 OUTLIER -105.74 153.61 7.18 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-N 119.775 1.17 . . . . 10.0 110.731 -175.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 60.1 t -134.79 119.11 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 C-N-CA 120.789 -0.365 . . . . 10.0 110.244 173.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.75 ' CD1' HD21 ' A' ' 28' ' ' LEU . 15.7 mt -108.0 140.95 24.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 C-N-CA 119.861 -0.735 . . . . 10.0 109.132 -174.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 96.8 m -124.91 101.05 6.88 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 114.776 -1.102 . . . . 10.0 108.947 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 65' ' ' SER . 2.6 p -90.0 135.77 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.673 0 C-N-CA 124.016 0.927 . . . . 10.0 111.102 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -96.69 -177.05 3.78 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.746 -0.661 . . . . 10.0 112.572 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.448 ' OE2' ' HB3' ' A' ' 4' ' ' LYS . 29.3 mt-10 -55.07 -32.36 61.88 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.411 -1.268 . . . . 10.0 113.182 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.85 -11.25 59.87 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.611 -0.722 . . . . 10.0 111.334 -170.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.527 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 11.9 mmpt? 84.21 3.78 0.77 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.184 -1.043 . . . . 10.0 108.184 -164.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.541 ' O ' HG23 ' A' ' 60' ' ' VAL . 73.3 m -71.82 174.46 6.86 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.997 -1.456 . . . . 10.0 108.651 172.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.874 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -168.91 -175.45 2.36 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 119.655 1.116 . . . . 10.0 110.259 175.336 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 p -159.74 166.47 30.39 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 102.821 -3.029 . . . . 10.0 102.821 177.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.472 ' CB ' HG12 ' A' ' 58' ' ' ILE . 48.2 p90 -163.27 155.1 17.61 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.464 0.649 . . . . 10.0 109.492 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.405 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 9.4 pt -120.39 165.94 15.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 114.697 -1.138 . . . . 10.0 108.353 -177.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.418 HG12 HG23 ' A' ' 56' ' ' VAL . 19.8 mt -138.46 113.13 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 107.152 -1.425 . . . . 10.0 107.152 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.585 ' HB3' ' HD2' ' A' ' 73' ' ' PRO . 11.6 mmmm -75.78 104.38 6.29 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 122.079 0.942 . . . . 10.0 112.676 -160.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.525 ' O ' ' HD2' ' A' ' 112' ' ' LYS . 65.6 p -64.5 -24.97 1.35 Allowed Pre-proline 0 CA--C 1.566 1.56 0 CA-C-N 113.52 -1.673 . . . . 10.0 114.48 171.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.599 ' HD3' ' CG ' ' A' ' 115' ' ' ASP . 74.9 Cg_exo -38.83 -53.3 1.94 Allowed 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 122.993 2.462 . . . . 10.0 115.005 -173.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.433 ' CD ' ' HB2' ' A' ' 73' ' ' PRO . 19.5 Cg_endo -59.13 99.33 0.11 Allowed 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 121.502 1.468 . . . . 10.0 110.618 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.683 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . . . -72.44 -8.48 55.28 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.113 -0.494 . . . . 10.0 111.115 -174.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.63 -38.58 46.9 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 123.916 0.76 . . . . 10.0 112.094 -175.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.531 ' HB3' ' SD ' ' A' ' 52' ' ' MET . 36.2 m-85 -70.7 -54.89 10.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.548 0.69 . . . . 10.0 111.223 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.734 ' HB3' HD12 ' A' ' 108' ' ' ILE . 3.7 mm? -74.86 -30.51 61.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.598 0.713 . . . . 10.0 110.109 -173.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.624 HD11 ' HB2' ' A' ' 132' ' ' ALA . 0.8 OUTLIER -62.07 -39.08 91.2 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.933 -0.766 . . . . 10.0 108.933 175.311 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.71 ' HG2' HG13 ' A' ' 85' ' ' ILE . 84.0 mttt -62.27 -20.39 64.22 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.042 -0.526 . . . . 10.0 111.775 172.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.445 ' HA ' ' HD2' ' A' ' 81' ' ' LYS . 13.5 tptp -62.88 -44.31 96.46 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 119.553 -0.859 . . . . 10.0 110.848 173.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.75 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -76.87 -53.09 8.35 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.273 1.429 . . . . 10.0 112.024 171.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -73.36 116.66 14.18 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 111.655 -2.52 . . . . 10.0 107.752 -177.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.92 16.95 24.62 Favored Glycine 0 CA--C 1.507 -0.451 0 CA-C-N 120.557 1.526 . . . . 10.0 111.745 -160.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.71 HG13 ' HG2' ' A' ' 80' ' ' LYS . 31.6 pt -68.35 90.9 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-N 114.463 -0.869 . . . . 10.0 111.881 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -158.04 49.87 0.4 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.541 0.686 . . . . 10.0 110.533 -176.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.54 23.06 0.06 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.496 -0.775 . . . . 10.0 110.783 -178.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.86 49.29 4.12 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.781 -0.723 . . . . 10.0 113.761 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.4 m 41.53 66.18 0.73 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.996 0.739 . . . . 10.0 112.996 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.452 ' O ' ' HB3' ' A' ' 91' ' ' GLU . 23.7 p -80.5 118.39 22.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.337 -0.392 . . . . 10.0 111.561 178.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 90' ' ' SER . 39.1 tt0 85.23 99.83 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.624 0 O-C-N 124.141 0.9 . . . . 10.0 111.585 171.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.25 111.26 1.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.206 2.604 . . . . 10.0 112.388 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.429 ' HE3' ' OE2' ' A' ' 91' ' ' GLU . 31.2 mmtp -79.67 -154.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.972 0.415 . . . . 10.0 111.632 178.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -65.1 -35.51 81.36 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.702 -174.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -171.51 18.28 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.693 173.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 138' ' ' GLU . 25.6 pt -138.03 -175.37 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 120.675 -0.41 . . . . 10.0 110.931 -174.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.548 HG13 ' N ' ' A' ' 98' ' ' GLY . 11.5 p -156.09 -50.37 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 N-CA-C 112.583 0.586 . . . . 10.0 112.583 -168.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.548 ' N ' HG13 ' A' ' 97' ' ' VAL . . . -96.07 149.82 19.44 Favored Glycine 0 CA--C 1.503 -0.695 0 N-CA-C 109.818 -1.313 . . . . 10.0 109.818 171.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.891 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 0.7 OUTLIER -143.63 141.49 30.61 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 122.668 1.223 . . . . 10.0 110.841 168.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.869 ' HB ' ' HG2' ' A' ' 104' ' ' GLN . 1.7 m -163.34 -145.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 111.436 -2.62 . . . . 10.0 106.858 -165.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.483 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 1.3 t -163.84 141.81 7.38 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 120.478 -0.489 . . . . 10.0 110.363 -160.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.617 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 0.0 OUTLIER -44.07 -29.82 0.66 Allowed 'General case' 0 CA--C 1.555 1.137 0 O-C-N 124.606 1.192 . . . . 10.0 112.51 -172.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.56 ' N ' ' HD3' ' A' ' 102' ' ' ARG . 17.6 tppt? -60.14 -45.15 93.98 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.688 0.625 . . . . 10.0 112.688 175.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.869 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 0.7 OUTLIER -56.6 -47.14 80.25 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.725 -1.213 . . . . 10.0 107.725 178.26 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.953 HG23 ' HB ' ' A' ' 128' ' ' ILE . 2.0 mp -43.69 -51.16 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.654 0 CA-C-N 114.29 -1.323 . . . . 10.0 112.174 172.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.804 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 23.0 tt0 -52.48 -55.6 20.83 Favored 'General case' 0 CA--C 1.506 -0.724 0 O-C-N 124.287 0.992 . . . . 10.0 111.718 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.718 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 66.1 mm-40 -52.58 -57.21 10.71 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 114.408 -1.269 . . . . 10.0 109.993 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.734 HD12 ' HB3' ' A' ' 78' ' ' LEU . 16.4 mm -52.0 -50.4 34.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.496 -0.774 . . . . 10.0 110.534 175.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.415 ' HB3' HD11 ' A' ' 121' ' ' LEU . . . -53.33 -39.06 63.8 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.711 -0.677 . . . . 10.0 112.736 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.804 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 64.5 mttt -72.42 -50.38 26.75 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 122.045 0.926 . . . . 10.0 109.226 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 97.9 m -51.32 -34.03 31.71 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 113.522 -1.672 . . . . 10.0 113.325 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.683 ' HE2' ' HA ' ' A' ' 75' ' ' ALA . 5.6 mtmp? -119.16 17.2 13.21 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.506 0.67 . . . . 10.0 109.229 -172.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.817 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 43.5 ttm -50.66 -47.0 86.01 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 114.708 -1.133 . . . . 10.0 113.048 177.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 113' ' ' MET . 20.3 Cg_endo -57.9 -24.44 64.64 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.168 1.912 . . . . 10.0 112.384 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.599 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 4.3 m-20 -94.26 -49.81 5.55 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.206 -0.906 . . . . 10.0 112.317 -177.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.542 ' CD1' ' HA ' ' A' ' 73' ' ' PRO . 10.1 mp -65.6 38.28 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 114.396 -1.274 . . . . 10.0 113.014 -177.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.437 ' H ' ' C ' ' A' ' 115' ' ' ASP . 9.4 t30 19.59 51.12 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 O-C-N 124.843 1.34 . . . . 10.0 112.025 -171.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.817 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -80.93 107.56 13.85 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.131 0.789 . . . . 10.0 113.131 -173.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.45 -37.6 85.52 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.624 0.726 . . . . 10.0 109.282 169.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.8 p -151.87 144.25 24.08 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.203 -1.406 . . . . 10.0 107.203 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.656 ' O ' ' HG2' ' A' ' 125' ' ' MET . 62.3 tp -51.93 -31.75 30.0 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 114.311 1.226 . . . . 10.0 114.311 -175.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -49.87 -39.76 40.43 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.681 0.753 . . . . 10.0 110.074 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.619 ' O ' ' HG3' ' A' ' 126' ' ' LYS . . . -66.93 -49.46 65.43 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.771 -1.104 . . . . 10.0 111.186 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.591 ' HB3' HD12 ' A' ' 121' ' ' LEU . . . -56.19 -34.96 66.71 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.92 -0.712 . . . . 10.0 110.719 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.732 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 50.6 mmm -56.64 -45.25 81.7 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.058 0.762 . . . . 10.0 113.058 178.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.738 ' HD3' ' N ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -65.14 -36.36 84.01 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.776 -0.453 . . . . 10.0 109.776 -177.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.738 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 73.4 mt -54.37 -65.05 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-O 121.571 0.7 . . . . 10.0 110.707 174.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.953 ' HB ' HG23 ' A' ' 105' ' ' ILE . 20.5 mm -51.05 -54.26 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 CA-C-N 113.853 -1.521 . . . . 10.0 112.365 -177.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.549 ' HG2' ' HA ' ' A' ' 126' ' ' LYS . 6.6 pt-20 -56.45 -44.58 80.63 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.382 -0.599 . . . . 10.0 109.382 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.531 ' HA2' ' HD2' ' A' ' 133' ' ' LYS . . . -69.33 -46.9 54.92 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.869 -0.605 . . . . 10.0 111.81 -175.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.584 HG21 ' HB3' ' A' ' 75' ' ' ALA . 64.8 m -44.99 -61.29 1.68 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.648 -0.871 . . . . 10.0 108.648 168.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.624 ' HB2' HD11 ' A' ' 79' ' ' LEU . . . -49.06 -46.23 44.13 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.895 -0.593 . . . . 10.0 112.353 176.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.531 ' HD2' ' HA2' ' A' ' 130' ' ' GLY . 65.2 mttm -49.88 -53.64 24.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.815 176.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 9.4 m -67.23 -31.79 72.38 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.482 0.658 . . . . 10.0 110.476 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.549 ' SD ' HG22 ' A' ' 131' ' ' THR . 26.0 mtp -77.67 -1.15 29.59 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 114.071 1.137 . . . . 10.0 114.071 -177.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.66 28.8 56.55 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 119.403 1.001 . . . . 10.0 111.949 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.531 ' CG2' ' HB1' ' A' ' 132' ' ' ALA . 1.7 mp -107.11 124.75 63.1 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.076 0 CA-C-O 121.612 0.72 . . . . 10.0 109.993 176.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.891 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 1.3 pt-20 -87.42 149.89 24.15 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.268 -1.382 . . . . 10.0 107.268 176.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 23.7 m -118.88 136.92 54.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.03 -1.1 . . . . 10.0 108.03 174.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.648 HG22 ' O ' ' A' ' 100' ' ' VAL . 8.2 m -135.65 71.48 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 113.801 1.037 . . . . 10.0 113.801 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.833 -1.08 . . . . 10.0 112.564 141.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 109.491 -0.559 . . . . 10.0 109.491 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.69 -42.83 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 112.483 0.549 . . . . 10.0 112.483 -175.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 59.6 mttm -100.2 164.35 12.0 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.586 0.588 . . . . 10.0 112.586 -167.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -100.44 115.32 29.78 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.173 -0.922 . . . . 10.0 110.742 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 50.1 t -66.84 138.15 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 122.812 0.445 . . . . 10.0 111.356 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -108.92 -40.91 4.88 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.727 -0.471 . . . . 10.0 109.727 173.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.467 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -156.73 151.03 25.26 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 113.656 0.984 . . . . 10.0 113.656 -176.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -95.27 134.63 37.83 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.842 -1.072 . . . . 10.0 108.26 171.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.675 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.5 OUTLIER -119.95 81.77 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 108.662 -0.866 . . . . 10.0 108.662 171.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -79.05 126.63 30.95 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 120.69 1.587 . . . . 10.0 108.098 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.545 HD21 HD11 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.42 128.56 6.72 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 122.331 1.062 . . . . 10.0 111.603 -176.09 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -83.06 119.07 24.01 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 113.816 -1.538 . . . . 10.0 110.086 -171.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.545 HD11 HD21 ' A' ' 11' ' ' LEU . 58.2 mt -137.73 137.84 22.67 Favored Pre-proline 0 CA--C 1.507 -0.688 0 CA-C-O 121.697 0.76 . . . . 10.0 112.427 -170.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.818 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 33.8 Cg_exo -56.05 123.8 14.72 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.752 2.968 . . . . 10.0 112.131 173.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.612 ' HB2' HD11 ' A' ' 54' ' ' LEU . . . -61.82 127.01 29.37 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 107.538 -1.282 . . . . 10.0 107.538 170.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.18 -5.78 81.84 Favored Glycine 0 N--CA 1.441 -1.014 0 O-C-N 125.765 1.916 . . . . 10.0 113.242 -175.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.818 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 2.2 mmmp? -138.47 104.65 5.21 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.562 1.181 . . . . 10.0 112.247 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.63 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -167.76 133.29 1.95 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.049 -1.432 . . . . 10.0 111.712 173.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.697 ' HA ' ' HB2' ' A' ' 39' ' ' CYS . 1.8 t -179.01 -40.66 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.102 -0.954 . . . . 10.0 113.075 177.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.692 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 85.0 Cg_endo -105.75 124.43 0.05 OUTLIER 'Trans proline' 0 N--CA 1.415 -3.146 0 N-CA-C 115.821 1.431 . . . . 10.0 115.821 -161.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.11 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 9.75 -84.56 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.545 0 CA-C-N 109.745 -3.389 . . . . 10.0 115.084 165.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.944 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 39.4 Cg_exo -28.74 -57.27 0.13 Allowed 'Trans proline' 0 CA--C 1.562 1.88 0 C-N-CA 122.912 2.408 . . . . 10.0 115.898 -164.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.944 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 6.0 Cg_exo -81.38 -55.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 123.102 2.534 . . . . 10.0 111.919 171.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.08 HG12 HD12 ' A' ' 35' ' ' ILE . 49.6 t -81.01 -52.49 14.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 112.209 -2.269 . . . . 10.0 113.659 -166.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 1.11 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -48.0 -74.07 0.28 Allowed Glycine 0 C--O 1.214 -1.122 0 CA-C-N 114.702 -1.135 . . . . 10.0 113.681 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.677 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 34.7 Cg_exo -46.9 -42.86 24.91 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.514 2.809 . . . . 10.0 112.833 175.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.04 -79.95 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.248 0.547 . . . . 10.0 111.011 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.817 ' HB2' HD11 ' A' ' 35' ' ' ILE . 2.2 mt -67.65 -47.1 70.53 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 114.178 1.177 . . . . 10.0 114.178 -177.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.78 -37.24 92.16 Favored Glycine 0 C--N 1.32 -0.351 0 CA-C-N 115.606 -0.724 . . . . 10.0 113.432 -173.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.54 -26.73 67.11 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.848 -0.427 . . . . 10.0 109.848 175.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -99.86 16.66 23.03 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 120.055 -0.658 . . . . 10.0 110.09 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.9 9.21 85.7 Favored Glycine 0 CA--C 1.503 -0.658 0 CA-C-N 114.809 -1.087 . . . . 10.0 113.532 168.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.749 HG11 ' CD2' ' A' ' 66' ' ' PHE . 11.4 t -81.77 147.14 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 114.078 1.14 . . . . 10.0 114.078 -172.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -69.03 96.93 0.82 Allowed 'General case' 0 C--N 1.347 0.457 0 C-N-CA 123.38 0.672 . . . . 10.0 110.765 171.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.08 HD12 HG12 ' A' ' 24' ' ' VAL . 20.0 mm -55.52 -38.41 49.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 121.983 0.897 . . . . 10.0 112.163 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -46.94 74.31 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 113.611 -1.631 . . . . 10.0 112.076 175.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.631 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 17.7 mt-10 -58.83 -43.74 90.73 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 118.66 -1.216 . . . . 10.0 110.479 174.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.576 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 79.3 t80 -54.71 -56.82 15.15 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 113.599 0.963 . . . . 10.0 113.599 173.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.697 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -55.92 -52.36 64.38 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 114.001 -1.454 . . . . 10.0 111.666 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -65.79 -21.61 66.51 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 119.097 -1.041 . . . . 10.0 109.02 -176.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.768 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 85.9 mtt180 -78.13 -63.53 1.37 Allowed 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 115.311 -0.859 . . . . 10.0 112.144 171.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.638 ' CZ ' HG21 ' A' ' 46' ' ' THR . 75.3 t80 -55.15 -44.38 75.06 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-O 121.251 0.548 . . . . 10.0 110.367 -172.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.631 HD22 ' N ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER -60.48 -49.25 78.32 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.056 -0.974 . . . . 10.0 109.911 -178.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.17 96.76 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 119.035 -1.066 . . . . 10.0 112.349 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.768 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 4.6 mm-40 -65.43 -43.37 90.71 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.951 0.882 . . . . 10.0 110.756 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.639 ' CG2' HD12 ' A' ' 54' ' ' LEU . 71.6 p -92.52 4.66 53.12 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 114.223 -1.353 . . . . 10.0 112.136 -171.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -47.22 -36.89 9.44 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.809 -1.087 . . . . 10.0 112.548 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -81.33 -40.69 23.2 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.678 -0.692 . . . . 10.0 111.823 -176.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.0 mttp -92.01 18.54 7.81 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 108.822 -0.807 . . . . 10.0 108.822 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.429 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -52.42 147.64 7.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.803 -1.089 . . . . 10.0 113.393 -177.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.49 18.96 31.32 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-N 114.813 -1.085 . . . . 10.0 110.513 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.557 ' HB2' HD21 ' A' ' 54' ' ' LEU . 61.6 mtt -138.34 127.65 24.49 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 116.693 -2.003 . . . . 10.0 114.866 -167.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.4 mm -65.23 91.71 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 O-C-N 121.787 -0.57 . . . . 10.0 109.58 170.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.639 HD12 ' CG2' ' A' ' 46' ' ' THR . 8.3 mt -84.63 130.65 52.42 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.928 -0.768 . . . . 10.0 108.928 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.506 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 14.3 Cg_exo -71.79 105.91 1.89 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.557 1.505 . . . . 10.0 110.635 173.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -97.22 142.81 13.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 119.9 1.227 . . . . 10.0 110.597 -174.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 89.4 t -119.71 111.83 34.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 120.332 -0.547 . . . . 10.0 110.431 171.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.783 ' CD1' HD21 ' A' ' 28' ' ' LEU . 15.5 mt -105.8 139.22 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.932 0 N-CA-C 107.972 -1.122 . . . . 10.0 107.972 -174.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.8 m -123.24 97.31 5.36 Favored 'General case' 0 N--CA 1.402 -2.836 0 CA-C-N 114.793 -1.094 . . . . 10.0 108.787 178.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.518 HG21 HG22 ' A' ' 33' ' ' VAL . 4.4 p -86.66 137.37 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.956 0 CA-C-N 119.402 1.001 . . . . 10.0 110.089 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.448 ' HE2' ' HG1' ' A' ' 67' ' ' THR . 77.9 m-85 -95.8 172.11 8.23 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.777 0.799 . . . . 10.0 112.857 -177.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -60.38 -22.96 63.93 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.249 -1.341 . . . . 10.0 111.841 -177.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.485 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 10.7 m-20 -77.68 -10.47 59.54 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.353 -0.839 . . . . 10.0 111.527 -176.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 55.1 mtpt 83.85 2.5 0.91 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 124.35 1.031 . . . . 10.0 109.459 -166.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.51 ' O ' HG23 ' A' ' 60' ' ' VAL . 14.6 t -73.74 172.13 12.03 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 113.924 -1.489 . . . . 10.0 107.369 174.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.749 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -169.75 -178.82 3.1 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 120.45 1.477 . . . . 10.0 109.692 175.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.448 ' HG1' ' HE2' ' A' ' 61' ' ' TYR . 5.3 p -161.83 169.41 21.37 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 103.542 -2.762 . . . . 10.0 103.542 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.449 ' CB ' HG12 ' A' ' 58' ' ' ILE . 49.8 p90 -162.5 159.3 24.75 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.545 -0.539 . . . . 10.0 109.545 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.9 mt -119.62 166.66 13.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 107.256 -1.387 . . . . 10.0 107.256 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.483 HD12 ' CE1' ' A' ' 42' ' ' PHE . 6.4 mm -126.42 122.18 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 107.004 -1.48 . . . . 10.0 107.004 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.586 ' C ' ' HD2' ' A' ' 73' ' ' PRO . 10.5 mmtp -76.64 96.82 4.25 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 122.188 0.994 . . . . 10.0 112.288 -169.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.733 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 3.4 t -59.46 -35.08 26.67 Favored Pre-proline 0 CA--C 1.56 1.362 0 CA-C-N 113.189 -1.823 . . . . 10.0 112.891 166.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.733 ' HD2' ' N ' ' A' ' 72' ' ' THR . 1.2 Cg_endo -39.69 -47.1 3.61 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 124.33 3.354 . . . . 10.0 116.114 -173.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.566 ' HD3' ' HG2' ' A' ' 73' ' ' PRO . 27.9 Cg_exo -61.62 88.57 0.1 OUTLIER 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 121.267 1.311 . . . . 10.0 111.061 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.656 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -62.54 -17.54 60.07 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.404 -0.816 . . . . 10.0 110.923 -177.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.759 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 17.1 m -54.06 -37.93 64.71 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.868 -0.605 . . . . 10.0 111.331 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -75.08 -50.27 16.98 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.22 0.533 . . . . 10.0 111.27 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.784 ' HB3' HD12 ' A' ' 108' ' ' ILE . 3.5 mm? -70.93 -27.53 63.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.186 0.517 . . . . 10.0 110.377 -176.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.429 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 62.1 mt -75.16 -21.66 58.63 Favored 'General case' 0 C--O 1.209 -1.039 0 CA-C-N 115.954 -0.566 . . . . 10.0 110.619 175.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.759 ' HG2' ' O ' ' A' ' 76' ' ' SER . 75.2 mmtt -61.84 -36.82 82.32 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.349 0.595 . . . . 10.0 109.676 171.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -60.8 -51.13 70.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.581 -0.736 . . . . 10.0 112.43 176.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 1.069 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -75.08 -64.99 0.93 Allowed 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 123.149 1.452 . . . . 10.0 110.715 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 79' ' ' LEU . . . -75.58 116.64 16.5 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 111.514 -2.584 . . . . 10.0 108.427 176.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -96.53 32.58 6.38 Favored Glycine 0 C--N 1.318 -0.463 0 C-N-CA 118.264 -1.922 . . . . 10.0 111.049 -163.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.495 HG22 HG22 ' A' ' 97' ' ' VAL . 49.6 pt -70.61 66.5 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 113.412 0.893 . . . . 10.0 113.412 -173.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 87' ' ' LYS . 16.2 mt-10 -72.11 75.55 0.95 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.2 0.524 . . . . 10.0 110.641 174.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 86' ' ' GLU . 75.4 mttt -167.39 -44.72 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.843 -1.071 . . . . 10.0 108.637 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 116.22 -47.66 1.02 Allowed Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.493 -0.776 . . . . 10.0 111.953 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.9 t 78.89 112.93 0.07 Allowed 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.467 0.707 . . . . 10.0 110.838 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 44.9 m -159.65 38.01 0.19 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.789 -0.819 . . . . 10.0 108.789 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.619 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 7.2 tp10 -171.62 -58.91 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 114.914 -1.039 . . . . 10.0 110.643 -173.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.619 ' HD3' ' HB3' ' A' ' 91' ' ' GLU . 88.7 Cg_endo -79.4 33.53 0.5 Allowed 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.161 1.907 . . . . 10.0 113.18 -175.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -76.8 68.8 3.07 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.397 -0.594 . . . . 10.0 109.397 177.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -162.52 -60.7 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.605 -0.725 . . . . 10.0 109.223 -175.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -77.13 -14.21 59.83 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 108.491 -0.929 . . . . 10.0 108.491 176.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.818 HG21 ' HB3' ' A' ' 138' ' ' GLU . 50.1 mm 73.25 111.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 114.007 -1.451 . . . . 10.0 111.358 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.495 HG22 HG22 ' A' ' 85' ' ' ILE . 4.2 p -58.12 -49.89 80.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 113.761 -1.563 . . . . 10.0 112.167 -173.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.465 ' N ' HG13 ' A' ' 97' ' ' VAL . . . -168.95 173.59 43.48 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 108.852 -1.699 . . . . 10.0 108.852 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.636 ' O ' HG13 ' A' ' 100' ' ' VAL . 16.9 mtmt -149.15 177.85 9.26 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-N 117.37 0.585 . . . . 10.0 109.981 -159.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 1.069 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -166.5 111.55 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.496 -1.108 0 CA-C-O 122.643 1.211 . . . . 10.0 111.816 167.241 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.689 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 1.1 t -41.58 147.27 0.19 Allowed 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 112.071 -2.331 . . . . 10.0 113.954 173.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.569 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 11.5 mmm180 -39.21 -37.78 0.44 Allowed 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 111.725 -2.489 . . . . 10.0 112.911 -170.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -57.46 -48.39 79.29 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.651 0.611 . . . . 10.0 112.651 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.658 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.5 OUTLIER -59.28 -46.01 89.7 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.115 -0.698 . . . . 10.0 109.115 -178.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.692 HG23 ' HB ' ' A' ' 128' ' ' ILE . 30.6 mm -40.49 -56.89 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 114.883 -1.053 . . . . 10.0 112.448 168.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.821 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 26.6 tt0 -44.51 -60.15 2.1 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.165 0.802 . . . . 10.0 113.165 -178.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.499 ' HA ' ' HD3' ' A' ' 110' ' ' LYS . 25.9 mt-10 -56.11 -49.66 73.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.619 -0.719 . . . . 10.0 110.653 -175.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.784 HD12 ' HB3' ' A' ' 78' ' ' LEU . 21.2 mm -50.62 -55.71 5.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.366 -0.834 . . . . 10.0 110.206 172.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.525 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -49.9 -47.19 52.26 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 113.298 0.851 . . . . 10.0 113.298 177.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.821 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 12.5 mtpp -67.16 -49.33 65.14 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.664 0.745 . . . . 10.0 109.923 -173.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.3 m -58.31 -29.92 66.26 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 114.557 -1.201 . . . . 10.0 112.003 177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.739 ' HB3' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -93.24 -16.27 24.97 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.589 0.755 . . . . 10.0 110.759 -176.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.965 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 5.1 ttp -48.75 -44.46 68.71 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 113.448 0.907 . . . . 10.0 113.448 -175.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 113' ' ' MET . 12.6 Cg_endo -56.06 -30.28 77.97 Favored 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 121.836 1.691 . . . . 10.0 111.615 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.435 ' CB ' ' HD3' ' A' ' 73' ' ' PRO . 0.2 OUTLIER -93.34 -45.86 7.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.525 -1.216 . . . . 10.0 111.875 -176.417 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.739 HD22 ' HB3' ' A' ' 112' ' ' LYS . 3.6 mp -63.49 -2.95 1.78 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.127 -1.397 . . . . 10.0 112.218 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 61.0 t30 61.69 45.43 7.96 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.297 -1.32 . . . . 10.0 109.548 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.965 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -86.35 121.0 28.31 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.691 -1.595 . . . . 10.0 112.289 -176.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -67.6 -33.22 74.56 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.225 -0.657 . . . . 10.0 109.225 171.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.0 t -154.96 143.87 20.85 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.965 -1.494 . . . . 10.0 106.965 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' A' ' 124' ' ' ALA . 29.7 tp -53.45 -31.11 44.06 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.19 1.552 . . . . 10.0 115.19 -172.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -48.89 -40.16 28.72 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.722 0.692 . . . . 10.0 110.083 175.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.4 -47.82 66.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.622 -1.172 . . . . 10.0 111.04 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.571 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -57.93 -36.61 72.75 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.624 -0.43 . . . . 10.0 110.429 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.554 ' HG3' ' HG ' ' A' ' 121' ' ' LEU . 64.7 mtp -61.82 -34.75 76.5 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.361 0.6 . . . . 10.0 110.169 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -64.12 -51.23 64.92 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.682 -1.144 . . . . 10.0 109.465 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.531 HG21 ' HG ' ' A' ' 116' ' ' LEU . 76.1 mt -50.98 -62.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 CA-C-N 115.266 -0.879 . . . . 10.0 110.727 177.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.692 ' HB ' HG23 ' A' ' 105' ' ' ILE . 26.5 mm -50.36 -54.51 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.078 0 CA-C-N 114.779 -1.1 . . . . 10.0 111.153 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' A' ' 133' ' ' LYS . 42.5 tt0 -53.56 -44.83 69.6 Favored 'General case' 0 N--CA 1.435 -1.214 0 O-C-N 124.119 0.887 . . . . 10.0 109.227 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -72.45 -45.93 35.22 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.618 -0.801 . . . . 10.0 111.698 -175.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.656 HG21 ' HB3' ' A' ' 75' ' ' ALA . 85.8 m -46.48 -60.1 2.56 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.359 -0.92 . . . . 10.0 109.575 171.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -48.24 -48.14 35.49 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.396 -0.82 . . . . 10.0 111.926 175.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 130' ' ' GLY . 47.9 mtpt -47.62 -54.25 12.43 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.755 0.659 . . . . 10.0 111.52 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 44.9 m -64.58 -30.82 71.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.879 0.371 . . . . 10.0 111.019 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.416 ' HE1' ' HA ' ' A' ' 76' ' ' SER . 43.5 mtm -79.65 7.94 7.47 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.502 0.927 . . . . 10.0 113.502 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.7 3.74 80.3 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 119.436 1.016 . . . . 10.0 111.564 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.523 HG23 ' HA ' ' A' ' 99' ' ' LYS . 39.9 mt -99.29 134.93 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-O 121.712 0.767 . . . . 10.0 112.58 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.818 ' HB3' HG21 ' A' ' 96' ' ' ILE . 0.0 OUTLIER -96.89 160.03 14.59 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.704 -1.135 . . . . 10.0 109.571 177.279 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.3 m -107.66 131.63 57.39 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.647 0 N-CA-C 106.68 -1.6 . . . . 10.0 106.68 170.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.689 ' O ' ' HA ' ' A' ' 101' ' ' THR . 3.4 m -117.22 -178.9 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-N 114.809 -1.087 . . . . 10.0 109.661 -174.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 38.9 t70 . . . . . 0 C--N 1.281 -2.407 0 CA-C-N 112.635 -2.075 . . . . 10.0 109.026 163.961 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.481 1.102 0 CA-C-O 120.829 0.347 . . . . 10.0 110.207 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.39 103.73 4.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.314 -0.403 . . . . 10.0 110.244 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.425 ' HB3' ' CD1' ' A' ' 61' ' ' TYR . 44.8 mtmt -82.28 152.44 26.33 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.353 0.597 . . . . 10.0 110.402 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.607 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -144.23 112.57 6.46 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.1 -0.955 . . . . 10.0 109.225 -175.549 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.8 t -65.02 139.96 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 122.671 0.388 . . . . 10.0 111.874 -173.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.526 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . . . -112.07 -36.58 5.32 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.134 -0.485 . . . . 10.0 109.708 172.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.478 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -155.4 143.03 19.69 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 113.25 0.833 . . . . 10.0 113.25 -177.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -93.16 130.1 38.94 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.648 -1.241 . . . . 10.0 107.648 170.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.683 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -119.95 81.66 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 109.051 -0.722 . . . . 10.0 109.051 176.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.462 ' HG2' HG13 ' A' ' 57' ' ' VAL . 9.6 mtmp? -79.13 127.39 31.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 120.137 1.335 . . . . 10.0 108.413 175.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.632 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.3 127.62 6.4 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.295 1.045 . . . . 10.0 111.731 -175.025 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -83.13 121.62 27.29 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.172 -1.377 . . . . 10.0 110.117 -172.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.632 HD21 HD11 ' A' ' 11' ' ' LEU . 69.3 mt -139.16 139.88 24.57 Favored Pre-proline 0 CA--C 1.506 -0.728 0 CA-C-O 121.737 0.78 . . . . 10.0 111.963 -170.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.853 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 11.9 Cg_exo -59.61 124.65 15.9 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 123.426 2.751 . . . . 10.0 111.506 173.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.625 ' CB ' ' HB ' ' A' ' 46' ' ' THR . . . -61.87 126.98 29.24 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 107.956 -1.127 . . . . 10.0 107.956 170.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.85 -2.23 88.34 Favored Glycine 0 N--CA 1.44 -1.093 0 O-C-N 125.66 1.85 . . . . 10.0 112.933 -175.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.853 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 74.9 mmtt -140.27 107.74 5.57 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 118.007 0.904 . . . . 10.0 112.422 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.71 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -169.77 134.41 1.35 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.92 -1.491 . . . . 10.0 112.052 171.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.546 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 1.6 t 178.92 -39.61 0.0 OUTLIER Pre-proline 0 C--N 1.324 -0.542 0 O-C-N 124.157 0.911 . . . . 10.0 113.169 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.725 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 71.8 Cg_endo -103.71 122.44 0.07 OUTLIER 'Trans proline' 0 N--CA 1.417 -2.983 0 N-CA-C 115.935 1.475 . . . . 10.0 115.935 -161.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.966 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 9.12 -82.91 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.451 0 CA-C-N 110.283 -3.144 . . . . 10.0 115.06 162.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.714 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 70.1 Cg_exo -33.16 -56.97 0.34 Allowed 'Trans proline' 0 CA--C 1.564 2.019 0 C-N-CA 122.182 1.921 . . . . 10.0 115.676 -164.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.725 ' HD2' ' O ' ' A' ' 20' ' ' PRO . 58.2 Cg_endo -78.62 -59.24 0.04 OUTLIER 'Trans proline' 0 CA--C 1.553 1.457 0 C-N-CA 122.734 2.29 . . . . 10.0 113.158 170.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.9 t -80.89 -36.81 15.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 112.441 -2.163 . . . . 10.0 113.388 -165.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.966 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -53.92 -69.03 1.35 Allowed Glycine 0 C--N 1.305 -1.142 0 CA-C-N 113.514 -1.676 . . . . 10.0 112.471 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 70.2 Cg_exo -50.87 -43.41 47.21 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.845 2.363 . . . . 10.0 112.117 172.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.45 ' O ' ' HD2' ' A' ' 31' ' ' HIS . . . -50.81 -96.54 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 112.372 0.508 . . . . 10.0 112.372 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.787 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.307 0.0 OUTLIER -75.11 -26.36 59.19 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 118.152 -1.419 . . . . 10.0 113.573 -176.233 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.577 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -68.53 -40.99 85.99 Favored Glycine 0 N--CA 1.465 0.589 0 C-N-CA 120.926 -0.654 . . . . 10.0 112.68 -175.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -60.96 -21.41 63.45 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.112 -0.635 . . . . 10.0 110.099 175.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.45 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 97.8 m-70 -99.09 19.81 14.53 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.629 -0.828 . . . . 10.0 110.215 178.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.559 ' HA3' ' HD2' ' A' ' 64' ' ' LYS . . . 86.59 4.61 82.82 Favored Glycine 0 CA--C 1.501 -0.785 0 CA-C-N 115.201 -0.909 . . . . 10.0 113.363 167.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.787 ' HB ' HD23 ' A' ' 28' ' ' LEU . 4.6 t -83.01 146.2 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 113.414 0.894 . . . . 10.0 113.414 -172.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 0.6 OUTLIER -69.07 99.96 1.18 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.818 0.447 . . . . 10.0 110.321 171.731 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.667 HD11 ' HA2' ' A' ' 25' ' ' GLY . 83.2 mt -53.0 -40.14 35.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.807 0.813 . . . . 10.0 111.594 175.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 72.2 mtm -68.04 -46.66 70.53 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.67 -1.605 . . . . 10.0 111.783 178.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.541 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 10.4 tp10 -56.13 -45.25 79.64 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 120.298 -0.561 . . . . 10.0 109.758 174.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.576 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 48.0 t80 -57.04 -55.34 35.92 Favored 'General case' 0 C--O 1.212 -0.877 0 N-CA-C 113.97 1.1 . . . . 10.0 113.97 171.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -50.35 71.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.663 -1.153 . . . . 10.0 111.886 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.72 -22.76 66.63 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 119.368 -0.933 . . . . 10.0 108.753 -178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.745 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 87.2 mtt180 -76.95 -64.18 1.19 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.264 -0.88 . . . . 10.0 112.168 171.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.62 ' CZ ' HG21 ' A' ' 46' ' ' THR . 80.2 t80 -55.27 -47.38 75.58 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.419 0.628 . . . . 10.0 110.094 -171.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.71 HD21 ' HB3' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -61.02 -48.24 82.72 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.489 -1.232 . . . . 10.0 110.317 -177.46 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.48 91.25 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.076 -1.05 . . . . 10.0 112.119 177.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.745 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 7.7 mm-40 -65.62 -40.35 92.48 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.823 0.821 . . . . 10.0 110.751 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.625 ' HB ' ' CB ' ' A' ' 15' ' ' ALA . 73.0 p -93.11 2.87 56.52 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 114.436 -1.256 . . . . 10.0 112.835 -170.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.11 -35.4 11.38 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.993 -1.003 . . . . 10.0 112.281 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -81.43 -43.1 19.4 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 115.314 -0.857 . . . . 10.0 111.561 -176.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.7 mttp -92.17 20.65 5.75 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.799 -0.815 . . . . 10.0 108.799 -176.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.416 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -53.3 149.21 7.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.952 -1.022 . . . . 10.0 113.09 -178.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.41 18.95 36.91 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.937 -1.029 . . . . 10.0 110.671 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.736 ' SD ' ' HB2' ' A' ' 77' ' ' PHE . 59.8 mtt -140.38 125.55 18.64 Favored 'General case' 0 C--O 1.212 -0.902 0 C-N-CA 117.419 -1.712 . . . . 10.0 113.941 -165.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 50.1 mm -66.82 90.73 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 118.657 0.662 . . . . 10.0 109.665 172.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.598 HD12 ' CG2' ' A' ' 46' ' ' THR . 10.0 mt -81.7 140.12 47.39 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.426 -0.583 . . . . 10.0 109.426 -177.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.744 ' HG2' ' HG2' ' A' ' 74' ' ' PRO . 3.6 Cg_exo -79.35 103.85 1.67 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.228 1.952 . . . . 10.0 110.896 172.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.408 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -97.99 155.64 3.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 119.885 1.22 . . . . 10.0 111.178 -175.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.462 HG13 ' HG2' ' A' ' 10' ' ' LYS . 96.7 t -134.79 112.51 15.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.015 174.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.683 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 24.4 mt -102.63 142.27 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.716 0 N-CA-C 108.133 -1.062 . . . . 10.0 108.133 -174.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.7 m -124.77 96.63 4.95 Favored 'General case' 0 N--CA 1.406 -2.648 0 CA-C-N 115.011 -0.995 . . . . 10.0 108.861 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.602 HG21 HG22 ' A' ' 33' ' ' VAL . 2.0 p -90.5 135.85 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 CA-C-N 119.479 1.036 . . . . 10.0 110.268 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.425 ' CD1' ' HB3' ' A' ' 3' ' ' LYS . 82.8 m-85 -91.86 170.6 9.75 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 114.99 -1.004 . . . . 10.0 112.635 -176.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.607 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 14.2 mt-10 -60.4 -20.78 60.9 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.684 -1.598 . . . . 10.0 112.03 -176.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 2.9 m-20 -85.53 -4.72 59.24 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.329 -0.85 . . . . 10.0 112.09 -176.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.559 ' HD2' ' HA3' ' A' ' 32' ' ' GLY . 40.2 mmtt 81.99 0.65 1.45 Allowed 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 122.188 0.994 . . . . 10.0 110.334 -169.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.52 ' O ' HG23 ' A' ' 60' ' ' VAL . 17.4 m -70.83 168.43 16.8 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.736 -1.574 . . . . 10.0 107.289 173.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.675 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -168.94 -177.12 2.87 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 120.687 1.585 . . . . 10.0 109.818 176.115 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.2 p -162.6 169.35 20.34 Favored 'General case' 0 N--CA 1.421 -1.903 0 N-CA-C 103.077 -2.935 . . . . 10.0 103.077 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.445 ' CB ' HG12 ' A' ' 58' ' ' ILE . 42.4 p90 -163.39 159.91 22.92 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.756 -0.831 . . . . 10.0 108.756 177.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 23.7 pt -129.19 161.57 38.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 107.468 -1.308 . . . . 10.0 107.468 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.417 HD13 ' CG2' ' A' ' 46' ' ' THR . 7.6 mt -126.95 120.15 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 106.568 -1.641 . . . . 10.0 106.568 -176.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.789 ' HE2' ' HA ' ' A' ' 71' ' ' LYS . 5.7 mmmm -76.4 98.2 4.49 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 122.325 1.06 . . . . 10.0 113.042 -160.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.623 ' O ' ' HE2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -44.6 -44.45 20.68 Favored Pre-proline 0 CA--C 1.56 1.337 0 CA-C-N 112.682 -2.054 . . . . 10.0 114.997 164.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.653 ' HD3' ' CG ' ' A' ' 115' ' ' ASP . 2.4 Cg_endo -39.43 -56.01 1.41 Allowed 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 124.268 3.312 . . . . 10.0 116.205 -171.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.744 ' HG2' ' HG2' ' A' ' 55' ' ' PRO . 88.9 Cg_exo -43.5 -34.74 5.35 Favored 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 123.207 2.604 . . . . 10.0 113.729 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.684 ' HB1' HD23 ' A' ' 79' ' ' LEU . . . 73.98 -31.77 0.22 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.679 0.992 . . . . 10.0 113.679 170.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.695 ' O ' ' HD3' ' A' ' 80' ' ' LYS . 47.9 t -42.24 -56.96 2.72 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 123.753 0.658 . . . . 10.0 111.958 -175.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.736 ' HB2' ' SD ' ' A' ' 52' ' ' MET . 32.7 p90 -55.9 -37.02 68.33 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.574 0.583 . . . . 10.0 112.574 -175.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 78' ' ' LEU . 1.3 tp -88.55 -32.2 18.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.871 0.367 . . . . 10.0 110.595 -174.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.684 HD23 ' HB1' ' A' ' 75' ' ' ALA . 4.3 mm? -63.8 -33.15 75.03 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.47 -0.567 . . . . 10.0 109.47 172.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.695 ' HD3' ' O ' ' A' ' 76' ' ' SER . 3.9 mptp? -56.04 -46.47 78.87 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.816 -0.629 . . . . 10.0 110.12 172.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.411 ' HD3' ' HA ' ' A' ' 81' ' ' LYS . 2.8 mmtm -57.23 -43.42 82.86 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.509 0.929 . . . . 10.0 113.509 -176.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.68 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -65.94 -49.0 69.47 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 123.044 1.402 . . . . 10.0 110.086 175.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.526 ' HB1' ' HA3' ' A' ' 98' ' ' GLY . . . -63.61 -30.02 71.19 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 111.306 -2.679 . . . . 10.0 110.358 -171.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 96.47 -14.58 64.1 Favored Glycine 0 CA--C 1.491 -1.466 0 C-N-CA 120.448 -0.882 . . . . 10.0 111.424 172.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.558 HG13 ' HG3' ' A' ' 80' ' ' LYS . 6.0 pt -60.73 -162.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 114.4 -0.9 . . . . 10.0 111.693 170.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.448 ' H ' ' HB ' ' A' ' 85' ' ' ILE . 1.9 tm-20 87.62 80.3 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.31 -1.313 . . . . 10.0 109.5 -174.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -179.49 -41.32 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 114.062 -1.427 . . . . 10.0 107.702 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 171.93 155.96 11.61 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 114.294 -1.321 . . . . 10.0 110.727 177.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.9 m -161.88 -86.11 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.333 -0.617 . . . . 10.0 109.333 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.1 m 50.06 35.26 9.57 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.287 0.847 . . . . 10.0 113.287 171.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.521 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 1.5 tm-20 -171.72 -56.66 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 119.257 -0.402 . . . . 10.0 111.727 -178.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.521 ' HD3' ' HB3' ' A' ' 91' ' ' GLU . 21.6 Cg_exo -66.93 20.37 0.1 Allowed 'Trans proline' 0 C--N 1.361 1.212 0 C-N-CA 122.953 2.435 . . . . 10.0 114.817 -171.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -79.68 67.86 5.57 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.842 -0.799 . . . . 10.0 108.842 173.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -160.31 -80.43 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.526 -170.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.554 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 46.5 tttp -86.39 35.24 0.65 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.211 -0.663 . . . . 10.0 109.211 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 95' ' ' LYS . 5.1 mt 75.4 170.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 114.865 -1.061 . . . . 10.0 110.569 -175.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.653 HG13 ' H ' ' A' ' 98' ' ' GLY . 7.3 p -149.84 -53.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 112.358 0.503 . . . . 10.0 112.358 -172.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.765 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -111.17 154.72 16.52 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 109.16 -1.576 . . . . 10.0 109.16 169.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.805 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 21.1 pttp -153.8 153.43 32.14 Favored 'General case' 0 CA--C 1.474 -1.958 0 CA-C-O 122.358 1.075 . . . . 10.0 109.865 164.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.68 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.7 OUTLIER -164.62 -162.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.414 -2.251 0 CA-C-N 111.976 -2.374 . . . . 10.0 105.958 -167.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.598 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 9.6 p -119.49 159.37 24.42 Favored 'General case' 0 C--N 1.275 -2.639 0 C-N-CA 119.494 -0.882 . . . . 10.0 111.838 -170.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.674 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 29.0 mmt180 -44.0 -41.92 5.69 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.193 -1.367 . . . . 10.0 110.334 170.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.489 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 3.1 tppp? -59.03 -44.8 91.8 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.672 0.619 . . . . 10.0 112.672 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.631 ' O ' HG12 ' A' ' 108' ' ' ILE . 58.9 mm-40 -58.33 -52.85 63.87 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.763 -0.829 . . . . 10.0 108.763 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.712 HD12 HG22 ' A' ' 128' ' ' ILE . 31.4 mm -38.04 -51.68 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.704 0 CA-C-N 114.318 -1.31 . . . . 10.0 111.899 167.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.748 ' HA ' ' SD ' ' A' ' 125' ' ' MET . 34.2 tt0 -52.95 -58.7 6.07 Favored 'General case' 0 C--O 1.215 -0.746 0 C-N-CA 124.627 1.171 . . . . 10.0 113.55 -177.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -58.36 -47.08 84.95 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 119.913 -0.715 . . . . 10.0 110.554 -176.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.631 HG12 ' O ' ' A' ' 104' ' ' GLN . 19.8 mm -48.46 -60.75 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.558 166.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.577 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -51.33 -38.01 50.81 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 112.138 0.422 . . . . 10.0 112.138 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.683 ' O ' ' HG2' ' A' ' 113' ' ' MET . 83.4 mttt -70.36 -54.44 12.49 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.854 -174.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.74 HG23 ' HG3' ' A' ' 112' ' ' LYS . 5.8 t -57.05 -24.65 55.36 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.804 -0.635 . . . . 10.0 111.208 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.74 ' HG3' HG23 ' A' ' 111' ' ' THR . 5.8 mtpm? -105.98 -11.0 16.32 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 112.69 0.626 . . . . 10.0 112.69 -175.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.683 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 22.7 ptm -51.82 -31.5 6.36 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 113.845 1.054 . . . . 10.0 113.845 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 113' ' ' MET . 31.6 Cg_endo -63.02 -28.02 74.45 Favored 'Trans proline' 0 C--N 1.368 1.558 0 CA-C-N 121.063 1.415 . . . . 10.0 111.31 174.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.653 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -100.19 -38.51 8.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.406 -1.27 . . . . 10.0 113.431 -172.115 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.68 HD11 ' NZ ' ' A' ' 112' ' ' LYS . 3.0 mp -62.93 -1.37 0.88 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 114.928 -1.033 . . . . 10.0 112.021 -175.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 115' ' ' ASP . 56.7 t30 58.38 65.56 1.24 Allowed 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.084 -1.417 . . . . 10.0 109.596 175.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.537 ' HB1' ' HB3' ' A' ' 123' ' ' ALA . . . -142.86 143.07 31.93 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.88 -1.054 . . . . 10.0 112.142 -171.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.456 ' C ' HD22 ' A' ' 119' ' ' ASN . 0.2 OUTLIER -65.72 -74.93 0.1 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.444 -1.253 . . . . 10.0 109.553 176.139 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.7 m -82.52 147.79 28.46 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.371 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.671 HD13 ' C ' ' A' ' 121' ' ' LEU . 1.5 tm? -55.11 -34.36 63.62 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.462 -0.57 . . . . 10.0 109.462 163.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -50.78 -38.51 48.58 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.307 0.575 . . . . 10.0 111.102 173.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.537 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . . . -67.61 -45.57 75.04 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 118.635 -1.226 . . . . 10.0 110.466 175.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.579 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -56.29 -32.78 64.9 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.487 -0.324 . . . . 10.0 110.848 175.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.748 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 84.0 mmm -58.17 -37.09 74.06 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.017 0.437 . . . . 10.0 110.89 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.532 ' HA ' ' HG2' ' A' ' 129' ' ' GLU . 3.5 mptp? -62.56 -54.28 42.13 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.233 -0.894 . . . . 10.0 111.933 177.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.552 HD12 ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -51.55 -57.93 2.75 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 C-N-CA 119.178 -1.009 . . . . 10.0 110.595 178.375 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.712 HG22 HD12 ' A' ' 105' ' ' ILE . 24.1 mm -50.73 -58.41 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 CA-C-N 114.578 -1.192 . . . . 10.0 112.448 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.532 ' HG2' ' HA ' ' A' ' 126' ' ' LYS . 11.6 pt-20 -53.42 -44.32 68.68 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.862 -0.792 . . . . 10.0 108.862 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.4 -47.77 55.66 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.779 -0.725 . . . . 10.0 111.329 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 69.6 m -43.07 -67.18 0.3 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.105 -1.048 . . . . 10.0 108.727 170.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.551 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -51.18 -48.63 61.9 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.851 -0.613 . . . . 10.0 112.331 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -47.81 -52.81 17.53 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.95 -0.568 . . . . 10.0 111.919 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 28.9 t -64.72 -29.36 70.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.752 0.31 . . . . 10.0 110.98 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.495 ' HE2' ' HA ' ' A' ' 132' ' ' ALA . 56.9 mtm -82.45 2.25 33.61 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 114.29 1.218 . . . . 10.0 114.29 -175.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.78 10.9 69.02 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 120.148 1.34 . . . . 10.0 111.777 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.765 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 2.7 mp -99.09 125.26 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 CA-C-O 121.64 0.733 . . . . 10.0 110.593 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.805 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -91.26 157.12 17.33 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 114.618 -1.174 . . . . 10.0 108.915 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 17.6 m -117.47 127.84 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.726 -0.472 . . . . 10.0 109.726 174.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.598 ' H ' ' HA ' ' A' ' 101' ' ' THR . 18.5 m -147.28 74.49 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 N-CA-C 116.151 1.908 . . . . 10.0 116.151 -170.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.498 ' OD1' ' HB2' ' A' ' 102' ' ' ARG . 1.3 m-20 . . . . . 0 C--N 1.289 -2.043 0 C-N-CA 119.823 -0.751 . . . . 10.0 110.844 145.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 120.805 0.336 . . . . 10.0 110.759 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.91 141.28 22.4 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 173.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -140.9 90.36 2.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.848 0.356 . . . . 10.0 110.688 175.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.682 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . 61.4 tttp -107.15 125.12 50.67 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.274 -0.639 . . . . 10.0 109.274 175.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.4 t -61.21 124.7 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 120.813 0.34 . . . . 10.0 110.528 -174.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -111.97 -27.0 8.6 Favored 'General case' 0 N--CA 1.439 -1.006 0 C-N-CA 120.54 -0.464 . . . . 10.0 110.344 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.594 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -160.45 174.64 13.8 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.222 0.823 . . . . 10.0 113.222 177.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.51 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 23.2 mm-40 -129.86 127.32 39.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.399 -1.273 . . . . 10.0 108.244 177.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.799 HG21 ' HG ' ' A' ' 28' ' ' LEU . 1.4 mm -116.2 87.01 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.121 -0.696 . . . . 10.0 109.121 -178.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.433 ' HG2' HG22 ' A' ' 57' ' ' VAL . 15.4 mtpp -78.28 142.68 37.63 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 121.097 1.771 . . . . 10.0 110.255 175.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 24' ' ' VAL . 1.0 OUTLIER -156.81 135.48 11.6 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.649 -0.705 . . . . 10.0 109.115 -176.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -96.3 113.22 24.79 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.635 -0.876 . . . . 10.0 108.635 172.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.537 HD11 HD23 ' A' ' 11' ' ' LEU . 31.5 mt -132.51 145.87 59.08 Favored Pre-proline 0 CA--C 1.501 -0.913 0 CA-C-O 121.147 0.499 . . . . 10.0 111.269 -169.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.808 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 5.8 Cg_exo -71.66 123.15 9.19 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 123.102 2.534 . . . . 10.0 111.31 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.543 ' HB2' HD11 ' A' ' 54' ' ' LEU . . . -60.32 127.41 31.65 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 107.936 -1.135 . . . . 10.0 107.936 172.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.22 -1.05 89.34 Favored Glycine 0 N--CA 1.438 -1.19 0 O-C-N 125.671 1.857 . . . . 10.0 112.354 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.808 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 45.2 tptt -139.52 110.76 6.97 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 122.943 1.354 . . . . 10.0 112.588 179.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.617 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -161.4 128.95 4.13 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 112.669 -2.06 . . . . 10.0 108.753 168.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.417 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 25.3 p -158.7 66.8 3.21 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 105.897 -1.89 . . . . 10.0 105.897 -174.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.748 ' HG3' HG22 ' A' ' 35' ' ' ILE . 5.7 Cg_exo 12.37 49.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.659 1 C-N-CA 130.673 7.582 . . . . 10.0 116.814 -175.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.584 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -57.6 167.75 1.26 Allowed Pre-proline 0 N--CA 1.441 -0.916 0 CA-C-N 112.545 -2.116 . . . . 10.0 109.601 164.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.584 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 72.9 Cg_exo -36.97 -44.35 1.12 Allowed 'Trans proline' 0 CA--C 1.548 1.223 0 C-N-CA 123.648 2.899 . . . . 10.0 114.967 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 22' ' ' PRO . 18.7 Cg_exo -36.29 -66.14 0.12 Allowed 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.808 3.005 . . . . 10.0 114.508 168.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.99 HG12 HD12 ' A' ' 35' ' ' ILE . 58.9 t -85.61 -56.27 5.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 114.433 -1.258 . . . . 10.0 114.02 -164.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -46.22 -67.67 1.28 Allowed Glycine 0 CA--C 1.521 0.455 0 O-C-N 124.37 1.044 . . . . 10.0 113.276 -174.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.433 ' HD2' ' O ' ' A' ' 22' ' ' PRO . 90.5 Cg_exo -52.03 -46.23 33.8 Favored 'Trans proline' 0 C--O 1.222 -0.289 0 C-N-CA 123.876 3.051 . . . . 10.0 112.8 174.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.5 -79.28 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.296 0.569 . . . . 10.0 111.799 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.902 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . 1.5 mt -67.73 -45.03 76.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.793 -0.64 . . . . 10.0 112.694 -176.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.49 -38.16 90.28 Favored Glycine 0 C--N 1.324 -0.126 0 CA-C-N 115.912 -0.585 . . . . 10.0 112.674 -173.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -65.07 -21.89 66.89 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.915 0.388 . . . . 10.0 110.752 177.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -98.86 16.62 21.75 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.345 0.593 . . . . 10.0 109.958 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.0 2.9 89.42 Favored Glycine 0 CA--C 1.503 -0.68 0 CA-C-N 115.092 -0.958 . . . . 10.0 113.657 168.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.682 HG11 ' CD2' ' A' ' 66' ' ' PHE . 2.0 t -78.96 148.06 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 113.009 0.744 . . . . 10.0 113.009 -173.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.529 ' OD1' ' HB3' ' A' ' 37' ' ' GLU . 0.3 OUTLIER -71.06 90.71 0.86 Allowed 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.919 0.866 . . . . 10.0 109.997 172.532 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.99 HD12 HG12 ' A' ' 24' ' ' VAL . 11.5 mm -53.54 -40.87 43.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 113.818 -1.537 . . . . 10.0 112.081 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 50.6 mtm -66.0 -47.15 75.43 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.594 -1.639 . . . . 10.0 111.967 178.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.606 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 32.3 tt0 -58.71 -37.68 76.66 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 118.661 -1.216 . . . . 10.0 109.612 173.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.577 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 81.6 t80 -54.61 -58.95 5.5 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 119.554 -0.859 . . . . 10.0 112.767 170.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -54.51 -53.34 55.72 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 114.069 -1.423 . . . . 10.0 111.324 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -67.05 -21.9 65.89 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 119.694 -0.803 . . . . 10.0 109.749 -176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.816 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 13.7 mtm180 -76.56 -62.48 1.61 Allowed 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 119.543 -0.863 . . . . 10.0 112.286 169.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.618 ' CZ ' HG21 ' A' ' 46' ' ' THR . 63.9 t80 -52.41 -42.06 63.74 Favored 'General case' 0 C--O 1.22 -0.483 0 CA-C-N 118.006 0.366 . . . . 10.0 110.536 -172.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.617 HD21 ' HB3' ' A' ' 18' ' ' ALA . 0.9 OUTLIER -60.86 -50.08 74.87 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.817 179.512 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.72 -41.58 99.23 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.742 -0.783 . . . . 10.0 112.341 176.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.816 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 4.4 mm-40 -65.82 -44.23 86.21 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.751 0.786 . . . . 10.0 110.81 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.618 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 76.8 p -89.79 5.09 47.62 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.534 -1.212 . . . . 10.0 111.85 -170.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.88 -40.22 9.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.955 -1.02 . . . . 10.0 112.224 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.88 -32.7 65.58 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.692 -0.685 . . . . 10.0 111.166 -176.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -99.42 17.64 19.74 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.791 0.837 . . . . 10.0 110.105 -175.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -50.26 142.3 10.24 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.172 -0.922 . . . . 10.0 112.873 -176.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.31 18.92 31.86 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 115.541 -0.754 . . . . 10.0 111.456 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.617 ' SD ' ' HB2' ' A' ' 77' ' ' PHE . 45.7 mtm -141.15 129.72 22.68 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 116.853 -1.939 . . . . 10.0 114.386 -167.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.3 mm -67.52 92.06 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.567 -0.531 . . . . 10.0 109.567 172.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.638 ' HB3' ' CG2' ' A' ' 70' ' ' ILE . 6.5 mt -81.2 130.02 64.43 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 109.697 -0.483 . . . . 10.0 109.697 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.865 ' HG2' ' HG3' ' A' ' 74' ' ' PRO . 18.0 Cg_exo -71.31 103.02 1.34 Allowed 'Trans proline' 0 C--N 1.331 -0.347 0 C-N-CA 122.571 2.181 . . . . 10.0 111.233 172.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.09 156.48 3.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 119.505 1.048 . . . . 10.0 111.706 -175.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.433 HG22 ' HG2' ' A' ' 10' ' ' LYS . 96.0 t -135.98 117.75 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 CA-C-N 116.29 -0.414 . . . . 10.0 110.209 170.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.806 HG21 HD21 ' A' ' 28' ' ' LEU . 12.6 mt -109.93 135.04 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.705 0 N-CA-C 108.595 -0.891 . . . . 10.0 108.595 -175.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 72.0 m -117.7 95.47 4.95 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 114.954 -1.021 . . . . 10.0 108.308 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.594 ' CG1' ' HB3' ' A' ' 7' ' ' ALA . 2.7 p -86.73 138.11 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.012 0 CA-C-N 119.61 1.095 . . . . 10.0 110.784 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.421 ' HE2' ' HG1' ' A' ' 67' ' ' THR . 59.8 m-85 -92.87 163.85 13.55 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.514 -0.766 . . . . 10.0 111.745 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.682 ' HG2' ' HB3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -60.7 -19.9 59.79 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.605 -1.18 . . . . 10.0 112.093 -179.132 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.33 -4.69 52.04 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.317 -0.856 . . . . 10.0 111.861 -177.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 83.24 -1.74 1.2 Allowed 'General case' 0 CA--C 1.506 -0.743 0 O-C-N 124.318 1.011 . . . . 10.0 109.443 -170.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.6 m -72.6 168.71 18.08 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.572 -1.194 . . . . 10.0 108.327 174.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.682 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -169.47 -179.99 3.63 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 120.477 1.49 . . . . 10.0 109.471 176.088 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.421 ' HG1' ' HE2' ' A' ' 61' ' ' TYR . 1.1 p -160.54 168.67 24.55 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 103.241 -2.874 . . . . 10.0 103.241 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.573 ' HE1' ' HE ' ' A' ' 41' ' ' ARG . 51.4 p90 -163.56 155.94 17.85 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.759 -0.83 . . . . 10.0 108.759 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mt -124.19 167.58 17.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 106.922 -1.51 . . . . 10.0 106.922 -177.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.638 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 2.6 mm -121.84 124.69 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 N-CA-C 106.485 -1.672 . . . . 10.0 106.485 177.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.702 ' HB3' ' HG2' ' A' ' 73' ' ' PRO . 32.0 mmmt -78.73 101.51 7.59 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.943 0.878 . . . . 10.0 111.897 -165.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.787 ' HB ' ' HG2' ' A' ' 112' ' ' LYS . 8.3 p -56.6 -34.73 28.24 Favored Pre-proline 0 CA--C 1.562 1.423 0 CA-C-N 113.449 -1.705 . . . . 10.0 113.974 169.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.738 ' HD2' ' N ' ' A' ' 72' ' ' THR . 4.8 Cg_exo -35.68 -52.15 0.93 Allowed 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 124.838 3.692 . . . . 10.0 115.907 -176.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.865 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 16.7 Cg_endo -58.76 103.45 0.16 Allowed 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.401 1.401 . . . . 10.0 110.495 173.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.709 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -81.13 0.39 36.45 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.245 -0.434 . . . . 10.0 111.364 -171.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.7 t -61.7 -55.29 31.99 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.141 -0.481 . . . . 10.0 111.451 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.683 ' HE1' ' HG2' ' A' ' 74' ' ' PRO . 37.7 p90 -77.77 -27.51 50.31 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.609 0.596 . . . . 10.0 112.609 -171.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.523 ' HB3' HD12 ' A' ' 108' ' ' ILE . 1.1 mm? -75.14 -46.54 33.62 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.416 0.626 . . . . 10.0 110.721 174.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.625 ' HB2' ' O ' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -64.16 -35.6 81.31 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.808 -0.442 . . . . 10.0 109.808 -179.27 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.647 ' HA ' ' HB3' ' A' ' 83' ' ' ALA . 20.2 ttpt -60.61 -31.86 71.02 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.819 -0.628 . . . . 10.0 110.262 173.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 21.9 ttpp -52.56 -44.84 66.11 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 110.439 -0.208 . . . . 10.0 110.439 177.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 1.005 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -73.52 -46.81 45.52 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.81 1.644 . . . . 10.0 111.657 172.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.647 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . . . -62.94 -38.91 92.91 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 111.532 -2.576 . . . . 10.0 111.718 -168.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 85.48 -14.93 48.79 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.028 -1.082 . . . . 10.0 111.596 173.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.554 HG13 ' HG3' ' A' ' 80' ' ' LYS . 14.9 pt -59.35 131.35 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 114.25 -0.975 . . . . 10.0 111.675 174.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.429 ' HG3' ' HD2' ' A' ' 80' ' ' LYS . 4.5 tt0 -172.42 31.81 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.424 0.63 . . . . 10.0 109.324 172.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -166.66 -56.52 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.296 -0.865 . . . . 10.0 109.672 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -177.62 -114.73 0.41 Allowed Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.564 -0.743 . . . . 10.0 111.573 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.9 t -165.52 136.39 3.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.943 0.402 . . . . 10.0 111.238 -177.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.2 m -78.98 -8.35 58.84 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.629 -0.714 . . . . 10.0 111.162 175.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -173.39 99.48 0.32 Allowed Pre-proline 0 C--O 1.234 0.281 0 CA-C-O 120.916 0.389 . . . . 10.0 111.257 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -88.75 109.09 0.5 Allowed 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.633 2.222 . . . . 10.0 110.771 171.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.413 ' HD3' ' NH2' ' A' ' 94' ' ' ARG . 12.2 ptpt -72.63 -106.71 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.437 -0.347 . . . . 10.0 111.66 -176.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.413 ' NH2' ' HD3' ' A' ' 93' ' ' LYS . 0.5 OUTLIER -79.14 -36.62 40.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.184 0.516 . . . . 10.0 110.703 177.027 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.404 ' H ' ' H ' ' A' ' 96' ' ' ILE . 26.3 tptp -171.9 -5.23 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.47 -0.787 . . . . 10.0 111.793 -177.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.556 HD13 ' HB2' ' A' ' 138' ' ' GLU . 4.5 mt -83.56 176.82 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 122.061 -0.399 . . . . 10.0 109.946 -176.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 136' ' ' GLY . 12.4 p -138.82 -45.88 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 112.286 0.476 . . . . 10.0 112.286 -165.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -165.2 155.12 26.3 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 109.439 -1.464 . . . . 10.0 109.439 175.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.69 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 9.2 ptpt -137.87 169.75 17.24 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-O 122.734 1.254 . . . . 10.0 111.71 -161.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 1.005 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.8 OUTLIER -159.5 -144.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-N 111.456 -2.611 . . . . 10.0 106.132 -174.087 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.49 HG22 ' CG2' ' A' ' 140' ' ' VAL . 28.5 p -154.64 148.21 25.26 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.127 -1.805 . . . . 10.0 106.127 -157.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.668 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 38.3 mmt180 -43.7 -42.47 5.37 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 123.895 0.747 . . . . 10.0 109.894 174.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.8 tptm -57.46 -44.04 84.49 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.69 0.626 . . . . 10.0 112.69 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.591 ' O ' HG12 ' A' ' 108' ' ' ILE . 1.1 mp0 -60.35 -50.04 75.21 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 109.157 -0.683 . . . . 10.0 109.157 177.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.944 HG23 ' HB ' ' A' ' 128' ' ' ILE . 33.0 mm -40.59 -54.1 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 114.446 -1.252 . . . . 10.0 111.398 169.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.709 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 23.7 tt0 -49.17 -51.37 33.0 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.837 -1.074 . . . . 10.0 112.382 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -51.27 -60.76 2.76 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.131 -0.941 . . . . 10.0 110.016 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.601 HG22 ' HD3' ' A' ' 112' ' ' LYS . 13.4 mm -47.53 -53.0 4.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 113.811 -1.54 . . . . 10.0 110.552 174.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.428 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -52.84 -34.4 53.97 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.663 0.616 . . . . 10.0 112.663 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.709 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 64.3 mttm -73.54 -53.86 9.57 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 116.468 -0.333 . . . . 10.0 110.976 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.76 HG23 ' HG3' ' A' ' 112' ' ' LYS . 11.4 t -56.74 -33.68 66.79 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.293 -0.412 . . . . 10.0 111.704 -178.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.787 ' HG2' ' HB ' ' A' ' 72' ' ' THR . 17.7 mtpp -96.87 -1.31 46.23 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 122.736 0.414 . . . . 10.0 111.321 -177.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.543 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 52.6 ttm -49.33 -47.34 76.95 Favored Pre-proline 0 N--CA 1.468 0.446 0 N-CA-C 112.836 0.68 . . . . 10.0 112.836 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 113' ' ' MET . 32.8 Cg_endo -63.26 -26.55 71.96 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 121.443 1.429 . . . . 10.0 111.979 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.523 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 0.5 OUTLIER -97.97 -44.45 6.66 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.952 -1.022 . . . . 10.0 113.576 -171.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.695 HD13 ' HB3' ' A' ' 112' ' ' LYS . 2.2 mp -66.22 42.22 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.708 -1.133 . . . . 10.0 113.232 -177.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 65.9 t30 14.64 53.0 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 O-C-N 124.776 1.298 . . . . 10.0 112.28 -167.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.407 ' O ' ' CB ' ' A' ' 119' ' ' ASN . . . -65.8 -78.8 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.612 0.967 . . . . 10.0 113.612 -165.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 118' ' ' ALA . 38.5 t-20 99.72 -41.55 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.883 1.273 . . . . 10.0 108.323 -175.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 47.6 t -148.81 139.54 22.77 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 106.758 -1.571 . . . . 10.0 106.758 173.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.623 ' O ' ' HG2' ' A' ' 125' ' ' MET . 3.2 tm? -53.19 -33.76 54.06 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.157 -0.928 . . . . 10.0 113.324 -177.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -50.02 -42.62 49.73 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.749 0.785 . . . . 10.0 110.697 173.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.494 ' HA ' ' HD2' ' A' ' 126' ' ' LYS . . . -65.7 -49.09 69.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.487 -1.233 . . . . 10.0 110.719 -178.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.579 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -54.93 -37.9 66.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.527 178.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.625 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 78.4 mmm -52.96 -40.34 63.62 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.138 0.792 . . . . 10.0 113.138 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.494 ' HD2' ' HA ' ' A' ' 123' ' ' ALA . 10.3 mttt -63.25 -46.8 85.19 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.291 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.667 HD13 ' HG ' ' A' ' 116' ' ' LEU . 73.2 mt -50.19 -62.58 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-N 115.6 -0.727 . . . . 10.0 110.012 175.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.944 ' HB ' HG23 ' A' ' 105' ' ' ILE . 10.5 mm -53.18 -58.03 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.864 0 CA-C-N 114.058 -1.428 . . . . 10.0 111.441 -176.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.56 -44.01 62.58 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 123.849 0.718 . . . . 10.0 109.584 179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -69.9 -45.84 55.49 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.415 -0.897 . . . . 10.0 111.881 -177.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.709 HG21 ' HB3' ' A' ' 75' ' ' ALA . 22.4 m -48.2 -58.12 4.96 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 114.486 -0.857 . . . . 10.0 109.762 171.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.495 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -53.38 -44.57 68.74 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 111.812 0.301 . . . . 10.0 111.812 178.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 34.7 tttp -45.33 -55.15 6.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.491 -0.777 . . . . 10.0 110.956 174.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.0 m -64.58 -31.56 72.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.984 0.421 . . . . 10.0 111.529 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.429 ' HE1' ' HB3' ' A' ' 79' ' ' LEU . 10.7 mtm -78.61 -8.84 59.05 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.272 0.841 . . . . 10.0 113.272 -174.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.557 ' O ' HG12 ' A' ' 97' ' ' VAL . . . 88.72 14.36 61.38 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 119.587 1.085 . . . . 10.0 111.74 -178.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 2.0 mp -96.95 124.84 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.95 0 CA-C-O 121.624 0.726 . . . . 10.0 111.062 -177.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.69 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.3 OUTLIER -84.03 146.68 27.83 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.611 -1.177 . . . . 10.0 109.323 177.544 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.7 m -116.64 124.02 72.29 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.782 0 N-CA-C 106.458 -1.682 . . . . 10.0 106.458 174.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 100' ' ' VAL . 33.1 m -106.88 170.01 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.149 0 CA-C-N 113.753 -1.567 . . . . 10.0 110.063 -175.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 . . . . . 0 C--N 1.288 -2.078 0 CA-C-N 113.148 -1.842 . . . . 10.0 108.482 -177.451 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 N--CA 1.479 1.019 0 CA-C-O 121.211 0.529 . . . . 10.0 110.632 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.28 158.64 43.78 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.496 -0.774 . . . . 10.0 109.058 176.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.529 ' O ' ' HG3' ' A' ' 3' ' ' LYS . 21.9 pttm -115.41 106.11 13.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.337 1.065 . . . . 10.0 112.118 -178.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.448 ' HB3' ' HG3' ' A' ' 62' ' ' GLU . 21.2 ttpt -144.94 133.59 22.15 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.371 -1.344 . . . . 10.0 107.371 168.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.5 t -62.6 127.29 22.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 O-C-N 123.376 0.422 . . . . 10.0 111.148 -174.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -102.51 -28.55 12.11 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 109.091 -0.707 . . . . 10.0 109.091 176.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.542 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -162.52 177.85 9.1 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.295 0.85 . . . . 10.0 113.295 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.46 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 78.3 mt-30 -134.65 129.63 35.14 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 114.493 -1.23 . . . . 10.0 107.963 175.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.665 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 5.4 mt -124.1 87.24 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 109.038 -0.727 . . . . 10.0 109.038 -175.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.524 ' HG3' HG22 ' A' ' 57' ' ' VAL . 3.2 mppt? -78.37 146.39 34.66 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 120.991 -1.068 . . . . 10.0 110.178 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 10' ' ' LYS . 0.9 OUTLIER -156.77 137.16 12.97 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.088 -0.505 . . . . 10.0 109.902 -175.573 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.424 ' HB3' ' CG2' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -93.84 113.28 25.28 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.312 -0.996 . . . . 10.0 108.312 169.528 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.491 HD11 HG22 ' A' ' 24' ' ' VAL . 15.5 mt -132.1 152.88 80.97 Favored Pre-proline 0 C--O 1.212 -0.909 0 CA-C-O 121.31 0.576 . . . . 10.0 111.652 -171.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.677 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 5.5 Cg_exo -78.63 123.59 5.96 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 123.244 2.629 . . . . 10.0 111.784 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 50' ' ' ALA . . . -61.75 126.67 28.15 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.987 -1.116 . . . . 10.0 107.987 172.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.03 1.79 90.4 Favored Glycine 0 N--CA 1.438 -1.192 0 O-C-N 126.043 2.089 . . . . 10.0 112.108 -177.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.677 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 9.6 tptp -141.56 113.45 7.88 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 122.999 1.381 . . . . 10.0 112.102 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.525 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -159.04 140.56 13.26 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 112.869 -1.969 . . . . 10.0 108.561 164.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 48.0 p -157.64 61.02 2.12 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 105.837 -1.912 . . . . 10.0 105.837 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.695 ' HG3' ' CG2' ' A' ' 35' ' ' ILE . 0.1 OUTLIER 15.41 49.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.692 1 C-N-CA 129.687 6.925 . . . . 10.0 116.11 -178.011 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.64 ' HB1' ' HD2' ' A' ' 22' ' ' PRO . . . -56.08 170.58 0.44 Allowed Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 111.553 -2.567 . . . . 10.0 109.736 165.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.64 ' HD2' ' HB1' ' A' ' 21' ' ' ALA . 79.6 Cg_exo -37.39 -44.76 1.46 Allowed 'Trans proline' 0 C--N 1.358 1.067 0 C-N-CA 123.291 2.661 . . . . 10.0 114.814 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 22' ' ' PRO . 6.4 Cg_exo -38.18 -62.56 0.3 Allowed 'Trans proline' 0 C--N 1.359 1.088 0 C-N-CA 123.346 2.697 . . . . 10.0 114.374 170.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.942 HG12 HD12 ' A' ' 35' ' ' ILE . 61.6 t -87.44 -56.58 5.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 114.207 1.188 . . . . 10.0 114.207 -163.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.48 -66.52 2.2 Favored Glycine 0 C--O 1.226 -0.348 0 O-C-N 124.02 0.825 . . . . 10.0 113.366 -174.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.435 ' HD2' ' O ' ' A' ' 22' ' ' PRO . 86.4 Cg_exo -53.01 -42.41 64.77 Favored 'Trans proline' 0 C--O 1.225 -0.141 0 C-N-CA 123.262 2.641 . . . . 10.0 112.577 174.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.517 ' HB1' ' CG2' ' A' ' 9' ' ' ILE . . . -53.17 -79.76 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.401 0.619 . . . . 10.0 111.433 177.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.87 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . 2.5 mt -67.17 -46.77 72.97 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.521 -0.763 . . . . 10.0 113.016 -176.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.9 -35.6 87.39 Favored Glycine 0 C--O 1.228 -0.232 0 CA-C-N 116.428 -0.351 . . . . 10.0 112.931 -173.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -64.2 -22.72 67.05 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.72 0.295 . . . . 10.0 110.222 174.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -99.87 15.53 26.73 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.408 0.623 . . . . 10.0 109.603 175.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.462 ' HA3' ' CE ' ' A' ' 64' ' ' LYS . . . 74.28 14.47 80.68 Favored Glycine 0 CA--C 1.501 -0.799 0 CA-C-N 114.687 -1.142 . . . . 10.0 113.692 170.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.605 HG11 ' CD2' ' A' ' 66' ' ' PHE . 0.9 OUTLIER -82.74 148.88 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 C-N-CA 120.252 -0.579 . . . . 10.0 112.474 -177.074 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -71.11 92.78 0.99 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.701 0.762 . . . . 10.0 110.296 174.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.942 HD12 HG12 ' A' ' 24' ' ' VAL . 14.6 mm -53.94 -40.02 43.13 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 114.422 -1.263 . . . . 10.0 112.35 178.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -41.88 77.42 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 113.909 -1.496 . . . . 10.0 111.613 177.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.551 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 22.2 mt-10 -55.77 -44.71 77.94 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 118.932 -1.107 . . . . 10.0 109.611 169.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.673 ' CE1' HD11 ' A' ' 58' ' ' ILE . 84.6 t80 -52.74 -58.62 6.26 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 114.076 1.139 . . . . 10.0 114.076 172.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 39.9 t -56.9 -51.6 68.47 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 114.75 -1.114 . . . . 10.0 110.924 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.51 ' HA ' ' HD3' ' A' ' 40' ' ' LYS . 28.7 mmtp -67.47 -20.88 65.53 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 119.269 -0.972 . . . . 10.0 110.297 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.613 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 92.7 mtt180 -73.85 -62.85 1.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 119.912 -0.715 . . . . 10.0 112.103 170.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.514 ' CZ ' HG21 ' A' ' 46' ' ' THR . 73.3 t80 -56.42 -48.55 76.72 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-N 115.572 -0.74 . . . . 10.0 110.415 -173.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.525 HD21 ' HB3' ' A' ' 18' ' ' ALA . 0.9 OUTLIER -59.7 -49.44 77.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.308 -0.86 . . . . 10.0 110.286 -176.739 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.81 -46.08 91.06 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 119.169 -1.013 . . . . 10.0 112.71 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 9.5 pt-20 -71.32 -31.25 67.17 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 120.16 -0.616 . . . . 10.0 112.355 -176.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.523 ' CG2' HD12 ' A' ' 54' ' ' LEU . 63.3 p -91.06 2.88 55.99 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.45 -0.795 . . . . 10.0 111.591 -175.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.74 -38.71 7.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.001 -0.999 . . . . 10.0 112.934 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.535 ' OD1' ' HG3' ' A' ' 49' ' ' LYS . 0.5 OUTLIER -81.94 -26.49 33.98 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.729 -0.669 . . . . 10.0 112.199 -174.44 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.535 ' HG3' ' OD1' ' A' ' 48' ' ' ASP . 36.4 mttp -101.72 18.55 20.13 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.473 0.654 . . . . 10.0 109.437 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -50.32 140.95 12.5 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.704 -1.134 . . . . 10.0 112.928 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.59 18.08 26.7 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 114.984 -1.007 . . . . 10.0 110.774 -177.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.453 ' HB2' HD21 ' A' ' 54' ' ' LEU . 65.6 mtt -137.12 127.23 26.09 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 117.137 -1.825 . . . . 10.0 113.92 -167.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.424 ' CG2' ' HB3' ' A' ' 12' ' ' GLN . 50.9 mm -68.97 90.61 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.268 -0.641 . . . . 10.0 109.268 171.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.523 HD12 ' CG2' ' A' ' 46' ' ' THR . 6.6 mt -77.74 140.03 62.99 Favored Pre-proline 0 N--CA 1.449 -0.482 0 N-CA-C 108.665 -0.865 . . . . 10.0 108.665 -179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 54' ' ' LEU . 5.3 Cg_exo -77.92 104.78 1.91 Allowed 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.59 2.193 . . . . 10.0 110.889 172.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.54 151.26 4.9 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 CA-C-N 118.893 0.769 . . . . 10.0 111.324 -174.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.524 HG22 ' HG3' ' A' ' 10' ' ' LYS . 99.3 t -135.58 119.81 26.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 109.981 -0.377 . . . . 10.0 109.981 172.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.842 HG21 HD21 ' A' ' 28' ' ' LEU . 13.0 mt -108.81 137.55 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 N-CA-C 108.36 -0.978 . . . . 10.0 108.36 -174.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.0 m -123.07 96.57 5.06 Favored 'General case' 0 N--CA 1.407 -2.601 0 CA-C-N 114.688 -1.142 . . . . 10.0 108.818 178.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 65' ' ' SER . 4.3 p -85.73 137.28 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 CA-C-N 119.298 0.953 . . . . 10.0 110.436 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -100.71 178.17 4.78 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.797 0.808 . . . . 10.0 113.056 -176.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.448 ' HG3' ' HB3' ' A' ' 4' ' ' LYS . 28.0 mt-10 -50.57 -33.59 22.43 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.796 -1.547 . . . . 10.0 113.718 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.7 -6.51 57.34 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 112.517 0.562 . . . . 10.0 112.517 -172.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.462 ' CE ' ' HA3' ' A' ' 32' ' ' GLY . 26.9 mmmt 83.51 5.51 0.79 Allowed 'General case' 0 CA--C 1.508 -0.651 0 O-C-N 124.643 1.214 . . . . 10.0 108.569 -168.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.546 ' O ' HG23 ' A' ' 60' ' ' VAL . 22.0 t -73.74 175.79 6.88 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 113.355 -1.748 . . . . 10.0 107.67 173.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.605 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -170.0 -178.93 3.03 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 120.523 1.51 . . . . 10.0 109.866 176.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.9 p -157.64 170.31 22.68 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 103.233 -2.876 . . . . 10.0 103.233 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.46 ' HB3' HG12 ' A' ' 58' ' ' ILE . 48.7 p90 -163.4 157.58 20.11 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.802 -0.814 . . . . 10.0 108.802 174.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.481 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 29.2 pt -122.77 167.77 16.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.014 -1.106 . . . . 10.0 108.014 -176.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.463 HD12 ' CE1' ' A' ' 42' ' ' PHE . 1.9 mm -135.39 117.61 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 107.093 -1.447 . . . . 10.0 107.093 -176.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.629 ' HE2' ' OD2' ' A' ' 115' ' ' ASP . 9.4 mmmm -75.41 97.92 3.76 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.228 -0.589 . . . . 10.0 110.761 -172.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.26 98.0 0.16 Allowed Pre-proline 0 C--N 1.317 -0.809 0 O-C-N 124.639 1.212 . . . . 10.0 109.342 169.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.631 ' HG3' ' CD2' ' A' ' 77' ' ' PHE . 54.3 Cg_endo -67.54 137.29 42.22 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.409 2.073 . . . . 10.0 112.681 -162.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.932 ' HA ' HD11 ' A' ' 116' ' ' LEU . 85.1 Cg_exo -47.29 88.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.746 2.964 . . . . 10.0 113.689 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.68 ' H ' ' HD3' ' A' ' 112' ' ' LYS . . . 70.59 -41.82 0.51 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.073 -0.967 . . . . 10.0 113.569 174.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.9 p -40.83 -73.73 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.3 1.222 . . . . 10.0 114.3 -167.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.631 ' CD2' ' HG3' ' A' ' 73' ' ' PRO . 8.5 m-30 -61.97 -21.81 65.13 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.349 0.87 . . . . 10.0 113.349 -172.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.033 ' HB3' HD12 ' A' ' 108' ' ' ILE . 6.3 mp -101.02 -12.77 18.6 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 119.499 -0.88 . . . . 10.0 111.288 -178.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.463 ' CD1' ' HB1' ' A' ' 75' ' ' ALA . 50.6 mt -76.99 -26.48 53.92 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.07 -1.085 . . . . 10.0 108.07 165.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 61.5 mmtt -59.79 -38.72 82.68 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 115.207 -0.906 . . . . 10.0 109.5 167.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.538 ' HD3' ' HA ' ' A' ' 81' ' ' LYS . 53.5 mmtt -64.25 -44.64 91.17 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.528 0.936 . . . . 10.0 113.528 175.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.912 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -71.61 -56.31 6.1 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.562 1.945 . . . . 10.0 112.966 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.49 ' C ' ' H ' ' A' ' 85' ' ' ILE . . . -76.31 137.99 40.22 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 111.069 -2.787 . . . . 10.0 105.872 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -82.07 22.64 5.82 Favored Glycine 0 C--N 1.32 -0.341 0 CA-C-N 121.609 2.004 . . . . 10.0 110.776 -173.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.64 HG22 HG22 ' A' ' 97' ' ' VAL . 27.2 pt -68.1 103.71 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 113.407 -1.397 . . . . 10.0 112.614 -173.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -74.95 4.46 6.53 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 122.089 0.947 . . . . 10.0 110.068 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -172.11 -60.07 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.303 -1.317 . . . . 10.0 109.002 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.05 -110.44 4.02 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.477 -0.783 . . . . 10.0 111.386 -178.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.7 m -163.66 -94.34 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.509 -0.552 . . . . 10.0 109.509 177.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.468 ' O ' ' HG3' ' A' ' 91' ' ' GLU . 46.7 m -165.14 -43.74 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.827 -0.805 . . . . 10.0 108.827 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.822 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 35.6 mt-10 -164.59 -58.3 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 114.928 -1.033 . . . . 10.0 109.58 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.822 ' HD3' ' HB2' ' A' ' 91' ' ' GLU . 55.7 Cg_endo -96.17 106.16 0.1 Allowed 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.179 1.919 . . . . 10.0 112.515 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.51 ' HG3' ' HB ' ' A' ' 97' ' ' VAL . 5.3 tmtp? -80.8 -100.78 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.473 -1.306 . . . . 10.0 107.473 171.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.495 ' H ' ' HB3' ' A' ' 93' ' ' LYS . 13.1 ttm180 -178.49 -59.57 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 170.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.424 ' O ' ' HB ' ' A' ' 96' ' ' ILE . 47.1 mttp -87.73 10.19 19.11 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.234 -1.348 . . . . 10.0 110.503 -177.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.625 HG21 ' HB3' ' A' ' 138' ' ' GLU . 3.6 mt 72.45 116.98 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.461 0.113 0 CA-C-O 123.457 1.599 . . . . 10.0 112.208 -170.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.64 HG22 HG22 ' A' ' 85' ' ' ILE . 8.2 p -74.83 88.04 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 CA-C-N 111.404 -2.635 . . . . 10.0 111.308 -174.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 33.07 -168.76 0.01 OUTLIER Glycine 0 CA--C 1.533 1.204 0 CA-C-N 113.942 -1.481 . . . . 10.0 115.171 -165.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.668 ' CB ' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -160.85 178.26 9.59 Favored 'General case' 0 CA--C 1.488 -1.413 0 CA-C-O 121.791 0.805 . . . . 10.0 112.044 -172.122 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.912 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -159.8 -166.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 113.502 -1.681 . . . . 10.0 111.938 -179.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 39.0 p -97.56 143.29 28.4 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 112.734 -2.03 . . . . 10.0 111.473 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.649 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 0.4 OUTLIER -47.87 -41.18 23.58 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.599 -0.728 . . . . 10.0 109.925 166.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.06 -43.3 77.8 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.655 0.382 . . . . 10.0 111.758 175.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.597 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -57.52 -50.74 72.09 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.411 -0.959 . . . . 10.0 108.411 174.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.753 HG23 ' HB ' ' A' ' 128' ' ' ILE . 27.9 mm -44.2 -49.82 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 114.522 -1.217 . . . . 10.0 111.53 174.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.714 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 27.6 tt0 -50.88 -57.16 9.18 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.766 1.227 . . . . 10.0 112.356 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.686 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 70.0 mm-40 -51.66 -58.59 5.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.347 -1.297 . . . . 10.0 110.17 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.033 HD12 ' HB3' ' A' ' 78' ' ' LEU . 22.8 mm -48.33 -51.6 9.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.318 -0.855 . . . . 10.0 110.742 173.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.567 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -51.89 -42.66 62.89 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.499 0.555 . . . . 10.0 112.499 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.714 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 73.6 mttt -68.21 -52.58 32.67 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 122.045 0.926 . . . . 10.0 109.261 -177.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 85.5 m -51.46 -23.8 4.35 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 113.506 -1.679 . . . . 10.0 112.514 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.763 ' HB3' HD13 ' A' ' 116' ' ' LEU . 29.5 mttp -122.63 1.19 9.44 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 113.171 0.804 . . . . 10.0 113.171 -175.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.55 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 23.3 ptm -50.18 -36.81 22.62 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 113.149 0.796 . . . . 10.0 113.149 176.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 113' ' ' MET . 58.7 Cg_endo -69.55 -29.76 24.33 Favored 'Trans proline' 0 C--N 1.367 1.515 0 CA-C-N 120.989 1.389 . . . . 10.0 111.912 178.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.629 ' OD2' ' HE2' ' A' ' 71' ' ' LYS . 2.7 t70 -87.24 -46.02 10.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.132 0.968 . . . . 10.0 110.454 -173.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.932 HD11 ' HA ' ' A' ' 74' ' ' PRO . 4.9 mp -65.1 -1.1 1.94 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 113.68 -1.6 . . . . 10.0 112.191 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.401 ' H ' ' C ' ' A' ' 115' ' ' ASP . 26.0 m-80 58.98 50.39 8.39 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.853 -1.067 . . . . 10.0 109.247 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.413 ' O ' ' CB ' ' A' ' 119' ' ' ASN . . . -65.98 -74.78 0.1 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.28 -1.327 . . . . 10.0 113.099 -166.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.413 ' CB ' ' O ' ' A' ' 118' ' ' ALA . 27.3 t-20 102.43 -40.52 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.545 0 O-C-N 124.929 1.393 . . . . 10.0 109.354 -176.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 7.5 t -151.41 133.96 15.5 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 103.584 -2.747 . . . . 10.0 103.584 174.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.586 HD22 ' HB3' ' A' ' 124' ' ' ALA . 2.8 tm? -52.97 -35.05 58.59 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.386 0.884 . . . . 10.0 113.386 -173.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.588 ' HA ' ' HG3' ' A' ' 125' ' ' MET . 2.2 mp0 -51.46 -33.78 32.54 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 118.691 0.678 . . . . 10.0 110.734 175.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.42 -47.4 60.93 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 118.581 -1.247 . . . . 10.0 110.575 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.586 ' HB3' HD22 ' A' ' 121' ' ' LEU . . . -54.95 -39.01 68.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.835 -0.62 . . . . 10.0 110.305 175.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.589 ' O ' ' HB3' ' A' ' 129' ' ' GLU . 17.2 mtp -54.96 -38.43 67.75 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 112.124 0.416 . . . . 10.0 112.124 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -62.19 -47.51 84.15 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 108.929 -0.767 . . . . 10.0 108.929 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 124' ' ' ALA . 67.3 mt -50.92 -64.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 114.996 -1.002 . . . . 10.0 110.284 175.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.753 ' HB ' HG23 ' A' ' 105' ' ' ILE . 16.0 mm -52.81 -60.54 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 CA-C-N 114.496 -1.229 . . . . 10.0 111.394 -176.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.589 ' HB3' ' O ' ' A' ' 125' ' ' MET . 0.0 OUTLIER -51.75 -43.47 62.94 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.264 -0.88 . . . . 10.0 109.732 179.299 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.63 -45.25 29.35 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.717 -0.754 . . . . 10.0 111.909 -175.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.525 HG21 ' HB3' ' A' ' 75' ' ' ALA . 51.9 m -50.5 -56.97 9.23 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.513 -0.844 . . . . 10.0 109.765 173.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.99 -57.28 7.88 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 120.969 0.414 . . . . 10.0 111.031 175.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -46.45 -59.01 3.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.954 -1.021 . . . . 10.0 112.253 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.8 p -66.59 -24.5 66.34 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.057 0.391 . . . . 10.0 112.057 -174.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.54 ' O ' ' HG3' ' A' ' 135' ' ' MET . 0.0 OUTLIER -84.43 -3.41 58.33 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 112.936 0.717 . . . . 10.0 112.936 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.541 ' C ' HG12 ' A' ' 97' ' ' VAL . . . 105.05 -5.85 42.63 Favored Glycine 0 N--CA 1.441 -1.007 0 O-C-N 121.001 -1.062 . . . . 10.0 112.688 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.437 HG23 ' HA ' ' A' ' 99' ' ' LYS . 70.6 mt -87.43 129.87 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 CA-C-N 117.516 0.658 . . . . 10.0 111.093 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.668 ' HG2' ' CB ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -85.58 156.98 20.5 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.029 -0.987 . . . . 10.0 109.282 177.345 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 22.2 m -119.43 136.34 56.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 108.078 -1.082 . . . . 10.0 108.078 168.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.3 m -136.26 69.99 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 115.573 1.694 . . . . 10.0 115.573 -176.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.3 t70 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.113 -0.946 . . . . 10.0 109.296 138.928 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 120.538 0.208 . . . . 10.0 111.169 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.0 -77.96 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.832 0.349 . . . . 10.0 110.509 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -136.44 167.51 21.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.043 -0.526 . . . . 10.0 109.91 177.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 4' ' ' LYS . 29.5 mtpt -80.74 119.84 23.85 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.435 -0.348 . . . . 10.0 110.071 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 38.0 t -67.15 145.0 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.895 0.378 . . . . 10.0 111.389 -177.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.79 -36.41 4.51 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.27 173.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.464 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -159.61 151.17 20.1 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.272 1.212 . . . . 10.0 114.272 -177.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -93.71 129.19 40.12 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.303 -1.369 . . . . 10.0 107.303 168.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.697 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.8 OUTLIER -120.94 82.36 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 108.786 -0.82 . . . . 10.0 108.786 175.119 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -78.9 146.13 33.73 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 120.895 1.679 . . . . 10.0 109.42 177.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.487 HD23 HD11 ' A' ' 13' ' ' LEU . 0.8 OUTLIER -156.11 134.63 11.64 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.313 -0.625 . . . . 10.0 109.313 -174.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.523 ' OE1' ' HA ' ' A' ' 55' ' ' PRO . 10.9 mm100 -91.82 112.26 24.11 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.018 -1.105 . . . . 10.0 108.018 171.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.487 HD11 HD23 ' A' ' 11' ' ' LEU . 28.8 mt -131.54 133.97 24.99 Favored Pre-proline 0 CA--C 1.504 -0.803 0 CA-C-O 121.644 0.735 . . . . 10.0 112.463 -170.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.7 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 18.5 Cg_exo -56.75 122.18 11.37 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 123.292 2.661 . . . . 10.0 111.846 174.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.532 ' HB2' HD11 ' A' ' 54' ' ' LEU . . . -61.62 126.78 28.57 Favored 'General case' 0 N--CA 1.427 -1.606 0 N-CA-C 107.514 -1.291 . . . . 10.0 107.514 169.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.39 0.21 89.64 Favored Glycine 0 N--CA 1.44 -1.1 0 O-C-N 125.883 1.989 . . . . 10.0 112.998 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.7 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 18.6 tptp -142.8 98.88 3.37 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 118.331 1.066 . . . . 10.0 111.979 175.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.18 136.87 9.03 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.433 -1.258 . . . . 10.0 112.121 176.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.603 ' HA ' ' HB2' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -179.98 -54.96 0.0 OUTLIER Pre-proline 0 N--CA 1.443 -0.81 0 CA-C-N 115.318 -0.856 . . . . 10.0 111.836 174.677 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.67 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 73.5 Cg_endo -99.16 129.66 0.19 Allowed 'Trans proline' 0 N--CA 1.411 -3.372 0 N-CA-C 115.67 1.373 . . . . 10.0 115.67 -153.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.053 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 12.13 -83.54 0.0 OUTLIER Pre-proline 0 C--N 1.294 -1.842 0 CA-C-N 108.604 -3.907 . . . . 10.0 115.489 166.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.955 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 65.5 Cg_exo -30.53 -55.16 0.21 Allowed 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 122.963 2.442 . . . . 10.0 115.709 -164.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.955 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 5.2 Cg_exo -84.09 -56.55 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.438 2.759 . . . . 10.0 112.094 170.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.005 HG12 HD12 ' A' ' 35' ' ' ILE . 89.3 t -80.37 -53.76 12.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 112.719 -2.037 . . . . 10.0 114.922 -167.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 1.053 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -50.65 -74.48 0.28 Allowed Glycine 0 CA--C 1.52 0.389 0 CA-C-N 115.203 -0.908 . . . . 10.0 113.452 -173.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.837 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 17.0 Cg_exo -42.79 -43.99 8.95 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.77 2.98 . . . . 10.0 112.441 171.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 24' ' ' VAL . . . -50.06 -98.94 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 123.793 0.683 . . . . 10.0 112.43 177.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.931 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.341 0.0 OUTLIER -73.18 -34.33 65.94 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 117.555 -1.658 . . . . 10.0 113.138 -173.472 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.65 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -67.5 -39.53 91.11 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 121.164 -0.541 . . . . 10.0 113.505 -175.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.745 ' HG3' ' HA ' ' A' ' 26' ' ' PRO . 26.9 mt-30 -68.43 -6.46 24.85 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 118.635 -1.226 . . . . 10.0 111.212 175.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.553 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 72.6 m-70 -102.04 22.98 12.21 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.381 0.61 . . . . 10.0 109.584 168.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.28 -3.69 76.35 Favored Glycine 0 CA--C 1.503 -0.699 0 CA-C-N 115.306 -0.861 . . . . 10.0 113.567 168.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.931 ' HB ' HD23 ' A' ' 28' ' ' LEU . 5.0 t -82.99 149.79 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 113.785 1.031 . . . . 10.0 113.785 -170.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.507 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -71.39 99.3 1.95 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.001 0.429 . . . . 10.0 110.687 170.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.005 HD12 HG12 ' A' ' 24' ' ' VAL . 16.4 mm -51.49 -37.15 18.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 122.21 1.005 . . . . 10.0 111.643 172.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.662 ' HE2' ' HA ' ' A' ' 36' ' ' MET . 5.9 mmt -65.7 -50.31 65.35 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 113.312 -1.767 . . . . 10.0 111.957 174.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.507 ' HB3' ' HB3' ' A' ' 34' ' ' ASN . 5.6 tp10 -56.09 -41.09 74.64 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.079 -0.648 . . . . 10.0 110.211 174.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.726 ' CE1' HD11 ' A' ' 58' ' ' ILE . 89.9 t80 -56.24 -58.79 6.48 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 113.899 1.074 . . . . 10.0 113.899 171.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.603 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -62.72 -50.3 71.64 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 114.368 -1.287 . . . . 10.0 111.87 -175.415 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -62.88 -23.06 67.15 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 119.223 -0.991 . . . . 10.0 108.911 -177.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.842 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 63.0 mtt180 -75.5 -64.82 0.99 Allowed 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 119.252 -0.979 . . . . 10.0 111.798 166.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.537 ' CZ ' HG21 ' A' ' 46' ' ' THR . 60.3 t80 -50.99 -49.72 59.75 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.09 0.859 . . . . 10.0 111.571 -170.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -60.09 -49.88 75.92 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.514 -0.766 . . . . 10.0 110.425 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.05 -39.81 95.84 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 119.069 -1.052 . . . . 10.0 112.081 179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.842 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 5.9 mm-40 -66.89 -41.76 86.65 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.841 0.829 . . . . 10.0 111.047 -178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.537 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 81.7 p -90.91 1.5 56.95 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.414 -1.266 . . . . 10.0 112.056 -170.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.46 -37.23 5.01 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.995 -1.002 . . . . 10.0 112.921 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -82.19 -24.96 34.65 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.807 -0.633 . . . . 10.0 112.491 -174.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.4 mttp -104.5 19.06 21.01 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.487 0.66 . . . . 10.0 109.305 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -48.73 143.5 5.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.404 -1.271 . . . . 10.0 112.565 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.99 20.89 27.01 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 114.846 -1.07 . . . . 10.0 110.917 -177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.554 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 64.2 mtt -138.53 128.87 25.9 Favored 'General case' 0 C--O 1.206 -1.189 0 C-N-CA 117.083 -1.847 . . . . 10.0 114.154 -169.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.8 mm -70.01 93.2 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 121.586 -0.696 . . . . 10.0 109.754 172.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.768 HD22 ' HE2' ' A' ' 77' ' ' PHE . 3.3 mt -80.45 130.04 66.68 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 110.15 -0.315 . . . . 10.0 110.15 -176.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.523 ' HA ' ' OE1' ' A' ' 12' ' ' GLN . 21.1 Cg_exo -69.68 103.48 1.16 Allowed 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 122.683 2.256 . . . . 10.0 111.44 171.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 69' ' ' ILE . 0.5 OUTLIER -101.9 160.32 4.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 119.402 1.001 . . . . 10.0 112.217 -174.539 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 79.4 t -137.09 119.98 20.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.034 -0.53 . . . . 10.0 110.561 173.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.726 HD11 ' CE1' ' A' ' 38' ' ' PHE . 14.8 mt -110.65 138.2 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.596 0 N-CA-C 108.012 -1.107 . . . . 10.0 108.012 -178.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.4 m -123.48 96.57 5.03 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 114.837 -1.074 . . . . 10.0 108.801 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 65' ' ' SER . 2.3 p -89.04 139.03 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 CA-C-N 119.481 1.037 . . . . 10.0 110.568 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.499 ' HE2' ' HG1' ' A' ' 67' ' ' THR . 70.2 m-85 -96.06 167.86 10.96 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 112.747 0.647 . . . . 10.0 112.747 -177.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -56.66 -23.55 42.48 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 124.271 1.029 . . . . 10.0 112.808 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 6.7 m-20 -80.12 -7.43 58.9 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.683 -1.144 . . . . 10.0 111.287 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 3.2 mptt 79.99 3.4 2.01 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 114.645 -1.161 . . . . 10.0 111.974 -171.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.563 ' O ' HG23 ' A' ' 60' ' ' VAL . 15.6 m -73.11 173.89 8.73 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 107.498 -1.297 . . . . 10.0 107.498 170.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.88 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -168.81 -176.73 2.79 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 120.293 1.406 . . . . 10.0 108.778 174.505 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.499 ' HG1' ' HE2' ' A' ' 61' ' ' TYR . 1.3 p -159.77 168.85 24.93 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 102.759 -3.052 . . . . 10.0 102.759 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.447 ' CB ' HG12 ' A' ' 58' ' ' ILE . 53.3 p90 -163.24 152.89 15.25 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.933 -1.136 . . . . 10.0 107.933 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.514 ' O ' HG22 ' A' ' 56' ' ' VAL . 1.9 mt -116.47 168.84 7.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 106.232 -1.766 . . . . 10.0 106.232 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 31.8 mt -137.75 113.76 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 N-CA-C 106.306 -1.738 . . . . 10.0 106.306 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 55' ' ' PRO . 3.6 mptp? -77.3 102.12 6.59 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.604 -166.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.489 HG21 ' O ' ' A' ' 111' ' ' THR . 0.2 OUTLIER -58.28 91.24 0.03 OUTLIER Pre-proline 0 C--N 1.315 -0.906 0 O-C-N 124.733 1.271 . . . . 10.0 108.786 165.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.754 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . 49.3 Cg_endo -93.7 -166.63 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 123.541 2.828 . . . . 10.0 112.742 -156.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.754 ' HD2' ' HB2' ' A' ' 73' ' ' PRO . 67.5 Cg_exo -30.05 133.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 123.316 2.677 . . . . 10.0 111.785 168.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.691 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -60.52 -8.97 3.14 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.289 0.848 . . . . 10.0 113.289 -166.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 m -50.31 -29.23 9.32 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.604 0.716 . . . . 10.0 110.253 174.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.768 ' HE2' HD22 ' A' ' 54' ' ' LEU . 36.4 t80 -56.01 -66.03 0.5 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.532 -1.213 . . . . 10.0 111.441 176.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.659 HD23 ' HE2' ' A' ' 112' ' ' LYS . 2.7 mm? -82.19 -13.67 56.78 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 121.903 -0.498 . . . . 10.0 110.233 -175.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.637 HD12 HD13 ' A' ' 137' ' ' ILE . 3.0 mm? -72.9 -23.71 60.75 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 109.341 -0.614 . . . . 10.0 109.341 171.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.929 ' HE2' ' H ' ' A' ' 87' ' ' LYS . 21.4 mmtp -61.89 -40.73 96.43 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.423 -0.584 . . . . 10.0 109.423 167.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.488 ' HD3' ' HA ' ' A' ' 81' ' ' LYS . 24.9 mmtp -62.96 -48.25 79.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.581 -0.736 . . . . 10.0 112.839 174.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.889 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -72.23 -62.68 1.35 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 127.328 2.251 . . . . 10.0 113.564 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.563 ' HB1' HG12 ' A' ' 85' ' ' ILE . . . -76.6 145.97 38.58 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 110.864 -2.88 . . . . 10.0 106.941 -175.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.42 2.22 73.87 Favored Glycine 0 C--N 1.317 -0.479 0 CA-C-N 120.895 1.68 . . . . 10.0 111.246 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.78 HG21 HG22 ' A' ' 97' ' ' VAL . 27.0 pt -68.38 101.7 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.673 -0.763 . . . . 10.0 113.017 -176.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 9.1 tp10 -72.04 101.63 2.78 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.394 -0.595 . . . . 10.0 109.394 170.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.929 ' H ' ' HE2' ' A' ' 80' ' ' LYS . 9.7 mtmp? 90.8 -49.75 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.095 1.358 . . . . 10.0 108.776 -177.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.696 ' HA3' HD12 ' A' ' 85' ' ' ILE . . . 72.08 -137.55 25.45 Favored Glycine 0 N--CA 1.44 -1.075 0 CA-C-N 115.391 -0.822 . . . . 10.0 112.582 173.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 36.7 p -165.36 89.9 0.47 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.039 0.447 . . . . 10.0 110.339 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.5 p -77.22 -46.47 23.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.137 -0.483 . . . . 10.0 110.728 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.842 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 12.0 mm-40 -68.3 -61.58 3.83 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 115.843 -0.617 . . . . 10.0 111.515 -176.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.842 ' HD3' ' HB2' ' A' ' 91' ' ' GLU . 94.4 Cg_endo -92.91 154.86 2.73 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.273 1.982 . . . . 10.0 112.471 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -165.08 128.05 2.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.086 0.469 . . . . 10.0 110.049 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.1 tpt180 -162.9 -47.82 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.259 -0.645 . . . . 10.0 109.259 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -71.7 -33.27 68.65 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.177 -1.416 . . . . 10.0 107.177 173.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.6 mt 72.25 143.44 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.488 -1.414 0 CA-C-O 123.503 1.621 . . . . 10.0 112.632 173.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.78 HG22 HG21 ' A' ' 85' ' ' ILE . 0.9 OUTLIER -94.94 171.92 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.404 -2.739 0 CA-C-N 111.708 -2.496 . . . . 10.0 111.177 -160.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.475 ' N ' HG13 ' A' ' 97' ' ' VAL . . . -57.92 179.51 1.06 Allowed Glycine 0 C--N 1.308 -0.981 0 CA-C-N 113.819 -1.537 . . . . 10.0 113.088 176.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.457 ' HE2' ' HB3' ' A' ' 99' ' ' LYS . 9.8 ptpt -154.26 172.37 17.74 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 122.693 1.235 . . . . 10.0 111.883 -159.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.889 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -160.6 -146.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 111.889 -2.414 . . . . 10.0 105.965 -171.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.604 ' O ' ' HG3' ' A' ' 104' ' ' GLN . 1.7 t -162.06 139.73 8.67 Favored 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 119.834 -0.747 . . . . 10.0 109.511 -152.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.663 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 0.0 OUTLIER -43.14 -48.61 6.4 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 114.36 -1.291 . . . . 10.0 111.535 -173.509 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.531 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 0.1 OUTLIER -56.63 -46.09 81.18 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.127 0.788 . . . . 10.0 113.127 178.201 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.604 ' HG3' ' O ' ' A' ' 101' ' ' THR . 3.7 pp0? -67.74 -37.26 81.91 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.454 -0.943 . . . . 10.0 108.454 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.878 HG23 ' HB ' ' A' ' 128' ' ' ILE . 23.3 mm -47.26 -51.01 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 115.503 -0.771 . . . . 10.0 110.862 168.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.683 ' HG2' ' HE3' ' A' ' 110' ' ' LYS . 23.8 tt0 -50.36 -57.34 8.15 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.296 1.438 . . . . 10.0 113.191 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.491 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 4.3 pt-20 -59.09 -43.55 91.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.355 -0.839 . . . . 10.0 111.199 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.629 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 56.9 mt -51.71 -58.57 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 120.7 0.286 . . . . 10.0 110.919 166.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.489 ' HB3' HD11 ' A' ' 121' ' ' LEU . . . -44.69 -35.11 2.49 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 123.556 0.742 . . . . 10.0 112.334 177.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.683 ' HE3' ' HG2' ' A' ' 106' ' ' GLU . 96.6 mttt -74.45 -53.65 9.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.548 -0.751 . . . . 10.0 111.557 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 108' ' ' ILE . 2.1 t -59.41 -8.74 1.91 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.298 0.851 . . . . 10.0 113.298 -177.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.659 ' HE2' HD23 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -129.94 13.73 5.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.247 0.546 . . . . 10.0 110.379 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.514 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 1.8 ttt -50.65 -46.91 85.95 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 114.844 -1.071 . . . . 10.0 112.389 178.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 113' ' ' MET . 60.6 Cg_endo -69.2 -22.27 34.91 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 121.726 1.617 . . . . 10.0 113.299 -176.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -87.94 -55.15 3.88 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-O 122.344 1.068 . . . . 10.0 110.537 -175.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.597 HD22 ' HD3' ' A' ' 112' ' ' LYS . 7.1 mp -67.87 178.61 1.69 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 113.267 -1.788 . . . . 10.0 113.746 -168.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -96.72 41.88 1.1 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 112.002 -2.363 . . . . 10.0 112.645 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.613 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . . . -63.38 -99.68 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 113.756 1.021 . . . . 10.0 113.756 174.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.585 ' HB2' ' O ' ' A' ' 118' ' ' ALA . 5.0 m120 105.16 -78.01 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.8 1.64 . . . . 10.0 107.768 -168.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.449 ' HB3' ' OE1' ' A' ' 122' ' ' GLU . 47.2 m -81.54 146.65 30.05 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.735 -0.839 . . . . 10.0 108.735 163.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.759 ' O ' ' HG3' ' A' ' 125' ' ' MET . 61.1 tp -59.66 -37.68 79.42 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.15 -1.02 . . . . 10.0 110.548 167.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 126' ' ' LYS . 3.4 mp0 -51.21 -36.68 42.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.674 0.749 . . . . 10.0 109.617 171.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.605 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . . . -69.38 -46.96 65.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.577 -1.192 . . . . 10.0 110.735 177.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.613 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . . . -55.7 -41.29 73.56 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 110.179 -0.304 . . . . 10.0 110.179 176.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.759 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 75.2 mtp -55.75 -33.42 64.27 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 122.762 0.425 . . . . 10.0 111.827 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.605 ' HE2' ' HA ' ' A' ' 123' ' ' ALA . 42.6 mtmt -63.86 -50.77 67.51 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.629 -0.508 . . . . 10.0 109.629 178.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.457 ' CD1' HD23 ' A' ' 116' ' ' LEU . 47.5 mt -49.32 -63.86 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 121.49 0.662 . . . . 10.0 110.379 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.878 ' HB ' HG23 ' A' ' 105' ' ' ILE . 4.9 mm -52.13 -55.07 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 CA-C-N 113.843 -1.526 . . . . 10.0 111.306 -177.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.59 ' CD ' ' HE ' ' A' ' 102' ' ' ARG . 49.2 mt-10 -54.49 -44.51 72.72 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 109.923 -0.399 . . . . 10.0 109.923 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -69.62 -46.01 56.51 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 120.708 -0.758 . . . . 10.0 111.748 -174.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.691 HG21 ' HB3' ' A' ' 75' ' ' ALA . 51.6 m -50.09 -58.62 5.13 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.536 -0.832 . . . . 10.0 109.379 171.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.422 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -50.71 -53.4 31.69 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.008 0.433 . . . . 10.0 111.22 176.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -47.84 -48.43 30.95 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.198 -0.91 . . . . 10.0 111.32 176.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 27.2 t -63.61 -35.85 81.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.0 0.428 . . . . 10.0 110.732 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 53.4 mtm -84.66 10.68 10.58 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.579 0.955 . . . . 10.0 113.579 -174.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 81.55 8.19 87.28 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 119.341 0.973 . . . . 10.0 112.127 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.637 HD13 HD12 ' A' ' 79' ' ' LEU . 47.4 mt -94.73 124.93 47.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 CA-C-O 121.39 0.614 . . . . 10.0 112.017 -176.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -84.38 151.79 24.47 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.125 -1.03 . . . . 10.0 110.943 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 16.6 m -113.45 126.44 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.045 0 N-CA-C 107.8 -1.185 . . . . 10.0 107.8 168.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 100' ' ' VAL . 2.9 m -104.83 138.54 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-N 114.44 -1.255 . . . . 10.0 109.302 176.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 C--N 1.29 -2.003 0 CA-C-N 114.678 -1.146 . . . . 10.0 109.821 -177.09 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 120.609 0.243 . . . . 10.0 110.424 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.528 ' HB1' ' HE3' ' A' ' 4' ' ' LYS . . . 82.11 79.37 0.03 OUTLIER 'General case' 0 C--O 1.232 0.143 0 O-C-N 124.331 1.02 . . . . 10.0 113.398 168.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.507 ' HG3' ' HE1' ' A' ' 61' ' ' TYR . 20.5 tptt -83.75 89.9 7.24 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 106.754 -1.573 . . . . 10.0 106.754 162.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.597 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 10.3 mmtp -76.73 70.1 3.17 Favored 'General case' 0 C--O 1.196 -1.749 0 C-N-CA 120.316 -0.553 . . . . 10.0 110.25 -174.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.1 t -74.58 119.42 22.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 119.153 0.888 . . . . 10.0 109.863 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.427 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . . . -98.13 -35.18 10.48 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.83 -0.804 . . . . 10.0 108.83 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.401 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -161.29 -174.06 4.13 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.037 -0.983 . . . . 10.0 112.801 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 26.8 mt-30 -141.56 131.3 24.21 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.123 -1.399 . . . . 10.0 108.649 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.627 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.9 OUTLIER -120.89 80.98 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 108.945 -0.761 . . . . 10.0 108.945 -176.391 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 56' ' ' VAL . 57.4 tttp -79.43 128.5 33.43 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 119.82 1.191 . . . . 10.0 108.339 176.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.624 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.85 127.98 6.18 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 122.116 0.96 . . . . 10.0 111.471 -174.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.56 119.32 22.37 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.226 -1.352 . . . . 10.0 109.749 -172.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.624 HD21 HD11 ' A' ' 11' ' ' LEU . 46.8 mt -135.52 140.31 33.7 Favored Pre-proline 0 CA--C 1.502 -0.896 0 N-CA-C 113.138 0.792 . . . . 10.0 113.138 -170.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.679 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 14.7 Cg_exo -61.87 122.44 10.98 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 123.325 2.683 . . . . 10.0 111.241 174.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.523 ' CB ' ' HA ' ' A' ' 50' ' ' ALA . . . -60.84 125.11 22.49 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.637 -1.246 . . . . 10.0 107.637 169.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.83 1.83 89.82 Favored Glycine 0 N--CA 1.442 -0.905 0 O-C-N 126.015 2.072 . . . . 10.0 113.115 -173.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.679 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 7.6 tppt? -144.07 105.27 4.24 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.334 1.067 . . . . 10.0 113.14 177.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.617 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -172.47 128.89 0.55 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 113.776 -1.556 . . . . 10.0 111.202 170.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.543 ' H ' ' CD ' ' A' ' 20' ' ' PRO . 15.6 m -174.06 -43.46 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.132 0.895 . . . . 10.0 112.166 -174.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.828 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 44.2 Cg_endo -98.68 122.3 0.14 Allowed 'Trans proline' 0 N--CA 1.434 -2.008 0 C-N-CA 121.104 1.203 . . . . 10.0 114.892 -166.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.083 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . -3.51 -80.05 0.0 OUTLIER Pre-proline 0 C--O 1.212 -0.919 0 CA-C-N 111.658 -2.519 . . . . 10.0 114.542 166.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.871 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 52.4 Cg_exo -22.33 -55.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 123.978 3.119 . . . . 10.0 115.995 -165.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.871 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 10.0 Cg_endo -81.81 -75.97 0.01 OUTLIER 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 122.347 2.031 . . . . 10.0 112.151 168.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.449 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 92.7 t -60.95 -46.73 96.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 112.542 -2.117 . . . . 10.0 114.919 -171.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 1.083 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -49.55 -73.41 0.36 Allowed Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 114.472 -1.24 . . . . 10.0 113.225 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.693 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 11.2 Cg_exo -45.89 -43.17 19.86 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.885 3.057 . . . . 10.0 112.737 171.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.458 ' O ' ' HD2' ' A' ' 31' ' ' HIS . . . -49.22 -98.23 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.567 0.58 . . . . 10.0 112.567 175.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.675 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.297 0.0 OUTLIER -70.41 -25.38 63.19 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 118.278 -1.369 . . . . 10.0 113.529 -174.872 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.535 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -66.27 -35.54 90.47 Favored Glycine 0 N--CA 1.464 0.521 0 C-N-CA 121.285 -0.483 . . . . 10.0 112.513 -177.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -58.83 -25.93 63.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.136 0.493 . . . . 10.0 109.72 173.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.458 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 71.7 m-70 -99.55 17.89 19.3 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.584 0.707 . . . . 10.0 109.488 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.455 ' HA3' ' HE2' ' A' ' 64' ' ' LYS . . . 85.62 6.39 83.26 Favored Glycine 0 CA--C 1.5 -0.88 0 CA-C-N 114.492 -1.231 . . . . 10.0 113.411 168.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.78 HG11 ' CD2' ' A' ' 66' ' ' PHE . 1.9 t -86.66 147.74 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 114.044 1.127 . . . . 10.0 114.044 -172.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 88.5 m-20 -68.08 102.97 1.41 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.546 0.738 . . . . 10.0 111.348 174.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.589 ' CD1' ' HA2' ' A' ' 25' ' ' GLY . 90.2 mt -50.72 -45.84 27.76 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 CA-C-O 122.526 1.155 . . . . 10.0 110.6 172.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.419 ' SD ' ' N ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -67.2 -52.21 43.97 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 111.833 -2.44 . . . . 10.0 112.898 -177.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 34' ' ' ASN . 82.0 tt0 -56.12 -38.51 70.87 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 120.035 -0.666 . . . . 10.0 110.05 177.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.787 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 20.9 t80 -59.8 -59.29 5.66 Favored 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 114.045 1.128 . . . . 10.0 114.045 168.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.589 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -54.86 -53.36 56.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.498 -1.683 . . . . 10.0 112.11 -176.222 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.436 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 12.3 tppt? -68.63 -19.25 64.41 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.611 -0.836 . . . . 10.0 109.101 -176.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.782 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 64.9 mtt180 -79.91 -62.53 1.65 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.115 -1.034 . . . . 10.0 112.907 168.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.567 ' CZ ' HG21 ' A' ' 46' ' ' THR . 66.3 t80 -53.99 -45.69 71.5 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 119.213 0.915 . . . . 10.0 110.11 -174.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.617 HD21 ' HB3' ' A' ' 18' ' ' ALA . 0.9 OUTLIER -61.45 -51.36 69.01 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.536 -1.211 . . . . 10.0 110.874 -178.04 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.96 -37.38 86.85 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 118.815 -1.154 . . . . 10.0 111.811 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.782 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 7.6 mm-40 -67.48 -45.31 76.28 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.896 0.855 . . . . 10.0 110.882 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.596 ' CG2' HD12 ' A' ' 54' ' ' LEU . 82.7 p -85.67 2.77 43.93 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-N 114.567 -1.197 . . . . 10.0 112.111 -171.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -48.3 -36.59 14.49 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.812 -1.085 . . . . 10.0 112.318 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -83.4 -34.74 25.46 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.008 -0.996 . . . . 10.0 110.888 -174.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 mtpp -97.6 20.84 11.17 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.804 -0.813 . . . . 10.0 108.804 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.523 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -55.1 152.21 8.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.524 -1.216 . . . . 10.0 113.582 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.16 16.26 44.77 Favored Glycine 0 CA--C 1.507 -0.462 0 N-CA-C 109.879 -1.288 . . . . 10.0 109.879 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.46 ' HB2' HD21 ' A' ' 54' ' ' LEU . 45.7 mtm -137.97 125.8 22.5 Favored 'General case' 0 C--O 1.213 -0.859 0 C-N-CA 116.385 -2.126 . . . . 10.0 114.562 -166.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.0 mm -66.1 90.22 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 109.514 -0.55 . . . . 10.0 109.514 172.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.627 HD13 HG21 ' A' ' 70' ' ' ILE . 7.9 mt -79.4 128.69 74.49 Favored Pre-proline 0 N--CA 1.447 -0.61 0 N-CA-C 108.972 -0.751 . . . . 10.0 108.972 -177.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.659 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 11.0 Cg_exo -72.33 95.02 0.76 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.002 1.802 . . . . 10.0 110.756 174.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.503 ' O ' ' HG3' ' A' ' 10' ' ' LYS . 0.4 OUTLIER -92.38 157.74 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 119.125 0.875 . . . . 10.0 111.417 -171.06 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.426 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 89.4 t -135.04 117.53 22.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 110.278 -0.268 . . . . 10.0 110.278 172.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.627 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 24.0 mt -106.59 139.5 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 108.027 -1.101 . . . . 10.0 108.027 -175.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.7 m -123.44 98.36 5.82 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 108.481 -0.933 . . . . 10.0 108.481 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 65' ' ' SER . 1.5 p -87.03 136.0 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.07 0 CA-C-N 118.979 0.809 . . . . 10.0 111.286 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.597 ' HA ' ' O ' ' A' ' 4' ' ' LYS . 89.5 m-85 -94.12 170.19 9.71 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 114.989 -1.005 . . . . 10.0 113.011 -175.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.437 ' HG3' ' HB3' ' A' ' 4' ' ' LYS . 28.9 mt-10 -63.17 -17.61 62.57 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.535 -1.211 . . . . 10.0 111.824 -176.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -78.0 -10.78 59.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.136 175.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.455 ' HE2' ' HA3' ' A' ' 32' ' ' GLY . 1.6 mtpt 80.69 2.28 1.79 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.416 1.086 . . . . 10.0 109.527 -169.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.571 ' O ' HG23 ' A' ' 60' ' ' VAL . 21.2 p -69.26 -179.24 1.54 Allowed 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 113.776 -1.556 . . . . 10.0 108.616 170.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.787 ' CE2' ' HB2' ' A' ' 38' ' ' PHE . 0.0 OUTLIER -171.02 -175.1 1.65 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 120.032 1.287 . . . . 10.0 110.538 174.096 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 p -157.9 170.45 22.3 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 102.875 -3.009 . . . . 10.0 102.875 175.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -158.69 156.5 30.05 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.423 -0.954 . . . . 10.0 108.423 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.426 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 24.8 pt -128.71 153.26 37.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 107.272 -1.381 . . . . 10.0 107.272 -177.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.627 HG21 HD13 ' A' ' 54' ' ' LEU . 3.6 mm -107.87 132.0 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 N-CA-C 107.626 -1.25 . . . . 10.0 107.626 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.659 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 5.1 mmtp -77.32 85.54 3.74 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 118.942 -1.103 . . . . 10.0 109.337 176.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.835 HG23 ' HB3' ' A' ' 112' ' ' LYS . 15.3 t -63.99 -21.62 0.76 Allowed Pre-proline 0 CA--C 1.558 1.26 0 CA-C-N 112.745 -2.025 . . . . 10.0 113.151 174.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.888 ' HB3' ' HB2' ' A' ' 112' ' ' LYS . 56.8 Cg_endo -101.91 55.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.22 1.947 . . . . 10.0 117.144 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.572 ' HD3' ' O ' ' A' ' 71' ' ' LYS . 17.0 Cg_exo -71.86 -17.52 28.89 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 N-CA-C 107.9 -1.616 . . . . 10.0 107.9 154.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 69.19 -55.34 0.56 Allowed 'General case' 0 C--N 1.343 0.307 0 CA-C-N 113.335 -1.757 . . . . 10.0 111.481 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.547 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 13.5 p -56.87 -40.17 75.69 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.055 -0.52 . . . . 10.0 111.923 -176.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.622 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -74.75 -33.74 62.37 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.106 0.479 . . . . 10.0 111.697 -173.086 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.751 ' O ' ' HB2' ' A' ' 81' ' ' LYS . 3.7 tp -89.57 -17.8 27.83 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.533 -0.867 . . . . 10.0 108.905 177.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.651 HD21 ' HB2' ' A' ' 132' ' ' ALA . 8.7 tp -72.05 -23.26 61.34 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 108.316 -0.994 . . . . 10.0 108.316 168.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.622 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 24.0 mmtm -64.04 -27.5 69.15 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-O 121.195 0.521 . . . . 10.0 109.769 167.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.751 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -60.33 -45.18 94.34 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.484 -0.486 . . . . 10.0 111.508 171.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 1.001 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -71.07 -55.85 7.38 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.642 1.577 . . . . 10.0 112.075 173.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.7 122.25 22.95 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 111.907 -2.406 . . . . 10.0 107.63 -176.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 86' ' ' GLU . . . -85.65 11.12 62.55 Favored Glycine 0 C--N 1.32 -0.307 0 CA-C-N 120.815 1.643 . . . . 10.0 111.284 -164.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.432 ' C ' ' H ' ' A' ' 87' ' ' LYS . 36.8 pt -69.66 30.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 124.241 1.017 . . . . 10.0 113.118 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.419 ' H ' ' C ' ' A' ' 84' ' ' GLY . 2.2 tp10 -72.12 11.84 0.51 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.334 0.588 . . . . 10.0 111.452 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.432 ' H ' ' C ' ' A' ' 85' ' ' ILE . 66.4 mttm -161.04 90.39 0.83 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.178 -1.045 . . . . 10.0 108.178 -173.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.33 96.89 2.44 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.285 -0.959 . . . . 10.0 111.436 -175.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 6.3 p -163.54 77.4 0.4 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.472 0.653 . . . . 10.0 110.868 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.537 ' O ' ' HB2' ' A' ' 91' ' ' GLU . 13.0 m -79.29 22.81 0.41 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.69 -0.686 . . . . 10.0 111.149 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 90' ' ' SER . 23.3 mm-40 78.29 80.34 0.12 Allowed Pre-proline 0 N--CA 1.467 0.417 0 O-C-N 124.116 0.885 . . . . 10.0 109.825 -171.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -92.61 150.41 2.86 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.129 2.552 . . . . 10.0 113.622 -173.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.507 ' O ' ' HD3' ' A' ' 95' ' ' LYS . 24.5 pttm -165.36 174.32 10.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.855 -0.611 . . . . 10.0 109.967 175.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.477 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 0.1 OUTLIER 78.41 -80.33 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.277 0.631 . . . . 10.0 111.337 170.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.507 ' HD3' ' O ' ' A' ' 93' ' ' LYS . 0.4 OUTLIER -72.73 -13.6 61.37 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 107.705 -1.22 . . . . 10.0 107.705 179.193 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.492 HG23 ' H ' ' A' ' 97' ' ' VAL . 4.7 mt 75.56 174.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 113.447 -1.706 . . . . 10.0 109.924 175.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.556 HG13 ' N ' ' A' ' 98' ' ' GLY . 11.4 p -141.86 -50.98 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 113.648 0.981 . . . . 10.0 113.648 -168.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.625 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -156.56 165.93 33.13 Favored Glycine 0 N--CA 1.44 -1.084 0 N-CA-C 109.461 -1.456 . . . . 10.0 109.461 176.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.617 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -154.1 170.86 20.15 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-O 122.197 0.999 . . . . 10.0 110.57 -163.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 1.001 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -159.37 -143.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-N 112.834 -1.985 . . . . 10.0 106.584 -172.56 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.603 ' OG1' ' HG2' ' A' ' 104' ' ' GLN . 17.2 p -153.9 143.98 22.05 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 107.618 -1.253 . . . . 10.0 107.618 -153.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.629 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 12.9 tpt180 -42.62 -41.24 3.0 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 114.854 -1.066 . . . . 10.0 110.034 177.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 3.5 tmtm? -60.15 -46.26 90.28 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.403 0.52 . . . . 10.0 112.403 177.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.603 ' HG2' ' OG1' ' A' ' 101' ' ' THR . 14.0 mm100 -66.02 -42.82 89.16 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.982 -0.747 . . . . 10.0 108.982 -177.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.865 HG23 ' HB ' ' A' ' 128' ' ' ILE . 30.8 mm -40.53 -58.11 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 114.604 -1.18 . . . . 10.0 110.832 164.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.638 ' HG2' ' HE3' ' A' ' 110' ' ' LYS . 31.7 tt0 -47.79 -50.35 26.07 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 114.633 -1.167 . . . . 10.0 112.917 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.426 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 35.2 mm-40 -54.45 -58.1 8.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.303 -0.862 . . . . 10.0 111.143 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.682 ' O ' HG22 ' A' ' 111' ' ' THR . 11.8 mm -48.97 -53.58 7.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 CA-C-O 121.932 0.873 . . . . 10.0 109.95 172.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.524 ' CB ' HD11 ' A' ' 121' ' ' LEU . . . -48.67 -36.68 16.57 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.02 -0.991 . . . . 10.0 112.354 176.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.638 ' HE3' ' HG2' ' A' ' 106' ' ' GLU . 84.1 mttt -74.95 -54.02 7.95 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.409 -0.36 . . . . 10.0 111.44 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.682 HG22 ' O ' ' A' ' 108' ' ' ILE . 7.1 t -51.52 -22.93 3.53 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.242 1.201 . . . . 10.0 114.242 -171.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.888 ' HB2' ' HB3' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -130.01 19.4 5.48 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.576 0.703 . . . . 10.0 109.404 -174.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.66 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 54.8 ttm -52.21 -43.17 89.87 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 114.712 -1.131 . . . . 10.0 111.855 169.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.66 ' HD2' ' N ' ' A' ' 113' ' ' MET . 10.9 Cg_endo -52.64 -29.77 42.73 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.706 2.27 . . . . 10.0 112.259 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.528 ' CB ' ' HG3' ' A' ' 73' ' ' PRO . 21.1 t70 -91.19 -43.8 9.63 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.926 -1.034 . . . . 10.0 111.454 -176.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.867 HD21 HD12 ' A' ' 127' ' ' ILE . 3.2 mp -69.02 178.26 2.31 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 113.723 -1.581 . . . . 10.0 114.509 -167.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -94.29 29.55 2.17 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 111.303 -2.68 . . . . 10.0 112.209 171.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.659 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . . . -73.97 92.03 2.08 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 112.346 0.499 . . . . 10.0 112.346 175.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -66.28 -28.71 68.91 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.609 -0.885 . . . . 10.0 108.609 172.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 6.7 t -152.96 140.92 20.24 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 105.441 -2.059 . . . . 10.0 105.441 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.784 ' O ' ' HG3' ' A' ' 125' ' ' MET . 45.0 tp -53.07 -32.56 47.72 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.117 1.154 . . . . 10.0 114.117 -172.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -50.17 -35.92 28.2 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.591 0.71 . . . . 10.0 110.243 173.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.75 -50.56 56.6 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.236 -0.986 . . . . 10.0 110.969 176.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.716 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -60.23 -31.99 70.7 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 119.734 -0.786 . . . . 10.0 110.738 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.784 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 75.5 mtp -58.0 -36.42 72.63 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.701 0.286 . . . . 10.0 110.746 176.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -64.24 -54.06 39.43 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.101 0.56 . . . . 10.0 111.726 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.867 HD12 HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -51.48 -57.72 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 121.33 0.586 . . . . 10.0 110.739 179.005 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.865 ' HB ' HG23 ' A' ' 105' ' ' ILE . 21.5 mm -51.2 -54.06 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 CA-C-N 114.745 -1.116 . . . . 10.0 111.879 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.619 ' HG3' HG21 ' A' ' 105' ' ' ILE . 80.8 mt-10 -54.8 -40.97 70.04 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 123.325 0.391 . . . . 10.0 110.031 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -69.8 -46.8 51.56 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 120.194 -1.003 . . . . 10.0 111.015 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 86.3 m -44.59 -64.12 0.76 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 113.98 -1.11 . . . . 10.0 109.308 169.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.651 ' HB2' HD21 ' A' ' 79' ' ' LEU . . . -48.13 -50.3 29.14 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.008 -0.542 . . . . 10.0 111.775 177.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -49.05 -52.82 23.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.972 -1.013 . . . . 10.0 111.324 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 22.8 t -64.04 -33.02 74.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.868 0.366 . . . . 10.0 111.262 -177.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.516 ' CE ' HD23 ' A' ' 79' ' ' LEU . 67.9 mtm -84.46 8.07 17.63 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 114.316 1.228 . . . . 10.0 114.316 -174.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.452 ' O ' HG23 ' A' ' 96' ' ' ILE . . . 78.9 15.34 80.83 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 119.815 1.188 . . . . 10.0 111.603 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 19.4 mt -100.43 122.74 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 CA-C-O 121.5 0.667 . . . . 10.0 111.228 178.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.617 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -88.51 156.2 19.22 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-N 115.0 -1.0 . . . . 10.0 109.569 -179.217 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 17.1 m -115.47 121.22 66.78 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.194 0 CA-C-O 122.141 0.972 . . . . 10.0 108.517 172.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.646 HG22 ' O ' ' A' ' 100' ' ' VAL . 4.9 m -105.21 148.91 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 CA-C-N 113.752 -1.567 . . . . 10.0 108.544 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 34.2 t70 . . . . . 0 C--N 1.286 -2.168 0 CA-C-N 113.718 -1.583 . . . . 10.0 110.571 179.684 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtm . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 120.993 0.425 . . . . 10.0 110.225 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.79 153.94 30.52 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.968 -0.56 . . . . 10.0 109.737 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.417 ' HB2' ' CG ' ' A' ' 61' ' ' TYR . 22.3 pttm -69.11 117.72 11.11 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.427 0.632 . . . . 10.0 111.324 -178.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -99.09 140.58 33.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.419 -0.809 . . . . 10.0 109.81 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.6 t -61.32 130.13 25.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.771 0.32 . . . . 10.0 111.272 -176.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.63 -40.58 5.72 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.576 -0.527 . . . . 10.0 109.576 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.478 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -155.37 155.52 33.78 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 113.861 1.06 . . . . 10.0 113.861 -176.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -92.64 136.25 33.39 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.424 -1.262 . . . . 10.0 109.145 170.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.702 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -123.62 79.56 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 108.299 -1.0 . . . . 10.0 108.299 165.317 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.477 ' HG2' HG13 ' A' ' 57' ' ' VAL . 52.9 mttm -81.33 125.58 30.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 120.531 1.514 . . . . 10.0 107.751 175.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.587 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -158.15 131.35 7.49 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 122.485 1.136 . . . . 10.0 112.562 -172.155 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.721 ' HB3' HG23 ' A' ' 53' ' ' ILE . 23.2 mt-30 -84.04 116.51 22.88 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 113.79 -1.55 . . . . 10.0 111.489 -173.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.587 HD21 HD11 ' A' ' 11' ' ' LEU . 80.0 mt -136.65 140.73 32.96 Favored Pre-proline 0 C--O 1.219 -0.542 0 N-CA-C 113.262 0.838 . . . . 10.0 113.262 -172.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.843 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 36.0 Cg_exo -63.28 131.95 34.23 Favored 'Trans proline' 0 C--N 1.332 -0.327 0 C-N-CA 124.443 3.429 . . . . 10.0 113.445 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.517 ' O ' ' HA2' ' A' ' 51' ' ' GLY . . . -56.73 124.41 18.32 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 108.447 -0.945 . . . . 10.0 108.447 167.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.33 7.16 82.13 Favored Glycine 0 N--CA 1.444 -0.818 0 O-C-N 125.356 1.66 . . . . 10.0 113.507 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.843 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 24.5 mmtp -142.49 97.95 3.21 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.236 1.018 . . . . 10.0 112.798 178.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.712 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -171.35 135.84 0.98 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.321 -1.309 . . . . 10.0 112.967 172.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.624 HG23 ' HD3' ' A' ' 20' ' ' PRO . 1.1 t -179.04 -45.3 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 114.894 -1.048 . . . . 10.0 113.354 175.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.744 ' HD2' ' H ' ' A' ' 21' ' ' ALA . 69.6 Cg_endo -118.34 -46.54 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.257 0 N-CA-C 117.002 1.885 . . . . 10.0 117.002 -171.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.744 ' H ' ' HD2' ' A' ' 20' ' ' PRO . . . -47.48 154.74 0.82 Allowed Pre-proline 0 N--CA 1.467 0.392 0 N-CA-C 113.688 0.995 . . . . 10.0 113.688 -165.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.527 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 53.5 Cg_exo -38.94 -41.18 1.71 Allowed 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 124.583 3.522 . . . . 10.0 115.075 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 22' ' ' PRO . 3.1 Cg_exo -41.26 -54.69 2.49 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.542 2.161 . . . . 10.0 112.448 167.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.632 HG13 HD12 ' A' ' 28' ' ' LEU . 89.2 t -89.68 -55.54 6.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.59 -1.186 . . . . 10.0 113.887 -170.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.511 ' HA2' ' CD1' ' A' ' 35' ' ' ILE . . . -45.61 -73.2 0.3 Allowed Glycine 0 C--N 1.337 0.59 0 CA-C-N 114.247 -1.342 . . . . 10.0 113.668 -175.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 22' ' ' PRO . 88.9 Cg_exo -51.27 -44.44 43.03 Favored 'Trans proline' 0 C--O 1.225 -0.133 0 C-N-CA 123.561 2.84 . . . . 10.0 112.667 173.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 23' ' ' PRO . . . -50.71 -76.19 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.496 0.665 . . . . 10.0 111.38 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.712 ' HB2' HG12 ' A' ' 35' ' ' ILE . 3.8 mt -69.34 -44.33 71.85 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.331 -0.849 . . . . 10.0 113.098 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.44 -44.35 97.75 Favored Glycine 0 C--O 1.229 -0.159 0 CA-C-N 116.253 -0.431 . . . . 10.0 112.949 -173.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -62.06 -25.43 67.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.647 0.261 . . . . 10.0 110.565 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -101.34 13.64 34.43 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 120.113 -0.635 . . . . 10.0 110.787 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.34 12.94 83.83 Favored Glycine 0 CA--C 1.503 -0.707 0 CA-C-N 114.947 -1.024 . . . . 10.0 113.036 169.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.599 HG22 HG21 ' A' ' 60' ' ' VAL . 48.3 t -81.78 142.39 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 115.194 -0.503 . . . . 10.0 111.992 -173.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 81.6 m-20 -67.29 90.27 0.22 Allowed 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.025 0.441 . . . . 10.0 110.022 175.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.712 HG12 ' HB2' ' A' ' 28' ' ' LEU . 33.7 mt -55.24 -39.65 52.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.767 0.794 . . . . 10.0 111.463 177.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.616 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 62.9 mtm -64.55 -50.61 66.6 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.903 -1.498 . . . . 10.0 111.113 176.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.586 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 20.2 tt0 -55.66 -50.05 71.27 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 120.05 -0.66 . . . . 10.0 110.313 174.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.644 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . 61.9 t80 -55.65 -54.97 37.67 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 113.732 1.012 . . . . 10.0 113.732 176.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.641 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 8.8 p -56.19 -48.11 77.02 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.346 -0.843 . . . . 10.0 110.662 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.419 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 46.5 mmtm -67.69 -22.32 65.28 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.712 -0.795 . . . . 10.0 109.925 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.82 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 29.9 mtp180 -75.77 -63.75 1.23 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.651 -0.704 . . . . 10.0 111.559 171.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.644 ' CZ ' HG21 ' A' ' 46' ' ' THR . 79.3 t80 -55.33 -47.16 76.1 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.481 0.658 . . . . 10.0 110.619 -173.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.712 HD21 ' HB3' ' A' ' 18' ' ' ALA . 0.9 OUTLIER -61.06 -48.3 82.38 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.674 -1.148 . . . . 10.0 110.539 -176.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.88 -39.94 93.68 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 118.901 -1.12 . . . . 10.0 111.737 177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.82 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 11.4 mm-40 -66.53 -39.21 88.49 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.711 0.767 . . . . 10.0 111.786 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.648 ' CG2' HD12 ' A' ' 54' ' ' LEU . 64.6 p -92.6 -10.96 35.58 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 114.096 1.146 . . . . 10.0 114.096 -166.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -50.52 -37.19 37.8 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 113.575 0.954 . . . . 10.0 113.575 -171.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -75.35 -35.99 61.08 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.576 -0.738 . . . . 10.0 109.268 -175.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.515 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 4.3 mppt? -93.87 49.33 1.33 Allowed 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 122.926 0.49 . . . . 10.0 110.848 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.815 ' CB ' ' HG3' ' A' ' 52' ' ' MET . . . 100.0 -152.84 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 114.885 1.439 . . . . 10.0 114.885 146.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 15' ' ' ALA . . . -123.99 83.6 0.36 Allowed Glycine 0 N--CA 1.419 -2.466 0 N-CA-C 105.491 -3.043 . . . . 10.0 105.491 164.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.815 ' HG3' ' CB ' ' A' ' 50' ' ' ALA . 29.3 mtm -139.1 131.15 27.93 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 116.214 1.931 . . . . 10.0 116.214 -160.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.721 HG23 ' HB3' ' A' ' 12' ' ' GLN . 0.4 OUTLIER -67.94 94.29 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 C-N-CA 119.38 -0.928 . . . . 10.0 110.225 171.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.648 HD12 ' CG2' ' A' ' 46' ' ' THR . 11.4 mt -83.36 128.53 64.08 Favored Pre-proline 0 N--CA 1.437 -1.108 0 CA-C-N 115.139 -0.937 . . . . 10.0 108.788 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.427 ' HD2' ' HD3' ' A' ' 73' ' ' PRO . 26.9 Cg_exo -64.88 98.05 0.29 Allowed 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.216 1.944 . . . . 10.0 110.946 175.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -97.47 153.74 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 119.011 0.823 . . . . 10.0 110.946 -173.451 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.477 HG13 ' HG2' ' A' ' 10' ' ' LYS . 92.4 t -134.27 114.23 18.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 C-N-CA 121.015 -0.274 . . . . 10.0 110.359 173.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.702 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 22.8 mt -106.66 137.49 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.795 0 N-CA-C 108.003 -1.11 . . . . 10.0 108.003 -173.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 31.6 m -121.76 95.53 4.71 Favored 'General case' 0 N--CA 1.405 -2.675 0 CA-C-N 114.707 -1.133 . . . . 10.0 108.642 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.599 HG21 HG22 ' A' ' 33' ' ' VAL . 3.1 p -86.64 137.14 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-N 119.28 0.945 . . . . 10.0 110.599 -178.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.452 ' CD2' ' HA ' ' A' ' 66' ' ' PHE . 66.0 m-85 -96.28 172.49 7.92 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 113.001 0.741 . . . . 10.0 113.001 -176.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -53.86 -27.25 28.82 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.03 -1.441 . . . . 10.0 112.602 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.572 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 4.0 m-20 -77.61 -10.76 59.69 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.371 -0.832 . . . . 10.0 111.591 -173.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 51.5 mtpt 83.3 -0.16 1.13 Allowed 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 122.276 1.036 . . . . 10.0 109.537 -164.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.488 ' O ' HG23 ' A' ' 60' ' ' VAL . 50.6 m -70.89 170.77 11.95 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 113.626 -1.624 . . . . 10.0 108.234 173.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.644 ' CZ ' ' HB2' ' A' ' 38' ' ' PHE . 6.0 p90 -168.44 -176.12 2.74 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 120.372 1.442 . . . . 10.0 110.373 175.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.6 p -157.72 171.74 19.77 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 103.1 -2.926 . . . . 10.0 103.1 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.442 ' CB ' HG12 ' A' ' 58' ' ' ILE . 38.1 p90 -161.41 155.62 22.56 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.404 -0.962 . . . . 10.0 108.404 177.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.408 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 29.9 pt -128.53 166.97 24.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 107.289 -1.375 . . . . 10.0 107.289 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.482 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 2.5 mt -138.1 119.02 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 107.544 -1.28 . . . . 10.0 107.544 -177.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.421 ' HZ2' ' HB2' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -83.44 67.55 9.38 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.597 -0.89 . . . . 10.0 108.597 -176.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -20.59 96.37 0.05 OUTLIER Pre-proline 0 C--O 1.224 -0.24 0 O-C-N 125.879 1.987 . . . . 10.0 112.244 176.005 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.427 ' HD3' ' HD2' ' A' ' 55' ' ' PRO . 3.8 Cg_exo -36.65 124.3 0.38 Allowed 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 124.406 3.404 . . . . 10.0 113.65 -167.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.872 ' HA ' ' HZ1' ' A' ' 112' ' ' LYS . 86.1 Cg_exo -48.09 86.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 124.17 3.247 . . . . 10.0 114.085 -176.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 1.092 ' H ' ' HE2' ' A' ' 112' ' ' LYS . . . 72.49 -49.75 0.7 Allowed 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 124.708 1.203 . . . . 10.0 112.509 173.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.675 ' HA ' ' HE1' ' A' ' 135' ' ' MET . 8.0 p -37.39 -65.29 0.32 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 114.116 1.154 . . . . 10.0 114.116 -171.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.714 ' HB3' ' SD ' ' A' ' 52' ' ' MET . 41.6 m-85 -72.32 -40.75 67.22 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.26 0.837 . . . . 10.0 113.26 -171.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.812 ' HB3' HD12 ' A' ' 108' ' ' ILE . 2.7 mm? -68.32 -30.62 69.64 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.547 -0.721 . . . . 10.0 109.863 177.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.538 HD13 ' HB2' ' A' ' 132' ' ' ALA . 28.0 mt -70.94 -25.41 62.73 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.967 -0.56 . . . . 10.0 110.914 175.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.774 ' HA ' HG13 ' A' ' 85' ' ' ILE . 25.1 mmmt -54.15 -49.28 69.62 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 108.638 -0.875 . . . . 10.0 108.638 174.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -58.33 -44.99 88.92 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.881 0.697 . . . . 10.0 112.881 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.751 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -65.86 -55.57 16.35 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 123.031 1.396 . . . . 10.0 110.165 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.559 ' HB1' ' HA3' ' A' ' 98' ' ' GLY . . . -63.84 -33.12 74.97 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 111.119 -2.764 . . . . 10.0 110.597 -172.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 102.09 -15.33 56.66 Favored Glycine 0 C--N 1.309 -0.932 0 C-N-CA 120.154 -1.022 . . . . 10.0 110.934 177.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.774 HG13 ' HA ' ' A' ' 80' ' ' LYS . 3.5 pt -57.11 97.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 121.555 0.693 . . . . 10.0 110.63 170.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -165.92 131.36 2.43 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.034 -0.984 . . . . 10.0 108.827 -173.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 58.6 tttp 84.08 -33.42 0.07 Allowed 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 123.942 0.897 . . . . 10.0 109.555 177.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 176.29 -49.71 0.11 Allowed Glycine 0 N--CA 1.438 -1.205 0 C-N-CA 120.038 -1.077 . . . . 10.0 113.448 172.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.5 p 49.88 104.44 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.741 0.816 . . . . 10.0 112.301 -174.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.0 m -73.02 12.68 0.5 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.623 -0.717 . . . . 10.0 112.923 -173.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 66.88 89.8 0.09 OUTLIER Pre-proline 0 C--O 1.235 0.312 0 CA-C-O 120.963 0.411 . . . . 10.0 110.781 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.786 ' HD2' ' HA ' ' A' ' 97' ' ' VAL . 72.4 Cg_endo -78.85 106.51 2.1 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.572 2.182 . . . . 10.0 111.886 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -77.71 76.33 4.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.017 0.436 . . . . 10.0 111.231 -174.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -164.18 -45.13 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.078 -0.964 . . . . 10.0 108.413 175.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.849 ' HD2' ' HE2' ' A' ' 99' ' ' LYS . 24.3 mmtp -79.22 -95.07 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 106.837 -1.542 . . . . 10.0 106.837 173.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.567 ' HB ' ' O ' ' A' ' 136' ' ' GLY . 1.6 mt -153.14 -61.69 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.49 -1.351 0 N-CA-C 106.468 -1.679 . . . . 10.0 106.468 164.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.786 ' HA ' ' HD2' ' A' ' 92' ' ' PRO . 3.3 p -157.59 -51.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 CA-C-N 112.38 -2.191 . . . . 10.0 108.41 168.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.625 ' H ' HG13 ' A' ' 97' ' ' VAL . . . -133.92 147.99 19.26 Favored Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 109.325 -1.51 . . . . 10.0 109.325 164.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.849 ' HE2' ' HD2' ' A' ' 95' ' ' LYS . 64.4 pttt -148.11 160.95 42.36 Favored 'General case' 0 CA--C 1.472 -2.022 0 CA-C-O 122.144 0.973 . . . . 10.0 108.803 172.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.751 HG11 ' HB1' ' A' ' 82' ' ' ALA . 1.2 m -161.18 -162.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.411 -2.399 0 CA-C-N 112.486 -2.143 . . . . 10.0 106.772 -166.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.521 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 15.9 p -121.7 159.06 27.36 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 114.543 -1.208 . . . . 10.0 111.106 -173.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.672 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 16.2 tpt180 -43.12 -44.84 5.16 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.919 -1.492 . . . . 10.0 110.165 171.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.52 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -58.01 -44.29 87.17 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.801 0.667 . . . . 10.0 112.801 177.429 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.579 ' HG2' ' HB1' ' A' ' 82' ' ' ALA . 1.4 tp60 -55.63 -54.86 38.92 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.895 -0.78 . . . . 10.0 108.895 177.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.744 HG23 ' HB ' ' A' ' 128' ' ' ILE . 45.5 mm -35.96 -52.93 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.576 0 CA-C-N 113.985 -1.461 . . . . 10.0 112.604 167.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.673 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 25.5 tt0 -47.57 -59.63 3.12 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.529 1.132 . . . . 10.0 113.183 -175.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -55.94 -49.82 72.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.129 -0.941 . . . . 10.0 110.519 -178.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.812 HD12 ' HB3' ' A' ' 78' ' ' LEU . 13.8 mm -49.86 -57.42 2.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.652 -0.704 . . . . 10.0 110.641 171.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.556 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -52.23 -35.65 50.19 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.923 -0.581 . . . . 10.0 112.371 177.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.673 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 46.9 mttt -74.97 -56.09 5.1 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.707 -0.679 . . . . 10.0 111.42 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.47 HG23 ' CG ' ' A' ' 112' ' ' LYS . 13.2 t -54.47 -30.41 53.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.931 -0.577 . . . . 10.0 112.375 -176.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 1.092 ' HE2' ' H ' ' A' ' 75' ' ' ALA . 0.8 OUTLIER -113.48 23.71 12.92 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 121.062 -0.255 . . . . 10.0 110.888 -178.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.761 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 46.5 ttm -48.48 -44.3 64.85 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.359 -0.382 . . . . 10.0 111.696 175.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 113' ' ' MET . 56.7 Cg_endo -68.04 -20.64 44.11 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.587 1.525 . . . . 10.0 113.172 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -83.55 -54.95 4.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.604 -0.726 . . . . 10.0 110.441 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.602 ' HG ' HG21 ' A' ' 127' ' ' ILE . 0.0 OUTLIER -65.43 -0.32 1.86 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.686 -1.143 . . . . 10.0 112.618 -177.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 15.5 m120 60.25 46.93 9.72 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.717 -1.128 . . . . 10.0 109.309 -177.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.761 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -79.84 113.63 18.14 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.358 -1.292 . . . . 10.0 112.625 -173.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -67.39 -36.04 80.52 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.148 -0.686 . . . . 10.0 109.148 169.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.5 p -150.59 146.4 26.52 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.955 -1.128 . . . . 10.0 107.955 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.609 ' O ' ' HG2' ' A' ' 125' ' ' MET . 39.6 tp -53.06 -40.47 64.03 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 114.446 1.276 . . . . 10.0 114.446 -177.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -51.13 -35.19 34.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.309 0.576 . . . . 10.0 111.026 176.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.587 ' O ' ' HG3' ' A' ' 126' ' ' LYS . . . -67.64 -49.08 64.69 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 118.816 -1.153 . . . . 10.0 110.607 173.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.668 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -56.86 -29.05 62.53 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.684 -0.806 . . . . 10.0 110.328 176.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.649 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 82.8 mmm -61.55 -41.55 97.52 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 113.06 0.763 . . . . 10.0 113.06 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.737 ' HD3' ' N ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -66.7 -45.27 79.31 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 122.161 -0.337 . . . . 10.0 111.816 178.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.737 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -55.12 -60.59 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 C-N-CA 120.164 -0.614 . . . . 10.0 110.662 178.443 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.744 ' HB ' HG23 ' A' ' 105' ' ' ILE . 19.8 mm -50.36 -55.02 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.219 0 CA-C-N 115.614 -0.721 . . . . 10.0 110.774 -177.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -54.46 -44.3 72.44 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 114.753 -1.112 . . . . 10.0 108.898 179.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.594 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -72.07 -46.2 37.08 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 121.154 -0.546 . . . . 10.0 112.166 -174.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.621 HG21 ' HB3' ' A' ' 75' ' ' ALA . 68.1 m -46.96 -57.69 4.73 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.483 0.658 . . . . 10.0 109.431 171.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.563 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -49.08 -43.26 40.96 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 114.94 -1.027 . . . . 10.0 111.876 175.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 130' ' ' GLY . 58.6 mttp -48.74 -53.02 20.64 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.439 0.462 . . . . 10.0 110.876 176.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.9 m -66.96 -32.87 74.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.024 0.44 . . . . 10.0 111.446 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.675 ' HE1' ' HA ' ' A' ' 76' ' ' SER . 38.3 mtm -79.85 -1.05 37.31 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.934 1.087 . . . . 10.0 113.934 -175.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.567 ' O ' ' HB ' ' A' ' 96' ' ' ILE . . . 83.49 23.78 52.76 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 119.619 1.1 . . . . 10.0 112.142 -177.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 3.0 mp -109.26 126.63 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 CA-C-O 121.525 0.679 . . . . 10.0 111.043 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.753 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -91.9 157.86 16.6 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.553 -1.203 . . . . 10.0 108.906 179.31 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 19.5 m -119.02 134.52 62.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.177 -0.675 . . . . 10.0 109.177 171.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.64 HG22 ' O ' ' A' ' 100' ' ' VAL . 28.7 m -133.85 71.07 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 116.052 1.871 . . . . 10.0 116.052 -173.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 20.5 t0 . . . . . 0 C--N 1.3 -1.571 0 CA-C-N 114.321 -1.309 . . . . 10.0 109.041 138.791 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.435 ' CE ' ' HA ' ' A' ' 1' ' ' MET . 10.0 mmt . . . . . 0 N--CA 1.485 1.289 0 N-CA-C 109.694 -0.484 . . . . 10.0 109.694 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.16 -108.72 0.43 Allowed 'General case' 0 C--N 1.331 -0.221 0 O-C-N 123.716 0.635 . . . . 10.0 110.108 -173.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -141.51 110.26 6.11 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.857 -0.423 . . . . 10.0 109.857 171.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 10.3 mtmp? -102.31 143.69 31.76 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.776 -0.453 . . . . 10.0 109.776 177.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.442 HG13 HG23 ' A' ' 59' ' ' THR . 45.2 t -62.13 131.53 27.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 116.222 -0.444 . . . . 10.0 111.155 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.93 -35.39 7.31 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.687 -0.486 . . . . 10.0 109.687 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.512 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -154.11 141.27 19.45 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.327 0.862 . . . . 10.0 113.327 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -94.2 126.96 39.76 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 106.654 -1.61 . . . . 10.0 106.654 171.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.648 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 1.9 mt -125.67 85.59 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 120.241 -0.584 . . . . 10.0 109.864 -177.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.566 ' HG2' HG22 ' A' ' 57' ' ' VAL . 58.1 mttp -75.92 132.86 40.53 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 120.338 -0.545 . . . . 10.0 109.85 176.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.697 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -158.34 127.21 5.55 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.154 0.978 . . . . 10.0 111.607 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -85.92 122.87 30.59 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.502 -1.226 . . . . 10.0 110.724 -172.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.697 HD21 HD11 ' A' ' 11' ' ' LEU . 94.0 mt -141.56 135.66 14.96 Favored Pre-proline 0 CA--C 1.51 -0.584 0 CA-C-O 121.659 0.742 . . . . 10.0 112.044 -172.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.671 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 53.1 Cg_exo -49.94 124.34 12.4 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.818 3.012 . . . . 10.0 112.943 170.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.61 ' CB ' ' HA ' ' A' ' 50' ' ' ALA . . . -62.73 128.76 37.44 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.599 -1.259 . . . . 10.0 107.599 170.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.35 0.48 78.35 Favored Glycine 0 N--CA 1.446 -0.693 0 O-C-N 125.513 1.758 . . . . 10.0 112.992 -174.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.671 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -143.84 96.08 2.84 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.941 0.877 . . . . 10.0 112.038 -178.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.546 ' O ' ' HB2' ' A' ' 39' ' ' CYS . . . -170.62 135.85 1.19 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.073 -1.422 . . . . 10.0 112.733 177.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.74 ' H ' ' HD3' ' A' ' 20' ' ' PRO . 5.9 t -179.61 -36.26 0.0 OUTLIER Pre-proline 0 N--CA 1.443 -0.777 0 CA-C-N 115.236 -0.893 . . . . 10.0 113.357 176.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.74 ' HD3' ' H ' ' A' ' 19' ' ' THR . 89.3 Cg_endo -104.04 129.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.409 -3.476 0 N-CA-C 116.492 1.689 . . . . 10.0 116.492 -157.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.962 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . 13.09 -58.24 0.0 OUTLIER Pre-proline 0 C--N 1.288 -2.078 0 CA-C-N 109.228 -3.624 . . . . 10.0 118.546 152.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.771 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 45.3 Cg_exo -57.69 -63.9 0.14 Allowed 'Trans proline' 0 CA--C 1.566 2.115 0 CA-C-N 123.576 2.313 . . . . 10.0 115.409 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.771 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 58.6 Cg_endo -77.42 -52.04 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.681 2.254 . . . . 10.0 112.74 176.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.013 HG12 HD12 ' A' ' 35' ' ' ILE . 77.5 t -81.89 -49.46 17.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 111.702 -2.499 . . . . 10.0 111.894 -166.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.766 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -44.15 -52.97 6.83 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 113.968 -1.469 . . . . 10.0 113.39 178.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.962 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 23.9 Cg_exo -71.96 -43.82 1.1 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.179 2.586 . . . . 10.0 111.236 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.514 ' O ' ' HD2' ' A' ' 31' ' ' HIS . . . -50.58 -93.81 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.434 0.459 . . . . 10.0 111.897 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.778 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.356 0.0 OUTLIER -77.15 -19.24 57.12 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 117.306 -1.758 . . . . 10.0 113.797 -174.535 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.55 -39.48 60.84 Favored Glycine 0 N--CA 1.467 0.714 0 C-N-CA 120.666 -0.778 . . . . 10.0 113.092 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.608 ' HB3' ' O ' ' A' ' 26' ' ' PRO . 13.0 tt0 -56.61 -26.14 54.83 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.746 0.308 . . . . 10.0 110.628 175.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.514 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 70.0 m-70 -96.47 23.63 6.62 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.739 -0.784 . . . . 10.0 109.86 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.444 ' HA3' ' CE ' ' A' ' 64' ' ' LYS . . . 81.66 6.92 88.72 Favored Glycine 0 CA--C 1.494 -1.232 0 CA-C-N 115.27 -0.877 . . . . 10.0 112.813 167.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.888 HG11 ' CD2' ' A' ' 66' ' ' PHE . 2.4 t -85.26 146.97 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 113.628 0.973 . . . . 10.0 113.628 -175.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.609 ' ND2' ' HB3' ' A' ' 37' ' ' GLU . 0.2 OUTLIER -69.97 101.71 1.84 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.649 0.737 . . . . 10.0 111.477 174.321 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.013 HD12 HG12 ' A' ' 24' ' ' VAL . 21.2 mm -53.49 -39.25 35.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 114.152 -1.385 . . . . 10.0 112.175 176.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.735 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 3.2 mpp? -66.13 -51.38 58.5 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.335 -1.757 . . . . 10.0 111.907 177.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.609 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 44.0 tt0 -57.83 -40.13 79.28 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.109 -1.036 . . . . 10.0 110.23 176.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.65 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 89.0 t80 -57.47 -58.97 5.95 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 113.877 1.066 . . . . 10.0 113.877 171.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.735 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 19.8 p -60.08 -47.43 85.91 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 114.563 -1.199 . . . . 10.0 111.36 -175.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -65.26 -24.29 67.28 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.988 -0.745 . . . . 10.0 108.988 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.782 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 19.2 mtp180 -74.2 -64.48 1.01 Allowed 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.598 -0.841 . . . . 10.0 112.35 170.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.625 ' CZ ' HG21 ' A' ' 46' ' ' THR . 76.5 t80 -53.37 -45.18 69.11 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 121.157 0.503 . . . . 10.0 110.376 -172.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.628 HD22 ' N ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER -59.18 -51.01 71.85 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.026 -0.988 . . . . 10.0 110.235 -177.685 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.27 -41.67 99.04 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.209 -0.996 . . . . 10.0 112.232 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.782 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 10.6 mt-10 -68.6 -40.33 80.47 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.795 0.807 . . . . 10.0 111.166 -176.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.625 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 75.4 p -87.81 0.54 55.64 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 114.778 -1.101 . . . . 10.0 112.28 -173.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -45.04 -35.27 2.9 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 124.231 1.013 . . . . 10.0 113.233 -175.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -86.91 -33.54 19.69 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.806 -0.634 . . . . 10.0 112.391 -173.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.575 ' HB3' ' HZ ' ' A' ' 77' ' ' PHE . 39.3 mttm -96.94 20.45 11.12 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.181 -0.674 . . . . 10.0 109.181 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.61 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -54.36 157.74 2.65 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 125.223 1.409 . . . . 10.0 114.128 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.05 22.07 43.39 Favored Glycine 0 CA--C 1.501 -0.812 0 N-CA-C 109.121 -1.592 . . . . 10.0 109.121 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.615 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 40.4 tpp -140.99 120.21 12.94 Favored 'General case' 0 C--O 1.205 -1.242 0 C-N-CA 117.42 -1.712 . . . . 10.0 114.737 -159.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.6 mm -63.11 92.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 121.688 -0.632 . . . . 10.0 109.999 172.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.768 HD22 ' HE2' ' A' ' 77' ' ' PHE . 7.2 mt -82.65 129.37 62.73 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.71 -0.478 . . . . 10.0 109.71 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.405 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 14.9 Cg_exo -71.51 103.37 1.42 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 121.918 1.746 . . . . 10.0 110.262 171.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.02 153.79 3.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 119.726 1.148 . . . . 10.0 110.903 -173.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.566 HG22 ' HG2' ' A' ' 10' ' ' LYS . 61.5 t -133.09 111.66 16.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.983 -0.377 . . . . 10.0 109.983 176.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.648 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 17.2 mt -102.9 140.66 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.789 0 N-CA-C 108.534 -0.913 . . . . 10.0 108.534 -172.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.442 HG23 HG13 ' A' ' 5' ' ' VAL . 57.2 m -125.19 94.45 4.17 Favored 'General case' 0 N--CA 1.402 -2.863 0 CA-C-N 114.774 -1.103 . . . . 10.0 108.873 177.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 65' ' ' SER . 2.2 p -89.82 134.67 28.25 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 O-C-N 121.264 -0.898 . . . . 10.0 110.16 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -91.84 172.34 8.53 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.69 -0.686 . . . . 10.0 112.658 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -63.75 -19.25 64.82 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.298 -0.865 . . . . 10.0 111.393 -178.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.442 ' HB3' ' OG ' ' A' ' 65' ' ' SER . 27.3 t70 -77.55 -10.45 59.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.811 -1.086 . . . . 10.0 111.237 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.444 ' CE ' ' HA3' ' A' ' 32' ' ' GLY . 28.1 mmmt 82.55 -3.76 1.38 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.328 1.051 . . . . 10.0 110.961 -172.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.606 ' O ' HG23 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -68.93 179.45 1.83 Allowed 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.661 -0.866 . . . . 10.0 108.661 170.843 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.888 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -166.06 -176.51 3.78 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 119.851 1.205 . . . . 10.0 109.828 175.128 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.3 p -158.12 166.84 31.45 Favored 'General case' 0 N--CA 1.413 -2.283 0 N-CA-C 102.275 -3.231 . . . . 10.0 102.275 178.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.428 ' CB ' HG12 ' A' ' 58' ' ' ILE . 45.1 p90 -163.66 154.64 16.23 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.207 -1.035 . . . . 10.0 108.207 175.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.518 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 29.2 pt -117.01 164.14 13.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.613 -1.254 . . . . 10.0 107.613 -177.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.488 HG21 HD13 ' A' ' 54' ' ' LEU . 10.5 mm -117.22 126.27 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 106.561 -1.644 . . . . 10.0 106.561 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.465 ' HD3' ' HA ' ' A' ' 71' ' ' LYS . 50.3 mmtt -72.47 104.29 3.76 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 119.576 -0.85 . . . . 10.0 109.988 -177.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.692 ' O ' ' HE2' ' A' ' 112' ' ' LYS . 8.2 p -41.57 139.06 1.55 Allowed Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 112.973 -1.921 . . . . 10.0 109.27 174.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.446 ' HB3' ' HB3' ' A' ' 77' ' ' PHE . 8.7 Cg_exo -32.59 104.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 124.192 3.262 . . . . 10.0 113.256 -174.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -38.85 -47.66 2.76 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.064 2.509 . . . . 10.0 110.565 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.585 ' CB ' HG21 ' A' ' 131' ' ' THR . . . 174.91 -47.58 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 113.824 -1.534 . . . . 10.0 109.364 159.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.643 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 83.9 p -64.68 -30.46 71.48 Favored 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 109.817 -0.438 . . . . 10.0 109.817 -178.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.768 ' HE2' HD22 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -41.89 -70.27 0.11 Allowed 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.87 0.868 . . . . 10.0 111.122 175.478 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.781 ' HB3' HD12 ' A' ' 108' ' ' ILE . 12.5 tp -90.25 -17.48 27.39 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.078 -0.51 . . . . 10.0 109.849 -170.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.7 mt -69.2 -33.16 72.92 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.259 172.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.643 ' HG3' ' O ' ' A' ' 76' ' ' SER . 48.5 mttp -60.81 -41.52 95.85 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 109.35 -0.611 . . . . 10.0 109.35 171.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -58.4 -39.91 80.98 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.851 -0.613 . . . . 10.0 112.422 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.814 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -69.96 -53.03 19.6 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.975 1.369 . . . . 10.0 110.875 174.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.87 -37.93 89.27 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 111.473 -2.603 . . . . 10.0 111.437 -171.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 87.36 66.21 1.35 Allowed Glycine 0 C--N 1.311 -0.813 0 C-N-CA 120.005 -1.093 . . . . 10.0 110.836 -178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.4 pt -159.01 69.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 122.294 1.045 . . . . 10.0 109.304 -173.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 18.3 mt-10 -73.48 74.26 1.42 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.196 -1.365 . . . . 10.0 111.8 -173.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 86' ' ' GLU . 10.0 mtpm? 82.35 7.11 0.93 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.627 -0.715 . . . . 10.0 109.91 172.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.92 8.92 74.18 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.012 -0.994 . . . . 10.0 112.08 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.0 p -75.66 -168.04 0.79 Allowed 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 122.628 0.371 . . . . 10.0 111.474 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.3 t 76.59 29.46 0.67 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.91 175.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.746 ' HB3' ' HD3' ' A' ' 92' ' ' PRO . 31.1 tt0 -172.1 -55.58 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.625 176.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.746 ' HD3' ' HB3' ' A' ' 91' ' ' GLU . 20.6 Cg_exo -66.88 102.69 0.65 Allowed 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.892 1.728 . . . . 10.0 112.474 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -159.86 95.95 1.21 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.982 -0.554 . . . . 10.0 110.491 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.466 ' C ' ' H ' ' A' ' 96' ' ' ILE . 56.1 ttm-85 -170.17 -64.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.888 0.375 . . . . 10.0 110.442 172.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.404 ' HD2' ' HA ' ' A' ' 95' ' ' LYS . 46.7 tptt -77.36 9.36 3.26 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.719 0.771 . . . . 10.0 109.322 -177.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.466 ' H ' ' C ' ' A' ' 94' ' ' ARG . 1.4 mt 72.78 104.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.182 -1.372 . . . . 10.0 111.68 -174.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 97' ' ' VAL . 7.1 p -62.31 101.85 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 112.582 -2.099 . . . . 10.0 111.694 -175.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 38.92 -161.83 0.01 OUTLIER Glycine 0 C--N 1.323 -0.181 0 CA-C-N 114.21 -1.359 . . . . 10.0 112.656 -170.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.573 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 8.4 ptpp? -158.85 177.58 11.01 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 122.273 1.035 . . . . 10.0 111.022 177.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.814 HG11 ' HB1' ' A' ' 82' ' ' ALA . 1.0 OUTLIER -155.54 -145.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 CA-C-N 112.285 -2.234 . . . . 10.0 105.981 -176.147 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.62 HG23 HE21 ' A' ' 104' ' ' GLN . 0.1 OUTLIER -162.77 142.72 9.32 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 109.048 -0.723 . . . . 10.0 109.048 -157.44 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.732 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 1.5 tpt180 -43.31 -39.97 3.33 Favored 'General case' 0 CA--C 1.545 0.776 0 O-C-N 124.934 1.396 . . . . 10.0 110.795 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.557 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 17.8 tppt? -60.13 -44.42 94.93 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.521 0.563 . . . . 10.0 112.521 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.65 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -63.81 -47.96 78.76 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.758 -0.83 . . . . 10.0 108.758 178.509 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.732 ' HB ' ' O ' ' A' ' 102' ' ' ARG . 43.2 mm -35.53 -58.15 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-N 114.949 -1.023 . . . . 10.0 111.544 163.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.647 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 33.1 tt0 -47.33 -54.65 10.54 Favored 'General case' 0 C--O 1.209 -1.07 0 C-N-CA 124.636 1.174 . . . . 10.0 113.146 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -53.2 -58.15 8.03 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 123.743 0.652 . . . . 10.0 110.971 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.781 HD12 ' HB3' ' A' ' 78' ' ' LEU . 7.7 mm -46.79 -55.86 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.243 -0.889 . . . . 10.0 109.963 172.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.618 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -53.27 -38.08 62.74 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.684 -0.689 . . . . 10.0 112.833 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.647 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 76.4 mttt -72.2 -56.92 4.73 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 116.109 -0.496 . . . . 10.0 111.052 -173.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.457 ' O ' HG21 ' A' ' 72' ' ' THR . 1.8 t -54.61 -33.3 60.22 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.171 -0.922 . . . . 10.0 110.168 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 1.063 ' HD2' HD13 ' A' ' 116' ' ' LEU . 4.5 mmtt -91.74 -12.22 34.57 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 112.64 0.607 . . . . 10.0 112.64 -177.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.4 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 45.7 ttm -37.27 -52.7 2.27 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 113.25 0.833 . . . . 10.0 113.25 177.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 113' ' ' MET . 30.7 Cg_endo -64.49 -22.74 65.19 Favored 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 121.456 1.437 . . . . 10.0 112.988 -178.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.751 ' HB3' ' HD3' ' A' ' 112' ' ' LYS . 3.6 t70 -99.25 -42.19 7.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.819 0.818 . . . . 10.0 112.152 -175.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 1.063 HD13 ' HD2' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -63.82 -0.22 1.0 Allowed 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 114.105 -1.407 . . . . 10.0 111.815 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.447 ' H ' ' C ' ' A' ' 115' ' ' ASP . 2.6 p-10 56.85 43.88 24.21 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 113.971 -1.468 . . . . 10.0 108.886 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 119' ' ' ASN . . . -65.39 -74.62 0.1 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 112.7 -2.045 . . . . 10.0 113.272 -166.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.452 ' HB3' ' O ' ' A' ' 118' ' ' ALA . 28.7 t-20 103.57 -42.87 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 O-C-N 125.08 1.488 . . . . 10.0 109.096 -173.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.5 t -153.79 139.75 18.23 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.391 -1.707 . . . . 10.0 106.391 173.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.597 ' O ' HD13 ' A' ' 121' ' ' LEU . 1.5 tm? -50.47 -35.26 28.18 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.34 0.867 . . . . 10.0 113.34 -174.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.536 ' HA ' ' HG3' ' A' ' 125' ' ' MET . 1.6 mp0 -51.15 -41.31 60.03 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.584 0.707 . . . . 10.0 111.013 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.93 -47.37 74.94 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 118.787 -1.165 . . . . 10.0 110.488 177.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.482 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -58.6 -29.86 66.78 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.837 -0.345 . . . . 10.0 111.0 176.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.536 ' HG3' ' HA ' ' A' ' 122' ' ' GLU . 5.0 mtp -54.92 -41.02 70.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.903 0.382 . . . . 10.0 111.087 175.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -63.37 -54.68 33.03 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.632 -0.713 . . . . 10.0 112.173 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.944 HD12 HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -52.29 -59.35 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 120.212 -0.595 . . . . 10.0 111.144 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.632 ' HB ' HG23 ' A' ' 105' ' ' ILE . 27.4 mm -51.7 -56.65 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 CA-C-N 114.841 -1.072 . . . . 10.0 111.676 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.56 ' HG3' HG21 ' A' ' 105' ' ' ILE . 5.3 mt-10 -51.95 -44.15 63.8 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 123.824 0.702 . . . . 10.0 109.143 177.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -68.73 -45.97 63.18 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.393 -0.908 . . . . 10.0 111.08 -175.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.585 HG21 ' CB ' ' A' ' 75' ' ' ALA . 49.9 m -46.75 -64.77 0.68 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.144 -1.028 . . . . 10.0 109.148 169.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -47.49 -52.62 16.67 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.147 0.499 . . . . 10.0 111.561 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -52.19 -53.5 42.47 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.943 -1.026 . . . . 10.0 112.163 178.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 22.9 p -68.34 -25.5 65.14 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.044 0.45 . . . . 10.0 110.599 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.406 ' HG3' ' O ' ' A' ' 131' ' ' THR . 45.1 mtm -75.42 -8.41 56.63 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 112.731 0.641 . . . . 10.0 112.731 178.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 96' ' ' ILE . . . 96.48 2.65 60.11 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 118.995 0.816 . . . . 10.0 111.765 179.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 51.7 mt -95.02 136.38 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 CA-C-N 117.54 0.67 . . . . 10.0 112.029 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.577 ' HG3' ' N ' ' A' ' 139' ' ' VAL . 0.0 OUTLIER -84.7 156.28 21.54 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 119.097 -1.041 . . . . 10.0 110.544 177.22 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.577 ' N ' ' HG3' ' A' ' 138' ' ' GLU . 17.3 m -120.03 126.21 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.55 0 N-CA-C 107.561 -1.274 . . . . 10.0 107.561 170.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 100' ' ' VAL . 26.2 m -107.2 167.95 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 CA-C-N 113.555 -1.657 . . . . 10.0 108.415 176.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 . . . . . 0 C--N 1.285 -2.198 0 CA-C-N 113.921 -1.49 . . . . 10.0 110.814 178.563 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ppp? . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 112.195 0.443 . . . . 10.0 112.195 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.37 -58.4 7.21 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 120.975 0.417 . . . . 10.0 110.958 -177.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -135.98 154.66 51.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.017 -0.538 . . . . 10.0 109.773 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -73.0 114.88 11.64 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.003 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.7 t -65.61 141.3 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 122.737 0.415 . . . . 10.0 111.097 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -109.48 -46.77 3.48 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.198 175.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.401 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -156.39 156.98 34.8 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 114.034 1.124 . . . . 10.0 114.034 -173.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -92.05 136.31 33.27 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.244 -1.344 . . . . 10.0 108.357 169.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.678 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -122.73 82.0 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 108.799 -0.815 . . . . 10.0 108.799 169.478 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.469 ' HG2' HG22 ' A' ' 57' ' ' VAL . 48.1 mtpt -78.9 130.97 36.21 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 120.444 1.474 . . . . 10.0 108.396 172.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.576 HD21 HD11 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -159.21 129.59 5.82 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.95 0.881 . . . . 10.0 111.255 -178.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -83.23 119.71 24.9 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.346 -1.297 . . . . 10.0 109.941 -172.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.576 HD11 HD21 ' A' ' 11' ' ' LEU . 55.2 mt -137.07 135.54 19.89 Favored Pre-proline 0 CA--C 1.5 -0.97 0 CA-C-O 121.878 0.847 . . . . 10.0 112.659 -171.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.786 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 25.2 Cg_exo -54.35 123.12 12.81 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 123.622 2.882 . . . . 10.0 111.486 172.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.595 ' CB ' ' HB ' ' A' ' 46' ' ' THR . . . -61.35 125.45 23.81 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.158 -1.423 . . . . 10.0 107.158 168.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.0 -0.97 89.3 Favored Glycine 0 N--CA 1.44 -1.039 0 O-C-N 125.774 1.921 . . . . 10.0 113.233 -175.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.786 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 19.4 tptm -143.47 109.34 5.22 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.296 1.048 . . . . 10.0 112.705 176.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.719 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -171.69 142.21 1.54 Allowed 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.256 -1.338 . . . . 10.0 112.747 172.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.575 ' H ' ' HD3' ' A' ' 20' ' ' PRO . 2.7 t 179.44 -43.02 0.0 OUTLIER Pre-proline 0 C--O 1.207 -1.165 0 O-C-N 124.059 0.85 . . . . 10.0 113.129 175.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.655 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 85.6 Cg_endo -103.25 131.19 0.1 OUTLIER 'Trans proline' 0 N--CA 1.413 -3.259 0 N-CA-C 117.175 1.952 . . . . 10.0 117.175 -153.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.938 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . 13.96 -57.37 0.0 OUTLIER Pre-proline 0 C--N 1.289 -2.041 0 CA-C-N 108.615 -3.902 . . . . 10.0 119.275 153.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.708 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 32.5 Cg_exo -60.46 -63.33 0.12 Allowed 'Trans proline' 0 CA--C 1.562 1.888 0 CA-C-N 123.415 2.255 . . . . 10.0 115.252 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.708 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 55.7 Cg_endo -75.16 -52.86 0.1 Allowed 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.412 2.075 . . . . 10.0 112.239 174.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.765 HG12 HD13 ' A' ' 35' ' ' ILE . 83.1 t -83.26 -47.27 18.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-N 111.622 -2.535 . . . . 10.0 112.155 -166.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.924 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -42.67 -53.23 5.27 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 114.241 -1.345 . . . . 10.0 114.232 176.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.938 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 32.5 Cg_exo -70.01 -45.73 1.36 Allowed 'Trans proline' 0 CA--C 1.51 -0.719 0 C-N-CA 123.249 2.633 . . . . 10.0 111.324 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.536 ' HB1' ' CG2' ' A' ' 9' ' ' ILE . . . -51.33 -68.42 0.17 Allowed 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.376 0.608 . . . . 10.0 111.061 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.674 HD12 HG13 ' A' ' 24' ' ' VAL . 5.9 mt -78.0 -51.62 10.07 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.84 1.052 . . . . 10.0 113.84 -176.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.19 -42.01 96.97 Favored Glycine 0 N--CA 1.461 0.304 0 CA-C-N 116.117 -0.492 . . . . 10.0 113.314 -171.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -60.27 -25.93 66.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.716 0.294 . . . . 10.0 110.646 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.452 ' HD2' HD13 ' A' ' 9' ' ' ILE . 15.6 m-70 -102.3 16.75 25.29 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.641 -0.824 . . . . 10.0 110.623 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.48 9.25 87.1 Favored Glycine 0 CA--C 1.501 -0.797 0 CA-C-N 114.904 -1.043 . . . . 10.0 113.2 168.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.743 HG11 ' CD2' ' A' ' 66' ' ' PHE . 1.9 t -83.06 147.83 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 113.357 0.873 . . . . 10.0 113.357 -174.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -68.64 100.41 1.13 Allowed 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.224 0.535 . . . . 10.0 111.132 172.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.765 HD13 HG12 ' A' ' 24' ' ' VAL . 1.4 mm -52.12 -42.03 34.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.684 -1.144 . . . . 10.0 111.132 173.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 82.9 mtp -64.75 -53.18 51.24 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 112.973 -1.921 . . . . 10.0 111.749 177.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 40.9 mt-10 -57.09 -41.21 78.45 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 118.945 -1.102 . . . . 10.0 110.93 177.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.673 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 75.5 t80 -57.83 -57.87 10.88 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 113.701 1.0 . . . . 10.0 113.701 172.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -56.15 -49.57 73.57 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.339 -1.301 . . . . 10.0 111.366 -178.561 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.451 ' HD3' ' O ' ' A' ' 40' ' ' LYS . 12.7 tmtt? -66.96 -22.83 65.91 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.665 -0.865 . . . . 10.0 108.665 -178.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.765 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 26.8 mtt180 -75.93 -64.45 1.08 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 119.062 -1.055 . . . . 10.0 112.253 170.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.626 ' CZ ' HG21 ' A' ' 46' ' ' THR . 70.1 t80 -55.98 -45.72 78.89 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.032 0.444 . . . . 10.0 110.883 -172.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.719 HD21 ' HB3' ' A' ' 18' ' ' ALA . 0.9 OUTLIER -61.09 -48.99 79.12 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.246 -0.888 . . . . 10.0 110.191 -178.106 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.43 -36.96 85.46 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 118.971 -1.092 . . . . 10.0 112.084 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.765 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 42.4 mm-40 -64.01 -47.84 78.72 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.933 0.873 . . . . 10.0 110.687 178.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.626 HG21 ' CZ ' ' A' ' 42' ' ' PHE . 73.3 p -89.44 5.88 43.31 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.017 -1.447 . . . . 10.0 112.209 -168.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -47.9 -35.86 11.26 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.488 -1.233 . . . . 10.0 112.616 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -86.39 -36.39 19.2 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 115.491 -0.777 . . . . 10.0 111.487 -174.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -95.91 20.11 10.48 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.673 -0.862 . . . . 10.0 108.673 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.467 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -53.75 150.1 7.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.06 -1.427 . . . . 10.0 112.73 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.92 20.32 28.76 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 114.759 -1.11 . . . . 10.0 110.36 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.547 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 63.3 mtt -138.88 127.32 23.0 Favored 'General case' 0 C--O 1.208 -1.094 0 C-N-CA 117.527 -1.669 . . . . 10.0 114.595 -168.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.3 mm -67.15 91.93 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 118.773 0.715 . . . . 10.0 109.213 169.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.592 HD12 ' CG2' ' A' ' 46' ' ' THR . 9.4 mt -80.67 136.8 51.37 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.059 -0.719 . . . . 10.0 109.059 -176.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.487 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 7.4 Cg_exo -75.7 104.25 1.87 Allowed 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.202 1.935 . . . . 10.0 110.682 172.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.457 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -99.86 152.99 4.53 Favored 'Isoleucine or valine' 0 C--N 1.344 0.363 0 CA-C-N 119.706 1.139 . . . . 10.0 111.112 -174.701 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.469 HG22 ' HG2' ' A' ' 10' ' ' LYS . 97.1 t -134.15 113.57 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 110.106 -0.331 . . . . 10.0 110.106 174.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.678 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 20.6 mt -108.14 139.96 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 108.099 -1.074 . . . . 10.0 108.099 -174.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 60.5 m -122.31 97.08 5.3 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 114.833 -1.076 . . . . 10.0 108.88 176.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 65' ' ' SER . 2.6 p -87.86 138.12 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.186 0 O-C-N 121.017 -1.052 . . . . 10.0 110.461 -178.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.409 ' CD2' ' HA ' ' A' ' 66' ' ' PHE . 72.9 m-85 -93.78 172.12 8.45 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.179 -0.919 . . . . 10.0 112.961 -177.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -62.96 -21.31 66.01 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 113.813 -1.539 . . . . 10.0 111.43 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -76.89 -12.9 60.02 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 113.905 -1.498 . . . . 10.0 110.997 -178.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.68 ' HE2' ' HA ' ' A' ' 64' ' ' LYS . 8.5 mmpt? 83.77 -3.26 1.13 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.244 1.018 . . . . 10.0 110.11 -170.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.524 ' O ' HG23 ' A' ' 60' ' ' VAL . 31.6 m -69.57 179.2 2.19 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.349 -0.841 . . . . 10.0 109.349 171.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.743 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -170.25 -176.25 2.17 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 119.639 1.109 . . . . 10.0 110.174 175.379 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.5 p -158.36 164.26 36.5 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 102.987 -2.968 . . . . 10.0 102.987 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.445 ' CB ' HG12 ' A' ' 58' ' ' ILE . 50.7 p90 -161.31 157.29 25.24 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.403 0.62 . . . . 10.0 109.539 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.425 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 23.1 pt -127.99 165.86 26.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 114.846 -1.07 . . . . 10.0 108.31 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.448 HD12 ' CE1' ' A' ' 42' ' ' PHE . 1.7 mm -127.86 130.46 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 108.396 -0.965 . . . . 10.0 108.396 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 65.1 mmtt -77.88 83.26 4.22 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.025 -0.731 . . . . 10.0 109.025 176.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.401 ' OG1' ' HA ' ' A' ' 112' ' ' LYS . 18.8 p -30.01 101.17 0.15 Allowed Pre-proline 0 C--N 1.326 -0.437 0 O-C-N 125.845 1.965 . . . . 10.0 110.934 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.618 ' HB2' HD13 ' A' ' 78' ' ' LEU . 50.9 Cg_exo -20.52 106.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.359 1.13 1 C-N-CA 125.432 4.088 . . . . 10.0 114.326 -164.032 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.576 ' O ' ' HD3' ' A' ' 112' ' ' LYS . 24.8 Cg_exo -23.64 -54.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.361 1.189 1 C-N-CA 126.143 4.562 . . . . 10.0 115.229 -169.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -176.6 -43.68 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 120.46 0.171 . . . . 10.0 111.313 171.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.64 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 23.1 t -57.34 -35.53 70.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.05 -0.523 . . . . 10.0 112.152 -171.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -70.32 -40.27 74.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.922 0.392 . . . . 10.0 111.552 -178.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.618 HD13 ' HB2' ' A' ' 73' ' ' PRO . 8.5 mp -82.53 -26.62 32.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.252 0.549 . . . . 10.0 110.071 -178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.4 mt -60.56 -40.42 91.55 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.91 -0.774 . . . . 10.0 108.91 170.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.741 ' HG2' HG23 ' A' ' 85' ' ' ILE . 59.0 mttp -63.46 -23.35 67.36 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.481 -0.327 . . . . 10.0 111.189 175.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.577 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -58.02 -52.43 65.55 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 121.005 -0.278 . . . . 10.0 110.594 174.024 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.823 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -84.52 -62.48 1.54 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.466 1.506 . . . . 10.0 112.113 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.67 123.61 22.31 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 111.329 -2.668 . . . . 10.0 107.929 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -88.04 33.02 4.14 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 119.059 -1.543 . . . . 10.0 111.939 -169.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.741 HG23 ' HG2' ' A' ' 80' ' ' LYS . 14.2 tt -61.8 108.79 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 CA-C-O 121.836 0.826 . . . . 10.0 110.011 174.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.462 ' C ' ' HD3' ' A' ' 87' ' ' LYS . 23.5 tt0 -161.77 29.11 0.12 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 122.488 1.137 . . . . 10.0 108.083 -170.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.462 ' HD3' ' C ' ' A' ' 86' ' ' GLU . 4.3 mppt? -151.57 20.82 0.72 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 113.882 -1.508 . . . . 10.0 107.94 -176.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.53 -178.16 53.88 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 114.693 -1.14 . . . . 10.0 112.402 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.7 t -163.88 134.49 4.38 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.785 -0.82 . . . . 10.0 108.785 174.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.9 t -161.77 36.13 0.13 Allowed 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.661 -0.866 . . . . 10.0 108.661 -176.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.601 ' HG2' ' HD3' ' A' ' 95' ' ' LYS . 18.7 tp10 -167.82 78.8 0.89 Allowed Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 114.813 -1.085 . . . . 10.0 109.56 -175.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.63 ' O ' ' HG2' ' A' ' 93' ' ' LYS . 29.0 Cg_endo -91.93 136.51 1.72 Allowed 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 123.342 2.694 . . . . 10.0 111.322 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.962 ' HG3' ' HG3' ' A' ' 94' ' ' ARG . 13.3 ptpt 64.48 167.02 0.16 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.374 1.07 . . . . 10.0 110.42 -172.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.962 ' HG3' ' HG3' ' A' ' 93' ' ' LYS . 40.6 mtm180 70.28 -13.6 0.44 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.13 0.572 . . . . 10.0 112.265 178.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.601 ' HD3' ' HG2' ' A' ' 91' ' ' GLU . 64.2 tttm -170.67 -48.0 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.367 -0.133 . . . . 10.0 110.878 -167.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.423 ' HB ' ' O ' ' A' ' 136' ' ' GLY . 27.8 pt 48.25 -165.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.792 0.837 . . . . 10.0 113.079 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.551 HG13 ' N ' ' A' ' 98' ' ' GLY . 7.7 p -141.34 -49.49 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 112.954 0.724 . . . . 10.0 112.954 -169.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.551 ' N ' HG13 ' A' ' 97' ' ' VAL . . . -169.57 152.28 19.24 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.263 -1.135 . . . . 10.0 110.263 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.677 ' CB ' ' HB3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -148.21 177.42 9.41 Favored 'General case' 0 CA--C 1.48 -1.739 0 CA-C-O 122.625 1.202 . . . . 10.0 110.491 -166.17 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.823 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.7 OUTLIER -164.89 -163.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.414 -2.266 0 CA-C-N 111.308 -2.678 . . . . 10.0 105.639 -166.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.481 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 0.5 OUTLIER -127.98 156.26 42.97 Favored 'General case' 0 C--N 1.269 -2.901 0 C-N-CA 118.41 -1.316 . . . . 10.0 112.816 -169.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.673 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 8.4 tpp180 -40.37 -41.54 1.4 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 113.635 -1.621 . . . . 10.0 110.958 177.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -57.45 -44.15 84.53 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.922 0.712 . . . . 10.0 112.922 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.669 ' HG3' ' HB2' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -61.75 -50.2 73.33 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.601 -0.84 . . . . 10.0 108.804 176.057 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.941 HG21 ' HG3' ' A' ' 129' ' ' GLU . 27.3 mm -38.32 -56.56 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.703 -1.135 . . . . 10.0 110.897 170.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.512 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 28.9 tt0 -50.68 -60.89 2.57 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.744 1.218 . . . . 10.0 113.222 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 31.4 mt-10 -57.97 -55.86 29.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.366 -1.288 . . . . 10.0 111.338 -176.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.585 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 46.8 mt -47.71 -50.05 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 CA-C-N 116.651 -0.25 . . . . 10.0 110.568 171.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.534 ' HB3' HD11 ' A' ' 121' ' ' LEU . . . -49.46 -51.03 38.51 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.109 0.781 . . . . 10.0 113.109 176.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.595 ' HB3' HD13 ' A' ' 121' ' ' LEU . 0.0 OUTLIER -76.07 -30.1 58.21 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.057 0.391 . . . . 10.0 112.057 -174.011 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 22.4 m -54.39 -46.38 73.09 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.033 0.444 . . . . 10.0 111.153 173.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 0.5 OUTLIER -100.4 17.69 20.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.867 -0.606 . . . . 10.0 111.026 -176.192 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.965 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 45.2 ttm -47.64 -46.71 61.0 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.017 -0.538 . . . . 10.0 112.229 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 113' ' ' MET . 33.2 Cg_endo -64.79 -21.7 64.37 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 121.521 1.481 . . . . 10.0 113.493 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.48 ' OD1' ' HD2' ' A' ' 71' ' ' LYS . 24.6 t70 -90.12 -53.2 4.58 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.812 0.815 . . . . 10.0 110.872 -178.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.5 HD13 ' HB2' ' A' ' 112' ' ' LYS . 10.3 mp -63.61 -2.96 1.88 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 113.72 -1.582 . . . . 10.0 111.49 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.418 HD22 ' HA ' ' A' ' 117' ' ' ASN . 2.9 t-20 60.92 48.19 6.92 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 113.852 -1.522 . . . . 10.0 109.644 176.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.965 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -80.47 114.36 19.31 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.134 -1.394 . . . . 10.0 112.522 -173.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -67.59 -36.22 80.48 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.455 0.645 . . . . 10.0 110.028 171.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.7 p -151.22 143.5 24.11 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 106.841 -1.54 . . . . 10.0 106.841 176.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.679 ' O ' ' HG3' ' A' ' 125' ' ' MET . 58.6 tp -54.27 -34.84 61.72 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 113.794 1.035 . . . . 10.0 113.794 -175.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -48.73 -39.78 26.06 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.59 0.709 . . . . 10.0 110.326 173.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.558 ' HA ' ' HD3' ' A' ' 126' ' ' LYS . . . -66.64 -49.61 65.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.927 -1.033 . . . . 10.0 110.836 176.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.579 ' HB3' HD12 ' A' ' 121' ' ' LEU . . . -57.16 -36.47 70.79 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.632 0.253 . . . . 10.0 110.381 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.679 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 83.1 mtp -55.48 -35.65 65.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.183 -0.462 . . . . 10.0 111.981 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.558 ' HD3' ' HA ' ' A' ' 123' ' ' ALA . 0.1 OUTLIER -64.52 -49.3 71.85 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 110.026 -0.361 . . . . 10.0 110.026 177.397 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.431 ' H ' HG13 ' A' ' 127' ' ' ILE . 55.8 mt -50.68 -63.64 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 CA-C-O 121.336 0.589 . . . . 10.0 110.846 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.827 ' HB ' HG23 ' A' ' 105' ' ' ILE . 27.5 mm -50.76 -55.53 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 CA-C-N 114.45 -1.25 . . . . 10.0 111.687 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.941 ' HG3' HG21 ' A' ' 105' ' ' ILE . 7.1 mt-10 -52.83 -45.36 67.28 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 123.811 0.695 . . . . 10.0 109.72 178.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -71.6 -44.78 48.55 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.468 -0.872 . . . . 10.0 111.71 -174.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 90.9 m -45.75 -61.49 1.69 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.253 -0.973 . . . . 10.0 109.943 170.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.64 -49.39 47.34 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.565 -1.198 . . . . 10.0 111.876 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 19.6 ttmm -48.37 -54.57 13.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.555 -0.748 . . . . 10.0 111.55 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.4 t -63.23 -31.47 72.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.572 0.701 . . . . 10.0 110.382 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 35.8 mtp -80.06 7.72 8.57 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.897 1.073 . . . . 10.0 113.897 -176.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.493 ' O ' HG12 ' A' ' 97' ' ' VAL . . . 84.64 3.8 88.0 Favored Glycine 0 C--N 1.334 0.422 0 CA-C-N 119.478 1.035 . . . . 10.0 111.789 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 33.3 mt -96.78 127.79 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 CA-C-O 121.959 0.885 . . . . 10.0 111.83 -176.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.677 ' HB3' ' CB ' ' A' ' 99' ' ' LYS . 39.1 tt0 -88.21 159.43 18.15 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.156 -1.384 . . . . 10.0 108.768 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.54 HG11 ' HG2' ' A' ' 129' ' ' GLU . 17.9 m -117.92 134.1 62.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 108.341 -0.985 . . . . 10.0 108.341 167.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 100' ' ' VAL . 26.9 m -138.62 69.37 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 N-CA-C 114.784 1.401 . . . . 10.0 114.784 -174.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 24.9 t70 . . . . . 0 C--N 1.298 -1.673 0 CA-C-O 117.771 -1.109 . . . . 10.0 110.257 145.455 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 121.057 0.456 . . . . 10.0 111.428 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.55 107.67 2.64 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.168 -0.924 . . . . 10.0 108.83 174.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.575 ' HB3' ' CG ' ' A' ' 61' ' ' TYR . 35.7 mtmm -67.62 123.55 20.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.181 0.515 . . . . 10.0 111.973 -173.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 2.3 mtpp -99.17 132.98 44.1 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.339 -0.846 . . . . 10.0 109.723 175.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.5 t -62.93 138.61 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 122.833 0.453 . . . . 10.0 111.719 -176.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -110.61 -38.47 5.17 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 173.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.527 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -154.28 141.34 19.35 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.857 0.688 . . . . 10.0 112.857 -179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -98.67 115.65 29.15 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.053 -1.462 . . . . 10.0 107.053 173.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.615 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 3.7 mt -113.9 85.45 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.051 0 N-CA-C 108.803 -0.814 . . . . 10.0 108.803 -174.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.469 ' O ' HD12 ' A' ' 11' ' ' LEU . 10.1 mtmp? -77.85 148.26 34.75 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 119.136 0.88 . . . . 10.0 110.304 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 10' ' ' LYS . 0.8 OUTLIER -156.38 135.3 11.88 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 109.003 -0.74 . . . . 10.0 109.003 -178.226 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -93.79 111.46 23.16 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.199 -1.038 . . . . 10.0 108.199 169.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 15.0 mt -127.94 135.21 27.16 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 121.594 0.711 . . . . 10.0 112.324 -166.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.592 ' HB2' ' HB3' ' A' ' 17' ' ' LYS . 22.1 Cg_exo -57.88 121.2 9.61 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.532 2.821 . . . . 10.0 111.861 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.564 ' CB ' ' HB ' ' A' ' 46' ' ' THR . . . -61.72 127.48 31.66 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 107.768 -1.197 . . . . 10.0 107.768 170.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.9 0.36 89.38 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 125.695 1.872 . . . . 10.0 112.625 -174.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.592 ' HB3' ' HB2' ' A' ' 14' ' ' PRO . 4.6 tmtp? -141.09 100.95 3.93 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.992 0.901 . . . . 10.0 111.911 177.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -163.84 132.24 3.67 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.421 -1.263 . . . . 10.0 112.395 176.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.469 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -177.03 -53.68 0.0 OUTLIER Pre-proline 0 N--CA 1.448 -0.537 0 N-CA-C 112.697 0.629 . . . . 10.0 112.697 178.5 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.619 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 80.6 Cg_endo -104.53 128.09 0.07 OUTLIER 'Trans proline' 0 N--CA 1.416 -3.044 0 N-CA-C 116.211 1.581 . . . . 10.0 116.211 -154.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.02 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 16.04 -84.11 0.0 OUTLIER Pre-proline 0 C--N 1.294 -1.806 0 CA-C-N 108.58 -3.918 . . . . 10.0 116.251 165.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.593 ' CB ' ' HD3' ' A' ' 23' ' ' PRO . 3.2 Cg_exo -31.31 -56.79 0.23 Allowed 'Trans proline' 0 CA--C 1.558 1.679 0 C-N-CA 122.906 2.404 . . . . 10.0 115.419 -165.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.619 ' HD2' ' O ' ' A' ' 20' ' ' PRO . 5.4 Cg_exo -83.95 -49.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 123.346 2.697 . . . . 10.0 112.237 171.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.972 HG12 HD13 ' A' ' 35' ' ' ILE . 57.9 t -88.87 -45.68 15.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 112.449 -2.16 . . . . 10.0 113.484 -163.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 1.02 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -47.56 -80.6 0.05 OUTLIER Glycine 0 C--O 1.221 -0.692 0 CA-C-N 114.609 -1.178 . . . . 10.0 114.304 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.632 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 13.0 Cg_exo -43.28 -41.2 9.97 Favored 'Trans proline' 0 CA--C 1.52 -0.223 0 C-N-CA 123.544 2.83 . . . . 10.0 112.316 174.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 24' ' ' VAL . . . -52.47 -77.94 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.644 0.735 . . . . 10.0 111.255 176.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.778 HD12 HG13 ' A' ' 24' ' ' VAL . 6.9 mt -75.55 -42.74 51.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.961 -1.018 . . . . 10.0 113.725 -173.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.9 -38.22 95.77 Favored Glycine 0 N--CA 1.463 0.489 0 CA-C-N 116.526 -0.306 . . . . 10.0 113.214 -176.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -63.87 -21.18 66.33 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 119.506 -0.877 . . . . 10.0 109.699 175.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -103.91 7.17 36.78 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.888 -0.725 . . . . 10.0 111.861 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.65 ' HA3' ' NZ ' ' A' ' 64' ' ' LYS . . . 56.79 37.44 77.48 Favored Glycine 0 CA--C 1.509 -0.31 0 CA-C-N 115.309 -0.86 . . . . 10.0 112.899 178.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.645 HG11 HD22 ' A' ' 28' ' ' LEU . 55.8 t -74.72 -32.15 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 115.734 1.753 . . . . 10.0 115.734 -169.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 90.06 78.17 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 125.3 1.44 . . . . 10.0 109.581 -169.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.972 HD13 HG12 ' A' ' 24' ' ' VAL . 1.4 mt -51.92 -40.63 28.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 113.046 -1.888 . . . . 10.0 113.336 176.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 87.5 mtp -63.04 -47.18 84.11 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 117.523 -1.671 . . . . 10.0 111.495 173.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.603 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 21.7 tp10 -60.0 -43.47 95.16 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 118.979 -1.088 . . . . 10.0 110.252 176.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.577 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 71.7 t80 -56.5 -57.04 14.05 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 113.928 1.084 . . . . 10.0 113.928 172.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.43 -50.14 73.98 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.882 0.873 . . . . 10.0 111.729 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -63.29 -22.88 67.15 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.244 -0.982 . . . . 10.0 108.756 -178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.831 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 33.1 mtm-85 -78.53 -64.31 1.2 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 118.228 -0.892 . . . . 10.0 112.192 168.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.598 ' CZ ' HG21 ' A' ' 46' ' ' THR . 69.8 t80 -53.11 -48.0 68.18 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 119.477 1.035 . . . . 10.0 110.224 -169.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -60.02 -50.24 74.52 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.037 -0.983 . . . . 10.0 110.326 -178.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.72 93.71 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 119.157 -1.017 . . . . 10.0 111.943 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.831 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 7.0 mm-40 -66.26 -44.72 82.86 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 122.203 1.002 . . . . 10.0 110.713 -178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.61 ' CG2' HD12 ' A' ' 54' ' ' LEU . 81.6 p -89.76 0.5 56.96 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 113.963 -1.472 . . . . 10.0 111.986 -171.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.08 -38.81 8.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.307 -0.86 . . . . 10.0 112.44 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -79.44 -25.63 41.96 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.551 -0.75 . . . . 10.0 111.206 -173.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -108.41 21.66 17.0 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.555 0.742 . . . . 10.0 109.955 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -52.64 148.19 7.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.991 -1.004 . . . . 10.0 112.868 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.9 19.27 31.8 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 110.816 -0.914 . . . . 10.0 110.816 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.688 ' SD ' ' HB3' ' A' ' 77' ' ' PHE . 67.4 mtt -139.28 126.21 20.97 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 117.211 -1.796 . . . . 10.0 114.555 -166.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.3 mm -68.13 91.51 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.255 -0.646 . . . . 10.0 109.255 172.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.61 HD12 ' CG2' ' A' ' 46' ' ' THR . 7.7 mt -82.45 131.68 54.77 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.619 -0.511 . . . . 10.0 109.619 -177.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.587 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 17.1 Cg_exo -69.62 102.82 1.05 Allowed 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.394 2.063 . . . . 10.0 111.196 172.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.486 HG23 HG12 ' A' ' 70' ' ' ILE . 0.4 OUTLIER -101.03 156.84 4.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-N 119.501 1.046 . . . . 10.0 111.016 -175.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.483 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 86.9 t -136.23 116.1 17.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.085 -0.507 . . . . 10.0 110.508 172.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.738 HD13 HD21 ' A' ' 28' ' ' LEU . 18.1 mt -105.57 140.39 23.78 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.925 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 -175.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.3 m -126.96 95.88 4.45 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 114.962 -1.017 . . . . 10.0 109.14 177.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.527 ' CG1' ' HB3' ' A' ' 7' ' ' ALA . 3.3 p -85.99 136.0 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 CA-C-N 119.124 0.875 . . . . 10.0 109.827 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.642 ' HE2' ' HG1' ' A' ' 67' ' ' THR . 82.2 m-85 -94.51 173.33 7.68 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.496 0.665 . . . . 10.0 112.55 -176.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 24.8 mt-10 -62.14 -19.33 62.92 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.638 -1.164 . . . . 10.0 112.285 -177.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 4.6 m-20 -78.35 -11.55 59.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.588 -0.733 . . . . 10.0 111.041 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.65 ' NZ ' ' HA3' ' A' ' 32' ' ' GLY . 18.6 mtpp 82.04 1.19 1.42 Allowed 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 114.654 -1.157 . . . . 10.0 110.329 -167.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.502 ' O ' HG23 ' A' ' 60' ' ' VAL . 51.0 m -70.53 174.7 5.5 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.369 -1.287 . . . . 10.0 108.184 172.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.614 ' CD1' HG13 ' A' ' 33' ' ' VAL . 8.8 p90 -167.99 -179.02 3.97 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 121.394 1.906 . . . . 10.0 110.326 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.642 ' HG1' ' HE2' ' A' ' 61' ' ' TYR . 1.5 p -161.51 171.88 17.37 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 103.791 -2.67 . . . . 10.0 103.791 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 50.7 p90 -163.52 157.76 20.02 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.757 -0.831 . . . . 10.0 108.757 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.483 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 31.3 pt -127.77 164.9 28.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 107.767 -1.197 . . . . 10.0 107.767 -178.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.497 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 8.2 mt -138.84 123.17 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 N-CA-C 108.034 -1.099 . . . . 10.0 108.034 -174.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.647 ' C ' ' HD2' ' A' ' 73' ' ' PRO . 41.5 mmtt -75.93 95.07 3.47 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.896 1.331 . . . . 10.0 113.531 -168.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.66 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -59.83 -33.46 16.03 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-N 112.554 -2.112 . . . . 10.0 114.743 167.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.741 ' HD3' ' HB3' ' A' ' 115' ' ' ASP . 9.2 Cg_endo -50.11 -42.19 46.96 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.683 2.922 . . . . 10.0 117.282 -171.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.587 ' HD3' ' HG2' ' A' ' 73' ' ' PRO . 82.9 Cg_exo -44.98 -31.33 5.33 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 122.366 2.044 . . . . 10.0 113.141 -178.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.731 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . . . 70.32 -38.47 0.41 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.72 1.007 . . . . 10.0 113.72 170.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.45 ' HA ' ' HE1' ' A' ' 135' ' ' MET . 49.8 m -50.04 -31.21 12.44 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 122.982 0.513 . . . . 10.0 111.85 -175.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.688 ' HB3' ' SD ' ' A' ' 52' ' ' MET . 73.6 m-85 -61.19 -55.58 30.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.165 0.507 . . . . 10.0 111.257 178.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.642 HD23 ' HZ1' ' A' ' 112' ' ' LYS . 3.3 mm? -78.72 -27.03 44.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.211 -0.45 . . . . 10.0 110.912 -175.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.871 HD22 HG21 ' A' ' 108' ' ' ILE . 3.5 mm? -59.56 -50.24 74.65 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.716 -0.475 . . . . 10.0 109.716 174.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.541 ' HA ' ' HB3' ' A' ' 83' ' ' ALA . 63.3 mttp -66.47 -15.39 63.32 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.281 -0.418 . . . . 10.0 111.557 177.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.52 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 3.1 tppp? -61.69 -38.77 89.07 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 120.778 -0.369 . . . . 10.0 110.294 171.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.875 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -85.44 -57.31 3.12 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.428 1.891 . . . . 10.0 112.394 172.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.541 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . . . -62.22 111.68 2.08 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 110.76 -2.927 . . . . 10.0 107.268 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.15 14.71 63.81 Favored Glycine 0 CA--C 1.501 -0.834 0 C-N-CA 118.605 -1.759 . . . . 10.0 111.619 -157.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 33.2 pt -62.74 153.82 6.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 114.257 -0.972 . . . . 10.0 112.109 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -163.28 66.33 0.19 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.065 -0.971 . . . . 10.0 108.871 175.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 64.1 tttp 79.19 -55.05 0.43 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 114.576 -1.193 . . . . 10.0 112.185 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -93.6 17.22 59.0 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 115.553 0.981 . . . . 10.0 115.553 -166.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.7 t -74.49 -71.7 0.33 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 118.374 1.087 . . . . 10.0 108.851 172.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.1 m 73.32 -30.33 0.21 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 114.646 1.35 . . . . 10.0 114.646 165.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -168.3 85.6 0.71 Allowed Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 118.389 0.54 . . . . 10.0 111.834 -170.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -101.9 -12.13 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.433 2.755 . . . . 10.0 113.778 172.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -161.79 -79.13 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.898 0.703 . . . . 10.0 112.898 -176.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.576 ' HD3' ' O ' ' A' ' 94' ' ' ARG . 4.2 tmt_? -158.74 84.74 0.82 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.434 0.635 . . . . 10.0 109.306 -175.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.828 ' HA ' ' HE3' ' A' ' 95' ' ' LYS . 1.2 tpmt? 78.74 -7.18 1.82 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.07 -1.423 . . . . 10.0 109.989 173.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.476 ' CG2' ' N ' ' A' ' 97' ' ' VAL . 8.0 mt -85.99 176.0 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 108.678 -0.86 . . . . 10.0 108.678 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.501 HG13 ' N ' ' A' ' 98' ' ' GLY . 14.5 p -139.56 -46.03 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 112.311 0.486 . . . . 10.0 112.311 -174.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.721 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -159.18 165.49 34.3 Favored Glycine 0 CA--C 1.497 -1.059 0 N-CA-C 109.034 -1.627 . . . . 10.0 109.034 174.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.754 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 13.4 pttm -152.01 169.75 21.58 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 122.394 1.092 . . . . 10.0 110.771 -166.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.875 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.1 OUTLIER -161.9 -145.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-N 112.119 -2.31 . . . . 10.0 105.807 -169.331 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 0.1 OUTLIER -162.49 144.99 10.99 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.372 -0.931 . . . . 10.0 108.937 -155.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.65 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 16.0 mmm180 -41.68 -50.14 4.21 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 124.57 1.169 . . . . 10.0 111.562 -177.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 24.8 tptp -56.31 -43.7 79.2 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.223 0.453 . . . . 10.0 112.223 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.57 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -61.39 -49.05 78.45 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.149 -0.686 . . . . 10.0 109.149 177.378 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.812 HG21 ' HG3' ' A' ' 129' ' ' GLU . 25.8 mm -40.26 -53.6 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 114.948 -1.024 . . . . 10.0 111.017 170.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.722 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 21.7 tt0 -51.02 -56.54 12.0 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 114.935 -1.029 . . . . 10.0 112.872 178.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.541 ' OE2' ' HE3' ' A' ' 110' ' ' LYS . 19.2 mm-40 -51.82 -58.49 6.28 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.119 -0.946 . . . . 10.0 110.551 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.871 HG21 HD22 ' A' ' 79' ' ' LEU . 26.3 mm -50.2 -50.37 20.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.851 -1.068 . . . . 10.0 110.679 173.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.547 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -51.19 -36.24 40.34 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 112.578 0.584 . . . . 10.0 112.578 175.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.722 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 39.7 mttm -71.74 -54.0 11.66 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.256 -177.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.606 HG22 ' O ' ' A' ' 108' ' ' ILE . 6.1 t -53.5 -28.51 31.43 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.666 0.617 . . . . 10.0 112.666 -175.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.731 ' HE3' ' HA ' ' A' ' 75' ' ' ALA . 0.2 OUTLIER -118.07 17.59 14.03 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.904 -0.497 . . . . 10.0 111.55 -177.727 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.686 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 48.6 ttm -49.17 -47.26 76.15 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.706 -0.679 . . . . 10.0 112.342 175.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 113' ' ' MET . 33.6 Cg_endo -61.53 -25.58 79.7 Favored 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 122.099 1.866 . . . . 10.0 112.418 -177.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.741 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 2.0 m-20 -93.96 -45.76 7.46 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.074 -0.966 . . . . 10.0 112.143 -173.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.691 HD21 HD12 ' A' ' 127' ' ' ILE . 5.3 mp -62.12 -4.35 1.66 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 114.661 -1.154 . . . . 10.0 111.268 179.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 115' ' ' ASP . 14.2 m120 64.23 43.86 4.67 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 113.87 -1.514 . . . . 10.0 109.066 177.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.686 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -80.64 109.13 14.88 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.942 -1.481 . . . . 10.0 112.331 -174.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -68.48 -36.43 78.94 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.902 -0.777 . . . . 10.0 108.902 173.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 87.3 p -145.88 143.42 29.57 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.089 -1.448 . . . . 10.0 107.089 172.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.608 ' O ' ' HG3' ' A' ' 125' ' ' MET . 41.1 tp -53.45 -29.46 35.73 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 114.944 1.461 . . . . 10.0 114.944 -174.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 122' ' ' GLU . 3.2 mp0 -50.67 -33.9 24.39 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 122.016 0.913 . . . . 10.0 110.067 174.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.9 -49.81 41.81 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.133 -1.394 . . . . 10.0 110.264 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.631 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -57.35 -35.29 69.73 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.991 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.608 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 79.8 mtp -55.61 -39.47 70.82 Favored 'General case' 0 C--N 1.316 -0.878 0 O-C-N 122.249 -0.282 . . . . 10.0 111.639 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -64.13 -52.34 59.58 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.447 0.536 . . . . 10.0 112.447 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.691 HD12 HD21 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -52.24 -58.87 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.527 0 C-N-CA 119.879 -0.728 . . . . 10.0 110.412 177.649 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.711 ' HB ' HG23 ' A' ' 105' ' ' ILE . 22.9 mm -49.81 -55.92 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 CA-C-N 115.184 -0.916 . . . . 10.0 111.473 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.812 ' HG3' HG21 ' A' ' 105' ' ' ILE . 8.0 mt-10 -52.69 -42.64 64.96 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 123.718 0.636 . . . . 10.0 109.828 177.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -75.02 -46.02 18.12 Favored Glycine 0 C--N 1.338 0.647 0 C-N-CA 121.215 -0.517 . . . . 10.0 112.643 -174.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.435 HG21 ' HB3' ' A' ' 75' ' ' ALA . 53.7 m -46.31 -59.74 2.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.942 -0.762 . . . . 10.0 108.942 170.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.503 ' HB1' ' CG2' ' A' ' 137' ' ' ILE . . . -52.17 -50.02 62.66 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.232 -0.44 . . . . 10.0 111.959 174.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.459 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 50.4 tttm -46.11 -50.8 14.96 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 123.656 0.598 . . . . 10.0 111.45 176.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.8 m -60.97 -38.3 85.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.39 -0.368 . . . . 10.0 111.845 -175.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.783 ' HG3' HD13 ' A' ' 137' ' ' ILE . 14.9 ptt? -91.4 17.7 8.16 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.274 1.213 . . . . 10.0 114.274 -174.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.46 ' O ' HG12 ' A' ' 97' ' ' VAL . . . 89.22 13.04 62.48 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 120.043 1.292 . . . . 10.0 112.99 175.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.783 HD13 ' HG3' ' A' ' 135' ' ' MET . 2.4 mp -98.99 126.72 52.15 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-O 121.683 0.754 . . . . 10.0 111.375 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.754 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -87.81 156.22 19.51 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 114.574 -1.194 . . . . 10.0 109.476 177.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.477 HG11 ' HG2' ' A' ' 129' ' ' GLU . 17.0 m -115.87 125.48 73.02 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.536 0 N-CA-C 108.14 -1.059 . . . . 10.0 108.14 169.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 100' ' ' VAL . 28.3 m -105.24 152.82 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.162 0 CA-C-N 113.753 -1.567 . . . . 10.0 107.693 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 . . . . . 0 C--N 1.275 -2.639 0 CA-C-N 114.048 -1.433 . . . . 10.0 111.101 -175.468 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.1 ttm . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 111.391 0.145 . . . . 10.0 111.391 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.31 134.55 33.78 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.748 0.309 . . . . 10.0 110.404 -178.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -110.06 124.27 51.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.743 0.782 . . . . 10.0 112.495 -177.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.545 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 2.9 tppp? -138.68 145.93 40.99 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 106.453 -1.684 . . . . 10.0 106.453 170.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.5 t -61.47 126.82 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.521 0.6 . . . . 10.0 111.579 -171.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.27 -39.28 5.73 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.852 -0.613 . . . . 10.0 109.518 176.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.506 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -154.88 144.68 21.57 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.463 0.912 . . . . 10.0 113.463 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -92.37 133.65 35.67 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 107.436 -1.32 . . . . 10.0 107.436 169.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.695 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -121.53 82.72 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.717 -0.846 . . . . 10.0 108.717 175.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.3 mttm -77.67 126.54 31.04 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 120.199 1.363 . . . . 10.0 107.826 175.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.665 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -156.96 123.56 5.03 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 122.868 1.318 . . . . 10.0 111.92 -175.387 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -85.22 122.36 29.3 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.257 -1.792 . . . . 10.0 110.387 -171.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.665 HD21 HD11 ' A' ' 11' ' ' LEU . 85.6 mt -140.46 145.32 40.37 Favored Pre-proline 0 C--O 1.214 -0.764 0 CA-C-O 121.197 0.523 . . . . 10.0 111.903 -170.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.806 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 2.8 Cg_exo -67.75 127.27 15.96 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 123.815 3.01 . . . . 10.0 111.816 177.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.574 ' HB2' HD11 ' A' ' 54' ' ' LEU . . . -62.1 129.77 42.36 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 172.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.02 -2.38 84.07 Favored Glycine 0 N--CA 1.441 -0.974 0 O-C-N 125.619 1.824 . . . . 10.0 112.574 -175.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.806 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 28.8 mmtp -138.79 102.78 4.65 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.743 0.782 . . . . 10.0 111.639 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.688 ' O ' ' HB2' ' A' ' 39' ' ' CYS . . . -170.27 133.97 1.15 Allowed 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.174 -1.375 . . . . 10.0 111.951 172.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.637 ' HA ' ' CB ' ' A' ' 39' ' ' CYS . 3.4 t 179.69 -39.79 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 114.694 -1.139 . . . . 10.0 112.939 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.791 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 97.4 Cg_endo -104.31 124.44 0.07 OUTLIER 'Trans proline' 0 N--CA 1.411 -3.352 0 N-CA-C 115.659 1.369 . . . . 10.0 115.659 -161.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.012 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 6.18 -82.08 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.552 0 CA-C-N 109.799 -3.364 . . . . 10.0 114.606 161.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.864 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 68.3 Cg_exo -30.01 -56.62 0.18 Allowed 'Trans proline' 0 CA--C 1.56 1.804 0 C-N-CA 122.791 2.327 . . . . 10.0 115.521 -164.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.864 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 38.2 Cg_endo -82.19 -71.98 0.01 OUTLIER 'Trans proline' 0 CA--C 1.552 1.417 0 C-N-CA 122.817 2.345 . . . . 10.0 112.321 168.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.986 HG12 HD12 ' A' ' 35' ' ' ILE . 96.0 t -53.93 -52.84 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 127.869 2.467 . . . . 10.0 114.756 -175.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 1.012 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -45.44 -69.69 0.74 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 114.493 -1.231 . . . . 10.0 112.939 -178.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.651 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 24.0 Cg_exo -47.75 -49.63 13.21 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.206 2.604 . . . . 10.0 112.99 172.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.466 ' O ' ' HD2' ' A' ' 31' ' ' HIS . . . -43.61 -100.2 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.84 0 O-C-N 124.285 0.99 . . . . 10.0 112.789 176.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.844 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.342 0.0 OUTLIER -76.43 -27.28 56.17 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 117.759 -1.577 . . . . 10.0 113.838 -175.067 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.501 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -69.69 -40.4 76.64 Favored Glycine 0 CA--C 1.527 0.787 0 O-C-N 121.781 -0.575 . . . . 10.0 113.279 -174.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.473 ' HB3' ' O ' ' A' ' 26' ' ' PRO . 29.1 tt0 -59.87 -19.5 51.63 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 120.471 -0.492 . . . . 10.0 109.902 175.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.466 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 83.7 m-70 -98.92 24.53 7.6 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.201 -0.599 . . . . 10.0 110.334 176.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.849 ' HA3' ' HD2' ' A' ' 64' ' ' LYS . . . 89.17 -1.44 82.7 Favored Glycine 0 CA--C 1.495 -1.164 0 CA-C-N 115.48 -0.782 . . . . 10.0 112.608 166.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.905 HG11 ' CD2' ' A' ' 66' ' ' PHE . 3.1 t -83.44 148.64 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 114.107 1.151 . . . . 10.0 114.107 -170.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.418 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 4.9 m-20 -67.67 96.57 0.56 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.361 0.664 . . . . 10.0 110.56 172.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.986 HD12 HG12 ' A' ' 24' ' ' VAL . 17.2 mm -52.43 -39.24 28.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 122.005 0.907 . . . . 10.0 111.444 173.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.756 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 71.0 mtm -66.22 -50.4 63.93 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.447 -1.706 . . . . 10.0 112.087 175.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.53 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 1.6 tt0 -58.34 -40.16 81.43 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.138 -1.025 . . . . 10.0 110.128 176.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.59 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 90.8 t80 -56.15 -57.89 10.28 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 114.009 1.114 . . . . 10.0 114.009 170.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.756 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 14.2 p -59.63 -50.42 73.92 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 114.093 -1.412 . . . . 10.0 111.759 -176.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.409 ' N ' ' SG ' ' A' ' 39' ' ' CYS . 58.5 tttm -66.42 -21.18 66.21 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 119.914 -0.714 . . . . 10.0 109.367 -179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.802 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 3.8 mtp180 -73.59 -65.65 0.8 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.352 -0.939 . . . . 10.0 112.146 169.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.577 ' CZ ' HG21 ' A' ' 46' ' ' THR . 72.9 t80 -53.58 -45.04 69.81 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 115.952 -0.567 . . . . 10.0 110.806 -171.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.604 HD22 ' N ' ' A' ' 43' ' ' ASN . 0.9 OUTLIER -59.62 -52.34 65.95 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.113 -0.949 . . . . 10.0 110.724 -178.301 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.03 96.28 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 118.817 -1.153 . . . . 10.0 112.385 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.802 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 13.1 mt-10 -67.55 -41.81 83.65 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.868 0.842 . . . . 10.0 111.142 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.602 ' CG2' HD12 ' A' ' 54' ' ' LEU . 80.1 p -88.84 4.56 47.3 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.782 -1.099 . . . . 10.0 112.155 -172.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.95 -42.65 18.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.106 -0.952 . . . . 10.0 112.168 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.68 -47.7 84.59 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 114.517 -1.22 . . . . 10.0 111.574 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.514 ' HB3' ' HE3' ' A' ' 52' ' ' MET . 39.6 mttm -101.36 24.1 10.07 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.268 0.556 . . . . 10.0 110.265 -171.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -53.23 145.09 14.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.695 -1.138 . . . . 10.0 112.622 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.34 16.75 36.4 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 110.844 -0.902 . . . . 10.0 110.844 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.519 ' SD ' ' HD1' ' A' ' 77' ' ' PHE . 41.0 mtm -141.88 127.37 18.91 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 117.675 -1.61 . . . . 10.0 115.144 -165.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.0 mm -65.9 92.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 O-C-N 121.759 -0.588 . . . . 10.0 109.947 174.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.602 HD12 ' CG2' ' A' ' 46' ' ' THR . 6.9 mt -83.51 129.83 58.53 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 108.2 -1.037 . . . . 10.0 108.2 178.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -71.5 111.41 3.11 Favored 'Trans proline' 0 C--N 1.332 -0.334 0 C-N-CA 121.8 1.666 . . . . 10.0 110.619 174.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -100.11 153.56 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 119.997 1.272 . . . . 10.0 111.133 -176.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.417 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 77.1 t -134.1 116.8 23.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 109.786 -0.45 . . . . 10.0 109.786 174.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.695 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 17.5 mt -107.6 140.86 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 N-CA-C 108.704 -0.85 . . . . 10.0 108.704 -173.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.5 m -123.48 100.68 6.93 Favored 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 114.942 -1.026 . . . . 10.0 108.621 173.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 65' ' ' SER . 1.6 p -91.89 136.56 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.815 0 CA-C-N 119.227 0.921 . . . . 10.0 110.35 -177.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -95.7 172.52 7.99 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.041 0.448 . . . . 10.0 112.055 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.545 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 58.7 mt-10 -57.22 -20.59 28.14 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 113.996 -1.457 . . . . 10.0 111.959 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -73.69 -18.02 61.06 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.618 -1.173 . . . . 10.0 110.919 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.849 ' HD2' ' HA3' ' A' ' 32' ' ' GLY . 23.8 mtmt 82.27 -3.98 1.44 Allowed 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 124.205 1.002 . . . . 10.0 110.173 -164.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.607 ' O ' HG23 ' A' ' 60' ' ' VAL . 28.6 t -68.25 176.5 2.73 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.506 -0.924 . . . . 10.0 108.506 171.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.905 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -166.98 -176.84 3.54 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 120.124 1.329 . . . . 10.0 110.11 176.502 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.4 p -162.08 161.0 28.1 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 103.018 -2.956 . . . . 10.0 103.018 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.46 ' CB ' HG12 ' A' ' 58' ' ' ILE . 47.0 p90 -160.96 158.17 27.61 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 109.045 -0.724 . . . . 10.0 109.045 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.417 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 30.4 pt -119.95 165.98 14.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 114.443 -1.253 . . . . 10.0 108.059 -175.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.453 HD12 ' CE1' ' A' ' 42' ' ' PHE . 4.4 mm -125.09 119.93 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 N-CA-C 106.704 -1.591 . . . . 10.0 106.704 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.691 ' C ' ' HD2' ' A' ' 73' ' ' PRO . 29.5 mmmt -77.28 86.87 3.7 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.671 0.748 . . . . 10.0 110.731 -169.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.746 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 12.7 t -67.71 -13.9 0.25 Allowed Pre-proline 0 CA--C 1.57 1.748 0 CA-C-N 114.04 -1.437 . . . . 10.0 114.597 174.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 1.028 ' HD3' ' HB3' ' A' ' 115' ' ' ASP . 3.9 Cg_exo -34.76 -51.89 0.68 Allowed 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 124.057 3.171 . . . . 10.0 115.298 174.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.462 ' HD2' ' O ' ' A' ' 71' ' ' LYS . 27.2 Cg_exo -62.49 112.03 1.48 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 CA-C-N 120.633 1.262 . . . . 10.0 110.987 173.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.574 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -80.35 3.69 20.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.844 0.355 . . . . 10.0 110.582 -178.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.673 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 1.4 m -56.16 -36.61 68.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.561 -0.745 . . . . 10.0 111.306 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.588 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 24.7 m-85 -65.54 -57.22 8.74 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-O 122.194 0.997 . . . . 10.0 111.433 -176.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.582 ' H ' HD22 ' A' ' 78' ' ' LEU . 0.8 OUTLIER -73.82 -23.72 59.7 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.123 -0.944 . . . . 10.0 109.894 -173.434 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.463 ' HA ' ' HB3' ' A' ' 82' ' ' ALA . 49.2 mt -83.01 -13.71 55.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.698 -0.683 . . . . 10.0 110.9 174.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.673 ' HG2' ' O ' ' A' ' 76' ' ' SER . 28.4 mmtp -56.15 -60.87 2.87 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.833 -0.803 . . . . 10.0 108.833 170.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -63.71 -45.11 91.48 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.86 -0.609 . . . . 10.0 112.064 178.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.98 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -61.77 -57.95 9.89 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 123.137 1.446 . . . . 10.0 110.115 -171.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 79' ' ' LEU . . . -66.76 -33.54 75.86 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 111.472 -2.604 . . . . 10.0 110.067 178.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.64 1.82 70.67 Favored Glycine 0 CA--C 1.499 -0.938 0 N-CA-C 110.536 -1.026 . . . . 10.0 110.536 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.519 HG22 ' CG2' ' A' ' 97' ' ' VAL . 34.1 pt -68.18 161.86 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 CA-C-N 113.797 -1.201 . . . . 10.0 112.904 -176.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -149.08 27.59 0.85 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.108 -1.405 . . . . 10.0 108.299 172.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -168.64 -29.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.779 -1.101 . . . . 10.0 110.463 -174.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.412 ' O ' ' HB ' ' A' ' 97' ' ' VAL . . . 85.97 -130.56 9.98 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.359 -1.096 . . . . 10.0 110.359 -178.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.719 ' HB3' ' HA3' ' A' ' 136' ' ' GLY . 27.3 t -160.81 101.42 1.3 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.265 0.555 . . . . 10.0 109.932 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.4 p -70.91 105.8 3.4 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.179 -0.674 . . . . 10.0 109.179 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 82.47 90.6 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.259 0 O-C-N 124.489 1.118 . . . . 10.0 108.824 -173.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -88.44 77.55 1.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.872 2.382 . . . . 10.0 114.417 -167.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.56 137.8 4.15 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 110.019 -0.363 . . . . 10.0 110.019 173.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 73.84 -43.95 0.56 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.183 0.993 . . . . 10.0 111.705 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -71.75 -67.74 0.51 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.538 -0.912 . . . . 10.0 108.538 176.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.405 ' O ' HG22 ' A' ' 96' ' ' ILE . 8.6 mt 47.28 92.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 113.372 -1.74 . . . . 10.0 112.347 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.588 HG13 ' H ' ' A' ' 98' ' ' GLY . 3.4 p -44.67 -59.04 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 113.242 -1.799 . . . . 10.0 113.692 -166.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.588 ' H ' HG13 ' A' ' 97' ' ' VAL . . . -171.26 173.64 44.82 Favored Glycine 0 CA--C 1.49 -1.509 0 N-CA-C 108.621 -1.792 . . . . 10.0 108.621 -171.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.689 ' HB2' ' HB3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -150.56 -179.8 7.53 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 122.853 1.311 . . . . 10.0 112.223 -160.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.98 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -155.33 -144.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.992 0 CA-C-N 111.527 -2.579 . . . . 10.0 105.182 -176.429 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 1.4 t -166.02 142.84 5.23 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 107.087 -1.449 . . . . 10.0 107.087 -155.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.686 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 23.1 tpp180 -41.62 -42.03 2.36 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 124.732 1.27 . . . . 10.0 111.204 -171.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 25.3 tptp -59.91 -46.44 89.33 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.737 1.014 . . . . 10.0 113.737 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.569 ' O ' HG13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -60.09 -45.66 92.18 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.189 -1.041 . . . . 10.0 108.189 178.691 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 1.002 HG23 ' HB ' ' A' ' 128' ' ' ILE . 39.4 mm -43.13 -52.77 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 CA-C-N 114.393 -1.276 . . . . 10.0 111.25 170.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.799 ' HG2' ' HD2' ' A' ' 110' ' ' LYS . 16.9 tt0 -48.52 -61.84 1.81 Allowed 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.967 -1.015 . . . . 10.0 112.967 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.566 ' HA ' ' HD3' ' A' ' 110' ' ' LYS . 37.7 mt-10 -56.62 -46.67 80.79 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.695 -1.139 . . . . 10.0 110.844 -175.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.72 HG22 ' HD3' ' A' ' 112' ' ' LYS . 34.2 mt -52.8 -58.43 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 115.759 -0.655 . . . . 10.0 110.085 169.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.487 ' HB3' HD11 ' A' ' 121' ' ' LEU . . . -45.48 -40.6 8.59 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.473 0.709 . . . . 10.0 112.695 177.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.799 ' HD2' ' HG2' ' A' ' 106' ' ' GLU . 38.9 mtpt -73.22 -48.76 32.29 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.737 -0.665 . . . . 10.0 111.368 -175.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 108' ' ' ILE . 1.1 t -57.2 -38.41 73.63 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 112.573 0.583 . . . . 10.0 112.573 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.72 ' HD3' HG22 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -98.21 6.46 47.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 122.602 0.361 . . . . 10.0 111.172 -174.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.636 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 54.1 ttm -50.25 -38.86 42.29 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.491 -0.777 . . . . 10.0 112.669 176.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 113' ' ' MET . 35.1 Cg_endo -61.28 -31.74 89.51 Favored 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 121.726 1.617 . . . . 10.0 111.782 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 1.028 ' HB3' ' HD3' ' A' ' 73' ' ' PRO . 0.4 OUTLIER -93.71 -52.99 4.21 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 113.891 -1.504 . . . . 10.0 112.719 -170.263 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.517 HD11 ' HA ' ' A' ' 113' ' ' MET . 0.3 OUTLIER -72.99 -177.46 2.43 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 123.034 1.397 . . . . 10.0 113.871 -173.18 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -96.46 49.03 1.1 Allowed 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 112.443 -2.162 . . . . 10.0 113.088 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.695 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . . . -64.66 -102.64 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.811 1.041 . . . . 10.0 113.811 173.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 118' ' ' ALA . 24.5 t-20 107.12 -78.42 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.829 1.652 . . . . 10.0 107.789 -167.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.2 t -87.15 147.86 25.44 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.622 -1.251 . . . . 10.0 107.622 162.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.679 ' O ' ' HG2' ' A' ' 125' ' ' MET . 61.8 tp -56.25 -34.7 66.64 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.673 -0.811 . . . . 10.0 110.938 166.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 126' ' ' LYS . 32.2 mt-10 -48.35 -40.46 25.51 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.564 0.697 . . . . 10.0 110.38 173.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.25 -47.73 63.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.545 -1.207 . . . . 10.0 110.959 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.695 ' HB2' ' HB2' ' A' ' 118' ' ' ALA . . . -56.83 -40.35 75.87 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.405 -0.518 . . . . 10.0 110.122 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.792 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 74.7 mmm -53.35 -40.24 64.75 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.387 0.675 . . . . 10.0 110.727 176.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.662 ' HA ' ' HG2' ' A' ' 129' ' ' GLU . 13.6 mmmm -68.32 -45.07 73.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.06 -0.973 . . . . 10.0 110.234 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.466 ' CD1' HD22 ' A' ' 116' ' ' LEU . 92.8 mt -49.73 -65.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 CA-C-O 121.178 0.514 . . . . 10.0 110.175 173.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 1.002 ' HB ' HG23 ' A' ' 105' ' ' ILE . 12.5 mm -50.79 -56.19 5.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.711 -1.131 . . . . 10.0 112.399 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.662 ' HG2' ' HA ' ' A' ' 126' ' ' LYS . 0.3 OUTLIER -56.51 -41.86 77.39 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 109.14 -0.689 . . . . 10.0 109.14 -177.793 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.659 ' N ' ' HG3' ' A' ' 129' ' ' GLU . . . -72.83 -47.62 24.96 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.58 -0.736 . . . . 10.0 111.563 -175.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.574 HG21 ' HB3' ' A' ' 75' ' ' ALA . 35.3 m -46.25 -61.8 1.62 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.099 -1.051 . . . . 10.0 109.691 170.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.427 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -48.17 -47.84 34.83 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.0 -0.545 . . . . 10.0 111.97 174.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.589 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 79.1 tttt -48.53 -54.22 15.24 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.938 -1.028 . . . . 10.0 111.593 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.5 m -66.85 -29.28 69.16 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.044 0.45 . . . . 10.0 111.197 179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 49.8 mtm -80.44 4.49 17.97 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 113.52 0.933 . . . . 10.0 113.52 -177.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.719 ' HA3' ' HB3' ' A' ' 89' ' ' SER . . . 83.97 11.43 79.01 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 119.364 0.984 . . . . 10.0 111.784 178.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.498 HD11 HD13 ' A' ' 85' ' ' ILE . 27.4 mt -101.66 131.33 49.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 CA-C-O 121.509 0.671 . . . . 10.0 112.411 -179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.689 ' HB3' ' HB2' ' A' ' 99' ' ' LYS . 7.8 tp10 -84.79 156.61 21.29 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 115.188 -0.915 . . . . 10.0 110.279 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.7 m -117.98 121.88 68.37 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.218 0 N-CA-C 107.889 -1.152 . . . . 10.0 107.889 165.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.803 HG22 ' O ' ' A' ' 100' ' ' VAL . 25.1 m -101.52 143.17 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 CA-C-N 113.961 -1.472 . . . . 10.0 108.265 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 19.7 t70 . . . . . 0 C--N 1.286 -2.163 0 CA-C-N 113.48 -1.691 . . . . 10.0 109.98 -173.378 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.4 mtm . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 110.25 -0.278 . . . . 10.0 110.25 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.75 101.3 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.082 0.771 . . . . 10.0 113.082 174.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.8 ' HB2' ' CE1' ' A' ' 61' ' ' TYR . 37.3 mmtt -100.87 167.15 10.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.734 -0.666 . . . . 10.0 109.321 173.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.509 ' HB3' ' HG3' ' A' ' 62' ' ' GLU . 30.5 mmtm -69.67 91.75 0.63 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.77 -0.195 . . . . 10.0 111.26 178.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.1 t -63.24 140.36 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.027 0.531 . . . . 10.0 111.329 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.46 -37.67 4.26 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 120.84 -0.344 . . . . 10.0 110.306 174.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.491 ' HB3' HG13 ' A' ' 60' ' ' VAL . . . -153.67 153.0 31.47 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 113.19 0.811 . . . . 10.0 113.19 -176.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -95.6 134.07 38.91 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.023 -1.103 . . . . 10.0 108.023 170.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.717 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.7 OUTLIER -120.65 80.19 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 168.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.415 ' HG2' HG13 ' A' ' 57' ' ' VAL . 55.5 mtmt -82.52 127.61 33.49 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 120.265 1.393 . . . . 10.0 108.482 176.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.663 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.27 128.75 6.91 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.959 0.885 . . . . 10.0 111.412 -174.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -78.52 122.67 26.17 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.311 -1.313 . . . . 10.0 110.141 -172.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.663 HD21 HD11 ' A' ' 11' ' ' LEU . 89.2 mt -140.43 133.66 14.93 Favored Pre-proline 0 N--CA 1.443 -0.817 0 CA-C-O 121.805 0.812 . . . . 10.0 112.072 -173.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.775 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 50.1 Cg_exo -52.0 125.08 16.19 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 124.072 3.181 . . . . 10.0 112.62 171.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.538 ' CB ' ' HB ' ' A' ' 46' ' ' THR . . . -62.13 127.29 30.69 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 107.696 -1.224 . . . . 10.0 107.696 169.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.85 -2.72 82.6 Favored Glycine 0 N--CA 1.443 -0.888 0 O-C-N 125.987 2.055 . . . . 10.0 112.744 -174.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.775 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 15.9 mmtp -140.16 99.62 3.71 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.083 0.944 . . . . 10.0 112.553 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.435 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -168.29 134.72 1.96 Allowed 'General case' 0 CA--C 1.503 -0.838 0 CA-C-N 114.073 -1.421 . . . . 10.0 111.767 174.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.707 ' HA ' ' HB2' ' A' ' 39' ' ' CYS . 1.6 t -178.11 -48.46 0.0 OUTLIER Pre-proline 0 N--CA 1.438 -1.06 0 CA-C-N 115.154 -0.93 . . . . 10.0 112.674 176.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.707 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 83.0 Cg_endo -104.62 133.25 0.09 OUTLIER 'Trans proline' 0 N--CA 1.409 -3.468 0 N-CA-C 117.049 1.903 . . . . 10.0 117.049 -152.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.92 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . 12.67 -63.3 0.0 OUTLIER Pre-proline 0 C--N 1.284 -2.243 0 CA-C-N 108.473 -3.967 . . . . 10.0 117.52 154.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.806 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 52.8 Cg_exo -52.63 -63.88 0.22 Allowed 'Trans proline' 0 CA--C 1.566 2.096 0 CA-C-N 123.964 2.451 . . . . 10.0 114.513 -177.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.806 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 60.4 Cg_endo -78.05 -52.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 122.624 2.216 . . . . 10.0 113.109 174.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.921 HG12 HD13 ' A' ' 35' ' ' ILE . 79.8 t -80.99 -45.27 21.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 CA-C-N 111.995 -2.366 . . . . 10.0 112.689 -166.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.833 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -40.57 -64.75 1.13 Allowed Glycine 0 CA--C 1.521 0.448 0 O-C-N 124.808 1.318 . . . . 10.0 113.32 178.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.92 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 80.1 Cg_exo -58.77 -48.4 14.91 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.798 2.999 . . . . 10.0 111.39 177.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.633 ' O ' ' HD2' ' A' ' 31' ' ' HIS . . . -48.4 -94.22 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 124.344 1.028 . . . . 10.0 111.764 -176.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.658 HD13 ' H ' ' A' ' 28' ' ' LEU 0.314 0.0 OUTLIER -81.02 -28.55 35.4 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 118.119 -1.432 . . . . 10.0 114.198 -174.946 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.544 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -68.75 -40.84 85.01 Favored Glycine 0 N--CA 1.468 0.769 0 O-C-N 121.17 -0.956 . . . . 10.0 113.248 -176.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.578 ' HG3' ' HA ' ' A' ' 26' ' ' PRO . 27.5 mt-30 -66.26 -6.8 15.07 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 118.639 -1.225 . . . . 10.0 110.603 175.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.633 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 88.2 m-70 -105.82 16.26 25.48 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 120.496 -0.482 . . . . 10.0 111.49 171.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.75 ' HA3' ' HD2' ' A' ' 64' ' ' LYS . . . 69.65 22.74 76.81 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.763 -0.653 . . . . 10.0 113.862 172.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.634 HG13 ' CD1' ' A' ' 66' ' ' PHE . 73.9 t -75.22 -30.02 22.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -167.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 91.18 79.27 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 122.868 1.318 . . . . 10.0 109.982 -172.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.921 HD13 HG12 ' A' ' 24' ' ' VAL . 1.1 mm -47.36 -49.19 9.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 112.055 -2.339 . . . . 10.0 113.579 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 79.4 mtp -64.33 -46.63 82.68 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.587 -1.642 . . . . 10.0 111.31 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.709 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 21.3 tt0 -62.52 -42.21 99.37 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 117.955 -1.498 . . . . 10.0 110.589 178.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.688 ' HB2' ' CZ ' ' A' ' 66' ' ' PHE . 38.6 t80 -56.87 -53.38 58.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.457 0.91 . . . . 10.0 113.457 172.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.707 ' HB2' ' HA ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -57.48 -47.1 82.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.286 -0.87 . . . . 10.0 111.16 179.407 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -65.57 -22.11 66.66 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.138 -1.025 . . . . 10.0 109.357 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.752 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 94.2 mtt180 -76.91 -65.55 0.93 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.444 -0.798 . . . . 10.0 112.3 173.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.634 ' CZ ' HG21 ' A' ' 46' ' ' THR . 67.4 t80 -57.28 -42.43 81.63 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.108 0.48 . . . . 10.0 110.305 -171.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.58 HD22 ' N ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER -58.87 -52.17 66.9 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.316 -0.856 . . . . 10.0 109.916 179.491 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.59 -39.87 92.73 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 119.476 -0.89 . . . . 10.0 112.229 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.752 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 27.9 mm-40 -64.21 -47.66 78.87 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 122.034 0.921 . . . . 10.0 110.887 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.663 ' CG2' HD12 ' A' ' 54' ' ' LEU . 63.1 p -89.13 3.3 52.31 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.104 -1.407 . . . . 10.0 112.026 -169.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.21 -41.12 12.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.139 -0.937 . . . . 10.0 113.043 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.96 -19.86 29.8 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.794 -0.639 . . . . 10.0 111.573 -171.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.438 ' NZ ' ' HB3' ' A' ' 49' ' ' LYS . 6.1 mtpm? -109.18 21.57 16.97 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 123.605 0.762 . . . . 10.0 109.194 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.03 150.91 3.99 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.936 -1.029 . . . . 10.0 113.09 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.6 20.36 32.09 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 110.564 -1.014 . . . . 10.0 110.564 -178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.596 ' HB2' HD21 ' A' ' 54' ' ' LEU . 66.9 mtt -137.75 124.45 21.05 Favored 'General case' 0 C--O 1.211 -0.924 0 C-N-CA 117.203 -1.799 . . . . 10.0 113.829 -168.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 50.3 mm -65.77 91.7 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.928 -0.767 . . . . 10.0 108.928 171.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.735 HD13 HG21 ' A' ' 70' ' ' ILE . 8.9 mt -84.69 126.42 68.66 Favored Pre-proline 0 N--CA 1.448 -0.534 0 N-CA-C 108.79 -0.819 . . . . 10.0 108.79 -178.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.762 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 20.6 Cg_exo -68.52 106.77 1.49 Allowed 'Trans proline' 0 C--N 1.329 -0.458 0 C-N-CA 121.654 1.569 . . . . 10.0 110.619 172.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.4 OUTLIER -96.67 142.98 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 120.254 1.388 . . . . 10.0 110.891 -174.698 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 58.3 t -116.67 111.23 34.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 C-N-CA 120.594 -0.442 . . . . 10.0 110.654 171.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.717 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 28.6 mt -105.11 138.38 30.27 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.829 0 N-CA-C 107.139 -1.43 . . . . 10.0 107.139 -176.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.7 m -122.95 95.08 4.48 Favored 'General case' 0 N--CA 1.408 -2.559 0 CA-C-N 115.009 -0.996 . . . . 10.0 108.849 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.538 HG21 HG22 ' A' ' 33' ' ' VAL . 1.5 p -87.8 135.21 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.819 0 CA-C-N 119.425 1.011 . . . . 10.0 110.804 -178.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.8 ' CE1' ' HB2' ' A' ' 3' ' ' LYS . 70.4 m-85 -93.47 177.58 5.98 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.576 -0.738 . . . . 10.0 112.689 -173.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.509 ' HG3' ' HB3' ' A' ' 4' ' ' LYS . 5.9 mm-40 -55.63 -24.75 35.29 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 113.896 -1.502 . . . . 10.0 112.652 -178.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.514 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 20.0 t70 -79.37 -15.81 57.28 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 114.988 -1.005 . . . . 10.0 111.163 -177.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.75 ' HD2' ' HA3' ' A' ' 32' ' ' GLY . 28.6 mtmm 82.3 5.35 1.08 Allowed 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 114.764 -1.107 . . . . 10.0 110.339 -160.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.481 ' O ' HG23 ' A' ' 60' ' ' VAL . 21.5 t -71.26 173.08 8.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.002 -1.851 . . . . 10.0 106.002 175.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.688 ' CZ ' ' HB2' ' A' ' 38' ' ' PHE . 29.9 p90 -169.86 -177.18 2.56 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 121.994 2.179 . . . . 10.0 111.391 177.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.9 p -157.39 175.08 14.46 Favored 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 103.156 -2.905 . . . . 10.0 103.156 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 21.6 p90 -163.84 159.42 21.13 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.549 -0.908 . . . . 10.0 108.549 177.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.3 161.64 41.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.299 -1.371 . . . . 10.0 107.299 177.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.735 HG21 HD13 ' A' ' 54' ' ' LEU . 4.9 mm -109.52 134.06 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 108.228 -1.027 . . . . 10.0 108.228 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.823 ' NZ ' ' HA ' ' A' ' 71' ' ' LYS . 0.0 OUTLIER -81.88 91.05 6.48 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.179 0.514 . . . . 10.0 109.964 178.083 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.951 ' HB ' ' HG3' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -50.16 104.17 0.41 Allowed Pre-proline 0 C--N 1.312 -1.037 0 CA-C-N 113.846 -1.524 . . . . 10.0 110.144 173.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.521 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 39.1 Cg_endo -66.5 149.35 84.46 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.608 2.206 . . . . 10.0 112.683 -169.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.877 ' HA ' HD11 ' A' ' 116' ' ' LEU . 47.5 Cg_exo -33.45 -61.24 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 124.098 3.199 . . . . 10.0 113.507 -178.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.54 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -174.28 10.8 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 112.853 0.686 . . . . 10.0 112.853 176.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.5 t -60.06 -64.24 1.02 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.068 0.461 . . . . 10.0 111.383 -174.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.48 ' HD2' ' HG3' ' A' ' 73' ' ' PRO . 80.7 m-85 -71.66 -28.61 63.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.179 -0.464 . . . . 10.0 111.231 -176.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.671 ' O ' ' HB3' ' A' ' 81' ' ' LYS . 3.0 mm? -84.21 -28.4 27.33 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 121.094 0.474 . . . . 10.0 111.098 -173.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 75' ' ' ALA . 11.3 mt -72.68 -36.33 67.86 Favored 'General case' 0 C--O 1.211 -0.952 0 C-N-CA 120.048 -0.661 . . . . 10.0 109.685 175.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -65.98 -21.34 66.4 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.02 0.438 . . . . 10.0 110.557 174.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.671 ' HB3' ' O ' ' A' ' 78' ' ' LEU . 1.8 tmtp? -57.6 -50.25 73.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.391 -0.368 . . . . 10.0 110.536 171.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 1.069 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -79.12 -55.2 5.29 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.288 1.835 . . . . 10.0 113.208 176.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.21 121.88 22.8 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 111.152 -2.749 . . . . 10.0 107.453 -177.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -87.45 18.57 37.02 Favored Glycine 0 C--N 1.317 -0.496 0 C-N-CA 118.575 -1.774 . . . . 10.0 111.184 -166.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.442 HG22 HG22 ' A' ' 97' ' ' VAL . 19.2 pt -64.19 147.24 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 114.181 -1.01 . . . . 10.0 112.196 -176.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -159.76 32.15 0.19 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.039 -0.982 . . . . 10.0 108.524 175.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -160.38 -46.44 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 113.605 -1.634 . . . . 10.0 106.619 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.7 -178.63 44.12 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 114.875 -1.057 . . . . 10.0 113.701 166.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.6 p -78.68 -171.37 2.5 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.617 -0.791 . . . . 10.0 111.491 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.682 ' O ' ' HG3' ' A' ' 91' ' ' GLU . 47.1 p -154.84 12.1 0.37 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.231 -1.026 . . . . 10.0 108.231 174.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.682 ' HG3' ' O ' ' A' ' 90' ' ' SER . 6.3 mt-10 -172.18 119.36 0.43 Allowed Pre-proline 0 N--CA 1.454 -0.246 0 CA-C-N 113.749 -1.569 . . . . 10.0 107.206 -168.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 91' ' ' GLU . 1.5 Cg_endo -82.66 24.17 0.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.62 2.213 . . . . 10.0 113.586 -172.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -155.69 133.71 11.38 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 122.336 0.254 . . . . 10.0 110.761 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 70.05 -69.36 0.17 Allowed 'General case' 0 N--CA 1.465 0.301 0 O-C-N 124.213 0.946 . . . . 10.0 111.802 174.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -72.54 64.87 0.64 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.655 0.74 . . . . 10.0 110.404 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.422 ' HB ' ' O ' ' A' ' 136' ' ' GLY . 46.8 pt -85.06 -167.86 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.408 -0.814 . . . . 10.0 110.87 174.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.52 HG13 ' N ' ' A' ' 98' ' ' GLY . 7.2 p -141.99 -47.41 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 113.001 0.741 . . . . 10.0 113.001 -163.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 137' ' ' ILE . . . -169.75 168.34 41.26 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 110.517 -1.033 . . . . 10.0 110.517 177.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.539 ' O ' HG13 ' A' ' 100' ' ' VAL . 0.7 OUTLIER -158.19 173.97 15.89 Favored 'General case' 0 CA--C 1.481 -1.705 0 CA-C-O 121.23 0.538 . . . . 10.0 110.847 -160.737 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 1.069 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -164.36 -169.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 113.769 -1.559 . . . . 10.0 110.631 -171.513 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.8 p -104.86 141.48 36.45 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 114.252 -1.34 . . . . 10.0 112.3 -169.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.699 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 5.0 ttp180 -46.53 -38.69 9.71 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.717 -0.674 . . . . 10.0 110.207 171.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 20.1 tptm -58.17 -45.42 87.53 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.211 -0.45 . . . . 10.0 111.658 174.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.553 ' HG3' ' CB ' ' A' ' 82' ' ' ALA . 2.2 tm0? -60.13 -56.73 18.02 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.339 -0.615 . . . . 10.0 109.339 175.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.799 HG23 ' HB ' ' A' ' 128' ' ' ILE . 24.3 mm -26.72 -57.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 123.812 0.695 . . . . 10.0 112.317 162.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.733 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 30.1 tt0 -50.35 -58.07 6.5 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.008 0.923 . . . . 10.0 112.904 178.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.96 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 8.5 mt-10 -55.61 -46.43 77.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.488 -0.778 . . . . 10.0 110.767 -178.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.573 HD12 ' HB3' ' A' ' 78' ' ' LEU . 31.4 mm -58.88 -50.38 79.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.455 -0.793 . . . . 10.0 109.407 175.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.447 ' HB1' ' CB ' ' A' ' 124' ' ' ALA . . . -53.81 -40.53 66.44 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.158 -0.928 . . . . 10.0 113.248 176.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.96 ' HD2' ' HA ' ' A' ' 107' ' ' GLU . 36.4 mttm -63.87 -50.04 70.38 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-O 121.693 0.758 . . . . 10.0 109.125 -177.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 89.4 m -49.12 -59.46 3.63 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 113.786 -1.552 . . . . 10.0 111.926 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.951 ' HG3' ' HB ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -93.51 16.57 13.3 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.691 0.997 . . . . 10.0 113.691 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.616 ' HG3' ' HB3' ' A' ' 118' ' ' ALA . 47.6 ttm -41.94 -50.9 10.37 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 118.593 0.633 . . . . 10.0 111.902 168.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 113' ' ' MET . 42.5 Cg_endo -66.69 -20.9 52.44 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 121.583 1.522 . . . . 10.0 113.321 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' A' ' 117' ' ' ASN . 0.7 OUTLIER -91.94 -49.73 6.08 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.647 0.737 . . . . 10.0 111.26 -177.368 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.877 HD11 ' HA ' ' A' ' 74' ' ' PRO . 7.2 mp -62.58 -3.23 1.37 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.235 -1.348 . . . . 10.0 111.494 178.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' A' ' 115' ' ' ASP . 58.5 t30 64.03 45.34 4.21 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.108 -1.406 . . . . 10.0 109.268 177.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.616 ' HB3' ' HG3' ' A' ' 113' ' ' MET . . . -85.13 119.76 25.88 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 113.448 -1.705 . . . . 10.0 113.041 -174.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -65.36 -42.92 92.26 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.782 -0.822 . . . . 10.0 108.782 167.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.2 p -143.88 149.26 36.65 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 107.957 -1.127 . . . . 10.0 107.957 -177.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.519 HD11 ' HA ' ' A' ' 106' ' ' GLU . 0.4 OUTLIER -50.42 -39.8 48.42 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 114.753 -1.112 . . . . 10.0 112.041 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.562 ' HA ' ' HG3' ' A' ' 125' ' ' MET . 1.8 mp0 -47.88 -42.11 26.01 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.786 0.803 . . . . 10.0 111.135 177.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.89 -48.0 70.07 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 118.428 -1.309 . . . . 10.0 110.831 177.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.496 ' HA ' HD12 ' A' ' 127' ' ' ILE . . . -55.59 -38.26 69.17 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.007 177.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.686 ' O ' ' HB2' ' A' ' 129' ' ' GLU . 20.6 mtp -55.06 -39.4 69.19 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.59 0.709 . . . . 10.0 110.076 -176.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.669 ' HA ' ' HE2' ' A' ' 126' ' ' LYS . 0.3 OUTLIER -65.34 -46.66 79.36 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.153 -1.385 . . . . 10.0 110.441 -178.281 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 124' ' ' ALA . 63.6 mt -52.37 -62.81 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.288 0 CA-C-N 116.165 -0.471 . . . . 10.0 111.112 175.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.799 ' HB ' HG23 ' A' ' 105' ' ' ILE . 11.8 mm -53.67 -54.44 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.121 0 CA-C-N 115.08 -0.964 . . . . 10.0 110.349 -177.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.686 ' HB2' ' O ' ' A' ' 125' ' ' MET . 0.8 OUTLIER -53.24 -41.68 65.68 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.076 -0.965 . . . . 10.0 110.097 178.342 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.55 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -75.21 -44.41 22.9 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.843 -0.694 . . . . 10.0 111.86 -176.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.54 HG21 ' HB3' ' A' ' 75' ' ' ALA . 93.0 m -47.5 -59.8 2.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.099 -1.051 . . . . 10.0 109.28 170.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.512 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -50.51 -51.33 48.51 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.739 -0.664 . . . . 10.0 111.274 174.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.55 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 77.3 tttt -44.75 -56.04 4.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.854 -1.066 . . . . 10.0 111.792 175.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.3 t -64.11 -31.22 72.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.108 0.48 . . . . 10.0 111.176 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 50.3 mtm -83.12 4.52 26.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.837 1.051 . . . . 10.0 113.837 -176.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.422 ' O ' ' HB ' ' A' ' 96' ' ' ILE . . . 83.75 12.68 77.04 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 120.161 1.346 . . . . 10.0 111.929 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 25.6 mt -101.79 124.14 55.41 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 CA-C-O 121.579 0.705 . . . . 10.0 111.29 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 139' ' ' VAL . 0.0 OUTLIER -88.58 158.44 18.27 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 114.549 -1.205 . . . . 10.0 109.317 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.424 ' N ' ' HG3' ' A' ' 138' ' ' GLU . 17.6 m -115.08 135.16 55.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 N-CA-C 108.093 -1.077 . . . . 10.0 108.093 169.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.4 m -133.17 69.43 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 114.869 1.433 . . . . 10.0 114.869 -176.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 21.5 t70 . . . . . 0 C--N 1.31 -1.117 0 CA-C-O 118.666 -0.683 . . . . 10.0 110.657 140.788 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.6 mmm . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.806 0.336 . . . . 10.0 110.732 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.13 179.33 6.97 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.237 -0.438 . . . . 10.0 109.945 176.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -78.39 162.84 26.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.855 -175.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.414 ' HB2' ' OE2' ' A' ' 62' ' ' GLU . 60.2 mttm -90.0 139.79 30.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.002 0.43 . . . . 10.0 111.136 -174.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.8 132.75 28.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.297 -0.865 . . . . 10.0 111.552 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.453 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . . . -102.98 -37.2 7.9 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.089 -0.708 . . . . 10.0 109.089 173.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.447 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -154.89 -175.2 5.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.899 0.857 . . . . 10.0 112.66 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 4.1 pt20 -142.0 130.48 22.51 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.087 -1.415 . . . . 10.0 108.241 178.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.626 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -119.77 84.13 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 109.406 -0.591 . . . . 10.0 109.406 -176.579 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.418 ' NZ ' ' HB2' ' A' ' 10' ' ' LYS . 8.0 mtmp? -77.56 130.27 36.71 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 120.664 1.574 . . . . 10.0 107.72 176.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.706 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.87 124.84 4.99 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 122.379 1.085 . . . . 10.0 111.594 -176.607 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -82.85 120.18 25.33 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.878 -1.51 . . . . 10.0 109.716 -172.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.706 HD21 HD11 ' A' ' 11' ' ' LEU . 92.1 mt -137.34 138.73 25.76 Favored Pre-proline 0 CA--C 1.5 -0.953 0 CA-C-O 121.512 0.672 . . . . 10.0 112.036 -172.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.875 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 40.1 Cg_exo -55.71 124.88 17.37 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 123.204 2.603 . . . . 10.0 111.646 171.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.565 ' O ' ' HA ' ' A' ' 50' ' ' ALA . . . -62.02 126.39 27.17 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 106.996 -1.483 . . . . 10.0 106.996 168.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.29 -5.04 79.08 Favored Glycine 0 CA--C 1.529 0.909 0 O-C-N 125.515 1.759 . . . . 10.0 113.599 -175.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.875 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 31.9 mmtp -139.89 102.59 4.45 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.519 1.159 . . . . 10.0 111.674 178.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.642 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -170.17 130.7 0.96 Allowed 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.17 -1.377 . . . . 10.0 111.927 175.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 65.0 m -166.7 -59.38 0.01 OUTLIER Pre-proline 0 N--CA 1.437 -1.122 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.907 -177.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.808 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 84.1 Cg_endo -108.05 136.22 0.05 OUTLIER 'Trans proline' 0 N--CA 1.421 -2.778 0 N-CA-C 117.05 1.904 . . . . 10.0 117.05 -157.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.064 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 11.69 -85.63 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.585 1 CA-C-N 108.393 -4.003 . . . . 10.0 115.335 167.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.853 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 56.9 Cg_exo -32.08 -54.43 0.32 Allowed 'Trans proline' 0 CA--C 1.558 1.711 0 C-N-CA 122.662 2.242 . . . . 10.0 115.579 -163.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.853 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 32.0 Cg_endo -84.54 -53.63 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 122.516 2.144 . . . . 10.0 112.651 168.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.808 HG12 ' CD1' ' A' ' 35' ' ' ILE . 75.9 t -81.53 -55.98 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 113.331 -1.759 . . . . 10.0 113.991 -167.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 1.064 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -43.1 -77.46 0.09 OUTLIER Glycine 0 CA--C 1.519 0.335 0 CA-C-N 114.736 -1.12 . . . . 10.0 114.1 -177.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.808 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 22.8 Cg_exo -45.09 -41.82 16.18 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.817 3.011 . . . . 10.0 112.681 173.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 24' ' ' VAL . . . -51.08 -101.52 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 123.475 0.484 . . . . 10.0 111.858 176.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.824 HD23 ' HB ' ' A' ' 33' ' ' VAL 0.308 0.0 OUTLIER -73.33 -25.8 60.77 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 117.511 -1.676 . . . . 10.0 112.951 -172.422 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.536 ' N ' HD22 ' A' ' 28' ' ' LEU . . . -71.83 -40.78 57.34 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 121.098 -0.572 . . . . 10.0 113.024 -176.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.409 ' HB3' ' O ' ' A' ' 26' ' ' PRO . 10.2 tt0 -63.09 -16.71 60.86 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 119.178 -1.009 . . . . 10.0 109.712 175.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.526 ' HD2' ' O ' ' A' ' 27' ' ' ALA . 95.7 m-70 -98.88 20.1 13.78 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 120.12 -0.632 . . . . 10.0 110.102 176.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.47 -1.64 76.39 Favored Glycine 0 CA--C 1.5 -0.872 0 CA-C-N 115.201 -0.909 . . . . 10.0 113.126 167.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.824 ' HB ' HD23 ' A' ' 28' ' ' LEU . 11.3 t -82.48 147.1 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 113.305 0.854 . . . . 10.0 113.305 -172.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -69.69 98.91 1.25 Allowed 'General case' 0 C--N 1.341 0.219 0 CA-C-O 121.291 0.567 . . . . 10.0 110.868 172.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.808 ' CD1' HG12 ' A' ' 24' ' ' VAL . 2.5 mm -52.31 -39.25 27.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.867 -1.061 . . . . 10.0 111.464 174.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.702 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 85.3 mtp -64.61 -52.1 59.24 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 113.244 -1.798 . . . . 10.0 111.618 176.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.64 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 31.1 mt-10 -58.49 -40.12 81.92 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.11 -1.036 . . . . 10.0 111.024 176.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.62 ' CE1' HD11 ' A' ' 58' ' ' ILE . 90.3 t80 -58.33 -59.74 4.87 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.929 1.085 . . . . 10.0 113.929 172.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.702 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 18.3 p -58.82 -48.05 82.64 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 114.832 -1.077 . . . . 10.0 111.761 -177.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -65.22 -22.74 66.92 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.824 -0.806 . . . . 10.0 108.824 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.743 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 10.7 mtm180 -78.45 -63.26 1.44 Allowed 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 119.321 -0.952 . . . . 10.0 112.899 170.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.582 ' CZ ' HG21 ' A' ' 46' ' ' THR . 67.4 t80 -55.2 -43.61 74.59 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 118.717 0.689 . . . . 10.0 110.403 -172.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.642 HD21 ' HB3' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -59.8 -51.38 69.97 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.311 -0.858 . . . . 10.0 109.851 -179.625 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.98 -40.25 97.18 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 119.239 -0.985 . . . . 10.0 112.182 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.743 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 23.5 mt-10 -67.92 -45.24 74.93 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.578 0.704 . . . . 10.0 111.079 -178.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.584 ' CG2' HD12 ' A' ' 54' ' ' LEU . 72.3 p -86.93 6.2 33.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.998 -1.001 . . . . 10.0 112.209 -172.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.7 -34.61 5.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.632 -1.167 . . . . 10.0 112.561 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -79.63 -38.54 33.6 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.585 -0.734 . . . . 10.0 112.053 -176.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -94.14 18.66 10.42 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 109.127 -0.694 . . . . 10.0 109.127 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 15' ' ' ALA . . . -50.46 133.88 24.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.08 -0.963 . . . . 10.0 112.661 -178.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.05 19.48 10.1 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 114.786 -1.097 . . . . 10.0 110.799 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.587 ' HB2' HD21 ' A' ' 54' ' ' LEU . 67.3 mtt -137.5 127.48 25.81 Favored 'General case' 0 C--O 1.208 -1.108 0 C-N-CA 117.457 -1.697 . . . . 10.0 114.295 -169.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.2 mm -65.94 91.74 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 118.688 0.676 . . . . 10.0 109.372 169.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.593 HD13 HG21 ' A' ' 70' ' ' ILE . 6.9 mt -81.08 138.06 49.41 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 -177.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 54' ' ' LEU . 3.7 Cg_exo -78.67 104.84 1.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.95 1.766 . . . . 10.0 110.472 172.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -101.01 144.14 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 119.716 1.144 . . . . 10.0 110.995 -175.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 68' ' ' PHE . 85.0 t -119.4 118.51 57.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 116.224 -0.444 . . . . 10.0 110.475 171.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.626 ' HB ' ' HB ' ' A' ' 9' ' ' ILE . 16.4 mt -104.94 141.29 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.722 0 N-CA-C 108.515 -0.921 . . . . 10.0 108.515 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 89.8 m -127.68 97.89 5.0 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 114.714 -1.13 . . . . 10.0 109.134 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 65' ' ' SER . 2.1 p -91.3 136.03 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 O-C-N 121.276 -0.89 . . . . 10.0 110.618 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.437 ' HE2' HG23 ' A' ' 67' ' ' THR . 65.2 m-85 -92.48 171.14 9.23 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.586 -0.734 . . . . 10.0 112.292 -175.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.453 ' HA ' ' HB2' ' A' ' 6' ' ' ALA . 39.7 mt-10 -58.38 -23.51 57.22 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.594 -1.184 . . . . 10.0 112.77 -177.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 2.8 m-20 -81.27 -6.41 58.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.872 -0.604 . . . . 10.0 112.568 -176.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 53.5 mtpt 83.97 1.31 0.95 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.967 0.889 . . . . 10.0 110.011 -167.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.598 ' O ' HG23 ' A' ' 60' ' ' VAL . 8.5 t -72.01 172.23 10.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 114.313 -1.312 . . . . 10.0 108.016 172.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.801 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -167.6 -177.48 3.55 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 120.241 1.382 . . . . 10.0 109.501 176.207 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.505 ' HA ' HH22 ' A' ' 41' ' ' ARG . 22.2 p -157.82 169.95 23.46 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 103.217 -2.883 . . . . 10.0 103.217 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.447 ' HB3' HG12 ' A' ' 58' ' ' ILE . 56.2 p90 -164.18 153.86 14.24 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.622 -0.881 . . . . 10.0 108.622 176.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.5 pt -131.89 153.24 38.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 108.178 -1.045 . . . . 10.0 108.178 -176.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.593 HG21 HD13 ' A' ' 54' ' ' LEU . 1.6 mm -107.39 131.76 56.68 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 N-CA-C 107.389 -1.338 . . . . 10.0 107.389 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.662 ' C ' ' HD2' ' A' ' 73' ' ' PRO . 13.9 mmmm -77.71 90.2 4.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.033 0.92 . . . . 10.0 110.999 -177.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.602 ' N ' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -60.63 -32.93 12.52 Favored Pre-proline 0 CA--C 1.562 1.434 0 CA-C-N 113.758 -1.564 . . . . 10.0 115.134 172.49 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.664 ' HG2' ' HD3' ' A' ' 74' ' ' PRO . 14.0 Cg_endo -54.8 -36.69 91.61 Favored 'Trans proline' 0 C--N 1.38 2.204 0 C-N-CA 123.377 2.718 . . . . 10.0 117.281 -170.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.664 ' HD3' ' HG2' ' A' ' 73' ' ' PRO . 79.8 Cg_exo -47.14 -29.25 8.72 Favored 'Trans proline' 0 C--N 1.366 1.481 0 C-N-CA 121.963 1.776 . . . . 10.0 112.504 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.411 ' HB3' HG21 ' A' ' 131' ' ' THR . . . 73.04 -42.33 0.53 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.474 0.916 . . . . 10.0 113.474 169.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.2 p -45.43 -35.65 3.84 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 123.575 0.75 . . . . 10.0 112.69 -175.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.556 ' HB3' ' SD ' ' A' ' 52' ' ' MET . 75.3 m-85 -55.14 -50.31 69.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.545 0.688 . . . . 10.0 111.34 178.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.774 ' HB3' HD12 ' A' ' 108' ' ' ILE . 4.8 mp -93.25 -12.58 29.83 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.081 -0.648 . . . . 10.0 111.591 -174.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 79' ' ' LEU . 3.3 mm? -62.12 -37.28 84.52 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.17 -1.048 . . . . 10.0 108.17 166.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -56.74 -43.17 80.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.104 -0.953 . . . . 10.0 110.185 172.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? -54.94 -46.71 75.0 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.517 -0.765 . . . . 10.0 112.33 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.75 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -70.44 -49.17 51.48 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.087 1.355 . . . . 10.0 111.678 174.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.513 ' HB3' HG12 ' A' ' 85' ' ' ILE . . . -64.59 -30.92 71.95 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 111.413 -2.63 . . . . 10.0 111.298 -167.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.594 ' C ' ' H ' ' A' ' 86' ' ' GLU . . . 93.7 -31.99 6.12 Favored Glycine 0 CA--C 1.501 -0.838 0 N-CA-C 110.209 -1.156 . . . . 10.0 110.209 174.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.513 HG12 ' HB3' ' A' ' 83' ' ' ALA . 40.5 pt -47.48 17.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 115.676 1.732 . . . . 10.0 115.676 166.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.594 ' H ' ' C ' ' A' ' 84' ' ' GLY . 28.9 tt0 -75.01 60.06 0.97 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.8 -0.815 . . . . 10.0 108.8 171.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -173.69 -38.29 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.698 -1.137 . . . . 10.0 109.048 -173.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 142.01 -72.02 0.4 Allowed Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.187 -0.915 . . . . 10.0 111.426 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.3 m 65.33 114.19 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.442 0.639 . . . . 10.0 111.186 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.16 43.59 0.2 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.129 -0.693 . . . . 10.0 109.129 -174.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.748 ' HB2' ' HD3' ' A' ' 92' ' ' PRO . 38.8 mt-10 -162.03 -50.21 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 114.613 -1.176 . . . . 10.0 108.921 -174.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.748 ' HD3' ' HB2' ' A' ' 91' ' ' GLU . 4.8 Cg_exo -75.3 108.12 2.63 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 121.687 1.591 . . . . 10.0 110.628 169.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.749 ' HB2' ' HA ' ' A' ' 97' ' ' VAL . 28.1 mmtp 66.63 -170.96 0.19 Allowed 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.287 -0.635 . . . . 10.0 109.287 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -165.62 -44.29 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.791 0.329 . . . . 10.0 110.378 174.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.724 ' HG2' HG23 ' A' ' 96' ' ' ILE . 0.0 OUTLIER -66.82 -30.63 70.87 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.41 -0.516 . . . . 10.0 111.135 -172.768 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.847 HD13 ' HB3' ' A' ' 138' ' ' GLU . 2.4 pp -138.39 1.81 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 CA-C-N 116.393 -0.367 . . . . 10.0 110.609 174.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.749 ' HA ' ' HB2' ' A' ' 93' ' ' LYS . 13.5 p 49.08 -57.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 116.118 1.895 . . . . 10.0 116.118 176.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 96' ' ' ILE . . . -152.39 162.04 29.7 Favored Glycine 0 N--CA 1.431 -1.661 0 N-CA-C 109.793 -1.323 . . . . 10.0 109.793 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.754 ' CB ' ' HG2' ' A' ' 138' ' ' GLU . 0.1 OUTLIER -139.93 168.53 19.6 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 122.851 1.31 . . . . 10.0 111.187 -170.478 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.75 HG11 ' HB1' ' A' ' 82' ' ' ALA . 2.6 m -156.37 -146.65 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 CA-C-N 111.516 -2.583 . . . . 10.0 104.732 -171.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.419 ' HA ' ' H ' ' A' ' 140' ' ' VAL . 6.6 t -164.5 156.84 16.55 Favored 'General case' 0 C--N 1.282 -2.344 0 C-N-CA 117.693 -1.603 . . . . 10.0 110.71 -163.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.558 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 1.3 tmt_? -41.79 -42.94 2.79 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 112.718 -2.037 . . . . 10.0 110.628 -175.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -59.27 -44.22 92.46 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.032 0.753 . . . . 10.0 113.032 177.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.663 ' O ' HG12 ' A' ' 108' ' ' ILE . 3.1 mp0 -60.7 -51.76 67.99 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.392 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.706 HG23 ' HB ' ' A' ' 128' ' ' ILE . 39.3 mm -36.95 -53.32 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 CA-C-N 114.806 -1.088 . . . . 10.0 111.309 167.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.796 ' HA ' ' SD ' ' A' ' 125' ' ' MET . 4.9 tt0 -50.81 -60.25 3.25 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.833 -1.076 . . . . 10.0 113.168 -177.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -55.97 -48.97 74.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.157 -0.928 . . . . 10.0 110.502 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.774 HD12 ' HB3' ' A' ' 78' ' ' LEU . 18.4 mm -51.77 -56.58 5.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.593 171.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.545 ' HB2' HG13 ' A' ' 128' ' ' ILE . . . -50.83 -35.19 31.13 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.371 0.508 . . . . 10.0 112.371 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.757 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 92.7 mttt -76.91 -51.59 10.94 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 116.004 -0.544 . . . . 10.0 111.113 -178.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 108' ' ' ILE . 10.3 t -57.26 -17.73 13.13 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.145 0.794 . . . . 10.0 113.145 -176.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.624 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 0.1 OUTLIER -132.21 18.84 4.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.374 0.607 . . . . 10.0 110.011 -179.248 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.64 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 46.5 ttm -48.52 -45.63 69.14 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 114.798 -1.092 . . . . 10.0 112.307 175.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' A' ' 113' ' ' MET . 19.0 Cg_endo -55.8 -23.62 42.7 Favored 'Trans proline' 0 C--N 1.363 1.291 0 C-N-CA 122.364 2.043 . . . . 10.0 112.338 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.625 ' CG ' ' HD3' ' A' ' 73' ' ' PRO . 5.0 m-20 -96.8 -46.44 6.26 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.883 -1.053 . . . . 10.0 112.85 -173.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.595 ' CD2' HD12 ' A' ' 127' ' ' ILE . 6.6 mp -63.92 36.92 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 114.525 -1.216 . . . . 10.0 112.986 -176.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.484 ' H ' ' C ' ' A' ' 115' ' ' ASP . 0.2 OUTLIER 17.96 54.34 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.181 1.392 . . . . 10.0 112.279 -172.099 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -103.23 123.27 46.43 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 113.464 0.913 . . . . 10.0 113.464 -174.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -67.64 -33.55 75.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.34 0.59 . . . . 10.0 109.854 169.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.1 p -148.43 145.41 27.99 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.569 -0.9 . . . . 10.0 108.569 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.678 ' O ' ' HG2' ' A' ' 125' ' ' MET . 56.7 tp -51.85 -38.44 55.97 Favored 'General case' 0 C--O 1.219 -0.542 0 N-CA-C 114.52 1.304 . . . . 10.0 114.52 -176.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.556 ' O ' ' HD3' ' A' ' 126' ' ' LYS . 19.8 mm-40 -49.66 -37.14 27.31 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.24 0.543 . . . . 10.0 110.931 176.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.04 -47.8 70.28 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 118.651 -1.22 . . . . 10.0 110.574 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.564 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -59.06 -30.98 68.45 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.212 0.53 . . . . 10.0 110.658 177.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.796 ' SD ' ' HA ' ' A' ' 106' ' ' GLU . 86.8 mmm -58.21 -38.71 77.31 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.495 0.664 . . . . 10.0 110.771 178.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.556 ' HD3' ' O ' ' A' ' 122' ' ' GLU . 4.0 mptp? -65.14 -52.04 57.59 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.954 -1.021 . . . . 10.0 111.846 177.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.595 HD12 ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -52.36 -58.83 2.0 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.688 0 C-N-CA 119.803 -0.759 . . . . 10.0 110.806 178.504 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.706 ' HB ' HG23 ' A' ' 105' ' ' ILE . 27.4 mm -50.75 -58.96 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.88 0 C-N-CA 123.801 0.84 . . . . 10.0 111.746 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.667 ' HG3' HG21 ' A' ' 105' ' ' ILE . 4.3 mt-10 -52.76 -43.68 65.97 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.548 -0.751 . . . . 10.0 109.453 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -71.5 -46.66 39.08 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.461 -0.876 . . . . 10.0 111.481 -176.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.411 HG21 ' HB3' ' A' ' 75' ' ' ALA . 51.7 m -46.63 -62.41 1.39 Allowed 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 113.972 -1.114 . . . . 10.0 110.047 173.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.81 ' HB1' ' HB ' ' A' ' 137' ' ' ILE . . . -50.91 -48.64 60.55 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.845 -0.616 . . . . 10.0 111.699 174.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 58.7 tttm -47.31 -54.99 9.62 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.366 -0.834 . . . . 10.0 111.037 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 41.7 m -65.91 -28.56 69.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.061 0.457 . . . . 10.0 110.637 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . . . . . . . . . 43.6 mtm -81.29 -2.26 48.33 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.507 0.928 . . . . 10.0 113.507 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 80.88 44.58 8.2 Favored Glycine 0 C--O 1.216 -1.01 0 CA-C-N 119.696 1.135 . . . . 10.0 112.219 -177.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.81 ' HB ' ' HB1' ' A' ' 132' ' ' ALA . 1.9 mm -119.86 127.12 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.67 0 CA-C-O 121.389 0.614 . . . . 10.0 110.475 175.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.847 ' HB3' HD13 ' A' ' 96' ' ' ILE . 0.0 OUTLIER -87.49 145.76 26.11 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 114.948 -1.024 . . . . 10.0 109.326 176.104 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 18.9 m -113.46 134.62 55.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 107.634 -1.247 . . . . 10.0 107.634 171.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.632 HG22 ' O ' ' A' ' 100' ' ' VAL . 12.9 m -129.65 72.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 114.674 1.361 . . . . 10.0 114.674 -178.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.024 0 N-CA-C 114.216 1.191 . . . . 10.0 114.216 140.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 tpt . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.591 0.234 . . . . 10.0 110.869 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.89 145.67 44.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.601 -0.272 . . . . 10.0 110.605 -178.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -128.66 155.83 44.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.999 0.428 . . . . 10.0 110.83 177.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.524 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 27.4 mtpp -136.14 119.98 17.39 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.051 -0.722 . . . . 10.0 109.051 177.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.4 t -62.97 133.97 28.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 122.392 0.277 . . . . 10.0 110.679 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.53 -38.61 6.39 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.394 -0.595 . . . . 10.0 109.394 174.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.522 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -157.44 159.02 36.9 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 113.58 0.955 . . . . 10.0 113.58 -175.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.804 HE21 ' HA ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -100.88 135.45 42.3 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.53 -1.214 . . . . 10.0 108.416 170.208 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.643 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -120.16 80.15 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 108.317 -0.994 . . . . 10.0 108.317 167.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.466 ' HG2' HG13 ' A' ' 57' ' ' VAL . 36.2 mttm -80.79 129.69 34.66 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 121.08 1.764 . . . . 10.0 107.484 176.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.519 HD21 HD11 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -158.09 130.28 7.01 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 122.209 1.004 . . . . 10.0 111.601 -176.603 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -81.75 119.13 23.47 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.026 -1.443 . . . . 10.0 109.664 -172.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.519 HD11 HD21 ' A' ' 11' ' ' LEU . 33.2 mt -136.06 133.97 20.02 Favored Pre-proline 0 CA--C 1.504 -0.822 0 CA-C-O 121.495 0.664 . . . . 10.0 112.578 -169.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.605 ' HB2' ' CB ' ' A' ' 17' ' ' LYS . 39.8 Cg_exo -56.05 122.97 12.71 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 123.534 2.823 . . . . 10.0 111.866 172.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.648 ' HB1' ' HB ' ' A' ' 46' ' ' THR . . . -60.38 128.53 37.17 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 107.814 -1.18 . . . . 10.0 107.814 170.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.6 1.29 82.53 Favored Glycine 0 CA--C 1.527 0.832 0 O-C-N 125.808 1.942 . . . . 10.0 112.972 -175.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.605 ' CB ' ' HB2' ' A' ' 14' ' ' PRO . 0.7 OUTLIER -142.01 88.66 2.12 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.022 0.911 . . . . 10.0 112.089 -177.773 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.642 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -163.75 133.02 3.95 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.898 -1.046 . . . . 10.0 112.514 177.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.566 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 4.5 t 175.07 -42.86 0.0 OUTLIER Pre-proline 0 C--O 1.22 -0.487 0 O-C-N 124.349 1.031 . . . . 10.0 112.615 177.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.7 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 56.5 Cg_endo -99.07 121.45 0.12 Allowed 'Trans proline' 0 N--CA 1.42 -2.845 0 CA-C-N 120.612 1.254 . . . . 10.0 115.24 -159.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.067 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 10.65 -85.19 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 109.907 -3.315 . . . . 10.0 115.26 167.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.805 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 26.2 Cg_exo -25.11 -57.52 0.07 OUTLIER 'Trans proline' 0 CA--C 1.561 1.83 0 C-N-CA 123.543 2.829 . . . . 10.0 115.913 -165.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.805 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 1.0 OUTLIER -86.16 -59.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.363 1.309 0 C-N-CA 123.365 2.71 . . . . 10.0 112.474 171.401 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.664 HG13 HD12 ' A' ' 28' ' ' LEU . 36.7 t -73.95 -43.07 52.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 112.159 -2.292 . . . . 10.0 113.759 -168.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 1.067 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -54.74 -71.8 0.66 Allowed Glycine 0 C--O 1.218 -0.857 0 CA-C-N 114.588 -1.187 . . . . 10.0 113.221 -177.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.619 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 17.1 Cg_exo -46.15 -46.27 16.7 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.52 2.813 . . . . 10.0 112.653 173.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -48.7 -75.25 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.437 0.637 . . . . 10.0 111.375 177.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.699 HD21 ' CD1' ' A' ' 58' ' ' ILE . 5.0 mt -69.65 -46.96 64.94 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 113.512 0.93 . . . . 10.0 113.512 -177.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.43 -40.33 97.49 Favored Glycine 0 C--N 1.32 -0.35 0 CA-C-N 115.462 -0.79 . . . . 10.0 113.481 -172.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -63.44 -27.14 69.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.057 0.456 . . . . 10.0 110.327 178.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -99.11 13.18 33.79 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.379 0.609 . . . . 10.0 110.353 177.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.511 ' O ' ' HE3' ' A' ' 64' ' ' LYS . . . 76.45 11.41 85.15 Favored Glycine 0 CA--C 1.501 -0.799 0 CA-C-N 114.883 -1.053 . . . . 10.0 113.319 171.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.811 HG13 ' CD1' ' A' ' 66' ' ' PHE . 59.6 t -80.92 139.58 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 112.117 0.414 . . . . 10.0 112.117 -172.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.434 ' HB3' ' HB3' ' A' ' 37' ' ' GLU . 0.4 OUTLIER -70.5 100.52 1.81 Allowed 'General case' 0 C--N 1.343 0.284 0 CA-C-O 121.586 0.708 . . . . 10.0 110.875 178.363 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.504 ' CD1' ' HA2' ' A' ' 25' ' ' GLY . 92.9 mt -51.0 -45.9 29.66 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 114.604 -1.18 . . . . 10.0 111.931 175.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.8 mtm -64.73 -54.68 27.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 112.997 -1.91 . . . . 10.0 111.246 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 34' ' ' ASN . 9.1 tp10 -53.37 -44.02 68.25 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 121.172 -0.211 . . . . 10.0 110.432 177.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.59 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 56.7 t80 -59.79 -56.24 24.26 Favored 'General case' 0 C--O 1.213 -0.834 0 N-CA-C 114.052 1.131 . . . . 10.0 114.052 171.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.468 ' SG ' ' HB ' ' A' ' 19' ' ' THR . 0.0 OUTLIER -57.59 -49.79 75.24 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.968 0.907 . . . . 10.0 111.968 -177.739 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -65.46 -21.18 66.61 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 119.471 -0.892 . . . . 10.0 108.853 -176.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.661 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 46.9 mtt180 -78.9 -62.04 1.82 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.221 -0.9 . . . . 10.0 112.652 168.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.621 ' CZ ' HG21 ' A' ' 46' ' ' THR . 79.4 t80 -53.27 -48.4 68.34 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.535 0.683 . . . . 10.0 110.065 -173.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.642 HD21 ' HB3' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -61.16 -47.78 84.61 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.674 -1.148 . . . . 10.0 110.27 -176.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.79 -38.91 92.51 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 119.163 -1.015 . . . . 10.0 112.077 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.661 ' HG2' ' O ' ' A' ' 41' ' ' ARG . 37.1 mm-40 -63.24 -45.84 89.71 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 122.147 0.975 . . . . 10.0 110.303 178.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.648 ' HB ' ' HB1' ' A' ' 15' ' ' ALA . 70.0 p -90.87 -0.48 57.74 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.15 -1.386 . . . . 10.0 112.477 -167.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -46.35 -37.09 7.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.15 -0.932 . . . . 10.0 112.577 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -83.64 -24.76 31.26 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.337 -0.847 . . . . 10.0 111.429 -172.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.7 mtmm -113.23 25.84 10.99 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.54 0.686 . . . . 10.0 109.959 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.458 ' HA ' ' CB ' ' A' ' 15' ' ' ALA . . . -54.13 154.92 3.92 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.39 -1.277 . . . . 10.0 113.257 177.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.95 21.06 40.57 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.574 -1.01 . . . . 10.0 110.574 -177.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.602 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 67.3 mtt -139.47 125.23 19.52 Favored 'General case' 0 C--O 1.209 -1.065 0 C-N-CA 116.866 -1.934 . . . . 10.0 114.653 -166.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.6 mm -66.88 91.39 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 109.409 -0.589 . . . . 10.0 109.409 172.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.613 HD12 ' CG2' ' A' ' 46' ' ' THR . 7.2 mt -82.2 131.49 56.07 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.62 -0.511 . . . . 10.0 109.62 -177.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.509 ' HB2' ' HB2' ' A' ' 71' ' ' LYS . 13.5 Cg_exo -72.06 96.04 0.77 Allowed 'Trans proline' 0 C--N 1.331 -0.377 0 C-N-CA 122.5 2.133 . . . . 10.0 111.265 173.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -92.96 157.65 2.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 119.586 1.084 . . . . 10.0 111.579 -174.668 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.497 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 95.2 t -135.39 115.94 18.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.102 -0.499 . . . . 10.0 110.4 173.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.699 ' CD1' HD21 ' A' ' 28' ' ' LEU . 25.5 mt -108.81 138.0 37.98 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.742 0 N-CA-C 107.953 -1.129 . . . . 10.0 107.953 -174.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 88.3 m -123.13 92.83 3.78 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-N 114.845 -1.07 . . . . 10.0 109.102 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.611 HG21 HG22 ' A' ' 33' ' ' VAL . 2.6 p -86.0 134.8 26.43 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 O-C-N 121.258 -0.901 . . . . 10.0 110.817 -177.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -91.98 173.58 7.77 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.748 0.785 . . . . 10.0 112.939 -176.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.524 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 59.7 mt-10 -61.71 -15.98 45.19 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.122 -1.399 . . . . 10.0 112.506 -178.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.61 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 7.1 m-20 -75.52 -17.41 60.1 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.51 -0.476 . . . . 10.0 110.692 177.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 42.1 mtpt 82.41 1.62 1.28 Allowed 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 124.492 1.12 . . . . 10.0 109.993 -160.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.51 ' O ' HG23 ' A' ' 60' ' ' VAL . 28.7 t -73.43 174.32 8.34 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 113.313 -1.767 . . . . 10.0 106.846 173.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.811 ' CD1' HG13 ' A' ' 33' ' ' VAL . 55.7 p90 -169.35 -176.1 2.42 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 122.077 2.217 . . . . 10.0 110.764 177.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.4 p -157.32 174.91 14.71 Favored 'General case' 0 N--CA 1.425 -1.689 0 N-CA-C 103.022 -2.955 . . . . 10.0 103.022 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.444 ' CB ' HG12 ' A' ' 58' ' ' ILE . 35.8 p90 -163.72 157.92 19.69 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.472 -0.936 . . . . 10.0 108.472 177.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.497 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 38.8 pt -127.74 166.99 23.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 106.702 -1.592 . . . . 10.0 106.702 177.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.469 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 8.9 mt -134.17 124.8 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 107.514 -1.291 . . . . 10.0 107.514 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.509 ' HB2' ' HB2' ' A' ' 55' ' ' PRO . 30.4 mmmt -76.93 81.78 3.48 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.721 -0.844 . . . . 10.0 108.721 -176.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.709 ' CG2' ' HA ' ' A' ' 112' ' ' LYS . 1.7 t -50.66 116.5 7.03 Favored Pre-proline 0 C--N 1.312 -1.035 0 N-CA-C 107.057 -1.46 . . . . 10.0 107.057 174.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.706 ' HG3' ' CE1' ' A' ' 77' ' ' PHE . 61.3 Cg_endo -65.87 166.46 20.39 Favored 'Trans proline' 0 CA--C 1.517 -0.331 0 C-N-CA 123.451 2.767 . . . . 10.0 114.939 -153.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.878 ' HA ' HD21 ' A' ' 116' ' ' LEU . 19.7 Cg_exo -67.63 55.67 0.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 123.141 2.56 . . . . 10.0 111.14 170.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.496 ' HB2' HD13 ' A' ' 128' ' ' ILE . . . 75.46 -22.33 0.27 Allowed 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 113.572 0.952 . . . . 10.0 113.572 173.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.2 p -38.06 -78.89 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.571 1.322 . . . . 10.0 114.571 -167.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.706 ' CE1' ' HG3' ' A' ' 73' ' ' PRO . 3.2 p90 -82.51 -18.84 40.13 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.009 0.744 . . . . 10.0 113.009 -173.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.616 ' HB3' HD12 ' A' ' 108' ' ' ILE . 2.7 mm? -67.99 -36.19 79.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.399 0.618 . . . . 10.0 109.765 172.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.714 HD13 ' HB2' ' A' ' 132' ' ' ALA . 27.0 mt -62.56 -39.48 93.78 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 115.683 -0.69 . . . . 10.0 110.837 176.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.497 ' HA ' ' HB3' ' A' ' 83' ' ' ALA . 37.0 ttpt -66.04 -17.4 64.66 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 120.37 -0.532 . . . . 10.0 111.01 176.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.542 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 11.3 mmmm -64.56 -39.47 93.81 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 121.572 -0.705 . . . . 10.0 111.117 169.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 1.02 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -78.5 -56.33 4.52 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.492 1.917 . . . . 10.0 112.277 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.497 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . . . -61.76 119.47 8.8 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 110.825 -2.898 . . . . 10.0 105.844 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.77 6.03 59.87 Favored Glycine 0 N--CA 1.46 0.25 0 CA-C-N 121.814 2.097 . . . . 10.0 110.484 -169.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.631 ' CD1' ' HA3' ' A' ' 98' ' ' GLY . 0.9 OUTLIER -58.48 139.34 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.004 0 C-N-CA 125.317 1.447 . . . . 10.0 114.114 -179.775 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.419 ' O ' ' HB3' ' A' ' 87' ' ' LYS . 0.7 OUTLIER -170.64 51.65 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.945 -1.479 . . . . 10.0 107.283 168.461 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 86' ' ' GLU . 24.1 tptm 90.07 79.46 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.053 -1.43 . . . . 10.0 108.499 -172.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.66 62.56 0.24 Allowed Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.338 -0.847 . . . . 10.0 112.035 -174.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.6 p -168.71 170.54 9.31 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.461 -0.57 . . . . 10.0 109.461 -178.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.9 p -165.98 -79.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.45 0.167 . . . . 10.0 111.037 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.664 ' N ' ' HD2' ' A' ' 92' ' ' PRO . 1.7 mp0 -62.63 -45.29 88.49 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 112.18 0.437 . . . . 10.0 112.18 176.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.754 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 54.7 Cg_exo -25.62 144.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.368 1.6 1 C-N-CA 125.379 4.052 . . . . 10.0 116.166 176.491 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -69.95 138.8 52.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.059 -0.973 . . . . 10.0 110.989 -176.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.84 18.96 8.48 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.266 -0.879 . . . . 10.0 109.568 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.2 tttm 80.58 -9.91 1.31 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 114.581 -1.19 . . . . 10.0 111.19 175.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.807 HG23 ' HA3' ' A' ' 136' ' ' GLY . 1.0 OUTLIER -151.95 109.72 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.749 0 CA-C-O 122.725 1.25 . . . . 10.0 112.802 -178.654 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.754 ' HB ' ' HB3' ' A' ' 92' ' ' PRO . 3.9 p -61.35 -41.42 89.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 117.027 2.232 . . . . 10.0 117.027 177.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.631 ' HA3' ' CD1' ' A' ' 85' ' ' ILE . . . -58.32 160.13 13.89 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 114.593 0.597 . . . . 10.0 114.593 -158.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.863 ' HB3' ' HB3' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -154.79 172.34 18.13 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 115.593 -0.303 . . . . 10.0 111.201 -157.901 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 1.02 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -168.29 114.16 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-O 122.887 1.327 . . . . 10.0 111.869 179.511 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 140' ' ' VAL . 1.2 t -39.78 143.62 0.23 Allowed 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 111.458 -2.61 . . . . 10.0 114.149 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.764 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 26.6 mtt180 -46.34 -32.63 3.28 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 112.243 -2.253 . . . . 10.0 113.732 -170.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.517 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 17.5 tppt? -57.67 -44.22 85.58 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.859 -0.526 . . . . 10.0 111.742 178.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.521 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.6 OUTLIER -56.95 -47.99 79.38 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.603 -0.888 . . . . 10.0 108.603 176.21 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.999 HG23 ' HB ' ' A' ' 128' ' ' ILE . 32.7 mm -43.09 -49.41 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.141 -1.391 . . . . 10.0 111.852 173.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.8 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 28.8 tt0 -46.86 -62.17 1.52 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.093 0.957 . . . . 10.0 113.262 175.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.641 ' HA ' ' HD3' ' A' ' 110' ' ' LYS . 47.7 mt-10 -52.73 -54.8 28.69 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 115.232 -0.895 . . . . 10.0 110.803 -176.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.652 ' O ' HG22 ' A' ' 111' ' ' THR . 24.5 mm -47.42 -55.43 2.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.124 -0.944 . . . . 10.0 110.126 170.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.633 ' O ' ' HE2' ' A' ' 112' ' ' LYS . . . -49.19 -36.95 21.1 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.888 0.699 . . . . 10.0 112.888 176.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.8 ' HG3' ' O ' ' A' ' 106' ' ' GLU . 51.4 mtpt -72.58 -49.24 33.69 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.832 -0.622 . . . . 10.0 111.299 -174.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.652 HG22 ' O ' ' A' ' 108' ' ' ILE . 6.1 t -53.67 -36.57 62.28 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.091 0.404 . . . . 10.0 112.091 -177.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.815 ' HD2' HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -106.71 13.5 27.97 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 113.336 0.865 . . . . 10.0 113.336 -174.792 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.701 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 14.6 ptp -55.2 -39.37 76.69 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 113.056 0.762 . . . . 10.0 113.056 176.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.626 ' HD3' ' HG3' ' A' ' 113' ' ' MET . 73.2 Cg_endo -71.13 -28.94 18.25 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 121.326 1.35 . . . . 10.0 112.112 -179.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -95.88 -42.48 8.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.825 -1.079 . . . . 10.0 113.673 -170.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.878 HD21 ' HA ' ' A' ' 74' ' ' PRO . 1.1 mp -71.16 9.64 0.71 Allowed 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.118 -0.946 . . . . 10.0 113.272 -177.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 63.77 36.44 10.54 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 122.21 1.005 . . . . 10.0 108.529 174.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' A' ' 119' ' ' ASN . . . -69.56 -69.85 0.32 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 113.9 -1.5 . . . . 10.0 113.076 -167.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.431 ' HB3' ' O ' ' A' ' 118' ' ' ALA . 27.3 t-20 100.87 -38.88 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 O-C-N 124.659 1.224 . . . . 10.0 110.412 -178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 89.2 p -145.92 144.76 30.37 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.023 -1.473 . . . . 10.0 107.023 177.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.574 ' O ' ' HG3' ' A' ' 125' ' ' MET . 50.8 tp -58.59 -41.98 87.02 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 112.915 0.709 . . . . 10.0 112.915 178.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -48.23 -43.64 32.45 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.394 0.616 . . . . 10.0 109.687 174.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.59 ' O ' ' HG3' ' A' ' 126' ' ' LYS . . . -62.88 -51.93 65.09 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.624 -1.171 . . . . 10.0 111.292 173.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.716 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -55.34 -30.49 60.38 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.252 -0.905 . . . . 10.0 111.652 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.574 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 83.4 mtp -61.55 -46.33 90.35 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.791 1.034 . . . . 10.0 113.791 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.74 ' HD3' ' N ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -62.83 -40.02 96.12 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.094 0.405 . . . . 10.0 112.094 -178.04 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.74 ' N ' ' HD3' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -55.11 -59.33 2.5 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 C-N-CA 118.785 -1.166 . . . . 10.0 109.779 174.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.999 ' HB ' HG23 ' A' ' 105' ' ' ILE . 12.9 mm -49.47 -57.85 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 CA-C-N 114.82 -1.082 . . . . 10.0 111.856 -175.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' A' ' 125' ' ' MET . 6.8 pt-20 -55.77 -44.71 77.97 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.118 -0.633 . . . . 10.0 109.948 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -69.15 -49.2 41.81 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.601 -0.727 . . . . 10.0 112.396 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.514 HG21 ' O ' ' A' ' 74' ' ' PRO . 44.9 m -45.72 -62.04 1.46 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.853 -0.673 . . . . 10.0 109.904 171.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.714 ' HB2' HD13 ' A' ' 79' ' ' LEU . . . -49.37 -51.09 36.99 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.222 -0.444 . . . . 10.0 111.235 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -48.29 -48.61 35.74 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 123.911 0.757 . . . . 10.0 111.759 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.1 m -62.53 -39.69 94.38 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.636 0.255 . . . . 10.0 111.254 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.668 ' HG3' HD13 ' A' ' 137' ' ' ILE . 23.6 ptt? -90.63 15.69 10.5 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.477 0.917 . . . . 10.0 113.477 -173.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.807 ' HA3' HG23 ' A' ' 96' ' ' ILE . . . 103.5 -21.78 38.01 Favored Glycine 0 C--N 1.331 0.273 0 CA-C-N 119.627 1.103 . . . . 10.0 112.759 177.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.668 HD13 ' HG3' ' A' ' 135' ' ' MET . 2.0 mp -83.15 128.33 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.04 0 CA-C-O 122.94 1.353 . . . . 10.0 111.33 -169.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.863 ' HB3' ' HB3' ' A' ' 99' ' ' LYS . 3.3 tp10 -85.64 157.93 20.22 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 112.288 -2.233 . . . . 10.0 109.196 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.458 ' N ' ' HG3' ' A' ' 138' ' ' GLU . 17.1 m -116.49 124.73 72.99 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.371 0 N-CA-C 107.59 -1.263 . . . . 10.0 107.59 168.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 101' ' ' THR . 1.8 m -98.28 160.12 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 C-N-CA 119.143 -1.023 . . . . 10.0 109.409 -175.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 C--N 1.297 -1.694 0 CA-C-N 115.059 -0.973 . . . . 10.0 110.085 179.735 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 ppp? . . . . . 0 N--CA 1.484 1.262 0 CA-C-O 119.689 -0.196 . . . . 10.0 110.542 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -41.49 121.59 1.71 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.232 0.613 . . . . 10.0 112.196 -179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.558 ' HB3' ' CG ' ' A' ' 61' ' ' TYR . 80.9 mttt -99.24 119.49 37.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.712 -0.676 . . . . 10.0 112.192 -170.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 62' ' ' GLU . 75.8 mmtt -117.63 142.69 46.93 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.279 -1.008 . . . . 10.0 108.279 167.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.22 129.52 25.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.689 0.28 . . . . 10.0 110.851 -174.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -105.56 -36.3 7.16 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 175.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.541 ' HB3' ' CG1' ' A' ' 60' ' ' VAL . . . -158.91 178.26 10.28 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.177 0.806 . . . . 10.0 113.177 -177.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.53 ' HA ' ' O ' ' A' ' 58' ' ' ILE . 93.9 mt-30 -129.32 132.73 47.17 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.182 -1.372 . . . . 10.0 109.184 174.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.633 ' HB ' ' HB ' ' A' ' 58' ' ' ILE . 0.4 OUTLIER -116.47 81.14 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 N-CA-C 108.452 -0.944 . . . . 10.0 108.452 176.303 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -81.63 123.58 28.81 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 120.256 -1.527 . . . . 10.0 108.412 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.655 HD11 HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -157.7 132.93 8.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.986 0.898 . . . . 10.0 111.881 -173.061 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.404 ' HB3' ' CG2' ' A' ' 53' ' ' ILE . 0.2 OUTLIER -87.13 123.57 32.32 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.726 -1.125 . . . . 10.0 110.815 -172.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.655 HD21 HD11 ' A' ' 11' ' ' LEU . 82.7 mt -138.82 137.94 20.69 Favored Pre-proline 0 C--O 1.218 -0.564 0 CA-C-O 121.51 0.671 . . . . 10.0 112.648 -174.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.8 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 23.6 Cg_exo -58.45 134.18 59.52 Favored 'Trans proline' 0 C--N 1.327 -0.583 0 C-N-CA 124.238 3.292 . . . . 10.0 112.518 174.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.512 ' HB1' ' O ' ' A' ' 46' ' ' THR . . . -56.1 133.93 52.37 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.131 -1.433 . . . . 10.0 107.131 166.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.33 0.06 50.99 Favored Glycine 0 N--CA 1.443 -0.897 0 O-C-N 125.448 1.717 . . . . 10.0 113.449 174.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.8 ' HB2' ' HB2' ' A' ' 14' ' ' PRO . 14.0 mmmm -138.41 77.45 1.63 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.481 1.141 . . . . 10.0 111.017 -178.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.724 ' HB3' HD21 ' A' ' 43' ' ' ASN . . . -156.96 130.73 8.21 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.907 -0.717 . . . . 10.0 112.027 176.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.586 ' HA ' ' HB3' ' A' ' 39' ' ' CYS . 1.5 t -179.27 -41.66 0.0 OUTLIER Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 114.092 -1.413 . . . . 10.0 112.328 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.723 ' O ' ' HD2' ' A' ' 23' ' ' PRO . 98.7 Cg_endo -103.08 127.31 0.09 OUTLIER 'Trans proline' 0 N--CA 1.408 -3.51 0 N-CA-C 115.503 1.309 . . . . 10.0 115.503 -161.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 1.085 ' HA ' ' HA3' ' A' ' 25' ' ' GLY . . . 11.09 -86.54 0.0 OUTLIER Pre-proline 0 C--N 1.295 -1.764 0 CA-C-N 109.12 -3.673 . . . . 10.0 115.605 166.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.906 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 51.3 Cg_exo -30.88 -55.09 0.23 Allowed 'Trans proline' 0 CA--C 1.559 1.773 0 C-N-CA 122.863 2.376 . . . . 10.0 115.74 -162.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.906 ' HD3' ' HB2' ' A' ' 22' ' ' PRO . 5.0 Cg_exo -81.53 -57.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.791 2.327 . . . . 10.0 112.246 171.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.022 HG12 HD12 ' A' ' 35' ' ' ILE . 57.5 t -79.83 -52.01 15.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 112.556 -2.111 . . . . 10.0 114.187 -167.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 1.085 ' HA3' ' HA ' ' A' ' 21' ' ' ALA . . . -50.73 -74.51 0.28 Allowed Glycine 0 C--O 1.216 -0.982 0 CA-C-N 114.831 -1.077 . . . . 10.0 113.537 -176.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.751 ' HD2' ' O ' ' A' ' 21' ' ' ALA . 19.9 Cg_exo -45.01 -43.88 15.29 Favored 'Trans proline' 0 CA--C 1.517 -0.344 0 C-N-CA 123.777 2.985 . . . . 10.0 112.993 174.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 24' ' ' VAL . . . -50.24 -77.23 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.498 0.666 . . . . 10.0 111.271 175.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.772 HD21 ' CD1' ' A' ' 58' ' ' ILE . 3.3 mt -69.65 -48.49 59.64 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.872 1.064 . . . . 10.0 113.872 -176.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.62 -37.21 88.72 Favored Glycine 0 C--N 1.32 -0.353 0 CA-C-N 115.416 -0.811 . . . . 10.0 113.261 -174.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -63.75 -24.92 67.96 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.706 0.289 . . . . 10.0 110.559 176.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -100.47 16.52 24.32 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.652 0.739 . . . . 10.0 109.899 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.14 3.39 88.96 Favored Glycine 0 CA--C 1.5 -0.858 0 CA-C-N 114.549 -1.205 . . . . 10.0 113.59 168.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.864 HG11 ' CD2' ' A' ' 66' ' ' PHE . 2.9 t -80.56 146.45 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 113.664 0.987 . . . . 10.0 113.664 -171.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.919 HD22 ' HG2' ' A' ' 37' ' ' GLU . 54.5 t30 -74.27 104.17 4.94 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.643 0.735 . . . . 10.0 110.973 174.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 1.022 HD12 HG12 ' A' ' 24' ' ' VAL . 22.3 mm -53.91 -38.14 35.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 114.092 -1.413 . . . . 10.0 112.413 177.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.806 ' HA ' ' SG ' ' A' ' 39' ' ' CYS . 0.0 OUTLIER -61.8 -56.83 15.37 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 113.503 -1.68 . . . . 10.0 112.038 176.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.919 ' HG2' HD22 ' A' ' 34' ' ' ASN . 21.1 mm-40 -56.64 -35.28 68.17 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.737 -1.185 . . . . 10.0 110.46 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.621 ' HB2' ' CE2' ' A' ' 66' ' ' PHE . 87.3 t80 -60.11 -60.53 3.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 114.187 1.18 . . . . 10.0 114.187 171.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.806 ' SG ' ' HA ' ' A' ' 36' ' ' MET . 20.9 p -60.84 -47.01 88.3 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.005 -0.998 . . . . 10.0 111.706 -176.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.575 ' HE2' ' HB3' ' A' ' 36' ' ' MET . 52.5 mtmt -63.83 -23.69 67.46 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 119.416 -0.914 . . . . 10.0 109.59 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.762 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 20.3 mtp180 -73.98 -65.09 0.88 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 119.658 -0.817 . . . . 10.0 111.504 168.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.65 ' HZ ' ' HB2' ' A' ' 54' ' ' LEU . 71.4 t80 -54.34 -48.58 71.26 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.17 0.51 . . . . 10.0 110.559 -170.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.724 HD21 ' HB3' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -61.2 -50.89 71.29 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.265 -0.879 . . . . 10.0 110.32 -176.712 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.0 -38.83 87.44 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 118.88 -1.128 . . . . 10.0 111.77 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.762 ' HG3' ' O ' ' A' ' 41' ' ' ARG . 13.3 mt-10 -67.48 -42.52 82.82 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.769 0.795 . . . . 10.0 111.296 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.624 ' CG2' HD12 ' A' ' 54' ' ' LEU . 68.0 p -89.62 -2.17 58.23 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 114.877 -1.056 . . . . 10.0 112.342 -169.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -44.51 -37.54 3.57 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 124.098 0.874 . . . . 10.0 112.696 -174.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -80.8 -21.06 41.23 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.298 -0.864 . . . . 10.0 111.357 -172.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.908 ' HB3' ' HZ ' ' A' ' 77' ' ' PHE . 51.8 mttp -100.97 23.52 10.58 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 123.399 1.571 . . . . 10.0 109.238 -179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . 0.382 . . 49.03 -90.24 0.02 OUTLIER 'General case' 0 CA--C 1.47 -2.122 0 N-CA-C 119.641 3.2 . . . . 10.0 119.641 165.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -137.99 76.6 0.35 Allowed Glycine 0 N--CA 1.429 -1.822 0 N-CA-C 109.9 -1.28 . . . . 10.0 109.9 -171.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.756 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 24.9 mmt -138.61 126.38 22.24 Favored 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 116.907 -1.917 . . . . 10.0 114.177 -164.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.404 ' CG2' ' HB3' ' A' ' 12' ' ' GLN . 32.2 mm -64.7 85.53 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 109.432 -0.581 . . . . 10.0 109.432 175.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.65 ' HB2' ' HZ ' ' A' ' 42' ' ' PHE . 9.8 mt -80.88 132.3 57.68 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 109.434 -0.58 . . . . 10.0 109.434 -175.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 54' ' ' LEU . 16.1 Cg_exo -71.33 93.91 0.66 Allowed 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.753 2.302 . . . . 10.0 111.888 176.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.45 HG12 ' H ' ' A' ' 11' ' ' LEU . 0.5 OUTLIER -92.69 154.66 3.18 Favored 'Isoleucine or valine' 0 C--N 1.345 0.383 0 CA-C-N 119.081 0.855 . . . . 10.0 111.236 -174.591 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.434 ' HB ' ' CG1' ' A' ' 69' ' ' ILE . 90.3 t -134.68 116.22 20.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.332 -0.395 . . . . 10.0 110.181 172.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.772 ' CD1' HD21 ' A' ' 28' ' ' LEU . 16.1 mt -105.62 140.24 24.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 108.16 -1.052 . . . . 10.0 108.16 -173.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.8 m -124.52 95.38 4.51 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 114.927 -1.033 . . . . 10.0 108.611 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 65' ' ' SER . 3.5 p -85.28 137.52 20.69 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 CA-C-N 119.167 0.894 . . . . 10.0 110.827 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.558 ' CG ' ' HB3' ' A' ' 3' ' ' LYS . 85.0 m-85 -95.91 170.87 9.0 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 112.855 0.687 . . . . 10.0 112.855 -177.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 4' ' ' LYS . 24.5 mt-10 -60.89 -20.98 62.86 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.688 -1.142 . . . . 10.0 112.259 -178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.526 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 7.2 t70 -73.96 -15.35 61.11 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.137 -0.938 . . . . 10.0 110.934 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 44.5 mtpt 84.54 0.77 0.87 Allowed 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 114.722 -1.127 . . . . 10.0 110.782 -169.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.582 ' O ' HG23 ' A' ' 60' ' ' VAL . 8.8 p -73.85 -177.08 2.67 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 114.87 -1.059 . . . . 10.0 108.777 170.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.864 ' CD2' HG11 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -170.22 -176.92 2.35 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 120.38 1.446 . . . . 10.0 109.483 176.171 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.1 p -159.44 173.04 16.82 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 103.127 -2.916 . . . . 10.0 103.127 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.451 ' CB ' HG12 ' A' ' 58' ' ' ILE . 47.8 p90 -164.48 162.74 22.08 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 109.361 -0.607 . . . . 10.0 109.361 175.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.434 ' CG1' ' HB ' ' A' ' 57' ' ' VAL . 24.9 pt -130.71 167.73 25.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 107.206 -1.405 . . . . 10.0 107.206 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.532 ' CG2' ' HB3' ' A' ' 54' ' ' LEU . 4.3 mt -137.24 121.98 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 108.058 -1.09 . . . . 10.0 108.058 -178.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -84.46 72.63 10.6 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.073 -0.714 . . . . 10.0 109.073 -176.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.425 ' HA ' ' HD2' ' A' ' 73' ' ' PRO . 6.7 t -30.98 99.09 0.12 Allowed Pre-proline 0 C--N 1.318 -0.796 0 O-C-N 126.078 2.111 . . . . 10.0 110.762 176.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.668 ' HG2' ' HD2' ' A' ' 77' ' ' PHE . 3.3 Cg_endo -47.1 139.26 15.49 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 124.237 3.291 . . . . 10.0 114.214 -163.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.736 ' HA ' HD11 ' A' ' 116' ' ' LEU . 94.9 Cg_exo -20.8 -79.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.844 1 C-N-CA 126.245 4.63 . . . . 10.0 115.387 -168.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.615 ' HB3' HG21 ' A' ' 131' ' ' THR . . . -143.48 -39.01 0.32 Allowed 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.033 -0.667 . . . . 10.0 111.501 -178.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.774 ' HA ' ' HE1' ' A' ' 135' ' ' MET . 1.7 p -41.96 -56.15 2.88 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 124.221 0.951 . . . . 10.0 112.697 -174.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.908 ' HZ ' ' HB3' ' A' ' 49' ' ' LYS . 0.7 OUTLIER -53.87 -65.93 0.48 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.012 -0.54 . . . . 10.0 112.242 -179.378 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.706 HD23 ' HE2' ' A' ' 112' ' ' LYS . 1.3 mm? -76.88 -12.62 59.98 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.25 -0.98 . . . . 10.0 111.789 -172.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 79' ' ' LEU . 13.5 mt -67.15 -30.55 70.56 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.106 -0.702 . . . . 10.0 109.106 168.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 76' ' ' SER . 98.1 mttt -64.37 -23.65 67.37 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.481 171.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 78' ' ' LEU . 6.7 mmmt -63.48 -48.01 79.39 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.432 0.53 . . . . 10.0 112.432 170.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 1.049 ' HB1' HG11 ' A' ' 100' ' ' VAL . . . -68.59 -41.0 80.25 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.373 1.869 . . . . 10.0 111.665 174.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.535 ' HB1' HG23 ' A' ' 85' ' ' ILE . . . -79.84 156.83 27.19 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 111.644 -2.525 . . . . 10.0 108.081 -177.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -95.0 12.41 68.49 Favored Glycine 0 N--CA 1.463 0.454 0 C-N-CA 118.493 -1.813 . . . . 10.0 111.754 172.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.782 HG22 HG22 ' A' ' 97' ' ' VAL . 23.7 pt -69.66 35.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 114.903 1.445 . . . . 10.0 114.903 -172.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 4.7 tt0 -71.35 9.75 0.73 Allowed 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.638 -0.664 . . . . 10.0 112.296 -177.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -167.05 -28.86 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 O-C-N 122.179 -0.326 . . . . 10.0 110.97 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 131.44 159.82 9.62 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.396 -0.907 . . . . 10.0 112.533 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.3 m -163.69 158.68 20.68 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.742 -0.466 . . . . 10.0 109.742 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.9 p -159.14 18.23 0.18 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.65 0.738 . . . . 10.0 109.291 175.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.447 ' O ' ' HE2' ' A' ' 93' ' ' LYS . 2.2 mm-40 -65.6 -47.12 68.13 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 114.445 -1.252 . . . . 10.0 111.913 -174.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -54.48 -28.84 56.58 Favored 'Trans proline' 0 C--N 1.361 1.192 0 C-N-CA 122.437 2.091 . . . . 10.0 113.152 178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 91' ' ' GLU . 40.5 mtmt 60.19 73.69 0.47 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.394 0.616 . . . . 10.0 111.505 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 4.1 tpp180 -164.68 21.81 0.06 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.784 -0.821 . . . . 10.0 108.784 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 9.3 mptt 74.04 -17.81 0.43 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.325 -0.852 . . . . 10.0 111.335 -171.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 136' ' ' GLY . 5.7 pt -82.7 174.43 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 C-N-CA 120.163 -0.615 . . . . 10.0 110.401 -176.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.782 HG22 HG22 ' A' ' 85' ' ' ILE . 4.8 p -150.88 -54.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 115.907 -0.588 . . . . 10.0 111.772 -163.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.777 ' H ' HG13 ' A' ' 97' ' ' VAL . . . -113.31 162.43 12.37 Favored Glycine 0 CA--C 1.495 -1.157 0 N-CA-C 108.714 -1.754 . . . . 10.0 108.714 166.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.799 ' HB2' ' HG2' ' A' ' 138' ' ' GLU . 11.3 ptpt -151.58 156.17 39.92 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-O 122.41 1.1 . . . . 10.0 109.574 168.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 1.049 HG11 ' HB1' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -160.0 -144.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-N 112.278 -2.237 . . . . 10.0 106.538 -168.158 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.495 ' H ' ' HB ' ' A' ' 100' ' ' VAL . 0.1 OUTLIER -165.19 146.91 7.68 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 108.359 -0.978 . . . . 10.0 108.359 -155.294 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.722 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 1.6 mmt85 -43.97 -40.94 5.0 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 124.219 0.95 . . . . 10.0 111.638 -175.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 106' ' ' GLU . 2.1 tmtt? -55.54 -50.59 69.61 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.133 0.492 . . . . 10.0 111.621 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.634 ' O ' HG12 ' A' ' 108' ' ' ILE . 18.5 mm-40 -62.28 -44.94 95.37 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 108.665 -0.865 . . . . 10.0 108.665 -178.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.722 ' HB ' ' O ' ' A' ' 102' ' ' ARG . 38.9 mm -41.07 -54.64 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 114.297 -1.32 . . . . 10.0 111.596 166.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.694 ' O ' ' HG3' ' A' ' 110' ' ' LYS . 45.5 tt0 -49.79 -53.16 26.92 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.803 0.841 . . . . 10.0 112.359 177.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.702 ' HA ' ' HD2' ' A' ' 110' ' ' LYS . 47.3 mm-40 -51.74 -55.56 18.94 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 114.958 -1.019 . . . . 10.0 109.996 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.634 HG12 ' O ' ' A' ' 104' ' ' GLN . 10.5 mm -49.61 -58.51 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.285 -0.87 . . . . 10.0 110.098 172.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.454 ' HB1' ' HB3' ' A' ' 124' ' ' ALA . . . -50.8 -33.56 23.98 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.032 0.753 . . . . 10.0 113.032 -178.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.702 ' HD2' ' HA ' ' A' ' 107' ' ' GLU . 53.7 mttm -67.52 -57.24 6.85 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.915 0.864 . . . . 10.0 109.165 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 90.5 m -53.42 -36.07 61.11 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 113.716 -1.584 . . . . 10.0 111.995 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.706 ' HE2' HD23 ' A' ' 78' ' ' LEU . 32.3 mmtp -96.45 -7.88 33.71 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.741 0.645 . . . . 10.0 112.741 -173.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.412 ' N ' ' HD2' ' A' ' 114' ' ' PRO . 43.4 ttm -39.18 -49.28 4.45 Favored Pre-proline 0 CA--C 1.532 0.282 0 O-C-N 123.565 0.54 . . . . 10.0 112.386 175.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 113' ' ' MET . 61.6 Cg_endo -70.61 -23.45 26.89 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 120.991 1.128 . . . . 10.0 113.625 -177.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -88.21 -53.34 4.75 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.108 0.48 . . . . 10.0 110.991 -178.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.736 HD11 ' HA ' ' A' ' 74' ' ' PRO . 1.6 mp -65.02 34.3 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.153 -1.385 . . . . 10.0 113.018 -175.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 19.78 51.86 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 O-C-N 124.51 1.131 . . . . 10.0 111.816 -167.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.433 ' O ' ' CB ' ' A' ' 119' ' ' ASN . . . -66.3 -79.13 0.05 OUTLIER 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 113.62 0.97 . . . . 10.0 113.62 -165.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 118' ' ' ALA . 3.1 t-20 101.94 -42.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 O-C-N 125.527 1.767 . . . . 10.0 108.947 -172.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.3 t -146.72 145.29 29.92 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.004 -1.11 . . . . 10.0 108.004 176.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.449 ' O ' ' HG3' ' A' ' 125' ' ' MET . 0.6 OUTLIER -51.68 -46.04 63.68 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.514 -0.766 . . . . 10.0 112.729 -179.132 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.517 ' H ' ' CD ' ' A' ' 122' ' ' GLU . 2.4 mp0 -50.22 -37.39 35.17 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.597 0.713 . . . . 10.0 110.781 178.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.38 -47.05 65.41 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 118.429 -1.308 . . . . 10.0 111.143 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.738 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -57.71 -34.88 69.94 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.66 -0.7 . . . . 10.0 110.769 175.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.449 ' HG3' ' O ' ' A' ' 121' ' ' LEU . 7.7 mtt -53.74 -40.77 66.43 Favored 'General case' 0 N--CA 1.463 0.186 0 O-C-N 121.985 -0.447 . . . . 10.0 112.01 176.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -62.06 -51.83 66.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.017 -0.538 . . . . 10.0 111.761 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.7 HD12 ' CD2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -53.47 -56.67 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 119.81 -0.756 . . . . 10.0 110.475 177.459 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.738 HG12 ' O ' ' A' ' 124' ' ' ALA . 11.8 mm -50.74 -51.49 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 CA-C-N 115.138 -0.937 . . . . 10.0 110.949 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 125' ' ' MET . 49.4 mt-10 -51.97 -42.72 63.14 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 120.44 -0.504 . . . . 10.0 110.087 177.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 133' ' ' LYS . . . -69.79 -49.65 34.65 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.612 -0.804 . . . . 10.0 111.358 -175.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.615 HG21 ' HB3' ' A' ' 75' ' ' ALA . 99.2 m -49.26 -60.5 2.76 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.267 -0.966 . . . . 10.0 109.827 173.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -49.21 -50.04 40.08 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.433 -0.349 . . . . 10.0 111.358 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 130' ' ' GLY . 88.1 tttt -45.7 -59.27 2.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.553 -0.748 . . . . 10.0 111.951 174.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.1 t -65.04 -28.07 69.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.801 0.334 . . . . 10.0 111.305 -176.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.774 ' HE1' ' HA ' ' A' ' 76' ' ' SER . 54.0 mtm -80.43 -6.14 57.62 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.936 0.717 . . . . 10.0 112.936 -177.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.473 ' O ' ' HB ' ' A' ' 96' ' ' ILE . . . 82.83 29.15 35.78 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 118.966 0.803 . . . . 10.0 111.852 -177.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 98' ' ' GLY . 8.4 mt -112.69 123.75 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.256 0 CA-C-O 121.608 0.718 . . . . 10.0 110.764 177.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.799 ' HG2' ' HB2' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -84.84 150.61 24.89 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.552 -1.204 . . . . 10.0 109.633 -179.13 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 18.2 m -115.43 131.26 68.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.052 -1.092 . . . . 10.0 108.052 170.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 100' ' ' VAL . 30.6 m -123.63 62.84 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 114.657 1.354 . . . . 10.0 114.657 -177.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.462 ' OXT' ' HB2' ' A' ' 102' ' ' ARG . 9.6 t70 . . . . . 0 C--N 1.291 -1.943 0 CA-C-N 114.303 -1.317 . . . . 10.0 109.627 143.186 . . . . . . . . 1 1 . 1 stop_ save_